PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Buckwell, C; Fava, GA				Buckwell, Charlie; Fava, Giovanni A.			Should the drug industry use key opinion leaders?	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Buckwell, Charlie] Complete Med Grp, Macclesfield SK10 1AQ, Cheshire, England; [Fava, Giovanni A.] Univ Bologna, Bologna, Italy	University of Bologna	Buckwell, C (corresponding author), Complete Med Grp, Macclesfield SK10 1AQ, Cheshire, England.	Charlie.Buckwetl@complete-grp.com; giovanniandrea.fava@unibo.it							0	14	14	1	10	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 21	2008	336	7658					1404	1405		10.1136/bmj.39541.702870.59	http://dx.doi.org/10.1136/bmj.39541.702870.59			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	318WJ	18566075	Green Published			2022-12-28	WOS:000257123200027
J	Green, M; Drife, JO				Green, Malcolm; Drife, James Owen			Are international medical conferences an outdated luxury the planet can't afford?	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Green, Malcolm] Univ London Imperial Coll Sci Technol & Med, London SW8 2EF, England; [Drife, James Owen] Univ Leeds, Gen Infirm, Leeds LS1 3EX, W Yorkshire, England	Imperial College London; Leeds General Infirmary; University of Leeds	Green, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, London SW8 2EF, England.	malcolm@malcolmgreen.net; j.o.drife@leeds.ac.uk							0	43	44	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 28	2008	336	7659					1466	1467		10.1136/bmj.a358	http://dx.doi.org/10.1136/bmj.a358			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	324GN	18583676	Green Published			2022-12-28	WOS:000257505900031
J	Warne, T; Serrano-Vega, MJ; Baker, JG; Moukhametzianov, R; Edwards, PC; Henderson, R; Leslie, AGW; Tate, CG; Schertler, GFX				Warne, Tony; Serrano-Vega, Maria J.; Baker, Jillian G.; Moukhametzianov, Rouslan; Edwards, Patricia C.; Henderson, Richard; Leslie, Andrew G. W.; Tate, Christopher G.; Schertler, Gebhard F. X.			Structure of a beta(1)-adrenergic G-protein-coupled receptor	NATURE			English	Article							2ND EXTRACELLULAR LOOP; BETA-ADRENERGIC-RECEPTORS; HIGH-AFFINITY BINDING; BETA(2)-ADRENERGIC RECEPTOR; CRYSTAL-STRUCTURE; BETA-1-ADRENERGIC RECEPTOR; MUSCARINIC RECEPTOR; AGONIST ACTIVATION; PROVIDE EVIDENCE; AMINO-ACIDS	G-protein-coupled receptors have a major role in transmembrane signalling in most eukaryotes and many are important drug targets. Here we report the 2.7 angstrom resolution crystal structure of a beta(1)-adrenergic receptor in complex with the high-affinity antagonist cyanopindolol. The modified turkey (Meleagris gallopavo) receptor was selected to be in its antagonist conformation and its thermostability improved by earlier limited mutagenesis. The ligand-binding pocket comprises 15 side chains from amino acid residues in 4 transmembrane alpha-helices and extracellular loop 2. This loop defines the entrance of the ligand-binding pocket and is stabilized by two disulphide bonds and a sodium ion. Binding of cyanopindolol to the beta(1)-adrenergic receptor and binding of carazolol to the beta(2)-adrenergic receptor involve similar interactions. A short well-defined helix in cytoplasmic loop 2, not observed in either rhodopsin or the beta(2)-adrenergic receptor, directly interacts by means of a tyrosine with the highly conserved DRY motif at the end of helix 3 that is essential for receptor activation.	[Warne, Tony; Serrano-Vega, Maria J.; Moukhametzianov, Rouslan; Edwards, Patricia C.; Henderson, Richard; Leslie, Andrew G. W.; Tate, Christopher G.; Schertler, Gebhard F. X.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Baker, Jillian G.] Univ Nottingham, Inst Cell Signalling, Sch Med, Queens Med Ctr, Nottingham NG7 2UH, England	MRC Laboratory Molecular Biology; University of Nottingham	Tate, CG (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	cgt@mrc-lmb.cam.ac.uk; gfx@mrc-lmb.cam.ac.uk	Schertler, Gebhard/M-9512-2014; soler, martha maricel m gomez/L-6025-2014	soler, martha maricel m gomez/0000-0002-4412-8108; Warne, Tony/0000-0001-9646-6080; Schertler, Gebhard F.X./0000-0002-5846-6810; baker, jillian/0000-0003-2371-8202; Tate, Christopher/0000-0002-2008-9183	MRC [MC_U105184325, MC_U105178937, MC_U105184322] Funding Source: UKRI; Medical Research Council [MC_U105178937, MC_U105184322, MC_U105184325, U.1051.04.020(78937)] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Avlani VA, 2007, J BIOL CHEM, V282, P25677, DOI 10.1074/jbc.M702311200; Baker JG, 2005, BRIT J PHARMACOL, V144, P317, DOI 10.1038/sj.bjp.0706048; Baker JG, 2003, MOL PHARMACOL, V64, P1357, DOI 10.1124/mol.64.6.1357; Baker JG, 2003, MOL PHARMACOL, V63, P1312, DOI 10.1124/mol.63.6.1312; Baker JG, 2005, J PHARMACOL EXP THER, V313, P1163, DOI 10.1124/jpet.104.082875; Baldwin JM, 1997, J MOL BIOL, V272, P144, DOI 10.1006/jmbi.1997.1240; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; BLACK JW, 1989, ANGEW CHEM INT EDIT, V28, P886, DOI 10.1002/anie.198908861; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Burstein ES, 1998, J BIOL CHEM, V273, P24322, DOI 10.1074/jbc.273.38.24322; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; DONALDSON J, 1988, BIOCHEM PHARMACOL, V37, P715, DOI 10.1016/0006-2952(88)90146-3; Elling CE, 1999, P NATL ACAD SCI USA, V96, P12322, DOI 10.1073/pnas.96.22.12322; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Foord SM, 2005, PHARMACOL REV, V57, P279, DOI 10.1124/pr.57.2.5; Fredriksson R, 2005, MOL PHARMACOL, V67, P1414, DOI 10.1124/mol.104.009001; Gether U, 1997, J BIOL CHEM, V272, P2587, DOI 10.1074/jbc.272.5.2587; Harding MM, 2002, ACTA CRYSTALLOGR D, V58, P872, DOI 10.1107/S0907444902003712; Hubbell WL, 2003, ADV PROTEIN CHEM, V63, P243; Isogaya M, 1998, MOL PHARMACOL, V54, P616; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kikkawa H, 1998, MOL PHARMACOL, V53, P128, DOI 10.1124/mol.53.1.128; Klco JM, 2005, NAT STRUCT MOL BIOL, V12, P320, DOI 10.1038/nsmb913; Lattion AL, 1999, FEBS LETT, V457, P302, DOI 10.1016/S0014-5793(99)01064-9; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Liapakis G, 2000, J BIOL CHEM, V275, P37779, DOI 10.1074/jbc.M002092200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PARKER EM, 1991, J BIOL CHEM, V266, P519; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Riekel C, 2005, CURR OPIN STRUC BIOL, V15, P556, DOI 10.1016/j.sbi.2005.08.013; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; SAMAMA P, 1994, MOL PHARMACOL, V45, P390; Sato T, 1999, BRIT J PHARMACOL, V128, P272, DOI 10.1038/sj.bjp.0702813; Scarselli M, 2007, J BIOL CHEM, V282, P7385, DOI 10.1074/jbc.M610394200; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105; Shi L, 2004, P NATL ACAD SCI USA, V101, P440, DOI 10.1073/pnas.2237265100; Standfuss J, 2007, J MOL BIOL, V372, P1179, DOI 10.1016/j.jmb.2007.03.007; STRADER CD, 1989, J BIOL CHEM, V264, P13572; Sugimoto Y, 2002, J PHARMACOL EXP THER, V301, P51, DOI 10.1124/jpet.301.1.51; Voigtlander U, 2003, MOL PHARMACOL, V64, P21, DOI 10.1124/mol.64.1.21; Warne T, 2003, BBA-BIOMEMBRANES, V1610, P133, DOI 10.1016/S0005-2736(02)00716-2; WESS J, 1990, MOL PHARMACOL, V38, P517; WONG SKF, 1994, J BIOL CHEM, V269, P18968; WONG SKF, 1990, J BIOL CHEM, V265, P6219; YARDEN Y, 1986, P NATL ACAD SCI USA, V83, P6795, DOI 10.1073/pnas.83.18.6795	52	1195	1240	2	161	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2008	454	7203					486	491		10.1038/nature07101	http://dx.doi.org/10.1038/nature07101			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329IC	18594507	Green Accepted			2022-12-28	WOS:000257860300044
J	Ruiz, JR; Sui, X; Lobelo, F; Morrow, JR; Jackson, AW; Sjostrom, M; Blair, SN				Ruiz, Jonatan R.; Sui, Xuemei; Lobelo, Felipe; Morrow, James R., Jr.; Jackson, Allen W.; Sjostrom, Michael; Blair, Steven N.			Association between muscular strength and mortality in men: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ALL-CAUSE MORTALITY; OPTIMAL GRIP SPAN; BODY-MASS INDEX; CARDIORESPIRATORY FITNESS; CARDIOVASCULAR-DISEASE; PHYSICAL-ACTIVITY; MUSCLE STRENGTH; METABOLIC SYNDROME; RESISTANCE EXERCISE; CLINICAL-CARDIOLOGY	Objective To examine prospectively the association between muscular strength and mortality from all causes, cardiovascular disease, and cancer in men. Design Prospective cohort study. Setting Aerobics centre longitudinal study. Participants 8762 men aged 20-80. Main outcome measures All cause mortality up to 31 December 2003; muscular strength, quantified by combining one repetition maximal measures for leg and bench presses and further categorised as age specific thirds of the combined strength variable; and cardiorespiratory fitness assessed by a maximal exercise test on a treadmill. Results During an average follow-up of 18.9 years, 503 deaths occurred (145 cardiovascular disease, 199 cancer). Age adjusted death rates per 10 000 person years across incremental thirds of muscular strength were 38.9, 25.9, and 26.6 for all causes; 12.1, 7.6, and 6.6 for cardiovascular disease; and 6.1, 4.9, and 4.2 for cancer (all P<0.01 for linear trend). After adjusting for age, physical activity, smoking, alcohol intake, body mass index, baseline medical conditions, and family history of cardiovascular disease, hazard ratios across incremental thirds of muscular strength for all cause mortality were 1.0 (referent), 0.72 (95% confidence interval 0.58 to 0.90), and 0.77 (0.62 to 0.96); for death from cardiovascular disease were 1.0 (referent), 0.74 (0.50 to 1.10), and 0.71 (0.47 to 1.07); and for death from cancer were 1.0 (referent), 0.72 (0.51 to 1.00), and 0.68 (0.48 to 0.97). The pattern of the association between muscular strength and death from all causes and cancer persisted after further adjustment for cardiorespiratory fitness; however, the association between muscular strength and death from cardiovascular disease was attenuated after further adjustment for cardiorespiratory fitness. Conclusion Muscular strength is inversely and independently associated with death from ail causes and cancer in men, even after adjusting for cardiorespiratory fitness and other potential confounders.	[Ruiz, Jonatan R.; Sjostrom, Michael] Karolinska Inst, Dept Biosci & Nutr, Novum, Unit Prevent Nutr, Huddinge, Sweden; [Ruiz, Jonatan R.] Univ Granada, Sch Med, Dept Physiol, Granada, Spain; [Sui, Xuemei; Lobelo, Felipe; Blair, Steven N.] Univ S Carolina, Dept Exercise Sci, Arnold Sch Publ Hlth, Columbia, SC 29208 USA; [Morrow, James R., Jr.; Jackson, Allen W.; Blair, Steven N.] Univ N Texas, Dept Kinesiol Hlth Promot & Recreat, Denton, TX 76203 USA	Karolinska Institutet; University of Granada; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of North Texas System; University of North Texas Denton	Ruiz, JR (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Novum, Unit Prevent Nutr, Huddinge, Sweden.	ruizj@ugr.es	RUIZ, JONATAN R/M-1338-2015; lobelo, felipe/B-9148-2013; Lobelo, R.L Felipe/AAB-2264-2021	RUIZ, JONATAN R/0000-0002-7548-7138; Lobelo, R.L Felipe/0000-0003-4185-7193	NHLBI NIH HHS [HL62508] Funding Source: Medline; NIA NIH HHS [AG06945] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG006945, R37AG006945] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Al Snih S, 2002, J AM GERIATR SOC, V50, P1250, DOI 10.1046/j.1532-5415.2002.50312.x; Alley DE, 2007, JAMA-J AM MED ASSOC, V298, P2020, DOI 10.1001/jama.298.17.2020; *AM COLL SPORTS ME, 2005, ACSMS GUID EX TEST P; Baik I, 2000, AM J EPIDEMIOL, V152, P264, DOI 10.1093/aje/152.3.264; BALKE B, 1959, U S Armed Forces Med J, V10, P675; BLAIR SN, 1995, JAMA-J AM MED ASSOC, V273, P1093, DOI 10.1001/jama.273.14.1093; Blair SN, 1996, JAMA-J AM MED ASSOC, V276, P205, DOI 10.1001/jama.276.3.205; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; Blair SN, 2004, J PHYS ACT HEALTH, V1, P7, DOI DOI 10.1123/JPAH.1.1.7; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; EKELUND LG, 1988, NEW ENGL J MED, V319, P1379, DOI 10.1056/NEJM198811243192104; Espana-Romero V, 2008, J HAND SURG-AM, V33A, P378, DOI 10.1016/j.jhsa.2007.11.013; Fleg JL, 2005, CIRCULATION, V112, P674, DOI 10.1161/CIRCULATIONAHA.105.545459; FUJITA Y, 1995, J CLIN EPIDEMIOL, V48, P1349, DOI 10.1016/0895-4356(95)00533-1; Gale CR, 2007, INT J EPIDEMIOL, V36, P228, DOI 10.1093/ije/dyl224; Gibbons LW, 2000, AM J CARDIOL, V86, P53, DOI 10.1016/S0002-9149(00)00827-4; Gulati M, 2005, NEW ENGL J MED, V353, P468, DOI 10.1056/NEJMoa044154; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hughes VA, 2001, J GERONTOL A-BIOL, V56, pB209, DOI 10.1093/gerona/56.5.B209; Jurca R, 2005, MED SCI SPORT EXER, V37, P1849, DOI 10.1249/01.mss.0000175865.17614.74; Jurca R, 2004, MED SCI SPORT EXER, V36, P1301, DOI 10.1249/01.MSS.0000135780.88930.A9; Katzmarzyk PT, 2002, MED SCI SPORT EXER, V34, P740, DOI 10.1097/00005768-200205000-00002; Kraemer WJ, 2002, MED SCI SPORT EXER, V34, P364, DOI 10.1097/00005768-200202000-00027; LAUKKANEN P, 1995, AGE AGEING, V24, P468, DOI 10.1093/ageing/24.6.468; Lee CD, 1999, AM J CLIN NUTR, V69, P373; Metter EJ, 2002, J GERONTOL A-BIOL, V57, pB359, DOI 10.1093/gerona/57.10.B359; Mora S, 2003, JAMA-J AM MED ASSOC, V290, P1600, DOI 10.1001/jama.290.12.1600; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Newman AB, 2006, J GERONTOL A-BIOL, V61, P72, DOI 10.1093/gerona/61.1.72; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; PHILLIPS P, 1986, AGE AGEING, V15, P53, DOI 10.1093/ageing/15.1.53; Pickering TG, 2005, CIRCULATION, V111, P697, DOI 10.1161/01.CIR.0000154900.76284.F6; POLLOCK ML, 1976, AM HEART J, V92, P39, DOI 10.1016/S0002-8703(76)80401-2; Pollock ML, 2000, CIRCULATION, V101, P828, DOI 10.1161/01.CIR.101.7.828; Rantanen T, 2000, J GERONTOL A-BIOL, V55, pM168, DOI 10.1093/gerona/55.3.M168; Rantanen T, 1997, J AM GERIATR SOC, V45, P1439, DOI 10.1111/j.1532-5415.1997.tb03193.x; Rantanen T, 2003, J AM GERIATR SOC, V51, P636, DOI 10.1034/j.1600-0579.2003.00207.x; Rantanen T., 2016, J AGING PHYS ACTIV, V2, P206, DOI 10.1123/japa.2.3.206; Ruiz LR, 2006, J HAND SURG-AM, V31A, P1367, DOI 10.1016/j.jhsa.2006.06.014; Ruiz-Ruiz J, 2002, J HAND SURG-AM, V27A, P897, DOI 10.1053/jhsu.2002.34315; Sasaki H, 2007, AM J MED, V120, P337, DOI 10.1016/j.amjmed.2006.04.018; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; Stump CS, 2006, ANN MED, V38, P389, DOI 10.1080/07853890600888413; Sui XM, 2007, JAMA-J AM MED ASSOC, V298, P2507, DOI 10.1001/jama.298.21.2507; Sui XM, 2007, AM J HYPERTENS, V20, P608, DOI 10.1016/j.amjhyper.2007.01.009; Sui XM, 2007, AM J EPIDEMIOL, V165, P1413, DOI 10.1093/aje/kwm031; Swallow EB, 2007, THORAX, V62, P115, DOI 10.1136/thx.2006.062026; Thomis MAI, 1998, MED SCI SPORT EXER, V30, P724, DOI 10.1097/00005768-199805000-00013; Wei M, 1999, JAMA-J AM MED ASSOC, V282, P1547, DOI 10.1001/jama.282.16.1547; Williams MA, 2007, CIRCULATION, V116, P572, DOI 10.1161/CIRCULATIONAHA.107.185214; Wolfe RR, 2006, AM J CLIN NUTR, V84, P475, DOI 10.1093/ajcn/84.3.475	52	514	525	1	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 12	2008	337	7661							a439	10.1136/bmj.a439	http://dx.doi.org/10.1136/bmj.a439			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	330SA	18595904	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000257961900033
J	Sideris, PJ; Nielsen, UG; Gan, ZH; Grey, CP				Sideris, Paul J.; Nielsen, Ulla Gro; Gan, Zhehong; Grey, Clare P.			Mg/Al ordering in layered double hydroxides revealed by multinuclear NMR spectroscopy	SCIENCE			English	Article							HYDROTALCITE-LIKE COMPOUNDS; NUCLEAR-MAGNETIC-RESONANCE; STATE MG-25 NMR; MAS NMR; THERMAL-DECOMPOSITION; MINERALS; MG(OH)2; ANIONS; AL-27; SPINS	The anion- exchange ability of layered double hydroxides ( LDHs) has been exploited to create materials for use in catalysis, drug delivery, and environmental remediation. The specific cation arrangements in the hydroxide layers of hydrotalcite- like LDHs, of general formula Mg(1-x)(2+)Al(x)(3+)OH(2)(Anion(x/n)(n-)).yH(2)O, have, however, remained elusive, and their elucidation could enhance the functional optimization of these materials. We applied rapid ( 60 kilohertz) magic angle spinning ( MAS) to obtain high- resolution hydrogen- 1 nuclear magnetic resonance ( (1)H NMR) spectra and characterize the magnesium and aluminum distribution. These data, in combination with (1)H-(27)Al double- resonance and (25)Mg triple- quantum MAS NMR data, show that the cations are fully ordered for magnesium: aluminum ratios of 2:1 and that at lower aluminum content, a nonrandom distribution of cations persists, with no Al(3+)-Al(3+) close contacts. The application of rapid MAS NMR methods to investigate proton distributions in a wide range of materials is readily envisaged.	[Sideris, Paul J.; Nielsen, Ulla Gro; Grey, Clare P.] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; [Sideris, Paul J.; Nielsen, Ulla Gro; Grey, Clare P.] SUNY Stony Brook, Ctr Environm Mol Sci, Stony Brook, NY 11794 USA; [Gan, Zhehong] Natl High Magnet Field Lab, Ctr Interdisciplinary Magnet Resonance, Tallahassee, FL 32310 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University System of Florida; Florida State University	Grey, CP (corresponding author), SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA.	cgrey@notes.cc.sunysb.edu	Grey, Clare P/Q-8860-2017; Gan, Zhehong/C-2400-2011	Grey, Clare P/0000-0001-5572-192X; Gan, Zhehong/0000-0002-9855-5113; Nielsen, Ulla Gro/0000-0002-2336-3061				Aramendia MA, 1997, J SOLID STATE CHEM, V131, P78, DOI 10.1006/jssc.1997.7347; BASTOW TJ, 1991, SOLID STATE COMMUN, V77, P547, DOI 10.1016/0038-1098(91)90737-G; Bontchev RP, 2003, CHEM MATER, V15, P3669, DOI 10.1021/cm034231r; Carriazo D, 2007, APPL CLAY SCI, V37, P231, DOI 10.1016/j.clay.2007.01.006; Cavani F, 1991, CATAL TODAY, V11, P173, DOI 10.1016/0920-5861(91)80068-K; Costantino U, 2008, MICROPOR MESOPOR MAT, V107, P149, DOI 10.1016/j.micromeso.2007.02.005; Dowell NG, 2004, J PHYS CHEM B, V108, P13292, DOI 10.1021/jp047868m; DUPREE R, 1988, J CHEM SOC CHEM COMM, P1483, DOI 10.1039/c39880001483; FRYDMAN L, 1995, J AM CHEM SOC, V117, P5367, DOI 10.1021/ja00124a023; Grant CV, 2000, J AM CHEM SOC, V122, P11743, DOI 10.1021/ja003188v; GREY CP, 1995, J AM CHEM SOC, V117, P8232, DOI 10.1021/ja00136a022; He J, 2006, STRUCT BOND, V119, P89, DOI 10.1007/430_006; Hofmeister W., 1992, CRYSTALLOGR REV, V3, P3; Hou XQ, 2000, CHEM MATER, V12, P1890, DOI 10.1021/cm990787w; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; Khan AI, 2002, J MATER CHEM, V12, P3191, DOI 10.1039/b204076j; Leroux F, 2001, CHEM MATER, V13, P3507, DOI 10.1021/cm0110268; MACKENZIE KJD, 1994, AM MINERAL, V79, P250; MACKENZIE KJD, 1993, THERMOCHIM ACTA, V230, P339, DOI 10.1016/0040-6031(93)80371-G; MACKENZIE KJD, 1993, J MATER CHEM, V3, P1263, DOI 10.1039/jm9930301263; Radha AV, 2007, ACTA CRYSTALLOGR B, V63, P243, DOI 10.1107/S010876810700122X; REY F, 1992, J CHEM SOC FARADAY T, V88, P2233, DOI 10.1039/ft9928802233; Rives V, 1999, COORDIN CHEM REV, V181, P61, DOI 10.1016/S0010-8545(98)00216-1; Rocha J, 1999, J MATER CHEM, V9, P2499, DOI 10.1039/a903231b; SAMOSON A, 1985, CHEM PHYS LETT, V119, P29, DOI 10.1016/0009-2614(85)85414-2; Sham S, 2000, INORG CHEM, V39, P4, DOI 10.1021/ic991060c; STERNBERG U, 1994, J MAGN RESON SER A, V108, P142, DOI 10.1006/jmra.1994.1104; Vaccari A, 1999, APPL CLAY SCI, V14, P161, DOI 10.1016/S0169-1317(98)00058-1; VANDERPOL A, 1994, J PHYS CHEM-US, V98, P4050, DOI 10.1021/j100066a024; YESINOWSKI JP, 1988, J AM CHEM SOC, V110, P1367, DOI 10.1021/ja00213a007	30	521	543	16	480	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 4	2008	321	5885					113	117		10.1126/science.1157581	http://dx.doi.org/10.1126/science.1157581			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QE	18599785				2022-12-28	WOS:000257320800049
J	Bhaskaran, K; Hamouda, O; Sannes, M; Boufassa, F; Johnson, AM; Lambert, PC; Porter, K				Bhaskaran, Krishnan; Hamouda, Osamah; Sannes, Mette; Boufassa, Faroudy; Johnson, Anne M.; Lambert, Paul C.; Porter, Kholoud		CASCADE Collaboration	Changes in the risk of death after HIV seroconversion compared with mortality in the general population	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; RELATIVE SURVIVAL; INFECTED ADULTS; SUBSTANCE-ABUSE; COHORT; AGE; INDIVIDUALS; ASSOCIATION; EUROSIDA; RECOVERY	Context Mortality among human immunodeficiency virus ( HIV) - infected individuals has decreased dramatically in countries with good access to treatment and may now be close to mortality in the general uninfected population. Objective To evaluate changes in the mortality gap between HIV- infected individuals and the general uninfected population. Design, Setting, and Population Mortality following HIV seroconversion in a large multinational collaboration of HIV seroconverter cohorts ( CASCADE) was compared with expected mortality, calculated by applying general population death rates matched on demographic factors. A Poisson- based model adjusted for duration of infection was constructed to assess changes over calendar time in the excess mortality among HIV-infected individuals. Data pooled in September 2007 were analyzed in March 2008, covering years at risk 1981- 2006. Main Outcome Measure Excess mortality among HIV- infected individuals compared with that of the general uninfected population. Results Of 16 534 individuals with median duration of follow- up of 6.3 years ( range, 1 day to 23.8 years), 2571 died, compared with 235 deaths expected in an equivalent general population cohort. The excess mortality rate ( per 1000 person- years) decreased from 40.8 ( 95% confidence interval [ CI], 38.5- 43.0; 1275.9 excess deaths in 31 302 person- years) before the introduction of highly active antiretroviral therapy ( pre- 1996) to 6.1 ( 95% CI, 4.8- 7.4; 89.6 excess deaths in 14 703 person- years) in 2004- 2006 ( adjusted excess hazard ratio, 0.05 [ 95% CI, 0.03- 0.09] for 2004- 2006 vs pre- 1996). By 2004- 2006, no excess mortality was observed in the first 5 years following HIV seroconversion among those infected sexually, though a cumulative excess probability of death remained over the longer term ( 4.8% [ 95% CI, 2.5%- 8.6%] in the first 10 years among those aged 15- 24 years). Conclusions Mortality rates for HIV- infected persons have become much closer to general mortality rates since the introduction of highly active antiretroviral therapy. In industrialized countries, persons infected sexually with HIV now appear to experience mortality rates similar to those of the general population in the first 5 years following infection, though a mortality excess remains as duration of HIV infection lengthens.	[Bhaskaran, Krishnan; Porter, Kholoud] MRC, Clin Trials Unit, London NW1 2DA, England; [Hamouda, Osamah] Robert Koch Inst, D-1000 Berlin, Germany; [Sannes, Mette] Ullevaal Univ Hosp, Oslo, Norway; [Boufassa, Faroudy] Hop Bicetre, INSERM, U822, Paris, France; [Johnson, Anne M.] UCL, London, England; [Lambert, Paul C.] Univ Leicester, Leicester, Leics, England	Medical Research Council Clinical Trials Unit; Robert Koch Institute; University of Oslo; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of London; University College London; University of Leicester	Porter, K (corresponding author), MRC, Clin Trials Unit, 222 Euston Rd, London NW1 2DA, England.	kp@ctu.mrc.ac.uk	lutsar, irja/H-3177-2015; Muga, Roberto/AAY-8655-2021; Guiguet, Marguerite/L-8480-2018; rezza, giovanni/D-4393-2016; VALLET, Yannick/F-9979-2011; Hernández-Aguado, Ildefonso/I-2634-2015; DEL AMO VALERO, JULIA/M-7020-2015	Muga, Roberto/0000-0001-6301-431X; rezza, giovanni/0000-0003-0268-6790; Hernández-Aguado, Ildefonso/0000-0003-1911-5759; DEL AMO VALERO, JULIA/0000-0002-3104-540X; Bhaskaran, Krishnan/0000-0001-5364-8757; Johnson, Anne/0000-0003-1330-7100; delpech, valerie/0000-0002-9952-8109; Lambert, Paul/0000-0002-5337-663X; Porter, Kholoud/0000-0002-9226-6206	Medical Research Council [MC_U122886351] Funding Source: Medline; MRC [MC_U122886351] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Brenner H, 2001, BRIT J CANCER, V85, P367, DOI 10.1054/bjoc.2001.1905; Capocaccia R, 2003, ANN ONCOL, V14, pV14, DOI 10.1093/annonc/mdg751; Chander G, 2006, DRUGS, V66, P769, DOI 10.2165/00003495-200666060-00004; Colonna M, 2006, EUR J CANCER, V42, P2598, DOI 10.1016/j.ejca.2006.04.026; CUTLER SJ, 1958, J CHRON DIS, V8, P699; Dickman PW, 2004, STAT MED, V23, P51, DOI 10.1002/sim.1597; EDERER F, 1959, 10 NCI END RES EV SE; EDERER FRED, 1961, NATL CANCER INST MONOGR, V6, P101; Ewings FM, 2008, AIDS, V22, P89, DOI 10.1097/QAD.0b013e3282f3915e; Friis-Moller N, 2003, AIDS, V17, P1179, DOI 10.1097/00002030-200305230-00010; Gallagher R, 2000, PAIN MED, V1, P224; Gazzard B, 2006, HIV MED, V7, P487, DOI 10.1111/j.1468-1293.2006.00424.x; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Hammer SM, 2006, JAMA-J AM MED ASSOC, V296, P827, DOI 10.1001/jama.296.7.827; Hinkin CH, 2004, AIDS, V18, pS19, DOI 10.1097/00002030-200418001-00004; Jaggy C, 2003, LANCET, V362, P877, DOI 10.1016/S0140-6736(03)14307-3; Kaufmann GR, 2003, ARCH INTERN MED, V163, P2187, DOI 10.1001/archinte.163.18.2187; Keiser O, 2004, AIDS, V18, P1835, DOI 10.1097/00002030-200409030-00013; Lert F, 2007, INT J DRUG POLICY, V18, P255, DOI 10.1016/j.drugpo.2007.05.002; Lohse N, 2007, ANN INTERN MED, V146, P87, DOI 10.7326/0003-4819-146-2-200701160-00003; May M, 2007, AIDS, V21, P1185, DOI 10.1097/QAD.0b013e328133f285; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; Porter K, 2003, LANCET, V362, P1267, DOI 10.1016/S0140-6736(03)14570-9; Porter K, 2000, AIDS, V14, P1899; Rockstroh JK, 2005, J INFECT DIS, V192, P992, DOI 10.1086/432762; Roy P, 2000, EUR J CANCER, V36, P384, DOI 10.1016/S0959-8049(99)00267-1; Silverberg MJ, 2007, ARCH INTERN MED, V167, P684, DOI 10.1001/archinte.167.7.684; van Sighem A, 2005, JAIDS-J ACQ IMM DEF, V40, P212, DOI 10.1097/01.qai.0000165911.97085.d0; Viard JP, 2001, J INFECT DIS, V183, P1290, DOI 10.1086/319678	29	332	341	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 2	2008	300	1					51	59		10.1001/jama.300.1.51	http://dx.doi.org/10.1001/jama.300.1.51			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320NW	18594040	Bronze			2022-12-28	WOS:000257242800024
J	Delamothe, T				Delamothe, Tony			NHS at 60 - How the NHS measures up	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH; NATIONS					tdelamothe@bmj.com						[Anonymous], 2008, ANN INTERN MED, V148, P55, DOI 10.7326/0003-4819-148-1-200801010-00196; APPLEBY A, 2005, BRIT SOCIAL ATTITUDE, P109; *BRIT MED ASS, 2007, RAT WAY FORW NHS ENG; *COMM FUND, 2007 INT HLTH POL SU; Davis K, 2007, MIRROR MIRROR WALL I; Delamothe T, 2008, BRIT MED J, V336, P1410, DOI 10.1136/bmj.a292; Delamothe T, 2008, BRIT MED J, V336, P1278, DOI 10.1136/bmj.a169; Delamothe T, 2008, BRIT MED J, V336, P1344, DOI 10.1136/bmj.a253; Delamothe T, 2008, BRIT MED J, V336, P1216, DOI 10.1136/bmj.39582.501192.94; *DEP HLTH, 2007, NAT SURV LOC HLTH SE; *HEALTHC COMM, NAT SURV AD INP 2007; Leatherman S, 2008, QUEST QUALITY REFINI; Nolte E, 2003, BRIT MED J, V327, P1129, DOI 10.1136/bmj.327.7424.1129; Nolte E, 2008, HEALTH AFFAIR, V27, P58, DOI 10.1377/hlthaff.27.1.58; POWELL JE, 1966, NEW LOOK MEDICINE PO, P16; Verdecchia A, 2007, LANCET ONCOL, V8, P784, DOI 10.1016/S1470-2045(07)70246-2; Wanless D, 2001, SECURING OUR FUTURE; Williams A, 2001, HEALTH ECON, V10, P93, DOI 10.1002/hec.594; World Health Organization, 2000, WORLD HLTH REP 2000	19	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 28	2008	336	7659					1469	1471		10.1136/bmj.a385	http://dx.doi.org/10.1136/bmj.a385			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	324GN	18583679	Green Published			2022-12-28	WOS:000257505900033
J	Timmins, N				Timmins, Nick			NHS goes to the PROMS	BRITISH MEDICAL JOURNAL			English	Editorial Material												Nick.timmins@ft.com							0	54	54	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 28	2008	336	7659					1464	1465		10.1136/bmj.39618.627951.80	http://dx.doi.org/10.1136/bmj.39618.627951.80			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	324GN	18583674	Green Published			2022-12-28	WOS:000257505900030
J	Cai, YY; Chin, HF; Lazarova, D; Menon, S; Fu, CM; Cai, HQ; Sclafani, A; Rodgers, DW; De La Cruz, EM; Ferro-Novick, S; Reinisch, KM				Cai, Yiying; Chin, Harvey F.; Lazarova, Darina; Menon, Shekar; Fu, Chunmei; Cai, Huaqing; Sclafani, Anthony; Rodgers, David W.; De La Cruz, Enrique M.; Ferro-Novick, Susan; Reinisch, Karin M.			The structural basis for activation of the Rab Ypt1p by the TRAPP membrane-tethering complexes	CELL			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; CRYSTAL-STRUCTURE; CIS-GOLGI; GTPASE; BET3; SPECIFICITY; MECHANISM; SUBUNITS; VPS9; REFINEMENT	The multimeric membrane-tethering complexes TRAPPI and TRAPPII share seven subunits, of which four (Bet3p, Bet5p, Trs23p, and Trs31p) are minimally needed to activate the Rab GTPase Ypt1p in an event preceding membrane fusion. Here, we present the structure of a heteropentameric TRAPPI assembly complexed with Ypt1p. We propose that TRAPPI facilitates nucleotide exchange primarily by stabilizing the nucleotide-binding pocket of Ypt1p in an open, solvent-accessible form. Bet3p, Bet5p, and Trs23p interact directly with Ypt1p to stabilize this form, while the C terminus of Bet3p invades the pocket to participate in its remodeling. The Trs31p subunit does not interact directly with the GTPase but allosterically regulates the TRAPPI interface with Ypt1p. Our findings imply that TRAPPII activates Ypt1p by an identical mechanism. This view of a multimeric membrane-tethering assembly complexed with a Rab provides a framework for understanding events preceding membrane fusion at the molecular level.	[Cai, Yiying; Lazarova, Darina; Menon, Shekar; Fu, Chunmei; Cai, Huaqing; Sclafani, Anthony; Ferro-Novick, Susan; Reinisch, Karin M.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Chin, Harvey F.; De La Cruz, Enrique M.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Rodgers, David W.] Univ Kentucky, Dept Mol & Cellular Biochem, Coll Med, Lexington, KY 40536 USA; [Cai, Yiying; Lazarova, Darina; Menon, Shekar; Cai, Huaqing; Sclafani, Anthony; Ferro-Novick, Susan] Yale Univ, Howard Hughes Med Inst, Dept Cell Biol, Sch Med, New Haven, CT 06519 USA	Yale University; Yale University; University of Kentucky; Howard Hughes Medical Institute; Yale University	Reinisch, KM (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, 333 Cedar St, New Haven, CT 06520 USA.	susan.ferronovick@yale.edu; karin.reinisch@yale.edu		Cai, Huaqing/0000-0001-8434-6639	Howard Hughes Medical Institute Funding Source: Medline; NCRR NIH HHS [RR020171, P20 RR020171] Funding Source: Medline; NIDA NIH HHS [R01 DA002243, DA02243] Funding Source: Medline; NIDCD NIH HHS [F31 DC009143-01, F31 DC009143, 1F31DC009143-01] Funding Source: Medline; NIGMS NIH HHS [GM071688, R01 GM071688, T32-GM07223, R01 GM080616-01, GM080616, R01 GM080616, R01 GM071688-02] Funding Source: Medline; NINDS NIH HHS [R01 NS038041-04, NS38041, R01 NS038041, R56 NS038041] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080616, T32GM007223, R01GM071688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038041, R56NS038041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F31DC009143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA002243] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cai HQ, 2005, J CELL BIOL, V171, P823, DOI 10.1083/jcb.200505145; Cai HQ, 2007, DEV CELL, V12, P671, DOI 10.1016/j.devcel.2007.04.005; Cai HQ, 2007, NATURE, V445, P941, DOI 10.1038/nature05527; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Delprato A, 2004, CELL, V118, P607, DOI 10.1016/j.cell.2004.08.009; Delprato A, 2007, NAT STRUCT MOL BIOL, V14, P406, DOI 10.1038/nsmb1232; Dong G, 2007, MOL CELL, V25, P455, DOI 10.1016/j.molcel.2007.01.013; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Eathiraj S, 2005, NATURE, V436, P415, DOI 10.1038/nature03798; Esters H, 2001, J MOL BIOL, V310, P141, DOI 10.1006/jmbi.2001.4735; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Hannemann DE, 2005, BIOCHEMISTRY-US, V44, P8826, DOI 10.1021/bi0473509; Heras B, 2005, ACTA CRYSTALLOGR D, V61, P1173, DOI 10.1107/S0907444905019451; Itzen A, 2007, J MOL BIOL, V365, P1359, DOI 10.1016/j.jmb.2006.10.096; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jones S, 2000, MOL BIOL CELL, V11, P4403, DOI 10.1091/mbc.11.12.4403; Kim MS, 2005, TRAFFIC, V6, P1183, DOI 10.1111/j.1600-0854.2005.00352.x; Kim YG, 2006, CELL, V127, P817, DOI 10.1016/j.cell.2006.09.029; Kim YG, 2005, NAT STRUCT MOL BIOL, V12, P38, DOI 10.1038/nsmb871; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P12543, DOI 10.1021/bi00039a008; Kleywegt G. J., 2001, INT TABLES CRYSTALLO, VF, P353, DOI DOI 10.1107/97809553602060000111; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P208, DOI 10.1016/S0076-6879(97)77013-7; Koumandou VL, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-29; Kuehn MJ, 1998, NATURE, V391, P187, DOI 10.1038/34438; Kummel D, 2006, P NATL ACAD SCI USA, V103, P12701, DOI 10.1073/pnas.0603513103; Kummel D, 2006, J MOL BIOL, V361, P22, DOI 10.1016/j.jmb.2006.06.012; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Morozova N, 2006, NAT CELL BIOL, V8, P1263, DOI 10.1038/ncb1489; Moyer BD, 2001, TRAFFIC, V2, P268, DOI 10.1034/j.1600-0854.2001.1o007.x; NICHOLLS A, 1993, GRASP GRAPHICAL REPR; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Renault L, 2001, CELL, V105, P245, DOI 10.1016/S0092-8674(01)00315-4; RODGERS DW, 2001, INT TABLES CRYSTAL F, P202; Sacher M, 2000, EUR J CELL BIOL, V79, P71, DOI 10.1078/S0171-9335(04)70009-6; Sacher M, 1998, EMBO J, V17, P2494, DOI 10.1093/emboj/17.9.2494; Sacher M, 2001, MOL CELL, V7, P433, DOI 10.1016/S1097-2765(01)00190-3; Sato Y, 2007, P NATL ACAD SCI USA, V104, P8305, DOI 10.1073/pnas.0701550104; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Turnbull AP, 2005, EMBO J, V24, P875, DOI 10.1038/sj.emboj.7600565; Wang W, 2000, J CELL BIOL, V151, P289, DOI 10.1083/jcb.151.2.289; Wang W, 2002, MOL BIOL CELL, V13, P3336, DOI 10.1091/mbc.01-12-0577; Yu S, 2006, J CELL BIOL, V174, P359, DOI 10.1083/jcb.200603044	47	132	136	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 27	2008	133	7					1202	1213		10.1016/j.cell.2008.04.049	http://dx.doi.org/10.1016/j.cell.2008.04.049			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	319DP	18585354	Green Accepted, Bronze			2022-12-28	WOS:000257144600017
J	Coleman, JR; Papamichail, D; Skiena, S; Futcher, B; Wimmer, E; Mueller, S				Coleman, J. Robert; Papamichail, Dimitris; Skiena, Steven; Futcher, Bruce; Wimmer, Eckard; Mueller, Steffen			Virus attenuation by genome-scale changes in codon pair bias	SCIENCE			English	Article							POLIOVIRUS; RNA; DEOPTIMIZATION; STRATEGY	As a result of the redundancy of the genetic code, adjacent pairs of amino acids can be encoded by as many as 36 different pairs of synonymous codons. A species- specific "codon pair bias" provides that some synonymous codon pairs are used more or less frequently than statistically predicted. We synthesized de novo large DNA molecules using hundreds of over- or underrepresented synonymous codon pairs to encode the poliovirus capsid protein. Underrepresented codon pairs caused decreased rates of protein translation, and polioviruses containing such amino acid- independent changes were attenuated in mice. Polioviruses thus customized were used to immunize mice and provided protective immunity after challenge. This "death by a thousand cuts" strategy could be generally applicable to attenuating many kinds of viruses.	[Coleman, J. Robert; Futcher, Bruce; Wimmer, Eckard; Mueller, Steffen] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; [Papamichail, Dimitris; Skiena, Steven] SUNY Stony Brook, Dept Comp Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Wimmer, E (corresponding author), SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA.	ewimmer@ms.cc.sunysb.edu	Papamichail, Dimitris/A-5712-2010; Mueller, Steffen/HGE-0738-2022	Mueller, Steffen/0000-0003-2660-258X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI015122, R01AI015122, R01AI075219] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI075219-01A1, R01 AI075219, R37 AI015122-34, R37 AI015122, AI075219, AI15122] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Buchan JR, 2006, NUCLEIC ACIDS RES, V34, P1015, DOI 10.1093/nar/gkj488; Burns CC, 2006, J VIROL, V80, P3259, DOI 10.1128/JVI.80.7.3259-3272.2006; Cello J, 2002, SCIENCE, V297, P1016, DOI 10.1126/science.1072266; Chan LY, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100025; Fedorov A, 2002, NUCLEIC ACIDS RES, V30, P1192, DOI 10.1093/nar/30.5.1192; Flanagan EB, 2001, J VIROL, V75, P6107, DOI 10.1128/JVI.75.13.6107-6114.2001; GUTMAN GA, 1989, P NATL ACAD SCI USA, V86, P3699, DOI 10.1073/pnas.86.10.3699; Jiang P, 2007, P NATL ACAD SCI USA, V104, P9457, DOI 10.1073/pnas.0700451104; Kew O, 2002, SCIENCE, V296, P356, DOI 10.1126/science.1068284; Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; KOIKE S, 1994, COLD SPRING HARBOR M, P463; Landsteiner K., 1909, Z IMMUNITATSFORSCH, V2, P377; Moura G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000847; Mueller S, 2006, J VIROL, V80, P9687, DOI 10.1128/JVI.00738-06; Toyoda H, 2007, CANCER RES, V67, P2857, DOI 10.1158/0008-5472.CAN-06-3713; VANDERWERF S, 1986, P NATL ACAD SCI USA, V83, P2330; WIMMER E, 1993, ANNU REV GENET, V27, P353, DOI 10.1146/annurev.ge.27.120193.002033; Zhao WD, 2001, J VIROL, V75, P3719, DOI 10.1128/JVI.75.8.3719-3730.2001	18	433	477	3	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2008	320	5884					1784	1787		10.1126/science.1155761	http://dx.doi.org/10.1126/science.1155761			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318VP	18583614	Green Accepted			2022-12-28	WOS:000257121200041
J	Hackett, SJ; Kimball, RT; Reddy, S; Bowie, RCK; Braun, EL; Braun, MJ; Chojnowski, JL; Cox, WA; Han, KL; Harshman, J; Huddleston, CJ; Marks, BD; Miglia, KJ; Moore, WS; Sheldon, FH; Steadman, DW; Witt, CC; Yuri, T				Hackett, Shannon J.; Kimball, Rebecca T.; Reddy, Sushma; Bowie, Rauri C. K.; Braun, Edward L.; Braun, Michael J.; Chojnowski, Jena L.; Cox, W. Andrew; Han, Kin-Lan; Harshman, John; Huddleston, Christopher J.; Marks, Ben D.; Miglia, Kathleen J.; Moore, William S.; Sheldon, Frederick H.; Steadman, David W.; Witt, Christopher C.; Yuri, Tamaki			A phylogenomic study of birds reveals their evolutionary history	SCIENCE			English	Article							EXPLOSIVE EVOLUTION; DIVERGENCES; SEQUENCES; CHARACTERS; UTILITY; GENES; TAXA	Deep avian evolutionary relationships have been difficult to resolve as a result of a putative explosive radiation. Our study examined similar to 32 kilobases of aligned nuclear DNA sequences from 19 independent loci for 169 species, representing all major extant groups, and recovered a robust phylogeny from a genome- wide signal supported by multiple analytical methods. We documented well- supported, previously unrecognized interordinal relationships ( such as a sister relationship between passerines and parrots) and corroborated previously contentious groupings ( such as flamingos and grebes). Our conclusions challenge current classifications and alter our understanding of trait evolution; for example, some diurnal birds evolved from nocturnal ancestors. Our results provide a valuable resource for phylogenetic and comparative studies in birds.	[Kimball, Rebecca T.; Braun, Edward L.; Chojnowski, Jena L.; Cox, W. Andrew; Han, Kin-Lan; Yuri, Tamaki] Univ Florida, Dept Zool, Gainesville, FL 32611 USA; [Hackett, Shannon J.; Reddy, Sushma; Bowie, Rauri C. K.; Harshman, John] Field Museum Nat Hist, Dept Zool, Chicago, IL 60605 USA; [Bowie, Rauri C. K.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Bowie, Rauri C. K.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Bowie, Rauri C. K.] Percy Fitzpatrick Inst African Ornithol, Dept Sci & Technol, Natl Res Fdn Ctr Excellence, ZA-7602 Matieland, South Africa; [Bowie, Rauri C. K.] Univ Stellenbosch, Dept Bot & Zool, ZA-7602 Matieland, South Africa; [Braun, Michael J.; Han, Kin-Lan; Huddleston, Christopher J.; Yuri, Tamaki] Smithsonian Inst, Dept Vertebrate Zool, Suitland, MD 20746 USA; [Braun, Edward L.; Han, Kin-Lan] Univ Maryland, Behav Ecol Evolut & Systemat Program, College Pk, MD 20742 USA; [Marks, Ben D.; Sheldon, Frederick H.; Witt, Christopher C.] Louisiana State Univ, Museum Nat Sci, Baton Rouge, LA 70803 USA; [Miglia, Kathleen J.; Moore, William S.] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA; [Steadman, David W.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Witt, Christopher C.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Witt, Christopher C.] Univ New Mexico, Museum SW Biol, Albuquerque, NM 87131 USA	State University System of Florida; University of Florida; Field Museum of Natural History (Chicago); University of California System; University of California Berkeley; University of California System; University of California Berkeley; National Research Foundation - South Africa; Stellenbosch University; Smithsonian Institution; University System of Maryland; University of Maryland College Park; Louisiana State University System; Louisiana State University; Wayne State University; State University System of Florida; University of Florida; University of New Mexico; University of New Mexico	Kimball, RT (corresponding author), Univ Florida, Dept Zool, Gainesville, FL 32611 USA.	rkimball@ufl.edu	Kimball, Rebecca T/C-2290-2009; Bowie, Rauri/H-9165-2019; Han, Kin-Lan/G-7121-2011; Kimball, Rebecca/Q-6862-2019; Witt, Christopher/D-8587-2012	Bowie, Rauri/0000-0001-8328-6021; Kimball, Rebecca/0000-0001-5449-5481; Witt, Christopher/0000-0003-2781-1543; Reddy, Sushma/0000-0001-7263-0763; Yuri, Tamaki/0000-0001-6394-5755; Braun, Edward/0000-0003-1643-5212; Cox, William/0000-0002-1205-5979				Braun EL, 2002, SYST BIOL, V51, P614, DOI 10.1080/10635150290102294; Brown JW, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-6; Chojnowski JL, 2008, GENE, V410, P89, DOI 10.1016/j.gene.2007.11.016; Chubb AL, 2004, MOL PHYLOGENET EVOL, V30, P140, DOI 10.1016/S1055-7903(03)00159-3; Cracraft J, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P143; Cracraft J, 2004, ASSEMBLING THE TREE OF LIFE, P468; Delsuc F, 2005, NAT REV GENET, V6, P361, DOI 10.1038/nrg1603; Ericson PGP, 2006, BIOL LETTERS, V2, P543, DOI 10.1098/rsbl.2006.0523; Fain MG, 2004, EVOLUTION, V58, P2558; FEDUCCIA A, 1995, SCIENCE, V267, P637, DOI 10.1126/science.267.5198.637; GRIFFITHS CS, 1994, AUK, V111, P787, DOI 10.2307/4088811; Groth JG, 1999, MOL PHYLOGENET EVOL, V12, P115, DOI 10.1006/mpev.1998.0603; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Jimenez-Guri E, 2007, SCIENCE, V317, P116, DOI 10.1126/science.1142024; Livezey BC, 2007, ZOOL J LINN SOC-LOND, V149, P1, DOI 10.1111/j.1096-3642.2006.00293.x; Mayr G, 2003, CLADISTICS, V19, P527, DOI [10.1016/j.cladistics.2003.10.003, 10.1111/j.1096-0031.2003.tb00387.x]; Mindell DP, 1999, SYST BIOL, V48, P138, DOI 10.1080/106351599260490; Murphy WJ, 2004, TRENDS GENET, V20, P631, DOI 10.1016/j.tig.2004.09.005; Paton T, 2002, P ROY SOC B-BIOL SCI, V269, P839, DOI 10.1098/rspb.2002.1961; Paton TA, 2003, MOL PHYLOGENET EVOL, V29, P268, DOI 10.1016/S1055-7903(03)00098-8; Peters J.L., 1931, CHECK LIST BIRDS WOR, V1; Poe S, 2004, EVOLUTION, V58, P404, DOI 10.1111/j.0014-3820.2004.tb01655.x; Sibley C.G., 1990, PHYLOGENY CLASSIFICA; Sibley CG, 1990, DISTRIBUTION TAXONOM; Slack KE, 2007, MOL PHYLOGENET EVOL, V42, P1, DOI 10.1016/j.ympev.2006.06.002; Sorenson MD, 2003, MOL BIOL EVOL, V20, P1484, DOI 10.1093/molbev/msg157; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Van Tuinen M, 2001, P ROY SOC B-BIOL SCI, V268, P1345; Zwickl DJ, 2006, THESIS; [No title captured]; [No title captured]	31	1440	1482	9	570	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2008	320	5884					1763	1768		10.1126/science.1157704	http://dx.doi.org/10.1126/science.1157704			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318VP	18583609				2022-12-28	WOS:000257121200035
J	Nimmo, F; Hart, SD; Korycansky, DG; Agnor, CB				Nimmo, F.; Hart, S. D.; Korycansky, D. G.; Agnor, C. B.			Implications of an impact origin for the martian hemispheric dichotomy	NATURE			English	Article							CRUSTAL DICHOTOMY; MARS; TOPOGRAPHY; EVOLUTION; MELT	The observation that one hemisphere of Mars is lower and has a thinner crust than the other ( the 'martian hemispheric dichotomy')(1-3) has been a puzzle for 30 years. The dichotomy may have arisen as a result of internal mechanisms such as convection(4,5). Alternatively, it may have been caused by one(6) or several(7) giant impacts, but quantitative tests of the impact hypothesis have not been published. Here we use a high- resolution, two-dimensional, axially symmetric hydrocode(8,9) to model vertical impacts over a range of parameters appropriate to early Mars. We propose that the impact model, in addition to excavating a crustal cavity of the correct size, explains two other observations. First, crustal disruption(10) at the impact antipode is probably responsible for the observed antipodal decline in magnetic field strength(11). Second, the impact- generated melt forming the northern lowlands crust is predicted to derive from a deep, depleted mantle source. This prediction is consistent with characteristics of martian shergottite meteorites(12,13) and suggests a dichotomy formation time similar to 100 Myr after martian accretion(13), comparable to that of the Moon- forming impact on Earth(14).	[Nimmo, F.; Hart, S. D.; Korycansky, D. G.] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA; [Agnor, C. B.] Queen Mary Univ London, Astron Unit, London E1 4NS, England	University of California System; University of California Santa Cruz; University of London; Queen Mary University London	Nimmo, F (corresponding author), Univ Calif Santa Cruz, Dept Earth & Planetary Sci, 1156 High St, Santa Cruz, CA 95064 USA.	fnimmo@es.ucsc.edu						Acuna MH, 1999, SCIENCE, V284, P790, DOI 10.1126/science.284.5415.790; Agee CB, 2004, EARTH PLANET SC LETT, V224, P415, DOI 10.1016/j.epsl.2004.05.022; Beals C. S., 1963, MOON METEOR COMET, P235; Bruesch LS, 2004, ICARUS, V168, P457, DOI 10.1016/j.icarus.2003.11.007; Debaille V, 2007, NATURE, V450, P525, DOI 10.1038/nature06317; FREY H, 1988, GEOPHYS RES LETT, V15, P229, DOI 10.1029/GL015i003p00229; Frey HV, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024484; Hood LL, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016657; Hynek BM, 2001, GEOLOGY, V29, P407, DOI 10.1130/0091-7613(2001)029<0407:EFEDOT>2.0.CO;2; Kleine T, 2005, SCIENCE, V310, P1671, DOI 10.1126/science.1118842; Korycansky DG, 2000, ICARUS, V146, P387, DOI 10.1006/icar.2000.6426; MCGILL GE, 1991, ICARUS, V93, P386, DOI 10.1016/0019-1035(91)90221-E; Melosh H.J., 1989, OXFORD MONOGRAPHS GE; Neumann GA, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2004JE002262; Nyquist LE, 2001, SPACE SCI REV, V96, P105, DOI 10.1023/A:1011993105172; OKEEFE JD, 1977, P LUNAR PLANET SCI C, V8, P3357; Phillips RJ, 2001, SCIENCE, V291, P2587, DOI 10.1126/science.1058701; Pierazzo E, 2000, ICARUS, V145, P252, DOI 10.1006/icar.1999.6332; Purucker M, 2000, GEOPHYS RES LETT, V27, P2449, DOI 10.1029/2000GL000072; Smith DE, 1999, SCIENCE, V284, P1495, DOI 10.1126/science.284.5419.1495; Spudis P. D., 2005, GEOLOGY MULTIRING IM; Tanaka KL, 1997, J GEOPHYS RES-PLANET, V102, P4131, DOI 10.1029/96JE02862; Turner S, 2001, SCIENCE, V292, P1363, DOI 10.1126/science.1059904; Watters TR, 2007, ANNU REV EARTH PL SC, V35, P621, DOI 10.1146/annurev.earth.35.031306.140220; WILHELMS DE, 1984, NATURE, V309, P138, DOI 10.1038/309138a0; WISE DU, 1979, J GEOPHYS RES, V84, P7934, DOI 10.1029/JB084iB14p07934; Zhong SJ, 2001, EARTH PLANET SC LETT, V189, P75, DOI 10.1016/S0012-821X(01)00345-4; Zuber MT, 2000, SCIENCE, V287, P1788, DOI 10.1126/science.287.5459.1788	29	119	122	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2008	453	7199					1220	U32		10.1038/nature07025	http://dx.doi.org/10.1038/nature07025			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318FA	18580946				2022-12-28	WOS:000257075800038
J	Malenka, DJ; Kaplan, AV; Lucas, FL; Sharp, SM; Skinner, JS				Malenka, David J.; Kaplan, Aaron V.; Lucas, F. Lee; Sharp, Sandra M.; Skinner, Jonathan S.			Outcomes following coronary stenting in the era of bare-metal vs the era of drug-eluting stents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LONG-TERM OUTCOMES; MYOCARDIAL-INFARCTION; CLINICAL-OUTCOMES; MULTICENTER REGISTRY; UNCOATED STENTS; POOLED ANALYSIS; OFF-LABEL; THROMBOSIS; SIROLIMUS; IMPLANTATION	Context Although drug-eluting stents reduce restenosis rates relative to bare- metal stents, concerns have been raised that drug- eluting stents may also be associated with an increased risk of stent thrombosis. Our study focused on the effect of stent type on population- based interventional outcomes. Objective To compare outcomes of Medicare beneficiaries who underwent non-emergent coronary stenting before and after the availability of drug- eluting stents. Design, Setting, and Patients Observational study of 38 917 Medicare patients who underwent nonemergent coronary stenting from October 2002 through March 2003 when only bare- metal stents were available ( bare- metal stent era cohort) and 28 086 similar patients who underwent coronary stenting from September through December 2003, when 61.5% of patients received a drug- eluting stent and 38.5% received a bare- metal stent ( drug- eluting stent era cohort). Follow- up data were available through December 31, 2005. Main Outcome Measures Coronary revascularization ( percutaneous coronary intervention, coronary artery bypass surgery), ST- elevation myocardial infarction, survival through 2 years of follow- up. Results Relative to the bare- metal stent era, patients treated in the drug- eluting stent era had lower 2- year risks for repeat percutaneous coronary interventions ( 17.1% vs 20.0%, P <. 001) and coronary artery bypass surgery ( 2.7% vs 4.2%, P <. 01). The difference in need for repeat revascularization procedures between these 2 eras remained significant after risk adjustment ( hazard ratio, 0.82; 95% confidence interval, 0.79- 0.85). There was no difference in unadjusted mortality risks at 2 years ( 8.4% vs 8.4%, P=. 98), but a small decrease in ST- elevation myocardial infarction existed ( 2.4% vs 2.0%, P <. 001). The adjusted hazard of death or ST- elevation myocardial infarction at 2 years was similar ( hazard ratio, 0.96; 95% confidence interval, 0.92- 1.01). Conclusion The widespread adoption of drug- eluting stents into routine practice was associated with a decline in the need for repeat revascularization procedures and had similar 2- year risks for death or ST- elevation myocardial infarction to bare- metal stents.	[Malenka, David J.; Kaplan, Aaron V.] Dartmouth Hitchcock Med Ctr, Cardiol Sect, Lebanon, NH 03756 USA; [Malenka, David J.; Kaplan, Aaron V.] Dartmouth Coll, Dartmouth Med Sch, Dept Med, Hanover, NH 03755 USA; [Malenka, David J.; Lucas, F. Lee; Sharp, Sandra M.; Skinner, Jonathan S.] Dartmouth Coll, Dartmouth Inst Hlth Policy & Clin Practice, Hanover, NH 03755 USA; [Skinner, Jonathan S.] Dartmouth Coll, Dept Econ, Hanover, NH 03755 USA; [Lucas, F. Lee] Maine Med Ctr, Ctr Outcomes Res & Evaluat, Portland, ME 04102 USA	Dartmouth College; Dartmouth College; Dartmouth College; Dartmouth College; Maine Medical Center	Malenka, DJ (corresponding author), Dartmouth Hitchcock Med Ctr, Cardiol Sect, 1 Med Ctr Dr, Lebanon, NH 03756 USA.	david.malenka@hitchcock.org			NIA NIH HHS [P01 AG019783, P01 AG019783-08] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG019783] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Becker SO, 2002, STATA J, V2, P358, DOI 10.1177/1536867X0200200403; Beohar N, 2007, JAMA-J AM MED ASSOC, V297, P1992, DOI 10.1001/jama.297.18.1992; Bland JM, 2004, BRIT MED J, V328, P1073, DOI 10.1136/bmj.328.7447.1073; Camenzind E, 2007, CIRCULATION, V115, P1440, DOI 10.1161/CIRCULATIONAHA.106.666800; Chen MS, 2006, AM HEART J, V151, P1260, DOI 10.1016/j.ahj.2005.08.011; Cutlip DE, 2001, CIRCULATION, V103, P1967; Cutlip DE, 1999, J AM COLL CARDIOL, V34, P698, DOI 10.1016/S0735-1097(99)00271-5; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Daemen J, 2007, AM J CARDIOL, V99, P1027, DOI 10.1016/j.amjcard.2006.11.070; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; Eisenstein EL, 2007, JAMA-J AM MED ASSOC, V297, P159, DOI 10.1001/jama.297.2.joc60179; Fajadet J, 2005, CIRCULATION, V111, P1040, DOI 10.1161/01.CIR.0000156334.24955.B2; Hannan EL, 2008, CIRCULATION, V117, P2071, DOI 10.1161/CIRCULATIONAHA.107.725531; Harrington RA, 2007, JAMA-J AM MED ASSOC, V297, P2028, DOI 10.1001/jama.297.18.2028; Hirano K., 2001, HLTH SERVICES OUTCOM, V2, P259, DOI [10.1023/A:1020371312283, DOI 10.1023/A:1020371312283]; Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126; Karrillon GJ, 1996, CIRCULATION, V94, P1519, DOI 10.1161/01.CIR.94.7.1519; Kastrati A, 2007, NEW ENGL J MED, V356, P1030, DOI 10.1056/NEJMoa067484; Kaul S, 2007, J AM COLL CARDIOL, V50, P128, DOI 10.1016/j.jacc.2007.04.030; Krucoff MW, 2007, CIRCULATION, V115, P2990, DOI 10.1161/CIRCULATIONAHA.107.707778; Kuchulakanti PK, 2006, CIRCULATION, V113, P1108, DOI 10.1161/CIRCULATIONAHA.105.600155; Laarman GJ, 2006, NEW ENGL J MED, V355, P1105, DOI 10.1056/NEJMoa062598; Lagerqvist B, 2007, NEW ENGL J MED, V356, P1009, DOI 10.1056/NEJMoa067722; Laskey WK, 2007, CIRCULATION, V115, P2352, DOI 10.1161/CIRCULATIONAHA.107.688416; Marzocchi A, 2007, CIRCULATION, V115, P3181, DOI 10.1161/CIRCULATIONAHA.106.667592; Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731; Moussa I, 1997, J AM COLL CARDIOL, V29, P6, DOI 10.1016/S0735-1097(96)00452-4; NELSON WA, 1972, TECHNOMETRICS, V19, P945; Nordmann AJ, 2006, EUR HEART J, V27, P2784, DOI 10.1093/eurheartj/ehl282; Ong ATL, 2005, J AM COLL CARDIOL, V45, P947, DOI 10.1016/j.jacc.2004.09.079; Pfisterer M, 2006, J AM COLL CARDIOL, V48, P2584, DOI 10.1016/j.jacc.2006.10.026; *PRACT MAN INF COR, 1999, INT CLASS DIS 9 REV; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; Serruys PW, 2007, CIRCULATION, V115, P1433, DOI 10.1161/CIRCULATIONAHA.106.666826; Shuchman M, 2006, NEW ENGL J MED, V355, P1949, DOI 10.1056/NEJMp068234; Spaulding C, 2007, NEW ENGL J MED, V356, P989, DOI 10.1056/NEJMoa066633; Spaulding C, 2006, NEW ENGL J MED, V355, P1093, DOI 10.1056/NEJMoa062006; Spertus JA, 2006, CIRCULATION, V113, P2803, DOI 10.1161/CIRCULATIONAHA.106.618066; Stone GW, 2007, CIRCULATION, V115, P2842, DOI 10.1161/CIRCULATIONAHA.106.687186; Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193; Tu JV, 2007, NEW ENGL J MED, V357, P1393, DOI 10.1056/NEJMoa071076; Weisz G, 2006, J AM COLL CARDIOL, V47, P1350, DOI 10.1016/j.jacc.2005.11.077; Williams DO, 2006, CIRCULATION, V114, P2154, DOI 10.1161/CIRCULATIONAHA.106.667915; Win HK, 2007, JAMA-J AM MED ASSOC, V297, P2001, DOI 10.1001/jama.297.18.2001	44	88	89	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 25	2008	299	24					2868	2876		10.1001/jama.299.24.2868	http://dx.doi.org/10.1001/jama.299.24.2868			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	317LN	18577731	Green Accepted, Bronze			2022-12-28	WOS:000257021800024
J	Durrington, HJ; Summers, C				Durrington, Hannah J.; Summers, Charlotte			Recent changes in the management of community acquired pneumonia in adults	BMJ-BRITISH MEDICAL JOURNAL			English	Review							STAPHYLOCOCCUS-AUREUS; ATYPICAL PATHOGENS; ANTIBIOTICS; GUIDELINES; SEVERITY; METAANALYSIS; INFLUENZA; ETIOLOGY; OUTCOMES; PATIENT		[Durrington, Hannah J.; Summers, Charlotte] Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Dept Med, Cambridge CB2 2QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Summers, C (corresponding author), Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Dept Med, Cambridge CB2 2QQ, England.	cs493@medschl.cam.ac.uk	Durrington, Hannah/B-4564-2016; Summers, Charlotte/A-6973-2012	Durrington, Hannah/0000-0002-9990-9446; Summers, Charlotte/0000-0002-7269-2873	Wellcome Trust [077940] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Arnold FW, 2007, AM J RESP CRIT CARE, V175, P1086, DOI 10.1164/rccm.200603-350OC; Aujesky D, 2005, AM J MED, V118, P384, DOI 10.1016/j.amjmed.2005.01.006; Bauer TT, 2006, J INTERN MED, V260, P93, DOI 10.1111/j.1365-2796.2006.01657.x; Brueggemann AB, 2007, PLOS PATHOG, V3, P1628, DOI 10.1371/journal.ppat.0030168; Buising KL, 2006, THORAX, V61, P419, DOI 10.1136/thx.2005.051326; Evans GM, 1938, LANCET, V2, P14; File TM, 2003, LANCET, V362, P1991, DOI 10.1016/S0140-6736(03)15021-0; Fine MJ, 1997, ARCH INTERN MED, V157, P36, DOI 10.1001/archinte.157.1.36; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Friend JAR, 2001, THORAX, V56, P1, DOI 10.1136/thorax.56.1.1; Hageman JC, 2006, EMERG INFECT DIS, V12, P894, DOI 10.3201/eid1206.051141; *HLTH PROT AG, 2007, ANTI RES ENGL WAL NO; Houck PM, 2004, ARCH INTERN MED, V164, P637, DOI 10.1001/archinte.164.6.637; Kanwar M, 2007, CHEST, V131, P1865, DOI 10.1378/chest.07-0164; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; Li JZ, 2007, AM J MED, V120, P783, DOI 10.1016/j.amjmed.2007.04.023; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Lim WS, 2001, THORAX, V56, P296, DOI 10.1136/thorax.56.4.296; Macfarlane JT, 2004, THORAX, V59, P364, DOI 10.1136/thx.2004.024992; Man SY, 2007, THORAX, V62, P348, DOI 10.1136/thx.2006.069740; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Metlay JP, 1997, JAMA-J AM MED ASSOC, V278, P1440, DOI 10.1001/jama.278.17.1440; Mills GD, 2005, BMJ-BRIT MED J, V330, P456, DOI 10.1136/bmj.38334.591586.82; MOUSSAOUI R, 2006, BMJ-BRIT MED J, V332, P1355, DOI DOI 10.1136/BMJ.332.7554.1355; Oosterheert JJ, 2006, BMJ-BRIT MED J, V333, P1193, DOI 10.1136/bmj.38993.560984.BE; OSLER W, 1901, PRINCIPLES PRACTICE; Pogue M., 2007, Morbidity and Mortality Weekly Report, V56, P325; Waterer GW, 2006, CHEST, V130, P11, DOI 10.1378/chest.130.1.11; WOODHEAD MA, 1987, LANCET, V1, P671	29	18	22	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 21	2008	336	7658					1429	1433		10.1136/bmj.a285	http://dx.doi.org/10.1136/bmj.a285			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	318WJ	18566081	Green Published			2022-12-28	WOS:000257123200036
J	Keegan, BM; Weinshenker, BG				Keegan, B. Mark; Weinshenker, Brian G.			Laquinimod, a new oral drug for multiple sclerosis	LANCET			English	Editorial Material							SPIN-ECHO MRI; HYPOINTENSE LESIONS; RELAPSING MS; DOUBLE-BLIND; DISABILITY; TRIAL; NATALIZUMAB; IMPAIRMENT; GADOLINIUM; BURDEN		[Keegan, B. Mark; Weinshenker, Brian G.] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA	Mayo Clinic	Keegan, BM (corresponding author), Mayo Clin, Dept Neurol, Rochester, MN 55905 USA.	keegan.bmark@mayo.edu	Weinshenker, Brian G/ABH-6146-2020	Weinshenker, Brian G/0000-0001-5806-6203				Berger JR, 2005, NEW ENGL J MED, V353, P414, DOI 10.1056/NEJMe058122; Comi G, 2008, LANCET, V371, P2085, DOI 10.1016/S0140-6736(08)60918-6; Comi G, 2001, ANN NEUROL, V49, P290, DOI 10.1002/ana.64.abs; Cutter GR, 1999, BRAIN, V122, P871, DOI 10.1093/brain/122.5.871; Fisniku LK, 2008, BRAIN, V131, P808, DOI 10.1093/brain/awm329; Kappos L, 1999, LANCET, V353, P964, DOI 10.1016/S0140-6736(98)03053-0; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Li DKB, 1999, ANN NEUROL, V46, P197, DOI 10.1002/1531-8249(199908)46:2<197::AID-ANA9>3.0.CO;2-P; Li DKB, 2006, NEUROLOGY, V66, P1384, DOI 10.1212/01.wnl.0000210506.00078.5c; Miller DH, 2007, NEUROLOGY, V68, P1390, DOI 10.1212/01.wnl.0000260064.77700.fd; Miller DH, 2002, CLIN NEUROL NEUROSUR, V104, P236, DOI 10.1016/S0303-8467(02)00045-8; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Noseworthy JH, 2000, NEUROLOGY, V54, P1726, DOI 10.1212/WNL.54.9.1726; Polman C, 2005, NEUROLOGY, V64, P987, DOI 10.1212/01.WNL.0000154520.48391.69; Truyen L, 1996, NEUROLOGY, V47, P1469, DOI 10.1212/WNL.47.6.1469; van Walderveen MAA, 1998, NEUROLOGY, V50, P1282, DOI 10.1212/WNL.50.5.1282; vanWaesberghe JHTM, 1997, AM J NEURORADIOL, V18, P1279	17	6	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 21	2008	371	9630					2059	2060		10.1016/S0140-6736(08)60894-6	http://dx.doi.org/10.1016/S0140-6736(08)60894-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	316ER	18572062				2022-12-28	WOS:000256932200004
J	Hunder, NN; Wallen, H; Cao, JH; Hendricks, DW; Reilly, JZ; Rodmyre, R; Jungbluth, A; Gnjatic, S; Thompson, JA; Yee, C				Hunder, Naomi N.; Wallen, Herschel; Cao, Jianhong; Hendricks, Deborah W.; Reilly, John Z.; Rodmyre, Rebecca; Jungbluth, Achim; Gnjatic, Sacha; Thompson, John A.; Yee, Cassian			Treatment of metastatic melanoma with autologous CD4+T cells against NY-ESO-1	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							T-CELLS; IMMUNE-RESPONSE; ADOPTIVE IMMUNOTHERAPY; CANCER-PATIENTS; TUMOR-ANTIGENS; PHASE-I; LYMPHOCYTES; THERAPY; PEPTIDE; SPECIFICITIES	We developed an in vitro method for isolating and expanding autologous CD4+ T-cell clones with specificity for the melanoma-associated antigen NY-ESO-1. We infused these cells into a patient with refractory metastatic melanoma who had not undergone any previous conditioning or cytokine treatment. We show that the transferred CD4+ T cells mediated a durable clinical remission and led to endogenous responses against melanoma antigens other than NY-ESO-1.	[Hunder, Naomi N.; Wallen, Herschel; Cao, Jianhong; Hendricks, Deborah W.; Reilly, John Z.; Rodmyre, Rebecca; Yee, Cassian] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Thompson, John A.; Yee, Cassian] Univ Washington, Seattle, WA 98195 USA; [Jungbluth, Achim; Gnjatic, Sacha] Mem Sloan Kettering Canc Ctr, Ludwig Inst Canc Res New York Branch, New York, NY 10021 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Memorial Sloan Kettering Cancer Center	Yee, C (corresponding author), Fred Hutchinson Canc Res Ctr, Room D3-100,1100 Fairview Ave N, Seattle, WA 98109 USA.	cyee@fhcrc.org	Thompson, John A/T-7985-2019	Thompson, John A/0000-0002-0872-7306; Gnjatic, Sacha/0000-0001-5643-9520	NATIONAL CANCER INSTITUTE [R01CA104711, R21CA128283] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000037] Funding Source: NIH RePORTER; NCI NIH HHS [CA1047113, R21 CA128283, R01 CA104711-05, R01 CA104711, R21 CA128283-02, CA12823] Funding Source: Medline; NCRR NIH HHS [M01 RR000037, M01 RR000037-47] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BEVAN MJ, 1976, J EXP MED, V143, P1283, DOI 10.1084/jem.143.5.1283; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Gattinoni L, 2006, NAT REV IMMUNOL, V6, P383, DOI 10.1038/nri1842; Gnjatic S, 2003, P NATL ACAD SCI USA, V100, P8862, DOI 10.1073/pnas.1133324100; GREENBERG PD, 1991, ADV IMMUNOL, V49, P281; GREENBERG PD, 1985, J EXP MED, V161, P1122, DOI 10.1084/jem.161.5.1122; Hung K, 1998, J EXP MED, V188, P2357, DOI 10.1084/jem.188.12.2357; Jager E, 1998, J EXP MED, V187, P265, DOI 10.1084/jem.187.2.265; Khong HT, 2004, J IMMUNOTHER, V27, P472, DOI 10.1097/00002371-200411000-00007; Li YQ, 2005, J IMMUNOL, V175, P2261, DOI 10.4049/jimmunol.175.4.2261; Liao XS, 2004, MOL THER, V9, P757, DOI 10.1016/j.ymthe.2004.02.011; Mackensen A, 2006, J CLIN ONCOL, V24, P5060, DOI 10.1200/JCO.2006.07.1100; Mitchell MS, 2002, J CLIN ONCOL, V20, P1075, DOI 10.1200/JCO.20.4.1075; Nowak AK, 2003, J IMMUNOL, V170, P4905, DOI 10.4049/jimmunol.170.10.4905; Odunsi K, 2007, P NATL ACAD SCI USA, V104, P12837, DOI 10.1073/pnas.0703342104; RIDDELL SR, 1990, J IMMUNOL METHODS, V128, P189, DOI 10.1016/0022-1759(90)90210-M; ROMERDAHL CA, 1988, CANCER RES, V48, P2325; Stockert E, 1998, J EXP MED, V187, P1349, DOI 10.1084/jem.187.8.1349; Yee C, 2002, P NATL ACAD SCI USA, V99, P16168, DOI 10.1073/pnas.242600099; Zeng G, 2002, CANCER RES, V62, P3630	20	682	733	0	49	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 19	2008	358	25					2698	2703		10.1056/NEJMoa0800251	http://dx.doi.org/10.1056/NEJMoa0800251			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	314NC	18565862	Green Accepted, Bronze			2022-12-28	WOS:000256815100006
J	Kober, L; Torp-Pedersen, C; McMurray, JJV; Gotzsche, O; Levy, S; Crijns, H; Amlie, J; Carlsen, J				Kober, Lars; Torp-Pedersen, Christian; McMurray, John J. V.; Gotzsche, Ole; Levy, Samuel; Crijns, Harry; Amlie, Jan; Carlsen, Jan		Dronedarone Study Grp	Increased mortality after dronedarone therapy for severe heart failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LEFT-VENTRICULAR DYSFUNCTION; RECENT MYOCARDIAL-INFARCTION; ATRIAL-FIBRILLATION; RANDOMIZED TRIAL; AMIODARONE; PREVENTION; DOFETILIDE; CREATININE; FLUTTER; RISK	Background Dronedarone is a novel antiarrhythmic drug with electrophysiological properties that are similar to those of amiodarone, but it does not contain iodine and thus does not cause iodine-related adverse reactions. Therefore, it may be of value in the treatment of patients with heart failure. Methods In a multicenter study with a double-blind design, we planned to randomly assign 1000 patients who were hospitalized with symptomatic heart failure and severe left ventricular systolic dysfunction to receive 400 mg of dronedarone twice a day or placebo. The primary end point was the composite of death from any cause or hospitalization for heart failure. Results After inclusion of 627 patients (310 in the dronedarone group and 317 in the placebo group), the trial was prematurely terminated for safety reasons, at the recommendation of the data and safety monitoring board, in accordance with the board's predefined rules for termination of the study. During a median follow-up of 2 months, 25 patients in the dronedarone group (8.1%) and 12 patients in the placebo group (3.8%) died (hazard ratio in the dronedarone group, 2.13; 95% confidence interval [CI], 1.07 to 4.25; P=0.03). The excess mortality was predominantly related to worsening of heart failure - 10 deaths in the dronedarone group and 2 in the placebo group. The primary end point did not differ significantly between the two groups; there were 53 events in the dronedarone group (17.1%) and 40 events in the placebo group (12.6%) (hazard ratio, 1.38; 95% CI, 0.92 to 2.09; P=0.12). More increases in the creatinine concentration were reported as serious adverse events in the dronedarone group than in the placebo group. Conclusions In patients with severe heart failure and left ventricular systolic dysfunction, treatment with dronedarone was associated with increased early mortality related to the worsening of heart failure.	[Kober, Lars] Univ Copenhagen, Rigshosp, Dept Cardiol, DK-2100 Copenhagen, Denmark; [Torp-Pedersen, Christian] Gentofte Univ Hosp, Dept Cardiol, Copenhagen, Denmark; [McMurray, John J. V.] Univ Glasgow, Fac Med, British Heart Fdn Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Gotzsche, Ole] Aarhus Univ Hosp, Dept Cardiol, DK-8000 Aarhus, Denmark; [Levy, Samuel] Univ Aix Marseille 1, Hop Nord, Div Cardiol, Marseille, France; [Crijns, Harry] Univ Hosp Maastricht, Dept Cardiol, Maastricht, Netherlands; [Amlie, Jan] Univ Oslo, Rikshosp, Dept Cardiol, N-0027 Oslo, Norway; [Carlsen, Jan] Cyncron, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; University of Glasgow; Aarhus University; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Maastricht University; Maastricht University Medical Centre (MUMC); University of Oslo; National Hospital Norway	Kober, L (corresponding author), Univ Copenhagen, Rigshosp, Dept Cardiol, Blegdamsvej 7, DK-2100 Copenhagen, Denmark.	lk@heart.dk	Ponikowski, Piotr/O-6454-2015; mcmurray, John/B-2467-2013; Torp-Pedersen, Christian/E-5931-2013	Ponikowski, Piotr/0000-0002-3391-7064; mcmurray, John/0000-0002-6317-3975; Naslund, Ulf/0000-0003-4100-8298; Kober, Lars/0000-0002-6635-1466				ANDERSON DC, 1992, ANN INTERN MED, V116, P1, DOI 10.7326/0003-4819-116-1-1; Bardy GH, 2005, NEW ENGL J MED, V352, P2146; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Cairns JA, 1997, LANCET, V349, P675, DOI 10.1016/S0140-6736(96)08171-8; Cairns JA, 1997, LANCET, V349, P1776; Hohnloser SH, 2008, J CARDIOVASC ELECTR, V19, P69, DOI 10.1111/j.1540-8167.2007.01016.x; Julian DG, 1997, LANCET, V349, P667, DOI 10.1016/S0140-6736(96)09145-3; Julian DG, 1997, LANCET, V349, P1776; JULIAN DG, 1997, LANCET, V349, P1180; KOBER L, 1994, EUR HEART J, V15, P1616; Kober L, 2000, LANCET, V356, P2052, DOI 10.1016/S0140-6736(00)03402-4; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; MIDDLEKAUFF HR, 1991, CIRCULATION, V84, P40, DOI 10.1161/01.CIR.84.1.40; Morales AI, 2003, PHARMACOL TOXICOL, V92, P39, DOI 10.1034/j.1600-0773.2003.920107.x; Pardaens K, 1997, HEART, V78, P564, DOI 10.1136/hrt.78.6.564; POLLAK PT, 1993, BRIT J CLIN PHARMACO, V36, P125, DOI 10.1111/j.1365-2125.1993.tb04207.x; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Singh BN, 2007, NEW ENGL J MED, V357, P987, DOI 10.1056/NEJMoa054686; SINGH SN, 1995, NEW ENGL J MED, V333, P77, DOI 10.1056/NEJM199507133330201; Torp-Pedersen C, 1999, NEW ENGL J MED, V341, P857, DOI 10.1056/NEJM199909163411201; Touboul P, 2003, EUR HEART J, V24, P1481, DOI 10.1016/S0195-668X(03)00321-X; Tschuppert Y, 2007, BRIT J CLIN PHARMACO, V64, P785, DOI 10.1111/j.1365-2125.2007.02998.x; Vorperian VR, 1997, J AM COLL CARDIOL, V30, P791, DOI 10.1016/S0735-1097(97)00220-9; Waldo AL, 1996, LANCET, V348, P7, DOI 10.1016/S0140-6736(96)02149-6; WALDO AL, 1996, LANCET, V348, P416	25	626	667	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 19	2008	358	25					2678	2687		10.1056/NEJMoa0800456	http://dx.doi.org/10.1056/NEJMoa0800456			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	314NC	18565860				2022-12-28	WOS:000256815100004
J	Tinetti, ME				Tinetti, Mary E.			Over-the-counter sales of statins and other drugs for asymptomatic conditions	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CHOLESTEROL; LOVASTATIN; STROKE; HEALTH; RISK		Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA	Yale University; Yale University	Tinetti, ME (corresponding author), Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA.							Amarenco P, 2006, NEW ENGL J MED, V355, P549; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bang OY, 2007, NEUROLOGY, V68, P1547; Bang OY, 2007, NEUROLOGY, V68, P737, DOI 10.1212/01.wnl.0000252799.64165.d5; Brass EP, 2006, AM J CARDIOL, V97, P851, DOI 10.1016/j.amjcard.2005.10.022; Bruckert E, 2005, CARDIOVASC DRUG THER, V19, P403, DOI 10.1007/s10557-005-5686-z; Donohue JM, 2007, NEW ENGL J MED, V357, P673, DOI 10.1056/NEJMsa070502; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; GAHART MT, 2003, HLTH AFF MILLWOOD S; Gaist D, 2002, NEUROLOGY, V58, P1333, DOI 10.1212/WNL.58.9.1333; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; McClellan M, 2007, NEW ENGL J MED, V356, P1700, DOI 10.1056/NEJMp078057; Melin JM, 2004, AM J CARDIOL, V94, P1243, DOI 10.1016/j.amjcard.2004.08.007; Nag SS, 2005, AM J CARDIOL, V95, P862, DOI 10.1016/j.amjcard.2004.11.051; Psaty BM, 2006, NEW ENGL J MED, V355, P1753, DOI 10.1056/NEJMp068228; Sinzinger H, 2004, BRIT J CLIN PHARMACO, V57, P525, DOI 10.1111/j.1365-2125.2003.02044.x	17	15	15	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 19	2008	358	25					2728	2732		10.1056/NEJMsb0801202	http://dx.doi.org/10.1056/NEJMsb0801202			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	314NC	18565867				2022-12-28	WOS:000256815100012
J	Turner, NC; Jones, AL				Turner, Nicholas C.; Jones, Alison L.			Management of breast cancer - Part I	BMJ-BRITISH MEDICAL JOURNAL			English	Review							WOMEN; RISK; BRCA2; TRIAL; RADIOTHERAPY; IRRADIATION; RALOXIFENE; REDUCTION; TAMOXIFEN; SURVIVAL		[Turner, Nicholas C.; Jones, Alison L.] Royal Free Hosp NHS Fdn Trust, Dept Med Oncol, London NW3 2QG, England; [Turner, Nicholas C.] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Jones, Alison L.] UCL Hosp NHS Fdn Trust, London, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; University College London	Jones, AL (corresponding author), Royal Free Hosp NHS Fdn Trust, Dept Med Oncol, London NW3 2QG, England.	alison.jones@royalfree.nhs.uk		Turner, Nicholas/0000-0001-8937-0873				Abe O, 2005, LANCET, V366, P2087; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Benitez PR, 2007, AM J SURG, V194, P456, DOI 10.1016/j.amjsurg.2007.06.010; Bentzen SM, 2008, LANCET, V371, P1098, DOI 10.1016/S0140-6736(08)60348-7; Blumencranz P, 2007, AM J SURG, V194, P426, DOI 10.1016/j.amjsurg.2007.07.008; Brohet RM, 2007, J CLIN ONCOL, V25, P3831, DOI 10.1200/JCO.2007.11.1179; Chlebowski RT, 2006, JNCI-J NATL CANCER I, V98, P1767, DOI 10.1093/jnci/djj494; Cunnick GH, 2004, AM J SURG, V188, P78, DOI 10.1016/j.amjsurg.2004.02.004; Cuzick J, 2003, LANCET, V361, P296, DOI 10.1016/S0140-6736(03)12342-2; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; Gebski V, 2006, JNCI-J NATL CANCER I, V98, P26, DOI 10.1093/jnci/djj002; Gotzsche PC, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub2; Heiss G, 2008, JAMA-J AM MED ASSOC, V299, P1036, DOI 10.1001/jama.299.9.1036; International Agency for Research on Cancer, 2002, IARC HDB CANC PREV, V7; King MC, 2001, JAMA-J AM MED ASSOC, V286, P2251, DOI 10.1001/jama.286.18.2251; Kuhl CK, 2007, LANCET, V370, P485, DOI 10.1016/S0140-6736(07)61232-X; Leach MO, 2005, LANCET, V365, P1769, DOI 10.1016/S0140-6736(05)66481-1; Lim SML, 2005, AM J SURG, V190, P641, DOI 10.1016/j.amjsurg.2005.06.031; Mansel RE, 2006, J NATL CANCER I, V98, P599, DOI 10.1093/jnci/djj158; Meijers-Heijboer H, 2001, NEW ENGL J MED, V345, P159, DOI 10.1056/NEJM200107193450301; Metcalfe KA, 2008, INT J CANCER, V122, P2017, DOI 10.1002/ijc.23340; Michels KB, 2007, CANCER-AM CANCER SOC, V109, P2712, DOI 10.1002/cncr.22654; Peto R, 2000, LANCET, V355, P1822, DOI 10.1016/S0140-6736(00)02277-7; Pierce JP, 2007, JAMA-J AM MED ASSOC, V298, P289, DOI 10.1001/jama.298.3.289; Robson M, 2007, NEW ENGL J MED, V357, P154, DOI 10.1056/NEJMcp071286; Stratton MR, 2008, NAT GENET, V40, P17, DOI 10.1038/ng.2007.53; Travis LB, 2005, JNCI-J NATL CANCER I, V97, P1428, DOI 10.1093/jnci/dji290; Vaidya JS, 2004, LANCET ONCOL, V5, P165, DOI 10.1016/S1470-2045(04)01412-3; Vogel VG, 2006, JAMA-J AM MED ASSOC, V295, P2727, DOI 10.1001/jama.295.23.joc60074; Whelan T, 2002, J NATL CANCER I, V94, P1143	30	11	11	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 12	2008	337	7661							a421	10.1136/bmj.a421	http://dx.doi.org/10.1136/bmj.a421			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	330SA	18614462	Green Published			2022-12-28	WOS:000257961900037
J	List, JA				List, John A.			Economics - Homo experimentalis evolves	SCIENCE			English	Editorial Material									[List, John A.] Univ Chicago, Chicago, IL 60637 USA; [List, John A.] Natl Bur Econ Res, Chicago, IL 60637 USA	University of Chicago; National Bureau of Economic Research	List, JA (corresponding author), Univ Chicago, Chicago, IL 60637 USA.	jlist@uchicago.edu		List, John/0000-0002-1740-3848				ANDERSON ET, 2008, ECON INQ, V46, P3; Harrison GW, 2004, J ECON LIT, V42, P1009, DOI 10.1257/0022051043004577; Hausman J.A., 1985, SOCIAL EXPT; Heckman JJ, 2008, INT STAT REV, V76, P1, DOI 10.1111/j.1751-5823.2007.00024.x; KARLAN D, 2007, AM ECON REV, V95, P1688; REILEY D, 2006, ADV EC AN POL, V6, P7	6	16	16	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 11	2008	321	5886					207	208		10.1126/science.1156716	http://dx.doi.org/10.1126/science.1156716			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	324IS	18621657	Green Submitted			2022-12-28	WOS:000257512900025
J	Breton, RP; Kaspi, VM; Kramer, M; McLaughlin, MA; Lyutikov, M; Ransom, SM; Stairs, IH; Ferdman, RD; Camilo, F; Possenti, A				Breton, Rene P.; Kaspi, Victoria M.; Kramer, Michael; McLaughlin, Maura A.; Lyutikov, Maxim; Ransom, Scott M.; Stairs, Ingrid H.; Ferdman, Robert D.; Camilo, Fernando; Possenti, Andrea			Relativistic spin precession in the double pulsar	SCIENCE			English	Article							GRAVITY; SYSTEM; J0737-3039; ECLIPSE; TESTS	The double pulsar PSR J0737-3039A/B consists of two neutron stars in a highly relativistic orbit that displays a roughly 30- second eclipse when pulsar A passes behind pulsar B. Describing this eclipse of pulsar A as due to absorption occurring in the magnetosphere of pulsar B, we successfully used a simple geometric model to characterize the observed changing eclipse morphology and to measure the relativistic precession of pulsar B's spin axis around the total orbital angular momentum. This provides a test of general relativity and alternative theories of gravity in the strong- field regime. Our measured relativistic spin precession rate of 4.77 degrees+(0 degrees.66)(-0 degrees.65) per year ( 68% confidence level) is consistent with that predicted by general relativity within an uncertainty of 13%.	[Breton, Rene P.; Kaspi, Victoria M.] McGill Univ, Dept Phys, Montreal, PQ H3A 2T8, Canada; [Kramer, Michael] Univ Manchester, Jodrell Bank Observ, Manchester M13 9PL, Lancs, England; [McLaughlin, Maura A.] W Virginia Univ, Dept Phys, Morgantown, WV 26506 USA; [McLaughlin, Maura A.] Natl Radio Astron Observ, Green Bank, WV 24944 USA; [Lyutikov, Maxim] Purdue Univ, Dept Phys, W Lafayette, IN 47907 USA; [Ransom, Scott M.] Natl Radio Astron Observ, Charlottesville, VA 22903 USA; [Stairs, Ingrid H.; Ferdman, Robert D.] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada; [Ferdman, Robert D.] CNRS, Lab Phys & Chim Environm, F-45071 Orleans 2, France; [Camilo, Fernando] Columbia Univ, Columbia Astrophys Lab, New York, NY 10027 USA; [Possenti, Andrea] Ist Nazl Astrofis, Osservatorio Astron Cagliari, I-09012 Poggio Dei Pini, Capoterra, Italy	McGill University; University of Manchester; Jodrell Bank Centre for Astrophysics; West Virginia University; National Radio Astronomy Observatory (NRAO); Purdue University System; Purdue University; Purdue University West Lafayette Campus; National Radio Astronomy Observatory (NRAO); University of British Columbia; Centre National de la Recherche Scientifique (CNRS); Columbia University; Istituto Nazionale Astrofisica (INAF)	Breton, RP (corresponding author), McGill Univ, Dept Phys, 3600 Univ St, Montreal, PQ H3A 2T8, Canada.	bretonr@physics.mcgill.ca	Breton, Rene P/A-5536-2017; Lyutikov, Maxim/AAX-1992-2020; Breton, Rene/AAA-7257-2020	Breton, Rene P/0000-0001-8522-4983; Breton, Rene/0000-0001-8522-4983; McLaughlin, Maura/0000-0001-7697-7422; Ferdman, Robert/0000-0002-2223-1235; Ransom, Scott/0000-0001-5799-9714; Kramer, Michael/0000-0002-4175-2271				BARKER BM, 1975, PHYS REV D, V12, P329, DOI 10.1103/PhysRevD.12.329; Burgay M, 2005, ASTROPHYS J, V624, pL113, DOI 10.1086/430668; Burgay M, 2003, NATURE, V426, P531, DOI 10.1038/nature02124; DAMOUR T, 1992, PHYS REV D, V45, P1840, DOI 10.1103/PhysRevD.45.1840; DAMOUR T, 1992, CLASSICAL QUANT GRAV, V9, P2093, DOI 10.1088/0264-9381/9/9/015; DAMOUR T, 1992, PHYS REV D, V46, P4128, DOI 10.1103/PhysRevD.46.4128; Damour T, 1996, PHYS REV D, V53, P5541, DOI 10.1103/PhysRevD.53.5541; Hotan AW, 2005, ASTROPHYS J, V624, P906, DOI 10.1086/429270; Kaplan DL, 2005, PUBL ASTRON SOC PAC, V117, P643, DOI 10.1086/430368; Kaspi VM, 2004, ASTROPHYS J, V613, pL137, DOI 10.1086/425128; Kramer M, 2006, SCIENCE, V314, P97, DOI 10.1126/science.1132305; Lyne AG, 2004, SCIENCE, V303, P1153, DOI 10.1126/science.1094645; Lyutikov M, 2005, ASTROPHYS J, V634, P1223, DOI 10.1086/432252; McLaughlin MA, 2004, ASTROPHYS J, V616, pL131, DOI 10.1086/426813; OCONNELL RF, 1974, EXPT GRAVITATION, P496; Ransom SM, 2002, ASTRON J, V124, P1788, DOI 10.1086/342285; Stairs IH, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.141101; WEISBERG JM, 1989, ASTROPHYS J, V347, P1030, DOI 10.1086/168193; Will Clifford M, 2001, Living Rev Relativ, V4, P4, DOI 10.12942/lrr-2001-4	19	117	117	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 4	2008	321	5885					104	107		10.1126/science.1159295	http://dx.doi.org/10.1126/science.1159295			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QE	18599782	Green Submitted			2022-12-28	WOS:000257320800046
J	Read, KA; Mahajan, AS; Carpenter, LJ; Evans, MJ; Faria, BVE; Heard, DE; Hopkins, JR; Lee, JD; Moller, SJ; Lewis, AC; Mendes, L; McQuaid, JB; Oetjen, H; Saiz-Lopez, A; Pilling, MJ; Plane, JMC				Read, Katie A.; Mahajan, Anoop S.; Carpenter, Lucy J.; Evans, Mathew J.; Faria, Bruno V. E.; Heard, Dwayne E.; Hopkins, James R.; Lee, James D.; Moller, Sarah J.; Lewis, Alastair C.; Mendes, Luis; McQuaid, James B.; Oetjen, Hilke; Saiz-Lopez, Alfonso; Pilling, Michael J.; Plane, John M. C.			Extensive halogen-mediated ozone destruction over the tropical Atlantic Ocean	NATURE			English	Article							MARINE BOUNDARY-LAYER; TROPOSPHERIC CHEMISTRY; BROMINE CHEMISTRY; MODEL; SIMULATION; BRO; OH	Increasing tropospheric ozone levels over the past 150 years have led to a significant climate perturbation(1); the prediction of future trends in tropospheric ozone will require a full understanding of both its precursor emissions and its destruction processes. A large proportion of tropospheric ozone loss occurs in the tropical marine boundary layer(2,3) and is thought to be driven primarily by high ozone photolysis rates in the presence of high concentrations of water vapour. A further reduction in the tropospheric ozone burden through bromine and iodine emitted from open- ocean marine sources has been postulated by numerical models(4-7), but thus far has not been verified by observations. Here we report eight months of spectroscopic measurements at the Cape Verde Observatory indicative of the ubiquitous daytime presence of bromine monoxide and iodine monoxide in the tropical marine boundary layer. A year- round data set of co- located in situ surface trace gas measurements made in conjunction with low- level aircraft observations shows that the mean daily observed ozone loss is similar to 50 per cent greater than that simulated by a global chemistry model using a classical photochemistry scheme that excludes halogen chemistry. We perform box model calculations that indicate that the observed halogen concentrations induce the extra ozone loss required for the models to match observations. Our results show that halogen chemistry has a significant and extensive influence on photochemical ozone loss in the tropical Atlantic Ocean boundary layer. The omission of halogen sources and their chemistry in atmospheric models may lead to significant errors in calculations of global ozone budgets, tropospheric oxidizing capacity and methane oxidation rates, both historically and in the future.	[Read, Katie A.; Carpenter, Lucy J.; Moller, Sarah J.] Univ York, Dept Chem, York YO10 5DD, N Yorkshire, England; [Mahajan, Anoop S.; Heard, Dwayne E.; Oetjen, Hilke; Pilling, Michael J.; Plane, John M. C.] Univ Leeds, Sch Chem, Leeds LS2 9JT, W Yorkshire, England; [Evans, Mathew J.; McQuaid, James B.] Univ Leeds, SEE, Leeds LS2 9JT, W Yorkshire, England; [Faria, Bruno V. E.; Mendes, Luis] INMG, Mindelo, Cape Verde; [Hopkins, James R.; Lee, James D.; Lewis, Alastair C.] Univ York, NCAS, York YO10 5DD, N Yorkshire, England; [Saiz-Lopez, Alfonso] CALTECH, Jet Prop Lab, Div Earth & Space Sci, Pasadena, CA 91109 USA	University of York - UK; University of Leeds; University of Leeds; University of York - UK; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Carpenter, LJ (corresponding author), Univ York, Dept Chem, York YO10 5DD, N Yorkshire, England.	ljc4@york.ac.uk; j.m.c.plane@leeds.ac.uk	Heard, Dwayne/M-3624-2017; Lewis, Alastair C/A-6721-2008; Saiz-Lopez, Alfonso/B-3759-2015; Evans, Mathew J/A-3886-2012; McQuaid, James B/C-7450-2011; Oetjen, Hilke/H-3708-2016; Mahajan, Anoop S/D-2714-2012; Plane, John M C/C-7444-2015; Oetjen, Hilke/AAU-5212-2021; Carpenter, Lucy J/E-6742-2013	Heard, Dwayne/0000-0002-0357-6238; Lewis, Alastair C/0000-0002-4075-3651; Saiz-Lopez, Alfonso/0000-0002-0060-1581; Evans, Mathew J/0000-0003-4775-032X; McQuaid, James B/0000-0001-8702-0415; Oetjen, Hilke/0000-0002-3542-1337; Mahajan, Anoop S/0000-0002-2909-5432; Plane, John M C/0000-0003-3648-6893; Oetjen, Hilke/0000-0002-3542-1337; Read, Katie/0000-0002-4044-455X; Lee, James D/0000-0001-5397-2872; Moller, Sarah/0000-0003-4923-9509; HOPKINS, JAMES/0000-0002-0447-2633; Carpenter, Lucy/0000-0002-6257-3950	NERC [NE/D006570/1, NE/E011330/1, NE/E01111X/1, ncas10008, NE/D006562/1] Funding Source: UKRI; Natural Environment Research Council [ncas10008, NE/E01111X/1, NER/J/S/2002/00641, NE/E011330/1, NE/D006562/1, NE/D006570/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Allan BJ, 2000, J GEOPHYS RES-ATMOS, V105, P24191, DOI 10.1029/2000JD900314; Bey I, 2001, J GEOPHYS RES-ATMOS, V106, P23073, DOI 10.1029/2001JD000807; Bloss WJ, 2005, FARADAY DISCUSS, V130, P425, DOI 10.1039/b419090d; Davis D, 2004, ATMOS ENVIRON, V38, P5375, DOI 10.1016/j.atmosenv.2004.04.039; Dickerson RR, 1999, J GEOPHYS RES-ATMOS, V104, P21385, DOI 10.1029/1999JD900023; Falkowski PG, 1997, NATURE, V387, P272, DOI 10.1038/387272a0; Galbally IE, 2000, GEOPHYS RES LETT, V27, P3841, DOI 10.1029/1999GL010943; Hopkins J.R., 2002, J ENVIRON MONITOR, V4, P1; Horowitz LW, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002853; *IPCC, CLIM CHANG 2007 PHYS; JUNGE CE, 1962, TELLUS, V14, P363, DOI 10.3402/tellusa.v14i4.9563; Lawrence MG, 2001, ATMOS CHEM PHYS, V1, P37, DOI 10.5194/acp-1-37-2001; Lelieveld J, 2004, SCIENCE, V304, P1483, DOI 10.1126/science.1096777; Leser H, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL015811; Parrish DD, 1998, J GEOPHYS RES-ATMOS, V103, P13357, DOI 10.1029/98JD00376; Plane JMC, 2006, ANAL TECHNIQUES ATMO; Platt U., 1994, AIR MONITORING SPECT, P27; Sander R, 1999, GEOPHYS RES LETT, V26, P2857, DOI 10.1029/1999GL900478; Simmonds PG, 2004, ATMOS ENVIRON, V38, P4769, DOI 10.1016/j.atmosenv.2004.04.036; TOUMI R, 1994, GEOPHYS RES LETT, V21, P117, DOI 10.1029/93GL03536; Vogt R, 1999, J ATMOS CHEM, V32, P375, DOI 10.1023/A:1006179901037; Vogt R, 1996, NATURE, V383, P327, DOI 10.1038/383327a0; von Glasow R, 2004, ATMOS CHEM PHYS, V4, P2481, DOI 10.5194/acp-4-2481-2004; von Glasow R, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000942; Wild O, 2000, J ATMOS CHEM, V37, P245, DOI 10.1023/A:1006415919030; Yang X, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD006244	26	312	317	6	171	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2008	453	7199					1232	1235		10.1038/nature07035	http://dx.doi.org/10.1038/nature07035			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318FA	18580948				2022-12-28	WOS:000257075800041
J	Goulielmakis, E; Schultze, M; Hofstetter, M; Yakovlev, VS; Gagnon, J; Uiberacker, M; Aquila, AL; Gullikson, EM; Attwood, DT; Kienberger, R; Krausz, F; Kleineberg, U				Goulielmakis, E.; Schultze, M.; Hofstetter, M.; Yakovlev, V. S.; Gagnon, J.; Uiberacker, M.; Aquila, A. L.; Gullikson, E. M.; Attwood, D. T.; Kienberger, R.; Krausz, F.; Kleineberg, U.			Single-cycle nonlinear optics	SCIENCE			English	Article							ATTOSECOND CONTROL; PHASE RETRIEVAL; IONIZATION; PULSES; SPECTRA; ATOMS	Nonlinear optics plays a central role in the advancement of optical science and laser- based technologies. We report on the confinement of the nonlinear interaction of light with matter to a single wave cycle and demonstrate its utility for time- resolved and strong- field science. The electric field of 3.3- femtosecond, 0.72- micron laser pulses with a controlled and measured waveform ionizes atoms near the crests of the central wave cycle, with ionization being virtually switched off outside this interval. Isolated sub- 100- attosecond pulses of extreme ultraviolet light ( photon energy similar to 80 electron volts), containing similar to 0.5 nanojoule of energy, emerge from the interaction with a conversion efficiency of similar to 10(-6). These tools enable the study of the precision control of electron motion with light fields and electron- electron interactions with a resolution approaching the atomic unit of time (similar to 24 attoseconds).	[Goulielmakis, E.; Schultze, M.; Gagnon, J.; Kienberger, R.; Krausz, F.] Max Planck Inst Quantum Opt, D-85748 Garching, Germany; [Hofstetter, M.; Yakovlev, V. S.; Uiberacker, M.; Krausz, F.; Kleineberg, U.] Univ Munich, Dept Phys, D-85748 Garching, Germany; [Aquila, A. L.; Gullikson, E. M.; Attwood, D. T.] Univ Calif Berkeley, Lawrence Berkeley Lab, Ctr Xray Opt, Berkeley, CA 94720 USA	Max Planck Society; University of Munich; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Goulielmakis, E (corresponding author), Max Planck Inst Quantum Opt, Hans Kopfermann Str 1, D-85748 Garching, Germany.	elgo@mpq.mpg.de; krausz@lmu.de; ulf.kleineberg@physik.uni-muenchen.de	Yakovlev, Vladislav S/C-4091-2015; Goulielmakis, Eleftherios/F-1693-2011; Hädrich, Steffen/B-4331-2008; Goulielmakis, Eleftherios/AAZ-1052-2020	Yakovlev, Vladislav S/0000-0002-0648-9375; Goulielmakis, Eleftherios/0000-0003-3386-0245; Kienberger, Reinhard/0000-0001-8781-3685; Schultze, Martin/0000-0003-0438-9255; Aquila, Andrew/0000-0003-0358-2774				Baltuska A, 2003, NATURE, V421, P611, DOI 10.1038/nature01414; Breidbach J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.033901; Cavalieri AL, 2007, NATURE, V449, P1029, DOI 10.1038/nature06229; Cavalieri AL, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/7/242; CORKUM PB, 1993, PHYS REV LETT, V71, P1994, DOI 10.1103/PhysRevLett.71.1994; Goulielmakis E, 2004, SCIENCE, V305, P1267, DOI 10.1126/science.1100866; Goulielmakis E, 2007, SCIENCE, V317, P769, DOI 10.1126/science.1142855; Haworth CA, 2007, NAT PHYS, V3, P52, DOI 10.1038/nphys463; Hu SX, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.073004; Kane DJ, 1997, J OPT SOC AM B, V14, P935, DOI 10.1364/JOSAB.14.000935; Kienberger R, 2004, NATURE, V427, P817, DOI 10.1038/nature02277; Kling MF, 2006, SCIENCE, V312, P246, DOI 10.1126/science.1126259; Kuleff AI, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1961341; Loh ZH, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.143601; Lopez-Martens R, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.033001; Mairesse Y, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.011401; Oishi Y, 2006, OPT EXPRESS, V14, P7230, DOI 10.1364/OE.14.007230; Pfeifer T, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.163901; Remacle F, 2006, P NATL ACAD SCI USA, V103, P6793, DOI 10.1073/pnas.0601855103; Salieres P, 2001, SCIENCE, V292, P902, DOI 10.1126/science.108836; Sansone G, 2006, SCIENCE, V314, P443, DOI 10.1126/science.1132838; SCHAFER KJ, 1993, PHYS REV LETT, V70, P1599, DOI 10.1103/PhysRevLett.70.1599; SVENSSON S, 1988, J ELECTRON SPECTROSC, V47, P327, DOI 10.1016/0368-2048(88)85020-5; TREBINO R, 1993, J OPT SOC AM A, V10, P1101, DOI 10.1364/JOSAA.10.001101; Uiberacker M, 2007, NATURE, V446, P627, DOI 10.1038/nature05648; Varju K, 2005, LASER PHYS, V15, P888; Yakovlev VS, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.153901; Yudin GL, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.035401	28	1296	1368	9	385	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2008	320	5883					1614	1617		10.1126/science.1157846	http://dx.doi.org/10.1126/science.1157846			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	315NM	18566281	Green Submitted			2022-12-28	WOS:000256886700041
J	Trock, BJ; Han, M; Freedland, SJ; Humphreys, EB; DeWeese, TL; Partin, AW; Walsh, PC				Trock, Bruce J.; Han, Misop; Freedland, Stephen J.; Humphreys, Elizabeth B.; DeWeese, Theodore L.; Partin, Alan W.; Walsh, Patrick C.			Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ANTIGEN DOUBLING TIME; RADIATION-THERAPY; BREAST-CANCER; POSTOPERATIVE RADIOTHERAPY; LOCAL RECURRENCE; FAILURE; SURGERY; PSA	Context Biochemical disease recurrence after radical prostatectomy often prompts salvage radiotherapy, but no studies to date have had sufficient numbers of patients or follow-up to determine whether radiotherapy improves survival, and if so, the sub-group of men most likely to benefit. Objectives To quantify the relative improvement in prostate cancer-specific survival of salvage radiotherapy vs no therapy after biochemical recurrence following prostatectomy, and to identify subgroups for whom salvage treatment is most beneficial. Design, Setting, and Patients Retrospective analysis of a cohort of 635 US men undergoing prostatectomy from 1982-2004, followed up through December 28, 2007, who experienced biochemical and/or local recurrence and received no salvage treatment (n = 397), salvage radiotherapy alone (n = 160), or salvage radiotherapy combined with hormonal therapy (n = 78). Main Outcome Measure Prostate cancer-specific survival defined from time of recurrence until death from disease. Results With a median follow-up of 6 years after recurrence and 9 years after prostatectomy, 116 men (18%) died from prostate cancer, including 89 (22%) who received no salvage treatment, 18 (11%) who received salvage radiotherapy alone, and 9 (12%) who received salvage radiotherapy and hormonal therapy. Salvage radiotherapy alone was associated with a significant 3-fold increase in prostate cancer-specific survival relative to those who received no salvage treatment (hazard ratio [HR], 0.32 [95% confidence interval {CI}, 0.19-0.54]; P <.001). Addition of hormonal therapy to salvage radiotherapy was not associated with any additional increase in prostate cancer-specific survival (HR, 0.34 [95% CI, 0.17-0.69]; P = .003). The increase in prostate cancer-specific survival associated with salvage radiotherapy was limited to men with a prostate-specific antigen doubling time of less than 6 months and remained after adjustment for pathological stage and other established prognostic factors. Salvage radiotherapy initiated more than 2 years after recurrence provided no significant increase in prostate cancer-specific survival. Men whose prostate-specific antigen level never became undetectable after salvage radiotherapy did not experience a significant increase in prostate cancer-specific survival. Salvage radiotherapy also was associated with a significant increase in overall survival. Conclusions Salvage radiotherapy administered within 2 years of biochemical recurrence was associated with a significant increase in prostate cancer-specific survival among men with a prostate-specific antigen doubling time of less than 6 months, independent of other prognostic features such as pathological stage or Gleason score. These preliminary findings should be validated in other settings, and ultimately, in a randomized controlled trial.	[Trock, Bruce J.; Han, Misop; Humphreys, Elizabeth B.; Partin, Alan W.; Walsh, Patrick C.] Johns Hopkins Univ, Sch Med, James Buchanan Brady Urol Inst, Baltimore, MD 21287 USA; [DeWeese, Theodore L.] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD 21287 USA; [Freedland, Stephen J.] Durham Vet Affairs Med Ctr, Surg Sect, Durham, NC USA; [Freedland, Stephen J.] Duke Univ, Sch Med, Duke Prostate Ctr, Dept Surg, Durham, NC USA; [Freedland, Stephen J.] Duke Univ, Sch Med, Duke Prostate Ctr, Dept Pathol, Durham, NC USA	Johns Hopkins University; Johns Hopkins University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; Duke University	Trock, BJ (corresponding author), Johns Hopkins Univ, Sch Med, James Buchanan Brady Urol Inst, 600 N Wolfe St,546 Phipps Bldg, Baltimore, MD 21287 USA.	btrock@jhmi.edu			NATIONAL CANCER INSTITUTE [P50CA058236, P30CA006973] Funding Source: NIH RePORTER; NCI NIH HHS [CA58236, P30 CA006973, P50 CA058236, P50 CA058236-13] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abe O, 2005, LANCET, V366, P2087; Anscher MS, 2000, INT J RADIAT ONCOL, V48, P369, DOI 10.1016/S0360-3016(00)00645-3; Boccon-Gibod L, 2007, EUR UROL SUPPL, V6, P521, DOI 10.1016/j.eursup.2007.01.026; Bolla M, 2005, LANCET, V366, P572, DOI 10.1016/S0140-6736(05)67101-2; Buskirk SJ, 2006, J UROLOGY, V176, P985, DOI 10.1016/j.juro.2006.04.083; Chawla AK, 2002, UROLOGY, V59, P726, DOI 10.1016/S0090-4295(02)01540-6; Choo R, 2006, BJU INT, V98, P773, DOI 10.1111/j.1464-410X.2006.06423.x; Han M, 2001, UROL CLIN N AM, V28, P555, DOI 10.1016/S0094-0143(05)70163-4; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Katz MS, 2003, J CLIN ONCOL, V21, P483, DOI 10.1200/JCO.2003.12.043; Leventis AK, 2001, J CLIN ONCOL, V19, P1030, DOI 10.1200/JCO.2001.19.4.1030; Liauw SL, 2003, UROLOGY, V61, P1204, DOI 10.1016/S0090-4295(03)00044-X; Maffezzini M, 2007, EUR UROL, V51, P605, DOI 10.1016/j.eururo.2006.10.062; Overgaard M, 1999, LANCET, V353, P1641, DOI 10.1016/S0140-6736(98)09201-0; Overgaard M, 1997, NEW ENGL J MED, V337, P949, DOI 10.1056/NEJM199710023371401; PARTIN AW, 1994, UROLOGY, V43, P649, DOI 10.1016/0090-4295(94)90180-5; Penson DF, 2007, J UROLOGY, V177, P2020, DOI 10.1016/j.juro.2007.01.121; Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591; Ragaz J, 2005, JNCI-J NATL CANCER I, V97, P116, DOI 10.1093/jnci/djh297; Song DY, 2002, UROLOGY, V60, P281, DOI 10.1016/S0090-4295(02)01709-0; Stephenson AJ, 2004, JAMA-J AM MED ASSOC, V291, P1325, DOI 10.1001/jama.291.11.1325; Stephenson AJ, 2007, J CLIN ONCOL, V25, P2035, DOI 10.1200/JCO.2006.08.9607; Thompson IM, 2006, JAMA-J AM MED ASSOC, V296, P2329, DOI 10.1001/jama.296.19.2329; Ward JF, 2005, NAT CLIN PRACT UROL, V2, P174, DOI 10.1038/ncpuro0145; Ward JF, 2004, J UROLOGY, V172, P2244, DOI 10.1097/01.ju.0000145262.34748.2b	25	514	524	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 18	2008	299	23					2760	2769		10.1001/jama.299.23.2760	http://dx.doi.org/10.1001/jama.299.23.2760			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	314JH	18560003	Green Accepted, Bronze			2022-12-28	WOS:000256805200024
J	Bunnell, R; Cherutich, P				Bunnell, Rebecca; Cherutich, Peter			Universal HIV testing and counselling in Africa	LANCET			English	Editorial Material							ANTIRETROVIRAL THERAPY; UGANDA; TRANSMISSION		[Bunnell, Rebecca] Ctr Dis Control & Prevent Kenya, Global Programme AIDS, Nairobi, Kenya; [Cherutich, Peter] Minist Hlth, Natl AIDS STD Control Programme, Nairobi, Kenya		Bunnell, R (corresponding author), Ctr Dis Control & Prevent Kenya, Global Programme AIDS, POB 606-00621 Village Market, Nairobi, Kenya.	rrb7@cdc.gov						Apondi R, 2007, JAIDS-J ACQ IMM DEF, V44, P71, DOI 10.1097/01.qai.0000243113.29412.dd; Baryarama F, 2004, JAIDS-J ACQ IMM DEF, V37, P1180, DOI 10.1097/01.qai.0000127063.76701.bb; Bunnell R, 2008, AIDS, V22, P617, DOI 10.1097/QAD.0b013e3282f56b53; *CDCP, COUPLS HIV COUNS TES; Cohen MS, 2007, ANN INTERN MED, V146, P591, DOI 10.7326/0003-4819-146-8-200704170-00010; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; *MEAS DHS MACRO IN, DEM HLTH SURV; NASCOP, 2005, AIDS KEN; UNAIDS, 2007, FIN RES REQ ACH UN A; Wanyenze RK, 2008, B WORLD HEALTH ORGAN, V86, P302, DOI 10.2471/BLT.07.042580; Were WA, 2006, JAIDS-J ACQ IMM DEF, V43, P91, DOI 10.1097/01.qai.0000225021.81384.28; *WHO, WHO TEST COUNS TOOLK; *WHO UNAIDS UNICEF, 2007, UN ACC SCAL PRIOR HI; Williams BG, 2006, PLOS MED, V3, P1032, DOI 10.1371/journal.pmed.0030262	14	23	23	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN-JUL	2008	371	9631					2148	2150		10.1016/S0140-6736(08)60929-0	http://dx.doi.org/10.1016/S0140-6736(08)60929-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	326CP	18586156				2022-12-28	WOS:000257635800005
J	Horton, R				Horton, Richard			What does a National Health Service mean in the 21st century?	LANCET			English	Editorial Material							MENTAL-HEALTH		[Horton, Richard] The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, 32 Jamestown Rd, London NW1 7BY, England.	richard.horton@lancet.com						[Anonymous], 2008, LANCET, V371, P1638, DOI 10.1016/S0140-6736(08)60701-1; [Anonymous], 2007, Lancet, V370, P2070; *AUD COMM, 2007, REV NHS FIN YEAR 200; BAKER G, 2008, TIMES LONDON    0419, P43; BENNETT R, 2008, TIMES LONDON    0424, P21; Black C., 2008, WORKING HLTH TOMORRO; *BMA, CAR NHS 60; Bobbio N, 2005, AGE RIGHTS; Campbell EG, 2007, ANN INTERN MED, V147, P795, DOI 10.7326/0003-4819-147-11-200712040-00012; Daniels Norman, 2008, JUST HLTH M HLTH NEE; Darzi A, 2008, LANCET, V371, P1563, DOI 10.1016/S0140-6736(08)60672-8; Devlin K, 2009, DAILY TELEGRAPH 0517, P1; DIXON A, 2008, GOVERNING NHS ALTERN; Donaldson L, 2007, LANCET, V369, P857, DOI 10.1016/S0140-6736(07)60327-4; EVERIDGE W, 1942, SOCIAL INSURANCE ALL; Frenk J, 2006, LANCET, V368, P1524, DOI 10.1016/S0140-6736(06)69564-0; Hart JT, 2008, LANCET, V371, P1883, DOI 10.1016/S0140-6736(08)60802-8; HUNT P, 2006, IMPLEMENTATION GEN A; Josephson AM, 2007, PSYCHIAT CLIN N AM, V30, P181, DOI 10.1016/j.psc.2007.01.005; Kripalani S, 2007, AM J PREV MED, V33, P83, DOI 10.1016/j.amepre.2007.03.018; Leatherman S, 2008, QUEST QUALITY REFINI; Levenson R., 2008, UNDERSTANDING DOCTOR; Lindert J, 2008, EUR PSYCHIAT, V23, pS14, DOI 10.1016/S0924-9338(08)70057-9; McCrone PR., 2008, PAYING PRICE COST ME; Meeuwesen L, 2007, PATIENT EDUC COUNS, V67, P183, DOI 10.1016/j.pec.2007.03.013; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; *NAT AUD OFF, 2008, NAT PROGR IT NHS PRO; National Audit Office, 2007, IMPR PFI TEND PROC; Nolte E, 2008, HEALTH AFFAIR, V27, P58, DOI 10.1377/hlthaff.27.1.58; ONEILL S, 2008, TIMES           0425, P6; Patel V, 2007, LANCET, V369, P1302, DOI 10.1016/S0140-6736(07)60368-7; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Royal College of Physicians, 2005, DOCT SOC MED PROF CH; STILGOE J, 2008, TALKING CURE WHY CON; Taylor K, 2008, J ROY SOC MED, V101, P182, DOI 10.1258/jrsm.2007.070276; Todd Janet, 2000, M WOLLSTONECRAFT REV; UN Economic and Social Council, RIGHT HIGH ATT STAND; United Nations, UN DECL HUM RIGHTS; WHO World Health Organization, 2006, CONST WHO; WINTOUR P, 2008, GUARDIAN LONDON 0219, P11; WOLLSTONECRAFT M, 1936, POLITICAL WRITINGS; Zandbelt LC, 2007, PATIENT EDUC COUNS, V65, P396, DOI 10.1016/j.pec.2006.09.011; 2007, LANCET, V370, P2; 2008, LANCET, V371, P178; 2008, BMA NEWS LONDON 0517, P1	45	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN-JUL	2008	371	9631					2213	2218		10.1016/S0140-6736(08)60956-3	http://dx.doi.org/10.1016/S0140-6736(08)60956-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	326CP	18586176				2022-12-28	WOS:000257635800028
J	Taylor, S; Marandi, A				Taylor, Sebastian; Marandi, Alireza			Social determinants of health and the design of health programmes for the poor	BRITISH MEDICAL JOURNAL			English	Editorial Material							IMPROVING ACCESS; EQUITY-FUND; CAMBODIA; CARE		[Taylor, Sebastian] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; [Marandi, Alireza] Shahid Beheshti Univ, Tehran, Iran	University of London; University College London; Shahid Beheshti University	Taylor, S (corresponding author), UCL, Dept Epidemiol & Publ Hlth, Mortimer St, London WC1E 6BT, England.	ebastian.taylor@ucl.ac.uk						Anderson AS, 2007, NUTR BULL, V32, P15, DOI 10.1111/j.1467-3010.2007.00612.x; Asadi-Lari M, 2004, PUBLIC HEALTH, V118, P395, DOI 10.1016/j.puhe.2004.05.011; BESHRAOV D, 2001, RETHINKING WIC EVALU; Goldberg N., 2005, GRAMEEN FDN US PUBLI; Gwatkin D., 2005, WHAT WORKS WHAT DOES; Gwatkin D. R, 2000, CURRENT STATE KNOWLE; Hardeman W, 2004, HEALTH POLICY PLANN, V19, P22, DOI 10.1093/heapol/czh003; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; *HRP, 2002, YOUNG FEM MIGR WORK; International Food Policy Research Institute, 2002, PROGRESA BREAK CYCL; Jacobs B, 2006, HEALTH POLICY PLANN, V21, P27, DOI 10.1093/heapol/czj001; Jacobs B, 2007, INT J HEALTH PLAN M, V22, P183, DOI 10.1002/hpm.890; MAHRYAR A, 2004, SCAL POV RED GLOB LE; Marandi A, 1998, HLTH ISLAMIC REPUBLI; Mkandawire T., 2005, TARGETING UNIVERSALI; Noirhomme M, 2007, HEALTH POLICY PLANN, V22, P246, DOI 10.1093/heapol/czm015; RONAGHY HA, 1973, LANCET, V2, P427; Roudi-Fahimi Farzaneh, 2002, IRANS FAMILY PLANNIN; RUSH D, 1988, AM J CLIN NUTR, V48, P439, DOI 10.1093/ajcn/48.2.439; Tugwell P, 2006, LANCET, V367, P1128, DOI 10.1016/S0140-6736(06)68490-0; Whitehead M, 2001, LANCET, V358, P833, DOI 10.1016/S0140-6736(01)05975-X; *WHO COMM SOC DET, 2007, CHALL IN HLTH SYST F; ZEIGHAMI B, 1976, VILL HLTH WORK P WOR; ZEIGHAMI B, 1977, PUBLIC HLTH REP, V92	24	5	5	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 2	2008	337	7664							a290	10.1136/bmj.a290	http://dx.doi.org/10.1136/bmj.a290			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	339EN	18614520				2022-12-28	WOS:000258561000026
J	Bynum, B				Bynum, Bill			Historical keyword - Guineapig	LANCET			English	Editorial Material												w.bynum@ucl.ac.uk							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 12	2008	372	9633					107	107		10.1016/S0140-6736(08)61019-3	http://dx.doi.org/10.1016/S0140-6736(08)61019-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	324XJ	18620938				2022-12-28	WOS:000257552400013
J	Kayser, B; Smith, ACT				Kayser, Bengt; Smith, Aaron C. T.			Globalisation of anti-doping: the reverse side of the medal	BRITISH MEDICAL JOURNAL			English	Editorial Material							SPORT; DRUGS		[Kayser, Bengt] Univ Geneva, Inst Movement Sci & Sports Med, CH-1211 Geneva 4, Switzerland; [Smith, Aaron C. T.] La Trobe Univ, Fac Law & Management, Melbourne, Vic, Australia	University of Geneva; La Trobe University	Kayser, B (corresponding author), Univ Geneva, Inst Movement Sci & Sports Med, CH-1211 Geneva 4, Switzerland.	bengt.kayser@medecine.unige.ch	Kayser, Bengt/M-8643-2013	Kayser, Bengt/0000-0002-9776-7501				Aitken C, 2002, DRUG ALCOHOL DEPEN, V65, P303, DOI 10.1016/S0376-8716(01)00174-0; [Anonymous], 2000, SPORT HLTH DRUGS CRI; Caulkins J. P., 2005, AM J PUBLIC HEALTH, V85, P1059; Dawson RT, 2001, J ENDOCRINOL, V170, P55, DOI 10.1677/joe.0.1700055; DONATI S, 2007, WORLD TRAFFIC DOPING; Dunning E., 2003, International Review for the Sociology of Sport, V38, P351, DOI 10.1177/10126902030383006; Frederick-Recascino C. M., 2003, Journal of Sport Behavior, V26, P240; Joffe A, 2007, PEDIATRICS, V119, P627, DOI 10.1542/peds.2006-3688; Kayser Bengt, 2007, BMC Med Ethics, V8, P2, DOI 10.1186/1472-6939-8-2; Long J., 2001, Sport in the city: the role of sport in economic and social regeneration, P187; LUNDBY C, IN PRESS J APPL PHYS; MCVEIGH J, 2003, INT J DRUG POLICY, V14, P6; Melia P, 1996, CLIN J SPORT MED, V6, P9, DOI 10.1097/00042752-199601000-00004; Morris L., 2004, Youth Studies Australia, V23, P47; Pope HG, 2004, ADDICTION, V99, P1189, DOI 10.1111/j.1360-0443.2004.00781.x; Savulescu J, 2004, BRIT J SPORT MED, V38, P666, DOI 10.1136/bjsm.2003.005249; Smith ACT, 2008, DRUG ALCOHOL REV, V27, P123, DOI 10.1080/09595230701829355; UNESCO, 2005, INT CONV DOP SPORT; World Anti-Doping Agency (WADA), 2008, PROGR STAT; Yesalis CE, 2000, CLIN J SPORT MED, V10, P1, DOI 10.1097/00042752-200001000-00001	20	44	45	1	10	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 12	2008	337	7661							a584	10.1136/bmj.a584	http://dx.doi.org/10.1136/bmj.a584			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	330SA	18614466				2022-12-28	WOS:000257961900031
J	Pasanen, K; Parkkari, J; Pasanen, M; Hiilloskorpi, H; Makinen, T; Jarvinen, M; Kannus, P				Pasanen, Kati; Parkkari, Jari; Pasanen, Matti; Hiilloskorpi, Hannele; Makinen, Tanja; Jarvinen, Markku; Kannus, Pekka			Neuromuscular training and the risk of leg injuries in female floorball players: cluster randomised controlled study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							EUROPEAN TEAM HANDBALL; SOCCER INJURIES; ANKLE SPRAINS; CONTROLLED-TRIAL; SPORTS INJURIES; FOLLOW-UP; PREVENTION; PROGRAM; OSTEOARTHRITIS; INTERVENTION	Objective To investigate whether a neuromuscular training programme is effective in preventing non-contact leg injuries in female floorball players. Design Cluster randomised controlled study. Setting 28 top level female floorball teams in Finland. Participants 457 players (mean age 24 years)-256 (14 teams) in the intervention group and 201 (14 teams) in the control group-followed up for one league season (six months). Intervention A neuromuscular training programme to enhance players' motor skills and body control, as well as to activate and prepare their neuromuscular system for sports specific manoeuvres. Main outcome measure Acute non-contact injuries of the legs. Results During the season, 72 acute non-contact leg injuries occurred, 20 in the intervention group and 52 in the control group. The injury incidence per 1000 hours playing and practise in the intervention group was 0.65 (95% confidence interval 0.37 to 1.13) and in the control group was 2.08 (1.58 to 2.72). The risk of non-contact leg injury was 66% lower (adjusted incidence rate ratio 0.34, 95% confidence interval 0.20 to 0.57) in the intervention group. Conclusion A neuromuscular training programme was effective in preventing acute non-contact injuries of the legs in female floorball players. Neuromuscular training can be recommended in the weekly training of these athletes. Trial registration Current Controlled Trials ISRCTN26550281.	[Pasanen, Kati; Parkkari, Jari; Pasanen, Matti; Hiilloskorpi, Hannele; Makinen, Tanja] UKK Inst Hlth Promot Res, Tampere Res Ctr Sports Med, FIN-33501 Tampere, Finland; [Kannus, Pekka] UKK Inst Hlth Promot Res, Injury & Osteoporosis Res Ctr, FIN-33501 Tampere, Finland; [Jarvinen, Markku] Univ Tampere, Tampere Univ Hosp & Med Sch, Dept Surg, FIN-33101 Tampere, Finland	UKK Institute; UKK Institute; Tampere University; Tampere University Hospital	Pasanen, K (corresponding author), UKK Inst Hlth Promot Res, Tampere Res Ctr Sports Med, FIN-33501 Tampere, Finland.	kati.pasanen@uta.fi	Pasanen, Kati/Z-2085-2018	Pasanen, Kati/0000-0002-0427-2877				Aaltonen S, 2007, ARCH INTERN MED, V167, P1585, DOI 10.1001/archinte.167.15.1585; Deacon A, 1997, MED J AUSTRALIA, V166, P187, DOI 10.5694/j.1326-5377.1997.tb140072.x; EKSTRAND J, 1983, AM J SPORT MED, V11, P116, DOI 10.1177/036354658301100302; EKSTRAND J, 1983, INT J SPORTS MED, V4, P124, DOI 10.1055/s-2008-1026025; EKSTRAND J, 1983, MED SCI SPORT EXER, V15, P267, DOI 10.1249/00005768-198315030-00014; Emery CA, 2005, CAN MED ASSOC J, V172, P749, DOI 10.1503/cmaj.1040805; Heidt RS, 2000, AM J SPORT MED, V28, P659, DOI 10.1177/03635465000280050601; Hewett TE, 1999, AM J SPORT MED, V27, P699, DOI 10.1177/03635465990270060301; Hinton RY, 2005, AM J SPORT MED, V33, P1305, DOI 10.1177/0363546504274148; Kofotolis ND, 2007, AM J SPORT MED, V35, P458, DOI 10.1177/0363546506294857; Lofgren O., 1994, Scandinavian Journal of Medicine and Science in Sports, V4, P211; Lohmander LS, 2007, AM J SPORT MED, V35, P1756, DOI 10.1177/0363546507307396; McGuine TA, 2006, AM J SPORT MED, V34, P1103, DOI 10.1177/0363546505284191; McHugh MP, 2006, AM J SPORT MED, V34, P464, DOI 10.1177/0363546505280427; Messina DF, 1999, AM J SPORT MED, V27, P294, DOI 10.1177/03635465990270030401; Olsen O, 2005, BMJ-BRIT MED J, V330, P1, DOI DOI 10.1136//BMJ.38330.632801.8F; Parkkari J, 2004, INT J SPORTS MED, V25, P209, DOI 10.1055/s-2004-819935; Pasanen K, 2008, SCAND J MED SCI SPOR, V18, P49, DOI 10.1111/j.1600-0838.2007.00640.x; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Snellman K, 2001, INT J SPORTS MED, V22, P531, DOI 10.1055/s-2001-17609; Soderman K, 2000, KNEE SURG SPORT TR A, V8, P356, DOI 10.1007/s001670000147; Verhagen E, 2004, AM J SPORT MED, V32, P1385, DOI 10.1177/0363546503262177; Wedderkopp N, 1999, SCAND J MED SCI SPOR, V9, P41; Wedderkopp N, 1997, SCAND J MED SCI SPOR, V7, P342; Wikstrom J, 1997, SCAND J MED SCI SPOR, V7, P38	25	70	71	2	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 12	2008	337	7661							a295	10.1136/bmj.a295	http://dx.doi.org/10.1136/bmj.a295			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	330SA	18595903	Green Published			2022-12-28	WOS:000257961900034
J	Shaffer, AL; Emre, NCT; Lamy, L; Ngo, VN; Wright, G; Xiao, WM; Powell, J; Dave, S; Yu, X; Zhao, H; Zeng, YX; Chen, BZ; Epstein, J; Staudt, LM				Shaffer, Arthur L.; Emre, N. C. Tolga; Lamy, Laurence; Ngo, Vu N.; Wright, George; Xiao, Wenming; Powell, John; Dave, Sandeep; Yu, Xin; Zhao, Hong; Zeng, Yuxin; Chen, Bangzheng; Epstein, Joshua; Staudt, Louis M.			IRF4 addiction in multiple myeloma	NATURE			English	Article							PLASMA-CELL DIFFERENTIATION; LYMPHOMA-CELLS; MYC; EXPRESSION; CANCER; ACTIVATION; PROFILES; SURVIVAL	The transcription factor IRF4 ( interferon regulatory factor 4) is required during an immune response for lymphocyte activation and the generation of immunoglobulin- secreting plasma cells(1-3). Multiple myeloma, a malignancy of plasma cells, has a complex molecular aetiology with several subgroups defined by gene expression profiling and recurrent chromosomal translocations(4,5). Moreover, the malignant clone can sustain multiple oncogenic lesions, accumulating genetic damage as the disease progresses(6,7). Current therapies for myeloma can extend survival but are not curative(8,9). Hence, new therapeutic strategies are needed that target molecular pathways shared by all subtypes of myeloma. Here we show, using a loss- of- function, RNA- interference- based genetic screen, that IRF4 inhibition is toxic to myeloma cell lines, regardless of transforming oncogenic mechanism. Gene expression profiling and genome- wide chromatin immunoprecipitation analysis uncovered an extensive network of IRF4 target genes and identified MYC as a direct target of IRF4 in activated B cells and myeloma. Unexpectedly, IRF4 was itself a direct target of MYC transactivation, generating an autoregulatory circuit in myeloma cells. Although IRF4 is not genetically altered in most myelomas, they are nonetheless addicted to an aberrant IRF4 regulatory network that fuses the gene expression programmes of normal plasma cells and activated B cells.	[Shaffer, Arthur L.; Emre, N. C. Tolga; Lamy, Laurence; Ngo, Vu N.; Dave, Sandeep; Yu, Xin; Zhao, Hong; Staudt, Louis M.] NCI, Metab Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Wright, George] NCI, Biometr Res Branch, Rockville, MD 20892 USA; [Xiao, Wenming; Powell, John] NIH, Bioinformat & Mol Anal Sect, Div Computat Biosci, Ctr Informat Technol, Bethesda, MD 20892 USA; [Zeng, Yuxin; Chen, Bangzheng; Epstein, Joshua] Univ Arkansas Med Sci, Myeloma Inst Res & Therapy, Little Rock, AR 72212 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT); University of Arkansas System; University of Arkansas Medical Sciences	Staudt, LM (corresponding author), NCI, Metab Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	lstaudt@mail.nih.gov	Staudt, Louis/AAC-5324-2019; Emre, Tolga/A-1787-2016; Wright, George W/M-1660-2017	Emre, Tolga/0000-0001-8021-5228; Ngo, Vu/0000-0002-9501-6990	Intramural NIH HHS [Z99 CA999999] Funding Source: Medline; NCI NIH HHS [R01 CA113992-02, CA113992, R01 CA113992, CA97513, R33 CA097513-03] Funding Source: Medline; CENTER FOR INFORMATION TECHNOLOGY [Z01CT000260] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIABC011010, R33CA097513, R01CA113992, ZIABC011007] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Barlogie B, 2004, BLOOD, V103, P20, DOI 10.1182/blood-2003-04-1045; Bergsagel PL, 1996, P NATL ACAD SCI USA, V93, P13931, DOI 10.1073/pnas.93.24.13931; Carrasco DR, 2006, CANCER CELL, V9, P313, DOI 10.1016/j.ccr.2006.03.019; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; DIB A, IN PRESS J NATL CANC; Garraway LA, 2006, NAT REV CANCER, V6, P593, DOI 10.1038/nrc1947; GE H, 1994, CELL, V78, P513, DOI 10.1016/0092-8674(94)90428-6; Guney I, 2006, P NATL ACAD SCI USA, V103, P3645, DOI 10.1073/pnas.0600069103; Gutierrez NC, 2007, LEUKEMIA, V21, P541, DOI 10.1038/sj.leu.2404520; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Kim JW, 2007, MOL CELL BIOL, V27, P7381, DOI 10.1128/MCB.00440-07; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Kuehl WM, 2002, NAT REV CANCER, V2, P175, DOI 10.1038/nrc746; Liu J, 2006, CURR TOP MICROBIOL, V302, P1; Mitsiades CS, 2004, CANCER CELL, V6, P439, DOI 10.1016/j.ccr.2004.10.020; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Polo JM, 2004, NAT MED, V10, P1329, DOI 10.1038/nm1134; Sciammas R, 2006, IMMUNITY, V25, P225, DOI 10.1016/j.immuni.2006.07.009; Shou YP, 2000, P NATL ACAD SCI USA, V97, P228, DOI 10.1073/pnas.97.1.228; Solimini NL, 2007, CELL, V130, P986, DOI 10.1016/j.cell.2007.09.007; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tamura T, 2005, J IMMUNOL, V174, P2573, DOI 10.4049/jimmunol.174.5.2573; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103; Zhan F, 2006, BLOOD, V108, P2020, DOI 10.1182/blood-2005-11-013458	29	482	501	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 10	2008	454	7201					226	231		10.1038/nature07064	http://dx.doi.org/10.1038/nature07064			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	323RU	18568025	Green Accepted			2022-12-28	WOS:000257466900046
J	Walsh, KJ; Richardson, DC; Michel, P				Walsh, Kevin J.; Richardson, Derek C.; Michel, Patrick			Rotational breakup as the origin of small binary asteroids	NATURE			English	Article							COLLISIONS; MODEL	Asteroids with satellites are observed throughout the Solar System, from subkilometre near-Earth asteroid pairs to systems of large and distant bodies in the Kuiper belt. The smallest and closest systems are found among the near- Earth and small inner main- belt asteroids, which typically have rapidly rotating primaries and close secondaries on circular orbits. About 15 per cent of near- Earth and main- belt asteroids with diameters under 10 km have satellites(1,2). The mechanism that forms such similar binaries in these two dynamically different populations was hitherto unclear. Here we show that these binaries are created by the slow spinup of a `rubble pile' asteroid by means of the thermal YORP ( Yarkovsky - O'Keefe - Radzievskii - Paddack) effect. We find that mass shed from the equator of a critically spinning body accretes into a satellite if the material is collisionally dissipative and the primary maintains a low equatorial elongation. The satellite forms mostly from material originating near the primary's surface and enters into a close, low- eccentricity orbit. The properties of binaries produced by our model match those currently observed in the small near- Earth and main- belt asteroid populations, including 1999 KW4 ( refs 3, 4).	[Walsh, Kevin J.; Michel, Patrick] Univ Nice, UMR Cassiopee 6202, CNRS, Observ Cote Azur, F-06304 Nice 4, France; [Walsh, Kevin J.; Richardson, Derek C.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur; University System of Maryland; University of Maryland College Park	Walsh, KJ (corresponding author), Univ Nice, UMR Cassiopee 6202, CNRS, Observ Cote Azur, BP 4229, F-06304 Nice 4, France.	kwalsh@oca.eu	Richardson, Derek C/J-4257-2018; Michel, Patrick/AGX-0167-2022	Richardson, Derek C/0000-0002-0054-6850; Michel, Patrick/0000-0002-0884-1993				Cuk M, 2007, ASTROPHYS J, V659, pL57, DOI 10.1086/516572; Durda DD, 2004, ICARUS, V167, P382, DOI 10.1016/j.icarus.2003.09.017; FUJII Y, 2007, LUNAR PLANET SCI C, V38; Fujiwara A, 2006, SCIENCE, V312, P1330, DOI 10.1126/science.1125841; Kaasalainen M, 2007, NATURE, V446, P420, DOI 10.1038/nature05614; Lowry SC, 2007, SCIENCE, V316, P272, DOI 10.1126/science.1139040; Michel P, 2001, SCIENCE, V294, P1696, DOI 10.1126/science.1065189; Ostro SJ, 2006, SCIENCE, V314, P1276, DOI 10.1126/science.1133622; PADDACK SJ, 1975, GEOPHYS RES LETT, V2, P365, DOI 10.1029/GL002i009p00365; Pravec P, 2007, ICARUS, V190, P250, DOI 10.1016/j.icarus.2007.02.023; Pravec P, 2006, ICARUS, V181, P63, DOI 10.1016/j.icarus.2005.10.014; Pravec P, 2000, ICARUS, V148, P12, DOI 10.1006/icar.2000.6482; Richardson DC, 2005, ICARUS, V173, P349, DOI 10.1016/j.icarus.2004.09.007; RICHARDSON DC, 2002, ASTEROIDS, V3, P501; Richardson DC, 2006, ANNU REV EARTH PL SC, V34, P47, DOI 10.1146/annurev.earth.32.101802.120208; Rubincam DP, 2000, ICARUS, V148, P2, DOI 10.1006/icar.2000.6485; Scheeres DJ, 2006, SCIENCE, V314, P1280, DOI 10.1126/science.1133599; SUPULVER KD, 1995, ICARUS, V113, P188, DOI 10.1006/icar.1995.1015; Taylor PA, 2007, SCIENCE, V316, P274, DOI 10.1126/science.1139038; Walsh KJ, 2008, ICARUS, V193, P553, DOI 10.1016/j.icarus.2007.08.020; Walsh KJ, 2006, ICARUS, V180, P201, DOI 10.1016/j.icarus.2005.08.015	21	271	278	2	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2008	454	7201					188	191		10.1038/nature07078	http://dx.doi.org/10.1038/nature07078			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	323RU	18615078				2022-12-28	WOS:000257466900037
J	Lu-Yao, GL; Albertsen, PC; Moore, DF; Shih, WC; Lin, Y; DiPaola, RS; Yao, SL				Lu-Yao, Grace L.; Albertsen, Peter C.; Moore, Dirk F.; Shih, Weichung; Lin, Yong; DiPaola, Robert S.; Yao, Siu-Long			Survival following primary androgen deprivation therapy among men with localized prostate cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PLUS RADIATION-THERAPY; BICALUTAMIDE 150 MG; COMORBIDITY INDEX; CURATIVE INTENT; UNITED-STATES; SUPPRESSION; IMMEDIATE; DISEASE; RADIOTHERAPY; ABLATION	Context Despite a lack of data, increasing numbers of patients are receiving primary androgen deprivation therapy ( PADT) as an alternative to surgery, radiation, or conservative management for the treatment of localized prostate cancer. Objective To evaluate the association between PADT and survival in elderly men with localized prostate cancer. Design, Setting, and Patients A population- based cohort study of 19 271 men aged 66 years or older receiving Medicare who did not receive definitive local therapy for clinical stage T1-T2 prostate cancer. These patients were diagnosed in 1992- 2002 within predefined US geographical areas, with follow- up through December 31, 2006, for all- cause mortality and through December 31, 2004, for prostate cancer - specific mortality. Instrumental variable analysis was used to address potential biases associated with unmeasured confounding variables. Main Outcome Measures Prostate cancer - specific survival and overall survival. Results Among patients with localized prostate cancer ( median age, 77 years), 7867 ( 41%) received PADT, and 11 404 were treated with conservative management, not including PADT. During the follow- up period, there were 1560 prostate cancer deaths and 11 045 deaths from all causes. Primary androgen deprivation therapy was associated with lower 10- year prostate cancer - specific survival ( 80.1% vs 82.6%; hazard ratio [ HR], 1.17; 95% confidence interval [ CI], 1.03- 1.33) and no increase in 10- year overall survival ( 30.2% vs 30.3%; HR, 1.00; 95% CI, 0.96- 1.05) compared with conservative management. However, in a prespecified subset analysis, PADT use in men with poorly differentiated cancer was associated with improved prostate cancer specific survival ( 59.8% vs 54.3%; HR, 0.84; 95% CI, 0.70- 1.00; P=. 049) but not overall survival ( 17.3% vs 15.3%; HR, 0.92; 95% CI, 0.84- 1.01). Conclusion Primary androgen deprivation therapy is not associated with improved survival among the majority of elderly men with localized prostate cancer when compared with conservative management.	[Lu-Yao, Grace L.; Moore, Dirk F.; Shih, Weichung; Lin, Yong; DiPaola, Robert S.; Yao, Siu-Long] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst New Jersey, New Brunswick, NJ 08901 USA; [Lu-Yao, Grace L.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Environm & Occupat Med, Piscataway, NJ 08854 USA; [Moore, Dirk F.; Shih, Weichung; Lin, Yong] Univ Med & Dent New Jersey, Sch Publ Hlth, Dept Biostat, Piscataway, NJ 08854 USA; [Lu-Yao, Grace L.; DiPaola, Robert S.; Yao, Siu-Long] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Med, New Brunswick, NJ 08903 USA; [Albertsen, Peter C.] Univ Connecticut, Dept Urol Surg, Farmington, CT USA; [Lu-Yao, Grace L.; DiPaola, Robert S.] Dean & Betty Gallo Prostate Canc Ctr, New Brunswick, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Connecticut	Yao, SL (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst New Jersey, 195 Little Albany St,Room 5544, New Brunswick, NJ 08901 USA.	syao@aya.yale.edu		Lu-Yao, Grace/0000-0002-6017-9175	NCI NIH HHS [P30 CA072720, R01 CA116399-01A1, R01 CA116399, CA-72720-10, R01 CA116399-02, R01 CA116399-03] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA072720, R01CA116399] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adib RS, 1997, BRIT J UROL, V79, P235; Akaza H, 2006, CANCER SCI, V97, P243, DOI 10.1111/j.1349-7006.2006.00180.x; Akaza H, 2006, BJU INT, V98, P573, DOI 10.1111/j.1464-410X.2006.06349.x; Albertsen PC, 2000, J UROLOGY, V163, P519, DOI 10.1016/S0022-5347(05)67915-3; ALBERTSEN PC, 1995, JAMA-J AM MED ASSOC, V274, P626, DOI 10.1001/jama.274.8.626; Angrist JD, 1996, J AM STAT ASSOC, V91, P444, DOI 10.2307/2291629; [Anonymous], 1967, Surg Gynecol Obstet, V124, P1011; Banach-Petrosky W, 2007, CANCER RES, V67, P9089, DOI 10.1158/0008-5472.CAN-07-2887; Bolla M, 1997, NEW ENGL J MED, V337, P295, DOI 10.1056/NEJM199707313370502; Bolla M, 2002, LANCET, V360, P103, DOI 10.1016/S0140-6736(02)09408-4; Cooperberg MR, 2003, J NATL CANCER I, V95, P981, DOI 10.1093/jnci/95.13.981; Cooperberg MR, 2004, J UROLOGY, V171, P1393, DOI 10.1097/01.ju.0000107247.81471.06; D'Amico AV, 2007, J CLIN ONCOL, V25, P2420, DOI 10.1200/JCO.2006.09.3369; D'Amico AV, 2006, J CLIN ONCOL, V24, P4190, DOI 10.1200/JCO.2006.06.8239; D'Amico AV, 2004, JAMA-J AM MED ASSOC, V292, P821, DOI 10.1001/jama.292.7.821; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; DHOORE W, 1993, METHOD INFORM MED, V32, P382; Earle CC, 2001, J CLIN ONCOL, V19, P1064, DOI 10.1200/JCO.2001.19.4.1064; Fowler JE, 1996, J UROLOGY, V156, P1714, DOI 10.1016/S0022-5347(01)65489-2; Han GZ, 2005, P NATL ACAD SCI USA, V102, P1151, DOI 10.1073/pnas.0408925102; ISAACS JT, 1981, CANCER RES, V41, P5070; Iversen P, 2004, J UROLOGY, V172, P1871, DOI 10.1097/01.ju.0000139719.99825.54; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kapoor D, 2005, CLIN ENDOCRINOL, V63, P239, DOI 10.1111/j.1365-2265.2005.02299.x; Kawakami J, 2006, CANCER, V106, P1708, DOI 10.1002/cncr.21799; Keating NL, 2006, J CLIN ONCOL, V24, P4448, DOI 10.1200/JCO.2006.06.2497; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Labrie F, 2002, UROLOGY, V60, P115, DOI 10.1016/S0090-4295(02)01639-4; Makhsida N, 2005, J UROLOGY, V174, P827, DOI 10.1097/01.ju.0000169490.78443.59; MAKUC DM, 1991, VITAL HLTH STAT, V2, P1; McLeod DG, 2006, BJU INT, V97, P247, DOI 10.1111/j.1464-410X.2005.06051.x; Messing EM, 1999, NEW ENGL J MED, V341, P1781, DOI 10.1056/NEJM199912093412401; Penson DF, 2001, J NATL CANCER I, V93, P1822, DOI 10.1093/jnci/93.23.1822; Potosky AL, 2004, J NATL CANCER I, V96, P1358, DOI 10.1093/jnci/djh259; Potosky AL, 2002, J NATL CANCER I, V94, P430, DOI 10.1093/jnci/94.6.430; Schroder FH, 2004, J UROLOGY, V172, P923, DOI 10.1097/01.ju.0000135742.13171.d2; Seidenfeld J, 2000, ANN INTERN MED, V132, P566, DOI 10.7326/0003-4819-132-7-200004040-00009; Shahinian VB, 2006, JNCI-J NATL CANCER I, V98, P839, DOI 10.1093/jnci/djj230; Shahinian VB, 2005, CANCER-AM CANCER SOC, V103, P1615, DOI 10.1002/cncr.20955; Shahinian VB, 2005, NEW ENGL J MED, V352, P154, DOI 10.1056/NEJMoa041943; Smith MR, 2002, J CLIN ENDOCR METAB, V87, P599, DOI 10.1210/jc.87.2.599; Studer UE, 2006, J CLIN ONCOL, V24, P1868, DOI 10.1200/JCO.2005.04.7423; Studer UE, 2004, J CLIN ONCOL, V22, P4109, DOI 10.1200/JCO.2004.11.514; Studer UE, 2008, EUR UROL, V53, P941, DOI 10.1016/j.eururo.2007.12.032; STUKEL TA, 2007, JAMA-J AM MED ASSOC, V297, P279; Therneau TM, 2000, MODELING SURVIVAL DA; Warren JL, 2002, MED CARE, V40, P3; Weight CJ, 2008, CANCER-AM CANCER SOC, V112, P2195, DOI 10.1002/cncr.23421	48	222	228	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 9	2008	300	2					173	181		10.1001/jama.300.2.173	http://dx.doi.org/10.1001/jama.300.2.173			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	323GV	18612114	Green Accepted, Bronze			2022-12-28	WOS:000257435500021
J	McClintock, WE; Bradley, ET; Vervack, RJ; Killen, RM; Sprague, AL; Izenberg, NR; Solomon, SC				McClintock, William E.; Bradley, E. Todd; Vervack, Ronald J., Jr.; Killen, Rosemary M.; Sprague, Ann L.; Izenberg, Noam R.; Solomon, Sean C.			Mercury's exosphere: Observations during MESSENGER's first Mercury flyby	SCIENCE			English	Article							SODIUM TAIL; ATMOSPHERE; MARINER-10; DISCOVERY; REGOLITH; MISSION; CALCIUM; MODEL; MOON; NA	During MESSENGER's first Mercury flyby, the Mercury Atmospheric and Surface Composition Spectrometer measured Mercury's exospheric emissions, including those from the antisunward sodium tail, calcium and sodium close to the planet, and hydrogen at high altitudes on the dayside. Spatial variations indicate that multiple source and loss processes generate and maintain the exosphere. Energetic processes connected to the solar wind and magnetospheric interaction with the planet likely played an important role in determining the distributions of exospheric species during the flyby.	[McClintock, William E.] Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80303 USA; [Bradley, E. Todd] Univ Cent Florida, Dept Phys, Orlando, FL 32816 USA; [Vervack, Ronald J., Jr.; Izenberg, Noam R.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Killen, Rosemary M.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Sprague, Ann L.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Solomon, Sean C.] Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA	University of Colorado System; University of Colorado Boulder; State University System of Florida; University of Central Florida; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; University System of Maryland; University of Maryland College Park; University of Arizona; Carnegie Institution for Science	McClintock, WE (corresponding author), Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80303 USA.	william.mcclintock@lasp.colorado.edu	Izenberg, Noam R/F-3952-2015; Vervack, Ronald J/C-2702-2016; Killen, Rosemary M/E-7127-2012	Izenberg, Noam R/0000-0003-1629-6478; Vervack, Ronald J/0000-0002-8227-9564; 				Baumgardner J, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032337; Bida TA, 2000, NATURE, V404, P159, DOI 10.1038/35004521; BROADFOOT AL, 1974, SCIENCE, V185, P166, DOI 10.1126/science.185.4146.166; BROADFOOT AL, 1976, GEOPHYS RES LETT, V3, P577, DOI 10.1029/GL003i010p00577; Cassidy TA, 2005, ICARUS, V176, P499, DOI 10.1016/j.icarus.2005.02.013; CHAMBERLAIN JW, 1963, PLANET SPACE SCI, V11, P901, DOI 10.1016/0032-0633(63)90122-3; Killen RM, 2005, ICARUS, V173, P300, DOI 10.1016/j.icarus.2004.08.022; Killen RM, 2004, ICARUS, V171, P1, DOI 10.1016/j.icarus.2004.04.007; Killen RM, 2001, J GEOPHYS RES-PLANET, V106, P20509, DOI 10.1029/2000JE001401; Killen RM, 1999, PLANET SPACE SCI, V47, P1449, DOI 10.1016/S0032-0633(99)00071-9; Killen R, 2007, SPACE SCI REV, V132, P433, DOI 10.1007/s11214-007-9232-0; Leblanc F, 2006, ICARUS, V185, P395, DOI 10.1016/j.icarus.2006.08.006; McClintock WE, 2007, SPACE SCI REV, V131, P481, DOI 10.1007/s11214-007-9264-5; Morgan TH, 1997, PLANET SPACE SCI, V45, P81, DOI 10.1016/S0032-0633(96)00099-2; POTTER A, 1985, SCIENCE, V229, P651, DOI 10.1126/science.229.4714.651; Potter AE, 2008, ICARUS, V194, P1, DOI 10.1016/j.icarus.2007.09.023; Potter AE, 2007, ICARUS, V186, P571, DOI 10.1016/j.icarus.2006.09.025; POTTER AE, 1986, ICARUS, V67, P336, DOI 10.1016/0019-1035(86)90113-2; Potter AE, 2002, METEORIT PLANET SCI, V37, P1165, DOI 10.1111/j.1945-5100.2002.tb00886.x; Sarantos M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032310; SHEMANSKY DE, 1977, REV GEOPHYS, V15, P491, DOI 10.1029/RG015i004p00491; Slavin JA, 2008, SCIENCE, V321, P85, DOI 10.1126/science.1159040; Solomon SC, 2008, SCIENCE, V321, P59, DOI 10.1126/science.1159706; Solomon SC, 2007, SPACE SCI REV, V131, P3, DOI 10.1007/s11214-007-9247-6; Sprague AL, 1998, ICARUS, V136, P60, DOI 10.1006/icar.1998.6009; Sprague AL, 1997, ICARUS, V129, P506, DOI 10.1006/icar.1997.5784; SPRAGUE AL, 1995, ICARUS, V118, P211, DOI 10.1006/icar.1995.1186; Travnicek P, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028518; Yakshinskiy BV, 1999, NATURE, V400, P642, DOI 10.1038/23204	29	66	66	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2008	321	5885					92	94		10.1126/science.1159467	http://dx.doi.org/10.1126/science.1159467			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QE	18599778				2022-12-28	WOS:000257320800042
J	Shortell, SM; Casalino, LP				Shortell, Stephen M.; Casalino, Lawrence P.			Health care reform requires accountable care systems	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ORGANIZATION; INTEGRATION; QUALITY		[Shortell, Stephen M.] Univ Calif Berkeley, Sch Publ Hlth, Div Hlth Policy & Management, Berkeley, CA 94720 USA; [Casalino, Lawrence P.] Univ Chicago, Div Biol Sci, Dept Hlth Studies, Chicago, IL 60637 USA	University of California System; University of California Berkeley; University of Chicago	Shortell, SM (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Hlth Policy & Management, 140 Warren Hall, Berkeley, CA 94720 USA.	shortell@berkeley.edu	Greiver, Michelle/N-8764-2015; Casalino, Lawrence/ABE-1245-2020	Greiver, Michelle/0000-0001-8957-0285; Casalino, Lawrence/0000-0002-7927-7859				American College of Physicians, 2006, ADV MED HOM PAT CTR; American Hospital Association, 2007, HOSP STAT; Casalino LP, 2006, J HEALTH POLIT POLIC, V31, P569, DOI 10.1215/03616878-2005-007; Casalino LP, 2003, ARCH INTERN MED, V163, P1958, DOI 10.1001/archinte.163.16.1958; *COMM COST MED CAR, 1932, MED CAR AM PEOPL; Cortese D, 2007, HEALTH AFFAIR, V26, pW68, DOI 10.1377/hlthaff.26.1.w68; Crosson FJ, 2005, HEALTH AFFAIR, V24, P1543, DOI 10.1377/hlthaff.24.6.1543; Fisher ES, 2007, HEALTH AFFAIR, V26, pW44, DOI 10.1377/hlthaff.26.1.w44; Fuchs VR, 2005, ANN INTERN MED, V143, P76, DOI 10.7326/0003-4819-143-1-200507050-00012; Gillies RR, 2006, HEALTH SERV RES, V41, P1181, DOI 10.1111/j.1475-6773.2006.00529.x; Mehrotra A, 2006, ANN INTERN MED, V145, P826, DOI 10.7326/0003-4819-145-11-200612050-00007; Ministry of Health, 2001, PRIMARY HLTH CARE ST; Rittenhouse DR, 2004, HEALTH AFFAIR, V23, P51, DOI 10.1377/hlthaff.23.6.51; SHORTELL SM, 2004, 21 CENTURY HLTH SYST, P6	14	113	113	0	20	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 2	2008	300	1					95	97		10.1001/jama.300.1.95	http://dx.doi.org/10.1001/jama.300.1.95			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320NW	18594045				2022-12-28	WOS:000257242800030
J	Berger, JT; DeRenzo, EG; Schwartz, J				Berger, Jeffrey T.; DeRenzo, Evan G.; Schwartz, Jack			Surrogate decision making: Reconciling ethical theory and clinical practice	ANNALS OF INTERNAL MEDICINE			English	Article							OF-LIFE CARE; ADVANCE DIRECTIVES; FAMILY-MEMBERS; SUSTAINING TREATMENTS; PUBLIC PREFERENCES; OLDER-ADULTS; ILL PATIENTS; END; PHYSICIANS; AUTONOMY	The care of adult patients without decision-making abilities is a routine part of medical practice. Decisions for these patients are typically made by surrogates according to a process governed by a hierarchy of 3 distinct decision-making standards: patients' known wishes, substituted judgments, and best interests. Although this framework offers some guidance, it does not readily incorporate many important considerations of patients and families and does not account for the ways in which many patients and surrogates prefer to make decisions. In this article, the authors review the research on surrogate decision making, compare it with normative standards, and offer ways in which the 2 can be reconciled for the patient's benefit.	SUNY Stony Brook, Sch Med, Stony Brook, NY 11794 USA; Washington Hosp Ctr, Washington, DC 20010 USA; Off Attorney Gen Maryland, Baltimore, MD USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; MedStar Washington Hospital Center	Berger, JT (corresponding author), 222 Stat Pl N,Suite 518, Mineola, NY 11501 USA.	jberger@winthrop.org						Alpert HR, 1998, J GEN INTERN MED, V13, P175, DOI 10.1046/j.1525-1497.1998.00052.x; *AM GER SOC ETH CO, 2002, LEG ETH ISS GER REV, P19; *AM MED ASS, 1997, COD MED ETH CURR OP, P3; Anderson CJ, 2003, PSYCHOL BULL, V129, P139, DOI 10.1037//0033-2909.129.1.139; ASCH DA, 1995, AM J RESP CRIT CARE, V151, P288, DOI 10.1164/ajrccm.151.2.7842181; BEAUCHAMP JF, 1994, RESPECT AUTONOMY PRI, P120; Berger JT, 2005, J CLIN ETHIC, V16, P3; Berger JT, 2004, J CLIN ETHIC, V15, P237; Berger JT, 1998, J CLIN ETHIC, V9, P127; Chambers-Evans J, 2005, J CLIN ETHIC, V16, P28; Chan HM, 2004, BIOETHICS, V18, P87, DOI 10.1111/j.1467-8519.2004.00383.x; DANIS M, 1991, NEW ENGL J MED, V324, P882, DOI 10.1056/NEJM199103283241304; Fagerlin A, 2004, HASTINGS CENT REP, V34, P30, DOI 10.2307/3527683; Fagerlin A, 2001, HEALTH PSYCHOL, V20, P166, DOI 10.1037/0278-6133.20.3.166; Farber NJ, 2006, ARCH INTERN MED, V166, P560, DOI 10.1001/archinte.166.5.560; Fins JJ, 2005, J PAIN SYMPTOM MANAG, V29, P55, DOI 10.1016/j.jpainsymman.2004.07.004; Fried TR, 2003, ARCH INTERN MED, V163, P2073, DOI 10.1001/archinte.163.17.2073; GASNER MR, 1990, J AM GERIATR SOC, V38, P594, DOI 10.1111/j.1532-5415.1990.tb02414.x; Giger Joyce Newman, 2006, J Cult Divers, V13, P3; Goodman MD, 1998, CRIT CARE MED, V26, P701, DOI 10.1097/00003246-199804000-00018; Hardin SB, 2004, ARCH INTERN MED, V164, P1531, DOI 10.1001/archinte.164.14.1531; Hawkins NA, 2005, GERONTOLOGIST, V45, P107, DOI 10.1093/geront/45.1.107; Helton MR, 2006, ANN FAM MED, V4, P221, DOI 10.1370/afm.536; High D M, 1993, J Aging Health, V5, P497, DOI 10.1177/089826439300500405; Ho A, 2008, SCAND J CARING SCI, V22, P128, DOI 10.1111/j.1471-6712.2007.00561.x; Hollingshead AB, 1996, HUM COMMUN RES, V23, P193, DOI 10.1111/j.1468-2958.1996.tb00392.x; Hyun I, 2003, CAMB Q HEALTHC ETHIC, V12, P196, DOI 10.1017/S0963180103002111; JECKER NS, 1993, J CLIN ETHIC, V4, P16; LOEWENSTEIN GF, 1989, J PERS SOC PSYCHOL, V57, P426, DOI 10.1037/0022-3514.57.3.426; Lynn J, 1991, Law Med Health Care, V19, P101; Mappes Thomas A., 1994, Kennedy Institute of Ethics Journal, V4, P27; Matsumura S, 2002, J GEN INTERN MED, V17, P531, DOI 10.1046/j.1525-1497.2002.10734.x; Moazam F, 2000, HASTINGS CENT REP, V30, P28, DOI 10.2307/3528451; Moore CD, 2003, SOC WORK HEALTH CARE, V37, P1, DOI 10.1300/J010v37n02_01; NELSON JL, 1992, HASTINGS CENT REP, V22, P6; *NY STAT BAR ASS, 2007, NEW YORK LIV WILL IN; Perkins HS, 2007, ANN INTERN MED, V147, P51, DOI 10.7326/0003-4819-147-1-200707030-00008; Puchalski CM, 2000, J AM GERIATR SOC, V48, pS84, DOI 10.1111/j.1532-5415.2000.tb03146.x; Roberto KA, 1999, FAM RELAT, V48, P167, DOI 10.2307/585080; Samuelson W, 1988, J RISK UNCERTAINTY, V1, P7, DOI 10.1007/BF00055564; SEHGAL A, 1992, JAMA-J AM MED ASSOC, V267, P59, DOI 10.1001/jama.267.1.59; Seymour J, 2004, SOC SCI MED, V59, P57, DOI 10.1016/j.socscimed.2003.10.005; Shalowitz DI, 2007, PLOS MED, V4, P423, DOI 10.1371/journal.pmed.0040035; Shalowitz DI, 2006, ARCH INTERN MED, V166, P493, DOI 10.1001/archinte.166.5.493; Shrank WH, 2005, J GEN INTERN MED, V20, P703, DOI 10.1111/j.1525-1497.2005.0151.x; Singer PA, 1998, ARCH INTERN MED, V158, P879, DOI 10.1001/archinte.158.8.879; Snyder L, 2005, ANN INTERN MED, V142, P560, DOI 10.7326/0003-4819-142-7-200504050-00014; SONNENBLICK M, 1993, J AM GERIATR SOC, V41, P599, DOI 10.1111/j.1532-5415.1993.tb06729.x; Sugarman J, 2001, J AM GERIATR SOC, V49, P1110, DOI 10.1046/j.1532-5415.2001.49218.x; Sulmasy DP, 2007, J AM GERIATR SOC, V55, P1981, DOI 10.1111/j.1532-5415.2007.01473.x; SULMASY DP, 2006, J GEN INTERN MED; Swanson JW, 1996, SOC SCI MED, V42, P125, DOI 10.1016/0277-9536(95)00082-8; Teno JM, 1997, J AM GERIATR SOC, V45, P508, DOI 10.1111/j.1532-5415.1997.tb05179.x; Terry PB, 1999, J CLIN ETHIC, V10, P286; Thompson T, 2003, BRIT MED J, V327, P1011, DOI 10.1136/bmj.327.7422.1011; Tilden VP, 2001, NURS RES, V50, P105, DOI 10.1097/00006199-200103000-00006; Winzelberg GS, 2005, J AM GERIATR SOC, V53, P1046, DOI 10.1111/j.1532-5415.2005.53317.x; Young AJ, 2006, HEALTH COMMUN, V19, P49, DOI 10.1207/s15327027hc1901_6; 2005, NAT C COMMISSIONERS, P93	59	59	60	0	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 1	2008	149	1					48	+		10.7326/0003-4819-149-1-200807010-00010	http://dx.doi.org/10.7326/0003-4819-149-1-200807010-00010			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	323EZ	18591637				2022-12-28	WOS:000257428200007
J	Calonge, N; Petitti, DB; DeWitt, TG; Dietrich, A; Gregory, KD; Harris, R; Isham, G; LeFevre, ML; Leipzig, R; Loveland-Cherry, C; Marion, LN; Melnyk, B; Moyer, VA; Ockene, JK; Sawaya, GF; Yawn, BP				Calonge, Ned; Petitti, Diana B.; DeWitt, Thomas G.; Dietrich, Allen; Gregory, Kimberly D.; Harris, Russell; Isham, George; LeFevre, Michael L.; Leipzig, Rosanne; Loveland-Cherry, Carol; Marion, Lucy N.; Melnyk, Bernadette; Moyer, Virginia A.; Ockene, Judith K.; Sawaya, George F.; Yawn, Barbara P.		US Preventive Serv Task Force	Screening for asymptomatic bacteriuria in adults: US preventive services task force reaffirmation recommendation statement	ANNALS OF INTERNAL MEDICINE			English	Article								Description: Reaffirmation of the 2004 U. S. Preventive Services Task Force recommendation statement about screening for asymptomatic bacteriuria in adults. Methods: The U. S. Preventive Services Task Force did a targeted literature search for evidence on the benefits and harms of screening for asymptomatic bacteriuria in pregnant women, nonpregnant women, and men. Recommendations: Screen for asymptomatic bacteriuria with urine culture in pregnant women at 12 to 16 weeks' gestation or at the first prenatal visit, if later. (Grade A recommendation.) Do not screen for asymptomatic bacteriuria in men and nonpregnant women. (Grade D recommendation.).	[Calonge, Ned] Colorado Dept Publ Hlth & Environm, Denver, CO USA; [US Preventive Serv Task Force] US Prevent Serv Task Force, Agcy Healthcare Res & Qual, Rockville, MD USA; [Petitti, Diana B.] Univ So Calif, Keck Sch Med, Sierra Madre, CA USA; [DeWitt, Thomas G.] Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA; [Dietrich, Allen] Dartmouth Med Sch, Lebanon, NH USA; [Gregory, Kimberly D.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Harris, Russell] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Isham, George] HealthPartners, Minneapolis, MN USA; [LeFevre, Michael L.] Univ Missouri, Sch Med, Columbia, MO USA; [Leipzig, Rosanne] Mt Sinai Sch Med, New York, NY USA; [Loveland-Cherry, Carol] Univ Michigan, Sch Nursing, Ann Arbor, MI 48109 USA; [Marion, Lucy N.] Med Coll Georgia, Sch Nursing, Augusta, GA 30912 USA; [Melnyk, Bernadette] Arizona State Coll Nursing & Healthcare Innovat, Phoenix, AZ USA; [Moyer, Virginia A.] Univ Texas Houston, Hlth Sci Ctr, Houston, TX USA; [Ockene, Judith K.] Univ Massachusetts, Sch Med, Worcester, MA USA; [Sawaya, George F.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Yawn, Barbara P.] Olmsted Med Ctr, Rochester, MI USA	Colorado Department of Public Health & Environment; Agency for Healthcare Research & Quality; University of Southern California; Cincinnati Children's Hospital Medical Center; Dartmouth College; Cedars Sinai Medical Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Missouri System; University of Missouri Columbia; Icahn School of Medicine at Mount Sinai; University of Michigan System; University of Michigan; University System of Georgia; Augusta University; University of Texas System; University of Texas Health Science Center Houston; University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California San Francisco	Calonge, N (corresponding author), Colorado Dept Publ Hlth & Environm, Denver, CO USA.		Melnyk, Bernadette J/E-9868-2013					ACOG Committee on Gynecologic Practice, 2006, Obstet Gynecol, V108, P1615; *AM AC FAM PHYS, 2007, SUMM REC CLIN PREV S; *AM AC PED AM COLL, 2007, GUID PER CAR, P100; GARTLEHNER G, 2004, AHRQ PUBLICATION; Lin K, 2008, ANN INTERN MED, V149, pW20, DOI 10.7326/0003-4819-149-1-200807010-00009-w1; Nicolle LE, 2005, CLIN INFECT DIS, V40, P643, DOI 10.1086/427507; *US PREV SERV TASK, 1996, GUID CLIN PREV SERV, P347; US Preventive Services Task Force, 2004, SCREEN AS BACT REC S	8	53	53	1	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 1	2008	149	1					43	+		10.7326/0003-4819-149-1-200807010-00009	http://dx.doi.org/10.7326/0003-4819-149-1-200807010-00009			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	323EZ	18591636				2022-12-28	WOS:000257428200006
J	Dhaun, N; Webb, DJ				Dhaun, Neeraj; Webb, David J.			Endothelin-receptor antagonism: the future is bright	LANCET			English	Editorial Material							PULMONARY ARTERIAL-HYPERTENSION; BOSENTAN; THERAPY		[Dhaun, Neeraj; Webb, David J.] Univ Edinburgh, Queens Med Res Inst, Edinburgh EH16 4TJ, Midlothian, Scotland	University of Edinburgh	Dhaun, N (corresponding author), Univ Edinburgh, Queens Med Res Inst, Edinburgh EH16 4TJ, Midlothian, Scotland.	bean.dhaun@ed.ac.uk						Barst RJ, 2006, J AM COLL CARDIOL, V47, P2049, DOI 10.1016/j.jacc.2006.01.057; Channick RN, 2001, LANCET, V358, P1119, DOI 10.1016/S0140-6736(01)06250-X; Dhaun N, 2007, TRENDS PHARMACOL SCI, V28, P573, DOI 10.1016/j.tips.2007.10.002; Dupuis J, 2008, EUR RESPIR J, V31, P407, DOI 10.1183/09031936.00078207; Galie N, 2008, LANCET, V371, P2093, DOI 10.1016/S0140-6736(08)60919-8; Galie N, 2005, J AM COLL CARDIOL, V46, P529, DOI 10.1016/j.jacc.2005.04.050; McLaughlin VV, 2006, AM J RESP CRIT CARE, V174, P1257, DOI 10.1164/rccm.200603-358OC; Rubin LJ, 2002, NEW ENGL J MED, V346, P896, DOI 10.1056/NEJMoa012212; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0	9	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 21	2008	371	9630					2061	2062		10.1016/S0140-6736(08)60895-8	http://dx.doi.org/10.1016/S0140-6736(08)60895-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	316ER	18572063				2022-12-28	WOS:000256932200005
J	Page, DP				Page, David P.			Athabasca Valles, Mars: A lava-draped channel system	SCIENCE			English	Editorial Material							GROUND ICE		Open Univ, Planetary & Space Sci Res Inst, Milton Keynes MK7 6AA, Bucks, England	Open University - UK	Page, DP (corresponding author), Open Univ, Planetary & Space Sci Res Inst, Milton Keynes MK7 6AA, Bucks, England.	D.P.Page@open.ac.uk		Page, David/0000-0002-8360-6483				Burr DA, 2005, ICARUS, V178, P56, DOI 10.1016/j.icarus.2005.04.012; GREELEY R, 1987, USGS MISC INVESTIGAT; Jaeger WL, 2007, SCIENCE, V317, P1709, DOI 10.1126/science.1143315; Keszthelyi L, 2000, J GEOPHYS RES-PLANET, V105, P15027, DOI 10.1029/1999JE001191; Lanagan PD, 2001, GEOPHYS RES LETT, V28, P2365, DOI 10.1029/2001GL012932; McEwen AS, 2005, ICARUS, V176, P351, DOI 10.1016/j.icarus.2005.02.009; Melosh H.J., 1989, OXFORD MONOGRAPHS GE; Page DP, 2007, ICARUS, V189, P83, DOI 10.1016/j.icarus.2007.01.005; Page DP, 2006, ICARUS, V183, P46, DOI 10.1016/j.icarus.2006.01.017; PLESCIA JB, 1990, ICARUS, V88, P465, DOI 10.1016/0019-1035(90)90095-Q; RICE JW, 2002, LUNAR PLANET SCI, V33, P2026; SCOTT D, 1986, USGS MISC INVESTIGAT; Wilhelms D.E., 1987, USGS PROFESSIONAL PA; Wilson RCL, 1998, GEOL SOC SPEC PUBL, P303, DOI 10.1144/GSL.SP.1998.143.01.20	14	23	24	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2008	320	5883								10.1126/science.1154849	http://dx.doi.org/10.1126/science.1154849			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	315NM	18566267				2022-12-28	WOS:000256886700025
J	Mathys, KC; Garg, S				Mathys, Kenneth C.; Garg, Seema			Central hemiretinal arterial occlusion	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Mathys, Kenneth C.; Garg, Seema] Univ N Carolina, Chapel Hill, NC 27517 USA	University of North Carolina; University of North Carolina Chapel Hill	Mathys, KC (corresponding author), Univ N Carolina, Chapel Hill, NC 27517 USA.								0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 19	2008	358	25					2716	2716		10.1056/NEJMicm073656	http://dx.doi.org/10.1056/NEJMicm073656			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	314NC	18565864				2022-12-28	WOS:000256815100008
J	Smulders, YM; Verhagen, DWM				Smulders, Yvo M.; Verhagen, Dominique W. M.			LESSON OF THE WEEK Giant cell arteritis causing aortic dissection and acute hypertension	BRITISH MEDICAL JOURNAL			English	Article							POLYMYALGIA-RHEUMATICA; TEMPORAL ARTERITIS		[Smulders, Yvo M.; Verhagen, Dominique W. M.] Vrije Univ Amsterdam, Med Ctr, Div Internal Med, NL-1081 HV Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Smulders, YM (corresponding author), Vrije Univ Amsterdam, Med Ctr, Div Internal Med, POB 7057, NL-1081 HV Amsterdam, Netherlands.	y.smulders@vumc.nl	Smulders, YM/AAG-7506-2021					Blockmans D, 2000, AM J MED, V108, P246, DOI 10.1016/S0002-9343(99)00424-6; EVANS JM, 1995, ANN INTERN MED, V122, P502, DOI 10.7326/0003-4819-122-7-199504010-00004; Hamrin B, 1972, Acta Med Scand Suppl, V533, P1; Honing M L H, 2005, Ned Tijdschr Geneeskd, V149, P1947; Januzzi JL, 2001, AM J CARDIOL, V88, P686, DOI 10.1016/S0002-9149(01)01818-5; Salvarani C, 2004, ARTHRIT RHEUM-ARTHR, V51, P264, DOI 10.1002/art.20227; Weyand CM, 2003, ANN INTERN MED, V139, P505, DOI 10.7326/0003-4819-139-6-200309160-00015	7	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 1	2008	337								a426	10.1136/bmj.39503.769225.BE	http://dx.doi.org/10.1136/bmj.39503.769225.BE			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368AM	18614463				2022-12-28	WOS:000260593700034
J	Nunn, AJ; Mwaba, P; Chintu, C; Mwinga, A; Darbyshire, JH; Zumla, A				Nunn, Andrew J.; Mwaba, Peter; Chintu, Chifumbe; Mwinga, Alwyn; Darbyshire, Janet H.; Zumla, Alimuddin		UNZA UCLMS Project LUCOT Collabora	Role of co-trimoxazole prophylaxis in reducing mortality in HIV infected adults being treated for tuberculosis: randomised clinical trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TRIMETHOPRIM-SULFAMETHOXAZOLE; HIV-1-INFECTED ADULTS; COTE-DIVOIRE; RESISTANCE; MALAWI; PYRIMETHAMINE; MORBIDITY; MALARIA; ABIDJAN; AFRICA	Objective To assess the impact of prophylactic oral cotrimoxazole in reducing mortality in HIV positive Zambian adults being treated for pulmonary tuberculosis. Design Double blind placebo controlled randomised clinical trial. Participants Two groups of antiretroviral treatment naive adults with HIV infection: patients newly diagnosed as having tuberculosis and receiving tuberculosis treatment either for the first time or for retreatment after relapse; previously treated patients not receiving treatment. Intervention Oral co-trimoxazole or matching placebo daily. Primary outcome measures Time to death and occurrence of serious adverse events related to study drug. Results 1003 patients were randomised: 835 (416 co-trimoxazole, 419 placebo) were receiving treatment for tuberculosis, 762 (376 co-trimoxazole, 386 placebo) of them newly diagnosed previously untreated patients and 73 (40 co-trimoxazole, 33 placebo) receiving a retreatment regimen; 168 (84 co-trimoxazole, 84 placebo) were not on treatment but had received treatment in the past. Of 835 participants receiving tuberculosis treatment, follow-up information was available for 757, with a total of 1012.6 person years of follow-up. A total of 310 (147 cotrimoxazole, 163 placebo) participants died, corresponding to death rates of 27.3 and 34.4 per 100 person years. In the Cox regression analysis, the hazard ratio for death (co-trimoxazole:placebo) was 0.79 (95% confidence interval 0.63 to 0.99). The effect of co-trimoxazole waned with time, possibly owing to falling adherence levels; in a per protocol analysis based on patients who spent at least 90% of their time at risk supplied with study drug, the hazard ratio was 0.65 (0.45 to 0.93). Conclusions Prophylaxis with co-trimoxazole reduces mortality in HIV infected adults with pulmonary tuberculosis. Co-trimoxazole was generally safe and well tolerated.	[Nunn, Andrew J.; Darbyshire, Janet H.] MRC, Clin Trials Unit, London NW1 2DA, England; [Mwaba, Peter; Chintu, Chifumbe; Mwinga, Alwyn] UNZA, Sch Med, Univ Teaching Hosp, Lusaka, Zambia; [Zumla, Alimuddin] UCL, Ctr Infect Dis & Int Hlth, London W1T 4JF, England	Medical Research Council Clinical Trials Unit; University of Zambia; University of London; University College London	Nunn, AJ (corresponding author), MRC, Clin Trials Unit, London NW1 2DA, England.	ajn@ctu.mrc.ac.uk	ZUMLA, Alimuddin/ABA-8208-2020; Mwaba, Peter/V-6017-2019	ZUMLA, Alimuddin/0000-0002-5111-5735; Nunn, Andrew/0000-0002-9158-4595	MRC [MC_U122888469] Funding Source: UKRI; Medical Research Council [MC_U122888469] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Anglaret X, 1999, LANCET, V353, P1463, DOI 10.1016/S0140-6736(98)07399-1; Bortolotti W, 2002, AIDS, V16, P1309, DOI 10.1097/00002030-200207050-00002; Chintu C, 2004, LANCET, V364, P1865, DOI 10.1016/S0140-6736(04)17442-4; Grimwade K, 2005, AIDS, V19, P163, DOI 10.1097/00002030-200501280-00008; Gwanzura L, 2003, INT J ANTIMICROB AG, V21, P557, DOI 10.1016/S0924-8579(03)00052-9; Iyer JK, 2001, LANCET, V358, P1066, DOI 10.1016/S0140-6736(01)06201-8; *JOINT UN PROGR HI, 2000, PROV WHO UNAIDS SECR; Kassa-Kelembho E, 2003, ACTA TROP, V89, P67, DOI 10.1016/j.actatropica.2003.09.004; Laufer MK, 2006, AM J TROP MED HYG, V75, P373, DOI 10.4269/ajtmh.2006.75.373; Malamba SS, 2006, AM J TROP MED HYG, V75, P375, DOI 10.4269/ajtmh.2006.75.375; Martinson NA, 2007, AIDS, V21, P2043, DOI 10.1097/QAD.0b013e3282eea47f; Maynart M, 2001, J ACQ IMMUN DEF SYND, V26, P130, DOI 10.1097/00126334-200102010-00004; Mermin J, 2004, LANCET, V364, P1428, DOI 10.1016/S0140-6736(04)17225-5; MURRAY J, 2000, INT J TUBERC LUNG D, V6, P1035; Mwansa J, 2002, EMERG INFECT DIS, V8, P92, DOI 10.3201/eid0801.010018; Mwaungulu FBD, 2004, B WORLD HEALTH ORGAN, V82, P354; Mwinga A, 2002, LANCET, V360, P1050, DOI 10.1016/S0140-6736(02)11141-X; Nyamande K, 2007, INT J TUBERC LUNG D, V11, P1308; Royston P, 2005, STATA J, V5, P279, DOI 10.1177/1536867X0500500212; ROYSTON P, 1994, J R STAT SOC C-APPL, V43, P429, DOI 10.2307/2986270; WHO, 2005, TB HIV RES PRIOR RES; Wiktor SZ, 1999, LANCET, V353, P1469, DOI 10.1016/S0140-6736(99)03465-0; World Health Organization, 2008, GLOB TUB CONTR SURV; World Health Organization, 2003, TREATM TUB GUID NAT, DOI DOI 10.1016/S0035-9203(99)90185-2; World Health Organization, 2006, WHO EXP CONS COTR PR; Zachariah R, 2003, AIDS, V17, P1053, DOI 10.1097/00002030-200305020-00015; Zachariah R, 2002, T ROY SOC TROP MED H, V96, P202, DOI 10.1016/S0035-9203(02)90306-8	27	65	65	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 26	2008	337	7663							a257	10.1136/bmj.a257	http://dx.doi.org/10.1136/bmj.a257			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	335EG	18617486	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000258273000040
J	Chauhan, S; Gupta, M; Sachdev, A; D'Cruz, S; Kaur, I				Chauhan, Sandeep; Gupta, Manisha; Sachdev, Atul; D'Cruz, Sanjay; Kaur, Ikjot			Cullen's and Turner's sign associated with portal hypertension	LANCET			English	Editorial Material									[Chauhan, Sandeep; Gupta, Manisha; Sachdev, Atul; D'Cruz, Sanjay; Kaur, Ikjot] Govt Med Coll & Hosp, Dept Med, Chandigarh, India		Chauhan, S (corresponding author), Govt Med Coll & Hosp, Dept Med, Sector 32, Chandigarh, India.	schauhan@doctors.org.uk	Sachdev, Atul/AAE-4831-2020	Gupta, Manisha/0000-0001-6987-779X					0	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 5	2008	372	9632					54	54		10.1016/S0140-6736(08)60993-9	http://dx.doi.org/10.1016/S0140-6736(08)60993-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	321XN	18603159				2022-12-28	WOS:000257339900032
J	Zhou, B; Ma, Q; Rajagopal, S; Wu, SM; Domian, I; Rivera-Feliciano, J; Jiang, DW; von Gise, A; Ikeda, S; Chien, KR; Pu, WT				Zhou, Bin; Ma, Qing; Rajagopal, Satish; Wu, Sean M.; Domian, Ibrahim; Rivera-Feliciano, Jose; Jiang, Dawei; von Gise, Alexander; Ikeda, Sadakatsu; Chien, Kenneth R.; Pu, William T.			Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart	NATURE			English	Article							SMOOTH-MUSCLE-CELLS; CARDIOVASCULAR PROGENITORS; PERICARDIAL MESODERM; REPORTER STRAIN; EXPRESSION; ORIGIN; MOUSE; NEOVASCULARIZATION; DIFFERENTIATION; POPULATION	The heart is formed from cardiogenic progenitors expressing the transcription factors Nkx2-5 and Isl1 ( refs 1 and 2). These multipotent progenitors give rise to cardiomyocyte, smooth muscle and endothelial cells, the major lineages of the mature heart(3,4). Here we identify a novel cardiogenic precursor marked by expression of the transcription factor Wt1 and located within the epicardium - an epithelial sheet overlying the heart. During normal murine heart development, a subset of these Wt1(+) precursors differentiated into fully functional cardiomyocytes. Wt1(+) proepicardial cells arose from progenitors that express Nkx2-5 and Isl1, suggesting that they share a developmental origin with multipotent Nkx2-5(+) and Isl1(+) progenitors. These results identify Wt1(+) epicardial cells as previously unrecognized cardiomyocyte progenitors, and lay the foundation for future efforts to harness the cardiogenic potential of these progenitors for cardiac regeneration and repair.	[Zhou, Bin; Ma, Qing; Rajagopal, Satish; Jiang, Dawei; von Gise, Alexander; Ikeda, Sadakatsu; Pu, William T.] Childrens Hosp, Harvard Stem Cell Inst, Boston, MA 02115 USA; [Zhou, Bin; Ma, Qing; Rajagopal, Satish; Jiang, Dawei; von Gise, Alexander; Ikeda, Sadakatsu; Pu, William T.] Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; [Zhou, Bin; Ma, Qing; Rajagopal, Satish; Rivera-Feliciano, Jose; von Gise, Alexander; Ikeda, Sadakatsu; Pu, William T.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Wu, Sean M.; Domian, Ibrahim; Chien, Kenneth R.] Harvard Univ, Harvard Stem Cell Inst, Boston, MA 02114 USA; [Wu, Sean M.; Domian, Ibrahim; Chien, Kenneth R.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [von Gise, Alexander] Charite Univ Med Berlin, Clin Neonatol, D-10117 Berlin, Germany	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard University; Massachusetts General Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Pu, WT (corresponding author), Childrens Hosp, Harvard Stem Cell Inst, 300 Longwood Ave, Boston, MA 02115 USA.	wpu@enders.tch.harvard.edu	Pu, William/AAJ-8301-2020; von Gise, Alexander/C-3997-2016	Pu, William/0000-0002-4551-8079; von Gise, Alexander/0000-0001-7886-3031; Wu, Sean/0000-0002-0000-3821; Zhou, Bin/0000-0001-5278-5522	NHLBI NIH HHS [P50 HL074734, T32 HL007572, P50 HL074734-05] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL074734] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Brent AE, 2003, CELL, V113, P235, DOI 10.1016/S0092-8674(03)00268-X; Dettman RW, 1998, DEV BIOL, V193, P169, DOI 10.1006/dbio.1997.8801; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Gittenberger-de Groot AC, 1998, CIRC RES, V82, P1043, DOI 10.1161/01.RES.82.10.1043; Gutstein DE, 2003, J CELL SCI, V116, P875, DOI 10.1242/jcs.00258; HEIKINHEIMO M, 1994, DEV BIOL, V164, P361, DOI 10.1006/dbio.1994.1206; Jiao K, 2003, GENE DEV, V17, P2362, DOI 10.1101/gad.1124803; Kruithof BPT, 2006, DEV BIOL, V295, P507, DOI 10.1016/j.ydbio.2006.03.033; Laugwitz KL, 2008, DEVELOPMENT, V135, P193, DOI 10.1242/dev.001883; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Le YZ, 1999, ANAL BIOCHEM, V270, P334, DOI 10.1006/abio.1999.4110; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Manner J, 1999, ANAT RECORD, V255, P212; Manner J, 2001, CELLS TISSUES ORGANS, V169, P89, DOI 10.1159/000047867; Mao XH, 1999, P NATL ACAD SCI USA, V96, P5037, DOI 10.1073/pnas.96.9.5037; Martin-Puig S, 2008, CELL STEM CELL, V2, P320, DOI 10.1016/j.stem.2008.03.010; Merki E, 2005, P NATL ACAD SCI USA, V102, P18455, DOI 10.1073/pnas.0504343102; Mikawa T, 1996, DEV BIOL, V174, P221, DOI 10.1006/dbio.1996.0068; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Moses Kelvin A., 2001, Genesis The Journal of Genetics and Development, V31, P176, DOI 10.1002/gene.10022; Pu WT, 2003, CIRC RES, V92, P725, DOI 10.1161/01.RES.0000069211.82346.46; Qyang Y, 2007, CELL STEM CELL, V1, P165, DOI 10.1016/j.stem.2007.05.018; Rivera-Feliciano J, 2006, DEVELOPMENT, V133, P3607, DOI 10.1242/dev.02519; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stanley EG, 2002, INT J DEV BIOL, V46, P431; Verzi MP, 2005, DEV BIOL, V287, P134, DOI 10.1016/j.ydbio.2005.08.041; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095; Watt AJ, 2004, P NATL ACAD SCI USA, V101, P12573, DOI 10.1073/pnas.0400752101; Wessels A, 2004, ANAT REC PART A, V276A, P43, DOI 10.1002/ar.a.10129; Wilm B, 2005, DEVELOPMENT, V132, P5317, DOI 10.1242/dev.02141; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Yang L, 2006, DEVELOPMENT, V133, P1575, DOI 10.1242/dev.02322; Zhou B, 2006, J THROMB HAEMOST, V4, P993, DOI 10.1111/j.1538-7836.2006.01906.x	36	721	759	2	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2008	454	7200					109	U5		10.1038/nature07060	http://dx.doi.org/10.1038/nature07060			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321MC	18568026	Green Accepted			2022-12-28	WOS:000257308300047
J	Llewellyn, ME; Barretto, RPJ; Delp, SL; Schnitzer, MJ				Llewellyn, Michael E.; Barretto, Robert P. J.; Delp, Scott L.; Schnitzer, Mark J.			Minimally invasive high-speed imaging of sarcomere contractile dynamics in mice and humans	NATURE			English	Article							IN-VIVO; 2ND-HARMONIC GENERATION; MUSCLE; MICROSCOPY; FLUORESCENCE; PROTEINS; MOUSE; CELLS	Sarcomeres are the basic contractile units of striated muscle. Our knowledge about sarcomere dynamics has primarily come from in vitro studies of muscle fibres(1) and analysis of optical diffraction patterns obtained from living muscles(2,3). Both approaches involve highly invasive procedures and neither allows examination of individual sarcomeres in live subjects. Here we report direct visualization of individual sarcomeres and their dynamical length variations using minimally invasive optical microendoscopy(4) to observe second-harmonic frequencies of light generated in the muscle fibres(5,6) of live mice and humans. Using microendoscopes as small as 350 mm in diameter, we imaged individual sarcomeres in both passive and activated muscle. Our measurements permit in vivo characterization of sarcomere length changes that occur with alterations in body posture and visualization of local variations in sarcomere length not apparent in aggregate length determinations. High-speed data acquisition enabled observation of sarcomere contractile dynamics with millisecond-scale resolution. These experiments point the way to in vivo imaging studies demonstrating how sarcomere performance varies with physical conditioning and physiological state, as well as imaging diagnostics revealing how neuromuscular diseases affect contractile dynamics.	[Llewellyn, Michael E.; Barretto, Robert P. J.; Delp, Scott L.; Schnitzer, Mark J.] Stanford Univ, Bio X Program, James H Clark Ctr Biomed Engn & Sci, Stanford, CA 94305 USA	Stanford University	Schnitzer, MJ (corresponding author), Stanford Univ, Bio X Program, James H Clark Ctr Biomed Engn & Sci, Stanford, CA 94305 USA.	mschnitz@stanford.edu		Delp, Scott/0000-0002-9643-7551	NINDS NIH HHS [R01NS050533, R01 NS050533, R01 NS050533-01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050533] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Campagnola PJ, 2003, NAT BIOTECHNOL, V21, P1356, DOI 10.1038/nbt894; Campagnola PJ, 2002, BIOPHYS J, V82, P493, DOI 10.1016/S0006-3495(02)75414-3; Chu SW, 2004, BIOPHYS J, V86, P3914, DOI 10.1529/biophysj.103.034595; Clarkson E, 2004, J PATHOL, V204, P407, DOI 10.1002/path.1648; CUTTS A, 1988, J ANAT, V160, P79; Delp SL, 2007, IEEE T BIO-MED ENG, V54, P1940, DOI 10.1109/TBME.2007.901024; DELP SL, 1990, IEEE T BIO-MED ENG, V37, P757, DOI 10.1109/10.102791; Goulding D, 1997, J MUSCLE RES CELL M, V18, P465, DOI 10.1023/A:1018650915751; Hoppeler H, 2003, MED SCI SPORT EXER, V35, P95, DOI 10.1097/00005768-200301000-00016; HUXLEY AF, 1954, NATURE, V173, P971, DOI 10.1038/173971a0; HUXLEY H, 1954, NATURE, V173, P973, DOI 10.1038/173973a0; Jung JC, 2004, J NEUROPHYSIOL, V92, P3121, DOI 10.1152/jn.00234.2004; Jung JC, 2003, OPT LETT, V28, P902, DOI 10.1364/OL.28.000902; Laing NG, 2005, BIOESSAYS, V27, P809, DOI 10.1002/bies.20269; Levene MJ, 2004, J NEUROPHYSIOL, V91, P1908, DOI 10.1152/jn.01007.2003; LIEBER RL, 1994, J NEUROPHYSIOL, V71, P874, DOI 10.1152/jn.1994.71.3.874; Lieber RL, 2005, J HAND SURG-AM, V30A, P273, DOI 10.1016/j.jhsa.2004.10.003; Manal K, 2002, COMPUT BIOL MED, V32, P25, DOI 10.1016/S0010-4825(01)00024-5; Moreaux L, 2001, BIOPHYS J, V80, P1568, DOI 10.1016/S0006-3495(01)76129-2; Pellegrino MA, 2003, J PHYSIOL-LONDON, V546, P677, DOI 10.1113/jphysiol.2002.027375; Perreault EJ, 2003, J NEUROPHYSIOL, V89, P738, DOI 10.1152/jn.00168.2002; Plotnikov SV, 2006, BIOPHYS J, V90, P693, DOI 10.1529/biophysj.105.071555; PLOTNIKOV SV, IN PRESS J BIOMED OP; Ponten E, 2007, MUSCLE NERVE, V36, P47, DOI 10.1002/mus.20780; Rothstein EC, 2005, BIOPHYS J, V88, P2165, DOI 10.1529/biophysj.104.053165; Schurmann S, 2007, PROC SPIE, V6442, DOI 10.1117/12.700917; Telley IA, 2007, J MUSCLE RES CELL M, V28, P89, DOI 10.1007/s10974-007-9107-8; YEH Y, 1980, BIOPHYS J, V29, P509, DOI 10.1016/S0006-3495(80)85149-6; Zipfel WR, 2003, P NATL ACAD SCI USA, V100, P7075, DOI 10.1073/pnas.0832308100; Zoumi A, 2002, P NATL ACAD SCI USA, V99, P11014, DOI 10.1073/pnas.172368799	30	229	238	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2008	454	7205					784	788		10.1038/nature07104	http://dx.doi.org/10.1038/nature07104			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334NH	18600262	Green Accepted			2022-12-28	WOS:000258228000049
J	Sprecher, SG; Desplan, C				Sprecher, Simon G.; Desplan, Claude			Switch of rhodopsin expression in terminally differentiated Drosophila sensory neurons	NATURE			English	Article							FINGER TRANSCRIPTION FACTOR; VISUAL-SYSTEM; SINGLE CONES; CLOCK NEURONS; PHOTORECEPTORS; RETINA; ADULT; LIGHT; MELANOGASTER; SENSELESS	Specificity of sensory neurons requires restricted expression of one sensory receptor gene and the exclusion of all others within a given cell. In the Drosophila retina, functional identity of photoreceptors depends on light-sensitive Rhodopsins (Rhs). The much simpler larval eye (Bolwig organ) is composed of about 12 photoreceptors, eight of which are green-sensitive (Rh6) and four bluesensitive (Rh5)(1). The larval eye becomes the adult extraretinal 'eyelet' composed of four green-sensitive (Rh6) photoreceptors(2,3). Here we show that, during metamorphosis, all Rh6 photoreceptors die, whereas the Rh5 photoreceptors switch fate by turning off Rh5 and then turning on Rh6 expression. This switch occurs without apparent changes in the programme of transcription factors that specify larval photoreceptor subtypes. We also show that the transcription factor Senseless (Sens) mediates the very different cellular behaviours of Rh5 and Rh6 photoreceptors. Sens is restricted to Rh5 photoreceptors and must be excluded from Rh6 photoreceptors to allow them to die at metamorphosis. Finally, we show that Ecdysone receptor (EcR) functions autonomously both for the death of larval Rh6 photoreceptors and for the sensory switch of Rh5 photoreceptors to express Rh6. This fate switch of functioning, terminally differentiated neurons provides a novel, unexpected example of hard-wired sensory plasticity.	[Sprecher, Simon G.; Desplan, Claude] NYU, Ctr Dev Genet, Dept Biol, Silver Ctr 1090, New York, NY 10003 USA	New York University	Desplan, C (corresponding author), NYU, Ctr Dev Genet, Dept Biol, Silver Ctr 1090, 100 Washington Sq E, New York, NY 10003 USA.	cd38@nyu.edu	Sprecher, Simon/B-5188-2012; Sprecher, Simon/K-4249-2015	Sprecher, Simon/0000-0001-9060-3750; Desplan, Claude/0000-0002-6914-1413	NCRR NIH HHS [C06 RR015518, C06 RR-15518-01] Funding Source: Medline; NEI NIH HHS [R01 EY013010-01, R01 EY013010, EY013010] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015518] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013010] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Applebury ML, 2000, NEURON, V27, P513, DOI 10.1016/S0896-6273(00)00062-3; Busto M, 1999, J NEUROSCI, V19, P3337; Chandrasekaran V, 2003, DEVELOPMENT, V130, P4719, DOI 10.1242/dev.00677; Cheng CL, 2007, J EXP BIOL, V210, P4123, DOI 10.1242/jeb.009217; Cheng CL, 2006, J COMP NEUROL, V495, P213, DOI 10.1002/cne.20879; Cheng CL, 2004, NATURE, V428, P279, DOI 10.1038/428279a; Daniel A, 1999, DEVELOPMENT, V126, P2945; Devarakonda S, 2003, EMBO J, V22, P5827, DOI 10.1093/emboj/cdg569; Hassan J, 2005, J COMP NEUROL, V481, P266, DOI 10.1002/cne.20383; Helfrich-Forster C, 2002, J NEUROSCI, V22, P9255; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; Kimura H, 2005, DNA REPAIR, V4, P939, DOI 10.1016/j.dnarep.2005.04.012; Kozlova T, 2003, SCIENCE, V301, P1911, DOI 10.1126/science.1087419; Kuo CT, 2005, P NATL ACAD SCI USA, V102, P15230, DOI 10.1073/pnas.0507393102; LOI PK, 1993, J EXP BIOL, V181, P175; Makino CL, 1996, J GEN PHYSIOL, V108, P27, DOI 10.1085/jgp.108.1.27; Malpel S, 2002, DEVELOPMENT, V129, P1443; Mazzoni EO, 2004, DEV NEUROSCI-BASEL, V26, P388, DOI 10.1159/000082281; Mazzoni EO, 2005, NEURON, V45, P293, DOI 10.1016/j.neuron.2004.12.038; Mealey-Ferrara ML, 2003, J NEUROGENET, V17, P171, DOI 10.1080/01677060390256422; Mikeladze-Dvali T, 2005, CELL, V122, P775, DOI 10.1016/j.cell.2005.07.026; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; Sprecher SG, 2007, GENE DEV, V21, P2182, DOI 10.1101/gad.1565407; Tahayato A, 2003, DEV CELL, V5, P391, DOI 10.1016/S1534-5807(03)00239-9; TALBOT WS, 1993, CELL, V73, P1323, DOI 10.1016/0092-8674(93)90359-X; Veleri S, 2007, J BIOL RHYTHM, V22, P29, DOI 10.1177/0748730406295754; Wallis D, 2003, DEVELOPMENT, V130, P221, DOI 10.1242/dev.00190; Xiao M, 2000, J COMP NEUROL, V425, P545; Yasuyama K, 1999, J COMP NEUROL, V412, P193, DOI 10.1002/(SICI)1096-9861(19990920)412:2<193::AID-CNE1>3.0.CO;2-0; Zheng XY, 2003, CELL, V112, P303, DOI 10.1016/S0092-8674(03)00072-2	30	83	85	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2008	454	7203					533	537		10.1038/nature07062	http://dx.doi.org/10.1038/nature07062			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329IC	18594514	Green Accepted, Green Submitted			2022-12-28	WOS:000257860300055
J	Shabajee, N; Lamb, EJ; Sturgess, I; Sumathipala, RW				Shabajee, N.; Lamb, E. J.; Sturgess, I.; Sumathipala, R. W.			Lesson of the week - Omeprazole and refractory hypomagnesaemia	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MAGNESIUM; ABSORPTION		[Shabajee, N.; Lamb, E. J.] Kent & Canterbury Hosp, Dept Clin Biochem, E Kent Hosp NHS Trust, Canterbury CT1 3NG, Kent, England; [Sturgess, I.; Sumathipala, R. W.] E Kent Hosp NHS Trust, Dept Hlth Care Older Person, Canterbury CT1 3NG, Kent, England	University of Kent	Lamb, EJ (corresponding author), Kent & Canterbury Hosp, Dept Clin Biochem, E Kent Hosp NHS Trust, Canterbury CT1 3NG, Kent, England.	Edmund.lamb@ekht.nhs.uk						ALLGROVE J, 1984, CLIN ENDOCRINOL, V21, P435, DOI 10.1111/j.1365-2265.1984.tb03230.x; Epstein M, 2006, NEW ENGL J MED, V355, P1834, DOI 10.1056/NEJMc066308; Evenepoel P, 2001, BEST PRACT RES CL GA, V15, P539, DOI 10.1053/bega.2000.0197; Marples D, 1996, J CLIN INVEST, V97, P1960, DOI 10.1172/JCI118628; Quamme GA, 1997, KIDNEY INT, V52, P1180, DOI 10.1038/ki.1997.443; RYAN MF, 1991, ANN CLIN BIOCHEM, V28, P19, DOI 10.1177/000456329102800103; SERFATYLACROSNIERE C, 1995, J AM COLL NUTR, V14, P364	7	56	59	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 19	2008	337	7662							a425	10.1136/bmj.39505.738981.BE	http://dx.doi.org/10.1136/bmj.39505.738981.BE			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	330SB	18617497	Green Published			2022-12-28	WOS:000257962000045
J	Millstone, E; Lang, T				Millstone, Erik; Lang, Tim			Risking regulatory capture at the UK's Food Standards Agency?	LANCET			English	Editorial Material									[Millstone, Erik] Univ Sussex, Brighton BN1 9QE, E Sussex, England; [Lang, Tim] City Univ London, Ctr Food Policy, London EC1V 0HB, England	University of Sussex; City University London	Millstone, E (corresponding author), Univ Sussex, Brighton BN1 9QE, E Sussex, England.	e.p.millstone@sussex.ac.uk						AVERY N, 1993, CRACKING CODEX REPOR; *BBC NEWS, 2008, EU BACKS RIV FOOD LA; Bernstein MH., 1955, REGULATING BUSINESS, DOI 10.1515/9781400878789; *CONS RES DEPT, 2007, PUBL HLTH OUR PRIOR; *FOOD STAND AG, DET BOARD MEMB THEIR; *FOOD STAND AG, 2007, 50 FOOD STAND AG; JAMES P, 1997, FOOD STANDARDS AGENC; Lang T, 2005, PUBLIC HEALTH NUTR, V8, P11, DOI [10.1079/PHN2005654, 10.1079/PHN2004654]; LOBSTEIN T, 2008, GUARDIAN        0107; MacMillan T, 2003, GEOFORUM, V34, P187, DOI 10.1016/S0016-7185(02)00091-X; MassonMatthee MD, 2007, CODEX ALIMENTARIUS COMMISSION AND ITS STANDARDS, P1, DOI 10.1007/978-90-6704-515-5; Millstone E, 2000, NAT MED, V6, P1307, DOI 10.1038/82102; Millstone E., 2008, RISK ASSESSMENT POLI; *MIN AGR FISH FOOD, 1998, FOOD STAND AG FORC C; MULLER RA, 1989, EOS, V70, P276; NESTLE M, 2002, FOODS POLITICS; REVILL J, 2007, OBSERVER        0916; WATTERSON A, 1993, LANCET, V342, P131, DOI 10.1016/0140-6736(93)91341-I; Wilson B., 2008, SWINDLED POISON SWEE	19	7	7	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 12	2008	372	9633					94	95		10.1016/S0140-6736(08)61012-0	http://dx.doi.org/10.1016/S0140-6736(08)61012-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	324XJ	18620933				2022-12-28	WOS:000257552400007
J	Steinbrook, R				Steinbrook, Robert			The (slowly) vanishing prescription pad	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material												rsteinbrook@attglobal.net						Fischer MA, 2007, DRUG SAFETY, V30, P461, DOI 10.2165/00002018-200730060-00001; Grossman JM, 2007, HEALTH AFFAIR, V26, pW393, DOI 10.1377/hlthaff.26.3.w393; Institute of Medicine, 2007, PREV MED ERR; *SURESCRIPTS, 2007, NAT PROGR REP E PRES	4	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 10	2008	359	2					115	117		10.1056/NEJMp0802864	http://dx.doi.org/10.1056/NEJMp0802864			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	323PJ	18614780				2022-12-28	WOS:000257459000002
J	Coombes, R				Coombes, Rebecca			The NHS debate	BRITISH MEDICAL JOURNAL			English	Editorial Material												rcoombes@bmjgroup.com							0	1	2	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 5	2008	337	7660							a628	10.1136/bmj.a628	http://dx.doi.org/10.1136/bmj.a628			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	326DF	18595901				2022-12-28	WOS:000257637500026
J	Takemi, K; Jimba, M; Ishii, S; Katsuma, Y; Nakamura, Y				Takemi, Keizo; Jimba, Masamine; Ishii, Sumie; Katsuma, Yasushi; Nakamura, Yasuhide		Working Grp Challenges Global Hlth	Human security approach for global health	LANCET			English	Editorial Material									[Takemi, Keizo] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Cambridge, MA 02138 USA; [Jimba, Masamine] Univ Tokyo, Grad Sch Med, Dept Int Community Hlth, Tokyo, Japan; [Ishii, Sumie] Japanese Org Int Cooperat Family Planning, Tokyo, Japan; [Katsuma, Yasushi] Waseda Univ, Grad Sch Asia Pacific Studies, Tokyo, Japan; [Nakamura, Yasuhide] Osaka Univ, Grad Sch Human Sci, Dept Int Collaborat, Osaka, Japan	Harvard University; Harvard T.H. Chan School of Public Health; University of Tokyo; Waseda University; Osaka University	Takemi, K (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Cambridge, MA 02138 USA.	keizo55@takemi.net	Katsuma, Yasushi/AAR-6775-2020; Jimba, Masamine/AAF-5630-2020	Katsuma, Yasushi/0000-0002-2957-9867				Commission on Human Security, 2003, HUMAN SECURITY NOW P; Hubbard Susan, 2008, BUILDING RESILIENCE; Human Security Centre, 2005, HUM SEC REP 2005 WAR; Koumura M, 2007, LANCET, V370, P1983, DOI 10.1016/S0140-6736(07)61726-7; OKAZAKI I, 2007, STRATEGIC PEACE INT, P105; Reich MR, 2008, LANCET, V371, P865, DOI 10.1016/S0140-6736(08)60384-0; SUTO N, 2007, STRATEGIC PEACE INT, P61; United Nations Development Programme, 1994, HUM DEV REP 1994	8	18	18	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 5	2008	372	9632					13	14		10.1016/S0140-6736(08)60971-X	http://dx.doi.org/10.1016/S0140-6736(08)60971-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	321XN	18603145				2022-12-28	WOS:000257339900010
J	Gueugniaud, PY; David, JS; Chanzy, E; Hubert, H; Dubien, PY; Mauriaucourt, P; Braganca, C; Billeres, X; Clotteau-Lambert, MP; Fuster, P; Thiercelin, D; Debaty, G; Ricard-Hibon, A; Roux, P; Espesson, C; Querellou, E; Ducros, L; Ecollan, P; Halbout, L; Savary, D; Guillaumee, F; Maupoint, R; Capelle, P; Bracq, C; Dreyfus, P; Nouguier, P; Gache, A; Meurisse, C; Boulanger, B; Lae, C; Metzger, J; Raphael, V; Beruben, A; Wenzel, V; Guinhouya, C; Vilhelm, C; Marret, E				Gueugniaud, Pierre-Yves; David, Jean-Stephane; Chanzy, Eric; Hubert, Herve; Dubien, Pierre-Yves; Mauriaucourt, Patrick; Braganca, Coralie; Billeres, Xavier; Clotteau-Lambert, Marie-Paule; Fuster, Patrick; Thiercelin, Didier; Debaty, Guillaume; Ricard-Hibon, Agnes; Roux, Patrick; Espesson, Catherine; Querellou, Emgan; Ducros, Laurent; Ecollan, Patrick; Halbout, Laurent; Savary, Dominique; Guillaumee, Frederic; Maupoint, Regine; Capelle, Philippe; Bracq, Cecile; Dreyfus, Philippe; Nouguier, Philippe; Gache, Antoine; Meurisse, Claude; Boulanger, Bertrand; Lae, Claude; Metzger, Jacques; Raphael, Valerie; Beruben, Arielle; Wenzel, Volker; Guinhouya, Comlavi; Vilhelm, Christian; Marret, Emmanuel			Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HOSPITAL CARDIAC-ARREST; GUIDELINES; PRESSURE	Background: During the administration of advanced cardiac life support for resuscitation from cardiac arrest, a combination of vasopressin and epinephrine may be more effective than epinephrine or vasopressin alone, but evidence is insufficient to make clinical recommendations. Methods: In a multicenter study, we randomly assigned adults with out-of-hospital cardiac arrest to receive successive injections of either 1 mg of epinephrine and 40 IU of vasopressin or 1 mg of epinephrine and saline placebo, followed by administration of the same combination of study drugs if spontaneous circulation was not restored and subsequently by additional epinephrine if needed. The primary end point was survival to hospital admission; the secondary end points were return of spontaneous circulation, survival to hospital discharge, good neurologic recovery, and 1-year survival. Results: A total of 1442 patients were assigned to receive a combination of epinephrine and vasopressin, and 1452 to receive epinephrine alone. The treatment groups had similar baseline characteristics except that there were more men in the group receiving combination therapy than in the group receiving epinephrine alone (P=0.03). There were no significant differences between the combination-therapy and the epinephrine-only groups in survival to hospital admission (20.7% vs. 21.3%; relative risk of death, 1.01; 95% confidence interval [CI], 0.97 to 1.05), return of spontaneous circulation (28.6% vs. 29.5%; relative risk, 1.01; 95% CI, 0.97 to 1.06), survival to hospital discharge (1.7% vs. 2.3%; relative risk, 1.01; 95% CI, 1.00 to 1.02), 1-year survival (1.3% vs. 2.1%; relative risk, 1.01; 95% CI, 1.00 to 1.02), or good neurologic recovery at hospital discharge (37.5% vs. 51.5%; relative risk, 1.29; 95% CI, 0.81 to 2.06). Conclusions: As compared with epinephrine alone, the combination of vasopressin and epinephrine during advanced cardiac life support for out-of-hospital cardiac arrest does not improve outcome. (ClinicalTrials.gov number, NCT00127907.).	[Gueugniaud, Pierre-Yves; David, Jean-Stephane] Univ Lyon 1, Hospices Civils Lyon, SAMU 69, F-69365 Lyon, France; [Chanzy, Eric] SAMU 93, Bobigny, France; [Hubert, Herve; Guinhouya, Comlavi; Vilhelm, Christian] Univ Lille, Hlth Engn Inst, Lille, France; [Dubien, Pierre-Yves] Hop Edouard Herriot, SMUR, Lyon, France; [Mauriaucourt, Patrick] SAMU 59, Lille, France; [Braganca, Coralie] SAMU 33, Bordeaux, France; [Billeres, Xavier] Bataillon Marins Pompiers, Marseille, France; [Clotteau-Lambert, Marie-Paule] SAMU 44, Nantes, France; [Fuster, Patrick] CHU Lyon Sud, SMUR, Lyon, France; [Thiercelin, Didier] SAMU 06, Nice, France; [Debaty, Guillaume] SAMU 38, Grenoble, France; [Ricard-Hibon, Agnes] Hop Beaujon, SMUR, Beaujon, France; [Roux, Patrick] SAMU 31, Toulouse, France; [Espesson, Catherine] SAMU 42, St Etienne, France; [Querellou, Emgan] SAMU 29, Brest, France; [Ducros, Laurent] CHU Lariboisiere, SMUR, Paris, France; [Ecollan, Patrick] CHU Pitie Salpetriere, SMUR, Paris, France; [Halbout, Laurent] SAMU 14, Caen, France; [Savary, Dominique] SAMU 74, Annecy, France; [Guillaumee, Frederic] Hop Croix Rousse, SMUR, F-69317 Lyon, France; [Maupoint, Regine] SAMU 01, Bourg en Bresse, France; [Capelle, Philippe] Maubeuge Hosp, SMUR, Maubeuge, France; [Bracq, Cecile] Dunkerque Hosp, SMUR, Dunkerque, France; [Dreyfus, Philippe] SAMU 21, Dijon, France; [Nouguier, Philippe] SAMU 13, Marseille, France; [Gache, Antoine] SAMU 30, Nimes, France; [Meurisse, Claude] Valenciennes Hosp, SMUR, Valenciennes, France; [Boulanger, Bertrand] SAMU 56, Vannes, France; [Lae, Claude] Annemasse Hosp, SMUR, Annemasse, France; [Metzger, Jacques] St Denis Hosp, SMUR, St Denis, France; [Raphael, Valerie] Aulnay Hosp, SMUR, Aulnay Sous Bois, France; [Beruben, Arielle] Montfermeil Hosp, SMUR, Montfermeil, France; [Marret, Emmanuel] Hop Tenon, F-75970 Paris, France; [Wenzel, Volker] Innsbruck Med Univ, Innsbruck, Austria	CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite de Lille - ISITE; Universite de Lille; CHU Lyon; CHU Lyon; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Lyon; CH de Valenciennes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Medical University of Innsbruck	Gueugniaud, PY (corresponding author), CHU Lyon Sud, Pole Urgence, Dept Anesthesiol & Crit Care Med, F-69495 Lyon, France.	pierre-yves.gueugniaud@chu-lyon.fr	Hubert, Herve/A-8520-2012; Debaty, Guillaume/M-2810-2013; David, Jean Stephane/H-9399-2019	Hubert, Herve/0000-0003-2944-7597; Debaty, Guillaume/0000-0003-2879-0326; David, Jean Stephane/0000-0001-6274-7044				ABRAMSON NS, 1986, NEW ENGL J MED, V314, P397; Adnet F, 2004, RESUSCITATION, V63, P7, DOI 10.1016/j.resuscitation.2004.04.001; Aung K, 2005, ARCH INTERN MED, V165, P17, DOI 10.1001/archinte.165.1.17; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; BROWN CG, 1992, NEW ENGL J MED, V327, P1051, DOI 10.1056/NEJM199210083271503; Bunch TJ, 2003, NEW ENGL J MED, V348, P2626, DOI 10.1056/NEJMoa023053; Callaway CW, 2006, AM J CARDIOL, V98, P1316, DOI 10.1016/j.amjcard.2006.06.022; Cobb LA, 2002, JAMA-J AM MED ASSOC, V288, P3008, DOI 10.1001/jama.288.23.3008; CUMMINS RO, 1991, ANN EMERG MED, V20, P861; European Resuscitation Council, 2000, RESUSCITATION, V46, P3; Gueugniaud PY, 1998, NEW ENGL J MED, V339, P1595, DOI 10.1056/NEJM199811263392204; Holzer M, 2002, NEW ENGL J MED, V346, P549; International Liaison Committee on R, 2005, RESUSCITATION, V67, P213; LINDNER KH, 1992, ANESTHESIOLOGY, V77, P662, DOI 10.1097/00000542-199210000-00008; LINDNER KH, 1995, CIRCULATION, V91, P215, DOI 10.1161/01.CIR.91.1.215; Mally S, 2007, CRIT CARE, V11, DOI 10.1186/cc5726; Mayr VD, 2001, CIRCULATION, V104, P1651, DOI 10.1161/hc3901.095896; Popp E, 2007, RESUSCITATION, V72, P137, DOI 10.1016/j.resuscitation.2006.05.015; Prengel AW, 1996, STROKE, V27, P1241, DOI 10.1161/01.STR.27.7.1241; Sanders AB, 2005, JAMA-J AM MED ASSOC, V293, P363, DOI 10.1001/jama.293.3.363; Stiell IG, 2001, LANCET, V358, P105, DOI 10.1016/S0140-6736(01)05328-4; Sunde K, 2007, RESUSCITATION, V73, P29, DOI 10.1016/j.resuscitation.2006.08.016; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003; Wenzel V, 2000, J AM COLL CARDIOL, V35, P527, DOI 10.1016/S0735-1097(99)00562-8; Wenzel V, 2004, NEW ENGL J MED, V350, P105, DOI 10.1056/NEJMoa025431; Wenzel V, 1999, CIRCULATION, V99, P1379, DOI 10.1161/01.CIR.99.10.1379	26	198	209	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 3	2008	359	1					21	30		10.1056/NEJMoa0706873	http://dx.doi.org/10.1056/NEJMoa0706873			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320PB	18596271				2022-12-28	WOS:000257246000004
J	Nemchin, AA; Whitehouse, MJ; Menneken, M; Geisler, T; Pidgeon, RT; Wilde, SA				Nemchin, Alexander A.; Whitehouse, Martin J.; Menneken, Martina; Geisler, Thorsten; Pidgeon, Robert T.; Wilde, Simon A.			A light carbon reservoir recorded in zircon-hosted diamond from the Jack Hills	NATURE			English	Article							ORIGIN; CRUST; EARTH; EVOLUTION; IMPACT; FLUID; MOON; GA	The recent discovery of diamond - graphite inclusions in the Earth's oldest zircon grains ( formed up to 4,252 Myr ago) from the Jack Hills metasediments in Western Australia(1) provides a unique opportunity to investigate Earth's earliest known carbon reservoir. Here we report ion microprobe analyses of the carbon isotope composition of these diamond - graphite inclusions. The observed delta(13) C-PDB values ( expressed using the PeeDee Belemnite standard) range between -5 per mil and -58 per mil with a median of -31 per mil. This extends beyond typical mantle values of around -6 per mil to values observed in metamorphic and some eclogitic diamonds that are interpreted to reflect deep subduction of low-delta(13) C-PDB biogenic surface carbon. Low delta(13) C-PDB values may also be produced by inorganic chemical reactions(2), and therefore are not unambiguous evidence for life on Earth as early as 4,250 Myr ago. Regardless, our results suggest that a low-delta(13) C-PDB reservoir may have existed on the early Earth.	[Nemchin, Alexander A.; Pidgeon, Robert T.; Wilde, Simon A.] Curtin Univ Technol, Western Australian Sch Mines, Dept Appl Geol, Bentley, WA 6102, Australia; [Whitehouse, Martin J.] Swedish Museum Nat Hist, Lab Isotope Geol, SE-10405 Stockholm, Sweden; [Menneken, Martina; Geisler, Thorsten] Univ Munster, Inst Mineral, D-48149 Munster, Germany	Curtin University; Swedish Museum of Natural History; University of Munster	Nemchin, AA (corresponding author), Curtin Univ Technol, Western Australian Sch Mines, Dept Appl Geol, Bentley, WA 6102, Australia.	nemchina@kalg.curtin.edu.au	Whitehouse, Martin J/E-1425-2013; Wilde, Simon Alexander/C-5174-2009	Whitehouse, Martin J/0000-0003-2227-577X; Wilde, Simon Alexander/0000-0002-4546-8278; Menneken, Martina/0000-0003-4106-7458; Nemchin, Alexander/0000-0002-3955-3409				Amelin Y, 2000, GEOCHIM COSMOCHIM AC, V64, P4205, DOI 10.1016/S0016-7037(00)00493-2; Bedard JH, 2006, GEOCHIM COSMOCHIM AC, V70, P1188, DOI 10.1016/j.gca.2005.11.008; Canup RM, 2001, NATURE, V412, P708, DOI 10.1038/35089010; Cartigny P, 2005, ELEMENTS, V1, P79, DOI 10.2113/gselements.1.2.79; Farquhar J, 1999, EARTH PLANET SC LETT, V171, P607, DOI 10.1016/S0012-821X(99)00177-6; Geisler T, 2007, ELEMENTS, V3, P43, DOI 10.2113/gselements.3.1.43; Haggerty SE, 1999, SCIENCE, V285, P851, DOI 10.1126/science.285.5429.851; Harrison TM, 2005, SCIENCE, V310, P1947, DOI 10.1126/science.1117926; Harte B, 1999, MINERAL MAG, V63, P829, DOI 10.1180/002646199548961; HAZEN RM, 1979, AM MINERAL, V64, P196; Heaney PJ, 2005, ELEMENTS, V1, P85, DOI 10.2113/gselements.1.2.85; Horita J, 2005, CHEM GEOL, V218, P171, DOI 10.1016/j.chemgeo.2005.01.017; Horita J, 1999, SCIENCE, V285, P1055, DOI 10.1126/science.285.5430.1055; Hoskin PWO, 2003, REV MINERAL GEOCHEM, V53, P27, DOI 10.2113/0530027; Kerley G.I., 2001, SAND20012619; Kramers JD, 2007, J GEOL SOC LONDON, V164, P3, DOI 10.1144/0016-76492006-028; Krot AN, 2005, TREATISE GEOCHEM, V1, P83; MAAS R, 1992, GEOCHIM COSMOCHIM AC, V56, P1281, DOI 10.1016/0016-7037(92)90062-N; McCollom TM, 2006, EARTH PLANET SC LETT, V243, P74, DOI 10.1016/j.epsl.2006.01.027; McKeegan KD, 2006, SCIENCE, V314, P1724, DOI 10.1126/science.1135992; Menneken M, 2007, NATURE, V448, P917, DOI 10.1038/nature06083; Nemchin AA, 2006, EARTH PLANET SC LETT, V244, P218, DOI 10.1016/j.epsl.2006.01.054; Rizvanova NG, 2000, CONTRIB MINERAL PETR, V139, P101, DOI 10.1007/s004100050576; RUSSELL SS, 1991, SCIENCE, V254, P1188, DOI 10.1126/science.254.5035.1188; SCHIDLOWSKI M, 1988, NATURE, V333, P313, DOI 10.1038/333313a0; SHIREY SB, 2008, DID PLATE TECTONICS, P1; Verchovsky AB, 1998, SCIENCE, V281, P1165, DOI 10.1126/science.281.5380.1165; Whitehouse MJ, 2007, DEV PREC G, V15, P841, DOI 10.1016/S0166-2635(07)15071-4; Williams IS, 2007, NATURE, V448, P880, DOI 10.1038/448880a	31	45	49	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2008	454	7200					92	U3		10.1038/nature07102	http://dx.doi.org/10.1038/nature07102			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321MC	18596808				2022-12-28	WOS:000257308300043
J	Ahlberg, PE; Clack, JA; Luksevics, E; Blom, H; Zupins, I				Ahlberg, Per E.; Clack, Jennifer A.; Luksevics, Ervins; Blom, Henning; Zupins, Ivars			Ventastega curonica and the origin of tetrapod morphology	NATURE			English	Article							CRASSIGYRINUS-SCOTICUS LYDEKKER; ACANTHOSTEGA-GUNNARI JARVIK; EARLIEST KNOWN TETRAPOD; DEVONIAN TETRAPOD; EVOLUTION; FISH; SKELETON; INTERRELATIONSHIPS; BRAINCASE; ANATOMY	The gap in our understanding of the evolutionary transition from fish to tetrapod is beginning to close thanks to the discovery of new intermediate forms such as Tiktaalik roseae. Here we narrow it further by presenting the skull, exceptionally preserved braincase, shoulder girdle and partial pelvis of Ventastega curonica from the Late Devonian of Latvia, a transitional intermediate form between the 'elpistostegids' Panderichthys and Tiktaalik and the Devonian tetrapods ( limbed vertebrates) Acanthostega and Ichthyostega. Ventastega is the most primitive Devonian tetrapod represented by extensive remains, and casts light on a part of the phylogeny otherwise only represented by fragmentary taxa: it illuminates the origin of principal tetrapod structures and the extent of morphological diversity among the transitional forms.	[Ahlberg, Per E.; Blom, Henning] Uppsala Univ, Subdept Evolutionary Organismal Biol, Dept Physiol & Dev Biol, S-75236 Uppsala, Sweden; [Clack, Jennifer A.] Univ Cambridge, Museum Zool, Cambridge CB2 3EJ, England; [Luksevics, Ervins] Univ Latvia, Dept Geol, LV-1586 Riga, Latvia; [Zupins, Ivars] Nat Hist Museum Latvia, LV-1712 Riga, Latvia	Uppsala University; University of Cambridge; University of Latvia	Ahlberg, PE (corresponding author), Uppsala Univ, Subdept Evolutionary Organismal Biol, Dept Physiol & Dev Biol, Norbyvagen 18A, S-75236 Uppsala, Sweden.	per.ahlberg@ebc.uu.se	Ahlberg, Per/E-8086-2013; Luksevics, Ervins/ABH-9291-2020	Ahlberg, Per/0000-0001-9054-2900				Ahlberg PE, 2005, J VERTEBR PALEONTOL, V25, P720, DOI 10.1671/0272-4634(2005)025[0720:NLOTEK]2.0.CO;2; Ahlberg PE, 2005, NATURE, V437, P137, DOI 10.1038/nature03893; AHLBERG PE, 1995, NATURE, V373, P420, DOI 10.1038/373420a0; Ahlberg PE, 1998, T ROY SOC EDIN-EARTH, V89, P11, DOI 10.1017/S0263593300002340; Ahlberg PE, 1998, ZOOL J LINN SOC-LOND, V122, P99; AHLBERG PE, 1994, PHILOS T ROY SOC B, V343, P303, DOI 10.1098/rstb.1994.0027; Ahlberg PE, 1996, NATURE, V381, P61, DOI 10.1038/381061a0; Ahlberg PE, 2000, PALAEONTOLOGY, V43, P533, DOI 10.1111/j.0031-0239.2000.00138.x; [Anonymous], 2004, ACTA U LATVIENSIS; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Brazeau MD, 2006, NATURE, V439, P318, DOI 10.1038/nature04196; Campbell KSW, 1977, ALCHERINGA, V1, P369, DOI 10.1080/03115517708527771; CLACK JA, 1987, PHILOS T ROY SOC B, V318, P1, DOI 10.1098/rstb.1987.0082; Clack JA, 2003, NATURE, V425, P65, DOI 10.1038/nature01904; Clack JA, 1998, ZOOL J LINN SOC-LOND, V122, P61, DOI 10.1006/zjls.1997.0114; Clack JA, 2003, T ROY SOC EDIN-EARTH, V93, P163; Clack JA, 1998, T ROY SOC EDIN-EARTH, V88, P127, DOI 10.1017/S0263593300006908; CLACK JA, 1988, PALAEONTOLOGY, V31, P85; Clack JA, 2007, INTEGR COMP BIOL, V47, P510, DOI 10.1093/icb/icm055; Clement G, 2004, NATURE, V427, P412, DOI 10.1038/427412a; COATES MI, 1991, NATURE, V352, P234, DOI 10.1038/352234a0; Coates MI, 1996, T ROY SOC EDIN-EARTH, V87, P363, DOI 10.1017/S0263593300006787; Daeschler EB, 2006, NATURE, V440, P757, DOI 10.1038/nature04639; Daeschler EB, 2000, J PALEONTOL, V74, P301, DOI 10.1666/0022-3360(2000)074<0301:ETJFTL>2.0.CO;2; DAESCHLER EB, 1994, SCIENCE, V265, P639, DOI 10.1126/science.265.5172.639; Jarvik E., 1952, Meddelelser om Gronland, V114, P1; JARVIK E, 1990, BASIC STRUCTURE EVOL, V1; Jarvik Erik, 1996, Fossils and Strata, V40, P1; LEBEDEV OA, 1995, ZOOL J LINN SOC-LOND, V114, P307, DOI 10.1006/zjls.1995.0027; LEBEDEV OA, 1993, PALAEONTOLOGY, V36, P721; LONG JA, 1997, RECORDS W AUSTR MU S, V57, P1; Long JA, 2006, NATURE, V444, P199, DOI 10.1038/nature05243; PANCHEN AL, 1990, T ROY SOC EDIN-EARTH, V81, P31, DOI 10.1017/S0263593300005113; Rohlf F. J., 2004, TPSDIG VERSION 1 40; ROHLF FJ, 2004, TPSRELW VERSION 1 39; Ruta M, 2003, BIOL REV, V78, P251, DOI 10.1017/S1464793102006103; SAVESODERBERGH G, 1932, MEDDR GRONLAND, V94, P1; SCHULTZE HP, 1985, PALAEONTOLOGY, V28, P293; Shubin NH, 2004, SCIENCE, V304, P90, DOI 10.1126/science.1094295; Shubin NH, 2006, NATURE, V440, P764, DOI 10.1038/nature04637; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; Vorobeva E.I., 1977, Trudy Paleontologicheskogo Instituta, V163, P1; Vorobyeva E., 1991, P68; Vorobyeva Emilia I., 1995, Geobios Memoire Special (Villeurbanne), V19, P285; Young G. C., 2006, ALCHERINGA, V1, P409; Zhu M, 2002, NATURE, V420, P760, DOI 10.1038/420760a	46	67	69	2	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 26	2008	453	7199					1199	1204		10.1038/nature06991	http://dx.doi.org/10.1038/nature06991			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318FA	18580942	Green Published			2022-12-28	WOS:000257075800034
J	Pharoah, PDP; Antoniou, AC; Easton, DF; Ponder, BAJ				Pharoah, Paul D. P.; Antoniou, Antonis C.; Easton, Douglas F.; Ponder, Bruce A. J.			Polygenes, risk prediction, and targeted prevention of breast cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY; MUTATIONS; VARIANT; BRCA1; WOMEN; TWINS	Background: New developments in the search for susceptibility alleles in complex disorders provide support for the possibility of a polygenic approach to the prevention and treatment of common diseases. Methods: We examined the implications, both for individualized disease prevention and for public health policy, of findings concerning the risk of breast cancer that are based on common genetic variation. Results: Our analysis suggests that the risk profile generated by the known, common, moderate-risk alleles does not provide sufficient discrimination to warrant individualized prevention. However, useful risk stratification may be possible in the context of programs for disease prevention in the general population. Conclusions: The clinical use of single, common, low-penetrance genes is limited, but a few susceptibility alleles may distinguish women who are at high risk for breast cancer from those who are at low risk, particularly in the context of population screening.	[Pharoah, Paul D. P.; Ponder, Bruce A. J.] Univ Cambridge, Dept Oncol, Cambridge, England; [Antoniou, Antonis C.; Easton, Douglas F.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Ponder, Bruce A. J.] Li Ka Shing Ctr, Canc Res UK Cambridge Res Inst, Cambridge, England	University of Cambridge; University of Cambridge; Cancer Research UK; CRUK Cambridge Institute	Pharoah, PDP (corresponding author), Strangeways Res Lab, Worts Causeway, Cambridge CB1 8RN, England.	paul.pharoah@srl.cam.ac.uk	Pharoah, Paul/V-6658-2019	Pharoah, Paul/0000-0001-8494-732X	Cancer Research UK [10118] Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Amundadottir LT, 2004, PLOS MED, V1, P229, DOI 10.1371/journal.pmed.0010065; ANTONIOU AC, 2005, PLOS MED, V2, pE124; Beaudet AL, 1999, AM J HUM GENET, V64, P1, DOI 10.1086/302217; Bell DW, 1999, SCIENCE, V286, P2528, DOI 10.1126/science.286.5449.2528; Bell J, 1998, BMJ-BRIT MED J, V316, P618, DOI 10.1136/bmj.316.7131.618; Beral V, 2001, LANCET, V358, P1389, DOI 10.1016/S0140-6736(01)06524-2; Cox A, 2007, NAT GENET, V39, P688, DOI 10.1038/ng0507-688b; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; Easton D, 2004, AM J HUM GENET, V74, P1175, DOI 10.1086/421251; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Easton H. S., 1999, Ryegrass endophyte: an essential New Zealand symbiosis. Proceedings of a New Zealand Grassland Association symposium held in Napier, New Zealand, 8 October, 1999., P1; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Friend SH, 1996, NAT GENET, V13, P16, DOI 10.1038/ng0596-16; Holtzman NA, 2000, NEW ENGL J MED, V343, P141, DOI 10.1056/NEJM200007133430213; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; *OFF NAT STAT, 2004, SER MB1 OFF NAT STAT, V35; Peto J, 2000, NAT GENET, V26, P411, DOI 10.1038/82533; Pharoah PDP, 1998, BREAST, V7, P255, DOI 10.1016/S0960-9776(98)90091-1; Pharoah PDP, 1997, INT J CANCER, V71, P800, DOI 10.1002/(SICI)1097-0215(19970529)71:5<800::AID-IJC18>3.3.CO;2-R; Pharoah PDP, 2004, NAT REV CANCER, V4, P850, DOI 10.1038/nrc1476; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Swift M, 1997, LANCET, V350, P740, DOI 10.1016/S0140-6736(05)63548-9; Thompson D, 2005, JNCI-J NATL CANCER I, V97, P813, DOI 10.1093/jnci/dji141; Vahteristo P, 2002, AM J HUM GENET, V71, P432, DOI 10.1086/341943; Vineis P, 2001, LANCET, V357, P709, DOI 10.1016/S0140-6736(00)04136-2	31	415	428	0	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 26	2008	358	26					2796	2803		10.1056/NEJMsa0708739	http://dx.doi.org/10.1056/NEJMsa0708739			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	317UO	18579814				2022-12-28	WOS:000257045900006
J	Sohn, RA; Willis, C; Humphris, S; Shank, TM; Singh, H; Edmonds, HN; Kunz, C; Hedman, U; Helmke, E; Jakuba, M; Liljebladh, B; Linder, J; Murphy, C; Nakamura, KI; Sato, T; Schlindwein, V; Stranne, C; Tausenfreund, M; Upchurch, L; Winsor, P; Jakobsson, M; Soule, A				Sohn, Robert A.; Willis, Claire; Humphris, Susan; Shank, Timothy M.; Singh, Hanumant; Edmonds, Henrietta N.; Kunz, Clayton; Hedman, Ulf; Helmke, Elisabeth; Jakuba, Michael; Liljebladh, Bengt; Linder, Julia; Murphy, Christopher; Nakamura, Ko-ichi; Sato, Taichi; Schlindwein, Vera; Stranne, Christian; Tausenfreund, Maria; Upchurch, Lucia; Winsor, Peter; Jakobsson, Martin; Soule, Adam			Explosive volcanism on the ultraslow-spreading Gakkel ridge, Arctic Ocean	NATURE			English	Article							MID-ATLANTIC RIDGE	Roughly 60% of the Earth's outer surface is composed of oceanic crust formed by volcanic processes at mid- ocean ridges. Although only a small fraction of this vast volcanic terrain has been visually surveyed or sampled, the available evidence suggests that explosive eruptions are rare on mid- ocean ridges, particularly at depths below the critical point for seawater ( 3,000 m)(1). A pyroclastic deposit has never been observed on the sea floor below 3,000 m, presumably because the volatile content of mid- ocean- ridge basalts is generally too low to produce the gas fractions required for fragmenting a magma at such high hydrostatic pressure. We employed new deep submergence technologies during an International Polar Year expedition to the Gakkel ridge in the Arctic Basin at 856 E, to acquire photographic and video images of 'zero- age' volcanic terrain on this remote, ice- covered ridge. Here we present images revealing that the axial valley at 4,000 m water depth is blanketed with unconsolidated pyroclastic deposits, including bubble wall fragments (limu o Pele)(2), covering a large ( > 10 km(2)) area. At least 13.5 wt% CO2 is necessary to fragment magma at these depths(3), which is about tenfold the highest values previously measured in a mid- ocean- ridge basalt(4). These observations raise important questions about the accumulation and discharge of magmatic volatiles at ultraslow spreading rates on the Gakkel ridge(5) and demonstrate that large- scale pyroclastic activity is possible along even the deepest portions of the global mid- ocean ridge volcanic system.	[Sohn, Robert A.; Willis, Claire; Humphris, Susan; Shank, Timothy M.; Singh, Hanumant; Kunz, Clayton; Murphy, Christopher; Winsor, Peter; Soule, Adam] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Edmonds, Henrietta N.; Upchurch, Lucia] Univ Texas Austin, Inst Marine Sci, Port Aransas, TX 78373 USA; [Hedman, Ulf] Swedish Polar Secretariat, S-10405 Stockholm, Sweden; [Helmke, Elisabeth; Linder, Julia; Schlindwein, Vera; Tausenfreund, Maria] Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany; [Jakuba, Michael] Johns Hopkins Univ, Baltimore, MD 21218 USA; [Liljebladh, Bengt; Stranne, Christian] Univ Gothenburg, S-40530 Gothenburg, Sweden; [Nakamura, Ko-ichi] AIST, Higashi, Tokyo, Japan; [Sato, Taichi] Univ Tokyo, Ocean Res Inst, Tokyo 1648639, Japan; [Jakobsson, Martin] Stockholm Univ, Dept Geol & Geochem, S-10691 Stockholm, Sweden	Woods Hole Oceanographic Institution; University of Texas System; University of Texas Austin; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Johns Hopkins University; University of Gothenburg; National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo; Stockholm University	Sohn, RA (corresponding author), Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA.	rsohn@whoi.edu	stranne, christian/A-3932-2010; stranne, christian/L-4382-2013; Jakobsson, Martin/F-6214-2010; Sato, Taichi/N-2235-2018	stranne, christian/0000-0003-1004-5213; Sato, Taichi/0000-0002-2158-3730; Soule, Adam/0000-0002-4691-6300; Sohn, Robert/0000-0002-9050-8603; Pontbriand, Claire/0000-0001-8886-154X; Upchurch, Lucia/0000-0003-1351-6332; Schlindwein, Vera/0000-0001-5570-2753; Jakobsson, Martin/0000-0002-9033-3559				BOTTINGA Y, 1990, J GEOPHYS RES-SOLID, V95, P5125, DOI 10.1029/JB095iB04p05125; Clague D.A., 2003, EXPLOSIVE SUBAQUEOUS, V140, P111; Clague DA, 2002, GEOPH MONOG SERIES, V128, P65; Clague DA, 2000, B VOLCANOL, V61, P437, DOI 10.1007/PL00008910; Dick HJB, 2003, NATURE, V426, P405, DOI 10.1038/nature02128; Edmonds HN, 2003, NATURE, V421, P252, DOI 10.1038/nature01351; Edwards MH, 2001, NATURE, V409, P808, DOI 10.1038/35057258; EISSEN JP, 2003, EXPLOSIVE SUBAQUEOUS, P143; Fouquet Y, 1998, TERRA NOVA, V10, P280; GRAHAM DW, 2006, OFIOLITI, V31, P234; Head JW, 2003, J VOLCANOL GEOTH RES, V121, P155, DOI 10.1016/S0377-0273(02)00425-0; Hekinian R, 2000, J VOLCANOL GEOTH RES, V98, P49, DOI 10.1016/S0377-0273(99)00190-0; HON K, 1988, HAWAII GEOL SOC AM A, V20, pA112; JAVOY M, 1991, EARTH PLANET SC LETT, V107, P598, DOI 10.1016/0012-821X(91)90104-P; Michael PJ, 2003, NATURE, V423, P956, DOI 10.1038/nature01704; MUELLER C, 2000, EOS, V81, P265; Schlindwein V, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023767; SELLA GF, 2002, J GEOPHYS RES, V107, DOI DOI 10.1029/2000JB0000033; SHANK TM, 2007, EOS, V88; SPARKS RSJ, 1978, J VOLCANOL GEOTH RES, V3, P1, DOI 10.1016/0377-0273(78)90002-1; Tolstoy M, 2001, GEOLOGY, V29, P1139, DOI 10.1130/0091-7613(2001)029<1139:SCOVAA>2.0.CO;2; Wessel P, 1991, EOS T AM GEOPHYS UN, V72, P445, DOI [10.1029/90EO00319, DOI 10.1029/90EO00319, DOI 10.1029/90E000319]; White JD., 2003, EXPLOSIVE SUBAQUEOUS, V140, P1, DOI DOI 10.1029/140GM01	23	93	98	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2008	453	7199					1236	1238		10.1038/nature07075	http://dx.doi.org/10.1038/nature07075			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318FA	18580949	Green Submitted			2022-12-28	WOS:000257075800042
J	Moynihan, R				Moynihan, Ray			Key opinion leaders - Independent experts or drug representatives in disguise?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Newcastle, Newcastle, NSW 2308, Australia	University of Newcastle	Moynihan, R (corresponding author), Univ Newcastle, Newcastle, NSW 2308, Australia.		Moynihan, Ray/ABC-3010-2020					Cook J., 2001, PHARM MARKETING, V6, P1422; *CUTT EDG INF, 2007, PHARM OP LEAD MAN; *KOL, OP LEAD DEV; *KOL, OP LEAD MAN SERV; Spurgeon D, 2008, BRIT MED J, V336, P742, DOI 10.1136/bmj.39534.514884.DB	5	96	97	3	35	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 21	2008	336	7658					1402	1403		10.1136/bmj.39575.675787.651	http://dx.doi.org/10.1136/bmj.39575.675787.651			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	318WJ	18566074	Green Published, Green Submitted			2022-12-28	WOS:000257123200026
J	Blair, KM; Turner, L; Winkelman, JT; Berg, HC; Kearns, DB				Blair, Kris M.; Turner, Linda; Winkelman, Jared T.; Berg, Howard C.; Kearns, Daniel B.			A molecular clutch disables flagella in the Bacillus subtilis biofilm	SCIENCE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; ROTOR PROTEIN FLIG; ESCHERICHIA-COLI; BACTERIAL FLAGELLA; TORQUE GENERATION; OPTICAL TWEEZERS; MASTER REGULATOR; MOTOR; COMPONENT; RESIDUES	Biofilms are multicellular aggregates of sessile bacteria encased by an extracellular matrix and are important medically as a source of drug- resistant microbes. In Bacillus subtilis, we found that an operon required for biofilm matrix biosynthesis also encoded an inhibitor of motility, EpsE. EpsE arrested flagellar rotation in a manner similar to that of a clutch, by disengaging motor force-generating elements in cells embedded in the biofilm matrix. The clutch is a simple, rapid, and potentially reversible form of motility control.	[Blair, Kris M.; Winkelman, Jared T.; Kearns, Daniel B.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Turner, Linda; Berg, Howard C.] Rowland Inst Sci Inc, Cambridge, MA 02142 USA; [Berg, Howard C.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Indiana University System; Indiana University Bloomington; Harvard University	Kearns, DB (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	dbkearns@indiana.edu		Kearns, Daniel/0000-0002-3460-8378; Blair, Kris/0000-0002-2887-5592	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065540] Funding Source: NIH RePORTER; NIAID NIH HHS [AI065540] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; BLAIR DF, 1990, CELL, V60, P439, DOI 10.1016/0092-8674(90)90595-6; BLOCK SM, 1991, CYTOMETRY, V12, P492, DOI 10.1002/cyto.990120605; BLOCK SM, 1989, NATURE, V338, P514, DOI 10.1038/338514a0; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; Brown PN, 2007, J BACTERIOL, V189, P305, DOI 10.1128/JB.01281-06; Brown PN, 2002, EMBO J, V21, P3225, DOI 10.1093/emboj/cdf332; Chu F, 2006, MOL MICROBIOL, V59, P1216, DOI 10.1111/j.1365-2958.2005.05019.x; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Darnton NC, 2007, J BACTERIOL, V189, P1756, DOI 10.1128/JB.01501-06; Garinot-Schneider C, 2000, J BIOL CHEM, V275, P31407, DOI 10.1074/jbc.M004524200; IRIKURA VM, 1993, J BACTERIOL, V175, P802, DOI 10.1128/JB.175.3.802-810.1993; Kearns DB, 2005, MOL MICROBIOL, V55, P739, DOI 10.1111/j.1365-2958.2004.04440.x; Kojima S, 2001, BIOCHEMISTRY-US, V40, P13041, DOI 10.1021/bi011263o; Kolter R, 2006, NATURE, V441, P300, DOI 10.1038/441300a; Lloyd SA, 1997, J MOL BIOL, V266, P733, DOI 10.1006/jmbi.1996.0836; Lloyd SA, 1996, J BACTERIOL, V178, P223, DOI 10.1128/jb.178.1.223-231.1996; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; Marykwas DL, 1996, J MOL BIOL, V256, P564, DOI 10.1006/jmbi.1996.0109; Mashimo T, 2007, J BACTERIOL, V189, P5153, DOI 10.1128/JB.00061-07; Thomas DR, 2006, J BACTERIOL, V188, P7039, DOI 10.1128/JB.00552-06; Zhou JD, 1998, P NATL ACAD SCI USA, V95, P6436, DOI 10.1073/pnas.95.11.6436	23	219	223	1	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 20	2008	320	5883					1636	1638		10.1126/science.1157877	http://dx.doi.org/10.1126/science.1157877			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	315NM	18566286				2022-12-28	WOS:000256886700048
J	Wen, CP; Cheng, TYD; Tsai, MK; Chang, YC; Chan, HT; Tsai, SP; Chiang, PH; Hsu, CC; Sung, PK; Hsu, YH; Wen, SF				Wen, Chi Pang; Cheng, Ting Yuan David; Tsai, Min Kuang; Chang, Yen Chen; Chan, Hui Ting; Tsai, Shan Pou; Chiang, Po Huang; Hsu, Chih Cheng; Sung, Pei Kun; Hsu, Yi Hua; Wen, Sung Feng			All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan	LANCET			English	Article							CARDIOVASCULAR MORTALITY; SERUM CREATININE; NATIONAL-HEALTH; US POPULATION; PREVALENCE; RISK; ALBUMINURIA; AWARENESS; INDIVIDUALS; ASSOCIATION	Background Both end-stage renal disease and chronic kidney disease are increasing worldwide; however, the full effect of chronic kidney disease is unknown because mortality risks for all five stages are unavailable. We assessed prevalence and mortality risks for all stages of chronic kidney disease and quantified its attributable mortality in Taiwan. Methods The cohort consisted of 462 293 individuals aged older than 20 years who participated in a standard medical screening programme since 1994. As of Dec 31, 2006, we identified 14436 deaths. Chronic kidney disease was determined by glomerular filtration rate and urinary protein. We estimated national prevalence in Taiwan from the cohort by adjusting age and educational levels. Hazard ratios (HRs) were calculated with Cox proportionate hazards model. We calculated mortality attributable to chronic kidney disease for national population and for low socioeconomic status. Findings The national prevalence of chronic kidney disease was 11.93% (95% Cl 11.66-12.28), but only 3.54% (3.37-3.68) of participants in the cohort were aware of their disorder. Prevalence was substantially higher in the group with low socioeconomic status than in the high status group (19.87% [19.84-19.91] vs 7.33% [7.31-7.35]). 56 977 (12%) of cohort participants had chronic kidney disease; those with disease had 83% higher mortality for all cause (HR 1 . 83 [1 . 73-1.93]) and 100% higher for cardiovascular diseases (2 . 00 [1.78-2. 25]), in a cohort that was observed for 13 years with median follow-up of 7.5 years (IQR 4. 0-10. 1). 10.3% (95% CI 9 .57-11.03) of deaths in the entire population were attributable to chronic kidney disease, but 17.5% (16.27-18.67) of deaths in the low socioeconomic status population. 2350 (39%) deaths occurred before 65 years of age in those with chronic kidney disease. Regular users of Chinese herbal medicines had a 20% (odds ratio 1.20 [1.16-1.24]) increased risk of developing chronic kidney disease. Interpretation The high prevalence of chronic kidney disease and its associated all-cause mortality, especially in people with low socioeconomic status, make reduction of this disorder a public-health priority. Promotion of its recognition through the general public knowing their glomerular filtration rate and testing their urine is crucial to reduce premature deaths from all causes and to attenuate this global epidemic.	[Wen, Chi Pang; Tsai, Min Kuang; Chang, Yen Chen; Chan, Hui Ting; Chiang, Po Huang; Hsu, Chih Cheng] Natl Hlth Res Inst, Ctr Hlth Policy Res & Dev, Zhunan 350, Taiwan; [Cheng, Ting Yuan David] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Tsai, Shan Pou] Univ Texas Houston, Sch Publ Hlth, Houston, TX USA; [Sung, Pei Kun; Hsu, Yi Hua] MJ Hlth Management Inst, Taipei, Taiwan; [Wen, Sung Feng] Univ Wisconsin, Sch Med & Publ Hlth, Nephrol Sect, Dept Med, Madison, WI USA	National Health Research Institutes - Taiwan; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Wisconsin System; University of Wisconsin Madison	Wen, CP (corresponding author), Natl Hlth Res Inst, Ctr Hlth Policy Res & Dev, 35 Keyan Rd, Zhunan 350, Taiwan.	cwengood@nhri.org.tw	Wen, Chi-Pang/E-3851-2010; Chiang, Po-Huang/E-3996-2010; Hsu, Chih-Cheng/E-3849-2010					Arnlov J, 2005, CIRCULATION, V112, P969, DOI 10.1161/CIRCULATIONAHA.105.538132; *CDCP, 2002, MMWR-MORBID MORTAL W, V51, P300; Cheng TY, 2005, TOB CONTROL, V14, pI23, DOI 10.1136/tc.2003.005546; Coresh J, 2005, J AM SOC NEPHROL, V16, P180, DOI 10.1681/ASN.2004070539; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Coresh J, 2002, J AM SOC NEPHROL, V13, P2811, DOI 10.1097/01.ASN.0000037420.89149.C9; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Cosyns JP, 2003, DRUG SAFETY, V26, P33, DOI 10.2165/00002018-200326010-00004; Couser WG, 2007, J AM SOC NEPHROL, V18, P2803, DOI 10.1681/ASN.2007080964; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; El Nahas AM, 2005, LANCET, V365, P331, DOI 10.1016/S0140-6736(05)17789-7; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Fried LF, 2005, J AM SOC NEPHROL, V16, P3728, DOI 10.1681/ASN.2005040384; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hallan S, 2007, ARCH INTERN MED, V167, P2490, DOI 10.1001/archinte.167.22.2490; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; HOSMER D, 2008, APPL SURVIVAL ANAL R, P392; Hsu CC, 2006, AM J KIDNEY DIS, V48, P727, DOI 10.1053/j.ajkd.2006.07.018; Jafar TH, 2001, ANN INTERN MED, V135, P73, DOI 10.7326/0003-4819-135-2-200107170-00007; Merkin SS, 2007, SOC SCI MED, V65, P809, DOI 10.1016/j.socscimed.2007.04.011; Myers GL, 2006, CLIN CHEM, V52, P5, DOI 10.1373/clinchem.2005.0525144; Nickolas TL, 2004, AM J KIDNEY DIS, V44, P185, DOI 10.1053/j.ajkd.2004.04.023; Raymond NT, 2007, NEPHROL DIAL TRANSPL, V22, P3214, DOI 10.1093/ndt/gfm396; *ROCH, 2008, MID M SPEC INF; Shlipak MG, 2005, JAMA-J AM MED ASSOC, V293, P1737, DOI 10.1001/jama.293.14.1737; Shoham DA, 2007, AM J KIDNEY DIS, V49, P217, DOI 10.1053/j.ajkd.2006.11.031; Stevens LA, 2007, AM J KIDNEY DIS, V50, P21, DOI 10.1053/j.ajkd.2007.04.004; *US REN DAT SYST, 2007, ANN DAT REP ATL CHRO; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2; Wen CP, 2008, ANN INTERN MED, V148, P258, DOI 10.7326/0003-4819-148-4-200802190-00004; Wen CP, 2005, TOB CONTROL, V14, pI76, DOI 10.1136/tc.2004.007955; Wen CP, 2005, TOB CONTROL, V14, pI51, DOI 10.1136/tc.2004.008011; Wojcikowski K, 2004, NEPHROLOGY, V9, P313, DOI 10.1111/j.1440-1797.2004.00310.x; Wu DM, 2001, INT J OBESITY, V25, P1189, DOI 10.1038/sj.ijo.0801679	35	691	714	2	62	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN-JUL	2008	371	9631					2173	2182		10.1016/S0140-6736(08)60952-6	http://dx.doi.org/10.1016/S0140-6736(08)60952-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	326CP	18586172				2022-12-28	WOS:000257635800024
J	Chatterjee, P				Chatterjee, Patralekha			Health costs of recycling	BRITISH MEDICAL JOURNAL			English	Editorial Material												patralekha.chatterjee@gmail.com							0	3	3	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 16	2008	337	7666							a296	10.1136/bmj.a296	http://dx.doi.org/10.1136/bmj.a296			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	340TZ	18617494				2022-12-28	WOS:000258669200021
J	Faham, S; Watanabe, A; Besserer, GM; Cascio, D; Specht, A; Hirayama, BA; Wright, EM; Abramson, J				Faham, Salem; Watanabe, Akira; Besserer, Gabriel Mercado; Cascio, Duilio; Specht, Alexandre; Hirayama, Bruce A.; Wright, Ernest M.; Abramson, Jeff			The crystal structure of a sodium galactose transporter reveals mechanistic insights into Na(+)/sugar symport	SCIENCE			English	Article							NA+/GLUCOSE COTRANSPORTER SGLT1; X-RAY STRUCTURE; ESCHERICHIA-COLI; NA+/I-SYMPORTER; MOLECULAR CHARACTERIZATION; CONFORMATIONAL-CHANGES; MEMBRANE; BINDING; SELECTIVITY; PROTEINS	Membrane transporters that use energy stored in sodium gradients to drive nutrients into cells constitute a major class of proteins. We report the crystal structure of a member of the solute sodium symporters (SSS), the Vibrio parahaemolyticus sodium/galactose symporter (vSGLT). The similar to 3.0 angstrom structure contains 14 transmembrane (TM) helices in an inward-facing conformation with a core structure of inverted repeats of 5 TM helices (TM2 to TM6 and TM7 to TM11). Galactose is bound in the center of the core, occluded from the outside solutions by hydrophobic residues. Surprisingly, the architecture of the core is similar to that of the leucine transporter (LeuT) from a different gene family. Modeling the outward-facing conformation based on the LeuT structure, in conjunction with biophysical data, provides insight into structural rearrangements for active transport.	[Faham, Salem; Watanabe, Akira; Besserer, Gabriel Mercado; Hirayama, Bruce A.; Wright, Ernest M.; Abramson, Jeff] Univ Calif Los Angeles, Dept Physiol, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Cascio, Duilio] Univ Calif Los Angeles, UCLA Dept Energy Inst Genom & Proteom, Los Angeles, CA 90095 USA; [Specht, Alexandre] Univ Strasbourg 1, Chim Bioorgan Lab, CNRS, Fac Pharm,UMR 7175, F-67401 Illkirch Graffenstaden, France	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Wright, EM (corresponding author), Univ Calif Los Angeles, Dept Physiol, David Geffen Sch Med, Los Angeles, CA 90095 USA.	ewright@mednet.ucla.edu; jabramson@mednet.ucla.edu	SPECHT, Alexandre/K-9736-2018	SPECHT, Alexandre/0000-0001-5056-5278	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019567, R01DK044602] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078844] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK019567, R01 DK044602, DK19567, DK44602] Funding Source: Medline; NIGMS NIH HHS [GM07844, R01 GM078844-03, R01 GM078844-02, R01 GM078844, R01 GM078844-01] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; CRANE RK, 1961, MEMBRANE TRANSPORT M, P439; De la Vieja A, 2007, J BIOL CHEM, V282, P25290, DOI 10.1074/jbc.M700147200; Dohan O, 2003, ENDOCR REV, V24, P48, DOI 10.1210/er.2001-0029; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; EDWAR N, 2006, CURR PROTOC BIOINF S, V15; Eskandari S, 1997, J BIOL CHEM, V272, P27230, DOI 10.1074/jbc.272.43.27230; Eskandari S, 1998, P NATL ACAD SCI USA, V95, P11235, DOI 10.1073/pnas.95.19.11235; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; HEDIGER MA, 1987, NATURE, V330, P379, DOI 10.1038/330379a0; HEDIGER MA, 1991, BIOCHIM BIOPHYS ACTA, V1064, P360, DOI 10.1016/0005-2736(91)90323-Z; Hilger D, 2008, J BIOL CHEM, V283, P4921, DOI 10.1074/jbc.M706741200; Hirayama BA, 2007, BIOCHEMISTRY-US, V46, P13391, DOI 10.1021/bi701562k; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Jung H, 2002, FEBS LETT, V529, P73, DOI 10.1016/S0014-5793(02)03184-8; Kinch LN, 2002, CURR OPIN STRUC BIOL, V12, P400, DOI 10.1016/S0959-440X(02)00338-X; Loo DDF, 1998, P NATL ACAD SCI USA, V95, P7789, DOI 10.1073/pnas.95.13.7789; Loo DDF, 2006, J GEN PHYSIOL, V128, P701, DOI 10.1085/jgp.200609643; Mackenzie B, 1998, J MEMBRANE BIOL, V162, P101, DOI 10.1007/s002329900347; Panayotova-Heiermann M, 1998, BIOCHEMISTRY-US, V37, P10522, DOI 10.1021/bi9800395; Pirch T, 2003, J BIOL CHEM, V278, P42942, DOI 10.1074/jbc.M308253200; Reed-Tsur MD, 2008, ENDOCRINOLOGY, V149, P3077, DOI 10.1210/en.2008-0027; SCHULTZ SG, 1970, PHYSIOL REV, V50, P637, DOI 10.1152/physrev.1970.50.4.637; Sujatha MS, 2004, PROTEINS, V55, P44, DOI 10.1002/prot.10612; Turk E, 2000, J BIOL CHEM, V275, P25711, DOI 10.1074/jbc.M003127200; Turk E, 2006, BIOCHEMISTRY-US, V45, P1470, DOI 10.1021/bi052160z; Turk E, 1997, J MEMBRANE BIOL, V159, P1, DOI 10.1007/s002329900264; Veenstra M, 2004, BIOCHEMISTRY-US, V43, P3620, DOI 10.1021/bi0357210; Wright EM, 2007, J INTERN MED, V261, P32, DOI 10.1111/j.1365-2796.2006.01746.x; Wright EM, 2004, PHYSIOLOGY, V19, P370, DOI 10.1152/physiol.00026.2004; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; ZOU JY, 1993, J MOL BIOL, V233, P739, DOI 10.1006/jmbi.1993.1549	33	413	417	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 8	2008	321	5890					810	814		10.1126/science.1160406	http://dx.doi.org/10.1126/science.1160406			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334ZQ	18599740	Green Accepted			2022-12-28	WOS:000258261000038
J	Umbach, JL; Kramer, MF; Jurak, I; Karnowski, HW; Coen, DM; Cullen, BR				Umbach, Jennifer Lin; Kramer, Martha F.; Jurak, Igor; Karnowski, Heather W.; Coen, Donald M.; Cullen, Bryan R.			MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs	NATURE			English	Article							HERPES-SIMPLEX-VIRUS; READING-FRAME-P; TYPE-1 LATENCY; NEURONAL SURVIVAL; GENE-EXPRESSION; SENSORY NEURONS; TRANSCRIPT; REACTIVATION; CELLS; ICP0	Herpesviruses are characterized by their ability to maintain lifelong latent infections in their animal hosts. However, the mechanisms that allow establishment and maintenance of the latent state remain poorly understood. Herpes simplex virus 1 (HSV-1) establishes latency in neurons of sensory ganglia, where the only abundant viral gene product is a non-coding RNA, the latency associated transcript (LAT)(1,2). Here we show that LAT functions as a primary microRNA (miRNA) precursor that encodes four distinct miRNAs in HSV-1 infected cells. One of these miRNAs, miR-H2-3p, is transcribed in an antisense orientation to ICP0-a viral immediate-early transcriptional activator that is important for productive HSV-1 replication and thought to have a role in reactivation from latency(3). We show that miR-H2-3p is able to reduce ICP0 protein expression, but does not significantly affect ICP0 messenger RNA levels. We also identified a fifth HSV-1 miRNA in latently infected trigeminal ganglia, miR-H6, which derives from a previously unknown transcript distinct from LAT. miR-H6 shows extended seed complementarity to the mRNA encoding a second HSV-1 transcription factor, ICP4, and inhibits expression of ICP4, which is required for expression of most HSV-1 genes during productive infection(4). These results may explain the reported ability of LAT to promote latency(5-9). Thus, HSV-1 expresses at least two primary miRNA precursors in latently infected neurons that may facilitate the establishment and maintenance of viral latency by post-transcriptionally regulating viral gene expression.	[Umbach, Jennifer Lin; Karnowski, Heather W.; Cullen, Bryan R.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Umbach, Jennifer Lin; Karnowski, Heather W.; Cullen, Bryan R.] Duke Univ, Med Ctr, Ctr Virol, Durham, NC 27710 USA; [Kramer, Martha F.; Jurak, Igor; Coen, Donald M.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Duke University; Duke University; Harvard University; Harvard Medical School	Cullen, BR (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.	culle002@mc.duke.edu	Jurak, Igor/Q-7042-2018	Jurak, Igor/0000-0002-7271-2643	NCI NIH HHS [T32 CA009111] Funding Source: Medline; NIAID NIH HHS [R01 AI067968, R01 AI067968-03, R01 AI067968-02] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067968] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alvira MR, 1999, J VIROL, V73, P3866, DOI 10.1128/JVI.73.5.3866-3876.1999; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bloom DC, 2004, INT REV IMMUNOL, V23, P187, DOI 10.1080/08830180490265592; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; CAI WH, 1993, J VIROL, V67, P7501, DOI 10.1128/JVI.67.12.7501-7512.1993; Cai XZ, 2005, P NATL ACAD SCI USA, V102, P5570, DOI 10.1073/pnas.0408192102; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen SH, 2002, J VIROL, V76, P4764, DOI 10.1128/JVI.76.10.4764-4772.2002; Chen SH, 1997, J VIROL, V71, P5878, DOI 10.1128/JVI.71.8.5878-5884.1997; COEN DM, 1985, J VIROL, V53, P477, DOI 10.1128/JVI.53.2.477-488.1985; Cui C, 2006, J VIROL, V80, P5499, DOI 10.1128/JVI.00200-06; Dolken L, 2007, J VIROL, V81, P13771, DOI 10.1128/JVI.01313-07; Everett RD, 2000, BIOESSAYS, V22, P761, DOI 10.1002/1521-1878(200008)22:8<761::AID-BIES10>3.0.CO;2-A; FARRELL MJ, 1991, P NATL ACAD SCI USA, V88, P790, DOI 10.1073/pnas.88.3.790; Feldman LT, 2002, P NATL ACAD SCI USA, V99, P978, DOI 10.1073/pnas.022301899; Garber DA, 1997, J VIROL, V71, P5885, DOI 10.1128/JVI.71.8.5885-5893.1997; GOLDIN AL, 1981, J VIROL, V38, P50, DOI 10.1128/JVI.38.1.50-58.1981; Gupta A, 2006, NATURE, V442, P82, DOI 10.1038/nature04836; Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009; Halford WP, 2001, J VIROL, V75, P6143, DOI 10.1128/JVI.75.13.6143-6153.2001; Kang W, 2006, VIROLOGY, V356, P106, DOI 10.1016/j.virol.2006.07.033; Lee LY, 1998, J VIROL, V72, P4250, DOI 10.1128/JVI.72.5.4250-4264.1998; LEIB DA, 1989, J VIROL, V63, P759, DOI 10.1128/JVI.63.2.759-768.1989; Murphy E, 2008, P NATL ACAD SCI USA, V105, P5453, DOI 10.1073/pnas.0711910105; Perng GC, 2002, J VIROL, V76, P8003, DOI 10.1128/JVI.76.16.8003-8010.2002; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; PRESTON CM, 1979, J VIROL, V29, P275, DOI 10.1128/JVI.29.1.275-284.1979; Randall G, 1997, J VIROL, V71, P7750, DOI 10.1128/JVI.71.10.7750-7757.1997; SAWTELL NM, 1992, J VIROL, V66, P2157, DOI 10.1128/JVI.66.4.2157-2169.1992; Sawtell NM, 1997, J VIROL, V71, P5423, DOI 10.1128/JVI.71.7.5423-5431.1997; SEKULOVICH RE, 1988, J VIROL, V62, P4510, DOI 10.1128/JVI.62.12.4510-4522.1988; STEVENS JG, 1987, SCIENCE, V235, P1056, DOI 10.1126/science.2434993; Thompson RL, 2003, J VIROL, V77, P12319, DOI 10.1128/JVI.77.22.12319-12330.2003; Thompson RL, 1997, J VIROL, V71, P5432, DOI 10.1128/JVI.71.7.5432-5440.1997; Thompson RL, 2001, J VIROL, V75, P6660, DOI 10.1128/JVI.75.14.6660-6675.2001; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; YEH L, 1993, J VIROL, V67, P7373, DOI 10.1128/JVI.67.12.7373-7382.1993	37	490	541	1	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2008	454	7205					780	U108		10.1038/nature07103	http://dx.doi.org/10.1038/nature07103			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334NH	18596690	Green Accepted			2022-12-28	WOS:000258228000048
J	Keenan, RA; De Riva, A; Corleis, B; Hepburn, L; Licence, S; Winkler, TH; Martensson, IL				Keenan, Rebecca A.; De Riva, Alessandra; Corleis, Bjorn; Hepburn, Lucy; Licence, Steve; Winkler, Thomas H.; Martensson, Inga-Lill			Censoring of autoreactive B cell development by the pre-B cell receptor	SCIENCE			English	Article							SURROGATE LIGHT-CHAIN; ANTIBODY DIVERSITY; SELECTION; GENE; REPERTOIRE; MICE; DNA	Antibody diversity occurs randomly as B cells recombine their immunoglobulin ( Ig) heavy- and light- chain genes during development. This process inevitably generates reactivity against self structures, and several mechanisms prevent the development of autoreactive B cells. We report here a role for the pre- B cell receptor, composed of Ig heavy and surrogate light chains, in the negative selection of cells expressing Ig heavy chains with the potential to generate autoantibodies. Surrogate light- chain- deficient (SLC-/-) mice harbored elevated levels of antinuclear antibodies (ANAs) in their serum and showed evidence of escape of pre- B cells expressing prototypic autoantibody heavy chains from negative selection, leading to mature autoantibody secreting CD21(-)CD23(-) B cells in the periphery. Thus, the pre- B cell receptor appears to censor the development of certain autoantibody- secreting cells and may represent an important factor in multifactorial autoimmune diseases.	[Keenan, Rebecca A.; De Riva, Alessandra; Corleis, Bjorn; Hepburn, Lucy; Licence, Steve; Martensson, Inga-Lill] Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge CB22 3AT, England; [Corleis, Bjorn] Univ Freiburg, Fac Biol, Dept Mol Immunol, D-79108 Freiburg, Germany; [Winkler, Thomas H.] Nikolaus Fiebiger Ctr, Hematopoiesis Unit, D-91054 Erlangen, Germany	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Freiburg; University of Erlangen Nuremberg	Martensson, IL (corresponding author), Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge CB22 3AT, England.	lill.martensson@bbsrc.ac.uk		Martensson, Inga-Lill/0000-0003-3415-0560	Biotechnology and Biological Sciences Research Council Funding Source: Medline; Medical Research Council Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BARBAS SM, 1995, P NATL ACAD SCI USA, V92, P2529, DOI 10.1073/pnas.92.7.2529; Burrows PD, 2002, SEMIN IMMUNOL, V14, P343, DOI 10.1016/S1044-5323(02)00067-2; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; Giles I, 2006, J IMMUNOL, V177, P1729, DOI 10.4049/jimmunol.177.3.1729; Goodnow CC, 2007, CELL, V130, P25, DOI 10.1016/j.cell.2007.06.033; Harfst E, 2005, IMMUNOL LETT, V101, P173, DOI 10.1016/j.imlet.2005.05.013; ICHIHARA Y, 1989, EUR J IMMUNOL, V19, P1849, DOI 10.1002/eji.1830191014; KAARTINEN M, 1985, IMMUNOL TODAY, V6, P324, DOI 10.1016/0167-5699(85)90127-6; KEENAN R, 2006, THESIS CAMBRIDGE U, P23513; KLEINFIELD R, 1986, NATURE, V322, P843, DOI 10.1038/322843a0; Kotzin BL, 1996, CELL, V85, P303, DOI 10.1016/S0092-8674(00)81108-3; Martensson IL, 2007, CURR OPIN IMMUNOL, V19, P137, DOI 10.1016/j.coi.2007.02.006; Melchers F, 2000, IMMUNOL REV, V175, P33, DOI 10.1111/j.1600-065X.2000.imr017510.x; MELCHERS F, 1993, IMMUNOL TODAY, V14, P60, DOI 10.1016/0167-5699(93)90060-X; Minegishi Y, 1998, J EXP MED, V187, P71, DOI 10.1084/jem.187.1.71; Minegishi Y, 2001, IMMUNITY, V14, P631, DOI 10.1016/S1074-7613(01)00131-5; PILLAI S, 1987, NATURE, V329, P172, DOI 10.1038/329172a0; RADIC MZ, 1994, ANNU REV IMMUNOL, V12, P487, DOI 10.1146/annurev.iy.12.040194.002415; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; RETH M, 1986, NATURE, V322, P840, DOI 10.1038/322840a0; Shimizu T, 2002, J IMMUNOL, V168, P6286, DOI 10.4049/jimmunol.168.12.6286; Shlomchik MJ, 2008, IMMUNITY, V28, P18, DOI 10.1016/j.immuni.2007.12.004; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Vettermann C, 2006, SEMIN IMMUNOL, V18, P44, DOI 10.1016/j.smim.2006.01.001; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Xu JL, 2000, IMMUNITY, V13, P37, DOI 10.1016/S1074-7613(00)00006-6	27	100	101	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 1	2008	321	5889					696	699		10.1126/science.1157533	http://dx.doi.org/10.1126/science.1157533			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	332IW	18566249				2022-12-28	WOS:000258077700045
J	Luik, RM; Wang, B; Prakriya, M; Wu, MM; Lewis, RS				Luik, Riina M.; Wang, Bin; Prakriya, Murali; Wu, Minnie M.; Lewis, Richard S.			Oligomerization of STIM1 couples ER calcium depletion to CRAC channel activation	NATURE			English	Article							STROMAL INTERACTION MOLECULE-1; OPERATED CA2+ ENTRY; PLASMA-MEMBRANE; ENDOPLASMIC-RETICULUM; STORE DEPLETION; PROTEIN; ORAI1; MECHANISM; DOMAIN; SENSOR	Ca(2+)-release-activated Ca(2+) (CRAC) channels generate sustained Ca(2+) signals that are essential for a range of cell functions, including antigen-stimulated T lymphocyte activation and proliferation(1,2). Recent studies(3) have revealed that the depletion of Ca(2+) from the endoplasmic reticulum (ER) triggers the oligomerization of stromal interaction molecule 1 (STIM1), the ER Ca(2+) sensor, and its redistribution to ER-plasma membrane (ER-PM) junctions(4-8) where the CRAC channel subunit ORAI1 accumulates in the plasma membrane and CRAC channels open(9-12). However, how the loss of ER Ca(2+) sets into motion these coordinated molecular rearrangements remains unclear. Here we define the relationships among [Ca(2+)](ER), STIM1 redistribution and CRAC channel activation and identify STIM1 oligomerization as the critical [Ca(2+)](ER)-dependent event that drives store-operated Ca(2+) entry. In human Jurkat leukaemic T cells expressing an ER-targeted Ca(2+) indicator, CRAC channel activation and STIM1 redistribution follow the same function of [Ca(2+)](ER), reaching half-maximum at similar to 200 mu M with a Hill coefficient of similar to 4. Because STIM1 binds only a single Ca(2+) ion(5), the high apparent cooperativity suggests that STIM1 must first oligomerize to enable its accumulation at ER-PM junctions. To assess directly the causal role of STIM1 oligomerization in store-operated Ca(2+) entry, we replaced the luminal Ca(2+)-sensing domain of STIM1 with the 12-kDa FK506- and rapamycin-binding protein (FKBP12, also known as FKBP1A) or the FKBP-rapamycin binding (FRB) domain of the mammalian target of rapamycin (mTOR, also known as FRAP1). A rapamycin analogue oligomerizes the fusion proteins and causes them to accumulate at ER-PM junctions and activate CRAC channels without depleting Ca(2+) from the ER. Thus, STIM1 oligomerization is the critical transduction event through which Ca(2+) store depletion controls store-operated Ca(2+) entry, acting as a switch that triggers the self-organization and activation of STIM1-ORAI1 clusters at ER-PM junctions.	[Luik, Riina M.; Wang, Bin; Prakriya, Murali; Wu, Minnie M.; Lewis, Richard S.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA	Stanford University	Lewis, RS (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	rslewis@stanford.edu		Lewis, Richard/0000-0002-6010-7403; Prakriya, Murali/0000-0003-0781-4480	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045374] Funding Source: NIH RePORTER; NIAID NIH HHS [T32 AI007290] Funding Source: Medline; NIGMS NIH HHS [R01 GM045374, R01 GM045374-18] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; Bautista DM, 2002, J PHYSIOL-LONDON, V541, P877, DOI 10.1113/jphysiol.2001.016154; Bayle JH, 2006, CHEM BIOL, V13, P99, DOI 10.1016/j.chembiol.2005.10.017; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Li ZZ, 2007, J BIOL CHEM, V282, P29448, DOI 10.1074/jbc.M703573200; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Prakriya M, 2003, CELL CALCIUM, V33, P311, DOI 10.1016/S0143-4160(03)00045-9; Prakriya M, 2001, J PHYSIOL-LONDON, V536, P3, DOI 10.1111/j.1469-7793.2001.t01-1-00003.x; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Varnai P, 2007, J BIOL CHEM, V282, P29678, DOI 10.1074/jbc.M704339200; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Williams RT, 2002, BBA-PROTEIN STRUCT M, V1596, P131, DOI 10.1016/S0167-4838(02)00211-X; Wu MM, 2007, CELL CALCIUM, V42, P163, DOI 10.1016/j.ceca.2007.03.003; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Xu PY, 2006, BIOCHEM BIOPH RES CO, V350, P969, DOI 10.1016/j.bbrc.2006.09.134; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; ZWEIFACH A, 1995, J BIOL CHEM, V270, P14445, DOI 10.1074/jbc.270.24.14445	31	407	417	2	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 24	2008	454	7203					538	U11		10.1038/nature07065	http://dx.doi.org/10.1038/nature07065			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329IC	18596693	Green Accepted			2022-12-28	WOS:000257860300056
J	Beckman, N; Waern, M; Gustafson, D; Skoog, I				Beckman, Nils; Waern, Margda; Gustafson, Deborah; Skoog, Ingmar			Secular trends in self reported sexual activity and satisfaction in Swedish 70 year olds: cross sectional survey of four populations, 1971-2001	BMJ-BRITISH MEDICAL JOURNAL			English	Article							UNITED-STATES; BEHAVIOR; WOMEN; MEN; MIDDLE; PREVALENCE; SENESCENCE; ATTITUDES; PATTERNS; PEOPLE	Objective To study secular trends in self reported sexual behaviour among 70 year olds. Design Cross sectional survey. Settings Four samples representative of the general population in Gothenburg, Sweden. Participants 1506 adults (946 women, 560 men) examined in 1971-2, 1976-7, 1992-3, and 2000-1. Main outcome measures Sexual intercourse, attitudes to sexuality in later life, sexual dysfunctions, and marital satisfaction. Results From 1971 to 2000 the proportion of 70 year olds reporting sexual intercourse increased among all groups: married men from 52% to 68% (P=0.002), married women from 38% to 56% (P=0.001), unmarried men from 30% to 54% (P=0.016), and unmarried women from 0.8% to 12% (P<0.001). Men and women from later birth cohorts reported higher satisfaction with sexuality, fewer sexual dysfunctions, and more positive attitudes to sexuality in later life than those from earlier birth cohorts. A larger proportion of men (57% v 40%, P<0.001) and women (52% v 35%, P<0.001) reported very happy relationships in 2000-1 compared with those in 1971-2. Sexual debut before age 20 increased in both sexes: in men from 52% to 77% (P<0.001) and in women from 19% to 64% (P<0.001). Conclusion Self reported quantity and quality of sexual experiences among Swedish 70 year olds has improved over a 30 year period.	[Beckman, Nils; Waern, Margda; Gustafson, Deborah; Skoog, Ingmar] Univ Gothenburg, Neuropsychiat Epidemiol Unit, Inst Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden	University of Gothenburg	Beckman, N (corresponding author), Neuropsyk SU Molndal, Neuropsychiat Epidemiol Unit, Wallinsgatan 6, SE-43141 Molndal, Sweden.	nils.beckman@neuro.gu.se						American Psychiatric Association, 1987, DIAGN STAT MAN MENT; Caron SL, 2002, ADOLESCENCE, V37, P515; DIOKNO AC, 1990, ARCH INTERN MED, V150, P197, DOI 10.1001/archinte.150.1.197; Fasolo CB, 2005, J SEX MED, V2, P376, DOI 10.1111/j.1743-6109.2005.20350.x; GEORGE LK, 1981, ARCH GEN PSYCHIAT, V38, P919; Gott M, 2003, SOC SCI MED, V56, P1617, DOI 10.1016/S0277-9536(02)00180-6; KIVELA S, 1986, NORDISK SEXOLOGI, P18; Laumann EO, 2005, INT J IMPOT RES, V17, P39, DOI 10.1038/sj.ijir.3901250; LEWIN B, 1998, SEXUALITY SWEDEN SEX; Lindau ST, 2007, NEW ENGL J MED, V357, P762, DOI 10.1056/NEJMoa067423; Nicolosi A, 2006, WORLD J UROL, V24, P423, DOI 10.1007/s00345-006-0088-9; NILSSON L V, 1983, Journal of Clinical and Experimental Gerontology, V5, P101; PERSSON G, 1980, J PSYCHOSOM RES, V24, P335, DOI 10.1016/0022-3999(80)90025-2; PFEIFFER E, 1969, J GERONTOL, V24, P193, DOI 10.1093/geronj/24.2.193; PFEIFFER E, 1968, ARCH GEN PSYCHIAT, V19, P753; PFEIFFER E, 1972, J AM GERIATR SOC, V20, P151, DOI 10.1111/j.1532-5415.1972.tb00789.x; RINDER L, 1975, ACTA MED SCAND, V198, P397, DOI 10.1111/j.0954-6820.1975.tb19563.x; Skoog I, 1993, Int Psychogeriatr, V5, P33, DOI 10.1017/S1041610293001371; SKOOG I, 1993, NEW ENGL J MED, V328, P153, DOI 10.1056/NEJM199301213280301; SUNDSTROM K, 2000, DO OTHERS DO SEXUALI; TURNER CF, 1995, SEX TRANSM DIS, V22, P173, DOI 10.1097/00007435-199505000-00009; VERWOERDT A, 1969, GERIATRICS, V24, P137; VERWOERDT A, 1969, J GERIATR PSYCHIAT, V2, P163; vonSydow K, 1996, ARCH SEX BEHAV, V25, P473, DOI 10.1007/BF02437543; Wilhelmson K, 2002, AGING CLIN EXP RES, V14, P361	25	144	148	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 19	2008	337	7662							a279	10.1136/bmj.a279	http://dx.doi.org/10.1136/bmj.a279			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	330SB	18614505	Bronze, Green Published			2022-12-28	WOS:000257962000039
J	Sondak, VK; Flaherty, LE				Sondak, Vernon K.; Flaherty, Lawrence E.			Adjuvant therapy of melanoma: is pegylated interferon alfa-2b what we've been waiting for?	LANCET			English	Editorial Material									[Sondak, Vernon K.] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Sondak, Vernon K.] Univ S Florida, Coll Med, Tampa, FL 33612 USA; [Flaherty, Lawrence E.] Karmanos Canc Inst, Detroit, MI USA; [Flaherty, Lawrence E.] Wayne State Univ, Sch Med, Detroit, MI USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Barbara Ann Karmanos Cancer Institute; Wayne State University	Sondak, VK (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA.	vernon.sondak@moffitt.org						Bukowski R, 2002, J CLIN ONCOL, V20, P3841, DOI 10.1200/JCO.2002.02.051; Eggermont AMM, 2008, LANCET, V372, P117, DOI 10.1016/S0140-6736(08)61033-8; Eggermont AMM, 2005, LANCET, V366, P1189, DOI 10.1016/S0140-6736(05)67482-X; Gogas H, 2006, NEW ENGL J MED, V354, P709, DOI 10.1056/NEJMoa053007; Kilbridge KL, 2002, J CLIN ONCOL, V20, P1311, DOI 10.1200/JCO.20.5.1311; Kirkwood JM, 2004, CLIN CANCER RES, V10, P1670, DOI 10.1158/1078-0432.CCR-1103-3; Kirkwood JM, 2008, NAT CLIN PRACT ONCOL, V5, P2, DOI 10.1038/ncponc1004; Schuchter LM, 2004, J CLIN ONCOL, V22, P7, DOI 10.1200/JCO.2004.10.907; SONDAK VK, 2008, CANC PRINCIPLE PRACT, P497; TARHINI AA, 2008, J CLIN ONCOL, V26, pS485; Wheatley K, 2007, J CLIN ONCOL, V25, P4693, DOI 10.1200/JCO.2007.13.3389	11	10	10	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 12	2008	372	9633					89	90		10.1016/S0140-6736(08)61011-9	http://dx.doi.org/10.1016/S0140-6736(08)61011-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	324XJ	18620932				2022-12-28	WOS:000257552400004
J	Sutcliffe, JS				Sutcliffe, James S.			Genetics - Insights into the pathogenesis of autism	SCIENCE			English	Editorial Material							SPECTRUM DISORDERS; DIAGNOSIS; 16P11.2; RISK		[Sutcliffe, James S.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Vanderbilt University	Sutcliffe, JS (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA.	james.s.sutcliffe@vanderbilt.edu	Sutcliffe, James S/C-1348-2012	Sutcliffe, James S/0000-0001-5200-6007				Christian SL, 2008, BIOL PSYCHIAT, V63, P1111, DOI 10.1016/j.biopsych.2008.01.009; Kanner L, 1943, NERV CHILD, V2, P217; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Landa RJ, 2008, NAT CLIN PRACT NEURO, V4, P138, DOI 10.1038/ncpneuro0731; Landa RJ, 2007, ARCH GEN PSYCHIAT, V64, P853, DOI 10.1001/archpsyc.64.7.853; Lauritsen MB, 2005, J CHILD PSYCHOL PSYC, V46, P963, DOI 10.1111/j.1469-7610.2004.00391.x; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; O'Roak BJ, 2008, AUTISM RES, V1, P4, DOI 10.1002/aur.3; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974	12	39	39	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 11	2008	321	5886					208	209		10.1126/science.1160555	http://dx.doi.org/10.1126/science.1160555			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	324IS	18621658				2022-12-28	WOS:000257512900026
J	Park, JH; Scheerer, P; Hofmann, KP; Choe, HW; Ernst, OP				Park, Jung Hee; Scheerer, Patrick; Hofmann, Klaus Peter; Choe, Hui-Woog; Ernst, Oliver Peter			Crystal structure of the ligand-free G-protein-coupled receptor opsin	NATURE			English	Article							BETA(2)-ADRENERGIC RECEPTOR; TRANSMEMBRANE HELICES; METARHODOPSIN-III; BOVINE RHODOPSIN; DARK-ADAPTATION; ACTIVATION; BINDING; CRYSTALLOGRAPHY; INTERMEDIATE; TRANSDUCIN	In the G- protein- coupled receptor ( GPCR) rhodopsin, the inactivating ligand 11- cis- retinal is bound in the seven- transmembrane helix ( TM) bundle and is cis/ trans isomerized by light to form active metarhodopsin II. With metarhodopsin II decay, all- trans- retinal is released, and opsin is reloaded with new 11- cis- retinal. Here we present the crystal structure of ligand- free native opsin from bovine retinal rod cells at 2.9 angstrorm (angstrom) resolution. Compared to rhodopsin, opsin shows prominent structural changes in the conserved E(D)RY and NPxxY(x)(5,6)F regions and in TM5 - TM7. At the cytoplasmic side, TM6 is tilted outwards by 6 - 7 angstrom, whereas the helix structure of TM5 is more elongated and close to TM6. These structural changes, some of which were attributed to an active GPCR state, reorganize the empty retinal- binding pocket to disclose two openings that may serve the entry and exit of retinal. The opsin structure sheds new light on ligand binding to GPCRs and on GPCR activation.	[Park, Jung Hee; Scheerer, Patrick; Hofmann, Klaus Peter; Choe, Hui-Woog; Ernst, Oliver Peter] Charite Univ Med Berlin, Inst Med Phys & Biophys CC2, D-10117 Berlin, Germany; [Hofmann, Klaus Peter] Humboldt Univ, Zentrum Biophys & Bioinformat, D-10115 Berlin, Germany; [Choe, Hui-Woog] Chonbuk Natl Univ, Coll Nat Sci, Dept Chem, Chonju 561756, South Korea	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; Jeonbuk National University	Ernst, OP (corresponding author), Charite Univ Med Berlin, Inst Med Phys & Biophys CC2, Charitepl 1, D-10117 Berlin, Germany.	klaus_peter.hofmann@charite.de; hwchoe@chonbuk.ac.kr; oliver.ernst@charite.de	soler, martha maricel m gomez/L-6025-2014	soler, martha maricel m gomez/0000-0002-4412-8108; Scheerer, Patrick/0000-0001-5028-2075				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Bartl FJ, 2007, PHYS CHEM CHEM PHYS, V9, P1648, DOI 10.1039/b616365c; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; COHEN GB, 1992, BIOCHEMISTRY-US, V31, P12592, DOI 10.1021/bi00165a008; Crocker E, 2006, J MOL BIOL, V357, P163, DOI 10.1016/j.jmb.2005.12.046; DeLano W.L, PYMOL MOL GRAPHICS S; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FARRENS DL, 1995, J BIOL CHEM, V270, P5073, DOI 10.1074/jbc.270.10.5073; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Filipek S, 2003, ANNU REV PHYSIOL, V65, P851, DOI 10.1146/annurev.physiol.65.092101.142611; Fritze O, 2003, P NATL ACAD SCI USA, V100, P2290, DOI 10.1073/pnas.0435715100; Heck M, 2003, J BIOL CHEM, V278, P3162, DOI 10.1074/jbc.M209675200; HOFMANN KP, 1992, J BIOL CHEM, V267, P15701; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Jager S, 1996, BIOCHEMISTRY-US, V35, P2901, DOI 10.1021/bi9524068; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; Kefalov VJ, 2001, NEURON, V29, P749, DOI 10.1016/S0896-6273(01)00249-5; Knierim B, 2007, P NATL ACAD SCI USA, V104, P20290, DOI 10.1073/pnas.0710393104; Krebs A, 2003, J BIOL CHEM, V278, P50217, DOI 10.1074/jbc.M307995200; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Liu W, 2004, J MOL BIOL, V337, P713, DOI 10.1016/j.jmb.2004.02.001; Ludeke S, 2005, J MOL BIOL, V353, P345, DOI 10.1016/j.jmb.2005.08.039; McBee JK, 2001, PROG RETIN EYE RES, V20, P469, DOI 10.1016/S1350-9462(01)00002-7; Menon ST, 2001, PHYSIOL REV, V81, P1659, DOI 10.1152/physrev.2001.81.4.1659; Nakamichi H, 2006, P NATL ACAD SCI USA, V103, P12729, DOI 10.1073/pnas.0601765103; Okada T, 1998, PHOTOCHEM PHOTOBIOL, V67, P495, DOI 10.1111/j.1751-1097.1998.tb09445.x; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Okada T, 2001, TRENDS BIOCHEM SCI, V26, P318, DOI 10.1016/S0968-0004(01)01799-6; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Ruprecht JJ, 2004, EMBO J, V23, P3609, DOI 10.1038/sj.emboj.7600374; Sachs K, 2000, METHOD ENZYMOL, V315, P238; Sachs K, 2000, J BIOL CHEM, V275, P6189, DOI 10.1074/jbc.275.9.6189; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Scheer A, 1997, P NATL ACAD SCI USA, V94, P808, DOI 10.1073/pnas.94.3.808; Sheikh SP, 1996, NATURE, V383, P347, DOI 10.1038/383347a0; Shi L, 2002, J BIOL CHEM, V277, P14777, DOI 10.1074/jbc.M108967200; Standfuss J, 2007, J MOL BIOL, V372, P1179, DOI 10.1016/j.jmb.2007.03.007; SURYA A, 1995, J BIOL CHEM, V270, P5024, DOI 10.1074/jbc.270.10.5024; Vogel R, 2001, J BIOL CHEM, V276, P38487, DOI 10.1074/jbc.M105423200; Xie GF, 2003, BIOCHEMISTRY-US, V42, P1995, DOI 10.1021/bi020611z	52	758	768	1	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2008	454	7201					183	U33		10.1038/nature07063	http://dx.doi.org/10.1038/nature07063			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	323RU	18563085	Green Submitted			2022-12-28	WOS:000257466900036
J	Yamada, T; Dautry, A; Walport, M				Yamada, Tadataka; Dautry, Alice; Walport, Mark			Ready for avian flu?	NATURE			English	Editorial Material							VACCINE		[Yamada, Tadataka] Bill & Melinda Gates Fdn, Global Hlth Program, Seattle, WA 98102 USA; [Dautry, Alice] Inst Pasteur, F-75724 Paris, France; [Walport, Mark] Wellcome Trust Res Labs, London NW1 2BE, England	Bill & Melinda Gates Foundation; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Yamada, T (corresponding author), Bill & Melinda Gates Fdn, Global Hlth Program, 1551 Eastlake Ave E, Seattle, WA 98102 USA.			Walport, Mark/0000-0001-7220-5273				Leroux-Roels I, 2007, LANCET, V370, P580, DOI 10.1016/S0140-6736(07)61297-5; Murray CJL, 2006, LANCET, V368, P2211, DOI 10.1016/S0140-6736(06)69895-4; Stephenson I, 2005, J INFECT DIS, V191, P1210, DOI 10.1086/428948	3	9	9	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 10	2008	454	7201					162	162		10.1038/454162a	http://dx.doi.org/10.1038/454162a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	323RU	18615064	Bronze			2022-12-28	WOS:000257466900021
J	Delamothe, T				Delamothe, Tony			A fairly happy birthday	BRITISH MEDICAL JOURNAL			English	Editorial Material							NHS		BMJ, London WC1H 9JR, England		Delamothe, T (corresponding author), BMJ, London WC1H 9JR, England.	tdelamothe@bmj.com						APPLEBY A, 2005, BRIT SOCIAL ATTITUDE, P109; Berwick DM, 2006, BMJ-BRIT MED J, V333, P254, DOI 10.1136/bmj.333.7561.254; Boyd J., 2007, 2006 INPATIENTS IMPO; Brown G., 2008, FINANCIAL TIMES 0310; CARVEL J, 2007, GUARDIAN        0514; Cole A, 2008, BRIT MED J, V336, P1406, DOI 10.1136/bmj.a330; COWPER A, 2006, BR J HLTH CARE MANAG, V12, P361; DELAMOTHE T, 2007, BRIT MED J, V335, P1100; Delamothe T, 2008, BMJ-BRIT MED J, V336, P1469, DOI 10.1136/bmj.a385; *DEP HLTH, 2006, NAT SURV LOC HLTH SE; Greer Scott L, 2004, 4 WAY BET DEVOLUTION; Ham C, 2008, BRIT MED J, V336, P805, DOI 10.1136/bmj.39532.445197.AD; Hawe E, 2008, OHE COMPENDIUM HLTH; *HEALTHC COMM, 2005, PRIM CAR TRUSTS SURV; Healthcare Commission and Audit Commission, 2008, IS TREATM WORK PROGR; *IPS MORI, POL MON TRENDS MOST; Leatherman S, 2008, QUEST QUALITY REFINI; Light D, 2004, BRIT MED J, V328, P763, DOI 10.1136/bmj.328.7442.763; Nichols LM, 2004, HEALTH AFFAIR, V23, P8, DOI 10.1377/hlthaff.23.2.8; Pollock A., 2005, NHS PLC; Pollock AM, 2008, BMJ-BRIT MED J, V336, P421, DOI 10.1136/bmj.39470.505556.80; Stevens S, 2004, HEALTH AFFAIR, V23, P37, DOI 10.1377/hlthaff.23.3.37; TIMMINS N, 2008, FINANCIAL TIMES 0606; TIMMINS N, 2008, FINANCIAL TIMES 0512; TIMMINS N, 2008, FINANCIAL TIMES 0605; Webster C., 2002, NATL HLTH SERVICE PO; 2008, FINANCIAL TIMES 0501, P8	27	5	5	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 5	2008	337	7660							a524	10.1136/bmj.a524	http://dx.doi.org/10.1136/bmj.a524			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	326DF	18595936				2022-12-28	WOS:000257637500029
J	Goldston, D				Goldston, David			Getting it across	NATURE			English	Editorial Material											Goldston, D (corresponding author), Harvard Univ, Ctr Environm, Cambridge, MA 02138 USA.	partyofonecolumn@gmail.com							0	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2008	454	7200					16	16		10.1038/454016a	http://dx.doi.org/10.1038/454016a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321MC	18596778	Bronze			2022-12-28	WOS:000257308300012
J	Mehanna, HM; Moledina, J; Travis, J				Mehanna, Hisham M.; Moledina, Jamil; Travis, Jane			Refeeding syndrome: what it is, and how to prevent and treat it	BRITISH MEDICAL JOURNAL			English	Review							CRITICALLY ILL PATIENTS; SEVERE HYPOPHOSPHATEMIA		[Mehanna, Hisham M.; Moledina, Jamil] Univ Hosp Coventry, Inst Head & Neck Studies & Educ, Dept Otorhinolaryngol Head & Neck Surg, Coventry CV2 2DX, W Midlands, England; [Mehanna, Hisham M.] Heart England Fdn Trust, Birmingham, W Midlands, England; [Travis, Jane] Univ Hosp Coventry, Dept Dietet, Coventry, W Midlands, England	University of Warwick; Heart of England NHS Foundation Trust; University of Warwick	Mehanna, HM (corresponding author), Univ Hosp Coventry, Inst Head & Neck Studies & Educ, Dept Otorhinolaryngol Head & Neck Surg, Coventry CV2 2DX, W Midlands, England.	Hisham.Mehanna@uhcw.nhs.uk		Mehanna, Hisham/0000-0002-5544-6224				CAMP MA, 1990, MINER ELECTROL METAB, V16, P365; Crook MA, 2001, NUTRITION, V17, P632, DOI 10.1016/S0899-9007(01)00542-1; Dewar H, 2001, POCKET GUIDE CLIN NU, P131; *EV BAS ON CALL DA, 2007, LEV EV; HAYEK ME, 1989, ARCH SURG-CHICAGO, V124, P1325; Hearing SD, 2004, BRIT MED J, V328, P908, DOI 10.1136/bmj.328.7445.908; Klein CJ, 1998, J AM DIET ASSOC, V98, P795, DOI 10.1016/S0002-8223(98)00179-5; KNOCHEL JP, 1977, ARCH INTERN MED, V137, P203, DOI 10.1001/archinte.137.2.203; Marik PE, 1996, ARCH SURG-CHICAGO, V131, P1043, DOI 10.1001/archsurg.1996.01430220037007; Martinez MJ, 2006, NUTR HOSP, V21, P657; MCCRAY S, 2004, PRACTICAL GASTROENTE, V27, P26; National Institute for Health and Clinical Excellence, 2006, NUTR SUPP AD CLIN GU; Perreault MM, 1997, ANN PHARMACOTHER, V31, P683, DOI 10.1177/106002809703100603; REULER JB, 1985, NEW ENGL J MED, V312, P1035, DOI 10.1056/NEJM198504183121606; SILVIS SE, 1972, GASTROENTEROLOGY, V62, P513; SOLOMON SM, 1990, JPEN-PARENTER ENTER, V14, P90, DOI 10.1177/014860719001400190; Terlevich A, 2003, ALIMENT PHARM THER, V17, P1325, DOI 10.1046/j.1365-2036.2003.01567.x; VEVERBRANTS E, 1969, J CLIN ENDOCR METAB, V29, P55, DOI 10.1210/jcem-29-1-55; WACKER WEC, 1968, NEW ENGL J MED, V278, P658, DOI 10.1056/NEJM196803212781205; Weinster RL, 1980, AM J CLIN NUTR, V34, P393	20	296	313	0	43	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 28	2008	336	7659					1495	1498		10.1136/bmj.a301	http://dx.doi.org/10.1136/bmj.a301			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	324GN	18583681	Green Published			2022-12-28	WOS:000257505900039
J	Cain, DM; Detsky, AS				Cain, Daylian M.; Detsky, Allan S.			Everyone's a little bit biased (even physicians)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CONFLICTS-OF-INTEREST		[Detsky, Allan S.] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Cain, Daylian M.] Yale Univ, Sch Management, New Haven, CT USA; [Detsky, Allan S.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Detsky, Allan S.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Detsky, Allan S.] Univ Hlth Network, Dept Med, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Yale University; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Detsky, AS (corresponding author), Mt Sinai Hosp, Dept Med, 427-600 Univ Ave, Toronto, ON M5G 1X5, Canada.	adetsky@mtsinai.on.ca						Brennan TA, 2006, JAMA-J AM MED ASSOC, V295, P429, DOI 10.1001/jama.295.4.429; BUDIANSKY S, 1995, US NEWS WORLD R 0130, V52; Cain DM, 2005, J LEGAL STUD, V34, P1, DOI 10.1086/426699; Dawson E, 2002, PERS SOC PSYCHOL B, V28, P1379, DOI 10.1177/014616702236869; Detsky AS, 2006, CAN MED ASSOC J, V175, P1033, DOI 10.1503/cmaj.061181; GAZANNIGA MS, 1978, INTEGRATED MIND; Haidt J, 2001, PSYCHOL REV, V108, P814, DOI 10.1037//0033-295X.108.4.814; McCormick BB, 2001, JAMA-J AM MED ASSOC, V286, P1994, DOI 10.1001/jama.286.16.1994; MOORE DA, 2005, CONFLCITS INTEREST P; MOORE DA, 2004, 2004E40 CARN MELL TE; Sackett DL, 1985, CLIN EPIDEMIOLOGY BA; Surowiecki J., 2002, NEW YORKER      1209, P38; Tatsioni A, 2007, JAMA-J AM MED ASSOC, V298, P2517, DOI 10.1001/jama.298.21.2517; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124	14	105	106	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 25	2008	299	24					2893	2895		10.1001/jama.299.24.2893	http://dx.doi.org/10.1001/jama.299.24.2893			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	317LN	18577735				2022-12-28	WOS:000257021800028
J	Wolfe, RR; Miller, SL				Wolfe, Robert R.; Miller, Sharon L.			The recommended dietary allowance of protein - A misunderstood concept	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PRESSURE; HEALTH; MUSCLE		[Wolfe, Robert R.] Univ Arkansas Med Sci, Donald W Reynolds Inst Aging, Ctr Translat Res Aging & Longev, Little Rock, AR 72205 USA; [Miller, Sharon L.] SLM Consulting, Little Rock, AR USA	University of Arkansas System; University of Arkansas Medical Sciences	Wolfe, RR (corresponding author), Univ Arkansas Med Sci, Donald W Reynolds Inst Aging, Ctr Translat Res Aging & Longev, 4301 W Markham St,Slot 806, Little Rock, AR 72205 USA.	rwolfe2@uams.edu						Campbell WW, 2001, J GERONTOL A-BIOL, V56, pM373, DOI 10.1093/gerona/56.6.M373; Dawson-Hughes B, 2003, P NUTR SOC, V62, P505, DOI 10.1079/PNS2003267; Institute of Medicine, 2005, DIET REF INT EN CARB; Jeor STS, 2001, CIRCULATION, V104, P1869, DOI 10.1161/hc4001.096152; Stamler J, 1996, CIRCULATION, V94, P1629, DOI 10.1161/01.CIR.94.7.1629; Stratton RJ, 2005, AGEING RES REV, V4, P422, DOI 10.1016/j.arr.2005.03.005; U.S. Department of Agriculture, NAT SCH LUNCH PROGR; U.S. Department of Health and Human Services, 2005, 2005 DIET GUID AM; Wilson MMG, 2002, AM J CLIN NUTR, V75, P944, DOI 10.1093/ajcn/75.5.944; Wolfe RR, 2006, AM J CLIN NUTR, V84, P475, DOI 10.1093/ajcn/84.3.475; Wright Jacqueline D, 2003, Adv Data, P1	11	63	66	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 25	2008	299	24					2891	2893		10.1001/jama.299.24.2891	http://dx.doi.org/10.1001/jama.299.24.2891			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	317LN	18577734				2022-12-28	WOS:000257021800027
J	Southwell, K				Southwell, Karen			Quantum coherence	NATURE			English	Editorial Material																			0	30	30	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 19	2008	453	7198					1003	1003		10.1038/4531003a	http://dx.doi.org/10.1038/4531003a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314WM	18563149	Bronze			2022-12-28	WOS:000256839900040
J	Dunkle, KL; Stephenson, R; Karita, E; Chomba, E; Kayitenkore, K; Vwalika, C; Greenberg, L; Allen, S				Dunkle, Kristin L.; Stephenson, Rob; Karita, Etienne; Chomba, Elwyn; Kayitenkore, Kayitesi; Vwalika, Cheswa; Greenberg, Lauren; Allen, Susan			New heterosexually transmitted HIV infections in married or cohabiting couples in urban Zambia and Rwanda: an analysis of survey and clinical data	LANCET			English	Article							SUB-SAHARAN AFRICA; HUMAN-IMMUNODEFICIENCY-VIRUS; DISCORDANT COUPLES; HIV-1-DISCORDANT COUPLES; SEXUAL-BEHAVIOR; COITAL ACT; TRANSMISSION; UGANDA; RATES; RISK	Background Sub-Saharan Africa has a high rate of HIV infection, most of which is attributable to heterosexual transmission. Few attempts have been made to assess the extent of HIV transmission within marriages, and HIV-prevention efforts remain focused on abstinence and non-marital sex. We aimed to estimate the proportion of heterosexual transmission of HIV which occurs within married or cohabiting couples in urban Zambia and Rwanda each year. Methods We used population-based data from Demographic and Health Surveys (DHS) on heterosexual behaviour in Zambia in 2001-02 and in Rwanda in 2005. We also used data on the HIV serostatus of married or cohabiting couples and non-cohabiting couples that was collected through a voluntary counselling and testing service for urban couples in Lusaka, in Zambia, and Kigali, in Rwanda. We estimated the probability that an individual would acquire an incident HIV infection from a cohabiting or non-cohabiting sexual partner, and then the proportion of total heterosexual HIV transmission which occurs within married or cohabiting couples in these settings each year. Findings We analysed DHS data from 1739 Zambian women, 540 Zambian men, 1176 Rwandan women, and 606 Rwandan men. Under our base model, we estimated that 55 . 1% to 92.7% of new heterosexually acquired HIV infections among adults in urban Zambia and Rwanda occurred within serodiscordant marital or cohabiting relationships, depending on the sex of the index partner and on location. Under our extended model, which incorporated the higher rates of reported condom use that we found with non-cohabiting partners, we estimated that 60.3% to 94.2% of new heterosexually acquired infections occurred within marriage or cohabitation. We estimated that an intervention for couples which reduced transmission in serodiscordant urban cohabiting couples from 20% to 7% every year could avert 35.7% to 60.3% of heterosexually transmitted HIV infections that would otherwise occur. Interpretation Since most heterosexual HIV transmission for both men and women in urban Zambia and Rwanda takes place within marriage or cohabitation, voluntary counselling and testing for couples should be promoted, as should other evidence-based interventions that target heterosexual couples. Funding US National Institute of Mental Health, National Institute of Child Health and Human Development, National Institute of Allergy and Infectious Diseases, Fogarty AIDS International Training and Research Program, Emory Center for AIDS Research, and the International AIDS Vaccine Initiative.	[Dunkle, Kristin L.] Emory Univ, Dept Behav Sci & Hlth Educ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Dunkle, Kristin L.] Emory Univ, Emory Ctr AIDS Res, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Stephenson, Rob; Greenberg, Lauren; Allen, Susan] Emory Univ, Hubert Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Karita, Etienne; Kayitenkore, Kayitesi; Allen, Susan] Rwanda Zambia HIV Res Grp, Projet San Francisco, Kigali, Rwanda; [Chomba, Elwyn; Vwalika, Cheswa; Allen, Susan] Rwanda Zambia HIV Res Grp, Zambia Emory HIV Res Project, Lusaka, Zambia	Emory University; Rollins School Public Health; Emory University; Rollins School Public Health; Emory University; Rollins School Public Health	Dunkle, KL (corresponding author), Emory Univ, Dept Behav Sci & Hlth Educ, Rollins Sch Publ Hlth, 1520 Clifton Rd NE, Atlanta, GA 30322 USA.	kdunkle@sph.emory.edu	Dunkle, Kristin/AAU-5488-2020; Stephenson, Rob/J-9876-2012	Dunkle, Kristin/0000-0003-3071-5544; 	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD040125] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW001042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409, P30AI027767, R01AI040951] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066767] Funding Source: NIH RePORTER; FIC NIH HHS [FIC 2D43 TW001042] Funding Source: Medline; NIAID NIH HHS [P30 AI27767, P30 AI027767, P30 AI050409, R01 AI40951] Funding Source: Medline; NICHD NIH HHS [R01 HD040125, R01 HD 40125] Funding Source: Medline; NIMH NIH HHS [R01 MH 66767, R01 MH066767] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Allen S, 2003, AIDS, V17, P733, DOI 10.1097/00002030-200303280-00012; ALLEN S, 1992, BRIT MED J, V304, P1605, DOI 10.1136/bmj.304.6842.1605; ALLEN S, 1992, JAMA-J AM MED ASSOC, V268, P3338, DOI 10.1001/jama.268.23.3338; ALLEN S, 1993, AM J PUBLIC HEALTH, V83, P705, DOI 10.2105/AJPH.83.5.705; Bongaarts J, 2007, POP STUD-J DEMOG, V61, P73, DOI 10.1080/00324720601048343; Carpenter LM, 1999, AIDS, V13, P1083, DOI 10.1097/00002030-199906180-00012; Centers for Disease Control and Prevention, 2007, COUPL HIV COUNS TEST; *CENTR STAT OFRF C, 2003, ZAMB DEM HLTH SURV 2; Chomba E, 2008, JAIDS-J ACQ IMM DEF, V47, P108, DOI 10.1097/QAI.0b013e31815b2d67; Clark S, 2004, STUD FAMILY PLANN, V35, P149, DOI 10.1111/j.1728-4465.2004.00019.x; Clark S, 2006, INT FAM PLAN PERSPEC, V32, P79, DOI 10.1363/3207906; *CSO ORC MACR, 2007, ZIMB DEM HLTH SURV 2; Desgrees-Du-Lou A, 2009, AIDS BEHAV, V13, P348, DOI 10.1007/s10461-007-9316-6; El-Bassel N, 2003, AM J PUBLIC HEALTH, V93, P963, DOI 10.2105/AJPH.93.6.963; Fideli OS, 2001, AIDS RES HUM RETROV, V17, P901, DOI 10.1089/088922201750290023; Glynn JR, 2003, JAIDS-J ACQ IMM DEF, V33, P526, DOI 10.1097/00126334-200308010-00015; Glynn JR, 2001, AIDS, V15, pS51, DOI 10.1097/00002030-200108004-00006; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Guthrie BL, 2007, CURR HIV RES, V5, P416, DOI 10.2174/157016207781023992; HIRA SK, 1990, J ACQ IMMUN DEF SYND, V3, P83; Hirsch JS, 2007, AM J PUBLIC HEALTH, V97, P986, DOI 10.2105/AJPH.2006.088492; Hugonnet S, 2002, J ACQ IMMUN DEF SYND, V30, P73, DOI 10.1097/00042560-200205010-00010; *INSR ORC MACR, 2006, RWAND DEM HLTH SURV; Kakimoto K, 2007, AIDS CARE, V19, P381, DOI 10.1080/09540120500520998; KAMENGA M, 1991, AIDS, V5, P61, DOI 10.1097/00002030-199101000-00009; Lurie MN, 2003, AIDS, V17, P2245, DOI 10.1097/00002030-200310170-00013; *MOHSW BOS ORC MAC, 2005, LES DEM HLTH SURV 20; Painter TM, 2007, AJAR-AFR J AIDS RES, V6, P25, DOI 10.2989/16085900709490396; Parikh SA, 2007, AM J PUBLIC HEALTH, V97, P1198, DOI 10.2105/AJPH.2006.088682; Sagay A S, 2006, Afr J Med Med Sci, V35 Suppl, P125; Smith DJ, 2007, AM J PUBLIC HEALTH, V97, P997, DOI 10.2105/AJPH.2006.088583; Stephenson R, 2008, AIDS CARE, V20, P395, DOI 10.1080/09540120701593497; *TACAIDS NBS ORC M, 2005, TANZ HIV AIDS IND SU; Trask SA, 2002, J VIROL, V76, P397, DOI 10.1128/JVI.76.1.397-405.2002; *UNAIDS, 2006, REP GLOB AIDS EP 200; Wardlow H, 2007, AM J PUBLIC HEALTH, V97, P1006, DOI 10.2105/AJPH.2006.088559; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Were WA, 2006, JAIDS-J ACQ IMM DEF, V43, P91, DOI 10.1097/01.qai.0000225021.81384.28	38	370	377	0	38	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN-JUL	2008	371	9631					2183	2191		10.1016/S0140-6736(08)60953-8	http://dx.doi.org/10.1016/S0140-6736(08)60953-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	326CP	18586173				2022-12-28	WOS:000257635800025
J	Lee, SW; Hong, YS				Lee, Sung-Woo; Hong, Yun-Sik			Extracorporeal life-support in patients requiring CPR	LANCET			English	Editorial Material							CARDIAC-ARREST; CARDIOPULMONARY-RESUSCITATION; BYPASS		[Lee, Sung-Woo; Hong, Yun-Sik] Korea Univ, Emergency Dept, Ansan Hosp, Seoul 425707, South Korea	Korea University; Korea University Medicine (KU Medicine)	Lee, SW (corresponding author), Korea Univ, Emergency Dept, Ansan Hosp, Seoul 425707, South Korea.	kuedlee@korea.ac.kr						*AM HEART ASS, 2005, CIRCULATION, V112, P47; CHEN YS, 2008, LANCET          0707; Dalton HJ, 2005, SEMIN PERINATOL, V29, P24, DOI 10.1053/j.semperi.2005.02.005; Eich C, 2005, RESUSCITATION, V67, P145, DOI 10.1016/j.resuscitation.2005.05.002; Martin GB, 1998, CHEST, V113, P743, DOI 10.1378/chest.113.3.743; MULLER XM, 2001, ASAIO J, V46, P426; Nagao K, 2000, J AM COLL CARDIOL, V36, P776, DOI 10.1016/S0735-1097(00)00779-8; Nichol G, 1999, ANN EMERG MED, V34, P517, DOI 10.1016/S0196-0644(99)80054-7; Peberdy MA, 2003, RESUSCITATION, V58, P297, DOI 10.1016/S0300-9572(03)00215-6; Schultz SC, 1996, RESUSCITATION, V33, P13, DOI 10.1016/S0300-9572(96)00986-0; Shin JS, 2007, RESUSCITATION, V73, P309, DOI 10.1016/j.resuscitation.2006.09.011	11	11	11	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 16	2008	372	9638					512	514		10.1016/S0140-6736(08)60959-9	http://dx.doi.org/10.1016/S0140-6736(08)60959-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	339MS	18603292				2022-12-28	WOS:000258582300006
J	Hong, ST; Bang, S; Hyun, S; Kang, JK; Jeong, K; Paik, D; Chung, JK; Kim, J				Hong, Sung-Tae; Bang, Sunhoe; Hyun, Seogang; Kang, Jongkyun; Jeong, Kyunghwa; Paik, Donggi; Chung, Jongkyeong; Kim, Jaeseob			cAMP signalling in mushroom bodies modulates temperature preference behaviour in Drosophila	NATURE			English	Article							TOXIN LIGHT-CHAIN; SHORT-TERM-MEMORY; OLFACTORY MEMORY; EXPRESSION; NEURONS; GENETICS; SYSTEMS; GENES	Homoiotherms, for example mammals, regulate their body temperature with physiological responses such as a change of metabolic rate and sweating. In contrast, the body temperature of poikilotherms, for example Drosophila, is the result of heat exchange with the surrounding environment as a result of the large ratio of surface area to volume of their bodies(1,2). Accordingly, these animals must instinctively move to places with an environmental temperature as close as possible to their genetically determined desired temperature. The temperature that Drosophila instinctively prefers has a function equivalent to the 'set point' temperature in mammals. Although various temperature-gated TRP channels have been discovered(3,4), molecular and cellular components in Drosophila brain responsible for determining the desired temperature remain unknown. We identified these components by performing a large-scale genetic screen of temperature preference behaviour (TPB) in Drosophila(5,6). In parallel, we mapped areas of the Drosophila brain controlling TPB by targeted inactivation of neurons with tetanus toxin(7) and a potassium channel (Kir2.1)(8) driven with various brain-specific GAL4s. Here we show that mushroom bodies (MBs) and the cyclic AMP-cAMP-dependent protein kinase A (cAMP-PKA) pathway are essential for controlling TPB. Furthermore, targeted expression of cAMP-PKA pathway components in only the MB was sufficient to rescue abnormal TPB of the corresponding mutants. Preferred temperatures were affected by the level of cAMP and PKA activity in the MBs in various PKA pathway mutants.	[Hong, Sung-Tae; Bang, Sunhoe; Hyun, Seogang; Kang, Jongkyun; Jeong, Kyunghwa; Paik, Donggi; Chung, Jongkyeong; Kim, Jaeseob] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST)	Kim, J (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea.	kjaeseob@kaist.ac.kr	Kang, Jongkyun/AAT-7581-2021	Kang, Jongkyun/0000-0003-0259-110X; Hong, Sung-Tae/0000-0001-5981-4859; Paik, Donggi/0000-0003-1031-0371				Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; Bear M.F., 2007, NEUROSCIENCE, Vthird; DAVIS RL, 1981, J CELL BIOL, V90, P101, DOI 10.1083/jcb.90.1.101; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; deBelle JS, 1996, P NATL ACAD SCI USA, V93, P9875, DOI 10.1073/pnas.93.18.9875; EISEL U, 1993, EMBO J, V12, P3365, DOI 10.1002/j.1460-2075.1993.tb06010.x; Ferris J, 2006, NAT NEUROSCI, V9, P1036, DOI 10.1038/nn1738; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Hong ST, 2006, J NEUROSCI, V26, P7245, DOI 10.1523/JNEUROSCI.5426-05.2006; Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932; Keene AC, 2007, NAT REV NEUROSCI, V8, P341, DOI 10.1038/nrn2098; Krashes MJ, 2007, NEURON, V53, P103, DOI 10.1016/j.neuron.2006.11.021; Lee Y, 2005, NAT GENET, V37, P305, DOI 10.1038/ng1513; LEVIN LR, 1992, CELL, V68, P479, DOI 10.1016/0092-8674(92)90185-F; Liu L, 2003, NAT NEUROSCI, V6, P267, DOI 10.1038/nn1009; McBride SMJ, 1999, NEURON, V24, P967, DOI 10.1016/S0896-6273(00)81043-0; McGuire SE, 2004, TRENDS GENET, V20, P384, DOI 10.1016/j.tig.2004.06.012; Riemensperger T, 2005, CURR BIOL, V15, P1953, DOI 10.1016/j.cub.2005.09.042; Rister J, 2006, J NEUROBIOL, V66, P1271, DOI 10.1002/neu.20284; Rodan AR, 2002, J NEUROSCI, V22, P9490; Rosenzweig M, 2005, GENE DEV, V19, P419, DOI 10.1101/gad.1278205; Sayeed O, 1996, P NATL ACAD SCI USA, V93, P6079, DOI 10.1073/pnas.93.12.6079; Skoulakis EMC, 2006, CELL MOL LIFE SCI, V63, P975, DOI 10.1007/s00018-006-6023-9; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Thum AS, 2006, J COMP NEUROL, V498, P194, DOI 10.1002/cne.21022; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672; Zars T, 2001, J COMP PHYSIOL A, V187, P235, DOI 10.1007/s003590100194	27	56	59	1	14	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 7	2008	454	7205					771	U97		10.1038/nature07090	http://dx.doi.org/10.1038/nature07090			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334NH	18594510				2022-12-28	WOS:000258228000046
J	Meissner, A; Mikkelsen, TS; Gu, HC; Wernig, M; Hanna, J; Sivachenko, A; Zhang, XL; Bernstein, BE; Nusbaum, C; Jaffe, DB; Gnirke, A; Jaenisch, R; Lander, ES				Meissner, Alexander; Mikkelsen, Tarjei S.; Gu, Hongcang; Wernig, Marius; Hanna, Jacob; Sivachenko, Andrey; Zhang, Xiaolan; Bernstein, Bradley E.; Nusbaum, Chad; Jaffe, David B.; Gnirke, Andreas; Jaenisch, Rudolf; Lander, Eric S.			Genome-scale DNA methylation maps of pluripotent and differentiated cells	NATURE			English	Article							EMBRYONIC STEM-CELLS; DISTINCT; CANCER; GENES; HYPERMETHYLATION; SIGNATURES; PROMOTERS; PATTERNS; DISPLAY	DNA methylation is essential for normal development(1-3) and has been implicated in many pathologies including cancer(4,5). Our knowledge about the genome-wide distribution of DNA methylation, how it changes during cellular differentiation and how it relates to histone methylation and other chromatin modifications in mammals remains limited. Here we report the generation and analysis of genome-scale DNA methylation profiles at nucleotide resolution in mammalian cells. Using high-throughput reduced representation bisulphite sequencing(6) and single-molecule-based sequencing, we generated DNA methylation maps covering most CpG islands, and a representative sampling of conserved non-coding elements, transposons and other genomic features, for mouse embryonic stem cells, embryonic-stem-cell-derived and primary neural cells, and eight other primary tissues. Several key findings emerge from the data. First, DNA methylation patterns are better correlated with histone methylation patterns than with the underlying genome sequence context. Second, methylation of CpGs are dynamic epigenetic marks that undergo extensive changes during cellular differentiation, particularly in regulatory regions outside of core promoters. Third, analysis of embryonic-stem-cell-derived and primary cells reveals that 'weak' CpG islands associated with a specific set of developmentally regulated genes undergo aberrant hypermethylation during extended proliferation in vitro, in a pattern reminiscent of that reported in some primary tumours. More generally, the results establish reduced representation bisulphite sequencing as a powerful technology for epigenetic profiling of cell populations relevant to developmental biology, cancer and regenerative medicine.	[Meissner, Alexander; Wernig, Marius; Hanna, Jacob; Jaenisch, Rudolf; Lander, Eric S.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Meissner, Alexander; Mikkelsen, Tarjei S.; Gu, Hongcang; Sivachenko, Andrey; Zhang, Xiaolan; Bernstein, Bradley E.; Nusbaum, Chad; Jaffe, David B.; Gnirke, Andreas; Lander, Eric S.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Meissner, Alexander] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Mikkelsen, Tarjei S.] MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Bernstein, Bradley E.] Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA; [Bernstein, Bradley E.] Massachusetts Gen Hosp, Canc Res Ctr, Charlestown, MA 02129 USA; [Bernstein, Bradley E.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Jaenisch, Rudolf; Lander, Eric S.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02114 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Jaenisch, R (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu; lander@broad.mit.edu	Hu, Ruogu/B-2203-2008; Mikkelsen, Tarjei S/A-1306-2007; Hanna, Jacob/K-1339-2012	Mikkelsen, Tarjei S/0000-0002-8133-3135; Hanna, Jacob/0000-0003-2042-9974; Gu, Hongcang/0000-0002-1439-7606	NHGRI NIH HHS [R01 HG004401, R01 HG004401-02, U54 HG003067-06, U54 HG003067-04, U54 HG003067] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067, R01HG004401] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Aubert J, 2003, P NATL ACAD SCI USA, V100, P11836, DOI 10.1073/pnas.1734197100; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bouhon IA, 2006, STEM CELLS, V24, P1908, DOI 10.1634/stemcells.2006-0031; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Edwards CA, 2007, CURR OPIN CELL BIOL, V19, P281, DOI 10.1016/j.ceb.2007.04.013; Esteve PO, 2006, GENE DEV, V20, P3089, DOI 10.1101/gad.1463706; Feinberg AP, 2004, SEMIN CANCER BIOL, V14, P427, DOI 10.1016/j.semcancer.2004.06.005; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; JONES PA, 1990, PHILOS T R SOC B, V326, P277, DOI 10.1098/rstb.1990.0011; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Ohm JE, 2007, CELL CYCLE, V6, P1040, DOI 10.4161/cc.6.9.4210; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Sharma MK, 2007, CANCER RES, V67, P890, DOI 10.1158/0008-5472.CAN-06-0973; Shen Y, 2006, HUM MOL GENET, V15, P2623, DOI 10.1093/hmg/ddl188; Smiraglia DJ, 2001, HUM MOL GENET, V10, P1413, DOI 10.1093/hmg/10.13.1413; Voo KS, 2000, MOL CELL BIOL, V20, P2108; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; West AG, 2005, HUM MOL GENET, V14, pR101, DOI 10.1093/hmg/ddi104	30	1830	1921	2	324	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2008	454	7205					766	U91		10.1038/nature07107	http://dx.doi.org/10.1038/nature07107			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334NH	18600261	Green Accepted			2022-12-28	WOS:000258228000045
J	Flicker, L				Flicker, Leon			Should geriatric medicine remain a specialty? Yes	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Flicker, Leon] Univ Western Australia, Royal Perth Hosp, Western Australian Ctr Hlth & Ageing, Sch Med & Pharmacol, Perth, WA 6001, Australia	Royal Perth Hospital; University of Western Australia	Flicker, L (corresponding author), Univ Western Australia, Royal Perth Hosp, Western Australian Ctr Hlth & Ageing, Sch Med & Pharmacol, Perth, WA 6001, Australia.	leonflic@cyllene.uwa.edu.au	Flicker, Leon/AAE-1530-2022	Flicker, Leon/0000-0002-3650-0475					0	6	6	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 12	2008	337	7661							a516	10.1136/bmj.39538.481273.AD	http://dx.doi.org/10.1136/bmj.39538.481273.AD			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	330SA	18595935				2022-12-28	WOS:000257961900028
J	Weiser, TG; Regenbogen, SE; Thompson, KD; Haynes, AB; Lipsitz, SR; Berry, WR; Gawande, AA				Weiser, Thomas G.; Regenbogen, Scott E.; Thompson, Katherine D.; Haynes, Alex B.; Lipsitz, Stuart R.; Berry, William R.; Gawande, Atul A.			An estimation of the global volume of surgery: a modelling strategy based on available data	LANCET			English	Article							ADVERSE EVENTS; MORTALITY; EPIDEMIOLOGY; DISEASE; BURDEN	Background Little is known about the amount and availability of surgical care globally. We estimated the number of major operations undertaken worldwide, described their distribution, and assessed the importance of surgical care in global public-health policy. Methods We gathered demographic, health, and economic data for 192 member states of WHO. Data for the rate of surgery were sought from several sources including governmental agencies, statistical and epidemiological organisations, published studies, and individuals involved in surgical policy initiatives. We also obtained per-head total expenditure on health from analyses done in 2004. Major surgery was defined as any intervention occurring in a hospital operating theatre involving the incision, excision, manipulation, or suturing of tissue, usually requiring regional or general anaesthesia or sedation. We created a model to estimate rates of major surgery for countries for which such data were unavailable, then used demographic information to calculate the total worldwide volume of surgery. Findings We obtained surgical data for 56 (29%) of 192 WHO member states. We estimated that 234.2 (95% Cl 187.2-281.2) million major surgical procedures are undertaken every year worldwide. Countries spending US$100 or less per head on health care have an estimated mean rate of major surgery of 295 (SE 53) procedures per 100 000 population per year, whereas those spending more than $1000 have a mean rate of 11110 (SE 1300; p<0 . 0001). Middle-expenditure ($401-1000) and high-expenditure (>$1000) countries, accounting for 30.2% of the world's population, provided 73.6% (172.3 million) of operations worldwide in 2004, whereas poor-expenditure (<=$100) countries account for 34.8% of the global population yet undertook only 3.5% (8 . 1 million) of all surgical procedures in 2004. Interpretation Worldwide volume of surgery is large. In view of the high death and complication rates of major surgical procedures, surgical safety should now be a substantial global public-health concern. The disproportionate scarcity of surgical access in low-income settings suggests a large unaddressed disease burden worldwide. Public-health efforts and surveillance in surgery should be established.	[Weiser, Thomas G.; Regenbogen, Scott E.; Thompson, Katherine D.; Haynes, Alex B.; Berry, William R.; Gawande, Atul A.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Weiser, Thomas G.] Univ Calif Davis, Dept Surg, Sacramento, CA 95817 USA; [Regenbogen, Scott E.; Haynes, Alex B.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Lipsitz, Stuart R.; Gawande, Atul A.] Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California Davis; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital	Weiser, TG (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.	tweiser@hsph.harvard.edu	Weiser, Thomas G/AAC-4609-2022; Haynes, Alex/K-1446-2013	Weiser, Thomas G/0000-0002-3118-3888; Haynes, Alex/0000-0002-5731-329X; Gawande, Atul/0000-0002-1824-9176				[Anonymous], 1996, GLOBAL BURDEN DIS CO; [Anonymous], 2006, WORLD POP DAT SHEET; Bickler SW, 2000, B WORLD HEALTH ORGAN, V78, P1330; Gawande AA, 1999, SURGERY, V126, P66, DOI 10.1067/msy.1999.98664; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Kable AK, 2002, INT J QUAL HEALTH C, V14, P269, DOI 10.1093/intqhc/14.4.269; Maman AFOB, 2005, TROP DOCT, V35, P220, DOI 10.1258/004947505774938666; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; McConkey SJ, 2002, WORLD J SURG, V26, P509, DOI 10.1007/s00268-001-0258-2; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Omran AR, 2005, MILBANK Q, V83, P731, DOI 10.1111/j.1468-0009.2005.00398.x; Peden M, 2002, INJURY CHART BOOK GR; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; United Nations Population Fund, 2005, COUNTR PROF POP REPR; *US BUR CENS, INFL CALC; WHO, 2006, WORK TOG HLTH WORLD; WHO/World Alliance for Patient Safety, 2007, 1 INT CONS M 2 GLOB; World Alliance for Patient Safety, 2007, GLOB PAT SAF CHALL 2; World Health Organization, 2006, WORLD HLTH STAT 2006; World Health Organization, 2007, WORLD HLTH STAT 2007; Yii MK, 2002, BRIT J SURG, V89, P110, DOI 10.1046/j.0007-1323.2001.01979.x	22	1548	1619	4	71	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 12	2008	372	9633					139	144		10.1016/S0140-6736(08)60878-8	http://dx.doi.org/10.1016/S0140-6736(08)60878-8			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	324XJ	18582931				2022-12-28	WOS:000257552400028
J	Schoenfelder, S; Fraser, P				Schoenfelder, Stefan; Fraser, Peter			Interchromosomal huddle kickstarts antiviral defense	CELL			English	Editorial Material							TRANSCRIPTION	Long-distance chromosomal interactions are emerging as a potential mechanism of gene expression control. In this issue, Apostolou and Thanos (2008) describe how viral infection elicits interchromosomal associations between the interferon-beta (IFN-beta) gene enhancer and DNA binding sites of the transcription factor NF-kappa B, resulting in the initiation of transcription and an antiviral response.	[Schoenfelder, Stefan; Fraser, Peter] Babraham Inst, Lab Chromatin & Gene Express, Cambridge CB22 3AT, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Fraser, P (corresponding author), Babraham Inst, Lab Chromatin & Gene Express, Babraham Res Campus, Cambridge CB22 3AT, England.	peter.fraser@bbsrc.ac.uk	Fraser, Peter/B-7549-2009	Fraser, Peter/0000-0002-0041-1227				Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Lomvardas S, 2002, CELL, V110, P261, DOI 10.1016/S0092-8674(02)00822-X; Nunez E, 2008, CELL, V132, P996, DOI 10.1016/j.cell.2008.01.051; Osborne CS, 2007, PLOS BIOL, V5, P1763, DOI 10.1371/journal.pbio.0050192; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	7	2	2	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 11	2008	134	1					14	16		10.1016/j.cell.2008.06.041	http://dx.doi.org/10.1016/j.cell.2008.06.041			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	324IU	18614003	Bronze			2022-12-28	WOS:000257513100006
J	Zech, T; Machesky, L				Zech, Tobias; Machesky, Laura			Rab5 and Rac team up in cell motility	CELL			English	Editorial Material							MIGRATION	Cell motility requires actin assembly mediated by Rac, a Rho family GTPase. In this issue, Palamidessi et al. (2008) show that Rab5-directed trafficking of Rac to the cell membrane is required for Rac-mediated actin assembly. Trafficking of Rac may influence the mode of cell migration during morphogenesis and cancer metastasis.	[Zech, Tobias; Machesky, Laura] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland	Beatson Institute	Zech, T (corresponding author), Beatson Inst Canc Res, Garscube Estate, Glasgow G61 1BD, Lanark, Scotland.	t.zech@beatson.gla.ac.uk; l.machesky@beatson.gla.ac.uk	Machesky, Laura/Z-4554-2019	Machesky, Laura/0000-0002-7592-9856; Zech, Tobias/0000-0001-8394-088X	Medical Research Council [G117/569] Funding Source: Medline; MRC [G117/569] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Caswell PT, 2007, DEV CELL, V13, P496, DOI 10.1016/j.devcel.2007.08.012; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Jekely G, 2005, DEV CELL, V9, P197, DOI 10.1016/j.devcel.2005.06.004; Orth JD, 2006, CANCER RES, V66, P3603, DOI 10.1158/0008-5472.CAN-05-2916; Radhakrishna H, 1999, J CELL SCI, V112, P855; Wolf K, 2006, BRIT J DERMATOL, V154, P11, DOI 10.1111/j.1365-2133.2006.07231.x	7	11	11	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 11	2008	134	1					18	20		10.1016/j.cell.2008.06.039	http://dx.doi.org/10.1016/j.cell.2008.06.039			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	324IU	18614005	Bronze			2022-12-28	WOS:000257513100008
J	Hodgson-Zingman, DM; Karst, ML; Zingman, LV; Heublein, DM; Darbar, D; Herron, KJ; Ballew, JD; de Andrade, M; Burnett, JC; Olson, TM				Hodgson-Zingman, Denice M.; Karst, Margaret L.; Zingman, Leonid V.; Heublein, Denise M.; Darbar, Dawood; Herron, Kathleen J.; Ballew, Jeffrey D.; de Andrade, Mariza; Burnett, John C., Jr.; Olson, Timothy M.			Atrial natriuretic peptide frameshift mutation in familial atrial fibrillation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OF-FUNCTION MUTATION; SHATTUCK-LECTURE; HEART-FAILURE; RISK; RECEPTORS		[Karst, Margaret L.; Darbar, Dawood; Herron, Kathleen J.; Ballew, Jeffrey D.; Olson, Timothy M.] Mayo Clin, Coll Med, Dept Internal Med, Cardiovasc Genet Lab, Rochester, MN 55905 USA; [Hodgson-Zingman, Denice M.; Zingman, Leonid V.] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA USA; [Olson, Timothy M.] Mayo Clin, Coll Med, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA; [Heublein, Denise M.; Burnett, John C., Jr.] Mayo Clin, Coll Med, Dept Physiol, Cardiorenal Res Lab, Rochester, MN 55905 USA; [Heublein, Denise M.; Burnett, John C., Jr.] Mayo Clin, Coll Med, Dept Internal Med, Cardiorenal Res Lab, Rochester, MN 55905 USA; [de Andrade, Mariza] Mayo Clin, Coll Med, Dept Hlth Sci Res, Rochester, MN 55905 USA	Mayo Clinic; University of Iowa; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Olson, TM (corresponding author), Mayo Clin, Coll Med, Dept Internal Med, Cardiovasc Genet Lab, 200 1st St SW, Rochester, MN 55905 USA.	olson.timothy@mayo.edu	Darbar, Dawood/C-9079-2015; Zingman, Leonid V/GXG-0136-2022	Darbar, Dawood/0000-0002-4103-5977; Zingman, Leonid V/0000-0002-7566-4616; de Andrade, Mariza/0000-0003-2329-2686; Hodgson-Zingman, Denice/0000-0002-6875-1367; Olson, Timothy/0000-0003-2716-9423	NHLBI NIH HHS [R01 HL075495-01A2, P01 HL76611, R01 HL075495, R01 HL36634, K23 HL075266-04, R01 HL075495-02, P01 HL076611, R01 HL036634, K23 HL075266] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036634, K23HL075266, R01HL075495, P01HL076611] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Braunwald E, 1997, NEW ENGL J MED, V337, P1360, DOI 10.1056/NEJM199711063371906; Brugada R, 1997, NEW ENGL J MED, V336, P905, DOI 10.1056/NEJM199703273361302; BURNETT JC, 1986, SCIENCE, V231, P1145, DOI 10.1126/science.2935937; Chen HH, 2002, J AM COLL CARDIOL, V40, P1186, DOI 10.1016/S0735-1097(02)02127-7; Chen YH, 2003, SCIENCE, V299, P251, DOI 10.1126/science.1077771; CROZIER I, 1993, PACE, V16, P738, DOI 10.1111/j.1540-8159.1993.tb01653.x; Darbar D, 2003, J AM COLL CARDIOL, V41, P2185, DOI 10.1016/S0735-1097(03)00465-0; Fatkin D, 2007, CIRCULATION, V116, P782, DOI 10.1161/CIRCULATIONAHA.106.688889; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P2851, DOI 10.1001/jama.291.23.2851; Gollob MH, 2006, NEW ENGL J MED, V354, P2677, DOI 10.1056/NEJMoa052800; Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007; Johns DG, 2007, BIOCHEM BIOPH RES CO, V358, P145, DOI 10.1016/j.bbrc.2007.04.079; Kato T, 2005, J CLIN INVEST, V115, P2716, DOI 10.1172/JCI24280; LEGRAND B, 1992, PFLUG ARCH EUR J PHY, V421, P486, DOI 10.1007/BF00370260; Levin ER, 1998, NEW ENGL J MED, V339, P321; Lloyd-Jones DM, 2004, CIRCULATION, V110, P1042, DOI 10.1161/01.CIR.0000140263.20897.42; Lonardo G, 2004, CARDIOVASC RES, V63, P528, DOI 10.1016/j.cardiores.2004.03.004; Murad F, 2006, NEW ENGL J MED, V355, P2003, DOI 10.1056/NEJMsa063904; Olson TM, 2006, HUM MOL GENET, V15, P2185, DOI 10.1093/hmg/ddl143; Olson TM, 2005, JAMA-J AM MED ASSOC, V293, P447, DOI 10.1001/jama.293.4.447; Potter LR, 2006, ENDOCR REV, V27, P47, DOI 10.1210/er.2005-0014; SORBERA LA, 1990, SCIENCE, V247, P969, DOI 10.1126/science.2154853; Stambler BS, 2005, J CARDIOVASC ELECTR, V16, P1341, DOI 10.1111/j.1540-8167.2005.00259.x	23	239	248	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 10	2008	359	2					158	165		10.1056/NEJMoa0706300	http://dx.doi.org/10.1056/NEJMoa0706300			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	323PJ	18614783	Green Accepted			2022-12-28	WOS:000257459000007
J	Lynch, HT; Ferrara, K; Barlogie, B; Coleman, EA; Lynch, JF; Weisenburger, D; Sanger, W; Watson, P; Nipper, H; Witt, V; Thome, S				Lynch, Henry T.; Ferrara, Kelly; Barlogie, Bart; Coleman, Elizabeth A.; Lynch, Jane F.; Weisenburger, Dennis; Sanger, Warren; Watson, Patrice; Nipper, Henry; Witt, Vinetta; Thome, Stephan			Familial myeloma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MULTIPLE-MYELOMA; MONOCLONAL GAMMOPATHY; UNDETERMINED SIGNIFICANCE; CANCER; RISK	We describe a family with five cases of multiple myeloma, three cases of monoclonal gammopathy of undetermined significance (MGUS), and five cases of prostate cancer in two generations. The putative progenitor had progeny with two female partners. The progeny had prostate cancer, multiple myeloma, and MGUS.	[Lynch, Henry T.; Ferrara, Kelly; Lynch, Jane F.; Watson, Patrice; Thome, Stephan] Creighton Univ, Sch Med, Omaha, NE 68178 USA; [Weisenburger, Dennis; Sanger, Warren] Nebraska Med Ctr, Omaha, NE USA; [Nipper, Henry] Creighton Univ, Med Ctr, Omaha, NE USA; [Barlogie, Bart; Coleman, Elizabeth A.] Univ Arkansas Med Sci, Little Rock, AR 72205 USA; [Witt, Vinetta] Newberry Coll, Newberry, SC 29108 USA	Creighton University; University of Nebraska System; University of Nebraska Medical Center; Creighton University; University of Arkansas System; University of Arkansas Medical Sciences	Lynch, HT (corresponding author), Creighton Univ, Sch Med, Omaha, NE 68178 USA.				NCI NIH HHS [U01 CA086389-09, 1U01 CA 86389, U01 CA086389] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U01CA086389] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alexander DD, 2007, INT J CANCER, P40, DOI 10.1002/ijc.22718; Bradwell AR, 2001, CLIN CHEM, V47, P673; BRESLOW NE, 1987, IARC SCI PUBLICATION, V82; Brown LM, 1999, CANCER, V85, P2385; Dilworth D, 2000, BLOOD, V95, P1869, DOI 10.1182/blood.V95.5.1869.005k09_1869_1871; ERIKSSON M, 1992, CANCER CAUSE CONTROL, V3, P63, DOI 10.1007/BF00051914; Gerkes EH, 2007, HERED CANCER CLIN PR, V5, P72, DOI 10.1186/1897-4287-5-2-72; JEPPSSON JO, 1979, CLIN CHEM, V25, P629; Keren DF, 2002, CLIN LAB MED, P1448; Kyle RA, 2006, BRIT J HAEMATOL, V134, P573, DOI 10.1111/j.1365-2141.2006.06235.x; Landgren O, 2006, BLOOD, V107, P904, DOI 10.1182/blood-2005-08-3449; Landgren O, 2007, MAYO CLIN PROC, V82, P1468, DOI 10.4065/82.12.1468; Lynch HT, 2005, J CLIN ONCOL, V23, P685, DOI 10.1200/JCO.2005.10.126; Lynch HT, 2002, CANCER-AM CANCER SOC, V94, P84, DOI 10.1002/cncr.10159; Lynch HT, 2001, CANCER, V91, P625, DOI 10.1002/1097-0142(20010215)91:4<625::AID-CNCR1044>3.0.CO;2-4; Lynch HT, 2001, JNCI-J NATL CANCER I, V93, P1479, DOI 10.1093/jnci/93.19.1479; Malpas JS, 1998, MULTIPLE MYELOMA BIO; Morgan GJ, 2002, BIOMED PHARMACOTHER, V56, P223, DOI 10.1016/S0753-3322(02)00194-4; Ogmundsdottir HM, 2005, HAEMATOLOGICA, V90, P66; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Zighelboim I, 2007, GYNECOL ONCOL, V105, P390, DOI 10.1016/j.ygyno.2006.12.022	21	60	61	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 10	2008	359	2					152	157		10.1056/NEJMoa0708704	http://dx.doi.org/10.1056/NEJMoa0708704			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	323PJ	18614782	Green Accepted			2022-12-28	WOS:000257459000006
J	Salzberg, S				Salzberg, Steven			The contents of the syringe	NATURE			English	Editorial Material									Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Salzberg, S (corresponding author), Univ Maryland, Ctr Bioinformat & Computat Biol, 3125 Biomol Sci Bldg, College Pk, MD 20742 USA.		Salzberg, Steven L/F-6162-2011; Salzberg, Steven/Q-6514-2019	Salzberg, Steven L/0000-0002-8859-7432; Salzberg, Steven/0000-0002-8859-7432	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083873] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM006845] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM083873-05, R01 GM083873] Funding Source: Medline; NLM NIH HHS [R01 LM006845, R01 LM006845-08, R01 LM006845-09] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Ghedin E, 2005, NATURE, V437, P1162, DOI 10.1038/nature04239	1	36	37	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 10	2008	454	7201					160	161		10.1038/454160a	http://dx.doi.org/10.1038/454160a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	323RU	18615063	Green Accepted			2022-12-28	WOS:000257466900020
J	Gorrindo, T; Groves, JE				Gorrindo, Tristan; Groves, James E.			Web searching for information about physicians	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PATIENT; CARE		[Gorrindo, Tristan; Groves, James E.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Gorrindo, Tristan; Groves, James E.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Gorrindo, T (corresponding author), Massachusetts Gen Hosp, Dept Psychiat, Wang ACC 812, Boston, MA 02114 USA.	tristan.gorrindo@mgh.harvard.edu		Gorrindo, Tristan/0000-0003-0522-9288				BANJO S, 2008, WALL STREET J   0217, P2; Beach MC, 2004, J GEN INTERN MED, V19, P911, DOI 10.1111/j.1525-1497.2004.30604.x; Dixson, 2007, CAREER DISTINCTION S; FALLOWS D, 2005, SEARCH ENGINE USERS; Fox S., 2005, FUTURE INTERNET SURV; Fung CH, 2008, ANN INTERN MED, V148, P111, DOI 10.7326/0003-4819-148-2-200801150-00006; GROVES JE, 1978, NEW ENGL J MED, V298, P883, DOI 10.1056/NEJM197804202981605; *MASS GROUP INS CO, CLIN PERF IMPR IN	8	41	41	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 9	2008	300	2					213	215		10.1001/jama.2008.44	http://dx.doi.org/10.1001/jama.2008.44			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	323GV	18612120				2022-12-28	WOS:000257435500027
J	Snow, J				Snow, Jon			How the media are failing the health service	BRITISH MEDICAL JOURNAL			English	Editorial Material									Channel 4 News, London, England		Snow, J (corresponding author), Channel 4 News, London, England.	Jon.Snow@itn.co.uk	Snow, Jon/M-5841-2016						0	3	3	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 5	2008	337	7660							a572	10.1136/bmj.a572	http://dx.doi.org/10.1136/bmj.a572			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	326DF	18595940				2022-12-28	WOS:000257637500028
J	Rabinovich, M; Huerta, R; Laurent, G				Rabinovich, Misha; Huerta, Ramon; Laurent, Gilles			Neuroscience - Transient dynamics for neural processing	SCIENCE			English	Editorial Material							ODOR REPRESENTATIONS		[Rabinovich, Misha; Huerta, Ramon] Univ Calif San Diego, Inst Nonlinear Sci, La Jolla, CA 92093 USA; [Laurent, Gilles] CALTECH, Div Biol, Pasadena, CA 91125 USA	University of California System; University of California San Diego; California Institute of Technology	Rabinovich, M (corresponding author), Univ Calif San Diego, Inst Nonlinear Sci, La Jolla, CA 92093 USA.	laurentg@caltech.edu	Huerta, Ramon/J-4316-2012; Laurent, Gilles/A-4583-2012; Huerta, Ramon/C-9296-2013	Huerta, Ramon/0000-0003-3925-5169; Laurent, Gilles/0000-0002-2296-114X; Huerta, Ramon/0000-0003-3925-5169; Rabinovich, Mikhail I./0000-0003-4499-5348				Baeg EH, 2003, NEURON, V40, P177, DOI 10.1016/S0896-6273(03)00597-X; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Huerta R, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.238104; Jones M., 2007, P NATL ACAD SCI USA, V104, P18772; LAURENT G, 1994, SCIENCE, V265, P1872, DOI 10.1126/science.265.5180.1872; Lin LN, 2005, P NATL ACAD SCI USA, V102, P6125, DOI 10.1073/pnas.0408233102; LINDSTROM T, 1993, J MATH BIOL, V31, P541, DOI 10.1007/BF00161198; Maass W, 2002, NEURAL COMPUT, V14, P2531, DOI 10.1162/089976602760407955; Mazor O, 2005, NEURON, V48, P661, DOI 10.1016/j.neuron.2005.09.032; Nowotny T, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.128106; Rabinovich M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.068102; Rabinovich MI, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000072; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142	15	304	306	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2008	321	5885					48	50		10.1126/science.1155564	http://dx.doi.org/10.1126/science.1155564			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QE	18599763				2022-12-28	WOS:000257320800027
J	Slavin, JA; Acuna, MH; Anderson, BJ; Baker, DN; Benna, M; Gloeckler, G; Gold, RE; Ho, GC; Killen, RM; Korth, H; Krimigis, SM; McNutt, RL; Nittler, LR; Raines, JM; Schriver, D; Solomon, SC; Starr, RD; Travnicek, P; Zurbuchen, TH				Slavin, James A.; Acuna, Mario H.; Anderson, Brian J.; Baker, Daniel N.; Benna, Mehdi; Gloeckler, George; Gold, Robert E.; Ho, George C.; Killen, Rosemary M.; Korth, Haje; Krimigis, Stamatios M.; McNutt, Ralph L., Jr.; Nittler, Larry R.; Raines, Jim M.; Schriver, David; Solomon, Sean C.; Starr, Richard D.; Travnicek, Pavel; Zurbuchen, Thomas H.			Mercury's magnetosphere after MESSENGER's first flyby	SCIENCE			English	Article							SOLAR-WIND; GEOTAIL OBSERVATIONS; ULF WAVES; MAGNETOTAIL; SPECTROMETER; INSTRUMENT; SPACECRAFT; EARTH; MODEL; IONS	Observations by MESSENGER show that Mercury's magnetosphere is immersed in a comet- like cloud of planetary ions. The most abundant, Na+, is broadly distributed but exhibits flux maxima in the magnetosheath, where the local plasma flow speed is high, and near the spacecraft's closest approach, where atmospheric density should peak. The magnetic field showed reconnection signatures in the form of flux transfer events, azimuthal rotations consistent with Kelvin- Helmholtz waves along the magnetopause, and extensive ultralow- frequency wave activity. Two outbound current sheet boundaries were observed, across which the magnetic field decreased in a manner suggestive of a double magnetopause. The separation of these current layers, comparable to the gyro- radius of a Na+ pickup ion entering the magnetosphere after being accelerated in the magnetosheath, may indicate a planetary ion boundary layer.	[Slavin, James A.] NASA, Heliophys Sci Div, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Acuna, Mario H.; Benna, Mehdi] NASA, Solar Syst Explorat Div, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Anderson, Brian J.; Gold, Robert E.; Ho, George C.; Korth, Haje; Krimigis, Stamatios M.; McNutt, Ralph L., Jr.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Baker, Daniel N.] Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80303 USA; [Gloeckler, George; Raines, Jim M.; Zurbuchen, Thomas H.] Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA; [Gloeckler, George; Killen, Rosemary M.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Krimigis, Stamatios M.] Acad Athens, Athens 11527, Greece; [Nittler, Larry R.; Solomon, Sean C.] Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; [Schriver, David] Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90024 USA; [Starr, Richard D.] Catholic Univ Amer, Dept Phys, Washington, DC 20064 USA; [Travnicek, Pavel] Acad Sci Czech Republic, Inst Astron, CR-12023 Prague, Czech Republic	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; University of Colorado System; University of Colorado Boulder; University of Michigan System; University of Michigan; University System of Maryland; University of Maryland College Park; Academy of Athens; Carnegie Institution for Science; University of California System; University of California Los Angeles; Catholic University of America; Czech Academy of Sciences; Astronomical Institute of the Czech Academy of Sciences	Slavin, JA (corresponding author), NASA, Heliophys Sci Div, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA.	james.a.slavin@nasa.gov	Ho, George/G-3650-2015; Slavin, James A/H-3170-2012; Korth, Haje/C-3182-2016; Raines, Jim M./O-5649-2016; Anderson, Brian J/I-8615-2012; Travnicek, Pavel/G-8608-2014; McNutt, Ralph L/E-8006-2010; Krimigis, Stamatios/G-4591-2019; Ho, George/GMW-9642-2022; Benna, Mehdi/F-3489-2012; Killen, Rosemary M/E-7127-2012	Ho, George/0000-0003-1093-2066; Slavin, James A/0000-0002-9206-724X; Korth, Haje/0000-0001-7394-7439; McNutt, Ralph L/0000-0002-4722-9166; Krimigis, Stamatios/0000-0003-2781-2386; Ho, George/0000-0003-1093-2066; 				Anderson BJ, 2008, SCIENCE, V321, P82, DOI 10.1126/science.1159081; Anderson BJ, 2007, SPACE SCI REV, V131, P417, DOI 10.1007/s11214-007-9246-7; Andrews GB, 2007, SPACE SCI REV, V131, P523, DOI 10.1007/s11214-007-9272-5; Blomberg LG, 2007, SPACE SCI REV, V132, P575, DOI 10.1007/s11214-007-9282-3; Boardsen SA, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031504; BRINCA AL, 1987, ASTRON ASTROPHYS, V187, P311; CONNERNEY JEP, 1988, MERCURY, P494; Delcourt DC, 2003, ANN GEOPHYS-GERMANY, V21, P1723, DOI 10.5194/angeo-21-1723-2003; Fairfield DH, 2000, J GEOPHYS RES-SPACE, V105, P21159, DOI 10.1029/1999JA000316; Fujimoto M, 1998, J GEOPHYS RES-SPACE, V103, P4391, DOI 10.1029/97JA03340; Glassmeier KH, 2004, ADV SPACE RES, V33, P1875, DOI 10.1016/j.asr.2003.04.047; IP WH, 1987, ICARUS, V71, P441, DOI 10.1016/0019-1035(87)90039-X; Kabin K, 2000, ICARUS, V143, P397, DOI 10.1006/icar.1999.6252; Kallio E, 2003, ANN GEOPHYS-GERMANY, V21, P2133, DOI 10.5194/angeo-21-2133-2003; KUZNETSOVA MM, 1986, P JOINT VAR AB INT S, P137; McClintock WE, 2008, SCIENCE, V321, P92, DOI 10.1126/science.1159467; POTTER A, 1985, SCIENCE, V229, P651, DOI 10.1126/science.229.4714.651; RUSSELL CT, 1978, SPACE SCI REV, V22, P681, DOI 10.1007/BF00212619; RUSSELL CT, 1989, GEOPHYS RES LETT, V16, P1253, DOI 10.1029/GL016i011p01253; RUSSELL CT, 1985, J GEOPHYS RES-SPACE, V90, P1067, DOI 10.1029/JA090iA11p11067; RUSSELL CT, 1988, MERCURY, P514; Schlemm CE, 2007, SPACE SCI REV, V131, P393, DOI 10.1007/s11214-007-9248-5; SLAVIN JA, 1985, J GEOPHYS RES-SPACE, V90, P875, DOI 10.1029/JA090iA11p10875; SLAVIN JA, 1979, J GEOPHYS RES-SPACE, V84, P2076, DOI 10.1029/JA084iA05p02076; Solomon SC, 2001, PLANET SPACE SCI, V49, P1445, DOI 10.1016/S0032-0633(01)00085-X; Starr R, 1999, ADV SPACE RES, V24, P1159, DOI 10.1016/S0273-1177(99)80209-9; Travnicek P, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028518; Zurbuchen TH, 2008, SCIENCE, V321, P90, DOI 10.1126/science.1159314	28	141	141	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2008	321	5885					85	89		10.1126/science.1159040	http://dx.doi.org/10.1126/science.1159040			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QE	18599776				2022-12-28	WOS:000257320800040
J	Zurbuchen, TH; Raines, JM; Gloeckler, G; Krimigis, SM; Slavin, JA; Koehn, PL; Killen, RM; Sprague, AL; McNutt, RL; Solomon, SC				Zurbuchen, Thomas H.; Raines, Jim M.; Gloeckler, George; Krimigis, Stamatios M.; Slavin, James A.; Koehn, Patrick L.; Killen, Rosemary M.; Sprague, Ann L.; McNutt, Ralph L., Jr.; Solomon, Sean C.			MESSENGER observations of the composition of Mercury's ionized exosphere and plasma environment	SCIENCE			English	Article							SOLAR-WIND; MAGNETOSPHERE; SPECTROMETER; MODEL	The region around Mercury is filled with ions that originate from interactions of the solar wind with Mercury's space environment and through ionization of its exosphere. The MESSENGER spacecraft's observations of Mercury's ionized exosphere during its first flyby yielded Na(+), O(+), and K(+) abundances, consistent with expectations from observations of neutral species. There are increases in ions at a mass per charge (m/q) = 32 to 35, which we interpret to be S(+) and H(2)S(+), with ( S(+) + H(2)S(+))/( Na(+) + Mg(+)) = 0.67 +/- 0.06, and from water- group ions around m/ q = 18, at an abundance of 0.20 +/- 0.03 relative to Na(+) plus Mg(+). The fluxes of Na(+), O(+), and heavier ions are largest near the planet, but these Mercury- derived ions fill the magnetosphere. Doubly ionized ions originating from Mercury imply that electrons with energies less than 1 kiloelectron volt are substantially energized in Mercury's magnetosphere.	[Zurbuchen, Thomas H.; Raines, Jim M.; Gloeckler, George] Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA; [Krimigis, Stamatios M.; McNutt, Ralph L., Jr.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Krimigis, Stamatios M.] Acad Athens, Astron & Appl Math Res Ctr, Athens 11527, Greece; [Slavin, James A.] NASA, Heliophys Sci Div, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Koehn, Patrick L.] Eastern Michigan Univ, Dept Phys & Astron, Ypsilanti, MI 48197 USA; [Killen, Rosemary M.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Sprague, Ann L.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Solomon, Sean C.] Carnegie Inst Washington, Dept Terr Magnetism, Washington, DC 20015 USA	University of Michigan System; University of Michigan; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Academy of Athens; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Eastern Michigan University; University System of Maryland; University of Maryland College Park; University of Arizona; Carnegie Institution for Science	Zurbuchen, TH (corresponding author), Univ Michigan, Dept Atmospher Ocean & Space Sci, 2455 Hayward St, Ann Arbor, MI 48109 USA.	thomasz@umich.edu	Raines, Jim M./O-5649-2016; Krimigis, Stamatios/G-4591-2019; Killen, Rosemary M/E-7127-2012; McNutt, Ralph L/E-8006-2010; Slavin, James A/H-3170-2012	Krimigis, Stamatios/0000-0003-2781-2386; McNutt, Ralph L/0000-0002-4722-9166; Slavin, James A/0000-0002-9206-724X				Andrews GB, 2007, SPACE SCI REV, V131, P523, DOI 10.1007/s11214-007-9272-5; Delcourt DC, 2003, ANN GEOPHYS-GERMANY, V21, P1723, DOI 10.5194/angeo-21-1723-2003; Huebner W., 1992, SOLAR PHOTO RATES PL; Kabin K, 2000, ICARUS, V143, P397, DOI 10.1006/icar.1999.6252; Mazzotta P, 1998, ASTRON ASTROPHYS SUP, V133, P403, DOI 10.1051/aas:1998330; McClintock WE, 2008, SCIENCE, V321, P92, DOI 10.1126/science.1159467; Mukai T, 2004, ADV SPACE RES, V33, P2166, DOI 10.1016/s0273-1177(03)00443-5; NESS NF, 1974, SCIENCE, V185, P151, DOI 10.1126/science.185.4146.151; POTTER AE, 1990, SCIENCE, V248, P835, DOI 10.1126/science.248.4957.835; POTTER AE, 1995, GEOPHYS RES LETT, V22, P3289, DOI 10.1029/95GL03181; Slavin JA, 2008, SCIENCE, V321, P85, DOI 10.1126/science.1159040; Slavin JA, 2007, SPACE SCI REV, V131, P133, DOI 10.1007/s11214-007-9154-x; SPRAGUE AL, 1995, ICARUS, V118, P211, DOI 10.1006/icar.1995.1186; Sprague AL, 1998, ICARUS, V133, P174, DOI 10.1006/icar.1998.5929; SPRAGUE AL, 1992, J GEOPHYS RES-PLANET, V97, P18257, DOI 10.1029/92JE01690; von Steiger R, 2000, J GEOPHYS RES-SPACE, V105, P27217, DOI 10.1029/1999JA000358	16	109	110	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 4	2008	321	5885					90	92		10.1126/science.1159314	http://dx.doi.org/10.1126/science.1159314			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QE	18599777				2022-12-28	WOS:000257320800041
J	DesRoches, CM; Campbell, EG; Rao, SR; Donelan, K; Ferris, TG; Jha, A; Kaushal, R; Levy, DE; Rosenbaum, S; Shields, AE; Blumenthal, D				DesRoches, Catherine M.; Campbell, Eric G.; Rao, Sowmya R.; Donelan, Karen; Ferris, Timothy G.; Jha, Ashish; Kaushal, Rainu; Levy, Douglas E.; Rosenbaum, Sara; Shields, Alexandra E.; Blumenthal, David			Electronic health records in ambulatory care - A national survey of physicians	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SYSTEMS; COSTS	Background: Electronic health records have the potential to improve the delivery of health care services. However, in the United States, physicians have been slow to adopt such systems. This study assessed physicians' adoption of outpatient electronic health records, their satisfaction with such systems, the perceived effect of the systems on the quality of care, and the perceived barriers to adoption. Methods: In late 2007 and early 2008, we conducted a national survey of 2758 physicians, which represented a response rate of 62%. Using a definition for electronic health records that was based on expert consensus, we determined the proportion of physicians who were using such records in an office setting and the relationship between adoption and the characteristics of individual physicians and their practices. Results: Four percent of physicians reported having an extensive, fully functional electronic-records system, and 13% reported having a basic system. In multivariate analyses, primary care physicians and those practicing in large groups, in hospitals or medical centers, and in the western region of the United States were more likely to use electronic health records. Physicians reported positive effects of these systems on several dimensions of quality of care and high levels of satisfaction. Financial barriers were viewed as having the greatest effect on decisions about the adoption of electronic health records. Conclusions: Physicians who use electronic health records believe such systems improve the quality of care and are generally satisfied with the systems. However, as of early 2008, electronic systems had been adopted by only a small minority of U.S. physicians, who may differ from later adopters of these systems.	[DesRoches, Catherine M.; Campbell, Eric G.; Rao, Sowmya R.; Donelan, Karen; Levy, Douglas E.; Shields, Alexandra E.; Blumenthal, David] Massachusetts Gen Hosp, Inst Hlth Policy, Boston, MA 02114 USA; [Ferris, Timothy G.] Massachusetts Gen Hosp, Massachusetts Gen Phys Org, Boston, MA 02114 USA; [Jha, Ashish] Harvard Univ, Sch Med, Boston, MA USA; [Kaushal, Rainu] Weill Cornell Med Coll, New York, NY USA; [Rosenbaum, Sara] George Washington Univ, Dept Hlth Policy, Washington, DC USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Cornell University; George Washington University	DesRoches, CM (corresponding author), Massachusetts Gen Hosp, Inst Hlth Policy, Suite 900,50 Staniford St, Boston, MA 02114 USA.	cdesroches@partners.org	Donelan, Karen/R-6162-2019; DesRoches, Catherine/ABC-9869-2020; Levy, Douglas/W-1516-2019; Chang, Shulan/H-2270-2011	DesRoches, Catherine/0000-0001-5373-855X; Levy, Douglas/0000-0001-9446-7899; 				[Anonymous], 2002, SAS ONLINEDOC 9 1 3; Bates DW, 2005, HEALTH AFFAIR, V24, P1180, DOI 10.1377/hlthaff.24.5.1180; BLUMENTHAL D, 2006, HLTH INFORMATION TEC; Chaudhry B, 2006, ANN INTERN MED, V144, P742, DOI 10.7326/0003-4819-144-10-200605160-00125; Hillestad R, 2005, HEALTH AFFAIR, V24, P1103, DOI 10.1377/hlthaff.24.5.1103; HING ES, 2007, DHHS PUBLICATION, P1; *HJ KAIS FAM FDN, 2008 PRES CAND HLTH; ISO/TC 215, 2003, 215 ISOTC; Jha AK, 2006, HEALTH AFFAIR, V25, pW496, DOI 10.1377/hlthaff.25.w496; Kaushal R, 2006, J AM MED INFORM ASSN, V13, P261, DOI 10.1197/jamia.M1984; Korn EL., 1999, ANAL HLTH SURVEYS; Miller RH, 2005, HEALTH AFFAIR, V24, P1127, DOI 10.1377/hlthaff.24.5.1127; Miller RH, 2007, HEALTH AFFAIR, V26, P206, DOI 10.1377/hlthaff.26.1.206; Protti Denis, 2007, Healthc Q, V10, P107; *RES TRIANGL I, 2004, SUDAAN LANG MAN REL; Schoen C, 2006, HEALTH AFFAIR, V25, pW555, DOI 10.1377/hlthaff.25.w555; Shekelle Paul G, 2006, Evid Rep Technol Assess (Full Rep), P1	17	714	720	1	97	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 3	2008	359	1					50	60		10.1056/NEJMsa0802005	http://dx.doi.org/10.1056/NEJMsa0802005			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	320PB	18565855				2022-12-28	WOS:000257246000007
J	Gluckman, PD; Hanson, MA; Cooper, C; Thornburg, KL				Gluckman, Peter D.; Hanson, Mark A.; Cooper, Cyrus; Thornburg, Kent L.			Effect of in utero and early-life conditions on adult health and disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							LOW-PROTEIN DIET; RENIN-ANGIOTENSIN SYSTEM; LOW-BIRTH-WEIGHT; BODY-MASS INDEX; GLUCOCORTICOID-RECEPTOR; DEVELOPMENTAL ORIGINS; EPIGENETIC MODIFICATION; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; METABOLIC SYNDROME		[Gluckman, Peter D.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Gluckman, Peter D.] Natl Res Ctr Growth & Dev, Auckland, New Zealand; [Hanson, Mark A.] Univ Southampton, Inst Dev Sci, Southampton, Hants, England; [Cooper, Cyrus] Univ Southampton, MRC, Epidemiol Resource Ctr, Southampton, Hants, England; [Thornburg, Kent L.] Oregon Hlth & Sci Univ, Heart Res Ctr, Portland, OR 97201 USA	University of Auckland; University of Auckland; University of Southampton; University of Southampton; Oregon Health & Science University	Gluckman, PD (corresponding author), Univ Auckland, Liggins Inst, Private Bag 92019, Auckland 1, New Zealand.	pd.gluckman@auckland.ac.nz	Hanson, Mark/AAE-8236-2019	Hanson, Mark/0000-0002-6907-613X; marengoni, alessandra/0000-0002-4851-1825; Cooper, Cyrus/0000-0003-3510-0709; Thornburg, Kent/0000-0002-5561-4785	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD034430] Funding Source: NIH RePORTER; Arthritis Research UK Funding Source: Medline; British Heart Foundation Funding Source: Medline; Medical Research Council Funding Source: Medline; NICHD NIH HHS [P01 HD34430, P01 HD034430-07, P01 HD034430, P01 HD034430-09, P01 HD034430-06, P01 HD034430-08, P01 HD034430-130003] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Arthritis Research UK(Versus Arthritis); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aberg A, 2001, EARLY HUM DEV, V61, P85, DOI 10.1016/S0378-3782(00)00125-0; Aerts L, 2006, INT J BIOCHEM CELL B, V38, P894, DOI 10.1016/j.biocel.2005.07.006; Antoniades L, 2003, RHEUMATOLOGY, V42, P791, DOI 10.1093/rheumatology/keg227; Barbera A, 2000, AM J PHYSIOL-REG I, V279, pR1157, DOI 10.1152/ajpregu.2000.279.4.R1157; Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; Barker DJP, 1998, CLIN SCI, V95, P115, DOI 10.1042/CS19980019; Barker DJP, 2001, BMJ-BRIT MED J, V323, P1273, DOI 10.1136/bmj.323.7324.1273; BARKER DJP, 1986, LANCET, V1, P1077; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Benyshek DC, 2006, AM J PHYS ANTHROPOL, V131, P120, DOI 10.1002/ajpa.20334; Bhargava SK, 2004, NEW ENGL J MED, V350, P865, DOI 10.1056/NEJMoa035698; Bloomfield FH, 2003, ENDOCRINOLOGY, V144, P2933, DOI 10.1210/en.2003-0189; Bogdarina I, 2007, CIRC RES, V100, P520, DOI 10.1161/01.RES.0000258855.60637.58; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Brawley L, 2003, PEDIATR RES, V54, P83, DOI 10.1203/01.PDR.0000065731.00639.02; Brealy S, 2006, SCI AM, V294, P98; Brook JS, 1999, PSYCHOL REP, V85, P227, DOI 10.2466/PR0.85.5.227-241; BURDGE GC, IN PRESS BR J NUTR; Burdge GC, 2007, BRIT J NUTR, V97, P435, DOI 10.1017/S0007114507352392; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Charalambous Marika, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P3, DOI 10.1097/MED.0b013e328013daa2; Chong SY, 2004, CURR OPIN GENET DEV, V14, P692, DOI 10.1016/j.gde.2004.09.001; Cleal JK, 2007, P NATL ACAD SCI USA, V104, P9529, DOI 10.1073/pnas.0610373104; Cooper C, 1997, ANN RHEUM DIS, V56, P17, DOI 10.1136/ard.56.1.17; Davis L, 2005, J PHYSIOL-LONDON, V565, P35, DOI 10.1113/jphysiol.2004.082388; Dennison EM, 2001, PAEDIATR PERINAT EP, V15, P211, DOI 10.1046/j.1365-3016.2001.00350.x; Desai M, 2003, J Matern Fetal Neonatal Med, V13, P197, DOI 10.1080/713605834; DIAMOND J, 1991, NAT HIST, P2; Doherty AS, 2000, BIOL REPROD, V62, P1526, DOI 10.1095/biolreprod62.6.1526; DOSSANTOS SI, 2004, BRIT J CANCER, V91, P519; Drake AJ, 2005, AM J PHYSIOL-REG I, V288, pR34, DOI 10.1152/ajpregu.00106.2004; Fernandez-Twinn DS, 2006, AM J PHYSIOL-REG I, V291, pR429, DOI 10.1152/ajpregu.00608.2005; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Francis D, 1999, SCIENCE, V286, P1155, DOI 10.1126/science.286.5442.1155; Frankel S, 1996, LANCET, V348, P1478, DOI 10.1016/S0140-6736(96)03482-4; Gale CR, 2006, ARTERIOSCL THROM VAS, V26, P1877, DOI 10.1161/01.ATV.0000228819.13039.b8; Gluckman PD, 2006, TRENDS ENDOCRIN MET, V17, P7, DOI 10.1016/j.tem.2005.11.006; Gluckman PD, 2005, TRENDS ECOL EVOL, V20, P527, DOI 10.1016/j.tree.2005.08.001; Gluckman PD, 2004, PEDIATR RES, V56, P311, DOI 10.1203/01.PDR.0000135998.08025.FB; Gluckman PD, 2005, P ROY SOC B-BIOL SCI, V272, P671, DOI 10.1098/rspb.2004.3001; Gluckman PD, 2007, P NATL ACAD SCI USA, V104, P12796, DOI 10.1073/pnas.0705667104; Gluckman Peter D, 2004, Semin Fetal Neonatal Med, V9, P419, DOI 10.1016/j.siny.2004.03.001; Godfrey K, 1996, BRIT MED J, V312, P410, DOI 10.1136/bmj.312.7028.410; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Harder T, 2005, AM J EPIDEMIOL, V162, P397, DOI 10.1093/aje/kwi222; Hattersley AT, 1999, LANCET, V353, P1789, DOI 10.1016/S0140-6736(98)07546-1; Hillier TA, 2007, DIABETES CARE, V30, P2287, DOI 10.2337/dc06-2361; Hofman PL, 2004, NEW ENGL J MED, V351, P2888; Hoppe CC, 2007, AM J PHYSIOL-REG I, V292, pR462, DOI 10.1152/ajpregu.00079.2006; Hovi P, 2007, NEW ENGL J MED, V356, P2053, DOI 10.1056/NEJMoa067187; Ibanez L, 2003, HUM REPROD, V18, P1565, DOI 10.1093/humrep/deg351; Jablonka E, 1995, PHILOS T R SOC B, V350, P133, DOI 10.1098/rstb.1995.0147; Jaquiery AL, 2006, J PHYSIOL-LONDON, V572, P109, DOI 10.1113/jphysiol.2006.105734; Javaid MK, 2002, BEST PRACT RES CL EN, V16, P349, DOI 10.1053/beem.2002.0199; Kaati G, 2002, EUR J HUM GENET, V10, P682, DOI 10.1038/sj.ejhg.5200859; Kapoor A, 2006, J PHYSIOL-LONDON, V572, P31, DOI 10.1113/jphysiol.2006.105254; Kensara OA, 2005, AM J CLIN NUTR, V82, P980; Kirkwood TBL, 2005, MECH AGEING DEV, V126, P1011, DOI 10.1016/j.mad.2005.03.021; Kuzawa CW, 2005, AM J HUM BIOL, V17, P5, DOI 10.1002/ajhb.20091; Kuzawa CW., 2008, EVOLUTION HLTH DIS, P253; Kwong WY, 2000, DEVELOPMENT, V127, P4195; Langley-Evans SC, 2000, INT J FOOD SCI NUTR, V51, P11, DOI 10.1080/096374800100859; Langley-Evans SC, 1999, LIFE SCI, V64, P965, DOI 10.1016/S0024-3205(99)00022-3; Levitt NS, 1996, NEUROENDOCRINOLOGY, V64, P412, DOI 10.1159/000127146; Li GH, 2003, J SOC GYNECOL INVEST, V10, P265, DOI 10.1016/S1071-5576(03)00074-1; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; Lillycrop KA, 2007, BRIT J NUTR, V97, P1064, DOI 10.1017/S000711450769196X; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Morton SMB, 2006, DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE, P98, DOI 10.1017/CBO9780511544699.009; Musha Y, 2006, PEDIATR RES, V59, P784, DOI 10.1203/01.pdr.0000219126.78372.c8; NEEL JV, 1962, AM J HUM GENET, V14, P353; Nyirenda MJ, 1998, J CLIN INVEST, V101, P2174, DOI 10.1172/JCI1567; OSMOND C, 1993, BRIT MED J, V307, P1519, DOI 10.1136/bmj.307.6918.1519; Ozanne SE, 2005, DIABETOLOGIA, V48, P547, DOI 10.1007/s00125-005-1669-7; Pham TD, 2003, AM J PHYSIOL-REG I, V285, pR962, DOI 10.1152/ajpregu.00201.2003; Quinlan J, 2007, J AM SOC NEPHROL, V18, P1915, DOI 10.1681/ASN.2006101107; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Reusens B, 2006, INT J BIOCHEM CELL B, V38, P913, DOI 10.1016/j.biocel.2005.10.012; RichEdwards JW, 1997, BRIT MED J, V315, P396, DOI 10.1136/bmj.315.7105.396; Robinson SM, 2004, EUR J CLIN NUTR, V58, P1174, DOI 10.1038/sj.ejcn.1601946; Sayer AA, 2001, GERONTOLOGY, V47, P9, DOI 10.1159/000052764; Seckl JR, 2004, ANN NY ACAD SCI, V1032, P63, DOI 10.1196/annals.1314.006; Sinclair KD, 2007, P NATL ACAD SCI USA, V104, P19351, DOI 10.1073/pnas.0707258104; Torrens C, 2003, J PHYSIOL-LONDON, V547, P77, DOI 10.1113/jphysiol.2002.026120; TREVATHAN WR, 1988, AM ANTHROPOL, V90, P674, DOI 10.1525/aa.1988.90.3.02a00100; Vehaskari VM, 2007, PEDIATR NEPHROL, V22, P490, DOI 10.1007/s00467-006-0353-6; Vehaskari VM, 2001, KIDNEY INT, V59, P238, DOI 10.1046/j.1523-1755.2001.00484.x; Vickers MH, 2005, ENDOCRINOLOGY, V146, P4211, DOI 10.1210/en.2005-0581; Vickers MH, 2000, AM J PHYSIOL-ENDOC M, V279, pE83; Vickers MH, 2003, AM J PHYSIOL-REG I, V285, pR271, DOI 10.1152/ajpregu.00051.2003; Watkins AJ, 2007, P NATL ACAD SCI USA, V104, P5449, DOI 10.1073/pnas.0610317104; Weaver ICG, 2006, P NATL ACAD SCI USA, V103, P3480, DOI 10.1073/pnas.0507526103; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Welberg LAM, 2001, NEUROSCIENCE, V104, P71, DOI 10.1016/S0306-4522(01)00065-3; Whincup PH, 2002, BRIT MED J, V324, P635, DOI 10.1136/bmj.324.7338.635; WHO, 2003, WHO TECH REP SER, V916, P1; Woods LL, 2005, AM J PHYSIOL-REG I, V289, pR1131, DOI 10.1152/ajpregu.00037.2003; Woods LL, 2001, PEDIATR RES, V49, P460, DOI 10.1203/00006450-200104000-00005; World Health Organization, 2006, PROM OPT FET DEV REP; Wyrwoll CS, 2006, ENDOCRINOLOGY, V147, P599, DOI 10.1210/en.2005-0748; Yajnik CS, 2008, DIABETOLOGIA, V51, P29, DOI 10.1007/s00125-007-0793-y; Yajnik CS, 2003, INT J OBESITY, V27, P173, DOI 10.1038/sj.ijo.802219; Zandi-Nejad K, 2006, HYPERTENSION, V47, P502, DOI 10.1161/01.HYP.0000198544.09909.1a; Zhang SL, 2007, PEDIATR NEPHROL, V22, P813, DOI 10.1007/s00467-007-0444-z	106	2503	2574	12	313	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 3	2008	359	1					61	73		10.1056/NEJMra0708473	http://dx.doi.org/10.1056/NEJMra0708473			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320PB	18596274	Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000257246000008
J	Bollinger, JM				Bollinger, J. Martin, Jr.			Biochemistry - Electron relay in proteins	SCIENCE			English	Editorial Material							COLI RIBONUCLEOTIDE REDUCTASE; RADICAL PROPAGATION; MUTAGENESIS; PATHWAY; R1		Penn State Univ, Dept Chem, University Pk, PA 16802 USA; Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Bollinger, JM (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.	jmb21@psu.edu	Bollinger, Joseph/C-1425-2016					BERATAN DN, 1991, SCIENCE, V252, P1285, DOI 10.1126/science.1656523; Ekberg M, 1996, J BIOL CHEM, V271, P20655, DOI 10.1074/jbc.271.34.20655; Ge J, 2003, BIOCHEMISTRY-US, V42, P10071, DOI 10.1021/bi034374r; Gray HB, 2003, Q REV BIOPHYS, V36, P341, DOI 10.1017/S0033583503003913; Gray HB, 2005, P NATL ACAD SCI USA, V102, P3534, DOI 10.1073/pnas.0408029102; MAO SS, 1992, BIOCHEMISTRY-US, V31, P9752, DOI 10.1021/bi00155a031; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Rova U, 1999, J BIOL CHEM, V274, P23746, DOI 10.1074/jbc.274.34.23746; ROVA U, 1995, BIOCHEMISTRY-US, V34, P4267, DOI 10.1021/bi00013a016; Seyedsayamdost MR, 2007, J AM CHEM SOC, V129, P15060, DOI 10.1021/ja076043y; Seyedsayamdost MR, 2007, J AM CHEM SOC, V129, P2226, DOI 10.1021/ja0685607; Seyedsayamdost MR, 2006, J AM CHEM SOC, V128, P1562, DOI 10.1021/ja055927j; Shih C, 2008, SCIENCE, V320, P1760, DOI 10.1126/science.1158241; Stubbe J, 2003, CHEM REV, V103, P2167, DOI 10.1021/cr020421u; UHLIN U, 1994, NATURE, V370, P533, DOI 10.1038/370533a0	15	37	38	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2008	320	5884					1730	1731		10.1126/science.1160001	http://dx.doi.org/10.1126/science.1160001			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318VP	18583602				2022-12-28	WOS:000257121200026
J	Laughlin, JD; Ha, TS; Jones, DNM; Smith, DP				Laughlin, John D.; Ha, Tal Soo; Jones, David N. M.; Smith, Dean P.			Activation of pheromone-sensitive neurons is mediated by conformational activation of pheromone-binding protein	CELL			English	Article							DROSOPHILA-MELANOGASTER; GYPSY-MOTH; LYMANTRIA-DISPAR; BOMBYX-MORI; ANTHERAEA-POLYPHEMUS; ODORANT RECEPTORS; OLFACTORY NEURONS; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; NMR STRUCTURE	Detection of volatile odorants by olfactory neurons is thought to result from direct activation of seven-transmembrane odorant receptors by odor molecules. Here, we show that detection of the Drosophila pheromone, 11-cis vaccenyl acetate (cVA), is instead mediated by pheromone-induced conformational shifts in the extracellular pheromone-binding protein, LUSH. We show that LUSH undergoes a pheromone-specific conformational change that triggers the firing of pheromone-sensitive neurons. Amino acid substitutions in LUSH that are predicted to reduce or enhance the conformational shift alter sensitivity to cVA as predicted in vivo. One substitution, LUSHD118A, produces a dominant-active LUSH protein that stimulates T1 neurons through the neuronal receptor components Or67d and SNMP in the complete absence of pheromone. Structural analysis of LUSHD118A reveals that it closely resembles cVA-bound LUSH. Therefore, the pheromone-binding protein is an inactive, extracellular ligand converted by pheromone molecules into an activator of pheromone-sensitive neurons and reveals a distinct paradigm for detection of odorants.	[Ha, Tal Soo; Smith, Dean P.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Ha, Tal Soo; Smith, Dean P.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Jones, David N. M.] Univ Colorado Denver, Program Biomol Struct, Aurora, CO 80045 USA; [Jones, David N. M.] Hlth Sci Ctr, Aurora, CO 80045 USA; [Laughlin, John D.; Jones, David N. M.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80045 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Smith, DP (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	dean.smith@utsouthwestern.edu	Jones, David N/C-5764-2013	Smith, Dean/0000-0002-4271-0436	Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [P30 CA046934] Funding Source: Medline; NIAAA NIH HHS [R01 AA013618] Funding Source: Medline; NIDCD NIH HHS [R01 DC002539, R01DC02539, R01 DC008834] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008834, R01DC002539] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Benton R, 2007, TRENDS NEUROSCI, V30, P512, DOI 10.1016/j.tins.2007.07.004; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; BRIEGER G, 1970, Science (Washington D C), V167, P1262, DOI 10.1126/science.167.3922.1262; Bucci BK, 2006, BIOCHEMISTRY-US, V45, P1693, DOI 10.1021/bi0516576; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; BUTTERWORTH FM, 1969, SCIENCE, V163, P1356, DOI 10.1126/science.163.3873.1356; Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; Clyne Peter, 1997, Invertebrate Neuroscience, V3, P127, DOI 10.1007/BF02480367; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; DeLano W.L, PYMOL MOL GRAPHICS S; Dickens JC, 1997, J CHEM ECOL, V23, P2197, DOI 10.1023/B:JOEC.0000006439.21448.53; Ebbs ML, 2007, PFLUG ARCH EUR J PHY, V454, P735, DOI 10.1007/s00424-007-0246-y; Ejima A, 2007, CURR BIOL, V17, P599, DOI 10.1016/j.cub.2007.01.053; Grant GG, 1996, NATURWISSENSCHAFTEN, V83, P328, DOI 10.1007/BF01152217; Grosse-Wilde E, 2007, EUR J NEUROSCI, V25, P2364, DOI 10.1111/j.1460-9568.2007.05512.x; Grosse-Wilde E, 2006, CHEM SENSES, V31, P547, DOI 10.1093/chemse/bjj059; Ha TS, 2006, J NEUROSCI, V26, P8727, DOI 10.1523/JNEUROSCI.0876-06.2006; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; Hallem EA, 2004, TRENDS GENET, V20, P453, DOI 10.1016/j.tig.2004.06.015; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hallem EA, 2004, NEURON, V42, P359, DOI 10.1016/S0896-6273(04)00256-9; HANSEN K, 1984, PHYSIOL ENTOMOL, V9, P9, DOI 10.1111/j.1365-3032.1984.tb00676.x; Honson N, 2003, CHEM SENSES, V28, P479, DOI 10.1093/chemse/28.6.479; Horst R, 2001, P NATL ACAD SCI USA, V98, P14374, DOI 10.1073/pnas.251532998; JIN X, 2008, P NATL ACAD IN PRESS; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAISSLIN.KE, 1970, NATURWISSENSCHAFTEN, V57, P23, DOI 10.1007/BF00593550; Kaissling K.-E., 1998, STRUCTURE INFORM SEN, P98; Kaissling KE, 1996, CHEM SENSES, V21, P257, DOI 10.1093/chemse/21.2.257; Kaissling KE, 2001, CHEM SENSES, V26, P125, DOI 10.1093/chemse/26.2.125; Kim MS, 1998, GENETICS, V150, P711; Kimoto H, 2005, NATURE, V437, P898, DOI 10.1038/nature04033; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Kruse SW, 2003, NAT STRUCT BIOL, V10, P694, DOI 10.1038/nsb960; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Lartigue A, 2004, J BIOL CHEM, V279, P4459, DOI 10.1074/jbc.M311212200; Lartigue A, 2003, J BIOL CHEM, V278, P30213, DOI 10.1074/jbc.M304688200; Leal WS, 2005, TOP CURR CHEM, V240, P1, DOI 10.1007/b98314; Lee D, 2002, FEBS LETT, V531, P314, DOI 10.1016/S0014-5793(02)03548-2; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Pophof B, 2004, CHEM SENSES, V29, P117, DOI 10.1093/chemse/bjh012; Pophof B, 2002, NATURWISSENSCHAFTEN, V89, P515, DOI 10.1007/s00114-002-0364-5; Rogers ME, 1997, J BIOL CHEM, V272, P14792, DOI 10.1074/jbc.272.23.14792; Sandler BH, 2000, CHEM BIOL, V7, P143, DOI 10.1016/S1074-5521(00)00078-8; Sherborne AL, 2007, CURR BIOL, V17, P2061, DOI 10.1016/j.cub.2007.10.041; Smith DP, 2007, PFLUG ARCH EUR J PHY, V454, P749, DOI 10.1007/s00424-006-0190-2; Thode AB, 2008, J MOL BIOL, V376, P1360, DOI 10.1016/j.jmb.2007.12.063; Tsodikov OV, 2002, J COMPUT CHEM, V23, P600, DOI 10.1002/jcc.10061; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; VANDERMEER RK, 1986, J INSECT PHYSIOL, V32, P681, DOI 10.1016/0022-1910(86)90109-5; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wojtasek H, 1999, J BIOL CHEM, V274, P30950, DOI 10.1074/jbc.274.43.30950; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Zhou JJ, 2004, FEBS LETT, V558, P23, DOI 10.1016/S0014-5793(03)01521-7	64	335	357	8	76	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 27	2008	133	7					1255	1265		10.1016/j.cell.2008.04.046	http://dx.doi.org/10.1016/j.cell.2008.04.046			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	319DP	18585358	Green Accepted, Bronze			2022-12-28	WOS:000257144600021
J	Vincent, JP				Vincent, Jean-Paul			Hedgehog nanopackages ready for dispatch	CELL			English	Editorial Material							MORPHOGEN GRADIENTS	Hedgehog proteins are intercellular long-range signaling molecules that spread within tissues and activate gene expression during development. Vyas et al. (2008) propose that Hedgehog forms nanometer-sized oligomers that localize in proteoglycan-rich clusters at the surface of cells expressing Hedgehog. This nanoscale organization and enrichment in clusters ensures that Hedgehog is able to spread and activate signaling over many cell diameters.	Natl Inst Med Res, MRC, London NW7 1AA, England	MRC National Institute for Medical Research	Vincent, JP (corresponding author), Natl Inst Med Res, MRC, London NW7 1AA, England.	jvincen@nimr.mrc.ac.uk			MRC [MC_U117584268] Funding Source: UKRI; Medical Research Council [MC_U117584268] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ashe HL, 2006, DEVELOPMENT, V133, P385, DOI 10.1242/dev.02238; Burke R, 1999, CELL, V99, P803, DOI 10.1016/S0092-8674(00)81677-3; Capurro MI, 2008, DEV CELL, V14, P700, DOI 10.1016/j.devcel.2008.03.006; Eaton S, 2008, NAT REV MOL CELL BIO, V9, P437, DOI 10.1038/nrm2414; Gallet A, 2008, DEV CELL, V14, P712, DOI 10.1016/j.devcel.2008.03.001; Guerrero I, 2007, TRENDS CELL BIOL, V17, P1, DOI 10.1016/j.tcb.2006.11.002; Mann RK, 2004, ANNU REV BIOCHEM, V73, P891, DOI 10.1146/annurev.biochem.73.011303.073933; Saha K, 2006, DEVELOPMENT, V133, P889, DOI 10.1242/dev.02254; Takei Y, 2004, DEVELOPMENT, V131, P73, DOI 10.1242/dev.00913	9	1	1	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 27	2008	133	7					1139	1141		10.1016/j.cell.2008.06.011	http://dx.doi.org/10.1016/j.cell.2008.06.011			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	319DP	18585347	Bronze			2022-12-28	WOS:000257144600010
J	Marinova, MM; Aharonson, O; Asphaug, E				Marinova, Margarita M.; Aharonson, Oded; Asphaug, Erik			Mega-impact formation of the Mars hemispheric dichotomy	NATURE			English	Article							CRUSTAL DICHOTOMY; GIANT IMPACT; ORIGIN; TOPOGRAPHY; EVOLUTION; MANTLE; MODEL; MOON	The Mars hemispheric dichotomy is expressed as a dramatic difference in elevation, crustal thickness and crater density between the southern highlands and northern lowlands ( which cover similar to 42% of the surface)(1,2). Despite the prominence of the dichotomy, its origin has remained enigmatic and models for its formation largely untested(3-5). Endogenic degree-1 convection models with north - south asymmetry are incomplete in that they are restricted to simulating only mantle dynamics and they neglect crustal evolution, whereas exogenic multiple impact events are statistically unlikely to concentrate in one hemisphere(6). A single mega-impact of the requisite size has not previously been modelled. However, it has been hypothesized that such an event could obliterate the evidence of its occurrence by completely covering the surface with melt(7) or catastrophically disrupting the planet(3,8). Here we present a set of single- impact initial conditions by which a large impactor can produce features consistent with the observed dichotomy's crustal structure and persistence. Using three- dimensional hydrodynamic simulations, large variations are predicted in post- impact states depending on impact energy, velocity and, importantly, impact angle, with trends more pronounced or unseen in commonly studied smaller impacts(9). For impact energies of similar to(3-6) x 10(29) J, at low impact velocities (6-10 km s(-1)) and oblique impact angles ( 30 - 60 degrees), the resulting crustal removal boundary is similar in size and ellipticity to the observed characteristics of the lowlands basin. Under these conditions, the melt distribution is largely contained within the area of impact and thus does not erase the evidence of the impact's occurrence. The antiquity of the dichotomy(10) is consistent with the contemporaneous presence of impactors of diameter 1,600 - 2,700 km in Mars- crossing orbits(3), and the impact angle is consistent with the expected distribution(11).	[Marinova, Margarita M.; Aharonson, Oded] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Asphaug, Erik] Univ Calif Santa Cruz, Dept Earth Sci, Santa Cruz, CA 95064 USA	California Institute of Technology; University of California System; University of California Santa Cruz	Marinova, MM (corresponding author), CALTECH, Div Geol & Planetary Sci, MC 150-21, Pasadena, CA 91125 USA.	mmm@caltech.edu	Asphaug, Erik/AAC-9455-2020	Aharonson, Oded/0000-0001-9930-2495				Aharonson O, 2001, J GEOPHYS RES-PLANET, V106, P23723, DOI 10.1029/2000JE001403; ANDERSON DL, 1995, MINERAL PHYS CRYSTAL, P64; ASIMOW PD, 2007, GOLDSCHM C ABSTR; BENZ W, 1986, ICARUS, V66, P515, DOI 10.1016/0019-1035(86)90088-6; BENZ W, 1990, P NATO ADV RES WORKS, P1; Bertka CM, 1998, EARTH PLANET SC LETT, V157, P79, DOI 10.1016/S0012-821X(98)00030-2; Canup RM, 2001, NATURE, V412, P708, DOI 10.1038/35089010; CANUP RM, 2000, ORIGIN EARTH MOON, P113; Cintala MJ, 1998, METEORIT PLANET SCI, V33, P889, DOI 10.1111/j.1945-5100.1998.tb01695.x; FREY H, 1988, GEOPHYS RES LETT, V15, P229, DOI 10.1029/GL015i003p00229; Frey HV, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013832; GAULT DE, 1978, T AM GEOPHYS UNION, V59, P1121; Gilbert G. K., 1893, B PHILOS SOC WASHING, V12, P241; HART SH, 2007, P 7 INT C MARS; HASHIMOTO A, 1983, GEOCHEM J, V17, P111, DOI 10.2343/geochemj.17.111; HAUCK SA, 2002, J GEOPHYS RES, V107; KLEIN C, 2002, MANUAL MINERAL SCI, P491; MCGILL GE, 1991, ICARUS, V93, P386, DOI 10.1016/0019-1035(91)90221-E; Melosh H.J., 1989, OXFORD MONOGRAPHS GE; Nimmo F, 2005, ANNU REV EARTH PL SC, V33, P133, DOI 10.1146/annurev.earth.33.092203.122637; Sanloup C, 1999, PHYS EARTH PLANET IN, V112, P43, DOI 10.1016/S0031-9201(98)00175-7; Shoemaker EM, 1962, PHYS ASTRONOMY MOON, P283, DOI 10.1016/C2013-0-12487-7; Smith DE, 1999, SCIENCE, V284, P1495, DOI 10.1126/science.284.5419.1495; Solomon SC, 2005, SCIENCE, V307, P1214, DOI 10.1126/science.1101812; Tillotson J.H., 1962, GA3216; WILHELMS DE, 1984, NATURE, V309, P138, DOI 10.1038/309138a0; Yoder CF, 2003, SCIENCE, V300, P299, DOI 10.1126/science.1079645; Zhong SJ, 2001, EARTH PLANET SC LETT, V189, P75, DOI 10.1016/S0012-821X(01)00345-4; Zuber MT, 2001, NATURE, V412, P220, DOI 10.1038/35084163	29	171	172	2	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2008	453	7199					1216	1219		10.1038/nature07070	http://dx.doi.org/10.1038/nature07070			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318FA	18580945				2022-12-28	WOS:000257075800037
J	Nath, I				Nath, Indira			Christopher Curtis (1939-2008) - Obituary	NATURE			English	Biographical-Item									LEPRA Blue Peter Res Ctr, Hyderabad 501301, Andhra Pradesh, India		Nath, I (corresponding author), LEPRA Blue Peter Res Ctr, Hyderabad 501301, Andhra Pradesh, India.	indiranath@bprcleprasociety.org						CURTIS C, PUBLICATION LIST	1	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 19	2008	453	7198					1002	1002		10.1038/4531002a	http://dx.doi.org/10.1038/4531002a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314WM	18563148	Bronze			2022-12-28	WOS:000256839900039
J	Gong, Y; Cao, P; Yu, HJ; Jiang, T				Gong, Yong; Cao, Peng; Yu, Hong-jun; Jiang, Tao			Crystal structure of the neurotrophin-3 and p75(NTR) symmetrical complex	NATURE			English	Article							NERVE GROWTH-FACTOR; RECEPTORS; BINDING; ACTIVATION; TRKA; P75	Neurotrophins (NTs) are important regulators for the survival, differentiation and maintenance of different peripheral and central neurons. NTs bind to two distinct classes of glycosylated receptor: the p75 neurotrophin receptor (p75(NTR)) and tyrosine kinase receptors (Trks). Whereas p75(NTR) binds to all NTs, the Trk subtypes are specific for each NT1,2. The question of whether NTs stimulate p75(NTR) by inducing receptor homodimerization is still under debate. Here we report the 2.6-angstrom resolution crystal structure of neurotrophin-3 (NT-3) complexed to the ectodomain of glycosylated p75(NTR). In contrast to the previously reported asymmetric complex structure, which contains a dimer of nerve growth factor (NGF) bound to a single ectodomain of deglycosylated p75(NTR) (ref. 3), we show that NT-3 forms a central homodimer around which two glycosylated p75(NTR) molecules bind symmetrically. Symmetrical binding occurs along the NT-3 interfaces, resulting in a 2:2 ligand-receptor cluster. A comparison of the symmetrical and asymmetric structures reveals significant differences in ligand receptor interactions and p75(NTR) conformations. Biochemical experiments indicate that both NT-3 and NGF bind to p75(NTR) with 2:2 stoichiometry in solution, whereas the 2:1 complexes are the result of artificial deglycosylation. We therefore propose that the symmetrical 2:2 complex reflects a native state of p75(NTR) activation at the cell surface. These results provide a model for NTs-p75(NTR) recognition and signal generation, as well as insights into coordination between p75(NTR) and Trks.	[Gong, Yong; Cao, Peng; Yu, Hong-jun; Jiang, Tao] Chinese Acad Sci, Natl Key Lab Biomacromol, Inst Biophys, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS	Jiang, T (corresponding author), Chinese Acad Sci, Natl Key Lab Biomacromol, Inst Biophys, 15 Datun Rd, Beijing 100101, Peoples R China.	tjiang@ibp.ac.cn		, Peng/0000-0002-2044-3074; Yu, Hongjun/0000-0002-1483-2962				[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Aurikko JP, 2005, J BIOL CHEM, V280, P33453, DOI 10.1074/jbc.M503189200; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; BARIBAULT TJ, 1985, J NEUROSCI RES, V14, P49, DOI 10.1002/jnr.490140105; Barker PA, 2007, NEURON, V53, P1, DOI 10.1016/j.neuron.2006.12.018; BOTHWELL M, 1995, ANNU REV NEUROSCI, V18, P223, DOI 10.1146/annurev.neuro.18.1.223; Butte MJ, 1998, BIOCHEMISTRY-US, V37, P16846, DOI 10.1021/bi981254o; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; He XL, 2004, SCIENCE, V304, P870, DOI 10.1126/science.1095190; He XL, 2001, SCIENCE, V293, P1657, DOI 10.1126/science.1062246; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; McInnes C, 1997, BIOPOLYMERS, V43, P339, DOI 10.1002/(SICI)1097-0282(1997)43:5<339::AID-BIP2>3.0.CO;2-W; Mongkolsapaya J, 1999, NAT STRUCT BIOL, V6, P1048; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nykjaer A, 2005, CURR OPIN NEUROBIOL, V15, P49, DOI 10.1016/j.conb.2005.01.004; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; RODRIGUEZTEBAR A, 1992, EMBO J, V11, P917, DOI 10.1002/j.1460-2075.1992.tb05130.x; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schweigreiter R, 2006, BIOESSAYS, V28, P583, DOI 10.1002/bies.20419; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wehrman T, 2007, NEURON, V53, P25, DOI 10.1016/j.neuron.2006.09.034; Wiesmann C, 1999, NATURE, V401, P184, DOI 10.1038/43705	28	91	97	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2008	454	7205					789	U114		10.1038/nature07089	http://dx.doi.org/10.1038/nature07089			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334NH	18596692				2022-12-28	WOS:000258228000050
J	Ferguson, CB; Mahsud-Dornan, S; Patterson, RN				Ferguson, Charles B.; Mahsud-Dornan, Samina; Patterson, R. Neil			Pregnancy plus - Inflammatory bowel disease in pregnancy	BMJ-BRITISH MEDICAL JOURNAL			English	Article							POUCH-ANAL ANASTOMOSIS; CROHNS-DISEASE; ULCERATIVE-COLITIS; INCREASED RISK; WOMEN; FERTILITY; ILEAL; EPIDEMIOLOGY; METAANALYSIS; DELIVERY		[Ferguson, Charles B.; Mahsud-Dornan, Samina] Royal Hosp, Belfast BT12 6BA, Antrim, North Ireland; [Patterson, R. Neil] Antrim Area Hosp, Antrim BT41 2RL, Antrim, North Ireland		Ferguson, CB (corresponding author), Royal Hosp, Belfast BT12 6BA, Antrim, North Ireland.	charlieferguson@doctors.org.uk						BAIRD DD, 1990, GASTROENTEROLOGY, V99, P987, DOI 10.1016/0016-5085(90)90617-A; Binder V, 2004, BEST PRACT RES CL GA, V18, P463, DOI [10.1016/j.bpg.2003.12.002, 10.1016/j.bpg.2003.13.002]; Cappell MS, 1996, DIGEST DIS SCI, V41, P2353, DOI 10.1007/BF02100127; Caprilli R, 2006, GUT, V55, DOI 10.1136/gut.2005.081950c; Castiglione F, 1996, ITAL J GASTROENTEROL, V28, P199; Cornish J, 2007, GUT, V56, P830, DOI 10.1136/gut.2006.108324; Cosnes J, 1996, GASTROENTEROLOGY, V110, P424, DOI 10.1053/gast.1996.v110.pm8566589; Elbaz G, 2005, INT J GYNECOL OBSTET, V90, P193, DOI 10.1016/j.ijgo.2005.06.003; Hudson M, 1997, INT J GYNECOL OBSTET, V58, P229, DOI 10.1016/S0020-7292(97)00088-X; Ilnyckyj A, 1999, AM J GASTROENTEROL, V94, P3274, DOI 10.1111/j.1572-0241.1999.01537.x; Kane S, 2005, AM J GASTROENTEROL, V100, P102, DOI 10.1111/j.1572-0241.2005.40785.x; KHOSLA R, 1984, GUT, V25, P52, DOI 10.1136/gut.25.1.52; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Mahadevan U, 2007, GASTROENTEROLOGY, V133, P1106, DOI 10.1053/j.gastro.2007.07.019; MAYBERRY JF, 1986, GUT, V27, P821, DOI 10.1136/gut.27.7.821; NWOKOLO CU, 1994, GUT, V35, P220, DOI 10.1136/gut.35.2.220; Rigas A, 1993, Ann Epidemiol, V3, P387, DOI 10.1016/1047-2797(93)90066-D; Riis L, 2006, AM J GASTROENTEROL, V101, P1539, DOI 10.1111/j.1572-0241.2006.00602.x; Tiainen J, 1999, SCAND J GASTROENTERO, V34, P185; Waljee A, 2006, GUT, V55, P1575, DOI 10.1136/gut.2005.090316; WILLOUGHBY CP, 1980, GUT, V21, P469, DOI 10.1136/gut.21.6.469; WOOLFSON K, 1990, DIS COLON RECTUM, V33, P869, DOI 10.1007/BF02051924	22	23	23	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 19	2008	337	7662							a427	10.1136/bmj.39566.681458.BE	http://dx.doi.org/10.1136/bmj.39566.681458.BE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	330SB	18599468	Green Published			2022-12-28	WOS:000257962000044
J	Atwood, G				Atwood, Greg			Engineering - Phase-change materials for systems. electronic memories	SCIENCE			English	Editorial Material									[Atwood, Greg] Numonyx BV, R&D Technol Dev, Santa Clara, CA 95054 USA		Atwood, G (corresponding author), Numonyx BV, R&D Technol Dev, 2200 Miss Coll Blvd, Santa Clara, CA 95054 USA.	greg.atwood@numonyx.com						ATWOOD G, 2005, DEV RES C 20 22 JUN; Bedeschi F., 2008, INT SOL STAT CIRC C; Kolobov AV, 2004, NAT MATER, V3, P703, DOI 10.1038/nmat1215; PELLIZZER F, 2006, S VLSI TECHN 24 26 A	4	133	134	6	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 11	2008	321	5886					210	211		10.1126/science.1160231	http://dx.doi.org/10.1126/science.1160231			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	324IS	18621659				2022-12-28	WOS:000257512900027
J	Viteau, M; Chotia, A; Allegrini, M; Bouloufa, N; Dulieu, O; Comparat, D; Pillet, P				Viteau, Matthieu; Chotia, Amodsen; Allegrini, Maria; Bouloufa, Nadia; Dulieu, Olivier; Comparat, Daniel; Pillet, Pierre			Optical pumping and vibrational cooling of molecules	SCIENCE			English	Article							FREE POLARIZATION SPECTROSCOPY; STATE; PHOTOASSOCIATION; CS-2; CS2	The methods producing cold molecules from cold atoms tend to leave molecular ensembles with substantial residual internal energy. For instance, cesium molecules initially formed via photoassociation of cold cesium atoms are in several vibrational levels nu of the electronic ground state. We applied a broadband femtosecond laser that redistributes the vibrational population in the ground state via a few electronic excitation/ spontaneous emission cycles. The laser pulses are shaped to remove the excitation frequency band of the nu = 0 level, preventing re- excitation from that state. We observed a fast and efficient accumulation (similar to 70% of the initially detected molecules) in the lowest vibrational level, nu = 0, of the singlet electronic state. The validity of this incoherent depopulation pumping method is very general and opens exciting prospects for laser cooling and manipulation of molecules.	[Viteau, Matthieu; Chotia, Amodsen; Allegrini, Maria; Bouloufa, Nadia; Dulieu, Olivier; Comparat, Daniel; Pillet, Pierre] Ctr Univ Paris Sud, Aime Cotton Lab, CNRS, F-91405 Orsay, France; [Allegrini, Maria] Univ Pisa, Dipartimento Fis, Consorzio Nazl Interuniv Sci Fisiche Mat, I-56127 Pisa, Italy	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Pisa	Pillet, P (corresponding author), Ctr Univ Paris Sud, Aime Cotton Lab, CNRS, Batiment 505, F-91405 Orsay, France.	pierre.pillet@lac.u-psud.fr	Comparat, Daniel/AAX-8685-2020; Chotia, Amodsen/A-8340-2014	Chotia, Amodsen/0000-0003-3527-9569; Comparat, Daniel/0000-0001-5884-2882				Bahns JT, 1996, J CHEM PHYS, V104, P9689, DOI 10.1063/1.471731; BARTANA A, 1999, CHEM PHYS, V99, P196; Bethlem HL, 1999, PHYS REV LETT, V83, P1558, DOI 10.1103/PhysRevLett.83.1558; DIEMER U, 1989, CHEM PHYS LETT, V164, P419, DOI 10.1016/0009-2614(89)85231-5; Dion CM, 2001, PHYS REV LETT, V86, P2253, DOI 10.1103/PhysRevLett.86.2253; Doyle J, 2004, EUR PHYS J D, V31, P149, DOI 10.1140/epjd/e2004-00151-x; Dulieu O, 2006, J PHYS B-AT MOL OPT, V39, DOI 10.1088/0953-4075/39/19/E01; Elioff MS, 2003, SCIENCE, V302, P1940, DOI 10.1126/science.1090679; Felinto D, 2003, OPT COMMUN, V215, P69, DOI 10.1016/S0030-4018(02)02230-7; Fioretti A, 1998, PHYS REV LETT, V80, P4402, DOI 10.1103/PhysRevLett.80.4402; Gupta M, 1999, J PHYS CHEM A, V103, P10670, DOI 10.1021/jp993560x; Jochim S, 2003, SCIENCE, V302, P2101, DOI 10.1126/science.1093280; Krems RV, 2005, INT REV PHYS CHEM, V24, P99, DOI 10.1080/01442350500167161; Morigi G, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.073001; Nikolov AN, 1999, PHYS REV LETT, V82, P703, DOI 10.1103/PhysRevLett.82.703; RAAB M, 1982, J CHEM PHYS, V76, P4370, DOI 10.1063/1.443571; Rangwala SA, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.043406; Sage JM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.203001; SCHIRMER SG, 2000, PHYS REV A, V63, P2302; Tannor DJ, 1999, FARADAY DISCUSS, V113, P365, DOI 10.1039/a902103e; Theis M, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.123001; Vogelius IS, 2004, J PHYS B-AT MOL OPT, V37, P4571, DOI 10.1088/0953-4075/37/22/015; Vogelius IS, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.173003; WEICKENMEIER W, 1985, J CHEM PHYS, V82, P5354, DOI 10.1063/1.448618; Weinstein JD, 1998, NATURE, V395, P148, DOI 10.1038/25949; Winkler K, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.043201	26	229	230	0	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 11	2008	321	5886					232	234		10.1126/science.1159496	http://dx.doi.org/10.1126/science.1159496			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	324IS	18621665	Green Submitted			2022-12-28	WOS:000257512900035
J	Murchie, SL; Watters, TR; Robinson, MS; Head, JW; Strom, RG; Chapman, CR; Solomon, SC; McClintock, WE; Prockter, LM; Domingue, DL; Blewett, DT				Murchie, Scott L.; Watters, Thomas R.; Robinson, Mark S.; Head, James W.; Strom, Robert G.; Chapman, Clark R.; Solomon, Sean C.; McClintock, William E.; Prockter, Louise M.; Domingue, Deborah L.; Blewett, David T.			Geology of the Caloris basin, Mercury: A view from MESSENGER	SCIENCE			English	Article							LUNAR; VOLCANISM	The Caloris basin, the youngest known large impact basin on Mercury, is revealed in MESSENGER images to be modified by volcanism and deformation in a manner distinct from that of lunar impact basins. The morphology and spatial distribution of basin materials themselves closely match lunar counterparts. Evidence for a volcanic origin of the basin's interior plains includes embayed craters on the basin floor and diffuse deposits surrounding rimless depressions interpreted to be of pyroclastic origin. Unlike lunar maria, the volcanic plains in Caloris are higher in albedo than surrounding basin materials and lack spectral evidence for ferrous iron- bearing silicates. Tectonic landforms, contractional wrinkle ridges and extensional troughs, have distributions and age relations different from their counterparts in and around lunar basins, indicating a different stress history.	[Murchie, Scott L.; Prockter, Louise M.; Domingue, Deborah L.; Blewett, David T.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Watters, Thomas R.] Smithsonian Inst, Natl Air & Space Museum, Ctr Earth & Planetary Studies, Washington, DC 20015 USA; [Robinson, Mark S.] Arizona State Univ, Dept Geol Sci, Tempe, AZ 85251 USA; [Head, James W.] Brown Univ, Dept Geol Sci, Providence, RI 02906 USA; [Strom, Robert G.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Chapman, Clark R.] SW Res Inst, Boulder, CO 80302 USA; [Solomon, Sean C.] Carnegie Inst Washington, Dept Terr Magnetism, Washington, DC USA; [McClintock, William E.] Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80303 USA	Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Smithsonian Institution; Arizona State University; Arizona State University-Tempe; Brown University; University of Arizona; Carnegie Institution for Science; University of Colorado System; University of Colorado Boulder	Murchie, SL (corresponding author), Johns Hopkins Univ, Appl Phys Lab, Johns Hopkins Rd, Laurel, MD 20723 USA.		Robinson, Mark/ABI-6841-2020; Murchie, Scott L/E-8030-2015; Blewett, David T/I-4904-2012	Murchie, Scott L/0000-0002-1616-8751; Blewett, David T/0000-0002-9241-6358				ADAMS JB, 1974, P LUNAR PLANET SCI C, V5, P171; BOYCE JM, 1976, P LUNAR PLANET SCI C, V7, P2717; CINTALA MJ, 1992, J GEOPHYS RES-PLANET, V97, P947, DOI 10.1029/91JE02207; GOLOMBEK MP, 1979, J GEOPHYS RES, V84, P4657, DOI 10.1029/JB084iB09p04657; GUEST JE, 1983, USGS MISCELLANEOUS I; Harmon JK, 2007, ICARUS, V187, P374, DOI 10.1016/j.icarus.2006.09.026; Hawkins SE, 2007, SPACE SCI REV, V131, P247, DOI 10.1007/sl11214-007-9266-3; Head JW, 2008, SCIENCE, V321, P69, DOI 10.1126/science.1159256; Head JW, 2007, SPACE SCI REV, V131, P41, DOI 10.1007/s11214-007-9263-6; HEAD JW, 1980, MOON PLANETS, V22, P235, DOI 10.1007/BF00898434; KENNEDY PJ, 2008, IN PRESS J GEOPHYS R; LUCCHITTA BK, 1978, P LUNAR PLANET SCI C, V9, P3459; MCCAULEY JF, 1977, PHYS EARTH PLANET IN, V15, P220, DOI 10.1016/0031-9201(77)90033-4; Melosh H.J., 1988, TECTONICS MERCURY, P374; Melosh H.J., 1978, LUNAR PLANETARY SCI, V9, P3513; Pieters C., 1993, REMOTE GEOCHEMICAL A, P309; Robinson MS, 2008, SCIENCE, V321, P66, DOI 10.1126/science.1160080; SOLOMON SC, 1980, REV GEOPHYS, V18, P107, DOI 10.1029/RG018i001p00107; Solomon SC, 2008, SCIENCE, V321, P59, DOI 10.1126/science.1159706; Spudis P.D., 1988, MERCURY, P118; STROM RG, 1975, J GEOPHYS RES, V80, P2478, DOI 10.1029/JB080i017p02478; Strom RG, 2008, SCIENCE, V321, P79, DOI 10.1126/science.1159317; TRASK NJ, 1976, ICARUS, V28, P559, DOI 10.1016/0019-1035(76)90129-9; Watters TR, 2005, GEOLOGY, V33, P669, DOI 10.1130/G21678.1; Watters TR, 2004, ICARUS, V171, P284, DOI 10.1016/j.icarus.2004.05.024; WATTERS TR, 1988, J GEOPHYS RES-SOLID, V93, P10236, DOI 10.1029/JB093iB09p10236; WILHELMS DE, 1976, ICARUS, V28, P551, DOI 10.1016/0019-1035(76)90128-7	27	117	121	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 4	2008	321	5885					73	76		10.1126/science.1159261	http://dx.doi.org/10.1126/science.1159261			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QE	18599772				2022-12-28	WOS:000257320800036
J	Tsukamoto, S; Kuma, A; Murakami, M; Kishi, C; Yamamoto, A; Mizushima, N				Tsukamoto, Satoshi; Kuma, Akiko; Murakami, Mirei; Kishi, Chieko; Yamamoto, Akitsugu; Mizushima, Noboru			Autophagy is essential for preimplantation development of mouse embryos	SCIENCE			English	Article							SELF-DIGESTION; CELLS; TRANSITION; MARKER; LC3; DEGRADATION; INHIBITION; OOCYTES; DISEASE; MICE	After fertilization, maternal proteins in oocytes are degraded and new proteins encoded by the zygotic genome are synthesized. We found that autophagy, a process for the degradation of cytoplasmic constituents in the lysosome, plays a critical role during this period. Autophagy was triggered by fertilization and up- regulated in early mouse embryos. Autophagy- defective oocytes derived from oocyte- specific Atg5 ( autophagy- related 5) knockout mice failed to develop beyond the four- and eight- cell stages if they were fertilized by Atg5- null sperm, but could develop if they were fertilized by wild- type sperm. Protein synthesis rates were reduced in the autophagy- null embryos. Thus, autophagic degradation within early embryos is essential for preimplantation development in mammals.	[Tsukamoto, Satoshi; Kuma, Akiko; Murakami, Mirei; Kishi, Chieko; Mizushima, Noboru] Tokyo Med & Dent Univ, Dept Physiol & Cell Biol, Bunkyo Ku, Tokyo 1138519, Japan; [Kuma, Akiko; Mizushima, Noboru] Japan Sci & Technol Agcy, SORST, Kawaguchi, Saitama 3320012, Japan; [Yamamoto, Akitsugu] Nagahama Inst Biosci & Technol, Dept Biosci, Nagahama 5260829, Japan	Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST)	Mizushima, N (corresponding author), Tokyo Med & Dent Univ, Dept Physiol & Cell Biol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	nmizu.phy2@tmd.ac.jp	Mizushima, Noboru/C-3635-2009	Mizushima, Noboru/0000-0002-6258-6444; Tsukamoto, Satoshi/0000-0001-7063-8825				BOSMIKICH A, 1995, MOL REPROD DEV, V41, P84, DOI 10.1002/mrd.1080410113; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; de Vries WN, 2000, GENESIS, V26, P110, DOI 10.1002/(SICI)1526-968X(200002)26:2<110::AID-GENE2>3.0.CO;2-8; DeRenzo C, 2004, TRENDS CELL BIOL, V14, P420, DOI 10.1016/j.tcb.2004.07.005; Eskelinen EL, 2002, TRAFFIC, V3, P878, DOI 10.1034/j.1600-0854.2002.31204.x; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hosokawa N, 2006, FEBS LETT, V580, P2623, DOI 10.1016/j.febslet.2006.04.008; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kuma A, 2007, AUTOPHAGY, V3, P323, DOI 10.4161/auto.4012; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; MERZ EA, 1981, J REPROD FERTIL, V61, P415, DOI 10.1530/jrf.0.0610415; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Schier AF, 2007, SCIENCE, V316, P406, DOI 10.1126/science.1140693; Shvets E, 2008, AUTOPHAGY, V4, P621, DOI 10.4161/auto.5939; Stitzel ML, 2007, SCIENCE, V316, P407, DOI 10.1126/science.1138236; Sun-Wada GH, 2000, DEV BIOL, V228, P315, DOI 10.1006/dbio.2000.9963; Tadros W, 2005, DEV DYNAM, V232, P593, DOI 10.1002/dvdy.20297; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697	23	409	431	2	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2008	321	5885					117	120		10.1126/science.1154822	http://dx.doi.org/10.1126/science.1154822			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QE	18599786				2022-12-28	WOS:000257320800050
J	Decker, RB; Krimigis, SM; Roelof, EC; Hill, ME; Armstrong, TP; Gloeckler, G; Hamilton, DC; Lanzerotti, LJ				Decker, R. B.; Krimigis, S. M.; Roelof, E. C.; Hill, M. E.; Armstrong, T. P.; Gloeckler, G.; Hamilton, D. C.; Lanzerotti, L. J.			Mediation of the solar wind termination shock by non-thermal ions	NATURE			English	Article							INTERSTELLAR MAGNETIC-FIELD; VOYAGER-1; ACCELERATION	Broad regions on both sides of the solar wind termination shock are populated by high intensities of non- thermal ions and electrons. The pre- shock particles in the solar wind have been measured by the spacecraft Voyager 1 ( refs 1 - 5) and Voyager 2 ( refs 3, 6). The post- shock particles in the heliosheath have also been measured by Voyager 1 ( refs 3 - 5). It was not clear, however, what effect these particles might have on the physics of the shock transition until Voyager 2 crossed the shock on 31 August - 1 September 2007 ( refs 7 - 9). Unlike Voyager 1, Voyager 2 is making plasma measurements(7). Data from the plasma(7) and magnetic field(8) instruments on Voyager 2 indicate that non- thermal ion distributions probably have key roles in mediating dynamical processes at the termination shock and in the heliosheath. Here we report that intensities of low- energy ions measured by Voyager 2 produce non- thermal partial ion pressures in the heliosheath that are comparable to ( or exceed) both the thermal plasma pressures and the scalar magnetic field pressures. We conclude that these ions are the >0.028 MeV portion of the non- thermal ion distribution that determines the termination shock structure(8) and the acceleration of which extracts a large fraction of bulk- flow kinetic energy from the incident solar wind(7).	[Decker, R. B.; Krimigis, S. M.; Roelof, E. C.; Hill, M. E.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Krimigis, S. M.] Acad Athens, Athens 11527, Greece; [Armstrong, T. P.] Fundamental Technol, Lawrence, KS 66046 USA; [Gloeckler, G.] Univ Michigan, Ann Arbor, MI 48109 USA; [Hamilton, D. C.] Univ Maryland, College Pk, MD 20742 USA; [Lanzerotti, L. J.] New Jersey Inst Technol, Newark, NJ 07102 USA; [Lanzerotti, L. J.] Alcatel Lucent, Murray Hill, NJ 07974 USA	Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Academy of Athens; University of Michigan System; University of Michigan; University System of Maryland; University of Maryland College Park; New Jersey Institute of Technology; Alcatel-Lucent	Decker, RB (corresponding author), Johns Hopkins Univ, Appl Phys Lab, Johns Hopkins Rd, Laurel, MD 20723 USA.	robert.decker@jhuapl.edu	Krimigis, Stamatios/G-4591-2019; Hill, Matthew/H-4312-2016; Roelof, Edmond/G-6654-2019	Krimigis, Stamatios/0000-0003-2781-2386; Hill, Matthew/0000-0002-5674-4936; Roelof, Edmond/0000-0002-2270-0652; Hamilton, Douglas/0000-0001-6103-8019				Burlaga LF, 2005, SCIENCE, V309, P2027, DOI 10.1126/science.1117542; Decker RB, 2006, AIP CONF PROC, V858, P73; Decker RB, 2005, SCIENCE, V309, P2020, DOI 10.1126/science.1117569; Fisk LA, 2006, ASTROPHYS J, V644, P631, DOI 10.1086/503535; Giacalone J, 2006, ASTROPHYS J, V649, pL137, DOI 10.1086/508463; Gurnett DA, 2005, SCIENCE, V309, P2025, DOI 10.1126/science.1117425; JOKIPII JR, 2007, EOS, V88; Krimigis SM, 2003, NATURE, V426, P45, DOI 10.1038/nature02068; KRIMIGIS SM, 1977, SPACE SCI REV, V21, P329, DOI 10.1007/BF00211545; KRIMIGIS SM, 2005, CONNECTING SUN HELIS, P21; Le Roux JA, 2007, ASTROPHYS J, V662, P350, DOI 10.1086/517601; McDonald FB, 2003, NATURE, V426, P48, DOI 10.1038/nature02066; Opher M, 2006, ASTROPHYS J, V640, pL71, DOI 10.1086/503251; Pogorelov NV, 2007, ASTROPHYS J, V668, P611, DOI 10.1086/520952; Pogorelov NV, 2006, AIP CONF PROC, V858, P3; Richardson JD, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027983; Richardson JD, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2005JA011156; Stone EC, 2005, SCIENCE, V309, P2017, DOI 10.1126/science.1117684; Washimi H, 2007, ASTROPHYS J, V670, pL139, DOI 10.1086/524358	19	210	210	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2008	454	7200					67	70		10.1038/nature07030	http://dx.doi.org/10.1038/nature07030			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321MC	18596801	Green Published			2022-12-28	WOS:000257308300036
J	Hippisley-Cox, J; Coupland, C; Vinogradova, Y; Robson, J; Minhas, R; Sheikh, A; Brindle, P				Hippisley-Cox, Julia; Coupland, Carol; Vinogradova, Yana; Robson, John; Minhas, Rubin; Sheikh, Aziz; Brindle, Peter			Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; ETHNIC-DIFFERENCES; MISSING DATA; MULTIPLE IMPUTATION; SOCIAL INEQUALITIES; ATRIAL-FIBRILLATION; SOUTH ASIANS; FRAMINGHAM; MORTALITY; STROKE	Objective To develop and validate version two of the QRISK cardiovascular disease risk algorithm (QRISK2) to provide accurate estimates of cardiovascular risk in patients from different ethnic groups in England and Wales and to compare its performance with the modified Version of Framingham score recommended by the National Institute for Health and Clinical Excellence (NICE). Design Prospective open cohort study with routinely collected data from general practice, 1 January 1993 to 31 March 2008. Setting 531 practices in England and Wales contributing to the national QRESEARCH database. Participants 2.3 million patients aged 35-74 (over 16 million personyears) with 140 000 cardiovascular events. Overall population (derivation and validation cohorts) comprised 2.22 million people who were white or whose ethnic group was not recorded, 22 013 south Asian, 11595 black African, 10402 black Caribbean, and 19 792 from Chinese or other Asian or other ethnic groups. Main outcome measures First (incident) diagnosis of cardiovascular disease (coronary heart disease, stroke, and transient ischaemic attack) recorded in general practice records or linked Office for National Statistics death certificates. Risk factors included self assigned ethnicity, age, sex, smoking status, systolic blood pressure, ratio of total serum cholesterol:high density lipoprotein cholesterol, body mass index, family history of coronary heart disease in first degree relative under 60 years, Townsend deprivation score, treated hypertension, type 2 diabetes, renal disease, atrial fibrillation, and rheumatoid arthritis. Results The validation statistics indicated that QRISK2 had improved discrimination and calibration compared with the modified Framingham score. The QRISK2 algorithm explained 43% of the variation in women and 38% in men compared with 39% and 35%, respectively, by the modified Framingham score. Of the 112 156 patients classified as high risk (that is, >= 20% risk over 10 years) by the modified Framingham score, 46 094 (41.1%) would be reclassified at low risk With QRISK2. The 10 year observed risk among these reclassified patients was 16.6% (95% confidence interval 16.1% to 17.0%)-that is, below the 20% treatment threshold. Of the 78 024 patients classified at high risk on QRISK2, 11962 (15.3%) would be reclassified at low risk by the modified Framingham score. The 10 year observed risk among these patients was 23.3% (22.2% to 24.4%)-that is, above the 20% threshold. In the validation cohort, the annual incidence rate of cardiovascular events among those with a QRISK2 score of >= 20% was 30.6 per 1000 person years (29.8 to 31.5) for women and 32.5 per 1000 person years (31.9, to 33.1) for men. The corresponding figures for the modified Framingham equation were 25.7 per 1000 person years (25.0 to 26.3) for women and 26.4 (26.0 to 26.8) for men). At the 20% threshold, the population identified by QRISK2 was at higher risk of a CV event than the population identified by the Framingham score. Conclusions Incorporating ethnicity, deprivation, and other clinical conditions into the QRISK2 algorithm for risk of cardiovascular disease improves the accuracy of identification of those at high risk in a nationally representative population. At the 20% threshold, QRISK2 is likely to be a more efficient and equitable tool for treatment decisions for the primary prevention of cardiovascular disease. As the validation was performed in a similar population to the population from which the algorithm was derived, it potentially has a "home advantage." Further validation in other populations is therefore advised.	[Hippisley-Cox, Julia; Coupland, Carol; Vinogradova, Yana] Div Primary Care, Nottingham NG2 7RD, England; [Robson, John] Barts & London Queen Marys Sch Med & Dent, Hlth Sci Ctr, London E1 2AT, England; [Minhas, Rubin] Medway Primary Care Trust, Unit 2, Gillingham ME7 0NJ, Kent, England; [Sheikh, Aziz] Univ Edinburgh, Div Community Hlth Sci, GP Sect, Edinburgh EH8 9DX, Midlothian, Scotland; [Brindle, Peter] Bristol Primary Care Trust, Avon Primary Care Res Collaborat, Bristol BS2 8EE, Avon, England	University of London; Queen Mary University London; University of Edinburgh	Hippisley-Cox, J (corresponding author), Div Primary Care, Tower Bldg, Univ Pk, Nottingham NG2 7RD, England.	julia.hippisley-cox@nottingham.ac.uk	Hippisley-Cox, Julia/AAY-2788-2020; Robson, John/H-3904-2014; Sheikh, Aziz/D-2818-2009	Hippisley-Cox, Julia/0000-0002-2479-7283; Robson, John/0000-0001-6889-0415; Sheikh, Aziz/0000-0001-7022-3056; Vinogradova, Yana/0000-0002-3030-5257; Coupland, Carol/0000-0002-2327-3306				ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Bhopal R, 2000, J PUBLIC HEALTH MED, V22, P375, DOI 10.1093/pubmed/22.3.375; Bhopal R, 1999, BRIT MED J, V319, P215, DOI 10.1136/bmj.319.7204.215; Bhopal R, 2005, BRIT MED J, V331, P1096, DOI 10.1136/bmj.331.7525.1096; Bhopal R, 2005, J PUBLIC HEALTH-UK, V27, P93, DOI 10.1093/pubmed/fdh202; Brindle P, 2006, HEART, V92, P1595, DOI 10.1136/hrt.2006.092346; *BRIT HEART FDN, 2007, COR HEART DIS STAT; CAR J, 2008, IMPACT EHEALTH QUALI, P672; Chaturvedi N, 2003, HEART, V89, P681, DOI 10.1136/heart.89.6.681; Clark TG, 2003, J CLIN EPIDEMIOL, V56, P28, DOI 10.1016/S0895-4356(02)00539-5; Cooper RS, 2003, NEW ENGL J MED, V348, P1166, DOI 10.1056/NEJMsb022863; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; *DEP HLTH, 2008, PUTT PREV 1 VASC CHE, P15; *DEP HLTH, 2003, TACKL HLTH IN PROGR, P83; *DEP HLTH, 2005, PRACT GUID ETHN MON, P61; Gail MH, 2005, BIOSTATISTICS, V6, P227, DOI 10.1093/biostatistics/kxi005; GAINES K, 1995, NEUROEPIDEMIOLOGY, V14, P209, DOI 10.1159/000109798; Gill PS, 2005, BRIT MED J, V330, P196, DOI 10.1136/bmj.330.7484.196-a; GILL PS, 2008, IN PRESS HLTH CARE N; Graf E, 1999, STAT MED, V18, P2529; Gray A, 2002, BRIT MED J, V325, P860, DOI 10.1136/bmj.325.7369.860; GROUP TAM, 1989, BMJ-BRIT MED J, V298, P573; Hippisley-Cox J, 2008, HEART, V94, P34, DOI 10.1136/hrt.2007.134890; Hippisley- Cox J., 2005, COMP KEY PRACTICE CH; Hippisley-Cox J, 2007, BMJ-BRIT MED J, V335, P136, DOI 10.1136/bmj.39261.471806.55; Large P., 2006, POPULATION ESTIMATES; Maradit-Kremers H, 2005, ARTHRITIS RHEUM-US, V52, P402, DOI 10.1002/art.20853; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; Molokhia M, 2000, FAM PRACT, V17, P60, DOI 10.1093/fampra/17.1.60; Moons KGM, 2006, J CLIN EPIDEMIOL, V59, P1092, DOI 10.1016/j.jclinepi.2006.01.009; *NAT COLL CTR PRIM, 2008, SECT 4 3 GUID CARD R, P43; *NAT COLL CTR PRIM, 2007, CARD RISK ASS MOD BL, P216; National Institute for Health and Clinical Excellence, 2006, STAT PREV CARD EV PA; Nazroo James Y., 2001, Ethnicity and Disease, V11, P401; North of England Hypertension Guideline Development Group (UK), 2004, ESS HYP MAN AD PAT P; O'Flaherty M, 2008, HEART, V94, P178, DOI 10.1136/hrt.2007.118323; PATEL K, 2004, EPIDEMIC CORONARY HE, P164; Ramsay SE, 2008, J EPIDEMIOL COMMUN H, V62, P75, DOI 10.1136/jech.2006.053207; Ranganathan M, 2006, PLOS MED, V3, P329, DOI 10.1371/journal.pmed.0030044; Royston P, 2004, STAT MED, V23, P723, DOI 10.1002/sim.1621; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Royston P, 2005, STATA J, V5, P527, DOI 10.1177/1536867X0500500404; Royston P, 2006, STATA J, V6, P83, DOI 10.1177/1536867X0600600105; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; SAMAK MJ, 2003, CIRCULATION, V108, P2154; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Stevens RJ, 2001, CLIN SCI, V101, P671, DOI 10.1042/CS20000335; Stewart JA, 1999, BRIT MED J, V318, P967, DOI 10.1136/bmj.318.7189.967; Steyerberg EW, 2007, J CLIN EPIDEMIOL, V60, P979, DOI 10.1016/j.jclinepi.2007.03.003; Victora CG, 2000, LANCET, V356, P1093, DOI 10.1016/S0140-6736(00)02741-0; Wang TJ, 2003, CIRCULATION, V107, P2920, DOI 10.1161/01.CIR.0000072767.89944.6E; Ward Paul R, 2007, Int J Equity Health, V6, P2, DOI 10.1186/1475-9276-6-2; Weakliem DL, 1999, SOCIOL METHOD RES, V27, P359, DOI 10.1177/0049124199027003002; Whitty CJM, 1999, ATHEROSCLEROSIS, V142, P279, DOI 10.1016/S0021-9150(98)00239-1; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Woodward M, 2007, HEART, V93, P172, DOI 10.1136/hrt.2006.108167; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zaman J, 2008, HEART, V94, P406, DOI 10.1136/hrt.2007.127480	59	924	946	1	72	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 28	2008	336	7659					1475	+		10.1136/bmj.39609.449676.25	http://dx.doi.org/10.1136/bmj.39609.449676.25			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	324GN	18573856	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000257505900035
J	Ooi, SKT; Bestor, TH				Ooi, Steen K. T.; Bestor, Timothy H.			The colorful history of active DNA demethylation	CELL			English	Review							METHYLATION; GLYCOSYLASE; EXTRACTS; PROMOTER; PROTEIN; REPAIR; MBD2	Patterns of DNA cytosine methylation are subject to mitotic inheritance in both plants and vertebrates. Plants use 5-methylcytosine glycosylases and the base excision repair pathway to remove excess cytosine methylation. In mammals, active demethylation has been proposed to operate via several very different mechanisms. Two recent reports in Nature now claim that the demethylation process is initiated by the same enzymes that establish the methylation mark, the DNA methyltransferases DNMT3A and DNMT3B (Kangaspeska et al., 2008; Metivier et al., 2008).	[Ooi, Steen K. T.; Bestor, Timothy H.] Columbia Univ, Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA	Columbia University	Bestor, TH (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA.	thb12@columbia.edu		Ooi, Steen/0000-0003-4198-9014				Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Bhattacharya SK, 1999, NATURE, V397, P579, DOI 10.1038/17533; Cortazar D, 2007, DNA REPAIR, V6, P489, DOI 10.1016/j.dnarep.2006.10.013; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; GJERSET RA, 1982, J BIOL CHEM, V257, P8581; Hendrich B, 2001, GENE DEV, V15, P710, DOI 10.1101/gad.194101; Jin SG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000013; JOST JP, 1993, P NATL ACAD SCI USA, V90, P4684, DOI 10.1073/pnas.90.10.4684; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Lin IG, 2000, MOL CELL BIOL, V20, P2343, DOI 10.1128/MCB.20.7.2343-2349.2000; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Ng HH, 1999, NAT GENET, V23, P58, DOI 10.1038/12659; Penterman J, 2007, PLANT PHYSIOL, V145, P1549, DOI 10.1104/pp.107.107730; SHEN JC, 1992, CELL, V71, P1073, DOI 10.1016/S0092-8674(05)80057-1; Swisher JFA, 1998, NUCLEIC ACIDS RES, V26, P5573, DOI 10.1093/nar/26.24.5573; Weiss A, 1996, CELL, V86, P709, DOI 10.1016/S0092-8674(00)80146-4; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5; Zhu JK, 2008, CELL, V133, P395, DOI 10.1016/j.cell.2008.04.016	19	402	424	3	67	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 27	2008	133	7					1145	1148		10.1016/j.cell.2008.06.009	http://dx.doi.org/10.1016/j.cell.2008.06.009			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	319DP	18585349	Bronze			2022-12-28	WOS:000257144600012
J	van der Togt, R; van Lieshout, EJ; Hensbroek, R; Beinat, E; Binnekade, JM; Bakker, PJM				van der Togt, Remko; van Lieshout, Erik Jan; Hensbroek, Reinout; Beinat, E.; Binnekade, J. M.; Bakker, P. J. M.			Electromagnetic interference from radio frequency identification inducing potentially hazardous incidents in critical care medical equipment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLINICAL-EVALUATION; PHONE INTERFERENCE; PATIENT SAFETY; OPERATING-ROOM; TECHNOLOGY; SYSTEM	Context Health care applications of autoidentification technologies, such as radio frequency identification ( RFID), have been proposed to improve patient safety and also the tracking and tracing of medical equipment. However, electromagnetic interference ( EMI) by RFID on medical devices has never been reported. Objective To assess and classify incidents of EMI by RFID on critical care equipment. Design and Setting Without a patient being connected, EMI by 2 RFID systems ( active 125 kHz and passive 868 MHz) was assessed under controlled conditions during May 2006, in the proximity of 41 medical devices ( in 17 categories, 22 different manufacturers) at the Academic Medical Centre, University of Amsterdam, Amsterdam, the Netherlands. Assessment took place according to an international test protocol. Incidents of EMI were classified according to a critical care adverse events scale as hazardous, significant, or light. Results In 123 EMI tests ( 3 per medical device), RFID induced 34 EMI incidents: 22 were classified as hazardous, 2 as significant, and 10 as light. The passive 868- MHz RFID signal induced a higher number of incidents ( 26 incidents in 41 EMI tests; 63%) compared with the active 125- kHz RFID signal ( 8 incidents in 41 EMI tests; 20%); difference 44% ( 95% confidence interval, 27%- 53%; P <. 001). The passive 868- MHz RFID signal induced EMI in 26 medical devices, including 8 that were also affected by the active 125- kHz RFID signal ( 26 in 41 devices; 63%). The median distance between the RFID reader and the medical device in all EMI incidents was 30 cm ( range, 0.1- 600 cm). Conclusions In a controlled nonclinical setting, RFID induced potentially hazardous incidents in medical devices. Implementation of RFID in the critical care environment should require on- site EMI tests and updates of international standards.	[van Lieshout, Erik Jan; Binnekade, J. M.] Univ Amsterdam, Acad Med Ctr, Dept Intens Care, NL-1100 AZ Amsterdam, Netherlands; [van der Togt, Remko; Beinat, E.] Vrije Univ Amsterdam, Inst Environm Studies, Spatial Informat Lab, Amsterdam, Netherlands; [van Lieshout, Erik Jan; Binnekade, J. M.] Univ Amsterdam, Acad Med Ctr, Mobile Intens Care Unit, NL-1100 AZ Amsterdam, Netherlands; [Binnekade, J. M.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1100 AZ Amsterdam, Netherlands; [Bakker, P. J. M.] Univ Amsterdam, Acad Med Ctr, Dept Qual Assurance & Innovat, NL-1100 AZ Amsterdam, Netherlands; [Hensbroek, Reinout] TNO Netherlands Org Appl Sci Res, Leiden, Netherlands; [Beinat, E.] Salzburg Univ, Fac Sci, A-5020 Salzburg, Austria	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Netherlands Organization Applied Science Research; Salzburg University	van Lieshout, EJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Intens Care, Meibergdreef 9, NL-1100 AZ Amsterdam, Netherlands.	e.j.vanlieshout@amc.nl						Ashar BS, 2007, JAMA-J AM MED ASSOC, V298, P2305, DOI 10.1001/jama.298.19.2305; Chang A, 2005, INT J QUAL HEALTH C, V17, P95, DOI 10.1093/intqhc/mzi021; DAS R, 2006, IDT6752; Delvaux M, 2005, ENDOSCOPY, V37, P801, DOI 10.1055/s-2005-870241; Dempsey P, 2005, POWER ENGINEER, V19, P22, DOI 10.1049/pe:20050103; Dzik S, 2007, TRANSFUSION, V47, p125S, DOI 10.1111/j.1537-2995.2007.01367.x; Egan MT, 2007, SURG INNOV, V14, P41, DOI 10.1177/1553350606298971; *EUR TEL STAND I, 2008, ETSI WORLD CLASS STA; Gladman AS, 2007, CRIT CARE, V11, DOI 10.1186/cc6112; HARROP P, RFID HEALTHCARE PHAR; *I EL EL ENG, 1997, C6318 IEEE; *IDTECHEX, RFID HEALTHC RFID KN; *IDTECHEX, 2006, RFID FREQ BANDS DEF; Irnich W, 1996, PACE, V19, P1431, DOI 10.1111/j.1540-8159.1996.tb03155.x; Irnich W, 2002, PACE, V25, P1235, DOI 10.1046/j.1460-9592.2002.01235.x; Kabachinski Jeff, 2005, Biomed Instrum Technol, V39, P131; Kivlahan Coleen, 2002, Jt Comm J Qual Improv, V28, P583; Lawrentschuk N, 2004, MED J AUSTRALIA, V181, P145, DOI 10.5694/j.1326-5377.2004.tb06205.x; Macario A, 2006, ARCH SURG-CHICAGO, V141, P659, DOI 10.1001/archsurg.141.7.659; Marjamaa RA, 2006, ANESTH ANALG, V102, P1183, DOI 10.1213/01.ane.0000196527.96964.72; Nagy P, 2006, SURG INNOV, V13, P61, DOI 10.1177/155335060601300110; Reicher Joshua, 2007, J Clin Monit Comput, V21, P155, DOI 10.1007/s10877-007-9069-9; Rogers A, 2007, SURG ENDOSC, V21, P1235, DOI 10.1007/s00464-007-9308-7; Saito Y, 2007, STUD HEALTH TECHNOL, V129, P1478; Santucci PA, 1998, NEW ENGL J MED, V339, P1371, DOI 10.1056/NEJM199811053391905; Tan K S, 2000, Biomed Instrum Technol, V34, P115; TOMEK A, 2007, IMPLANTABLE RFID GLU; Tri JL, 2001, MAYO CLIN PROC, V76, P11, DOI 10.4065/76.1.11; *US FDA, 2002, DRAFT GUID IND FDA S; Van Lieshout EJ, 2007, CRIT CARE, V11, DOI 10.1186/cc6115; Wallin MKEB, 2005, ANESTH ANALG, V101, P1393, DOI 10.1213/01.ANE.0000180216.83554.00; Wicks Angela M, 2006, Hosp Top, V84, P3, DOI 10.3200/HTPS.84.3.3-9; Young D, 2006, AM J HEALTH-SYST PH, V63, P500, DOI 10.2146/news050060	33	146	151	0	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 25	2008	299	24					2884	2890		10.1001/jama.299.24.2884	http://dx.doi.org/10.1001/jama.299.24.2884			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	317LN	18577733	Bronze			2022-12-28	WOS:000257021800026
J	Bavry, AA; Bhatt, DL				Bavry, Anthony A.; Bhatt, Deepak L.			Appropriate use of drug-eluting stents: balancing the reduction in restenosis with the concern of bate thrombosis	LANCET			English	Review							PERCUTANEOUS CORONARY INTERVENTION; BARE-METAL STENTS; RANDOMIZED CLINICAL-TRIALS; DUAL ANTIPLATELET THERAPY; ANGIOGRAPHIC FOLLOW-UP; LONG-TERM OUTCOMES; MYOCARDIAL-INFARCTION; POOLED ANALYSIS; DIABETES-MELLITUS; WASHINGTON RADIATION	Restenosis is a serious occurrence that can lead not only to recurrent angina and repeat revascularisation but also to acute coronary syndromes. Drug-eluting stents revolutionised interventional cardiology owing to their pronounced ability to reduce restenosis compared with bare-metal stents. Attention has now shifted to safety of these devices because of evidence suggesting an association with late stent thrombosis. Findings of randomised clinical trials have not shown that drug-eluting stents result in excess mortality after 4-5 years of follow-up. Current recommendations are that individuals with a drug-eluting stent should receive at least 12 months of uninterrupted dual antiplatelet treatment; patients must understand the importance of this long-term regimen. Patients' assessment should focus on bleeding abnormalities, pre-existing disorders that need anticoagulation treatment, and possible future surgical procedures, since these factors could all contraindicate use of drug-eluting stents. Many people will do well with a bare-metal stent, whereas for individuals with a high likelihood of restenosis and late thrombosis, medical management or surgical revascularisation might be preferred options.	[Bavry, Anthony A.; Bhatt, Deepak L.] Cleveland Clin, Cardiovasc Coordinating Ctr, Dept Cardiovasc Med, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Bhatt, DL (corresponding author), Cleveland Clin, Cardiovasc Coordinating Ctr, Dept Cardiovasc Med, 9500 Euclid Ave,Desk F25, Cleveland, OH 44195 USA.	DLBHATTMD@alum.mit.edu						Airoldi F, 2007, CIRCULATION, V116, P745, DOI 10.1161/CIRCULATIONAHA.106.686048; Alderman E, 1997, CIRCULATION, V96, P1761, DOI 10.1161/01.CIR.96.6.1761; Artang R, 2007, AM J CARDIOL, V99, P1039, DOI 10.1016/j.amjcard.2006.12.025; Assali AR, 2006, AM J CARDIOL, V98, P729, DOI 10.1016/j.amjcard.2006.04.007; Bavry AA, 2005, AM J CARDIOL, V95, P1469, DOI 10.1016/j.amjcard.2005.02.015; Bavry AA, 2005, J AM COLL CARDIOL, V45, P941, DOI 10.1016/j.jacc.2004.11.064; Bavry AA, 2007, AM HEART J, V153, P719, DOI 10.1016/j.ahj.2007.02.017; Bavry AA, 2007, CIRCULATION, V116, P696, DOI 10.1161/CIRCULATIONAHA.107.719484; Bavry Anthony A, 2006, J Invasive Cardiol, V18, P403; Bavry AA, 2007, ANN INTERN MED, V146, P230, DOI 10.7326/0003-4819-146-3-200702060-00146; Bavry AA, 2006, AM J MED, V119, P1056, DOI 10.1016/j.amjmed.2006.01.023; Beohar N, 2007, JAMA-J AM MED ASSOC, V297, P1992, DOI 10.1001/jama.297.18.1992; Berger PB, 1999, CIRCULATION, V99, P248, DOI 10.1161/01.CIR.99.2.248; Bhatt DL, 2007, J AM COLL CARDIOL, V49, P1982, DOI 10.1016/j.jacc.2007.03.025; Bhatt DL, 2000, JAMA-J AM MED ASSOC, V284, P1549, DOI 10.1001/jama.284.12.1549; Biondi-Zoccai GGL, 2007, INT J CARDIOL, V114, P104, DOI 10.1016/j.ijcard.2005.11.019; Biondi-Zoccai GL, 2005, INT J CARDIOL, V100, P119, DOI 10.1016/j.ijcard.2004.11.001; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Briguori C, 2002, J AM COLL CARDIOL, V40, P403, DOI 10.1016/S0735-1097(02)01989-7; Buonamici P, 2007, J AM COLL CARDIOL, V49, P2312, DOI 10.1016/j.jacc.2007.01.094; Chen MS, 2006, AM HEART J, V151, P1260, DOI 10.1016/j.ahj.2005.08.011; Cook S, 2007, CIRCULATION, V115, P2426, DOI 10.1161/CIRCULATIONAHA.106.658237; Dacey LJ, 2000, ANN THORAC SURG, V70, P1986, DOI 10.1016/S0003-4975(00)02133-0; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; Dibra A, 2007, J AM COLL CARDIOL, V49, P616, DOI 10.1016/j.jacc.2006.10.049; DOVLE JT, 2007, J AM COLL CARDIOL, V49, P2223; Eisenstein EL, 2007, JAMA-J AM MED ASSOC, V297, P159, DOI 10.1001/jama.297.2.joc60179; Elezi S, 1998, J AM COLL CARDIOL, V32, P1866, DOI 10.1016/S0735-1097(98)00467-7; Ellis SG, 2004, CATHETER CARDIO INTE, V63, P135, DOI 10.1002/ccd.20132; Ellis SG, 2007, J AM COLL CARDIOL, V49, P1043, DOI 10.1016/j.jacc.2007.01.015; Fujii K, 2005, J AM COLL CARDIOL, V45, P995, DOI 10.1016/j.jacc.2004.12.066; Grines CL, 2007, J AM COLL CARDIOL, V49, P734, DOI 10.1016/j.jacc.2007.01.003; Heller LI, 2001, CATHETER CARDIO INTE, V53, P23, DOI 10.1002/ccd.1124; Helton TJ, 2007, AM J CARDIOVASC DRUG, V7, P289, DOI 10.2165/00129784-200707040-00006; Hochman JS, 2006, NEW ENGL J MED, V355, P2395, DOI 10.1056/NEJMoa066139; Hoffman SN, 2003, J AM COLL CARDIOL, V41, P1293, DOI 10.1016/S0735-1097(03)00157-8; Holmes DR, 2006, EUR HEART J, V27, P2815, DOI 10.1093/eurheartj/ehl385; Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126; Indolfi C, 2005, AM J CARDIOL, V95, P1146, DOI 10.1016/j.amjcard.2005.01.040; Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; Kaluza GL, 2000, J AM COLL CARDIOL, V35, P1288, DOI 10.1016/S0735-1097(00)00521-0; Kandzari David E, 2006, J Interv Cardiol, V19, P405, DOI 10.1111/j.1540-8183.2006.00184.x; Kandzari David E, 2006, J Invasive Cardiol, V18, P398; Kandzari DE, 2005, AM J CARDIOL, V96, P750, DOI 10.1016/j.amjcard.2005.05.015; Kastrati A, 2005, JAMA-J AM MED ASSOC, V294, P819, DOI 10.1001/jama.294.7.819; Kastrati A, 2001, CIRCULATION, V103, P2816; Kastrati A, 1997, J AM COLL CARDIOL, V30, P1428, DOI 10.1016/S0735-1097(97)00334-3; Kastrati A, 2007, NEW ENGL J MED, V356, P1030, DOI 10.1056/NEJMoa067484; Katritsis DG, 2005, AM J CARDIOL, V95, P640, DOI 10.1016/j.amjcard.2004.10.041; Kereiakes DJ, 2006, J AM COLL CARDIOL, V48, P21, DOI 10.1016/j.jacc.2006.02.058; Kittleson MM, 2005, CAN J CARDIOL, V21, P581; Kuchulakanti PK, 2006, CIRCULATION, V113, P1108, DOI 10.1161/CIRCULATIONAHA.105.600155; Lagerqvist B, 2007, NEW ENGL J MED, V356, P1009, DOI 10.1056/NEJMoa067722; Lasala John M, 2006, J Interv Cardiol, V19, P422, DOI 10.1111/j.1540-8183.2006.00183.x; Lee CW, 2007, CATHETER CARDIO INTE, V69, P821, DOI 10.1002/ccd.21019; Lord SJ, 2005, MED J AUSTRALIA, V183, P464, DOI 10.5694/j.1326-5377.2005.tb07124.x; Mathew V, 2004, CIRCULATION, V109, P476, DOI 10.1161/01.CIR.0000109693.64957.20; Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731; McFalls EO, 2004, NEW ENGL J MED, V351, P2795, DOI 10.1056/NEJMoa041905; Mintz GS, 2006, J AM COLL CARDIOL, V48, P421, DOI 10.1016/j.jacc.2006.04.068; Moreno R, 2005, J AM COLL CARDIOL, V45, P954, DOI 10.1016/j.jacc.2004.11.065; Nayak AK, 2006, CIRC J, V70, P1026, DOI 10.1253/circj.70.1026; Nordmann AJ, 2006, EUR HEART J, V27, P2784, DOI 10.1093/eurheartj/ehl282; Orford JL, 2004, AM HEART J, V147, P463, DOI 10.1016/j.ahj.2003.06.004; Pache J, 2005, EUR HEART J, V26, P1262, DOI 10.1093/eurheartj/ehi098; Park DW, 2006, AM J CARDIOL, V98, P352, DOI 10.1016/j.amjcard.2006.02.039; Pasceri V, 2007, AM HEART J, V153, P749, DOI 10.1016/j.ahj.2007.02.016; Pfisterer M, 2006, J AM COLL CARDIOL, V48, P2584, DOI 10.1016/j.jacc.2006.10.026; Poldermans D, 2007, J AM COLL CARDIOL, V49, P1763, DOI 10.1016/j.jacc.2006.11.052; Rabbat MG, 2007, CLEV CLIN J MED, V74, P129, DOI 10.3949/ccjm.74.2.129; Roiron C, 2006, HEART, V92, P641, DOI 10.1136/hrt.2005.061622; Schampaert E, 2006, AM J CARDIOL, V98, P36, DOI 10.1016/j.amjcard.2006.01.049; Schuhlen H, 2004, AM HEART J, V147, P317, DOI 10.1016/j.ahj.2003.10.002; Shafiq N, 2005, BRIT J CLIN PHARMACO, V59, P94, DOI 10.1111/j.1365-2125.2005.02258.x; Sidhu S, 2006, BRIT J CLIN PHARMACO, V61, P720, DOI 10.1111/j.1365-2125.2006.02614.x; Spaulding C, 2007, NEW ENGL J MED, V356, P989, DOI 10.1056/NEJMoa066633; Spertus JA, 2006, CIRCULATION, V113, P2803, DOI 10.1161/CIRCULATIONAHA.106.618066; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Stettler C, 2006, HEART, V92, P650, DOI 10.1136/hrt.2005.070698; Stettler C, 2007, LANCET, V370, P937, DOI 10.1016/S0140-6736(07)61444-5; Stone GW, 2007, CIRCULATION, V115, P2842, DOI 10.1161/CIRCULATIONAHA.106.687186; Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193; Togni M, 2005, J AM COLL CARDIOL, V46, P231, DOI 10.1016/j.jacc.2005.01.062; Tung R, 2006, ANN INTERN MED, V144, P913, DOI 10.7326/0003-4819-144-12-200606200-00009; Van Belle E, 2001, CIRCULATION, V103, P1218; Virmani R, 2004, CIRCULATION, V109, P701, DOI 10.1161/01.CIR.0000116202.41966.D4; Waksman R, 2001, CIRCULATION, V103, P2332; Waksman R, 2002, CIRCULATION, V106, P776, DOI 10.1161/01.CIR.0000028605.04359.FE; Wang FW, 2002, CATHETER CARDIO INTE, V55, P142, DOI 10.1002/ccd.10041; Win HK, 2007, JAMA-J AM MED ASSOC, V297, P2001, DOI 10.1001/jama.297.18.2001; Yang EH, 2005, J AM COLL CARDIOL, V46, P2004, DOI 10.1016/j.jacc.2005.06.083; Yock CA, 2006, CLIN CARDIOL, V29, P352, DOI 10.1002/clc.4960290807	93	99	104	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 21	2008	371	9630					2134	2143		10.1016/S0140-6736(08)60922-8	http://dx.doi.org/10.1016/S0140-6736(08)60922-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	316ER	18572082				2022-12-28	WOS:000256932200033
J	Roy, D; Talajic, M; Nattel, S; Wyse, DG; Dorian, P; Lee, KL; Bourassa, MG; Arnold, JMO; Buxton, AE; Camm, AJ; Connolly, SJ; Dubuc, M; Ducharme, A; Guerra, PG; Hohnloser, SH; Lambert, J; Le Heuzey, JY; O'Hara, G; Pedersen, OD; Rouleau, JL; Singh, BN; Stevenson, LW; Stevenson, WG; Thibault, B; Waldo, AL				Roy, Denis; Talajic, Mario; Nattel, Stanley; Wyse, D. George; Dorian, Paul; Lee, Kerry L.; Bourassa, Martial G.; Arnold, J. Malcolm O.; Buxton, Alfred E.; Camm, A. John; Connolly, Stuart J.; Dubuc, Marc; Ducharme, Anique; Guerra, Peter G.; Hohnloser, Stefan H.; Lambert, Jean; Le Heuzey, Jean-Yves; O'Hara, Gilles; Pedersen, Ole Dyg; Rouleau, Jean-Lucien; Singh, Bramah N.; Stevenson, Lynne Warner; Stevenson, William G.; Thibault, Bernard; Waldo, Albert L.		Atrial Fibrillation & Congestive H	Rhythm control versus rate control for atrial fibrillation and heart failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; VENTRICULAR SYSTOLIC DYSFUNCTION; ANTIARRHYTHMIC DRUG-THERAPY; SINUS RHYTHM; PROGNOSTIC-SIGNIFICANCE; RANDOMIZED-TRIAL; RISK; MORTALITY; MAINTENANCE; AMIODARONE	Background It is common practice to restore and maintain sinus rhythm in patients with atrial fibrillation and heart failure. This approach is based in part on data indicating that atrial fibrillation is a predictor of death in patients with heart failure and suggesting that the suppression of atrial fibrillation may favorably affect the outcome. However, the benefits and risks of this approach have not been adequately studied. Methods We conducted a multicenter, randomized trial comparing the maintenance of sinus rhythm (rhythm control) with control of the ventricular rate (rate control) in patients with a left ventricular ejection fraction of 35% or less, symptoms of congestive heart failure, and a history of atrial fibrillation. The primary outcome was the time to death from cardiovascular causes. Results A total of 1376 patients were enrolled (682 in the rhythm-control group and 694 in the rate-control group) and were followed for a mean of 37 months. Of these patients, 182 (27%) in the rhythm-control group died from cardiovascular causes, as compared with 175 (25%) in the rate-control group (hazard ratio in the rhythm-control group, 1.06; 95% confidence interval, 0.86 to 1.30; P=0.59 by the log-rank test). Secondary outcomes were similar in the two groups, including death from any cause (32% in the rhythm-control group and 33% in the rate-control group), stroke (3% and 4%, respectively), worsening heart failure (28% and 31%), and the composite of death from cardiovascular causes, stroke, or worsening heart failure (43% and 46%). There were also no significant differences favoring either strategy in any predefined subgroup. Conclusions In patients with atrial fibrillation and congestive heart failure, a routine strategy of rhythm control does not reduce the rate of death from cardiovascular causes, as compared with a rate-control strategy.	[Roy, Denis; Talajic, Mario; Nattel, Stanley; Bourassa, Martial G.; Dubuc, Marc; Ducharme, Anique; Guerra, Peter G.; Lambert, Jean; Rouleau, Jean-Lucien; Thibault, Bernard] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Roy, Denis; Talajic, Mario; Nattel, Stanley; Bourassa, Martial G.; Dubuc, Marc; Ducharme, Anique; Guerra, Peter G.; Lambert, Jean; Rouleau, Jean-Lucien; Thibault, Bernard] Univ Montreal, Montreal, PQ, Canada; [Wyse, D. George] Libin Cardiovasc Inst, Calgary, AB, Canada; [Dorian, Paul] St Michaels Hosp, Toronto, ON M5B 1W8, Canada; [Lee, Kerry L.] Duke Univ, Med Ctr, Durham, NC USA; [Arnold, J. Malcolm O.] London Hlth Sci Ctr, London, ON, Canada; [Buxton, Alfred E.] Rhode Isl Hosp, Lifespan Acad Ctr, Providence, RI USA; [Camm, A. John] Univ London St Georges Hosp, Med Ctr, London, England; [Connolly, Stuart J.] Populat Hlth Res Inst, Hamilton, ON, Canada; [Hohnloser, Stefan H.] Goethe Univ Frankfurt, Frankfurt, Germany; [Le Heuzey, Jean-Yves] Hop Europeen Georges Pompidou, Paris, France; [O'Hara, Gilles] Inst Cardiol Quebec, Quebec City, PQ, Canada; [Pedersen, Ole Dyg] Bispebjerg Hosp, Copenhagen, Denmark; [Singh, Bramah N.] W Los Angeles Vet Affairs Med Ctr, Los Angeles, CA 90073 USA; [Stevenson, Lynne Warner; Stevenson, William G.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Waldo, Albert L.] Case Western Reserve Univ Hosp, Med Ctr, Cleveland, OH 44106 USA	Universite de Montreal; Universite de Montreal; Libin Cardiovascular Institute Of Alberta; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Duke University; London Health Sciences Centre; Lifespan Health Rhode Island; Rhode Island Hospital; St Georges University London; Population Health Research Institute; Goethe University Frankfurt; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Laval University; University of Copenhagen; Bispebjerg Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; West Los Angeles VA Medical Center; Harvard University; Brigham & Women's Hospital; Case Western Reserve University; Case Western Reserve University Hospital	Roy, D (corresponding author), Montreal Heart Inst, 5000 Belanger St, Montreal, PQ H1T 1C8, Canada.	d_roy@icm-mhi.com	Arnold, Malcolm/G-2869-2011; Ducharme, Anique/AAC-5946-2020	Ducharme, Anique/0000-0003-1681-9187; Raitt, Merritt/0000-0001-5638-7732; Nattel, Stanley/0000-0002-5565-3311; Bourassa, Martial G./0000-0002-4439-8650; Talajic, Mario/0000-0001-8469-4748; jourdain, patrick/0000-0002-5202-6902				Agner E, 2002, AM HEART J, V144, P597, DOI 10.1067/mhj.2002.125326; *AM HEART ASS, 2002, 2002 HEART STROK STA; Bardy GH, 2005, NEW ENGL J MED, V352, P2146; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; BOURASSA MG, 1993, J AM COLL CARDIOL, V22, pA14, DOI 10.1016/0735-1097(93)90456-B; Braunwald E, 1997, NEW ENGL J MED, V337, P1360, DOI 10.1056/NEJM199711063371906; Brignole M, 2002, EUR HEART J, V23, P892, DOI 10.1053/euhj.2001.2971; Carlsson J, 2003, J AM COLL CARDIOL, V41, P1690, DOI 10.1016/S0735-1097(03)00332-2; CARSON PE, 1993, CIRCULATION, V87, P102; COPLEN SE, 1991, CIRCULATION, V83, P714; COPLEN SE, 1990, CIRCULATION, V82, P1106, DOI 10.1161/01.CIR.82.4.1106; Deedwania PC, 1998, CIRCULATION, V98, P2574, DOI 10.1161/01.CIR.98.23.2574; DOVAL HC, 1994, LANCET, V344, P493, DOI 10.1016/S0140-6736(94)91895-3; Dries DL, 1998, J AM COLL CARDIOL, V32, P695, DOI 10.1016/S0735-1097(98)00297-6; Ehrlich JR, 2002, J CARDIOVASC ELECTR, V13, P399, DOI 10.1046/j.1540-8167.2002.00399.x; FEINBERG WM, 1995, ARCH INTERN MED, V155, P469, DOI 10.1001/archinte.155.5.469; FLAKER GC, 1992, J AM COLL CARDIOL, V20, P527, DOI 10.1016/0735-1097(92)90003-6; Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292; Gronefeld Gerian C, 2003, J Cardiovasc Pharmacol Ther, V8, P107, DOI 10.1177/107424840300800203; Hogg K, 2004, J AM COLL CARDIOL, V43, P317, DOI 10.1016/j.jacc.2003.07.046; Hohnloser SH, 2000, LANCET, V356, P1789, DOI 10.1016/S0140-6736(00)03230-X; Hsu LF, 2004, NEW ENGL J MED, V351, P2373, DOI 10.1056/NEJMoa041018; Hynes BJ, 2003, CURR OPIN CARDIOL, V18, P32, DOI 10.1097/00001573-200301000-00005; Lehto M, 2005, EUR HEART J, V26, P350, DOI 10.1093/eurheartj/ehi064; Maisel WH, 2003, AM J CARDIOL, V91, p2D, DOI 10.1016/S0002-9149(02)03373-8; Mathew J, 2000, CHEST, V118, P914, DOI 10.1378/chest.118.4.914; MIDDLEKAUFF HR, 1991, CIRCULATION, V84, P40, DOI 10.1161/01.CIR.84.1.40; Moser DK, 2002, CIRCULATION, V105, P2810, DOI 10.1161/01.CIR.0000021745.45349.BB; Naccarelli GV, 2003, J CARDIOVASC ELECTR, V14, pS281, DOI 10.1046/j.1540-8167.2003.90404.x; Nohria A, 2002, JAMA-J AM MED ASSOC, V287, P628, DOI 10.1001/jama.287.5.628; Olsson LG, 2006, J AM COLL CARDIOL, V47, P1997, DOI 10.1016/j.jacc.2006.01.060; Opolski G, 2004, CHEST, V126, P476, DOI 10.1378/chest.126.2.476; Stevenson WG, 1997, J AM COLL CARDIOL, V30, P1902; Stevenson WG, 1996, J AM COLL CARDIOL, V28, P1458, DOI 10.1016/S0735-1097(96)00358-0; Stulak JM, 2006, ANN THORAC SURG, V82, P494, DOI 10.1016/j.athoracsur.2006.03.075; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; Van Gelder IC, 2002, NEW ENGL J MED, V347, P1834, DOI 10.1056/NEJMoa021375; Wang TJ, 2003, CIRCULATION, V107, P2920, DOI 10.1161/01.CIR.0000072767.89944.6E; Wyse DG, 2003, J CARDIOVASC ELECTR, V14, pS35, DOI 10.1046/j.1540-8167.14.s9.17.x; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328; Zareba W, 2006, HEART RHYTHM, V3, P631, DOI 10.1016/j.hrthm.2006.02.012; Zipes DP, 2006, J AM COLL CARDIOL, V48, P1064, DOI DOI 10.1016/J.JACC.2006.07.008	43	1056	1113	1	46	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 19	2008	358	25					2667	2677		10.1056/NEJMoa0708789	http://dx.doi.org/10.1056/NEJMoa0708789			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	314NC	18565859				2022-12-28	WOS:000256815100003
J	Feldman, BM; Rider, LG; Reed, AM; Pachman, LM				Feldman, Brian M.; Rider, Lisa G.; Reed, Ann M.; Pachman, Lauren M.			Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood	LANCET			English	Review							NECROSIS-FACTOR-ALPHA; BONE-MINERAL DENSITY; INTERNATIONAL CONSENSUS; CLINICAL CHARACTERISTICS; AMYOPATHIC DERMATOMYOSITIS; INTRAVENOUS IMMUNOGLOBULIN; MACROPHAGIC MYOFASCIITIS; CHRONIC POLYMYOSITIS; NATIONAL-INSTITUTE; RHEUMATIC-DISEASES	Juvenile dermatomyositis, the most common inflammatory myopathy of childhood, is a rare systemic autoimmune vasculopathy that is characterised by weakness in proximal muscles and pathognomonic skin rashes. The length of time before the initiation of treatment affects presenting symptoms, laboratory measures, and pathophysiology. It also affects disease outcomes, including the development of pathological calcifications, which are associated with increased morbidity. Both genetic and environmental risk factors seem to have a role in the cause of juvenile dermatomyositis; HLA B8-DRB1*0301 ancestral haplotype is a strong immunogenetic risk factor, and antecedent infections and birth seasonality suggest that environmental stimuli might increase risk. Activation of dendritic cells with upregulation of genes induced by type-1 interferon (alpha) in muscle and peripheral blood seems to be central to disease pathogenesis. Treatment often includes combinations of corticosteroids, methotrexate, and other immunosuppressive agents. Disease outcome, if treatment is initiated early, is generally good. Randomised controlled trials are needed to define the most effective treatments.	[Feldman, Brian M.] Univ Toronto, Hosp Sick Children, Div Rheumatol, Dept Pediat, Toronto, ON M5G 1X8, Canada; [Feldman, Brian M.] Univ Toronto, Hosp Sick Children, Div Rheumatol, Dept Hlth Policy Management & Evaulat, Toronto, ON M5G 1X8, Canada; [Feldman, Brian M.] Univ Toronto, Hosp Sick Children, Div Rheumatol, Dept Publ Hlth Sci, Toronto, ON M5G 1X8, Canada; [Rider, Lisa G.] NIEHS, Environm Autoimmun Grp, Off Clin Res, NIH,Dept Hlth & Human Serv, Bethesda, MD USA; [Reed, Ann M.] Mayo Clin, Dept Med, Div Rheumatol, Mayo Coll Med, Rochester, MN USA; [Reed, Ann M.] Mayo Clin, Dept Pediat, Div Rheumatol, Mayo Coll Med, Rochester, MN USA; [Pachman, Lauren M.] Northwestern Univ, Feinberg Sch Med, Childrens Mem Hosp, Dept Pediat,Div Rheumatol, Chicago, IL 60611 USA; [Pachman, Lauren M.] Childrens Mem Res Ctr, Mol & Cellular Pathobiol Program, Chicago, IL USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Mayo Clinic; Mayo Clinic; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine	Feldman, BM (corresponding author), Univ Toronto, Hosp Sick Children, Div Rheumatol, Dept Pediat, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	brian.feldman@sickkids.ca	Feldman, Brian M/A-8586-2011; Pachman, Lauren/AAZ-6061-2021; Rider, Lisa G/C-7083-2018	Pachman, Lauren/0000-0001-8117-574X; Rider, Lisa G/0000-0002-6912-2458	Intramural NIH HHS Funding Source: Medline; NIAMS NIH HHS [R01 AR48289] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048289] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Al-Mayouf S, 2000, CLIN RHEUMATOL, V19, P138, DOI 10.1007/s100670050032; Al-Mayouf SM, 2000, J RHEUMATOL, V27, P2498; Alexanderson H, 2007, ARTHRIT RHEUM-ARTHR, V57, P768, DOI 10.1002/art.22780; Alsufyani KA, 2005, J RHEUMATOL, V32, P729; Artlett CM, 2000, LANCET, V356, P2155, DOI 10.1016/S0140-6736(00)03499-1; Baechler EC, 2007, MOL MED, V13, P59, DOI 10.2119/2006-00085.Baechler; BANKER BQ, 1966, MEDICINE, V45, P261, DOI 10.1097/00005792-196607000-00001; BLANE CE, 1984, AM J ROENTGENOL, V142, P397, DOI 10.2214/ajr.142.2.397; BOHAN A, 1975, NEW ENGL J MED, V292, P403, DOI 10.1056/NEJM197502202920807; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; BOWLES NE, 1987, LANCET, V1, P1004; BOWYER SL, 1983, J PEDIATR-US, V103, P882, DOI 10.1016/S0022-3476(83)80706-9; BRAUNSTEIN EM, 1980, BRIT J RADIOL, V53, P1011, DOI 10.1259/0007-1285-53-634-1011; Brown VE, 2006, RHEUMATOLOGY, V45, P990, DOI 10.1093/rheumatology/kel025; BUNCH TW, 1981, ARTHRITIS RHEUM, V24, P45, DOI 10.1002/art.1780240107; Caproni M, 2004, BRIT J DERMATOL, V151, P784, DOI 10.1111/j.1365-2133.2004.06144.x; CHALMERS A, 1982, CAN MED ASSOC J, V126, P31; Chinoy H, 2007, ANN RHEUM DIS, V66, P1345, DOI 10.1136/ard.2006.068502; Christen-Zaech S, 2008, ARTHRITIS RHEUM, V58, P571, DOI 10.1002/art.23299; CHRISTENSEN ML, 1986, ARTHRITIS RHEUM, V29, P1365, DOI 10.1002/art.1780291109; Compeyrot-Lacassagne S, 2005, PEDIATR CLIN N AM, V52, P493, DOI 10.1016/j.pcl.2005.01.004; Constantin T, 2006, AUTOIMMUNITY, V39, P223, DOI 10.1080/08916930600622819; Cooper GS, 1999, ENVIRON HEALTH PERSP, V107, P693, DOI 10.2307/3434329; Cooper MA, 2007, ARTHRITIS RHEUM, V56, P3107, DOI 10.1002/art.22856; CROWE WE, 1982, ARTHRITIS RHEUM, V25, P126, DOI 10.1002/art.1780250203; Dalakas MC, 2003, LANCET, V362, P971, DOI 10.1016/S0140-6736(03)14368-1; DALAKAS MC, 1993, NEW ENGL J MED, V329, P1993, DOI 10.1056/NEJM199312303292704; Danko K, 2004, MEDICINE, V83, P35, DOI 10.1097/01.md.0000109755.65914.5e; de Padilla CML, 2007, ARTHRITIS RHEUM, V56, P1658, DOI 10.1002/art.22558; Dolezalova P, 2003, ANN RHEUM DIS, V62, P444, DOI 10.1136/ard.62.5.444; Dorph C, 2006, ANN RHEUM DIS, V65, P1565, DOI 10.1136/ard.2005.051086; Edge JC, 2006, ARCH DERMATOL, V142, P65, DOI 10.1001/archderm.142.1.65; el-Azhary RA, 2002, J AM ACAD DERMATOL, V46, P560, DOI 10.1067/mjd.2002.120620; Englund P, 2002, ARTHRITIS RHEUM, V46, P1044, DOI 10.1002/art.10140; Feldman BM, 1996, J RHEUMATOL, V23, P1502; FISCHER TJ, 1979, AM J DIS CHILD, V133, P386, DOI 10.1001/archpedi.1979.02130040040009; Gruis KL, 2006, CLIN NEUROPATHOL, V25, P172; HANISSIAN AS, 1982, J RHEUMATOL, V9, P390; HECKMATT J, 1989, LANCET, V1, P1063, DOI 10.1016/S0140-6736(89)92456-2; Hengstman GJD, 2003, EUR NEUROL, V50, P10, DOI 10.1159/000070852; HERNANDEZ RJ, 1993, AM J ROENTGENOL, V161, P359, DOI 10.2214/ajr.161.2.8333378; Hicks JE, 2002, ARTHRIT RHEUM-ARTHR, V47, P118, DOI 10.1002/art.10237; Hollar C B, 2004, J Dermatolog Treat, V15, P35; Huber Adam, 2005, Curr Rheumatol Rep, V7, P441, DOI 10.1007/s11926-005-0048-1; Huber AM, 2000, ARTHRITIS RHEUM, V43, P541, DOI 10.1002/1529-0131(200003)43:3<541::AID-ANR9>3.0.CO;2-T; Huemer C, 2001, J RHEUMATOL, V28, P610; Iannone F, 2006, J RHEUMATOL, V33, P1802; Ingegnoli F, 2005, CLIN EXP RHEUMATOL, V23, P905; Isenberg DA, 2004, RHEUMATOLOGY, V43, P49, DOI 10.1093/rheumatology/keg427; Kaji K, 2007, RHEUMATOLOGY, V46, P25, DOI 10.1093/rheumatology/kel161; Kimball AB, 2000, ARTHRITIS RHEUM, V43, P1866, DOI 10.1002/1529-0131(200008)43:8<1866::AID-ANR24>3.0.CO;2-6; Klein-Gitelman MS, 2000, ARTHRIT CARE RES, V13, P360, DOI 10.1002/1529-0131(200012)13:6<360::AID-ART5>3.0.CO;2-Q; Kobayashi S, 1997, ACTA PAEDIATR JAPON, V39, P257; KOCH MJ, 1976, AM J EPIDEMIOL, V104, P627, DOI 10.1093/oxfordjournals.aje.a112341; Krahn M, 2006, ANN NEUROL, V59, P905, DOI 10.1002/ana.20833; LANG BA, 1991, AM J MED, V91, P169, DOI 10.1016/0002-9343(91)90010-U; Levine TD, 2005, ARTHRITIS RHEUM, V52, P601, DOI 10.1002/art.20849; Li CKC, 2004, J RHEUMATOL, V31, P605; LOVE LA, 1991, MEDICINE, V70, P360, DOI 10.1097/00005792-199111000-00002; Maillard SM, 2005, ARTHRIT RHEUM-ARTHR, V53, P558, DOI 10.1002/art.21332; Maillard SM, 2004, RHEUMATOLOGY, V43, P603, DOI 10.1093/rheumatology/keh130; Mamyrova G, 2005, JAMA-J AM MED ASSOC, V294, P2170, DOI 10.1001/jama.294.17.2170; Mamyrova G, 2007, ARTHRIT RHEUM-ARTHR, V57, P881, DOI 10.1002/art.22782; Mamyrova G, 2006, ARTHRITIS RHEUM-US, V54, P3979, DOI 10.1002/art.22216; Nalda AM, 2006, MED CLIN-BARCELONA, V127, P697, DOI 10.1016/S0025-7753(06)72367-3; Massa M, 2002, ARTHRITIS RHEUM, V46, P3015, DOI 10.1002/art.10566; McCann LJ, 2007, RHEUMATOLOGY, V46, P1363, DOI 10.1093/rheumatology/kem131; McCann LJ, 2006, RHEUMATOLOGY, V45, P1255, DOI 10.1093/rheumatology/kel099; Mendez EP, 2003, ARTHRIT RHEUM-ARTHR, V49, P300, DOI 10.1002/art.11122; Miles L, 2007, ARTHRIT RHEUM-ARTHR, V57, P1183, DOI 10.1002/art.22993; Miller FW, 2001, RHEUMATOLOGY, V40, P1262, DOI 10.1093/rheumatology/40.11.1262; Miller J J 3rd, 1977, Arthritis Rheum, V20, P332; MILLER JJ, 1973, J PEDIATR-US, V83, P543, DOI 10.1016/S0022-3476(73)80212-4; MILLER LC, 1992, ARTHRITIS RHEUM, V35, P1143, DOI 10.1002/art.1780351006; Mitchell JP, 2001, J PEDIATR-US, V138, P942, DOI 10.1067/mpd.2001.113363; MOORE EC, 1992, ANN RHEUM DIS, V51, P378, DOI 10.1136/ard.51.3.378; Nagaraju K, 2005, ARTHRITIS RHEUM, V52, P1824, DOI 10.1002/art.21103; Neves FD, 2007, CLIN RHEUMATOL, V26, P105, DOI 10.1007/s10067-005-0109-x; Nirmalananthan N, 2004, CURR OPIN RHEUMATOL, V16, P684, DOI 10.1097/01.bor.0000143441.27065.bc; Noss EH, 2006, J RHEUMATOL, V33, P1021; O'Connor KA, 2006, CLIN IMMUNOL, V120, P319, DOI 10.1016/j.clim.2006.05.011; O'Hanlon TP, 2006, MEDICINE, V85, P111, DOI 10.1097/01.md.0000217525.82287.eb; ODDIS C, RITUXIMAB MYOSITIS R; Oddis CV, 2005, ARTHRITIS RHEUM, V52, P2607, DOI 10.1002/art.21291; OLSON NY, 1989, J RHEUMATOL, V16, P1545; Pachman LM, 2006, ARTHRITIS RHEUM-US, V54, P3345, DOI 10.1002/art.22158; Pachman Lauren M., 1994, Arthritis and Rheumatism, V37, pS429; Pachman LM, 1997, ARTHRITIS RHEUM, V40, P1526, DOI 10.1002/art.1780400822; Pachman LM, 1998, J RHEUMATOL, V25, P1198; Pachman LM, 2000, ARTHRITIS RHEUM, V43, P2368, DOI 10.1002/1529-0131(200010)43:10<2368::AID-ANR26>3.0.CO;2-8; PACHMAN LM, 1995, ARTHRITIS RHEUM, V38, P1513, DOI 10.1002/art.1780381019; Pachman LM, 2005, ARTHRIT RHEUM-ARTHR, V53, P166, DOI 10.1002/art.21068; PACHMAN LM, 1977, LANCET, V2, P1238; PACHMAN LM, 1995, PEDIATR CLIN N AM, V42, P1071; *PED RHEUM INT TRI, JUV DERM TRIAL; Pegoraro E, 1996, ANN NEUROL, V40, P782, DOI 10.1002/ana.410400515; PISTOIA V, 1993, CLIN EXP RHEUMATOL, V11, P203; Plamondon S, 2000, J RHEUMATOL, V27, P2031; Pope E, 2006, J AM ACAD DERMATOL, V55, P947, DOI 10.1016/j.jaad.2006.05.005; *PRINTO PAED RHEUM, INF PAED RHEUM DIS; Ramanan AV, 2005, ARTHRITIS RHEUM-US, V52, P3570, DOI 10.1002/art.21378; Ramanan AV, 2002, RHEUM DIS CLIN N AM, V28, P833, DOI 10.1016/S0889-857X(02)00024-8; REED AM, 1991, HUM IMMUNOL, V32, P235, DOI 10.1016/0198-8859(91)90085-N; Reed AM, 2004, J IMMUNOL, V172, P5041, DOI 10.4049/jimmunol.172.8.5041; Reed AM, 2002, RHEUM DIS CLIN N AM, V28, P891, DOI 10.1016/S0889-857X(02)00029-7; Reed AM, 2000, LANCET, V356, P2156, DOI 10.1016/S0140-6736(00)03500-5; Reiff A, 1997, J RHEUMATOL, V24, P2436; Rider LG, 2000, CLIN EXP IMMUNOL, V121, P47, DOI 10.1046/j.1365-2249.2000.01266.x; Rider LG, 2004, ARTHRITIS RHEUM-US, V50, P2281, DOI 10.1002/art.20349; Rider LG, 1997, RHEUM DIS CLIN N AM, V23, P619, DOI 10.1016/S0889-857X(05)70350-1; Rider LG, 2002, RHEUM DIS CLIN N AM, V28, P935, DOI 10.1016/S0889-857X(02)00027-3; RIDER LG, 2003, PEDIAT RHEUMATOL ONL, V1, P119; RIDER LG, 2007, MYOSITIS YOU GUIDE D; Rider LG, 2007, AUTOIMMUN REV, V6, P241, DOI 10.1016/j.autrev.2006.08.009; Riley P, 2004, RHEUMATOLOGY, V43, P491, DOI 10.1093/rheumatology/keh082; Rivas E, 2005, PEDIATR NEUROL, V33, P350, DOI 10.1016/j.pediatrneurol.2005.05.024; ROIFMAN CM, 1987, JAMA-J AM MED ASSOC, V258, P513, DOI 10.1001/jama.1987.03400040111034; Rouster-Stevens KA, 2008, ARTHRIT RHEUM-ARTHR, V59, P222, DOI 10.1002/art.23341; Rouster-Stevens KA, 2007, ARTHRITIS RHEUM, V56, P977, DOI 10.1002/art.22433; Ruperto N, 2008, ARTHRIT RHEUM-ARTHR, V59, P4, DOI 10.1002/art.23248; Sallum AME, 2006, AUTOIMMUN REV, V5, P93, DOI 10.1016/j.autrev.2005.05.008; SANSOME A, 1995, ARCH DIS CHILD, V72, P25, DOI 10.1136/adc.72.1.25; Smith RL, 2004, J RHEUMATOL, V31, P1644; Sontheimer RD, 2004, J RHEUMATOL, V31, P539; Sordet C, 2006, JOINT BONE SPINE, V73, P646, DOI 10.1016/j.jbspin.2006.04.005; SPENCER CH, 1984, J PEDIATR-US, V105, P399, DOI 10.1016/S0022-3476(84)80012-8; Stefanski JC, 1998, CLIN PEDIATR, V37, P561, DOI 10.1177/000992289803700907; Sugiura T, 2000, J IMMUNOL, V164, P6593, DOI 10.4049/jimmunol.164.12.6593; Sullivan D B, 1977, Arthritis Rheum, V20, P327; Summers RM, 1998, RADIOLOGY, V209, P191, DOI 10.1148/radiology.209.1.9769831; SYMMONS DPM, 1995, BRIT J RHEUMATOL, V34, P732; Targoff IN, 2006, ARTHRITIS RHEUM, V54, P3682, DOI 10.1002/art.22164; Tezak Z, 2002, J IMMUNOL, V168, P4154, DOI 10.4049/jimmunol.168.8.4154; TOPI GC, 1979, BRIT J DERMATOL, V101, P589, DOI 10.1111/j.1365-2133.1979.tb11891.x; Vegosen LJ, 2007, ARTHRITIS RHEUM-US, V56, P2719, DOI 10.1002/art.22751; Verma S, 2006, ARTHRIT RHEUM-ARTHR, V55, P564, DOI 10.1002/art.22108; Wedderburn LR, 2007, ARTHRIT RHEUM-ARTHR, V57, P1192, DOI 10.1002/art.23012; Zhao Y, 2007, CLIN IMMUNOL, V125, P165, DOI 10.1016/j.clim.2007.06.011	138	248	276	0	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN-JUL	2008	371	9631					2201	2212		10.1016/S0140-6736(08)60955-1	http://dx.doi.org/10.1016/S0140-6736(08)60955-1			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	326CP	18586175				2022-12-28	WOS:000257635800027
J	Liu, B; Beral, V; Balkwill, A; Green, J; Sweetland, S; Reeves, G				Liu, Bette; Beral, Valerie; Balkwill, Angela; Green, Jane; Sweetland, Sian; Reeves, Gillian		Million Women Study Collaborators	Gallbladder disease and use of transdermal versus oral hormone replacement therapy in postmenopausal women: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SYMPTOMATIC GALLSTONE DISEASE; RISK; CHOLECYSTECTOMY; CONSUMPTION; STAY	Objective To determine whether transdermal compared with oral use of hormone replacement therapy reduces the risk of gallbladder disease in postmenopausal women. Design Prospective cohort study (Million Women Study). Setting Women registered with the National Health Service (NHS) in England and Scotland. Participants 1001391 postmenopausal women (mean age 56) recruited between 1996 and 2001 from NHS breast screening centres and followed by record linkage to routinely collected NHS hospital admission data for gallbladder disease. Main outcome measures Adjusted relative risk and standardised incidence rates of hospital admission for gallbladder disease or cholecystectomy according to use of hormone replacement therapy. Results During follow-up 19 889 women were admitted for gallbladder disease; 17 190 (86%) had a cholecystectomy. Compared with never users of hormone replacement therapy, current users were more likely to be admitted for gallbladder disease (relative risk 1.64, 95% confidence interval 1.58 to 1.69) but risks were substantially lower with transdermal therapy than with oral therapy (relative risk 1.17, 1.10 to 1.24 v 1.74, 1.68 to 1.80; heterogeneity P < 0.001). Among women using oral therapy, equine oestrogens were associated with a slightly greater risk of gallbladder disease than estradiol (relative risk 1.79, 1.72 to 1.87 v 1.62, 1.54 to 1.70; heterogeneity P<0.001) and higher doses of oestrogen increased the risk more than lower doses: equine oestrogens > 0.625 mg, 1.91 (1.78 to 2.04) v <= 0.625 mg, 1.76 (1.68 to 1.84); heterogeneity P=0.02; estradiol. > 1 mg, 1.68 (1.59 to 1.77) v <= l mg, 1.44 (1.31 to 1.59); heterogeneity P=0.003. The risk of gallbladder disease decreased with time since stopping therapy (trend P=0.004). Results were similar taking cholecystectomy as the outcome. Standardised hospital admission rates per 100 women over five years for cholecystectomy were 1.1 in never users, 1.3 with transdermal therapy, and 2.0 with oral therapy. Conclusion Gallbladder disease is common in postmenopausal women and use of hormone replacement therapy increases the risk. Use of transdermal therapy rather than oral therapy over a five year period could avoid one cholecystectomy in every 140 users.	[Liu, Bette; Beral, Valerie; Balkwill, Angela; Green, Jane; Sweetland, Sian; Reeves, Gillian] Univ Oxford, Epidemiol Unit, Oxford OX3 7LF, England	University of Oxford	Liu, B (corresponding author), Univ Oxford, Epidemiol Unit, Oxford OX3 7LF, England.	Bette.Liu@ceu.ox.ac.uk		Balkwill, Angela/0000-0002-6327-6245; Liu, Bette/0000-0002-0787-5825	Cancer Research UK [C570/A5028]; NHS; UK Medical Research Council [G0700474]; Medical Research Council [G9900923, G0700474] Funding Source: researchfish; MRC [G9900923, G0700474] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); NHS; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Cancer Research UK [grant No C570/A5028], the NHS breast screening programme, and the UK Medical Research Council [grant No G0700474]. The funders had no involvement in the design and conduct of the study; the collection, management, analysis, and interpretation of the data; or the preparation, review, or approval of this manuscript.	Banks E, 2004, JAMA-J AM MED ASSOC, V291, P2212, DOI 10.1001/jama.291.18.2212; Banks E, 2001, J Epidemiol Biostat, V6, P357; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Beral V, 2005, LANCET, V365, P1543, DOI 10.1016/S0140-6736(05)66455-0; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; Beral V, 2007, LANCET, V369, P1703, DOI 10.1016/S0140-6736(07)60534-0; Cirillo DJ, 2005, JAMA-J AM MED ASSOC, V293, P330, DOI 10.1001/jama.293.3.330; COULTER A, 1986, CONTRACEPTION, V33, P127, DOI 10.1016/0010-7824(86)90079-X; GANGAR K, 1989, BRIT MED J, V299, P601, DOI 10.1136/bmj.299.6699.601-a; GRODSTEIN F, 1994, OBSTET GYNECOL, V83, P5; *INF CTR, 2007, HOSP EP STAT; Kendrick Stephen, 1993, Health Bulletin (Edinburgh), V51, P72; Leitzmann MF, 1998, ANN INTERN MED, V128, P417, DOI 10.7326/0003-4819-128-6-199803150-00001; Leitzmann MF, 2003, AM J CLIN NUTR, V78, P339, DOI 10.1093/ajcn/78.2.339; Leitzmann MF, 2002, GASTROENTEROLOGY, V123, P1823, DOI 10.1053/gast.2002.37054; Liu B, 2008, J PUBLIC HEALTH-UK, V30, P161, DOI 10.1093/pubmed/fdn011; Liu B, 2007, J CLIN EPIDEMIOL, V60, P1190, DOI 10.1016/j.jclinepi.2007.02.007; LUMSDEN M, 2004, MENOPAUSE HORMONE RE, P187; Mamdani MM, 2000, CAN MED ASSOC J, V162, P1421; MEHTA D, 1999, BRIT NATL FORMULARY; MURRAY FE, 1994, GUT, V35, P107, DOI 10.1136/gut.35.1.107; Office of Population Censuses and Surveys, 2000, CLASS SURG OP PROC; PETITTI DB, 1988, GASTROENTEROLOGY, V94, P91, DOI 10.1016/0016-5085(88)90614-2; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Simon JA, 2001, ANN INTERN MED, V135, P493, DOI 10.7326/0003-4819-135-7-200110020-00008; Sweetman S. C., 2007, MARTINDALE COMPLETE; The Million Women Study Collaborative Group, 1999, BREAST CANCER RES, V1, P73, DOI DOI 10.1186/BCR16; THIJS C, 1993, AM J PUBLIC HEALTH, V83, P1113, DOI 10.2105/AJPH.83.8.1113; Tsai CJ, 2006, AM J MED, V119, P760, DOI 10.1016/j.amjmed.2006.02.040; Watson J, 2007, EUR J CLIN PHARMACOL, V63, P843, DOI 10.1007/s00228-007-0320-6; Williams B, 2000, J PUBLIC HEALTH MED, V22, P68, DOI 10.1093/pubmed/22.1.68; World Health Organization, 2004, ICD 10 INT STAT CLAS, V2nd	32	51	57	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 2	2008	337	7664							a386	10.1136/bmj.a386	http://dx.doi.org/10.1136/bmj.a386			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	339EN	18617493	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000258561000030
J	Eggermont, AMM; Suciu, S; Santinami, M; Testori, A; Kruit, WHJ; Marsden, J; Punt, CJA; Sales, F; Gore, M; MacKie, R; Kusic, Z; Dummer, R; Hauschild, A; Musat, E; Spatz, A; Keilholz, U				Eggermont, Alexander M. M.; Suciu, Stefan; Santinami, Mario; Testori, Alessandro; Kruit, Wim H. J.; Marsden, Jeremy; Punt, Cornelis J. A.; Sales, Francois; Gore, Martin; MacKie, Rona; Kusic, Zvonko; Dummer, Reinhard; Hauschild, Axel; Musat, Elena; Spatz, Alain; Keilholz, Ulrich		EORTC Melanoma Grp	Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial	LANCET			English	Article							COOPERATIVE-ONCOLOGY-GROUP; HIGH-RISK MELANOMA; PROGNOSTIC-FACTORS; CUTANEOUS MELANOMA; ALPHA-2A; COMMITTEE	Background Any benefit of adjuvant interferon alfa-2b for melanoma could depend on dose and duration of treatment. Our aim was to determine whether pegylated interferon alfa-2b can facilitate prolonged exposure while maintaining tolerability. Methods 1256 patients with resected stage III melanoma were randomly assigned to observation (n=629) or pegylated interferon alfa-2b (n=627) 6 pg/kg per week for 8 weeks (induction) then 3 pg/kg per week (maintenance) for an intended duration of 5 years. Randomisation was stratified for microscopic (N1) versus macroscopic (N2) nodal involvement, number of positive nodes, ulceration and tumour thickness, sex, and Centre. Randomisation was done with a minimisation technique. The primary endpoint was recurrence-free survival. Analyses were done by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00006249. Findings All randomised patients were included in the primary efficacy analysis. 608 patients in the interferon group and 613 patients in the observation group were included in safety analyses. The median length of treatment with pegylated interferon alfa-2b was 12 (IQR 3.8-33-4) months. At 3.8 (3.2-4.2) years median follow-up, 328 recurrence events had occurred in the interferon group compared with 368 in the observation group (hazard ratio 0 . 82, 95% CI 0 . 71-0.96; p=0 . 01); the 4-year rate of recurrence-free survival was 45.6% (SE 2.2) in the interferon group and 38.9% (2.2) in the observation group. There was no difference in overall survival between the groups. Grade 3 adverse events occurred in 246 (40%) patients in the interferon group and 60 (10%) in the observation group; grade 4 adverse events occurred in 32 (5%) patients in the interferon group and 14 (2%) in the observation group. In the interferon group, the most common grade 3 or 4 adverse events were fatigue (97 patients, 16%), hepatotoxicity (66, 11%), and depression (39, 6%). Treatment with pegylated interferon alfa-2b was discontinued because of toxicity in 191 (31%) patients. Interpretation Adjuvant pegylated interferon alfa-2b for stage III melanoma has a significant, sustained effect on recurrence-free survival. Funding Schering Plough Research International.	[Eggermont, Alexander M. M.; Kruit, Wim H. J.] Erasmus Univ, Med Ctr, Dr Daniel Den Hoed Canc Ctr, NL-3075 EA Rotterdam, Netherlands; [Suciu, Stefan; Musat, Elena] EORTC Headquarters, Brussels, Belgium; [Santinami, Mario] Ist Nazl Tumori, I-20133 Milan, Italy; [Testori, Alessandro] Ist Europeo Oncol, Milan, Italy; [Marsden, Jeremy] Univ Hosp Birmingham, Birmingham, W Midlands, England; [Punt, Cornelis J. A.] Radboud Univ Nijmegen Med Ctr, Nijmegen, Netherlands; [Sales, Francois] Inst Jules Bordet, B-1000 Brussels, Belgium; [Gore, Martin] Royal Marsden Hosp NHS, London, England; [MacKie, Rona] Univ Glasgow, Glasgow, Lanark, Scotland; [Kusic, Zvonko] Univ Hosp Sestre Milosrdnice, Zagreb, Croatia; [Dummer, Reinhard] Univ Clin Zurich, Zurich, Switzerland; [Hauschild, Axel] Univ Hosp Kiel, Kiel, Germany; [Spatz, Alain] Inst Gustave Roussy, Villejuif, France; [Keilholz, Ulrich] Charite, Berlin, Germany	Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; European Organisation for Research & Treatment of Cancer; Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS European Institute of Oncology (IEO); University of Birmingham; Radboud University Nijmegen; Institut Jules Bordet; Royal Marsden NHS Foundation Trust; University of Glasgow; University of Kiel; Schleswig Holstein University Hospital; UNICANCER; Gustave Roussy; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Eggermont, AMM (corresponding author), Erasmus Univ, Med Ctr, Dr Daniel Den Hoed Canc Ctr, 301 Groene Hilledijk, NL-3075 EA Rotterdam, Netherlands.	a.m.m.eggermont@erasmusmc.nl	Ortiz-Romero, Pablo Luis/B-3027-2011; Hauschild, Axel/B-3185-2010; SPATZ, ALAN/B-8645-2009; Ottensmeier, Christian H/E-8131-2012; Lorigan, Paul/J-6898-2015; Krajsova, Ivana/I-4505-2017; Santinami, Mario/I-3795-2017; Mayordomo, Jose/K-3453-2013	Ortiz-Romero, Pablo Luis/0000-0003-2985-9639; SPATZ, ALAN/0000-0003-3020-1420; Ottensmeier, Christian H/0000-0003-3619-1657; Lorigan, Paul/0000-0002-8875-2164; Krajsova, Ivana/0000-0002-1599-6424; Santinami, Mario/0000-0001-8436-4757; Lacour, Jean-Philippe/0000-0001-7663-2053; McArthur, Grant/0000-0001-8908-6071; Leccia, M.Therese/0000-0003-1222-0396; TESTORI, ALESSANDRO/0000-0003-3685-0210; Ochsenbein, Adrian/0000-0003-1773-5436; groenewegen, gerard/0000-0002-0752-1744				Balch CM, 2006, NEW ENGL J MED, V355, P1370, DOI 10.1056/NEJMe068147; Balch CM, 2001, J CLIN ONCOL, V19, P3622, DOI 10.1200/JCO.2001.19.16.3622; Bouwhuis M, 2007, J CLIN ONCOL, V25; BOUWHUIS MG, 2007, EJC SUPPL, V6, P5; Bukowski RM, 2002, CANCER, V95, P389, DOI 10.1002/cncr.10663; Cancer Therapy Evaluation Program, 1999, COMM TOX CRIT VERS 2; Cascinelli N, 2001, LANCET, V358, P866, DOI 10.1016/S0140-6736(01)06068-8; Eggermont AMM, 2005, LANCET, V366, P1189, DOI 10.1016/S0140-6736(05)67482-X; Eggermont AMM, 2002, SEMIN ONCOL, V29, P382, DOI 10.1053/sonc.2002.34117; FREEDMAN LS, 1976, BIOMETRICS, V32, P691, DOI 10.2307/2529759; Glue P, 2000, CLIN PHARMACOL THER, V68, P556, DOI 10.1067/mcp.2000.110973; Gogas H, 2006, NEW ENGL J MED, V354, P709, DOI 10.1056/NEJMoa053007; Grob JJ, 1998, LANCET, V351, P1905, DOI 10.1016/S0140-6736(97)12445-X; Hancock BW, 2004, J CLIN ONCOL, V22, P53, DOI 10.1200/JCO.2004.03.185; Hwu WJ, 2006, CANCER-AM CANCER SOC, V106, P2445, DOI 10.1002/cncr.21909; Kalbfleisch JD, 2002, SURVIVAL ANAL FAILUR; Kirkwood JM, 2000, J CLIN ONCOL, V18, P2444, DOI 10.1200/JCO.2000.18.12.2444; Kirkwood JM, 1996, J CLIN ONCOL, V14, P7, DOI 10.1200/JCO.1996.14.1.7; Kirkwood JM, 2004, CLIN CANCER RES, V10, P1670, DOI 10.1158/1078-0432.CCR-1103-3; Michallet M, 2004, LEUKEMIA, V18, P309, DOI 10.1038/sj.leu.2403217; PEDUZZI P, 1993, STAT MED, V12, P1185, DOI 10.1002/sim.4780121102; Pehamberger H, 1998, J CLIN ONCOL, V16, P1425, DOI 10.1200/JCO.1998.16.4.1425; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Spieth K, 2008, ANN ONCOL, V19, P801, DOI 10.1093/annonc/mdm565; Wheatley K, 2003, CANCER TREAT REV, V29, P241, DOI 10.1016/S0305-7372(03)00074-4; Wheatley K, 2007, J CLIN ONCOL, V25, P4693, DOI 10.1200/JCO.2007.13.3389	26	470	487	0	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 12	2008	372	9633					117	126		10.1016/S0140-6736(08)61033-8	http://dx.doi.org/10.1016/S0140-6736(08)61033-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	324XJ	18620949	Green Accepted			2022-12-28	WOS:000257552400026
J	Yang, JC				Yang, James C.			Vitespen: a vaccine for renal cancer?	LANCET			English	Editorial Material							MELANOMA		NCI, Surg Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Yang, JC (corresponding author), NCI, Surg Branch, Bldg 10, Bethesda, MD 20892 USA.	jamesyang@mail.nih.gov						*ANT, 2008, ONC APPR RUSS TREATM; Dudley ME, 2005, J CLIN ONCOL, V23, P2346, DOI 10.1200/JCO.2005.00.240; Jonasch E, 2008, BRIT J CANCER, V98, P1336, DOI 10.1038/sj.bjc.6604266; Mazzaferro V, 2003, CLIN CANCER RES, V9, P3235; Rosenberg SA, 2005, J IMMUNOL, V175, P6169, DOI 10.4049/jimmunol.175.9.6169; Srivastava PK, 2001, VACCINE, V19, P2590, DOI 10.1016/S0264-410X(00)00492-8; WOOD C, 2008, LANCET          0704	7	11	11	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 12	2008	372	9633					92	93		10.1016/S0140-6736(08)60698-4	http://dx.doi.org/10.1016/S0140-6736(08)60698-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	324XJ	18602687				2022-12-28	WOS:000257552400006
J	Lucht, M; Rosskopf, D				Lucht, Michael; Rosskopf, Dieter			Comment on "genetically determined differences in learning from errors"	SCIENCE			English	Editorial Material							ALCOHOL DEPENDENCE; RECEPTOR GENE; DRD2; ANKK1; ASSOCIATION; DOPAMINE	Klein et al. ( Reports, 7 December 2007, p. 1642) used individuals with a polymorphism adjacent to the dopamine receptor 2 gene as naturally occurring models for reduced brain dopamine receptor density in a probabilistic learning task. We raise the concern that this polymorphism resides in the gene for the kinase ANKK1, where it causes a nonconservative amino acid exchange.	[Lucht, Michael] Ernst Moritz Arndt Univ Greifswald, Hosp Psychiat & Psychotherapy, D-18437 Greifswald, Germany; [Rosskopf, Dieter] Ernst Moritz Arndt Univ Greifswald, Inst Pharmacol, D-17487 Greifswald, Germany	Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald	Lucht, M (corresponding author), Ernst Moritz Arndt Univ Greifswald, Hosp Psychiat & Psychotherapy, Haus 30, D-18437 Greifswald, Germany.	lucht@uni-greifswald.de						Dick DM, 2007, ALCOHOL CLIN EXP RES, V31, P1645, DOI 10.1111/j.1530-0277.2007.00470.x; Dubertret C, 2004, SCHIZOPHR RES, V67, P75, DOI 10.1016/S0920-9964(03)00220-2; Frank MJ, 2007, SCIENCE, V318, P1309, DOI 10.1126/science.1146157; Frank MJ, 2007, P NATL ACAD SCI USA, V104, P16311, DOI 10.1073/pnas.0706111104; Klein TA, 2007, SCIENCE, V318, P1642, DOI 10.1126/science.1145044; Laakso A, 2005, PHARMACOGENET GENOM, V15, P387, DOI 10.1097/01213011-200506000-00003; Laruelle M, 1998, MOL PSYCHIATR, V3, P261, DOI 10.1038/sj.mp.4000343; Neville MJ, 2004, HUM MUTAT, V23, P540, DOI 10.1002/humu.20039; Yang BZ, 2007, HUM MOL GENET, V16, P2844, DOI 10.1093/hmg/ddm240	9	21	21	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 11	2008	321	5886								10.1126/science.1155372	http://dx.doi.org/10.1126/science.1155372			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	324IS	18621654				2022-12-28	WOS:000257512900019
J	Palamidessi, A; Frittoli, E; Garre, M; Faretta, M; Mione, M; Testa, I; Diaspro, A; Lanzetti, L; Scita, G; Di Fiore, PP				Palamidessi, Andrea; Frittoli, Emanuela; Garre, Massimiliano; Faretta, Mario; Mione, Marina; Testa, Ilaria; Diaspro, Alberto; Lanzetti, Letizia; Scita, Giorgio; Di Fiore, Pier Paolo			Endocytic trafficking of Rac is required for the spatial restriction of signaling in cell migration	CELL			English	Article							LIVING CELLS; RHO-GTPASES; MEMBRANE; CANCER; PROTEINS; INTEGRIN; INVASION; POLARITY; INTERNALIZATION; LOCALIZATION	The small GTPases, Rab5 and Rac, are essential for endocytosis and actin remodeling, respectively. Coordination of these processes is critical to achieve spatial restriction of intracellular signaling, which is essential for a variety of polarized functions. Here, we show that clathrin- and Rab5- mediated endocytosis are required for the activation of Rac induced by motogenic stimuli. Rac activation occurs on early endosomes, where the RacGEF Tiam1 is also recruited. Subsequent recycling of Rac to the plasma membrane ensures localized signaling, leading to the formation of actin- based migratory protrusions. Thus, membrane trafficking of Rac is required for the spatial resolution of Rac-dependent motogenic signals. We further demonstrate that a Rab5-to-Rac circuitry controls the morphology of motile mammalian tumor cells and primordial germinal cells during zebrafish development, suggesting that this circuitry is relevant for the regulation of migratory programs in various cells, in both in vitro settings and whole organisms.	[Palamidessi, Andrea; Frittoli, Emanuela; Garre, Massimiliano; Faretta, Mario; Mione, Marina; Scita, Giorgio; Di Fiore, Pier Paolo] Fdn Ist FIRC Oncol Mol, IFOM, I-20139 Milan, Italy; [Garre, Massimiliano; Faretta, Mario; Di Fiore, Pier Paolo] Ist Europeo Oncol, Dipartimento Oncol Sperimentale, I-20141 Milan, Italy; [Testa, Ilaria; Diaspro, Alberto] Univ Genoa, Dept Phys, LAMBS MicroScoBio, I-16146 Genoa, Italy; [Lanzetti, Letizia] Univ Turin, Ist Ric & Cura Cancro, Dipartimento Sci Oncol, I-10060 Turin, Italy; [Scita, Giorgio; Di Fiore, Pier Paolo] Univ Milan, Dipartimento Med Chirurg & Odontoiatria, I-20122 Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; IRCCS European Institute of Oncology (IEO); University of Genoa; University of Turin; University of Milan	Scita, G (corresponding author), Fdn Ist FIRC Oncol Mol, IFOM, Via Adamello 16, I-20139 Milan, Italy.	giorgio.scita@ifom-ieo-campus.it; pierpaolo.difiore@ifom-ieo-campus.it	Mione, Maria Caterina/ABG-9926-2021; Mione, Maria Caterina/I-3073-2013; Di Fiore, Pier Paolo/K-2130-2012; Faretta, Mario/H-8946-2012; Diaspro, Alberto/E-7833-2010; Palamidessi, Andrea/F-1203-2018; Scita, Giorgio/J-9670-2012	Di Fiore, Pier Paolo/0000-0002-2252-0950; Faretta, Mario/0000-0003-1678-5781; Diaspro, Alberto/0000-0002-4916-5928; Scita, Giorgio/0000-0001-7984-1889; Garre', Massimiliano/0000-0001-9332-0270; Testa, Ilaria/0000-0003-4005-4997; LANZETTI, Letizia/0000-0001-7541-5524; Mione, Maria Caterina/0000-0002-9040-3705; palamidessi, andrea/0000-0002-7134-7023	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Arvelo Francisco, 2006, Invest. clín, V47, P185; Balasubramanian N, 2007, NAT CELL BIOL, V9, P1381, DOI 10.1038/ncb1657; Blaser H, 2006, DEV CELL, V11, P613, DOI 10.1016/j.devcel.2006.09.023; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Caswell PT, 2007, DEV CELL, V13, P496, DOI 10.1016/j.devcel.2007.08.012; Caswell PT, 2006, TRAFFIC, V7, P14, DOI 10.1111/j.1600-0854.2005.00362.x; Daniotti M, 2004, ONCOGENE, V23, P5968, DOI 10.1038/sj.onc.1207780; del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; Del Pozo MA, 2007, TRENDS CELL BIOL, V17, P246, DOI 10.1016/j.tcb.2007.03.001; Donaldson JG, 2005, BIOCHEM SOC T, V33, P639, DOI 10.1042/BST0330639; Drummond AH, 1999, ANN NY ACAD SCI, V878, P228, DOI 10.1111/j.1749-6632.1999.tb07688.x; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Fukui Y, 2002, CELL BIOL INT, V26, P933, DOI 10.1006/cbir.2002.0959; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Jekely G, 2005, DEV CELL, V9, P197, DOI 10.1016/j.devcel.2005.06.004; Jiang XJ, 2002, MOL BIOL CELL, V13, P1522, DOI 10.1091/mbc.01-11-0552; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Lanzetti L, 2004, NATURE, V429, P309, DOI 10.1038/nature02542; Lu H, 2005, NAT CELL BIOL, V7, P1232, DOI 10.1038/ncb1324; Marco E, 2007, CELL, V129, P411, DOI 10.1016/j.cell.2007.02.043; McDonald JA, 2003, DEVELOPMENT, V130, P3469, DOI 10.1242/dev.00574; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; Orth JD, 2003, CURR OPIN CELL BIOL, V15, P31, DOI 10.1016/S0955-0674(02)00010-8; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Pinner S, 2008, NAT CELL BIOL, V10, P127, DOI 10.1038/ncb1675; Punnonen EL, 1998, EUR J CELL BIOL, V75, P344, DOI 10.1016/S0171-9335(98)80067-8; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; Raz E, 2004, CURR OPIN CELL BIOL, V16, P169, DOI 10.1016/j.ceb.2004.01.004; Roy S, 2002, MOL CELL BIOL, V22, P5128, DOI 10.1128/MCB.22.14.5128-5140.2002; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sahai E, 2002, NAT CELL BIOL, V4, P408, DOI 10.1038/ncb796; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Scita G, 1999, NATURE, V401, P290, DOI 10.1038/45822; Spaargaren M, 1999, MOL BIOL CELL, V10, P3239, DOI 10.1091/mbc.10.10.3239; Suetsugu S, 2003, DEV CELL, V5, P595, DOI 10.1016/S1534-5807(03)00297-1; Valdez-Taubas J, 2003, CURR BIOL, V13, P1636, DOI 10.1016/j.cub.2003.09.001; Wedlich D, 2002, CURR OPIN CELL BIOL, V14, P563, DOI 10.1016/S0955-0674(02)00374-5; Wolf K, 2006, BRIT J DERMATOL, V154, P11, DOI 10.1111/j.1365-2133.2006.07231.x; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	41	332	338	1	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 11	2008	134	1					135	147		10.1016/j.cell.2008.05.034	http://dx.doi.org/10.1016/j.cell.2008.05.034			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	324IU	18614017	Bronze			2022-12-28	WOS:000257513100020
J	Friedman, M				Friedman, Matt			The evolutionary origin of flatfish asymmetry	NATURE			English	Article							PLEURONECTIFORMES; ACANTHOMORPHS; PHYLOGENY; BEHAVIOR; RECORD	All adult flatfishes ( Pleuronectiformes), including the gastronomically familiar plaice, sole, turbot and halibut, have highly asymmetrical skulls, with both eyes placed on one side of the head. This arrangement, one of the most extraordinary anatomical specializations among vertebrates, arises through migration of one eye during late larval development. Although the transformation of symmetrical larvae into asymmetrical juveniles is well documented(1-7), the evolutionary origins of flatfish asymmetry are uncertain(1,2) because there are no transitional forms linking flatfishes with their symmetrical relatives(8,9). The supposed inviability of such intermediates gave pleuronectiforms a prominent role in evolutionary debates(10-16), leading to attacks on natural selection(11) and arguments for saltatory change(14,15). Here I show that Amphistium and the new genus Heteronectes, both extinct spiny- finned fishes from the Eocene epoch of Europe, are the most primitive pleuronectiforms known. The orbital region of the skull in both taxa is strongly asymmetrical, as in living flatfishes, but these genera retain many primitive characters unknown in extant forms. Most remarkably, orbital migration was incomplete in Amphistium and Heteronectes, with eyes remaining on opposite sides of the head in post- metamorphic individuals. This condition is intermediate between that in living pleuronectiforms and the arrangement found in other fishes. Amphistium and Heteronectes indicate that the evolution of the profound cranial asymmetry of extant flatfishes was gradual in nature.	[Friedman, Matt] Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA; [Friedman, Matt] Field Museum Nat Hist, Dept Geol, Chicago, IL 60605 USA	University of Chicago; Field Museum of Natural History (Chicago)	Friedman, M (corresponding author), Univ Chicago, Comm Evolutionary Biol, 1025 E 57th St, Chicago, IL 60637 USA.	mattf@uchicago.edu	Friedman, Matt/F-6991-2012					AHLSTROM EH, 1984, ONTOGENY SYSTEMATICS, P640; BLOT J, 1969, MEM MUS CIV STOR NAT, V1, P1; Chanet B, 1997, ANN SCI NAT ZOOL, V18, P105; Chanet B., 1999, STUDI RICERCHE GIACI, VVIII, P220; CHANET B, 1994, N JB GEOL PALAONT MH, P391; CHAPLEAU F, 1993, B MAR SCI, V52, P516; Darwin C., 1872, ORIGIN SPECIES MEANS, V144, P971; Gaudant J., 1979, Bulletin d'Information des Geologues du Bassin de Paris, V16, P11; Goldschmidt R, 1933, SCIENCE, V78, P539, DOI 10.1126/science.78.2033.539; Goldschmidt R., 1940, MAT BASIS EVOLUTION; GOSLINE WA, 1961, COPEIA, P265; Hoshino K, 2006, ICHTHYOL RES, V53, P435, DOI 10.1007/s10228-006-0366-y; Hubbs Carl L., 1944, PAPERS MICHIGAN ACAD SCI ARTS AND LETT, V30, P229; JOHNSON GD, 1993, B MAR SCI, V52, P554; Kyle HM, 1923, PHILOS T R SOC LON B, V211, P75, DOI 10.1098/rstb.1923.0002; Lamarck JBPAM, 1809, PHILOS ZOOLOGIQUE; LIEW HC, 1988, AUST J MAR FRESH RES, V39, P51; Mivart St. George, 1871, GENESIS SPECIES; Norman JR, 1934, SYSTEMATIC MONOGRAPH, VI; Okada N, 2001, CELL TISSUE RES, V304, P59, DOI 10.1007/s004410100353; Palmer AR, 1996, P NATL ACAD SCI USA, V93, P14279, DOI 10.1073/pnas.93.25.14279; Patterson C., 1993, P621; PATTERSON C, 1993, B MAR SCI, V52, P29; Schreiber AM, 2006, J EXP BIOL, V209, P610, DOI 10.1242/jeb.02056; Stiassny MLJ, 2004, ASSEMBLING THE TREE OF LIFE, P410; STICKNEY RR, 1973, COPEIA, P154, DOI 10.2307/1442378; Trevisani E, 2005, PALAEOGEOGR PALAEOCL, V223, P260, DOI 10.1016/j.palaeo.2005.04.008; Von WAHLERT GERD, 1965, SYST ZOOL, V14, P288; Wagemans F, 2001, J FISH BIOL, V59, P1350, DOI 10.1006/jfbi.2001.1747; Wallace A. R., 1889, DARWINISM	30	95	100	2	152	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2008	454	7201					209	212		10.1038/nature07108	http://dx.doi.org/10.1038/nature07108			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	323RU	18615083				2022-12-28	WOS:000257466900042
J	Davis, CL				Davis, Connie L.			Sex mismatches in kidney transplantation	LANCET			English	Editorial Material							Y-CHROMOSOME; RENAL MASS; ANTIGEN; GENDER; EVOLUTION; OUTCOMES; CELLS		Univ Washington, Div Nephrol & Transplantat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Davis, CL (corresponding author), Univ Washington, Div Nephrol & Transplantat, Seattle, WA 98195 USA.	cdavis@u.washington.edu						Ali S, 2002, GENE, V283, P1, DOI 10.1016/S0378-1119(01)00860-5; Bohringer D, 2006, TRANSPLANTATION, V82, P1037, DOI 10.1097/01.tp.0000235908.54766.44; Delbridge ML, 1999, REV REPROD, V4, P101, DOI 10.1530/ror.0.0040101; Douverny JB, 2007, NEPHROL DIAL TRANSPL, V22, P3646, DOI 10.1093/ndt/gfm487; Gratwohl A, 2008, LANCET, V372, P49, DOI 10.1016/S0140-6736(08)60992-7; Lbernon M, 2007, TRANSPL P, V39, P2095, DOI 10.1016/j.transproceed.2007.06.026; Naesens M, 2007, AM J TRANSPLANT, V7, P2504, DOI 10.1111/j.1600-6143.2007.01949.x; Oh CK, 2006, CLIN TRANSPLANT, V20, P163, DOI 10.1111/j.1399-0012.2005.00459.x; Oien CM, 2007, TRANSPLANTATION, V83, P600, DOI 10.1097/01.tp.0000255583.34329.dd; Poggio ED, 2006, AM J TRANSPLANT, V6, P616, DOI 10.1111/j.1600-6143.2005.01225.x; Rosinski KV, 2008, BLOOD, V111, P4817, DOI 10.1182/blood-2007-06-096313; Verginis P, 2008, P NATL ACAD SCI USA, V105, P3479, DOI 10.1073/pnas.0800149105; Zeier M, 2002, J AM SOC NEPHROL, V13, P2570, DOI 10.1097/01.ASN.0000030078.74889.69	13	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 5	2008	372	9632					10	11		10.1016/S0140-6736(08)60969-1	http://dx.doi.org/10.1016/S0140-6736(08)60969-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	321XN	18603143				2022-12-28	WOS:000257339900008
J	Suzuki, H; Thiele, TR; Faumont, S; Ezcurra, M; Lockery, SR; Schafer, WR				Suzuki, Hiroshi; Thiele, Tod R.; Faumont, Serge; Ezcurra, Marina; Lockery, Shawn R.; Schafer, William R.			Functional asymmetry in Caenorhabditis elegans taste neurons and its computational role in chemotaxis	NATURE			English	Article							NUCLEOTIDE-GATED CHANNEL; OLFACTORY RECEPTOR-CELLS; C-ELEGANS; BEHAVIOR; RESPONSES; PROTEINS; CIRCUIT; VESICLE	Chemotaxis in Caenorhabditis elegans, like chemotaxis in bacteria(1), involves a random walk biased by the time derivative of attractant concentration(2,3), but how the derivative is computed is unknown. Laser ablations have shown that the strongest deficits in chemotaxis to salts are obtained when the ASE chemosensory neurons ( ASEL and ASER) are ablated, indicating that this pair has a dominant role(4). Although these neurons are left - right homologues anatomically, they exhibit marked asymmetries in gene expression and ion preference(5-7). Here, using optical recordings of calcium concentration in ASE neurons in intact animals, we demonstrate an additional asymmetry: ASEL is an ON- cell, stimulated by increases in NaCl concentration, whereas ASER is an OFF-cell, stimulated by decreases in NaCl concentration. Both responses are reliable yet transient, indicating that ASE neurons report changes in concentration rather than absolute levels. Recordings from synaptic and sensory transduction mutants show that the ON - OFF asymmetry is the result of intrinsic differences between ASE neurons. Unilateral activation experiments indicate that the asymmetry extends to the level of behavioural output: ASEL lengthens bouts of forward locomotion ( runs) whereas ASER promotes direction changes ( turns). Notably, the input and output asymmetries of ASE neurons are precisely those of a simple yet novel neuronal motif for computing the time derivative of chemosensory information, which is the fundamental computation of C. elegans chemotaxis(3,8). Evidence for ON and OFF cells in other chemosensory networks(9-12) suggests that this motif may be common in animals that navigate by taste and smell.	[Thiele, Tod R.; Faumont, Serge; Lockery, Shawn R.] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA; [Suzuki, Hiroshi; Schafer, William R.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Ezcurra, Marina; Schafer, William R.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	University of Oregon; University of California System; University of California San Diego; MRC Laboratory Molecular Biology	Lockery, SR (corresponding author), Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA.	shawn@uoregon.edu		Thiele, Tod/0000-0003-2628-8359; Schafer, William/0000-0002-6676-8034	Medical Research Council [MC_U105185857] Funding Source: Medline; NIDA NIH HHS [R01 DA016445, DA016445] Funding Source: Medline; NIMH NIH HHS [R21 MH112105, R01 MH051383, R29 MH051383, R01 MH051383-14, MH051383] Funding Source: Medline; MRC [MC_U105185857] Funding Source: UKRI; NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH051383, R21MH112105, R01MH051383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016445] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; Bargmann CI, 1995, METHOD CELL BIOL, V48, P225; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; Daniels SA, 2000, GENETICS, V156, P123; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; DUSENBERY DB, 1980, J COMP PHYSL, V136, P127; Faumont S, 2005, J NEUROBIOL, V65, P171, DOI 10.1002/neu.20196; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Hills T, 2004, J NEUROSCI, V24, P1217, DOI 10.1523/JNEUROSCI.1569-03.2004; Hinterwirth A, 2004, EUR J NEUROSCI, V19, P3389, DOI 10.1111/j.0953-816X.2004.03386.x; Hirose T, 2003, DEVELOPMENT, V130, P1089, DOI 10.1242/dev.00330; Johnston RJ, 2005, P NATL ACAD SCI USA, V102, P12449, DOI 10.1073/pnas.0505530102; Kerr R, 2000, NEURON, V26, P583, DOI 10.1016/S0896-6273(00)81196-4; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; L'Etoile ND, 2002, NEURON, V36, P1079, DOI 10.1016/S0896-6273(02)01066-8; Liu L, 2007, NATURE, V450, P294, DOI 10.1038/nature06223; MAIR RG, 1982, J PHYSIOL-LONDON, V326, P341, DOI 10.1113/jphysiol.1982.sp014197; MICHEL WC, 1991, J NEUROPHYSIOL, V65, P446, DOI 10.1152/jn.1991.65.3.446; Miller AC, 2005, J NEUROSCI, V25, P3369, DOI 10.1523/JNEUROSCI.5133-04.2005; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Nonet ML, 1998, J NEUROSCI, V18, P70; Pierce-Shimomura JT, 2001, NATURE, V410, P694, DOI 10.1038/35070575; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Richmond JE, 1999, NAT NEUROSCI, V2, P791, DOI 10.1038/12160; SCHILLER PH, 1992, TRENDS NEUROSCI, V15, P86, DOI 10.1016/0166-2236(92)90017-3; SEGALL JE, 1986, P NATL ACAD SCI USA, V83, P8987, DOI 10.1073/pnas.83.23.8987; Speese S, 2007, J NEUROSCI, V27, P6150, DOI 10.1523/JNEUROSCI.1466-07.2007; TAKAGI SF, 1959, NATURE, V184, P60, DOI 10.1038/184060a0; Tobin DM, 2002, NEURON, V35, P307, DOI 10.1016/S0896-6273(02)00757-2; WINER BJ, 1991, STAT PRINCIPLES EXPT, P354; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384	32	157	169	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 3	2008	454	7200					114	U6		10.1038/nature06927	http://dx.doi.org/10.1038/nature06927			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321MC	18596810	Green Accepted			2022-12-28	WOS:000257308300048
J	Finn, OJ				Finn, Olivera J.			Molecular origins of cancer - Cancer immunology	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							REGULATORY T-CELLS; TUMOR-ASSOCIATED ANTIGEN; DENDRITIC CELLS; METASTATIC MELANOMA; MONOCLONAL-ANTIBODY; IN-VIVO; INDOLEAMINE 2,3-DIOXYGENASE; INFILTRATING LYMPHOCYTES; MEDIATED REGRESSION; INFECTIOUS-DISEASES		Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Finn, OJ (corresponding author), Univ Pittsburgh, Sch Med, Dept Immunol, E1044,Biomed Sci Tower, Pittsburgh, PA 15261 USA.	ojfinn@pitt.edu	Yousry, Tarek A/B-3417-2009		NATIONAL CANCER INSTITUTE [P50CA090440, R01CA056103, R01CA168392, P01CA073743] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA073743, P50 CA090440, R01 CA056103, R01 CA168392] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aarnoudse CA, 2006, CURR OPIN IMMUNOL, V18, P105, DOI 10.1016/j.coi.2005.11.001; Albonico HU, 1998, MED HYPOTHESES, V51, P315, DOI 10.1016/S0306-9877(98)90055-X; Anderson MJ, 2007, J IMMUNOL, V179, P7184, DOI 10.4049/jimmunol.179.10.7184; Anderson MJ, 2007, J IMMUNOL, V178, P1268, DOI 10.4049/jimmunol.178.3.1268; Antonia SJ, 2006, CLIN CANCER RES, V12, P878, DOI 10.1158/1078-0432.CCR-05-2013; Appella E, 1995, Biomed Pept Proteins Nucleic Acids, V1, P177; AWWAD M, 1989, CANCER RES, V49, P1649; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Baxevanis CN, 2006, CANCER IMMUNOL IMMUN, V55, P85, DOI 10.1007/s00262-005-0692-3; Bergmann C, 2007, CANCER IMMUNOL IMMUN, V56, P1429, DOI 10.1007/s00262-007-0280-9; Bernhardt SL, 2006, BRIT J CANCER, V95, P1474, DOI 10.1038/sj.bjc.6603437; Butts C, 2005, J CLIN ONCOL, V23, P6674, DOI 10.1200/JCO.2005.13.011; Carlos CA, 2005, J IMMUNOL, V175, P1628, DOI 10.4049/jimmunol.175.3.1628; Cavallo F, 2006, ADV IMMUNOL, V90, P175, DOI 10.1016/S0065-2776(06)90005-4; CHEEVER MA, 1981, CANCER RES, V41, P2658; CHEEVER MA, 1981, J IMMUNOL, V126, P1318; Chen YT, 1997, P NATL ACAD SCI USA, V94, P1914, DOI 10.1073/pnas.94.5.1914; Chesnut R W, 1995, Pharm Biotechnol, V6, P847; Chikamatsu K, 2007, HEAD NECK-J SCI SPEC, V29, P120, DOI 10.1002/hed.20490; Cramer DW, 2005, CANCER EPIDEM BIOMAR, V14, P1125, DOI 10.1158/1055-9965.EPI-05-0035; Czerniecki BJ, 2007, CANCER RES, V67, P1842, DOI 10.1158/0008-5472.CAN-06-4038; Dave SS, 2004, NEW ENGL J MED, V351, P2159, DOI 10.1056/NEJMoa041869; Disis ML, 2004, J CLIN ONCOL, V22, P1916, DOI 10.1200/JCO.2004.09.005; Dudley ME, 2005, J CLIN ONCOL, V23, P2346, DOI 10.1200/JCO.2005.00.240; Dunn GP, 2005, NAT IMMUNOL, V6, P852, DOI 10.1038/ni0805-852b; Dunn GP, 2005, NAT IMMUNOL, V6, P722, DOI 10.1038/ni1213; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Emens LA, 2005, CANCER RES, V65, P8059, DOI 10.1158/0008-5472.CAN-05-1797; Fay JW, 2006, CANCER IMMUNOL IMMUN, V55, P1209, DOI 10.1007/s00262-005-0106-6; Fecci PE, 2006, CANCER RES, V66, P3294, DOI 10.1158/0008-5472.CAN-05-3773; Finke LH, 2007, VACCINE, V25, pB97, DOI 10.1016/j.vaccine.2007.06.067; Gallo P, 2007, INT J CANCER, V120, P574, DOI 10.1002/ijc.22274; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Garcia-Hernandez MD, 2008, CANCER RES, V68, P861, DOI 10.1158/0008-5472.CAN-07-0445; Giaccone G, 2005, J CLIN ONCOL, V23, P3235, DOI 10.1200/JCO.2005.08.409; GILLIS S, 1978, J EXP MED, V148, P1093, DOI 10.1084/jem.148.4.1093; Gould P, 2006, LANCET ONCOL, V7, P710, DOI 10.1016/S1470-2045(06)70846-4; Graziano DF, 2005, CANC TREAT, V123, P89; HELLSTROM KE, 1982, SPRINGER SEMIN IMMUN, V5, P127; Hislop AD, 2007, ANNU REV IMMUNOL, V25, P587, DOI 10.1146/annurev.immunol.25.022106.141553; Hodge JW, 2003, CLIN CANCER RES, V9, P1837; Hodi FS, 2003, P NATL ACAD SCI USA, V100, P4712, DOI 10.1073/pnas.0830997100; Hou DY, 2007, CANCER RES, V67, P792, DOI 10.1158/0008-5472.CAN-06-2925; Houston A, 2003, BRIT J CANCER, V89, P1345, DOI 10.1038/sj.bjc.6601240; Imai K, 2000, LANCET, V356, P1795, DOI 10.1016/S0140-6736(00)03231-1; Inoges S, 2006, J NATL CANCER I, V98, P1292, DOI 10.1093/jnci/djj358; Jager E, 2002, CURR OPIN IMMUNOL, V14, P178, DOI 10.1016/S0952-7915(02)00318-7; Ji H, 2006, ONCOGENE, V25, P2105, DOI 10.1038/sj.onc.1209237; June CH, 2007, J CLIN INVEST, V117, P1466, DOI 10.1172/JCI32446; Kao H, 2001, CLIN CANCER RES, V7, p773S; Kao H, 2001, J EXP MED, V194, P1313, DOI 10.1084/jem.194.9.1313; Kim ES, 2004, SEMIN ONCOL, V31, P61, DOI 10.1053/j.seminoncol.2003.12.016; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kohrt HE, 2005, PLOS MED, V2, P904, DOI 10.1371/journal.pmed.0020284; Korman AJ, 2006, ADV IMMUNOL, V90, P297, DOI 10.1016/S0065-2776(06)90008-X; Krone B, 2003, EUR J CANCER, V39, P2372, DOI 10.1016/S0959-8049(03)00625-7; Kusmartsev S, 2005, J IMMUNOL, V175, P4583, DOI 10.4049/jimmunol.175.7.4583; Lien S., 2008, V181, P131; Liu VC, 2007, J IMMUNOL, V178, P2883, DOI 10.4049/jimmunol.178.5.2883; Lollini PL, 2006, NAT REV CANCER, V6, P204, DOI 10.1038/nrc1815; Lowy DR, 2006, J CLIN INVEST, V116, P1167, DOI 10.1172/JCI28607; Ludewig B, 2004, J EXP MED, V200, P637, DOI 10.1084/jem.20040358; Mackensen A, 2006, J CLIN ONCOL, V24, P5060, DOI 10.1200/JCO.2006.07.1100; Mahnke K, 2007, INT J CANCER, V120, P2723, DOI 10.1002/ijc.22617; Melero I, 2007, NAT REV CANCER, V7, P95, DOI 10.1038/nrc2051; MELIEF CJM, 1989, COLD SH Q B, V54, P597; Mendelsohn J, 1997, CLIN CANCER RES, V3, P2703; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Muller AJ, 2007, CURR CANCER DRUG TAR, V7, P31, DOI 10.2174/156800907780006896; Munn DH, 2002, SCIENCE, V297, P1867, DOI 10.1126/science.1073514; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Nagaraj S, 2007, ADV EXP MED BIOL, V601, P213; NORTH RJ, 1986, J EXP MED, V164, P1652, DOI 10.1084/jem.164.5.1652; Palucka AK, 2006, J IMMUNOTHER, V29, P545, DOI 10.1097/01.cji.0000211309.90621.8b; Patel PH, 2008, ANN PHARMACOTHER, V42, P91, DOI 10.1345/aph.1K429; Phan GQ, 2003, P NATL ACAD SCI USA, V100, P8372, DOI 10.1073/pnas.1533209100; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Piersma SJ, 2007, CANCER RES, V67, P354, DOI 10.1158/0008-5472.CAN-06-3388; Powell DJ, 2007, J IMMUNOL, V179, P4919, DOI 10.4049/jimmunol.179.7.4919; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Redfern CH, 2006, J CLIN ONCOL, V24, P3107, DOI 10.1200/JCO.2005.04.4289; Renkvist N, 2001, CANCER IMMUNOL IMMUN, V50, P3, DOI 10.1007/s002620000169; Ribas A, 2007, ONCOLOGIST, V12, P873, DOI 10.1634/theoncologist.12-7-873; Rock KL, 2005, IMMUNOL REV, V207, P166, DOI 10.1111/j.0105-2896.2005.00301.x; Rock KL, 2005, SPRINGER SEMIN IMMUN, V26, P231, DOI 10.1007/s00281-004-0173-3; Roithmaier S, 2007, J HEART LUNG TRANSPL, V26, P845, DOI 10.1016/j.healun.2007.05.019; Russell JP, 2004, J IMMUNOL, V172, P4059, DOI 10.4049/jimmunol.172.7.4059; Saeland E, 2007, CANCER IMMUNOL IMMUN, V56, P1225, DOI 10.1007/s00262-006-0274-z; Sahin U, 1997, CURR OPIN IMMUNOL, V9, P709, DOI 10.1016/S0952-7915(97)80053-2; Schmielau J, 2001, CANCER RES, V61, P4756; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Sharma P, 2007, P NATL ACAD SCI USA, V104, P3967, DOI 10.1073/pnas.0611618104; Simson L, 2007, J IMMUNOL, V178, P4222, DOI 10.4049/jimmunol.178.7.4222; Sinha P, 2007, J IMMUNOL, V179, P977, DOI 10.4049/jimmunol.179.2.977; SLINGLUFF CL, 1994, CURR OPIN IMMUNOL, V6, P733, DOI 10.1016/0952-7915(94)90077-9; Small EJ, 2007, CLIN CANCER RES, V13, P1810, DOI 10.1158/1078-0432.CCR-06-2318; Smyth MJ, 2006, ADV IMMUNOL, V90, P1, DOI 10.1016/S0065-2776(06)90001-7; Soares MM, 2001, J IMMUNOL, V166, P6555, DOI 10.4049/jimmunol.166.11.6555; SRIVASTAVA PK, 1988, IMMUNOL TODAY, V9, P78, DOI 10.1016/0167-5699(88)91269-8; SUN ZT, 1991, CANCER DETECT PREV, V15, P313; Suzuki H, 2005, CLIN CANCER RES, V11, P1521, DOI 10.1158/1078-0432.CCR-04-0538; Teicher BA, 2007, CLIN CANCER RES, V13, P6247, DOI 10.1158/1078-0432.CCR-07-1654; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Vlad AM, 2004, ADV IMMUNOL, V82, P249, DOI 10.1016/S0065-2776(04)82006-6; Wahlin BE, 2007, CLIN CANCER RES, V13, P388, DOI 10.1158/1078-0432.CCR-06-1734; Weiner GJ, 2004, EXPERT OPIN BIOL TH, V4, P375, DOI 10.1517/14712598.4.3.375; Woo EY, 2001, CANCER RES, V61, P4766; Wu CJ, 2006, ADV IMMUNOL, V90, P133, DOI 10.1016/S0065-2776(06)90004-2; Wu CJ, 2005, CLIN CANCER RES, V11, P4504, DOI 10.1158/1078-0432.CCR-05-0036; Yee C, 2002, P NATL ACAD SCI USA, V99, P16168, DOI 10.1073/pnas.242600099; Zeng G, 2006, J IMMUNOL, V177, P3582, DOI 10.4049/jimmunol.177.6.3582; Zheng XF, 2006, J IMMUNOL, V177, P5639, DOI 10.4049/jimmunol.177.8.5639; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	116	668	706	7	116	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 19	2008	358	25					2704	2715		10.1056/NEJMra072739	http://dx.doi.org/10.1056/NEJMra072739			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	314NC	18565863				2022-12-28	WOS:000256815100007
J	Groh, WJ; Groh, MR; Saha, C; Kincaid, JC; Simmons, Z; Ciafaloni, E; Pourmand, R; Otten, RF; Bhakta, D; Nair, GV; Marashdeh, MM; Zipes, DP; Pascuzzi, RM				Groh, William J.; Groh, Miriam R.; Saha, Chandan; Kincaid, John C.; Simmons, Zachary; Ciafaloni, Emma; Pourmand, Rahman; Otten, Richard F.; Bhakta, Deepak; Nair, Girish V.; Marashdeh, Mohammad M.; Zipes, Douglas P.; Pascuzzi, Robert M.			Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VENTRICULAR-TACHYCARDIA; CARDIAC EVENTS; HEART; DISEASE; ARRHYTHMIAS; EXPANSION; MORTALITY; REPEAT; COHORT	Background Sudden death can occur as a consequence of cardiac- conduction abnormalities in the neuromuscular disease myotonic dystrophy type 1. The determinants of the risk of sudden death remain imprecise. Methods We assessed whether the electrocardiogram (ECG) was useful in predicting sudden death in 406 adult patients with genetically confirmed myotonic dystrophy type 1. A patient was characterized as having a severe abnormality if the ECG had at least one of the following features: rhythm other than sinus, PR interval of 240 msec or more, QRS duration of 120 msec or more, or second-degree or third-degree atrioventricular block. Results Patients with severe abnormalities according to the entry ECG were older than patients without severe abnormalities, had more severe skeletal-muscle impairment, and were more likely to have heart failure, left ventricular systolic dysfunction, or atrial tachyarrhythmia. Such patients were more likely to receive a pacemaker or an implantable cardioverter-defibrillator during the follow-up period. During a mean follow-up period of 5.7 years, 81 patients died; there were 27 sudden deaths, 32 deaths from progressive neuromuscular respiratory failure, 5 nonsudden deaths from cardiac causes, and 17 deaths from other causes. Among the 17 patients who died suddenly in whom postcollapse rhythm was evaluated, a ventricular tachyarrhythmia was observed in 9. A severe ECG abnormality (relative risk, 3.30; 95% confidence interval [CI], 1.24 to 8.78) and a clinical diagnosis of atrial tachyarrhythmia (relative risk, 5.18; 95% CI, 2.28 to 11.77) were independent risk factors for sudden death. Conclusions Patients with adult myotonic dystrophy type 1 are at high risk for arrhythmias and sudden death. A severe abnormality on the ECG and a diagnosis of an atrial tachyarrhythmia predict sudden death.	[Groh, William J.; Groh, Miriam R.; Otten, Richard F.; Bhakta, Deepak; Nair, Girish V.; Marashdeh, Mohammad M.; Zipes, Douglas P.] Indiana Univ, Krannert Inst Cardiol, Dept Med, Indianapolis, IN 46202 USA; [Saha, Chandan] Indiana Univ, Div Biostat, Indianapolis, IN 46202 USA; [Kincaid, John C.; Pascuzzi, Robert M.] Indiana Univ, Dept Neurol, Indianapolis, IN 46202 USA; [Simmons, Zachary] Penn State Univ, Dept Neurol, Hershey, PA USA; [Ciafaloni, Emma] Univ Rochester, Dept Neurol, Rochester, NY USA; [Pourmand, Rahman] SUNY Stony Brook, Dept Neurol, Stony Brook, NY 11794 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Rochester; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Groh, WJ (corresponding author), Indiana Univ, Krannert Inst Cardiol, Dept Med, 1800 N Capitol,Rm E406, Indianapolis, IN 46202 USA.	wgroh@iupui.edu		Zipes, Douglas/0000-0001-7141-6829	NCRR NIH HHS [MO1 RR00750-27S1] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000750] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		[Anonymous], 1989, NEW ENGL J MED, V321, P406; ASHIZAWA T, 1991, LANCET, V338, P642, DOI 10.1016/0140-6736(91)90659-D; ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0; Babuty D, 1999, HEART, V82, P634, DOI 10.1136/hrt.82.5.634; Bassez G, 2004, NEUROLOGY, V63, P1939, DOI 10.1212/01.WNL.0000144343.91136.CF; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Bhakta D, 2004, AM HEART J, V147, P224, DOI 10.1016/j.ahj.2003.08.008; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; Chugh SS, 2004, J AM COLL CARDIOL, V44, P1268, DOI 10.1016/j.jacc.2004.06.029; Clarke NRA, 2001, HEART, V86, P411, DOI 10.1136/heart.86.4.411; Colleran JA, 1997, AM J CARDIOL, V80, P1494, DOI 10.1016/S0002-9149(97)00742-X; de Die-Smulders CEM, 1998, BRAIN, V121, P1557, DOI 10.1093/brain/121.8.1557; FISCH C, 1951, AM HEART J, V41, P525, DOI 10.1016/0002-8703(51)90020-8; FLOREK RC, 1990, WESTERN J MED, V153, P24; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; Gregoratos Gabriel, 2002, Circulation, V106, P2145, DOI 10.1161/01.CIR.0000035996.46455.09; GRIGG LE, 1985, J AM COLL CARDIOL, V6, P254, DOI 10.1016/S0735-1097(85)80286-2; Hadian D, 2002, J CARDIOVASC ELECTR, V13, P72, DOI 10.1046/j.1540-8167.2002.00072.x; HAWLEY RJ, 1991, NEUROLOGY, V41, P259, DOI 10.1212/WNL.41.2_Part_1.259; *INT MYOT DYSTR CO, 2005, NEUROLOGY, V54, P1218; Lazarus A, 1999, CIRCULATION, V99, P1041, DOI 10.1161/01.CIR.99.8.1041; Lazarus A, 2002, J AM COLL CARDIOL, V40, P1645, DOI 10.1016/S0735-1097(02)02339-2; Mathieu J, 1999, NEUROLOGY, V52, P1658, DOI 10.1212/WNL.52.8.1658; Mathieu J, 2001, NEUROLOGY, V56, P336, DOI 10.1212/WNL.56.3.336; Merino JL, 1998, CIRCULATION, V98, P541, DOI 10.1161/01.CIR.98.6.541; NGUYEN HH, 1988, J AM COLL CARDIOL, V11, P662, DOI 10.1016/0735-1097(88)91547-1; Pelargonio G, 2002, HEART, V88, P665, DOI 10.1136/heart.88.6.665; Phillips MF, 1997, CARDIOVASC RES, V33, P13, DOI 10.1016/S0008-6363(96)00163-0; Pratt CM, 1996, CIRCULATION, V93, P519, DOI 10.1161/01.CIR.93.3.519; Rogers MT, 2002, NEUROMUSCULAR DISORD, V12, P358, DOI 10.1016/S0960-8966(02)00004-4	31	314	322	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 19	2008	358	25					2688	2697		10.1056/NEJMoa062800	http://dx.doi.org/10.1056/NEJMoa062800			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	314NC	18565861	Bronze			2022-12-28	WOS:000256815100005
J	Fischbach, RL; Loike, JD				Fischbach, Ruth L.; Loike, John D.			The art of medicine - Postmortem fatherhood: life after life	LANCET			English	Editorial Material							RETRIEVAL		[Fischbach, Ruth L.; Loike, John D.] Columbia Univ, Ctr Bioeth, New York, NY 10032 USA	Columbia University	Fischbach, RL (corresponding author), Columbia Univ, Ctr Bioeth, New York, NY 10032 USA.	rf416@columbia.edu						COHEN P, 1998, NEW SCI, V2126, P23; HELLER A, 2007, SAN FRANCISCO G 0129; Jakobovitz Y., 2005, JEWISH ACTION, V5765, P26; Landau R, 2004, HUM REPROD, V19, P1952, DOI 10.1093/humrep/deh360; RAPPOPORT SA, DECEASED FAMILY ORGA; Strong C, 2006, CAMB Q HEALTHC ETHIC, V15, P161	6	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN-JUL	2008	371	9631					2166	2167		10.1016/S0140-6736(08)60942-3	http://dx.doi.org/10.1016/S0140-6736(08)60942-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	326CP	18595168				2022-12-28	WOS:000257635800014
J	Likhtik, E; Popa, D; Apergis-Schoute, J; Fidacaro, GA; Pare, D				Likhtik, Ekaterina; Popa, Daniela; Apergis-Schoute, John; Fidacaro, George A., Jr.; Pare, Denis			Amygdala intercalated neurons are required for expression of fear extinction	NATURE			English	Article							MEDIAL PREFRONTAL CORTEX; DOPAMINE D1 RECEPTOR; POTENTIATED STARTLE; NMDA RECEPTORS; FACILITATION; MECHANISMS; MU	Congruent findings from studies of fear learning in animals and humans indicate that research on the circuits mediating fear constitutes our best hope of understanding human anxiety disorders(1-4). In mammals, repeated presentations of a conditioned stimulus that was previously paired to a noxious stimulus leads to the gradual disappearance of conditioned fear responses. Although much evidence suggests that this extinction process depends on plastic events in the amygdala(1-7), the underlying mechanisms remain unclear. Intercalated ( ITC) amygdala neurons constitute probable mediators of extinction because they receive information about the conditioned stimulus from the basolateral amygdala ( BLA)(8,9), and contribute inhibitory projections to the central nucleus ( CEA)(10,11), the main output station of the amygdala for conditioned fear responses(12). Thus, after extinction training, ITC cells could reduce the impact of conditioned- stimulus- related BLA inputs to the CEA by means of feed- forward inhibition. Here we test the hypothesis that ITC neurons mediate extinction by lesioning them with a toxin that selectively targets cells expressing mu- opioid receptors (mu ORs). Electron microscopic observations revealed that the incidence of mu OR- immunoreactive synapses is much higher in ITC cell clusters than in the BLA or CEA and that mORs typically have a post- synaptic location in ITC cells. In keeping with this, bilateral infusions of the mu OR agonist dermorphin conjugated to the toxin saporin in the vicinity of ITC neurons caused a 34% reduction in the number of ITC cells but no significant cell loss in surrounding nuclei. Moreover, ITC lesions caused a marked deficit in the expression of extinction that correlated negatively with the number of surviving ITC neurons but not CEA cells. Because ITC cells exhibit an unusual pattern of receptor expression, these findings open new avenues for the treatment of anxiety disorders.	[Likhtik, Ekaterina; Popa, Daniela; Apergis-Schoute, John; Fidacaro, George A., Jr.; Pare, Denis] Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick	Pare, D (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA.	pare@andromeda.rutgers.edu		Popa, Daniela/0000-0002-8389-1122	NIMH NIH HHS [F31 MH076415, R01MH-073610, F31 MH76415, R01 MH073610-04, R01 MH073610, F31 MH076415-02] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH076415, R01MH073610] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bremner JD, 2007, PROG BRAIN RES, V167, P171, DOI 10.1016/S0079-6123(07)67012-5; Burgos-Robles A, 2007, NEURON, V53, P871, DOI 10.1016/j.neuron.2007.02.021; Davis M., 2000, AMYGDALA, P213; FALLS WA, 1992, J NEUROSCI, V12, P854; Fuxe K, 2003, NEUROSCIENCE, V119, P733, DOI 10.1016/S0306-4522(03)00148-9; Gaudriault G, 1997, J BIOL CHEM, V272, P2880, DOI 10.1074/jbc.272.5.2880; Harris JA, 1998, PSYCHOPHARMACOLOGY, V140, P105, DOI 10.1007/s002130050745; Hobin JA, 2003, J NEUROSCI, V23, P8410; Jacobsen KX, 2006, NEUROSCIENCE, V141, P2007, DOI 10.1016/j.neuroscience.2006.05.054; Lee H, 1998, J NEUROSCI, V18, P8444; Marowsky A, 2005, NEURON, V48, P1025, DOI 10.1016/j.neuron.2005.10.029; McDonald AJ, 1996, NEUROSCIENCE, V71, P55, DOI 10.1016/0306-4522(95)00417-3; Milad MR, 2008, J PSYCHIATR RES, V42, P515, DOI 10.1016/j.jpsychires.2008.01.017; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; PARE D, 1993, NEUROSCIENCE, V57, P1077, DOI 10.1016/0306-4522(93)90050-P; PARE D, 1993, NEUROSCIENCE, V57, P1061, DOI 10.1016/0306-4522(93)90049-L; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Poulin JF, 2006, J COMP NEUROL, V496, P859, DOI 10.1002/cne.20956; Quirk GJ, 2003, J NEUROSCI, V23, P8800, DOI 10.1523/jneurosci.23-25-08800.2003; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; Repa JC, 2001, NAT NEUROSCI, V4, P724, DOI 10.1038/89512; Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944; Royer S, 1999, J NEUROSCI, V19, P10575; Royer S, 2003, NATURE, V422, P518, DOI 10.1038/nature01530; Royer S, 2002, NEUROSCIENCE, V115, P455, DOI 10.1016/S0306-4522(02)00455-4; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Sotres-Bayon F, 2007, NEUROPSYCHOPHARMACOL, V32, P1929, DOI 10.1038/sj.npp.1301316; Walker DL, 2002, J NEUROSCI, V22, P2343, DOI 10.1523/JNEUROSCI.22-06-02343.2002; Wiley RG, 2003, ADV DRUG DELIVER REV, V55, P1043, DOI 10.1016/S0169-409X(03)00102-9	30	339	343	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 31	2008	454	7204					642	U48		10.1038/nature07167	http://dx.doi.org/10.1038/nature07167			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	331QC	18615014	Green Accepted			2022-12-28	WOS:000258026500048
J	Hasselmann, M; Gempe, T; Schiott, M; Nunes-Silva, CG; Otte, M; Beye, M				Hasselmann, Martin; Gempe, Tanja; Schiott, Morten; Nunes-Silva, Carlos Gustavo; Otte, Marianne; Beye, Martin			Evidence for the evolutionary nascence of a novel sex determination pathway in honeybees	NATURE			English	Article							TRANSFORMER GENE; APIS-MELLIFERA; DROSOPHILA; SELECTION; RNA; RECOMBINATION; DIVERSITY; PROTEINS; INSIGHTS; INSECTS	Sex determination in honeybees (Apis mellifera) is governed by heterozygosity at a single locus harbouring the complementary sex determiner (csd) gene(1), in contrast to the well-studied sex chromosome system of Drosophila melanogaster(2). Bees heterozygous at csd are females, whereas homozygotes and hemizygotes (haploid individuals) are males. Although at least 15 different csd alleles are known among natural bee populations(3), the mechanisms linking allelic interactions to switching of the sexual development programme are still obscure. Here we report a new component of the sex-determining pathway in honeybees, encoded 12 kilobases upstream of csd. The gene feminizer (fem) is the ancestrally conserved progenitor gene from which csd arose and encodes an SR-type protein, harbouring an Arg/Ser-rich domain. Fem shares the same arrangement of Arg/Ser- and proline-rich-domain with the Drosophila principal sex-determining gene transformer (tra), but lacks conserved motifs except for a 30-amino-acid motif that Fem shares only with Tra of another fly, Ceratitis capitata(4). Like tra, the fem transcript is alternatively spliced. The male-specific splice variant contains a premature stop codon and yields no functional product, whereas the female-specific splice variant encodes the functional protein. We show that RNA interference (RNAi)-induced knockdowns of the female-specific fem splice variant result in male bees, indicating that the fem product is required for entire female development. Furthermore, RNAi- induced knockdowns of female allelic csd transcripts result in the male-specific fem splice variant, suggesting that the fem gene implements the switch of developmental pathways controlled by heterozygosity at csd. Comparative analysis of fem and csd coding sequences from five bee species indicates a recent origin of csd in the honeybee lineage from the fem progenitor and provides evidence for positive selection at csd accompanied by purifying selection at fem. The fem locus in bees uncovers gene duplication and positive selection as evolutionary mechanisms underlying the origin of a novel sex determination pathway.	[Hasselmann, Martin; Gempe, Tanja; Schiott, Morten; Otte, Marianne; Beye, Martin] Univ Dusseldorf, Dept Genet, D-40225 Dusseldorf, Germany; [Schiott, Morten] Univ Copenhagen, Ctr Social Evolut, Dept Biol, DK-2100 Copenhagen, Denmark; [Nunes-Silva, Carlos Gustavo] INPA, GPA, BR-69060001 Manaus, Amazonas, Brazil	Heinrich Heine University Dusseldorf; University of Copenhagen; Institute Nacional de Pesquisas da Amazonia	Beye, M (corresponding author), Univ Dusseldorf, Dept Genet, Universitaetsstr 1, D-40225 Dusseldorf, Germany.	martin.beye@uni-duesseldorf.de	Hasselmann, Martin/ABB-6485-2021; Schiøtt, Morten/H-4118-2012; Nunes-Silva, Carlos Gustavo/D-8760-2013; Hasselmann, Martin/E-7681-2014; Schiøtt, Morten/AAJ-8945-2021	Hasselmann, Martin/0000-0003-3305-4024; Schiøtt, Morten/0000-0002-4309-8090; Nunes-Silva, Carlos Gustavo/0000-0003-2276-838X; Schiøtt, Morten/0000-0002-4309-8090; Otte, Marianne/0000-0001-7433-2444				BELL LR, 1988, CELL, V55, P1037, DOI 10.1016/0092-8674(88)90248-6; Beye M, 2004, BIOESSAYS, V26, P1131, DOI 10.1002/bies.20098; Beye M, 2003, CELL, V114, P419, DOI 10.1016/S0092-8674(03)00606-8; Blencowe BJ, 1999, BIOCHEM CELL BIOL, V77, P277, DOI 10.1139/bcb-77-4-277; BOGGS RT, 1987, CELL, V50, P739, DOI 10.1016/0092-8674(87)90332-1; Bull J.J., 1983, EVOLUTION SEX DETERM; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; BUTLER B, 1986, EMBO J, V5, P3607, DOI 10.1002/j.1460-2075.1986.tb04689.x; CHARLESWORTH B, 1978, AM NAT, V112, P975, DOI 10.1086/283342; Charlesworth D, 2005, HEREDITY, V95, P118, DOI 10.1038/sj.hdy.6800697; Cline TW, 1996, ANNU REV GENET, V30, P637, DOI 10.1146/annurev.genet.30.1.637; COOK JM, 1993, HEREDITY, V71, P421, DOI 10.1038/hdy.1993.157; Engel MS, 2001, P NATL ACAD SCI USA, V98, P1661, DOI 10.1073/pnas.98.4.1661; Graves JAM, 2006, CELL, V124, P901, DOI 10.1016/j.cell.2006.02.024; Grimaldi David, 2005, pi; Hasselmann M, 2004, P NATL ACAD SCI USA, V101, P4888, DOI 10.1073/pnas.0307147101; Hasselmann M, 2006, GENETICS, V174, P1469, DOI 10.1534/genetics.106.062018; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; HOSHIJIMA K, 1991, SCIENCE, V252, P833, DOI 10.1126/science.1902987; KERR WE, 1987, INSECT SOC, V34, P274, DOI 10.1007/BF02224359; KEYES LN, 1992, CELL, V68, P933, DOI 10.1016/0092-8674(92)90036-C; Kulathinal RJ, 2003, MOL BIOL EVOL, V20, P441, DOI 10.1093/molbev/msg053; Lewis D, 1942, BIOL REV CAMB PHILOS, V17, P46, DOI 10.1111/j.1469-185X.1942.tb00431.x; NEI M, 2000, MOL EVOLUTION PHYLOG, P216; NOTHIGER R, 1985, COLD SPRING HARB SYM, V50, P615, DOI 10.1101/SQB.1985.050.01.074; Otto SP, 2002, NAT REV GENET, V3, P252, DOI 10.1038/nrg761; Pane A, 2002, DEVELOPMENT, V129, P3715; Pomiankowski A, 2004, GENETICS, V166, P1761, DOI 10.1534/genetics.166.4.1761; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; WILKINS AS, 1995, BIOESSAYS, V17, P71, DOI 10.1002/bies.950170113	30	176	189	4	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 24	2008	454	7203					519	U7		10.1038/nature07052	http://dx.doi.org/10.1038/nature07052			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329IC	18594516				2022-12-28	WOS:000257860300052
J	Davis, RM				Davis, Ronald M.			Achieving racial harmony for the benefit of patients and communities - Contrition, reconciliation, and collaboration	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Davis, Ronald M.] Amer Med Assoc, Chicago, IL 60610 USA; [Davis, Ronald M.] Henry Ford Hlth Syst, Ctr Hlth Promot & Dis Prevent, Detroit, MI USA	American Medical Association; Henry Ford Health System; Henry Ford Hospital	Davis, RM (corresponding author), Amer Med Assoc, 515 N State St, Chicago, IL 60610 USA.	ron.davis@ama-assn.org						*AM MED ASS, AMA AP HIST RAC IN N; *AM MED ASS, 2006, COD MED ETH AM MED A; *AMA COUNC LONG RA, 1A07 AMA CLRPD; Baker RB, 2008, JAMA-J AM MED ASSOC, V300, P306, DOI 10.1001/jama.300.3.306; Casalino LP, 2007, HEALTH AFFAIR, V26, pW405, DOI 10.1377/hlthaff.26.3.w405; Casalino LP, 2007, HLTH AFF MILLWOOD, V26, P1794, DOI DOI 10.1377/HLTHAFF.26.3.W405; DAVIS RM, 2008, AM MED NEWS     0121, P19; Eibach RP, 2006, PERS SOC PSYCHOL B, V32, P66, DOI 10.1177/0146167205279585; Kao AC, 2004, ACAD MED, V79, P882, DOI 10.1097/00001888-200409000-00015; Mead H., 2008, RACIAL ETHNIC DISPAR; *MEDICINENET, DEF PRAYER MAIM; Rosner F, 1967, Bull Hist Med, V41, P440; TAVUCHIS NICHOLAS, 1991, MEA CULPA SOCIOLOGY, P13; *US DEP HHS, 2007, NAT HEALTHC DISP REP	14	24	24	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 16	2008	300	3					323	325		10.1001/jama.300.3.323	http://dx.doi.org/10.1001/jama.300.3.323			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	325ZB	18617634				2022-12-28	WOS:000257626600025
J	Carroll, SB				Carroll, Sean B.			Evo-devo and an expanding evolutionary synthesis: A genetic theory of morphological evolution	CELL			English	Review							HOMEOTIC GENES; HOX PROTEIN; TRANSCRIPTIONAL NETWORK; REGULATORY EVOLUTION; PARALLEL EVOLUTION; DROSOPHILA EMBRYOS; PATTERN-FORMATION; PELVIC REDUCTION; EYELESS GENE; TARGET GENES	Biologists have long sought to understand which genes and what kinds of changes in their sequences are responsible for the evolution of morphological diversity. Here, I outline eight principles derived from molecular and evolutionary developmental biology and review recent studies of species divergence that have led to a genetic theory of morphological evolution, which states that (1) form evolves largely by altering the expression of functionally conserved proteins, and (2) such changes largely occur through mutations in the cis-regulatory sequences of pleiotropic developmental regulatory loci and of the target genes within the vast networks they control.	Univ Wisconsin, Howard Hughes Med Inst, Mol Biol Lab, Madison, WI 53706 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison	Carroll, SB (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, Mol Biol Lab, Madison, WI 53706 USA.	sbcarrol@wisc.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Adachi Y, 2003, MECH DEVELOP, V120, P1113, DOI 10.1016/j.mod.2003.08.007; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; AVEROF M, 1995, NATURE, V376, P420, DOI 10.1038/376420a0; Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Belting HG, 1998, P NATL ACAD SCI USA, V95, P2355, DOI 10.1073/pnas.95.5.2355; Bolton EC, 2007, GENE DEV, V21, P2005, DOI 10.1101/gad.1564207; Bowler T, 2006, DEV BIOL, V299, P78, DOI 10.1016/j.ydbio.2006.07.007; BRITTEN RJ, 1971, Q REV BIOL, V46, P111, DOI 10.1086/406830; BURKE AC, 1995, DEVELOPMENT, V121, P333; CARROLL SB, 1995, NATURE, V376, P479, DOI 10.1038/376479a0; CARROLL SB, 1994, SCIENCE, V265, P109, DOI 10.1126/science.7912449; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; CARROLL SB, 1995, NATURE, V375, P58, DOI 10.1038/375058a0; CARROLL SB, 2005, DNA DIVERSITY MOL GE; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Cooper GM, 2007, NAT GENET, V39, pS22, DOI 10.1038/ng2054; Cretekos CJ, 2008, GENE DEV, V22, P141, DOI 10.1101/gad.1620408; Davidson EH, 2006, REG GEN GEN REG; DUBOULE D, 1989, EMBO J, V8, P1497, DOI 10.1002/j.1460-2075.1989.tb03534.x; FITZGERALD K, 1993, DEVELOPMENT, V119, P1019; FORTINI ME, 1990, GENE DEV, V4, P444, DOI 10.1101/gad.4.3.444; Galant R, 2002, NATURE, V415, P910, DOI 10.1038/nature717; Gebelein B, 2004, NATURE, V431, P653, DOI 10.1038/nature02946; Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X; GELBART WM, 1989, DEVELOPMENT, V107, P65; Gilbert SF, 1996, DEV BIOL, V173, P357, DOI 10.1006/dbio.1996.0032; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; Gould S. J., 1994, HENS TEETH HORSES TO; GRAHAM A, 1989, CELL, V57, P367, DOI 10.1016/0092-8674(89)90912-4; Grenier JK, 2000, P NATL ACAD SCI USA, V97, P704, DOI 10.1073/pnas.97.2.704; Grenier JK, 1997, CURR BIOL, V7, P547, DOI 10.1016/S0960-9822(06)00253-3; Grens A, 1995, DEVELOPMENT, V121, P4027; HADORN E, 1961, DEV GENETICS LETHAL; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; Hall BK, 2003, INT J DEV BIOL, V47, P491; Han W, 1998, MOL CELL BIOL, V18, P3384, DOI 10.1128/MCB.18.6.3384; Hinman VF, 2007, DEV BIOL, V312, P584, DOI 10.1016/j.ydbio.2007.09.006; Hinman VF, 2007, P NATL ACAD SCI USA, V104, P19404, DOI 10.1073/pnas.0709994104; Hittinger CT, 2005, DEVELOPMENT, V132, P5261, DOI 10.1242/dev.02146; Hoegg S, 2005, TRENDS GENET, V21, P421, DOI 10.1016/j.tig.2005.06.004; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; Jeong S, 2008, CELL, V132, P783, DOI 10.1016/j.cell.2008.01.014; Jeong S, 2006, CELL, V125, P1387, DOI 10.1016/j.cell.2006.04.043; KIMURA M, 1974, P NATL ACAD SCI USA, V71, P2848, DOI 10.1073/pnas.71.7.2848; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Kusserow A, 2005, NATURE, V433, P156, DOI 10.1038/nature03158; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; LAWRENCE PA, 1984, CELL, V36, P570, DOI 10.1016/0092-8674(84)90333-7; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; LI XL, 1994, NATURE, V367, P83, DOI 10.1038/367083a0; Lohr U, 2005, CURR BIOL, V15, P643, DOI 10.1016/j.cub.2005.02.048; Lowe CB, 2007, P NATL ACAD SCI USA, V104, P8005, DOI 10.1073/pnas.0611223104; Lynch VJ, 2004, P ROY SOC B-BIOL SCI, V271, P2201, DOI 10.1098/rspb.2004.2848; MALICKI J, 1990, CELL, V63, P961, DOI 10.1016/0092-8674(90)90499-5; MCGINNIS N, 1990, CELL, V63, P969, DOI 10.1016/0092-8674(90)90500-E; MCGINNIS W, 1984, CELL, V37, P403, DOI 10.1016/0092-8674(84)90370-2; McGregor AP, 2007, NATURE, V448, P587, DOI 10.1038/nature05988; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Miller CT, 2007, CELL, V131, P1179, DOI 10.1016/j.cell.2007.10.055; Mundy NI, 2005, P ROY SOC B-BIOL SCI, V272, P1633, DOI 10.1098/rspb.2005.3107; Nasiadka A., 2002, AD DEV BIOL, V12, P155; Nichols SA, 2006, P NATL ACAD SCI USA, V103, P12451, DOI 10.1073/pnas.0604065103; Ochoa-Espinosa A, 2005, P NATL ACAD SCI USA, V102, P4960, DOI 10.1073/pnas.0500373102; Ohno S., 1970, EVOLUTION GENE DUPLI; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Panganiban G, 1997, P NATL ACAD SCI USA, V94, P5162, DOI 10.1073/pnas.94.10.5162; Papatsenko D, 2001, MECH DEVELOP, V101, P143, DOI 10.1016/S0925-4773(00)00581-5; Protas ME, 2006, NAT GENET, V38, P107, DOI 10.1038/ng1700; Prud'homme B, 2006, NATURE, V440, P1050, DOI 10.1038/nature04597; Raff RA, 2000, NAT REV GENET, V1, P74, DOI 10.1038/35049594; RICHARDSON Michael K, 2003, NAT GENET, V34, P351; Ronshaugen M, 2002, NATURE, V415, P914, DOI 10.1038/nature716; Sandmann T, 2007, GENE DEV, V21, P436, DOI 10.1101/gad.1509007; Schedl A, 1996, CELL, V86, P71, DOI 10.1016/S0092-8674(00)80078-1; SCOTT MP, 1984, P NATL ACAD SCI-BIOL, V81, P4115, DOI 10.1073/pnas.81.13.4115; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; Shapiro MD, 2006, P NATL ACAD SCI USA, V103, P13753, DOI 10.1073/pnas.0604706103; Shubin N, 1997, NATURE, V388, P639, DOI 10.1038/41710; Snyder M, 2008, J BIOL CHEM, V283, P3791, DOI 10.1074/jbc.M706976200; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Stauber M, 2002, P NATL ACAD SCI USA, V99, P274, DOI 10.1073/pnas.012292899; Steiner CC, 2007, PLOS BIOL, V5, P1880, DOI 10.1371/journal.pbio.0050219; STENT GS, 1984, CELL, V36, P567, DOI 10.1016/0092-8674(84)90332-5; Stern DL, 2000, EVOLUTION, V54, P1079, DOI 10.1554/0014-3820(2000)054[1079:PEDBAT]2.0.CO;2; Stern DL, 1998, NATURE, V396, P463, DOI 10.1038/24863; Sucena E, 2003, NATURE, V424, P935, DOI 10.1038/nature01768; Tuch BB, 2008, PLOS BIOL, V6, P352, DOI 10.1371/journal.pbio.0060038; VanderZwan-Butler CJ, 2007, DEV BIOL, V301, P350, DOI 10.1016/j.ydbio.2006.10.027; Wagner GP, 2007, NAT REV GENET, V8, P473, DOI 10.1038/nrg2099; Wang T, 2007, P NATL ACAD SCI USA, V104, P18613, DOI 10.1073/pnas.0703637104; Wang XD, 2002, GENE DEV, V16, P2345, DOI 10.1101/gad.996302; WARREN RW, 1994, NATURE, V372, P458, DOI 10.1038/372458a0; Wittkopp PJ, 2002, CURR BIOL, V12, P1547, DOI 10.1016/S0960-9822(02)01113-2; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Zhao YX, 2002, DEV BIOL, V244, P21, DOI 10.1006/dbio.2002.0595; Zhao YX, 2001, DEVELOPMENT, V128, P3197; Zinzen RP, 2006, DEV CELL, V11, P895, DOI 10.1016/j.devcel.2006.10.012; ZUCKERKANDL E, 1968, HEMOGLOBINS HAECKELS, P256; ZUCKERKANDL E, 1965, EVOLVING GENES PROTE, V5, P97	99	1235	1270	11	408	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 11	2008	134	1					25	36		10.1016/j.cell.2008.06.030	http://dx.doi.org/10.1016/j.cell.2008.06.030			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	324IU	18614008	Bronze			2022-12-28	WOS:000257513100011
J	Harris, JB; Michelow, IC; Westra, SJ; Kradin, RL				Harris, Jason B.; Michelow, Ian C.; Westra, Sjirk J.; Kradin, Richard L.			A boy with fever and pulmonary infiltrates - Necrotizing granulomatous pneumonitis due to A-terreus, complicating chronic granulomatous disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ASPERGILLUS-TERREUS; CLINICAL-FEATURES; P22(PHOX) SUBUNIT; FLAVOCYTOCHROME-B; TRANSPLANTATION; EPIDEMIOLOGY; TUBERCULOSIS; INFECTION; CHILDREN		[Harris, Jason B.; Michelow, Ian C.] Massachusetts Gen Hosp, Dept Pediat Pediat Infect Dis, Boston, MA 02114 USA; [Westra, Sjirk J.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Kradin, Richard L.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Harris, Jason B.; Michelow, Ian C.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Westra, Sjirk J.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Kradin, Richard L.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Harris, JB (corresponding author), Massachusetts Gen Hosp, Dept Pediat Pediat Infect Dis, Boston, MA 02114 USA.		Harris, Jason/ABF-2684-2020; Michelow, Ian C./AAH-2373-2020	Harris, Jason/0000-0003-3642-5126; Michelow, Ian C./0000-0002-8399-480X; Westra, Sjirk/0000-0002-9952-6891				Baddley JW, 2003, J CLIN MICROBIOL, V41, P5525, DOI 10.1128/JCM.41.12.5525-5529.2003; Chandler FW., 1987, PATHOLOGIC DIAGNOSIS, P303; Dahan I, 2002, J BIOL CHEM, V277, P8421, DOI 10.1074/jbc.M109778200; Gungor T, 2005, TRANSPLANTATION, V79, P1596, DOI 10.1097/01.TP.0000163466.73485.5E; Lass-Florl C, 2005, BRIT J HAEMATOL, V131, P201, DOI 10.1111/j.1365-2141.2005.05763.x; Moran CA, 2007, SEMIN DIAGN PATHOL, V24, P199, DOI 10.1053/j.semdp.2007.06.006; Roos D, 2003, MICROBES INFECT, V5, P1307, DOI 10.1016/j.micinf.2003.09.009; Rosenzweig SD, 2005, IMMUNOL REV, V203, P38, DOI 10.1111/j.0105-2896.2005.00227.x; Sastry J, 2006, PEDIATR BLOOD CANCER, V47, P327, DOI 10.1002/pbc.20865; Segal BH, 2000, MEDICINE, V79, P170, DOI 10.1097/00005792-200005000-00004; Segal BH, 1998, MEDICINE, V77, P345, DOI 10.1097/00005792-199809000-00004; STARKE JR, 2004, PEDIAT INFECT DIS, P1337; STEINER P, 1980, AM J DIS CHILD, V134, P747, DOI 10.1001/archpedi.1980.02130200017007; Taylor RM, 2004, J IMMUNOL, V173, P7349, DOI 10.4049/jimmunol.173.12.7349; Taylor RA, 2007, BIOCHEMISTRY-US, V46, P14291, DOI 10.1021/bi701626p; VALLEJO JG, 1994, PEDIATRICS, V94, P1; WALLGREN A, 1948, Tubercle, V29, P245, DOI 10.1016/S0041-3879(48)80033-4; Winkelstein JA, 2000, MEDICINE, V79, P155, DOI 10.1097/00005792-200005000-00003; WOLFSON JJ, 1968, RADIOLOGY, V91, P37, DOI 10.1148/91.1.37; World Health Organization, 2006, WHOHTMTB2006362	20	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 10	2008	359	2					178	187		10.1056/NEJMcpc0803619	http://dx.doi.org/10.1056/NEJMcpc0803619			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	323PJ	18614786				2022-12-28	WOS:000257459000011
J	Sebastian, SE; Harrison, N; Palm, E; Murphy, TP; Mielke, CH; Liang, RX; Bonn, DA; Hardy, WN; Lonzarich, GG				Sebastian, Suchitra E.; Harrison, N.; Palm, E.; Murphy, T. P.; Mielke, C. H.; Liang, Ruixing; Bonn, D. A.; Hardy, W. N.; Lonzarich, G. G.			A multi-component Fermi surface in the vortex state of an underdoped high-T-c superconductor	NATURE			English	Article							QUANTUM OSCILLATIONS; PHASE	To understand the origin of superconductivity, it is crucial to ascertain the nature and origin of the primary carriers available to participate in pairing(1-6). Recent quantum oscillation experiments on high- transition- temperature ( high- T-c) copper oxide superconductors(7-10) have revealed the existence of a Fermi surface akin to that in normal metals, comprising fermionic carriers that undergo orbital quantization(11). The unexpectedly small size of the observed carrier pocket, however, leaves open a variety of possibilities for the existence or form of any underlying magnetic order, and its relation to d- wave superconductivity(12-15). Here we report experiments on quantum oscillations in the magnetization ( the de Haas- van Alphen effect) in superconducting YBa2Cu3O6.51 that reveal more than one carrier pocket. In particular, we find evidence for the existence of a much larger pocket of heavier mass carriers playing a thermodynamically dominant role in this hole- doped superconductor. Importantly, characteristics of the multiple pockets within this more complete Fermi surface impose constraints on the wavevector of any underlying order and the location of the carriers in momentum space. These constraints enable us to construct a possible density- wave model with spiral or related modulated magnetic order, consistent with experimental observations.	[Sebastian, Suchitra E.; Lonzarich, G. G.] Univ Cambridge, Cavendish Lab, JJ Thomson Ave, Cambridge CB3 0HE, England; [Harrison, N.; Mielke, C. H.] Los Alamos Natl Lab, Natl High Magnet Field Lab, Los Alamos, NM 87545 USA; [Palm, E.; Murphy, T. P.] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32306 USA; [Liang, Ruixing; Bonn, D. A.; Hardy, W. N.] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z4, Canada; [Liang, Ruixing; Bonn, D. A.; Hardy, W. N.] Canadian Inst Adv Res, Toronto, ON M5G 1Z8, Canada	University of Cambridge; United States Department of Energy (DOE); Los Alamos National Laboratory; State University System of Florida; Florida State University; University of British Columbia; Canadian Institute for Advanced Research (CIFAR)	Sebastian, SE (corresponding author), Univ Cambridge, Cavendish Lab, JJ Thomson Ave, Cambridge CB3 0HE, England.	suchitra@phy.cam.ac.uk	Mielke, Charles H/S-6827-2016; Hardy, Walter Newbold/AAN-7827-2020	Mielke, Charles H/0000-0002-2096-5411; Harrison, Neil/0000-0001-5456-7756	Engineering and Physical Sciences Research Council [EP/C511778/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Anderson PW, 2004, J PHYS-CONDENS MAT, V16, pR755, DOI 10.1088/0953-8984/16/24/R02; Bangura AF, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.047004; Chaikin PM, 1996, J PHYS I, V6, P1875, DOI 10.1051/jp1:1996169; Chakravarty S, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.094503; CHAKRAVARTY S, 2007, FERMI POCKETS QUANTU; Chen WQ, 2008, EPL-EUROPHYS LETT, V82, DOI 10.1209/0295-5075/82/17004; Corcoran R, 1995, PHYSICA B, V206, P534, DOI 10.1016/0921-4526(94)00513-U; Damascelli A, 2003, REV MOD PHYS, V75, P473, DOI 10.1103/RevModPhys.75.473; Doiron-Leyraud N, 2007, NATURE, V447, P565, DOI 10.1038/nature05872; FAWCETT E, 1988, REV MOD PHYS, V60, P209, DOI 10.1103/RevModPhys.60.209; JAUDET C, 2007, DEHAASVANALPHEN OSCI; KAMPF AP, 1994, PHYS REP, V249, P220; Kaul RK, 2008, NAT PHYS, V4, P28, DOI 10.1038/nphys790; Lake B, 2001, SCIENCE, V291, P1759, DOI 10.1126/science.1056986; LeBoeuf D, 2007, NATURE, V450, P533, DOI 10.1038/nature06332; LEE PA, 2007, HIGH TEMPERATURE SUP; Liang RX, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.180505; Loram JW, 2001, J PHYS CHEM SOLIDS, V62, P59, DOI 10.1016/S0022-3697(00)00101-3; Miller RI, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.137002; Millis AJ, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.220503; NAUGHTON MJ, 1985, PHYS REV LETT, V55, P969, DOI 10.1103/PhysRevLett.55.969; Park T, 2006, NATURE, V440, P65, DOI 10.1038/nature04571; PODOLSKY D, 2008, QUANTUM OSCILLATIONS; SCHRIEFFER JR, 2007, HIGH TEMEPRATURE SUP; Shoenberg D., 1984, MAGNETIC OSCILLATION; SHRAIMAN BI, 1989, PHYS REV LETT, V62, P1564, DOI 10.1103/PhysRevLett.62.1564; Stock C, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.024522; Stock C, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.014502; Wosnitza J, 2000, PHYS REV B, V61, P7383, DOI 10.1103/PhysRevB.61.7383; Yelland EA, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.196405	31	208	212	1	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2008	454	7201					200	203		10.1038/nature07095	http://dx.doi.org/10.1038/nature07095			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	323RU	18615081	Green Submitted			2022-12-28	WOS:000257466900040
J	Eikelboom, JW; Weitz, JI				Eikelboom, John W.; Weitz, Jeffrey I.			Selective factor Xa inhibition for thromboprophylaxis	LANCET			English	Editorial Material							VENOUS THROMBOEMBOLISM; TOTAL HIP; KNEE REPLACEMENT; PROPHYLAXIS; PREVENTION; DURATION		[Eikelboom, John W.; Weitz, Jeffrey I.] McMaster Univ, Hamilton, ON L9K 1H8, Canada	McMaster University	Eikelboom, JW (corresponding author), McMaster Univ, Hamilton, ON L9K 1H8, Canada.	eikelbj@mcmaster.ca	Weitz, Jeffrey/AAD-1929-2019; Eikelboom, John/AAG-6117-2019	Weitz, Jeffrey/0000-0002-1092-7550; Eikelboom, John/0000-0003-4126-1285				*BAYER HEALTHC, 2008, PREV THROMB KNEE REP; Eikelboom JW, 2007, CIRCULATION, V116, P131, DOI 10.1161/CIRCULATIONAHA.107.712349; Eikelboom JW, 2001, LANCET, V358, P9, DOI 10.1016/S0140-6736(00)05249-1; Eriksson BI, 2007, LANCET, V370, P949, DOI 10.1016/S0140-6736(07)61445-7; ERIKSSON BI, 2007, ORAL RIVAROXABAN COM; Geerts WH, 2004, CHEST, V126, p338S, DOI 10.1378/chest.126.3_suppl.338S; Gross PL, 2008, ARTERIOSCL THROM VAS, V28, P380, DOI 10.1161/ATVBAHA.108.162677; KAKKAR AK, 2008, LANCET          0625, DOI DOI 10.1016/S0140-6736(08)60880-6; LASSEN MR, 2007, RIVAROXABAN ORAL DIR; Turpie AGG, 2007, ARTERIOSCL THROM VAS, V27, P1238, DOI 10.1161/ATVBAHA.107.139402; Warwick D, 2007, J BONE JOINT SURG BR, V89B, P799, DOI 10.1302/0301-620X.89B6.18844	11	6	11	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 5	2008	372	9632					6	8		10.1016/S0140-6736(08)60879-x	http://dx.doi.org/10.1016/S0140-6736(08)60879-x			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	321XN	18582929				2022-12-28	WOS:000257339900006
J	Loxterkamp, D				Loxterkamp, David			A friend in need	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Seaport Family Practice, Belfast, ME 04915 USA		Loxterkamp, D (corresponding author), Seaport Family Practice, Belfast, ME 04915 USA.	mclobster@verizon.net						CHAMPLIN L, 2007, AAFP NEWS NOW, V3	1	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 5	2008	337	7660							a528	10.1136/bmj.a528	http://dx.doi.org/10.1136/bmj.a528			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	326DF	18595896	Green Published			2022-12-28	WOS:000257637500030
J	van de Wal, RSW; Boot, W; van den Broeke, MR; Smeets, CJPP; Reijmer, CH; Donker, JJA; Oerlemans, J				van de Wal, R. S. W.; Boot, W.; van den Broeke, M. R.; Smeets, C. J. P. P.; Reijmer, C. H.; Donker, J. J. A.; Oerlemans, J.			Large and rapid melt-induced velocity changes in the ablation zone of the Greenland Ice Sheet	SCIENCE			English	Article							GLACIER	Continuous Global Positioning System observations reveal rapid and large ice velocity fluctuations in the western ablation zone of the Greenland Ice Sheet. Within days, ice velocity reacts to increased meltwater production and increases by a factor of 4. Such a response is much stronger and much faster than previously reported. Over a longer period of 17 years, annual ice velocities have decreased slightly, which suggests that the englacial hydraulic system adjusts constantly to the variable meltwater input, which results in a more or less constant ice flux over the years. The positive- feedback mechanism between melt rate and ice velocity appears to be a seasonal process that may have only a limited effect on the response of the ice sheet to climate warming over the next decades.	[van de Wal, R. S. W.; Boot, W.; van den Broeke, M. R.; Smeets, C. J. P. P.; Reijmer, C. H.; Donker, J. J. A.; Oerlemans, J.] Univ Utrecht, Inst Marine & Atmospher Res Utrecht, NL-3508 TC Utrecht, Netherlands	Utrecht University	van de Wal, RSW (corresponding author), Univ Utrecht, Inst Marine & Atmospher Res Utrecht, NL-3508 TC Utrecht, Netherlands.	r.s.w.vandewal@uu.nl	Reijmer, Carleen H/G-8736-2011; Van den Broeke, Michiel R./F-7867-2011; van de wal, roderik/D-1705-2011; Oerlemans, Johannes/G-3802-2011	Reijmer, Carleen H/0000-0001-8299-3883; Van den Broeke, Michiel R./0000-0003-4662-7565; van de wal, roderik/0000-0003-2543-3892; 				Abdalati W, 2001, J GEOPHYS RES-ATMOS, V106, P33729, DOI 10.1029/2001JD900192; Bartholomaus TC, 2008, NAT GEOSCI, V1, P33, DOI 10.1038/ngeo.2007.52; Das SB, 2008, SCIENCE, V320, P778, DOI 10.1126/science.1153360; Howat IM, 2007, SCIENCE, V315, P1559, DOI 10.1126/science.1138478; IKEN A, 1986, J GLACIOL, V32, P101, DOI 10.3189/S0022143000006936; Joughin I, 2008, SCIENCE, V320, P781, DOI 10.1126/science.1153288; Krabill W, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021533; Lemke P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P337; Rignot E, 2006, SCIENCE, V311, P986, DOI 10.1126/science.1121381; Stearns LA, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028982; van de Wal RSW, 2005, ANN GLACIOL-SER, V42, P311, DOI 10.3189/172756405781812529; van der Veen CJ, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028385; Vincenty T., 1975, SURVEY REV, V23, P88, DOI [10.1179/sre.1975.23.176.88, DOI 10.1179/SRE.1975.23.176.88]; Zwally HJ, 2002, SCIENCE, V297, P218, DOI 10.1126/science.1072708	14	228	228	1	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2008	321	5885					111	113		10.1126/science.1158540	http://dx.doi.org/10.1126/science.1158540			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QE	18599784				2022-12-28	WOS:000257320800048
J	Fan, E; Soong, C; Kain, KC; Detsky, AS				Fan, Eddy; Soong, Christine; Kain, Kevin C.; Detsky, Allan S.			A gut feeling	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INTESTINAL CAPILLARIASIS		[Kain, Kevin C.; Detsky, Allan S.] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Fan, Eddy] Univ Toronto, Interdepartmental Div Crit Care Med, Toronto, ON, Canada; [Fan, Eddy; Kain, Kevin C.; Detsky, Allan S.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Kain, Kevin C.] Univ Toronto, McLaughlin Rotman Ctr Global Hlth, Toronto, ON, Canada; [Kain, Kevin C.] Univ Toronto, McLaughlin Ctr Mol Med, Toronto, ON, Canada; [Detsky, Allan S.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Kain, Kevin C.] Ontario Prov Hlth Lab, Toronto, ON, Canada; Univ Hlth Network, Toronto, ON, Canada; [Soong, Christine] William Osler Hlth Ctr, Dept Med, Etobicoke, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Detsky, AS (corresponding author), Mt Sinai Hosp, Dept Med, 600 Univ Ave,Suite 427, Toronto, ON M5G 1X5, Canada.	allan.detsky@uhn.on.ca		Kain, Kevin/0000-0001-6068-1272				Bair MJ, 2004, WORLD J GASTROENTERO, V10, P2391; CHITWOOD MB, 1968, J PARASITOL, V54, P368, DOI 10.2307/3276953; CROSS JH, 1992, CLIN MICROBIOL REV, V5, P120, DOI 10.1128/CMR.5.2.120-129.1992; Elstein AS, 2006, BRIT MED J, V333, P944; Greenwald R, 2005, NEW ENGL J MED, V353, P2089, DOI 10.1056/NEJM200511103531923; Norman G, 2006, NEW ENGL J MED, V355, P2251, DOI 10.1056/NEJMe068134; Tang HW, 2006, BRIT MED J, V333, P1143, DOI 10.1136/bmj.39003.640567.AE; WHALEN GE, 1969, LANCET, V1, P13	8	2	3	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 3	2008	359	1					75	80		10.1056/NEJMcps0706713	http://dx.doi.org/10.1056/NEJMcps0706713			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320PB	18596276				2022-12-28	WOS:000257246000011
J	Wang, LH; Lin, RP; Larson, DE; Luhmann, JG				Wang, Linghua; Lin, Robert P.; Larson, Davin E.; Luhmann, Janet G.			Domination of heliosheath pressure by shock-accelerated pickup ions from observations of neutral atoms	NATURE			English	Article							LOW-ENERGY IONS; TERMINATION SHOCK; SOLAR-WIND; HYDROGEN; HELIUM	The solar wind blows an immense magnetic bubble, the heliosphere, in the local interstellar medium ( mostly neutral gas) flowing by the Sun(1). Recent measurements by Voyager 2 across the termination shock, where the solar wind is slowed to subsonic speeds before entering the heliosheath, found that the shocked solar wind plasma(2) contains only similar to 20 per cent of the energy released by the termination shock, whereas energetic particles(3) above similar to 28 keV contain only similar to 10 per cent; similar to 70 per cent of the energy is unaccounted for, leading to speculation(2,3) that the unmeasured pickup ions or energetic particles below similar to 28 keV contain the missing energy. Here we report the detection and mapping of heliosheath energetic ( 4 - 20 keV) neutral atoms produced by charge exchange of suprathermal ions with interstellar neutral atoms. The energetic neutral atoms come from a source similar to 60 degrees wide in longitude straddling the direction of the local interstellar medium. Their energy spectra resemble those of solar wind pickup ions, but with a knee at similar to 11 keV instead of similar to 4 keV, indicating that their parent ions are pickup ions energized by the termination shock. These termination- shock- energized pickup ions contain the missing similar to 70 per cent of the energy dissipated in the termination shock, and they dominate the pressure in the heliosheath.	[Wang, Linghua; Lin, Robert P.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Wang, Linghua; Lin, Robert P.; Larson, Davin E.; Luhmann, Janet G.] Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Wang, LH (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	windsound@ssl.berkeley.edu	Wang, Linghua/C-4938-2014	Wang, Linghua/0000-0001-7309-4325				Axford W.I., 1972, SOLAR WIND, P609; Collier MR, 2004, ADV SPACE RES-SERIES, V34, P166, DOI 10.1016/j.asr.2003.03.068; Decker RB, 2006, AIP CONF PROC, V858, P73; Fisk LA, 2006, ASTROPHYS J, V644, P631, DOI 10.1086/503535; Galli A, 2006, ASTROPHYS J, V644, P1317, DOI 10.1086/503765; Gloeckler G, 2004, ASTRON ASTROPHYS, V426, P845, DOI 10.1051/0004-6361:20035768; Gloeckler G, 2006, AIP CONF PROC, V858, P153; Gruntman M, 2001, J GEOPHYS RES-SPACE, V106, P15767, DOI 10.1029/2000JA000328; Heerikhuisen J, 2007, ASTROPHYS J, V655, pL53, DOI 10.1086/511764; Hilchenbach M, 1998, ASTROPHYS J, V503, P916, DOI 10.1086/306022; LIN RP, IN PRESS SPACE SCI R; LUHMANN JG, IN PRESS SPACE SCI R; RICHARDSON JD, 1995, GEOPHYS RES LETT, V22, P1469, DOI 10.1029/95GL01421; Witte M, 2004, ADV SPACE RES-SERIES, V34, P61, DOI 10.1016/j.asr.2003.01.037; Wurz P, 2006, AIP CONF PROC, V858, P269	15	16	17	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2008	454	7200					81	83		10.1038/nature07068	http://dx.doi.org/10.1038/nature07068			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321MC	18596805				2022-12-28	WOS:000257308300040
J	Farag, N; Ship, AN; Arroyo, JG				Farag, Nadine; Ship, Amy N.; Arroyo, Jorge G.			Update: A 76-year-old man with macular degeneration	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							OXIDATIVE STRESS; APOPTOSIS; SMOKING; ACID							Arroyo, Jorge/0000-0001-9812-296X				Arroyo JG, 2007, BRIT J OPHTHALMOL, V91, P130, DOI 10.1136/bjo.2006.106534; Arroyo JG, 2006, JAMA-J AM MED ASSOC, V295, P2394, DOI 10.1001/jama.295.20.2394; Baird PN, 2008, HUM MOL GENET, V17, P1299, DOI 10.1093/hmg/ddn018; Chucair AJ, 2007, INVEST OPHTH VIS SCI, V48, P5168, DOI 10.1167/iovs.07-0037; Duan YK, 2007, OPHTHALMOLOGY, V114, P732, DOI 10.1016/j.ophtha.2006.07.045; Kalayoglu MV, 2005, GRAEF ARCH CLIN EXP, V243, P1080, DOI 10.1007/s00417-005-1169-y; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Koto T, 2007, INVEST OPHTH VIS SCI, V48, P4328, DOI 10.1167/iovs.06-1148; Radke ND, 2004, ARCH OPHTHALMOL-CHIC, V122, P1159, DOI 10.1001/archopht.122.8.1159; Rotstein NP, 2003, INVEST OPHTH VIS SCI, V44, P2252, DOI 10.1167/iovs.02-0901; Scott WK, 2007, OPHTHALMOLOGY, V114, P1151, DOI 10.1016/j.ophtha.2006.08.054; Sieving PA, 2006, P NATL ACAD SCI USA, V103, P3896, DOI 10.1073/pnas.0600236103; Tan JSL, 2008, BRIT J OPHTHALMOL, V92, P509, DOI 10.1136/bjo.2007.131706; Tanito M, 2007, INVEST OPHTH VIS SCI, V48, P1900, DOI 10.1167/iovs.06-1057	14	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 2	2008	300	1					91	92		10.1001/jama.300.1.91	http://dx.doi.org/10.1001/jama.300.1.91			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320NW	18594043				2022-12-28	WOS:000257242800028
J	Christakis, NA				Christakis, Nicholas A.			Health care in a web	BRITISH MEDICAL JOURNAL			English	Editorial Material									Harvard Univ, Sch Med, Cambridge, MA 02138 USA; Mt Auburn Hosp, Cambridge, MA USA	Harvard University; Harvard University; Mount Auburn Hospital	Christakis, NA (corresponding author), Harvard Univ, Sch Med, Cambridge, MA 02138 USA.	christak@hcp.med.harvard.edu	Christakis, Nicholas A/C-3205-2009						0	7	7	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 28	2008	336	7659					1468	1468		10.1136/bmj.a452	http://dx.doi.org/10.1136/bmj.a452			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	324GN	18583678	Green Published			2022-12-28	WOS:000257505900032
J	Affolter, M; Slattery, M; Mann, RS				Affolter, Markus; Slattery, Matthew; Mann, Richard S.			A lexicon for homeodomain-DNA recognition	CELL			English	Editorial Material							HOX; PROTEIN	Decoding the cis-regulatory logic of eukaryotic genomes requires knowledge of the DNA-binding specificities of all transcription factors. New work (Berger et al., 2008; Noyes et al., 2008) provides individual specificities for nearly all Drosophila and mouse homeodomains, key DNA-binding domains in many transcription factors. The data underscore the complexity of determining target specificities in vivo.	[Affolter, Markus] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Slattery, Matthew; Mann, Richard S.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA	University of Basel; Columbia University	Affolter, M (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.	markus.affolter@unibas.ch; rsm10@columbia.edu		Affolter, Markus/0000-0002-5171-0016	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054510] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM054510] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Berkes CA, 2004, MOL CELL, V14, P465, DOI 10.1016/S1097-2765(04)00260-6; Galant R, 2002, DEVELOPMENT, V129, P3115; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; Joshi R, 2007, CELL, V131, P530, DOI 10.1016/j.cell.2007.09.024; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Mann RS, 1998, CURR OPIN GENET DEV, V8, P423, DOI 10.1016/S0959-437X(98)80113-5; Moens CB, 2006, DEV BIOL, V291, P193, DOI 10.1016/j.ydbio.2005.10.032; Warren CL, 2006, P NATL ACAD SCI USA, V103, P867, DOI 10.1073/pnas.0509843102	8	24	24	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 27	2008	133	7					1133	1135		10.1016/j.cell.2008.06.008	http://dx.doi.org/10.1016/j.cell.2008.06.008			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	319DP	18585344	Bronze			2022-12-28	WOS:000257144600007
J	Dreses-Werringloer, U; Lambert, JC; Vingtdeux, V; Zhao, HT; Vais, H; Siebert, A; Jain, A; Koppel, J; Rovelet-Lecrux, A; Hannequin, D; Pasquier, F; Galimberti, D; Scarpini, E; Mann, D; Lendon, C; Campion, D; Amouyel, P; Davies, P; Foskett, JK; Campagne, F; Marambaud, P				Dreses-Werringloer, Ute; Lambert, Jean-Charles; Vingtdeux, Valerie; Zhao, Haitian; Vais, Horia; Siebert, Adam; Jain, Ankit; Koppel, Jeremy; Rovelet-Lecrux, Anne; Hannequin, Didier; Pasquier, Florence; Galimberti, Daniela; Scarpini, Elio; Mann, David; Lendon, Corinne; Campion, Dominique; Amouyel, Philippe; Davies, Peter; Foskett, J. Kevin; Campagne, Fabien; Marambaud, Philippe			A polymorphism in CALHM1 influences Ca2+ homeostasis, A beta levels, and Alzheimer's disease risk	CELL			English	Article							CHROMOSOME 10Q; ASSOCIATION; CHANNELS; LOCUS; IDENTIFICATION; BINDING; LINKAGE; SCAN; GENE	Alzheimer's disease (AD) is a genetically heterogeneous disorder characterized by early hippocampal atrophy and cerebral amyloid-beta (A beta) peptide deposition. Using TissueInfo to screen for genes preferentially expressed in the hippocampus and located in AD linkage regions, we identified a gene on 10q24.33 that we call CALHM1. We show that CALHM1 encodes a multipass transmembrane glycoprotein that controls cytosolic Ca2+ concentrations and Ab levels. CALHM1 homomultimerizes, shares strong sequence similarities with the selectivity filter of the NMDA receptor, and generates a large Ca2+ conductance across the plasma membrane. Importantly, we determined that the CALHM1 P86L polymorphism (rs2986017) is significantly associated with AD in independent case-control studies of 3404 participants (allele-specific OR = 1.44, p = 2 x 10(-10)). We further found that the P86L polymorphism increases A beta levels by interfering with CALHM1-mediated Ca2+ permeability. We propose that CALHM1 encodes an essential component of a previously uncharacterized cerebral Ca2+ channel that controls Ab levels and susceptibility to late-onset AD.	[Campagne, Fabien] Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA; [Campagne, Fabien] Cornell Univ, Weill Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulazix Alsau, New York, NY 10021 USA; [Dreses-Werringloer, Ute; Vingtdeux, Valerie; Zhao, Haitian; Koppel, Jeremy; Davies, Peter; Marambaud, Philippe] N Shore LIJ, Litwin Zucker Res Ctr Study Alzheimers Dis, Feinstein Inst Med Res, Manhasset, NY 11030 USA; [Lambert, Jean-Charles; Amouyel, Philippe] Univ Lille 2, Inst Pasteur, INSERM, U744, F-59019 Lille, France; [Vais, Horia; Siebert, Adam; Jain, Ankit; Foskett, J. Kevin] Univ Penn, Dept Phys, Sch Med, Philadelphia, PA 19104 USA; [Rovelet-Lecrux, Anne; Hannequin, Didier; Campion, Dominique] Fac Med, INSERM, U614, F-76000 Rouen, France; [Pasquier, Florence] Univ Hosp, Dept Neurol, F-59037 Lille, France; [Galimberti, Daniela; Scarpini, Elio] Univ Milan, Dept Neurol Sci, Dino Ferrari Ctr, IRCCS Osped Maggiore Policlin, I-20122 Milan, Italy; [Mann, David] Univ Manchester, Greater Manchester Neurosci Ctr, Salford M6 8HD, Lancs, England; [Lendon, Corinne] Queensland Inst Med Res, Mol Psychiat Grp, Brisbane, Qld 4006, Australia; [Davies, Peter; Marambaud, Philippe] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA	Cornell University; Cornell University; Northwell Health; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; University of Pennsylvania; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Manchester; QIMR Berghofer Medical Research Institute; Yeshiva University; Albert Einstein College of Medicine	Campagne, F (corresponding author), Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA.	fac2003@med.cornell.edu; pmaramba@aecom.yu.edu	LICEND, CEMND/F-1296-2015; Campagne, Fabien/F-5158-2010; lambert, jean-charles/F-8787-2013; Pasquier, Florence/F-1527-2017; Lambert, jean-charles/A-9553-2014; Galimberti, Daniela/N-7209-2019; Rovelet-Lecrux, Anne/AAL-4305-2020; Foskett, Kevin/R-2549-2019; Vingtdeux, Valerie/C-2463-2012; Scarpini, Elio/K-6547-2016	lambert, jean-charles/0000-0003-0829-7817; Pasquier, Florence/0000-0001-9880-9788; Lambert, jean-charles/0000-0003-0829-7817; Galimberti, Daniela/0000-0002-9284-5953; Vingtdeux, Valerie/0000-0003-4550-503X; Amouyel, Philippe/0000-0001-9088-234X; Foskett, J. Kevin/0000-0002-8854-0268; Scarpini, Elio/0000-0002-6395-2119; Jain, Ankit/0000-0003-4032-1442; Campagne, Fabien/0000-0001-6237-3564; Marambaud, Philippe/0000-0002-8983-1497	NIMH NIH HHS [R01 MH059937, R01 MH059937-09] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059937] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bertram L, 2006, AM J HUM GENET, V79, P180, DOI 10.1086/505032; Bertram L, 2000, SCIENCE, V290, P2302, DOI 10.1126/science.290.5500.2302; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Blacker D, 2003, HUM MOL GENET, V12, P23, DOI 10.1093/hmg/ddg007; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BRESLOW NE, 1978, AM J EPIDEMIOL, V108, P299, DOI 10.1093/oxfordjournals.aje.a112623; Campagne F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-481; Conrad C, 2002, P NATL ACAD SCI USA, V99, P7751, DOI 10.1073/pnas.112194599; de Leon MJ, 2007, ANN NY ACAD SCI, V1097, P114, DOI 10.1196/annals.1379.012; Dingledine R, 1999, PHARMACOL REV, V51, P7; Ertekin-Taner N, 2000, SCIENCE, V290, P2303, DOI 10.1126/science.290.5500.2303; Farrer LA, 2003, HUM MOL GENET, V12, P415, DOI 10.1093/hmg/ddg037; Gouaux E, 2005, SCIENCE, V310, P1461, DOI 10.1126/science.1113666; Grupe A, 2006, AM J HUM GENET, V78, P78, DOI 10.1086/498851; Kasprzyk A, 2004, GENOME RES, V14, P160, DOI 10.1101/gr.1645104; Kehoe P, 1999, HUM MOL GENET, V8, P237, DOI 10.1093/hmg/8.2.237; Kennedy JL, 2003, SCIENCE, V302, P822, DOI 10.1126/science.1092132; KHACHATURIAN ZS, 1989, ANN NY ACAD SCI, V568, P1, DOI 10.1111/j.1749-6632.1989.tb12485.x; Kuwano R, 2006, HUM MOL GENET, V15, P2170, DOI 10.1093/hmg/ddl142; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; Lambert JC, 2007, PSYCHONEUROENDOCRINO, V32, pS62, DOI 10.1016/j.psyneuen.2007.05.015; Marambaud P, 2005, J BIOL CHEM, V280, P37377, DOI 10.1074/jbc.M508246200; Marambaud P, 2005, GENES BRAIN BEHAV, V4, P134, DOI 10.1111/j.1601-183X.2005.00086.x; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Minster RL, 2006, NEUROSCI LETT, V408, P170, DOI 10.1016/j.neulet.2006.08.081; Myers A, 2000, SCIENCE, V290, P2304, DOI 10.1126/science.290.5500.2304; Pastor Pau, 2004, Curr Psychiatry Rep, V6, P125, DOI 10.1007/s11920-004-0052-6; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; SHIBUYA I, 1992, ENDOCRINOLOGY, V131, P1936, DOI 10.1210/en.131.4.1936; Skrabanek L, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.21.e102; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Wilquet V, 2004, CURR OPIN NEUROBIOL, V14, P582, DOI 10.1016/j.conb.2004.08.001; Wollmuth LP, 2004, TRENDS NEUROSCI, V27, P321, DOI 10.1016/j.tins.2004.04.005	35	259	272	1	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 27	2008	133	7					1149	1161		10.1016/j.cell.2008.05.048	http://dx.doi.org/10.1016/j.cell.2008.05.048			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	319DP	18585350	Green Accepted, Bronze			2022-12-28	WOS:000257144600013
J	Lenoir, J; Gegout, JC; Marquet, PA; de Ruffray, P; Brisse, H				Lenoir, J.; Gegout, J. C.; Marquet, P. A.; de Ruffray, P.; Brisse, H.			A significant upward shift in plant species optimum elevation during the 20th century	SCIENCE			English	Article							CLIMATE-CHANGE; UPHILL SHIFTS; ALPINE PLANTS; GLOBAL CHANGE; RANGE; FINGERPRINTS; BUTTERFLIES; RESPONSES; MARGIN; EXTENT	Spatial fingerprints of climate change on biotic communities are usually associated with changes in the distribution of species at their latitudinal or altitudinal extremes. By comparing the altitudinal distribution of 171 forest plant species between 1905 and 1985 and 1986 and 2005 along the entire elevation range ( 0 to 2600 meters above sea level) in west Europe, we show that climate warming has resulted in a significant upward shift in species optimum elevation averaging 29 meters per decade. The shift is larger for species restricted to mountain habitats and for grassy species, which are characterized by faster population turnover. Our study shows that climate change affects the spatial core of the distributional range of plant species, in addition to their distributional margins, as previously reported.	[Lenoir, J.; Gegout, J. C.] Lab Etud Ressources Foret Bois LERFoB, AgroParisTech, UMR 1092, F-54000 Nancy, France; [Marquet, P. A.] Pontificia Univ Catolica Chile, CASEB, Dept Ecol, Santiago 6513677, Chile; [Marquet, P. A.] IEB, Santiago, Chile; [Marquet, P. A.] Santa Fe Inst, Santa Fe, NM 87501 USA; [de Ruffray, P.] Univ Strasbourg 1, CNRS, Inst Biol Mol Plantes, F-67084 Strasbourg, France; [Brisse, H.] Fac Sci & Tech St Jerome, CNRS, IMEP, UMR 6116, F-34397 Marseille 20, France	AgroParisTech; Pontificia Universidad Catolica de Chile; The Santa Fe Institute; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Lenoir, J (corresponding author), Lab Etud Ressources Foret Bois LERFoB, AgroParisTech, UMR 1092, 14 Rue Girardet, F-54000 Nancy, France.	jonathan.lenoir@agroparistech.fr	Marquet, Pablo A/B-7732-2009; Lenoir, Jonathan/AAE-8441-2019	Marquet, Pablo A/0000-0001-6369-9339; Lenoir, Jonathan/0000-0003-0638-9582; Gegout, Jean-Claude/0000-0002-5760-9920				Beniston M, 1997, CLIMATIC CHANGE, V36, P233, DOI 10.1023/A:1005380714349; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Chapin FS, 2004, AMBIO, V33, P361, DOI 10.1639/0044-7447(2004)033[0361:GCATBF]2.0.CO;2; Coudun C, 2006, ECOL MODEL, V199, P164, DOI 10.1016/j.ecolmodel.2006.05.024; DAMBRINE E, 1994, FOREST DECLINE ATMOS, P177; GRABHERR G, 1994, NATURE, V369, P448, DOI 10.1038/369448a0; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Hill JK, 2002, P ROY SOC B-BIOL SCI, V269, P2163, DOI 10.1098/rspb.2002.2134; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Jones PD, 2001, SCIENCE, V292, P662, DOI 10.1126/science.1059126; Keller F, 2000, REG ENVIRON CHANGE, V1, P70, DOI 10.1007/PL00011535; Konvicka M, 2003, GLOBAL ECOL BIOGEOGR, V12, P403, DOI 10.1046/j.1466-822X.2003.00053.x; Kullman L, 2002, J ECOL, V90, P68, DOI 10.1046/j.0022-0477.2001.00630.x; Lavergne S, 2006, GLOBAL CHANGE BIOL, V12, P1466, DOI 10.1111/j.1365-2486.2006.01183.x; Lesica P, 2004, J VEG SCI, V15, P679, DOI 10.1111/j.1654-1103.2004.tb02310.x; Moisselin J.M., 2002, METEOROLOGIE, V38, P45, DOI DOI 10.4267/2042/36233; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pauli H, 2007, GLOBAL CHANGE BIOL, V13, P147, DOI 10.1111/j.1365-2486.2006.01282.x; Penuelas J, 2003, GLOBAL CHANGE BIOL, V9, P131, DOI 10.1046/j.1365-2486.2003.00566.x; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Shoo LP, 2006, AUSTRAL ECOL, V31, P22, DOI 10.1111/j.1442-9993.2006.01539.x; Sturm M, 2001, NATURE, V411, P546, DOI 10.1038/35079180; Thuiller W, 2005, GLOBAL ECOL BIOGEOGR, V14, P347, DOI 10.1111/j.1466-822x.2005.00162.x; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Tryjanowski P, 2005, DIVERS DISTRIB, V11, P219, DOI 10.1111/j.1366-9516.2005.00140.x; Walther GR, 2005, J VEG SCI, V16, P541, DOI 10.1111/j.1654-1103.2005.tb02394.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wilson RJ, 2005, ECOL LETT, V8, P1138, DOI 10.1111/j.1461-0248.2005.00824.x	30	1348	1450	24	706	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 27	2008	320	5884					1768	1771		10.1126/science.1156831	http://dx.doi.org/10.1126/science.1156831			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318VP	18583610				2022-12-28	WOS:000257121200036
J	Nechiporuk, A; Raible, DW				Nechiporuk, Alex; Raible, David W.			FGF-dependent mechanosensory organ patterning in zebrafish	SCIENCE			English	Article							LATERAL-LINE; FLUORESCENT PROTEIN; TISSUE MIGRATION; REGENERATION; NEUROMASTS; EXPRESSION; COMPLEX; DOMAIN; GENES; PEA3	During development, organ primordia reorganize to form repeated functional units. In zebrafish ( Danio rerio), mechanosensory organs called neuromasts are deposited at regular intervals by the migrating posterior lateral line ( pLL) primordium. The pLL primordium is organized into polarized rosettes representing proto- neuromasts, each with a central atoh1a- positive focus of mechanosensory precursors. We show that rosettes form cyclically from a progenitor pool at the leading zone of the primordium as neuromasts are deposited from the trailing region. fgf3/10 signals localized to the leading zone are required for rosette formation, atoh1a expression, and primordium migration. We propose that the fibroblast growth factor ( FGF) source controls primordium organization, which, in turn, regulates the periodicity of neuromast deposition. This previously unrecognized mechanism may be applicable to understanding segmentation and morphogenesis in other organ systems.	[Nechiporuk, Alex; Raible, David W.] Univ Washington, Sch Med, Dept Biol Struct, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Nechiporuk, A (corresponding author), Oregon Hlth & Sci Univ, Sch Med, Dept Cell & Dev Biol, Portland, OR 97239 USA.	nechipor@ohsu.edu; draible@u.washington.edu		Raible, David/0000-0002-5342-5841	NICHD NIH HHS [R00 HD055303, K99 HD055303] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Andermann P, 2002, DEV BIOL, V251, P45, DOI 10.1006/dbio.2002.0820; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Choo BG, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-5; Cooper MS, 2005, DEV DYNAM, V232, P359, DOI 10.1002/dvdy.20252; Dambly-Chaudiere C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-23; Ghysen A, 2007, GENE DEV, V21, P2118, DOI 10.1101/gad.1568407; Gompel N, 2001, MECH DEVELOP, V105, P69, DOI 10.1016/S0925-4773(01)00382-3; Grandel H, 2000, DEVELOPMENT, V127, P4169; Haas P, 2006, DEV CELL, V10, P673, DOI 10.1016/j.devcel.2006.02.019; Hernandez PP, 2007, DEV NEUROBIOL, V67, P637, DOI 10.1002/dneu.20386; Huang P, 2005, CYTOKINE GROWTH F R, V16, P151, DOI 10.1016/j.cytogfr.2005.03.002; Itoh M, 2001, MECH DEVELOP, V102, P263, DOI 10.1016/S0925-4773(01)00308-2; Kiefer P, 1996, GENE, V168, P211, DOI 10.1016/0378-1119(95)00736-9; Lee Y, 2005, DEVELOPMENT, V132, P5173, DOI 10.1242/dev.02101; Millimaki BB, 2007, DEVELOPMENT, V134, P295, DOI 10.1242/dev.02734; Mizuno H, 2003, MOL CELL, V12, P1051, DOI 10.1016/S1097-2765(03)00393-9; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Ornitz DM, 2000, BIOESSAYS, V22, P108, DOI 10.1002/(SICI)1521-1878(200002)22:2<108::AID-BIES2>3.0.CO;2-M; Raible F, 2001, MECH DEVELOP, V107, P105, DOI 10.1016/S0925-4773(01)00456-7; Roehl H, 2001, CURR BIOL, V11, P503, DOI 10.1016/S0960-9822(01)00143-9; Valentin G, 2007, CURR BIOL, V17, P1026, DOI 10.1016/j.cub.2007.05.020	21	148	148	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 27	2008	320	5884					1774	1777		10.1126/science.1156547	http://dx.doi.org/10.1126/science.1156547			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318VP	18583612				2022-12-28	WOS:000257121200038
J	Blatt, R; Wineland, D				Blatt, Rainer; Wineland, David			Entangled states of trapped atomic ions	NATURE			English	Review							DETERMINISTIC QUANTUM TELEPORTATION; MULTIPARTICLE ENTANGLEMENT; REALIZATION; IMPLEMENTATION; SPECTROSCOPY; MANIPULATION; ARCHITECTURE; NOISE	To process information using quantum-mechanical principles, the states of individual particles need to be entangled and manipulated. One way to do this is to use trapped, laser-cooled atomic ions. Attaining a general-purpose quantum computer is, however, a distant goal, but recent experiments show that just a few entangled trapped ions can be used to improve the precision of measurements. If the entanglement in such systems can be scaled up to larger numbers of ions, simulations that are intractable on a classical computer might become possible.	[Blatt, Rainer] Univ Innsbruck, Inst Expt Phys, A-6020 Innsbruck, Austria; [Blatt, Rainer] Osterreichische Akad Wissensch, Inst Quantenopt & Quanteninformat, A-6020 Innsbruck, Austria; [Wineland, David] Natl Inst Stand & Technol, Boulder, CO 80305 USA	University of Innsbruck; Austrian Academy of Sciences; National Institute of Standards & Technology (NIST) - USA	Blatt, R (corresponding author), Univ Innsbruck, Inst Expt Phys, Technikerstr 25, A-6020 Innsbruck, Austria.	Rainer.Blatt@uibk.ac.at	Blatt, Rainer/H-9527-2014					Andre A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.230801; ASPECT A, 1981, PHYS REV LETT, V47, P460, DOI 10.1103/PhysRevLett.47.460; Bell J. S., 1987, SPEAKABLE UNSPEAKABL; Benhelm J, 2008, NAT PHYS, V4, P463, DOI 10.1038/nphys961; BENNETT CH, 1993, PHYS REV LETT, V70, P1895, DOI 10.1103/PhysRevLett.70.1895; Blatt R, 2004, LES HOUCH S, V79, P223; Blinov BB, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.040304; Bollinger JJ, 1996, PHYS REV A, V54, pR4649, DOI 10.1103/PhysRevA.54.R4649; BOLLINGER JJ, 1991, IEEE T INSTRUM MEAS, V40, P126, DOI 10.1109/TIM.1990.1032897; Chiaverini J, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.022324; Chiaverini J, 2005, SCIENCE, V308, P997, DOI 10.1126/science.1110335; Chiaverini J, 2005, QUANTUM INFORM COMPU, V5, P419; Chiaverini J, 2004, NATURE, V432, P602, DOI 10.1038/nature03074; Chuang IL, 1998, NATURE, V393, P143, DOI 10.1038/30181; CIRAC JI, 1995, PHYS REV LETT, V74, P4091, DOI 10.1103/PhysRevLett.74.4091; Cirac JI, 1997, PHYS REV LETT, V78, P3221, DOI 10.1103/PhysRevLett.78.3221; Cirac JI, 2000, NATURE, V404, P579, DOI 10.1038/35007021; DEHMELT H, 1990, REV MOD PHYS, V62, P525, DOI 10.1103/RevModPhys.62.525; DEHMELT HG, 1982, IEEE T INSTRUM MEAS, V31, P83, DOI 10.1109/TIM.1982.6312526; Deslauriers L, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.103007; DEUTSCH D, 1992, P ROY SOC LOND A MAT, V439, P553, DOI 10.1098/rspa.1992.0167; DEUTSCH D, 1985, P ROY SOC LOND A MAT, V400, P97, DOI 10.1098/rspa.1985.0070; DeVoe RG, 1998, PHYS REV A, V58, P910, DOI 10.1103/PhysRevA.58.910; DIEDRICH F, 1989, PHYS REV LETT, V62, P403, DOI 10.1103/PhysRevLett.62.403; Duan LM, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.062324; Duan LM, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.100502; Duan LM, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.127902; Dur W, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.062314; FEYNMAN RP, 1982, INT J THEOR PHYS, V21, P467, DOI 10.1007/BF02650179; FISK PTH, 1995, IEEE T INSTRUM MEAS, V44, P113, DOI 10.1109/19.377786; FREEDMAN SJ, 1972, PHYS REV LETT, V28, P938, DOI 10.1103/PhysRevLett.28.938; Grover LK, 1997, PHYS REV LETT, V79, P325, DOI 10.1103/PhysRevLett.79.325; Guerlin C, 2007, NATURE, V448, P889, DOI 10.1038/nature06057; Gulde S, 2003, NATURE, V421, P48, DOI 10.1038/nature01336; Haffner H, 2005, NATURE, V438, P643, DOI 10.1038/nature04279; Haljan PC, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.062316; Hensinger WK, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2164910; Home JP, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/9/188; Huber G, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/1/013004; HUCUL D, 2007, TRANSPORT ATOMIC ION; Huelga SF, 1997, PHYS REV LETT, V79, P3865, DOI 10.1103/PhysRevLett.79.3865; Hume DB, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.120502; ITANO WM, 1993, PHYS REV A, V47, P3554, DOI 10.1103/PhysRevA.47.3554; Kielpinski D, 2002, NATURE, V417, P709, DOI 10.1038/nature00784; Kim J, 2005, QUANTUM INFORM COMPU, V5, P515; Labaziewicz J, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.013001; Leibfried D, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.032324; Leibfried D, 2005, NATURE, V438, P639, DOI 10.1038/nature04251; Leibfried D, 2004, SCIENCE, V304, P1476, DOI 10.1126/science.1097576; Leibfried D, 2003, REV MOD PHYS, V75, P281, DOI 10.1103/RevModPhys.75.281; Leibfried D, 2003, NATURE, V422, P412, DOI 10.1038/nature01492; Leibrandt D, 2007, QUANTUM INF COMPUT, V7, P52; LIEBFRIED D, 2002, PHYS REV LETT, V89; Matsukevich DN, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.150404; Meyer V, 2001, PHYS REV LETT, V86, P5870, DOI 10.1103/PhysRevLett.86.5870; Milburn GJ, 2000, FORTSCHR PHYS, V48, P801, DOI 10.1002/1521-3978(200009)48:9/11<801::AID-PROP801>3.0.CO;2-1; Moehring DL, 2007, NATURE, V449, P68, DOI 10.1038/nature06118; Moehring DL, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.090410; Molmer K, 1999, PHYS REV LETT, V82, P1835, DOI 10.1103/PhysRevLett.82.1835; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Ozeri R, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.042329; PAUL W, 1990, REV MOD PHYS, V62, P531, DOI 10.1103/RevModPhys.62.531; Porras D, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.250501; Ramsey N. F., 1956, MOL BEAMS; Reichle R, 2006, NATURE, V443, P838, DOI 10.1038/nature05146; Riebe M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.220407; Rohde H, 2001, J OPT B-QUANTUM S O, V3, pS34, DOI 10.1088/1464-4266/3/1/357; Roos CF, 2006, NATURE, V443, P316, DOI 10.1038/nature05101; Roos CF, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.220402; Roos CF, 2004, SCIENCE, V304, P1478, DOI 10.1126/science.1097522; Rosenband T, 2008, SCIENCE, V319, P1808, DOI 10.1126/science.1154622; Rowe MA, 2002, QUANTUM INF COMPUT, V2, P257; Rowe MA, 2001, NATURE, V409, P791, DOI 10.1038/35057215; Sackett CA, 2000, NATURE, V404, P256, DOI 10.1038/35005011; Schaetz T, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.010501; Schmidt-Kaler F, 2003, APPL PHYS B-LASERS O, V77, P789, DOI 10.1007/s00340-003-1346-9; Schmidt-Kaler F, 2003, NATURE, V422, P408, DOI 10.1038/nature01494; Schrodinger E, 1935, NATURWISSENSCHAFTEN, V23, P807, DOI 10.1007/BF01491891; Seidelin S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.253003; SHOR PW, 1994, AN S FDN CO, P124; Solano E, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.060402; Steane AM, 1996, PHYS REV LETT, V77, P793, DOI 10.1103/PhysRevLett.77.793; Stick D, 2006, NAT PHYS, V2, P36, DOI 10.1038/nphys171; TAYLOR JM, 2007, T WIGNER CRYSTALS IO; Turchette QA, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.063418; Turchette QA, 1998, PHYS REV LETT, V81, P3631, DOI 10.1103/PhysRevLett.81.3631; Wineland DJ, 2004, LES HOUCH S, V79, P261; Wunderlich C, 2003, ADV ATOM MOL OPT PHY, V49, P293; Zhu SL, 2006, EUROPHYS LETT, V73, P485, DOI 10.1209/epl/i2005-10424-4	99	755	770	8	161	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2008	453	7198					1008	1015		10.1038/nature07125	http://dx.doi.org/10.1038/nature07125			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314WM	18563151				2022-12-28	WOS:000256839900042
J	Putnam, NH; Butts, T; Ferrier, DEK; Furlong, RF; Hellsten, U; Kawashima, T; Robinson-Rechavi, M; Shoguchi, E; Terry, A; Yu, JK; Benito-Gutierrez, E; Dubchak, I; Garcia-Fernandez, J; Gibson-Brown, JJ; Grigoriev, IV; Horton, AC; de Jong, PJ; Jurka, J; Kapitonov, VV; Kohara, Y; Kuroki, Y; Lindquist, E; Lucas, S; Osoegawa, K; Pennacchio, LA; Salamov, AA; Satou, Y; Sauka-Spengler, T; Schmutz, J; Shin-I, T; Toyoda, A; Bronner-Fraser, M; Fujiyama, A; Holland, LZ; Holland, PWH; Satoh, N; Rokhsar, DS				Putnam, Nicholas H.; Butts, Thomas; Ferrier, David E. K.; Furlong, Rebecca F.; Hellsten, Uffe; Kawashima, Takeshi; Robinson-Rechavi, Marc; Shoguchi, Eiichi; Terry, Astrid; Yu, Jr-Kai; Benito-Gutierrez, Elia; Dubchak, Inna; Garcia-Fernandez, Jordi; Gibson-Brown, Jeremy J.; Grigoriev, Igor V.; Horton, Amy C.; de Jong, Pieter J.; Jurka, Jerzy; Kapitonov, Vladimir V.; Kohara, Yuji; Kuroki, Yoko; Lindquist, Erika; Lucas, Susan; Osoegawa, Kazutoyo; Pennacchio, Len A.; Salamov, Asaf A.; Satou, Yutaka; Sauka-Spengler, Tatjana; Schmutz, Jeremy; Shin-I, Tadasu; Toyoda, Atsushi; Bronner-Fraser, Marianne; Fujiyama, Asao; Holland, Linda Z.; Holland, Peter W. H.; Satoh, Nori; Rokhsar, Daniel S.			The amphioxus genome and the evolution of the chordate karyotype	NATURE			English	Article							GENE DUPLICATIONS; REVEALS; VERTEBRATES; ORIGINS; RECONSTRUCTION; INSIGHTS; CHROMOSOMES; DIVERGENCE; PHYLOGENY; INFERENCE	Lancelets ('amphioxus') are the modern survivors of an ancient chordate lineage, with a fossil record dating back to the Cambrian period. Here we describe the structure and gene content of the highly polymorphic similar to 520-megabase genome of the Florida lancelet Branchiostoma floridae, and analyse it in the context of chordate evolution. Whole-genome comparisons illuminate the murky relationships among the three chordate groups (tunicates, lancelets and vertebrates), and allow not only reconstruction of the gene complement of the last common chordate ancestor but also partial reconstruction of its genomic organization, as well as a description of two genome-wide duplications and subsequent reorganizations in the vertebrate lineage. These genome-scale events shaped the vertebrate genome and provided additional genetic variation for exploitation during vertebrate evolution.	[Putnam, Nicholas H.; Hellsten, Uffe; Terry, Astrid; Dubchak, Inna; Grigoriev, Igor V.; Lindquist, Erika; Lucas, Susan; Pennacchio, Len A.; Salamov, Asaf A.; Rokhsar, Daniel S.] Dept Energy Joint Genome Inst, Walnut Creek, CA 94598 USA; [Putnam, Nicholas H.; Kawashima, Takeshi; Rokhsar, Daniel S.] Univ Calif Berkeley, Ctr Integrat Genom, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Butts, Thomas; Furlong, Rebecca F.; Holland, Linda Z.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Ferrier, David E. K.] Univ St Andrews, Gatty Marine Lab, St Andrews KY16 8LB, Fife, Scotland; [Robinson-Rechavi, Marc] Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland; [Robinson-Rechavi, Marc] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Shoguchi, Eiichi; Satou, Yutaka; Satoh, Nori] Kyoto Univ, Dept Zool, Grad Sch Sci, Sakyo Ku, Kyoto 6068502, Japan; [Yu, Jr-Kai; Sauka-Spengler, Tatjana; Bronner-Fraser, Marianne] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Benito-Gutierrez, Elia] Natl Inst Med Res, London NW7 1AA, England; [Garcia-Fernandez, Jordi] Univ Barcelona, Dept Genet, Fac Biol, E-08028 Barcelona, Spain; [Gibson-Brown, Jeremy J.; Horton, Amy C.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [de Jong, Pieter J.; Osoegawa, Kazutoyo] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; [Jurka, Jerzy; Kapitonov, Vladimir V.] Genet Informat Res Inst, Mountain View, CA 94043 USA; [Kohara, Yuji; Shin-I, Tadasu] Natl Inst Genet, Mishima, Shizuoka 4118540, Japan; [Kuroki, Yoko; Toyoda, Atsushi; Fujiyama, Asao] RIKEN, Genom Sci Ctr, Tsurumi Ku, Kanagawa 2300045, Japan; [Schmutz, Jeremy] JGI Stanford Human Genome Ctr, Palo Alto, CA 94304 USA; [Fujiyama, Asao] Res Org Informat & Syst, Natl Inst Informat, Chiyoda Ku, Tokyo 1018430, Japan; [Holland, Peter W. H.] Univ Calif San Diego, Scripps Inst Oceanog, Marine Biol Res Div, La Jolla, CA 92093 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Oxford; University of St Andrews; University of Lausanne; Swiss Institute of Bioinformatics; Kyoto University; California Institute of Technology; MRC National Institute for Medical Research; University of Barcelona; Washington University (WUSTL); Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; RIKEN; Research Organization of Information & Systems (ROIS); National Institute of Informatics (NII) - Japan; University of California System; University of California San Diego; Scripps Institution of Oceanography	Rokhsar, DS (corresponding author), Dept Energy Joint Genome Inst, Walnut Creek, CA 94598 USA.	satoh@ascidian.zool.kyoto-u.ac.jp; dsrokhsar@yahoo.com	Satou, Yutaka/AAJ-2194-2021; Putnam, Nicholas/B-9968-2008; Gutierrez, Elia Benito/ABG-6788-2021; Yu, Jr-Kai/H-4822-2019; Satou, Yutaka/K-7131-2012; Schmutz, Jeremy/N-3173-2013; Kawashima, Takeshi/M-4510-2015; Ferrier, David/D-7595-2013; Terry, Astrid/A-2538-2011; Robinson-Rechavi, Marc/E-9727-2011; Garcia-Fernandez, Jordi/B-3839-2013	Satou, Yutaka/0000-0001-5193-0708; Putnam, Nicholas/0000-0002-1315-782X; Gutierrez, Elia Benito/0000-0003-2435-0948; Yu, Jr-Kai/0000-0001-8591-0529; Satou, Yutaka/0000-0001-5193-0708; Schmutz, Jeremy/0000-0001-8062-9172; Holland, Peter/0000-0003-1533-9376; Rokhsar, Daniel/0000-0002-8704-2224; Ferrier, David/0000-0003-3247-6233; Horton, Amy/0000-0003-2148-5636; Grigoriev, Igor/0000-0002-3136-8903; Butts, Thomas/0000-0002-1781-5287; Bronner, Marianne/0000-0003-4274-1862; Sauka-Spengler, Tatjana/0000-0001-9289-0263; Pennacchio, Len/0000-0002-8748-3732; Terry, Astrid/0000-0002-5234-1224; Robinson-Rechavi, Marc/0000-0002-3437-3329; Furlong, Rebecca/0000-0002-8451-6471; Garcia-Fernandez, Jordi/0000-0001-5677-5970	Biotechnology and Biological Sciences Research Council [BBS/B/12067, BBS/B/12067/2] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Abi-Rached L, 2002, NAT GENET, V31, P100, DOI 10.1038/ng855; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Blair JE, 2005, MOL BIOL EVOL, V22, P2275, DOI 10.1093/molbev/msi225; Blomme T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r43; Bourlat SJ, 2006, NATURE, V444, P85, DOI 10.1038/nature05241; Britten RJ, 2003, P NATL ACAD SCI USA, V100, P4661, DOI 10.1073/pnas.0330964100; Brunet FG, 2006, MOL BIOL EVOL, V23, P1808, DOI 10.1093/molbev/msl049; Cameron CB, 2000, P NATL ACAD SCI USA, V97, P4469, DOI 10.1073/pnas.97.9.4469; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Castro LFC, 2004, IMMUNOGENETICS, V55, P782, DOI 10.1007/s00251-004-0642-9; Castro LFC, 2003, EVOL DEV, V5, P459, DOI 10.1046/j.1525-142X.2003.03052.x; Castro LFC, 2002, ZOOL SCI, V19, P1349, DOI 10.2108/zsj.19.1349; Chen JY, 1999, NATURE, V402, P518, DOI 10.1038/990080; CHEN JY, 1995, NATURE, V377, P720, DOI 10.1038/377720a0; Christoffels A, 2004, MOL BIOL EVOL, V21, P1146, DOI 10.1093/molbev/msh114; COSTA OG, 1834, CENNI ZOOLOGICI OSSI, P49; Danchin EGJ, 2004, TRENDS GENET, V20, P587, DOI 10.1016/j.tig.2004.09.009; De Bodt S, 2005, TRENDS ECOL EVOL, V20, P591, DOI 10.1016/j.tree.2005.07.008; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Donoghue PCJ, 2005, TRENDS ECOL EVOL, V20, P312, DOI 10.1016/j.tree.2005.04.008; Edvardsen RB, 2004, J MOL EVOL, V59, P448, DOI 10.1007/s00239-004-2636-5; Escriva H, 2002, MOL BIOL EVOL, V19, P1440, DOI 10.1093/oxfordjournals.molbev.a004207; Furlong RF, 2002, PHILOS T R SOC B, V357, P531, DOI 10.1098/rstb.2001.1035; GARCIAFERNANDEZ J, 1994, NATURE, V370, P563, DOI 10.1038/370563a0; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hellsten U, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-31; Hoegg S, 2004, J MOL EVOL, V59, P190, DOI 10.1007/s00239-004-2613-z; Holland LZ, 2008, GENOME RES, V18, P1100, DOI 10.1101/gr.073676.107; Holland LZ, 1999, CURR OPIN NEUROBIOL, V9, P596, DOI 10.1016/S0959-4388(99)00003-3; Holland ND, 2001, BIOESSAYS, V23, P142, DOI 10.1002/1521-1878(200102)23:2<142::AID-BIES1021>3.0.CO;2-5; HOLLAND PWH, 1994, DEVELOPMENT, P125; HOWELL WM, 1971, EXPERIENTIA, V27, P1495, DOI 10.1007/BF02154315; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hughes AL, 2005, EVOL DEV, V7, P196, DOI 10.1111/j.1525-142X.2005.05022.x; IVANOVAKAZAS OM, 1995, T SANKT PETERBURGSKO, V84, P1; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Kohn M, 2006, TRENDS GENET, V22, P203, DOI 10.1016/j.tig.2006.02.008; KOWALEVSKY A, 1866, MEM ACAD IMP SCI SAI, V11, P1; Kumar S, 2002, P NATL ACAD SCI USA, V99, P803, DOI 10.1073/pnas.022629899; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lowe CJ, 2003, CELL, V113, P853, DOI 10.1016/S0092-8674(03)00469-0; Luke GN, 2003, P NATL ACAD SCI USA, V100, P5292, DOI 10.1073/pnas.0836141100; Lundin Lars-Gustav, 2003, Journal of Structural and Functional Genomics, V3, P53, DOI 10.1023/A:1022600813840; Mallatt J, 2003, J MORPHOL, V258, P1, DOI 10.1002/jmor.10081; McLysaght A, 2002, NAT GENET, V31, P200, DOI 10.1038/ng884; MORRIS SC, 1979, SCI AM, V241, P122, DOI 10.1038/scientificamerican0779-122; Nachman MW, 2000, GENETICS, V156, P297; Nakatani Y, 2007, GENOME RES, V17, P1254, DOI 10.1101/gr.6316407; Naruse K, 2004, GENOME RES, V14, P820, DOI 10.1101/gr.2004004; Ohno S., 1970, P1; Panopoulou G, 2005, TRENDS GENET, V21, P559, DOI 10.1016/j.tig.2005.08.004; Panopoulou G, 2003, GENOME RES, V13, P1056, DOI 10.1101/gr.874803; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Popovici C, 2001, BIOCHEM BIOPH RES CO, V288, P362, DOI 10.1006/bbrc.2001.5794; Postlethwait JH, 2000, GENOME RES, V10, P1890, DOI 10.1101/gr.164800; Prochnik SE, 2007, DEV GENES EVOL, V217, P73, DOI 10.1007/s00427-006-0116-1; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Robinson-Rechavi M, 2004, MOL BIOL EVOL, V21, P580, DOI 10.1093/molbev/msh046; SCHMIDTKE J, 1977, NATURE, V266, P532, DOI 10.1038/266532a0; Shu D, 1996, NATURE, V380, P428, DOI 10.1038/380428a0; Small KS, 2007, P NATL ACAD SCI USA, V104, P5698, DOI 10.1073/pnas.0700890104; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Stokes MD, 1998, AM SCI, V86, P552, DOI 10.1511/1998.43.799; Swofford DL., 2003, PAUP PHYLOGENETIC AN; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; *U WASH, SEA LAMPR GEN PROJ; Valentine JW, 2000, PALEOBIOLOGY, V26, P513, DOI 10.1666/0094-8373(2000)026<0513:TGPTTE>2.0.CO;2; Venkatesh B, 2007, PLOS BIOL, V5, P932, DOI 10.1371/journal.pbio.0050101; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Weber JL, 1997, GENOME RES, V7, P401, DOI 10.1101/gr.7.5.401; Wolfe KH, 2001, NAT REV GENET, V2, P333, DOI 10.1038/35072009; Woods IG, 2005, GENOME RES, V15, P1307, DOI 10.1101/gr.4134305; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; YARRELL W, 1836, HIST BRIT FISHES, P468; Yu JK, 2007, NATURE, V445, P613, DOI 10.1038/nature05472	79	1172	1253	5	182	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 19	2008	453	7198					1064	U3		10.1038/nature06967	http://dx.doi.org/10.1038/nature06967			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314WM	18563158	Green Submitted, Green Accepted, hybrid			2022-12-28	WOS:000256839900049
J	Dillon, R; Hirschfield, GM; Allison, MED; Rege, KP				Dillon, Richard; Hirschfield, Gideon M.; Allison, Michael E. D.; Rege, Kanchan P.			Lesson of the week - Fatal reactivation of hepatitis B after chemotherapy for lymphoma	BRITISH MEDICAL JOURNAL			English	Article							VIRUS HBV REACTIVATION; IMMUNOSUPPRESSIVE THERAPY; CYTOTOXIC CHEMOTHERAPY; LAMIVUDINE PROPHYLAXIS; PREEMPTIVE LAMIVUDINE; INFECTION; RISK; PREVENTION; CARRIERS; CHOP		[Hirschfield, Gideon M.; Allison, Michael E. D.] Addenbrookes Hosp, Dept Hepatol, Cambridge CB2 2QQ, England; [Dillon, Richard; Rege, Kanchan P.] Hinchingbrooke Hosp, Dept Haematol, Huntingdon, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Hirschfield, GM (corresponding author), Addenbrookes Hosp, Dept Hepatol, Hills Rd, Cambridge CB2 2QQ, England.	gideon.hirschfield@uhn.on.ca	Hirschfield, Gideon M/M-2143-2015	Hirschfield, Gideon M/0000-0002-6736-2255; Allison, Michael/0000-0003-3677-3294; Dillon, Richard/0000-0001-9333-5296				Calabrese LH, 2006, ANN RHEUM DIS, V65, P983, DOI 10.1136/ard.2005.043257; Cheng AL, 2003, HEPATOLOGY, V37, P1320, DOI 10.1053/jhep.2003.50220; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Dai MS, 2004, ANN HEMATOL, V83, P769, DOI 10.1007/s00277-004-0899-y; Hui CK, 2006, GASTROENTEROLOGY, V131, P59, DOI 10.1053/j.gastro.2006.04.015; Kohrt HE, 2006, ALIMENT PHARM THERAP, V24, P1003, DOI 10.1111/j.1365-2036.2006.03081.x; Lalazar G, 2007, BRIT J HAEMATOL, V136, P699, DOI 10.1111/j.1365-2141.2006.06465.x; Lau GKK, 2003, GASTROENTEROLOGY, V125, P1742, DOI 10.1053/j.gastro.2003.09.026; Law JK, 2005, LEUKEMIA LYMPHOMA, V46, P1085, DOI 10.1080/10428190500062932; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; Li YH, 2006, CANCER-AM CANCER SOC, V106, P1320, DOI 10.1002/cncr.21701; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; LOK ASF, 1991, GASTROENTEROLOGY, V100, P182, DOI 10.1016/0016-5085(91)90599-G; Markovic S, 1999, HEPATO-GASTROENTEROL, V46, P2925; Sherman Morris, 2007, Can J Gastroenterol, V21 Suppl C, p5C; Yeo W, 2006, HEPATOLOGY, V43, P209, DOI 10.1002/hep.21051; Yeo W, 2004, BRIT J CANCER, V90, P1306, DOI 10.1038/sj.bjc.6601699	17	13	13	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 27	2008	337	7672							a423	10.1136/bmj.39490.680498.BE	http://dx.doi.org/10.1136/bmj.39490.680498.BE			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356SJ	18595895				2022-12-28	WOS:000259797600045
J	Gomez, C; Ozbudak, EM; Wunderlich, J; Baumann, D; Lewis, J; Pourquie, O				Gomez, Celine; Ozbudak, Ertugrul M.; Wunderlich, Joshua; Baumann, Diana; Lewis, Julian; Pourquie, Olivier			Control of segment number in vertebrate embryos	NATURE			English	Article							SOMITE BOUNDARY FORMATION; PARAXIAL MESODERM; CHICK-EMBRYO; MOUSE EMBRYO; CLOCK; EXPRESSION; GENE; SOMITOGENESIS; ACTIVATION; MORPHOGENESIS	The vertebrate body axis is subdivided into repeated segments, best exemplified by the vertebrae that derive from embryonic somites. The number of somites is precisely defined for any given species but varies widely from one species to another. To determine the mechanism controlling somite number, we have compared somitogenesis in zebrafish, chicken, mouse and corn snake embryos. Here we present evidence that in all of these species a similar 'clock-and-wavefront'(1-3) mechanism operates to control somitogenesis; in all of them, somitogenesis is brought to an end through a process in which the presomitic mesoderm, having first increased in size, gradually shrinks until it is exhausted, terminating somite formation. In snake embryos, however, the segmentation clock rate is much faster relative to developmental rate than in other amniotes, leading to a greatly increased number of smaller-sized somites.	[Gomez, Celine; Ozbudak, Ertugrul M.; Wunderlich, Joshua; Baumann, Diana; Pourquie, Olivier] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Lewis, Julian] London Res Inst, Canc Res UK, Vertebrate Dev Lab, London WC2A 3PX, England; [Pourquie, Olivier] Howard Hughes Med Inst, Kansas City, MO 64110 USA	Stowers Institute for Medical Research; Cancer Research UK; Howard Hughes Medical Institute	Pourquie, O (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.	olp@stowers-institute.org	Pourquié, Olivier/CAJ-5443-2022; Lewis, Julian H/E-8733-2010	Pourquié, Olivier/0000-0001-5189-1227; Ozbudak, Ertugrul/0000-0003-2858-4696	Cancer Research UK Funding Source: Medline; Howard Hughes Medical Institute Funding Source: Medline	Cancer Research UK(Cancer Research UK); Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Aulehla A, 2008, NAT CELL BIOL, V10, P186, DOI 10.1038/ncb1679; BURGESS R, 1995, DEV BIOL, V168, P296, DOI 10.1006/dbio.1995.1081; Cambray N, 2007, DEVELOPMENT, V134, P2829, DOI 10.1242/dev.02877; COOKE J, 1976, J THEOR BIOL, V58, P455, DOI 10.1016/S0022-5193(76)80131-2; Delfini MC, 2005, P NATL ACAD SCI USA, V102, P11343, DOI 10.1073/pnas.0502933102; Dequeant ML, 2008, NAT REV GENET, V9, P370, DOI 10.1038/nrg2320; Dequeant ML, 2006, SCIENCE, V314, P1595, DOI 10.1126/science.1133141; Diez del Corral R, 2003, NEURON, V40, P65; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; Forsberg H, 1998, CURR BIOL, V8, P1027, DOI 10.1016/S0960-9822(07)00424-1; Giudicelli F, 2007, PLOS BIOL, V5, P1309, DOI 10.1371/journal.pbio.0050150; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Mansouri A, 1997, DEV DYNAM, V210, P53, DOI 10.1002/(SICI)1097-0177(199709)210:1<53::AID-AJA6>3.0.CO;2-0; McGrew MJ, 1998, CURR BIOL, V8, P979, DOI 10.1016/S0960-9822(98)70401-4; Nakajima Y, 2006, DEVELOPMENT, V133, P2517, DOI 10.1242/dev.02422; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; POWNALL ME, 1992, DEV BIOL, V151, P67, DOI 10.1016/0012-1606(92)90214-2; PRIMMETT DRN, 1989, DEVELOPMENT, V105, P119; Richardson MK, 1998, DEVELOPMENT, V125, P151; SANDERS EJ, 1986, ANAT EMBRYOL, V174, P179, DOI 10.1007/BF00824333; SASSOON D, 1989, NATURE, V341, P303, DOI 10.1038/341303a0; Sawada A, 2001, DEVELOPMENT, V128, P4873; Shum ASW, 1999, MECH DEVELOP, V84, P17, DOI 10.1016/S0925-4773(99)00059-3; TAM PPL, 1981, J EMBRYOL EXP MORPH, V65, P103; Wittler L, 2007, EMBO REP, V8, P784, DOI 10.1038/sj.embor.7401030; Yoon JK, 2000, DEV BIOL, V222, P376, DOI 10.1006/dbio.2000.9717; Yoon JK, 2000, GENE DEV, V14, P3204, DOI 10.1101/gad.850000; Zug G. R., 2001, HERPETOLOGY, P57	30	291	296	2	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2008	454	7202					335	339		10.1038/nature07020	http://dx.doi.org/10.1038/nature07020			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	326ND	18563087				2022-12-28	WOS:000257665300039
J	Serrano, A; Batlle, D				Serrano, Andres; Batlle, Daniel			Bilateral kidney calcifications	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Serrano, Andres; Batlle, Daniel] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Serrano, A (corresponding author), Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA.								0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 3	2008	359	1					E1	E1		10.1056/NEJMicm072776	http://dx.doi.org/10.1056/NEJMicm072776			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320PB	18596268				2022-12-28	WOS:000257246000010
J	Sloboda, J				Sloboda, John			Science and music: The ear of the beholder	NATURE			English	Editorial Material									Univ Keele, Inst Law Polit & Justice, Newcastle ST5 5BG, Staffs, England	Keele University	Sloboda, J (corresponding author), Univ Keele, Inst Law Polit & Justice, Newcastle ST5 5BG, Staffs, England.								0	17	19	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 3	2008	454	7200					32	33		10.1038/454032a	http://dx.doi.org/10.1038/454032a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321MC	18596790				2022-12-28	WOS:000257308300024
J	Dejosez, M; Krumenacker, JS; Zitur, LJ; Passeri, M; Chu, LF; Zhou, SY; Thomson, JA; Zwaka, TP				Dejosez, Marion; Krumenacker, Joshua S.; Zitur, Laura Jo; Passeri, Marco; Chu, Li-Fang; Zhou Songyang; Thomson, James A.; Zwaka, Thomas P.			Ronin is essential for embryogenesis and the pluripotency of mouse embryonic stem cells	CELL			English	Article							TRANSCRIPTION FACTOR; SELF-RENEWAL; GERM-CELLS; DEVELOPMENTAL REGULATORS; POU-DOMAIN; EXPRESSION; PROTEIN; PROLIFERATION; FIBROBLASTS; NANOG	Pluripotency is a unique biological state that allows cells to differentiate into any tissue type. Here we describe a candidate pluripotency factor, Ronin, that possesses a THAP domain, which is associated with sequence-specific DNA binding and epigenetic silencing of gene expression. Ronin is expressed primarily during the earliest stages of murine embryonic development, and its deficiency in mice produces periimplantational lethality and defects in the inner cell mass. Conditional knockout of Ronin prevents the growth of ES cells while forced expression of Ronin allows ES cells to proliferate without differentiation under conditions that normally do not promote self-renewal. Ectopic expression also partly compensates for the effects of Oct4 knockdown. We demonstrate that Ronin binds directly to HCF-1, a key transcriptional regulator. Our findings identify Ronin as an essential factor underlying embryogenesis and ES cell pluripotency. Its association with HCF-1 suggests an epigenetic mechanism of gene repression in pluripotent cells.	[Dejosez, Marion; Krumenacker, Joshua S.; Zitur, Laura Jo; Passeri, Marco; Chu, Li-Fang; Zwaka, Thomas P.] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Dejosez, Marion; Zitur, Laura Jo; Zwaka, Thomas P.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Dejosez, Marion; Zitur, Laura Jo; Zwaka, Thomas P.] Baylor Coll Med, Dept Human Genet, Houston, TX 77030 USA; [Zhou Songyang] Baylor Coll Med, Dept Biochem, Houston, TX 77030 USA; [Thomson, James A.] Univ Wisconsin, Ctr Biotechnol, Madison, WI 53705 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Wisconsin System; University of Wisconsin Madison	Zwaka, TP (corresponding author), Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA.	tpzwaka@bcm.edu	Chu, Li-Fang/ABC-2853-2020	Chu, Li-Fang/0000-0002-4738-4481; ZITUR, LAURA/0000-0002-1238-2726	NHLBI NIH HHS [T32 HL092332, T32 HL092332-06] Funding Source: Medline; NIBIB NIH HHS [R01 EB005173-01, P20 EB007076, R01 EB005173] Funding Source: Medline; NIDDK NIH HHS [5T32DK060445] Funding Source: Medline; NIGMS NIH HHS [P01 GM081627-010004, R01 GM077442, P01 GM081627, P01 GM81627] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL092332] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P20EB007076, R01EB005173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK060445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081627, R01GM077442] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bessiere D, 2008, J BIOL CHEM, V283, P4352, DOI 10.1074/jbc.M707537200; Bessler JB, 2007, GENETICS, V175, P2029, DOI 10.1534/genetics.107.070987; Blackwell TK, 2004, CURR BIOL, V14, pR229, DOI 10.1016/j.cub.2004.02.052; Bouvet P, 2000, METH MOL B, V148, P603; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Cayrol C, 2007, BLOOD, V109, P584, DOI 10.1182/blood-2006-03-012013; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Freiman RN, 1997, GENE DEV, V11, P3122, DOI 10.1101/gad.11.23.3122; Frengen E, 2000, GENOMICS, V70, P273, DOI 10.1006/geno.2000.6389; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; Galan-Caridad JM, 2007, CELL, V129, P345, DOI 10.1016/j.cell.2007.03.014; Houlard M, 2006, PLOS GENET, V2, P1686, DOI 10.1371/journal.pgen.0020181; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Klochendler-Yeivin A, 2000, EMBO REP, V1, P500, DOI 10.1093/embo-reports/kvd129; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Macfarlan T, 2006, MOL ENDOCRINOL, V20, P335, DOI 10.1210/me.2005-0248; Macfarlan T, 2005, J BIOL CHEM, V280, P7346, DOI 10.1074/jbc.M411675200; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; OKAMOTO K, 1990, CELL, V60, P461, DOI 10.1016/0092-8674(90)90597-8; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; PEDERSEN RA, 1986, EXPT APPROACHES MAMM, P3; Reddy KC, 2004, CELL, V118, P439, DOI 10.1016/j.cell.2004.07.026; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; Roussigne M, 2003, ONCOGENE, V22, P2432, DOI 10.1038/sj.onc.1206271; Roussigne M, 2003, TRENDS BIOCHEM SCI, V28, P66, DOI 10.1016/S0968-0004(02)00013-0; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; WHYATT LM, 1993, MOL CELL BIOL, V13, P7971, DOI 10.1128/MCB.13.12.7971; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Yan B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r78; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	47	141	147	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 27	2008	133	7					1162	1174		10.1016/j.cell.2008.05.047	http://dx.doi.org/10.1016/j.cell.2008.05.047			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	319DP	18585351	Green Accepted, Bronze			2022-12-28	WOS:000257144600014
J	El-Azab, A				El-Azab, Anter			Materials science - The statistical mechanics of strain-hardened metals	SCIENCE			English	Editorial Material									Florida State Univ, Sch Computat Sci, Coll Arts & Sci, Tallahassee, FL 32306 USA; Florida State Univ, Mat Sci & Engn Program, Coll Arts & Sci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University	El-Azab, A (corresponding author), Florida State Univ, Sch Computat Sci, Coll Arts & Sci, Tallahassee, FL 32306 USA.	anter@scs.fsu.edu		El-Azab, Anter/0000-0002-9053-9063				[Anonymous], 1934, P R SOC LOND A, DOI [10.1098/rspa.1934.0107, DOI 10.1098/RSPA.1934.0107, DOI 10.1098/RSPA.1934.0106]; Boltzmann L., 1964, LECT GAS THEORY; Bulatov V., 2006, COMPUTER SIMULATIONS; Devincre B, 2008, SCIENCE, V320, P1745, DOI 10.1126/science.1156101; El-Azab A, 2006, SCRIPTA MATER, V54, P723, DOI 10.1016/j.scriptamat.2005.11.031; FRANCIOSI P, 1980, ACTA METALL MATER, V28, P273, DOI 10.1016/0001-6160(80)90162-5; Kocks UF, 2003, PROG MATER SCI, V48, P171, DOI 10.1016/S0079-6425(02)00003-8; KUHLMANNWILSDORF D, 1985, METALL TRANS A, V16, P2091, DOI 10.1007/BF02670414	8	7	7	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 27	2008	320	5884					1729	1730		10.1126/science.1160003	http://dx.doi.org/10.1126/science.1160003			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318VP	18583601				2022-12-28	WOS:000257121200025
J	Ideker, T				Ideker, Trey			Forging new ties between E-coli genes	CELL			English	Editorial Material							NETWORKS; PROTEIN	A recent study in Nature (Isalan et al., 2008) has examined the effects of systematically adding new transcriptional interactions in the bacterium Escherichia coli. Surprisingly, the majority of the engineered connections have no effect on growth, and in some cases the new connections enhance fitness. These findings reveal insights into the robustness and evolvability of gene networks.	Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Ideker, T (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	trey@bioeng.ucsd.edu		Ideker, Trey/0000-0002-1708-8454	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014811] Funding Source: NIH RePORTER; NIEHS NIH HHS [R01 ES014811-05, R01 ES014811-04, ES14811, R01 ES014811, R01 ES014811-05S1, R01 ES014811-01A1, R01 ES014811-02, R01 ES014811-02S1, R01 ES014811-03] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Beyer A, 2007, NAT REV GENET, V8, P699, DOI 10.1038/nrg2144; DITTO MD, 1994, J BACTERIOL, V176, P3738, DOI 10.1128/JB.176.12.3738-3748.1994; Ermolaeva M D, 2001, Curr Issues Mol Biol, V3, P91; Isalan M, 2008, NATURE, V452, P840, DOI 10.1038/nature06847; LANGE R, 1994, GENE DEV, V8, P1600, DOI 10.1101/gad.8.13.1600; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Vidal M, 1996, P NATL ACAD SCI USA, V93, P10315, DOI 10.1073/pnas.93.19.10315; Walker KA, 2004, J BIOL CHEM, V279, P50818, DOI 10.1074/jbc.M406285200	9	1	1	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 27	2008	133	7					1135	1137		10.1016/j.cell.2008.06.003	http://dx.doi.org/10.1016/j.cell.2008.06.003			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	319DP	18585345	Green Accepted, Bronze			2022-12-28	WOS:000257144600008
J	Ly, A; Nikolaev, A; Suresh, G; Zheng, YF; Tessier-Lavigne, M; Stein, E				Ly, Alice; Nikolaev, Anatoly; Suresh, Geetha; Zheng, Yufang; Tessier-Lavigne, Marc; Stein, Elke			DSCAM is a netrin receptor that collaborates with DCC in mediating turning responses to netrin-1	CELL			English	Article							AXON GUIDANCE; COMMISSURAL AXONS; NERVOUS-SYSTEM; DOWN-SYNDROME; SPINAL-CORD; MOLECULAR DIVERSITY; SELF-AVOIDANCE; SONIC HEDGEHOG; REQUIRE DSCAM; DROSOPHILA	During nervous system development, spinal commissural axons project toward and across the ventral midline. They are guided in part by netrin-1, made by midline cells, which attracts the axons by activating the netrin receptor DCC. However, previous studies suggest that additional receptor components are required. Here, we report that the Down's syndrome Cell Adhesion Molecule (DSCAM), a candidate gene implicated in the mental retardation phenotype of Down's syndrome, is expressed on spinal commissural axons, binds netrin-1, and is necessary for commissural axons to grow toward and across the midline. DSCAM and DCC can each mediate a turning response of these neurons to netrin-1. Similarly, Xenopus spinal neurons exogenously expressing DSCAM can be attracted by netrin-1 independently of DCC. These results show that DSCAM is a receptor that can mediate turning responses to netrin-1 and support a key role for netrin/DSCAM signaling in commissural axon guidance in vertebrates.	[Ly, Alice; Suresh, Geetha; Zheng, Yufang; Stein, Elke] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Stein, Elke] Yale Univ, Dept Cell Biol, New Haven, CT 06520 USA; [Stein, Elke] Yale Univ, Interdisciplinary Neurosci Program, New Haven, CT 06520 USA; [Stein, Elke] Yale Univ, Sch Med, New Haven, CT 06520 USA; [Nikolaev, Anatoly; Tessier-Lavigne, Marc] Genentech Inc, Div Res, San Francisco, CA 94080 USA	Yale University; Yale University; Yale University; Yale University; Roche Holding; Genentech	Stein, E (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, 266 Whitney Ave, New Haven, CT 06520 USA.	elke.stein@yale.edu	Stein, Elke/E-8107-2013; Zheng, Yufang/F-1091-2011	Stein, Elke/0000-0001-8965-5692; Zheng, Yufang/0000-0002-0488-2624; Nikolaev, Anatoly/0000-0003-2818-5839	Howard Hughes Medical Institute Funding Source: Medline; NCRR NIH HHS [S10-RR22636, S10 RR022636, S10 RR022636-01A1] Funding Source: Medline; NIGMS NIH HHS [T32 GM007499, T32-GM07499] Funding Source: Medline; NIMH NIH HHS [R01 MH071404-03, R01 MH071404] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022636] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007499] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071404] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Agarwala KL, 2001, BIOCHEM BIOPH RES CO, V285, P760, DOI 10.1006/bbrc.2001.5214; Antonarakis SE, 2006, TRENDS MOL MED, V12, P473, DOI 10.1016/j.molmed.2006.08.005; Barlow GM, 2002, BIOCHEM BIOPH RES CO, V293, P881, DOI 10.1016/S0006-291X(02)00307-8; Barlow GM, 2001, GENET MED, V3, P91, DOI 10.1097/00125817-200103000-00002; Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5; Chen BE, 2006, CELL, V125, P607, DOI 10.1016/j.cell.2006.03.034; Chen Z, 2008, NEURON, V58, P325, DOI 10.1016/j.neuron.2008.02.016; de la Torre JR, 1997, NEURON, V19, P1211, DOI 10.1016/S0896-6273(00)80413-4; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Ding YQ, 2005, DEVELOPMENT, V132, P2047, DOI 10.1242/dev.01798; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Fuerst PG, 2008, NATURE, V451, P470, DOI 10.1038/nature06514; Hattori D, 2007, NATURE, V449, P223, DOI 10.1038/nature06099; Hughes ME, 2007, NEURON, V54, P417, DOI 10.1016/j.neuron.2007.04.013; Kaprielian Z, 2001, DEV DYNAM, V221, P154, DOI 10.1002/dvdy.1143; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Matthews BJ, 2007, CELL, V129, P593, DOI 10.1016/j.cell.2007.04.013; Meijers R, 2007, NATURE, V449, P487, DOI 10.1038/nature06147; Millard SS, 2007, NATURE, V447, P720, DOI 10.1038/nature05855; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Okada A, 2006, NATURE, V444, P369, DOI 10.1038/nature05246; PLACZEK M, 1990, DEVELOPMENT, V110, P19; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Soba P, 2007, NEURON, V54, P403, DOI 10.1016/j.neuron.2007.03.029; Stein E, 2001, SCIENCE, V291, P1976, DOI 10.1126/science.1059391; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wojtowicz WM, 2007, CELL, V130, P1134, DOI 10.1016/j.cell.2007.08.026; Yamagata M, 2008, NATURE, V451, P465, DOI 10.1038/nature06469; Yamakawa K, 1998, HUM MOL GENET, V7, P227, DOI 10.1093/hmg/7.2.227; Yu TW, 2002, NAT NEUROSCI, V5, P1147, DOI 10.1038/nn956; Zhan XL, 2004, NEURON, V43, P673, DOI 10.1016/j.neuron.2004.07.020; ZHANG JQ, 1994, NATURE, V368, P140; Zhu HT, 2006, NAT NEUROSCI, V9, P349, DOI 10.1038/nn1652; Zipursky SL, 2006, TRENDS BIOCHEM SCI, V31, P581, DOI 10.1016/j.tibs.2006.08.003	39	194	201	0	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 27	2008	133	7					1241	1254		10.1016/j.cell.2008.05.030	http://dx.doi.org/10.1016/j.cell.2008.05.030			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	319DP	18585357	Bronze, Green Accepted			2022-12-28	WOS:000257144600020
J	Tseng, CK; Cheng, SC				Tseng, Chi-Kang; Cheng, Soo-Chen			Both catalytic steps of nuclear pre-mRNA splicing are reversible	SCIENCE			English	Article							SPLICEOSOME ACTIVATION; INTRON; HELICASE; YEAST; MUTATIONS; INVITRO; PRP22	Nuclear pre- messenger RNA ( pre- mRNA) splicing is an essential processing step for the production of mature mRNAs from most eukaryotic genes. Splicing is catalyzed by a large ribonucleoprotein complex, the spliceosome, which is composed of five small nuclear RNAs and more than 100 protein factors. Despite the complexity of the spliceosome, the chemistry of the splicing reaction is simple, consisting of two consecutive transesterification reactions. The presence of introns in spliceosomal RNAs of certain fungi has suggested that splicing may be reversible; however, this has never been demonstrated experimentally. By using affinity- purified spliceosomes, we have shown that both catalytic steps of splicing can be efficiently reversed under appropriate conditions. These results provide considerable insight into the catalytic	[Tseng, Chi-Kang; Cheng, Soo-Chen] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan; [Tseng, Chi-Kang; Cheng, Soo-Chen] Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan	Cheng, SC (corresponding author), Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan.	mbscc@ccvax.sinica.edu.tw	Cheng, Soo-Chen/AAZ-7956-2021	Cheng, Soo-Chen/0000-0002-7570-9415; Tseng, Chi-Kang/0000-0003-0288-1406				AUGUSTIN S, 1990, NATURE, V343, P383, DOI 10.1038/343383a0; Brow DA, 2002, ANNU REV GENET, V36, P333, DOI 10.1146/annurev.genet.36.043002.091635; COMPANY M, 1991, NATURE, V349, P487, DOI 10.1038/349487a0; JARRELL KA, 1988, J BIOL CHEM, V263, P3432; Kim SH, 1996, MOL CELL BIOL, V16, P6810; Mayas RM, 2006, NAT STRUCT MOL BIOL, V13, P482, DOI 10.1038/nsmb1093; MORL M, 1990, CELL, V60, P629, DOI 10.1016/0092-8674(90)90666-3; Query CC, 2004, MOL CELL, V14, P343, DOI 10.1016/S1097-2765(04)00217-5; Schwer B, 1998, EMBO J, V17, P2086, DOI 10.1093/emboj/17.7.2086; SCHWER B, 1992, EMBO J, V11, P5033, DOI 10.1002/j.1460-2075.1992.tb05610.x; Schwer B, 2000, EMBO J, V19, P6582, DOI 10.1093/emboj/19.23.6582; TANI T, 1989, NATURE, V337, P87, DOI 10.1038/337087a0; VIJAYRAGHAVAN U, 1986, EMBO J, V5, P1683, DOI 10.1002/j.1460-2075.1986.tb04412.x; Will CL, 2006, COLD SPRING HARB MON, V43, P369	14	78	79	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2008	320	5884					1782	1784		10.1126/science.1158993	http://dx.doi.org/10.1126/science.1158993			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318VP	18583613				2022-12-28	WOS:000257121200040
J	Astudillo, L; Arlet-Suau, E				Astudillo, Leonardo; Arlet-Suau, Elisabeth			Systemic sclerosis and acral osteolysis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Astudillo, Leonardo; Arlet-Suau, Elisabeth] Univ Hosp Purpan, F-31059 Toulouse, France	CHU de Toulouse	Astudillo, L (corresponding author), Univ Hosp Purpan, F-31059 Toulouse, France.			Astudillo, Leonardo/0000-0002-8231-1915					0	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 26	2008	358	26					2812	2812		10.1056/NEJMicm071345	http://dx.doi.org/10.1056/NEJMicm071345			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	317UO	18579816				2022-12-28	WOS:000257045900009
J	Bonkovsky, HL; Siao, P; Roig, Z; Hedley-Whyte, ET; Flotte, TJ; Bloom, AK; Harris, NL; Buonanno, FS; Gonzalez, E				Bonkovsky, Herbert L.; Siao, Peter; Roig, Zulmarie; Hedley-Whyte, E. Tessa; Flotte, Thomas J.; Bloom, Allyson K.; Harris, Nancy Lee; Buonanno, Ferdinando S.; Gonzalez, Ernesto			A woman with abdominal pain and weakness after gastric bypass surgery - Acute porphyria (variegate porphyria)	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE INTERMITTENT PORPHYRIA; SYNTHASE; REPRESSION; HEMATIN; GENE		[Bonkovsky, Herbert L.] Univ Connecticut, Ctr Hlth, Dept Med, Farmington, CT 06030 USA; [Bonkovsky, Herbert L.] Univ Connecticut, Ctr Hlth, Dept Mol Microbial & Struct Biol, Farmington, CT USA; [Bonkovsky, Herbert L.] Carolinas Med Ctr, Dept Med, Charlotte, NC 28203 USA; [Bonkovsky, Herbert L.] Univ N Carolina, Chapel Hill, NC USA; [Bonkovsky, Herbert L.] Univ N Carolina, Dept Biol, Charlotte, NC 28223 USA; [Siao, Peter] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Roig, Zulmarie] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Hedley-Whyte, E. Tessa; Flotte, Thomas J.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Siao, Peter] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Roig, Zulmarie] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Hedley-Whyte, E. Tessa; Flotte, Thomas J.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	University of Connecticut; University of Connecticut; Carolinas Medical Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Charlotte; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Bonkovsky, HL (corresponding author), Univ Connecticut, Ctr Hlth, Dept Med, Farmington, CT 06030 USA.		Hedley-Whyte, E Tessa/AAJ-9975-2021; Bonkovsky, Herbert L./AAH-1892-2021	Hedley-Whyte, E Tessa/0000-0002-1687-8905; Bonkovsky, Herbert L./0000-0001-7387-3230	NIDDK NIH HHS [R01 DK038825] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038825] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Albers JW, 2004, MUSCLE NERVE, V30, P410, DOI 10.1002/mus.20137; Anderson KE, 2005, ANN INTERN MED, V143, P316, DOI 10.7326/0003-4819-143-4-200508160-00023; Anderson KE, 2005, ANN INTERN MED, V142, P439, DOI 10.7326/0003-4819-142-6-200503150-00010; Bonkovsky H.L., 1990, HEPATOLOGY TXB LIVER, V2nd ed., P378; BONKOVSKY HL, 1991, AM J GASTROENTEROL, V86, P1050; BONKOWSK.HL, 1973, J NATL CANCER I, V50, P1215, DOI 10.1093/jnci/50.5.1215; Bonkowsky H L, 1982, Semin Liver Dis, V2, P108, DOI 10.1055/s-2008-1040701; BONKOWSKY HL, 1971, P NATL ACAD SCI USA, V68, P2725, DOI 10.1073/pnas.68.11.2725; DELAFAILLE HB, 1991, CURR PROBL DERMATOL, V20, P123; DeMaria EJ, 2007, NEW ENGL J MED, V356, P2176, DOI 10.1056/NEJMct067019; DENNYBROWN D, 1945, BRAIN, V68, P1, DOI 10.1093/brain/68.1.1; Fraser DJ, 2002, J BIOL CHEM, V277, P34717, DOI 10.1074/jbc.M204699200; Hahn M, 1998, DIS LIVER BILE DUCTS; Handschin C, 2005, CELL, V122, P505, DOI 10.1016/j.cell.2005.06.040; Kalman DR, 1998, CLIN DERMATOL, V16, P299, DOI 10.1016/S0738-081X(97)00209-5; Kolluri S, 2005, BIOCHEM J, V392, P173, DOI 10.1042/BJ20050354; Lambrecht RW, 1999, BIOCHEM PHARMACOL, V58, P887, DOI 10.1016/S0006-2952(99)00154-9; LITMAN DA, 1983, SCIENCE, V222, P1031, DOI 10.1126/science.6648517; MAYNARD B, 1992, J CUTAN PATHOL, V19, P40, DOI 10.1111/j.1600-0560.1992.tb01557.x; MEOLA T, 1993, DERMATOL CLIN, V11, P583, DOI 10.1016/S0733-8635(18)30252-3; MUSTAJOKI P, 1981, ANN INTERN MED, V95, P162, DOI 10.7326/0003-4819-95-2-162; PETERSON A, 1976, JAMA-J AM MED ASSOC, V235, P520, DOI 10.1001/jama.235.5.520; Soonawalla ZF, 2004, LANCET, V363, P705, DOI 10.1016/S0140-6736(04)15646-8; Varone CL, 1996, BIOCHEM CELL BIOL, V74, P271, DOI 10.1139/o96-029; Windebank AJ., 2005, PERIPHERAL NEUROPATH, P1883, DOI [10.1016/B978-0-7216-9491-7.50083-1, DOI 10.1016/B978-0-7216-9491-7.50083-1]	25	25	25	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 26	2008	358	26					2813	2825		10.1056/NEJMcpc0803190	http://dx.doi.org/10.1056/NEJMcpc0803190			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	317UO	18579817				2022-12-28	WOS:000257045900011
J	Celum, C; Wald, A; Hughes, J; Sanchez, J; Reid, S; Delany-Moretlwe, S; Cowan, F; Casapia, M; Ortiz, A; Fuchs, J; Buchbinder, S; Koblin, B; Zwerski, S; Rose, S; Wang, J; Corey, L				Celum, Connie; Wald, Anna; Hughes, James; Sanchez, Jorge; Reid, Stewart; Delany-Moretlwe, Sinead; Cowan, Frances; Casapia, Martin; Ortiz, Abner; Fuchs, Jonathan; Buchbinder, Susan; Koblin, Beryl; Zwerski, Sheryl; Rose, Scott; Wang, Jing; Corey, Lawrence		HPTN 039 Protocol Team	Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial	LANCET			English	Article							HERPES-SIMPLEX-VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; LINKED-IMMUNOSORBENT-ASSAY; TYPE-2 INFECTION; CLINICAL-TRIALS; GENITAL-TRACT; SUPPRESSION; METAANALYSIS; RISK; TRANSMISSION	Background Across many observational studies, herpes simplex virus type 2 (HSV-2) infection is associated with two-fold to three-fold increased risk for HIV-1 infection. We investigated whether HSV-2 suppression with aciclovir would reduce the risk of HIV-1 acquisition. Methods We undertook a double-blind, randomised, placebo-controlled phase III trial in HIV-negative, HSV-2 seropositive women in Africa and men who have sex with men (MSM) from sites in Peru and the USA. Participants were randomly assigned by block randomisation to twice daily aciclovir 400 mg (n=1637) or matching placebo (n=1640) for 12-18 months, and were seen monthly for dispensation of study drug, adherence counselling and measurement by pill count and self-reporting, and risk reduction counselling, and every 3 months for genital examination and HIV testing. The primary outcome was HIV-1 acquisition and secondary was incidence of genital ulcers. Analysis was by intention to treat. This study is registered with Clinicaltrials.gov, number NCT00076232. Findings 3172 participants (1358 women, 1814 MSM) were included in the primary dataset (1581 in aciclovir group, 1591 in control group). The incidence of HIV-1 was 3.9 per 100 person-years in the aciclovir group (75 events in 1935 person-years of follow-up) and 3.3 per 100 person-years in the placebo group (64 events in 1969 person-years of follow-up; hazard ratio 1 . 16 [95% CI 0 . 83-1.62]). Incidence of genital ulcers on examination was reduced by 47% (relative risk 0 . 53 [0.46-0.62]) and HSV-2 positive genital ulcers by 63% (0.37 [0.31-0.45]) in the aciclovir group. Adherence to dispensed study drug was 94% in the aciclovir group and 94% in the placebo group, and 85% of expected doses in the aciclovir group and 86% in the placebo group. Retention was 85% at 18 months in both groups (1028 of 1212 in aciclovir group, 1030 of 1208 in placebo group). We recorded no serious events related to the study drug. Interpretation Our results show that suppressive therapy with standard doses of aciclovir is not effective in reduction of HIV-1 acquisition in HSV-2 seropositive women and MSM. Novel strategies are needed to interrupt interactions between HSV-2 and HIV-1. Funding US National Institute of Allergy and Infectious Diseases, US National Institute of Child Health and Human Development, US National Institute of Drug Abuse, US National Institute of Mental Health, US Office of AIDS Research, and GlaxoSmithKline.	[Celum, Connie] Univ Washington, Harborview Med Ctr, Dept Global Hlth, Seattle, WA 98104 USA; [Celum, Connie; Wald, Anna; Corey, Lawrence] Univ Washington, Dept Med, Seattle, WA 98104 USA; [Celum, Connie; Wald, Anna] Univ Washington, Dept Epidemiol, Seattle, WA 98104 USA; [Wald, Anna; Corey, Lawrence] Univ Washington, Dept Lab Med, Seattle, WA 98104 USA; [Hughes, James] Univ Washington, Dept Biostat, Seattle, WA 98104 USA; [Wald, Anna; Wang, Jing; Corey, Lawrence] Fred Hutchinson Canc Res Ctr, Program Infect Dis, Seattle, WA 98104 USA; [Sanchez, Jorge; Casapia, Martin; Ortiz, Abner] Asociac Civil Salud & Educ, Lima, Peru; [Reid, Stewart] Univ Alabama, Dept Med, Birmingham, AL 35294 USA; [Reid, Stewart] Ctr Infect Dis Res, Lusaka, Zambia; [Delany-Moretlwe, Sinead] Univ Witwatersrand, Reprod Hlth & HIV Res Unit, Johannesburg, South Africa; [Cowan, Frances] UCL, Royal Free & Univ Coll Med Sch, London, England; [Fuchs, Jonathan; Buchbinder, Susan] San Francisco Dept Publ Hlth, San Francisco, CA USA; [Koblin, Beryl] New York Blood Ctr, New York, NY 10021 USA; [Zwerski, Sheryl] NIH, Div AIDS, Bethesda, MD 20892 USA; [Rose, Scott] Family Hlth Int, Res Triangle Pk, NC 27709 USA	Harborview Medical Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Alabama System; University of Alabama Birmingham; University of Witwatersrand; University of London; University College London; San Francisco Department of Public Health; New York Blood Center; National Institutes of Health (NIH) - USA	Celum, C (corresponding author), Univ Washington, Harborview Med Ctr, Dept Global Hlth, Box 359927,325 9th Ave, Seattle, WA 98104 USA.	ccelum@u.washington.edu	Corey, Lawrence/AAE-1796-2020; Wald, Anna/B-6272-2012	Corey, Lawrence/0000-0002-2179-2436; Wald, Anna/0000-0003-3486-6438; Cowan, Frances/0000-0003-3087-4422; Reid, Stewart/0000-0001-7779-4820; Casapia Morales, Wilfredo Martin/0000-0002-5972-0948	NIAID NIH HHS [U01 AI069466, U01 AI52054, UM1 AI068619, P30 AI027757, U01 AI052054-06, U01 AI069466-02, U01 AI052054, U01 AI46749, U01 AI046749] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757, U01AI069466, U01AI046749, U01AI052054] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ASHLEY RL, 1988, J CLIN MICROBIOL, V26, P662, DOI 10.1128/JCM.26.4.662-667.1988; BAETEN J, 2008, 15 C RETR OPP INF BO; Brown EL, 2006, AM J EPIDEMIOL, V164, P733, DOI 10.1093/aje/kwj270; *CDCP, 2006, MMWR RECOMM REP, V55, P18; Corey L, 2004, JAIDS-J ACQ IMM DEF, V35, P435, DOI 10.1097/00126334-200404150-00001; DELANY S, 2007, 14 C RETR OPP INF LO; DUNNE E, 2007, 14 C RETR OPP INF LO, P75; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Golden MR, 2005, SEX TRANSM DIS, V32, P771, DOI 10.1097/01.olq.0000175377.88358.f3; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Gupta R, 2004, J INFECT DIS, V190, P1374, DOI 10.1086/424519; Ioannidis JPA, 1998, J INFECT DIS, V178, P349, DOI 10.1086/515621; Jerome KR, 2002, J CLIN MICROBIOL, V40, P2609, DOI 10.1128/JCM.40.7.2609-2611.2002; Laeyendecker O, 2004, J CLIN MICROBIOL, V42, P1794, DOI 10.1128/JCM.42.4.1794-1796.2004; Lama JR, 2006, J INFECT DIS, V194, P1459, DOI 10.1086/508548; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; MERTZ GJ, 1988, JAMA-J AM MED ASSOC, V260, P201, DOI 10.1001/jama.260.2.201; MOSCA JD, 1987, NATURE, V325, P67, DOI 10.1038/325067a0; Nagot N, 2007, NEW ENGL J MED, V356, P790, DOI 10.1056/NEJMoa062607; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Ouedraogo A, 2006, AIDS, V20, P2305, DOI 10.1097/QAD.0b013e328010238d; Rebbapragada A, 2007, AIDS, V21, P589, DOI 10.1097/QAD.0b013e328012b896; Reitano M, 1998, J INFECT DIS, V178, P603, DOI 10.1086/515385; Reynolds SJ, 2003, J INFECT DIS, V187, P1513, DOI 10.1086/368357; Wald A, 2000, NEW ENGL J MED, V342, P844, DOI 10.1056/NEJM200003233421203; Wald A, 2002, J INFECT DIS, V185, P45, DOI 10.1086/338231; Wald A, 2003, J INFECT DIS, V188, P1345, DOI 10.1086/379043; Watson-Jones D, 2008, NEW ENGL J MED, V358, P1560, DOI 10.1056/NEJMoa0800260; Weiss Helen, 2004, Herpes, V11 Suppl 1, p24A; Zuckerman RA, 2007, J INFECT DIS, V196, P1500, DOI 10.1086/522523	31	316	322	0	34	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 21	2008	371	9630					2109	2119		10.1016/S0140-6736(08)60920-4	http://dx.doi.org/10.1016/S0140-6736(08)60920-4			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	316ER	18572080	Green Accepted			2022-12-28	WOS:000256932200031
J	Zanette, D				Zanette, Damian			Playing by numbers	NATURE			English	Editorial Material									Comis Nacl Energia Atom, Ctr Atom Bariloche, Stat & Interdisciplinary Phys Grp, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; Inst Balseiro, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina	Comision Nacional de Energia Atomica (CNEA); Centro Atomico Bariloche; Comision Nacional de Energia Atomica (CNEA); University Nacional Cuyo Mendoza; Instituto Balseiro	Zanette, D (corresponding author), Comis Nacl Energia Atom, Ctr Atom Bariloche, Stat & Interdisciplinary Phys Grp, Ave Ezequiel Bustillo 9500, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina.			Zanette, Damian/0000-0003-0681-0592					0	7	8	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 19	2008	453	7198					988	989		10.1038/453988a	http://dx.doi.org/10.1038/453988a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314WM	18563138	Bronze			2022-12-28	WOS:000256839900029
J	Tsai, SY; Opavsky, R; Sharma, N; Wu, LZ; Naidu, S; Nolan, E; Feria-Arias, E; Timmers, C; Opavska, J; de Bruin, A; Chong, JL; Trikha, P; Fernandez, SA; Stromberg, P; Rosol, TJ; Leone, G				Tsai, Shih-Yin; Opavsky, Rene; Sharma, Nidhi; Wu, Lizhao; Naidu, Shan; Nolan, Eric; Feria-Arias, Enrique; Timmers, Cynthia; Opavska, Jana; de Bruin, Alain; Chong, Jean-Leon; Trikha, Prashant; Fernandez, Soledad A.; Stromberg, Paul; Rosol, Thomas J.; Leone, Gustavo			Mouse development with a single E2F activator	NATURE			English	Article							TRANSCRIPTION FACTOR; CELL-CYCLE; PROLIFERATION; MICE; RB; IDENTIFICATION; SPECIFICITY; MATURATION; MECHANISM; BINDING	The E2F family is conserved from Caenorhabditis elegans to mammals, with some family members having transcription activation functions and others having repressor functions(1,2). Whereas C. elegans(3) and Drosophila melanogaster(4,5) have a single E2F activator protein and repressor protein, mammals have at least three activator and five repressor proteins(1,2,6). Why such genetic complexity evolved in mammals is not known. To begin to evaluate this genetic complexity, we targeted the inactivation of the entire subset of activators, E2f1, E2f2, E2f3a and E2f3b, singly or in combination in mice. We demonstrate that E2f3a is sufficient to support mouse embryonic and postnatal development. Remarkably, expression of E2f3b or E2f1 from the E2f3a locus ( E2f3a(3bki) or E2f3a(1ki), respectively) suppressed all the postnatal phenotypes associated with the inactivation of E2f3a. We conclude that there is significant functional redundancy among activators and that the specific requirement for E2f3a during postnatal development is dictated by regulatory sequences governing its selective spatiotemporal expression and not by its intrinsic protein functions. These findings provide a molecular basis for the observed specificity among E2F activators during development.	[Tsai, Shih-Yin; Opavsky, Rene; Sharma, Nidhi; Wu, Lizhao; Nolan, Eric; Feria-Arias, Enrique; Timmers, Cynthia; Opavska, Jana; de Bruin, Alain; Chong, Jean-Leon; Trikha, Prashant; Leone, Gustavo] Ohio State Univ, Dept Mol Genet, Coll Biol Sci, Columbus, OH 43210 USA; [Tsai, Shih-Yin; Opavsky, Rene; Sharma, Nidhi; Wu, Lizhao; Naidu, Shan; Nolan, Eric; Feria-Arias, Enrique; Timmers, Cynthia; Opavska, Jana; de Bruin, Alain; Chong, Jean-Leon; Trikha, Prashant; Leone, Gustavo] Ohio State Univ, Ctr Comprehens Canc, Human Canc Genet Program, Columbus, OH 43210 USA; [Tsai, Shih-Yin; Opavsky, Rene; Sharma, Nidhi; Wu, Lizhao; Naidu, Shan; Nolan, Eric; Feria-Arias, Enrique; Timmers, Cynthia; Opavska, Jana; de Bruin, Alain; Chong, Jean-Leon; Trikha, Prashant; Leone, Gustavo] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Coll Med, Columbus, OH 43210 USA; [Naidu, Shan; Stromberg, Paul; Rosol, Thomas J.] Ohio State Univ, Dept Vet Biosci, Coll Vet Med, Columbus, OH 43210 USA; [Fernandez, Soledad A.] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Leone, G (corresponding author), Ohio State Univ, Dept Mol Genet, Coll Biol Sci, 484 W 12Th Ave, Columbus, OH 43210 USA.	Gustavo.Leone@osumc.edu	de Bruin, Alain/AAL-9195-2020; Trikha, Prashant/B-5897-2012; Rosol, Thomas/G-9585-2011	Rosol, Thomas/0000-0003-3737-1190; Tsai, Shih-Yin/0000-0002-2834-6383; de Bruin, Alain/0000-0001-8579-2649	NIH [R01CA85619, R01HD042619, R01CA121275, R01HD047470, P01CA097189, K01CA102328]; DoD awards [BC0300893, BC061730]; T32 fellowship [CA106196]; Pew Charitable Trusts Scholar Award; Leukemia and Lymphoma Society Scholar Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047470, R01HD042619] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA097189, R01CA121275, R01CA085619, T32CA106196, K01CA102328] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DoD awards; T32 fellowship; Pew Charitable Trusts Scholar Award; Leukemia and Lymphoma Society Scholar Award(Leukemia and Lymphoma Society); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Moffitt and L. Rawahneh for histology expertise. We also thank J. Nevins, C. Bock and A. Otoshi for support in the generation of the E2f3a, E2f3b, E2f3a<SUP>3bki</SUP> and E2f3a<SUP>1ki</SUP> mice, and the Mouse Metabolic Phenotyping center at the University of Cincinnati for advice on the analysis of E2f1<SUP>-/-</SUP>E2f3a<SUP>-/-</SUP> mice. We are grateful to D. Guttridge, M. Ostrowski and M. Simcox for critically reading the manuscript and helpful suggestions. This work was funded by NIH grants to G. L. (R01CA85619, R01HD042619, R01CA121275, R01HD047470, P01CA097189), to L. W. ( K01CA102328), DoD awards to A.d.B. (BC0300893) and J.-L.C. (BC061730), and a T32 fellowship (CA106196) to R.O.G.L. is the recipient of the Pew Charitable Trusts Scholar Award and the Leukemia and Lymphoma Society Scholar Award.	Attwooll C, 2004, EMBO J, V23, P4709, DOI 10.1038/sj.emboj.7600481; Blais A, 2007, CURR OPIN CELL BIOL, V19, P658, DOI 10.1016/j.ceb.2007.10.003; Ceol CJ, 2001, MOL CELL, V7, P461, DOI 10.1016/S1097-2765(01)00194-0; Cloud JE, 2002, MOL CELL BIOL, V22, P2663, DOI 10.1128/MCB.22.8.2663-2672.2002; DeGregori J, 2006, CURR MOL MED, V6, P739; Dirlam A, 2007, MOL CELL BIOL, V27, P8713, DOI 10.1128/MCB.01118-07; DYNLACHT BD, 1994, P NATL ACAD SCI USA, V91, P6359, DOI 10.1073/pnas.91.14.6359; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; Gaubatz S, 2000, MOL CELL, V6, P729, DOI 10.1016/S1097-2765(00)00071-X; Giangrande PH, 2003, MOL CELL BIOL, V23, P3707, DOI 10.1128/MCB.23.11.3707-3720.2003; Giangrande PH, 2004, GENE DEV, V18, P2941, DOI 10.1101/gad.1239304; HELIN K, 1992, CELL, V70, P337, DOI 10.1016/0092-8674(92)90107-N; Humbert PO, 2000, GENE DEV, V14, P690; Jandacek RJ, 2004, GASTROENTEROLOGY, V127, P139, DOI 10.1053/j.gastro.2004.04.007; Leone G, 2000, MOL CELL BIOL, V20, P3626, DOI 10.1128/MCB.20.10.3626-3632.2000; Li FX, 2003, MOL CELL BIOL, V23, P3607, DOI 10.1128/MCB.23.10.3607-3622.2003; Li J, 2008, DEV CELL, V14, P62, DOI 10.1016/j.devcel.2007.10.017; Murga M, 2001, IMMUNITY, V15, P959, DOI 10.1016/S1074-7613(01)00254-0; Opavsky R, 2007, P NATL ACAD SCI USA, V104, P15400, DOI 10.1073/pnas.0706307104; Parisi T, 2007, MOL CELL BIOL, V27, P2283, DOI 10.1128/MCB.01854-06; Sawado T, 1998, BIOCHEM BIOPH RES CO, V251, P409, DOI 10.1006/bbrc.1998.9407; Schlisio S, 2002, EMBO J, V21, P5775, DOI 10.1093/emboj/cdf577; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593; Yamasaki L, 1996, CELL, V85, P537, DOI 10.1016/S0092-8674(00)81254-4; Zhu JW, 2001, MOL CELL BIOL, V21, P8547, DOI 10.1128/MCB.21.24.8547-8564.2001	26	75	75	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 28	2008	454	7208					1137	U69		10.1038/nature07066	http://dx.doi.org/10.1038/nature07066			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341MW	18594513	Green Accepted, Green Published			2022-12-28	WOS:000258719600042
J	Verheyden, JM; Sun, X				Verheyden, Jamie M.; Sun, Xin			An Fgf/Gremlin inhibitory feedback loop triggers termination of limb bud outgrowth	NATURE			English	Article							CONDITIONAL KNOCKOUT MICE; APICAL ECTODERMAL RIDGE; PROGRAMMED CELL-DEATH; FGF; GREMLIN; ANTAGONISM; EXPRESSION; SIZE; INACTIVATION; GENERATION	During organ formation and regeneration a proper balance between promoting and restricting growth is critical to achieve stereotypical size. Limb bud outgrowth is driven by signals in a positive feedback loop involving fibroblast growth factor ( Fgf) genes, sonic hedgehog ( Shh) and Gremlin1 ( Grem1)(1). Precise termination of these signals is essential to restrict limb bud size(2-4). The current model predicts a sequence of signal termination consistent with that in chick limb buds(4). Our finding that the sequence in mouse limb buds is different led us to explore alternative mechanisms. Here we show, by analysing compound mouse mutants defective in genes comprising the positive loop, genetic evidence that FGF signalling can repress Grem1 expression, revealing a novel Fgf/Grem1 inhibitory loop. This repression occurs both in mouse and chick limb buds, and is dependent on high FGF activity. These data support a mechanism where the positive Fgf/ Shh loop drives outgrowth and an increase in FGF signalling, which triggers the Fgf/ Grem1 inhibitory loop. The inhibitory loop then operates to terminate outgrowth signals in the order observed in either mouse or chick limb buds. Our study unveils the concept of a self- promoting and self- terminating circuit that may be used to attain proper tissue size in a broad spectrum of developmental and regenerative settings.	[Verheyden, Jamie M.; Sun, Xin] Univ Wisconsin, Genet Lab, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Sun, X (corresponding author), Univ Wisconsin, Genet Lab, Madison, WI 53706 USA.	xsun@wisc.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007133] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD045522-01A1, R01 HD045522-05, R01 HD045522-02, R01 HD045522, R01 HD045522-04, R01 HD045522-05S1, R01 HD045522-03] Funding Source: Medline; NIGMS NIH HHS [T32 GM007133, 5T32GM07133, T32 GM007133-25, T32 GM007133-26, T32 GM007133-27, T32 GM007133-24] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aegerter-Wilmsen T, 2007, MECH DEVELOP, V124, P318, DOI 10.1016/j.mod.2006.12.005; Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Capdevila J, 1999, MOL CELL, V4, P839, DOI 10.1016/S1097-2765(00)80393-7; Chiang C, 2001, DEV BIOL, V236, P421, DOI 10.1006/dbio.2001.0346; Day SJ, 2000, DEVELOPMENT, V127, P2977; Eswarakumar VP, 2002, DEVELOPMENT, V129, P3783; Garcia-Bellido AC, 1998, INT J DEV BIOL, V42, P353; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Hufnagel L, 2007, P NATL ACAD SCI USA, V104, P3835, DOI 10.1073/pnas.0607134104; Khokha MK, 2003, NAT GENET, V34, P303, DOI 10.1038/ng1178; Lewandoski M, 2000, NAT GENET, V26, P460, DOI 10.1038/82609; Lu PF, 2006, DEVELOPMENT, V133, P33, DOI 10.1242/dev.02172; Merino R, 1999, DEVELOPMENT, V126, P5515; Michos O, 2004, DEVELOPMENT, V131, P3401, DOI 10.1242/dev.01251; Minowada G, 1999, DEVELOPMENT, V126, P4465; Mishina Y, 2002, GENESIS, V32, P69, DOI 10.1002/gene.10038; Moon AM, 2000, NAT GENET, V26, P455, DOI 10.1038/82601; Neubuser A, 1997, CELL, V90, P247, DOI 10.1016/S0092-8674(00)80333-5; Nissim S, 2006, DEV BIOL, V299, P12, DOI 10.1016/j.ydbio.2006.05.026; Niswander L, 2002, INT J DEV BIOL, V46, P877; Ovchinnikov DA, 2006, DEV BIOL, V295, P103, DOI 10.1016/j.ydbio.2006.03.013; Pajni-Underwood S, 2007, DEVELOPMENT, V134, P2359, DOI 10.1242/dev.001677; Panman L, 2006, DEVELOPMENT, V133, P3419, DOI 10.1242/dev.02529; Pizette S, 1999, DEVELOPMENT, V126, P883; Sanz-Ezquerro JJ, 2003, CURR BIOL, V13, P1830, DOI 10.1016/j.cub.2003.09.040; Scherz PJ, 2004, SCIENCE, V305, P396, DOI 10.1126/science.1096966; Selever J, 2004, DEV BIOL, V276, P268, DOI 10.1016/j.ydbio.2004.08.024; Sun X, 2002, NATURE, V418, P501, DOI 10.1038/nature00902; Sun X, 2000, NAT GENET, V25, P83, DOI 10.1038/75644; Verheyden JM, 2005, DEVELOPMENT, V132, P4235, DOI 10.1242/dev.02001; Xu XL, 2002, GENESIS, V32, P85, DOI 10.1002/gene.10028; Zuniga A, 1999, NATURE, V401, P598, DOI 10.1038/44157	32	133	137	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 31	2008	454	7204					638	U45		10.1038/nature07085	http://dx.doi.org/10.1038/nature07085			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	331QC	18594511	Green Accepted			2022-12-28	WOS:000258026500047
J	Maheswaran, S; Sequist, LV; Nagrath, S; Ulkus, L; Brannigan, B; Collura, CV; Inserra, E; Diederichs, S; Iafrate, AJ; Bell, DW; Digumarthy, S; Muzikansky, A; Irimia, D; Settleman, J; Tompkins, RG; Lynch, TJ; Toner, M; Haber, DA				Maheswaran, Shyamala; Sequist, Lecia V.; Nagrath, Sunitha; Ulkus, Lindsey; Brannigan, Brian; Collura, Chey V.; Inserra, Elizabeth; Diederichs, Sven; Iafrate, A. John; Bell, Daphne W.; Digumarthy, Subba; Muzikansky, Alona; Irimia, Daniel; Settleman, Jeffrey; Tompkins, Ronald G.; Lynch, Thomas J.; Toner, Mehmet; Haber, Daniel A.			Detection of mutations in EGFR in circulating lung-cancer cells	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FACTOR RECEPTOR MUTATIONS; TUMOR-CELLS; ACQUIRED-RESISTANCE; PHASE-II; GEFITINIB; AMPLIFICATION; ADENOCARCINOMAS; SENSITIVITY; PREDICTORS; INHIBITOR	Background The use of tyrosine kinase inhibitors to target the epidermal growth factor receptor gene (EGFR) in patients with non-small-cell lung cancer is effective but limited by the emergence of drug-resistance mutations. Molecular characterization of circulating tumor cells may provide a strategy for noninvasive serial monitoring of tumor genotypes during treatment. Methods We captured highly purified circulating tumor cells from the blood of patients with non-small-cell lung cancer using a microfluidic device containing microposts coated with antibodies against epithelial cells. We performed EGFR mutational analysis on DNA recovered from circulating tumor cells using allele-specific polymerase-chain-reaction amplification and compared the results with those from concurrently isolated free plasma DNA and from the original tumor-biopsy specimens. Results We isolated circulating tumor cells from 27 patients with metastatic non-small-cell lung cancer (median number, 74 cells per milliliter). We identified the expected EGFR activating mutation in circulating tumor cells from 11 of 12 patients (92%) and in matched free plasma DNA from 4 of 12 patients (33%) (P=0.009). We detected the T790M mutation, which confers drug resistance, in circulating tumor cells collected from patients with EGFR mutations who had received tyrosine kinase inhibitors. When T790M was detectable in pretreatment tumor-biopsy specimens, the presence of the mutation correlated with reduced progression-free survival (7.7 months vs. 16.5 months, P<0.001). Serial analysis of circulating tumor cells showed that a reduction in the number of captured cells was associated with a radiographic tumor response; an increase in the number of cells was associated with tumor progression, with the emergence of additional EGFR mutations in some cases. Conclusions Molecular analysis of circulating tumor cells from the blood of patients with lung cancer offers the possibility of monitoring changes in epithelial tumor genotypes during the course of treatment.	[Maheswaran, Shyamala; Sequist, Lecia V.; Ulkus, Lindsey; Brannigan, Brian; Inserra, Elizabeth; Diederichs, Sven; Bell, Daphne W.; Digumarthy, Subba; Muzikansky, Alona; Settleman, Jeffrey; Lynch, Thomas J.; Haber, Daniel A.] Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; [Nagrath, Sunitha; Collura, Chey V.; Irimia, Daniel; Tompkins, Ronald G.; Toner, Mehmet] Massachusetts Gen Hosp, Biomicroelectromech Syst Resource Ctr, Boston, MA 02114 USA; [Maheswaran, Shyamala; Nagrath, Sunitha; Irimia, Daniel; Tompkins, Ronald G.; Toner, Mehmet] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Sequist, Lecia V.; Lynch, Thomas J.; Haber, Daniel A.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Iafrate, A. John] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Digumarthy, Subba] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Muzikansky, Alona] Massachusetts Gen Hosp, Biostat Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; [Tompkins, Ronald G.; Toner, Mehmet] Shriners Hosp Children, Boston, MA USA; [Haber, Daniel A.] Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Haber, DA (corresponding author), Massachusetts Gen Hosp, Ctr Canc, CNY-7,Bldg 149,13th St, Charlestown, MA 02129 USA.	haber@helix.mgh.harvard.edu	Irimia, Daniel/S-5404-2019; Irimia, Daniel/A-4095-2008; Diederichs, Sven/J-6237-2012	Irimia, Daniel/0000-0001-7347-2082; Irimia, Daniel/0000-0001-7347-2082; Diederichs, Sven/0000-0001-7901-4752	NATIONAL CANCER INSTITUTE [R01CA129933] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG200338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002503] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R01 CA129933-01A1, R01 CA129933] Funding Source: Medline; NIBIB NIH HHS [P41 EB002503] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Asahina H, 2006, BRIT J CANCER, V95, P998, DOI 10.1038/sj.bjc.6603393; Ashworth T. R, 1869, AUST MED J, V14, P146, DOI DOI 10.1038/SJ.BJC.6604218; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Bell DW, 2005, NAT GENET, V37, P1315, DOI 10.1038/ng1671; Bell DW, 2005, J CLIN ONCOL, V23, P8081, DOI 10.1200/JCO.2005.02.7078; Braun S, 2004, NEW ENGL J MED, V351, P824, DOI 10.1056/NEJMe048163; Cristofanilli M, 2005, J CLIN ONCOL, V23, P1420, DOI 10.1200/JCO.2005.08.140; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; CRISTOFANILLI M, 2005, J CLIN ONCOL, V23, P4808; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Godin-Heymann N, 2007, CANCER RES, V67, P7319, DOI 10.1158/0008-5472.CAN-06-4625; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Greulich H, 2005, PLOS MED, V2, P1167, DOI 10.1371/journal.pmed.0020313; Inoue A, 2006, J CLIN ONCOL, V24, P3340, DOI 10.1200/JCO.2005.05.4692; Inukai M, 2006, CANCER RES, V66, P7854, DOI 10.1158/0008-5472.CAN-06-1951; Ji HB, 2006, CANCER CELL, V9, P485, DOI 10.1016/j.ccr.2006.04.022; Kimura H, 2006, CLIN CANCER RES, V12, P3915, DOI 10.1158/1078-0432.CCR-05-2324; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kwak EL, 2005, P NATL ACAD SCI USA, V102, P7665, DOI 10.1073/pnas.0502860102; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Papadopoulos N, 2006, NAT BIOTECHNOL, V24, P985, DOI 10.1038/nbt1234; Politi K, 2006, GENE DEV, V20, P1496, DOI 10.1101/gad.1417406; Sequist LV, 2008, J CLIN ONCOL, V26, P2442, DOI 10.1200/JCO.2007.14.8494; Sequist LV, 2007, J CLIN ONCOL, V25, P587, DOI 10.1200/JCO.2006.07.3585; Smerage JB, 2006, BRIT J CANCER, V94, P8, DOI 10.1038/sj.bjc.6602871; Smirnov DA, 2005, CANCER RES, V65, P4993, DOI 10.1158/0008-5472.CAN-04-4330; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Tsao MS, 2005, NEW ENGL J MED, V353, P1741; Tsao MS, 2005, NEW ENGL J MED, V353, P133, DOI 10.1056/NEJMoa050736; Whitcombe D, 1999, NAT BIOTECHNOL, V17, P804, DOI 10.1038/11751; Zieglschmid V, 2005, CRIT REV CL LAB SCI, V42, P155, DOI 10.1080/10408360590913696	37	1328	1451	8	367	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2008	359	4					366	377		10.1056/NEJMoa0800668	http://dx.doi.org/10.1056/NEJMoa0800668			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329FK	18596266	Green Accepted			2022-12-28	WOS:000257852100005
J	Logie, DE; Rowson, M; Ndagije, F				Logie, Dorothy E.; Rowson, Michael; Ndagije, Felix			Innovations in Rwanda's health system: looking to the future	LANCET			English	Article							PERFORMANCE; COUNTRIES; INSURANCE	Rwanda is making substantial progress towards improvement of health and is working towards achievement of the Millennium Development Goals, which is a challenging task because the country has had genocide in 1994, has few natural resources, is landlocked, and has high population growth. Like many impoverished sub-Saharan countries, Rwanda's health system has had an uncoordinated plethora of donors, shortage of health staff, inequity of access, and poor quality of care in health facilities. This report describes three health system developments introduced by the Rwandan government that are improving these barriers to care-ie, the coordination of donors and external aid with government policy, and monitoring the effectiveness of aid; a country-wide independent community health insurance scheme; and the introduction of a performance-based pay initiative. If these innovations are successful, they might be of interest to other sub-Saharan countries. However, Rwanda still does not have sufficient financial resources for health and will need additional external aid for some time to attain the Millennium Development Goals.	[Rowson, Michael] UCL, Ctr Int Hlth & Dev, Inst Child Hlth, London WC1H 1EH, England; [Logie, Dorothy E.] Queen Margaret Univ, Edinburgh, Midlothian, Scotland	University of London; University College London; Queen Margaret University	Rowson, M (corresponding author), UCL, Ctr Int Hlth & Dev, Inst Child Hlth, 30 Guilford St, London WC1H 1EH, England.	m.rowson@ucl.ac.uk						*AFR DEV BANK, 2006, AID DEBT REL DEV AFR; BASINGA P, 2008, SCAL INN SERV DEL PR; Brikci N, 2007, LANCET, V369, P10, DOI 10.1016/S0140-6736(07)60008-7; CLAVER G, 2006, POST GENOCIDE RECONS; De Allegri M, 2007, BMJ-BRIT MED J, V334, P1282, DOI 10.1136/bmj.39240.632963.80; *DEM HLTH SURV, 2006, RWAND DEM HLTH SURV; *GOV RWAND, 2004, VIS 2020; Government of Rwanda, HLTH SECT STRAT PLAN; Hongoro C, 2004, LANCET, V364, P1451, DOI 10.1016/S0140-6736(04)17229-2; Kalk A, 2005, TROP MED INT HEALTH, V10, P872, DOI 10.1111/j.1365-3156.2005.01464.x; Meessen B, 2005, COMP 2 OUTPUT BASED; *NAT I STAT, 2006, PREL POV UPD REP INT; *NAT I STAT RWAND, ALL ODDS ACH MDGS RW; *ORG EC COOP DEV, 2006, SCAL ACH HLTH MDGS R; Organisation for Economic Co-operation and Development, PAR DECL AID EFF; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; *RWAND MIN HLTH, HLTH IND; Schmidt JO, 2006, TROP MED INT HEALTH, V11, P1327, DOI 10.1111/j.1365-3156.2006.01661.x; Soeters R, 2006, B WORLD HEALTH ORGAN, V84, P884; *UN DEV PROGR GOV, 2007, REC SUST HUM DEV; *UNAIDS, 2008 PROGR REP SUBM; UNFPA, 2007, STAT WORLDS POP 2007; *WORLD BANK, GOV MATT 2007 WORLDW	23	102	104	0	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 19	2008	372	9634					256	261		10.1016/S0140-6736(08)60962-9	http://dx.doi.org/10.1016/S0140-6736(08)60962-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	327YH	18619670				2022-12-28	WOS:000257763900035
J	Dalton, HR; Maskell, GF				Dalton, H. R.; Maskell, G. F.			Rational imaging - Investigating occult gastrointestinal haemorrhage	BRITISH MEDICAL JOURNAL			English	Editorial Material							CAPSULE ENDOSCOPY; ENTEROCLYSIS; ENTEROSCOPY		[Dalton, H. R.; Maskell, G. F.] Royal Cornwall Hosp, Truro TR1 3LJ, England	Royal Cornwall Hospital	Dalton, HR (corresponding author), Royal Cornwall Hosp, Truro TR1 3LJ, England.	harry.dalton@rcht.cornwall.nhs.uk		Dalton, Harry/0000-0001-7786-5457				Antes G, 1996, EUR RADIOL, V6, P851; Hadithi M, 2006, AM J GASTROENTEROL, V101, P52, DOI 10.1111/j.1572-0241.2005.00346.x; Hasan F, 2004, J ROY SOC MED, V97, P81, DOI 10.1258/jrsm.97.2.81; Jain TP, 2007, CLIN RADIOL, V62, P660, DOI 10.1016/j.crad.2007.01.026; Nolan DJ, 1997, CLIN RADIOL, V52, P809, DOI 10.1016/S0009-9260(97)80075-X; Polese L, 2008, ENDOSCOPY, V40, P23, DOI 10.1055/s-2007-967039; SCHWARTZ MJ, 1984, AM J GASTROENTEROL, V79, P611; Sidhu R, 2008, J CLIN GASTROENTEROL, V42, P54, DOI 10.1097/01.mcg.0000225655.85060.74; Triester SL, 2005, AM J GASTROENTEROL, V100, P2407, DOI 10.1111/j.1572-0241.2005.00274.x; Yamamoto H, 2004, CLIN GASTROENTEROL H, V2, P1010, DOI 10.1016/S1542-3565(04)00453-7	10	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 12	2008	337	7661							a422	10.1136/bmj.39577.673507.BE	http://dx.doi.org/10.1136/bmj.39577.673507.BE			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	330SA	18599466	Green Published			2022-12-28	WOS:000257961900038
J	Bensinger, SJ; Bradley, MN; Joseph, SB; Zelcer, N; Janssen, EM; Hausner, MA; Shih, R; Parks, JS; Edwards, PA; Jamieson, BD; Tontonoz, P				Bensinger, Steven J.; Bradley, Michelle N.; Joseph, Sean B.; Zelcer, Noam; Janssen, Edith M.; Hausner, Mary Ann; Shih, Roger; Parks, John S.; Edwards, Peter A.; Jamieson, Beth D.; Tontonoz, Peter			LXR signaling couples sterol metabolism to proliferation in the acquired immune response	CELL			English	Article							LIVER-X-RECEPTORS; CHOLESTEROL EFFLUX; NUCLEAR RECEPTORS; CELL-GROWTH; IDENTIFICATION; INHIBITION; PATHWAYS; BINDING; LYMPHOCYTES; ACTIVATION	Cholesterol is essential for membrane synthesis; however, the mechanisms that link cellular lipid metabolism to proliferation are incompletely understood. We demonstrate here that cellular cholesterol levels in dividing T cells are maintained in part through reciprocal regulation of the LXR and SREBP transcriptional programs. T cell activation triggers induction of the oxysterol- metabolizing enzyme SULT2B1, consequent suppression of the LXR pathway for cholesterol transport, and promotion of the SREBP pathway for cholesterol synthesis. Ligation of LXR during T cell activation inhibits mitogen- driven expansion, whereas loss of LXRb confers a proliferative advantage. Inactivation of the sterol transporter ABCG1 uncouples LXR signaling from proliferation, directly linking sterol homeostasis to the antiproliferative action of LXR. Mice lacking LXRb exhibit lymphoid hyperplasia and enhanced responses to antigenic challenge, indicating that proper regulation of LXR- dependent sterol metabolism is important for immune responses. These results implicate LXR signaling in a metabolic checkpoint that modulates cell proliferation and immunity.	[Hausner, Mary Ann; Shih, Roger; Jamieson, Beth D.] Univ Calif Los Angeles, Dept Med, Div Hematol Oncol, Los Angeles, CA 90049 USA; [Edwards, Peter A.] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90049 USA; [Janssen, Edith M.] La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA; [Parks, John S.] Wake Forest Univ, Sch Med, Dept Pathol, Winston Salem, NC 27157 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; La Jolla Institute for Immunology; Wake Forest University		ptontonoz@mednet.ucla.edu	Zelcer, Noam/C-6393-2009	Joseph, Sean/0000-0002-2602-8517; Zelcer, Noam/0000-0001-6935-7532; janssen, edith/0000-0001-7881-6307	Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [CA-16042, P30 CA016042] Funding Source: Medline; NCRR NIH HHS [RR021975, K01 RR021975] Funding Source: Medline; NHLBI NIH HHS [HL049373, HL30568, R01 HL066088-07, P01 HL030568, R01 HL066088, P01 HL049373] Funding Source: Medline; NIAID NIH HHS [AI-28697, P30 AI028697] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K01RR021975] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL049373, P01HL030568, R01HL066088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alves NL, 2006, IMMUNITY, V24, P703, DOI 10.1016/j.immuni.2006.03.018; Beadling Carol, 2002, Med Immunol, V1, P2, DOI 10.1186/1476-9433-1-2; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; BROWN MS, 1974, J BIOL CHEM, V249, P7306; Castrillo A, 2003, MOL CELL, V12, P805, DOI 10.1016/S1097-2765(03)00384-8; CHAKRABARTI R, 1991, J BIOL CHEM, V266, P12216; Chang TY, 2006, ANNU REV CELL DEV BI, V22, P129, DOI 10.1146/annurev.cellbio.22.010305.104656; CHEN HW, 1975, P NATL ACAD SCI USA, V72, P1950, DOI 10.1073/pnas.72.5.1950; CHEN HW, 1974, NATURE, V251, P419, DOI 10.1038/251419a0; Chen WL, 2007, CELL METAB, V5, P73, DOI 10.1016/j.cmet.2006.11.012; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Fuda H, 2007, J LIPID RES, V48, P1343, DOI 10.1194/jlr.M700018-JLR200; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Hindinger C, 2006, J NEUROSCI RES, V84, P1225, DOI 10.1002/jnr.21038; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Javitt NB, 2001, ENDOCRINOLOGY, V142, P2978, DOI 10.1210/en.142.7.2978; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Joseph SB, 2004, CELL, V119, P299, DOI 10.1016/j.cell.2004.09.032; Kennedy MA, 2005, CELL METAB, V1, P121, DOI 10.1016/j.cmet.2005.01.002; Kovanen PE, 2005, INT IMMUNOL, V17, P1009, DOI 10.1093/intimm/dxh283; Kwak B, 2000, NAT MED, V6, P1399, DOI 10.1038/82219; Laffitte BA, 2001, MOL CELL BIOL, V21, P7558, DOI 10.1128/MCB.21.22.7558-7568.2001; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; MACDONALD HR, 1979, J IMMUNOL, V122, P1067; Martinez-Botas J, 2001, BBA-MOL CELL BIOL L, V1532, P185, DOI 10.1016/S1388-1981(01)00125-1; Martinez-Botas J, 1999, FASEB J, V13, P1359, DOI 10.1096/fasebj.13.11.1359; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Rathmell JC, 2000, MOL CELL, V6, P683, DOI 10.1016/S1097-2765(00)00066-6; Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459; ROOS D, 1973, EXP CELL RES, V77, P127, DOI 10.1016/0014-4827(73)90561-2; Schoenberger SP, 1998, J IMMUNOL, V161, P3808; Schulze-Luehrmann J, 2006, IMMUNITY, V25, P701, DOI 10.1016/j.immuni.2006.10.010; Simons K, 2000, SCIENCE, V290, P1721, DOI 10.1126/science.290.5497.1721; Tangirala RK, 2002, P NATL ACAD SCI USA, V99, P11896, DOI 10.1073/pnas.182199799; Tarr PT, 2008, J LIPID RES, V49, P169, DOI 10.1194/jlr.M700364-JLR200; Terasaka N, 2007, P NATL ACAD SCI USA, V104, P15093, DOI 10.1073/pnas.0704602104; Timmins JM, 2005, J CLIN INVEST, V115, P1333, DOI 10.1172/JCI200523915; Toes REM, 1998, J IMMUNOL, V160, P4449; Tontonoz P, 2003, MOL ENDOCRINOL, V17, P985, DOI 10.1210/me.2003-0061; Valledor AF, 2004, P NATL ACAD SCI USA, V101, P17813, DOI 10.1073/pnas.0407749101; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Wan YY, 2000, P NATL ACAD SCI USA, V97, P13784, DOI 10.1073/pnas.250356297; Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101; Weitz-Schmidt G, 2001, NAT MED, V7, P687, DOI 10.1038/89058; Yancey PG, 2003, ARTERIOSCL THROM VAS, V23, P712, DOI 10.1161/01.ATV.0000057572.97137.DD; Zelcer N, 2003, BIOCHEM J, V371, P361, DOI 10.1042/BJ20021886	49	478	494	0	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 11	2008	134	1					97	111		10.1016/j.cell.2008.04.052	http://dx.doi.org/10.1016/j.cell.2008.04.052			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	324IU	18614014	Bronze, Green Accepted			2022-12-28	WOS:000257513100017
J	Morrow, EM; Yoo, SY; Flavell, SW; Kim, TK; Lin, YX; Hill, RS; Mukaddes, NM; Balkhy, S; Gascon, G; Hashmi, A; Al-Saad, S; Ware, J; Joseph, RM; Greenblatt, R; Gleason, D; Ertelt, JA; Apse, KA; Bodell, A; Partlow, JN; Barry, B; Yao, H; Markianos, K; Ferland, RJ; Greenberg, ME; Walsh, CA				Morrow, Eric M.; Yoo, Seung-Yun; Flavell, Steven W.; Kim, Tae-Kyung; Lin, Yingxi; Hill, Robert Sean; Mukaddes, Nahit M.; Balkhy, Soher; Gascon, Generoso; Hashmi, Asif; Al-Saad, Samira; Ware, Janice; Joseph, Robert M.; Greenblatt, Rachel; Gleason, Danielle; Ertelt, Julia A.; Apse, Kira A.; Bodell, Adria; Partlow, Jennifer N.; Barry, Brenda; Yao, Hui; Markianos, Kyriacos; Ferland, Russell J.; Greenberg, Michael E.; Walsh, Christopher A.			Identifying autism loci and genes by tracing recent shared ancestry	SCIENCE			English	Article							TRANSCRIPTION FACTORS; MUTATIONS; DISORDERS; LINKAGE; PROTEIN; MEMBER; ASSOCIATION; SUPERFAMILY; INHERITANCE; PLASTICITY	To find inherited causes of autism- spectrum disorders, we studied families in which parents share ancestors, enhancing the role of inherited factors. We mapped several loci, some containing large, inherited, homozygous deletions that are likely mutations. The largest deletions implicated genes, including PCDH10 ( protocadherin 10) and DIA1 ( deleted in autism1, or c3orf58), whose level of expression changes in response to neuronal activity, a marker of genes involved in synaptic changes that underlie learning. A subset of genes, including NHE9 (Na+/H+ exchanger 9), showed additional potential mutations in patients with unrelated parents. Our findings highlight the utility of "homozygosity mapping" in heterogeneous disorders like autism but also suggest that defective regulation of gene expression after neural activity may be a mechanism common to seemingly diverse autism mutations.	[Morrow, Eric M.; Yoo, Seung-Yun; Hill, Robert Sean; Greenblatt, Rachel; Gleason, Danielle; Ertelt, Julia A.; Apse, Kira A.; Bodell, Adria; Partlow, Jennifer N.; Barry, Brenda; Yao, Hui; Markianos, Kyriacos; Walsh, Christopher A.] Childrens Hosp, Div Genet, Boston, MA 02115 USA; [Morrow, Eric M.; Yoo, Seung-Yun; Hill, Robert Sean; Greenblatt, Rachel; Gleason, Danielle; Ertelt, Julia A.; Apse, Kira A.; Bodell, Adria; Partlow, Jennifer N.; Barry, Brenda; Yao, Hui; Markianos, Kyriacos; Walsh, Christopher A.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Morrow, Eric M.; Yoo, Seung-Yun; Hill, Robert Sean; Greenblatt, Rachel; Gleason, Danielle; Ertelt, Julia A.; Apse, Kira A.; Bodell, Adria; Partlow, Jennifer N.; Barry, Brenda; Walsh, Christopher A.] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02115 USA; [Morrow, Eric M.; Yoo, Seung-Yun; Hill, Robert Sean; Greenblatt, Rachel; Gleason, Danielle; Ertelt, Julia A.; Apse, Kira A.; Bodell, Adria; Partlow, Jennifer N.; Barry, Brenda; Walsh, Christopher A.] Beth Israel Deaconess Med Ctr, Howard Hughes Med Inst, Boston, MA 02115 USA; [Morrow, Eric M.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Morrow, Eric M.; Yoo, Seung-Yun; Hill, Robert Sean; Walsh, Christopher A.] MIT, Program Med & Populat Genet, Broad Inst, Cambridge, MA 02142 USA; [Morrow, Eric M.; Yoo, Seung-Yun; Hill, Robert Sean; Walsh, Christopher A.] Harvard Univ, Cambridge, MA 02142 USA; [Morrow, Eric M.; Yoo, Seung-Yun; Flavell, Steven W.; Kim, Tae-Kyung; Lin, Yingxi; Hill, Robert Sean; Ware, Janice; Joseph, Robert M.; Apse, Kira A.; Greenberg, Michael E.; Walsh, Christopher A.] Autism Consortium, Boston, MA 02115 USA; [Flavell, Steven W.; Kim, Tae-Kyung; Lin, Yingxi; Greenberg, Michael E.] Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Flavell, Steven W.; Kim, Tae-Kyung; Lin, Yingxi; Greenberg, Michael E.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Flavell, Steven W.; Kim, Tae-Kyung; Lin, Yingxi; Greenberg, Michael E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Mukaddes, Nahit M.] Istanbul Univ, Istanbul Fac Med, Dept Child Psychiat, Istanbul, Turkey; [Balkhy, Soher; Gascon, Generoso] King Faisal Specialist Hosp & Res Ctr, Dept Neurosci & Pediat, Jeddah, Saudi Arabia; [Gascon, Generoso] Brown Univ, Sch Med, Providence, RI 02912 USA; [Hashmi, Asif] Combined Mil Hosp, Dept Neurol, Lahore, Pakistan; [Al-Saad, Samira] Kuwait Ctr Autism, Kuwait, Kuwait; [Ware, Janice] Childrens Hosp, Dev Med Ctr, Boston, MA 02115 USA; [Joseph, Robert M.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Ferland, Russell J.] Rensselaer Polytech Inst, Dept Biol, Troy, NY 12180 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Istanbul University; King Faisal Specialist Hospital & Research Center; Brown University; Harvard University; Boston Children's Hospital; Boston University; Rensselaer Polytechnic Institute	Walsh, CA (corresponding author), Childrens Hosp, Div Genet, 300 Longwood Ave, Boston, MA 02115 USA.	christopher.walsh@childrens.harvard.edu	Warfield, Simon/B-3352-2009; Morrow, Eric/J-2767-2013; Ferland, Russell/E-3500-2010; Kim, Tae-Kyung/AAX-4230-2020; Ferland, Russell/Q-6793-2019; Yao, Huiqin/AAX-3787-2020	Warfield, Simon/0000-0002-7659-3880; Morrow, Eric/0000-0003-3430-3520; Kim, Tae-Kyung/0000-0001-5161-9864; Ferland, Russell/0000-0002-8044-2479; Yao, Huiqin/0000-0003-4742-8971; /0000-0002-7002-1275; Markianos, Kyriacos/0000-0003-0214-6014; Walsh, Christopher/0000-0002-0156-2238; Joseph, Robert/0000-0001-6879-0254; Flavell, Steven/0000-0001-9464-1877	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [N01HG065403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064547, K23MH080954, R01MH083565, K01MH071801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048276] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NHGRI NIH HHS [N01-HG-65403] Funding Source: Medline; NICHD NIH HHS [5P30HD018655-26] Funding Source: Medline; NIMH NIH HHS [K01 MH071801-04, R01 MH083565, MH64547, K01 MH071801-05, K23 MH080954, K01 MH071801, 1K23MH080954-01, K23 MH080954-01, 1R01 MH083565, 1K01MH71801] Funding Source: Medline; NINDS NIH HHS [R01 NS048276, R01 NS048276-05, R01 NS048276-02, R01 NS048276-04, 5R01NS048276-05, R01 NS048276-03, R01 NS048276-01] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Canitano R, 2007, EUR CHILD ADOLES PSY, V16, P61, DOI 10.1007/s00787-006-0563-2; Cox GA, 1997, CELL, V91, P139, DOI 10.1016/S0092-8674(01)80016-7; de Silva MG, 2003, J MED GENET, V40, P733, DOI 10.1136/jmg.40.10.733; Dixon-Salazar T, 2004, AM J HUM GENET, V75, P979, DOI 10.1086/425985; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Fombonne E, 2003, J AUTISM DEV DISORD, V33, P365, DOI 10.1023/A:1025054610557; Gilfillan GD, 2008, AM J HUM GENET, V82, P1003, DOI 10.1016/j.ajhg.2008.01.013; Hamamy HA, 2007, SAUDI MED J, V28, P1015; Hoodfar E, 1996, J MED GENET, V33, P212, DOI 10.1136/jmg.33.3.212; Jacquemont ML, 2006, J MED GENET, V43, P843, DOI 10.1136/jmg.2006.043166; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; Jiang YH, 2004, AM J MED GENET A, V131A, P1, DOI 10.1002/ajmg.a.30297; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LI C, 2001, GENOME BIOL, V2, P8; Mani A, 2002, P NATL ACAD SCI USA, V99, P15054, DOI 10.1073/pnas.192582999; Martin CL, 2007, AM J MED GENET B, V144B, P869, DOI 10.1002/ajmg.b.30530; Palferman S, 2001, AM J HUM GENET, V69, P570; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Piao XH, 2004, SCIENCE, V303, P2033, DOI 10.1126/science.1092780; Risch N, 1999, AM J HUM GENET, V65, P493, DOI 10.1086/302497; RITVO ER, 1985, AM J PSYCHIAT, V142, P187; Rudan I, 2006, NAT GENET, V38, P1224, DOI 10.1038/ng1106-1224; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shaffer UG, 2006, J PEDIATR-US, V149, P98, DOI 10.1016/j.jpeds.2006.02.006; SMITH CAB, 1953, J R STAT SOC B, V15, P153; Sur M, 2005, SCIENCE, V310, P805, DOI 10.1126/science.1112070; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Takano Y, 2004, J BIOL CHEM, V279, P18926, DOI 10.1074/jbc.M309148200; Takatalo MS, 2006, PROTEOMICS, V6, P3502, DOI 10.1002/pmic.200500516; Uemura M, 2007, NAT NEUROSCI, V10, P1151, DOI 10.1038/nn1960; Vorstman JAS, 2006, J AM ACAD CHILD PSY, V45, P1104, DOI 10.1097/01.chi.0000228131.56956.c1; Vorstman JAS, 2006, MOL PSYCHIATR, V11, P18, DOI 10.1038/sj.mp.4001757; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090; YOSHIHARA Y, 1994, NEURON, V13, P415, DOI 10.1016/0896-6273(94)90357-3	43	537	560	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2008	321	5886					218	223		10.1126/science.1157657	http://dx.doi.org/10.1126/science.1157657			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	324IS	18621663	Green Accepted			2022-12-28	WOS:000257512900031
J	Hanson, B				Hanson, Brooks			Introduction - Mercury, up-close again	SCIENCE			English	Editorial Material																			0	3	3	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 4	2008	321	5885					58	58		10.1126/science.321.5885.58	http://dx.doi.org/10.1126/science.321.5885.58			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QE	18599767				2022-12-28	WOS:000257320800031
J	Murzin, AG				Murzin, Alexey G.			Biochemistry - Metamorphic proteins	SCIENCE			English	Editorial Material							T7 RNA-POLYMERASE; STRUCTURAL BASIS; TRANSCRIPTION; TRANSITION; FOLDS		MRC Ctr Prot Engn, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Murzin, AG (corresponding author), MRC Ctr Prot Engn, Hills Rd, Cambridge CB2 0QH, England.	agm@mrc-lmb.cam.ac.uk			Medical Research Council [MC_U105192716] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alexander-Brett JM, 2007, J EXP MED, V204, P3157, DOI 10.1084/jem.20071677; Andreeva A, 2006, CURR OPIN STRUC BIOL, V16, P399, DOI 10.1016/j.sbi.2006.04.003; Belogurov GA, 2007, MOL CELL, V26, P117, DOI 10.1016/j.molcel.2007.02.021; Littler DR, 2004, J BIOL CHEM, V279, P9298, DOI 10.1074/jbc.M308444200; Mapelli M, 2007, CELL, V131, P730, DOI 10.1016/j.cell.2007.08.049; Onuchic JN, 2004, CURR OPIN STRUC BIOL, V14, P70, DOI 10.1016/j.sbi.2004.01.009; Roche S, 2007, SCIENCE, V315, P843, DOI 10.1126/science.1135710; Roessler CG, 2008, P NATL ACAD SCI USA, V105, P2343, DOI 10.1073/pnas.0711589105; Tahirov TH, 2002, NATURE, V420, P43, DOI 10.1038/nature01129; Tuinstra RL, 2008, P NATL ACAD SCI USA, V105, P5057, DOI 10.1073/pnas.0709518105; Xu M, 2005, SCIENCE, V307, P113, DOI 10.1126/science.1105143; Yin YW, 2002, SCIENCE, V298, P1387, DOI 10.1126/science.1077464	12	162	162	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2008	320	5884					1725	1726		10.1126/science.1158868	http://dx.doi.org/10.1126/science.1158868			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318VP	18583598				2022-12-28	WOS:000257121200022
J	Pan, XX; Luhrmann, A; Satoh, A; Laskowski-Arce, MA; Roy, CR				Pan, Xiaoxiao; Luhrmann, Anja; Satoh, Ayano; Laskowski-Arce, Michelle A.; Roy, Craig R.			Ankyrin repeat proteins comprise a diverse family of bacterial type IV effectors	SCIENCE			English	Article							LEGIONELLA-PNEUMOPHILA; COXIELLA-BURNETII; WOLBACHIA-PIPIENTIS; SECRETION SYSTEMS; PATHOGENESIS; GENOME; ARCHITECTURE; INFECTION; ENDOSOMES; TRANSPORT	Specialized secretion systems are used by many bacteria to deliver effector proteins into host cells that can either mimic or disrupt the function of eukaryotic factors. We found that the intracellular pathogens Legionella pneumophila and Coxiella burnetii use a type IV secretion system to deliver into eukaryotic cells a large number of different bacterial proteins containing ankyrin repeat homology domains called Anks. The L. pneumophila AnkX protein prevented microtubule- dependent vesicular transport to interfere with fusion of the L. pneumophila- containing vacuole with late endosomes after infection of macrophages, which demonstrates that Ank proteins have effector functions important for bacterial infection of eukaryotic host cells.	[Pan, Xiaoxiao; Luhrmann, Anja; Laskowski-Arce, Michelle A.; Roy, Craig R.] Yale Univ, Sch Med, Sect Microbial Pathogenesis, New Haven, CT 06536 USA; [Satoh, Ayano] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06536 USA	Yale University; Yale University	Roy, CR (corresponding author), Yale Univ, Sch Med, Sect Microbial Pathogenesis, 295 Congress Ave, New Haven, CT 06536 USA.	craig.roy@yale.edu	Satoh, Ayano/B-2423-2011	Satoh, Ayano/0000-0003-3736-1283; Roy, Craig/0000-0003-4490-440X	NIAID NIH HHS [R01 AI041699-12, R01 AI041699, AI041699, R01 AI064559, R01 AI064559-03, AI064559] Funding Source: Medline; NIA NIH HHS [AG030101] Funding Source: Medline; NIGMS NIH HHS [GM060919] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064559, R56AI064559, R37AI041699, R01AI041699, R29AI041699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060919] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG030101] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ANIENTO F, 1993, J CELL BIOL, V123, P1373, DOI 10.1083/jcb.123.6.1373; Backert S, 2006, CURR OPIN MICROBIOL, V9, P207, DOI 10.1016/j.mib.2006.02.008; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Chien MC, 2004, SCIENCE, V305, P1966, DOI 10.1126/science.1099776; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; Driskell OJ, 2007, NAT CELL BIOL, V9, P113, DOI 10.1038/ncb1525; GOLTZ JS, 1992, P NATL ACAD SCI USA, V89, P7026, DOI 10.1073/pnas.89.15.7026; Iturbe-Ormaetxe I, 2005, J BACTERIOL, V187, P5136, DOI 10.1128/JB.187.15.5136-5145.2005; Lin MQ, 2007, CELL MICROBIOL, V9, P2644, DOI 10.1111/j.1462-5822.2007.00985.x; McGraw EA, 2004, CURR OPIN MICROBIOL, V7, P67, DOI 10.1016/j.mib.2003.12.003; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Nagai H, 2005, P NATL ACAD SCI USA, V102, P826, DOI 10.1073/pnas.0406239101; Ninio S, 2007, TRENDS MICROBIOL, V15, P372, DOI 10.1016/j.tim.2007.06.006; Ogata H, 2005, ANN NY ACAD SCI, V1063, P26, DOI 10.1196/annals.1355.004; Park J, 2004, CELL MICROBIOL, V6, P743, DOI 10.1111/j.1462-5822.2004.00400.x; Scales SJ, 1997, CELL, V90, P1137, DOI 10.1016/S0092-8674(00)80379-7; Seshadri R, 2003, P NATL ACAD SCI USA, V100, P5455, DOI 10.1073/pnas.0931379100; Walker T, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-39; Zamboni DS, 2003, MOL MICROBIOL, V49, P965, DOI 10.1046/j.1365-2958.2003.03626.x; Zusman T, 2003, INFECT IMMUN, V71, P3714, DOI 10.1128/IAI.71.7.3714-3723.2003	20	298	306	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 20	2008	320	5883					1651	1654		10.1126/science.1158160	http://dx.doi.org/10.1126/science.1158160			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	315NM	18566289	Green Accepted			2022-12-28	WOS:000256886700052
J	Sobngwi, E; Choukem, SP; Agbalika, F; Blondeau, B; Fetita, LS; Lebbe, C; Thiam, D; Cattan, P; Larghero, J; Foufelle, F; Ferre, P; Vexiau, P; Calvo, F; Gautier, JF				Sobngwi, Eugene; Choukem, Simeon Pierre; Agbalika, Felix; Blondeau, Bertrand; Fetita, Lila-Sabrina; Lebbe, Celeste; Thiam, Doudou; Cattan, Pierre; Larghero, Jerome; Foufelle, Fabienne; Ferre, Pascal; Vexiau, Patrick; Calvo, Fabien; Gautier, Jean-Francois			Ketosis-prone type 2 diabetes mellitus and human herpesvirus 8 infection in sub-Saharan Africans	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; KAPOSIS-SARCOMA; VIRUS-INFECTION; GENITAL HERPES; ONSET; KETOACIDOSIS; PREVALENCE; EPIDEMIOLOGY; ASSOCIATION; ANTIBODIES	Context An atypical form of type 2 diabetes mellitus (DM-2) is revealed by ketosis (ketosis-prone type 2 diabetes mellitus), frequently occurring in individuals who are black and of African origin, and characterized by an acute onset requiring transient insulin therapy. Its sudden onset suggests precipitating factors. Objective To investigate the putative role of human herpesvirus 8 (HHV-8) in the pathogenesis of ketosis-prone DM-2. Design, Setting, and Participants A cross-sectional study in which antibodies were searched against latent and lytic HHV-8 antigens using immunofluorescence. The presence of HHV-8 in genomic DNA was investigated in 22 of the participants at clinical onset of diabetes. We also tested whether HHV-8 was able to infect human pancreatic beta cells in culture in vitro. The study was conducted at Saint-Louis University Hospital, Paris, France, from January 2004 to July 2005. All participants were black and of African origin: 187 were consecutive diabetic patients of whom 81 had ketosis-prone DM-2 and 106 had nonketotic DM-2, and 90 individuals were nondiabetic control participants who were matched for age and sex. Main Outcome Measures Seroprevalence of HHV-8 and percentage of patients with HHV-8 viremia at onset in ketosis-prone DM-2. Results HHV-8 antibodies were found in 71 patients (87.7%) with ketosis-prone DM-2 vs 16 patients (15.1%) with nonketotic DM-2 (odds ratio, 39.9; 95% confidence interval, 17.1-93.4; P < .001) and 36 of the control participants (40.0%) (odds ratio, 10.7; 95% confidence interval, 4.9-23.4; P < .001). HHV-8 in genomic DNA was present in 6 of 13 patients with ketosis-prone DM-2 tested at acute onset and in 0 of 9 patients with nonketotic DM-2. HHV-8 proteins were present in human islet cells that were cultured for 4 days in the presence of HHV-8. Conclusions In this preliminary cross-sectional study, the presence of HHV-8 antibodies was associated with ketosis-prone DM-2 in patients of sub-Saharan African origin. Longitudinal studies are required to understand the clinical significance of these findings.	[Sobngwi, Eugene; Choukem, Simeon Pierre; Agbalika, Felix; Vexiau, Patrick; Gautier, Jean-Francois] Hop St Louis, Dept Endocrinol & Diabet, Assistance Publ Hop Paris, F-75475 Paris 10, France; [Agbalika, Felix] Hop St Louis, Dept Virol, Assistance Publ Hop Paris, F-75475 Paris 10, France; [Lebbe, Celeste] Hop St Louis, Dept Dermatol, Assistance Publ Hop Paris, F-75475 Paris 10, France; [Cattan, Pierre; Larghero, Jerome] Hop St Louis, Cell Therapy Unit, Assistance Publ Hop Paris, F-75475 Paris 10, France; [Cattan, Pierre] Hop St Louis, Dept Gen Surg, Assistance Publ Hop Paris, F-75475 Paris 10, France; [Calvo, Fabien; Gautier, Jean-Francois] Hop St Louis, INSERM, Assistance Publ Hop Paris, CIC9504, F-75475 Paris 10, France; [Agbalika, Felix; Lebbe, Celeste; Cattan, Pierre; Larghero, Jerome; Vexiau, Patrick; Calvo, Fabien; Gautier, Jean-Francois] Univ Paris 07, Paris, France; [Blondeau, Bertrand; Foufelle, Fabienne; Ferre, Pascal; Gautier, Jean-Francois] Univ Paris 06, INSERM, Ctr Rech Cordeliers, UMRS 872, F-75252 Paris 05, France; [Sobngwi, Eugene] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Thiam, Doudou] Univ Cheikh Anta Diop Dakar, Inst Hematol, Dakar, Senegal	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Newcastle University - UK; University Cheikh Anta Diop Dakar	Gautier, JF (corresponding author), Hop St Louis, Dept Endocrinol & Diabet, Assistance Publ Hop Paris, 1 Ave Claude Vellefaux, F-75475 Paris 10, France.	jean-francois.gautier@sls.aphp.fr	Ferré, Pascal/K-1250-2013	Ferré, Pascal/0000-0003-0115-7045; FOUFELLE, Fabienne/0000-0002-0752-622X; calvo, fabien/0000-0002-0298-7633; Blondeau, Bertrand/0000-0002-1106-1509				Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Bach JF, 2005, J AUTOIMMUN, V25, P74, DOI 10.1016/j.jaut.2005.09.024; BANERJI MA, 1990, MEDICINE, V69, P176, DOI 10.1097/00005792-199005000-00005; Cheng GF, 2005, J VIROL, V79, P1379, DOI 10.1128/JVI.79.3.1379-1388.2005; Chiou CC, 2006, J AM ACAD DERMATOL, V54, pS14, DOI 10.1016/j.jaad.2005.03.057; Crispo A, 2001, INT J MOL MED, V7, P535; DeOcampo A, 1999, CLIN PEDIATR, V38, P661, DOI 10.1177/000992289903801105; Goudsmit J, 2000, P NATL ACAD SCI USA, V97, P4838, DOI 10.1073/pnas.97.9.4838; Imagawa A, 2005, DIABETOLOGIA, V48, P290, DOI 10.1007/s00125-004-1624-z; Imagawa A, 2000, NEW ENGL J MED, V342, P301, DOI 10.1056/NEJM200002033420501; Jarviluoma A, 2006, BBA-REV CANCER, V1766, P140, DOI 10.1016/j.bbcan.2006.05.001; Kitabchi AE, 2003, J CLIN ENDOCR METAB, V88, P5087, DOI 10.1210/jc.2003-031656; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; LEBBE C, 1995, LANCET, V345, P1180, DOI 10.1016/S0140-6736(95)91011-5; Lecube A, 2006, DIABETES CARE, V29, P1140, DOI 10.2337/dc05-1995; Lisco A, 2006, J CLIN MICROBIOL, V44, P3863, DOI 10.1128/JCM.00791-06; LOPES EPA, 1994, LANCET, V343, P244, DOI 10.1016/S0140-6736(94)91035-9; Maldonado MR, 2004, ETHNIC DIS, V14, P243; Mauvais-Jarvis F, 2003, DIABETOLOGIA, V46, P728, DOI 10.1007/s00125-003-1093-9; Mauvais-Jarvis F, 2004, HUM MOL GENET, V13, P3151, DOI 10.1093/hmg/ddh341; Mauvais-Jarvis F, 2004, DIABETES, V53, P645, DOI 10.2337/diabetes.53.3.645; Min J, 1999, AIDS RES HUM RETROV, V15, P51, DOI 10.1089/088922299311709; Narita R, 2004, J HEPATOL, V41, P132, DOI 10.1016/j.jhep.2004.03.020; Oksenhendler E, 1998, NEW ENGL J MED, V338, P1585, DOI 10.1056/NEJM199805283382204; Pellet C, 2002, J INFECT DIS, V186, P110, DOI 10.1086/341088; Platt G, 2002, ONCOGENE, V21, P1823, DOI 10.1038/sj.onc.1205360; RICORDI C, 1988, DIABETES, V37, P413, DOI 10.2337/diabetes.37.4.413; Schulz TF, 2000, J ANTIMICROB CHEMOTH, V45, P15, DOI 10.1093/jac/45.suppl_4.15; Simpson GR, 1996, LANCET, V348, P1133, DOI 10.1016/S0140-6736(96)07560-5; Sobngwi E, 2005, J CLIN ENDOCR METAB, V90, P4446, DOI 10.1210/jc.2004-2545; Sobngwi E, 2002, DIABETIC MED, V19, P832, DOI 10.1046/j.1464-5491.2002.00802.x; Sobngwi E, 2002, DIABETES METAB, V28, P5; Sobngwi E, 2002, DIABETOLOGIA, V45, P283, DOI 10.1007/s00125-001-0739-8; Sun YH, 2005, DIABETES CARE, V28, P435, DOI 10.2337/diacare.28.2.435; TESFAYE S, 1991, DIABETES RES CLIN PR, V13, P83, DOI 10.1016/0168-8227(91)90037-E; Umpaichitra V, 2001, J CLIN ENDOCR METAB, V86, P1605, DOI 10.1210/jc.86.4.1605; Umpierrez GE, 2006, ANN INTERN MED, V144, P350, DOI 10.7326/0003-4819-144-5-200603070-00011; UMPIERREZ GE, 1995, DIABETES, V44, P790, DOI 10.2337/diabetes.44.7.790; Umpierrez GE, 1999, DIABETES CARE, V22, P1517, DOI 10.2337/diacare.22.9.1517; Weissmann A, 2000, J EUR ACAD DERMATOL, V14, P91, DOI 10.1046/j.1468-3083.2000.00022.x; WINTER WE, 1987, NEW ENGL J MED, V316, P285, DOI 10.1056/NEJM198702053160601	41	67	68	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 18	2008	299	23					2770	2776		10.1001/jama.299.23.2770	http://dx.doi.org/10.1001/jama.299.23.2770			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	314JH	18560004	Bronze			2022-12-28	WOS:000256805200025
J	Schaefer, AL; Greenberg, EP; Oliver, CM; Oda, Y; Huang, JJ; Bittan-Banin, G; Peres, CM; Schmidt, S; Juhaszova, K; Sufrin, JR; Harwood, CS				Schaefer, Amy L.; Greenberg, E. P.; Oliver, Colin M.; Oda, Yasuhiro; Huang, Jean J.; Bittan-Banin, Gili; Peres, Caroline M.; Schmidt, Silke; Juhaszova, Katarina; Sufrin, Janice R.; Harwood, Caroline S.			A new class of homoserine lactone quorum-sensing signals	NATURE			English	Article							IDENTIFICATION; AUTOINDUCER; GENES	Quorum sensing is a term used to describe cell- to- cell communication that allows cell- density- dependent gene expression. Many bacteria use acyl- homoserine lactone ( acyl- HSL) synthases to generate fatty acyl- HSL quorum- sensing signals, which function with signal receptors to control expression of specific genes. The fatty acyl group is derived from fatty acid biosynthesis and provides signal specificity, but the variety of signals is limited. Here we show that the photosynthetic bacterium Rhodopseudomonas palustris uses an acyl- HSL synthase to produce p- coumaroyl- HSL by using environmental p- coumaric acid rather than fatty acids from cellular pools. The bacterium has a signal receptor with homology to fatty acyl- HSL receptors that responds to p- coumaroyl- HSL to regulate global gene expression. We also found that p- coumaroyl- HSL is made by other bacteria including Bradyrhizobium sp. and Silicibacter pomeroyi. This discovery extends the range of possibilities for acyl- HSL quorum sensing and raises fundamental questions about quorum sensing within the context of environmental signalling.	[Schaefer, Amy L.; Greenberg, E. P.; Oda, Yasuhiro; Huang, Jean J.; Bittan-Banin, Gili; Juhaszova, Katarina; Harwood, Caroline S.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Oliver, Colin M.; Sufrin, Janice R.] SUNY Buffalo, Roswell Pk Canc Inst, Mol Pharmacol & Canc Therapeut Program, Buffalo, NY 14263 USA; [Peres, Caroline M.] Danisco Genencor, Palo Alto, CA 94304 USA; [Schmidt, Silke] Goethe Univ Frankfurt, Inst Mol Biosci, D-60438 Frankfurt, Germany	University of Washington; University of Washington Seattle; Roswell Park Cancer Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Goethe University Frankfurt	Harwood, CS (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	csh5@u.washington.edu	Albers, Pieter/I-2563-2017; Schaefer, Amy/AAU-8576-2020	Schaefer, Amy/0000-0003-0581-054X; Greenberg, Everett/0000-0001-9474-8041	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059026] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Buchan A, 2004, APPL ENVIRON MICROB, V70, P1658, DOI 10.1128/AEM.70.3.1658-1668.2004; DEVINE JH, 1989, P NATL ACAD SCI USA, V86, P5688, DOI 10.1073/pnas.86.15.5688; DIXON RA, 1995, PLANT CELL, V7, P1085, DOI 10.1105/tpc.7.7.1085; Fuqua C, 1998, CURR OPIN MICROBIOL, V1, P183, DOI 10.1016/S1369-5274(98)80009-X; FUQUA WC, 1994, J BACTERIOL, V176, P2796, DOI 10.1128/JB.176.10.2796-2806.1994; Gehring AM, 1997, BIOCHEMISTRY-US, V36, P8495, DOI 10.1021/bi970453p; HARRISON FH, 2005, THESIS U IOWA; Hastings JW, 1999, J BACTERIOL, V181, P2667, DOI 10.1128/JB.181.9.2667-2668.1999; KIM MK, 1991, FEMS MICROBIOL LETT, V83, P199, DOI 10.1016/0378-1097(91)90354-D; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; Larimer FW, 2004, NAT BIOTECHNOL, V22, P55, DOI 10.1038/nbt923; Minogue TD, 2002, MOL MICROBIOL, V44, P1625, DOI 10.1046/j.1365-2958.2002.02987.x; Molouba F, 1999, APPL ENVIRON MICROB, V65, P3084; More MI, 1996, SCIENCE, V272, P1655, DOI 10.1126/science.272.5268.1655; MORENOHAGELSIEB G, 2002, BIOINFORMATICS S, V1, pS329; NEALSON KH, 1970, J BACTERIOL, V104, P313, DOI 10.1128/JB.104.1.313-322.1970; Oda Y, 2005, J BACTERIOL, V187, P7784, DOI 10.1128/JB.187.22.7784-7794.2005; Pan C, 2008, MOL CELL PROTEOMICS, V7, P938, DOI 10.1074/mcp.M700147-MCP200; PARALES RE, 1993, GENE, V133, P23, DOI 10.1016/0378-1119(93)90220-W; Parsek MR, 1999, P NATL ACAD SCI USA, V96, P4360, DOI 10.1073/pnas.96.8.4360; PEARSON JP, 1994, P NATL ACAD SCI USA, V91, P197, DOI 10.1073/pnas.91.1.197; Peng X, 2003, APPL ENVIRON MICROB, V69, P1417, DOI 10.1128/AEM.69.3.1417-1427.2003; QUANDT J, 1993, GENE, V127, P15, DOI 10.1016/0378-1119(93)90611-6; Rey FE, 2007, APPL ENVIRON MICROB, V73, P1665, DOI 10.1128/AEM.02565-06; Schaefer AL, 1996, P NATL ACAD SCI USA, V93, P9505, DOI 10.1073/pnas.93.18.9505; Schaefer AL, 2000, METHOD ENZYMOL, V305, P288; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; WHETTEN R, 1995, PLANT CELL, V7, P1001, DOI 10.2307/3870053; Whiteley M, 1999, P NATL ACAD SCI USA, V96, P13904, DOI 10.1073/pnas.96.24.13904	30	268	286	10	133	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 31	2008	454	7204					595	U6		10.1038/nature07088	http://dx.doi.org/10.1038/nature07088			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	331QC	18563084				2022-12-28	WOS:000258026500037
J	Firkins, L				Firkins, Lester			Setting research priorities: a layman's experience	BRITISH MEDICAL JOURNAL			English	Editorial Material												lesterfirkins@mac.com							0	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 12	2008	337	7661							a212	10.1136/bmj.a212	http://dx.doi.org/10.1136/bmj.a212			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	330SA	18614461				2022-12-28	WOS:000257961900039
J	Scherf, A; Riviere, L; Lopez-Rubio, JJ				Scherf, Artur; Riviere, Loic; Lopez-Rubio, Jose Juan			SnapShot: var gene expression in the malaria parasite	CELL			English	Editorial Material							MUTUALLY EXCLUSIVE EXPRESSION; PLASMODIUM-FALCIPARUM; ANTIGENIC VARIATION; VIRULENCE GENES		[Scherf, Artur; Riviere, Loic; Lopez-Rubio, Jose Juan] CNRS, Inst Pasteur, URA 2581, Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Scherf, A (corresponding author), CNRS, Inst Pasteur, URA 2581, Paris, France.		Scherf, Artur/A-9674-2014; lopez-rubio, jose juan/A-4509-2014	Scherf, Artur/0000-0003-2411-3328; lopez-rubio, jose juan/0000-0002-0555-1122				Deitsch KW, 2001, NATURE, V412, P875, DOI 10.1038/35091146; Dzikowski R, 2007, EMBO REP, V8, P959, DOI 10.1038/sj.embor.7401063; Freitas-Junior LH, 2005, CELL, V121, P25, DOI 10.1016/j.cell.2005.01.037; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Horrocks P, 2004, P NATL ACAD SCI USA, V101, P11129, DOI 10.1073/pnas.0402347101; Lopez-Rubio JJ, 2007, MOL MICROBIOL, V66, P1296, DOI 10.1111/j.1365-2958.2007.06009.x; Scherf A, 1998, EMBO J, V17, P5418, DOI 10.1093/emboj/17.18.5418; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Voss TS, 2006, NATURE, V439, P1004, DOI 10.1038/nature04407	9	12	12	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 11	2008	134	1					190	U12	190.e1	10.1016/j.cell.2008.06.042	http://dx.doi.org/10.1016/j.cell.2008.06.042			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	324IU	18614021	Bronze			2022-12-28	WOS:000257513100026
J	Pettifer, RF; Collins, SP; Laundy, D				Pettifer, Robert F.; Collins, Stephen P.; Laundy, David			Quadrupole transitions revealed by Borrmann spectroscopy	NATURE			English	Article							X-RAY-SCATTERING; ABSORPTION-SPECTRA; CRYSTAL OPTICS; DIFFRACTION; REFLECTION; DENSITY; EDGE	The Borrmann effect(1,2) - a dramatic increase in transparency to X- ray beams - is observed when X- rays satisfying Bragg's law diffract through a perfect crystal. The minimization of absorption seen in the Borrmann effect has been explained by noting that the electric field of the X- ray beam approaches zero amplitude at the crystal planes, thus avoiding the atoms. Here we show experimentally that under conditions of absorption suppression, the weaker electric quadrupole absorption transitions are effectively enhanced to such a degree that they can dominate the absorption spectrum. This effect can be exploited as an atomic spectroscopy technique; we show that quadrupole transitions give rise to additional structure at the L(1), L(2) and L(3) absorption edges of gadolinium in gadolinium gallium garnet, which mark the onset of excitations from 2s, 2p(1/2) and 2p(3/2) atomic core levels, respectively. Although the Borrmann effect served to underpin the development of the theory of X- ray diffraction(3-6), this is potentially the most important experimental application of the phenomenon since its first observation seven decades ago. Identifying quadrupole features in X- ray absorption spectroscopy is central to the interpretation of 'pre- edge' spectra, which are often taken to be indicators of local symmetry, valence and atomic environment(7). Quadrupolar absorption isolates states of different symmetries to that of the dominant dipole spectrum, and typically reveals orbitals that dominate the electronic ground- state properties of lanthanides and 3d transition metals, including magnetism. Results from our Borrmann spectroscopy technique feed into contemporary discussions regarding resonant X- ray diffraction(8) and the nature of pre-edge lines identified by inelastic X- ray scattering(7). Furthermore, because the Borrmann effect has been observed in photonic materials, it seems likely that the quadrupole enhancement reported here will play an important role in modern optics.	[Collins, Stephen P.] Diamond Light Source Ltd, Didcot O11 0DE, Oxon, England; [Pettifer, Robert F.; Collins, Stephen P.] Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England; [Laundy, David] STFC Daresbury Lab, Warrington WA4 4AD, Cheshire, England	Diamond Light Source; University of Warwick; STFC Daresbury Laboratory	Collins, SP (corresponding author), Diamond Light Source Ltd, Diamond House,Harwell Sci & Innovat Campus, Didcot O11 0DE, Oxon, England.	steve.collins@diamond.ac.uk	Collins, Stephen/AAG-7910-2020					BATSON PE, 1993, PHYS REV LETT, V70, P1822, DOI 10.1103/PhysRevLett.70.1822; BATTERMAN BW, 1964, REV MOD PHYS, V36, P681, DOI 10.1103/RevModPhys.36.681; BORIE B, 1966, ACTA CRYSTALLOGR, V12, P470; Borrmann G, 1941, PHYS Z, V42, P157; BORRMANN G, 1954, Z KRISTALLOGR, V106, P109; BROUDER C, 1990, J PHYS-CONDENS MAT, V2, P701, DOI 10.1088/0953-8984/2/3/018; Brown SD, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.247401; CHEN MH, 1971, PHYS REV A, V4, P1; Collins SP, 1998, J SYNCHROTRON RADIAT, V5, P1263, DOI 10.1107/S0909049598006803; Darwin CG, 1914, PHILOS MAG, V27, P675, DOI 10.1080/14786440408635139; Darwin CG, 1914, PHILOS MAG, V27, P315, DOI 10.1080/14786440208635093; de Groot F, 2001, CHEM REV, V101, P1779, DOI 10.1021/cr9900681; Dmitrienko VE, 2005, ACTA CRYSTALLOGR A, V61, P481, DOI 10.1107/S0108767305018209; Ewald PP, 1916, ANN PHYS-BERLIN, V49, P117; EWALD PP, 1965, REV MOD PHYS, V37, P46, DOI 10.1103/RevModPhys.37.46; Fabrizio M, 1998, PHYS REV LETT, V80, P3400, DOI 10.1103/PhysRevLett.80.3400; FEYNMAN RP, 1964, FEYNMAN LECTURES PHY, V2, P10; Gordon RA, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/26004; KRISCH MH, 1995, PHYS REV LETT, V74, P4931, DOI 10.1103/PhysRevLett.74.4931; Loeffen PW, 1996, PHYS REV B, V54, P14877, DOI 10.1103/PhysRevB.54.14877; Lovesey S.W., 1996, XRAY SCATTERING ABSO; MATERLIK G, 1983, PHYS REV LETT, V50, P267, DOI 10.1103/PhysRevLett.50.267; Sawada H, 1997, J SOLID STATE CHEM, V132, P300, DOI 10.1006/jssc.1997.7462; SCHULKE W, 1986, ACTA CRYSTALLOGR A, V42, P86, DOI 10.1107/S0108767386099828; THOLE BT, 1985, PHYS REV B, V32, P5107, DOI 10.1103/PhysRevB.32.5107; VATANYANTS IA, 2000, SOLID STATE COMMUN, V113, P299; von Laue M, 1960, RONTGENSTRAHL INTERF; WAGENFELD H, 1966, PHYS REV, V144, P216, DOI 10.1103/PhysRev.144.216; WARD AJ, 1995, J PHYS-CONDENS MAT, V7, P2217, DOI 10.1088/0953-8984/7/10/027; ZHANG Z, 1990, PHYS REV LETT, V65, P2650, DOI 10.1103/PhysRevLett.65.2650	30	27	28	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 10	2008	454	7201					196	199		10.1038/nature07099	http://dx.doi.org/10.1038/nature07099			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	323RU	18615080				2022-12-28	WOS:000257466900039
J	Markel, H; Gostin, LO				Markel, Howard; Gostin, Lawrence O.			Exposing poverty and inspiring medical humanitarianism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							LEAST HEALTHY PEOPLE; GLOBAL HEALTH		[Markel, Howard] Univ Michigan, Ctr Hist Med, Ann Arbor, MI 48109 USA; [Gostin, Lawrence O.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC USA	University of Michigan System; University of Michigan; Georgetown University	Markel, H (corresponding author), Univ Michigan, Ctr Hist Med, 100 Simpson Mem Inst,102 Observ, Ann Arbor, MI 48109 USA.	howard@umich.edu						Folkers GK, 2001, JAMA-J AM MED ASSOC, V286, P458, DOI 10.1001/jama.286.4.458; Gostin LO, 2008, GEORGETOWN LAW J, V96, P331; Gostin LO, 2007, JAMA-J AM MED ASSOC, V298, P89, DOI 10.1001/jama.298.1.89; Hoffman Elizabeth Cobbs, 2000, ALL YOU NEED IS LOVE; HOWARDJONES N, 1981, PERSPECT BIOL MED, V24, P467; Lee K, 2004, JAMA-J AM MED ASSOC, V291, P2636, DOI 10.1001/jama.291.21.2636; Leuchtenberg William E., 1963, FD ROOSEVELT NEW DEA, P101; LEVI MD, 1996, INTERACTIONS, V3, P50, DOI DOI 10.1145/234813.234819; Okie S, 2006, NEW ENGL J MED, V355, P1084, DOI 10.1056/NEJMp068186; RABELAIS F, 1944, 5 BOOKS GARGANTUA PA; RICHIN M, 1962, PROMISED CITY NEW YO; Riffs J. A, 1890, OTHER HALF LIVES STU; Schieber G., 2006, Finance & Development, V43, P46; United Nations, MILL DEV GOALS REP 2	14	1	1	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 9	2008	300	2					209	211		10.1001/jama.2008.45	http://dx.doi.org/10.1001/jama.2008.45			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	323GV	18612118				2022-12-28	WOS:000257435500025
J	Kakkar, AK; Brenner, B; Dahl, OE; Eriksson, BI; Mouret, P; Muntz, J; Soglian, AG; Pap, AF; Misselwitz, F; Haas, S				Kakkar, Ajay K.; Brenner, Benjamin; Dahl, Ola E.; Eriksson, Bengt I.; Mouret, Patrick; Muntz, Jim; Soglian, Andrea G.; Pap, Akos F.; Misselwitz, Frank; Haas, Sylvia		RECORD2 Investigators	Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial	LANCET			English	Article							WEIGHT HEPARIN-PROPHYLAXIS; FACTOR-XA INHIBITOR; PROLONGED THROMBOPROPHYLAXIS; ORTHOPEDIC-SURGERY; KNEE REPLACEMENT; TIME-COURSE; THROMBOSIS; DALTEPARIN; PLACEBO; BAY-59-7939	Background The risk of venous thromboembolism is high after total hip arthroplasty and could persist after hospital discharge. Our aim was to compare the use of rivaroxaban for extended thromboprophylaxis with short-term thromboprophylaxis with enoxaparin. Methods 2509 patients scheduled to undergo elective total hip arthroplasty were randomly assigned, stratified according to Centre, with a computer-generated randomisation code, to receive,oral rivaroxaban 10 mg once daily for 31-39 days (with placebo injection for 10-14 days; n=1252), or enoxaparin 40 mg once daily subcutaneously for 10-14 days (with placebo tablet for 31-39 days; n=1257). The primary efficacy outcome was the composite of deep-vein thrombosis (symptomatic or asymptornatic detected by mandatory, bilateral venography), non-fatal pulmonary embolism, and all-cause mortality up to day 30-42. Analyses were done in the modified intention-to-treat population, which consisted of all patients who had received at least one dose of study medication, had undergone planned surgery, and had adequate assessment of thromboembolism. This study is registered at ClinicalTrials.gov, number NCT00332020. Findings The modified intention-to-treat population for the analysis of the primary efficacy outcome consisted of 864 patients in the rivaroxaban group and 869 in the enoxaparin group. The primary outcome occurred in 17 (2 . 0%) patients in the rivaroxaban group, compared with 81 (9.3%) in the enoxaparin group (absolute risk reduction 7.3%, 95% CI 5.2-9.4; p<0 . 0001). The incidence of any on-treatment bleeding was much the same in both groups (81 [6.6%] events in 1228 patients in the rivaroxaban safety population vs 68 [5. 5%] of 1229 patients in the enoxaparin safety population; p=0 . 25). Interpretation Extended thromboprophylaxis with rivaroxaban was significantly more effective than short-term enoxaparin plus placebo for the prevention of venous thromboembolism, including symptomatic events, in patients undergoing total hip arthroplasty. Funding Bayer HealthCare AG, Johnson & Johnson Pharmaceutical Research and Development LLC.	[Kakkar, Ajay K.] Barts & London Queen Marys Sch Med & Dent, London E1 2AD, England; [Kakkar, Ajay K.; Dahl, Ola E.] Thrombosis Res Inst, London SW3 6LR, England; [Brenner, Benjamin] Rambam Med Ctr, Haifa, Israel; [Eriksson, Bengt I.] Sahlgrens Univ Hosp, Gothenburg, Sweden; [Mouret, Patrick] Frankfurt Hochst Clin, Frankfurt, Germany; [Muntz, Jim] Methodist Hosp, Houston, TX 77030 USA; [Muntz, Jim] St Lukes Episcopal Hosp, Houston, TX 77030 USA; [Soglian, Andrea G.] Bayer HealthCare, Milan, Italy; [Pap, Akos F.; Misselwitz, Frank] Bayer HealthCare, Wuppertal, Germany; [Haas, Sylvia] Tech Univ Munich, Inst Expt Oncol & Therapy Res, Munich, Germany	University of London; Queen Mary University London; Thrombosis Research Institute; Rambam Health Care Campus; Technion Israel Institute of Technology; Sahlgrenska University Hospital; The Methodist Hospital System; The Methodist Hospital - Houston; Saint Lukes Episcopal Hospital; Bayer AG; Bayer Healthcare Pharmaceuticals; Bayer AG; Bayer Healthcare Pharmaceuticals; Technical University of Munich	Kakkar, AK (corresponding author), Barts & London Queen Marys Sch Med & Dent, Turner St, London E1 2AD, England.	akkakkar@tri-london.ac.uk	Kaynar, Leylagul/F-6991-2013; Urina-Triana, Miguel A/H-2605-2016; Flondell, Magnus/AAB-9565-2020	Kaynar, Leylagul/0000-0002-2035-9462; Urina-Triana, Miguel A/0000-0001-6003-4622; Flondell, Magnus/0000-0003-4215-4561; Pap, Akos Ferenc/0000-0002-2161-3151; SALAS PEREZ, MARCIA/0000-0002-6398-2369; Raju, Dr KV Puttakempa/0000-0002-3687-0927				*AM AC ORTH SURG, AM AC ORTH SURG CLIN; Anderson FA, 2003, CHEST, V124, p349S, DOI 10.1378/chest.124.6_suppl.349S; [Anonymous], VEN THROMB RED RISK; Bergqvist D, 1996, NEW ENGL J MED, V335, P696, DOI 10.1056/NEJM199609053351002; Callaghan JJ, 2005, J ARTHROPLASTY, V20, P273, DOI 10.1016/j.arth.2005.01.014; Comp PC, 2001, J BONE JOINT SURG AM, V83A, P336, DOI 10.2106/00004623-200103000-00004; Dahl OE, 2004, DRUGS, V64, P17, DOI 10.2165/00003495-200464001-00004; Dahl OE, 1997, THROMB HAEMOSTASIS, V77, P26; Duncan B. W., MAKING HLTH CARE SAF; Eikelboom JW, 2001, LANCET, V358, P9, DOI 10.1016/S0140-6736(00)05249-1; Eriksson BI, 2007, THROMB RES, V120, P685, DOI 10.1016/j.thromres.2006.12.025; Eriksson BI, 2006, CIRCULATION, V114, P2374, DOI 10.1161/CIRCULATIONAHA.106.642074; Eriksson BI, 2006, J THROMB HAEMOST, V4, P121, DOI 10.1111/j.1538-7836.2005.01657.x; ERIKSSON BI, 2007, BLOOD, V110; Friedman RJ, 2007, J AM ACAD ORTHOP SUR, V15, P148, DOI 10.5435/00124635-200703000-00004; Geerts WH, 2004, CHEST, V126, p338S, DOI 10.1378/chest.126.3_suppl.338S; Hull RD, 2001, ANN INTERN MED, V135, P858, DOI 10.7326/0003-4819-135-10-200111200-00006; Hull RD, 2000, ARCH INTERN MED, V160, P2208, DOI 10.1001/archinte.160.14.2208; Kakkar AK, 2004, J THROMB HAEMOST, V2, P221, DOI 10.1111/j.1538-7933.2004.00588.x; KAKKAR VV, 1975, LANCET, V2, P674; Lassen MR, 1998, THROMB RES, V89, P281, DOI 10.1016/S0049-3848(98)00018-8; LASSEN MR, 2007, BLOOD, V110; O'Brien J, 2000, LANCET, V355, P1295; Planes A, 1996, LANCET, V348, P224, DOI 10.1016/S0140-6736(96)01453-5; Prandoni P, 2002, ARCH INTERN MED, V162, P1966, DOI 10.1001/archinte.162.17.1966; RABINOV K, 1972, ARCH SURG-CHICAGO, V104, P134; Rosencher N, 2003, TRANSFUSION, V43, P459, DOI 10.1046/j.1537-2995.2003.00348.x; Scottish Intercollegiate Guidelines Network (SIGN), 2002, PROPH VEN THROMB NAT; Warwick D, 2007, J BONE JOINT SURG BR, V89B, P799, DOI 10.1302/0301-620X.89B6.18844; White RH, 1998, ARCH INTERN MED, V158, P1525, DOI 10.1001/archinte.158.14.1525	30	817	889	1	72	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 5	2008	372	9632					31	39		10.1016/S0140-6736(08)60880-6	http://dx.doi.org/10.1016/S0140-6736(08)60880-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	321XN	18582928				2022-12-28	WOS:000257339900029
J	Owen, GS; Richardson, G; David, AS; Szmukler, G; Hayward, P; Hotopf, M				Owen, Gareth S.; Richardson, Genevra; David, Anthony S.; Szmukler, George; Hayward, Peter; Hotopf, Matthew			Mental capacity to make decisions on treatment in people admitted to psychiatric hospitals: cross sectional study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PREVALENCE; INCAPACITY; RISK	Objective To estimate the prevalence of menta I capacity to make decisions on treatment in people from different diagnostic and legal groups admitted to psychiatric hospital. Design Cross sectional study. Setting General adult acute psychiatric inpatient units. Participants 350 consecutive people admitted to psychiatric wards from the community over 16 months. Main outcome measure Mental capacity assessed by clinical interview and the MacArthur competence assessment tool for treatment. Results Estimates of mental capacity were obtained on 97% (n=338) of the 350 people admitted. Of those,an estimated 60% (95% confidence interval 55% to 65%) lacked mental capacity to make decisions on treatment. This proportion varied according to diagnosis, ranging from 97% (n=36) in people with mania to 4% (n=24) in people with personality disorder. Mental incapacity was common in patients admitted informally to the psychiatric wards (n=188; 39%, 32% to 46%). Incapacity and detention are closely associated under non-capacity based mental health law. Conclusions Mental incapacity to make decisions on treatment is common in people admitted to psychiatric wards from the community but cannot be presumed. It is usual in those detained under the Mental Health Act and common in those admitted voluntarily.	[Owen, Gareth S.; David, Anthony S.; Hotopf, Matthew] Kings Coll London, Inst Psychiat, Dept Psychol Med & Psychiat, London SE5 8AF, England; [Richardson, Genevra] Kings Coll London, Sch Law, London SE5 8AF, England; [Szmukler, George] Kings Coll London, Inst Psychiat, Dept Hlth Serv & Populat Res, London SE5 8AF, England; [Hayward, Peter] Maudsley Hosp & Inst Psychiat, Maudsley Psychol Ctr, London SE5 8AZ, England	University of London; King's College London; University of London; King's College London; University of London; King's College London; South London & Maudsley NHS Trust; University of London; King's College London	Hotopf, M (corresponding author), Kings Coll London, Inst Psychiat, Dept Psychol Med & Psychiat, London SE5 8AF, England.	m.hotopf@iop.kcl.ac.uk	David, Anthony S/C-1315-2011; David, Anthony/O-1750-2019; Hotopf, Matthew/E-4971-2010	David, Anthony S/0000-0003-0967-774X; David, Anthony/0000-0003-0967-774X; Owen, Gareth/0000-0002-5166-9332	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Appelbaum PS, 2007, NEW ENGL J MED, V357, P1834, DOI 10.1056/NEJMcp074045; Cairns R, 2005, BRIT J PSYCHIAT, V187, P379, DOI 10.1192/bjp.187.4.379; Cairns R, 2005, BRIT J PSYCHIAT, V187, P372, DOI 10.1192/bjp.187.4.372; Grisso T, 1997, PSYCHIATR SERV, V48, P1415; Okai D, 2007, BRIT J PSYCHIAT, V191, P291, DOI 10.1192/bjp.bp.106.035162; Raymont V, 2004, LANCET, V364, P1421, DOI 10.1016/S0140-6736(04)17224-3; Richardson G, 2007, INT J LAW PSYCHIAT, V30, P71, DOI 10.1016/j.ijlp.2005.08.013	7	86	87	1	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 5	2008	337	7660							a448	10.1136/bmj.39580.546597.BE	http://dx.doi.org/10.1136/bmj.39580.546597.BE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	326DF	18595931	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000257637500033
J	Lodge, TP				Lodge, Timothy P.			Materials science - A unique platform for materials design	SCIENCE			English	Editorial Material							THIN-FILM TRANSISTORS; IONIC LIQUIDS; COPOLYMERS; TRIBLOCK; GELS; ELECTROLYTES		[Lodge, Timothy P.] Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA; [Lodge, Timothy P.] Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Lodge, TP (corresponding author), Univ Minnesota, Dept Chem, 207 Pleasant St SE, Minneapolis, MN 55455 USA.	lodge@umn.edu		Lodge, Timothy/0000-0001-5916-8834	Direct For Mathematical & Physical Scien [0804197] Funding Source: National Science Foundation	Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))		Bara JE, 2007, IND ENG CHEM RES, V46, P5397, DOI 10.1021/ie0704492; Cho JH, 2008, ADV MATER, V20, P686, DOI 10.1002/adma.200701069; Ding J, 2003, CHEM MATER, V15, P2392, DOI 10.1021/cm020918k; Epps TH, 2004, MACROMOLECULES, V37, P7085, DOI 10.1021/ma0493426; He Y, 2008, MACROMOLECULES, V41, P167, DOI 10.1021/ma702014z; He YY, 2007, J PHYS CHEM B, V111, P4645, DOI 10.1021/jp064574n; Lee J, 2007, J AM CHEM SOC, V129, P4532, DOI 10.1021/ja070875e; Lu W, 2002, SCIENCE, V297, P983, DOI 10.1126/science.1072651; Simone PM, 2008, MACROMOLECULES, V41, P1753, DOI 10.1021/ma702252v; Susan MA, 2005, J AM CHEM SOC, V127, P4976, DOI 10.1021/ja045155b; Tang JB, 2005, CHEM COMMUN, P3325, DOI 10.1039/b501940k; Ueki T, 2008, MACROMOLECULES, V41, P3739, DOI 10.1021/ma800171k	12	370	377	6	193	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 4	2008	321	5885					50	51		10.1126/science.1159652	http://dx.doi.org/10.1126/science.1159652			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QE	18599764				2022-12-28	WOS:000257320800028
J	Zuber, MT; Smith, DE; Solomon, SC; Phillips, RJ; Peale, SJ; Head, JW; Hauck, SA; McNutt, RL; Oberst, J; Neumann, GA; Lemoine, FG; Sun, XL; Barnouin-Jha, O; Harmon, JK				Zuber, Maria T.; Smith, David E.; Solomon, Sean C.; Phillips, Roger J.; Peale, Stanton J.; Head, James W., III; Hauck, Steven A., II; McNutt, Ralph L., Jr.; Oberst, Juergen; Neumann, Gregory A.; Lemoine, Frank G.; Sun, Xiaoli; Barnouin-Jha, Olivier; Harmon, John K.			Laser altimeter observations from MESSENGER's first Mercury flyby	SCIENCE			English	Article							CORE	A 3200- kilometers- long profile of Mercury by the Mercury Laser Altimeter on the MESSENGER spacecraft spans similar to 20% of the near- equatorial region of the planet. Topography along the profile is characterized by a 5.2- kilometer dynamic range and 930- meter root- mean- square roughness. At long wavelengths, topography slopes eastward by 0.02 degrees, implying a variation of equatorial shape that is at least partially compensated. Sampled craters on Mercury are shallower than their counterparts on the Moon, at least in part the result of Mercury's higher gravity. Crater floors vary in roughness and slope, implying complex modification over a range of length scales.	[Zuber, Maria T.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Smith, David E.; Neumann, Gregory A.; Lemoine, Frank G.; Sun, Xiaoli] NASA, Solar Syst Explorat Div, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Solomon, Sean C.] Carnegie Inst Washington, Dept Terr Magnetism, Washington, DC 20015 USA; [Phillips, Roger J.] SW Res Inst, Boulder, CO 80302 USA; [Peale, Stanton J.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Head, James W., III] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Hauck, Steven A., II] Case Western Reserve Univ, Dept Geol Sci, Cleveland, OH 44106 USA; [McNutt, Ralph L., Jr.; Barnouin-Jha, Olivier] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Oberst, Juergen] DLR, Inst Planetary Res, D-12489 Berlin, Germany; [Harmon, John K.] Natl Astron & Ionosphere Ctr, Arecibo Observ, Arecibo, PR 00612 USA	Massachusetts Institute of Technology (MIT); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Carnegie Institution for Science; University of California System; University of California Santa Barbara; Brown University; Case Western Reserve University; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Helmholtz Association; German Aerospace Centre (DLR); National Aeronautics & Space Administration (NASA)	Zuber, MT (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.	zuber@mit.edu	Sun, Xiaoli/B-5120-2013; Hauck, Steven A/A-7865-2008; McNutt, Ralph L/E-8006-2010; Neumann, Gregory A/I-5591-2013; Lemoine, Frank/D-1215-2013; Barnouin, Olivier S/I-7475-2015	Hauck, Steven A/0000-0001-8245-146X; McNutt, Ralph L/0000-0002-4722-9166; Neumann, Gregory A/0000-0003-0644-9944; Barnouin, Olivier S/0000-0002-3578-7750; Lemoine, Frank G./0000-0002-3051-1456				Abshire JB, 2000, APPL OPTICS, V39, P2449, DOI 10.1364/AO.39.002449; Anderson JD, 1996, ICARUS, V124, P690, DOI 10.1006/icar.1996.0242; Cavanaugh JF, 2007, SPACE SCI REV, V131, P451, DOI 10.1007/s11214-007-9273-4; Harder H, 2001, ICARUS, V151, P118, DOI 10.1006/icar.2001.6586; HARMON JK, 1986, J GEOPHYS RES-SOLID, V91, P385, DOI 10.1029/JB091iB01p00385; HARMON JK, 1988, MERCURY, P101; Harmon JK, 2007, ICARUS, V187, P374, DOI 10.1016/j.icarus.2006.09.026; Hauck SA, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030793; Margot JL, 2007, SCIENCE, V316, P710, DOI 10.1126/science.1140514; Margot JL, 1999, J GEOPHYS RES-PLANET, V104, P11875, DOI 10.1029/1998JE900047; Pike R.J., 1980, P LUNAR PLANET SCI C, V11, P2159; PIKE RJ, 1988, MERCURY, P165; Solomon SC, 2008, SCIENCE, V321, P59, DOI 10.1126/science.1159706; Yoder C. F., 1995, GLOBAL EARTH PHYS	14	38	38	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 4	2008	321	5885					77	79		10.1126/science.1159086	http://dx.doi.org/10.1126/science.1159086			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QE	18599773				2022-12-28	WOS:000257320800037
J	Lin, K; Fajardo, K				Lin, Kenneth; Fajardo, Kevin			Screening for asymptomatic bacteriuria in adults: Evidence for the U.S. Preventive Services Task Force reaffirmation recommendation statement	ANNALS OF INTERNAL MEDICINE			English	Article							WOMEN	Background: Asymptomatic bacteriuria is common, and screening for this condition in pregnant women is a well-established, evidence-based standard of current medical practice. Screening other groups of adults has not been shown to improve outcomes. Purpose: To review new and substantial evidence on screening for asymptomatic bacteriuria, to support the work of the U. S. Preventive Services Task Force. Data Sources: English-language studies of adults (age > 18 years) indexed in PubMed and the Cochrane Library and published from 1 January 2002 through 30 April 2007. Study Selection: For benefits of screening or treatment for screened populations, systematic reviews; meta-analyses; and randomized, controlled trials were included. For harms of screening, systematic reviews; meta-analyses; randomized, controlled trials; cohort studies; case-control studies; and case series of large multisite databases were included. Two reviewers independently reviewed titles, abstracts, and full articles for inclusion. Data Extraction: Two reviewers extracted data from studies on benefits of screening and treatment (including decreases in the incidence of adverse maternal and fetal outcomes, symptomatic urinary tract infections, hypertension, and renal function decline). Data Synthesis: An updated Cochrane systematic review of 14 randomized, controlled trials of treatment supports screening for asymptomatic bacteriuria in pregnant women. A randomized, controlled trial and a prospective cohort study show that screening nonpregnant women with diabetes for asymptomatic bacteriuria is unlikely to produce benefits. No new evidence on screening men for asymptomatic bacteriuria or on harms of screening was found. Limitation: The focused search strategy may have missed some smaller studies on the benefits and harms of screening for asymptomatic bacteriuria. Conclusion: The available evidence continues to support screening for asymptomatic bacteriuria in pregnant women, but not in other groups of adults.	[Lin, Kenneth; Fajardo, Kevin] Agcy Healthcare Res & Qual, Ctr Primary Care Prevent & Clin Partnerships, Rockville, MD 20850 USA	Agency for Healthcare Research & Quality	Lin, K (corresponding author), Agcy Healthcare Res & Qual, Ctr Primary Care Prevent & Clin Partnerships, 540 Gaither Rd, Rockville, MD 20850 USA.	kenneth.lin@ahrq.hhs.gov						GARTLEHNER G, 2004, AHRQ PUBLICATION; Harding GKM, 2002, NEW ENGL J MED, V347, P1576, DOI 10.1056/NEJMoa021042; McIsaac W, 2005, J OBSTET GYNAECOL CA, V27, P20, DOI 10.1016/S1701-2163(16)30167-0; Meiland R, 2006, ARCH INTERN MED, V166, P2222, DOI 10.1001/archinte.166.20.2222; Smaill F, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000490.pub2; Smaill F., 2001, COCHRANE DB SYST REV, V2, DOI [DOI 10.1002/14651858.CD000490, 10.1002/14651858.CD000490]; Teppa RJ, 2005, J SOC GYNECOL INVEST, V12, P50, DOI 10.1016/j.jsgi.2004.07.007; *US PREV SERV TASK, 1996, GUID CLIN PREV SERV, P347; US Preventive Services Task Force, 2004, SCREEN AS BACT REC S	9	71	76	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 1	2008	149	1					W20	W24		10.7326/0003-4819-149-1-200807010-00009-w1	http://dx.doi.org/10.7326/0003-4819-149-1-200807010-00009-w1			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	323EZ	18591632				2022-12-28	WOS:000257428200008
J	Goadsby, PJ; Goldberg, J; Silberstein, SD				Goadsby, Peter J.; Goldberg, Jay; Silberstein, Stephen D.			Pregnancy plus - Migraine in pregnancy	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEADACHES; PREECLAMPSIA; WOMEN; AURA		[Goadsby, Peter J.] Univ Calif San Francisco, Dept Neurol, Headache Grp, San Francisco, CA 94143 USA; [Goldberg, Jay] Thomas Jefferson Univ, Jefferson Med Coll, Dept Obstet & Gynecol, Philadelphia, PA 19107 USA; [Silberstein, Stephen D.] Jefferson Headache Ctr, Philadelphia, PA USA	University of California System; University of California San Francisco; Jefferson University; Jefferson University	Goadsby, PJ (corresponding author), Univ Calif San Francisco, Dept Neurol, Headache Grp, 505 Parnassus Ave, San Francisco, CA 94143 USA.	peter.goadsby@ucsf.edu	Goadsby, Peter J/Z-1970-2019	Goadsby, Peter J/0000-0003-3260-5904				Adeney KL, 2006, HEADACHE, V46, P794, DOI 10.1111/j.1526-4610.2006.00432.x; Briggs G., 2005, DRUGS PREGNANCY LACT; Diener Hans-Christoph, 2007, Curr Pain Headache Rep, V11, P236, DOI 10.1007/s11916-007-0196-2; Evans EW, 2008, ANN PHARMACOTHER, V42, P543, DOI 10.1345/aph.1K176; Friedman J.M., 2000, TERATOGENIC EFFECTS; Goadsby PJ, 2002, NEW ENGL J MED, V346, P257, DOI 10.1056/NEJMra010917; GRANELLA F, 1993, HEADACHE, V33, P385, DOI 10.1111/j.1526-4610.1993.hed3307385.x; Hughes G, 2007, CLIN REV ALLERG IMMU, V32, P3, DOI 10.1007/BF02686077; Kallen B, 2001, HEADACHE, V41, P351, DOI 10.1046/j.1526-4610.2001.111006351.x; Lance JW, 2005, MECH MANAGEMENT HEAD; Lipton RB, 2001, HEADACHE, V41, P646, DOI 10.1046/j.1526-4610.2001.041007646.x; Marcus DA, 1999, HEADACHE, V39, P21, DOI 10.1046/j.1526-4610.1999.3901021.x; Melhado EM, 2007, CAN J NEUROL SCI, V34, P187, DOI 10.1017/S0317167100006028; Mitsikostas DD, 2004, BRAIN, V127, P1200, DOI 10.1093/brain/awh146; Olesen C, 2000, HEADACHE, V40, P20, DOI 10.1046/j.1526-4610.2000.00003.x; Olesen J, 2005, HEADACHES; PHILIPP EE, 1964, BRIT MED J, V1, P749, DOI 10.1136/bmj.1.5385.749; RASMUSSEN BK, 1992, CEPHALALGIA, V12, P221, DOI 10.1046/j.1468-2982.1992.1204221.x; Sances G, 2003, CEPHALALGIA, V23, P197, DOI 10.1046/j.1468-2982.2003.00480.x; Sanchez SE, 2008, AM J HYPERTENS, V21, P360, DOI 10.1038/ajh.2007.46; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Silberstein SD, 2002, HEADACHE CLIN PRACTI; STEIN G, 1984, ACTA NEUROL SCAND, V69, P74, DOI 10.1111/j.1600-0404.1984.tb07782.x; WAINSCOTT G, 1978, POSTGRAD MED J, V54, P98, DOI 10.1136/pgmj.54.628.98	24	38	42	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 28	2008	336	7659					1502	1504		10.1136/bmj.39559.675891.AD	http://dx.doi.org/10.1136/bmj.39559.675891.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	324GN	18583683	Green Published			2022-12-28	WOS:000257505900041
J	Cully, M; Downward, J				Cully, Megan; Downward, Julian			SnapShot: Ras signaling	CELL			English	Editorial Material							SMALL GTPASES; MTOR		[Cully, Megan; Downward, Julian] Canc Res UK London Res Inst, London WC2A 3PX, England	Cancer Research UK	Cully, M (corresponding author), Canc Res UK London Res Inst, London WC2A 3PX, England.		Downward, Julian/A-3251-2012	Downward, Julian/0000-0002-2331-4729; Cully, Megan/0000-0003-4726-134X				BUDAY L, 2008, BIOCH BIOPHYS ACTA, DOI DOI 10.1016/J.BBCAN.2008.05.001; Bunney TD, 2006, TRENDS CELL BIOL, V16, P640, DOI 10.1016/j.tcb.2006.10.007; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Mitin N, 2005, CURR BIOL, V15, pR563, DOI 10.1016/j.cub.2005.07.010; Mor A, 2007, IMMUNOL REV, V218, P114, DOI 10.1111/j.1600-065X.2007.00538.x; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869	10	59	60	1	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 27	2008	133	7					1292	U190	1292.e1	10.1016/j.cell.2008.06.020	http://dx.doi.org/10.1016/j.cell.2008.06.020			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	319DP	18585361	Bronze			2022-12-28	WOS:000257144600026
J	Gormley, WT; Phillips, D; Gayer, T				Gormley, William T., Jr.; Phillips, Deborah; Gayer, Ted			The early years - Preschool programs can boost school readiness	SCIENCE			English	Editorial Material							FOLLOW-UP; CHILDREN		[Gormley, William T., Jr.; Phillips, Deborah; Gayer, Ted] Georgetown Univ, Georgetown Publ Policy Inst, Washington, DC 20007 USA; [Gormley, William T., Jr.; Phillips, Deborah; Gayer, Ted] Georgetown Univ, CROCUS, Washington, DC 20007 USA	Georgetown University; Georgetown University	Gormley, WT (corresponding author), Georgetown Univ, Georgetown Publ Policy Inst, Washington, DC 20007 USA.	gormleyw@georgetown.edu						BARNETT WS, 1993, AM J ORTHOPSYCHIAT, V63, P500, DOI 10.1037/h0079481; Heckman JJ, 2006, SCIENCE, V312, P1900, DOI 10.1126/science.1128898; Magnuson KA, 2007, ECON EDUC REV, V26, P33, DOI 10.1016/j.econedurev.2005.09.008; Puma M., 2005, HEAD START IMPACT ST; Reynolds AJ, 2001, JAMA-J AM MED ASSOC, V285, P2339, DOI 10.1001/jama.285.18.2339; Wong VC, 2008, J POLICY ANAL MANAG, V27, P122, DOI 10.1002/pam.20310; Zigler E, 2006, VISION FOR UNIVERSAL PRESCHOOL EDUCATION, P1, DOI 10.2277/ 0521612993	7	127	128	3	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 27	2008	320	5884					1723	1724		10.1126/science.1156019	http://dx.doi.org/10.1126/science.1156019			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	318VP	18583597				2022-12-28	WOS:000257121200021
J	Watkinson, AF; Yeow, TN; Fraser, C				Watkinson, Anthony F.; Yeow, Tow Non; Fraser, Clementine			Rational imaging - Endovascular stenting to treat obstruction of the superior vena cava	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ENHANCED MR VENOGRAPHY; CT; PLACEMENT; DISEASE		[Watkinson, Anthony F.; Yeow, Tow Non; Fraser, Clementine] Royal Devon & Exeter Hosp, Peninsula Med Sch, Exeter EX2 5DW, Devon, England	University of Exeter	Watkinson, AF (corresponding author), Royal Devon & Exeter Hosp, Peninsula Med Sch, Exeter EX2 5DW, Devon, England.	anthony.watkinson@rdeft.nhs.uk						BECHTOLD RE, 1985, RADIOLOGY, V157, P485, DOI 10.1148/radiology.157.2.4048460; Chee CE, 2007, NAT CLIN PRACT CARD, V4, P226, DOI 10.1038/ncpcardio0850; CROWE MTI, 1995, CARDIOVASC INTER RAD, V18, P367, DOI 10.1007/BF00338303; Entwisle KG, 1996, CLIN RADIOL, V51, P593, DOI 10.1016/S0009-9260(96)80144-9; Eren S, 2006, EUR J RADIOL, V59, P93, DOI 10.1016/j.ejrad.2006.01.003; Kalra M, 2003, J VASC SURG, V38, P215, DOI 10.1016/S0741-5214(03)00331-8; Kee ST, 1998, RADIOLOGY, V206, P187, DOI 10.1148/radiology.206.1.9423671; KIM HJ, 1993, AM J ROENTGENOL, V161, P539, DOI 10.2214/ajr.161.3.8352099; Lanciego C, 2001, AM J ROENTGENOL, V177, P585, DOI 10.2214/ajr.177.3.1770585; Lin J, 2005, CARDIOVASC INTER RAD, V28, P795, DOI 10.1007/s00270-004-0054-0; *NAT I HLTH CLIN E, 2004, IPG79; Nicholson AA, 1997, J VASC INTERV RADIOL, V8, P781, DOI 10.1016/S1051-0443(97)70660-2; Ostler P J, 1997, Clin Oncol (R Coll Radiol), V9, P83, DOI 10.1016/S0936-6555(05)80445-5; PARISH JM, 1981, MAYO CLIN PROC, V56, P407; PLEKKER D, 2007, RESPIRATION     0925; Rice TW, 2006, MEDICINE, V85, P37, DOI 10.1097/01.md.0000198474.99876.f0; Rowell NP, 2002, CLIN ONCOL-UK, V14, P338, DOI 10.1053/clon.2002.0095; Smayra T, 2001, CARDIOVASC INTER RAD, V24, P388, DOI 10.1007/s00270-001-0055-1; STOCK KW, 1995, THORAX, V50, P1151, DOI 10.1136/thx.50.11.1151; Thornton MJ, 1999, AM J ROENTGENOL, V173, P999, DOI 10.2214/ajr.173.4.10511166	20	20	22	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 21	2008	336	7658					1434	1437		10.1136/bmj.39562.512789.80	http://dx.doi.org/10.1136/bmj.39562.512789.80			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	318WJ	18566082	Green Published			2022-12-28	WOS:000257123200037
J	Prawer, S; Greentree, AD				Prawer, Steven; Greentree, Andrew D.			Applied physics - Diamond for quantum computing	SCIENCE			English	Editorial Material									[Prawer, Steven; Greentree, Andrew D.] Univ Melbourne, Sch Phys, Melbourne, Vic 3010, Australia	University of Melbourne	Prawer, S (corresponding author), Univ Melbourne, Sch Phys, Melbourne, Vic 3010, Australia.	s.prawer@unimelb.edu.au; a.greentree@unimelb.edu.au	Greentree, Andrew D/A-8503-2008	Greentree, Andrew D/0000-0002-3505-9163; PRAWER, STEVEN/0000-0002-4959-0828				Baldwin JW, 2006, DIAM RELAT MATER, V15, P2061, DOI 10.1016/j.diamond.2006.09.009; Batalov A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.077401; Benjamin SC, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/8/141; Devitt SJ, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.052312; Gaebel T, 2006, NAT PHYS, V2, P408, DOI 10.1038/nphys318; Dutt MVG, 2007, SCIENCE, V316, P1312, DOI 10.1126/science.1139831; Hanson R, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.087601; Isberg J, 2002, SCIENCE, V297, P1670, DOI 10.1126/science.1074374; Kurtsiefer C, 2000, PHYS REV LETT, V85, P290, DOI 10.1103/PhysRevLett.85.290; Olivero P, 2005, ADV MATER, V17, P2427, DOI 10.1002/adma.200500752; Santori C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.247401; Tamarat P, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.083002; Wang CF, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2813023; Wang CF, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2709626; Wu E, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/12/434	15	87	90	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 20	2008	320	5883					1601	1602		10.1126/science.1158340	http://dx.doi.org/10.1126/science.1158340			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	315NM	18566276				2022-12-28	WOS:000256886700036
J	Clarke, J; Wilhelm, FK				Clarke, John; Wilhelm, Frank K.			Superconducting quantum bits	NATURE			English	Review							ZERO-VOLTAGE STATE; QUBITS; SUPERPOSITION; PHOTON; PAIR	Superconducting circuits are macroscopic in size but have generic quantum properties such as quantized energy levels, superposition of states, and entanglement, all of which are more commonly associated with atoms. Superconducting quantum bits (qubits) form the key component of these circuits. Their quantum state is manipulated by using electromagnetic pulses to control the magnetic flux, the electric charge or the phase difference across a Josephson junction (a device with nonlinear inductance and no energy dissipation). As such, superconducting qubits are not only of considerable fundamental interest but also might ultimately form the primitive building blocks of quantum computers.	[Clarke, John] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Clarke, John] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Wilhelm, Frank K.] Univ Waterloo, Inst Quantum Comp, Waterloo, ON N2L 3G1, Canada	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Waterloo	Clarke, J (corresponding author), Univ Calif Berkeley, Dept Phys, 366 LeConte Hall, Berkeley, CA 94720 USA.	jclarke@berkeley.edu; fwilhelm@iqc.ca	Wilhelm, Frank/F-7944-2017; Wilhelm, Frank/G-2162-2010	Wilhelm, Frank/0000-0003-1034-8476; 				Astafiev O, 2007, NATURE, V449, P588, DOI 10.1038/nature06141; Astafiev O, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.267007; Averin DV, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.057003; BARDEEN J, 1957, PHYS REV, V108, P1175, DOI 10.1103/PhysRev.108.1175; BENNETT CH, 1993, PHYS REV LETT, V70, P1895, DOI 10.1103/PhysRevLett.70.1895; Berkley AJ, 2003, SCIENCE, V300, P1548, DOI 10.1126/science.1084528; Bertet P, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.064512; Bertet P, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.257002; Blais A, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.062320; Bouchiat V, 1998, PHYS SCRIPTA, VT76, P165, DOI 10.1238/Physica.Topical.076a00165; Braginsky V. B., 1995, QUANTUM MEASUREMENT; CALDEIRA AO, 1983, ANN PHYS-NEW YORK, V149, P374, DOI 10.1016/0003-4916(83)90202-6; Clarke J., 2004, SQUID HDB FUNDAMENTA, V1; Cooper KB, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.180401; Devoret MH, 1997, LES HOUCH S, V63, P351; DEVORET MH, 1985, PHYS REV LETT, V55, P1908, DOI 10.1103/PhysRevLett.55.1908; Devoret MH, 2000, NATURE, V406, P1039, DOI 10.1038/35023253; DOLAN GJ, 1977, APPL PHYS LETT, V31, P337, DOI 10.1063/1.89690; DUTTA P, 1981, REV MOD PHYS, V53, P497, DOI 10.1103/RevModPhys.53.497; Duty T, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.140503; FAORO L, 2007, MICROSCOPIC ORIGIN L; Fowler AG, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.174507; Friedman JR, 2000, NATURE, V406, P43, DOI 10.1038/35017505; GRACJAR M, 2007, SISYPHUS DAMPING AMP; Grajcar M, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.060501; Grajcar M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.047006; HAROCHE S, 1989, PHYS TODAY, V42, P24, DOI 10.1063/1.881201; HELMER F., 2007, 2 DIMENSIONAL CAVITY; Hime T, 2006, SCIENCE, V314, P1427, DOI 10.1126/science.1134388; Houck AA, 2007, NATURE, V449, P328, DOI 10.1038/nature06126; Ithier G, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.134519; Johansson J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.127006; Koch J, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.042319; Koch RH, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.267003; Lantz J, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.140507; LEGGETT AJ, 1985, PHYS REV LETT, V54, P857, DOI 10.1103/PhysRevLett.54.857; Liu YX, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.067003; Lupascu A, 2007, NAT PHYS, V3, P119, DOI 10.1038/nphys509; Majer J, 2007, NATURE, V449, P443, DOI 10.1038/nature06184; Majer JB, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.090501; Makhlin Y, 2001, REV MOD PHYS, V73, P357, DOI 10.1103/RevModPhys.73.357; Makhlin Y, 1999, NATURE, V398, P305, DOI 10.1038/18613; Martinis JM, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.210503; MARTINIS JM, 1985, PHYS REV LETT, V55, P1543, DOI 10.1103/PhysRevLett.55.1543; McDermott R, 2005, SCIENCE, V307, P1299, DOI 10.1126/science.1107572; Nakamura Y, 1997, PHYS REV LETT, V79, P2328, DOI 10.1103/PhysRevLett.79.2328; Nakamura Y, 1999, NATURE, V398, P786, DOI 10.1038/19718; Niskanen AO, 2007, SCIENCE, V316, P723, DOI 10.1126/science.1141324; Pashkin YA, 2003, NATURE, V421, P823, DOI 10.1038/nature01365; Plantenberg JH, 2007, NATURE, V447, P836, DOI 10.1038/nature05896; Plourde BLT, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.140501; Rigetti C, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.240502; Schoelkopf RJ, 1998, SCIENCE, V280, P1238, DOI 10.1126/science.280.5367.1238; Schreier JA, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.180502; Schuster DI, 2007, NATURE, V445, P515, DOI 10.1038/nature05461; Siddiqi I, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.027005; Sillanpaa MA, 2007, NATURE, V449, P438, DOI 10.1038/nature06124; Slichter C.P., 1990, PRINCIPLES NUCL MAGN; Steffen M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.050502; Steffen M, 2006, SCIENCE, V313, P1423, DOI 10.1126/science.1130886; Tinkham M., 1996, INTRO SUPERCONDUCTIV, V2nd ed.; Valenzuela SO, 2006, SCIENCE, V314, P1589, DOI 10.1126/science.1134008; van der Wal CH, 2000, SCIENCE, V290, P773, DOI 10.1126/science.290.5492.773; Van Harlingen DJ, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.064517; Vion D, 2002, SCIENCE, V296, P886, DOI 10.1126/science.1069372; VOSS RF, 1981, PHYS REV LETT, V47, P265, DOI 10.1103/PhysRevLett.47.265; Wallraff A, 2004, NATURE, V431, P162, DOI 10.1038/nature02851; Wei LF, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.134506; WELLSTOOD FC, 1987, APPL PHYS LETT, V50, P772, DOI 10.1063/1.98041; Wilhelm FK, 2007, NATO SCI SER II-MATH, V244, P195, DOI 10.1007/978-1-4020-6137-0_6; WILHELM FK, 2001, USP FIZ NAUK S171, V44, P117; Yamamoto T, 2003, NATURE, V425, P941, DOI 10.1038/nature02015; [No title captured]; [No title captured]	79	1345	1382	17	389	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2008	453	7198					1031	1042		10.1038/nature07128	http://dx.doi.org/10.1038/nature07128			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314WM	18563154	Green Submitted			2022-12-28	WOS:000256839900045
J	Titus, SL; Wells, JA; Rhoades, LJ				Titus, Sandra L.; Wells, James A.; Rhoades, Lawrence J.			Repairing research integrity	NATURE			English	Editorial Material									[Titus, Sandra L.; Rhoades, Lawrence J.] Off Res Integr, Div Educ & Integr, Rockville, MD 20852 USA; [Wells, James A.] Univ Wisconsin, Off Res Policy, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Titus, SL (corresponding author), Off Res Integr, Div Educ & Integr, 1101 Wootton Pkwy,Suite 750, Rockville, MD 20852 USA.							Adams Douglas, 2005, Account Res, V12, P225, DOI 10.1080/08989620500217495; *DEP HLTH HUM SERV, 2005, PUBL HLTH SERV POL R; Institute of Medicine. (IOM), 1989, RESP COND RES HLTH S; Martinson BC, 2005, NATURE, V435, P737, DOI 10.1038/435737a; McCabe DL, 2001, ETHICS BEHAV, V11, P219, DOI 10.1207/S15327019EB1103_2; Rankin M, 1997, NURS RES, V46, P270, DOI 10.1097/00006199-199709000-00005; St James-Roberts I, 1976, NEW SCI, V72, P466; SWAZEY JP, 1993, AM SCI, V81, P542	8	166	174	1	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 19	2008	453	7198					980	982		10.1038/453980a	http://dx.doi.org/10.1038/453980a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314WM	18563131				2022-12-28	WOS:000256839900022
J	Weiner, LM				Weiner, Louis M.			Focus on research - Cancer immunotherapy - The endgame begins	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Weiner, Louis M.] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA	Georgetown University	Weiner, LM (corresponding author), Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA.				NCI NIH HHS [R01 CA121033, R01 CA050633-18, R01 CA050633, R01 CA121033-02] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA121033, R01CA050633] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		DURANT JR, 1987, NEW ENGL J MED, V316, P939, DOI 10.1056/NEJM198704093161509; MILLER RA, 1982, NEW ENGL J MED, V306, P517, DOI 10.1056/NEJM198203043060906; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Taylor C, 2007, CLIN CANCER RES, V13, P5133, DOI 10.1158/1078-0432.CCR-07-0507	5	30	32	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 19	2008	358	25					2664	2665		10.1056/NEJMp0803663	http://dx.doi.org/10.1056/NEJMp0803663			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	314NC	18565858	Green Accepted			2022-12-28	WOS:000256815100002
J	Cuzick, J				Cuzick, Jack			Primary endpoints for randomised trials of cancer therapy	LANCET			English	Editorial Material							EXTENDED ADJUVANT THERAPY; BREAST-CANCER; ANASTROZOLE; TAMOXIFEN		[Cuzick, Jack] Queen Mary Univ London, Canc Res UK Ctr Epidemiol Math & Stat, Wolfson Inst Prevent Med, London EC1M 6BQ, England	Cancer Research UK; University of London; Queen Mary University London	Cuzick, J (corresponding author), Queen Mary Univ London, Canc Res UK Ctr Epidemiol Math & Stat, Wolfson Inst Prevent Med, London EC1M 6BQ, England.	jack.cuzick@cancer.org.uk						Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Coates AS, 2007, J CLIN ONCOL, V25, P486, DOI 10.1200/JCO.2006.08.8617; Coombes RC, 2007, LANCET, V369, P559, DOI 10.1016/S0140-6736(07)60200-1; Goss PE, 2005, JNCI-J NATL CANCER I, V97, P1262, DOI 10.1093/jnci/dji250; Gotzsche PC, 2000, LANCET, V355, P129, DOI 10.1016/S0140-6736(99)06065-1; Hanrahan EO, 2007, J CLIN ONCOL, V25, P4952, DOI 10.1200/JCO.2006.08.0499; Hudis CA, 2007, J CLIN ONCOL, V25, P2127, DOI 10.1200/JCO.2006.10.3523; Jakesz R, 2005, LANCET, V366, P455, DOI 10.1016/S0140-6736(05)67059-6; Jakesz R, 2007, JNCI-J NATL CANCER I, V99, P1845, DOI 10.1093/jnci/djm246; Punt CJA, 2007, JNCI-J NATL CANCER I, V99, P998, DOI 10.1093/jnci/djm024; US Food & Drug Administration, 2007, CLIN TRIAL ENDP APPR; Williams N, 2008, LANCET ONCOL, V9, P45, DOI 10.1016/S1470-2045(07)70385-6	12	26	26	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN-JUL	2008	371	9631					2156	2158		10.1016/S0140-6736(08)60933-2	http://dx.doi.org/10.1016/S0140-6736(08)60933-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	326CP	18586160				2022-12-28	WOS:000257635800009
J	Heath, I				Heath, Iona			R-E-S-P-E-C-T - find out what it means	BRITISH MEDICAL JOURNAL			English	Editorial Material												iona.heath@dsl.pipex.com							0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 12	2008	337	7661							a672	10.1136/bmj.a672	http://dx.doi.org/10.1136/bmj.a672			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	330SA	18599475				2022-12-28	WOS:000257961900030
J	An, JJ; Gharami, K; Liao, GY; Woo, NH; Lau, AG; Vanevski, F; Torre, ER; Jones, KR; Feng, Y; Lu, B; Xu, B				An, Juan Ji; Gharami, Kusumika; Liao, Guey-Ying; Woo, Newton H.; Lau, Anthony G.; Vanevski, Filip; Torre, Enrique R.; Jones, Kevin R.; Feng, Yue; Lu, Bai; Xu, Baoji			Distinct role of long 3 ' UTR BDNF mRNA in spine morphology and synaptic plasticity in hippocampal neurons	CELL			English	Article							DENDRITIC PROTEIN-SYNTHESIS; NEUROTROPHIC FACTOR; TERM POTENTIATION; KNOCKOUT MICE; REGULATORY MECHANISMS; RECEPTOR; TRANSLATION; TRKB; TRANSMISSION; ELEMENT	The brain produces two brain-derived neurotrophic factor (BDNF) transcripts, with either short or long 30 untranslated regions (30 UTRs). The physiological significance of the two forms of mRNAs encoding the same protein is unknown. Here, we show that the short and long 30 UTR BDNF mRNAs are involved in different cellular functions. The short 30 UTR mRNAs are restricted to somata, whereas the long 30 UTR mRNAs are also localized in dendrites. In a mouse mutant where the long 30 UTR is truncated, dendritic targeting of BDNF mRNAs is impaired. There is little BDNF in hippocampal dendrites despite normal levels of total BDNF protein. This mutant exhibits deficits in pruning and enlargement of dendritic spines, as well as selective impairment in long-term potentiation in dendrites, but not somata, of hippocampal neurons. These results provide insights into local and dendritic actions of BDNF and reveal a mechanism for differential regulation of subcellular functions of proteins.	[An, Juan Ji; Gharami, Kusumika; Liao, Guey-Ying; Vanevski, Filip; Xu, Baoji] Georgetown Univ, Sch Med, Dept Pharmacol, Washington, DC 20057 USA; [Woo, Newton H.; Lu, Bai] NICHHD, Sect Neural Dev & Plast, Bethesda, MD 20892 USA; [Lau, Anthony G.; Feng, Yue] Emory Univ, Dept Pharmacol, Atlanta, GA 30322 USA; [Torre, Enrique R.] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA; [Jones, Kevin R.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	Georgetown University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Emory University; Emory University; University of Colorado System; University of Colorado Boulder	Xu, B (corresponding author), Georgetown Univ, Sch Med, Dept Pharmacol, Washington, DC 20057 USA.	bx3@georgetown.edu	Lu, Bai/A-4018-2012	JONES, KEVIN/0000-0002-3802-7562; Feng, Yue/0000-0002-7905-2182; Lu, Bai/0000-0001-5418-9759	NINDS NIH HHS [R01 NS050596-03, R01 NS050596-01A1S1, R01 NS050596-02, R56 NS050596, NS050596, R01 NS050596-01A1, R01 NS050596] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000714] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS050596, R01NS050596] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Blichenberg A, 2001, EUR J NEUROSCI, V13, P1881, DOI 10.1046/j.0953-816x.2001.01565.x; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Gartner A, 2006, J NEUROSCI, V26, P3496, DOI 10.1523/JNEUROSCI.3792-05.2006; Gharami K, 2008, J NEUROCHEM, V105, P369, DOI 10.1111/j.1471-4159.2007.05137.x; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; Gorski JA, 2003, J NEUROSCI, V23, P6856; Horton AC, 2005, NEURON, V48, P757, DOI 10.1016/j.neuron.2005.11.005; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Ji YY, 2005, NAT NEUROSCI, V8, P164, DOI 10.1038/nn1381; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; Kobayashi H, 2005, EUR J NEUROSCI, V22, P2977, DOI 10.1111/j.1460-9568.2005.04508.x; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Kovalchuk Y, 2002, SCIENCE, V295, P1729, DOI 10.1126/science.1067766; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Liu QR, 2006, BRAIN RES, V1067, P1, DOI 10.1016/j.brainres.2005.10.004; Lochner JE, 2006, J NEUROBIOL, V66, P564, DOI 10.1002/neu.20250; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; Marz P, 1998, P NATL ACAD SCI USA, V95, P3251, DOI 10.1073/pnas.95.6.3251; Matsumoto T, 2008, NAT NEUROSCI, V11, P131, DOI 10.1038/nn2038; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Miller S, 2002, NEURON, V36, P507, DOI 10.1016/S0896-6273(02)00978-9; Muddashetty RS, 2007, J NEUROSCI, V27, P5338, DOI 10.1523/JNEUROSCI.0937-07.2007; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Paradies MA, 1997, J NEUROBIOL, V33, P473, DOI 10.1002/(SICI)1097-4695(199710)33:4<473::AID-NEU10>3.0.CO;2-D; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Pozzo-Miller LD, 1999, J NEUROSCI, V19, P4972; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Rook MS, 2000, J NEUROSCI, V20, P6385, DOI 10.1523/JNEUROSCI.20-17-06385.2000; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Sala C, 2000, J NEUROSCI, V20, P3529, DOI 10.1523/JNEUROSCI.20-10-03529.2000; Schratt GM, 2004, J NEUROSCI, V24, P7366, DOI 10.1523/JNEUROSCI.1739-04.2004; Steward O, 2003, NEURON, V40, P347, DOI 10.1016/S0896-6273(03)00635-4; Sutton MA, 2004, SCIENCE, V304, P1979, DOI 10.1126/science.1096202; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; Tongiorgi E, 2004, J NEUROSCI, V24, P6842, DOI 10.1523/JNEUROSCI.5471-03.2004; Tongiorgi E, 1997, J NEUROSCI, V17, P9492; Woo NH, 2005, NAT NEUROSCI, V8, P1069, DOI 10.1038/nn1510; Xu BJ, 2000, J NEUROSCI, V20, P6888, DOI 10.1523/JNEUROSCI.20-18-06888.2000; Yin Y, 2002, P NATL ACAD SCI USA, V99, P2368, DOI 10.1073/pnas.042693699; Zagrebelsky M, 2005, J NEUROSCI, V25, P9989, DOI 10.1523/JNEUROSCI.2492-05.2005; Zuo Y, 2005, NATURE, V436, P261, DOI 10.1038/nature03715	49	466	479	1	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 11	2008	134	1					175	187		10.1016/j.cell.2008.05.045	http://dx.doi.org/10.1016/j.cell.2008.05.045			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	324IU	18614020	Bronze, Green Accepted			2022-12-28	WOS:000257513100023
J	French, JA; Pedley, TA				French, Jacqueline A.; Pedley, Timothy A.			Initial management of epilepsy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TECHNOLOGY-ASSESSMENT SUBCOMMITTEE; QUALITY STANDARDS SUBCOMMITTEE; RANDOMIZED CONTROLLED-TRIAL; ANTIEPILEPTIC DRUGS; AMERICAN-ACADEMY; ANTICONVULSANT MEDICATION; UNPROVOKED SEIZURES; REFRACTORY EPILEPSY; VALPROATE; WOMEN		[French, Jacqueline A.] NYU, Sch Med, Dept Neurol, Comprehens Epilepsy Ctr, New York, NY 10016 USA; [Pedley, Timothy A.] Columbia Univ, Med Ctr, Dept Neurol, New York, NY USA	New York University; Columbia University	French, JA (corresponding author), NYU, Sch Med, Dept Neurol, Comprehens Epilepsy Ctr, 403 E 34th St,4th Fl, New York, NY 10016 USA.	jacqueline.french@nyumc.org	French, Jacqueline A/G-6795-2013	French, Jacqueline A/0000-0003-2242-8027				Adab N, 2004, J NEUROL NEUROSUR PS, V75, P1575, DOI 10.1136/jnnp.2003.029132; ANNEGERS JF, 1995, EPILEPSIA, V36, P327, DOI 10.1111/j.1528-1157.1995.tb01005.x; Annegers JF, 1999, EPILEPSIA, V40, P502, DOI 10.1111/j.1528-1157.1999.tb00748.x; Banerjee P. N., 2008, EPILEPSY COMPREHENSI, P45; Barrett Camilla, 2003, Epilepsy Research, V52, P147, DOI 10.1016/S0920-1211(02)00237-1; Ben-Menachem E, 2007, EPILEPSIA, V48, P42, DOI 10.1111/j.1528-1167.2007.01402.x; Berg AT, 2008, EPILEPSIA, V49, P13, DOI 10.1111/j.1528-1167.2008.01444.x; BERG AT, 1994, NEUROLOGY, V44, P601, DOI 10.1212/WNL.44.4.601; Betts T, 2003, SEIZURE-EUR J EPILEP, V12, P323, DOI 10.1016/S1059-1311(03)00065-7; Beydoun A, 1997, EPILEPSIA, V38, pS21, DOI 10.1111/j.1528-1157.1997.tb05201.x; Bialer M, 2007, EPILEPSIA, V48, P1825, DOI 10.1111/j.1528-1167.2007.01272.x; BILO L, 1988, EPILEPSIA, V29, P612, DOI 10.1111/j.1528-1157.1988.tb03770.x; Biton V, 2006, NEUROLOGIST, V12, P163, DOI 10.1097/01.nrl.0000202599.21758.9a; Bronen RA, 1996, RADIOLOGY, V201, P97, DOI 10.1148/radiology.201.1.8816528; Christensen J, 2007, LANCET NEUROL, V6, P693, DOI 10.1016/S1474-4422(07)70175-8; Chung WH, 2004, NATURE, V428, P486, DOI 10.1038/428486a; Cloyd J, 2006, EPILEPSY RES, V68, pS39, DOI 10.1016/j.eplepsyres.2005.07.016; Drezner MK, 2004, EPILEPSY BEHAV, V5, pS41, DOI 10.1016/j.yebeh.2003.11.028; Duncan S, 2007, CURR OPIN NEUROL, V20, P175, DOI 10.1097/WCO.0b013e32805866fb; *EP FDN, MOOD DIS EP NEUR DIS; *EP FDN, DRIV INF STAT; FISCH B, 2003, CURRENT PRACTICE CLI, P262; Food and Drug Administration, INF HEALTHC PROF SUI; French JA, 2004, NEUROLOGY, V62, P1252, DOI 10.1212/01.WNL.0000123693.82339.FC; GIDAL B, 1994, NEUROLOGY, V44, P1418, DOI 10.1212/WNL.44.8.1418; GILLIAM F, 2006, DEPRESSION BRAIN DYS, P173; Gilliam FG, 2006, LANCET NEUROL, V5, P399, DOI 10.1016/S1474-4422(06)70415-X; Glauser T, 2006, EPILEPSIA, V47, P1094, DOI 10.1111/j.1528-1167.2006.00585.x; Harden CL, 2007, NEUROLOGY, V69, P1772, DOI 10.1212/01.wnl.0000285083.25882.0e; Harden Cynthia L, 2005, Epilepsy Curr, V5, P142, DOI 10.1111/j.1535-7511.2005.00039.x; HAUSER WA, 1991, EPILEPSIA, V32, P429, DOI 10.1111/j.1528-1157.1991.tb04675.x; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; HERZBERG L, 1978, LANCET, V1, P1097; Herzog AG, 2005, CURR OPIN NEUROL, V18, P167, DOI 10.1097/01.wco.0000162859.42218.fd; Herzog AG, 2004, ANN NEUROL, V55, P148; Herzog AG, 2003, ANN NEUROL, V54, P625, DOI 10.1002/ana.10732; Herzog AG, 2001, EPILEPSIA, V42, P311, DOI 10.1046/j.1528-1157.2001.33500.x; INDACO A, 1992, EPILEPSY RES, V12, P45, DOI 10.1016/0920-1211(92)90090-G; Isojarvi JIT, 1998, ANN NEUROL, V43, P446, DOI 10.1002/ana.410430406; ISOJARVI JIT, 1993, NEW ENGL J MED, V329, P1383, DOI 10.1056/NEJM199311043291904; Israni RK, 2006, SEMIN DIALYSIS, V19, P408, DOI 10.1111/j.1525-139X.2006.00195.x; Kanner AM, 1999, NEUROLOGY, V53, pS26; Krumholz A, 2007, NEUROLOGY, V69, P1996, DOI 10.1212/01.wnl.0000285084.93652.43; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Marson A, 2005, LANCET, V365, P2007, DOI 10.1016/S0140-6736(05)66694-9; Marson AG, 2007, LANCET, V369, P1016, DOI 10.1016/S0140-6736(07)60461-9; MENDEZ MF, 1986, ARCH NEUROL-CHICAGO, V43, P766, DOI 10.1001/archneur.1986.00520080014012; Mendis G P, 1993, Seizure, V2, P319, DOI 10.1016/S1059-1311(05)80149-9; Nasreddine W, 2008, EPILEPSIA, V49, P438, DOI 10.1111/j.1528-1167.2007.01429.x; Pack AM, 2005, ANN NEUROL, V57, P252, DOI 10.1002/ana.20378; Patsalos PN, 2003, LANCET NEUROL, V2, P473, DOI 10.1016/S1474-4422(03)00483-6; PATSALOS PN, IN PRESS EPILEPSIA; Pennell PB, 2007, EPILEPSY BEHAV, V11, P263, DOI 10.1016/j.yebeh.2007.08.018; Perucca E, 1998, EPILEPSIA, V39, P5, DOI 10.1111/j.1528-1157.1998.tb01268.x; Sheth RD, 2004, NEUROLOGY, V63, pS24, DOI 10.1212/WNL.63.10_suppl_4.S24; Specchio LM, 2004, CNS DRUGS, V18, P201, DOI 10.2165/00023210-200418040-00001; Vinten J, 2005, NEUROLOGY, V64, P949, DOI 10.1212/01.WNL.0000154514.82948.69	57	61	65	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 10	2008	359	2					166	176		10.1056/NEJMcp0801738	http://dx.doi.org/10.1056/NEJMcp0801738			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	323PJ	18614784	Green Published			2022-12-28	WOS:000257459000008
J	Gray, A; Goodacre, S; Newby, DE; Masson, M; Sampson, F; Nicholl, J				Gray, Alasdair; Goodacre, Steve; Newby, David E.; Masson, Moyra; Sampson, Fiona; Nicholl, Jon		3CPO Trialists	Noninvasive ventilation in acute cardiogenic pulmonary edema	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POSITIVE AIRWAY PRESSURE; ACUTE HEART-FAILURE; EMERGENCY-DEPARTMENT PATIENTS; ACUTE RESPIRATORY-FAILURE; MYOCARDIAL-INFARCTION; SUPPORT VENTILATION; RANDOMIZED-TRIAL; OXYGEN-THERAPY; METAANALYSIS; MORTALITY	Background: Noninvasive ventilation (continuous positive airway pressure [CPAP] or noninvasive intermittent positive-pressure ventilation [NIPPV]) appears to be of benefit in the immediate treatment of patients with acute cardiogenic pulmonary edema and may reduce mortality. We conducted a study to determine whether noninvasive ventilation reduces mortality and whether there are important differences in outcome associated with the method of treatment (CPAP or NIPPV). Methods: In a multicenter, open, prospective, randomized, controlled trial, patients were assigned to standard oxygen therapy, CPAP (5 to 15 cm of water), or NIPPV (inspiratory pressure, 8 to 20 cm of water; expiratory pressure, 4 to 10 cm of water). The primary end point for the comparison between noninvasive ventilation and standard oxygen therapy was death within 7 days after the initiation of treatment, and the primary end point for the comparison between NIPPV and CPAP was death or intubation within 7 days. Results: A total of 1069 patients (mean [+/-SD] age, 77.7+/-9.7 years; female sex, 56.9%) were assigned to standard oxygen therapy (367 patients), CPAP (346 patients), or NIPPV (356 patients). There was no significant difference in 7-day mortality between patients receiving standard oxygen therapy (9.8%) and those undergoing noninvasive ventilation (9.5%, P=0.87). There was no significant difference in the combined end point of death or intubation within 7 days between the two groups of patients undergoing noninvasive ventilation (11.7% for CPAP and 11.1% for NIPPV, P=0.81). As compared with standard oxygen therapy, noninvasive ventilation was associated with greater mean improvements at 1 hour after the beginning of treatment in patient-reported dyspnea (treatment difference, 0.7 on a visual-analogue scale ranging from 1 to 10; 95% confidence interval [CI], 0.2 to 1.3; P=0.008), heart rate (treatment difference, 4 beats per minute; 95% CI, 1 to 6; P=0.004), acidosis (treatment difference, pH 0.03; 95% CI, 0.02 to 0.04; P<0.001), and hypercapnia (treatment difference, 0.7 kPa [5.2 mm Hg]; 95% CI, 0.4 to 0.9; P<0.001). There were no treatment-related adverse events. Conclusions: In patients with acute cardiogenic pulmonary edema, noninvasive ventilation induces a more rapid improvement in respiratory distress and metabolic disturbance than does standard oxygen therapy but has no effect on short-term mortality. (Current Controlled Trials number, ISRCTN07448447.).	[Gray, Alasdair; Masson, Moyra] Royal Infirm Edinburgh NHS Trust, Dept Emergency Med, Edinburgh EH16 4SA, Midlothian, Scotland; [Goodacre, Steve; Sampson, Fiona; Nicholl, Jon] Univ Sheffield, Sheffield, S Yorkshire, England; [Newby, David E.] Univ Edinburgh, Edinburgh, Midlothian, Scotland	Royal Infirmary of Edinburgh; University of Edinburgh; University of Sheffield; University of Edinburgh	Gray, A (corresponding author), Royal Infirm Edinburgh NHS Trust, Dept Emergency Med, Little France, Edinburgh EH16 4SA, Midlothian, Scotland.	alasdair.gray@luht.scot.nhs.uk	Newby, David Ernest/AAB-1364-2019; Coats, Timothy/AAW-1254-2021	Coats, Timothy/0000-0003-2736-2784; Goodacre, Steve/0000-0003-0803-8444; Sampson, Fiona/0000-0003-2321-0302; Walter, Darren/0000-0002-0819-3287				Adams KF, 2005, AM HEART J, V149, P209, DOI 10.1016/j.ahj.2004.08.005; Agarwal R, 2005, POSTGRAD MED J, V81, P637, DOI 10.1136/pgmj.2004.031229; American Heart Association, 2005, HEART DIS STROKE STA; BARATZ DM, 1992, CHEST, V102, P1397, DOI 10.1378/chest.102.5.1397; Baudouin S, 2002, THORAX, V57, P192; Bellone A, 2004, CRIT CARE MED, V32, P1860, DOI 10.1097/01.CCM.0000139694.47326.B6; BERSTEN AD, 1991, NEW ENGL J MED, V325, P1825, DOI 10.1056/NEJM199112263252601; Chadda K, 2002, CRIT CARE MED, V30, P2457, DOI 10.1097/00003246-200211000-00009; Collins SP, 2006, ANN EMERG MED, V48, P260, DOI 10.1016/j.annemergmed.2006.01.038; Crane SD, 2004, EMERG MED J, V21, P155, DOI 10.1136/emj.2003.005413; Felker GM, 2003, AM HEART J, V145, pS18, DOI 10.1067/mhj.2003.150; Flather MD, 1997, CONTROL CLIN TRIALS, V18, P568, DOI 10.1016/S0197-2456(97)00024-X; Gheorghiade M, 2006, JAMA-J AM MED ASSOC, V296, P2217, DOI 10.1001/jama.296.18.2217; Girou E, 2003, JAMA-J AM MED ASSOC, V290, P2985, DOI 10.1001/jama.290.22.2985; Karras DJ, 2000, ACAD EMERG MED, V7, P327, DOI 10.1111/j.1553-2712.2000.tb02231.x; KATZ JA, 1985, ANESTHESIOLOGY, V63, P598, DOI 10.1097/00000542-198512000-00008; Kelly CA, 2002, EUR HEART J, V23, P1379, DOI 10.1053/euhj.2001.3156; L'Her E, 2004, INTENS CARE MED, V30, P882, DOI 10.1007/s00134-004-2183-y; LeLorier J, 1997, NEW ENGL J MED, V337, P536, DOI 10.1056/NEJM199708213370806; Lenique F, 1997, AM J RESP CRIT CARE, V155, P500, DOI 10.1164/ajrccm.155.2.9032185; Masip J, 2005, JAMA-J AM MED ASSOC, V294, P3124, DOI 10.1001/jama.294.24.3124; Masip J, 2000, LANCET, V356, P2126, DOI 10.1016/S0140-6736(00)03492-9; Mehta S, 1997, CRIT CARE MED, V25, P620, DOI 10.1097/00003246-199704000-00011; NAUGHTON MT, 1995, CIRCULATION, V91, P1725, DOI 10.1161/01.CIR.91.6.1725; Nava S, 2003, AM J RESP CRIT CARE, V168, P1432, DOI 10.1164/rccm.200211-1270OC; Nieminen MS, 2006, EUR HEART J, V27, P2725, DOI 10.1093/eurheartj/ehl193; Peter JV, 2006, LANCET, V367, P1155, DOI 10.1016/S0140-6736(06)68506-1; STEVENSON R, 1993, BMJ-BRIT MED J, V307, P349, DOI 10.1136/bmj.307.6900.349; STEVENSON R, 1993, BRIT MED J, V307, P909; Tavazzi L, 2006, EUR HEART J, V27, P1207, DOI 10.1093/eurheartj/ehi845; Thygesen K, 2007, EUR HEART J, V28, P2525	31	388	424	3	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 10	2008	359	2					142	151		10.1056/NEJMoa0707992	http://dx.doi.org/10.1056/NEJMoa0707992			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	323PJ	18614781				2022-12-28	WOS:000257459000005
J	Kjelstrup, KB; Solstad, T; Brun, VH; Hafting, T; Leutgeb, S; Witter, MP; Moser, EI; Moser, MB				Kjelstrup, Kirsten Brun; Solstad, Trygve; Brun, Vegard Heimly; Hafting, Torkel; Leutgeb, Stefan; Witter, Menno P.; Moser, Edvard I.; Moser, May-Britt			Finite scale of spatial representation in the hippocampus	SCIENCE			English	Article							PARAHIPPOCAMPAL REGION; VENTRAL HIPPOCAMPUS; ENTORHINAL CORTEX; FUNCTIONAL NEUROANATOMY; ENSEMBLE CODE; ORGANIZATION; RAT; DYNAMICS; MEMORY; MAP	To determine how spatial scale is represented in the pyramidal cell population of the hippocampus, we recorded neural activity at multiple longitudinal levels of this brain area while rats ran back and forth on an 18- meter- long linear track. CA3 cells had well- defined place fields at all levels. The scale of representation increased almost linearly from <1 meter at the dorsal pole to similar to 10 meters at the ventral pole. The results suggest that the place- cell map includes the entire hippocampus and that environments are represented in the hippocampus at a topographically graded but finite continuum of scales.	[Kjelstrup, Kirsten Brun; Solstad, Trygve; Brun, Vegard Heimly; Hafting, Torkel; Leutgeb, Stefan; Witter, Menno P.; Moser, Edvard I.; Moser, May-Britt] Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, N-7489 Trondheim, Norway; [Kjelstrup, Kirsten Brun; Solstad, Trygve; Brun, Vegard Heimly; Hafting, Torkel; Leutgeb, Stefan; Witter, Menno P.; Moser, Edvard I.; Moser, May-Britt] Norwegian Univ Sci & Technol, Ctr Biol Memory, N-7489 Trondheim, Norway; [Witter, Menno P.] Vrije Univ Amsterdam Med Ctr, Dept Anat & Neurosci, Neurosci Res Inst, NL-1007 MB Amsterdam, Netherlands	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Moser, EI (corresponding author), Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, N-7489 Trondheim, Norway.	edvard.moser@ntnu.no	Brun, Vegard Heimly/ADZ-5405-2022	Brun, Vegard Heimly/0000-0002-4136-3073; Hafting, Torkel/0000-0002-0928-3487				AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; ANDERSEN P, 1971, EXP BRAIN RES, V13, P222; Bannerman DM, 2002, BEHAV NEUROSCI, V116, P884, DOI 10.1037//0735-7044.116.5.884; Dolorfo CL, 1998, J COMP NEUROL, V398, P49, DOI 10.1002/(SICI)1096-9861(19980817)398:1<49::AID-CNE4>3.0.CO;2-9; Flanagan JG, 2006, CURR OPIN NEUROBIOL, V16, P59, DOI 10.1016/j.conb.2006.01.010; Furtak SC, 2007, HIPPOCAMPUS, V17, P709, DOI 10.1002/hipo.20314; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Gothard KM, 1996, J NEUROSCI, V16, P8027; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Jackson W.B., 1982, P1077; JUNG MW, 1994, J NEUROSCI, V14, P7347; Kerr KM, 2007, HIPPOCAMPUS, V17, P697, DOI 10.1002/hipo.20315; Kjelstrup KG, 2002, P NATL ACAD SCI USA, V99, P10825, DOI 10.1073/pnas.152112399; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Maurer AP, 2006, HIPPOCAMPUS, V16, P785, DOI 10.1002/hipo.20202; Maurer AP, 2005, HIPPOCAMPUS, V15, P841, DOI 10.1002/hipo.20114; McLaughlin T, 2005, ANNU REV NEUROSCI, V28, P327, DOI 10.1146/annurev.neuro.28.061604.135714; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; MOSER E, 1993, J NEUROSCI, V13, P3916; MOSER EI, IN PRESS ANN REV NEU, V31; Moser MB, 1998, HIPPOCAMPUS, V8, P608, DOI 10.1002/(SICI)1098-1063(1998)8:6<608::AID-HIPO3>3.0.CO;2-7; Moser MB, 1998, J NEUROSCI, V18, P7535; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Petrovich GD, 2001, BRAIN RES REV, V38, P247, DOI 10.1016/S0165-0173(01)00080-7; Pikkarainen M, 1999, J COMP NEUROL, V403, P229; POUCET B, 1994, NEUROREPORT, V5, P2045, DOI 10.1097/00001756-199410270-00014; SOLSTAD T, 2007, SOC NEUR ABSTR, V33; Steffenach HA, 2002, P NATL ACAD SCI USA, V99, P3194, DOI 10.1073/pnas.042700999; STROUD DC, 1982, J MAMMAL, V63, P151, DOI 10.2307/1380682; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; WITTER MP, 1989, PROG NEUROBIOL, V33, P161, DOI 10.1016/0301-0082(89)90009-9	33	414	419	0	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 4	2008	321	5885					140	143		10.1126/science.1157086	http://dx.doi.org/10.1126/science.1157086			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QE	18599792				2022-12-28	WOS:000257320800057
J	Hackbarth, G; Reischauer, R; Mutti, A				Hackbarth, Glenn; Reischauer, Robert; Mutti, Anne			Collective accountability for medical care - Toward bundled medicare payments	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hackbarth, Glenn; Reischauer, Robert; Mutti, Anne] Med PAC, Washington, DC USA; [Reischauer, Robert] Urban Inst, Washington, DC 20037 USA	Urban Institute	Hackbarth, G (corresponding author), Med PAC, Washington, DC USA.							Coleman EA, 2005, ARCH INTERN MED, V165, P1842, DOI 10.1001/archinte.165.16.1842; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Naylor MD, 1999, JAMA-J AM MED ASSOC, V281, P613, DOI 10.1001/jama.281.7.613; *PENNS HLTH CAR CO, 2006, PENNS GUID COR ART B; Stason W., 1998, MED PARTICIPATING HE	5	126	126	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 3	2008	359	1					3	5		10.1056/NEJMp0803749	http://dx.doi.org/10.1056/NEJMp0803749			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	320PB	18596270				2022-12-28	WOS:000257246000002
J	Stone, EC; Cummings, AC; McDonald, FB; Heikkila, BC; Lal, N; Webber, WR				Stone, Edward C.; Cummings, Alan C.; McDonald, Frank B.; Heikkila, Bryant C.; Lal, Nand; Webber, William R.			An asymmetric solar wind termination shock	NATURE			English	Article							INTERSTELLAR MAGNETIC-FIELD; ENERGETIC PARTICLES; VOYAGER-1; ACCELERATION; HELIOSHEATH; HELIOSPHERE; ANISOTROPIES; INTENSITIES; SPACECRAFT; UPSTREAM	Voyager 2 crossed the solar wind termination shock at 83.7 AU in the southern hemisphere, 10 AU closer to the Sun than found by Voyager 1 in the north(1-4). This asymmetry could indicate an asymmetric pressure from an interstellar magnetic field(5,6), from transient-induced shock motion(7), or from the solar wind dynamic pressure. Here we report that the intensity of 4 - 5 MeV protons accelerated by the shock near Voyager 2 was three times that observed concurrently by Voyager 1, indicating differences in the shock at the two locations. ( Companion papers report on the plasma(8), magnetic field(9), plasma- wave(10) and lower energy particle(11) observations at the shock.) Voyager 2 did not find the source of anomalous cosmic rays at the shock, suggesting that the source is elsewhere on the shock(12-14) or in the heliosheath(15-19). The small intensity gradient of Galactic cosmic ray helium indicates that either the gradient is further out in the heliosheath(20) or the local interstellar Galactic cosmic ray intensity is lower than expected(21).	[Stone, Edward C.; Cummings, Alan C.] CALTECH, Pasadena, CA 91125 USA; [McDonald, Frank B.] Univ Maryland, Inst Phys Sci & Technol, College Pk, MD 20742 USA; [Heikkila, Bryant C.; Lal, Nand] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Webber, William R.] New Mexico State Univ, Dept Phys & Astron, Las Cruces, NM 88003 USA	California Institute of Technology; University System of Maryland; University of Maryland College Park; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; New Mexico State University	Stone, EC (corresponding author), CALTECH, Pasadena, CA 91125 USA.	ecs@srl.caltech.edu						Burlaga LF, 2005, SCIENCE, V309, P2027, DOI 10.1126/science.1117542; CUMMINGS AC, IN PRESS P 30 INT CO; Decker RB, 2005, SCIENCE, V309, P2020, DOI 10.1126/science.1117569; Ferreira SES, 2007, J GEOPHYS RES-SPACE, V112, DOI 10.1029/2007JA012477; Ferreira SES, 2002, J GEOPHYS RES-SPACE, V107, DOI 10.1029/2001JA000226; Fisk LA, 2006, ASTROPHYS J, V644, P631, DOI 10.1086/503535; Florinski V, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026371; Florinski V, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2002JA009695; Giacalone J, 2006, ASTROPHYS J, V649, pL137, DOI 10.1086/508463; Gloeckler G, 2006, ASTROPHYS J, V648, pL63, DOI 10.1086/507841; Gurnett DA, 2005, SCIENCE, V309, P2025, DOI 10.1126/science.1117425; Jokipii JR, 2006, AIP CONF PROC, V858, P143; Jokipii JR, 2004, ASTROPHYS J, V611, pL141, DOI 10.1086/423993; Kota J, 2006, AIP CONF PROC, V858, P171; KOTA J, IN PRESS P 30 INT CO; Langner UW, 2006, AIP CONF PROC, V858, P233; McComas DJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025437; McDonald FB, 2005, AIP CONF PROC, V781, P261, DOI 10.1063/1.2032706; Moraal H, 2006, AIP CONF PROC, V858, P219; Opher M, 2006, ASTROPHYS J, V640, pL71, DOI 10.1086/503251; Pogorelov NV, 2007, ASTROPHYS J, V668, P611, DOI 10.1086/520952; Schwadron NA, 2008, ASTROPHYS J, V675, P1584, DOI 10.1086/527026; Stone EC, 2005, SCIENCE, V309, P2017, DOI 10.1126/science.1117684; Washimi H, 2007, ASTROPHYS J, V670, pL139, DOI 10.1086/524358; Webber WR, 2001, J GEOPHYS RES-SPACE, V106, P29323, DOI 10.1029/2001JA000118; Zhang M, 2006, AIP CONF PROC, V858, P226	26	309	309	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2008	454	7200					71	74		10.1038/nature07022	http://dx.doi.org/10.1038/nature07022			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321MC	18596802				2022-12-28	WOS:000257308300037
J	Marrazzo, JM; Thomas, KK; Fiedler, TL; Ringwood, K; Fredricks, DN				Marrazzo, Jeanne M.; Thomas, Katherine K.; Fiedler, Tina L.; Ringwood, Kathleen; Fredricks, David N.			Relationship of specific vaginal bacteria and bacterial vaginosis treatment failure in women who have sex with women	ANNALS OF INTERNAL MEDICINE			English	Article							0.75-PERCENT METRONIDAZOLE GEL; INTRAVAGINAL METRONIDAZOLE; THERAPY; PCR; SUSCEPTIBILITY; IDENTIFICATION; CLINDAMYCIN; RECURRENCE; VAGINITIS; EFFICACY	Background: Bacterial vaginosis frequently persists after treatment. The role of newly defined bacterial vaginosis-associated bacteria (BVAB), which have a specificity for this condition of 97% or greater, has not been assessed. Objective: To define risks for bacterial vaginosis persistence, including pretreatment detection of specific vaginal bacteria, among women reporting sex with women. Design: Observational cohort study. Setting: University-based research clinic. Patients: 335 women age 16 to 29 years reporting sex with at least 1 woman in the past year. Participants were recruited through advertisements and provider referral. Intervention: Bacterial vaginosis was treated with intravaginal metronidazole gel (0.75%), 37.5 mg nightly for 5 nights. Measurements: Species-specific 16S recombinant DNA polymerase chain reaction assays targeting 17 bacterial species were applied to vaginal fluid obtained at baseline. Test of cure by clinical criteria and Gram stain analysis and repeated polymerase chain reaction assays of vaginal fluid were performed 1 month after treatment, and interim behaviors were assessed by using computer-assisted self-interview. Results: Of 335 women, 24% of whom also reported sex with men within 3 months before enrollment, 131 (39%) had bacterial vaginosis. In the 120 (92%) women who returned for follow- up, the incidence of persistent bacterial vaginosis was 26% and was statistically significantly higher in women with baseline detection of 3 Clostridiales bacteria, designated as BVAB1 (risk ratio, 2.0 [95% CI, 1.1 to 4.0]), BVAB2 (risk ratio, 8.7 [CI, 2.5 to infinity]), or BVAB3 (risk ratio, 3.1 [CI, 1.7 to 5.8]); Peptoniphilus lacrimalis (risk ratio, 3.5 [CI, 1.6 to 15.5]); and Megasphaera phylotype 2 (risk ratio, 3.4 [CI, 1.4 to 5.5]). Persistence was lower with treatment adherence ( risk ratio, 0.4 [0.2 to 0.9]). Detection of these bacteria at the test- of- cure visit was associated with persistence, whereas posttreatment sexual activity was not. Limitations: Findings may not be generalizable to women who have sex only with men, or to women whose bacterial vaginosis is treated with oral antibiotics. The study may be too small and may involve a population that is too highly selected to draw definitive conclusions about associations of persistent infection with posttreatment sexual behaviors. Conclusion: Persistent bacterial vaginosis is associated with several bacteria in the Clostridiales order, Megasphaera phylotype 2, and P. lacrimalis, suggesting that vaginal microbiology at diagnosis may determine risk for antibiotic failure.	[Marrazzo, Jeanne M.] Univ Washington, Harborview Med Ctr, Seattle, WA 98104 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA	Harborview Medical Center; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Marrazzo, JM (corresponding author), Univ Washington, Harborview Med Ctr, Mailbox 359931,325 9th Ave, Seattle, WA 98104 USA.	jmm2@u.washington.edu		Marrazzo, Jeanne/0000-0002-9277-7364; Thomas, Katherine K/0000-0002-7024-468X; Fredricks, David/0000-0003-2735-6800	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052228, R03AI053250, R01AI061628] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI052228-05, R01 AI052228, R03 AI053250-02, R01 AI061628, R01 AI061628-03] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AGNEW KJ, 1995, SEX TRANSM DIS, V22, P269, DOI 10.1097/00007435-199509000-00001; AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Beigi RH, 2004, AM J OBSTET GYNECOL, V191, P1124, DOI 10.1016/j.ajog.2004.05.033; Bradshaw CS, 2006, J INFECT DIS, V194, P828, DOI 10.1086/506621; Bradshaw CS, 2006, J INFECT DIS, V193, P1478, DOI 10.1086/503780; De Backer E, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-51; EFRON B, 1986, INTRO BOOSTRAP; Ezaki T, 2001, INT J SYST EVOL MICR, V51, P1521, DOI 10.1099/00207713-51-4-1521; Ferris MJ, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-5; Fredricks DN, 2007, J CLIN MICROBIOL, V45, P3270, DOI 10.1128/JCM.01272-07; Fredricks David N, 2005, Curr Infect Dis Rep, V7, P463, DOI 10.1007/s11908-005-0049-2; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Fredricks DN, 1999, BIOTECHNIQUES, V26, P198, DOI 10.2144/99262bm04; Freeman CD, 1997, DRUGS, V54, P679, DOI 10.2165/00003495-199754050-00003; Hanson JM, 2000, J REPROD MED, V45, P889; HILLER SL, 2008, SEXUALLY TE IN PRESS; HILLIER SL, 1993, OBSTET GYNECOL, V81, P963; Koumans EH, 2007, SEX TRANSM DIS, V34, P864, DOI 10.1097/OLQ.0b013e318074e565; Leitich H, 2003, AM J OBSTET GYNECOL, V189, P139, DOI 10.1067/mob.2003.339; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Limaye AP, 2001, J INFECT DIS, V183, P1669, DOI 10.1086/320711; Livengood CH, 1999, SEX TRANSM DIS, V26, P137, DOI 10.1097/00007435-199903000-00003; LIVENGOOD CH, 1994, AM J OBSTET GYNECOL, V170, P759, DOI 10.1016/S0002-9378(94)70278-0; Marrazzo JM, 2002, J INFECT DIS, V185, P1307, DOI 10.1086/339884; MELTZER MC, 2008, SEX TRANSM DIS; Myer L, 2005, J INFECT DIS, V192, P1372, DOI 10.1086/462427; NG LK, 1989, FEMS MICROBIOL LETT, V61, P47, DOI 10.1111/j.1574-6968.1989.tb03550.x; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Nyirjesy P, 2006, AM J OBSTET GYNECOL, V194, P1277, DOI 10.1016/j.ajog.2005.11.006; Nyirjesy P, 2007, SEX TRANSM DIS, V34, P197, DOI 10.1097/01.olq.0000235152.98601.d7; Sanchez S, 2004, AM J OBSTET GYNECOL, V191, P1898, DOI 10.1016/j.ajog.2004.06.089; Schwebke JR, 2005, SEX TRANSM DIS, V32, P654, DOI 10.1097/01.olq.0000175396.10304.62; SKARIN A, 1983, SCAND J INFECT DIS, P81; Sobel JD, 2006, AM J OBSTET GYNECOL, V194, P1283, DOI 10.1016/j.ajog.2005.11.041; Sobel JD, 1997, NEW ENGL J MED, V337, P1896, DOI 10.1056/NEJM199712253372607; Song YL, 2003, MICROBIOL-SGM, V149, P1719, DOI 10.1099/mic.0.26227-0; SPIEGEL CA, 1983, J INFECT DIS, V148, P817, DOI 10.1093/infdis/148.5.817; Sweet R L, 2000, Infect Dis Obstet Gynecol, V8, P184, DOI 10.1155/S1064744900000260; Swidsinski A, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.06.039; THOMAS KK, 2007, 17 M INT SOC SEX TRA; Tohill Beth C, 2004, Infect Dis Obstet Gynecol, V12, P121, DOI 10.1080/10647440400020711	42	92	103	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 1	2008	149	1					20	+		10.7326/0003-4819-149-1-200807010-00006	http://dx.doi.org/10.7326/0003-4819-149-1-200807010-00006			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	323EZ	18591634	Green Accepted			2022-12-28	WOS:000257428200003
J	Brooke, BS; Habashi, JP; Judge, DP; Patel, N; Loeys, B; Dietz, HC				Brooke, Benjamin S.; Habashi, Jennifer P.; Judge, Daniel P.; Patel, Nishant; Loeys, Bart; Dietz, Harry C., III			Angiotensin II blockade and aortic-root dilation in Marfan's syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TGF-BETA ACTIVATION; MOUSE MODEL; PATHOGENESIS; PROGRESSION; ANTAGONIST; DISORDERS; ANEURYSMS; LOSARTAN; ATENOLOL; THERAPY	Background: Progressive enlargement of the aortic root, leading to dissection, is the main cause of premature death in patients with Marfan's syndrome. Recent data from mouse models of Marfan's syndrome suggest that aortic-root enlargement is caused by excessive signaling by transforming growth factor (beta) (TGF-(beta)) that can be mitigated by treatment with TGF-(beta) antagonists, including angiotensin II-receptor blockers (ARBs). We evaluated the clinical response to ARBs in pediatric patients with Marfan's syndrome who had severe aortic-root enlargement. Methods: We identified 18 pediatric patients with Marfan's syndrome who had been followed during 12 to 47 months of therapy with ARBs after other medical therapy had failed to prevent progressive aortic-root enlargement. The ARB was losartan in 17 patients and irbesartan in 1 patient. We evaluated the efficacy of ARB therapy by comparing the rates of change in aortic-root diameter before and after the initiation of treatment with ARBs. Results: The mean (+/-SD) rate of change in aortic-root diameter decreased significantly from 3.54+/-2.87 mm per year during previous medical therapy to 0.46+/-0.62 mm per year during ARB therapy (P<0.001). The deviation of aortic-root enlargement from normal, as expressed by the rate of change in z scores, was reduced by a mean difference of 1.47 z scores per year (95% confidence interval, 0.70 to 2.24; P<0.001) after the initiation of ARB therapy. The sinotubular junction, which is prone to dilation in Marfan's syndrome as well, also showed a reduced rate of change in diameter during ARB therapy (P<0.05), whereas the distal ascending aorta, which does not normally become dilated in Marfan's syndrome, was not affected by ARB therapy. Conclusions: In a small cohort study, the use of ARB therapy in patients with Marfan's syndrome significantly slowed the rate of progressive aortic-root dilation. These findings require confirmation in a randomized trial.	[Brooke, Benjamin S.; Habashi, Jennifer P.; Patel, Nishant; Loeys, Bart; Dietz, Harry C., III] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Brooke, Benjamin S.; Habashi, Jennifer P.; Patel, Nishant; Loeys, Bart; Dietz, Harry C., III] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Brooke, Benjamin S.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Judge, Daniel P.] Johns Hopkins Univ, Sch Med, Dept Med & Cardiol, Baltimore, MD 21205 USA; [Loeys, Bart] Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Ghent University; Ghent University Hospital	Dietz, HC (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, 539 Broadway Res Bldg,733 N Broadway, Baltimore, MD 21205 USA.	hdietz@jhmi.edu	Loeys, Bart/B-3236-2017	Loeys, Bart/0000-0003-3703-9518; Judge, Daniel/0000-0002-3407-0248	Howard Hughes Medical Institute Funding Source: Medline; NIAMS NIH HHS [R01 AR041135, L30 AR054201-01, L30 AR054201, R01 AR041135-14, P01 AR049698-040004, P01 AR049698] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041135, P01AR049698] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Ahimastos AA, 2007, JAMA-J AM MED ASSOC, V298, P1539, DOI 10.1001/jama.298.13.1539; Burnier M, 2001, CIRCULATION, V103, P904, DOI 10.1161/01.CIR.103.6.904; Campistol JM, 2001, NEPHROL DIAL TRANSPL, V16, P114, DOI 10.1093/ndt/16.suppl_1.114; Daugherty A, 2001, BRIT J PHARMACOL, V134, P865, DOI 10.1038/sj.bjp.0704331; Daugherty A, 2006, ANN NY ACAD SCI, V1085, P82, DOI 10.1196/annals.1383.035; DePaepe A, 1996, AM J MED GENET, V62, P417, DOI 10.1002/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.0.CO;2-R; DIETZ HC, 1995, HUM MOL GENET, V4, P1799, DOI 10.1093/hmg/4.suppl_1.1799; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; Gelb BD, 2006, NEW ENGL J MED, V355, P841, DOI 10.1056/NEJMe068122; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Judge DP, 2005, LANCET, V366, P1965, DOI 10.1016/S0140-6736(05)67789-6; Lacro RV, 2007, AM HEART J, V154, P624, DOI 10.1016/j.ahj.2007.06.024; Lavoie P, 2005, J HYPERTENS, V23, P1895, DOI 10.1097/01.hjh.0000182521.44440.c5; Lim DS, 2001, CIRCULATION, V103, P789, DOI 10.1161/01.CIR.103.6.789; Milewicz DM, 2005, CIRCULATION, V111, pE150, DOI 10.1161/01.CIR.0000155243.70456.F4; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Ng CM, 2004, J CLIN INVEST, V114, P1586, DOI 10.1172/JCI22715; *PED HEART NETW, MARF STUD BAS; Rossi-Foulkes R, 1999, AM J CARDIOL, V83, P1364, DOI 10.1016/S0002-9149(99)00101-0; SHORES J, 1994, NEW ENGL J MED, V330, P1335, DOI 10.1056/NEJM199405123301902; Sluysmans T, 2005, J APPL PHYSIOL, V99, P445, DOI 10.1152/japplphysiol.01144.2004; Wu L, 2001, CIRCULATION, V104, P2716, DOI 10.1161/hc4601.099404; Yetman AT, 2005, AM J CARDIOL, V95, P1125, DOI 10.1016/j.amjcard.2005.01.032; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; Zhou Y, 2006, BIOCHEM BIOPH RES CO, V339, P633, DOI 10.1016/j.bbrc.2005.11.060	25	558	576	0	42	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 26	2008	358	26					2787	2795		10.1056/NEJMoa0706585	http://dx.doi.org/10.1056/NEJMoa0706585			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	317UO	18579813	Green Accepted, Green Published			2022-12-28	WOS:000257045900005
J	Enquist, JA; Stoltz, BM				Enquist, John A., Jr.; Stoltz, Brian M.			The total synthesis of (-)-cyanthiwigin F by means of double catalytic enantioselective alkylation	NATURE			English	Article							SPONGE MYRMEKIODERMA-STYX; QUATERNARY STEREOCENTERS; ORGANIC-SYNTHESIS; ALLYLATION; AC	Double catalytic enantioselective transformations are powerful synthetic methods that can facilitate the construction of stereochemically complex molecules in a single operation(1,2). In addition to generating two or more stereocentres in a single reaction, multiple asymmetric reactions also impart increased enantiomeric excess to the final product in comparison with the analogous single transformation(3-6). Furthermore, multiple asymmetric operations have the potential to independently construct several stereocentres at remote points within the same molecular scaffold, rather than relying on pre- existing chiral centres that are proximal to the reactive site(1). Despite the inherent benefits of multiple catalytic enantioselective reactions, their application to natural product total synthesis remains largely underutilized(2). Here we report the use of a double stereoablative(7) enantioselective alkylation reaction in a concise synthesis of the marine diterpenoid ( -)-cyanthiwigin F ( ref. 8). By employing a technique for independent, selective formation of two stereocentres in a single stereoconvergent operation, we demonstrate that a complicated mixture of racemic and meso diastereomers may be smoothly converted to a synthetically useful intermediate with exceptional enantiomeric excess. The stereochemical information generated by means of this catalytic transformation facilitates the easy and rapid completion of the total synthesis of this marine natural product.	[Enquist, John A., Jr.; Stoltz, Brian M.] CALTECH, Arnold & Mabel Beckman Labs Chem Synth, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology	Stoltz, BM (corresponding author), CALTECH, Arnold & Mabel Beckman Labs Chem Synth, Div Chem & Chem Engn, 1200 E Calif Blvd,MC164-30, Pasadena, CA 91125 USA.	stoltz@caltech.edu			NIGMS NIH HHS [R01 GM080269, R01GM080269-01, R01 GM080269-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080269] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baba S., 1994, B SOC CHIM FR, V131, P525; Baran PS, 2007, NATURE, V446, P404, DOI 10.1038/nature05569; Behenna DC, 2004, J AM CHEM SOC, V126, P15044, DOI 10.1021/ja044812x; Cozzi PG, 2007, EUR J ORG CHEM, V2007, P5969, DOI 10.1002/ejoc.200700318; EBERT H, 1885, LIEBIGS ANN CHEM, V229, P45; Eliel E. L., 1994, STEREOCHEMISTRY ORGA, P965; Greene T.W., 1999, PROTECTIVE GROUPS OR, V3; Helmchen G, 2000, ACCOUNTS CHEM RES, V33, P336, DOI 10.1021/ar9900865; Hoffmann RW, 2006, SYNTHESIS-STUTTGART, P3531, DOI 10.1055/s-2006-950311; Kagan HB, 2001, TETRAHEDRON, V57, P2449, DOI 10.1016/S0040-4020(01)00065-5; Kolodiazhnyi OI, 2003, TETRAHEDRON, V59, P5953, DOI 10.1016/S0040-4020(03)00911-6; Langenbeck W, 1936, Z PHYS CHEM A-CHEM T, V177, P401; MASAMUNE S, 1985, ANGEW CHEM INT EDIT, V24, P1, DOI 10.1002/anie.198500013; McFadden RM, 2006, J AM CHEM SOC, V128, P7738, DOI 10.1021/ja061853f; Mohr JT, 2005, ANGEW CHEM INT EDIT, V44, P6924, DOI 10.1002/anie.200502018; Mohr JT, 2007, ORG BIOMOL CHEM, V5, P3571, DOI 10.1039/b711159m; Peng JN, 2003, ORG LETT, V5, P4575, DOI 10.1021/ol035592f; Peng JN, 2002, TETRAHEDRON, V58, P7809, DOI 10.1016/S0040-4020(02)00937-7; Pfeiffer MWB, 2005, J AM CHEM SOC, V127, P5334, DOI 10.1021/ja0509836; POSS CS, 1994, ACCOUNTS CHEM RES, V27, P9, DOI 10.1021/ar00037a002; RAUTENSTRAUCH V, 1994, B SOC CHIM FR, V131, P515; Reddy TJ, 2006, ORG LETT, V8, P5585, DOI 10.1021/ol062304h; Robinson R, 1917, J CHEM SOC, V111, P762, DOI 10.1039/ct9171100762; Saito T, 1998, J ANTIBIOT, V51, P983, DOI 10.7164/antibiotics.51.983; SENNETT SH, 1992, J NAT PROD, V55, P1421, DOI 10.1021/np50088a006; Stewart IC, 2007, ORG LETT, V9, P1589, DOI 10.1021/ol0705144; Taishi T, 1998, TETRAHEDRON LETT, V39, P4347, DOI 10.1016/S0040-4039(98)00769-2; Trost BM, 2006, SYNTHESIS-STUTTGART, P369, DOI 10.1055/s-2006-926302; VIGNERON JP, 1973, TETRAHEDRON, V29, P1055, DOI 10.1016/0040-4020(73)80060-2; Yoshikai K, 2005, J ORG CHEM, V70, P681, DOI 10.1021/jo048275a	30	204	226	1	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 26	2008	453	7199					1228	1231		10.1038/nature07046	http://dx.doi.org/10.1038/nature07046			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	318FA	18580947	Green Accepted			2022-12-28	WOS:000257075800040
J	Eriksson, BI; Borris, LC; Friedman, RJ; Haas, S; Huisman, MV; Kakkar, AK; Bandel, TJ; Beckmann, H; Muehlhofer, E; Misselwitz, F; Geerts, W				Eriksson, Bengt I.; Borris, Lars C.; Friedman, Richard J.; Haas, Sylvia; Huisman, Menno V.; Kakkar, Ajay K.; Bandel, Tiemo J.; Beckmann, Horst; Muehlhofer, Eva; Misselwitz, Frank; Geerts, William		RECORD1 Study Grp	Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FACTOR-XA INHIBITOR; MOLECULAR-WEIGHT HEPARIN; MAJOR ORTHOPEDIC-SURGERY; DEEP-VENOUS THROMBOSIS; KNEE REPLACEMENT; DOUBLE-BLIND; ORAL XIMELAGATRAN; THROMBOEMBOLISM; PREVENTION; BAY-59-7939	Background: This phase 3 trial compared the efficacy and safety of rivaroxaban, an oral direct inhibitor of factor Xa, with those of enoxaparin for extended thromboprophylaxis in patients undergoing total hip arthroplasty. Methods: In this randomized, double-blind study, we assigned 4541 patients to receive either 10 mg of oral rivaroxaban once daily, beginning after surgery, or 40 mg of enoxaparin subcutaneously once daily, beginning the evening before surgery, plus a placebo tablet or injection. The primary efficacy outcome was the composite of deep-vein thrombosis (either symptomatic or detected by bilateral venography if the patient was asymptomatic), nonfatal pulmonary embolism, or death from any cause at 36 days (range, 30 to 42). The main secondary efficacy outcome was major venous thromboembolism (proximal deep-vein thrombosis, nonfatal pulmonary embolism, or death from venous thromboembolism). The primary safety outcome was major bleeding. Results: A total of 3153 patients were included in the superiority analysis (after 1388 exclusions), and 4433 were included in the safety analysis (after 108 exclusions). The primary efficacy outcome occurred in 18 of 1595 patients (1.1%) in the rivaroxaban group and in 58 of 1558 patients (3.7%) in the enoxaparin group (absolute risk reduction, 2.6%; 95% confidence interval [CI], 1.5 to 3.7; P<0.001). Major venous thromboembolism occurred in 4 of 1686 patients (0.2%) in the rivaroxaban group and in 33 of 1678 patients (2.0%) in the enoxaparin group (absolute risk reduction, 1.7%; 95% CI, 1.0 to 2.5; P<0.001). Major bleeding occurred in 6 of 2209 patients (0.3%) in the rivaroxaban group and in 2 of 2224 patients (0.1%) in the enoxaparin group (P=0.18). Conclusions: A once-daily, 10-mg oral dose of rivaroxaban was significantly more effective for extended thromboprophylaxis than a once-daily, 40-mg subcutaneous dose of enoxaparin in patients undergoing elective total hip arthroplasty. The two drugs had similar safety profiles. (ClinicalTrials.gov number, NCT00329628.).	[Eriksson, Bengt I.] Sahlgrens Univ Hosp, Dept Orthoped, SE-41685 Gothenburg, Sweden; [Borris, Lars C.] Aarhus Univ Hosp, DK-8000 Aarhus, Denmark; [Friedman, Richard J.] Med Univ S Carolina, Charleston, SC 29425 USA; [Haas, Sylvia] Tech Univ Munich, Inst Expt Oncol & Therapy Res, Munich, Germany; [Huisman, Menno V.] Leiden Univ, Med Ctr, Leiden, Netherlands; [Kakkar, Ajay K.] Thrombosis Res Inst, London SW3 6LR, England; [Kakkar, Ajay K.] Barts & London Queen Marys Sch Med & Dent, London, England; [Bandel, Tiemo J.; Beckmann, Horst; Muehlhofer, Eva; Misselwitz, Frank] Bayer HealthCare, Wuppertal, Germany; [Geerts, William] Univ Toronto, Toronto, ON, Canada	Sahlgrenska University Hospital; Aarhus University; Medical University of South Carolina; Technical University of Munich; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Thrombosis Research Institute; University of London; Queen Mary University London; Bayer AG; Bayer Healthcare Pharmaceuticals; University of Toronto	Eriksson, BI (corresponding author), Sahlgrens Univ Hosp, Dept Orthoped, Smorslottsgatan 1, SE-41685 Gothenburg, Sweden.	b.eriksson@orthop.gu.se	Lodigiani, Corrado/AAW-1964-2020; Kaynar, Leylagul/F-6991-2013	Lodigiani, Corrado/0000-0002-9152-9385; Kaynar, Leylagul/0000-0002-2035-9462; Borris, Lars/0000-0002-0527-1518; Gomar-Sancho, Francisco/0000-0001-7672-1291; Windhager, Reinhard/0000-0002-6321-1804				Ansell J, 2004, CHEST, V126, p204S, DOI 10.1378/chest.126.3_suppl.204S; Ansell J, 2005, CHEST, V127, P415; Bergqvist D, 1996, NEW ENGL J MED, V335, P696, DOI 10.1056/NEJM199609053351002; Comp PC, 2001, J BONE JOINT SURG AM, V83A, P336, DOI 10.2106/00004623-200103000-00004; Dahl OE, 2003, J THROMB HAEMOST, V1, P896, DOI 10.1046/j.1538-7836.2003.00236.x; Davies L M, 2000, Value Health, V3, P397, DOI 10.1046/j.1524-4733.2000.36005.x; Eikelboom JW, 2001, LANCET, V358, P9, DOI 10.1016/S0140-6736(00)05249-1; Eriksson BI, 2007, LANCET, V370, P2004; Eriksson BI, 2007, THROMB RES, V120, P685, DOI 10.1016/j.thromres.2006.12.025; Eriksson BI, 2007, LANCET, V370, P949, DOI 10.1016/S0140-6736(07)61445-7; Eriksson BI, 2006, CIRCULATION, V114, P2374, DOI 10.1161/CIRCULATIONAHA.106.642074; Eriksson BI, 2006, J THROMB HAEMOST, V4, P121, DOI 10.1111/j.1538-7836.2005.01657.x; Eriksson BI, 2003, J THROMB HAEMOST, V1, P2490, DOI 10.1111/j.1538-7836.2003.00494.x; Eriksson BI, 2003, THROMB HAEMOSTASIS, V89, P288; Eriksson BI, 2001, NEW ENGL J MED, V345, P1298, DOI 10.1056/NEJMoa011100; Geerts WH, 2004, CHEST, V126, p338S, DOI 10.1378/chest.126.3_suppl.338S; Hull RD, 2001, ANN INTERN MED, V135, P858, DOI 10.7326/0003-4819-135-10-200111200-00006; Kubitza D, 2005, CLIN PHARMACOL THER, V78, P412, DOI 10.1016/j.clpt.2005.06.011; Kubitza D, 2005, EUR J CLIN PHARMACOL, V61, P873, DOI 10.1007/s00228-005-0043-5; Mueck W, 2008, CLIN PHARMACOKINET, V47, P203, DOI 10.2165/00003088-200847030-00006; O'Donnell M, 2003, ARCH INTERN MED, V163, P1362, DOI 10.1001/archinte.163.11.1362; Planes A, 1996, LANCET, V348, P224, DOI 10.1016/S0140-6736(96)01453-5; RABINOV K, 1972, ARCH SURG-CHICAGO, V104, P134; Rosencher N, 2003, TRANSFUSION, V43, P459, DOI 10.1046/j.1537-2995.2003.00348.x; Samama CM, 2002, ARCH INTERN MED, V162, P2191, DOI 10.1001/archinte.162.19.2191; Turpie AGG, 2005, J THROMB HAEMOST, V3, P2479, DOI 10.1111/j.1538-7836.2005.01602.x; Turpie AGG, 2002, ARCH INTERN MED, V162, P1833, DOI 10.1001/archinte.162.16.1833	27	1055	1146	2	90	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 26	2008	358	26					2765	2775		10.1056/NEJMoa0800374	http://dx.doi.org/10.1056/NEJMoa0800374			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	317UO	18579811	Bronze			2022-12-28	WOS:000257045900003
J	Murphy, MT; Flambaum, VV; Muller, S; Henkel, C				Murphy, Michael T.; Flambaum, Victor V.; Muller, Sebastien; Henkel, Christian			Strong limit on a variable proton-to-electron mass ratio from molecules in the distant universe	SCIENCE			English	Article							FINE-STRUCTURE CONSTANT; GRAVITATIONAL LENS B0218+357; EINSTEIN RING B0218+357; ABSORPTION-LINES; FORMALDEHYDE; CONSTRAINTS; REDSHIFT; Z=0.685; SPECTRA	The Standard Model of particle physics assumes that the so- called fundamental constants are universal and unchanging. Absorption lines arising in molecular clouds along quasar sightlines offer a precise test for variations in the proton- to- electron mass ratio, m, over cosmological time and distance scales. The inversion transitions of ammonia are particularly sensitive to m as compared to molecular rotational transitions. Comparing the available ammonia spectra observed toward the quasar B0218+357 with new, high- quality rotational spectra, we present the first detailed measurement of m with this technique, limiting relative deviations from the laboratory value to \Delta mu/mu\ < 1.8 x 10(-6) ( 95% confidence level) at approximately half the universe's current age- the strongest astrophysical constraint to date. Higher- quality ammonia observations will reduce both the statistical and systematic uncertainties in these observations.	[Murphy, Michael T.] Swinburne Univ Technol, Ctr Astrophys & Supercomp, Hawthorn, Vic 3122, Australia; [Flambaum, Victor V.] Univ New S Wales, Sch Phys, Sydney, NSW 2052, Australia; [Muller, Sebastien] Acad Sinica, Inst Astron & Astrophys, Taipei 106, Taiwan; [Henkel, Christian] Max Planck Inst Radioastron, D-53121 Bonn, Germany	Swinburne University of Technology; University of New South Wales Sydney; Academia Sinica - Taiwan; Max Planck Society	Murphy, MT (corresponding author), Swinburne Univ Technol, Ctr Astrophys & Supercomp, Mail H39,POB 218, Hawthorn, Vic 3122, Australia.	mmurphy@swin.edu.au	Murphy, Michael/B-8832-2008	Murphy, Michael/0000-0002-7040-5498; /0000-0002-9931-1313				Biggs AD, 2003, MON NOT R ASTRON SOC, V338, P599, DOI 10.1046/j.1365-8711.2003.06050.x; Carilli CL, 2000, PHYS REV LETT, V85, P5511, DOI 10.1103/PhysRevLett.85.5511; CARILLI CL, 1993, ASTROPHYS J, V412, pL59, DOI 10.1086/186940; Chand H, 2004, ASTRON ASTROPHYS, V417, P853, DOI 10.1051/0004-6361:20035701; Cohen JG, 2003, ASTROPHYS J, V583, P67, DOI 10.1086/344837; Combes F, 1997, ASTROPHYS J, V486, pL79, DOI 10.1086/310849; Flambaum VV, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.240801; Ivanchik A, 2005, ASTRON ASTROPHYS, V440, P45, DOI 10.1051/0004-6361:20052648; Jethava N, 2007, ASTRON ASTROPHYS, V472, P435, DOI 10.1051/0004-6361:20077353; Kanekar N, 2003, MON NOT R ASTRON SOC, V345, pL7, DOI 10.1046/j.1365-8711.2003.07077.x; Menten KM, 1996, ASTROPHYS J, V465, pL99, DOI 10.1086/310147; Muller S, 2007, ASTRON ASTROPHYS, V468, pL53, DOI 10.1051/0004-6361:20077310; Murphy MT, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.239001; Murphy MT, 2008, MON NOT R ASTRON SOC, V384, P1053, DOI 10.1111/j.1365-2966.2007.12695.x; Murphy MT, 2004, LECT NOTES PHYS, V648, P131; Murphy MT, 2003, MON NOT R ASTRON SOC, V345, P609, DOI 10.1046/j.1365-8711.2003.06970.x; Murphy MT, 2001, MON NOT R ASTRON SOC, V327, P1208, DOI 10.1046/j.1365-8711.2001.04840.x; PATNAIK AR, 1993, MON NOT R ASTRON SOC, V261, P435, DOI 10.1093/mnras/261.2.435; Reinhold E, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.151101; Rosenband T, 2008, SCIENCE, V319, P1808, DOI 10.1126/science.1154622; Tzanavaris P, 2007, MON NOT R ASTRON SOC, V374, P634, DOI 10.1111/j.1365-2966.2006.11178.x; van Veldhoven J, 2004, EUR PHYS J D, V31, P337, DOI 10.1140/epjd/e2004-00160-9; Webb JK, 1999, PHYS REV LETT, V82, P884, DOI 10.1103/PhysRevLett.82.884; WIKLIND T, 1995, ASTRON ASTROPHYS, V299, P382; Wiklind T, 1999, ASTR SOC P, V156, P202; York T, 2005, MON NOT R ASTRON SOC, V357, P124, DOI 10.1111/j.1365-2966.2004.08618.x	27	133	134	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 20	2008	320	5883					1611	1613		10.1126/science.1156352	http://dx.doi.org/10.1126/science.1156352			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	315NM	18566280	Green Submitted			2022-12-28	WOS:000256886700040
J	Weyer, S				Weyer, Stefan			Geochemistry - What drives iron isotope fractionation in magma?	SCIENCE			English	Editorial Material							PLANETARY DIFFERENTIATION; BASALT DIFFERENTIATION; OXYGEN FUGACITY; MANTLE; EARTH; WEYER,S.		Univ Frankfurt, Inst Geowissensch, D-60431 Frankfurt, Germany	Goethe University Frankfurt	Weyer, S (corresponding author), Univ Frankfurt, Inst Geowissensch, Altenhofer Allee 1, D-60431 Frankfurt, Germany.	stefan.weyer@em.uni-frankfurt.de	Weyer, Stefan/AAA-8827-2020					Beard BL, 2007, EARTH PLANET SC LETT, V256, P633, DOI 10.1016/j.epsl.2007.01.037; Luck JM, 2003, GEOCHIM COSMOCHIM AC, V67, P143, DOI 10.1016/S0016-7037(02)01038-4; Poitrasson F, 2004, EARTH PLANET SC LETT, V223, P253, DOI 10.1016/j.epsl.2004.04.032; Schoenberg R, 2006, EARTH PLANET SC LETT, V252, P342, DOI 10.1016/j.epsl.2006.09.045; Shahar A, 2008, EARTH PLANET SC LETT, V268, P330, DOI 10.1016/j.epsl.2008.01.026; Teng FZ, 2008, SCIENCE, V320, P1620, DOI 10.1126/science.1157166; Teng FZ, 2007, EARTH PLANET SC LETT, V261, P84, DOI 10.1016/j.epsl.2007.06.004; Tomascak PB, 1999, GEOCHIM COSMOCHIM AC, V63, P907, DOI 10.1016/S0016-7037(98)00318-4; UREY HC, 1947, J CHEM SOC, P562, DOI 10.1039/jr9470000562; Weyer S, 2007, EARTH PLANET SC LETT, V256, P638, DOI 10.1016/j.epsl.2007.01.038; Weyer S, 2005, EARTH PLANET SC LETT, V240, P251, DOI 10.1016/j.epsl.2005.09.023; Weyer S, 2007, EARTH PLANET SC LETT, V259, P119, DOI 10.1016/j.epsl.2007.04.033; Williams HM, 2004, SCIENCE, V304, P1656, DOI 10.1126/science.1095679; Williams HM, 2005, EARTH PLANET SC LETT, V235, P435, DOI 10.1016/j.epsl.2005.04.020; Zhu XK, 2001, NATURE, V412, P311, DOI 10.1038/35085525	15	24	25	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 20	2008	320	5883					1600	1601		10.1126/science.1160204	http://dx.doi.org/10.1126/science.1160204			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	315NM	18566275				2022-12-28	WOS:000256886700035
J	Stumvoll, M; Goldstein, BJ; van Haeften, TW				Stumvoll, Michael; Goldstein, Barry J.; van Haeften, Timon W.			Type 2 diabetes: pathogenesis and treatment	LANCET			English	Editorial Material							GENOME-WIDE ASSOCIATION; BASAL INSULIN; RISK LOCI; FTO GENE; THERAPY; OBESITY; REPLICATION; CHILDHOOD; VARIANTS		[van Haeften, Timon W.] Univ Med Ctr Utrecht, Dept Internal Med, NL-3508 GA Utrecht, Netherlands; [Stumvoll, Michael] Univ Leipzig, Dept Med, Leipzig, Germany; [Goldstein, Barry J.] Thomas Jefferson Univ, Div Endocrinol Diabet & Metabol Dis, Dept Med, Philadelphia, PA 19107 USA	Utrecht University; Utrecht University Medical Center; Leipzig University; Jefferson University	van Haeften, TW (corresponding author), Univ Med Ctr Utrecht, Dept Internal Med, NL-3508 GA Utrecht, Netherlands.	T.W.vanHaeften@umcutrecht.nl	Stumvoll, Michael/ABE-1121-2021	Stumvoll, Michael/0000-0001-6225-8240				Amori RE, 2007, JAMA-J AM MED ASSOC, V298, P194, DOI 10.1001/jama.298.2.194; Bretzel RG, 2008, LANCET, V371, P1073, DOI 10.1016/S0140-6736(08)60485-7; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; *EUR MED AG, EMEA REC NEW WARN CO; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Holman RR, 2007, NEW ENGL J MED, V357, P1716, DOI 10.1056/NEJMoa075392; Nathan DM, 2008, DIABETOLOGIA, V51, P8, DOI 10.1007/s00125-007-0873-z; Sandhu MS, 2007, NAT GENET, V39, P951, DOI 10.1038/ng2067; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Tiffin N, 2006, NUCLEIC ACIDS RES, V34, P3067, DOI 10.1093/nar/gkl381; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	18	83	87	2	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN-JUL	2008	371	9631					2153	2156		10.1016/S0140-6736(08)60932-0	http://dx.doi.org/10.1016/S0140-6736(08)60932-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	326CP	18586159				2022-12-28	WOS:000257635800008
J	Martick, M; Horan, LH; Noller, HF; Scott, WG				Martick, Monika; Horan, Lucas H.; Noller, Harry F.; Scott, William G.			A discontinuous hammerhead ribozyme embedded in a mammalian messenger RNA	NATURE			English	Article							GENE-EXPRESSION; CLEAVAGE; LECTIN; FAMILY; TRANSCRIPTS; ALIGNMENT; SEQUENCE; GENOME; DECAY	Structured RNAs embedded in the untranslated regions (UTRs) of messenger RNAs can regulate gene expression. In bacteria, control of a metabolite gene is mediated by the self-cleaving activity of a ribozyme embedded in its 59 UTR1. This discovery has raised the question of whether gene-regulating ribozymes also exist in eukaryotic mRNAs. Here we show that highly active hammerhead ribozymes(2,3) are present in the 3 ' UTRs of rodent C-type lectin type II (Clec2) genes(4-7). Using a hammerhead RNA motif search with relaxed delimitation of the non-conserved regions, we detected ribozyme sequences in which the invariant regions, in contrast to the previously identified continuous hammerheads(8-10), occur as two fragments separated by hundreds of nucleotides. Notably, a fragment pair can assemble to form an active hammerhead ribozyme structure between the translation termination and the polyadenylation signals within the 3 ' UTR. We demonstrate that this hammerhead structure can self-cleave both in vitro and in vivo, and is able to reduce protein expression in mouse cells. These results indicate that an unrecognized mechanism of post-transcriptional gene regulation involving association of discontinuous ribozyme sequences within an mRNA may be modulating the expression of several CLEC2 proteins that function in bone remodelling and the immune response of several mammals.	[Martick, Monika; Horan, Lucas H.; Noller, Harry F.; Scott, William G.] Univ Calif Santa Cruz, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Martick, M (corresponding author), Univ Calif Santa Cruz, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA.	mmartick@yahoo.com		Horan, Lucas/0000-0002-9143-7667; Scott, William/0000-0002-9273-3564	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087721] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI043393-09, R01 AI043393] Funding Source: Medline; NIGMS NIH HHS [R01 GM087721] Funding Source: Medline; PHS HHS [R01043393] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Canny MD, 2004, J AM CHEM SOC, V126, P10848, DOI 10.1021/ja046848v; Carlyle JR, 2006, J IMMUNOL, V176, P7511, DOI 10.4049/jimmunol.176.12.7511; Carlyle JR, 2004, P NATL ACAD SCI USA, V101, P3527, DOI 10.1073/pnas.0308304101; Eddy S, 2008, RNABOB PROGRAM SEARC; Ferbeyre G, 1998, MOL CELL BIOL, V18, P3880, DOI 10.1128/MCB.18.7.3880; Flores R, 2001, METHOD ENZYMOL, V341, P540, DOI 10.1016/S0076-6879(01)41175-X; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; GAUTHERET D, 1990, COMPUT APPL BIOSCI, V6, P325; Hao L, 2006, P NATL ACAD SCI USA, V103, P3192, DOI 10.1073/pnas.0511280103; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Khvorova A, 2003, NAT STRUCT BIOL, V10, P708, DOI 10.1038/nsb959; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lockyer AE, 2003, PARASITOLOGY, V126, P203, DOI 10.1017/S0031182002002792; MARTICK M, 2007, THESIS U CALIFORNIA; Martick M, 2006, CELL, V126, P309, DOI 10.1016/j.cell.2006.06.036; Meaux S, 2006, RNA, V12, P1323, DOI 10.1261/rna.46306; Osborne EM, 2005, RNA, V11, P187, DOI 10.1261/rna.7950605; Plougastel B, 2001, IMMUNOGENETICS, V53, P209, DOI 10.1007/s002510100319; Przybilski R, 2005, PLANT CELL, V17, P1877, DOI 10.1105/tpc.105.032730; Rojas AA, 2000, NUCLEIC ACIDS RES, V28, P4037, DOI 10.1093/nar/28.20.4037; Salehi-Ashtiani K, 2006, SCIENCE, V313, P1788, DOI 10.1126/science.1129308; Serganov A, 2007, NAT REV GENET, V8, P776, DOI 10.1038/nrg2172; STERN S, 1988, METHOD ENZYMOL, V164, P481; Teixeira A, 2004, NATURE, V432, P526, DOI 10.1038/nature03032; Winkler WC, 2004, NATURE, V428, P281, DOI 10.1038/nature02362; Yen L, 2004, NATURE, V431, P471, DOI 10.1038/nature02844; Zhou H, 2001, J BIOL CHEM, V276, P14916, DOI 10.1074/jbc.M011554200; Zhou H, 2002, J BIOL CHEM, V277, P48808, DOI 10.1074/jbc.M209059200	29	120	124	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2008	454	7206					899	U57		10.1038/nature07117	http://dx.doi.org/10.1038/nature07117			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	336XH	18615019	Green Accepted			2022-12-28	WOS:000258398600039
J	Steffensen, JP; Andersen, KK; Bigler, M; Clausen, HB; Dahl-Jensen, D; Fischer, H; Goto-Azuma, K; Hansson, M; Johnsen, SJ; Jouzel, J; Masson-Delmotte, V; Popp, T; Rasmussen, SO; Rothlisberger, R; Ruth, U; Stauffer, B; Siggaard-Andersen, ML; Sveinbjornsdottir, AE; Svensson, A; White, JWC				Steffensen, Jorgen Peder; Andersen, Katrine K.; Bigler, Matthias; Clausen, Henrik B.; Dahl-Jensen, Dorthe; Fischer, Hubertus; Goto-Azuma, Kumiko; Hansson, Margareta; Johnsen, Sigfus J.; Jouzel, Jean; Masson-Delmotte, Valerie; Popp, Trevor; Rasmussen, Sune O.; Roethlisberger, Regine; Ruth, Urs; Stauffer, Bernhard; Siggaard-Andersen, Marie-Louise; Sveinbjornsdottir, Arny E.; Svensson, Anders; White, James W. C.			High-resolution Greenland Ice Core data show abrupt climate change happens in few years	SCIENCE			English	Article							LAST GLACIAL PERIOD; DEUTERIUM-EXCESS; OXYGEN-ISOTOPE; RECORD; GRIP; PRECIPITATION; SIMULATIONS; TERMINATION; ATLANTIC; ORIGIN	The last two abrupt warmings at the onset of our present warm interglacial period, interrupted by the Younger Dryas cooling event, were investigated at high temporal resolution from the North Greenland Ice Core Project ice core. The deuterium excess, a proxy of Greenland precipitation moisture source, switched mode within 1 to 3 years over these transitions and initiated a more gradual change ( over 50 years) of the Greenland air temperature, as recorded by stable water isotopes. The onsets of both abrupt Greenland warmings were slightly preceded by decreasing Greenland dust deposition, reflecting the wetting of Asian deserts. A northern shift of the Intertropical Convergence Zone could be the trigger of these abrupt shifts of Northern Hemisphere atmospheric circulation, resulting in changes of 2 to 4 kelvin in Greenland moisture source temperature from one year to the next.	[Steffensen, Jorgen Peder; Andersen, Katrine K.; Bigler, Matthias; Clausen, Henrik B.; Dahl-Jensen, Dorthe; Johnsen, Sigfus J.; Rasmussen, Sune O.; Siggaard-Andersen, Marie-Louise; Svensson, Anders] Univ Copenhagen, Niels Bohr Inst, Ctr Ice & Climate, DK-2100 Copenhagen, Denmark; [Bigler, Matthias; Fischer, Hubertus; Roethlisberger, Regine; Stauffer, Bernhard] Univ Bern, Inst Phys, CH-3012 Bern, Switzerland; [Fischer, Hubertus; Ruth, Urs] Alfred Wegener Inst Polar & Marine Res, D-27515 Bremerhaven, Germany; [Goto-Azuma, Kumiko] Natl Inst Polar Res, Itabashi Ku, Tokyo 1738515, Japan; [Hansson, Margareta] Stockholm Univ, Dept Phys Geog & Quarternary Geol, S-10691 Stockholm, Sweden; [Jouzel, Jean; Masson-Delmotte, Valerie] Univ Versailles St Quentin Yvelines, CEA Saclay, Inst Pierre Simon Laplace, Lab Sci Climat & Environm, F-91191 Gif Sur Yvette, France; [Popp, Trevor; White, James W. C.] Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA; [Roethlisberger, Regine] British Antarctic Survey, NERC, Cambridge CB3 0ET, England; [Sveinbjornsdottir, Arny E.] Raunvisindastofnun Haskolans, IS-3 Dunhagi, Iceland	University of Copenhagen; Niels Bohr Institute; University of Bern; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Research Organization of Information & Systems (ROIS); National Institute of Polar Research (NIPR) - Japan; Stockholm University; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); University of Colorado System; University of Colorado Boulder; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Steffensen, JP (corresponding author), Univ Copenhagen, Niels Bohr Inst, Ctr Ice & Climate, Juliane Maries Vej 30, DK-2100 Copenhagen, Denmark.	jps@gfy.ku.dk	Dahl-Jensen, Dorthe/N-4401-2016; Rasmussen, Sune/B-5560-2008; Svensson, Anders/A-2643-2010; Dahl-Jensen, Dorthe/AAO-6951-2020; Andersen, Katrine/B-4082-2016; White, James W.C./A-7845-2009; Rasmussen, Sune Olander/AAA-3190-2021; Fischer, Hubertus/A-1211-2014; Masson-Delmotte, Valerie L/G-1995-2011	Dahl-Jensen, Dorthe/0000-0002-1474-1948; Rasmussen, Sune/0000-0002-4177-3611; Svensson, Anders/0000-0002-4364-6085; Dahl-Jensen, Dorthe/0000-0002-1474-1948; Andersen, Katrine/0000-0003-4178-2195; White, James W.C./0000-0001-6041-4684; Rasmussen, Sune Olander/0000-0002-4177-3611; Fischer, Hubertus/0000-0002-2787-4221; Masson-Delmotte, Valerie L/0000-0001-8296-381X; Steffensen, Jorgen Peder/0000-0002-5516-1093	NERC [bas010016] Funding Source: UKRI; Natural Environment Research Council [bas010016] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Alley RB, 2003, SCIENCE, V299, P2005, DOI 10.1126/science.1081056; Andersen KK, 2004, NATURE, V431, P147, DOI 10.1038/nature02805; Barbante C, 2006, NATURE, V444, P195, DOI 10.1038/nature05301; Bigler M, 2004, THESIS U BERN SWITZE; Chiang JCH, 2005, CLIM DYNAM, V25, P477, DOI 10.1007/s00382-005-0040-5; DANSGAARD W, 1982, SCIENCE, V218, P1273, DOI 10.1126/science.218.4579.1273; DANSGAARD W, 1989, NATURE, V339, P532, DOI 10.1038/339532a0; DANSGAARD W, 1984, M EWING, V5, P288; FISHER DA, 1991, TELLUS B, V43, P401, DOI 10.1034/j.1600-0889.1991.t01-4-00006.x; GROOTES PM, 1993, NATURE, V366, P552, DOI 10.1038/366552a0; Hillaire-Marcel C, 2008, EARTH PLANET SC LETT, V268, P143, DOI 10.1016/j.epsl.2008.01.012; Hutterli MA, 2007, CLIM DYNAM, V28, P635, DOI 10.1007/s00382-006-0211-z; Johnsen SJ, 1989, TELLUS B, V41, P452, DOI 10.1111/j.1600-0889.1989.tb00321.x; Johnsen SJ, 2001, J QUATERNARY SCI, V16, P299, DOI 10.1002/jqs.622; Johnsen SJ, 1997, J GEOPHYS RES-OCEANS, V102, P26397, DOI 10.1029/97JC00167; Jouzel J, 2007, QUATERNARY SCI REV, V26, P1, DOI 10.1016/j.quascirev.2006.07.015; JOUZEL J, 1991, J GEOPHYS RES-ATMOS, V96, P7495, DOI 10.1029/90JD02663; Lambeck K, 2002, NATURE, V419, P199, DOI 10.1038/nature01089; Landais A, 2005, CR GEOSCI, V337, P947, DOI 10.1016/j.crte.2005.04.003; Lea DW, 2003, SCIENCE, V301, P1361, DOI 10.1126/science.1088470; Li C, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023492; Lowe J.J., 2015, RECONSTRUCTING QUATE, V3rd ed.; Masson-Delmotte V, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005575; Masson-Delmotte V, 2005, SCIENCE, V309, P118, DOI 10.1126/science.1108575; Mudelsee M, 2000, COMPUT GEOSCI, V26, P293, DOI 10.1016/S0098-3004(99)00141-7; Partin JW, 2007, NATURE, V449, P452, DOI 10.1038/nature06164; Rasmussen SO, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006079; Rothlisberger R, 2000, ENVIRON SCI TECHNOL, V34, P338, DOI 10.1021/es9907055; Ruth U, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002376; Ruth U, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL027876; Severinghaus JP, 1999, SCIENCE, V286, P930, DOI 10.1126/science.286.5441.930; Stocker TF, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000920; Svensson A, 2000, J GEOPHYS RES-ATMOS, V105, P4637, DOI 10.1029/1999JD901093; Werner M, 2001, TELLUS B, V53, P53, DOI 10.1034/j.1600-0889.2001.01154.x; Winton M, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL028017	35	564	581	3	286	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2008	321	5889					680	684		10.1126/science.1157707	http://dx.doi.org/10.1126/science.1157707			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	332IW	18566247	Green Published			2022-12-28	WOS:000258077700041
J	Kim, JB; Zaehres, H; Wu, GM; Gentile, L; Ko, K; Sebastiano, V; Arauzo-Bravo, MJ; Ruau, D; Han, DW; Zenke, M; Scholer, HR				Kim, Jeong Beom; Zaehres, Holm; Wu, Guangming; Gentile, Luca; Ko, Kinarm; Sebastiano, Vittorio; Arauzo-Bravo, Marcos J.; Ruau, David; Han, Dong Wook; Zenke, Martin; Schoeler, Hans R.			Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors	NATURE			English	Article							FIBROBLASTS; EXPRESSION; MOUSE; GENERATION; GENES; SOX2; P53	Reprogramming of somatic cells is a valuable tool to understand the mechanisms of regaining pluripotency and further opens up the possibility of generating patient- specific pluripotent stem cells. Reprogramming of mouse and human somatic cells into pluripotent stem cells, designated as induced pluripotent stem ( iPS) cells, has been possible with the expression of the transcription factor quartet Oct4 ( also known as Pou5f1), Sox2, c- Myc and Klf4 ( refs 1 - 11). Considering that ectopic expression of c- Myc causes tumorigenicity in offspring(2) and that retroviruses themselves can cause insertional mutagenesis, the generation of iPS cells with a minimal number of factors may hasten the clinical application of this approach. Here we show that adult mouse neural stem cells express higher endogenous levels of Sox2 and c- Myc than embryonic stem cells, and that exogenous Oct4 together with either Klf4 or c- Myc is sufficient to generate iPS cells from neural stem cells. These two- factor iPS cells are similar to embryonic stem cells at the molecular level, contribute to development of the germ line, and form chimaeras. We propose that, in inducing pluripotency, the number of reprogramming factors can be reduced when using somatic cells that endogenously express appropriate levels of complementing factors.	[Kim, Jeong Beom; Zaehres, Holm; Wu, Guangming; Gentile, Luca; Ko, Kinarm; Sebastiano, Vittorio; Arauzo-Bravo, Marcos J.; Han, Dong Wook; Schoeler, Hans R.] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany; [Ruau, David; Zenke, Martin] Univ Aachen, Sch Med, Rhein Westfal TH Aachen, Inst Biomed Engn,Dept Cell Biol, D-52074 Aachen, Germany	Max Planck Society; RWTH Aachen University	Scholer, HR (corresponding author), Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, Rontgenstr 20, D-48149 Munster, Germany.	schoeler@mpi-muenster.mpg.de	, HS/AAB-4434-2019; Gentile, Luca/E-4908-2019; Gentile, Luca/L-4473-2014; Marcos, Arauzo-Bravo/A-1706-2011; Han, Dong Wook/D-6041-2011	, HS/0000-0003-2643-5136; Gentile, Luca/0000-0002-7393-7502; Marcos, Arauzo-Bravo/0000-0002-3264-464X; Wu, Guangming/0000-0003-1923-7609; Kim, Jeong Beom/0000-0001-6230-8826				AOI T, 2008, SCIENCE         0214, DOI DOI 10.1126/SCIENCE.1154884; Do JT, 2004, STEM CELLS, V22, P941, DOI 10.1634/stemcells.22-6-941; Episkopou V, 2005, TRENDS NEUROSCI, V28, P219, DOI 10.1016/j.tins.2005.03.003; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Miura T, 2001, CYTOTECHNOLOGY, V36, P137, DOI 10.1023/A:1014016315003; Miyagi S, 2004, MOL CELL BIOL, V24, P4207, DOI 10.1128/MCB.24.10.4207-4220.2004; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Peeper DS, 2002, NAT CELL BIOL, V4, P148, DOI 10.1038/ncb742; Pollard SM, 2006, CEREB CORTEX, V16, pI112, DOI 10.1093/cercor/bhj167; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Ruau D, 2008, STEM CELLS, V26, P920, DOI 10.1634/stemcells.2007-0649; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Szabo PE, 2002, MECH DEVELOP, V115, P157, DOI 10.1016/S0925-4773(02)00087-4; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zaehres H, 2006, METHOD ENZYMOL, V420, P49, DOI 10.1016/S0076-6879(06)20004-1	26	718	874	2	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 31	2008	454	7204					646	U54		10.1038/nature07061	http://dx.doi.org/10.1038/nature07061			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	331QC	18594515				2022-12-28	WOS:000258026500049
J	Langan, SM; Smeeth, L; Hubbard, R; Fleming, KM; Smith, CJP; West, J				Langan, S. M.; Smeeth, L.; Hubbard, R.; Fleming, K. M.; Smith, C. J. P.; West, J.			Bullous pemphigoid and pemphigus vulgaris - incidence and mortality in the UK: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							EPIDEMIOLOGY; DATABASE; REGION; RISK	Objective To determine the incidence of and mortality from bullous pemphigoid and pemphigus vulgaris in the United kingdom. Design Retrospective historical cohort study. Setting Computerised medical records from the health improvement network, a large population based UK general practice database. Participants Patients with pemphigus vulgaris and bullous pemphigoid diagnostic codes and age, sex, and practice matched controls. Main outcome measures incidence and mortality compared with the control population by calendar period, age group, sex, geographical region, and degree of social deprivation. Results 869 people with bullous pemphigoid and 138 people with pemphigus vulgaris were identified. The median age at presentation for bullous pemphigoid was 80 (range 23-102) years, and 534 (61%) patients were female. The median age at presentation for pemphigus vulgaris was 71 (21-102) years, and 91 (66%) patients were female. Incidences of bullous pemphigoid and pemphigus vulgaris were 4.3 (95% confidence interval 4.0 to 4.6) and 0.7 (0.6 to 0.8) per 100 000 person years. The incidence of bullous pemphigoid increased overtime; the average yearly increase was 17% (incidence rate ratio=1.2, 95% confidence interval 1.1 to 1.2). An average yearly increase in incidence of pemphigus vulgaris of 11% (incidence rate ratio=1.1, 1.0 to 1.2) occurred. The risk of death for patients with bullous pemphigoid was twice as, great as for controls (adjusted hazard ratio=2.3, 95% confidence interval 2.0 to 2.7). For pemphigus vulgaris, the risk of death was three times greater than for controls (adjusted hazard ratio=3.3, 2.2 to 5.2). Conclusions Incidences of bullous pemphigoid and pemphigus vulgaris are increasing. The reasons for the changes in incidence are not clearly understood but have implications for identifying causative factors. Both disorders are associated with a high risk of death. Previous estimates may have underestimated the risk of death associated with these diseases.	[Langan, S. M.] Univ Nottingham, Queens Med Ctr, Ctr Evidence Based Dermatol, Nottingham NG7 2UH, England; [Smeeth, L.] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Ctr Populat Studies Noncommun Dis Epidemiol, London WC1, England; [Hubbard, R.; Fleming, K. M.; Smith, C. J. P.; West, J.] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2UH, England	University of Nottingham; University of London; London School of Hygiene & Tropical Medicine; University of Nottingham	Langan, SM (corresponding author), Univ Nottingham, Queens Med Ctr, Ctr Evidence Based Dermatol, Nottingham NG7 2UH, England.	sinead.langan@nottingham.ac.uk	West, Joe/I-6637-2012; Fleming, Kate M/A-6475-2010; West, Joe/M-3867-2019; Smeeth, Liam/X-5862-2018	West, Joe/0000-0002-1135-9356; Fleming, Kate M/0000-0002-6572-5016; West, Joe/0000-0002-1135-9356; Langan, Sinead/0000-0002-7022-7441; Smeeth, Liam/0000-0002-9168-6022	British Lung Foundation [C05/01] Funding Source: researchfish; Wellcome Trust [082178] Funding Source: Medline; Department of Health Funding Source: Medline	British Lung Foundation; Wellcome Trust(Wellcome Trust); Department of Health		ADAM BA, 1992, INT J DERMATOL, V31, P42, DOI 10.1111/j.1365-4362.1992.tb03519.x; Bath-Hextall F, 2007, INT J CANCER, V121, P2105, DOI 10.1002/ijc.22952; Colbert RL, 2004, J INVEST DERMATOL, V122, P1091, DOI 10.1111/j.0022-202X.2004.22504.x; Garcia-Doval I, 2006, BRIT J DERMATOL, V155, P820, DOI 10.1111/j.1365-2133.2006.07411.x; GELLIS S, 1941, ARCH DERMATOL SYPHIO, P44; Gudi VS, 2005, BRIT J DERMATOL, V153, P424, DOI 10.1111/j.1365-2133.2005.06662.x; HIETANEN J, 1982, ACTA DERM-VENEREOL, V62, P491; Joly P, 2005, J INVEST DERMATOL, V124, P664, DOI 10.1111/j.0022-202X.2005.23626.x; Joly P, 2002, NEW ENGL J MED, V346, P321, DOI 10.1056/NEJMoa011592; Jung M, 1999, J AM ACAD DERMATOL, V41, P266, DOI 10.1016/S0190-9622(99)70061-7; Lewis JD, 2007, PHARMACOEPIDEM DR S, V16, P393, DOI 10.1002/pds.1335; Lewis JD, 2002, PHARMACOEPIDEM DR S, V11, P211, DOI 10.1002/pds.698; Lewis JD, 2005, PHARMACOEPIDEM DR S, V14, P443, DOI 10.1002/pds.1115; NALDI L, 1993, INT J DERMATOL, V32, P424, DOI 10.1111/j.1365-4362.1993.tb02813.x; PISANTI S, 1974, ORAL SURG ORAL MED O, V38, P382, DOI 10.1016/0030-4220(74)90365-X; Roujeau JC, 1998, ARCH DERMATOL, V134, P465, DOI 10.1001/archderm.134.4.465; RYAN JG, 1971, ARCH DERMATOL, V104, P14, DOI 10.1001/archderm.104.1.14; Salmanpour R, 2006, INT J DERMATOL, V45, P103, DOI 10.1111/j.1365-4632.2004.02374.x; Uzun S, 2006, INT J DERMATOL, V45, P523, DOI 10.1111/j.1365-4632.2004.02533.x; V'lckova-Laskoska MT, 2007, INT J DERMATOL, V46, P253, DOI 10.1111/j.1365-4632.2006.03010.x	20	405	411	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 19	2008	337	7662							a180	10.1136/bmj.a180	http://dx.doi.org/10.1136/bmj.a180			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	330SB	18614511	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000257962000042
J	Webster, J; Clarke, S; Paterson, D; Hutton, A; van Dyk, S; Gale, C; Hopkins, T				Webster, Joan; Clarke, Samantha; Paterson, Dana; Hutton, Anne; van Dyk, Stacey; Gale, Catherine; Hopkins, Tracey			Routine care of peripheral intravenous catheters versus clinically indicated replacement: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INFUSION PHLEBITIS; PARENTERAL-NUTRITION; RISK-FACTORS; CANNULAE; THROMBOPHLEBITIS; COMPLICATIONS; CHILDREN; FAILURE	Objective To compare routine replacement of intravenous peripheral catheters with replacement only when clinically indicated. Design Randomised controlled trial. Setting Tertiary hospital in Australia. Participants 755 medical and 'surgical patients: 379 allocated to catheter replacement only when clinically indicated and 376 allocated to routine care of catheter (control group). Main outcome measure A composite measure of catheter failure resulting from phlebitis or infiltration. Results Catheters were removed because of phlebitis or infiltration from 123 of 376 (33%) patients in the control group compared with 143 of 379 (38%) patients in the intervention group; the difference was not significant (relative risk 1.15, 95% confidence interval 0.95 to 1.40). When the analysis was based on failure per 1000 device days (number of failures divided by number of days catheterised, divided by 1000), no difference could be detected between the groups (relative risk 0.98, 0.78 to 1.24). Infusion related costs were higher in the control group (mean $A41.02;19.71; pound 24.80; pound$38.55) than intervention group ($A36.40). The rate of phlebitis in both groups was low (4% in intervention group, 3% in control group). Conclusion Replacing peripheral intravenous catheters when clinically indicated has no effect the incidence of failure, based on a composite measure of phlebitis or infiltration. Larger trials are needed to test this finding using phlebitis alone as a more clinically meaningful outcome. Registration number Australian New Zealand Clinical Trials Registry ACTRN12605000147684.	[Webster, Joan; Clarke, Samantha; Paterson, Dana; Hutton, Anne; van Dyk, Stacey; Gale, Catherine; Hopkins, Tracey] Royal Brisbane & Womens Hosp, Ctr Clin Nursing, Herston, Qld 4029, Australia; [Webster, Joan] Griffith Univ, Royal Brisbane & Womens Hosp, Ctr Clin Nursing, Res Ctr Clin & Community Practice Innovat, Nathan, Qld 4111, Australia	Royal Brisbane & Women's Hospital; Griffith University; Royal Brisbane & Women's Hospital	Webster, J (corresponding author), Royal Brisbane & Womens Hosp, Ctr Clin Nursing, Herston, Qld 4029, Australia.	joan_webster@health.qld.gov.au							0	97	104	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 19	2008	337	7662					CP1	CP1	a339	10.1136/bmj.a339	http://dx.doi.org/10.1136/bmj.a339			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	330SB	18614482	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000257962000041
J	Saal, AE; Hauri, EH; Lo Cascio, M; Van Orman, JA; Rutherford, MC; Cooper, RF				Saal, Alberto E.; Hauri, Erik H.; Lo Cascio, Mauro; Van Orman, James A.; Rutherford, Malcolm C.; Cooper, Reid F.			Volatile content of lunar volcanic glasses and the presence of water in the Moon's interior	NATURE			English	Article							DETRITAL ZIRCONS; UPPER-MANTLE; EVOLUTION; SURFACE; IMPACT; CRUST; EARTH; FTIR	The Moon is generally thought to have formed and evolved through a single or a series of catastrophic heating events(1), during which most of the highly volatile elements were lost. Hydrogen, being the lightest element, is believed to have been completely lost during this period(2). Here we make use of considerable advances in secondary ion mass spectrometry(3) to obtain improved limits on the indigenous volatile (CO(2), H(2)O, F, S and Cl) contents of the most primitive basalts in the Moon - the lunar volcanic glasses. Although the pre- eruptive water content of the lunar volcanic glasses cannot be precisely constrained, numerical modelling of diffusive degassing of the very- low- Ti glasses provides a best estimate of 745 p. p. m. water, with a minimum of 260 p. p. m. at the 95 per cent confidence level. Our results indicate that, contrary to prevailing ideas, the bulk Moon might not be entirely depleted in highly volatile elements, including water. Thus, the presence of water must be considered in models constraining the Moon's formation and its thermal and chemical evolution.	[Saal, Alberto E.; Lo Cascio, Mauro; Rutherford, Malcolm C.; Cooper, Reid F.] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Hauri, Erik H.] Carnegie Inst Washington, Dept Terr Magnetism, Washington, DC 20015 USA; [Van Orman, James A.] Case Western Reserve Univ, Dept Geol Sci, Cleveland, OH 44106 USA	Brown University; Carnegie Institution for Science; Case Western Reserve University	Saal, AE (corresponding author), Brown Univ, Dept Geol Sci, Providence, RI 02912 USA.	asaal@brown.edu		Van Orman, James/0000-0001-8741-0288				Asimow PD, 2003, NATURE, V421, P815, DOI 10.1038/nature01429; Aubaud C, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021341; Bottke WF, 2007, ICARUS, V190, P203, DOI 10.1016/j.icarus.2007.02.010; Canup RM, 2004, ANNU REV ASTRON ASTR, V42, P441, DOI 10.1146/annurev.astro.41.082201.113457; Cavosie AJ, 2005, EARTH PLANET SC LETT, V235, P663, DOI 10.1016/j.epsl.2005.04.028; Crank J., 1975, MATH DIFFUSION; DELANO JW, 1986, J GEOPHYS RES-SOLID, V91, pD201, DOI 10.1029/JB091iB04p0D201; DELANO JW, 1994, LUNAR PLANET SCI, V25, P325; DELANO JW, 1979, P LUNAR PLANET SCI C, V10, P275; Elkins-Tanton LT, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017082; Epstein S., 1973, GEOCHIM COSM SUPPL, V2, P1559; EUGSTER O, 1977, P 8 LUN PLAN SCI C, V2, P3059; FOGEL RA, 1995, GEOCHIM COSMOCHIM AC, V59, P201, DOI 10.1016/0016-7037(94)00377-X; Gaetani GA, 1998, CONTRIB MINERAL PETR, V131, P323, DOI 10.1007/s004100050396; GIBSON EK, 1973, SCIENCE, V179, P69, DOI 10.1126/science.179.4068.69; GIBSON EK, 1977, P 8 LUN PLAN SCI C, V2, P1417; GOLDBERG RH, 1975, P LUNAR PLANET SCI C, V2, P2189; Hauri E, 2002, CHEM GEOL, V183, P99, DOI 10.1016/S0009-2541(01)00375-8; Hauri EH, 2006, EARTH PLANET SC LETT, V248, P715, DOI 10.1016/j.epsl.2006.06.014; HESS PC, 1995, EARTH PLANET SC LETT, V134, P501, DOI 10.1016/0012-821X(95)00138-3; Hirth G, 1996, EARTH PLANET SC LETT, V144, P93, DOI 10.1016/0012-821X(96)00154-9; JOVANOVIC S, 1975, P 6 LUN PLAN SCI C, V2, P1737; Koga K, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000378; Lakatos S., 1973, Moon, V7, P132, DOI 10.1007/BF00578812; Lucey P, 2006, REV MINERAL GEOCHEM, V60, P83, DOI 10.2138/rmg.2006.60.2; Mojzsis SJ, 2001, NATURE, V409, P178, DOI 10.1038/35051557; Pahlevan K, 2007, EARTH PLANET SC LETT, V262, P438, DOI 10.1016/j.epsl.2007.07.055; POUCHOU JL, 1991, ELECTRON PROBE QUANTITATION, P31; Ryder G, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001583; Shearer CK, 2006, REV MINERAL GEOCHEM, V60, P365, DOI 10.2138/rmg.2006.60.4; SHIMIZU N, 1982, ANNU REV EARTH PL SC, V10, P483, DOI 10.1146/annurev.ea.10.050182.002411; Wieczorek MA, 2006, REV MINERAL GEOCHEM, V60, P221, DOI 10.2138/rmg.2006.60.3; Wilde SA, 2001, NATURE, V409, P175, DOI 10.1038/35051550	33	414	433	9	163	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 10	2008	454	7201					192	U38		10.1038/nature07047	http://dx.doi.org/10.1038/nature07047			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	323RU	18615079				2022-12-28	WOS:000257466900038
J	Snow, SJ				Snow, Stephanie J.			The art of medicine - John Snow: the making of a hero?	LANCET			English	Biographical-Item									Univ Manchester, Ctr Hist Sci Technol & Med, Manchester M13 9PL, Lancs, England	University of Manchester	Snow, SJ (corresponding author), Univ Manchester, Ctr Hist Sci Technol & Med, Manchester M13 9PL, Lancs, England.			Snow, Stephanie/0000-0001-9957-7835					0	9	9	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 5	2008	372	9632					22	23		10.1016/S0140-6736(08)60978-2	http://dx.doi.org/10.1016/S0140-6736(08)60978-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	321XN	18613323				2022-12-28	WOS:000257339900015
J	Klausberger, T; Somogyi, P				Klausberger, Thomas; Somogyi, Peter			Neuronal diversity and temporal dynamics: The unity of hippocampal circuit operations	SCIENCE			English	Review							DUAL INTRACELLULAR-RECORDINGS; AXO-AXONIC CELLS; GAMMA-OSCILLATIONS; GABAERGIC NEURONS; PYRAMIDAL CELLS; POSITIVE INTERNEURONS; FREQUENCY-OSCILLATION; PHASE PRECESSION; STRATUM-ORIENS; GABA RELEASE	In the cerebral cortex, diverse types of neurons form intricate circuits and cooperate in time for the processing and storage of information. Recent advances reveal a spatiotemporal division of labor in cortical circuits, as exemplified in the CA1 hippocampal area. In particular, distinct GABAergic (gamma- aminobutyric acid- releasing) cell types subdivide the surface of pyramidal cells and act in discrete time windows, either on the same or on different subcellular compartments. They also interact with glutamatergic pyramidal cell inputs in a domain- specific manner and support synaptic temporal dynamics, network oscillations, selection of cell assemblies, and the implementation of brain states. The spatiotemporal specializations in cortical circuits reveal that cellular diversity and temporal dynamics coemerged during evolution, providing a basis for cognitive behavior.	[Klausberger, Thomas; Somogyi, Peter] Univ Oxford, MRC, Anat Neuropharmacol Unit, Oxford OX1 3TH, England; [Klausberger, Thomas] Med Univ Vienna, Ctr Brain Res, A-1090 Vienna, Austria	University of Oxford; Medical University of Vienna	Klausberger, T (corresponding author), Univ Oxford, MRC, Anat Neuropharmacol Unit, Oxford OX1 3TH, England.	thomas.klausberger@pharm.ox.ac.uk; peter.somogyi@pharm.ox.ac.uk			Medical Research Council [MC_UU_12020/3, MC_U138197110, MC_U138197107] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Acsady L, 1996, NEUROSCIENCE, V73, P317, DOI 10.1016/0306-4522(95)00609-5; Ali AB, 1998, J PHYSIOL-LONDON, V507, P201, DOI 10.1111/j.1469-7793.1998.201bu.x; Ali AB, 1998, J PHYSIOL-LONDON, V507, P185, DOI 10.1111/j.1469-7793.1998.185bu.x; Biro AA, 2005, J NEUROSCI, V25, P223, DOI 10.1523/JNEUROSCI.3688-04.2005; Borhegyi Z, 2004, J NEUROSCI, V24, P8470, DOI 10.1523/JNEUROSCI.1413-04.2004; CAJAL SRY, 1911, HISTOLOGIE SYSTEME N, pCH2; Cenquizca LA, 2006, J COMP NEUROL, V497, P101, DOI 10.1002/cne.20985; Cohen I, 2002, SCIENCE, V298, P1418, DOI 10.1126/science.1076510; Cossart R, 2006, HIPPOCAMPUS, V16, P408, DOI 10.1002/hipo.20169; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; Ego-Stengel V, 2007, HIPPOCAMPUS, V17, P161, DOI 10.1002/hipo.20253; Foldy C, 2007, NAT NEUROSCI, V10, P1128, DOI 10.1038/nn1952; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Fuchs EC, 2007, NEURON, V53, P591, DOI 10.1016/j.neuron.2007.01.031; FUENTEALBA P, UNPUB; Fuentealba P, 2008, NEURON, V57, P917, DOI 10.1016/j.neuron.2008.01.034; Ganter P, 2004, HIPPOCAMPUS, V14, P232, DOI 10.1002/hipo.10170; Geisler C, 2007, P NATL ACAD SCI USA, V104, P8149, DOI 10.1073/pnas.0610121104; Glickfeld LL, 2006, NAT NEUROSCI, V9, P807, DOI 10.1038/nn1688; Gloveli T, 2005, J PHYSIOL-LONDON, V562, P131, DOI 10.1113/jphysiol.2004.073007; Gulyas AI, 1996, J NEUROSCI, V16, P3397; Hajos N, 2004, J NEUROSCI, V24, P9127, DOI 10.1523/JNEUROSCI.2113-04.2004; Hajos N, 1997, J NEUROSCI, V17, P8427; Hardie JB, 2006, J NEUROSCI, V26, P8559, DOI 10.1523/JNEUROSCI.0547-06.2006; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; Houweling AR, 2008, NATURE, V451, P65, DOI 10.1038/nature06447; Jarsky T, 2008, J COMP NEUROL, V506, P535, DOI 10.1002/cne.21564; Jinno S, 2007, J NEUROSCI, V27, P8790, DOI 10.1523/JNEUROSCI.1847-07.2007; Katona I, 1999, J NEUROSCI, V19, P4544; Khalilov I, 2005, NEURON, V48, P787, DOI 10.1016/j.neuron.2005.09.026; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Klausberger T, 2005, J NEUROSCI, V25, P9782, DOI 10.1523/JNEUROSCI.3269-05.2005; Klausberger T, 2004, NAT NEUROSCI, V7, P41, DOI 10.1038/nn1159; Kocsis B, 2006, P NATL ACAD SCI USA, V103, P1059, DOI 10.1073/pnas.0508360103; Konopaske GT, 2006, NEUROSCIENCE, V138, P189, DOI 10.1016/j.neuroscience.2005.10.070; Lawrence JJ, 2006, J PHYSIOL-LONDON, V570, P595, DOI 10.1113/jphysiol.2005.100875; Leutgeb S, 2005, SCIENCE, V309, P619, DOI 10.1126/science.1114037; Lien CC, 2003, J NEUROSCI, V23, P2058; LUND JS, 1993, J COMP NEUROL, V328, P282, DOI 10.1002/cne.903280209; Marshall L, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-02-j0001.2002; Maurer AP, 2006, J NEUROSCI, V26, P13485, DOI 10.1523/JNEUROSCI.2882-06.2006; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; OKEEFE J, 1976, EXP NEUROL, V51, P78, DOI 10.1016/0014-4886(76)90055-8; Papp EC, 1999, NEUROSCIENCE, V90, P369, DOI 10.1016/S0306-4522(98)00455-2; Pawelzik H, 2002, J COMP NEUROL, V443, P346, DOI 10.1002/cne.10118; Penttonen M, 1998, EUR J NEUROSCI, V10, P718, DOI 10.1046/j.1460-9568.1998.00096.x; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; Price CJ, 2005, J NEUROSCI, V25, P6775, DOI 10.1523/JNEUROSCI.1135-05.2005; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; SIK A, 1994, SCIENCE, V265, P1722, DOI 10.1126/science.8085161; Silberberg G, 2004, J PHYSIOL-LONDON, V556, P19, DOI 10.1113/jphysiol.2004.060962; SOLTESZ I, 1993, J NEUROPHYSIOL, V70, P97, DOI 10.1152/jn.1993.70.1.97; SOMOGYI P, 1983, BRAIN RES, V259, P137, DOI 10.1016/0006-8993(83)91076-4; Stanic D, 2006, J COMP NEUROL, V499, P357, DOI 10.1002/cne.21046; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Szabadics J, 2006, SCIENCE, V311, P233, DOI 10.1126/science.1121325; Szabadics J, 2007, P NATL ACAD SCI USA, V104, P14831, DOI 10.1073/pnas.0707204104; Tamas G, 2004, EUR J NEUROSCI, V20, P2681, DOI 10.1111/j.1460-9568.2004.03719.x; Tamas G, 2003, SCIENCE, V299, P1902, DOI 10.1126/science.1082053; Tomioka R, 2005, EUR J NEUROSCI, V21, P1587, DOI 10.1111/j.1460-9568.2005.03989.x; TOTH K, 1993, J NEUROSCI, V13, P3712; Traub RD, 2005, J NEUROPHYSIOL, V94, P1225, DOI 10.1152/jn.00069.2005; Tukker JJ, 2007, J NEUROSCI, V27, P8184, DOI 10.1523/JNEUROSCI.1685-07.2007; Wiebe SP, 2001, J NEUROSCI, V21, P3955, DOI 10.1523/JNEUROSCI.21-11-03955.2001; Wilent WB, 2007, J NEUROPHYSIOL, V97, P4152, DOI 10.1152/jn.01200.2006; YLINEN A, 1995, HIPPOCAMPUS, V5, P78, DOI 10.1002/hipo.450050110; YLINEN A, 1995, J NEUROSCI, V15, P30	68	1367	1378	2	163	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2008	321	5885					53	57		10.1126/science.1149381	http://dx.doi.org/10.1126/science.1149381			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QE	18599766	Green Accepted			2022-12-28	WOS:000257320800030
J	Tsai, TYC; Choi, YS; Ma, WZ; Pomerening, JR; Tang, C; Ferrell, JE				Tsai, Tony Yu-Chen; Choi, Yoon Sup; Ma, Wenzhe; Pomerening, Joseph R.; Tang, Chao; Ferrell, James E., Jr.			Robust, tunable biological oscillations from interlinked positive and negative feedback loops	SCIENCE			English	Article							CELL-CYCLE OSCILLATOR; CIRCADIAN CLOCK; BUDDING YEAST; XENOPUS; PHOSPHORYLATION; MODEL; HYSTERESIS; ACTIVATION; MECHANISMS; EXTRACTS	A simple negative feedback loop of interacting genes or proteins has the potential to generate sustained oscillations. However, many biological oscillators also have a positive feedback loop, raising the question of what advantages the extra loop imparts. Through computational studies, we show that it is generally difficult to adjust a negative feedback oscillator's frequency without compromising its amplitude, whereas with positive- plus- negative feedback, one can achieve a widely tunable frequency and near- constant amplitude. This tunability makes the latter design suitable for biological rhythms like heartbeats and cell cycles that need to provide a constant output over a range of frequencies. Positive- plus- negative oscillators also appear to be more robust and easier to evolve, rationalizing why they are found in contexts where an adjustable frequency is unimportant.	[Tsai, Tony Yu-Chen; Choi, Yoon Sup; Ferrell, James E., Jr.] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Choi, Yoon Sup] Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Pohang 790784, South Korea; [Ma, Wenzhe; Tang, Chao] Peking Univ, Ctr Theoret Biol, Beijing 100871, Peoples R China; [Ma, Wenzhe; Tang, Chao] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94143 USA; [Pomerening, Joseph R.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Stanford University; Pohang University of Science & Technology (POSTECH); Peking University; University of California System; University of California San Francisco; Indiana University System; Indiana University Bloomington	Ferrell, JE (corresponding author), Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	james.ferrell@stanford.edu	Ma, Wenzhe/N-3320-2017	Tsai, Tony/0000-0003-1121-9406; Pomerening, Joseph/0000-0003-4120-9081; Tang, Chao/0000-0003-1474-3705	NIGMS NIH HHS [GM77544, GM61726, R01 GM061276-06, R01 GM077544, R01 GM061276-07, R01 GM077544-02, R01 GM077544-01, R01 GM061276, R01 GM061276-08] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061276, R01GM077544] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bar-Or RL, 2000, P NATL ACAD SCI USA, V97, P11250, DOI 10.1073/pnas.210171597; Bean JM, 2006, MOL CELL, V21, P3, DOI 10.1016/j.molcel.2005.10.035; Berridge MJ, 2001, NOVART FDN SYMP, V239, P52; Buttitta LA, 2007, CURR OPIN CELL BIOL, V19, P697, DOI 10.1016/j.ceb.2007.10.004; Chen KC, 2004, MOL BIOL CELL, V15, P3841, DOI 10.1091/mbc.E03-11-0794; Cross FR, 2003, DEV CELL, V4, P741, DOI 10.1016/S1534-5807(03)00119-9; DIRICK L, 1991, NATURE, V351, P754, DOI 10.1038/351754a0; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; FITZHUGH R, 1961, BIOPHYS J, V1, P445, DOI 10.1016/S0006-3495(61)86902-6; Fung E, 2005, NATURE, V435, P118, DOI 10.1038/nature03508; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Goldbeter A, 2002, NATURE, V420, P238, DOI 10.1038/nature01259; Goldbeter A, 2001, CHAOS, V11, P247, DOI 10.1063/1.1345727; GOODWIN BRIAN C., 1965, ADVANCE ENZYME REGULAT, V3, P425, DOI 10.1016/0065-2571(65)90067-1; HAHN HS, 1974, P NATL ACAD SCI USA, V71, P4067, DOI 10.1073/pnas.71.10.4067; Hartley RS, 1996, DEV BIOL, V173, P408, DOI 10.1006/dbio.1996.0036; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Igoshin OA, 2004, P NATL ACAD SCI USA, V101, P15760, DOI 10.1073/pnas.0407111101; Kim SY, 2005, MOL CELL BIOL, V25, P10580, DOI 10.1128/MCB.25.23.10580-10590.2005; KUMAGAI A, 1992, CELL, V70, P139, DOI 10.1016/0092-8674(92)90540-S; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Lee K, 2000, SCIENCE, V289, P107, DOI 10.1126/science.289.5476.107; Levine K, 1995, Prog Cell Cycle Res, V1, P101; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Mara A, 2007, TRENDS CELL BIOL, V17, P593, DOI 10.1016/j.tcb.2007.09.005; MEYER T, 1988, P NATL ACAD SCI USA, V85, P5051, DOI 10.1073/pnas.85.14.5051; MUELLER PR, 1995, MOL BIOL CELL, V6, P119, DOI 10.1091/mbc.6.1.119; NAGUMO J, 1962, P IRE, V50, P2061, DOI 10.1109/JRPROC.1962.288235; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; NAVE CR, 1995, HYPERPHYSICS; Nishiwaki T, 2007, EMBO J, V26, P4029, DOI 10.1038/sj.emboj.7601832; NOVAK B, 1993, J CELL SCI, V106, P1153; Pomerening JR, 2005, CELL, V122, P565, DOI 10.1016/j.cell.2005.06.016; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Ruoff P, 1996, NATURWISSENSCHAFTEN, V83, P514, DOI 10.1007/BF01141953; Rust MJ, 2007, SCIENCE, V318, P809, DOI 10.1126/science.1148596; Sha W, 2003, P NATL ACAD SCI USA, V100, P975, DOI 10.1073/pnas.0235349100; Smolen P, 1998, AM J PHYSIOL-CELL PH, V274, pC531, DOI 10.1152/ajpcell.1998.274.2.C531; STROGATZ SH, 1994, ONLINEAR DYNAMICS CH; STUART D, 1995, GENE DEV, V9, P2780, DOI 10.1101/gad.9.22.2780; Thron CD, 1996, BIOPHYS CHEM, V57, P239, DOI 10.1016/0301-4622(95)00075-5; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Tyson JJ, 2001, J THEOR BIOL, V210, P249, DOI 10.1006/jtbi.2001.2293; van der Pol B, 1928, PHILOS MAG, V6, P763	45	496	504	6	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 4	2008	321	5885					126	129		10.1126/science.1156951	http://dx.doi.org/10.1126/science.1156951			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QE	18599789	Green Accepted			2022-12-28	WOS:000257320800053
J	Goyon, J; Colin, A; Ovarlez, G; Ajdari, A; Bocquet, L				Goyon, J.; Colin, A.; Ovarlez, G.; Ajdari, A.; Bocquet, L.			Spatial cooperativity in soft glassy flows	NATURE			English	Article							STRUCTURAL RELAXATION; TRANSITION	Amorphous glassy materials of diverse nature - concentrated emulsions, granular materials, pastes, molecular glasses - display complex flow properties, intermediate between solid and liquid, which are at the root of their use in many applications(1-3). A general feature of such systems, well documented yet not really understood, is the strongly nonlinear nature of the flow rule relating stresses and strain rates(4,5). Here we use a microfluidic velocimetry technique to characterize the flow of thin layers of concentrated emulsions, confined in gaps of different thicknesses by surfaces of different roughnesses. We find evidence for finite- size effects in the flow behaviour and the absence of an intrinsic local flow rule. In contrast to the classical nonlinearities of the rheological behaviour of amorphous materials, we show that a rather simple nonlocal flow rule can account for all the velocity profiles. This nonlocality of the dynamics is quantified by a length, characteristic of cooperativity within the flow at these scales, that is unobservable in the liquid state ( lower emulsion concentrations) and that increases with concentration in the jammed state. Beyond its practical importance for applications involving thin layers ( for example, coatings), these non- locality and cooperativity effects have parallels in the behaviour of other glassy, jammed and granular systems, suggesting a possible fundamental universality.	[Bocquet, L.] Univ Lyon 1, Lab PMCN, CNRS, UMR 5586, F-69622 Villeurbanne, France; [Goyon, J.; Colin, A.] Univ Bordeaux 1, LOF, UMR CNRS Rhodia Bordeaux 1 5258, F-33608 Pessac, France; [Ovarlez, G.] Univ Paris Est, Inst Navier, LMSGC, F-77420 Champs Sur Marne, France; [Ajdari, A.] Gulliver, UMR CNRS ESPCI 7083, F-75005 Paris, France; [Bocquet, L.] Tech Univ Munich, Dept Phys, D-85748 Garching, Germany	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Universite Gustave-Eiffel; UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Technical University of Munich	Bocquet, L (corresponding author), Univ Lyon 1, Lab PMCN, CNRS, UMR 5586, F-69622 Villeurbanne, France.	annie.colin-exterieur@eu.rhodia.com; lyderic.bocquet@univ-lyon1.fr	bocquet, lyderic/A-2241-2012; COLIN, Annie/K-8714-2012; Ovarlez, Guillaume/D-8496-2011	bocquet, lyderic/0000-0003-3577-5335; Ovarlez, Guillaume/0000-0003-1554-1080				Berthier L, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.020201; Berthier L, 2005, SCIENCE, V310, P1797, DOI 10.1126/science.1120714; Biroli G, 2007, NAT PHYS, V3, P222, DOI 10.1038/nphys580; Coussot P, 2007, SOFT MATTER, V3, P528, DOI 10.1039/b611021p; Dauchot O, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.265701; Debenedetti PG, 2001, NATURE, V410, P259, DOI 10.1038/35065704; Deboeuf S, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.158303; Degre G, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2221501; Dhont JKG, 1999, PHYS REV E, V60, P4534, DOI 10.1103/PhysRevE.60.4534; Fuchs M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.248304; Gao Y, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.078301; Goldenberg C, 2005, NATURE, V435, P188, DOI 10.1038/nature03497; Goldman DI, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.145702; Helbing D, 2000, NATURE, V407, P487, DOI 10.1038/35035023; Isa L, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.198305; Jop P, 2006, NATURE, V441, P727, DOI 10.1038/nature04801; Kamrin K, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.041301; Keys AS, 2007, NAT PHYS, V3, P260, DOI 10.1038/nphys572; Leonforte F, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.055501; Liu AJ, 1998, NATURE, V396, P21, DOI 10.1038/23819; Mueth DM, 2000, NATURE, V406, P385, DOI 10.1038/35019032; Ostojic S, 2006, NATURE, V439, P828, DOI 10.1038/nature04549; Picard G, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.010501; Picard G, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.051501; Pouliquen O, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.248001; Priestley RD, 2005, SCIENCE, V309, P456, DOI 10.1126/science.1112217; PRINCEN HM, 1983, J COLLOID INTERF SCI, V91, P160, DOI 10.1016/0021-9797(83)90323-5; Schall P, 2007, SCIENCE, V318, P1895, DOI 10.1126/science.1149308; Varnik F, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.095702; Weeks ER, 2000, SCIENCE, V287, P627, DOI 10.1126/science.287.5453.627	30	300	303	5	150	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2008	454	7200					84	87		10.1038/nature07026	http://dx.doi.org/10.1038/nature07026			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321MC	18596806				2022-12-28	WOS:000257308300041
J	Andrews-Hanna, JC; Zuber, MT; Banerdt, WB				Andrews-Hanna, Jeffrey C.; Zuber, Maria T.; Banerdt, W. Bruce			The Borealis basin and the origin of the martian crustal dichotomy	NATURE			English	Article							INTERNAL STRUCTURE; MANTLE CONVECTION; GIANT IMPACTS; MARS; EVOLUTION; TOPOGRAPHY	The most prominent feature on the surface of Mars is the near-hemispheric dichotomy between the southern highlands and northern lowlands. The root of this dichotomy is a change in crustal thickness along an apparently irregular boundary, which can be traced around the planet, except where it is presumably buried beneath the Tharsis volcanic rise(1,2). The isostatic compensation of these distinct provinces(2,3) and the ancient population of impact craters buried beneath the young lowlands surface(4) suggest that the dichotomy is one of the most ancient features on the planet(3). However, the origin of this dichotomy has remained uncertain, with little evidence to distinguish between the suggested causes: a giant impact(5,6) or mantle convection/ overturn(7-9). Here we use the gravity(10) and topography(11) of Mars to constrain the location of the dichotomy boundary beneath Tharsis, taking advantage of the different modes of compensation for Tharsis and the dichotomy to separate their effects. We find that the dichotomy boundary along its entire path around the planet is accurately fitted by an ellipse measuring approximately 10,600 by 8,500 km, centred at 67 degrees N, 208 degrees E. We suggest that the elliptical nature of the crustal dichotomy is most simply explained by a giant impact, representing the largest such structure thus far identified in the Solar System.	[Andrews-Hanna, Jeffrey C.; Zuber, Maria T.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Banerdt, W. Bruce] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	Massachusetts Institute of Technology (MIT); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Andrews-Hanna, JC (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	jhanna@mit.edu	Banerdt, William/Q-7324-2019	Banerdt, William/0000-0003-3125-1542				ANDREWSHANNA JC, IN PRESS J GEOPHYS R, DOI DOI 10.1029/2008JE002980; Arkani-Hamed J, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2004JE002265; BANERDT WB, 1986, J GEOPHYS RES-SOLID, V91, P403, DOI 10.1029/JB091iB01p00403; Canup RM, 1996, ICARUS, V119, P427, DOI 10.1006/icar.1996.0028; Chapman C., 1988, MERCURY, P670; Elkins-Tanton LT, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2005JE002480; FREY H, 1988, GEOPHYS RES LETT, V15, P229, DOI 10.1029/GL015i003p00229; Frey HV, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013832; Grott M, 2008, ICARUS, V193, P503, DOI 10.1016/j.icarus.2007.08.015; Harder H, 1996, NATURE, V380, P507, DOI 10.1038/380507a0; KIEFER WS, 2007, LUNAR PLANET SCI C, V38; KONOPLIV AS, UNPUB NASA PLANET DA; MCGILL GE, 1991, ICARUS, V93, P386, DOI 10.1016/0019-1035(91)90221-E; McGovern PJ, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2004JE002286; McGovern PJ, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2002JE001854; Melosh H.J., 1989, OXFORD MONOGRAPHS GE; MELOSH HJ, 1978, GEOPHYS RES LETT, V5, P985, DOI 10.1029/GL005i011p00985; Mohit PS, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031252; Montesi LGJ, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001974; NEUMANN GA, 2008, LUNAR PLANET SCI C, V39; Nimmo F, 2001, J GEOPHYS RES-PLANET, V106, P5085, DOI 10.1029/2000JE001331; Parmentier EM, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2005JE002626; Phillips RJ, 2001, SCIENCE, V291, P2587, DOI 10.1126/science.1058701; Roberts JH, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002668; Smith DE, 2001, J GEOPHYS RES-PLANET, V106, P23689, DOI 10.1029/2000JE001364; Smrekar SE, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2004JE002260; Solomon SC, 2005, SCIENCE, V307, P1214, DOI 10.1126/science.1101812; STROM RG, 1975, J GEOPHYS RES, V80, P2478, DOI 10.1029/JB080i017p02478; TONKS WB, 1993, J GEOPHYS RES-PLANET, V98, P5319, DOI 10.1029/92JE02726; WETHERILL GW, 1985, SCIENCE, V228, P877, DOI 10.1126/science.228.4701.877; WILHELMS DE, 1984, NATURE, V309, P138, DOI 10.1038/309138a0; Zhong SJ, 2001, EARTH PLANET SC LETT, V189, P75, DOI 10.1016/S0012-821X(01)00345-4; Zuber MT, 2000, SCIENCE, V287, P1788, DOI 10.1126/science.287.5459.1788; [No title captured]	34	181	181	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2008	453	7199					1212	U27		10.1038/nature07011	http://dx.doi.org/10.1038/nature07011			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318FA	18580944				2022-12-28	WOS:000257075800036
J	Steinbrook, R				Steinbrook, Robert			Health care reform in Massachusetts - Expanding coverage, escalating costs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material												rsteinbrook@attglobal.net						ANGELL M, 2008, AM PROSPECT     0421; Gabel JR, 2008, HEALTH AFFAIR, V27, pW13, DOI 10.1377/hlthaff.27.1.w13; Long SK, 2008, HEALTH AFFAIR, V27, pW270, DOI 10.1377/hlthaff.27.4.w270; Steinbrook R, 2006, NEW ENGL J MED, V354, P2095, DOI 10.1056/NEJMp068097	4	15	15	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 26	2008	358	26					2757	2760		10.1056/NEJMp0804277	http://dx.doi.org/10.1056/NEJMp0804277			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	317UO	18579809				2022-12-28	WOS:000257045900001
J	Delamothe, T				Delamothe, Tony			NHS at 60 - A centrally funded health service, free at the point of delivery	BRITISH MEDICAL JOURNAL			English	Editorial Material							CARE		BMJ, London WC1H 9JR, England		Delamothe, T (corresponding author), BMJ, London WC1H 9JR, England.	tdelamothe@bmj.com						BRADSHAW B, 2008, ECONOMIST       0126; CHARLSON P, 2007, FREE POINT DELIVERY; Delamothe T, 2008, BRIT MED J, V336, P1344, DOI 10.1136/bmj.a253; *DEP HLTH, 2000, NHS PLAN; Dyer C, 2008, BRIT MED J, V336, P1265, DOI 10.1136/bmj.39602.519977.DB; HARI J, 2008, INDEPENDENT     1010; Hawe E, 2008, OHE COMPENDIUM HLTH; Klein R., 2006, NEW POLITICS NHS CRE, V5st edition; Krugman P, 2006, NEW YORK REV BOOKS, V53, P38; Lees CC, 2008, BMJ-BRIT MED J, V336, P1205, DOI 10.1136/bmj.a164; *MIN HLTH, 1946, CMD6761, P4; *ORG EC COOP DEV, HLTH EXP OECD HLTH D; Seddon N., 2007, QUITE LIKE HEAVEN OP; STEVENS S, 2005, PROSPECT         FEB, P32; Thomas SJ, 2008, BMJ-BRIT MED J, V336, P1219, DOI 10.1136/bmj.39549.605602.BE; TIMMINS N, 2008, FINANCIAL TIMES 0605, P3; TIMMINS N, 1995, 5 GIANTS BIOGRAPHY W; Wanless, 2002, SECURING OUR FUTURE; Wanless D, 2001, SECURING OUR FUTURE; Webster C., 2002, NATL HLTH SERVICE PO; Whitehead M, 1997, BRIT MED J, V315, P1006, DOI 10.1136/bmj.315.7114.1006	21	7	7	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 21	2008	336	7658					1410	1412		10.1136/bmj.a292	http://dx.doi.org/10.1136/bmj.a292			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	318WJ	18566079	Green Published			2022-12-28	WOS:000257123200030
J	de Vernal, A; Hillaire-Marcel, C				de Vernal, Anne; Hillaire-Marcel, Claude			Natural variability of Greenland climate, vegetation, and ice volume during the past million years	SCIENCE			English	Article							NORTHERN-HEMISPHERE; SEA; SHEET; MARGIN; MIDDLE; RECORD	The response of the Greenland ice sheet to global warming is a source of concern notably because of its potential contribution to changes in the sea level. We demonstrated the natural vulnerability of the ice sheet by using pollen records from marine sediment off southwest Greenland that indicate important changes of the vegetation in Greenland over the past million years. The vegetation that developed over southern Greenland during the last interglacial period is consistent with model experiments, suggesting a reduced volume of the Greenland ice sheet. Abundant spruce pollen indicates that boreal coniferous forest developed some 400,000 years ago during the "warm" interval of marine isotope stage 11, providing a time frame for the development and decline of boreal ecosystems over a nearly ice- free Greenland.	[de Vernal, Anne; Hillaire-Marcel, Claude] Univ Quebec, Geotop, Geochem & Geodynam Res Ctr, Montreal, PQ H3C 3P8, Canada	University of Quebec; University of Quebec Montreal	de Vernal, A (corresponding author), Univ Quebec, Geotop, Geochem & Geodynam Res Ctr, Case Postale 8888,Succursale Centreville, Montreal, PQ H3C 3P8, Canada.	devernal.anne@uqam.ca	Hillaire-Marcel, Claude/C-9153-2013; de Vernal, Anne/D-5602-2013; Hillaire-Marcel, Claude/H-1441-2012	Hillaire-Marcel, Claude/0000-0002-3733-4632; de Vernal, Anne/0000-0001-5656-724X; 				Aksu A.E., 1989, Proceedings of the Ocean Drilling Program Scientific Results, V105, P689, DOI 10.2973/odp.proc.sr.105.139.1989; Andersen KK, 2004, NATURE, V431, P147, DOI 10.1038/nature02805; Bennike O, 2002, PALAEOGEOGR PALAEOCL, V186, P1, DOI 10.1016/S0031-0182(02)00439-X; Berger A, 2002, SCIENCE, V297, P1287, DOI 10.1126/science.1076120; Bourgeois JC, 2001, J GEOPHYS RES-ATMOS, V106, P5255, DOI 10.1029/2000JD900708; de Vernal A, 2005, QUATERNARY SCI REV, V24, P897, DOI 10.1016/j.quascirev.2004.06.014; DEVERNAL A, 1989, P OCEAN DRILLING PRO, V0105; DEVERNAL A, 1992, NEOGENE QUATERNARY D, P329; Dowdeswell JA, 2006, SCIENCE, V311, P963, DOI 10.1126/science.1124190; Funder S, 1998, QUATERNARY SCI REV, V17, P77, DOI 10.1016/S0277-3791(97)00082-6; Giesecke T, 2004, J BIOGEOGR, V31, P1523, DOI 10.1111/j.1365-2699.2004.01095.x; Goni MFS, 1999, EARTH PLANET SC LETT, V171, P123; HEUSSER L, 1977, QUATERNARY RES, V7, P45, DOI 10.1016/0033-5894(77)90013-8; Hillaire-Marcel C, 2001, NATURE, V410, P1073, DOI 10.1038/35074059; Hillaire-Marcel C., 1989, Geographie Physique et Quaternaire, V43, P263; Kaplan JO, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002559; Koerner RM, 1988, ANN GLACIOL, V10, P85; LARSEN HC, 1994, SCIENCE, V264, P952, DOI 10.1126/science.264.5161.952; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; Luthcke SB, 2006, SCIENCE, V314, P1286, DOI 10.1126/science.1130776; Meesters AGCA, 1997, BOUND-LAY METEOROL, V85, P475, DOI 10.1023/A:1000514214823; *NAT OC DAT CTR, 2001, WORLD OC DAT 2001 SC; Otto-Bliesner BL, 2006, SCIENCE, V311, P1751, DOI 10.1126/science.1120808; Overpeck JT, 2006, SCIENCE, V311, P1747, DOI 10.1126/science.1115159; Rignot E, 2006, SCIENCE, V311, P986, DOI 10.1126/science.1121381; ROCHON A, 1994, CAN J EARTH SCI, V31, P115, DOI 10.1139/e94-010; Rousseau DD, 2006, REV PALAEOBOT PALYNO, V141, P277, DOI 10.1016/j.revpalbo.2006.05.001; Siegenthaler U, 2005, SCIENCE, V310, P1313, DOI 10.1126/science.1120130; Willerslev E, 2007, SCIENCE, V317, P111, DOI 10.1126/science.1141758	29	149	149	5	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2008	320	5883					1622	1625		10.1126/science.1153929	http://dx.doi.org/10.1126/science.1153929			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	315NM	18566284				2022-12-28	WOS:000256886700044
J	Schummers, J; Yu, HB; Sur, M				Schummers, James; Yu, Hongbo; Sur, Mriganka			Tuned responses of astrocytes and their influence on hemodynamic signals in the visual cortex	SCIENCE			English	Article							DEPENDENT GLUTAMATE RELEASE; IN-VIVO; FUNCTIONAL ARCHITECTURE; SYNAPTIC-TRANSMISSION; NEURONAL-ACTIVITY; CALCIUM WAVES; ORIENTATION; BRAIN; NETWORKS; RESOLUTION	Astrocytes have long been thought to act as a support network for neurons, with little role in information representation or processing. We used two- photon imaging of calcium signals in the ferret visual cortex in vivo to discover that astrocytes, like neurons, respond to visual stimuli, with distinct spatial receptive fields and sharp tuning to visual stimulus features including orientation and spatial frequency. The stimulus- feature preferences of astrocytes were exquisitely mapped across the cortical surface, in close register with neuronal maps. The spatially restricted stimulus-specific component of the intrinsic hemodynamic mapping signal was highly sensitive to astrocyte activation, indicating that astrocytes have a key role in coupling neuronal organization to mapping signals critical for noninvasive brain imaging. Furthermore, blocking astrocyte glutamate transporters influenced the magnitude and duration of adjacent visually driven neuronal responses.	[Schummers, James; Yu, Hongbo; Sur, Mriganka] MIT, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health	Sur, M (corresponding author), MIT, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	msur@mit.edu		Schummers, James/0000-0002-1030-824X				Alitto HJ, 2004, J NEUROPHYSIOL, V91, P2797, DOI 10.1152/jn.00943.2003; Anderson CM, 2000, GLIA, V32, P1; Araque A, 2000, J NEUROSCI, V20, P666, DOI 10.1523/JNEUROSCI.20-02-00666.2000; Attwell D, 2002, TRENDS NEUROSCI, V25, P621, DOI 10.1016/S0166-2236(02)02264-6; Baker GE, 1998, EUR J NEUROSCI, V10, P2657, DOI 10.1046/j.1460-9568.1998.t01-1-00276.x; Basole A, 2003, NATURE, V423, P986, DOI 10.1038/nature01721; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Cauli B, 2004, J NEUROSCI, V24, P8940, DOI 10.1523/JNEUROSCI.3065-04.2004; CHAPMAN B, 1993, J NEUROSCI, V13, P5251, DOI 10.1523/JNEUROSCI.13-12-05251.1993; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; DANI JW, 1992, NEURON, V8, P429, DOI 10.1016/0896-6273(92)90271-E; Dragoi V, 2001, NATURE, V411, P80, DOI 10.1038/35075070; Fields RD, 2002, SCIENCE, V298, P556, DOI 10.1126/science.298.5593.556; Filosa JA, 2004, CIRC RES, V95, pE73, DOI 10.1161/01.RES.0000148636.60732.2e; FROSTIG RD, 1990, P NATL ACAD SCI USA, V87, P6082, DOI 10.1073/pnas.87.16.6082; Gurden H, 2006, NEURON, V52, P335, DOI 10.1016/j.neuron.2006.07.022; Haber M, 2006, J NEUROSCI, V26, P8881, DOI 10.1523/JNEUROSCI.1302-06.2006; Harder DR, 1998, STROKE, V29, P229, DOI 10.1161/01.STR.29.1.229; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Hertz L, 2004, TRENDS NEUROSCI, V27, P735, DOI 10.1016/j.tins.2004.10.008; Hirase H, 2004, PLOS BIOL, V2, P494, DOI 10.1371/journal.pbio.0020096; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Hubener M, 1997, J NEUROSCI, V17, P9270; Issa NP, 2000, J NEUROSCI, V20, P8504, DOI 10.1523/JNEUROSCI.20-22-08504.2000; JAN DD, 2005, J NEUROSCI, V25, P2917, DOI DOI 10.1523/JNEUR0SCI.5042-04.2005; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Kang N, 2005, J NEUROPHYSIOL, V94, P4121, DOI 10.1152/jn.00448.2005; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; Marino J, 2005, NAT NEUROSCI, V8, P194, DOI 10.1038/nn1391; Metea MR, 2006, J NEUROSCI, V26, P2862, DOI 10.1523/JNEUROSCI.4048-05.2006; Montana V, 2004, J NEUROSCI, V24, P2633, DOI 10.1523/JNEUROSCI.3770-03.2004; Mulligan SJ, 2004, NATURE, V431, P195, DOI 10.1038/nature02827; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; Newman EA, 2003, TRENDS NEUROSCI, V26, P536, DOI 10.1016/S0166-2236(03)00237-6; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Ohki K, 2006, NATURE, V442, P925, DOI 10.1038/nature05019; Perea G, 2005, J NEUROSCI, V25, P2192, DOI 10.1523/JNEUROSCI.3965-04.2005; Polimeni JR, 2005, P NATL ACAD SCI USA, V102, P4158, DOI 10.1073/pnas.0500291102; Porter JT, 1996, J NEUROSCI, V16, P5073; Rancillac A, 2006, J NEUROSCI, V26, P6997, DOI 10.1523/JNEUROSCI.5515-05.2006; Schummers J, 2005, PROG BRAIN RES, V149, P65, DOI 10.1016/S0079-6123(05)49006-8; Schummers J, 2002, NEURON, V36, P969, DOI 10.1016/S0896-6273(02)01012-7; Sharpee TO, 2006, NATURE, V439, P936, DOI 10.1038/nature04519; Smetters D, 1999, METHODS, V18, P215, DOI 10.1006/meth.1999.0774; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999; Verkhratsky A, 1998, PHYSIOL REV, V78, P99, DOI 10.1152/physrev.1998.78.1.99; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Wang XH, 2006, NAT NEUROSCI, V9, P816, DOI 10.1038/nn1703; Yu H, 2005, NEURON, V47, P267, DOI 10.1016/j.neuron.2005.06.011; Zhang JM, 2003, NEURON, V40, P971, DOI 10.1016/S0896-6273(03)00717-7; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	55	431	446	4	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 20	2008	320	5883					1638	1643		10.1126/science.1156120	http://dx.doi.org/10.1126/science.1156120			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	315NM	18566287				2022-12-28	WOS:000256886700049
J	Hanson, R; Awschalom, DD				Hanson, Ronald; Awschalom, David D.			Coherent manipulation of single spins in semiconductors	NATURE			English	Review							DOUBLE-QUANTUM DOT; ELECTRON-SPIN; OPTICAL MANIPULATION; COUPLED ELECTRON; DIAMOND; COMPUTATION; DYNAMICS; SPINTRONICS; RELAXATION; NUCLEI	During the past few years, researchers have gained unprecedented control over spins in the solid state. What was considered almost impossible a decade ago, in both conceptual and practical terms, is now a reality: single spins can be isolated, initialized, coherently manipulated and read out using both electrical and optical techniques. Progress has been made towards full control of the quantum states of single and coupled spins in a variety of semiconductors and nanostructures, and towards understanding the mechanisms through which spins lose coherence in these systems. These abilities will allow pioneering investigations of fundamental quantum-mechanical processes and provide pathways towards applications in quantum information processing.	[Hanson, Ronald] Delft Univ Technol, Kavli Inst Nanosci, NL-2600 GA Delft, Netherlands; [Awschalom, David D.] Univ Calif Santa Barbara, Calif Nanosyst Inst, Santa Barbara, CA 93106 USA	Delft University of Technology; University of California System; University of California Santa Barbara	Hanson, R (corresponding author), Delft Univ Technol, Kavli Inst Nanosci, POB 5046, NL-2600 GA Delft, Netherlands.	r.hanson@tudelft.nl; awsch@physics.ucsb.edu	Hanson, Ronald/B-9555-2008					Amasha S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.046803; Ashoori RC, 1996, NATURE, V379, P413, DOI 10.1038/379413a0; Atature M, 2007, NAT PHYS, V3, P101, DOI 10.1038/nphys521; Atature M, 2006, SCIENCE, V312, P551, DOI 10.1126/science.1126074; AVERIN DV, 1990, PHYS REV LETT, V65, P2446, DOI 10.1103/PhysRevLett.65.2446; Awschalom DD, 2007, SCI AM, V297, P84, DOI 10.1038/scientificamerican1007-84; Awschalom DD, 1999, PHYS TODAY, V52, P33, DOI 10.1063/1.882695; Barrett SD, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.060310; Baugh J, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.096804; Berezovsky J, 2008, SCIENCE, V320, P349, DOI 10.1126/science.1154798; Berezovsky J, 2006, SCIENCE, V314, P1916, DOI 10.1126/science.1133862; Besombes L, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.207403; Bracker AS, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.047402; Braun PF, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.116601; Bulaev DV, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.076805; Childress L, 2006, SCIENCE, V314, P281, DOI 10.1126/science.1131871; COHENTANNOUDJI C, 1972, PHYS REV A-GEN PHYS, V5, P968, DOI 10.1103/PhysRevA.5.968; Coish WA, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.125337; Coish WA, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.195340; DiVincenzo DP, 2000, FORTSCHR PHYS, V48, P771, DOI 10.1002/1521-3978(200009)48:9/11<771::AID-PROP771>3.0.CO;2-E; DiVincenzo DP, 2000, NATURE, V408, P339, DOI 10.1038/35042541; Elzerman JM, 2004, NATURE, V430, P431, DOI 10.1039/nature02693; Erwin SC, 2006, NAT NANOTECHNOL, V1, P98, DOI 10.1038/nnano.2006.117; Fujisawa T, 2002, NATURE, V419, P278, DOI 10.1038/nature00976; Gaebel T, 2006, NAT PHYS, V2, P408, DOI 10.1038/nphys318; Gerardot BD, 2008, NATURE, V451, P441, DOI 10.1038/nature06472; Giedke G, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.032316; Greilich A, 2007, SCIENCE, V317, P1896, DOI 10.1126/science.1146850; Gruber A, 1997, SCIENCE, V276, P2012, DOI 10.1126/science.276.5321.2012; Dutt MVG, 2007, SCIENCE, V316, P1312, DOI 10.1126/science.1139831; Hanson R, 2008, SCIENCE, V320, P352, DOI 10.1126/science.1155400; Hanson R, 2007, REV MOD PHYS, V79, P1217, DOI 10.1103/RevModPhys.79.1217; Hanson R, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.087601; Hanson R, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.196802; Hanson R, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.050502; Hayashi T, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.226804; Heiss D, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.241306; Hu XD, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.100501; Hu YJ, 2007, NAT NANOTECHNOL, V2, P622, DOI 10.1038/nnano.2007.302; Imamoglu A, 1999, PHYS REV LETT, V83, P4204, DOI 10.1103/PhysRevLett.83.4204; Jelezko F, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.130501; Jelezko F, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.076401; Jelezko F, 2002, APPL PHYS LETT, V81, P2160, DOI 10.1063/1.1507838; Johnson AC, 2005, NATURE, V435, P925, DOI 10.1038/nature03815; Jung SW, 2004, APPL PHYS LETT, V85, P768, DOI 10.1063/1.1777802; Kane BE, 1998, NATURE, V393, P133, DOI 10.1038/30156; KASTNER MA, 1993, PHYS TODAY, V46, P24, DOI 10.1063/1.881393; Kato Y, 2003, SCIENCE, V299, P1201, DOI 10.1126/science.1080880; Kennedy TA, 2003, APPL PHYS LETT, V83, P4190, DOI 10.1063/1.1626791; Khaetskii AV, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.186802; Klauser D, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.205302; Koppens FHL, 2006, NATURE, V442, P766, DOI 10.1038/nature05065; Koppens FHL, 2005, SCIENCE, V309, P1346, DOI 10.1126/science.1113719; Kouwenhoven L, 1998, PHYS WORLD, V11, P35; Kouwenhoven LP, 2001, REP PROG PHYS, V64, P701, DOI 10.1088/0034-4885/64/6/201; Kroutvar M, 2004, NATURE, V432, P81, DOI 10.1038/nature03008; Laird EA, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.246601; Leger Y, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.107401; Levy J, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.147902; Liu HW, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.073310; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; Mason N, 2004, SCIENCE, V303, P655, DOI 10.1126/science.1093605; Meier F., 1984, OPTICAL ORIENTATION; Meijer J, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2103389; Merkulov IA, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.205309; Mikkelsen MH, 2007, NAT PHYS, V3, P770, DOI 10.1038/nphys736; Moehring DL, 2007, NATURE, V449, P68, DOI 10.1038/nature06118; Myers RC, 2008, NAT MATER, V7, P203, DOI 10.1038/nmat2123; Nowack KC, 2007, SCIENCE, V318, P1430, DOI 10.1126/science.1148092; Ono K, 2002, SCIENCE, V297, P1313, DOI 10.1126/science.1070958; Park YS, 2006, NANO LETT, V6, P2075, DOI 10.1021/nl061342r; Petta JR, 2005, SCIENCE, V309, P2180, DOI 10.1126/science.1116955; PIOROLADRIERE M, 2008, ELECT DRIVEN SINGLE; Rabeau JR, 2007, NANO LETT, V7, P3433, DOI 10.1021/nl0719271; Rabeau JR, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2158700; Reynhardt EC, 1998, J CHEM PHYS, V109, P8471, DOI 10.1063/1.477511; Santori C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.247401; Sapmaz S, 2006, NANO LETT, V6, P1350, DOI 10.1021/nl052498e; Simmons CB, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2816331; Stepanenko D, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.136401; TAKAHASHI S, 2008, QUENCHING SPIN DECOH; Tamarat P, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.083002; Taylor JM, 2005, NAT PHYS, V1, P177, DOI 10.1038/nphys174; Wolf SA, 2001, SCIENCE, V294, P1488, DOI 10.1126/science.1065389; Zrenner A, 2002, NATURE, V418, P612, DOI 10.1038/nature00912	86	371	376	2	138	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2008	453	7198					1043	1049		10.1038/nature07129	http://dx.doi.org/10.1038/nature07129			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314WM	18563155				2022-12-28	WOS:000256839900046
J	Vedral, V				Vedral, Vlatko			Quantifying entanglement in macroscopic systems	NATURE			English	Review							QUANTUM-MECHANICS; CURRENT SITUATION; STATES	Traditionally, entanglement was considered to be a quirk of microscopic objects that defied a common-sense explanation. Now, however, entanglement is recognized to be ubiquitous and robust. With the realization that entanglement can occur in macroscopic systems - and with the development of experiments aimed at exploiting this fact - new tools are required to define and quantify entanglement beyond the original microscopic framework.	Univ Leeds, Sch Phys & Astron, Leeds LS2 9JT, W Yorkshire, England; Natl Univ Singapore, Ctr Quantum Technol, Singapore 117543, Singapore; Natl Univ Singapore, Dept Phys, Singapore 117542, Singapore	University of Leeds; National University of Singapore; National University of Singapore	Vedral, V (corresponding author), Univ Leeds, Sch Phys & Astron, Leeds LS2 9JT, W Yorkshire, England.	vlatko.vedral@quantuminfo.org	Vedral, Vlatko/L-3270-2016; vedral, vlatko/P-1712-2014	Vedral, Vlatko/0000-0002-8588-2940; vedral, vlatko/0000-0003-4561-5124	EPSRC [EP/E004075/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/E004075/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Amico L, 2008, REV MOD PHYS, V80, P517, DOI 10.1103/RevModPhys.80.517; ANDERS J, 2008, QUANTUM INF COMPUT, V8; Anders J, 2007, OPEN SYST INF DYN, V14, P1, DOI 10.1007/s11080-007-9034-6; ANDERSON PW, 1973, MAT RES B, V81, P53; Arnesen MC, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.017901; BAUGH J, 2007, QUANTUM INFORMATION; Brukner C, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.012110; BRUKNER C, 2004, MACROSCOPIC THERMODY; Chandran A, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.170502; De Chiara G, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/6/095; Dur W, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.062314; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; Greenberger DM, 1989, BELLS THEOREM QUANTU, P73; Haffner H, 2005, NATURE, V438, P643, DOI 10.1038/nature04279; Heaney L, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.053605; Horodecki M, 1996, PHYS LETT A, V223, P1, DOI 10.1016/S0375-9601(96)00706-2; Horodecki M, 2001, QUANTUM INF COMPUT, V1, P3; Leggett A J, 1980, PROG THEOR PHYS SUPP, V69, P80; Lu CY, 2007, NAT PHYS, V3, P91, DOI 10.1038/nphys507; Narnhofer H, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.052326; Osborne TJ, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.032110; Osterloh A, 2002, NATURE, V416, P608, DOI 10.1038/416608a; PAGE DN, 1983, PHYS REV D, V27, P2885, DOI 10.1103/PhysRevD.27.2885; Recher P, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.165327; Schrodinger E, 1935, NATURWISSENSCHAFTEN, V23, P844, DOI 10.1007/BF01491987; Schrodinger E, 1935, NATURWISSENSCHAFTEN, V23, P807, DOI 10.1007/BF01491891; Schroedinger E., 1935, NATURWISSENSCHAFTEN, V23, P823, DOI [DOI 10.1007/BF01491914, 10.1007/BF01491914]; Toth G, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.052327; TOTH G, 2004, PHYS REV LETT, V94; Vedral V, 2006, NATURE, V439, P397, DOI 10.1038/439397a; Vedral V, 2004, NEW J PHYS, V6, DOI 10.1088/1367-2630/6/1/102; Vedral V, 2003, CENT EUR J PHYS, V1, P289, DOI 10.2478/BF02476298; Vedral V, 1997, PHYS REV LETT, V78, P2275, DOI 10.1103/PhysRevLett.78.2275; Verstraete F, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.010404; WERNER RF, 1989, PHYS REV A, V40, P4277, DOI 10.1103/PhysRevA.40.4277; Zeilinger A, 2005, NATURE, V433, P230, DOI 10.1038/nature03280	37	117	120	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2008	453	7198					1004	1007		10.1038/nature07124	http://dx.doi.org/10.1038/nature07124			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314WM	18563150				2022-12-28	WOS:000256839900041
J	Muller, D				Muller, D.			Trial by fire: In memoriam (vol 149, pg 60, 2008)	ANNALS OF INTERNAL MEDICINE			English	Correction																		Muller D, 2008, ANN INTERN MED, V149, P519, DOI 10.7326/0003-4819-149-1-200807010-00014	1	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 7	2008	149	7					519	519		10.7326/0003-4819-149-1-200807010-00014	http://dx.doi.org/10.7326/0003-4819-149-1-200807010-00014			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359QY	18591639				2022-12-28	WOS:000260004400019
J	Kumar, P; Narayan, R; Johnson, JL				Kumar, Pawan; Narayan, Ramesh; Johnson, Jarrett L.			Properties of gamma-ray burst progenitor stars	SCIENCE			English	Article							ACCRETION; AFTERGLOWS; LIGHT; JET	We determined some basic properties of stars that produce spectacular gamma-ray bursts at the end of their lives. We assumed that accretion of the outer portion of the stellar core by a central black hole fuels the prompt emission and that fall-back and accretion of the stellar envelope later produce the plateau in the x-ray light curve seen in some bursts. Using x-ray data for three bursts, we estimated the radius of the stellar core to be similar to(1-3) x 10(10) cm and that of the stellar envelope to be similar to(1 - 2) x 10(11) cm. The density profile in the envelope is fairly shallow, with rho similar to r(-2) (where rho is density and r is distance from the center of the explosion). The rotation speeds of the core and envelope are similar to 0.05 and similar to 0.2 of the local Keplerian speed, respectively.	[Kumar, Pawan; Johnson, Jarrett L.] Univ Texas Austin, Dept Astron, Austin, TX 78712 USA; [Narayan, Ramesh] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA	University of Texas System; University of Texas Austin; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution	Kumar, P (corresponding author), Univ Texas Austin, Dept Astron, RLM 15308, Austin, TX 78712 USA.	pk@astro.as.utexas.edu		Narayan, Ramesh/0000-0002-1919-2730				Burrows DN, 2005, SCIENCE, V309, P1833, DOI 10.1126/science.1116168; Fan YZ, 2006, MON NOT R ASTRON SOC, V369, P197, DOI 10.1111/j.1365-2966.2006.10280.x; Katz JI, 1998, PHYS REV LETT, V80, P1580, DOI 10.1103/PhysRevLett.80.1580; Kohri K, 2005, ASTROPHYS J, V629, P341, DOI 10.1086/431354; Kumar P, 2000, ASTROPHYS J, V541, pL51, DOI 10.1086/312905; Matzner CD, 2003, MON NOT R ASTRON SOC, V345, P575, DOI 10.1046/j.1365-8711.2003.06969.x; McKinney JC, 2005, ASTROPHYS J, V630, pL5, DOI 10.1086/468184; Narayan R, 2001, ASTROPHYS J, V557, P949, DOI 10.1086/322267; Paczynski B, 1998, ASTROPHYS J, V494, pL45, DOI 10.1086/311148; Panaitescu A, 2006, MON NOT R ASTRON SOC, V369, P2059, DOI 10.1111/j.1365-2966.2006.10453.x; Ramirez-Ruiz E, 2002, MON NOT R ASTRON SOC, V337, P1349, DOI 10.1046/j.1365-8711.2002.05995.x; Vaughan S, 2006, ASTROPHYS J, V638, P920, DOI 10.1086/499069; WOOSLEY SE, 1993, ASTROPHYS J, V405, P273, DOI 10.1086/172359; Zhang B, 2007, CHINESE J ASTRON AST, V7, P1, DOI 10.1088/1009-9271/7/1/01	14	86	87	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2008	321	5887					376	379		10.1126/science.1159003	http://dx.doi.org/10.1126/science.1159003			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FB	18583579	Green Submitted			2022-12-28	WOS:000257713900041
J	Stuckler, D; McKee, M				Stuckler, David; McKee, Martin			Five metaphors about global-health policy	LANCET			English	Editorial Material									[Stuckler, David] Univ Cambridge, Dept Sociol, Fac Social & Polit Sci, Cambridge CB2 1ST, England; [McKee, Martin] London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit, London WC1, England	University of Cambridge; University of London; London School of Hygiene & Tropical Medicine	Stuckler, D (corresponding author), Univ Cambridge, Dept Sociol, Fac Social & Polit Sci, Cambridge CB2 1ST, England.	ds450@cam.ac.uk	Mckee, Martin/E-6673-2018; McKee, Marc D/E-2187-2011; Stuckler, David/H-2261-2012	Mckee, Martin/0000-0002-0121-9683; McKee, Marc D/0000-0001-8349-965X; Stuckler, David/0000-0002-1288-8401				CHONG JR, 2008, LOS ANGELES TIM 0103; Donaldson L, 2007, LANCET, V369, P857, DOI 10.1016/S0140-6736(07)60327-4; EZZASTI M, 2004, COMP QUANTIFICATION; Horton R, 2007, LANCET, V369, P806, DOI 10.1016/S0140-6736(07)60378-X; Institute of Medicine, 1997, AM VIT INT GLOB HLTH; Lau RR, 2005, POLIT PSYCHOL, V26, P77, DOI 10.1111/j.1467-9221.2005.00410.x; Lederberg J, 1996, JAMA-J AM MED ASSOC, V276, P417, DOI 10.1001/jama.276.5.417; Obama B, 2007, FOREIGN AFF, V86, P2; Smith M, 1996, LANCET, V347, P1760, DOI 10.1016/S0140-6736(96)90836-3; STOERE J, 2007, LANCET, V369, P1373; *WHO, 2001, REP COMM MACR HLTH; *WHO, 2003, PRIM HLTH CAR FRAM F	12	47	48	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 12	2008	372	9633					95	97		10.1016/S0140-6736(08)61013-2	http://dx.doi.org/10.1016/S0140-6736(08)61013-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	324XJ	18620934	Green Published, Bronze			2022-12-28	WOS:000257552400008
J	Golledge, J; Eagle, KA				Golledge, Jonathan; Eagle, Kim A.			Acute aortic dissection	LANCET			English	Article							STENT-GRAFT PLACEMENT; HELICAL COMPUTED-TOMOGRAPHY; SYNDROME TYPE-IV; INTERNATIONAL-REGISTRY; SURGICAL-TREATMENT; ENDOVASCULAR REPAIR; MOUSE MODEL; VALVE; POPULATION; MANAGEMENT	We summarise advances in the epidemiology, presentation, pathogenesis, diagnosis, and management of acute aortic dissection. improved understanding of this problem has been assisted not only by establishment of an international registry but also by progress in molecular biology and genetics of connective-tissue diseases. Advances in endovascular products and techniques have provided new treatment options. Open surgical repair remains the main treatment for dissection in the ascending aorta, whereas endovascular treatment is increasingly being used in dissection that is limited to other parts of the aorta.	[Golledge, Jonathan] James Cook Univ, Sch Med, Dept Surg, Vasc Biol Unit, Townsville, Qld 4811, Australia; [Eagle, Kim A.] Univ Michigan Hlth Syst, Ctr Cardiovasc, Ann Arbor, MI USA	James Cook University; University of Michigan System; University of Michigan	Golledge, J (corresponding author), James Cook Univ, Sch Med, Dept Surg, Vasc Biol Unit, Townsville, Qld 4811, Australia.	jonathan.golledge@jcu.edu.au	golledge, jonathan/I-2371-2013		NHLBI NIH HHS [R01 HL080010-01] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080010] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Albornoz G, 2006, ANN THORAC SURG, V82, P1400, DOI 10.1016/j.athoracsur.2006.04.098; ARTS CHP, 2007, VASCULAR ENDOVASCULA; Bonderman D, 1999, CIRCULATION, V99, P2138, DOI 10.1161/01.CIR.99.16.2138; Bondy CA, 2006, J CLIN ENDOCR METAB, V91, P1785, DOI 10.1210/jc.2005-2625; Boutouyrie P, 2004, CIRCULATION, V109, P1530, DOI 10.1161/01.CIR.0000121741.50315.C2; Bunton TE, 2001, CIRC RES, V88, P37, DOI 10.1161/01.RES.88.1.37; Burt CW, 1999, AM J EMERG MED, V17, P552, DOI 10.1016/S0735-6757(99)90195-X; Centofanti P, 2006, ANN THORAC SURG, V82, P1658, DOI 10.1016/j.athoracsur.2006.05.065; Chavan A, 2005, J VASC INTERV RADIOL, V16, P823; Chen SL, 2006, CATHETER CARDIO INTE, V68, P319, DOI 10.1002/ccd.20821; Chung JW, 2000, RADIOLOGY, V214, P99, DOI 10.1148/radiology.214.1.r00ja3499; Clouse WD, 2004, MAYO CLIN PROC, V79, P176, DOI 10.4065/79.2.176; Collins JS, 2004, CIRCULATION, V110, pII237, DOI 10.1161/01.CIR.0000138219.67028.2a; Cripe L, 2004, J AM COLL CARDIOL, V44, P138, DOI 10.1016/j.jacc.2004.03.050; Dake MD, 1999, NEW ENGL J MED, V340, P1546, DOI 10.1056/NEJM199905203402004; Eagle KA, 2002, CIRCULATION, V105, P1529, DOI 10.1161/01.CIR.105.13.1529; Easo J, 2007, J ENDOVASC THER, V14, P260, DOI 10.1583/1545-1550(2007)14[260:TSPTTA]2.0.CO;2; Eggebrecht H, 2004, J AM COLL CARDIOL, V44, P804, DOI 10.1016/j.jacc.2004.04.053; Eggebrecht H, 2004, J ENDOVASC THER, V11, P161, DOI 10.1583/03-1114.1; Eggebrecht H, 2006, EUR HEART J, V27, P489, DOI 10.1093/eurheartj/ehi493; Erbel R, 2001, EUR HEART J, V22, P1642, DOI 10.1053/euhj.2001.2782; Estrera AL, 2007, ANN THORAC SURG, V83, pS842, DOI 10.1016/j.athoracsur.2006.10.081; Estrera AL, 2006, CIRCULATION, V114, pI384, DOI 10.1161/CIRCULATIONAHA.105.001479; Fattori R, 2006, EUR J VASC ENDOVASC, V31, P115, DOI 10.1016/j.ejvs.2005.10.016; Fedak PWM, 2003, J THORAC CARDIOV SUR, V126, P797, DOI 10.1016/S0022-5223(03)00398-2; Gaul C, 2007, STROKE, V38, P292, DOI 10.1161/01.STR.0000254594.33408.b1; Genoni M, 2002, EUR J CARDIO-THORAC, V22, P59, DOI 10.1016/S1010-7940(02)00203-8; Groenink M, 1999, HEART, V82, P499, DOI 10.1136/hrt.82.4.499; Guo DC, 2001, CIRCULATION, V103, P2461; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Hagan PG, 2000, JAMA-J AM MED ASSOC, V283, P897, DOI 10.1001/jama.283.7.897; Hasham SN, 2003, CIRCULATION, V107, P3184, DOI 10.1161/01.CIR.0000078634.33124.95; Hata M, 2007, CIRC J, V71, P1279, DOI 10.1253/circj.71.1279; Herold U, 2006, HERZ, V31, P434, DOI 10.1007/s00059-006-2839-1; Homme JL, 2006, AM J SURG PATHOL, V30, P1159, DOI 10.1097/01.pas.0000213270.38091.69; Januzzi JL, 2004, J AM COLL CARDIOL, V43, P665, DOI 10.1016/j.jacc.2003.08.054; Johnson TRC, 2007, AM J ROENTGENOL, V188, P76, DOI 10.2214/AJR.05.1153; Judge DP, 2005, LANCET, V366, P1965, DOI 10.1016/S0140-6736(05)67789-6; Lansman SL, 2002, ANN THORAC SURG, V74, pS1833, DOI 10.1016/S0003-4975(02)04134-6; Lauterbach SR, 2001, J VASC SURG, V33, P1185, DOI 10.1067/mva.2001.115377; Leurs LJ, 2004, J VASC SURG, V40, P670, DOI 10.1016/j.jvs.2004.07.008; Loeys BL, 2006, NEW ENGL J MED, V355, P788, DOI 10.1056/NEJMoa055695; Manfredini R, 2004, J VASC SURG, V40, P382, DOI 10.1016/j.jvs.2004.04.019; Mehta RH, 2002, CIRCULATION, V106, P1110, DOI 10.1161/01.CIR.0000027568.39540.4B; Mehta RH, 2002, CIRCULATION, V105, P200, DOI 10.1161/hc0202.102246; Mestres Carlos-A, 2007, Interact Cardiovasc Thorac Surg, V6, P257; Meszaros I, 2000, CHEST, V117, P1271, DOI 10.1378/chest.117.5.1271; MILLARCRAIG MW, 1978, LANCET, V1, P795; Miller DC, 2007, ANN THORAC SURG, V83, pS736, DOI 10.1016/j.athoracsur.2006.10.101; Miller DC, 2002, ANN THORAC SURG, V74, pS1857, DOI 10.1016/S0003-4975(02)04263-7; Mizuguchi T, 2004, NAT GENET, V36, P855, DOI 10.1038/ng1392; Mochizuki S, 2007, LANCET, V369, P1431, DOI 10.1016/S0140-6736(07)60669-2; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Nienaber CA, 2004, CIRCULATION, V109, P3014, DOI 10.1161/01.CIR.0000130644.78677.2C; Nienaber CA, 2005, AM HEART J, V149, P592, DOI 10.1016/j.ahj.2004.05.060; Nienaber CA, 1999, NEW ENGL J MED, V340, P1539, DOI 10.1056/NEJM199905203402003; Nienaber CA, 2006, J ENDOVASC THER, V13, P738, DOI 10.1583/06-1923.1; Nistri S, 2005, AM J CARDIOL, V96, P718, DOI 10.1016/j.amjcard.2005.04.051; Oderich GS, 2005, J VASC SURG, V42, P98, DOI 10.1016/j.jvs.2005.03.053; Olsson C, 2006, CIRCULATION, V114, P2611, DOI 10.1161/CIRCULATIONAHA.106.630400; Pannu H, 2005, CIRCULATION, V112, P513, DOI 10.1161/CIRCULATIONAHA.105.537340; Pape LA, 2007, CIRCULATION, V116, P1120, DOI 10.1161/CIRCULATIONAHA.107.702720; Pepin M, 2000, NEW ENGL J MED, V342, P673, DOI 10.1056/NEJM200003093421001; Pretre R, 1997, LANCET, V349, P1461, DOI 10.1016/S0140-6736(96)09372-5; Ramirez F, 2004, PHYSIOL GENOMICS, V19, P151, DOI 10.1152/physiolgenomics.00092.2004; Rampoldi V, 2007, ANN THORAC SURG, V83, P55, DOI 10.1016/j.athoracsur.2006.08.007; Resch TA, 2006, J CARDIOVASC SURG, V47, P503; Roseborough G, 2004, J VASC SURG, V40, P235, DOI 10.1016/j.jvs.2004.05.019; Santini F, 2007, INT J CARDIOL, V115, P305, DOI 10.1016/j.ijcard.2006.03.013; Shiga T, 2006, ARCH INTERN MED, V166, P1350, DOI 10.1001/archinte.166.13.1350; Shinohara T, 2003, ARTERIOSCL THROM VAS, V23, P1839, DOI 10.1161/01.ATV.0000085016.02363.80; SHORES J, 1994, NEW ENGL J MED, V330, P1335, DOI 10.1056/NEJM199405123301902; Sorokin VA, 2007, ANN THORAC SURG, V83, P666, DOI 10.1016/j.athoracsur.2006.07.057; Sundt TM, 2007, ANN THORAC SURG, V83, pS835, DOI 10.1016/j.athoracsur.2006.11.019; Suzuki T, 2000, ANN INTERN MED, V133, P537, DOI 10.7326/0003-4819-133-7-200010030-00013; Suzuki T, 2003, CIRCULATION, V108, P312, DOI 10.1161/01.cir.0000087386.07204.09; Tan MESH, 2005, ANN THORAC SURG, V80, P523, DOI 10.1016/j.athoracsur.2005.02.059; Trimarchi S, 2006, CIRCULATION, V114, pI357, DOI 10.1161/CIRCULATIONAHA.105.000620; Troxler M, 2001, BRIT J SURG, V88, P1169, DOI 10.1046/j.0007-1323.2001.01837.x; Tsai TT, 2007, CIRCULATION, V116, pI150, DOI 10.1161/CIRCULATIONAHA.106.681510; Tsai TT, 2007, NEW ENGL J MED, V357, P349, DOI 10.1056/NEJMoa063232; Tsai TT, 2006, CIRCULATION, V114, P2226, DOI 10.1161/CIRCULATIONAHA.106.622340; Tsai TT, 2006, CIRCULATION, V114, pI350, DOI 10.1161/CIRCULATIONAHA.105.000497; Umana JP, 2002, J THORAC CARDIOV SUR, V124, P896, DOI 10.1067/mtc.2002.123131; Van Kien PK, 2005, CIRCULATION, V112, P200, DOI 10.1161/CIRCULATIONAHA.104.506345; Wang XW, 2005, SURGERY, V138, P352, DOI 10.1016/j.surg.2005.06.006; Williams DM, 1997, RADIOLOGY, V203, P37, DOI 10.1148/radiology.203.1.9122414; Williams DM, 1997, RADIOLOGY, V203, P23, DOI 10.1148/radiology.203.1.9122399; Willoteaux S, 2004, EUR RADIOL, V14, P1999, DOI 10.1007/s00330-004-2441-y; Xu SD, 2006, J VASC SURG, V43, P1090, DOI 10.1016/j.jvs.2005.12.070; Zoppi N, 2004, J BIOL CHEM, V279, P18157, DOI 10.1074/jbc.M312609200	91	330	367	2	34	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 5	2008	372	9632					55	66		10.1016/S0140-6736(08)60994-0	http://dx.doi.org/10.1016/S0140-6736(08)60994-0			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	321XN	18603160				2022-12-28	WOS:000257339900033
J	Head, JW; Murchie, SL; Prockter, LM; Robinson, MS; Solomon, SC; Strom, RG; Chapman, CR; Watters, TR; McClintock, WE; Blewett, DT; Gillis-Davis, JJ				Head, James W.; Murchie, Scott L.; Prockter, Louise M.; Robinson, Mark S.; Solomon, Sean C.; Strom, Robert G.; Chapman, Clark R.; Watters, Thomas R.; McClintock, William E.; Blewett, David T.; Gillis-Davis, Jeffrey J.			Volcanism on Mercury: Evidence from the first MESSENGER flyby	SCIENCE			English	Article							LUNAR; CRATERS; CLASSIFICATION; TECTONISM; MISSION; GEOLOGY; ORIGIN; VENUS	The origin of plains on Mercury, whether by volcanic flooding or impact ejecta ponding, has been controversial since the Mariner 10 flybys ( 1974- 75). High- resolution images ( down to 150 meters per pixel) obtained during the first MESSENGER flyby show evidence for volcanic vents around the Caloris basin inner margin and demonstrate that plains were emplaced sequentially inside and adjacent to numerous large impact craters, to thicknesses in excess of several kilometers. Radial graben and a floor- fractured crater may indicate intrusive activity. These observations, coupled with additional evidence from color images and impact crater size- frequency distributions, support a volcanic origin for several regions of plains and substantiate the important role of volcanism in the geological history of Mercury.	[Head, James W.] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Murchie, Scott L.; Prockter, Louise M.; Blewett, David T.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Robinson, Mark S.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Solomon, Sean C.] Carnegie Inst Washington, Dept Terr Magnetism, Washington, DC 20015 USA; [Strom, Robert G.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Chapman, Clark R.] SW Res Inst, Boulder, CO 80302 USA; [Watters, Thomas R.] Smithsonian Inst, Natl Air & Space Museum, Ctr Earth & Planetary Studies, Washington, DC 20560 USA; [McClintock, William E.] Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80303 USA; [Gillis-Davis, Jeffrey J.] Univ Hawaii, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA	Brown University; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Arizona State University; Arizona State University-Tempe; Carnegie Institution for Science; University of Arizona; Smithsonian Institution; University of Colorado System; University of Colorado Boulder; University of Hawaii System	Head, JW (corresponding author), Brown Univ, Dept Geol Sci, Providence, RI 02912 USA.	James_Head@brown.edu	Murchie, Scott L/E-8030-2015; Blewett, David T/I-4904-2012; Robinson, Mark/ABI-6841-2020	Murchie, Scott L/0000-0002-1616-8751; Blewett, David T/0000-0002-9241-6358; 				Elkins-Tanton LT, 2004, EARTH PLANET SC LETT, V222, P17, DOI 10.1016/j.epsl.2004.02.017; HALL JL, 1981, J GEOPHYS RES, V86, P9537, DOI 10.1029/JB086iB10p09537; Head JW, 2007, SPACE SCI REV, V131, P41, DOI 10.1007/s11214-007-9263-6; HEAD JW, 1980, MOON PLANETS, V22, P235, DOI 10.1007/BF00898434; HEAD JW, 1982, MOON PLANETS, V26, P61, DOI 10.1007/BF00941369; HEAD JW, 2000, ENV EFFECTS VOLCANIC, P143; Krassilnikov AS, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001983; LUCCHITTA BK, 1974, P LUNAR PLANET SCI C, V5, P223; Malin M.C., 1978, P LUNAR PLANET SCI C, V9, P3395; Milkovich SM, 2002, METEORIT PLANET SCI, V37, P1209, DOI 10.1111/j.1945-5100.2002.tb00890.x; Murchie SL, 2008, SCIENCE, V321, P73, DOI 10.1126/science.1159261; MURRAY BC, 1975, J GEOPHYS RES, V80, P2508, DOI 10.1029/JB080i017p02508; OBERBECK VR, 1975, REV GEOPHYS, V13, P337, DOI 10.1029/RG013i002p00337; PARFITT EA, 1993, EARTH MOON PLANETS, V61, P249, DOI 10.1007/BF00572247; PIKE RJ, 1988, MERCURY, P165; Robinson MS, 2008, SCIENCE, V321, P66, DOI 10.1126/science.1160080; Robinson MS, 1997, SCIENCE, V275, P197, DOI 10.1126/science.275.5297.197; SCHULTZ PH, 1976, MOON PLANETS, V15, P241, DOI 10.1007/BF00562240; SCHULTZ PH, 1977, PHYS EARTH PLANET IN, V15, P202, DOI 10.1016/0031-9201(77)90032-2; Solomon SC, 2008, SCIENCE, V321, P59, DOI 10.1126/science.1159706; Solomon SC, 2007, SPACE SCI REV, V131, P3, DOI 10.1007/s11214-007-9247-6; Spudis P.D., 1988, MERCURY, P118; STROM RG, 1975, J GEOPHYS RES, V80, P2478, DOI 10.1029/JB080i017p02478; STROM RG, 1977, PHYS EARTH PLANET IN, V15, P156, DOI 10.1016/0031-9201(77)90028-0; Strom RG, 2008, SCIENCE, V321, P79, DOI 10.1126/science.1159317; TRASK NJ, 1972, EARTH PLANET SC LETT, V14, P201, DOI 10.1016/0012-821X(72)90007-6; WATTERS TR, 1993, J GEOPHYS RES-PLANET, V98, P17049, DOI 10.1029/93JE01138; Wilhelms D. E., 1987, US GEOL SURV PROF PA, V1348, P1; WILHELMS DE, 1976, ICARUS, V28, P551, DOI 10.1016/0019-1035(76)90128-7	29	145	148	3	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 4	2008	321	5885					69	72		10.1126/science.1159256	http://dx.doi.org/10.1126/science.1159256			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QE	18599771				2022-12-28	WOS:000257320800035
J	Richardson, JD; Kasper, JC; Wang, C; Belcher, JW; Lazarus, AJ				Richardson, John D.; Kasper, Justin C.; Wang, Chi; Belcher, John W.; Lazarus, Alan J.			Cool heliosheath plasma and deceleration of the upstream solar wind at the termination shock	NATURE			English	Article							INTERSTELLAR MAGNETIC-FIELD; VOYAGER-1	The solar wind blows outward from the Sun and forms a bubble of solar material in the interstellar medium. The termination shock occurs where the solar wind changes from being supersonic ( with respect to the surrounding interstellar medium) to being subsonic. The shock was crossed by Voyager 1 at a heliocentric radius of 94 AU ( 1 AU is the Earth - Sun distance) in December 2004 ( refs 1 - 3). The Voyager 2 plasma experiment observed a decrease in solar wind speed commencing on about 9 June 2007, which culminated in several crossings of the termination shock between 30 August and 1 September 2007 ( refs 4 - 7). Since then, Voyager 2 has remained in the heliosheath, the region of shocked solar wind. Here we report observations of plasma at and near the termination shock and in the heliosheath. The heliosphere is asymmetric, pushed inward in the Voyager 2 direction relative to the Voyager 1 direction. The termination shock is a weak, quasi- perpendicular shock that heats the thermal plasma very little. An unexpected finding is that the flow is still supersonic with respect to the thermal ions downstream of the termination shock. Most of the solar wind energy is transferred to the pickup ions or other energetic particles both upstream of and at the termination shock.	[Richardson, John D.; Belcher, John W.; Lazarus, Alan J.] MIT, Kavli Inst Astrophys & Space Res, Cambridge, MA 02139 USA; [Richardson, John D.; Wang, Chi] Chinese Acad Sci, Ctr Space Sci & Appl Res, State Key Lab Space Weather, Beijing 100080, Peoples R China; [Kasper, Justin C.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA	Massachusetts Institute of Technology (MIT); Chinese Academy of Sciences; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution	Richardson, JD (corresponding author), MIT, Kavli Inst Astrophys & Space Res, 37-655, Cambridge, MA 02139 USA.	jdr@space.mit.edu	Kasper, Justin C/D-1152-2010	Kasper, Justin C/0000-0002-7077-930X; Wang, Chi/0000-0001-6991-9398				Berdichevsky DB, 2000, J GEOPHYS RES-SPACE, V105, P27289, DOI 10.1029/1999JA000367; BRIDGE HS, 1977, SPACE SCI REV, V21, P259, DOI 10.1007/BF00211542; Burlaga LF, 2005, SCIENCE, V309, P2027, DOI 10.1126/science.1117542; Decker RB, 2005, SCIENCE, V309, P2020, DOI 10.1126/science.1117569; GIACALONE J, 2007, EOS, V88; Gloeckler G, 2005, ESA SPEC PUBL, V592, P107; Gurnett DA, 2005, SCIENCE, V309, P2025, DOI 10.1126/science.1117425; Izmodenov V, 2005, ASTRON ASTROPHYS, V429, P1069, DOI 10.1051/0004-6361:20041348; Jokipii JR, 2004, ASTROPHYS J, V611, pL141, DOI 10.1086/423993; Lallement R, 2005, SCIENCE, V307, P1447, DOI 10.1126/science.1107953; Lipatov AS, 1999, PHYS REV LETT, V82, P3609, DOI 10.1103/PhysRevLett.82.3609; Opher M, 2007, SCIENCE, V316, P875, DOI 10.1126/science.1139480; Opher M, 2006, ASTROPHYS J, V640, pL71, DOI 10.1086/503251; Pogorelov NV, 2007, ASTROPHYS J, V668, P611, DOI 10.1086/520952; Pogorelov NV, 2006, ASTROPHYS J, V644, P1299, DOI 10.1086/503703; Stone EC, 2005, SCIENCE, V309, P2017, DOI 10.1126/science.1117684; VINAS AF, 1986, J GEOPHYS RES, V91, P39, DOI 10.1029/JA091iA01p00039; Wang C, 2001, J GEOPHYS RES-SPACE, V106, P13007, DOI 10.1029/2000JA000388; Zank GP, 1996, J GEOPHYS RES-SPACE, V101, P457, DOI 10.1029/95JA02860	19	354	356	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2008	454	7200					63	66		10.1038/nature07024	http://dx.doi.org/10.1038/nature07024			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321MC	18596800				2022-12-28	WOS:000257308300035
J	Wachter, RM; Flanders, SA; Fee, C; Pronovost, PJ				Wachter, Robert M.; Flanders, Scott A.; Fee, Christopher; Pronovost, Peter J.			Public reporting of antibiotic timing in patients with pneumonia: Lessons from a flawed performance measure	ANNALS OF INTERNAL MEDICINE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; ACUTE MYOCARDIAL-INFARCTION; EMERGENCY-DEPARTMENT; MEDICARE PATIENTS; CORE MEASURES; OUTCOMES; TIME; MANAGEMENT; MORTALITY; QUALITY	The administration of antibiotics within 4 hours to patients with community-acquired pneumonia has been criticized as a quality standard because it pressures clinicians to rapidly administer antibiotics despite diagnostic uncertainty at the time of patients' initial presentations. The measure was recently revised (to 6 hours) in response to this criticism. On the basis of the experience with the 4-hour rule, the authors make 5 recommendations for the development of future publicly reported quality measures. First, results from samples with known diagnoses should be extrapolated cautiously, if at all, to patients without a diagnosis. Second, for some measures, "bands" of performance may make more sense than "all-or-nothing" expectations. Third, representative end users of quality measures should participate in measure development. Fourth, quality measurement and reporting programs should build in mechanisms to reassess measures over time. Finally, biases, both financial and intellectual, that may influence quality measure development should be minimized. These steps will increase the probability that future quality measures will improve care without creating negative unintended consequences.	[Wachter, Robert M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Michigan, Sch Med, Ann Arbor, MI USA; Johns Hopkins Sch Med, Baltimore, MD USA; Johns Hopkins Univ, Sch Publ Hlth, Baltimore, MD USA	University of California System; University of California San Francisco; University of Michigan System; University of Michigan; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Wachter, RM (corresponding author), Univ Calif San Francisco, Dept Med, Room M-994,505 Parnassus Ave, San Francisco, CA 94143 USA.	bobw@medicine.ucsf.edu						[Anonymous], Specifications Manual for Joint Commission National Quality Measures (v2018A); [Anonymous], 2007, MED HOSP VAL BAS PUR; Barlow G, 2007, THORAX, V62, P67, DOI 10.1136/thx.2005.056689; Cannon CP, 2000, JAMA-J AM MED ASSOC, V283, P2941, DOI 10.1001/jama.283.22.2941; Caplan LR, 1999, NEW ENGL J MED, V341, P1240; Dedier J, 2001, ARCH INTERN MED, V161, P2099, DOI 10.1001/archinte.161.17.2099; Fee C, 2006, ANN EMERG MED, V47, P505, DOI 10.1016/j.annemergmed.2005.11.046; Fee C, 2007, ANN EMERG MED, V50, P205, DOI 10.1016/j.annemergmed.2007.03.036; Fee C, 2007, ANN EMERG MED, V49, P553, DOI 10.1016/j.annemergmed.2006.11.008; Fine MJ, 1999, ARCH INTERN MED, V159, P970, DOI 10.1001/archinte.159.9.970; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Hayward RA, 2007, AM J MANAG CARE, V13, P126; Hayward RA, 2007, NEW ENGL J MED, V356, P951, DOI 10.1056/NEJMe068285; Houck PM, 2006, CHEST, V130, P1, DOI 10.1378/chest.130.1.1; Houck Peter M, 2005, Curr Opin Infect Dis, V18, P151, DOI 10.1097/01.qco.0000160905.94684.91; Houck PM, 2004, CHEST, V126, P320, DOI 10.1378/chest.126.1.320; Houck PM, 2004, ARCH INTERN MED, V164, P637, DOI 10.1001/archinte.164.6.637; Kanwar M, 2007, CHEST, V131, P1865, DOI 10.1378/chest.07-0164; Lindenauer PK, 2007, NEW ENGL J MED, V356, P486, DOI 10.1056/NEJMsa064964; Mandell LA, 2003, CLIN INFECT DIS, V37, P1405, DOI 10.1086/380488; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Meehan TP, 1997, JAMA-J AM MED ASSOC, V278, P2080, DOI 10.1001/jama.278.23.2080; Metersky ML, 2006, CHEST, V130, P16, DOI 10.1378/chest.130.1.16; Mitka M, 2007, JAMA-J AM MED ASSOC, V297, P1758, DOI 10.1001/jama.297.16.1758; Morrison LJ, 2000, JAMA-J AM MED ASSOC, V283, P2686, DOI 10.1001/jama.283.20.2686; Nolan T, 2006, JAMA-J AM MED ASSOC, V295, P1168, DOI 10.1001/jama.295.10.1168; Novack V, 2006, EUR J INTERN MED, V17, P43, DOI 10.1016/j.ejim.2005.07.008; Pines JM, 2007, ANN EMERG MED, V49, P561, DOI 10.1016/j.annemergmed.2006.12.007; Pines JM, 2006, ACAD EMERG MED, V13, P787, DOI 10.1197/j.aem.2006.02.015; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Rothman RE, 2006, ACAD EMERG MED, V13, P983, DOI 10.1197/j.aem.2006.07.019; Shojania KG, 2007, ANN INTERN MED, V147, P224, DOI 10.7326/0003-4819-147-4-200708210-00179; Silber SH, 2003, CHEST, V124, P1798, DOI 10.1378/chest.124.5.1798; Smith GCS, 2003, BRIT MED J, V327, P1459, DOI 10.1136/bmj.327.7429.1459; Vernon DD, 1999, PEDIATRICS, V103, P20, DOI 10.1542/peds.103.1.20; Wachter RM, 2006, JAMA-J AM MED ASSOC, V295, P2780, DOI 10.1001/jama.295.23.2780; Welker JA, 2008, ARCH INTERN MED, V168, P351, DOI 10.1001/archinternmed.2007.84; Yu KT, 2008, ANN EMERG MED, V51, P651, DOI 10.1016/j.annemergmed.2007.10.022	38	135	136	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 1	2008	149	1					29	+		10.7326/0003-4819-149-1-200807010-00007	http://dx.doi.org/10.7326/0003-4819-149-1-200807010-00007			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	323EZ	18591635				2022-12-28	WOS:000257428200004
J	Albert, J; Aliu, E; Anderhub, H; Antonelli, LA; Antoranz, P; Backes, M; Baixeras, C; Barrio, JA; Bartko, H; Bastieri, D; Becker, JK; Bednarek, W; Berger, K; Bernardini, E; Bigongiari, C; Biland, A; Bock, RK; Bonnoli, G; Bordas, P; Bosch-Ramon, V; Bretz, T; Britvitch, I; Camara, M; Carmona, E; Chilingarian, A; Commichau, S; Contreras, JL; Cortina, J; Costado, MT; Covino, S; Curtef, V; Dazzi, F; De Angelis, A; del Pozo, EDC; de los Reyes, R; De Lotto, B; De Maria, M; De Sabata, F; Mendez, CD; Dominguez, A; Dorner, D; Doro, M; Errando, M; Fagiolini, M; Ferenc, D; Fernandez, E; Firpo, R; Fonseca, MV; Font, L; Galante, N; Lopez, RJG; Garczarczyk, M; Gaug, M; Goebel, F; Hayashida, M; Herrero, A; Hohne, D; Hose, J; Hsu, CC; Huber, S; Jogler, T; Kneiske, TM; Kranich, D; La Barbera, A; Laille, A; Leonardo, E; Lindfors, E; Lombardi, S; Longo, F; Lopez, M; Lorenz, E; Majumdar, P; Maneva, G; Mankuzhiyil, N; Mannheim, K; Maraschi, L; Mariotti, M; Martinez, M; Mazin, D; Meucci, M; Meyer, M; Miranda, JM; Mirzoyan, R; Mizobuchi, S; Moles, M; Moralejo, A; Nieto, D; Nilsson, K; Ninkovic, J; Otte, N; Oya, I; Panniello, M; Paoletti, R; Paredes, JM; Pasanen, M; Pascoli, D; Pauss, F; Pegna, RG; Perez-Torres, MA; Persic, M; Peruzzo, L; Piccioli, A; Prada, F; Prandini, E; Puchades, N; Raymers, A; Rhode, W; Ribo, M; Rico, J; Rissi, M; Robert, A; Rugamer, S; Saggion, A; Saito, TY; Salvati, M; Sanchez-Conde, M; Sartori, P; Satalecka, K; Scalzotto, V; Scapin, V; Schmitt, R; Schweizer, T; Shayduk, M; Shinozaki, K; Shore, SN; Sidro, N; Sierpowska-Bartosik, A; Sillanpaa, A; Sobczynska, D; Spanier, F; Stamerra, A; Stark, LS; Takalo, L; Tavecchio, F; Temnikov, P; Tescaro, D; Teshima, M; Tluczykont, M; Torres, DF; Turini, N; Vankov, H; Venturini, A; Vitale, V; Wagner, RM; Wittek, W; Zabalza, V; Zandanel, F; Zanin, R; Zapatero, J				Albert, J.; Aliu, E.; Anderhub, H.; Antonelli, L. A.; Antoranz, P.; Backes, M.; Baixeras, C.; Barrio, J. A.; Bartko, H.; Bastieri, D.; Becker, J. K.; Bednarek, W.; Berger, K.; Bernardini, E.; Bigongiari, C.; Biland, A.; Bock, R. K.; Bonnoli, G.; Bordas, P.; Bosch-Ramon, V.; Bretz, T.; Britvitch, I.; Camara, M.; Carmona, E.; Chilingarian, A.; Commichau, S.; Contreras, J. L.; Cortina, J.; Costado, M. T.; Covino, S.; Curtef, V.; Dazzi, F.; De Angelis, A.; De Cea del Pozo, E.; de los Reyes, R.; De Lotto, B.; De Maria, M.; De Sabata, F.; Delgado Mendez, C.; Dominguez, A.; Dorner, D.; Doro, M.; Errando, M.; Fagiolini, M.; Ferenc, D.; Fernandez, E.; Firpo, R.; Fonseca, M. V.; Font, L.; Galante, N.; Garcia Lopez, R. J.; Garczarczyk, M.; Gaug, M.; Goebel, F.; Hayashida, M.; Herrero, A.; Hohne, D.; Hose, J.; Hsu, C. C.; Huber, S.; Jogler, T.; Kneiske, T. M.; Kranich, D.; La Barbera, A.; Laille, A.; Leonardo, E.; Lindfors, E.; Lombardi, S.; Longo, F.; Lopez, M.; Lorenz, E.; Majumdar, P.; Maneva, G.; Mankuzhiyil, N.; Mannheim, K.; Maraschi, L.; Mariotti, M.; Martinez, M.; Mazin, D.; Meucci, M.; Meyer, M.; Miranda, J. M.; Mirzoyan, R.; Mizobuchi, S.; Moles, M.; Moralejo, A.; Nieto, D.; Nilsson, K.; Ninkovic, J.; Otte, N.; Oya, I.; Panniello, M.; Paoletti, R.; Paredes, J. M.; Pasanen, M.; Pascoli, D.; Pauss, F.; Pegna, R. G.; Perez-Torres, M. A.; Persic, M.; Peruzzo, L.; Piccioli, A.; Prada, F.; Prandini, E.; Puchades, N.; Raymers, A.; Rhode, W.; Ribo, M.; Rico, J.; Rissi, M.; Robert, A.; Ruegamer, S.; Saggion, A.; Saito, T. Y.; Salvati, M.; Sanchez-Conde, M.; Sartori, P.; Satalecka, K.; Scalzotto, V.; Scapin, V.; Schmitt, R.; Schweizer, T.; Shayduk, M.; Shinozaki, K.; Shore, S. N.; Sidro, N.; Sierpowska-Bartosik, A.; Sillanpaa, A.; Sobczynska, D.; Spanier, F.; Stamerra, A.; Stark, L. S.; Takalo, L.; Tavecchio, F.; Temnikov, P.; Tescaro, D.; Teshima, M.; Tluczykont, M.; Torres, D. F.; Turini, N.; Vankov, H.; Venturini, A.; Vitale, V.; Wagner, R. M.; Wittek, W.; Zabalza, V.; Zandanel, F.; Zanin, R.; Zapatero, J.		MAGIC Collaboration	Very-high-energy gamma rays from a distant quasar: How transparent is the universe?	SCIENCE			English	Article							EXTRAGALACTIC BACKGROUND LIGHT; TELESCOPE; RADIATION; 3C-279; COUNTS	The atmospheric Cherenkov gamma- ray telescope MAGIC, designed for a low- energy threshold, has detected very- high- energy gamma rays from a giant flare of the distant Quasi- Stellar Radio Source ( in short: radio quasar) 3C 279, at a distance of more than 5 billion light- years ( a redshift of 0.536). No quasar has been observed previously in very- high- energy gamma radiation, and this is also the most distant object detected emitting gamma rays above 50 gigaelectron volts. Because high- energy gamma rays may be stopped by interacting with the diffuse background light in the universe, the observations by MAGIC imply a low amount for such light, consistent with that known from galaxy counts.	[Bartko, H.; Bock, R. K.; Carmona, E.; Galante, N.; Garczarczyk, M.; Goebel, F.; Hayashida, M.; Hose, J.; Hsu, C. C.; Jogler, T.; Lorenz, E.; Majumdar, P.; Mirzoyan, R.; Mizobuchi, S.; Ninkovic, J.; Otte, N.; Saito, T. Y.; Schweizer, T.; Shayduk, M.; Shinozaki, K.; Teshima, M.; Wagner, R. M.; Wittek, W.] Max Planck Inst Phys & Astrophys, D-80805 Munich, Germany; [Albert, J.; Berger, K.; Bretz, T.; Dorner, D.; Hohne, D.; Huber, S.; Mannheim, K.; Meyer, M.; Ruegamer, S.; Schmitt, R.; Spanier, F.] Univ Wurzburg, D-97074 Wurzburg, Germany; [Aliu, E.; Cortina, J.; Errando, M.; Fernandez, E.; Firpo, R.; Martinez, M.; Mazin, D.; Moralejo, A.; Puchades, N.; Rico, J.; Sidro, N.; Tescaro, D.; Zanin, R.] Univ Autonoma Barcelona, Inst Fis Altes Energies, E-08193 Barcelona, Spain; [Anderhub, H.; Biland, A.; Britvitch, I.; Commichau, S.; Kranich, D.; Lorenz, E.; Pauss, F.; Rissi, M.; Stark, L. S.] ETH, CH-8093 Zurich, Switzerland; [Antonelli, L. A.; Covino, S.; La Barbera, A.; Maraschi, L.; Salvati, M.; Tavecchio, F.] Natl Inst Astrophys, INAF, I-00136 Rome, Italy; [Antoranz, P.; Barrio, J. A.; Camara, M.; Contreras, J. L.; de los Reyes, R.; Fonseca, M. V.; Miranda, J. M.; Nieto, D.; Oya, I.] Univ Complutense, E-28040 Madrid, Spain; [Backes, M.; Becker, J. K.; Curtef, V.; Kneiske, T. M.; Rhode, W.] Tech Univ Dortmund, D-44221 Dortmund, Germany; [Baixeras, C.; Font, L.; Robert, A.; Zapatero, J.] Univ Autonoma Barcelona, E-08193 Barcelona, Spain; [Bartko, H.; Bock, R. K.; Carmona, E.; Galante, N.; Garczarczyk, M.; Goebel, F.; Hayashida, M.; Hose, J.; Hsu, C. C.; Jogler, T.; Lorenz, E.; Majumdar, P.; Mirzoyan, R.; Mizobuchi, S.; Ninkovic, J.; Otte, N.; Saito, T. Y.; Schweizer, T.; Shayduk, M.; Shinozaki, K.; Teshima, M.; Wagner, R. M.; Wittek, W.] Max Planck Inst Phys & Astrophys, D-80805 Munich, Germany; [Bastieri, D.; Bigongiari, C.; Bock, R. K.; Dazzi, F.; Doro, M.; Lombardi, S.; Lopez, M.; Mariotti, M.; Pascoli, D.; Peruzzo, L.; Prandini, E.; Saggion, A.; Sartori, P.; Scalzotto, V.; Venturini, A.] Univ Padua, I-35131 Padua, Italy; [Bastieri, D.; Bigongiari, C.; Bock, R. K.; Dazzi, F.; Doro, M.; Lombardi, S.; Lopez, M.; Mariotti, M.; Pascoli, D.; Peruzzo, L.; Prandini, E.; Saggion, A.; Sartori, P.; Scalzotto, V.; Venturini, A.] Ist Nazl Fis Nucl, I-35131 Padua, Italy; [Bednarek, W.; Sobczynska, D.] Univ Lodz, PL-90236 Lodz, Poland; [Bernardini, E.; Satalecka, K.; Tluczykont, M.] DESY, D-15738 Zeuthen, Germany; [Bonnoli, G.; Fagiolini, M.; Leonardo, E.; Meucci, M.; Paoletti, R.; Pegna, R. G.; Piccioli, A.; Stamerra, A.; Turini, N.] Univ Siena, I-53100 Siena, Italy; [Bonnoli, G.; Fagiolini, M.; Leonardo, E.; Meucci, M.; Paoletti, R.; Pegna, R. G.; Piccioli, A.; Stamerra, A.; Turini, N.] Ist Nazl Fis Nucl, I-53100 Siena, Italy; [Bordas, P.; Bosch-Ramon, V.; Paredes, J. M.; Ribo, M.; Zabalza, V.] Univ Barcelona, Inst Ciencias Cosmos IEEC, E-08028 Barcelona, Spain; [Chilingarian, A.; Raymers, A.] Yerevan Phys Inst, AM-375036 Yerevan, Armenia; [Costado, M. T.; Delgado Mendez, C.; Garcia Lopez, R. J.; Gaug, M.; Herrero, A.; Panniello, M.] Inst Astrofis Canarias, E-38200 San Cristobal la Laguna, Spain; [Costado, M. T.; Garcia Lopez, R. J.; Herrero, A.] Univ La Laguna, Dept Astrofis, E-38206 Tenerife, Spain; [De Angelis, A.; De Lotto, B.; De Maria, M.; De Sabata, F.; Longo, F.; Mankuzhiyil, N.; Persic, M.; Scapin, V.; Vitale, V.] Univ Udine, I-33100 Udine, Italy; [De Angelis, A.; De Lotto, B.; De Maria, M.; De Sabata, F.; Longo, F.; Mankuzhiyil, N.; Persic, M.; Scapin, V.; Vitale, V.] INFN Trieste, I-33100 Udine, Italy; [De Cea del Pozo, E.; Sierpowska-Bartosik, A.; Torres, D. F.] CSIC, IEEC, E-80193 Bellaterra, Spain; [Dominguez, A.; Moles, M.; Perez-Torres, M. A.; Prada, F.; Sanchez-Conde, M.; Zandanel, F.] CSIC, Inst Astrofis Andalucia, E-18080 Granada, Spain; [Ferenc, D.; Laille, A.] Univ Calif Davis, Davis, CA 95616 USA; [Lindfors, E.; Nilsson, K.; Pasanen, M.; Sillanpaa, A.; Takalo, L.] Turku Univ, Tuorla Observ, FI-21500 Piikkio, Finland; [Maneva, G.; Temnikov, P.; Vankov, H.] Inst Nucl Energy Res, BG-1784 Sofia, Bulgaria; [Otte, N.; Shayduk, M.] Humboldt Univ, D-12489 Berlin, Germany; [Persic, M.] INAF, Osservatorio Astron Trieste, I-34143 Trieste, Italy; [Persic, M.] Ist Nazl Fis Nucl, I-34143 Trieste, Italy; [Biland, A.; Rico, J.; Torres, D. F.] Inst Catalana Rec & Estud Avancats, E-08010 Barcelona, Spain; [Shore, S. N.] Univ Pisa, I-56126 Pisa, Italy	Max Planck Society; University of Wurzburg; Autonomous University of Barcelona; Barcelona Institute of Science & Technology; Institute for High Energy Physics (IFAE); Swiss Federal Institutes of Technology Domain; ETH Zurich; Istituto Nazionale Astrofisica (INAF); Complutense University of Madrid; Dortmund University of Technology; Autonomous University of Barcelona; Max Planck Society; University of Padua; Istituto Nazionale di Fisica Nucleare (INFN); University of Lodz; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Siena; Istituto Nazionale di Fisica Nucleare (INFN); Institut d'Estudis Espacials de Catalunya (IEEC); University of Barcelona; Yerevan Physics Institute; Instituto de Astrofisica de Canarias; Universidad de la Laguna; University of Udine; Istituto Nazionale di Fisica Nucleare (INFN); Consejo Superior de Investigaciones Cientificas (CSIC); Institut d'Estudis Espacials de Catalunya (IEEC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Astrofisica de Andalucia (IAA); University of California System; University of California Davis; University of Turku; Bulgarian Academy of Sciences; Humboldt University of Berlin; Istituto Nazionale Astrofisica (INAF); Istituto Nazionale di Fisica Nucleare (INFN); ICREA; University of Pisa	Bock, RK (corresponding author), Max Planck Inst Phys & Astrophys, D-80805 Munich, Germany.	rkbock@gmail.com	Doro, Michele/F-9458-2012; Bastieri, Denis/AAC-5917-2020; Torres, Diego F./AAF-7931-2019; Rodríguez, Manel Martínez/C-2539-2017; Backes, Michael/N-5126-2016; González, María Victoria Fonseca/E-8093-2019; Delgado, Carlos/K-7587-2014; Ribó, Marc/B-3579-2015; Dominguez, Alberto/J-4429-2016; Bosch-Ramon, Valenti/E-5274-2016; Covino, Stefano/AAQ-5188-2021; Gonzalez, María Victoria Fonseca MV Fonseca/I-2004-2015; Barrio, Juan A/L-3227-2014; Bernardini, Elisa/AAA-4810-2020; Antoranz, Pedro/H-5095-2015; Maneva, Galina M/L-7120-2016; Herrero, Artemio/H-7312-2015; Olaizola, Abelardo Moralejo/M-2916-2014; Mannheim, Karl/F-6705-2012; Nieto, Daniel/J-7250-2015; Gaug, Markus/L-2340-2014; Temnikov, Petar P./L-6999-2016; Bretz, Thomas/AAK-8726-2020; Rico, Javier/K-8004-2014; Torres, Diego F/ABD-7940-2020; Ninkovic, Jelena/G-5005-2012; Chilingarian, Ashot/B-1901-2014; Miranda, Jose Miguel/F-2913-2013; Cortina, Juan/C-2783-2017; Fernandez, Enrique/L-5387-2014; Miranda, Jose/HCI-6099-2022; De Angelis, Alessandro/B-5372-2009; Satalecka, Konstancja/AAT-1309-2020; González, Jose Luis Contreras/K-7255-2014; CAMARA, Mamadou Bailo/F-5785-2019; López-Moya, Marcos/L-2304-2014; Coma, Pol Bordas/AAA-2332-2020; Costado, M. Teresa/ABB-2702-2020; Fernández, Ester/K-9734-2014; Mazin, Daniel/N-8038-2016; Tjus, Julia/G-8145-2012; Font, Lluís/L-4197-2014; Otte, Adam Nepomuk/L-4638-2019; Torres, Diego F./O-9422-2016; ZANIN, Roberta/B-2316-2018; Lombardi, Saverio/Q-2818-2018	Doro, Michele/0000-0001-9104-3214; Bastieri, Denis/0000-0002-6954-8862; Torres, Diego F./0000-0002-1522-9065; Rodríguez, Manel Martínez/0000-0002-9763-9155; Backes, Michael/0000-0002-9326-6400; González, María Victoria Fonseca/0000-0003-2235-0725; Delgado, Carlos/0000-0002-7014-4101; Ribó, Marc/0000-0002-9931-4557; Dominguez, Alberto/0000-0002-3433-4610; Bosch-Ramon, Valenti/0000-0002-6043-5079; Covino, Stefano/0000-0001-9078-5507; Gonzalez, María Victoria Fonseca MV Fonseca/0000-0003-2235-0725; Barrio, Juan A/0000-0002-0965-0259; Bernardini, Elisa/0000-0003-3108-1141; Antoranz, Pedro/0000-0002-3015-3601; Maneva, Galina M/0000-0002-5959-4179; Olaizola, Abelardo Moralejo/0000-0002-1344-9080; Nieto, Daniel/0000-0003-3343-0755; Gaug, Markus/0000-0001-8442-7877; Temnikov, Petar P./0000-0002-9559-3384; Bretz, Thomas/0000-0002-3800-5531; Rico, Javier/0000-0003-4137-1134; Chilingarian, Ashot/0000-0002-2018-9715; Miranda, Jose Miguel/0000-0002-1472-9690; Cortina, Juan/0000-0003-4576-0452; Fernandez, Enrique/0000-0002-6405-9488; Satalecka, Konstancja/0000-0002-7669-266X; González, Jose Luis Contreras/0000-0001-7282-2394; López-Moya, Marcos/0000-0002-8791-7908; Coma, Pol Bordas/0000-0002-0266-8536; Costado, M. Teresa/0000-0002-2672-4061; Mazin, Daniel/0000-0002-2010-4005; Tjus, Julia/0000-0002-1748-7367; Font, Lluís/0000-0003-2109-5961; Otte, Adam Nepomuk/0000-0002-5955-6383; Torres, Diego F./0000-0002-1522-9065; Dazzi, Francesco/0000-0001-5409-6544; Rhode, Wolfgang/0000-0003-2636-5000; Bonnoli, Giacomo/0000-0003-2464-9077; Ninkovic, Jelena/0000-0003-1523-3635; leonardo, elvira/0000-0003-0271-7673; Turini, Nicola/0000-0002-9395-5230; Sanchez-Conde, Miguel/0000-0002-3849-9164; Spanier, Felix/0000-0001-6802-4744; Bigongiari, Ciro/0000-0003-3293-8522; Hsu, Ching-Cheng/0000-0001-9406-2023; Antonelli, Lucio Angelo/0000-0002-5037-9034; Errando, Manel/0000-0002-1853-863X; Sobczynska, Dorota/0000-0003-4973-7903; Prandini, Elisa/0000-0003-4502-9053; de los Reyes Lopez, Raquel/0000-0003-0485-9552; Bednarek, Wlodek/0000-0003-0605-108X; Persic, Massimo/0000-0003-1853-4900; Oya, Igor/0000-0002-3881-9324; Kneiske, Tanja M./0000-0002-3210-6200; LA BARBERA, ANTONINO/0000-0002-5880-8913; Tavecchio, Fabrizio/0000-0003-0256-0995; Paredes, Josep M./0000-0002-1566-9044; ZANIN, Roberta/0000-0001-6320-1801; Puchades, Neus/0000-0001-7816-8119; Paoletti, Riccardo/0000-0003-0158-2826; Stamerra, Antonio/0000-0002-9430-5264; De Lotto, Barbara/0000-0003-3624-4480; De Angelis, Alessandro/0000-0002-3288-2517; Lombardi, Saverio/0000-0002-6336-865X	ICREA Funding Source: Custom	ICREA(ICREA)		Aharonian F, 2008, ASTRON ASTROPHYS, V478, P387, DOI 10.1051/0004-6361:20078604; Aharonian F, 2006, NATURE, V440, P1018, DOI 10.1038/nature04680; Albert J, 2007, ASTROPHYS J, V667, pL21, DOI 10.1086/521982; BLANDFORD RD, 1972, ASTROPHYS LETT COMM, V10, P77; Fazio GG, 2004, ASTROPHYS J SUPPL S, V154, P39, DOI 10.1086/422585; FAZIO GG, 1970, NATURE, V226, P135, DOI 10.1038/226135a0; FUNK S, SLACPUB12871; HARTMAN RC, 1992, ASTROPHYS J, V385, pL1, DOI 10.1086/186263; Hauser MG, 2001, ANNU REV ASTRON ASTR, V39, P249, DOI 10.1146/annurev.astro.39.1.249; Kneiske TM, 2002, ASTRON ASTROPHYS, V386, P1, DOI 10.1051/0004-6361:20020211; Lorenz E, 2004, NEW ASTRON REV, V48, P339, DOI 10.1016/j.newar.2003.12.059; Madau P, 2000, MON NOT R ASTRON SOC, V312, pL9, DOI 10.1046/j.1365-8711.2000.03268.x; MANNHEIM K, 1992, ASTRON ASTROPHYS, V251, P121; MARASCHI L, 1992, ASTROPHYS J, V397, pL5, DOI 10.1086/186531; Primack JR, 2005, AIP CONF PROC, V745, P23, DOI 10.1063/1.1878394; Stecker FW, 2006, ASTROPHYS J, V648, P774, DOI 10.1086/506188; Stecker FW, 2007, ASTROPHYS J, V667, pL29, DOI 10.1086/522005	17	367	373	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 27	2008	320	5884					1752	1754		10.1126/science.1157087	http://dx.doi.org/10.1126/science.1157087			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318VP	18583607	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000257121200032
J	Anderson, DC; Gill, JS; Cinalli, RM; Nance, J				Anderson, Dorian C.; Gill, Jason S.; Cinalli, Ryan M.; Nance, Jeremy			Polarization of the C-elegans embryo by RhoGAP-mediated exclusion of PAR-6 from cell contacts	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; PROTEIN LOCALIZATION; MOUSE EMBRYO; POLARITY; CDC-42; GASTRULATION; CONTRACTILITY; ESTABLISHMENT; MECHANISMS; GTPASES	Early embryos of some metazoans polarize radially to facilitate critical patterning events such as gastrulation and asymmetric cell division; however, little is known about how radial polarity is established. Early embryos of Caenorhabditis elegans polarize radially when cell contacts restrict the polarity protein PAR- 6 to contact- free cell surfaces, where PAR- 6 regulates gastrulation movements. We have identified a Rho guanosine triphosphatase activating protein ( RhoGAP), PAC- 1, which mediates C. elegans radial polarity and gastrulation by excluding PAR- 6 from contacted cell surfaces. We show that PAC- 1 is recruited to cell contacts, and we suggest that PAC- 1 controls radial polarity by restricting active CDC- 42 to contact- free surfaces, where CDC- 42 binds and recruits PAR- 6. Thus, PAC- 1 provides a dynamic molecular link between cell contacts and PAR proteins that polarizes embryos radially.	[Anderson, Dorian C.; Gill, Jason S.; Cinalli, Ryan M.; Nance, Jeremy] NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY 10016 USA	New York University	Nance, J (corresponding author), NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, 540 1st Ave, New York, NY 10016 USA.	nance@saturn.med.nyu.edu		Nance, Jeremy/0000-0003-4212-7731	NICHD NIH HHS [T32HD07520] Funding Source: Medline; NIGMS NIH HHS [R01 GM078341-02, R01GM078341, R01 GM078341] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078341] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aceto D, 2006, DEV BIOL, V299, P386, DOI 10.1016/j.ydbio.2006.08.002; CHEN WN, 1994, J BIOL CHEM, V269, P820; Clayton L, 1999, DEV BIOL, V205, P322, DOI 10.1006/dbio.1998.9117; Dubois T, 2005, NAT CELL BIOL, V7, P353, DOI 10.1038/ncb1244; ETEMADMOGHADAM B, 1995, CELL, V83, P743, DOI 10.1016/0092-8674(95)90187-6; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Gotta M, 2001, CURR BIOL, V11, P482, DOI 10.1016/S0960-9822(01)00142-7; Hung TJ, 1999, DEVELOPMENT, V126, P127; Jenkins N, 2006, SCIENCE, V313, P1298, DOI 10.1126/science.1130291; Johnson MH, 2004, SEMIN CELL DEV BIOL, V15, P583, DOI 10.1016/j.semcdb.2004.04.002; Kay AJ, 2001, CURR BIOL, V11, P474, DOI 10.1016/S0960-9822(01)00141-5; Kumari S, 2008, NAT CELL BIOL, V10, P30, DOI 10.1038/ncb1666; Lee JY, 2006, CURR BIOL, V16, P1986, DOI 10.1016/j.cub.2006.08.090; Lee JY, 2003, DEVELOPMENT, V130, P307, DOI 10.1242/dev.00211; Maduro MF, 2001, MOL CELL, V7, P475, DOI 10.1016/S1097-2765(01)00195-2; Motegi F, 2006, NAT CELL BIOL, V8, P978, DOI 10.1038/ncb1459; Nance J, 2003, DEVELOPMENT, V130, P5339, DOI 10.1242/dev.00735; Nance J, 2002, DEVELOPMENT, V129, P387; Plusa B, 2005, J CELL SCI, V118, P505, DOI 10.1242/jcs.01666; Reese KJ, 2000, MOL CELL, V6, P445, DOI 10.1016/S1097-2765(00)00043-5; Schonegg S, 2006, DEVELOPMENT, V133, P3507, DOI 10.1242/dev.02527; Sousa S, 2005, NAT CELL BIOL, V7, P954, DOI 10.1038/ncb1308; Totong R, 2007, DEVELOPMENT, V134, P1259, DOI 10.1242/dev.02833; Vinot S, 2005, DEV BIOL, V282, P307, DOI 10.1016/j.ydbio.2005.03.001	24	82	92	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 27	2008	320	5884					1771	1774		10.1126/science.1156063	http://dx.doi.org/10.1126/science.1156063			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318VP	18583611	Green Accepted			2022-12-28	WOS:000257121200037
J	Devincre, B; Hoc, T; Kubin, L				Devincre, B.; Hoc, T.; Kubin, L.			Dislocation mean free paths and strain hardening of crystals	SCIENCE			English	Article							SINGLE-CRYSTALS; FCC CRYSTALS; SIMULATIONS; PLASTICITY; STRESS; COPPER	Predicting the strain hardening properties of crystals constitutes a long- standing challenge for dislocation theory. The main difficulty resides in the integration of dislocation processes through a wide range of time and length scales, up to macroscopic dimensions. In the present multiscale approach, dislocation dynamics simulations are used to establish a dislocation- based continuum model incorporating discrete and intermittent aspects of plastic flow. This is performed through the modeling of a key quantity, the mean free path of dislocations. The model is then integrated at the scale of bulk crystals, which allows for the detailed reproduction of the complex deformation curves of face- centered cubic crystals. Because of its predictive ability, the proposed framework has a large potential for further applications.	[Devincre, B.; Kubin, L.] Off Natl Etud & Rech Aerosp, Lab Etud Microstruct, CNRS, UMR 104, F-92322 Chatillon, France; [Hoc, T.] Ecole Cent Paris, Lab MSSMat, CNRS, UMR 8579, F-92295 Chatenay Malabry, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); National Office for Aerospace Studies & Research (ONERA); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Saclay	Kubin, L (corresponding author), Off Natl Etud & Rech Aerosp, Lab Etud Microstruct, CNRS, UMR 104, 20 Ave Div Leclerc,BP 72, F-92322 Chatillon, France.	ladislas.kubin@onera.fr		Hoc, Thierry/0000-0001-7467-1462				Bulatov V, 1998, NATURE, V391, P669, DOI 10.1038/35577; Bulatov VV, 2006, NATURE, V440, P1174, DOI 10.1038/nature04658; Cottrell AH, 2002, DISLOCATIONS IN SOLIDS, VOL 11, pVII, DOI 10.1016/S1572-4859(02)80002-X; Csikor FF, 2007, SCIENCE, V318, P251, DOI 10.1126/science.1143719; Devincre B, 2007, SCRIPTA MATER, V57, P905, DOI 10.1016/j.scriptamat.2007.07.026; Devincre B, 2006, SCRIPTA MATER, V54, P741, DOI 10.1016/j.scriptamat.2005.10.066; FRANCIOSI P, 1980, ACTA METALL MATER, V28, P273, DOI 10.1016/0001-6160(80)90162-5; Friedel J., 1967, DISLOCATIONS; Hirth IP, 1992, THEORY DISLOCATIONS; Hoc T, 2001, ACTA MATER, V49, P1835, DOI 10.1016/S1359-6454(01)00076-3; Kocks UF, 2003, PROG MATER SCI, V48, P171, DOI 10.1016/S0079-6425(02)00003-8; Kubin L, 2006, SCIENCE, V312, P864, DOI 10.1126/science.1125799; Kubin L, 2008, MAT SCI ENG A-STRUCT, V483-84, P19, DOI 10.1016/j.msea.2007.01.167; Madec R, 2003, SCIENCE, V301, P1879, DOI 10.1126/science.1085477; Miguel MC, 2001, NATURE, V410, P667, DOI 10.1038/35070524; Mitchell TE., 1964, PROGR APPL MAT RES, V6, P117; TAKEUCHI T, 1975, T JPN I MET, V16, P629, DOI 10.2320/matertrans1960.16.629; Teodosiu C., 1993, LARGE PLASTIC DEFORM, P153	18	308	316	7	169	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 27	2008	320	5884					1745	1748		10.1126/science.1156101	http://dx.doi.org/10.1126/science.1156101			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318VP	18583605				2022-12-28	WOS:000257121200030
J	Wake, N; Desai, AS				Wake, Nicole; Desai, Akshay S.			Spontaneous thrombolysis of an obstructed mechanical aortic valve	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Wake, Nicole; Desai, Akshay S.] Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Wake, N (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	nwake@partners.org	Desai, Akshay/ABE-7250-2020						0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 26	2008	358	26					E31	E31		10.1056/NEJMicm071573	http://dx.doi.org/10.1056/NEJMicm071573			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	317UO	18579808				2022-12-28	WOS:000257045900010
J	Bjornsson, HT; Sigurdsson, MI; Fallin, MD; Irizarry, RA; Aspelund, T; Cui, HM; Yu, WQ; Rongione, MA; Ekstrom, TJ; Harris, TB; Launer, LJ; Eiriksdottir, G; Leppert, MF; Sapienza, C; Gudnason, V; Feinberg, AP				Bjornsson, Hans T.; Sigurdsson, Martin I.; Fallin, M. Daniele; Irizarry, Rafael A.; Aspelund, Thor; Cui, Hengmi; Yu, Wenqiang; Rongione, Michael A.; Ekstrom, Tomas J.; Harris, Tamara B.; Launer, Lenore J.; Eiriksdottir, Gudny; Leppert, Mark F.; Sapienza, Carmen; Gudnason, Vilmundur; Feinberg, Andrew P.			Intra-individual change over time in DNA methylation with familial clustering	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EPIGENETICS; CANCER	Context Changes over time in epigenetic marks, which are modifications of DNA such as by DNA methylation, may help explain the late onset of common human diseases. However, changes in methylation or other epigenetic marks over time in a given individual have not yet been investigated. Objectives To determine whether there are longitudinal changes in global DNA methylation in individuals and to evaluate whether methylation maintenance demonstrates familial clustering. Design, Setting, and Participants We measured global DNA methylation by luminometric methylation assay, a quantitative measurement of genome- wide DNA methylation, on DNA sampled at 2 visits on average 11 years apart in 111 individuals from an Icelandic cohort ( 1991 and 2002- 2005) and on average 16 years apart in 126 individuals from a Utah sample ( 1982- 1985 and 1997- 2005). Main Outcome Measure Global methylation changes over time. Results Twenty- nine percent of Icelandic individuals showed greater than 10% methylation change over time ( P <. 001). The family- based Utah sample also showed intra-individual changes over time, and further demonstrated familial clustering of methylation change ( P=. 003). The family showing the greatest global methylation loss also demonstrated the greatest loss of gene- specific methylation by a separate methylation assay. Conclusion These data indicate that methylation changes over time and suggest that methylation maintenance may be under genetic control.	[Aspelund, Thor; Eiriksdottir, Gudny; Gudnason, Vilmundur] Hjartavernd, IS-201 Kopavogur, Iceland; [Bjornsson, Hans T.; Sigurdsson, Martin I.; Cui, Hengmi; Yu, Wenqiang; Rongione, Michael A.; Feinberg, Andrew P.] Johns Hopkins Univ, Dept Med, Baltimore, MD USA; [Fallin, M. Daniele] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [Fallin, M. Daniele; Irizarry, Rafael A.] Johns Hopkins Univ, Dept Biostat, Baltimore, MD 21205 USA; [Bjornsson, Hans T.; Sigurdsson, Martin I.; Fallin, M. Daniele; Irizarry, Rafael A.; Cui, Hengmi; Yu, Wenqiang; Rongione, Michael A.; Feinberg, Andrew P.] Johns Hopkins Univ, Ctr Epigenet, Baltimore, MD USA; [Ekstrom, Tomas J.] Karolinska Univ Hosp Solna, Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Harris, Tamara B.; Launer, Lenore J.] NIA, Lab Epidemiol Demog & Biometry, Intramural Res Program, Bethesda, MD 20892 USA; [Leppert, Mark F.] Univ Utah, Dept Human Genet, Salt Lake City, UT USA; [Leppert, Mark F.] Univ Utah, Eccles Inst Human Genet, Salt Lake City, UT USA; [Sapienza, Carmen] Temple Univ, Sch Med, Fels Inst Canc Res, Philadelphia, PA 19122 USA; [Sapienza, Carmen] Temple Univ, Sch Med, Dept Pathol, Philadelphia, PA 19122 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Karolinska Institutet; Karolinska University Hospital; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Gudnason, V (corresponding author), Hjartavernd, Holtasmari 1, IS-201 Kopavogur, Iceland.	v.gudnason@hjarta.is; afeinberg@jhu.edu	Aspelund, Thor/F-4826-2011; Feinberg, Andrew/AAY-7666-2020; Launer, Lenore J/A-8218-2010; Bjornsson, Hans T/A-2964-2013; Aspelund, Thor/C-5983-2008; Ekström, Tomas/B-7764-2013; Bjornsson, Hans/GSN-3911-2022; Sigurdsson, Martin Ingi/I-9655-2016; Aspelund, Thor/K-7022-2019; Gudnason, Vilmundur/K-6885-2015; Gudnason, Vilmundur/AAE-7126-2019	Bjornsson, Hans T/0000-0001-6635-6753; Aspelund, Thor/0000-0002-7998-5433; Bjornsson, Hans/0000-0001-6635-6753; Sigurdsson, Martin Ingi/0000-0001-7054-0844; Aspelund, Thor/0000-0002-7998-5433; Gudnason, Vilmundur/0000-0001-5696-0084; Gudnason, Vilmundur/0000-0001-5696-0084; Feinberg, Andrew/0000-0002-8364-1991	NATIONAL INSTITUTE ON AGING [ZIAAG007380] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 AG007380-02] Funding Source: Medline; NCRR NIH HHS [R01 RR021967-02, M01 RR000064, R01 RR021967, M01-RR00064] Funding Source: Medline; NHGRI NIH HHS [P50-HG003233, P50 HG003233] Funding Source: Medline; NIA NIH HHS [N01AG12100] Funding Source: Medline; NIEHS NIH HHS [R01-ES015211, R01 ES015211] Funding Source: Medline; NIGMS NIH HHS [R01 GM083084, R01 GM083084-02] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Bjornsson HT, 2004, TRENDS GENET, V20, P350, DOI 10.1016/j.tig.2004.06.009; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Cui HM, 2003, SCIENCE, V299, P1753, DOI 10.1126/science.1080902; Cui HM, 2001, CANCER RES, V61, P4947; DeBaun MR, 2003, AM J HUM GENET, V72, P156, DOI 10.1086/346031; Dolinoy DC, 2008, ENVIRON MOL MUTAGEN, V49, P4, DOI 10.1002/em.20366; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Feinberg AP, 2008, JAMA-J AM MED ASSOC, V299, P1345, DOI 10.1001/jama.299.11.1345; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Giovannucci E, 2004, J NUTR, V134, p2475S, DOI 10.1093/jn/134.9.2475S; Harris TB, 2007, AM J EPIDEMIOL, V165, P1076, DOI 10.1093/aje/kwk115; Jiang YH, 2004, ANNU REV GENOM HUM G, V5, P479, DOI 10.1146/annurev.genom.5.061903.180014; Karimi M, 2006, EXP CELL RES, V312, P1989, DOI 10.1016/j.yexcr.2006.03.006; Ladd-Acosta C, 2007, AM J HUM GENET, V81, P1304, DOI 10.1086/524110; Lehner B, 2006, NAT GENET, V38, P896, DOI 10.1038/ng1844; Mill J, 2007, MOL PSYCHIATR, V12, P799, DOI 10.1038/sj.mp.4001992; Petronis A, 2001, TRENDS GENET, V17, P142, DOI 10.1016/S0168-9525(00)02213-7; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Richardson B, 2003, CLIN IMMUNOL, V109, P72, DOI 10.1016/S1521-6616(03)00206-7; *SAGE, 2006, COMP PROGR VERS 5 2; Sandovici I, 2003, HUM MOL GENET, V12, P1569, DOI 10.1093/hmg/ddg167; SANO H, 1985, J CLIN INVEST, V76, P1314, DOI 10.1172/JCI112105; Sollars V, 2003, NAT GENET, V33, P70, DOI 10.1038/ng1067; Stenvinkel P, 2007, J INTERN MED, V261, P488, DOI 10.1111/j.1365-2796.2007.01777.x; Waterland RA, 2006, HUM MOL GENET, V15, P705, DOI 10.1093/hmg/ddi484	30	509	557	3	35	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 25	2008	299	24					2877	2883		10.1001/jama.299.24.2877	http://dx.doi.org/10.1001/jama.299.24.2877			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	317LN	18577732	Green Accepted, Bronze			2022-12-28	WOS:000257021800025
J	Cole, A				Cole, Andrew			Private practice	BRITISH MEDICAL JOURNAL			English	Editorial Material												a.cole71@ntlworld.com							0	3	3	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 21	2008	336	7658					1406	1407		10.1136/bmj.a330	http://dx.doi.org/10.1136/bmj.a330			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	318WJ	18566077	Green Published			2022-12-28	WOS:000257123200028
J	Bloch, I				Bloch, Immanuel			Quantum coherence and entanglement with ultracold atoms in optical lattices	NATURE			English	Review							BOSE-EINSTEIN CONDENSATION; NEUTRAL ATOMS; CONTROLLED COLLISIONS; MOTT INSULATOR; TRAPPED ATOMS; COMPUTATION; GAS; COMPUTER; MODELS; DOTS	At nanokelvin temperatures, ultracold quantum gases can be stored in optical lattices, which are arrays of microscopic trapping potentials formed by laser light. Such large arrays of atoms provide opportunities for investigating quantum coherence and generating large-scale entanglement, ultimately leading to quantum information processing in these artificial crystal structures. These arrays can also function as versatile model systems for the study of strongly interacting many-body systems on a lattice.	[Bloch, Immanuel] Johannes Gutenberg Univ Mainz, Inst Phys, D-55099 Mainz, Germany	Johannes Gutenberg University of Mainz	Bloch, I (corresponding author), Johannes Gutenberg Univ Mainz, Inst Phys, D-55099 Mainz, Germany.	bloch@uni-mainz.de	Bloch, Immanuel/N-9169-2019; Bloch, Immanuel/G-3174-2010	Bloch, Immanuel/0000-0002-0679-4759				Aliferis P, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.062314; Anderlini M, 2007, NATURE, V448, P452, DOI 10.1038/nature06011; ANDERSON MH, 1995, SCIENCE, V269, P198, DOI 10.1126/science.269.5221.198; ANDERSON PW, 1987, SCIENCE, V235, P1196, DOI 10.1126/science.235.4793.1196; [Anonymous], 2003, BOSEEINSTEIN CONDENS; AUERBACH A, 2006, INTERACTING ELECT QU; BARENCO A, 1995, PHYS REV A, V52, P3457, DOI 10.1103/PhysRevA.52.3457; Bernasconi C., 1993, Hematological Oncology, V11, P20; Beugnon J, 2007, NAT PHYS, V3, P696, DOI 10.1038/nphys698; Bloch I, 2005, NAT PHYS, V1, P23, DOI 10.1038/nphys138; BLOCH I, 2007, MANY BODY PHYS ULTRA; BRADLEY CC, 1995, PHYS REV LETT, V75, P1687, DOI 10.1103/PhysRevLett.75.1687; BROWNE DE, 2007, PHASE TRANSITION COM; Childs AM, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.032318; Cho J, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.020502; Courteille P, 1998, PHYS REV LETT, V81, P69, DOI 10.1103/PhysRevLett.81.69; DAVIS KB, 1995, PHYS REV LETT, V75, P3969, DOI 10.1103/PhysRevLett.75.3969; DeMarco B, 1999, SCIENCE, V285, P1703, DOI 10.1126/science.285.5434.1703; DEUTSCH D, 1989, P ROY SOC LOND A MAT, V425, P73, DOI 10.1098/rspa.1989.0099; DEUTSCH D, 1985, P ROY SOC LOND A MAT, V400, P97, DOI 10.1098/rspa.1985.0070; Duan LM, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.090402; Farhi E, 2001, SCIENCE, V292, P472, DOI 10.1126/science.1057726; FISHER MPA, 1989, PHYS REV B, V40, P546, DOI 10.1063/1.38820; Folling S, 2007, NATURE, V448, P1029, DOI 10.1038/nature06112; GORSHKOV AV, 2007, COHERENT QUANTUM OPT; Griessner A, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/2/044; Griessner A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.220403; Grimm R, 2000, ADV ATOM MOL OPT PHY, V42, P95, DOI 10.1016/S1049-250X(08)60186-X; Gross D, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.220503; Gross D, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.052315; Hanson R, 2007, REV MOD PHYS, V79, P1217, DOI 10.1103/RevModPhys.79.1217; Hayes D, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.070501; Heidemann R, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.163601; Hofstetter W, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.220407; Inouye S, 1998, NATURE, V392, P151, DOI 10.1038/32354; Jaksch D, 2005, ANN PHYS-NEW YORK, V315, P52, DOI 10.1016/j.aop.2004.09.010; Jaksch D, 1999, PHYS REV LETT, V82, P1975, DOI 10.1103/PhysRevLett.82.1975; Jaksch D, 2000, PHYS REV LETT, V85, P2208, DOI 10.1103/PhysRevLett.85.2208; Jessen PS, 1996, ADV ATOM MOL OPT PHY, V37, P95; Joo J, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.042344; JORRAND P, 2004, UNIFYING QUANTUM COM; Kiesel N, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.210502; Kitaev AY, 2003, ANN PHYS-NEW YORK, V303, P2, DOI 10.1016/S0003-4916(02)00018-0; Knill E, 1998, P ROY SOC A-MATH PHY, V454, P365, DOI 10.1098/rspa.1998.0166; Knill E, 2001, NATURE, V409, P46, DOI 10.1038/35051009; Kohl M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.080403; Kuklov AB, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.100401; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; Lewenstein M, 2007, ADV PHYS, V56, P243, DOI 10.1080/00018730701223200; Liebisch TC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.253002; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; Lukin MD, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.037901; Mandel O, 2003, NATURE, V425, P937, DOI 10.1038/nature02008; Micheli A, 2006, NAT PHYS, V2, P341, DOI 10.1038/nphys287; Miroshnychenko Y, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/9/191; Miroshnychenko Y, 2006, NATURE, V442, P151, DOI 10.1038/442151a; Nelson KD, 2007, NAT PHYS, V3, P556, DOI 10.1038/nphys645; Nielsen MA, 2003, PHYS LETT A, V308, P96, DOI 10.1016/S0375-9601(02)01803-0; Petta JR, 2005, SCIENCE, V309, P2180, DOI 10.1126/science.1116955; Raussendorf R, 2002, QUANTUM INFORM COMPU, V2, P443; Raussendorf R, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.190504; Schrader D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.150501; Schreck F, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.080403; Sebby-Strabley J, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.033605; Singer K, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.163001; Spielman IB, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.080404; Stoferle T, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.130403; Tong D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.063001; Trotzky S, 2008, SCIENCE, V319, P295, DOI 10.1126/science.1150841; Truscott AG, 2001, SCIENCE, V291, P2570, DOI 10.1126/science.1059318; Van den Nest M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.150504; VAUCHER B, 2007, CREATION RESILIENT E; Verstraete F, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.060302; Walther P, 2005, NATURE, V434, P169, DOI 10.1038/nature03347; Werner F, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.056401; Widera A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.190405; Yao A., 1993, P 34 ANN S FDN COMP, P352	86	267	269	1	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2008	453	7198					1016	1022		10.1038/nature07126	http://dx.doi.org/10.1038/nature07126			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314WM	18563152				2022-12-28	WOS:000256839900043
J	Thompson, A; Di Angelantonio, E; Sarwar, N; Erqou, S; Saleheen, D; Dullaart, RPF; Keavney, B; Ye, Z; Danesh, J				Thompson, Alexander; Di Angelantonio, Emanuele; Sarwar, Nadeem; Erqou, Sebhat; Saleheen, Danish; Dullaart, Robin P. F.; Keavney, Bernard; Ye, Zheng; Danesh, John			Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							HIGH-DENSITY-LIPOPROTEIN; PLASMA HDL-CHOLESTEROL; SINGLE-NUCLEOTIDE POLYMORPHISMS; PROSPECTIVE GENETIC-ANALYSIS; GENERAL JAPANESE POPULATION; INSULIN-RESISTANCE SYNDROME; ISOFLAVONE-ENRICHED FOODS; ISCHEMIC-HEART-DISEASE; INTIMA-MEDIA THICKNESS; TAQ 1B POLYMORPHISM	Context The importance of the cholesteryl ester transfer protein (CETP) pathway in coronary disease is uncertain. Study of CETP genotypes can help better understand the relevance of this pathway to lipid metabolism and disease risk. Objective To assess associations of CETP genotypes with CETP phenotypes, lipid levels, and coronary risk. Data Sources Studies published between January 1970 and January 2008 were identified through computer-based and manual searches using MEDLINE, EMBASE, BIOSIS, Science Citation Index, and the Chinese National Knowledge Infrastructure Database. Previously unreported studies were sought through correspondence with investigators. Study Selection Relevant studies related principally to 3 common (TaqIB [rs708272], I405V [rs5882], and -629C>A [rs1800775]) and 3 uncommon (D442G [rs2303790], -631C>A [rs1800776], and R451Q [rs1800777]) CETP polymorphisms. Data Extraction Information on CETP genotypes, CETP phenotypes, lipid levels, coronary disease, and study characteristics was abstracted from publications, supplied by investigators, or both. Results Ninety-two studies had data on CETP phenotypes, lipid levels, or both in 113 833 healthy participants, and 46 studies had data on 27 196 coronary cases and 55 338 controls. For each A allele inherited, individuals with the TaqIB polymorphism had lower mean CETP mass (-9.7%; 95% confidence interval [CI], -11.7% to -7.8%), lower mean CETP activity (-8.6%; 95% CI, -13.0% to -4.1%), higher mean high-density lipoprotein cholesterol (HDL-C) concentrations (4.5%; 95% CI, 3.8%-5.2%), and higher mean apolipoprotein A-I concentrations (2.4%; 95% CI, 1.6%-3.2%). The pattern of findings was very similar with the I405V and -629C>A polymorphisms. The combined per-allele odds ratios (ORs) for coronary disease were 0.95 (95% CI, 0.92-0.99) for TaqIB, 0.94 (95% CI, 0.89-1.00) for I405V, and 0.95 (95% CI, 0.91-1.00) for -629C>A. Conclusions Three CETP genotypes that are associated with moderate inhibition of CETP activity (and, therefore, modestly higher HDL-C levels) show weakly inverse associations with coronary risk. The ORs for coronary disease were compatible with the expected reductions in risk for equivalent increases in HDL-C concentration in available prospective studies.	[Thompson, Alexander; Di Angelantonio, Emanuele; Sarwar, Nadeem; Erqou, Sebhat; Saleheen, Danish; Ye, Zheng; Danesh, John] Univ Cambridge, Strangeways Res Lab, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England; [Dullaart, Robin P. F.] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands; [Keavney, Bernard] Newcastle Univ, Inst Human Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Cambridge; University of Groningen; Newcastle University - UK	Danesh, J (corresponding author), Univ Cambridge, Strangeways Res Lab, Dept Publ Hlth & Primary Care, Worts Causeway, Cambridge CB1 8RN, England.	john.danesh@phpc.cam.ac.uk	Thompson, Alexander/A-6109-2010; DiAngelantonio, Emanuele/ABE-6852-2020	Di Angelantonio, Emanuele/0000-0001-8776-6719; s, hema/0000-0002-3440-9475; Keavney, Bernard/0000-0001-9573-0812	British Heart Foundation Funding Source: Medline; Medical Research Council Funding Source: Medline	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Agerholm-Larsen B, 2000, CIRCULATION, V102, P2197; Agerholm-Larsen B, 2000, CIRCULATION, V101, P1907, DOI 10.1161/01.CIR.101.16.1907; AKITA H, 1994, J CLIN ENDOCR METAB, V79, P1615, DOI 10.1210/jc.79.6.1615; Al-Daghri NM, 2003, CLIN SCI, V105, P467, DOI 10.1042/CS20030007; Andrikopoulos GK, 2004, HEART, V90, P1336, DOI 10.1136/hrt.2003.019067; Arai H, 2005, J ATHEROSCLER THROMB, V12, P240, DOI 10.5551/jat.12.240; Arai Y, 2003, J MOL MED, V81, P102, DOI 10.1007/s00109-002-0407-6; Arca M, 2001, CLIN GENET, V60, P374, DOI 10.1034/j.1399-0004.2001.600510.x; Asselbergs FW, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-39; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Barzilai N, 2006, NEUROLOGY, V67, P2170, DOI 10.1212/01.wnl.0000249116.50854.65; Barzilai N, 2003, JAMA-J AM MED ASSOC, V290, P2030, DOI 10.1001/jama.290.15.2030; Bauerfeind A, 2002, HUM HERED, V54, P166, DOI 10.1159/000070662; Bauerfeind A, 2006, HUM HERED, V61, P123, DOI 10.1159/000093773; Bennet AM, 2007, JAMA-J AM MED ASSOC, V298, P1300, DOI 10.1001/jama.298.11.1300; Bergman A, 2007, PLOS COMPUT BIOL, V3, P1648, DOI 10.1371/journal.pcbi.0030170; Bernstein MS, 2003, MED SCI SPORT EXER, V35, P1124, DOI 10.1249/01.MSS.0000074444.27594.B0; Blankenberg S, 2004, Z KARDIOL, V93, P16, DOI 10.1007/s00392-004-1404-2; Boekholdt SM, 2005, CIRCULATION, V111, P278, DOI 10.1161/01.CIR.0000153341.46271.40; Boekholdt SM, 2003, J LIPID RES, V44, P1080, DOI 10.1194/jlr.R200018-JLR200; Boer JMA, 2001, ATHEROSCLEROSIS, V155, P149, DOI 10.1016/S0021-9150(00)00521-9; Borggreve SE, 2005, J CLIN ENDOCR METAB, V90, P4198, DOI 10.1210/jc.2005-0182; Borggreve SE, 2006, J CLIN ENDOCR METAB, V91, P3382, DOI 10.1210/jc.2005-2322; Bots ML, 2007, LANCET, V370, P153, DOI 10.1016/S0140-6736(07)61088-5; Bruce C, 1998, J LIPID RES, V39, P1071; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Carr MC, 2002, ARTERIOSCL THROM VAS, V22, P667, DOI 10.1161/01.ATV.0000013284.47317.95; Casas JP, 2006, AM J EPIDEMIOL, V164, P921, DOI 10.1093/aje/kwj302; Chaaba R, 2005, CLIN BIOCHEM, V38, P373, DOI 10.1016/j.clinbiochem.2004.12.011; Chen JH, 2002, J PROCESS CONTR, V12, P277, DOI 10.1016/S0959-1524(01)00027-0; Choi Hyun Suk, 2002, Korean Journal of Internal Medicine, V17, P83; Clark RW, 2004, ARTERIOSCL THROM VAS, V24, P490, DOI 10.1161/01.ATV.0000118278.21719.17; Corbex M, 2000, GENET EPIDEMIOL, V19, P64, DOI 10.1002/1098-2272(200007)19:1<64::AID-GEPI5>3.0.CO;2-E; Corella D, 2000, ATHEROSCLEROSIS, V152, P367, DOI 10.1016/S0021-9150(99)00477-3; Cuchel M, 2002, ATHEROSCLEROSIS, V163, P169, DOI 10.1016/S0021-9150(01)00769-9; Curb JD, 2004, J LIPID RES, V45, P948, DOI 10.1194/jlr.M300520-JLR200; Dachet C, 2000, ARTERIOSCL THROM VAS, V20, P507, DOI 10.1161/01.ATV.20.2.507; Dedoussis GV, 2007, HUM HERED, V63, P155, DOI 10.1159/000099827; Deguchi H, 2005, CIRCULATION, V112, P893, DOI 10.1161/CIRCULATIONAHA.104.521344; Dullaart RPF, 2008, SCAND J CLIN LAB INV, V68, P99, DOI 10.1080/00365510701519719; Dullaart RPF, 2007, EUR J CLIN INVEST, V37, P90, DOI 10.1111/j.1365-2362.2007.01756.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eiriksdottir G, 2001, ATHEROSCLEROSIS, V159, P187, DOI 10.1016/S0021-9150(01)00489-0; Elosua R, 2006, ATHEROSCLEROSIS, V189, P222, DOI 10.1016/j.atherosclerosis.2005.12.005; Falchi A, 2007, EXP MOL PATHOL, V83, P25, DOI 10.1016/j.yexmp.2006.12.007; Falchi A, 2005, EXP MOL PATHOL, V79, P210, DOI 10.1016/j.yexmp.2005.09.005; FREEMAN DJ, 1994, ARTERIOSCLER THROMB, V14, P336, DOI 10.1161/01.ATV.14.3.336; Freeman DJ, 2003, EUR HEART J, V24, P1833, DOI 10.1016/j.ehj.2003.07.001; Friedlander Y, 2000, ATHEROSCLEROSIS, V152, P239, DOI 10.1016/S0021-9150(99)00474-8; FUMERON F, 1995, J CLIN INVEST, V96, P1664, DOI 10.1172/JCI118207; Goto A, 2001, ATHEROSCLEROSIS, V159, P153, DOI 10.1016/S0021-9150(01)00476-2; Gudnason V, 1999, EUR J CLIN INVEST, V29, P116, DOI 10.1046/j.1365-2362.1999.00412.x; Gudnason V, 1997, CLIN GENET, V51, P15; Hall WL, 2006, AM J CLIN NUTR, V83, P592, DOI 10.1093/ajcn.83.3.592; Hall WL, 2005, AM J CLIN NUTR, V82, P1260, DOI 10.1093/ajcn/82.6.1260; Hamilton JA, 2007, NAT STRUCT MOL BIOL, V14, P95, DOI 10.1038/nsmb0207-95; HANNUKSELA ML, 1994, ATHEROSCLEROSIS, V110, P35, DOI 10.1016/0021-9150(94)90065-5; Heidema AG, 2007, GENET EPIDEMIOL, V31, P910, DOI 10.1002/gepi.20251; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hinds David A., 2004, Human Genomics, V1, P421; Hodoglugil U, 2005, CLIN GENET, V68, P118, DOI 10.1111/j.1399-0004.2005.00467.x; Hong SH, 2001, HUM BIOL, V73, P815, DOI 10.1353/hub.2001.0083; Horne BD, 2006, ANN HUM GENET, V70, P524, DOI 10.1111/j.1469-1809.2005.00244.x; Horne BD, 2007, J AM COLL CARDIOL, V49, P2053, DOI 10.1016/j.jacc.2007.02.039; Hsu LA, 2002, HUM GENET, V110, P57, DOI 10.1007/s00439-001-0640-z; HUANG GY, 1999, CHINA J MODERN MED, V9, P9; Hui Shu-Ping, 1997, Hokkaido Journal of Medical Science, V72, P319; Ikewaki K, 2003, METABOLISM, V52, P1564, DOI 10.1016/j.metabol.2003.07.011; INAZU A, 1990, NEW ENGL J MED, V323, P1234, DOI 10.1056/NEJM199011013231803; Inazu A, 2001, J HUM GENET, V46, P172, DOI 10.1007/s100380170084; Isaacs A, 2007, J CLIN ENDOCR METAB, V92, P2680, DOI 10.1210/jc.2007-0269; Isaacs A, 2007, EUR J CARDIOV PREV R, V14, P419, DOI 10.1097/HJR.0b013e32801101aa; Isbir T, 2003, CLIN GENET, V64, P228, DOI 10.1034/j.1399-0004.2003.00137.x; Jang Y, 2004, AM J CLIN NUTR, V80, P832; JUVONEN T, 1995, J LIPID RES, V36, P804; Kakko S, 1998, ATHEROSCLEROSIS, V136, P233, DOI 10.1016/S0021-9150(97)00201-3; Kakko S, 2000, EUR J CLIN INVEST, V30, P18; Kakko S, 2001, EUR J CLIN INVEST, V31, P593, DOI 10.1046/j.1365-2362.2001.00859.x; Kaplan DB, 2006, CLIN GENET, V69, P455, DOI 10.1111/j.1399-0004.2006.00612.x; Kark JD, 2000, ATHEROSCLEROSIS, V151, P509, DOI 10.1016/S0021-9150(99)00408-6; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kauma H, 1996, HUM GENET, V97, P156, DOI 10.1007/BF02265258; Keavney B, 2004, INT J EPIDEMIOL, V33, P1002, DOI 10.1093/ije/dyh275; Keavney B, 2006, INT J EPIDEMIOL, V35, P935, DOI 10.1093/ije/dyl114; Klos KLE, 2006, ARTERIOSCL THROM VAS, V26, P1828, DOI 10.1161/01.ATV.0000231523.19199.45; KONDO I, 1989, CLIN GENET, V35, P49; Krishna R, 2007, LANCET, V370, P1907, DOI 10.1016/S0140-6736(07)61813-3; Kuivenhoven JA, 1997, ARTERIOSCL THROM VAS, V17, P560, DOI 10.1161/01.ATV.17.3.560; Le Goff W, 2002, ATHEROSCLEROSIS, V161, P269, DOI 10.1016/S0021-9150(01)00641-4; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Lewis SJ, 2005, BMJ-BRIT MED J, V331, P1053, DOI 10.1136/bmj.38611.658947.55; Lira ME, 2004, BBA-MOL CELL BIOL L, V1684, P38, DOI 10.1016/j.bbalip.2004.06.002; Liu Jing, 2003, Zhonghua Liu Xing Bing Xue Za Zhi, V24, P300; Liu S, 2002, ATHEROSCLEROSIS, V161, P469, DOI 10.1016/S0021-9150(01)00673-6; Lloyd DB, 2005, J BIOL CHEM, V280, P14918, DOI 10.1074/jbc.M500523200; LU FE, 1999, CHIN J ARTERIOSCLER, V7, P208; Lu H, 2003, J MOL MED-JMM, V81, P246, DOI 10.1007/s00109-002-0414-7; Lucchi Tiziano, 2005, Ann Ital Med Int, V20, P45; Martinelli N, 2007, ATHEROSCLEROSIS, V191, P409, DOI 10.1016/j.atherosclerosis.2006.04.009; Mazzone T, 2007, LANCET, V370, P107, DOI 10.1016/S0140-6736(07)61063-0; McCaskie PA, 2007, HUM GENET, V121, P401, DOI 10.1007/s00439-007-0326-2; MENDIS S, 1990, ATHEROSCLEROSIS, V83, P21, DOI 10.1016/0021-9150(90)90126-4; Miltiadous G, 2005, NUTR METAB CARDIOVAS, V15, P219, DOI 10.1016/j.numecd.2004.09.004; MITCHELL RJ, 1994, HUM BIOL, V66, P13; Morgan TM, 2007, JAMA-J AM MED ASSOC, V297, P1551, DOI 10.1001/jama.297.14.1551; Motohashi Y, 2004, NUTR METAB CARDIOVAS, V14, P6, DOI 10.1016/S0939-4753(04)80041-3; Mukherjee M, 2004, CLIN GENET, V65, P412, DOI 10.1111/j.0009-9163.2004.0237.x; Nettleton JA, 2007, ATHEROSCLEROSIS, V194, pE131, DOI 10.1016/j.atherosclerosis.2006.11.025; Nicholls SJ, 2007, JAMA-J AM MED ASSOC, V297, P499, DOI 10.1001/jama.297.5.499; Noone E, 2000, BRIT J NUTR, V84, P203; Okamoto H, 2000, NATURE, V406, P203, DOI 10.1038/35018119; Okumura K, 2002, ATHEROSCLEROSIS, V161, P425, DOI 10.1016/S0021-9150(01)00653-0; Ordovas JM, 2000, ARTERIOSCL THROM VAS, V20, P1323, DOI 10.1161/01.ATV.20.5.1323; Packard C, 2002, INT J CLIN PRACT, V56, P761; Packard C, 2006, ATHEROSCLEROSIS SUPP, V7, P21, DOI 10.1016/j.atherosclerosissup.2006.01.004; Padmaja N, 2007, CLIN CHIM ACTA, V375, P140, DOI 10.1016/j.cca.2006.06.031; Pai JK, 2004, NEW ENGL J MED, V351, P2599, DOI 10.1056/NEJMoa040967; Pecheniuk NM, 2006, J THROMB HAEMOST, V4, P2080, DOI 10.1111/j.1538-7836.2006.02099.x; Plat J, 2002, EUR J CLIN INVEST, V32, P242, DOI 10.1046/j.1365-2362.2002.00982.x; [秦勤 Qin Qin], 2004, [中华心血管病杂志, Chinese Journal of Cardiology], V32, P522; Rader DJ, 2007, NEW ENGL J MED, V357, P2180, DOI 10.1056/NEJMe0707210; Riemens SC, 1999, J LIPID RES, V40, P1467; Ruiz-Narvaez EA, 2005, J LIPID RES, V46, P2605, DOI 10.1194/jlr.M500040-JLR200; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Sandhofer A, 2008, OBESITY, V16, P919, DOI 10.1038/oby.2007.130; Silva MCP, 2007, J AM GERIATR SOC, V55, P1483, DOI 10.1111/j.1532-5415.2007.01275.x; Singh IM, 2007, JAMA-J AM MED ASSOC, V298, P786, DOI 10.1001/jama.298.7.786; Smith GD, 2005, BMJ-BRIT MED J, V330, P1076, DOI 10.1136/bmj.330.7499.1076; Song GJ, 1997, MOL CELLS, V7, P615; Sorli JV, 2006, CLIN CHIM ACTA, V366, P196, DOI 10.1016/j.cca.2005.10.001; Tai ES, 2003, CLIN GENET, V63, P19, DOI 10.1034/j.1399-0004.2003.630104.x; Tall AR, 2007, NEW ENGL J MED, V356, P1364, DOI 10.1056/NEJMe078029; Tall AR, 2007, ARTERIOSCL THROM VAS, V27, P257, DOI 10.1161/01.ATV.0000256728.60226.77; Talmud PJ, 2002, ANN HUM GENET, V66, P111, DOI 10.1017/S0003480002001057; Tamminen M, 1996, ATHEROSCLEROSIS, V124, P237, DOI 10.1016/0021-9150(96)05833-9; TENKANEN H, 1991, HUM GENET, V87, P574; Thompson JF, 2005, ATHEROSCLEROSIS, V181, P45, DOI 10.1016/j.atherosclerosis.2005.01.015; Thompson JF, 2004, CLIN GENET, V66, P223, DOI 10.1111/j.1399-0004.2004.00289.x; Thompson JF, 2003, ATHEROSCLEROSIS, V167, P195, DOI 10.1016/S0021-9150(03)00005-4; Thompson JF, 2007, J LIPID RES, V48, P434, DOI 10.1194/jlr.M600372-JLR200; Tobin MD, 2004, EUR HEART J, V25, P459, DOI 10.1016/j.ehj.2003.11.014; Tsujita Y, 2007, ATHEROSCLEROSIS, V191, P199, DOI 10.1016/j.atherosclerosis.2006.03.028; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; VANACKER BA, ATHEROSCLEROSIS, DOI DOI 10.1016/ATHEROSCLEROSIS.2007.11.019; VANHIMBERGEN TM, 2007, ATHEROSCLEROSIS; Vergani C, 2006, ARCH GERONTOL GERIAT, V43, P213, DOI 10.1016/j.archger.2005.10.008; Vohl MC, 1999, INT J OBESITY, V23, P918, DOI 10.1038/sj.ijo.0800972; Volcik K, 2007, J STUD ALCOHOL DRUGS, V68, P485, DOI 10.15288/jsad.2007.68.485; [王伟 Wang Wei], 2004, [中华心血管病杂志, Chinese Journal of Cardiology], V32, P981; Weitgasser R, 2004, BIOMED PHARMACOTHER, V58, P619, DOI 10.1016/j.biopha.2004.09.010; Wheeler JG, 2004, LANCET, V363, P689, DOI 10.1016/S0140-6736(04)15642-0; Whiting BM, 2005, AM HEART J, V150, P243, DOI 10.1016/j.ahj.2004.08.034; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Wu JH, 2001, ATHEROSCLEROSIS, V159, P451, DOI 10.1016/S0021-9150(01)00524-X; Wu Yin, 2006, Zhonghua Yixue Yichuanxue Zazhi, V23, P640; Yamada Y, 2002, NEW ENGL J MED, V347, P1916, DOI 10.1056/NEJMoa021445; [鄢盛恺 Yan Shengkai], 2004, [中华检验医学杂志, Chinese Journal of Laboratory Medicine], V27, P671; Ye Z, 2006, LANCET, V367, P651, DOI 10.1016/S0140-6736(06)68263-9; Yilmaz H, 2005, CELL BIOCHEM FUNCT, V23, P23, DOI 10.1002/cbf.1124; Yilmaz H, 2004, INT J MOL MED, V13, P889; Zee RYL, 2006, J THROMB HAEMOST, V4, P341, DOI 10.1111/j.1538-7836.2006.01754.x; Zee RYL, 2004, HUM MOL GENET, V13, P389, DOI 10.1093/hmg/ddh039; [张国兵 Zhang Guobing], 2005, [中国动脉硬化杂志, Chinese Journal of Arteriosclerosis], V13, P88; Zheng Ke-qin, 2003, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V20, P23; Zheng KQ, 2005, INT J CARDIOL, V103, P259, DOI 10.1016/j.ijcard.2004.08.065; Zheng KQ, 2004, CHINESE MED J-PEKING, V117, P1288; Zheng KQ, 2004, ACTA BIOCH BIOPH SIN, V36, P33, DOI 10.1093/abbs/36.1.33; Zhong SB, 1996, J CLIN INVEST, V97, P2917, DOI 10.1172/JCI118751; 赵水平, 2004, [中华心血管病杂志, Chinese Journal of Cardiology], V32, P816	170	393	406	1	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 18	2008	299	23					2777	2788		10.1001/jama.299.23.2777	http://dx.doi.org/10.1001/jama.299.23.2777			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	314JH	18560005				2022-12-28	WOS:000256805200026
J	Cerletti, M; Jurga, S; Witczak, CA; Hirshman, MF; Shadrach, JL; Goodyear, LJ; Wagers, AJ				Cerletti, Massimiliano; Jurga, Sara; Witczak, Carol A.; Hirshman, Michael F.; Shadrach, Jennifer L.; Goodyear, Laurie J.; Wagers, Amy J.			Highly efficient, functional engraftment of skeletal muscle stem cells in dystrophic muscles	CELL			English	Article							MYOGENIC PROGENITOR CELLS; SATELLITE CELLS; HEMATOPOIETIC STEM; MUSCULAR-DYSTROPHY; GENE-EXPRESSION; MOUSE MUSCLE; QUIESCENT; MICE; REGENERATION; ACTIVATION	Satellite cells reside beneath the basal lamina of skeletal muscle fibers and include cells that act as precursors for muscle growth and repair. Although they share a common anatomical localization and typically are considered a homogeneous population, satellite cells actually exhibit substantial heterogeneity. We used cell-surface marker expression to purify from the satellite cell pool a distinct population of skeletal muscle precursors (SMPs) that function as muscle stem cells. When engrafted into muscle of dystrophin-deficient mdx mice, purified SMPs contributed to up to 94% of myofibers, restoring dystrophin expression and significantly improving muscle histology and contractile function. Transplanted SMPs also entered the satellite cell compartment, renewing the endogenous stem cell pool and participating in subsequent rounds of injury repair. Together, these studies indicate the presence in adult skeletal muscle of prospectively isolatable muscle-forming stem cells and directly demonstrate the efficacy of myogenic stem cell transplant for treating muscle degenerative disease.	[Cerletti, Massimiliano; Jurga, Sara; Shadrach, Jennifer L.; Wagers, Amy J.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Dev & Stem Cell Biol, Boston, MA 02115 USA; [Witczak, Carol A.; Hirshman, Michael F.; Goodyear, Laurie J.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Metab Sect, Boston, MA 02115 USA; [Cerletti, Massimiliano; Jurga, Sara; Shadrach, Jennifer L.; Wagers, Amy J.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Cerletti, Massimiliano; Jurga, Sara; Shadrach, Jennifer L.; Wagers, Amy J.] Harvard Univ, Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard University	Wagers, AJ (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Dev & Stem Cell Biol, 1 Joslin Pl, Boston, MA 02115 USA.	amy.wagers@joslin.harvard.edu	Jurga, Stefan/E-8862-2017	Jurga, Stefan/0000-0002-1665-6077	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR051663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068626] Funding Source: NIH RePORTER; NIAMS NIH HHS [F32 AR051663, F32AR051663] Funding Source: Medline; NIDDK NIH HHS [R01DK068626, R01 DK068626] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bachrach E, 2006, MUSCLE NERVE, V34, P44, DOI 10.1002/mus.20560; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; BLAU HM, 1983, P NATL ACAD SCI-BIOL, V80, P4856, DOI 10.1073/pnas.80.15.4856; Buckingham M, 2006, CURR OPIN GENET DEV, V16, P525, DOI 10.1016/j.gde.2006.08.008; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; COMELISON DD, 2001, DEV BIOL, V239, P79, DOI DOI 10.1006/DBI0.2001.0416; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721; Day K, 2007, DEV BIOL, V304, P246, DOI 10.1016/j.ydbio.2006.12.026; Deasy BM, 2007, J CELL BIOL, V177, P73, DOI 10.1083/jcb.200612094; Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542; Dezawa M, 2005, SCIENCE, V309, P314, DOI 10.1126/science.1110364; Dhawan J, 2005, TRENDS CELL BIOL, V15, P666, DOI 10.1016/j.tcb.2005.10.007; Durbeej M, 2002, CURR OPIN GENET DEV, V12, P349, DOI 10.1016/S0959-437X(02)00309-X; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Heslop L, 2000, J CELL SCI, V113, P2299; IRINTCHEV A, 1994, DEV DYNAM, V199, P326, DOI 10.1002/aja.1001990407; Jackson KA, 2004, STEM CELLS, V22, P180, DOI 10.1634/stemcells.22-2-180; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Lu QL, 2000, J CELL BIOL, V148, P985, DOI 10.1083/jcb.148.5.985; Luz MAM, 2002, BRAZ J MED BIOL RES, V35, P691, DOI 10.1590/S0100-879X2002000600009; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Miller RG, 1997, MUSCLE NERVE, V20, P469, DOI 10.1002/(SICI)1097-4598(199704)20:4<469::AID-MUS10>3.3.CO;2-1; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; MORGAN JE, 1993, J NEUROL SCI, V115, P191, DOI 10.1016/0022-510X(93)90224-M; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145; Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; Relaix F, 2003, GENE DEV, V17, P2950, DOI 10.1101/gad.281203; Rouger K, 2004, CELL TISSUE RES, V317, P319, DOI 10.1007/s00441-004-0911-9; Sampaolesi M, 2003, SCIENCE, V301, P487, DOI 10.1126/science.1082254; SCHULTZ E, 1978, J EXP ZOOL, V206, P451, DOI 10.1002/jez.1402060314; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Sherwood RI, 2004, STEM CELLS, V22, P1292, DOI 10.1634/stemcells.2004-0090; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; Swenson ES, 2007, STEM CELLS, V25, P2593, DOI 10.1634/stemcells.2007-0241; Wagers AJ, 2005, CELL, V122, P659, DOI 10.1016/j.cell.2005.08.021; Wernig G, 2005, P NATL ACAD SCI USA, V102, P11852, DOI 10.1073/pnas.0502507102; Wright DE, 2001, BLOOD, V97, P2278, DOI 10.1182/blood.V97.8.2278; WRIGHT WE, 1985, EXP CELL RES, V157, P343, DOI 10.1016/0014-4827(85)90119-3; Yablonka-Reuveni Z, 2006, DEV DYNAM, V235, P203, DOI 10.1002/dvdy.20602; YABLONKAREUVENI Z, 1994, DEV BIOL, V164, P588, DOI 10.1006/dbio.1994.1226; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007	48	333	349	0	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 11	2008	134	1					37	47		10.1016/j.cell.2008.05.049	http://dx.doi.org/10.1016/j.cell.2008.05.049			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	324IU	18614009	Bronze, Green Accepted			2022-12-28	WOS:000257513100012
J	Forneris, F; Mattevi, A				Forneris, Federico; Mattevi, Andrea			Enzymes without borders: Mobilizing substrates, delivering products	SCIENCE			English	Review							LEUKOTRIENE C-4 SYNTHASE; STATE NMR-SPECTROSCOPY; ACID AMIDE HYDROLASE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; HYDROXYSTEROID DEHYDROGENASES; MEMBRANE-PROTEINS; LIPID-BILAYERS; MD SIMULATIONS; SAPOSIN-B	Many cellular reactions involve both hydrophobic and hydrophilic molecules that reside within the chemically distinct environments defined by the phospholipid- based membranes and the aqueous lumens of cytoplasm and organelles. Enzymes performing this type of reaction are required to access a lipophilic substrate located in the membranes and to catalyze its reaction with a polar, water- soluble compound. Here, we explore the different binding strategies and chemical tricks that enzymes have developed to overcome this problem. These reactions can be catalyzed by integral membrane proteins that channel a hydrophilic molecule into their active site, as well as by water- soluble enzymes that are able to capture a lipophilic substrate from the phospholipid bilayer. Many chemical and biological aspects of this type of enzymology remain to be investigated and will require the integration of protein chemistry with membrane biology.	[Forneris, Federico; Mattevi, Andrea] Univ Pavia, Dept Genet & Microbiol, I-27100 Pavia, Italy	University of Pavia	Mattevi, A (corresponding author), Univ Pavia, Dept Genet & Microbiol, Via Ferrata 1, I-27100 Pavia, Italy.	mattevi@ipvgen.unipv.it	Forneris, Federico/AAL-5361-2020; mattevi, andrea/K-5464-2012; Mattevi, Andrea/R-4469-2019; Forneris, Federico/B-1145-2011	Forneris, Federico/0000-0002-7818-1804; mattevi, andrea/0000-0002-9523-7128; Mattevi, Andrea/0000-0002-9523-7128; Forneris, Federico/0000-0002-7818-1804				Ago H, 2007, NATURE, V448, P609, DOI 10.1038/nature05936; Ahn KW, 2004, BIOCHEMISTRY-US, V43, P827, DOI 10.1021/bi035697q; Ahn VE, 2003, P NATL ACAD SCI USA, V100, P38, DOI 10.1073/pnas.0136947100; Ahn VE, 2006, PROTEIN SCI, V15, P1849, DOI 10.1110/ps.062256606; Andersson M, 2008, STRUCTURE, V16, P21, DOI 10.1016/j.str.2007.10.016; Berg OG, 2001, CHEM REV, V101, P2613, DOI 10.1021/cr990139w; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Black PN, 2007, BBA-MOL CELL BIOL L, V1771, P286, DOI 10.1016/j.bbalip.2006.05.003; Blum A, 2003, PROG NUCLEIC ACID RE, V75, P173, DOI 10.1016/S0079-6603(03)75006-5; Bracey MH, 2002, SCIENCE, V298, P1793, DOI 10.1126/science.1076535; Bruhn H, 2005, BIOCHEM J, V389, P249, DOI 10.1042/BJ20050051; Canagarajah BJ, 2008, J MOL BIOL, V378, P737, DOI 10.1016/j.jmb.2008.01.075; Chandler D, 2005, NATURE, V437, P640, DOI 10.1038/nature04162; Christmas P, 2002, J BIOL CHEM, V277, P28902, DOI 10.1074/jbc.M203074200; De Maria L, 2007, APPL MICROBIOL BIOT, V74, P290, DOI 10.1007/s00253-006-0775-x; de Vet ECJM, 2000, CELL BIOCHEM BIOPHYS, V32, P117, DOI 10.1385/CBB:32:1-3:117; Falck E, 2008, J AM CHEM SOC, V130, P44, DOI 10.1021/ja7103558; Feng L, 2007, SCIENCE, V318, P1608, DOI 10.1126/science.1150755; Fowler PW, 2007, BIOCHEMISTRY-US, V46, P3108, DOI 10.1021/bi602455n; Goffin C, 1998, MICROBIOL MOL BIOL R, V62, P1079, DOI 10.1128/MMBR.62.4.1079-1093.1998; Goss KU, 2003, J CHEM EDUC, V80, P450, DOI 10.1021/ed080p450; Ha Y, 2007, CURR OPIN STRUC BIOL, V17, P405, DOI 10.1016/j.sbi.2007.06.010; Hernandez-Guzman FG, 2003, J BIOL CHEM, V278, P22989, DOI 10.1074/jbc.M211497200; Hisanaga Y, 2004, J BIOL CHEM, V279, P31717, DOI 10.1074/jbc.M400100200; Hoffmann F, 2007, DRUG METAB REV, V39, P87, DOI 10.1080/03602530600969440; Holm PJ, 2006, J MOL BIOL, V360, P934, DOI 10.1016/j.jmb.2006.05.056; Hong M, 2007, J PHYS CHEM B, V111, P10340, DOI 10.1021/jp073652j; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Jakobsson PJ, 1999, PROTEIN SCI, V8, P689, DOI 10.1110/ps.8.3.689; KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7; Kijac AZ, 2007, BIOCHEMISTRY-US, V46, P13696, DOI 10.1021/bi701411g; Lam BK, 2003, PROSTAG LEUKOTR ESS, V69, P111, DOI 10.1016/S0952-3278(03)00071-1; Lemberg MK, 2007, MOL CELL, V28, P930, DOI 10.1016/j.molcel.2007.12.003; Lovering AL, 2007, SCIENCE, V315, P1402, DOI 10.1126/science.1136611; McKinney MK, 2005, ANNU REV BIOCHEM, V74, P411, DOI 10.1146/annurev.biochem.74.082803.133450; Molina DM, 2007, NATURE, V448, P613, DOI 10.1038/nature06009; Muller DJ, 2008, PHARMACOL REV, V60, P43, DOI 10.1124/pr.107.07111; Nath A, 2007, BIOCHEMISTRY-US, V46, P2059, DOI 10.1021/bi602371n; Ogg D, 2005, J BIOL CHEM, V280, P3789, DOI 10.1074/jbc.M412463200; Patricelli MP, 2001, BIOCHEMISTRY-US, V40, P6107, DOI 10.1021/bi002578r; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; Raza H, 1996, BIOCHEM BIOPH RES CO, V228, P165, DOI 10.1006/bbrc.1996.1633; Razeto A, 2007, STRUCTURE, V15, P683, DOI 10.1016/j.str.2007.04.009; Rinaldo P, 2002, ANNU REV PHYSIOL, V64, P477, DOI 10.1146/annurev.physiol.64.082201.154705; Sampson NS, 2003, ACCOUNTS CHEM RES, V36, P713, DOI 10.1021/ar9800587; Scott KA, 2008, STRUCTURE, V16, P621, DOI 10.1016/j.str.2008.01.014; Sherbet DP, 2007, MOL CELL ENDOCRINOL, V265, P83, DOI 10.1016/j.mce.2006.12.021; Stokeley D, 2007, BIOCHEMISTRY-US, V46, P13573, DOI 10.1021/bi701320a; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Wendt KU, 1997, SCIENCE, V277, P1811, DOI 10.1126/science.277.5333.1811; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187	51	56	55	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 11	2008	321	5886					213	216		10.1126/science.1151118	http://dx.doi.org/10.1126/science.1151118			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	324IS	18621661				2022-12-28	WOS:000257512900029
J	Brook, RH				Brook, Robert H.			Health policy and public trust	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PROSPECTIVE PAYMENT SYSTEM; EMERGENCY ROOM; CARE; APPROPRIATENESS		[Brook, Robert H.] RAND Corp, RAND Hlth, Santa Monica, CA 90407 USA; [Brook, Robert H.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Brook, Robert H.] Univ Calif Los Angeles, Sch Publ Hlth, Westwood, CA USA	RAND Corporation; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Brook, RH (corresponding author), RAND Corp, RAND Hlth, 1776 Main St,POB 2138, Santa Monica, CA 90407 USA.	robert_brook@rand.org						BROOK RH, 1970, NEW ENGL J MED, V283, P904, DOI 10.1056/NEJM197010222831705; BROOK RH, 1973, ANN INTERN MED, V78, P333, DOI 10.7326/0003-4819-78-3-333; Jones L, 2007, JAMA-J AM MED ASSOC, V297, P407, DOI 10.1001/jama.297.4.407; KAHN KL, 1990, JAMA-J AM MED ASSOC, V264, P1953, DOI 10.1001/jama.264.15.1953; KOSECOFF J, 1990, JAMA-J AM MED ASSOC, V264, P1980, DOI 10.1001/jama.264.15.1980; Newhouse JP, 1993, FREE ALL LESSONS RAN; WINSLOW CM, 1988, JAMA-J AM MED ASSOC, V260, P505, DOI 10.1001/jama.260.4.505; WINSLOW CM, 1988, NEW ENGL J MED, V318, P721, DOI 10.1056/NEJM198803243181201	8	6	6	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 9	2008	300	2					211	213		10.1001/jama.2008.35	http://dx.doi.org/10.1001/jama.2008.35			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	323GV	18612119				2022-12-28	WOS:000257435500026
J	Anderson, BJ; Acuna, MH; Korth, H; Purucker, ME; Johnson, CL; Slavin, JA; Solomon, SC; McNutt, RL				Anderson, Brian J.; Acuna, Mario H.; Korth, Haje; Purucker, Michael E.; Johnson, Catherine L.; Slavin, James A.; Solomon, Sean C.; McNutt, Ralph L., Jr.			The structure of Mercury's magnetic field from MESSENGER's first flyby	SCIENCE			English	Article							ORIGIN	During its first flyby of Mercury, the MESSENGER spacecraft measured the planet's near- equatorial magnetic field. The field strength is consistent to within an estimated uncertainty of 10% with that observed near the equator by Mariner 10. Centered dipole solutions yield a southward planetary moment of 230 to 290 nanotesla R-M(3) ( where R-M is Mercury's mean radius) tilted between 5 and 12 from the rotation axis. Multipole solutions yield non- dipolar contributions of 22% to 52% of the dipole field magnitude. Magnetopause and tail currents account for part of the high- order field, and plasma pressure effects may explain the remainder, so that a pure centered dipole cannot be ruled out.	[Anderson, Brian J.; Korth, Haje; McNutt, Ralph L., Jr.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Acuna, Mario H.; Purucker, Michael E.] NASA, Solar Syst Explorat Div, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Johnson, Catherine L.] Univ British Columbia, Dept Earth & Ocean Sci, Vancouver, BC V6T 1Z4, Canada; [Slavin, James A.] NASA, Heliophys Sci Div, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Solomon, Sean C.] Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA	Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of British Columbia; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Carnegie Institution for Science	Anderson, BJ (corresponding author), Johns Hopkins Univ, Appl Phys Lab, 11100 Johns Hopkins Rd, Laurel, MD 20723 USA.	brian.anderson@jhuapl.edu	Johnson, Catherine L./AAZ-7295-2020; Anderson, Brian J/I-8615-2012; Korth, Haje/C-3182-2016; McNutt, Ralph L/E-8006-2010; Slavin, James A/H-3170-2012	Korth, Haje/0000-0001-7394-7439; McNutt, Ralph L/0000-0002-4722-9166; Slavin, James A/0000-0002-9206-724X				Anderson BJ, 2007, SPACE SCI REV, V131, P417, DOI 10.1007/s11214-007-9246-7; BLOXHAM J, 1989, PHILOS T R SOC A, V329, P415, DOI 10.1098/rsta.1989.0087; Christensen UR, 2006, NATURE, V444, P1056, DOI 10.1038/nature05342; CONNERNEY JEP, 1988, MERCURY, P494; JACKSON DJ, 1977, J GEOPHYS RES-SPACE, V82, P2828, DOI 10.1029/JA082i019p02828; JOHNSON CL, 1995, GEOPHYS J INT, V122, P489, DOI 10.1111/j.1365-246X.1995.tb07010.x; Korth H, 2004, PLANET SPACE SCI, V52, P733, DOI 10.1016/j.pss.2003.12.008; Luhmann JG, 1998, J GEOPHYS RES-SPACE, V103, P9113, DOI 10.1029/97JA03667; NESS NF, 1975, J GEOPHYS RES-SPACE, V80, P2708, DOI 10.1029/JA080i019p02708; NESS NF, 1974, SCIENCE, V185, P151, DOI 10.1126/science.185.4146.151; NESS NF, 1976, ICARUS, V28, P479, DOI 10.1016/0019-1035(76)90121-4; Parker RL, 1994, GEOPHYSICAL INVERSE; Slavin JA, 2008, SCIENCE, V321, P85, DOI 10.1126/science.1159040; SOLOMON SC, 1976, ICARUS, V28, P509, DOI 10.1016/0019-1035(76)90124-X; Solomon SC, 2008, SCIENCE, V321, P59, DOI 10.1126/science.1159706; SRNKA LJ, 1976, PHYS EARTH PLANET IN, V11, P184, DOI 10.1016/0031-9201(76)90062-5; Takahashi F, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025792; Travnicek P, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028518; Tsyganenko NA, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010798; Wicht J, 2007, SPACE SCI REV, V132, P261, DOI 10.1007/s11214-007-9280-5; WINCH D, 2007, ENCY GEOMAGNETISM PA, P448; Zurbuchen TH, 2008, SCIENCE, V321, P90, DOI 10.1126/science.1159314	22	138	139	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2008	321	5885					82	85		10.1126/science.1159081	http://dx.doi.org/10.1126/science.1159081			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QE	18599775				2022-12-28	WOS:000257320800039
J	Denrell, J				Denrell, Jerker			Sociology - Indirect social influence	SCIENCE			English	Editorial Material							EXPERIENCE		Stanford Univ, Grad Sch Business, Stanford, CA 94305 USA	Stanford University	Denrell, J (corresponding author), Stanford Univ, Grad Sch Business, Stanford, CA 94305 USA.	denrell@gsb.stanford.edu		Denrell, Jerker/0000-0001-9628-1924				ASCH SE, 1955, SCI AM, V193, P31, DOI 10.1038/scientificamerican1155-31; Cialdini RB, 2004, ANNU REV PSYCHOL, V55, P591, DOI 10.1146/annurev.psych.55.090902.142015; Denrell J, 2005, PSYCHOL REV, V112, P951, DOI 10.1037/0033-295X.112.4.951; Denrell J, 2007, PSYCHOL REV, V114, P398, DOI 10.1037/0033-295X.114.2.398; DEUTSCH MORTON, 1955, JOUR ABNORMAL AND SOCIAL PSYCHOL, V51-31, P629, DOI 10.1037/h0046408; Fiedler K, 2006, INFORMATION SAMPLING AND ADAPTIVE COGNITION, P1; Hertwig R, 2004, PSYCHOL SCI, V15, P534, DOI 10.1111/j.0956-7976.2004.00715.x; Moshkin NV, 2002, MARKET SCI, V21, P435, DOI 10.1287/mksc.21.4.435.136; Richerson P. J., 2005, NOT GENES ALONE CULT; Trope Y., 1996, SOCIAL PSYCHOL HDB B, P239	10	16	18	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2008	321	5885					47	48		10.1126/science.1157667	http://dx.doi.org/10.1126/science.1157667			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	321QE	18599762				2022-12-28	WOS:000257320800026
J	LeMieux, MC; Roberts, M; Barman, S; Jin, YW; Kim, JM; Bao, ZN				LeMieux, Melburne C.; Roberts, Mark; Barman, Soumendra; Jin, Yong Wan; Kim, Jong Min; Bao, Zhenan			Self-sorted, aligned nanotube networks for thin-film transistors	SCIENCE			English	Article							WALLED CARBON NANOTUBES; LARGE-SCALE; ELECTRONICS; ROUTE; TRANSPARENT; SEPARATION; TEMPLATES; ARRAYS	To find use in electronics, single- walled carbon nanotubes need to be efficiently separated by electronic type and aligned to ensure optimal and reproducible electronic properties. We report the fabrication of single- walled carbon nanotube ( SWNT) network field- effect transistors, deposited from solution, possessing controllable topology and an on/ off ratio as high as 900,000. The spin- assisted alignment and density of the SWNTs are tuned by different surfaces that effectively vary the degree of interaction with surface functionalities in the device channel. This leads to a self- sorted SWNT network in which nanotube chirality separation and simultaneous control of density and alignment occur in one step during device fabrication. Micro- Raman experiments corroborate device results as a function of surface chemistry, indicating enrichment of the specific SWNT electronic type absorbed onto the modified dielectric.	[LeMieux, Melburne C.; Roberts, Mark; Barman, Soumendra; Bao, Zhenan] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Jin, Yong Wan; Kim, Jong Min] Samsung Adv Inst Technol, Younggin Si 449712, Gyunggi Do, South Korea	Stanford University; Samsung	Bao, ZN (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.	zbao@stanford.edu	Roberts, Mark/H-9865-2016; Bao, Zhenan/AAC-5044-2019	Roberts, Mark/0000-0001-5971-6650; Bao, Zhenan/0000-0002-0972-1715				Ahn JH, 2006, SCIENCE, V314, P1754, DOI 10.1126/science.1132394; Artukovic E, 2005, NANO LETT, V5, P757, DOI 10.1021/nl050254o; Auvray S, 2005, NANO LETT, V5, P451, DOI 10.1021/nl048032y; Avouris P, 2007, NAT NANOTECHNOL, V2, P605, DOI 10.1038/nnano.2007.300; Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928; Chattopadhyay D, 2003, J AM CHEM SOC, V125, P3370, DOI 10.1021/ja028599l; Collins PC, 2001, SCIENCE, V292, P706, DOI 10.1126/science.1058782; Dresselhaus MS, 2002, CARBON, V40, P2043, DOI 10.1016/S0008-6223(02)00066-0; Duggal R, 2006, ADV MATER, V18, P29, DOI 10.1002/adma.200500625; Gruner G, 2006, J MATER CHEM, V16, P3533, DOI 10.1039/b603821m; Hu JT, 1999, ACCOUNTS CHEM RES, V32, P435, DOI 10.1021/ar9700365; Jorio A, 2001, PHYS REV LETT, V86, P1118, DOI 10.1103/PhysRevLett.86.1118; Keogh SM, 2004, J PHYS CHEM B, V108, P6233, DOI 10.1021/jp0369387; Kocabas C, 2007, NANO LETT, V7, P1195, DOI 10.1021/nl062907m; Krupke R, 2003, SCIENCE, V301, P344, DOI 10.1126/science.1086534; Lay MD, 2004, NANO LETT, V4, P603, DOI 10.1021/nl035233d; Liu J, 1999, CHEM PHYS LETT, V303, P125, DOI 10.1016/S0009-2614(99)00209-2; Lu J, 2007, SMALL, V3, P1566, DOI 10.1002/smll.200700127; Nish A, 2007, NAT NANOTECHNOL, V2, P640, DOI 10.1038/nnano.2007.290; Rao SG, 2003, NATURE, V425, P36, DOI 10.1038/425036a; Rowell MW, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2209887; Sharma R, 2007, NANO LETT, V7, P2693, DOI 10.1021/nl0711211; Snow ES, 2006, CHEM SOC REV, V35, P790, DOI 10.1039/b515473c; Snow ES, 2003, APPL PHYS LETT, V82, P2145, DOI 10.1063/1.1564291; Tsukruk VV, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.065502; Wang YH, 2006, P NATL ACAD SCI USA, V103, P2026, DOI 10.1073/pnas.0511022103; Zhao B, 2004, J NANOSCI NANOTECHNO, V4, P995, DOI 10.1166/jnn.2004.134	27	518	544	10	393	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2008	321	5885					101	104		10.1126/science.1156588	http://dx.doi.org/10.1126/science.1156588			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QE	18599781				2022-12-28	WOS:000257320800045
J	Curfman, GD; Morrissey, S; Drazen, JM				Curfman, Gregory D.; Morrissey, Stephen; Drazen, Jeffrey M.			Why doctors should worry about preemption	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material													Drazen, Jeffrey M/E-5841-2012	Morrissey, Stephen/0000-0001-6351-906X; Drazen, Jeffrey/0000-0003-2715-9890				BACIU A, 2007, FUTURE DRUG SAFETY P; KESSLER DA, 2008, GEORGETOWN LAW J, V96; Porter MJ, 1997, FOOD DRUG LAW J, V52, P7	3	15	15	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 3	2008	359	1					1	3		10.1056/NEJMp0804448	http://dx.doi.org/10.1056/NEJMp0804448			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320PB	18596269				2022-12-28	WOS:000257246000001
J	Mocumbi, AO; Ferreira, MB; Sidi, D; Yacoub, MH				Mocumbi, Ana Olga; Ferreira, Maria Beatriz; Sidi, Daniel; Yacoub, Magdi H.			A population study of endomyocardial fibrosis in a rural area of mozambique	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RHEUMATIC HEART-DISEASE; GEOGRAPHICAL-DISTRIBUTION; SURGICAL-TREATMENT; UGANDA; SURGERY; DIAGNOSIS; EMF	Background: Endomyocardial fibrosis is the most common restrictive cardiomyopathy worldwide. It has no specific treatment and carries a poor prognosis, since most patients present with advanced heart failure. On the basis of clinical series, regional variations in distribution have been reported within several countries in Africa, Asia, and South America, but large-scale data are lacking on the epidemiologic features and early stages of the disease. Methods: We used transthoracic echocardiography to determine the prevalence of endomyocardial fibrosis in a rural area of Mozambique. We screened a random sample of 1063 subjects of all age groups selected by clustering. Major and minor diagnostic criteria were defined, and a severity score was developed and applied. Cases were classified according to the distribution and severity of the lesions in the heart. Results: The estimated overall prevalence of endomyocardial fibrosis was 19.8%, or 211 of 1063 subjects (95% confidence interval [CI], 17.4 to 22.2). The prevalence was highest among persons 10 to 19 years of age (28.1%, or 73 of 260 subjects [95% CI, 22.6 to 33.6]) and was higher among male than among female subjects (23.0% vs. 17.5%, P=0.03). The most common form was biventricular endomyocardial fibrosis (a prevalence of 55.5%, or 117 of 211 subjects [95% CI, 48.8 to 62.2]), followed by right-sided endomyocardial fibrosis (a prevalence of 28.0%, or 59 of 211 subjects [95% CI, 21.9 to 34.1]). Most affected subjects had mild-to-moderate structural and functional echocardiographic abnormalities. Only 48 persons with endomyocardial fibrosis (22.7%) were symptomatic. The frequency of familial occurrence was high. Conclusions: Endomyocardial fibrosis is common in a rural area of Mozambique. By using echocardiography, we were able to detect early, asymptomatic stages of the disease. These findings may aid in the study of the pathogenesis of the disease and in the development of new management strategies.	[Mocumbi, Ana Olga; Yacoub, Magdi H.] Univ London Imperial Coll Sci Technol & Med, London, England; [Mocumbi, Ana Olga; Ferreira, Maria Beatriz; Sidi, Daniel; Yacoub, Magdi H.] Inst Coracao, Maputo, Mozambique; [Sidi, Daniel] Hop Necker Enfants Malad, Paris, France	Imperial College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Yacoub, MH (corresponding author), Harefield Hosp, Magdi Yacoub Inst, Harefield UB9 6JH, Middx, England.	m.yacoub@imperial.ac.uk	Ferreira, Maria Beatriz C/G-6561-2012	Mocumbi, Ana/0000-0002-9564-2860				Andy JJ, 1998, ACTA TROP, V69, P127, DOI 10.1016/S0001-706X(97)00125-3; BENNETT S, 1991, World Health Statistics Quarterly, V44, P98; Berensztein CS, 2000, J AM SOC ECHOCARDIOG, V13, P385, DOI 10.1016/S0894-7317(00)70008-3; BIJLSMA F, 1979, T ROY SOC TROP MED H, V73, P661, DOI 10.1016/0035-9203(79)90015-4; CHERIAN G, 1983, AM HEART J, V105, P659, DOI 10.1016/0002-8703(83)90491-X; CONNOR DH, 1967, AM HEART J, V74, P687, DOI 10.1016/0002-8703(67)90509-1; Ferreira B, 2002, B SOC PATHOL EXOT, V95, P276; Ferreira M B, 1992, Rev Port Cardiol, V11, P841; FERREIRA MB, 2000, THESIS PARIS 5 U REN; GONZALEZLAVIN L, 1983, AM HEART J, V105, P699, DOI 10.1016/0002-8703(83)90508-2; Hakim J. G., 1996, Central African Journal of Medicine, V42, P262; Hassan WM, 2005, CHEST, V128, P3985, DOI 10.1378/chest.128.6.3985; Kartha CC, 1995, CARDIOVASC RES, V30, P636, DOI 10.1016/S0008-6363(96)88509-9; KRISHNA S, 1978, 8 WORLD C CARD TOK S; Kutty VR, 1996, INT J EPIDEMIOL, V25, P1202, DOI 10.1093/ije/25.6.1202; LOWENTHAL MN, 1978, MED J ZAMBIA, V12, P2; Mady Charles, 2005, Arq. Bras. Cardiol., V84, P241, DOI 10.1590/S0066-782X2005000300009; METRAS D, 1985, CIRCULATION, V72, P274; Mocumbi AO, 2008, HEART, V94, P384, DOI 10.1136/hrt.2007.136101; Moraes F, 1999, EUR J CARDIO-THORAC, V15, P309, DOI 10.1016/S1010-7940(99)00027-5; Niino Tetsuya, 2002, Ann Thorac Cardiovasc Surg, V8, P173; PATEL AK, 1971, BRIT MED J, V4, P331, DOI 10.1136/bmj.4.5783.331; Rutakingirwa M, 1999, TROP MED INT HEALTH, V4, P229, DOI 10.1046/j.1365-3156.1999.43376.x; Salemi V M C, 2005, Heart, V91, P1399, DOI 10.1136/hrt.2005.063610; Schneider U, 1998, HEART, V79, P362, DOI 10.1136/hrt.79.4.362; SHAPER AG, 1970, PATHOL MICROBIOL, V35, P26, DOI 10.1159/000162195; SHAPER AG, 1968, BRIT HEART J, V30, P391; Sliwa K, 2005, CIRCULATION, V112, P3577, DOI 10.1161/CIRCULATIONAHA.105.542894; VALIATHAN MS, 1987, ANN THORAC SURG, V43, P68, DOI 10.1016/S0003-4975(10)60169-5; Yacoub S, 2008, NAT CLIN PRACT CARD, V5, P176, DOI 10.1038/ncpcardio1129; Yie Kilsoo, 2004, Interact Cardiovasc Thorac Surg, V3, P86, DOI 10.1016/S1569-9293(03)00189-0; Yin Ruixing, 2000, Chinese Medical Sciences Journal, V15, P55	32	122	126	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 3	2008	359	1					43	49		10.1056/NEJMoa0708629	http://dx.doi.org/10.1056/NEJMoa0708629			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320PB	18596273	Bronze			2022-12-28	WOS:000257246000006
J	Srihari, VH; Lee, TW				Srihari, Vinod H.; Lee, T. Warren			Evidence based case report - Pulmonary emobolism in a patient taking clozapine	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Srihari, Vinod H.; Lee, T. Warren] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06510 USA	Yale University	Srihari, VH (corresponding author), Yale Univ, Sch Med, Dept Psychiat, 333 Cedar St, New Haven, CT 06510 USA.	vinod.srihari@yale.edu	Srihari, Vinod H./B-9040-2018	Srihari, Vinod H./0000-0003-1556-2332				DALY LE, 2000, INTERPRETATION USES, P370; Geddes J, 1999, EVID BASED MENT HLTH, V2, P35, DOI DOI 10.1136/EBMH.2.2.35; Guyatt G., 2015, USERS GUIDES MED LIT; Haynes R B, 2001, Evid Based Ment Health, V4, P37; Parkin L, 2003, PHARMACOEPIDEM DR S, V12, P647, DOI 10.1002/pds.841; Rosenbaum J.F.A.G., 2005, HDB PSYCHIAT DRUG TH HDB PSYCHIAT DRUG TH; Stricker BHC, 2004, BRIT MED J, V329, P44, DOI 10.1136/bmj.329.7456.44; Strom BL, 2006, JAMA-J AM MED ASSOC, V295, P2072, DOI 10.1001/jama.295.17.2072; *THOMS HEALTHC, 2006, PHYS DESK REF; Walker AM, 1997, EPIDEMIOLOGY, V8, P671, DOI 10.1097/00001648-199710000-00010; Zornberg GL, 2000, LANCET, V356, P1219, DOI 10.1016/S0140-6736(00)02784-7	11	8	9	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 28	2008	336	7659					1499	1501		10.1136/bmj.39545.690613.47	http://dx.doi.org/10.1136/bmj.39545.690613.47			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	324GN	18583682	Green Published			2022-12-28	WOS:000257505900040
J	Stowers, L; Logan, DW				Stowers, Lisa; Logan, Darren W.			LUSH shapes up for a starring role in olfaction	CELL			English	Editorial Material							DROSOPHILA; RECEPTORS; CHANNELS; NEURONS	In the fruit fly Drosophila, odorant-binding proteins are secreted into the fluid that bathes olfactory neurons. Laughlin et al. (2008) now challenge the assumption that the odorant-binding protein LUSH passively transports its pheromone to a specific olfactory receptor. Instead, LUSH undergoes a conformational change upon pheromone binding that is sufficient for neuronal activation.	[Stowers, Lisa; Logan, Darren W.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Stowers, L (corresponding author), Scripps Res Inst, Dept Cell Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	stowers@scripps.edu	Logan, Darren/D-5629-2009; Stowers, Lisa/K-6137-2015	Logan, Darren/0000-0003-1545-5510; Stowers, Lisa/0000-0002-4403-1269				Datta SR, 2008, NATURE, V452, P473, DOI 10.1038/nature06808; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Kim MS, 1998, GENETICS, V150, P711; Pelosi P, 2001, CELL MOL LIFE SCI, V58, P503, DOI 10.1007/PL00000875; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Schlief ML, 2007, NAT NEUROSCI, V10, P623, DOI 10.1038/nn1881; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031	8	9	10	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 27	2008	133	7					1137	1139		10.1016/j.cell.2008.06.010	http://dx.doi.org/10.1016/j.cell.2008.06.010			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	319DP	18585346	Bronze			2022-12-28	WOS:000257144600009
J	Drescher, T; Klima, T; Schifferli, J				Drescher, Tilman; Klima, Theresia; Schifferli, Juerg			Seizures, hyponatraemia, and "poison"	LANCET			English	Editorial Material									[Drescher, Tilman; Klima, Theresia; Schifferli, Juerg] Univ Basel Hosp, Dept Internal Med, CH-4031 Basel, Switzerland	University of Basel	Drescher, T (corresponding author), Univ Basel Hosp, Dept Internal Med, CH-4031 Basel, Switzerland.	Dreschert@uhbs.ch						AMINOFF MJ, 1984, BRAIN, V107, P569, DOI 10.1093/brain/107.2.569; Reynolds RM, 2006, BMJ-BRIT MED J, V332, P702, DOI 10.1136/bmj.332.7543.702; Thaler SM, 1998, AM J KIDNEY DIS, V31, P1028, DOI 10.1053/ajkd.1998.v31.pm9631849; Verbalis JG, 2007, AM J MED, V120, pS1, DOI 10.1016/j.amjmed.2007.09.001	4	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 21	2008	371	9630					2144	2144		10.1016/S0140-6736(08)60923-X	http://dx.doi.org/10.1016/S0140-6736(08)60923-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	316ER	18572083				2022-12-28	WOS:000256932200034
J	Sandberg, R; Neilson, JR; Sarma, A; Sharp, PA; Burge, CB				Sandberg, Rickard; Neilson, Joel R.; Sarma, Arup; Sharp, Phillip A.; Burge, Christopher B.			Proliferating cells express mRNAs with shortened 3 ' untranslated regions and fewer microRNA target sites	SCIENCE			English	Article							ALTERNATIVE POLYADENYLATION; FACTOR CSTF-64; STIMULATORY FACTOR; GENE-EXPRESSION; EVENTS; DIFFERENTIATION; TRANSITION; SELECTION; SUBUNIT; BINDING	Messenger RNA ( mRNA) stability, localization, and translation are largely determined by sequences in the 3' untranslated region ( 3'UTR). We found a conserved increase in expression of mRNAs terminating at upstream polyadenylation sites after activation of primary murine CD4(+) T lymphocytes. This program, resulting in shorter 3' UTRs, is a characteristic of gene expression during immune cell activation and correlates with proliferation across diverse cell types and tissues. Forced expression of full- length 3' UTRs conferred reduced protein expression. In some cases the reduction in protein expression could be reversed by deletion of predicted microRNA target sites in the variably included region. Our data indicate that gene expression is coordinately regulated, such that states of increased proliferation are associated with widespread reductions in the 3' UTR- based regulatory capacity of mRNAs.	[Sandberg, Rickard; Sharp, Phillip A.; Burge, Christopher B.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Neilson, Joel R.; Sharp, Phillip A.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Sarma, Arup] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Sharp, PA (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	sharppa@mit.edu; cburge@mit.edu	Burge, Christopher B./AAH-2177-2020	Sandberg, Rickard/0000-0001-6473-1740; Neilson, Joel R./0000-0002-3408-608X	NCI NIH HHS [P30-CA14051, K99 CA131474, P01 CA042063-22, P01-CA42063, P30 CA014051, P01 CA042063] Funding Source: Medline; NHGRI NIH HHS [R01-HG002439, R01 HG002439, R01 HG002439-07] Funding Source: Medline; NIAID NIH HHS [U19 AI056900, U19 AI056900-010001] Funding Source: Medline; NIGMS NIH HHS [R01 GM034277, R01 GM034277-23, R01-GM34277] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA042063, P30CA014051, K99CA131474] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI056900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034277] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ara T, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-189; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Beaudoing E, 2001, GENOME RES, V11, P1520, DOI 10.1101/gr.190501; Brown KM, 2003, MOL CELL, V12, P1467, DOI 10.1016/S1097-2765(03)00453-2; Chuvpilo S, 1999, IMMUNITY, V10, P261, DOI 10.1016/S1074-7613(00)80026-6; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; EdwaldsGilbert G, 1997, NUCLEIC ACIDS RES, V25, P2547, DOI 10.1093/nar/25.13.2547; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Legendre M, 2006, PLOS COMPUT BIOL, V2, P333, DOI 10.1371/journal.pcbi.0020043; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Martincic K, 1998, P NATL ACAD SCI USA, V95, P11095, DOI 10.1073/pnas.95.19.11095; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; PEATTIE DA, 1994, GENE, V150, P251, DOI 10.1016/0378-1119(94)90434-0; Quesada V, 2003, EMBO J, V22, P3142, DOI 10.1093/emboj/cdg305; Shell SA, 2005, J BIOL CHEM, V280, P39950, DOI 10.1074/jbc.M508848200; Simpson GG, 2003, CELL, V113, P777, DOI 10.1016/S0092-8674(03)00425-2; Takagaki Y, 1998, MOL CELL, V2, P761, DOI 10.1016/S1097-2765(00)80291-9; Takagaki Y, 1996, CELL, V87, P941, DOI 10.1016/S0092-8674(00)82000-0; Veraldi KL, 2001, MOL CELL BIOL, V21, P1228, DOI 10.1128/MCB.21.4.1228-1238.2001; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Zhang HB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r100	21	969	994	2	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 20	2008	320	5883					1643	1647		10.1126/science.1155390	http://dx.doi.org/10.1126/science.1155390			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	315NM	18566288	Green Accepted			2022-12-28	WOS:000256886700050
J	Seki, A; Coppinger, JA; Jang, CY; Yates, JR; Fang, GW				Seki, Akiko; Coppinger, Judith A.; Jang, Chang-Young; Yates, John R., III; Fang, Guowei			Bora and the kinase Aurora A cooperatively activate the kinase Plk1 and control mitotic entry	SCIENCE			English	Article							POLO-LIKE KINASE; SCF-BETA-TRCP; CELL-CYCLE; PLX1; DOMAIN; POLO-LIKE-KINASE-1; PHOSPHORYLATION; PURIFICATION; PATHWAY; MITOSIS	A central question in the study of cell proliferation is, what controls cell- cycle transitions? Although the accumulation of mitotic cyclins drives the transition from the G(2) phase to the M phase in embryonic cells, the trigger for mitotic entry in somatic cells remains unknown. We report that the synergistic action of Bora and the kinase Aurora A ( Aur- A) controls the G(2)- M transition. Bora accumulates in the G(2) phase and promotes Aur- A- mediated activation of Polo- like kinase 1 ( Plk1), leading to the activation of cyclin- dependent kinase 1 and mitotic entry. Mechanistically, Bora interacts with Plk1 and controls the accessibility of its activation loop for phosphorylation and activation by Aur- A. Thus, Bora and Aur- A control mitotic entry, which provides a mechanism for one of the most important yet ill- defined events in the cell cycle.	[Seki, Akiko; Jang, Chang-Young; Fang, Guowei] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; [Coppinger, Judith A.; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	Stanford University; Scripps Research Institute	Fang, GW (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	gwfang@stanford.edu		coppinger, judith/0000-0001-6813-9840	NCRR NIH HHS [P41 RR011823, RR11823-10, P41 RR011823-10] Funding Source: Medline; NHLBI NIH HHS [R01 HL079442-04, HL079442, R01 HL079442] Funding Source: Medline; NIGMS NIH HHS [GM062852, R01 GM062852-05, R01 GM062852] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062852] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Eliassen A, 2003, NORW J GEOL, V83, P299; Erikson E, 2004, J BIOL CHEM, V279, P32219, DOI 10.1074/jbc.M403840200; Ferrari S, 2005, BIOCHEM J, V390, P293, DOI 10.1042/BJ20050343; Hansen DV, 2004, MOL BIOL CELL, V15, P5623, DOI 10.1091/mbc.E04-07-0598; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Hutterer A, 2006, DEV CELL, V11, P147, DOI 10.1016/j.devcel.2006.06.002; Jang YJ, 2002, J BIOL CHEM, V277, P44115, DOI 10.1074/jbc.M202172200; Jang YJ, 2002, P NATL ACAD SCI USA, V99, P1984, DOI 10.1073/pnas.042689299; Kelm O, 2002, J BIOL CHEM, V277, P25247, DOI 10.1074/jbc.M202855200; Kothe M, 2007, BIOCHEMISTRY-US, V46, P5960, DOI 10.1021/bi602474j; Kumagai A, 1996, SCIENCE, V273, P1377, DOI 10.1126/science.273.5280.1377; Lee KS, 1997, MOL CELL BIOL, V17, P3408, DOI 10.1128/MCB.17.6.3408; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Liu JJ, 2005, ONCOGENE, V24, P238, DOI 10.1038/sj.onc.1208220; Liu X, 2004, ONCOGENE, V23, P763, DOI 10.1038/sj.onc.1207188; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Qian YW, 1999, MOL CELL BIOL, V19, P8625; Qian YW, 1998, SCIENCE, V282, P1701, DOI 10.1126/science.282.5394.1701; Qian YW, 2001, MOL BIOL CELL, V12, P1791, DOI 10.1091/mbc.12.6.1791; Seki A, 2008, J CELL BIOL, V181, P65, DOI 10.1083/jcb.200712027; van Vugt MATM, 2005, ONCOGENE, V24, P2844, DOI 10.1038/sj.onc.1208617; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030	25	438	447	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 20	2008	320	5883					1655	1658		10.1126/science.1157425	http://dx.doi.org/10.1126/science.1157425			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	315NM	18566290	Green Accepted			2022-12-28	WOS:000256886700053
J	Stallard, T; Miller, S; Melin, H; Lystrup, M; Cowley, SWH; Bunce, EJ; Achilleos, N; Dougherty, M				Stallard, Tom; Miller, Steve; Melin, Henrik; Lystrup, Makenzie; Cowley, Stan W. H.; Bunce, Emma J.; Achilleos, Nicholas; Dougherty, Michele			Jovian-like aurorae on Saturn	NATURE			English	Article							H-3(+) INFRARED-EMISSION; IONOSPHERE; FIELD; OVAL; MAGNETOSPHERE; THERMOSPHERE; TEMPERATURE; DYNAMICS	Planetary aurorae are formed by energetic charged particles streaming along the planet's magnetic field lines into the upper atmosphere from the surrounding space environment. Earth's main auroral oval is formed through interactions with the solar wind(1), whereas that at Jupiter is formed through interactions with plasma from the moon Io inside its magnetic field (although other processes form aurorae at both planets(2,3)). At Saturn, only the main auroral oval has previously been observed and there remains much debate over its origin. Here we report the discovery of a secondary oval at Saturn that is similar to 25 per cent as bright as the main oval, and we show this to be caused by interaction with the middle magnetosphere around the planet. This is a weak equivalent of Jupiter's main oval, its relative dimness being due to the lack of as large a source of ions as Jupiter's volcanic moon Io. This result suggests that differences seen in the auroral emissions from Saturn and Jupiter are due to scaling differences in the conditions at each of these two planets, whereas the underlying formation processes are the same.	[Stallard, Tom; Cowley, Stan W. H.; Bunce, Emma J.] Univ Leicester, Dept Phys & Astron, Leicester LE1 7RH, Leics, England; [Miller, Steve; Lystrup, Makenzie; Achilleos, Nicholas] UCL, Dept Phys & Astron, London WC1E 6BT, England; [Melin, Henrik] Space Environm Technol, Planetary & Space Sci Div, Pasadena, CA 91107 USA; [Dougherty, Michele] Univ London Imperial Coll Sci Technol & Med, Dept Phys, Space & Atmospher Phys Grp, London SW7 2BW, England	University of Leicester; University of London; University College London; Imperial College London	Stallard, T (corresponding author), Univ Leicester, Dept Phys & Astron, Leicester LE1 7RH, Leics, England.	tss@ion.le.ac.uk	Bunce, Emma J/I-9067-2016; Stallard, Tom/W-8743-2019; Achilleos, Nicholas/C-1647-2008	Bunce, Emma J/0000-0002-9456-0345; Stallard, Tom/0000-0003-3990-670X; Miller, Steven/0000-0002-7159-6871; Achilleos, Nicholas/0000-0002-5886-3509; Cowley, Stanley/0000-0002-4041-0034	STFC [PP/E000983/1] Funding Source: UKRI; Science and Technology Facilities Council [PP/E000983/1] Funding Source: researchfish	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		Badman SV, 2006, ANN GEOPHYS-GERMANY, V24, P3533, DOI 10.5194/angeo-24-3533-2006; Clarke JT, 2005, NATURE, V433, P717, DOI 10.1038/nature03331; Cowley SWH, 2004, J GEOPHYS RES-SPACE, V109, DOI 10.1029/2003JA010375; Cowley SWH, 2003, ANN GEOPHYS-GERMANY, V21, P1691, DOI 10.5194/angeo-21-1691-2003; Cowley SWH, 2001, PLANET SPACE SCI, V49, P1067, DOI 10.1016/S0032-0633(00)00167-7; Crary FJ, 2005, NATURE, V433, P720, DOI 10.1038/nature03333; DUNGEY JW, 1961, PHYS REV LETT, V6, P47, DOI 10.1103/PhysRevLett.6.47; Gerard JC, 2004, J GEOPHYS RES-SPACE, V109, DOI 10.1029/2004JA010513; GREENE TP, 1993, P SOC PHOTO-OPT INS, V1946, P313, DOI 10.1117/12.158684; Grodent D, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010983; Grodent D, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2003JA010017; Hill TW, 2001, J GEOPHYS RES-SPACE, V106, P8101, DOI 10.1029/2000JA000302; Melin H, 2007, ICARUS, V186, P234, DOI 10.1016/j.icarus.2006.08.014; Saur J, 2006, NATURE, V439, P699, DOI 10.1038/nature04401; Sittler EC, 2006, J GEOPHYS RES-SPACE, V111, DOI 10.1029/2005JA011191; Stallard T, 2002, ICARUS, V156, P498, DOI 10.1006/icar.2001.6793; Stallard T, 2001, ICARUS, V154, P475, DOI 10.1006/icar.2001.6681; Stallard T, 1999, ASTROPHYS J, V521, pL149, DOI 10.1086/312189; Stallard T, 2007, ICARUS, V191, P678, DOI 10.1016/j.icarus.2007.05.016; Stallard T, 2007, ICARUS, V189, P1, DOI 10.1016/j.icarus.2006.12.027; Stallard TS, 2004, ICARUS, V167, P204, DOI 10.1016/j.icarus.2003.09.006; Stallard TS, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016031; Trauger JT, 1998, J GEOPHYS RES-PLANET, V103, P20237, DOI 10.1029/98JE01324	23	41	41	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2008	453	7198					1083	1085		10.1038/nature07077	http://dx.doi.org/10.1038/nature07077			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314WM	18563160				2022-12-28	WOS:000256839900052
J	Stassun, KG; Mathieu, RD; Cargile, PA; Aarnio, AN; Stempels, E; Geller, A				Stassun, Keivan G.; Mathieu, Robert D.; Cargile, Phillip A.; Aarnio, Alicia N.; Stempels, Eric; Geller, Aaron			Surprising dissimilarities in a newly formed pair of 'identical twin' stars	NATURE			English	Article							ORION NEBULA CLUSTER; SEQUENCE ECLIPSING BINARY; LOW-MASS; ABSOLUTE CALIBRATION; FORMING REGION; BROWN DWARFS; SYSTEM; 2MASS; TEMPERATURES; PHOTOMETRY	The mass and chemical composition of a star are the primary determinants of its basic physical properties - radius, temperature and luminosity - and how those properties evolve with time(1). Accordingly, two stars born at the same time, from the same natal material and with the same mass, are 'identical twins,' and as such might be expected to possess identical physical attributes. We have discovered in the Orion nebula a pair of stellar twins in a newborn binary star system(2). Each star in the binary has a mass of 0.41 +/- 0.01 solar masses, identical to within 2 per cent. Here we report that these twin stars have surface temperatures differing by similar to 300 K (similar to 10 per cent) and luminosities differing by similar to 50 per cent, both at high confidence level. Preliminary results indicate that the stars' radii also differ, by 5 - 10 per cent. These surprising dissimilarities suggest that one of the twins may have been delayed by several hundred thousand years in its formation relative to its sibling. Such a delay could only have been detected in a very young, definitively equal-mass binary system(3). Our findings reveal cosmic limits on the age synchronization of young binary stars, often used as tests for the age calibrations of star-formation models(4).	[Stassun, Keivan G.; Cargile, Phillip A.; Aarnio, Alicia N.] Vanderbilt Univ, Dept Phys & Astron, Nashville, TN 37235 USA; [Mathieu, Robert D.; Geller, Aaron] Univ Wisconsin, Dept Astron, Madison, WI 53706 USA; [Stempels, Eric] Univ St Andrews, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland	Vanderbilt University; University of Wisconsin System; University of Wisconsin Madison; University of St Andrews	Stassun, KG (corresponding author), Vanderbilt Univ, Dept Phys & Astron, Nashville, TN 37235 USA.	keivan.stassun@vanderbilt.edu		Cargile, Phillip/0000-0002-1617-8917; Aarnio, Alicia/0000-0002-1327-9659; Stassun, Keivan/0000-0002-3481-9052				Allard F, 2000, ASTROPHYS J, V539, P366, DOI 10.1086/309218; ANDERSEN J, 1991, ASTRON ASTROPHYS REV, V3, P91, DOI 10.1007/BF00873538; BAGNUOLO WG, 1991, ASTROPHYS J, V376, P266, DOI 10.1086/170276; CAMPINS H, 1985, ASTRON J, V90, P896, DOI 10.1086/113799; Cargile PA, 2008, ASTROPHYS J, V674, P329, DOI 10.1086/524346; Chabrier G, 2007, ASTRON ASTROPHYS, V472, pL17, DOI 10.1051/0004-6361:20077702; Cohen M, 2003, ASTRON J, V126, P1090, DOI 10.1086/376474; Cousins A.W.J., 1976, MEM R ASTRON SOC, V81, P25; Covino E, 2004, ASTRON ASTROPHYS, V427, P637, DOI 10.1051/0004-6361:20040348; Cox A. N, 2001, ALLENS ASTROPHYSICAL; D'Antona F., 1997, Memorie della Societa Astronomica Italiana, V68, P807; GENZEL R, 1989, ANNU REV ASTRON ASTR, V27, P41, DOI 10.1146/annurev.aa.27.090189.000353; Hillenbrand LA, 1997, ASTRON J, V113, P1733, DOI 10.1086/118389; Irwin J, 2007, MON NOT R ASTRON SOC, V380, P541, DOI [10.1111/j.1365-2966.2007.12117.x, 10.1111/j.1365-2966.2007.12091.x]; Luhman KL, 1999, ASTROPHYS J, V525, P466, DOI 10.1086/307902; Prsa A, 2005, ASTROPHYS J, V628, P426, DOI 10.1086/430591; RIBAS I, IN PRESS MEM SOC AST, V79; ROBBERTO M, 2005, BAAS, V37, P1404; Skrutskie MF, 2006, ASTRON J, V131, P1163, DOI 10.1086/498708; Slesnick CL, 2004, ASTROPHYS J, V610, P1045, DOI 10.1086/421898; Stassun KG, 2007, ASTROPHYS J, V664, P1154, DOI 10.1086/519231; Stassun KG, 2006, NATURE, V440, P311, DOI 10.1038/nature04570; Stassun KG, 2004, ASTROPHYS J SUPPL S, V151, P357, DOI 10.1086/382353; STELLINGWERF RF, 1978, ASTROPHYS J, V224, P953, DOI 10.1086/156444; Torres G, 2006, ASTROPHYS J, V640, P1018, DOI 10.1086/500188; WILSON RE, 1971, ASTROPHYS J, V166, P605, DOI 10.1086/150986; Zacharias N., 2004, BAAS, V36, P1418; ZUCKER S, 1994, ASTROPHYS J, V420, P806, DOI 10.1086/173605	29	44	45	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 19	2008	453	7198					1079	1082		10.1038/nature07069	http://dx.doi.org/10.1038/nature07069			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314WM	18563159	Green Submitted			2022-12-28	WOS:000256839900051
J	Golden, SH; Lazo, M; Carnethon, M; Bertoni, AG; Schreiner, PJ; Roux, AVD; Lee, HB; Lyketsos, C				Golden, Sherita Hill; Lazo, Mariana; Carnethon, Mercedes; Bertoni, Alain G.; Schreiner, Pamela J.; Roux, Ana V. Diez; Lee, Hochang Benjamin; Lyketsos, Constantine			Examining a bidirectional association between depressive symptoms and diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INSULIN-RESISTANCE; ATHEROSCLEROSIS RISK; COMORBID DEPRESSION; METABOLIC-CONTROL; MAJOR DEPRESSION; WEIGHT-GAIN; TYPE-2; MELLITUS; COMPLICATIONS; PREVALENCE	Context Depressive symptoms are associated with development of type 2 diabetes, but it is unclear whether type 2 diabetes is a risk factor for elevated depressive symptoms. Objective To examine the bidirectional association between depressive symptoms and type 2 diabetes. Design, Setting, and Participants Multi-Ethnic Study of Atherosclerosis, a longitudinal, ethnically diverse cohort study of US men and women aged 45 to 84 years enrolled in 2000-2002 and followed up until 2004-2005. Main Outcome Measures Elevated depressive symptoms defined by Center for Epidemiologic Studies Depression Scale (CES-D) score of 16 or higher, use of antidepressant medications, or both. The CES-D score was also modeled continuously. Participants were categorized as normal fasting glucose (<100 mg/dL), impaired fasting glucose (100-125 mg/dL), or type 2 diabetes (>= 126 mg/dL or receiving treatment). Analysis 1 included 5201 participants without type 2 diabetes at baseline and estimated the relative hazard of incident type 2 diabetes over 3.2 years for those with and without depressive symptoms. Analysis 2 included 4847 participants without depressive symptoms at baseline and calculated the relative odds of developing depressive symptoms over 3.1 years for those with and without type 2 diabetes. Results In analysis 1, the incidence rate of type 2 diabetes was 22.0 and 16.6 per 1000 person-years for those with and without elevated depressive symptoms, respectively. The risk of incident type 2 diabetes was 1.10 times higher for each 5-unit increment in CES-D score (95% confidence interval [CI], 1.02-1.19) after adjustment for demographic factors and body mass index. This association persisted following adjustment for metabolic, inflammatory, socioeconomic, or lifestyle factors, although it was no longer statistically significant following adjustment for the latter (relative hazard, 1.08; 95% CI, 0.99-1.19). In analysis 2, the incidence rates of elevated depressive symptoms per 1000-person years were 36.8 for participants with normal fasting glucose; 27.9 for impaired fasting glucose; 31.2 for untreated type 2 diabetes, and 61.9 for treated type 2 diabetes. Compared with normal fasting glucose, the demographic-adjusted odds ratios of developing elevated depressive symptoms were 0.79 (95% CI, 0.63-0.99) for impaired fasting glucose, 0.75 (95% CI, 0.44-1.27) for untreated type 2 diabetes, and 1.54 (95% CI, 1.13-2.09) for treated type 2 diabetes. None of these associations with incident depressive symptoms were materially altered with adjustment for body mass index, socioeconomic and lifestyle factors, and comorbidities. Findings in both analyses were comparable across ethnic groups. Conclusions A modest association of baseline depressive symptoms with incident type 2 diabetes existed that was partially explained by lifestyle factors. Impaired fasting glucose and untreated type 2 diabetes were inversely associated with incident depressive symptoms, whereas treated type 2 diabetes showed a positive association with depressive symptoms. These associations were not substantively affected by adjustment for potential confounding or mediating factors.	[Golden, Sherita Hill; Lazo, Mariana] Johns Hopkins Univ, Sch Med, Div Endocrinol & Metab, Dept Med, Baltimore, MD 21205 USA; [Golden, Sherita Hill; Lazo, Mariana] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD 21205 USA; [Lee, Hochang Benjamin; Lyketsos, Constantine] Johns Hopkins Univ, Dept Psychiat, Baltimore, MD 21205 USA; [Carnethon, Mercedes] Northwestern Univ, Dept Prevent Med, Chicago, IL 60611 USA; [Bertoni, Alain G.] Wake Forest Univ, Dept Epidemiol & Prevent, Winston Salem, NC 27109 USA; [Schreiner, Pamela J.] Univ Minnesota, Div Epidemiol & Community Hlth, St Paul, MN 55108 USA; [Roux, Ana V. Diez] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Northwestern University; Wake Forest University; University of Minnesota System; University of Minnesota Twin Cities; University of Michigan System; University of Michigan	Golden, SH (corresponding author), Johns Hopkins Univ, Sch Med, Div Endocrinol & Metab, Dept Med, 2024 E Monument St,Ste 2-600, Baltimore, MD 21205 USA.	sahill@jhmi.edu	Lazo, Mariana/A-9227-2018	Lazo, Mariana/0000-0002-3178-6734; Lee, Hochang/0000-0001-8379-4018; Schreiner, Pamela/0000-0002-9920-6257; Bertoni, Alain/0000-0002-7503-6273	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095161, N01HC095159, N01HC095164, N01HC095162, N01HC095160, N01HC095169, N01HC095165, N01HC095163] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076831, R43HL095169, R44HL095169, R21HL095165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK071565] Funding Source: NIH RePORTER	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ainsworth BE, 1999, J WOMEN HEALTH GEN-B, V8, P805, DOI 10.1089/152460999319129; Am Diabetes Assoc, 2006, DIABETES CARE, V29, pS4; Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069; Arroyo C, 2004, DIABETES CARE, V27, P129, DOI 10.2337/diacare.27.1.129; Beekman ATF, 1997, PSYCHOL MED, V27, P231, DOI 10.1017/S0033291796003510; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Black PH, 2003, BRAIN BEHAV IMMUN, V17, P350, DOI 10.1016/S0889-1591(03)00048-5; Black SA, 1999, DIABETES CARE, V22, P56, DOI 10.2337/diacare.22.1.56; BLOCK G, 1990, J CLIN EPIDEMIOL, V43, P1327, DOI 10.1016/0895-4356(90)90099-B; Brown LC, 2006, CAN MED ASSOC J, V175, P42, DOI 10.1503/cmaj.051429; CAMETHON MR, 2003, AM J EPIDEMIOL, V158, P416; Carnethon MR, 2007, ARCH INTERN MED, V167, P802, DOI 10.1001/archinte.167.8.802; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Ciechanowski PS, 2000, ARCH INTERN MED, V160, P3278, DOI 10.1001/archinte.160.21.3278; Cohen ST, 1997, PSYCHOSOMATICS, V38, P98, DOI 10.1016/S0033-3182(97)71477-4; de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015; de Jonge P, 2006, DIABETOLOGIA, V49, P2627, DOI 10.1007/s00125-006-0442-x; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Duncan BB, 2003, DIABETES, V52, P1799, DOI 10.2337/diabetes.52.7.1799; Eaton WW, 1996, DIABETES CARE, V19, P1097, DOI 10.2337/diacare.19.10.1097; Engum A, 2007, J PSYCHOSOM RES, V62, P31, DOI 10.1016/j.jpsychores.2006.07.009; Everson-Rose SA, 2004, DIABETES CARE, V27, P2856, DOI 10.2337/diacare.27.12.2856; Fava M, 2000, J CLIN PSYCHIAT, V61, P37; Fisher L, 2001, DIABETES CARE, V24, P1751, DOI 10.2337/diacare.24.10.1751; Ford DE, 2004, ARCH INTERN MED, V164, P1010, DOI 10.1001/archinte.164.9.1010; Geringer E S, 1988, J Geriatr Psychiatry Neurol, V1, P11, DOI 10.1177/089198878800100103; Golden SH, 2004, DIABETES CARE, V27, P429, DOI 10.2337/diacare.27.2.429; Golden SH, 2007, CURR DIABETES REV, V3, P252, DOI 10.2174/157339907782330021; Golden SH, 2007, PSYCHOSOM MED, V69, P529, DOI 10.1097/PSY.0b013e3180f61c5c; GOLDING JM, 1990, J NERV MENT DIS, V178, P161, DOI 10.1097/00005053-199003000-00003; Golomb BA, 2002, J CLIN EPIDEMIOL, V55, P767, DOI 10.1016/S0895-4356(02)00407-9; GRUNDY SM, 1993, JAMA-J AM MED ASSOC, V269, P3015, DOI 10.1001/jama.269.23.3015; Hanninen JA, 1999, DIABETES CARE, V22, P997, DOI 10.2337/diacare.22.6.997; Karlson B, 1997, DIABETIC MED, V14, P1066, DOI 10.1002/(SICI)1096-9136(199712)14:12<1066::AID-DIA462>3.0.CO;2-M; Kawakami N, 1999, DIABETES CARE, V22, P1071, DOI 10.2337/diacare.22.7.1071; Kiecolt-Glaser JK, 2002, J PSYCHOSOM RES, V53, P873, DOI 10.1016/S0022-3999(02)00309-4; Kim JM, 2006, BRIT J PSYCHIAT, V189, P26, DOI 10.1192/bjp.bp.105.015032; LAKE CR, 1982, AM J PSYCHIAT, V139, P1315; Lawlor DA, 2005, BRIT MED J, V330, P705, DOI 10.1136/bmj.38377.616921.F7; Lawlor DA, 2003, BRIT MED J, V327, P1383, DOI 10.1136/bmj.327.7428.1383; Lawlor DA, 2007, PSYCHOL MED, V37, P1151, DOI 10.1017/S0033291707000384; LEEDOM L, 1991, Journal of Diabetic Complications, V5, P38, DOI 10.1016/0891-6632(91)90009-E; LLOYD CE, 1992, DIABETES CARE, V15, P166, DOI 10.2337/diacare.15.2.166; MAES M, 1990, PSYCHOL MED, V20, P493, DOI 10.1017/S0033291700017001; Maraldi C, 2007, ARCH INTERN MED, V167, P1137, DOI 10.1001/archinte.167.11.1137; MARCUS MD, 1992, DIABETES CARE, V15, P253, DOI 10.2337/diacare.15.2.253; Mayer-Davis EJ, 1999, ANN EPIDEMIOL, V9, P314, DOI 10.1016/S1047-2797(98)00070-2; McDowell I., 1996, MEASURING HLTH GUIDE; Miyaoka Y, 1997, PSYCHIAT CLIN NEUROS, V51, P203, DOI 10.1111/j.1440-1819.1997.tb02583.x; Murphy JM., 2002, TXB PSYCHIAT EPIDEMI, P273; Musselman DL, 2003, BIOL PSYCHIAT, V54, P317, DOI 10.1016/S0006-3223(03)00569-9; NALIBOFF BD, 1989, J AM GERIATR SOC, V37, P838, DOI 10.1111/j.1532-5415.1989.tb02263.x; PADGETT DK, 1993, J NERV MENT DIS, V181, P123, DOI 10.1097/00005053-199302000-00008; Palinkas LA, 2004, DIABETIC MED, V21, P1185, DOI 10.1111/j.1464-5491.2004.01315.x; Peyrot M, 1997, DIABETES CARE, V20, P585, DOI 10.2337/diacare.20.4.585; Polsky D, 2005, ARCH INTERN MED, V165, P1260, DOI 10.1001/archinte.165.11.1260; POPKIN MK, 1988, ARCH GEN PSYCHIAT, V45, P64; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; RADLOFF LS, 2000, HDB PSYCHIAT MEASURE, P523; ROBERTS RE, 1980, PSYCHIAT RES, V2, P125, DOI 10.1016/0165-1781(80)90069-4; ROBINSON N, 1988, DIABETIC MED, V5, P268, DOI 10.1111/j.1464-5491.1988.tb00983.x; ROY A, 1988, ARCH GEN PSYCHIAT, V45, P849; Rubin RR, 2005, DIABETES CARE, V28, P830; Sachs GS, 1999, J CLIN PSYCHIAT, V60, P16; Saydah SH, 2003, DIABETES-METAB RES, V19, P202, DOI 10.1002/dmrr.353; Talbot F, 2000, DIABETES CARE, V23, P1556, DOI 10.2337/diacare.23.10.1556; VIINAMAKI H, 1995, ACTA PSYCHIAT SCAND, V92, P392, DOI 10.1111/j.1600-0447.1995.tb09602.x; WINOCOUR PH, 1990, DIABETES RES CLIN EX, V14, P171; WINOKUR A, 1988, AM J PSYCHIAT, V145, P325	69	588	602	1	49	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 18	2008	299	23					2751	2759		10.1001/jama.299.23.2751	http://dx.doi.org/10.1001/jama.299.23.2751			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	314JH	18560002	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000256805200023
J	Tanovic, A; Samel, SA; Essen, LO; Marahiel, MA				Tanovic, Alan; Samel, Stefan A.; Essen, Lars-Oliver; Marahiel, Mohamed A.			Crystal structure of the termination module of a nonribosomal peptide synthetase	SCIENCE			English	Article							FATTY-ACID SYNTHASE; PROTEIN INTERACTIONS; DOMAINS; BIOSYNTHESIS; ARCHITECTURE; ANTIBIOTICS; CYCLIZATION; POLYKETIDE; RESOLUTION	Nonribosomal peptide synthetases ( NRPSs) are modular multidomain enzymes that act as an assembly line to catalyze the biosynthesis of complex natural products. The crystal structure of the 144- kilodalton Bacillus subtilis termination module SrfA- C was solved at 2.6 angstrom resolution. The adenylation and condensation domains of SrfA- C associate closely to form a catalytic platform, with their active sites on the same side of the platform. The peptidyl carrier protein domain is flexibly tethered to this platform and thus can move with its substrate- loaded 4'-phosphopantetheine arm between the active site of the adenylation domain and the donor side of the condensation domain. The SrfA- C crystal structure has implications for the rational redesign of NRPSs as a means of producing novel bioactive peptides.	[Tanovic, Alan; Samel, Stefan A.; Essen, Lars-Oliver; Marahiel, Mohamed A.] Univ Marburg, Dept Chem, D-35032 Marburg, Germany	Philipps University Marburg	Essen, LO (corresponding author), Univ Marburg, Dept Chem, Hans Meerwein Str, D-35032 Marburg, Germany.	essen@chemie.uni-marburg.de; marahiel@chemie.uni-marburg.de	Essen, Lars-Oliver/L-3862-2016	Essen, Lars-Oliver/0000-0003-4272-4026				Bruner SD, 2002, STRUCTURE, V10, P301, DOI 10.1016/S0969-2126(02)00716-5; Caboche S, 2008, NUCLEIC ACIDS RES, V36, pD326, DOI 10.1093/nar/gkm792; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; Conti E, 1996, STRUCTURE, V4, P287, DOI 10.1016/S0969-2126(96)00033-0; Gulick AM, 2003, BIOCHEMISTRY-US, V42, P2866, DOI 10.1021/bi0271603; Hahn M, 2004, P NATL ACAD SCI USA, V101, P15585, DOI 10.1073/pnas.0404932101; Jenni S, 2006, SCIENCE, V311, P1263, DOI 10.1126/science.1123251; Keating TA, 2002, NAT STRUCT BIOL, V9, P522, DOI 10.1038/nsb810; Koglin A, 2006, SCIENCE, V312, P273, DOI 10.1126/science.1122928; Lai JR, 2006, BIOCHEMISTRY-US, V45, P14869, DOI 10.1021/bi061979p; Maier T, 2006, SCIENCE, V311, P1258, DOI 10.1126/science.1123248; May JJ, 2002, P NATL ACAD SCI USA, V99, P12120, DOI 10.1073/pnas.182156699; Samel SA, 2007, STRUCTURE, V15, P781, DOI 10.1016/j.str.2007.05.008; Sieber SA, 2002, CHEM BIOL, V9, P997, DOI 10.1016/S1074-5521(02)00214-4; STACHELHAUS T, 1995, SCIENCE, V269, P69, DOI 10.1126/science.7604280; Tang YY, 2006, P NATL ACAD SCI USA, V103, P11124, DOI 10.1073/pnas.0601924103; Walsh CT, 2004, SCIENCE, V303, P1805, DOI 10.1126/science.1094318; Weber T, 2000, STRUCT FOLD DES, V8, P407, DOI 10.1016/S0969-2126(00)00120-9; Weissman KJ, 2008, CHEMBIOCHEM, V9, P826, DOI 10.1002/cbic.200700751	19	246	252	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 1	2008	321	5889					659	663		10.1126/science.1159850	http://dx.doi.org/10.1126/science.1159850			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	332IW	18583577				2022-12-28	WOS:000258077700035
J	Haering, CH; Farcas, AM; Arumugam, P; Metson, J; Nasmyth, K				Haering, Christian H.; Farcas, Ana-Maria; Arumugam, Prakash; Metson, Jean; Nasmyth, Kim			The cohesin ring concatenates sister DNA molecules	NATURE			English	Article							SMC PROTEINS; PROTEASE; ARCHITECTURE; COMPLEXES; CLEAVAGE; YEAST; HINGE	Sister chromatid cohesion, which is essential for mitosis, is mediated by a multi- subunit protein complex called cohesin. Cohesin's Scc1, Smc1 and Smc3 subunits form a tripartite ring structure, and it has been proposed that cohesin holds sister DNA molecules together by trapping them inside its ring. To test this, we used site- specific crosslinking to create chemical connections at the three interfaces between the three constituent polypeptides of the ring, thereby creating covalently closed cohesin rings. As predicted by the ring entrapment model, this procedure produced dimeric DNA - cohesin structures that are resistant to protein denaturation. We conclude that cohesin rings concatenate individual sister minichromosome DNA molecules.	[Haering, Christian H.; Farcas, Ana-Maria; Arumugam, Prakash; Metson, Jean; Nasmyth, Kim] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Oxford	Nasmyth, K (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	kim.nasmyth@bioch.ox.ac.uk	Arumugam, Prakash/AAZ-6422-2020	Arumugam, Prakash/0000-0001-6217-8128; Haering, Christian/0000-0001-8301-1722; Nasmyth, Kim/0000-0001-7030-4403	Cancer Research UK Funding Source: Medline; Medical Research Council Funding Source: Medline; Wellcome Trust Funding Source: Medline	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Bausch C, 2007, MOL CELL BIOL, V27, P8522, DOI 10.1128/MCB.01007-07; Dhar G, 2004, CELL, V119, P33, DOI 10.1016/j.cell.2004.09.010; ESWAR N, 2006, CURR PROTOC BIOINF S, V15; Gruber S, 2003, CELL, V112, P765, DOI 10.1016/S0092-8674(03)00162-4; Gruber S, 2006, CELL, V127, P523, DOI 10.1016/j.cell.2006.08.048; Haering CH, 2004, MOL CELL, V15, P951, DOI 10.1016/j.molcel.2004.08.030; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Hirano M, 2002, EMBO J, V21, P5733, DOI 10.1093/emboj/cdf575; Hirano T, 2005, PHILOS T R SOC B, V360, P507, DOI 10.1098/rstb.2004.1606; Hwang DC, 2000, MOL CELLS, V10, P505, DOI 10.1007/s10059-000-0505-7; Ivanov D, 2007, MOL CELL, V27, P300, DOI 10.1016/j.molcel.2007.07.002; KIM JS, 1995, ANAL BIOCHEM, V225, P174, DOI 10.1006/abio.1995.1131; Milutinovich M, 2003, SCIENCE, V300, P1101, DOI 10.1126/science.1084478; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; Pauli A, 2008, DEV CELL, V14, P239, DOI 10.1016/j.devcel.2007.12.009; Schuldiner O, 2008, DEV CELL, V14, P227, DOI 10.1016/j.devcel.2007.11.001; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6	17	332	335	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 17	2008	454	7202					297	U19		10.1038/nature07098	http://dx.doi.org/10.1038/nature07098			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	326ND	18596691	Green Submitted			2022-12-28	WOS:000257665300030
J	Baker, RB; Washington, HA; Olakanmi, O; Savitt, TL; Jacobs, EA; Hoover, E; Wynia, MK				Baker, Robert B.; Washington, Harriet A.; Olakanmi, Ololade; Savitt, Todd L.; Jacobs, Elizabeth A.; Hoover, Eddie; Wynia, Matthew K.			African American physicians and organized medicine, 1846-1968 - Origins of a racial divide	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; DISPARITIES; SOCIETY; CARE	Like the nation as a whole, organized medicine in the United States carries a legacy of racial bias and segregation that should be understood and acknowledged. For more than 100 years, many state and local medical societies openly discriminated against black physicians, barring them from membership and from professional support and advancement. The American Medical Association was early and persistent in countenancing this racial segregation. Several key historical episodes demonstrate that many of the decisions and practices that established and maintained medical professional segregation were challenged by black and white physicians, both within and outside organized medicine. The effects of this history have been far reaching for the medical profession and, in particular, the legacy of segregation, bias, and exclusion continues to adversely affect African American physicians and the patients they serve.	[Olakanmi, Ololade; Wynia, Matthew K.] Amer Med Assoc, Inst Eth, Chicago, IL 60610 USA; [Baker, Robert B.] Union Coll, Union Grad Coll, Mt Sinai Bioeth Program, Schenectady, NY 12308 USA; [Baker, Robert B.] Union Coll, Union Grad Coll, Dept Philosophy, Schenectady, NY 12308 USA; [Savitt, Todd L.] E Carolina Univ, Dept Med Humanities, Brody Sch Med, Greenville, NC 27858 USA; [Jacobs, Elizabeth A.] John H Stroger Jr Hosp Cook Cty, Collaborat Res Unit, Chicago, IL USA; [Jacobs, Elizabeth A.] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Wynia, Matthew K.] Univ Chicago Hosp, Chicago, IL 60637 USA	American Medical Association; Union College; Union College; University of North Carolina; East Carolina University; John H Stroger Junior Hospital Cook County; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Rush University; University of Chicago; University of Illinois System	Wynia, MK (corresponding author), Amer Med Assoc, Inst Eth, 515 N State St, Chicago, IL 60610 USA.	matthew.wynia@ama-assn.org	Wynia, Matthew/T-2210-2019					*AM MED ASS, 1850, T AM MED ASS MAY 7 1, P57; *AM MED ASS, 2007, 1A07 CLRPD AM MED AS; *AM MED ASS, 1870, T AM MED ASS MAY 3 6; *AM MED ASS, 1952, P HOUS DEL AM MED AS; *AM MED ASS, 1870, NAT MED J, V1, P168; *AM MED ASS, 1847, T AM MED ASS MAY 4 7; *AM MED ASS, 1869, T AM MED ASS MAY 4 7, P56; *AM MED ASS, 1872, T AM MED ASS MAY 7 1; *AM MED ASS, 1963, P HOUS DEL AM MED AS; *AM MED ASS, 1963, P HOUS DEL AM MED AS, P17; *AM MED ASS, HIST AFR AM ORG MED; *AM MED ASS, 1873, T AM MED ASS MAY 6 9, P44; *AM MED ASS BOARD, 1938, BUS M BOARD TRUST AM, P48; *AM MED ASS BOARD, 1931, BUS M BOARD TRUST AM, P313; *AM MED ASS BOARD, 1939, BUS M BOARD TRUST AM, P89; *AM MED ASS LAW DE, 1966, AN CIV RIGHTS ACT RE, P4; Bach PB, 2004, NEW ENGL J MED, V351, P575, DOI 10.1056/NEJMsa040609; BAKER RB, 1999, AM MED ETHICS REVOLU, pR13; Brickman JP, 1999, J PUBLIC HEALTH POL, V20, P282, DOI 10.2307/3343402; Burrow JG, 1963, AMA VOICE AM MED; Byrd W. M., 2002, AM HLTH DILEMMA RACE; Byrd WM., 2000, AM HLTH DILEMMA MEDI; CAMPION FD, 1984, AMA US HLTH POLICY 1, P253; CLEMENT KW, 1964, J NATL MED ASSOC, V56, P213; COBB MW, 1939, 1 NEGRO MED SOC; COLOMBOTOS J, 1969, AM SOCIOL REV, V34, P318, DOI 10.2307/2092498; Dain Bruce, 2002, HIDEOUS MONSTER MIND; Davis, 1855, HIST AM MED ASS ITS; Fett Sharla M., 2002, WORKING CURES HEALIN, P2; FISHBEIN M, 1947, AM MED ASS 1847 1947; Flexner A, 1972, MED ED US CANADA REP; Gamble Vanessa Northington, 1995, MAKING PLACE OURSELV; Hasnain-Wynia R, 2007, ARCH INTERN MED, V167, P1233, DOI 10.1001/archinte.167.12.1233; Haynes DM, 2005, J HIST MED ALL SCI, V60, P170, DOI 10.1093/jhmas/jri022; HOWARD EB, 1971, DIGEST OFFICIAL ACTI, P169; Langer E, 1965, Science, V149, P282, DOI 10.1126/science.149.3681.282; Langer E, 1965, Science, V149, P164, DOI 10.1126/science.149.3680.164; LANGER E, 1965, SCIENCE, V149, P328; Ludmerer Kenneth M., 1985, LEARNING HEAL DEV AM; *MA HIST SOC, 2002, DEGRASSEHOWARD PAP 1; MARABLE M, 1991, RACE REFORM REBELLIO, P14; Morais Herbert M., 1967, HIST NEGRO MED; *NAT MED ASS, FOUND EARL YEARS LAT; *NAT MED CONV, 1847, P NAT MED CONV MAY 5; *NAT MED CONV, 1846, P NAT MED CONV MAY 5; NICKENS HW, 1985, JAMA-J AM MED ASSOC, V253, P2549, DOI 10.1001/jama.253.17.2549; REYBURN RR, 1870, NEW ERA WASHING 0127; Reynolds PP, 2004, AM J PUBLIC HEALTH, V94, P710, DOI 10.2105/AJPH.94.5.710; ROMAN CV, HIST MANIFESTO; Rosenbaum S, 2003, JAMA-J AM MED ASSOC, V289, P1546, DOI 10.1001/jama.289.12.1546; Savitt T, 2006, J NATL MED ASSOC, V98, P1415; Savitt Todd L., 1978, MED SLAVERY DIS HLTH; Smith DB, 2007, HEALTH AFFAIR, V26, P1794; Smith DB, 2007, HEALTH AFFAIR, V26, P1448, DOI 10.1377/hlthaff.26.5.1448; Smith David Barton, 2003, St Louis Univ Law J, V48, P37; SMITH DB, 1992, HOSP HEALTH SERV ADM, V37, P387; STANTON W, 1960, LEOPARDS SPOTS SCI A; Starr P, 1982, SOCIAL TRANSFORMATIO; Stokes AP, 1945, J NEGRO EDUC, V14, P535, DOI 10.2307/2966025; TIEDEMANN F, 1837, ECLECTIC J MED, V1, P301; *US BUR CENS, 2007, ANN EST POP SEX RAC; Woodward, 1966, STRANGE CAREER J CRO; 1964, P HOUS DEL AM MED AS; 1938, AM MED DIRECTORY; 1939, CHICAGO DEFENDE 0826, P3; 1870, NY TIMES        0507, P3; 1966, P HOUS DEL AM MED AS; 1965, J NATL MED ASS, V57, P156; 1938, CHICAGO DEFENDE 0910, P2; 1964, J NATL MED ASS, V56, P287; 1939, P HOUS DEL AM MED AS	71	69	69	2	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 16	2008	300	3					306	313		10.1001/jama.300.3.306	http://dx.doi.org/10.1001/jama.300.3.306			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	325ZB	18617633				2022-12-28	WOS:000257626600022
J	Hoft, DF				Hoft, Daniel F.			Tuberculosis vaccine development: goals, immunological design, and evaluation	LANCET			English	Review							REGULATORY T-CELLS; MYCOBACTERIUM-BOVIS BCG; CALMETTE-GUERIN VACCINATION; DELAYED-TYPE HYPERSENSITIVITY; LINKED IMMUNOSPOT ASSAY; GUINEA-PIG MODEL; PULMONARY TUBERCULOSIS; PROTECTIVE EFFICACY; INTERFERON-GAMMA; IMMUNE-RESPONSE	A third of the world's population is infected with Mycobacterium tuberculosis, and 2 million people die from tuberculosis every year even though the bacille Calmette Guerin (BCG) vaccine has been available for more than 75 years. In order to reduce the immense burden of tuberculosis, new vaccines or vaccination strategies, or both, are urgently needed. Why BCG vaccination has not reduced disease prevalence, especially in the developing world, is not yet understood. Important contributing factors might include background immunity induced by non-tuberculous environmental mycobacteria, diversity of BCG strains, and overattenuation of presently used strains. This review provides a summary of the immune responses thought to be important for protective tuberculosis immunity; various mycobacterial antigens that seem to be promising targets for vaccine-induced immunity; different vaccination approaches being developed for use in people; and the key issues involved in the selection of new vaccines for expanded phase II or III testing.	St Louis Univ, Hlth Sci Ctr, Edward A Doisy Res Ctr, Div Immunobiol,Dept Internal Med, St Louis, MO 63104 USA; St Louis Univ, Hlth Sci Ctr, Edward A Doisy Res Ctr, Div Immunobiol,Dept Mol Microbiol, St Louis, MO 63104 USA	Saint Louis University; Saint Louis University	Hoft, DF (corresponding author), St Louis Univ, Hlth Sci Ctr, Edward A Doisy Res Ctr, Div Immunobiol,Dept Internal Med, Room 807,1100 S Grand Blvd,8th Floor, St Louis, MO 63104 USA.	hoftdf@slu.edu						Aaron L, 2004, CLIN MICROBIOL INFEC, V10, P388, DOI 10.1111/j.1469-0691.2004.00758.x; Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Andersen P, 2000, INFECT IMMUN, V68, P621, DOI 10.1128/IAI.68.2.621-629.2000; Arinobu Y, 1999, CELL IMMUNOL, V191, P161, DOI 10.1006/cimm.1998.1431; BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0; Belkaid Y, 2005, NAT IMMUNOL, V6, P353, DOI 10.1038/ni1181; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Belman C, 1999, J BIOL CHEM, V274, P32079, DOI 10.1074/jbc.274.45.32079; Berthet FX, 1998, MICROBIOL-UK, V144, P3195, DOI 10.1099/00221287-144-11-3195; BLOOM BR, 1994, IMMUNOBIOLOGY, V191, P526, DOI 10.1016/S0171-2985(11)80459-6; Boon C, 2002, J BACTERIOL, V184, P6760, DOI 10.1128/JB.184.24.6760-6767.2002; Brandt L, 2004, INFECT IMMUN, V72, P6622, DOI 10.1128/IAI.72.11.6622-6632.2004; Brennan MJ, 2005, TUBERCULOSIS, V85, P7, DOI 10.1016/j.tube.2004.09.001; Brown RM, 2003, J INFECT DIS, V187, P513, DOI 10.1086/368096; Campbell JJ, 2001, J IMMUNOL, V166, P877, DOI 10.4049/jimmunol.166.2.877; Campbell JJ, 2000, CURR OPIN IMMUNOL, V12, P336, DOI 10.1016/S0952-7915(00)00096-0; Carding SR, 2002, NAT REV IMMUNOL, V2, P336, DOI 10.1038/nri797; Caruso AM, 1999, J IMMUNOL, V162, P5407; Chen LH, 2004, INFECT IMMUN, V72, P238, DOI 10.1128/IAI.72.1.238-246.2004; Cho S, 2000, P NATL ACAD SCI USA, V97, P12210, DOI 10.1073/pnas.210391497; Conradt P, 1999, MICROBES INFECT, V1, P753, DOI 10.1016/S1286-4579(99)80077-X; CONSTANT P, 1994, SCIENCE, V264, P267, DOI 10.1126/science.8146660; Cowley SC, 2003, J IMMUNOL, V171, P4689, DOI 10.4049/jimmunol.171.9.4689; Dascher CC, 2003, INT IMMUNOL, V15, P915, DOI 10.1093/intimm/dxg091; de Valliere S, 2005, INFECT IMMUN, V73, P6711, DOI 10.1128/IAI.73.10.6711-6720.2005; Dillon DC, 1999, INFECT IMMUN, V67, P2941, DOI 10.1128/IAI.67.6.2941-2950.1999; Feng CG, 2000, J INFECT DIS, V181, P1846, DOI 10.1086/315466; FLYNN JL, 1992, P NATL ACAD SCI USA, V89, P12013, DOI 10.1073/pnas.89.24.12013; Geginat J, 2001, J EXP MED, V194, P1711, DOI 10.1084/jem.194.12.1711; Gondek DC, 2005, J IMMUNOL, V174, P1783, DOI 10.4049/jimmunol.174.4.1783; Goonetilleke NP, 2003, J IMMUNOL, V171, P1602, DOI 10.4049/jimmunol.171.3.1602; Grode L, 2005, J CLIN INVEST, V115, P2472, DOI 10.1172/JCI24617; Grossman WJ, 2004, IMMUNITY, V21, P589, DOI 10.1016/j.immuni.2004.09.002; Guyot-Revol V, 2006, AM J RESP CRIT CARE, V173, P803, DOI 10.1164/rccm.200508-1294OC; HAVLIR DV, 1991, J CLIN INVEST, V87, P729, DOI 10.1172/JCI115053; Hill PC, 2005, J CLIN MICROBIOL, V43, P2070, DOI 10.1128/JCM.43.5.2070-2074.2005; Hill PC, 2005, CLIN INFECT DIS, V40, P273, DOI 10.1086/427030; Hill PC, 2004, CLIN INFECT DIS, V38, P966, DOI 10.1086/382362; Hiromatsu K, 2002, J IMMUNOL, V169, P330, DOI 10.4049/jimmunol.169.1.330; Hoft Daniel F., 1996, P269, DOI 10.1016/B978-012410580-5/50021-2; Hoft DF, 1999, ANN INTERN MED, V131, P32, DOI 10.7326/0003-4819-131-1-199907060-00007; Hoft DF, 1998, J IMMUNOL, V161, P1045; Hoft DF, 1999, CLIN INFECT DIS, V28, P785, DOI 10.1086/515201; Hoft DF, 2002, J INFECT DIS, V186, P1448, DOI 10.1086/344359; Hoft DF, 2000, CLIN INFECT DIS, V30, pS217, DOI 10.1086/313864; Horwitz MA, 2000, P NATL ACAD SCI USA, V97, P13853, DOI 10.1073/pnas.250480397; Horwitz MA, 2003, INFECT IMMUN, V71, P1672, DOI 10.1128/IAI.71.4.1672-1679.2003; Jackson M, 1999, INFECT IMMUN, V67, P2867, DOI 10.1128/IAI.67.6.2867-2873.1999; KABELITZ D, 1991, J EXP MED, V173, P1331, DOI 10.1084/jem.173.6.1331; Kampmann B, 2000, J INFECT DIS, V182, P895, DOI 10.1086/315766; Karakousis PC, 2004, J EXP MED, V200, P647, DOI 10.1084/jem.20040646; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Koch R., 1891, DEUT MED WOCHENSCHR, V17, P101, DOI [10.1055/s-0029-1206198, DOI 10.1055/S-0029-1206198]; Kursar M, 2007, J IMMUNOL, V178, P2661, DOI 10.4049/jimmunol.178.5.2661; LADEL CH, 1995, EUR J IMMUNOL, V25, P377, DOI 10.1002/eji.1830250211; Lafont V, 2001, J BIOL CHEM, V276, P15961, DOI 10.1074/jbc.M008684200; Lalvani T, 1998, P NATL ACAD SCI USA, V95, P270, DOI 10.1073/pnas.95.1.270; LANG F, 1995, J IMMUNOL, V154, P5986; Langermans JAM, 2005, VACCINE, V23, P2740, DOI 10.1016/j.vaccine.2004.11.051; Lewinsohn DM, 2000, J IMMUNOL, V165, P925, DOI 10.4049/jimmunol.165.2.925; Lewinsohn DM, 1998, J EXP MED, V187, P1633, DOI 10.1084/jem.187.10.1633; Li BQ, 1996, J IMMUNOL, V157, P4222; Lotte A, 1984, Adv Tuberc Res, V21, P107; Lowrie DB, 1999, NATURE, V400, P269, DOI 10.1038/22326; McConkey SJ, 2003, NAT MED, V9, P729, DOI 10.1038/nm881; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; MORITA CT, 1995, IMMUNITY, V3, P495, DOI 10.1016/1074-7613(95)90178-7; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Murray PJ, 1996, P NATL ACAD SCI USA, V93, P934, DOI 10.1073/pnas.93.2.934; Newport MJ, 1996, NEW ENGL J MED, V335, P1941, DOI 10.1056/NEJM199612263352602; O'Garra A, 2004, NAT MED, V10, P801, DOI 10.1038/nm0804-801; ODONNELL MA, 1994, INFECT IMMUN, V62, P2508, DOI 10.1128/IAI.62.6.2508-2514.1994; Orme IM, 2006, TUBERCULOSIS, V86, P68, DOI 10.1016/j.tube.2005.07.002; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; PORCELLI S, 1992, NATURE, V360, P593, DOI 10.1038/360593a0; Reed SG, 2003, TUBERCULOSIS, V83, P213, DOI 10.1016/S1472-9792(02)00080-X; Ribeiro-Rodrigues R, 2006, CLIN EXP IMMUNOL, V144, P25, DOI 10.1111/j.1365-2249.2006.03027.x; Roberts DM, 2004, J BIOL CHEM, V279, P23082, DOI 10.1074/jbc.M401230200; Roberts T, 2007, J INFECT DIS, V195, P870, DOI 10.1086/511277; Rook GAW, 2004, TRENDS IMMUNOL, V25, P483, DOI 10.1016/j.it.2004.06.005; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Sambandamurthy VK, 2005, INFECT IMMUN, V73, P1196, DOI 10.1128/IAI.73.2.1196-1203.2005; Sambandamurthy VK, 2002, NAT MED, V8, P1171, DOI 10.1038/nm765; Sampson SL, 2004, INFECT IMMUN, V72, P3031, DOI 10.1128/IAI.72.5.3031-3037.2004; Santosuosso M, 2005, J IMMUNOL, V174, P7986, DOI 10.4049/jimmunol.174.12.7986; Saunders BM, 2002, CELL IMMUNOL, V216, P65, DOI 10.1016/S0008-8749(02)00510-5; Scanga CA, 2000, J EXP MED, V192, P347, DOI 10.1084/jem.192.3.347; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Schneider J, 1998, NAT MED, V4, P397, DOI 10.1038/nm0498-397; SCHOEL B, 1994, EUR J IMMUNOL, V24, P1886, DOI 10.1002/eji.1830240826; SCHWEIGHOFFER T, 1993, J IMMUNOL, V151, P717; Shen Y, 2002, SCIENCE, V295, P2255, DOI 10.1126/science.1068819; Silver RF, 1998, J IMMUNOL, V160, P2408; Skeiky YAW, 2004, J IMMUNOL, V172, P7618, DOI 10.4049/jimmunol.172.12.7618; Skeiky YAW, 1999, INFECT IMMUN, V67, P3998, DOI 10.1128/IAI.67.8.3998-4007.1999; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; Stenger S, 1997, SCIENCE, V276, P1684, DOI 10.1126/science.276.5319.1684; Talbot EA, 1997, CLIN INFECT DIS, V24, P1139, DOI 10.1086/513642; TANAKA Y, 1995, NATURE, V375, P155, DOI 10.1038/375155a0; Teitelbaum R, 1998, P NATL ACAD SCI USA, V95, P15688, DOI 10.1073/pnas.95.26.15688; TSUKAGUCHI K, 1995, J IMMUNOL, V154, P1786; Turner OC, 2000, INFECT IMMUN, V68, P3674, DOI 10.1128/IAI.68.6.3674-3679.2000; Ulrichs T, 2003, INFECT IMMUN, V71, P3076, DOI 10.1128/IAI.71.6.3076-3087.2003; van Pinxteren LAH, 2000, EUR J IMMUNOL, V30, P3689, DOI 10.1002/1521-4141(200012)30:12<3689::AID-IMMU3689>3.3.CO;2-W; Vuola JM, 2005, J IMMUNOL, V174, P449, DOI 10.4049/jimmunol.174.1.449; Waddell RD, 2000, CLIN INFECT DIS, V30, pS309, DOI 10.1086/313880; Wang J, 2004, J IMMUNOL, V173, P6357, DOI 10.4049/jimmunol.173.10.6357; Wangoo A, 2001, J IMMUNOL, V166, P3432, DOI 10.4049/jimmunol.166.5.3432; WEINRICH OA, 2001, INFECT IMMUN, V69, P2773, DOI DOI 10.1128/IAI.69.5.2773-2778.2001; Wen L, 1998, J IMMUNOL, V160, P1965; Williams A, 2005, INFECT IMMUN, V73, P3814, DOI 10.1128/IAI.73.6.3814-3816.2005; Williams A, 2005, TUBERCULOSIS, V85, P29, DOI 10.1016/j.tube.2004.09.009; Worku S, 2003, INFECT IMMUN, V71, P1763, DOI 10.1128/IAI.71.4.1763-1773.2003; Wozniak TM, 2006, J IMMUNOL, V177, P8684, DOI 10.4049/jimmunol.177.12.8684; Young SL, 2002, INT IMMUNOL, V14, P793, DOI 10.1093/intimm/dxf050	118	108	121	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 12	2008	372	9633					164	175		10.1016/S0140-6736(08)61036-3	http://dx.doi.org/10.1016/S0140-6736(08)61036-3			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	324XJ	18620952				2022-12-28	WOS:000257552400031
J	MacDonald, R; Horton, R				MacDonald, Rhona; Horton, Richard			Global health and the G8 - is power just too sweet to share?	LANCET			English	Editorial Material									[MacDonald, Rhona; Horton, Richard] The Lancet, London NW1 7BY, England		MacDonald, R (corresponding author), The Lancet, London NW1 7BY, England.	rhona.macdonald@lancet.com						[Anonymous], 2008, KAMP DECL AG GLOB AC; *G8 ALT SUMM ORG, 2007, G8 2007; Koumura M, 2007, LANCET, V370, P1983, DOI 10.1016/S0140-6736(07)61726-7; Mills EJ, 2008, LANCET, V371, P685, DOI 10.1016/S0140-6736(08)60308-6; *POP ACT INT, ACC DEN US RESTR INT; Toyako Framework for Action on Global health, 2008, TOYAKO FRAMEWORK ACT; WHO, 2008, SAF WAT BETT HLTH; *WIK CONTR, 2008, G8; 2008, LANCET, V371, P2145; 2008, COUNTDOWN 2015 G8 UR; MAKE POVERTY HIST; 2008, G8 LEADERS COMMUNIQU	12	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 12	2008	372	9633					99	100		10.1016/S0140-6736(08)61004-1	http://dx.doi.org/10.1016/S0140-6736(08)61004-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	324XJ	18620936				2022-12-28	WOS:000257552400010
J	Bonnefoy, S; Menard, R				Bonnefoy, Serge; Menard, Robert			Deconstructing export of malaria proteins	CELL			English	Editorial Material							PLASMODIUM-FALCIPARUM; ERYTHROCYTE; VIRULENCE	The virulence of the malaria parasite Plasmodium falciparum is mediated by parasite proteins exported to the surface of infected erythrocytes. In this issue, Maier et al. ( 2008) report a screen of malaria parasite genes predicted to be involved in parasite protein export and trafficking within the host erythrocyte and discover that many more than expected are essential for parasite survival in vitro.	[Menard, Robert] Inst Pasteur, Unite Biol & Genet Paludisme, F-75724 Paris 15, France; [Bonnefoy, Serge] Inst Pasteur, Unite Immunol Mol Parasites, F-75724 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Menard, R (corresponding author), Inst Pasteur, Unite Biol & Genet Paludisme, F-75724 Paris 15, France.	rmenard@pasteur.fr	Bonnefoy, Serge/B-2466-2014	Bonnefoy, Serge/0000-0001-9148-0123				Charpian S, 2008, TRAFFIC, V9, P157, DOI 10.1111/j.1600-0854.2007.00648.x; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Lauer SA, 1997, SCIENCE, V276, P1122, DOI 10.1126/science.276.5315.1122; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Pei XH, 2007, BLOOD, V110, P1036, DOI 10.1182/blood-2007-02-076919; Ralph SA, 2005, CURR OPIN MICROBIOL, V8, P434, DOI 10.1016/j.mib.2005.06.007; Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12; van Ooij C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000084	8	6	6	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 11	2008	134	1					20	22		10.1016/j.cell.2008.06.040	http://dx.doi.org/10.1016/j.cell.2008.06.040			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	324IU	18614006	Bronze			2022-12-28	WOS:000257513100009
J	Campellone, KG; Webb, NJ; Znameroski, EA; Welch, MD				Campellone, Kenneth G.; Webb, Neil J.; Znameroski, Elizabeth A.; Welch, Matthew D.			WHAMM is an Arp2/3 complex activator that binds microtubules and functions in ER to Golgi transport	CELL			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; N-WASP; ACTIN CYTOSKELETON; LIVING CELLS; RUFFLE FORMATION; CORTACTIN; PROTEINS; WAVE2; DYNAMICS; MOTILITY	The Arp2/3 complex is an actin nucleator that plays a critical role in many cellular processes. Its activities are regulated by nucleation- promoting factors (NPFs) that function primarily during plasma membrane dynamics. Here we identify a mammalian NPF called WHAMM (WASP homolog associated with actin, membranes, and microtubules) that localizes to the cis- Golgi apparatus and tubulo- vesicular membrane transport intermediates. The modular organization of WHAMM includes an N- erminal domain that mediates Golgi membrane association, a coiled- coil region that binds microtubules, and a WCA segment that stimulates Arp2/3-mediated actin polymerization. Overexpression and depletion studies indicate that WHAMM is important for maintaining Golgi structure and facilitating anterograde membrane transport. The ability of WHAMM to interact with microtubules plays a role in membrane tubulation, while its capacity to induce actin assembly promotes tubule elongation. Thus, WHAMM is an important regulator of membrane dynamics functioning at the interface of the microtubule and actin cytoskeletons.	[Campellone, Kenneth G.; Webb, Neil J.; Znameroski, Elizabeth A.; Welch, Matthew D.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Campellone, KG (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	campellone@berkeley.edu; welch@berkeley.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059609] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM059609-09, R01-GM59609, R01 GM059609] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Appenzeller-Herzog C, 2006, J CELL SCI, V119, P2173, DOI 10.1242/jcs.03019; Benesch S, 2005, J CELL SCI, V118, P3103, DOI 10.1242/jcs.02444; Benesch S, 2002, J BIOL CHEM, V277, P37771, DOI 10.1074/jbc.M204145200; Cao H, 2005, NAT CELL BIOL, V7, P483, DOI 10.1038/ncb1246; Carlier MF, 2007, J BIOL CHEM, V282, P23005, DOI 10.1074/jbc.R700020200; Cosen-Binker LI, 2006, PHYSIOLOGY, V21, P352, DOI 10.1152/physiol.00012.2006; Daly RJ, 2004, BIOCHEM J, V382, P13, DOI 10.1042/BJ20040737; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Egea G, 2006, CURR OPIN CELL BIOL, V18, P168, DOI 10.1016/j.ceb.2006.02.007; Goley ED, 2004, MOL CELL, V16, P269, DOI 10.1016/j.molcel.2004.09.018; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Hehnly H, 2007, FEBS LETT, V581, P2112, DOI 10.1016/j.febslet.2007.01.094; Hirschberg K, 1998, J CELL BIOL, V143, P1485, DOI 10.1083/jcb.143.6.1485; Innocenti M, 2005, NAT CELL BIOL, V7, P969, DOI 10.1038/ncb1304; Innocenti M, 2004, NAT CELL BIOL, V6, P319, DOI 10.1038/ncb1105; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Legg JA, 2007, MOL BIOL CELL, V18, P678, DOI 10.1091/mbc.E06-06-0569; Linardopoulou EV, 2007, PLOS GENET, V3, P2477, DOI 10.1371/journal.pgen.0030237; Magdalena J, 2003, MOL BIOL CELL, V14, P670, DOI 10.1091/mbc.e02-06-0345; Marchand JB, 2001, NAT CELL BIOL, V3, P76, DOI 10.1038/35050590; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Millard TH, 2004, BIOCHEM J, V380, P1, DOI 10.1042/BJ20040176; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Scales SJ, 1997, CELL, V90, P1137, DOI 10.1016/S0092-8674(00)80379-7; Shikama N, 1999, MOL CELL, V4, P365, DOI 10.1016/S1097-2765(00)80338-X; Simpson JC, 2006, MOL BIOL CELL, V17, P723, DOI 10.1091/mbc.E05-06-0580; Steffen A, 2004, EMBO J, V23, P749, DOI 10.1038/sj.emboj.7600084; Stradal TEB, 2006, CURR OPIN CELL BIOL, V18, P4, DOI 10.1016/j.ceb.2005.12.003; Suetsugu S, 2003, DEV CELL, V5, P595, DOI 10.1016/S1534-5807(03)00297-1; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; Upadhyaya A, 2004, BIOPHYS J, V86, P2923, DOI 10.1016/S0006-3495(04)74343-X; Welch MD, 1997, J CELL BIOL, V138, P375, DOI 10.1083/jcb.138.2.375; Yamazaki D, 2003, NATURE, V424, P452, DOI 10.1038/nature01770; Yan C, 2003, EMBO J, V22, P3602, DOI 10.1093/emboj/cdg350; Yarar D, 2005, MOL BIOL CELL, V16, P964, DOI 10.1091/mbc.e04-09-0774	42	191	199	2	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 11	2008	134	1					148	161		10.1016/j.cell.2008.05.032	http://dx.doi.org/10.1016/j.cell.2008.05.032			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	324IU	18614018	Bronze, Green Accepted			2022-12-28	WOS:000257513100021
J	High, AA; Novitskaya, EE; Butov, LV; Hanson, M; Gossard, AC				High, Alex A.; Novitskaya, Ekaterina E.; Butov, Leonid V.; Hanson, Micah; Gossard, Arthur C.			Control of exciton fluxes in an excitonic integrated circuit	SCIENCE			English	Article							QUANTUM-WELL STRUCTURES; STORAGE; PHOTOLUMINESCENCE; TRANSISTOR; ABSORPTION; MODULATOR; TRAPS	Efficient signal communication uses photons. Signal processing, however, uses an optically inactive medium, electrons. Therefore, an interconnection between electronic signal processing and optical communication is required at the integrated circuit level. We demonstrated control of exciton fluxes in an excitonic integrated circuit. The circuit consists of three exciton optoelectronic transistors and performs operations with exciton fluxes, such as directional switching and merging. Photons transform into excitons at the circuit input, and the excitons transform into photons at the circuit output. The exciton flux from the input to the output is controlled by a pattern of the electrode voltages. The direct coupling of photons, used in communication, to excitons, used as the device- operation medium, may lead to the development of efficient exciton- based optoelectronic devices.	[High, Alex A.; Novitskaya, Ekaterina E.; Butov, Leonid V.] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Hanson, Micah; Gossard, Arthur C.] Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA	University of California System; University of California San Diego; University of California System; University of California Santa Barbara	Butov, LV (corresponding author), Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA.	lvbutov@physics.ucsd.edu	High, Alexander A/U-1307-2018; High, Alexander A/E-2541-2012	High, Alexander A/0000-0003-0428-5448				AULL BF, 1993, APPL PHYS LETT, V63, P1555, DOI 10.1063/1.110747; Butov LV, 2002, NATURE, V418, P751, DOI 10.1038/nature00943; CHEMLA DS, 1984, IEEE J QUANTUM ELECT, V20, P265, DOI 10.1109/JQE.1984.1072393; Chen G, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.045309; Gartner A, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2267263; Gibbs H., 2012, OPTICAL BISTABILITY; Green WMJ, 2007, OPT EXPRESS, V15, P17106, DOI 10.1364/OE.15.017106; HAGN M, 1995, APPL PHYS LETT, V67, P232, DOI 10.1063/1.114677; Hammack AT, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.227402; Hammack AT, 2006, J APPL PHYS, V99, DOI 10.1063/1.2181276; High AA, 2007, OPT LETT, V32, P2466, DOI 10.1364/OL.32.002466; Huber T, 1998, PHYS STATUS SOLIDI A, V166, pR5, DOI 10.1002/(SICI)1521-396X(199803)166:1<R5::AID-PSSA99995>3.0.CO;2-6; Ivanov AL, 2006, EUROPHYS LETT, V73, P920, DOI 10.1209/epl/i2006-10002-4; Ivanov AL, 1999, PHYS REV B, V59, P5032, DOI 10.1103/PhysRevB.59.5032; KELDYSH LV, 1968, SOV PHYS JETP-USSR, V27, P521; Krauss J, 2004, APPL PHYS LETT, V85, P5830, DOI 10.1063/1.1830676; LARIONOV AV, 2000, SOV PHYS JETP, V90, P1093; Lundstrom T, 1999, SCIENCE, V286, P2312, DOI 10.1126/science.286.5448.2312; MILLER DAB, 1985, PHYS REV B, V32, P1043, DOI 10.1103/PhysRevB.32.1043; Rapaport R, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.033319; Szymanska MH, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.193305; Voros Z, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.226401; Wakita K., 1998, SEMICONDUCTOR OPTICA; Winbow AG, 2007, NANO LETT, V7, P1349, DOI 10.1021/nl070386c; Xu QF, 2005, NATURE, V435, P325, DOI 10.1038/nature03569; Yang S, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.187402; Zhang SK, 2000, APPL PHYS LETT, V77, P4380, DOI 10.1063/1.1336160; Zimmermann S, 1997, PHYS REV B, V56, P13414, DOI 10.1103/PhysRevB.56.13414; Zimmermann S, 1999, SCIENCE, V283, P1292, DOI 10.1126/science.283.5406.1292	29	219	222	3	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 11	2008	321	5886					229	231		10.1126/science.1157845	http://dx.doi.org/10.1126/science.1157845			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	324IS	18566248				2022-12-28	WOS:000257512900034
J	Petesch, SJ; Lis, JT				Petesch, Steven J.; Lis, John T.			Rapid, transcription-independent loss of nucleosomes over a large chromatin domain at Hsp70 loci	CELL			English	Article							RNA-POLYMERASE-II; HEAT-SHOCK GENES; IN-VIVO; SACCHAROMYCES-CEREVISIAE; DROSOPHILA-MELANOGASTER; CHROMOSOMAL DOMAINS; DYNAMIC REGULATION; SODIUM-SALICYLATE; DNA INTERACTIONS; HUMAN GENOME	To efficiently transcribe genes, RNA Polymerase II (Pol II) must overcome barriers imposed by nucleosomes and higher- order chromatin structure. Many genes, including Drosophila melanogaster Hsp70, undergo changes in chromatin structure upon activation. To characterize these changes, we mapped the nucleosome landscape of Hsp70 after an instantaneous heat shock at high spatial and temporal resolution. Surprisingly, we find an initial disruption of nucleosomes across the entire gene within 30 s after activation, faster than the rate of Pol II transcription, followed by a second further disruption within 2 min. This initial change occurs independently of Pol II transcription. Furthermore, the rapid loss of nucleosomes extends beyond Hsp70 and halts at the scs and scs' insulating elements. An RNAi screen of 28 transcription and chromatin- related factors reveals that depletion of heat shock factor, GAGA Factor, or Poly(ADP)-Ribose Polymerase or its activity abolishes the loss of nucleosomes upon Hsp70 activation.	[Petesch, Steven J.; Lis, John T.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University	Lis, JT (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	jtl10@cornell.edu			NIGMS NIH HHS [T32-GM70723, R01 GM025232-31, R01 GM025232, R37 GM025232, GM25232] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025232, R37GM025232] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adelman K, 2006, MOL CELL BIOL, V26, P250, DOI 10.1128/MCB.26.1.250-260.2006; Adelman K, 2005, MOL CELL, V17, P103, DOI 10.1016/j.molcel.2004.11.028; Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Boehm AK, 2003, MOL CELL BIOL, V23, P7628, DOI 10.1128/MCB.23.21.7628-7637.2003; Bortvin A, 1996, SCIENCE, V272, P1473, DOI 10.1126/science.272.5267.1473; Brown SA, 1997, GENE DEV, V11, P3116, DOI 10.1101/gad.11.23.3116; Crawford GE, 2006, GENOME RES, V16, P123, DOI 10.1101/gr.4074106; CROWLEY TE, 1984, CELL, V39, P149, DOI 10.1016/0092-8674(84)90200-9; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Gaszner M, 1999, GENE DEV, V13, P2098, DOI 10.1101/gad.13.16.2098; GIARDINA C, 1993, J BIOL CHEM, V268, P23806; GIARDINA C, 1995, J BIOL CHEM, V270, P10369, DOI 10.1074/jbc.270.18.10369; GIARDINA C, 1992, GENE DEV, V6, P2190, DOI 10.1101/gad.6.11.2190; Jedlicka P, 1997, EMBO J, V16, P2452, DOI 10.1093/emboj/16.9.2452; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Johnson SM, 2006, GENOME RES, V16, P1505, DOI 10.1101/gr.5560806; KELLUM R, 1991, CELL, V64, P941, DOI 10.1016/0092-8674(91)90318-S; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; KNEZETIC JA, 1986, CELL, V45, P95, DOI 10.1016/0092-8674(86)90541-6; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Kuhn EJ, 2004, MOL CELL BIOL, V24, P1470, DOI 10.1128/MCB.24.4.1470-1480.2004; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; LEWIS M, 1975, P NATL ACAD SCI USA, V72, P3604, DOI 10.1073/pnas.72.9.3604; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lis JT, 2007, NATURE, V450, P198, DOI 10.1038/nature06324; LORCH Y, 1987, CELL, V49, P203, DOI 10.1016/0092-8674(87)90561-7; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; MCKNIGHT SL, 1979, CELL, V17, P551; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; NACHEVA GA, 1989, CELL, V58, P27, DOI 10.1016/0092-8674(89)90399-1; Ni ZY, 2008, MOL CELL BIOL, V28, P1161, DOI 10.1128/MCB.01859-07; OBRIEN T, 1995, GENE DEV, V9, P1098, DOI 10.1101/gad.9.9.1098; OBRIEN T, 1993, MOL CELL BIOL, V13, P3456, DOI 10.1128/MCB.13.6.3456; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Pinnola A, 2007, J BIOL CHEM, V282, P32511, DOI 10.1074/jbc.M705989200; Rando OJ, 2007, CURR OPIN CELL BIOL, V19, P250, DOI 10.1016/j.ceb.2007.04.006; RASMUSSEN EB, 1993, P NATL ACAD SCI USA, V90, P7923, DOI 10.1073/pnas.90.17.7923; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; ROUGVIE AE, 1990, MOL CELL BIOL, V10, P6041, DOI 10.1128/MCB.10.11.6041; Saha A, 2006, NAT REV MOL CELL BIO, V7, P437, DOI 10.1038/nrm1945; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Schmittgen TD, 2000, ANAL BIOCHEM, V285, P194, DOI 10.1006/abio.2000.4753; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Schwabish MA, 2006, MOL CELL, V22, P415, DOI 10.1016/j.molcel.2006.03.014; Sekinger EA, 2005, MOL CELL, V18, P735, DOI 10.1016/j.molcel.2005.05.003; Shogren-Knaak M, 2006, CELL CYCLE, V5, P1361, DOI 10.4161/cc.5.13.2891; SHOPLAND LS, 1995, GENE DEV, V9, P2756, DOI 10.1101/gad.9.22.2756; SIMON JA, 1985, CELL, V40, P805, DOI 10.1016/0092-8674(85)90340-X; SOLOMON MJ, 1988, CELL, V53, P937, DOI 10.1016/S0092-8674(88)90469-2; THUMMEL CS, 1990, CELL, V61, P101, DOI 10.1016/0092-8674(90)90218-4; Trinklein ND, 2007, GENOME RES, V17, P720, DOI 10.1101/gr.5716607; TSUKIYAMA T, 1994, NATURE, V367, P525, DOI 10.1038/367525a0; TSUKIYAMA T, 1995, CELL, V83, P1011, DOI 10.1016/0092-8674(95)90216-3; Tulin A, 2003, SCIENCE, V299, P560, DOI 10.1126/science.1078764; UDVARDY A, 1985, J MOL BIOL, V185, P341, DOI 10.1016/0022-2836(85)90408-5; VAZQUEZ J, 1994, EMBO J, V13, P5984, DOI 10.1002/j.1460-2075.1994.tb06944.x; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Wacker DA, 2007, MOL CELL BIOL, V27, P7475, DOI 10.1128/MCB.01314-07; Winegarden NA, 1996, J BIOL CHEM, V271, P26971, DOI 10.1074/jbc.271.43.26971; WU C, 1979, CELL, V16, P807, DOI 10.1016/0092-8674(79)90096-5; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yao J, 2007, MOL CELL, V28, P978, DOI 10.1016/j.molcel.2007.10.017; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zhao J, 2005, MOL CELL BIOL, V25, P8985, DOI 10.1128/MCB.25.20.8985-8999.2005; ZHAO K, 1995, CELL, V81, P879, DOI 10.1016/0092-8674(95)90008-X	67	245	252	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 11	2008	134	1					74	84		10.1016/j.cell.2008.05.029	http://dx.doi.org/10.1016/j.cell.2008.05.029			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	324IU	18614012	Green Accepted, Bronze			2022-12-28	WOS:000257513100015
J	Sheikh, A; Gatrad, R; Dhami, S				Sheikh, Aziz; Gatrad, Rashid; Dhami, Sangeeta			Practice pointer - Consultations for people from minority groups	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sheikh, Aziz] Univ Edinburgh, Div Community Hlth Sci, GP Sect, Edinburgh EH8 9DX, Midlothian, Scotland; [Gatrad, Rashid] Manor Hosp, Dept Paediat, Walsall WS2 2PS, W Midlands, England	University of Edinburgh	Sheikh, A (corresponding author), Univ Edinburgh, Div Community Hlth Sci, GP Sect, Edinburgh EH8 9DX, Midlothian, Scotland.	aziz.sheikh@ed.ac.uk	Sheikh, Aziz/D-2818-2009	Sheikh, Aziz/0000-0001-7022-3056; Dhami, Sangeeta/0000-0002-2823-3258				*DEP HLTH, SUMM GMS CONTR REV N; Gatrad AR, 2000, ARCH DIS CHILD, V82, P59, DOI 10.1136/adc.82.1.59; MACPHERSON W, S LAWRENCE INQUIRY; *NAT STAT, NEIGHB STAT; NAZROO JY, 1997, HLTH BRITAINS ETHNIC; *NHS NAT LIB HLTH, ETHN HLTH SPEC LIB; Sheikh A, 2004, BMJ-BRIT MED J, V329, P87, DOI 10.1136/bmj.38061.593935.F7; SHEIKH A, 2007, FINAL REPORT CHIEF S	8	12	12	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 5	2008	337	7660							a273	10.1136/bmj.a273	http://dx.doi.org/10.1136/bmj.a273			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	326DF	18595929	Green Published, Green Submitted			2022-12-28	WOS:000257637500036
J	Hlawacek, G; Puschnig, P; Frank, P; Winkler, A; Ambrosch-Draxl, C; Teichert, C				Hlawacek, Gregor; Puschnig, Peter; Frank, Paul; Winkler, Adolf; Ambrosch-Draxl, Claudia; Teichert, Christian			Characterization of step-edge barriers in organic thin-film growth	SCIENCE			English	Article							SELF-DIFFUSION; SURFACE; SEXIPHENYL; DIFFRACTION; NUCLEATION; HEXAPHENYL; LEED	Detailed understanding of growth mechanisms in organic thin- film deposition is crucial for tailoring growth morphologies, which in turn determine the physical properties of the resulting films. For growth of the rodlike molecule para- sexiphenyl, the evolution of terraced mounds is observed by atomic force microscopy. Using methods established in inorganic epitaxy, we demonstrate the existence of an additional barrier ( 0.67 electron volt) for step- edge crossing- the Ehrlich- Schwoebel barrier. This result was confirmed by transition state theory, which revealed a bending of the molecule at the step edge. A gradual reduction of this barrier in the first layers led to an almost layer- by- layer growth during early deposition stage. The reported phenomena are a direct consequence of the complexity of the molecular building blocks versus atomic systems.	[Hlawacek, Gregor; Teichert, Christian] Univ Min & Met Leoben, Inst Phys, A-8700 Leoben, Austria; [Puschnig, Peter; Ambrosch-Draxl, Claudia] Univ Min & Met Leoben, Chair Atomist Modelling & Design Mat, A-8700 Leoben, Austria; [Frank, Paul; Winkler, Adolf] Graz Univ Technol, Inst Solid State Phys, A-8010 Graz, Austria	University of Leoben; University of Leoben; Graz University of Technology	Teichert, C (corresponding author), Univ Min & Met Leoben, Inst Phys, A-8700 Leoben, Austria.	teichert@unileoben.ac.at	Puschnig, Peter/C-9203-2011; Draxl, Claudia/O-6189-2016; Teichert, Christian/F-1003-2013; Hlawacek, Gregor/C-7164-2008	Puschnig, Peter/0000-0002-8057-7795; Draxl, Claudia/0000-0003-3523-6657; Teichert, Christian/0000-0002-0796-2355; Hlawacek, Gregor/0000-0001-7192-716X				Balzer F, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.115408; Bauer E., 1958, Z KRISTALLOGR, V110, P372, DOI DOI 10.1524/ZKRI.1958.110.1-6.372; Brenner DW, 2002, J PHYS-CONDENS MAT, V14, P783, DOI 10.1088/0953-8984/14/4/312; CHIANG CK, 1977, PHYS REV LETT, V39, P1098, DOI 10.1103/PhysRevLett.39.1098; EHRLICH G, 1966, J CHEM PHYS, V44, P1039, DOI 10.1063/1.1726787; ELKINANI I, 1993, SOLID STATE COMMUN, V87, P105, DOI 10.1016/0038-1098(93)90335-K; Fendrich M, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.121302; Frank P, 2007, SURF SCI, V601, P2152, DOI 10.1016/j.susc.2007.03.018; Heringdorf FJMZ, 2001, NATURE, V412, P517, DOI 10.1038/35087532; Kalff M, 1999, SURF SCI, V426, pL447, DOI 10.1016/S0039-6028(99)00351-9; Kilian L, 2004, SURF SCI, V573, P359, DOI 10.1016/j.susc.2004.10.004; KLAUA M, 1975, ROST KRIST, V11, P65; Koller G, 2004, SURF SCI, V559, pL187, DOI 10.1016/j.susc.2004.04.019; Krug J, 2000, PHYS REV B, V61, P14037, DOI 10.1103/PhysRevB.61.14037; MEINEL K, 1988, J CRYST GROWTH, V89, P447, DOI 10.1016/0022-0248(88)90205-9; Michely T., 2004, SPRINGER SERIES SURF, P13, DOI 10.1007/978-3-642-18672-1; Plank H, 2003, THIN SOLID FILMS, V443, P108, DOI 10.1016/S0040-6090(03)01021-6; Resel R, 2003, THIN SOLID FILMS, V433, P1, DOI 10.1016/S0040-6090(03)00312-2; Schinzer S, 2000, EUR PHYS J B, V15, P161, DOI 10.1007/s100510051111; SCHWOEBEL RL, 1966, J APPL PHYS, V37, P3682, DOI 10.1063/1.1707904; SEAH MP, 1972, SURF SCI, V32, P703, DOI 10.1016/0039-6028(72)90196-3; Teichert C, 2006, APPL PHYS A-MATER, V82, P665, DOI 10.1007/s00339-005-3450-7; TEICHERT C, 1994, PHYS STATUS SOLIDI A, V146, P223, DOI 10.1002/pssa.2211460119; VENABLES JA, 1984, REP PROG PHYS, V47, P399, DOI 10.1088/0034-4885/47/4/002; Yamane H, 2006, J APPL PHYS, V99, DOI 10.1063/1.2192978; Yu BD, 1997, PHYS REV B, V55, P13916, DOI 10.1103/PhysRevB.55.13916; Zhao YP, 1998, PHYS REV B, V57, P1922, DOI 10.1103/PhysRevB.57.1922; Zorba S, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.245410	28	170	170	2	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2008	321	5885					108	111		10.1126/science.1159455	http://dx.doi.org/10.1126/science.1159455			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QE	18599783				2022-12-28	WOS:000257320800047
J	Strom, RG; Chapman, CR; Merline, WJ; Solomon, SC; Head, JW				Strom, Robert G.; Chapman, Clark R.; Merline, William J.; Solomon, Sean C.; Head, James W., III			Mercury cratering record viewed from MESSENGER's first flyby	SCIENCE			English	Article							IMPACT CRATERS; ORIGIN; YARKOVSKY; GEOLOGY	Morphologies and size- frequency distributions of impact craters on Mercury imaged during MESSENGER's first flyby elucidate the planet's geological history. Plains interior to the Caloris basin displaying color and albedo contrasts have comparable crater densities and therefore similar ages. Smooth plains exterior to Caloris exhibit a crater density similar to 40% less than on interior plains and are thus volcanic and not Caloris impact ejecta. The size distribution of smooth- plains craters matches that of lunar craters postdating the Late Heavy Bombardment, implying that the plains formed no earlier than 3.8 billion years ago ( Ga). At diameters less than or equal to 8 to 10 kilometers, secondary impact craters on Mercury are more abundant than primaries; this transition diameter is much larger than that on the Moon or Mars. A low density of craters on the peak- ring basin Raditladi implies that it may be younger than 1 Ga.	[Strom, Robert G.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Chapman, Clark R.; Merline, William J.] SW Res Inst, Boulder, CO 80302 USA; [Solomon, Sean C.] Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; [Head, James W., III] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA	University of Arizona; Carnegie Institution for Science; Brown University	Strom, RG (corresponding author), Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA.	rstrom@lpl.arizona.edu						[Anonymous], 1979, ICARUS, V37, P467, DOI 10.1016/0019-1035(79)90009-5; Bierhaus EB, 2005, NATURE, V437, P1125, DOI 10.1038/nature04069; Bottke WF, 2006, ANNU REV EARTH PL SC, V34, P157, DOI 10.1146/annurev.earth.34.031405.125154; GAULT DE, 1975, J GEOPHYS RES, V80, P2444, DOI 10.1029/JB080i017p02444; Gomes R, 2005, NATURE, V435, P466, DOI 10.1038/nature03676; Hawkins SE, 2007, SPACE SCI REV, V131, P247, DOI 10.1007/sl11214-007-9266-3; Head JW, 2007, SPACE SCI REV, V131, P41, DOI 10.1007/s11214-007-9263-6; McEwen AS, 2006, ANNU REV EARTH PL SC, V34, P535, DOI 10.1146/annurev.earth.34.031405.125018; McEwen AS, 2005, ICARUS, V176, P351, DOI 10.1016/j.icarus.2005.02.009; MELOSH HJ, 1985, GEOLOGY, V13, P144, DOI 10.1130/0091-7613(1985)13<144:EORFFP>2.0.CO;2; Morbidelli A, 2003, ICARUS, V163, P120, DOI 10.1016/S0019-1035(03)00047-2; Murchie SL, 2008, SCIENCE, V321, P73, DOI 10.1126/science.1159261; NEUKUM G, 2001, CHRONOLOGY EVOLUTION, P55; SCOTT DH, 1977, PHYS EARTH PLANET IN, V15, P173, DOI 10.1016/0031-9201(77)90029-2; Shoemaker E.M., 1965, NATURE LUNAR SURFACE, P23; Shoemaker EM, 1962, PHYS ASTRONOMY MOON, P283, DOI 10.1016/C2013-0-12487-7; Spudis P.D., 1988, MERCURY, P118; Strom R. G., 1988, MERCURY, P336; Strom R.G., 1992, MARS, P383, DOI DOI 10.1016/S0032-0633(99)00016-1; Strom RG, 2005, SCIENCE, V309, P1847, DOI 10.1126/science.1113544; Tsiganis K, 2005, NATURE, V435, P459, DOI 10.1038/nature03539	21	96	98	2	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2008	321	5885					79	81		10.1126/science.1159317	http://dx.doi.org/10.1126/science.1159317			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QE	18599774				2022-12-28	WOS:000257320800038
J	Gohn, GS; Koeberl, C; Miller, KG; Reimold, WU; Browning, JV; Cockell, CS; Horton, JW; Kenkmann, T; Kulpecz, AA; Powars, DS; Sanford, WE; Voytek, MA				Gohn, G. S.; Koeberl, C.; Miller, K. G.; Reimold, W. U.; Browning, J. V.; Cockell, C. S.; Horton, J. W., Jr.; Kenkmann, T.; Kulpecz, A. A.; Powars, D. S.; Sanford, W. E.; Voytek, M. A.			Deep drilling into the Chesapeake Bay impact structure	SCIENCE			English	Article							GLOBAL SEA-LEVEL; SUBSEAFLOOR SEDIMENTS; BOLIDE IMPACT; YAXCOPOIL-1; CHICXULUB; ORIGIN; LIFE	Samples from a 1.76- kilometer- deep corehole drilled near the center of the late Eocene Chesapeake Bay impact structure ( Virginia, USA) reveal its geologic, hydrologic, and biologic history. We conducted stratigraphic and petrologic analyses of the cores to elucidate the timing and results of impact- melt creation and distribution, transient- cavity collapse, and ocean- water resurge. Comparison of post- impact sedimentary sequences inside and outside the structure indicates that compaction of the crater fill influenced long- term sedimentation patterns in the mid- Atlantic region. Salty connate water of the target remains in the crater fill today, where it poses a potential threat to the regional groundwater resource. Observed depth variations in microbial abundance indicate a complex history of impact- related thermal sterilization and habitat modification, and subsequent post- impact repopulation.	[Gohn, G. S.; Horton, J. W., Jr.; Powars, D. S.; Sanford, W. E.; Voytek, M. A.] US Geol Survey, Reston, VA 20192 USA; [Koeberl, C.] Univ Vienna, Dept Lithospher Res, Ctr Earth Sci, A-1090 Vienna, Austria; [Miller, K. G.; Browning, J. V.; Kulpecz, A. A.] Rutgers State Univ, Dept Geol Sci, Piscataway, NJ 08854 USA; [Reimold, W. U.; Kenkmann, T.] Humboldt Univ, Museum Nat Hist Mineral, D-10115 Berlin, Germany; [Cockell, C. S.] Open Univ, Ctr Earth Planetary Space & Astron Res, Milton Keynes MK7 6AA, Bucks, England	United States Department of the Interior; United States Geological Survey; University of Vienna; Rutgers State University New Brunswick; Humboldt University of Berlin; Open University - UK	Gohn, GS (corresponding author), US Geol Survey, Reston, VA 20192 USA.	ggohn@usgs.gov	Reimold, Wolf Uwe/AAI-6226-2021	Hauser, Natalia/0000-0002-6975-6186	STFC [ST/F003102/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/F003102/1] Funding Source: researchfish	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		BROWNING JV, 2006, GEOL SOC AM BULL, V118, P657; Collins GS, 2005, GEOLOGY, V33, P925, DOI 10.1130/G21854.1; D'Hondt S, 2004, SCIENCE, V306, P2216, DOI 10.1126/science.1101155; Deutsch A, 2006, METEORIT PLANET SCI, V41, P689, DOI 10.1111/j.1945-5100.2006.tb00985.x; Gohn G.S., 2006, EOS T AM GEOPHYS UN, V87, P349, DOI DOI 10.1029/2006EO350001; Grant WD, 2004, PHILOS T R SOC B, V359, P1249, DOI 10.1098/rstb.2004.1502; GRONSTAL AL, 2007, GEOL SOC AM ABSTR, V39, P316; Hayden T, 2008, GEOLOGY, V36, P327, DOI 10.1130/G24408A.1; Horton J. W., 2007, GEOLOGICAL SOC AM AB, V39, P451; HORTON JR. J. W., 2005, 1688 US GEOL SURV; Kashefi K, 2003, SCIENCE, V301, P934, DOI 10.1126/science.1086823; Koeberl C, 1996, SCIENCE, V271, P1263, DOI 10.1126/science.271.5253.1263; MALINCRONICO ML, 2008, C LARG MET IMP PLAN; Manheim F.T., 1968, SOUTHEAST GEOL, V9, P215; MCFARLAND ER, 2005, 16885 US GEOL SURV; Miller KG, 1996, SCIENCE, V271, P1092, DOI 10.1126/science.271.5252.1092; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Parkes RJ, 2000, HYDROGEOL J, V8, P11, DOI 10.1007/PL00010971; PARKES RJ, 1994, NATURE, V371, P410, DOI 10.1038/371410a0; POAG CW, 1999, CHESAPEAKE INVADER; POAG CW, 2004, CHESAPEAKE BAY CRATE; POWARS D. S., 1999, 1612 US GEOL SURV; POWARS D. S., 2000, 1622 US GEOL SURV; RADFORD L, 1980, DOEET283731 US DOE; Robertson P. B., 1977, IMPACT EXPLOSION CRA, P687; Sanford W, 2003, J GEOCHEM EXPLOR, V78-9, P243, DOI 10.1016/S0375-6742(03)00108-0; Sanford W.E., 2004, EOS T AM GEOPHYS UN, V85, P369, DOI DOI 10.1029/2004EO390001; Sanford WE, 2005, GEOFLUIDS, V5, P185, DOI 10.1111/j.1468-8123.2005.00110.x; Stoffler D, 2004, METEORIT PLANET SCI, V39, P1035, DOI 10.1111/j.1945-5100.2004.tb01128.x; Wittmann A, 2007, GEOL SOC AM BULL, V119, P1151, DOI 10.1130/B26116.1	30	91	91	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 27	2008	320	5884					1740	1745		10.1126/science.1158708	http://dx.doi.org/10.1126/science.1158708			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318VP	18583604				2022-12-28	WOS:000257121200029
J	Berry, RM; Armitage, JP				Berry, Richard M.; Armitage, Judith P.			Microbiology - How bacteria change gear	SCIENCE			English	Editorial Material							MOTILITY		[Berry, Richard M.] Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England; [Armitage, Judith P.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Armitage, Judith P.] Univ Oxford, Oxford Ctr Integrat Syst Biol, Oxford OX1 3QU, England	University of Oxford; University of Oxford; University of Oxford	Berry, RM (corresponding author), Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England.	r.berry1@physics.ox.ac.uk						Blair KM, 2008, SCIENCE, V320, P1636, DOI 10.1126/science.1157877; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Kearns DB, 2005, MOL MICROBIOL, V55, P739, DOI 10.1111/j.1365-2958.2004.04440.x; Kolter R, 2006, NATURE, V441, P300, DOI 10.1038/441300a; Lemon KP, 2007, J BACTERIOL, V189, P4418, DOI 10.1128/JB.01967-06; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; Wood TK, 2006, APPL MICROBIOL BIOT, V72, P361, DOI 10.1007/s00253-005-0263-8	7	2	2	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2008	320	5883					1599	1600		10.1126/science.1160444	http://dx.doi.org/10.1126/science.1160444			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	315NM	18566274				2022-12-28	WOS:000256886700034
J	Imai, E; Matsuo, S				Imai, Enyu; Matsuo, Seiichi			Chronic kidney disease in Asia	LANCET			English	Editorial Material							PROTEINURIA; RISK		[Imai, Enyu] Osaka Univ, Grad Sch Med, Dept Nephrol, Suita, Osaka 5650871, Japan; [Matsuo, Seiichi] Nagoya Univ, Grad Sch Med, Dept Nephrol, Nagoya, Aichi 4648601, Japan	Osaka University; Nagoya University	Imai, E (corresponding author), Osaka Univ, Grad Sch Med, Dept Nephrol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	ADS12069@nifty.com						Imai Enyu, 2007, Clin Exp Nephrol, V11, P156, DOI 10.1007/s10157-007-0463-x; Iseki K, 2003, KIDNEY INT, V63, P1468, DOI 10.1046/j.1523-1755.2003.00868.x; Iseki K, 2004, AM J KIDNEY DIS, V44, P806, DOI 10.1016/S0272-6386(04)01080-7; *JAP SOC DIAL THER, 2007, OV REG DIAL TREATM J; Konta Tsuneo, 2007, Clin Exp Nephrol, V11, P51, DOI 10.1007/s10157-006-0458-z; SAMAK MJ, 2003, CIRCULATION, V108, P2154; Sitprija V, 2003, KIDNEY INT, V63, P128, DOI 10.1046/j.1523-1755.63.s83.27.x; United Nations, 2007, WORLD POP PROSP 2006; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6; *WORLD BANK, 2006, WORLD DEV IND 2006; Zhang LX, 2008, AM J KIDNEY DIS, V51, P373, DOI 10.1053/j.ajkd.2007.11.009	11	33	33	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN-JUL	2008	371	9631					2147	2148		10.1016/S0140-6736(08)60928-9	http://dx.doi.org/10.1016/S0140-6736(08)60928-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	326CP	18586155				2022-12-28	WOS:000257635800004
J	Laurberg, M; Asahara, H; Korostelev, A; Zhu, JY; Trakhanov, S; Noller, HF				Laurberg, Martin; Asahara, Haruichi; Korostelev, Andrei; Zhu, Jianyu; Trakhanov, Sergei; Noller, Harry F.			Structural basis for translation termination on the 70S ribosome	NATURE			English	Article							STOP CODON RECOGNITION; PEPTIDE-BOND FORMATION; TRANSFER-RNA; RELEASE FACTORS; GGQ MOTIF; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; CHAIN TERMINATION; DECODING CENTER; HUMAN ERF1	At termination of protein synthesis, type I release factors promote hydrolysis of the peptidyl-transfer RNA linkage in response to recognition of a stop codon. Here we describe the crystal structure of the Thermus thermophilus 70S ribosome in complex with the release factor RF1, tRNA and a messenger RNA containing a UAA stop codon, at 3.2 angstrom resolution. The stop codon is recognized in a pocket formed by conserved elements of RF1, including its PxT recognition motif, and 16S ribosomal RNA. The codon and the 30S subunit A site undergo an induced fit that results in stabilization of a conformation of RF1 that promotes its interaction with the peptidyl transferase centre. Unexpectedly, the main-chain amide group of Gln 230 in the universally conserved GGQ motif of the factor is positioned to contribute directly to peptidyl-tRNA hydrolysis.	[Laurberg, Martin; Asahara, Haruichi; Korostelev, Andrei; Zhu, Jianyu; Trakhanov, Sergei; Noller, Harry F.] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Laurberg, Martin; Asahara, Haruichi; Korostelev, Andrei; Zhu, Jianyu; Trakhanov, Sergei; Noller, Harry F.] Univ Calif Santa Cruz, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Noller, HF (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.	harry@nuvolari.ucsc.edu		Korostelev, Andrei/0000-0003-1588-717X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106105] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ali IK, 2006, MOL CELL, V23, P865, DOI 10.1016/j.molcel.2006.08.011; Amort M, 2007, NUCLEIC ACIDS RES, V35, P5130, DOI 10.1093/nar/gkm539; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CAPECCHI MR, 1967, P NATL ACAD SCI USA, V58, P1144, DOI 10.1073/pnas.58.3.1144; CAPECCHI MR, 1969, COLD SPRING HARB SYM, V34, P469, DOI 10.1101/SQB.1969.034.01.053; CASKEY CT, 1971, P NATL ACAD SCI USA, V68, P3163, DOI 10.1073/pnas.68.12.3163; Dincbas-Renqvist V, 2000, EMBO J, V19, P6900, DOI 10.1093/emboj/19.24.6900; Freistroffer DV, 2000, P NATL ACAD SCI USA, V97, P2046, DOI 10.1073/pnas.030541097; Frolova LY, 1999, RNA, V5, P1014, DOI 10.1017/S135583829999043X; Ito K, 2000, NATURE, V403, P680, DOI 10.1038/35001115; Klaholz BP, 2003, NATURE, V421, P90, DOI 10.1038/nature01225; Li GP, 2004, J MOL BIOL, V340, P921, DOI 10.1016/j.jmb.2004.06.007; Maegley KA, 1996, P NATL ACAD SCI USA, V93, P8160, DOI 10.1073/pnas.93.16.8160; Mora L, 2003, MOL MICROBIOL, V47, P267, DOI 10.1046/j.1365-2958.2003.03301.x; Nakamura Y, 2002, FEBS LETT, V514, P30, DOI 10.1016/S0014-5793(02)02330-X; Ogle JM, 2003, TRENDS BIOCHEM SCI, V28, P259, DOI 10.1016/S0968-0004(03)00066-5; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Petry S, 2005, CELL, V123, P1255, DOI 10.1016/j.cell.2005.09.039; Polacek N, 2003, MOL CELL, V11, P103, DOI 10.1016/S1097-2765(02)00825-0; Rawat UBS, 2003, NATURE, V421, P87, DOI 10.1038/nature01224; Schmeing TM, 2005, NATURE, V438, P520, DOI 10.1038/nature04152; Schmeing TM, 2005, MOL CELL, V20, P437, DOI 10.1016/j.molcel.2005.09.006; Schmeing TM, 2003, RNA, V9, P1345, DOI 10.1261/rna.5120503; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; SCOLNICK E, 1968, P NATL ACAD SCI USA, V61, P768, DOI 10.1073/pnas.61.2.768; SCOLNICK EM, 1969, P NATL ACAD SCI USA, V64, P1235, DOI 10.1073/pnas.64.4.1235; Seit-Nebi A, 2001, NUCLEIC ACIDS RES, V29, P3982, DOI 10.1093/nar/29.19.3982; Seit-Nebi A, 2000, MOL BIOL+, V34, P764, DOI 10.1007/BF02759621; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Shaw JJ, 2007, MOL CELL, V28, P458, DOI 10.1016/j.molcel.2007.09.007; Shin DH, 2004, J MOL BIOL, V341, P227, DOI 10.1016/j.jmb.2004.05.055; Song HW, 2000, CELL, V100, P311, DOI 10.1016/S0092-8674(00)80667-4; Trobro S, 2007, MOL CELL, V27, P758, DOI 10.1016/j.molcel.2007.06.032; Vestergaard B, 2005, MOL CELL, V20, P929, DOI 10.1016/j.molcel.2005.11.022; Vestergaard B, 2001, MOL CELL, V8, P1375, DOI 10.1016/S1097-2765(01)00415-4; VOGEL Z, 1969, BIOCHEMISTRY-US, V8, P5161, DOI 10.1021/bi00840a070; Youngman EM, 2006, COLD SPRING HARB SYM, V71, P545, DOI 10.1101/sqb.2006.71.036; Youngman EM, 2007, MOL CELL, V28, P533, DOI 10.1016/j.molcel.2007.09.015; Youngman EM, 2004, CELL, V117, P589, DOI 10.1016/S0092-8674(04)00411-8; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Zavialov AV, 2002, MOL CELL, V10, P789, DOI 10.1016/S1097-2765(02)00691-3; Zoldak G, 2007, NUCLEIC ACIDS RES, V35, P1343, DOI 10.1093/nar/gkl696	43	268	275	0	27	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 14	2008	454	7206					852	857		10.1038/nature07115	http://dx.doi.org/10.1038/nature07115			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	336XH	18596689				2022-12-28	WOS:000258398600028
J	Farrelly, C				Farrelly, Colin			Has the time come to take on time itself?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LIFE-SPAN; MICE		Univ Waterloo, Dept Polit Sci, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Farrelly, C (corresponding author), Univ Waterloo, Dept Polit Sci, Waterloo, ON N2L 3G1, Canada.	farrelly@uwaterloo.ca						Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bjelakovic G, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007176; Couzin J, 2005, SCIENCE, V309, P83, DOI 10.1126/science.309.5731.83; *FED INT FOR AG RE, 2004, OLD AM 2004 KEY IND; Feng ZH, 2007, P NATL ACAD SCI USA, V104, P16633, DOI 10.1073/pnas.0708043104; Hadley EC, 2005, CELL, V120, P557, DOI 10.1016/j.cell.2005.01.030; Hekimi S, 2006, NAT GENET, V38, P985, DOI 10.1038/ng1881; Kitani K, 2007, GERIATR GERONTOL INT, V7, P97, DOI 10.1111/j.1447-0594.2007.00377.x; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X; Miller RA, 2005, SCIENCE, V308, P1875, DOI 10.1126/science.1114393; NCI, 2011, SEER CANC STAT REV 1; Olshansky SJ, 2006, SCIENTIST, V20, P28; PEARSON H, 2006, NATURE          1102; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; *US DEP HHS, PREV CONTR CANC NAT; *US DEP HHS, 2004, HLTH US 2004, P234	17	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 19	2008	337	7662							a414	10.1136/bmj.a414	http://dx.doi.org/10.1136/bmj.a414			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	330SB	18614507	Green Published			2022-12-28	WOS:000257962000037
J	Bickler, SW; Spiegel, DA				Bickler, Stephen W.; Spiegel, David A.			Global surgery - defining a research agenda	LANCET			English	Editorial Material							SERVICES											[Anonymous], 2003, SURG CAR DISTR HOSP; [Anonymous], 2008, LAUNCH SAF SURG SAV; Cherrier R, 2004, AGRONOMIE, V24, P29, DOI 10.1051/agro:2003057; Debas HT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1245; Gosselin RA, 2006, WORLD J SURG, V30, P505, DOI 10.1007/s00268-005-0609-5; McCord C, 2003, INT J GYNECOL OBSTET, V81, P83, DOI 10.1016/S0020-7292(03)00072-9; Spiegel DA, 2007, LANCET, V370, P1013, DOI 10.1016/S0140-6736(07)61457-3; *UNAIDS, 2007, EP SLID; WEISER TG, 2008, LANCET          0625, P60878, DOI DOI 10.1016/S0140-6736(08)60878-8; *WHO, WORKSH REP; *WHO, 2003, INT MAN EM ESS SURG	11	63	64	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 12	2008	372	9633					90	92		10.1016/S0140-6736(08)60924-1	http://dx.doi.org/10.1016/S0140-6736(08)60924-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	324XJ	18582930				2022-12-28	WOS:000257552400005
J	Santos, FC; Santos, MD; Pacheco, JM				Santos, Francisco C.; Santos, Marta D.; Pacheco, Jorge M.			Social diversity promotes the emergence of cooperation in public goods games	NATURE			English	Article							EVOLUTIONARY DYNAMICS; INDIRECT RECIPROCITY; NETWORKS; PUNISHMENT; DILEMMAS; GRAPHS	Humans often cooperate in public goods games(1-3) and situations ranging from family issues to global warming(4,5). However, evolutionary game theory predicts(4,6) that the temptation to forgo the public good mostly wins over collective cooperative action, and this is often also seen in economic experiments(7). Here we show how social diversity provides an escape from this apparent paradox. Up to now, individuals have been treated as equivalent in all respects(4,8), in sharp contrast with real- life situations, where diversity is ubiquitous. We introduce social diversity by means of heterogeneous graphs and show that cooperation is promoted by the diversity associated with the number and size of the public goods game in which each individual participates and with the individual contribution to each such game. When social ties follow a scale- free distribution(9), cooperation is enhanced whenever all individuals are expected to contribute a fixed amount irrespective of the plethora of public goods games in which they engage. Our results may help to explain the emergence of cooperation in the absence of mechanisms based on individual reputation and punishment(10-12). Combining social diversity with reputation and punishment will provide instrumental clues on the self- organization of social communities and their economical implications.	[Santos, Marta D.; Pacheco, Jorge M.] Univ Lisbon, CFTC, ATP Grp, P-1649003 Lisbon, Portugal; [Santos, Francisco C.] Univ Libre Brussels, Comp & Decis Engn Dept, IRIDIA, B-1050 Brussels, Belgium; [Santos, Marta D.; Pacheco, Jorge M.] Univ Lisbon, Dept Fis, P-1649003 Lisbon, Portugal	Universidade de Lisboa; Universite Libre de Bruxelles; Universidade de Lisboa	Pacheco, JM (corresponding author), Univ Lisbon, CFTC, ATP Grp, Complexo Interdisciplinar,Av Prof Gama Pinto 2, P-1649003 Lisbon, Portugal.	pacheco@cii.fc.ul.pt	Santos, Marta/C-9573-2011; Santos, Francisco C./W-7781-2019; Santos, Marta/N-4772-2015; Pacheco, Jorge M./O-8184-2019; Santos, Francisco C./D-2394-2010; Pacheco, Jorge M/B-6116-2008	Santos, Marta/0000-0003-1824-0080; Santos, Francisco C./0000-0002-9103-2862; Pacheco, Jorge M./0000-0002-2579-8499; Santos, Francisco C./0000-0002-9103-2862; Pacheco, Jorge M/0000-0002-2579-8499				Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Binmore K.G., 1994, GAME THEORY SOCIAL C, V1; BOHEM C, 1999, HIERARCHY FOREST EVO; Boyd R, 2007, SCIENCE, V316, P1858, DOI 10.1126/science.1144339; Dorogotsev SN, 2003, EVOLUTION NETWORKS B; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; HARDIN G, 1968, SCIENCE, V162, P1248; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Hauert C, 2002, SCIENCE, V296, P1129, DOI 10.1126/science.1070582; Hauert C, 2007, SCIENCE, V316, P1905, DOI 10.1126/science.1141588; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Kollock P, 1998, ANNU REV SOCIOL, V24, P183, DOI 10.1146/annurev.soc.24.1.183; Lieberman E, 2005, NATURE, V433, P312, DOI 10.1038/nature03204; Milinski M, 2006, P NATL ACAD SCI USA, V103, P3994, DOI 10.1073/pnas.0504902103; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ohtsuki H, 2004, J THEOR BIOL, V231, P107, DOI 10.1016/j.jtbi.2004.06.005; Ohtsuki H, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108106; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Pacheco JM, 2006, PLOS COMPUT BIOL, V2, P1634, DOI 10.1371/journal.pcbi.0020178; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Santos FC, 2006, J EVOLUTION BIOL, V19, P726, DOI 10.1111/j.1420-9101.2005.01063.x; Santos FC, 2006, P NATL ACAD SCI USA, V103, P3490, DOI 10.1073/pnas.0508201103; Skyrms B., 2004, STAG HUNT EVOLUTION, DOI DOI 10.1017/CBO9781139165228; Szabo G, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.062903; Szabo G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.118101; Traulsen A, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011909	30	936	952	23	426	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2008	454	7201					213	U49		10.1038/nature06940	http://dx.doi.org/10.1038/nature06940			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	323RU	18615084				2022-12-28	WOS:000257466900043
J	Murphy, D; Hotopf, M; Wessely, S				Murphy, Dominic; Hotopf, Matthew; Wessely, Simon			Multiple vaccinations, health, and recall bias within UK armed forces deployed to Iraq: cohort study	BRITISH MEDICAL JOURNAL			English	Article							GULF-WAR VETERANS; RISK-FACTORS; ANTHRAX VACCINATION; EXPOSURES; SYMPTOMS; ILLNESS; PERSONNEL; SERVICE; TIME	Objective To assess the relation between self reported number of vaccinations received and health, and between numbers of vaccinations recorded from individuals' medical records and health. Design First phase of a cohort study. Setting UK armed forces personnel. Participants 4882 randomly selected military personnel deployed to Iraq since 2003 and a subset of 378 whose vaccination records were accessed. Main outcome measures Psychological distress, fatigue, symptoms of post-traumatic stress disorder, health perception, and multiple physical symptoms. Results Personnel who reported receiving two or more vaccinations on a single day were more likely to report symptoms of fatigue (adjusted risk ratio 1.17, 95% confidence interval 1.05 to 1.30), show caseness according to the general health questionnaire (1.31, 1.13 to 1.53), and have multiple physical symptoms (1.32, 1.08 to 1.60). These associations were no longer significant when number of vaccinations recorded in individuals' medical records was used as the independent variable. Conclusions Multiple vaccinations given to personnel in the UK armed forces in preparation for deployment to Iraq are not associated with adverse health consequences when vaccinations are recorded objectively from medical records. Adverse health consequences associated with self reported multiple vaccinations could be explained by recall bias.	[Murphy, Dominic; Hotopf, Matthew; Wessely, Simon] Kings Coll London, Kings Ctr Mil Hlth Res, London SE5 9RJ, England	University of London; King's College London	Murphy, D (corresponding author), Kings Coll London, Kings Ctr Mil Hlth Res, London SE5 9RJ, England.	dominic.murphy@iop.kcl.ac.uk	Wessely, Simon C/A-8713-2008; Hotopf, Matthew/E-4971-2010	Hotopf, Matthew/0000-0002-3980-4466; Wessely, Simon Charles/0000-0002-6743-9929; Murphy, Dominic/0000-0002-9530-2743				Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; Cherry N, 2001, OCCUP ENVIRON MED, V58, P299, DOI 10.1136/oem.58.5.299; Goldberg D, 1998, USERS GUIDE GEN HLTH; Horn O, 2006, LANCET, V367, P1742, DOI 10.1016/S0140-6736(06)68661-3; Hotopf M, 2005, INT J EPIDEMIOL, V34, P791, DOI 10.1093/ije/dyi102; Hotopf M, 2000, BRIT MED J, V320, P1363, DOI 10.1136/bmj.320.7246.1363; Hotopf M, 2004, PSYCHOL MED, V34, P747, DOI 10.1017/S0033291703001016; Hotopf M, 2006, LANCET, V367, P1731, DOI 10.1016/S0140-6736(06)68662-5; Kelsall HL, 2004, OCCUP ENVIRON MED, V61, P1006, DOI 10.1136/oem.2003.009258; Koren G, 2004, AM J OBSTET GYNECOL, V190, P485, DOI 10.1016/j.ajog.2003.08.039; Macfarlane GJ, 2003, BRIT MED J, V327, P1373, DOI 10.1136/bmj.327.7428.1373; McCauley LA, 1999, ENVIRON RES, V81, P195, DOI 10.1006/enrs.1999.3977; Murphy D, 2007, VACCINE, V25, P7641, DOI 10.1016/j.vaccine.2007.08.065; Payne DC, 2007, ANN EPIDEMIOL, V17, P697, DOI 10.1016/j.annepidem.2007.03.018; Rook GAW, 1997, LANCET, V349, P1831, DOI 10.1016/S0140-6736(97)01164-1; Shaheen S, 2000, BMJ-BRIT MED J, V320, P1351, DOI 10.1136/bmj.320.7246.1351; Smith B, 2007, AM J PREV MED, V32, P347, DOI 10.1016/j.amepre.2006.12.015; Steele L, 2000, AM J EPIDEMIOL, V152, P992, DOI 10.1093/aje/152.10.992; Tate AR, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-51; Unwin C, 1999, LANCET, V353, P169, DOI 10.1016/S0140-6736(98)11338-7; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wessely S, 2003, BRIT J PSYCHIAT, V183, P314, DOI 10.1192/bjp.183.4.314; Wolfe J, 2002, J OCCUP ENVIRON MED, V44, P271, DOI 10.1097/00043764-200203000-00015	24	6	6	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 5	2008	337	7660							a220	10.1136/bmj.a220	http://dx.doi.org/10.1136/bmj.a220			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	326DF	18595928	Green Published, Bronze			2022-12-28	WOS:000257637500034
J	Nabi, H; Kivimaki, M; De Vogli, R; Marmot, MG; Singh-Manoux, A				Nabi, Hermann; Kivimaki, Mika; De Vogli, Roberto; Marmot, Michael G.; Singh-Manoux, Archana			Positive and negative affect and risk of coronary heart disease: Whitehall II prospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							CARDIOVASCULAR-DISEASE; PSYCHOSOCIAL FACTORS; GLOBAL BURDEN; DEPRESSION; ANXIETY; ADULTS; ATHEROSCLEROSIS; ASSOCIATION; PROGRESSION; PREDICTORS	Objective To examine the associations between positive and negative affect and subsequent coronary heart disease events independently of established risk factors. Design Prospective cohort study with follow-up over 12 years. Setting 20 civil service departments originally located in London. Participants 10308 civil servants aged 35-55 years at entry into Whitehall II study in 1985. Main outcome measures Fatal coronary heart disease, clinically verified incident non-fatal myocardial infarction, and definite angina (n=619, mean follow-up 12.5 years). Results In Cox regression analysis adjusted for age, sex, ethnicity, and socioeconomic position, positive affect (hazard ratio=1.01, 95% confidence interval 0.82 to 1.24) and the balance between positive and negative affect, referred to as the affect balance score (hazard ratio = 0.89, 0.73 to 1.09), were not associated with coronary heart disease. Further adjustment for behaviour related risk factors (smoking, alcohol consumption, daily fruit and vegetable intake, exercise, body mass index), biological risk factors (hypertension, blood cholesterol, diabetes), and psychological stress at work did not change these results. However, participants in the highest third of negative affect had an increased incidence of coronary events (hazard ratio = 1.32, 1.09 to 1.60), and this association remained unchanged after adjustment for multiple confounders. Conclusions Positive affect and affect balance did not seem to be predictive of future coronary heart disease in men and women who were free of diagnosed coronary heart disease at recruitment to the study. A weak positive association between negative affect and coronary heart disease was found and needs to be confirmed in further studies.	[Nabi, Hermann; Kivimaki, Mika; De Vogli, Roberto; Marmot, Michael G.; Singh-Manoux, Archana] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; [Nabi, Hermann; Singh-Manoux, Archana] INSERM, U687, IFR69, F-94807 Villejuif, France; [Singh-Manoux, Archana] Hop St Perrine, Ctr Gerontol, F-75781 Paris, France	University of London; University College London; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Sainte-Perine - APHP	Nabi, H (corresponding author), UCL, Dept Epidemiol & Publ Hlth, Mortimer St, London WC1E 6BT, England.	H.Nabi@public-health.ucl.ac.uk	Marmot, M G/Y-3920-2019; Kivimaki, Mika/B-3607-2012; Singh-Manoux, Archana/F-6804-2013	Marmot, M G/0000-0002-2431-6419; Kivimaki, Mika/0000-0002-4699-5627; Singh-Manoux, Archana/0000-0002-1244-5037; Nabi, Hermann/0000-0002-7832-0413	AHRQ HHS [HS06516] Funding Source: Medline; British Heart Foundation [RG/07/008/23674] Funding Source: Medline; Medical Research Council [G19/35, G8802774, G0100222] Funding Source: Medline; Department of Health Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS006516] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Blazer DG, 2004, J AM GERIATR SOC, V52, P2052, DOI 10.1111/j.1532-5415.2004.52564.x; Bradburn N.M., 1969, STRUCTURE PSYCHOL WE, DOI DOI 10.1037/T10756-000; Carney RM, 2005, PSYCHOSOM MED, V67, pS29, DOI 10.1097/01.psy.0000162254.61556.d5; CLARK LA, 1991, J ABNORM PSYCHOL, V100, P316, DOI 10.1037/0021-843X.100.3.316; DIENER E, 1984, J PERS SOC PSYCHOL, V47, P1105, DOI 10.1037/0022-3514.47.5.1105; EAKER ED, 1992, AM J EPIDEMIOL, V135, P854, DOI 10.1093/oxfordjournals.aje.a116381; French-Belgian Collaborative Group, 1982, ADV CARDIOL, V29, P25; Grippo AJ, 2002, NEUROSCI BIOBEHAV R, V26, P941, DOI 10.1016/S0149-7634(03)00003-4; GUTZWILLER F, 1994, ANN MED, V26, P61, DOI 10.3109/07853899409147329; HAINES AP, 1987, BRIT MED J, V295, P297, DOI 10.1136/bmj.295.6593.297; Hamer DH, 1996, NAT GENET, V14, P125, DOI 10.1038/ng1096-125; Hemingway H, 1999, BMJ-BRIT MED J, V318, P1460, DOI 10.1136/bmj.318.7196.1460; Huppert F, 2004, SCI WELL BEING INTEG; Karasek R., 1990, HLTH WORK STRESS PRO; Kawachi I, 1996, CIRCULATION, V94, P2090, DOI 10.1161/01.CIR.94.9.2090; KOSKENVUO M, 1988, PSYCHOSOM MED, V50, P330, DOI 10.1097/00006842-198807000-00002; Kubzansky LD, 2000, J PSYCHOSOM RES, V48, P323, DOI 10.1016/S0022-3999(99)00091-4; Kuper Hannah, 2002, Semin Vasc Med, V2, P267, DOI 10.1055/s-2002-35401; LANDSBERGIS PA, 1994, SCAND J WORK ENV HEA, V20, P349, DOI 10.5271/sjweh.1386; Marmot M, 2005, INT J EPIDEMIOL, V34, P251, DOI 10.1093/ije/dyh372; Miller GE, 2002, AM J CARDIOL, V90, P1279, DOI 10.1016/S0002-9149(02)02863-1; Nicholson A, 2006, EUR HEART J, V27, P2763, DOI 10.1093/eurheartj/ehl338; Ostir GV, 2001, PSYCHOSOM MED, V63, P210, DOI 10.1097/00006842-200103000-00003; Paterniti S, 2001, ARTERIOSCL THROM VAS, V21, P136, DOI 10.1161/01.ATV.21.1.136; Polk DE, 2005, PSYCHONEUROENDOCRINO, V30, P261, DOI 10.1016/j.psyneuen.2004.08.004; Pressman SD, 2005, PSYCHOL BULL, V131, P925, DOI 10.1037/0033-2909.131.6.925; Rose G, 1982, CARDIOVASCULAR SURVE; Stewart JC, 2007, ARCH GEN PSYCHIAT, V64, P225, DOI 10.1001/archpsyc.64.2.225; Suls J, 2005, PSYCHOL BULL, V131, P260, DOI 10.1037/0033-2909.131.2.260; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; WATSON D, 1984, PSYCHOL BULL, V96, P465, DOI 10.1037/0033-2909.96.3.465; Yan LJL, 2003, JAMA-J AM MED ASSOC, V290, P2138, DOI 10.1001/jama.290.16.2138; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488	34	50	50	0	15	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 5	2008	337	7660							a118	10.1136/bmj.a118	http://dx.doi.org/10.1136/bmj.a118			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	326DF	18595926	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000257637500031
J	Carbajal, R; Rousset, A; Danan, C; Coquery, S; Nolent, P; Ducrocq, S; Saizou, C; Lapillonne, A; Granier, M; Durand, P; Lenclen, R; Coursol, A; Hubert, P; de Saint Blanquat, L; Boelle, PY; Annequin, D; Cimerman, P; Anand, KJS; Breart, G				Carbajal, Ricardo; Rousset, Andre; Danan, Claude; Coquery, Sarah; Nolent, Paul; Ducrocq, Sarah; Saizou, Carole; Lapillonne, Alexandre; Granier, Michele; Durand, Philippe; Lenclen, Richard; Coursol, Anne; Hubert, Philippe; de Saint Blanquat, Laure; Boelle, Pierre-Yves; Annequin, Daniel; Cimerman, Patricia; Anand, K. J. S.; Breart, Gerard			Epidemiology and treatment of painful procedures in neonates in intensive care units	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRETERM INFANTS; NEWBORN-INFANTS; ANALGESIA; RESPONSES; MORPHINE; REACTIVITY; EXPOSURE; STRESS; BABIES	Context Effective strategies to improve pain management in neonates require a clear understanding of the epidemiology and management of procedural pain. Objective To report epidemiological data on neonatal pain collected from a geographically defined region, based on direct bedside observation of neonates. Design, Setting, and Patients Between September 2005 and January 2006, data on all painful and stressful procedures and corresponding analgesic therapy from the first 14 days of admission were prospectively collected within a 6- week period from 430 neonates admitted to tertiary care centers in the Paris region of France ( 11.3 millions inhabitants) for the Epidemiology of Procedural Pain in Neonates ( EPIPPAIN) study. Main Outcome Measure Number of procedures considered painful or stressful by health personnel and corresponding analgesic therapy. Results The mean ( SD) gestational age and intensive care unit stay were 33.0 ( 4.6) weeks and 8.4 ( 4.6) calendar days, respectively. Neonates experienced 60 969 first- attempt procedures, with 42 413 ( 69.6%) painful and 18 556 ( 30.4%) stressful procedures; 11 546 supplemental attempts were performed during procedures including 10 366 ( 89.8%) for painful and 1180 ( 10.2%) for stressful procedures. Each neonate experienced a median of 115 ( range, 4- 613) procedures during the study period and 16 ( range, 0- 62) procedures per day of hospitalization. Of these, each neonate experienced a median of 75( range, 3- 364) painful procedures during the study period and 10 ( range, 0- 51) painful procedures per day of hospitalization. Of the 42 413 painful procedures, 2.1% were performed with pharmacological- only therapy; 18.2% with nonpharmacological- only interventions, 20.8% with pharmacological, nonpharmacological, or both types of therapy; and 79.2% without specific analgesia, and 34.2% were performed while the neonate was receiving concurrent analgesic or anesthetic infusions for other reasons. Prematurity, category of procedure, parental presence, surgery, daytime, and day of procedure after the first day of admission were associated with greater use of specific preprocedural analgesia, whereas mechanical ventilation, noninvasive ventilation and administration of nonspecific concurrent analgesia were associated with lower use of specific preprocedural analgesia. Conclusion During neonatal intensive care in the Paris region, large numbers of painful and stressful procedures were performed, the majority of which were not accompanied by analgesia.	[Carbajal, Ricardo; Cimerman, Patricia] Hop Enfants Armand Trousseau, Assistance Publ Hop Paris, Ctr Natl Ressources Lutte Douleur, F-75012 Paris, France; [Nolent, Paul] Hop Enfants Armand Trousseau, Assistance Publ Hop Paris, Unite Reanimat Neonatale & Pediat, F-75012 Paris, France; [Annequin, Daniel] Hop Enfants Armand Trousseau, Assistance Publ Hop Paris, Unite Fonct Analgesie Pediat, F-75012 Paris, France; [Carbajal, Ricardo; Breart, Gerard] Hop Tenon, Assistance Publ Hop Paris, INSERM, UMR S149,Epidemiol Res Unit Perinatal & Womens Hl, F-75970 Paris, France; [Rousset, Andre] CHI Andre Gregoire, Unite Reanimat Neonatale, Montreuil, France; [Danan, Claude] Ctr Hosp Gen Intercommunal Creteil, Unite Reanimat Neonatale, Creteil, France; [Coquery, Sarah] Hop Antoine Beclere, Assistance Publ Hop Paris, Unite Reanimat Neonatale, Clamart, France; [Ducrocq, Sarah] Hop Cochin Port Royal, Assistance Publ Hop Paris, Unite Reanimat Neonatale, Paris, France; [Saizou, Carole] Hop Robert Debre, Assistance Publ Hop Paris, Unite Reanimat Neonatale & Pediat, F-75019 Paris, France; [Lapillonne, Alexandre] Hop St Vincent de Paul, Assistance Publ Hop Paris, Unite Reanimat Neonatale & Pediat, F-75674 Paris, France; [de Saint Blanquat, Laure] Hop St Vincent de Paul, Assistance Publ Hop Paris, Unite Reanimat Chirurg, F-75674 Paris, France; [Granier, Michele] Hop Louise Michel, Unite Reanimat Neonatale, Evry, France; [Durand, Philippe] Hop Bicetre, Assistance Publ Hop Paris, Unite Reanimat Neonatale & Pediat, Le Kremlin Bicetre, France; [Lenclen, Richard] CHI Poissy St Germain en Laye, Unite Reanimat Neonatale, St Germain En Laye, France; [Coursol, Anne] Ctr Hosp Rene Dubos, Unite Reanimat Neonatale, Pontoise, France; [Hubert, Philippe] Hop Necker Enfants Malad, Assistance Publ Hop Paris, Unite Reanimat Neonatale & Pediat, Paris, France; [Boelle, Pierre-Yves] Hop St Antoine, Assistance Publ Hop Paris, Dept Sante Publ, INSERM UMR S707, F-75571 Paris, France; [Boelle, Pierre-Yves] Hop St Antoine, Assistance Publ Hop Paris, Dept Sante Publ, UPMC,UMR S 707, F-75571 Paris, France; [Anand, K. J. S.] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Saclay; Hospital Chi of Poissy Saint Germain; Centre Hospitalier Rene Dubos, Pontoise; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; University of Arkansas System; University of Arkansas Medical Sciences	Carbajal, R (corresponding author), Hop Enfants Armand Trousseau, Assistance Publ Hop Paris, Ctr Natl Ressources Lutte Douleur, 26 Av Dr Netter, F-75012 Paris, France.	ricardo.carbajal@trs.aphp.fr	Anand, Kanwaljeet/B-3287-2014	Anand, Kanwaljeet/0000-0001-6498-1483; Annequin, Daniel/0000-0001-6425-4016; breart, gerard/0000-0003-3142-9128; Boelle, Pierre-Yves/0000-0002-5367-8232				Allegaert K, 2007, EUR J PAIN, V11, P910, DOI 10.1016/j.ejpain.2007.01.007; Amer Acad Pediat, 2006, PEDIATRICS, V118, P2231, DOI 10.1542/peds.2006-2277; Anand KJS, 2006, PEDIATRICS, V117, pS9, DOI 10.1542/peds.2005-0620C; Anand KJS, 1998, BIOL NEONATE, V73, P1, DOI 10.1159/000013953; Anand KJS, 2004, ANESTHESIOLOGY, V101, P527, DOI 10.1097/00000542-200408000-00033; Anand KJS, 1996, PAIN, V67, P3, DOI 10.1016/0304-3959(96)03135-1; Anand KJS, 2001, ARCH PEDIAT ADOL MED, V155, P173, DOI 10.1001/archpedi.155.2.173; [Anonymous], 1979, Pain, V6, P249; Aranda JV, 2005, CLIN THER, V27, P877, DOI 10.1016/j.clinthera.2005.06.019; BARKER DP, 1995, ARCH DIS CHILD-FETAL, V72, pF47, DOI 10.1136/fn.72.1.F47; Bartocci M, 2006, PAIN, V122, P109, DOI 10.1016/j.pain.2006.01.015; Benis Marilyn M., 2001, Pediatric Research, V49, p392A; Carbajal R, 2005, PEDIATRICS, V115, P1494, DOI 10.1542/peds.2004-1425; CHROUSOS GP, 1992, JAMA-J AM MED ASSOC, V267, P1244, DOI 10.1001/jama.267.9.1244; De Lima J, 1999, BRIT J ANAESTH, V83, P662, DOI 10.1093/bja/83.4.662; FITZGERALD M, 1988, LANCET, V1, P292; FITZGERALD M, 1989, PAIN, V39, P31, DOI 10.1016/0304-3959(89)90172-3; Grunau R, 2002, CLIN PERINATOL, V29, P373; Grunau R., 2007, PAIN NEONATES INFANT, P45; Grunau RE, 2005, PAIN, V113, P293, DOI 10.1016/j.pain.2004.10.020; Grunau RE, 2000, CLIN J PAIN, V16, P37, DOI 10.1097/00002508-200003000-00007; Grunau RE, 2001, PEDIATRICS, V107, P105, DOI 10.1542/peds.107.1.105; Holsti L, 2005, EARLY HUM DEV, V81, P293, DOI 10.1016/j.earlhumdev.2004.08.002; Johnston CC, 1997, CLIN J PAIN, V13, P308, DOI 10.1097/00002508-199712000-00008; Johnston CC, 1996, PEDIATRICS, V98, P925; Lemons JA, 2000, PEDIATRICS, V105, P454; Moustogiannis AN, 1996, NEUROL RES, V18, P440; Porter F. L., 1998, RES CLIN FORUMS, V20, P9; Porter FL, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.1.e13; Ruda MA, 2000, SCIENCE, V289, P628, DOI 10.1126/science.289.5479.628; Simons SHP, 2003, ARCH PEDIAT ADOL MED, V157, P1058, DOI 10.1001/archpedi.157.11.1058; Simons SHP, 2003, JAMA-J AM MED ASSOC, V290, P2419, DOI 10.1001/jama.290.18.2419; Slater R, 2006, J NEUROSCI, V26, P3662, DOI 10.1523/JNEUROSCI.0348-06.2006; Slater R, 2006, PAIN, V123, P332, DOI 10.1016/j.pain.2006.05.009; Whitfield MF, 2000, CLIN PERINATOL, V27, P363, DOI 10.1016/S0095-5108(05)70026-9; WILSON G, 1991, EARLY HUM DEV, V25, P87, DOI 10.1016/0378-3782(91)90187-8	36	577	607	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 2	2008	300	1					60	70		10.1001/jama.300.1.60	http://dx.doi.org/10.1001/jama.300.1.60			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320NW	18594041	Bronze			2022-12-28	WOS:000257242800025
J	Conrad, MN; Lee, CY; Chao, G; Shinohara, M; Kosaka, H; Shinohara, A; Conchello, JA; Dresser, ME				Conrad, Michael N.; Lee, Chih-Ying; Chao, Gene; Shinohara, M.; Kosaka, H.; Shinohara, A.; Conchello, J. -A.; Dresser, Michael E.			Rapid telomere movement in meiotic prophase is promoted by NDJ1, MPS3, and CSM4 and is modulated by recombination	CELL			English	Article							SYNAPTONEMAL COMPLEX-FORMATION; DOUBLE-STRAND BREAKS; SPINDLE POLE BODY; SACCHAROMYCES-CEREVISIAE; CHROMOSOME SYNAPSIS; NUCLEAR-ENVELOPE; FISSION YEAST; CROSSOVER INTERFERENCE; ECTOPIC RECOMBINATION; BOUQUET FORMATION	Haploidization of the genome in meiosis requires that chromosomes be sorted exclusively into pairs stabilized by synaptonemal complexes (SCs) and crossovers. This sorting and pairing is accompanied by active chromosome positioning in meiotic prophase in which telomeres cluster near the spindle pole to form the bouquet before dispersing around the nuclear envelope. We now describe telomere-led rapid prophase movements (RPMs) that frequently exceed 1 mu m/s and persist throughout meiotic prophase. Bouquet formation and RPMs depend on NDJ1, MPS3, and a new member of this pathway, CSM4, which encodes a meiosis-specific nuclear envelope protein required specifically for telomere mobility. RPMs initiate independently of recombination but differ quantitatively in mutants that fail to complete recombination, suggesting that RPMs respond to recombination status. Together with recombination defects described for ndj1, our observations suggest that RPMs and SCs balance the disruption and stabilization of recombinational interactions, respectively, to regulate crossing over.	[Conrad, Michael N.; Lee, Chih-Ying; Chao, Gene; Conchello, J. -A.; Dresser, Michael E.] Oklahoma Med Res Fdn, Program Mol Cell & Dev Biol, Oklahoma City, OK 73104 USA; [Lee, Chih-Ying; Dresser, Michael E.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA; [Shinohara, M.; Kosaka, H.; Shinohara, A.] Osaka Univ, Div Integrated Prot Funct, Inst Prot Res, Osaka 4, Japan; [Conchello, J. -A.] Univ Oklahoma, Dept Elect Engn, Norman, OK 73019 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; Osaka University; University of Oklahoma System; University of Oklahoma - Norman	Dresser, ME (corresponding author), Oklahoma Med Res Fdn, Program Mol Cell & Dev Biol, 825 NE 13th St, Oklahoma City, OK 73104 USA.	dresserm@omrf.ouhsc.edu	Shinohara, Miki/E-7151-2013	Shinohara, Miki/0000-0002-7413-8235				Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Argueso JL, 2004, GENETICS, V168, P1805, DOI 10.1534/genetics.104.032912; Beilharz T, 2003, J BIOL CHEM, V278, P8219, DOI 10.1074/jbc.M212725200; Berg, 2018, RANDOM WALKS BIOL; Bishop DK, 2004, CELL, V117, P9, DOI 10.1016/S0092-8674(04)00297-1; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Blat Y, 2002, CELL, V111, P791, DOI 10.1016/S0092-8674(02)01167-4; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; Bystricky K, 2005, J CELL BIOL, V168, P375, DOI 10.1083/jcb.200409091; Cha RS, 2000, GENE DEV, V14, P493; Chambers SR, 1996, MOL CELL BIOL, V16, P6110; Cheung VG, 2007, AM J HUM GENET, V80, P526, DOI 10.1086/512131; CHIKASHIGE Y, 1994, SCIENCE, V264, P270, DOI 10.1126/science.8146661; Chikashige Y, 2006, CELL, V125, P59, DOI 10.1016/j.cell.2006.01.048; Chikashige Y, 2007, CHROMOSOMA, V116, P497, DOI 10.1007/s00412-007-0114-8; Chua PR, 1997, GENE DEV, V11, P1786, DOI 10.1101/gad.11.14.1786; Conchello JA, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2812554; Conrad MN, 2007, P NATL ACAD SCI USA, V104, P8863, DOI 10.1073/pnas.0606165104; Conrad MN, 1997, SCIENCE, V276, P1252, DOI 10.1126/science.276.5316.1252; de los Santos T, 2003, GENETICS, V164, P81; Dernburg AF, 1998, CELL, V94, P387, DOI 10.1016/S0092-8674(00)81481-6; Ding X, 2007, DEV CELL, V12, P863, DOI 10.1016/j.devcel.2007.03.018; Dresser ME, 1997, GENETICS, V147, P533; Fung JC, 2004, CELL, V116, P795, DOI 10.1016/S0092-8674(04)00249-1; Gital Z, 2005, CELL, V120, P329, DOI 10.1016/j.cell.2005.01.007; Goldman ASH, 2000, P NATL ACAD SCI USA, V97, P9537, DOI 10.1073/pnas.97.17.9537; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hayashi A, 1998, GENES CELLS, V3, P587, DOI 10.1046/j.1365-2443.1998.00215.x; Henderson KA, 2004, P NATL ACAD SCI USA, V101, P4519, DOI 10.1073/pnas.0400843101; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Inoue K, 2002, ANNU REV GENOM HUM G, V3, P199, DOI 10.1146/annurev.genom.3.032802.120023; Jaspersen SL, 2006, J CELL BIOL, V174, P665, DOI 10.1083/jcb.200601062; Kateneva AV, 2005, J CELL BIOL, V171, P241, DOI 10.1083/jcb.200505020; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kleckner N, 2004, P NATL ACAD SCI USA, V101, P12592, DOI 10.1073/pnas.0402724101; KLEIN F, 1992, J CELL BIOL, V117, P935, DOI 10.1083/jcb.117.5.935; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; McKim KS, 1998, SCIENCE, V279, P876, DOI 10.1126/science.279.5352.876; Miki F, 2004, MOL GENET GENOMICS, V270, P449, DOI 10.1007/s00438-003-0938-8; Miki F, 2002, MOL BIOL CELL, V13, P930, DOI 10.1091/mbc.01-11-0543; Moller-Jensen J, 2002, EMBO J, V21, P3119, DOI 10.1093/emboj/cdf320; PARVINEN M, 1976, NATURE, V260, P534, DOI 10.1038/260534a0; Penkner A, 2007, DEV CELL, V12, P873, DOI 10.1016/j.devcel.2007.05.004; Rabitsch KP, 2001, CURR BIOL, V11, P1001, DOI 10.1016/S0960-9822(01)00274-3; ROCKMILL B, 1995, GENE DEV, V9, P2684, DOI 10.1101/gad.9.21.2684; Ross LO, 1996, P NATL ACAD SCI USA, V93, P4979, DOI 10.1073/pnas.93.10.4979; Scherthan H, 2007, P NATL ACAD SCI USA, V104, P16934, DOI 10.1073/pnas.0704860104; Schlecht HB, 2004, GENETICS, V168, P1189, DOI 10.1534/genetics.104.029157; Schmitt J, 2007, P NATL ACAD SCI USA, V104, P7426, DOI 10.1073/pnas.0609198104; Shimanuki M, 1997, MOL GEN GENET, V254, P238, DOI 10.1007/s004380050412; SYM M, 1993, CELL, V72, P365, DOI 10.1016/0092-8674(93)90114-6; Trelles-Sticken E, 2000, J CELL BIOL, V151, P95, DOI 10.1083/jcb.151.1.95; Trelles-Sticken E, 2005, J CELL BIOL, V170, P213, DOI 10.1083/jcb.200501042; Villasante A, 2007, P NATL ACAD SCI USA, V104, P10542, DOI 10.1073/pnas.0703808104; White EJ, 2004, GENETICS, V167, P51, DOI 10.1534/genetics.167.1.51; XU LZ, 1995, MOL CELL BIOL, V15, P6572; YUMURA S, 1984, J CELL BIOL, V99, P894, DOI 10.1083/jcb.99.3.894; Zickler D, 2006, CHROMOSOMA, V115, P158, DOI 10.1007/s00412-006-0048-6; Zickler D, 1998, ANNU REV GENET, V32, P619, DOI 10.1146/annurev.genet.32.1.619	59	156	159	1	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 27	2008	133	7					1175	1187		10.1016/j.cell.2008.04.047	http://dx.doi.org/10.1016/j.cell.2008.04.047			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	319DP	18585352	Bronze			2022-12-28	WOS:000257144600015
J	Shih, C; Museth, AK; Abrahamsson, M; Blanco-Rodriguez, AM; Di Bilio, AJ; Sudhamsu, J; Crane, BR; Ronayne, KL; Towrie, M; Vlcek, A; Richards, JH; Winkler, JR; Gray, HB				Shih, Crystal; Museth, Anna Katrine; Abrahamsson, Malin; Blanco-Rodriguez, Ana Maria; Di Bilio, Angel J.; Sudhamsu, Jawahar; Crane, Brian R.; Ronayne, Kate L.; Towrie, Mike; Vlcek, Antonin, Jr.; Richards, John H.; Winkler, Jay R.; Gray, Harry B.			Tryptophan-accelerated electron flow through proteins	SCIENCE			English	Article							PSEUDOMONAS-AERUGINOSA AZURINS; RIBONUCLEOTIDE REDUCTASE; OXIDATION; RADICALS; DYNAMICS; TYROSINE; CURRENTS; PROTON; BONDS; WATER	Energy flow in biological structures often requires submillisecond charge transport over long molecular distances. Kinetics modeling suggests that charge- transfer rates can be greatly enhanced by multistep electron tunneling in which redox- active amino acid side chains act as intermediate donors or acceptors. We report transient optical and infrared spectroscopic experiments that quantify the extent to which an intervening tryptophan residue can facilitate electron transfer between distant metal redox centers in a mutant Pseudomonas aeruginosa azurin. Cu-1 oxidation by a photoexcited Re-1- diimine at position 124 on a histidine( 124)- glycine( 123)- tryptophan( 122)-methionine( 121) beta strand occurs in a few nanoseconds, fully two orders of magnitude faster than documented for single- step electron tunneling at a 19 angstrom donor- acceptor distance.	[Sudhamsu, Jawahar; Crane, Brian R.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Shih, Crystal; Museth, Anna Katrine; Abrahamsson, Malin; Di Bilio, Angel J.; Richards, John H.; Winkler, Jay R.; Gray, Harry B.] CALTECH, Beckman Inst, Pasadena, CA 91125 USA; [Blanco-Rodriguez, Ana Maria; Vlcek, Antonin, Jr.] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England; [Ronayne, Kate L.; Towrie, Mike] STFC Rutherford Appleton Lab, Cent Laser Facil, Didcot OX11 0QX, Oxon, England	Cornell University; California Institute of Technology; University of London; Queen Mary University London; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory	Crane, BR (corresponding author), Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA.	bc69@cornell.edu; a.vlcek@qmul.ac.uk; jhr@caltech.edu; winklerj@caltech.edu; hbgray@caltech.edu	Vlcek, Antonin/G-3908-2014; Sudhamsu, Jawahar/A-8751-2012; Winkler, Jay R/B-7372-2009	Towrie, Mike/0000-0002-1305-701X	NIDDK NIH HHS [DK19038] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK019038, R01DK019038] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Berlin YA, 2003, J PHYS CHEM A, V107, P3970, DOI 10.1021/jp034225i; Blanco-Rodriguez AM, 2006, J AM CHEM SOC, V128, P4365, DOI 10.1021/ja057451+; Cannizzo A, 2008, J AM CHEM SOC, V130, P8967, DOI 10.1021/ja710763w; Chang MCY, 2004, J AM CHEM SOC, V126, P16702, DOI 10.1021/ja044124d; Connick WB, 1995, INORG CHIM ACTA, V240, P169, DOI 10.1016/0020-1693(95)04532-5; Crane BR, 2001, J AM CHEM SOC, V123, P11623, DOI 10.1021/ja0115870; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; FREY PA, 1990, CHEM REV, V90, P1343, DOI 10.1021/cr00105a014; Gabrielsson A, 2006, J AM CHEM SOC, V128, P4253, DOI 10.1021/ja0539802; Gray HB, 1996, ANNU REV BIOCHEM, V65, P537, DOI 10.1146/annurev.bi.65.070196.002541; Gray HB, 2003, Q REV BIOPHYS, V36, P341, DOI 10.1017/S0033583503003913; Gray HB, 2005, P NATL ACAD SCI USA, V102, P3534, DOI 10.1073/pnas.0408029102; HARRIMAN A, 1987, J PHYS CHEM-US, V91, P6102, DOI 10.1021/j100308a011; Kobayashi C, 2003, J CHEM PHYS, V119, P3550, DOI 10.1063/1.1588293; LANGEN R, 1995, SCIENCE, V268, P1733, DOI 10.1126/science.7792598; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Prytkova TR, 2007, SCIENCE, V315, P622, DOI 10.1126/science.1134862; REGAN JJ, 1995, CHEM BIOL, V2, P489, DOI 10.1016/1074-5521(95)90266-X; Sjoberg BM, 1997, STRUCT BOND, V88, P139; Skourtis SS, 2005, P NATL ACAD SCI USA, V102, P3552, DOI 10.1073/pnas.0409047102; Skov LK, 1998, J AM CHEM SOC, V120, P1102, DOI 10.1021/ja972540a; SOLAR S, 1991, J PHYS CHEM-US, V95, P3639, DOI 10.1021/j100162a038; Stubbe J, 2003, CHEM REV, V103, P2167, DOI 10.1021/cr020421u; Stubbe J, 1998, CHEM REV, V98, P705, DOI 10.1021/cr9400875; Stuchebrukhov AA, 1996, J CHEM PHYS, V105, P10819, DOI 10.1063/1.472890; Tommos C, 2000, BBA-BIOENERGETICS, V1458, P199, DOI 10.1016/S0005-2728(00)00069-4; Winkler JR, 1999, PURE APPL CHEM, V71, P1753, DOI 10.1351/pac199971091753	28	344	348	1	188	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2008	320	5884					1760	1762		10.1126/science.1158241	http://dx.doi.org/10.1126/science.1158241			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318VP	18583608				2022-12-28	WOS:000257121200034
J	Warren, SC; Messina, LC; Slaughter, LS; Kamperman, M; Zhou, Q; Gruner, SM; DiSalvo, FJ; Wiesner, U				Warren, Scott C.; Messina, Lauren C.; Slaughter, Liane S.; Kamperman, Marleen; Zhou, Qin; Gruner, Sol M.; DiSalvo, Francis J.; Wiesner, Ulrich			Ordered mesoporous materials from metal nanoparticle-block copolymer self-assembly	SCIENCE			English	Article							POLYMER COMPOSITES; NANOCLUSTERS; FABRICATION; TRANSITION; SILICA; CARBON; ROUTE; PORES	The synthesis of ordered mesoporous metal composites and ordered mesoporous metals is a challenge because metals have high surface energies that favor low surface areas. We present results from the self- assembly of block copolymers with ligand- stabilized platinum nanoparticles, leading to lamellar CCM- Pt- 4 and inverse hexagonal ( CCM- Pt- 6) hybrid mesostructures with high nanoparticle loadings. Pyrolysis of the CCM- Pt- 6 hybrid produces an ordered mesoporous platinum- carbon nanocomposite with open and large pores (>= 10 nanometers). Removal of the carbon leads to ordered porous platinum mesostructures. The platinum- carbon nanocomposite has very high electrical conductivity ( 400 siemens per centimeter) for an ordered mesoporous material fabricated from block copolymer self- assembly.	[Warren, Scott C.; Kamperman, Marleen; Wiesner, Ulrich] Cornell Univ, Dept Mat Sci & Engn, Ithaca, NY 14853 USA; [Warren, Scott C.; Messina, Lauren C.; Slaughter, Liane S.; Zhou, Qin; DiSalvo, Francis J.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Gruner, Sol M.] Cornell Univ, Dept Phys, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University	Wiesner, U (corresponding author), Cornell Univ, Dept Mat Sci & Engn, Ithaca, NY 14853 USA.	ubw1@cornell.edu	Kamperman, Marleen/O-1810-2016; Gruner, Sol/G-2924-2010; Warren, Scott/B-8749-2013	Kamperman, Marleen/0000-0002-0520-4534; Gruner, Sol/0000-0002-1171-4426; Slaughter, Liane/0000-0001-9251-775X; Warren, Scott/0000-0002-2883-0204				Attard GS, 1997, ANGEW CHEM INT EDIT, V36, P1315, DOI 10.1002/anie.199713151; Balazs AC, 2006, SCIENCE, V314, P1107, DOI 10.1126/science.1130557; BUFFAT P, 1976, PHYS REV A, V13, P2287, DOI 10.1103/PhysRevA.13.2287; Chai J, 2007, NAT NANOTECHNOL, V2, P500, DOI 10.1038/nnano.2007.227; CHAN YNC, 1992, CHEM MATER, V4, P24, DOI 10.1021/cm00019a010; Creutz S, 1997, MACROMOLECULES, V30, P6, DOI 10.1021/ma961009h; Davis ME, 2002, NATURE, V417, P813, DOI 10.1038/nature00785; DELAMARCHE E, 1994, LANGMUIR, V10, P4103, DOI 10.1021/la00023a033; Erlebacher J, 2001, NATURE, V410, P450, DOI 10.1038/35068529; Ferrari AC, 2000, PHYS REV B, V61, P14095, DOI 10.1103/PhysRevB.61.14095; Fogg DE, 1997, MACROMOLECULES, V30, P417, DOI 10.1021/ma961103y; Haryono A, 2006, SMALL, V2, P600, DOI 10.1002/smll.200500474; Hostetler MJ, 1999, LANGMUIR, V15, P3782, DOI 10.1021/la981598f; Jiang JH, 2004, CHEM MATER, V16, P1362, DOI 10.1021/cm035237j; Kim BJ, 2007, LANGMUIR, V23, P7804, DOI 10.1021/la700507j; Kim BJ, 2006, MACROMOLECULES, V39, P4108, DOI 10.1021/ma060308w; Lee J, 2008, NAT MATER, V7, P222, DOI 10.1038/nmat2111; LI R, 1992, PHYS REV LETT, V68, P1168, DOI 10.1103/PhysRevLett.68.1168; Liang CD, 2004, ANGEW CHEM INT EDIT, V43, P5785, DOI 10.1002/anie.200461051; Liu J, 1998, SCIENCE, V280, P1253, DOI 10.1126/science.280.5367.1253; Lopes WA, 2001, NATURE, V414, P735, DOI 10.1038/414735a; Raney M., 1927, US Pat., Patent No. [1628190A, 1628190, 1,628,190]; Sivaramakrishnan S, 2007, NAT MATER, V6, P149, DOI 10.1038/nmat1806; Templin M, 1997, SCIENCE, V278, P1795, DOI 10.1126/science.278.5344.1795; Thompson RB, 2001, SCIENCE, V292, P2469, DOI 10.1126/science.1060585; Warren SC, 2007, NAT MATER, V6, P156, DOI 10.1038/nmat1819; Warren SC, 2006, J AM CHEM SOC, V128, P12074, DOI 10.1021/ja064469r; Yamauchi Y, 2004, J MATER CHEM, V14, P2935, DOI 10.1039/b406265e; Zhao DY, 1998, SCIENCE, V279, P548, DOI 10.1126/science.279.5350.548	29	500	516	10	595	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2008	320	5884					1748	1752		10.1126/science.1159950	http://dx.doi.org/10.1126/science.1159950			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318VP	18583606				2022-12-28	WOS:000257121200031
J	Hunter, DJ; Altshuler, D; Rader, DJ				Hunter, David J.; Altshuler, David; Rader, Daniel J.			From Darwin's finches to canaries in the coal mine - Mining the genome for new biology	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							LOCI		[Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Altshuler, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Altshuler, David] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Altshuler, David] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Rader, Daniel J.] Univ Penn, Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of Pennsylvania; Pennsylvania Medicine	Hunter, DJ (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.		Altshuler, David M/A-4476-2009	Altshuler, David M/0000-0002-7250-4107				Katan MB, 2004, INT J EPIDEMIOL, V33, P10, DOI 10.1093/ije/dyh023; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	5	63	66	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 26	2008	358	26					2760	2763		10.1056/NEJMp0804318	http://dx.doi.org/10.1056/NEJMp0804318			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	317UO	18579810				2022-12-28	WOS:000257045900002
J	Green, BB; Cook, AJ; Ralston, JD; Fishman, PA; Catz, SL; Carlson, J; Carrell, D; Tyll, L; Larson, EB; Thompson, RS				Green, Beverly B.; Cook, Andrea J.; Ralston, James D.; Fishman, Paul A.; Catz, Sheryl L.; Carlson, James; Carrell, David; Tyll, Lynda; Larson, Eric B.; Thompson, Robert S.			Effectiveness of home blood pressure monitoring, Web communication, and pharmacist care on hypertension control - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY IMPROVEMENT STRATEGIES; UNITED-STATES; METAANALYSIS; MANAGEMENT; SOCIETY; BURDEN	Context Treating hypertension decreases mortality and disability from cardiovascular disease, but most hypertension remains inadequately controlled. Objective To determine if a new model of care that uses patient Web services, home blood pressure ( BP) monitoring, and pharmacist- assisted care improves BP control. Design, Setting, and Participants A 3- group randomized controlled trial, the Electronic Communications and Home Blood Pressure Monitoring study was based on the Chronic Care Model. The trial was conducted at an integrated group practice in Washington state, enrolling 778 participants aged 25 to 75 years with uncontrolled essential hypertension and Internet access. Care was delivered over a secure patient Web site from June 2005 to December 2007. Interventions Participants were randomly assigned to usual care, home BP monitoring and secure patient Web site training only, or home BP monitoring and secure patient Web site training plus pharmacist care management delivered through Web communications. Main Outcome Measures Percentage of patients with controlled BP ( < 140/90 mm Hg) and changes in systolic and diastolic BP at 12 months. Results Of 778 patients, 730 ( 94%) completed the 1- year follow- up visit. Patients assigned to the home BP monitoring and Web training only group had a nonsignificant increase in the percentage of patients with controlled BP ( < 140/90 mm Hg) compared with usual care ( 36% [ 95% confidence interval {CI}, 30%- 42%] vs 31% [ 95% CI, 25%-37%]; P=. 21). Adding Web- based pharmacist care to home BP monitoring and Web training significantly increased the percentage of patients with controlled BP ( 56%; 95% CI, 49%- 62%) compared with usual care ( P <. 001) and home BP monitoring and Web training only ( P <. 001). Systolic BP was decreased stepwise from usual care to home BP monitoring and Web training only to home BP monitoring and Web training plus pharmacist care. Diastolic BP was decreased only in the pharmacist care group compared with both the usual care and home BP monitoring and Web training only groups. Compared with usual care, the patients who had baseline systolic BP of 160 mm Hg or higher and received home BP monitoring and Web training plus pharmacist care had a greater net reduction in systolic BP (- 13.2 mm Hg [ 95% CI, - 19.2 to - 7.1]; P <. 001) and diastolic BP (- 4.6 mm Hg [ 95% CI, - 8.0 to - 1.2]; P <. 001), and improved BP control ( relative risk, 3.32 [ 95% CI, 1.86 to 5.94]; P <. 001). Conclusion Pharmacist care management delivered through secure patient Web communications improved BP control in patients with hypertension. Trial Registration clinicaltrials. gov Identifier: NCT00158639.	[Green, Beverly B.; Larson, Eric B.; Thompson, Robert S.] Grp Hlth Ctr Hlth Studies, Seattle, WA 98110 USA; [Green, Beverly B.; Ralston, James D.; Carlson, James; Thompson, Robert S.] Grp Hlth Cooperat Puget Sound, Seattle, WA 98121 USA; [Green, Beverly B.; Larson, Eric B.; Thompson, Robert S.] Univ Washington, Sch Med, Seattle, WA USA; [Ralston, James D.; Fishman, Paul A.; Larson, Eric B.] Univ Washington, Sch Publ Hlth & Community Med, Seattle, WA 98195 USA; [Cook, Andrea J.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA	Group Health Cooperative; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Green, BB (corresponding author), Grp Hlth Ctr Hlth Studies, 1730 Minor Ave,Ste 1600, Seattle, WA 98110 USA.	green.b@ghc.org			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075263] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adler KG, 2006, J MED INTERNET RES, V8, DOI 10.2196/jmir.8.4.e26; [Anonymous], 2001, CROSSING QUALITY CHA, DOI DOI 10.17226/10027; Baguet JP, 2002, BLOOD PRESS MONIT, V7, P55, DOI 10.1097/00126097-200202000-00011; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P2469, DOI 10.1001/jama.288.19.2469; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1909, DOI 10.1001/jama.288.15.1909; Cappuccio FP, 2004, BMJ-BRIT MED J, V329, P145, DOI 10.1136/bmj.38121.684410.AE; CARRELL D, 2005, P AM INF ASS ANN SES; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Coleman A, 2006, BLOOD PRESS MONIT, V11, P27, DOI 10.1097/01.mbp.0000189788.05736.5f; *CONS ASS HEALTHC, CAHPS HLTH PLAN SURV; Cote Isabelle, 2004, Can J Clin Pharmacol, V11, pe232; Fahey T, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005182.pub3; Farivar SS, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-54; Fields LE, 2004, HYPERTENSION, V44, P398, DOI 10.1161/01.HYP.0000142248.54761.56; Fienberg S.E., 1980, ANAL CROSS CLASSIFIE, V2nd ed.; Green BB, 2003, AM J MANAG CARE, V9, P219; Green BB, 2008, CONTEMP CLIN TRIALS, V29, P376, DOI 10.1016/j.cct.2007.09.005; GREENFIELD S, 1985, ANN INTERN MED, V102, P520, DOI 10.7326/0003-4819-102-4-520; GREENFIELD S, 1988, J GEN INTERN MED, V3, P448, DOI 10.1007/BF02595921; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.199; Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; LEVIN JR, 1994, PSYCHOL BULL, V115, P153, DOI 10.1037/0033-2909.115.1.153; Little P, 2002, BMJ-BRIT MED J, V325, P254, DOI 10.1136/bmj.325.7358.254; Lloyd-Jones DM, 2005, JAMA-J AM MED ASSOC, V294, P466, DOI 10.1001/jama.294.4.466; Mancia G, 2002, ARCH INTERN MED, V162, P582, DOI 10.1001/archinte.162.5.582; MARCUS BH, 1992, RES Q EXERCISE SPORT, V63, P60, DOI 10.1080/02701367.1992.10607557; McNeill LH, 2007, J MED INTERNET RES, V9, DOI 10.2196/jmir.9.4.e35; *NAT COMM QUAL ASS, 2007, STAT HLTH CAR QUAL 2; O'Brien E, 2001, BMJ-BRIT MED J, V322, P531, DOI 10.1136/bmj.322.7285.531; *PEW INT AM LIF PR, 2006, DEM INT US; PIEGORSCH WW, 1991, BIOMETRICS, V47, P45, DOI 10.2307/2532494; R Development Core Team, 2007, R LANG ENV STAT COMP; Ralston JD, 2007, J AM MED INFORM ASSN, V14, P798, DOI 10.1197/jamia.M2302; ROSNER B, 1979, J CHRON DIS, V32, P451, DOI 10.1016/0021-9681(79)90105-X; Searle S.R., 1971, LINEAR MODELS; SEBER GAF, 2007, LINEAR REGRESSION AN; Staessen JA, 2000, OCCUP ENVIRON MED, V57, P510, DOI 10.1136/oem.57.8.510; Tsai AC, 2005, AM J MANAG CARE, V11, P478; Verberk WJ, 2005, J AM COLL CARDIOL, V46, P743, DOI 10.1016/j.jacc.2005.05.058; Wagner E H, 1996, Manag Care Q, V4, P12; Walsh JME, 2008, J CLIN HYPERTENS, V10, P311, DOI 10.1111/j.1751-7176.2008.07425.x; Walsh JME, 2006, MED CARE, V44, P646, DOI 10.1097/01.mlr.0000220260.30768.32; Wang TJ, 2005, CIRCULATION, V112, P1651, DOI 10.1161/CIRCULATIONAHA.104.490599; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	45	448	462	4	32	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 25	2008	299	24					2857	2867		10.1001/jama.299.24.2857	http://dx.doi.org/10.1001/jama.299.24.2857			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	317LN	18577730	Green Accepted			2022-12-28	WOS:000257021800023
J	De Cock, KM; De Lay, P				De Cock, Kevin M.; De Lay, Paul			HIV/AIDS estimates and the quest for universal access	LANCET			English	Editorial Material									[De Cock, Kevin M.] WHO, Dept HIV AIDS, CH-1211 Geneva, Switzerland; [De Lay, Paul] UNAIDS, Dept Evidence Monitoring & Policy, Geneva, Switzerland	World Health Organization; UNAIDS	De Cock, KM (corresponding author), WHO, Dept HIV AIDS, CH-1211 Geneva, Switzerland.	DecockK@who.int						[Anonymous], UN ACC SCAL UP PRIOR; *G8 GLEN SUMM, 2005, CHAIRS SUMM GLEN SUM; LAWRENCE J, 2008, INDEPENDENT     0608; *UN GEN ASS, 2008, IMPL DECL COMM HIV A	4	15	15	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 21	2008	371	9630					2068	2070		10.1016/S0140-6736(08)60732-1	http://dx.doi.org/10.1016/S0140-6736(08)60732-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	316ER	18571714				2022-12-28	WOS:000256932200010
J	Bettelli, E; Korn, T; Oukka, M; Kuchroo, VK				Bettelli, Estelle; Korn, Thomas; Oukka, Mohamed; Kuchroo, Vijay K.			Induction and effector functions of T(H)17 cells	NATURE			English	Review							GROWTH-FACTOR-BETA; CD4 T-CELLS; TGF-BETA; CUTTING EDGE; TH17 CELLS; AUTOIMMUNE ENCEPHALOMYELITIS; HETERODIMERIC CYTOKINE; CHRONIC INFLAMMATION; INDUCIBLE FACTOR; FAMILY-MEMBERS	T helper (T-H) cells constitute an important arm of the adaptive immune system because they coordinate defence against specific pathogens, and their unique cytokines and effector functions mediate different types of tissue inflammation. The recently discovered T(H)17 cells, the third subset of effector T helper cells, have been the subject of intense research aimed at understanding their role in immunity and disease. Here we review emerging data suggesting that T(H)17 cells have an important role in host defence against specific pathogens and are potent inducers of autoimmunity and tissue inflammation. In addition, the differentiation factors responsible for their generation have revealed an interesting reciprocal relationship with regulatory T (T-reg) cells, which prevent tissue inflammation and mediate self-tolerance.	[Bettelli, Estelle; Korn, Thomas; Oukka, Mohamed; Kuchroo, Vijay K.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Kuchroo, VK (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA.	vkuchroo@rics.bwh.harvard.edu	Korn, Thomas/AAE-6960-2019	Korn, Thomas/0000-0002-3633-0955	NIAID NIH HHS [R01 AI073542-01, R01 AI073542, R01 AI073542-02] Funding Source: Medline; NINDS NIH HHS [R01 NS059996] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059996] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Antov A, 2003, J IMMUNOL, V171, P3435, DOI 10.4049/jimmunol.171.7.3435; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Becher B, 2002, J CLIN INVEST, V110, P493, DOI 10.1172/JCI200215751; BENNUN A, 1981, EUR J IMMUNOL, V11, P195, DOI 10.1002/eji.1830110307; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chabaud M, 1999, ARTHRITIS RHEUM-US, V42, P963, DOI 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E; Chang SH, 2007, CELL RES, V17, P435, DOI 10.1038/cr.2007.35; Charlton B, 1995, CURR OPIN IMMUNOL, V7, P793, DOI 10.1016/0952-7915(95)80050-6; Chen Z, 2007, ARTHRITIS RHEUM-US, V56, P2936, DOI 10.1002/art.22866; Chen Z, 2006, P NATL ACAD SCI USA, V103, P8137, DOI 10.1073/pnas.0600666103; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Chung DR, 2003, J IMMUNOL, V170, P1958, DOI 10.4049/jimmunol.170.4.1958; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Coquet JM, 2007, J IMMUNOL, V178, P2827, DOI 10.4049/jimmunol.178.5.2827; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Du JG, 2008, J IMMUNOL, V180, P4785, DOI 10.4049/jimmunol.180.7.4785; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Dumoutier L, 2000, P NATL ACAD SCI USA, V97, P10144, DOI 10.1073/pnas.170291697; Evans HG, 2007, P NATL ACAD SCI USA, V104, P17034, DOI 10.1073/pnas.0708426104; Ferber IA, 1996, J IMMUNOL, V156, P5; Ferretti S, 2003, J IMMUNOL, V170, P2106, DOI 10.4049/jimmunol.170.4.2106; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Gunimaladevi I, 2006, FISH SHELLFISH IMMUN, V21, P393, DOI 10.1016/j.fsi.2006.01.004; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; Hurst SD, 2002, J IMMUNOL, V169, P443, DOI 10.4049/jimmunol.169.1.443; Hymowitz SG, 2001, EMBO J, V20, P5332, DOI 10.1093/emboj/20.19.5332; Infante-Duarte C, 2000, J IMMUNOL, V165, P6107, DOI 10.4049/jimmunol.165.11.6107; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kleinschek MA, 2007, J EXP MED, V204, P161, DOI 10.1084/jem.20061738; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kotenko SV, 2001, J BIOL CHEM, V276, P2725, DOI 10.1074/jbc.M007837200; Kuestner RE, 2007, J IMMUNOL, V179, P5462, DOI 10.4049/jimmunol.179.8.5462; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Leonard WJ, 2005, NAT REV IMMUNOL, V5, P688, DOI 10.1038/nri1688; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Liang SC, 2007, J IMMUNOL, V179, P7791, DOI 10.4049/jimmunol.179.11.7791; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Liu SJ, 2007, J LEUKOCYTE BIOL, V82, P354, DOI 10.1189/jlb.0207111; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; Lohr J, 2006, J EXP MED, V203, P2785, DOI 10.1084/jem.20061341; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Martel-Pelletier J, 1999, ARTHRITIS RHEUM-US, V42, P2399, DOI 10.1002/1529-0131(199911)42:11<2399::AID-ANR19>3.0.CO;2-Y; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Molet S, 2001, J ALLERGY CLIN IMMUN, V108, P430, DOI 10.1067/mai.2001.117929; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Parrish-Novak J, 2000, NATURE, V408, P57, DOI 10.1038/35040504; Pelletier M, 2004, J IMMUNOL, V173, P7521, DOI 10.4049/jimmunol.173.12.7521; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; Sato W, 2007, J IMMUNOL, V178, P7525, DOI 10.4049/jimmunol.178.12.7525; Spolski R, 2008, ANNU REV IMMUNOL, V26, P57, DOI 10.1146/annurev.immunol.26.021607.090316; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Starnes T, 2001, J IMMUNOL, V167, P4137, DOI 10.4049/jimmunol.167.8.4137; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; TAKESHITA T, 1992, SCIENCE, V257, P379, DOI 10.1126/science.1631559; Toy D, 2006, J IMMUNOL, V177, P36, DOI 10.4049/jimmunol.177.1.36; Uhlig HH, 2006, IMMUNITY, V25, P309, DOI 10.1016/j.immuni.2006.05.017; van Beelen AJ, 2007, IMMUNITY, V27, P660, DOI 10.1016/j.immuni.2007.08.013; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2006, CYTOKINE GROWTH F R, V17, P367, DOI 10.1016/j.cytogfr.2006.09.001; YANG L, 2008, NATURE          0511, DOI DOI 10.1038/NATURE07021; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Yao ZB, 1995, IMMUNITY, V3, P811, DOI 10.1016/1074-7613(95)90070-5; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023; Zeng R, 2005, J EXP MED, V201, P139, DOI 10.1084/jem.20041057; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; Zhou Q, 2005, INFECT IMMUN, V73, P935, DOI 10.1128/IAI.73.2.935-943.2005	100	944	1042	1	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2008	453	7198					1051	1057		10.1038/nature07036	http://dx.doi.org/10.1038/nature07036			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314WM	18563156	Green Accepted			2022-12-28	WOS:000256839900047
J	Williams, B; Lindholm, LH; Sever, P				Williams, Bryan; Lindholm, Lars H.; Sever, Peter			Systolic pressure is all that matters	LANCET			English	Editorial Material							NUTRITION EXAMINATION SURVEY; DIASTOLIC BLOOD-PRESSURE; GLOBAL BURDEN; NATIONAL-HEALTH; HYPERTENSION; DISEASE; POPULATION; MORTALITY; AGE		[Williams, Bryan] Univ Leicester, Leicester Royal Infirm, Dept Cardiovasc Sci, Leicester LE2 7LX, Leics, England; [Lindholm, Lars H.] Umea Univ Hosp, Dept Publ Hlth & Clin Med, S-90185 Umea, Sweden; [Sever, Peter] Univ London Imperial Coll Sci Technol & Med, Int Ctr Circulatory Hlth, London, England	University of Leicester; Umea University; Imperial College London	Williams, B (corresponding author), Univ Leicester, Leicester Royal Infirm, Dept Cardiovasc Sci, Clin Sci Bldg,POB 65, Leicester LE2 7LX, Leics, England.	bw17@le.ac.uk		Williams, Bryan/0000-0002-8094-1841				Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; [Anonymous], 1991, JAMA, V265, P3255; Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; DAHLOF B, 1991, LANCET, V338, P1281, DOI 10.1016/0140-6736(91)92589-T; Fagard RH, 2007, ARCH INTERN MED, V167, P1884, DOI 10.1001/archinte.167.17.1884; Franklin SS, 2001, HYPERTENSION, V37, P869, DOI 10.1161/01.HYP.37.3.869; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Higgins B, 2007, CLIN MED, V7, P612, DOI 10.7861/clinmedicine.7-6-612; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Lawes CMM, 2006, J HYPERTENS, V24, P413, DOI 10.1097/01.hjh.0000199801.72563.6f; Lawes CMM, 2003, HYPERTENSION, V42, P69, DOI 10.1161/01.HYP.0000075083.04415.4B; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; MacMahon S, 2008, LANCET, V371, P1480, DOI 10.1016/S0140-6736(08)60632-7; Mancia G, 2002, J HYPERTENS, V20, P1461, DOI 10.1097/00004872-200208000-00001; Mancia G, 2007, J HYPERTENS, V25, P1105, DOI 10.1097/01.hjh.0000280180.80455.83; OROURKE M, 1995, HYPERTENSION, V26, P2, DOI 10.1161/01.HYP.26.1.2; Sever P, 1999, BRIT MED J, V318, P1773, DOI 10.1136/bmj.318.7200.1773; STAMLER J, 1993, ARCH INTERN MED, V153, P598, DOI 10.1001/archinte.153.5.598; Vasan RS, 2001, NEW ENGL J MED, V345, P1291, DOI 10.1056/NEJMoa003417; Waeber B, 2006, AM J HYPERTENS, V19, P985, DOI 10.1016/j.amjhyper.2006.03.012; Yambe M, 2007, J HYPERTENS, V25, P87, DOI 10.1097/01.hjh.0000254375.73241.e2	24	149	155	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN-JUL	2008	371	9631					2219	2221		10.1016/S0140-6736(08)60804-1	http://dx.doi.org/10.1016/S0140-6736(08)60804-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	326CP	18561995				2022-12-28	WOS:000257635800029
J	Johnson, F; Cooke, L; Croker, H; Wardle, J				Johnson, F.; Cooke, L.; Croker, H.; Wardle, Jane			Changing perceptions of weight in Great Britain: comparison of two population surveys	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PARENTAL PERCEPTIONS; OVERWEIGHT; ATTITUDES; CHILDREN; OBESITY	Objectives To examine changes in public perceptions of overweight in Great Britain over an eight year period. Design Comparison of data on self perceived weight from population surveys in 1999 and 2007. Setting Household surveys of two representative samples in Great Britain. Participants 853 men and 944 women in 1999, and 847 men and 989 women in 2007. Main outcome measures Participants were asked to report their weight and height and classify their body size on a scale from "very underweight" to "obese." Results Self reported weights increased dramatically over time, but the weight at which individuals perceived themselves to be overweight also rose significantly. In 1999, 81% of overweight participants correctly identified themselves as overweight compared with 75% in 2007, demonstrating a decrease in sensitivity in the self diagnosis of overweight. Conclusions Despite media and health campaigns aiming to raise awareness of healthy weight, increasing numbers of overweight people fail to recognise that their weight is a cause for concern. This makes it less likely that they will see calls for weight control as personally relevant.	[Johnson, F.; Cooke, L.; Croker, H.; Wardle, Jane] UCL, Dept Epidemiol & Publ Hlth, Canc Res UK Hlth Behav Res Ctr, London WC1E 6BT, England	Cancer Research UK; University of London; University College London	Wardle, J (corresponding author), UCL, Dept Epidemiol & Publ Hlth, Canc Res UK Hlth Behav Res Ctr, Mortimer St, London WC1E 6BT, England.	j.wardle@ucl.ac.uk	Johnson, Fiona/F-1305-2014; Croker, Helen/M-9591-2019	Johnson, Fiona/0000-0002-4271-1834; Croker, Helen/0000-0002-7247-6599	Cancer Research UK; Economic and Social Research Council	Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	Cancer Research UK and the Economic and Social Research Council.	ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; CAMERON R, 1990, BEHAV ASSESS, V12, P91; Carnell S, 2005, INT J OBESITY, V29, P353, DOI 10.1038/sj.ijo.0802889; CASPER RC, 1990, PEDIATRICS, V86, P384; CONNORGREENE PA, 1988, WOMEN HEALTH, V14, P27, DOI 10.1300/J013v14n02_03; Crawford D, 1999, INT J OBESITY, V23, P738, DOI 10.1038/sj.ijo.0800922; Currin L, 2005, BRIT J PSYCHIAT, V186, P132, DOI 10.1192/bjp.186.2.132; Eckstein KC, 2006, PEDIATRICS, V117, P681, DOI 10.1542/peds.2005-0910; Evans WD, 2006, SOC MARK Q, V12, P19, DOI 10.1080/15245000600993086; Foresight, 2007, TACKL OB FUT CHOIC P; Hirani V, 2008, PUBLIC HEALTH NUTR, V11, P521, DOI 10.1017/S1368980007000845; *IFIC, 2005, FOOD THOUGHT, V6; Jeffery AN, 2005, BRIT MED J, V330, P23, DOI 10.1136/bmj.38315.451539.F7; Michie Susan, 2007, Psychol Health Med, V12, P521, DOI 10.1080/13548500701203441; Miller JC, 2007, OBESITY, V15, P165, DOI 10.1038/oby.2007.558; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Paeratakul S, 2002, OBES RES, V10, P345, DOI 10.1038/oby.2002.48; ROBERTS RJ, 1995, PUBLIC HEALTH, V109, P275, DOI 10.1016/S0033-3506(95)80205-3; RODIN J, 1993, ANN INTERN MED, V119, P643, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00003; Sciacca J P, 1991, J Community Health, V16, P159, DOI 10.1007/BF01323974; Wardle J, 2006, INT J OBESITY, V30, P644, DOI 10.1038/sj.ijo.0803050; Wardle J, 2004, HEALTH PSYCHOL, V23, P275, DOI 10.1037/0278-6133.23.3.275; WARDLE J, 1990, J PSYCHOSOM RES, V34, P377, DOI 10.1016/0022-3999(90)90061-8; Wardle J, 2002, INT J OBESITY, V26, P1144, DOI 10.1038/sj.ijo.0802046; Warin M, 2008, SOCIOL HEALTH ILL, V30, P97, DOI 10.1111/j.1467-9566.2007.01029.x	25	115	117	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 2	2008	337	7664							a494	10.1136/bmj.a494	http://dx.doi.org/10.1136/bmj.a494			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	339EN	18617488	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000258561000027
J	Herry, C; Ciocchi, S; Senn, V; Demmou, L; Muller, C; Luthi, A				Herry, Cyril; Ciocchi, Stephane; Senn, Verena; Demmou, Lynda; Mueller, Christian; Luethi, Andreas			Switching on and off fear by distinct neuronal circuits	NATURE			English	Article							HIPPOCAMPAL INACTIVATION DISRUPTS; MEDIAL PREFRONTAL CORTEX; LATERAL AMYGDALA NEURONS; BASOLATERAL AMYGDALA; EXTINCTION; MEMORY; RESPONSES; CONTEXT; ACQUISITION; MODULATION	Switching between exploratory and defensive behaviour is fundamental to survival of many animals, but how this transition is achieved by specific neuronal circuits is not known. Here, using the converse behavioural states of fear extinction and its context- dependent renewal as a model in mice, we show that bi- directional transitions between states of high and low fear are triggered by a rapid switch in the balance of activity between two distinct populations of basal amygdala neurons. These two populations are integrated into discrete neuronal circuits differentially connected with the hippocampus and the medial prefrontal cortex. Targeted and reversible neuronal inactivation of the basal amygdala prevents behavioural changes without affecting memory or expression of behaviour. Our findings indicate that switching between distinct behavioural states can be triggered by selective activation of specific neuronal circuits integrating sensory and contextual information. These observations provide a new framework for understanding context- dependent changes of fear behaviour.	[Herry, Cyril; Ciocchi, Stephane; Senn, Verena; Demmou, Lynda; Mueller, Christian; Luethi, Andreas] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Luthi, A (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	cyril.herry@fmi.ch; andreas.luthi@fmi.ch	Herry, Cyril/AAP-9902-2020	Herry, Cyril/0000-0003-2973-0843; Ciocchi, Stephane/0000-0002-5701-9250				Amorapanth P, 2000, NAT NEUROSCI, V3, P74, DOI 10.1038/71145; Anglada-Figueroa D, 2005, J NEUROSCI, V25, P9680, DOI 10.1523/JNEUROSCI.2600-05.2005; Berretta S, 2005, NEUROSCIENCE, V132, P943, DOI 10.1016/j.neuroscience.2005.01.020; Bouton ME, 2006, BIOL PSYCHIAT, V60, P352, DOI 10.1016/j.biopsych.2005.12.015; Bouton ME, 2002, BIOL PSYCHIAT, V52, P976, DOI 10.1016/S0006-3223(02)01546-9; Collins DR, 2000, LEARN MEMORY, V7, P97, DOI 10.1101/lm.7.2.97; Corcoran KA, 2005, J NEUROSCI, V25, P8978, DOI 10.1523/JNEUROSCI.2246-05.2005; Corcoran KA, 2001, J NEUROSCI, V21, P1720, DOI 10.1523/JNEUROSCI.21-05-01720.2001; FALLS WA, 1992, J NEUROSCI, V12, P854; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Gallistel CR, 2004, P NATL ACAD SCI USA, V101, P13124, DOI 10.1073/pnas.0404965101; Goosens KA, 2003, NEURON, V40, P1013, DOI 10.1016/S0896-6273(03)00728-1; Goosens KA, 2001, LEARN MEMORY, V8, P148, DOI 10.1101/lm.37601; Herry C, 2004, EUR J NEUROSCI, V20, P781, DOI 10.1111/j.1460-9568.2004.03542.x; Herry C, 2002, J NEUROSCI, V22, P577, DOI 10.1523/JNEUROSCI.22-02-00577.2002; Herry C, 2007, J NEUROSCI, V27, P5958, DOI 10.1523/JNEUROSCI.5218-06.2007; Herry C, 2006, EUR J NEUROSCI, V24, P261, DOI 10.1111/j.1460-9568.2006.04893.x; Hobin JA, 2006, HIPPOCAMPUS, V16, P174, DOI 10.1002/hipo.20144; Jackson A, 2007, J NEUROPHYSIOL, V98, P3109, DOI 10.1152/jn.00569.2007; Jing J, 2000, J NEUROPHYSIOL, V83, P1346, DOI 10.1152/jn.2000.83.3.1346; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Likhtik E, 2006, J NEUROPHYSIOL, V96, P3257, DOI 10.1152/jn.00577.2006; Lu KT, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0005.2001; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; MAREN S, 1991, BRAIN RES, V549, P311, DOI 10.1016/0006-8993(91)90473-9; McDonald AJ, 1996, NEUROSCIENCE, V71, P55, DOI 10.1016/0306-4522(95)00417-3; MCDONALD AJ, 1991, NEUROSCIENCE, V44, P1, DOI 10.1016/0306-4522(91)90247-L; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; Milad MR, 2005, PSYCHOPHYSIOLOGY, V42, P456, DOI 10.1111/j.1469-8986.2005.00302.x; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; MURAMOTO K, 1993, NEUROSCIENCE, V52, P621, DOI 10.1016/0306-4522(93)90411-8; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; Nader K, 2001, LEARN MEMORY, V8, P156, DOI 10.1101/lm.38101; Nicolelis MAL, 2003, P NATL ACAD SCI USA, V100, P11041, DOI 10.1073/pnas.1934665100; Pare D, 2003, PROG NEUROBIOL, V70, P409, DOI 10.1016/S0301-0082(03)00104-7; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; Paz R, 2006, NAT NEUROSCI, V9, P1321, DOI 10.1038/nn1771; Pitkanen A, 2000, ANN NY ACAD SCI, V911, P369; Quirk GJ, 2000, J NEUROSCI, V20, P6225, DOI 10.1523/JNEUROSCI.20-16-06225.2000; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; Quirk GJ, 2006, BIOL PSYCHIAT, V60, P337, DOI 10.1016/j.biopsych.2006.03.010; Repa JC, 2001, NAT NEUROSCI, V4, P724, DOI 10.1038/89512; Rodriguez BI, 1999, BEHAV RES THER, V37, P845, DOI 10.1016/S0005-7967(98)00106-5; Rosenkranz JA, 2003, J NEUROSCI, V23, P11054; Rosenkranz JA, 2002, NATURE, V417, P282, DOI 10.1038/417282a; Sotres-Bayon F, 2004, LEARN MEMORY, V11, P525, DOI 10.1101/lm.79504; Sotres-Bayon F, 2007, NEUROPSYCHOPHARMACOL, V32, P1929, DOI 10.1038/sj.npp.1301316; Stalnaker TA, 2007, NAT NEUROSCI, V10, P949, DOI 10.1038/nn1931; Stalnaker TA, 2007, NEURON, V54, P51, DOI 10.1016/j.neuron.2007.02.014; Yapici N, 2008, NATURE, V451, P33, DOI 10.1038/nature06483	50	665	715	2	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 31	2008	454	7204					600	U28		10.1038/nature07166	http://dx.doi.org/10.1038/nature07166			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	331QC	18615015				2022-12-28	WOS:000258026500038
J	McColl, K				McColl, Karen			New York's road to health	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												karen@karenmccoll.co.uk						*AM NONSM RIGHTS, OV 50 AM COV 100 SMO; BLOOMBERG M, M BLOOMBERG COMMITS; BLOOMBERG M, MAYOR BLOOMBERG ACCE; Cookson R., 2008, BMJ-BRIT MED J, V337, pa589, DOI DOI 10.1136/BMJ.A589; *CTR EC OPP, 2007, OPP NYC FAM REW; Mozaffarian D, 2006, NEW ENGL J MED, V354, P1601, DOI 10.1056/NEJMra054035; *NEW YORK CITY DEP, BOARD HLTH APPR REG; Popay Jennie, 2008, BMJ, V337, pa594, DOI 10.1136/bmj.a594	8	8	8	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 19	2008	337	7662							a673	10.1136/bmj.a673	http://dx.doi.org/10.1136/bmj.a673			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	330SB	18614510	Green Published			2022-12-28	WOS:000257962000034
J	Fang, Y; Seong, NH; Dlott, DD				Fang, Ying; Seong, Nak-Hyun; Dlott, Dana D.			Measurement of the distribution of site enhancements in surface-enhanced Raman scattering	SCIENCE			English	Article							SPECTROSCOPY; RESONANCES; PLASMON; SPHERE	On nanotextured noble-metal surfaces, surface-enhanced Raman scattering (SERS) is observed, where Raman scattering is enhanced by a factor, G, that is frequently about one million, but underlying the factor (G) over bar is a broad distribution of local enhancement factors, eta. We have measured this distribution for benzenethiolate molecules on a 330-nanometer silver-coated nanosphere lattice using incident light of wavelength 532 nanometers. A series of laser pulses with increasing electric fields burned away molecules at sites with progressively decreasing electromagnetic enhancement factors. The enhancement distribution P(eta)d eta was found to be a power law proportional to ((eta))(-1.75), with minimum and maximum values of 2.8 x 10(4) and 4.1 x 10(10), respectively. The hottest sites (eta > 10(9)) account for just 63 in 1,000,000 of the total but contribute 24% to the overall SERS intensity.	[Fang, Ying; Seong, Nak-Hyun; Dlott, Dana D.] Univ Illinois, Sch Chem Sci, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Dlott, DD (corresponding author), Univ Illinois, Sch Chem Sci, Urbana, IL 61801 USA.	dlott@scs.uiuc.edu	Im, Hwon/B-5659-2012; Fang, Ying/A-2329-2012; Fang, Ying/C-9792-2011	Dlott, Dana/0000-0001-8719-7093				ARAVIND PK, 1983, SURF SCI, V124, P506, DOI 10.1016/0039-6028(83)90806-3; ARAVIND PK, 1982, J PHYS CHEM-US, V86, P5076, DOI 10.1021/j100223a007; ARAVIND PK, 1981, SURF SCI, V110, P189, DOI 10.1016/0039-6028(81)90595-1; Dieringer JA, 2007, J AM CHEM SOC, V129, P16249, DOI 10.1021/ja077243c; Etchegoin PG, 2007, PHYS CHEM CHEM PHYS, V9, P4923, DOI 10.1039/b706395d; FLEISCHMANN M, 1974, CHEM PHYS LETT, V26, P163, DOI 10.1016/0009-2614(74)85388-1; GUI JY, 1991, LANGMUIR, V7, P955, DOI 10.1021/la00053a024; Haynes CL, 2001, J PHYS CHEM B, V105, P5599, DOI 10.1021/jp010657m; JEANMAIRE DL, 1977, J ELECTROANAL CHEM, V84, P1, DOI 10.1016/S0022-0728(77)80224-6; Kneipp K, 1999, CHEM PHYS, V247, P155, DOI 10.1016/S0301-0104(99)00165-2; Krug JT, 1999, J AM CHEM SOC, V121, P9208, DOI 10.1021/ja992058n; Le Ru EC, 2007, J PHYS CHEM C, V111, P13794, DOI 10.1021/jp0687908; Le Ru EC, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2390694; Le Ru EC, 2006, CHEM PHYS LETT, V423, P63, DOI 10.1016/j.cplett.2006.03.042; LIVER N, 1984, CHEM PHYS LETT, V111, P449, DOI 10.1016/0009-2614(84)85539-6; McFarland AD, 2005, J PHYS CHEM B, V109, P11279, DOI 10.1021/jp050508u; Moskovits M, 2006, TOP APPL PHYS, V103, P1; Mukamel S., 1995, PRINCIPLES NONLINEAR, V1st; Natan MJ, 2006, FARADAY DISCUSS, V132, P321, DOI 10.1039/b601494c; PARSON W W, 2015, MODERN OPTICAL SPECT; Pettinger B, 2005, J RAMAN SPECTROSC, V36, P541, DOI 10.1002/jrs.1332; Schatz GC, 2006, TOP APPL PHYS, V103, P19; Stockman MI, 1997, PHYS REV E, V56, P6494, DOI 10.1103/PhysRevE.56.6494; Toyota K, 2000, CHEM PHYS LETT, V323, P323, DOI 10.1016/S0009-2614(00)00532-7; Willets KA, 2007, ANNU REV PHYS CHEM, V58, P267, DOI 10.1146/annurev.physchem.58.032806.104607; Xu HX, 2003, CHEMPHYSCHEM, V4, P1001, DOI 10.1002/cphc.200200544; Xu HX, 2000, PHYS REV E, V62, P4318, DOI 10.1103/PhysRevE.62.4318; Yonzon CR, 2007, SPECTROSCOPY-US, V22, P42; Zhang XY, 2006, J NANOSCI NANOTECHNO, V6, P1920, DOI 10.1166/jnn.2006.322; Zhang XY, 2005, J AM CHEM SOC, V127, P4484, DOI 10.1021/ja043623b	30	869	883	32	705	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2008	321	5887					388	392		10.1126/science.1159499	http://dx.doi.org/10.1126/science.1159499			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FB	18583578				2022-12-28	WOS:000257713900045
J	Burke, KA; Franz, TM; Miller, DN; Schoenbaum, G				Burke, Kathryn A.; Franz, Theresa M.; Miller, Danielle N.; Schoenbaum, Geoffrey			The role of the orbitofrontal cortex in the pursuit of happiness and more specific rewards	NATURE			English	Article							NUCLEUS-ACCUMBENS CORE; CONDITIONED REINFORCEMENT; UNCONDITIONED STIMULUS; BASOLATERAL AMYGDALA; D-AMPHETAMINE; LESIONS; REPRESENTATION; COMPLEX; DISSOCIATION; POTENTIATION	Cues that reliably predict rewards trigger the thoughts and emotions normally evoked by those rewards. Humans and other animals will work, often quite hard, for these cues. This is termed conditioned reinforcement. The ability to use conditioned reinforcers to guide our behaviour is normally beneficial; however, it can go awry. For example, corporate icons, such as McDonald's Golden Arches, influence consumer behaviour in powerful and sometimes surprising ways(1), and drug- associated cues trigger relapse to drug seeking in addicts and animals exposed to addictive drugs, even after abstinence or extinction(2,3). Yet, despite their prevalence, it is not known how conditioned reinforcers control human or other animal behaviour. One possibility is that they act through the use of the specific rewards they predict; alternatively, they could control behaviour directly by activating emotions that are independent of any specific reward. In other words, the Golden Arches may drive business because they evoke thoughts of hamburgers and fries, or instead, may be effective because they also evoke feelings of hunger or happiness. Moreover, different brain circuits could support conditioned reinforcement mediated by thoughts of specific outcomes versus more general affective information. Here we have attempted to address these questions in rats. Rats were trained to learn that different cues predicted different rewards using specialized conditioning procedures that controlled whether the cues evoked thoughts of specific outcomes or general affective representations common to different outcomes. Subsequently, these rats were given the opportunity to press levers to obtain short and otherwise unrewarded presentations of these cues. We found that rats were willing to work for cues that evoked either outcome- specific or general affective representations. Furthermore the orbitofrontal cortex, a prefrontal region important for adaptive decision-making(4), was critical for the former but not for the latter form of conditioned reinforcement.	[Franz, Theresa M.; Schoenbaum, Geoffrey] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Burke, Kathryn A.] Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA; [Schoenbaum, Geoffrey] Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA; [Miller, Danielle N.] Baltimore Polytech Inst, Ingenu Project, Baltimore, MD 21209 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Schoenbaum, G (corresponding author), Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA.	schoenbg@schoenbaumlab.org			NIDA NIH HHS [R01 DA015718, R01 DA015718-06A2] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015718] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		BALLEINE BW, 2005, SOC NEUR ABSTR, P7116; CADOR M, 1989, NEUROSCIENCE, V30, P77, DOI 10.1016/0306-4522(89)90354-0; Corbit LH, 2005, J NEUROSCI, V25, P962, DOI 10.1523/JNEUROSCI.4507-04.2005; Cousens GA, 2003, INTEGR PHYS BEH SCI, V38, P272, DOI 10.1007/BF02688858; Feierstein CE, 2006, NEURON, V51, P495, DOI 10.1016/j.neuron.2006.06.032; Gallagher M, 1999, J NEUROSCI, V19, P6610; GANESAN R, 1988, J EXP PSYCHOL ANIM B, V14, P280, DOI 10.1037/0097-7403.14.3.280; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Hall J, 2001, EUR J NEUROSCI, V13, P1984, DOI 10.1046/j.0953-816x.2001.01577.x; Izquierdo A, 2004, J NEUROSCI, V24, P7540, DOI 10.1523/JNEUROSCI.1921-04.2004; Murray EA, 2007, J NEUROSCI, V27, P8166, DOI 10.1523/JNEUROSCI.1556-07.2007; O'Brien CP, 2005, AM J PSYCHIAT, V162, P1423, DOI 10.1176/appi.ajp.162.8.1423; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Parkinson JA, 2005, Q J EXP PSYCHOL-B, V58, P19, DOI 10.1080/02724990444000023; Parkinson JA, 2001, J NEUROSCI, V21, P7770, DOI 10.1523/JNEUROSCI.21-19-07770.2001; Parkinson JA, 1999, J NEUROSCI, V19, P2401; Pears A, 2003, J NEUROSCI, V23, P11189; Pickens CL, 2003, J NEUROSCI, V23, P11078; Rescorla RA, 1999, ANIM LEARN BEHAV, V27, P140, DOI 10.3758/BF03199671; Robinson TN, 2007, ARCH PEDIAT ADOL MED, V161, P792, DOI 10.1001/archpedi.161.8.792; Robledo P, 1996, BEHAV NEUROSCI, V110, P981, DOI 10.1037/0735-7044.110.5.981; Roesch MR, 2006, NEURON, V51, P509, DOI 10.1016/j.neuron.2006.06.027; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Setlow B, 2002, EUR J NEUROSCI, V15, P1841, DOI 10.1046/j.1460-9568.2002.02010.x; Setlow B, 2002, BEHAV NEUROSCI, V116, P267, DOI 10.1037//0735-7044.116.2.267; Shaham Y, 2003, PSYCHOPHARMACOLOGY, V168, P3, DOI 10.1007/s00213-002-1224-x; TAYLOR JR, 1984, PSYCHOPHARMACOLOGY, V84, P405, DOI 10.1007/BF00555222; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Weissenborn R, 1997, PSYCHOPHARMACOLOGY, V134, P242, DOI 10.1007/s002130050447	30	123	127	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 17	2008	454	7202					340	U45		10.1038/nature06993	http://dx.doi.org/10.1038/nature06993			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	326ND	18563088	Green Accepted			2022-12-28	WOS:000257665300040
J	Panesar, SS; Gatrad, R; Sheikh, A				Panesar, Sukhmeet Singh; Gatrad, Rashid; Sheikh, Aziz			Smokeless tobacco use by south Asian youth in the UK	LANCET			English	Editorial Material									[Sheikh, Aziz] Univ Edinburgh, Div Community Hlth Sci, Edinburgh EH8 9DX, Midlothian, Scotland; [Panesar, Sukhmeet Singh] Whittington Hosp NHS Trust, London, England; [Gatrad, Rashid] Manor Hosp, Walsall, W Midlands, England	University of Edinburgh	Sheikh, A (corresponding author), Univ Edinburgh, Div Community Hlth Sci, Edinburgh EH8 9DX, Midlothian, Scotland.	aziz.sheikh@ed.ac.uk	Sheikh, Aziz/D-2818-2009	Sheikh, Aziz/0000-0001-7022-3056				[Anonymous], 2002, TOB CONTROL, V11, P291, DOI 10.1136/tc.11.4.291; Bedi R, 1995, Prim Dent Care, V2, P39; Gatrad R, 2007, BMJ-BRIT MED J, V335, P20, DOI 10.1136/bmj.39227.409641.AD; Khan FA, 2000, J ORAL PATHOL MED, V29, P214, DOI 10.1034/j.1600-0714.2000.290504.x; Oakley E, 2005, B WORLD HEALTH ORGAN, V83, P656; Prabhu N T, 2001, Int J Paediatr Dent, V11, P18, DOI 10.1046/j.1365-263x.2001.00235.x; WARD W, 1999, UK PARLIAMENT CHILDR; Winstock AR, 2000, ADDICT BIOL, V5, P173, DOI 10.1080/13556210050003766	8	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 12	2008	372	9633					97	98		10.1016/S0140-6736(08)61014-4	http://dx.doi.org/10.1016/S0140-6736(08)61014-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	324XJ	18620935				2022-12-28	WOS:000257552400009
J	Ramaraj, R; O'Beirn, D; Bracewell, RM				Ramaraj, Radhakrishnan; O'Beirn, Diarmuid; Bracewell, Robert M.			A deviated tongue	LANCET			English	Editorial Material									[Ramaraj, Radhakrishnan] Univ Arizona, Coll Med, Tucson, AZ 85724 USA; [Ramaraj, Radhakrishnan; O'Beirn, Diarmuid] Llandudno Hosp, Dept Internal Med, Llandudno, Wales; [Bracewell, Robert M.] Llandudno Hosp, Dept Neurol, Llandudno, Wales; [Bracewell, Robert M.] Univ Wales, Wolfson Inst Clin & Cognit Neurosci, Bangor, Gwynedd, Wales	University of Arizona; Bangor University	Ramaraj, R (corresponding author), Univ Arizona, Coll Med, 1501 N Campbell Ave, Tucson, AZ 85724 USA.	drkutty2@gmail.com						GOETZ CG, 2003, TXB CLIN NEUROLOGY; Keane JR, 1996, ARCH NEUROL-CHICAGO, V53, P561, DOI 10.1001/archneur.1996.00550060105023	2	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 12	2008	372	9633					176	176		10.1016/S0140-6736(08)61037-5	http://dx.doi.org/10.1016/S0140-6736(08)61037-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	324XJ	18620953				2022-12-28	WOS:000257552400032
J	Watts, G				Watts, Geoff			How clean is your water?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												geoff@scileg.freeserve.co.uk						*ASS PRESS, 2008, SEN BLAST EPA NEWS D; Collier AC, 2007, ECOHEALTH, V4, P164, DOI 10.1007/s10393-007-0105-5; DONN J, 2008, PHARM LURKING US DRI; *DRINK WAT INSP, 2001, PHARM RES DRINK WAT; *EUR MED AG, HUM MED EMEA PRES PR; Heberer T, 2002, J HYDROL, V266, P175, DOI 10.1016/S0022-1694(02)00165-8; Johnson AC, 2008, J HYDROL, V348, P167, DOI 10.1016/j.jhydrol.2007.09.054; Loos R, 2007, ANAL BIOANAL CHEM, V387, P1469, DOI 10.1007/s00216-006-1036-7; Pomati F, 2006, ENVIRON SCI TECHNOL, V40, P2442, DOI 10.1021/es051715a	9	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 12	2008	337	7661							a237	10.1136/bmj.a237	http://dx.doi.org/10.1136/bmj.a237			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	330SA	18595920	Green Published			2022-12-28	WOS:000257961900029
J	Fazzio, TG; Huff, JT; Panning, B				Fazzio, Thomas G.; Huff, Jason T.; Panning, Barbara			An RNAi screen of chromatin proteins identifies Tip60-p400 as a regulator of embryonic stem cell identity	CELL			English	Article							SELF-RENEWAL; PLURIPOTENCY; DIFFERENTIATION; INTERFERENCE; EXPRESSION; NANOG; OCT4; ACETYLATION; MAINTENANCE; DISRUPTION	Proper regulation of chromatin structure is necessary for the maintenance of cell type-specific gene expression patterns. The embryonic stem cell (ESC) expression pattern governs self-renewal and pluripotency. Here, we present an RNAi screen in mouse ESCs of 1008 loci encoding chromatin proteins. We identified 68 proteins that exhibit diverse phenotypes upon knockdown (KD), including seven subunits of the Tip60-p400 complex. Phenotypic analyses revealed that Tip60-p400 is necessary to maintain characteristic features of ESCs. We show that p400 localization to the promoters of both silent and active genes is dependent upon histone H3 lysine 4 trimethylation (H3K4me3). Furthermore, the Tip60-p400 KD gene expression profile is enriched for developmental regulators and significantly overlaps with that of the transcription factor Nanog. Depletion of Nanog reduces p400 binding to target promoters without affecting H3K4me3 levels. Together, these data indicate that Tip60-p400 integrates signals from Nanog and H3K4me3 to regulate gene expression in ESCs.	[Fazzio, Thomas G.; Huff, Jason T.; Panning, Barbara] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Fazzio, TG (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	thomas.fazzio@ucsf.edu; bpanning@biochem.ucsf.edu		Huff, Jason/0000-0002-0088-1640	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085186, R01GM063671] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM085186, R01 GM063671, R01 GM085186-01A1, R01 GM63671] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baillat D, 2005, CELL, V123, P265, DOI 10.1016/j.cell.2005.08.019; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Benanti JA, 2002, MOL CELL BIOL, V22, P7385, DOI 10.1128/MCB.22.21.7385-7397.2002; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chan HM, 2005, GENE DEV, V19, P196, DOI 10.1101/gad.1280205; Cortez D, 2004, P NATL ACAD SCI USA, V101, P10078, DOI 10.1073/pnas.0403410101; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Fazzio TG, 2005, MOL CELL BIOL, V25, P9165, DOI 10.1128/MCB.25.21.9165-9174.2005; Foley E, 2004, PLOS BIOL, V2, P1091, DOI 10.1371/journal.pbio.0020203; Fujikura J, 2002, GENE DEV, V16, P784, DOI 10.1101/gad.968802; Gorrini C, 2007, NATURE, V448, P1063, DOI 10.1038/nature06055; Guidi CJ, 2001, MOL CELL BIOL, V21, P3598, DOI 10.1128/MCB.21.10.3598-3603.2001; Herceg Z, 2001, NAT GENET, V29, P206, DOI 10.1038/ng725; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Hough SR, 2006, STEM CELLS, V24, P1467, DOI 10.1634/stemcells.2005-0475; Ikura T, 2007, MOL CELL BIOL, V27, P7028, DOI 10.1128/MCB.00579-07; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kim JK, 2001, MOL CELL BIOL, V21, P7787, DOI 10.1128/MCB.21.22.7787-7795.2001; Kittler R, 2007, NAT METHODS, V4, P337, DOI 10.1038/NMETH1025; Klochendler-Yeivin A, 2000, EMBO REP, V1, P500, DOI 10.1093/embo-reports/kvd129; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; MARTIN GR, 1975, P NATL ACAD SCI USA, V72, P1441, DOI 10.1073/pnas.72.4.1441; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Matoba R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000026; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Morin-Kensicki Elizabeth M., 2001, Genesis The Journal of Genetics and Development, V31, P142, DOI 10.1002/gene.10017; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Ono T, 2003, CELL, V115, P109, DOI 10.1016/S0092-8674(03)00724-4; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Roberts CWM, 2000, P NATL ACAD SCI USA, V97, P13796, DOI 10.1073/pnas.250492697; Sapountzi V, 2006, INT J BIOCHEM CELL B, V38, P1496, DOI 10.1016/j.biocel.2006.03.003; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046; Squatrito M, 2006, TRENDS CELL BIOL, V16, P433, DOI 10.1016/j.tcb.2006.07.007; Velkey JM, 2003, GENESIS, V37, P18, DOI 10.1002/gene.10218; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Yang D, 2002, P NATL ACAD SCI USA, V99, P9942, DOI 10.1073/pnas.152327299; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	48	327	330	3	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 11	2008	134	1					162	174		10.1016/j.cell.2008.05.031	http://dx.doi.org/10.1016/j.cell.2008.05.031			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	324IU	18614019	Green Accepted, Bronze			2022-12-28	WOS:000257513100022
J	Peyrin-Biroulet, L; Desreumaux, P; Sandborn, WJ; Colombel, JF				Peyrin-Biroulet, Laurent; Desreumaux, Pierre; Sandborn, William J.; Colombel, Jean-Frederic			Crohn's disease: beyond antagonists of tumour necrosis factor	LANCET			English	Review							INFLAMMATORY-BOWEL-DISEASE; PLACEBO-CONTROLLED TRIAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; ACTIVE ULCERATIVE-COLITIS; STEM-CELL TRANSPLANTATION; INTERCELLULAR-ADHESION MOLECULE-1; RECOMBINANT HUMAN INTERLEUKIN-10; ANTIINTERFERON-GAMMA ANTIBODY; HUMANIZED MONOCLONAL-ANTIBODY; COLONY-STIMULATING FACTOR	In the past few years, antagonists of tumour necrosis factor have resulted in unforetold therapeutic benefits in Crohn's disease, but the magnitude and duration of responses are variable. New agents are therefore needed. Their development has benefited from advances in the understanding of the pathophysiology of this disease. Uncontrolled activation of the acquired immune system has an important role, and lymphocytes, cytokines, and adhesion molecules are broadly targeted for therapeutic intervention. With increasing evidence of an implication of the innate immune system and the intestinal epithelium, the therapeutic paradigm is also shifting from mere immunosuppression to the reinforcement of the intestinal barrier. We review mechanisms of actions of new drugs and the efficacy and adverse events from data from clinical trials. We discuss future directions, including new strategies with optimum endpoints.	[Peyrin-Biroulet, Laurent; Desreumaux, Pierre; Colombel, Jean-Frederic] CHU Lille, Hop Claude Huriez, F-59037 Lille, France; [Sandborn, William J.] Mayo Clin, Rochester, MN USA	Universite de Lille - ISITE; CHU Lille; Mayo Clinic	Colombel, JF (corresponding author), CHU Lille, Hop Claude Huriez, Rue Michel Polonovski, F-59037 Lille, France.	jfcolombel@chru-lille.fr	Desreumaux, Pierre F/R-6877-2018; Sandborn, William/ABE-8342-2020	Desreumaux, Pierre F/0000-0002-6127-5281; peyrin-biroulet, laurent/0000-0003-2536-6618				Abraham C, 2007, NEW ENGL J MED, V357, P708, DOI 10.1056/NEJMcibr073420; Bamias G, 2005, ANN INTERN MED, V143, P895, DOI 10.7326/0003-4819-143-12-200512200-00007; Barnich N, 2007, J CLIN INVEST, V117, P1566, DOI 10.1172/JCI30504; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Beaugerie L, 2006, GASTROENTEROLOGY, V130, P650, DOI 10.1053/j.gastro.2005.12.019; BEKKER P, 2007, GUT, V56, pA23; BEVILACQUA MP, 1993, ANNU REV IMMUNOL, V11, P767, DOI 10.1146/annurev.iy.11.040193.004003; Braat H, 2006, CLIN GASTROENTEROL H, V4, P754, DOI 10.1016/j.cgh.2006.03.028; BUCHMAN AL, 2006, GASTROENTEROLOGY, V131, P949, DOI DOI 10.1053/J.GASTRO.2006.06.097; Buhner S, 2006, GUT, V55, P342, DOI 10.1136/gut.2005.065557; Burakoff R, 2006, INFLAMM BOWEL DIS, V12, P558, DOI 10.1097/01.ibd.0000225337.14356.31; CanvaDelcambre V, 1996, ALIMENT PHARM THERAP, V10, P721, DOI 10.1046/j.1365-2036.1996.59201000.x; Carpenter PA, 2002, BLOOD, V99, P2712, DOI 10.1182/blood.V99.8.2712; Cho JH, 2007, GASTROENTEROLOGY, V133, P1327, DOI 10.1053/j.gastro.2007.08.032; Colombel JF, 2007, GASTROENTEROLOGY, V132, P52, DOI 10.1053/j.gastro.2006.11.041; Colombel JF, 2001, GUT, V49, P42, DOI 10.1136/gut.49.1.42; Creed TJ, 2003, ALIMENT PHARM THER, V18, P65, DOI 10.1046/j.1365-2036.2003.01639.x; Creed TJ, 2006, ALIMENT PHARM THER, V23, P1435, DOI 10.1111/j.1365-2036.2006.02904.x; D'Haens G, 2008, LANCET, V371, P660, DOI 10.1016/S0140-6736(08)60304-9; Di Marzo V, 2006, GUT, V55, P1373, DOI 10.1136/gut.2005.090472; Dieckgraefe BK, 2002, LANCET, V360, P1478, DOI 10.1016/S0140-6736(02)11437-1; DOTAN I, 2006, GUT, V55, pA22; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Dumont Francis J, 2005, Curr Opin Investig Drugs, V6, P537; Feagan BG, 2003, GASTROENTEROLOGY, V124, pA25, DOI 10.1016/S0016-5085(03)80125-7; Feagan BG, 2007, GASTROENTEROLOGY, V132, pA103; Fedorak RN, 2000, GASTROENTEROLOGY, V119, P1473, DOI 10.1053/gast.2000.20229; Garcia-Olmo D, 2005, DIS COLON RECTUM, V48, P1416, DOI 10.1007/s10350-005-0052-6; Genovese MC, 2005, NEW ENGL J MED, V353, P1114, DOI 10.1056/NEJMoa050524; Ghosh S, 2003, NEW ENGL J MED, V348, P24, DOI 10.1056/NEJMoa020732; Gordon FH, 2001, GASTROENTEROLOGY, V121, P268, DOI 10.1053/gast.2001.26260; Hanauer SB, 2006, GASTROENTEROLOGY, V130, P323, DOI 10.1053/j.gastro.2005.11.030; Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; Hanauer SB, 2006, NAT CLIN PRACT GASTR, V3, P415, DOI 10.1038/ncpgasthep0553; Herllinger KR, 2006, AM J GASTROENTEROL, V101, P793, DOI 10.1111/j.1572-0241.2005.00356.x; Hommes D, 2002, GASTROENTEROLOGY, V122, P7, DOI 10.1053/gast.2002.30770; Hommes DW, 2006, GUT, V55, P1131, DOI 10.1136/gut.2005.079392; Hommes D, 2006, GASTROENTEROLOGY, V130, pA111; Huang Y, 2002, WORLD J GASTROENTERO, V8, P1134, DOI 10.3748/wjg.v8.i6.1134; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Hyun JG, 2006, AM J GASTROENTEROL, V101, P569, DOI 10.1111/j.1572-0241.2006.00437.x; Ito H, 2004, GASTROENTEROLOGY, V126, P989, DOI 10.1053/j.gastro.2004.01.012; Jeong KJ, 2005, NAT BIOTECHNOL, V23, P1493, DOI 10.1038/nbt1205-1493; Kasran A, 2005, ALIMENT PHARM THER, V22, P111, DOI 10.1111/j.1365-2036.2005.02526.x; Keshav S, 2007, GASTROENTEROLOGY, V132, pA157; Kleinschmidt-DeMasters BK, 2005, NEW ENGL J MED, V353, P369, DOI 10.1056/NEJMoa051782; Korzenik JR, 2005, ALIMENT PHARM THER, V21, P391, DOI 10.1111/j.1365-2036.2005.02287.x; Korzenik JR, 2005, NEW ENGL J MED, V352, P2193, DOI 10.1056/NEJMoa041109; Korzenik JR, 2006, NAT REV DRUG DISCOV, V5, P197, DOI 10.1038/nrd1986; Kremer JM, 2006, ANN INTERN MED, V144, P865, DOI 10.7326/0003-4819-144-12-200606200-00003; Krueger GG, 2007, NEW ENGL J MED, V356, P580, DOI 10.1056/NEJMoa062382; Langer-Gould A, 2005, NEW ENGL J MED, V353, P375, DOI 10.1056/NEJMoa051847; Lemann M, 2006, GASTROENTEROLOGY, V130, P1054, DOI 10.1053/j.gastro.2006.02.014; Lopez-Cubero SO, 1998, GASTROENTEROLOGY, V114, P433, DOI 10.1016/S0016-5085(98)70525-6; LOWDER JN, 2006, GUT, V55, pA127; Macpherson A, 1996, GUT, V38, P365, DOI 10.1136/gut.38.3.365; Maini RN, 2006, ARTHRITIS RHEUM-US, V54, P2817, DOI 10.1002/art.22033; Mannon PJ, 2004, NEW ENGL J MED, V351, P2069, DOI 10.1056/NEJMoa033402; Margalit M, 2006, AM J GASTROENTEROL, V101, P561, DOI 10.1111/j.1572-0241.2006.00441.x; MITSUYAMA K, 1995, GUT, V36, P45, DOI 10.1136/gut.36.1.45; Neurath MF, 1996, J EXP MED, V183, P2605, DOI 10.1084/jem.183.6.2605; Nishimoto N, 2006, NAT CLIN PRACT RHEUM, V2, P619, DOI 10.1038/ncprheum0338; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Olaussen RW, 2007, GASTROENTEROLOGY, V132, P2371, DOI 10.1053/j.gastro.2007.04.023; Oyama Y, 2005, GASTROENTEROLOGY, V128, P552, DOI 10.1053/j.gastro.2004.11.051; Pizarro TT, 2007, ANNU REV MED, V58, P433, DOI 10.1146/annurev.med.58.121205.100607; Plamondon S, 2007, ALIMENT PHARM THER, V25, P557, DOI 10.1111/j.1365-2036.2006.03239.x; Plevy S, 2007, GASTROENTEROLOGY, V133, P1414, DOI 10.1053/j.gastro.2007.08.035; Present DH, 1999, NEW ENGL J MED, V340, P1398, DOI 10.1056/NEJM199905063401804; Rachmilewitz D, 2004, GASTROENTEROLOGY, V126, P520, DOI 10.1053/j.gastro.2003.11.019; Reinisch W, 2006, GUT, V55, P1138, DOI 10.1136/gut.2005.079434; Rolfe VE, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004826; Rosh JR, 2007, J PEDIATR GASTR NUTR, V44, P165, DOI 10.1097/MPG.0b013e318031d61a; Rutgeerts P, 2007, GUT, V56, P453, DOI 10.1136/gut.2005.088732; Salmi M, 2006, BLOOD, V108, P1555, DOI 10.1182/blood-2005-11-4599; Sandborn WJ, 2007, GASTROENTEROLOGY, V132, pA51; Sandborn WJ, 2007, ANN INTERN MED, V146, P829, DOI 10.7326/0003-4819-146-12-200706190-00159; Sandborn WJ, 2007, NEW ENGL J MED, V357, P228, DOI 10.1056/NEJMoa067594; Sandborn WJ, 2005, NEW ENGL J MED, V353, P1912, DOI 10.1056/NEJMoa043335; Sands BE, 2004, NEW ENGL J MED, V350, P876, DOI 10.1056/NEJMoa030815; Sands BE, 2002, ALIMENT PHARM THERAP, V16, P399, DOI 10.1046/j.1365-2036.2002.01179.x; Sands BE, 1999, GASTROENTEROLOGY, V117, P58, DOI 10.1016/S0016-5085(99)70550-0; SANDS BE, IN PRESS GASTROENTER; Sands BE, 2007, INFLAMM BOWEL DIS, V13, P2, DOI 10.1002/ibd.20014; Sands BE, 2006, J CLIN GASTROENTEROL, V40, P482, DOI 10.1097/00004836-200607000-00005; Schreiber S, 2006, CLIN GASTROENTEROL H, V4, P325, DOI 10.1016/j.cgh.2005.11.013; Schreiber S, 2001, GASTROENTEROLOGY, V120, P1339, DOI 10.1053/gast.2001.24015; Schreiber S, 2000, GASTROENTEROLOGY, V119, P1461, DOI 10.1053/gast.2000.20196; Shulman DI, 2000, ENDOCRINE, V12, P147, DOI 10.1385/ENDO:12:2:147; Silverman J, 2005, NAT BIOTECHNOL, V23, P1556, DOI 10.1038/nbt1166; Slonim AE, 2000, NEW ENGL J MED, V342, P1633, DOI 10.1056/NEJM200006013422203; Smolen JS, 2007, LANCET, V370, P1861, DOI 10.1016/S0140-6736(07)60784-3; Snowden JA, 2004, J RHEUMATOL, V31, P482; Stronkhorst A, 1997, GUT, V40, P320, DOI 10.1136/gut.40.3.320; Suzuki Y, 2004, DIGEST DIS SCI, V49, P565, DOI 10.1023/B:DDAS.0000026299.43792.ae; Tamboli CP, 2004, GUT, V53, P1057; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; Targan SR, 2007, GASTROENTEROLOGY, V132, P1672, DOI 10.1053/j.gastro.2007.03.024; Thulesen J, 2004, GUT, V53, P1145, DOI 10.1136/gut.2003.035212; Travis S, 2005, INFLAMM BOWEL DIS, V11, P713, DOI 10.1097/01.MIB.0000172807.26748.16; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Valentine JF, 2007, GASTROENTEROLOGY, V132, pA502; Van Assche G, 2006, GUT, V55, P1568, DOI 10.1136/gut.2005.089854; Van Assche G, 2003, AM J GASTROENTEROL, V98, P369, DOI 10.1016/S0002-9270(02)05907-5; Van Assche G, 2005, NEW ENGL J MED, V353, P362, DOI 10.1056/NEJMoa051586; Van Gossum A, 2007, INFLAMM BOWEL DIS, V13, P135, DOI 10.1002/ibd.20063; VERBEECK J, IN PRESS GUT; Vincenti F, 2007, ANNU REV MED, V58, P347, DOI 10.1146/annurev.med.58.080205.154004; Wallis K, 2007, ALIMENT PHARM THER, V25, P365, DOI 10.1111/j.1365-2036.2006.03193.x; Wang XP, 2001, PANCREAS, V23, P148, DOI 10.1097/00006676-200108000-00005; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yacyshyn BR, 2005, CLIN EXP IMMUNOL, V141, P141, DOI 10.1111/j.1365-2249.2005.02830.x; Yacyshyn BR, 2002, GUT, V51, P30, DOI 10.1136/gut.51.1.30; Yacyshyn BR, 2002, ALIMENT PHARM THER, V16, P1761, DOI 10.1046/j.1365-2036.2002.01341.x; Yacyshyn BR, 1998, GASTROENTEROLOGY, V114, P1133, DOI 10.1016/S0016-5085(98)70418-4; Yacyshyn B, 2007, CLIN GASTROENTEROL H, V5, P215, DOI 10.1016/j.cgh.2006.11.001; Yousry TA, 2006, NEW ENGL J MED, V354, P924, DOI 10.1056/NEJMoa054693	120	79	82	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 5	2008	372	9632					67	81		10.1016/S0140-6736(08)60995-2	http://dx.doi.org/10.1016/S0140-6736(08)60995-2			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	321XN	18603161				2022-12-28	WOS:000257339900034
J	McClintock, WE; Izenberg, NR; Holsclaw, GM; Blewett, DT; Domingue, DL; Head, JW; Helbert, J; McCoy, TJ; Murchie, SL; Robinson, MS; Solomon, SC; Sprague, AL; Vilas, F				McClintock, William E.; Izenberg, Noam R.; Holsclaw, Gregory M.; Blewett, David T.; Domingue, Deborah L.; Head, James W., III; Helbert, Joern; McCoy, Timothy J.; Murchie, Scott L.; Robinson, Mark S.; Solomon, Sean C.; Sprague, Ann L.; Vilas, Faith			Spectroscopic observations of Mercury's surface reflectance during MESSENGER's first mercury flyby	SCIENCE			English	Article							OPTICAL OBSERVATIONS; HERMEAN REGOLITH; LUNAR; SPECTRA; MOON; IRON; SOIL; MARINER-10; MISSION	During MESSENGER's first flyby of Mercury, the Mercury Atmospheric and Surface Composition Spectrometer made simultaneous mid- ultraviolet to near- infrared ( wavelengths of 200 to 1300 nanometers) reflectance observations of the surface. An ultraviolet absorption (< 280 nanometers) suggests that the ferrous oxide ( Fe(2+)) content of silicates in average surface material is low ( less than 2 to 3 weight percent). This result is supported by the lack of a detectable 1- micrometer Fe(2+) absorption band in high- spatial- resolution spectra of mature surface materials as well as immature crater ejecta, which suggests that the ferrous iron content may be low both on the surface and at depth. Differences in absorption features and slope among the spectra are evidence for variations in composition and regolith maturation of Mercury's surface.	[McClintock, William E.; Holsclaw, Gregory M.] Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80303 USA; [Izenberg, Noam R.; Blewett, David T.; Domingue, Deborah L.; Murchie, Scott L.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Head, James W., III] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Helbert, Joern] Deutsch Zentrum Luft & Raumfahrt, Inst Planetary Res, D-12489 Berlin, Germany; [McCoy, Timothy J.] Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20560 USA; [Robinson, Mark S.] Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; [Solomon, Sean C.] Carnegie Inst Washington, Dept Terr Magnetism, Washington, DC 20015 USA; [Sprague, Ann L.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Vilas, Faith] Univ Arizona, Multiple Mirror Telescope Observ, Tucson, AZ 85721 USA	University of Colorado System; University of Colorado Boulder; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Brown University; Helmholtz Association; German Aerospace Centre (DLR); Smithsonian Institution; Smithsonian National Museum of Natural History; Arizona State University; Arizona State University-Tempe; Carnegie Institution for Science; University of Arizona; University of Arizona	McClintock, WE (corresponding author), Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80303 USA.	william.mcclintock@lasp.colorado.edu	Holsclaw, Greg/AAX-2486-2021; Murchie, Scott L/E-8030-2015; Blewett, David T/I-4904-2012; Izenberg, Noam R/F-3952-2015; Robinson, Mark/ABI-6841-2020; Helbert, Jorn/P-1570-2019	Holsclaw, Greg/0000-0002-9059-9437; Murchie, Scott L/0000-0002-1616-8751; Blewett, David T/0000-0002-9241-6358; Izenberg, Noam R/0000-0003-1629-6478; Helbert, Jorn/0000-0001-5346-9505; Vilas, Faith/0000-0003-4723-5870; McCoy, Timothy/0000-0002-4573-3553				Blewett DT, 1997, ICARUS, V129, P217, DOI 10.1006/icar.1997.5785; Burns R.G., 1993, REMOTE GEOCHEMICAL A, P3; CINTALA MJ, 1992, J GEOPHYS RES-PLANET, V97, P947, DOI 10.1029/91JE02207; CLOUTIS EA, 2008, ICARUS; DENEVI BW, 2008, ICARUS; DOMINGUE DL, 2008, LUNAR PLANET SCI, V39, P1298; FISCHER EM, 1994, ICARUS, V111, P475, DOI 10.1006/icar.1994.1158; Fox GK, 1998, MON NOT R ASTRON SOC, V298, P303, DOI 10.1046/j.1365-8711.1998.01633.x; HAPKE B, 1975, J GEOPHYS RES, V80, P2431, DOI 10.1029/JB080i017p02431; HAPKE B, 1977, PHYS EARTH PLANET IN, V15, P264, DOI 10.1016/0031-9201(77)90035-8; HAPKE B, 1975, MOON PLANETS, V13, P339, DOI 10.1007/BF00567525; Hapke B, 2001, J GEOPHYS RES-PLANET, V106, P10039, DOI 10.1029/2000JE001338; Janz SJ, 1996, GEOPHYS RES LETT, V23, P2297, DOI 10.1029/96GL01122; Kieffer HH, 2005, ASTRON J, V129, P2887, DOI 10.1086/430185; LOEFFLER BM, 1974, GEOCHIM COSM SUPPL, V3, P3007; McClintock WE, 2007, SPACE SCI REV, V131, P481, DOI 10.1007/s11214-007-9264-5; MCCORD TB, 1979, J GEOPHYS RES, V84, P7664, DOI 10.1029/JB084iB13p07664; MCCORD TB, 1972, ICARUS, V17, P585, DOI 10.1016/0019-1035(72)90024-3; MCCORD TB, 1972, SCIENCE, V178, P745, DOI 10.1126/science.178.4062.745; Noble SK, 2007, ICARUS, V192, P629, DOI 10.1016/j.icarus.2007.07.021; Noble SK, 2003, SOLAR SYST RES+, V37, P31, DOI 10.1023/A:1022395605024; Pieters CM, 2000, METEORIT PLANET SCI, V35, P1101, DOI 10.1111/j.1945-5100.2000.tb01496.x; RAVA B, 1987, ICARUS, V71, P397, DOI 10.1016/0019-1035(87)90037-6; Robinson MS, 2008, SCIENCE, V321, P66, DOI 10.1126/science.1160080; Sprague AL, 1998, ICARUS, V133, P174, DOI 10.1006/icar.1998.5929; Sprague AL, 2002, METEORIT PLANET SCI, V37, P1255, DOI 10.1111/j.1945-5100.2002.tb00894.x; TOSSELL JA, 1974, AM MINERAL, V59, P319; VILAS F, 1985, ICARUS, V64, P133, DOI 10.1016/0019-1035(85)90044-2; VILAS F, 1988, MERCURY, P59; WAGNER JK, 1987, ICARUS, V69, P14, DOI 10.1016/0019-1035(87)90003-0; Warell J, 2006, ICARUS, V180, P281, DOI 10.1016/j.icarus.2005.09.007; Warell J, 2004, ICARUS, V168, P257, DOI 10.1016/j.icarus.2003.10.020; Warell J, 2003, ICARUS, V161, P199, DOI 10.1016/S0019-1035(02)00055-6; WELLS E, 1977, SCIENCE, V195, P977, DOI 10.1126/science.195.4282.977	34	86	86	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 4	2008	321	5885					62	65		10.1126/science.1159933	http://dx.doi.org/10.1126/science.1159933			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QE	18599769				2022-12-28	WOS:000257320800033
J	Stillman, MD				Stillman, Michael D.			Physicians behaving badly	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												michael.stillman@bmc.org						Moore C, 2007, ARCH INTERN MED, V167, P1305, DOI 10.1001/archinte.167.12.1305; Sijstermans R, 2007, INT J MED INFORM, V76, P336, DOI 10.1016/j.ijmedinf.2007.01.007	2	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 2	2008	300	1					21	22		10.1001/jama.300.1.21	http://dx.doi.org/10.1001/jama.300.1.21			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320NW	18594028				2022-12-28	WOS:000257242800001
J	Berry, A; Browne, J				Berry, Andrew; Browne, Janet			The other beetle-hunter	NATURE			English	Editorial Material									[Berry, Andrew] Harvard Univ, Biol Labs, Cambridge, MA 02138 USA; [Browne, Janet] Harvard Univ, Dept Hist Sci, Sci Ctr 371, Cambridge, MA 02138 USA	Harvard University; Harvard University	Berry, A (corresponding author), Harvard Univ, Biol Labs, 16 Divin Ave, Cambridge, MA 02138 USA.								0	5	6	1	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 26	2008	453	7199					1188	1190		10.1038/4531188a	http://dx.doi.org/10.1038/4531188a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318FA	18580934	Green Submitted			2022-12-28	WOS:000257075800027
J	Strasberg, SM				Strasberg, Steven M.			Acute calculous cholecystitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DELAYED LAPAROSCOPIC CHOLECYSTECTOMY; SUSPECTED ACUTE CHOLECYSTITIS; PERCUTANEOUS CHOLECYSTOSTOMY; HEPATOBILIARY SCINTIGRAPHY; NATURAL-HISTORY; RISK-FACTORS; CONVERSION; GALLSTONE; INJURY; BILE		[Strasberg, Steven M.] Washington Univ, Sect Hepatobiliary Pancreat Surg, St Louis, MO USA; [Strasberg, Steven M.] Barnes Jewish Hosp, St Louis, MO 63110 USA	Washington University (WUSTL); Barnes-Jewish Hospital; Washington University (WUSTL)	Strasberg, SM (corresponding author), Box 8109,660 Euclid Ave, St Louis, MO 63110 USA.	strasbergs@wustl.edu						Adamsen S, 1997, J AM COLL SURGEONS, V184, P571; Adedeji OA, 1996, J ROY COLL SURG EDIN, V41, P88; Akriviadis EA, 1997, GASTROENTEROLOGY, V113, P225, DOI 10.1016/S0016-5085(97)70099-4; American Gastroenterological Association, 2001, BURD GASTR DIS; Blaivas M, 2007, J EMERG MED, V33, P47, DOI 10.1016/j.jemermed.2007.02.044; Brodsky A, 2000, SURG ENDOSC, V14, P755, DOI 10.1007/s004640000182; CARTER HR, 1987, AM SURGEON, V53, P565; Chandler CF, 2000, AM SURGEON, V66, P896; Chatziioannou SN, 2000, SURGERY, V127, P609, DOI 10.1067/msy.2000.105868; CLAESSON B, 1984, ACTA CHIR SCAND, V150, P229; Everhart JE, 1999, GASTROENTEROLOGY, V117, P632, DOI 10.1016/S0016-5085(99)70456-7; FREITAS JE, 1982, CLIN NUCL MED, V7, P364, DOI 10.1097/00003072-198208000-00004; FRIED GM, 1994, AM J SURG, V167, P35, DOI 10.1016/0002-9610(94)90051-5; FRIEDMAN GD, 1989, J CLIN EPIDEMIOL, V42, P127, DOI 10.1016/0895-4356(89)90086-3; GRACIE WA, 1982, NEW ENGL J MED, V307, P798, DOI 10.1056/NEJM198209233071305; Gruber PJ, 1996, ANN EMERG MED, V28, P273, DOI 10.1016/S0196-0644(96)70025-2; Gurusamy KS, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005440.pub2; Hadad SM, 2007, WORLD J SURG, V31, P1298, DOI 10.1007/s00268-007-9050-2; Halachmi S, 2000, EUR J SURG, V166, P136; Hatzidakis AA, 2002, EUR RADIOL, V12, P1778, DOI 10.1007/s00330-001-1247-4; HICKMAN MS, 1988, ARCH SURG-CHICAGO, V123, P409; HICKS RJ, 1990, EUR J NUCL MED, V16, P747, DOI 10.1007/BF00998183; Hirota M, 2007, J HEPATO-BILIARY-PAN, V14, P78, DOI 10.1007/s00534-006-1159-4; JARVINEN H, 1978, ANN CLIN RES, V10, P247; Johansson M, 2004, DIGEST SURG, V21, P359, DOI 10.1159/000081352; JUVONEN T, 1992, EUR J SURG, V158, P365; KIM CK, 1993, J NUCL MED, V34, P1866; Kolla SB, 2004, SURG ENDOSC, V18, P1323, DOI 10.1007/s00464-003-9230-6; Lai PBS, 1998, BRIT J SURG, V85, P764; Lau H, 2006, SURG ENDOSC, V20, P82, DOI 10.1007/s00464-005-0100-2; LAU WY, 1990, AUST NZ J SURG, V60, P539, DOI 10.1111/j.1445-2197.1990.tb07422.x; Lim KR, 2007, ANN ACAD MED SINGAP, V36, P631; Lo CM, 1997, AM J SURG, V173, P513, DOI 10.1016/S0002-9610(97)00005-6; Lo CM, 1998, ANN SURG, V227, P461, DOI 10.1097/00000658-199804000-00001; MCGAHAN JP, 1989, RADIOLOGY, V173, P481, DOI 10.1148/radiology.173.2.2678261; MCSHERRY CK, 1985, ANN SURG, V202, P59; MORROW DJ, 1978, ARCH SURG-CHICAGO, V113, P1149; RALLS PW, 1985, RADIOLOGY, V155, P767, DOI 10.1148/radiology.155.3.3890007; ROSLYN JJ, 1980, AM J SURG, V140, P126, DOI 10.1016/0002-9610(80)90428-6; Russell JC, 1996, ARCH SURG-CHICAGO, V131, P382; SANABRIA JR, 1994, J AM COLL SURGEONS, V179, P696; Serralta AS, 2003, SURG LAPARO ENDO PER, V13, P71, DOI 10.1097/00129689-200304000-00002; Shikata S, 2005, SURG TODAY, V35, P553, DOI 10.1007/s00595-005-2998-3; Siddiqui T, 2008, AM J SURG, V195, P40, DOI 10.1016/j.amjsurg.2007.03.004; Solomkin JS, 2003, CLIN INFECT DIS, V37, P997, DOI 10.1086/378702; Strasberg SM, 2005, J AM COLL SURGEONS, V201, P604, DOI 10.1016/j.jamcollsurg.2005.04.032; STRASBERG SM, 1995, J AM COLL SURGEONS, V180, P101; Takada T, 2007, J HEPATO-BILIARY-PAN, V14, P1, DOI 10.1007/s00534-006-1150-0; Urbach DR, 2005, CAN MED ASSOC J, V172, P1015, DOI 10.1503/cmaj.1041363; Yamashita Y, 2007, J HEPATO-BILIARY-PAN, V14, P91, DOI 10.1007/s00534-006-1161-x; YEATMAN TJ, 1986, AM J EMERG MED, V4, P163, DOI 10.1016/0735-6757(86)90163-4	51	221	233	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 26	2008	358	26					2804	2811		10.1056/NEJMcp0800929	http://dx.doi.org/10.1056/NEJMcp0800929			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	317UO	18579815				2022-12-28	WOS:000257045900007
J	Comi, G; Pulizzi, A; Rovaris, M; Abramsky, O; Arbizu, T; Boiko, A; Gold, R; Havrdova, E; Komoly, S; Selmaj, KW; Sharrack, B; Filippi, M				Comi, G.; Pulizzi, A.; Rovaris, M.; Abramsky, O.; Arbizu, T.; Boiko, A.; Gold, R.; Havrdova, E.; Komoly, S.; Selmaj, K. W.; Sharrack, B.; Filippi, M.		LAQ 5062 Study Grp	Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study	LANCET			English	Article							SECONDARY PROGRESSIVE MS; BUDD-CHIARI-SYNDROME; CONTROLLED TRIAL; GLATIRAMER ACETATE; HYPOINTENSE LESIONS; INTERFERON BETA-1B; CLINICAL-TRIALS; SPIN-ECHO; LINOMIDE; METHYLPREDNISOLONE	Background A 24-week phase II trial has shown that 0 . 3 mg of laquinimod given daily to patients with relapsing-remitting multiple sclerosis was well tolerated and reduced the formation of active lesions. We assessed the effect of oral daily 0 . 3 and 0 . 6 mg laquinimod on MRI-monitored disease activity in a 36-week double-blind, placebo-controlled phase IIb study. Methods The study was done in 51 centres in nine countries. Inclusion criteria were one or more relapses in the year before entry and at least one gadolinium enhancing (GdE) lesion on screening MRI. Of 720 patients screened, 306 eligible patients were enrolled. Patients, aged 18-50 years, were randomly assigned to placebo (n=102), laquinimod 0 . 3 mg a day (n=98), or 0 . 6 mg a day (n=106). Brain MRI scans and clinical assessments were done at week -4, baseline, and monthly from week 12 to week 36. The primary outcome was the cumulative number of GdE lesions at weeks 24, 28, 32, and 36. The principal analysis of the primary endpoint was done on the intention-to-treat cohort. This study is registered with ClinicalTrials.gov, number NCT00349193. Findings Compared with placebo, treatment with laquinimod 0 . 6 mg per day showed a 40.4% reduction of the baseline adjusted mean cumulative number of GdE lesions per scan on the last four scans (simple means 4 - 2 [SD 9.2] vs 2.6 [5-3], p=0 . 0048); treatment with 0 . 3 mg per day showed no significant effects (3-9 [5.5] vs placebo, p=0.6740). Both doses of laquinimod were well tolerated, with some transient and dose-dependent increases in liver enzymes. A case of Budd-Chiari syndrome-ie, a thrombotic venous outflow obstruction of the liver-occurred after 1 month of exposure in a patient with underlying hypercoagulability who received 0.6 mg laquinimod. Anticoagulant treatment resulted in a decline of liver enzymes to normal without any clinical signs of hepatic decompensation. Interpretation In patients with relapsing-remitting multiple sclerosis, 0.6 mg per day laquinimod significantly reduced MRI-measured disease activity and was well tolerated. Funding Teva Pharmaceutical Industries.	[Comi, G.] Univ Vita Salute, San Raffaele Sci Inst, Dept Neurol, Inst Expt Neurol, I-20132 Milan, Italy; [Pulizzi, A.; Rovaris, M.; Filippi, M.] Univ Vita Salute, San Raffaele Sci Inst, Neuroimaging Res Unit, Milan, Italy; [Abramsky, O.] Hadassah Univ Hosp, Dept Neurol, IL-91120 Jerusalem, Israel; [Arbizu, T.] Univ Barcelona, Univ Hosp Bellvitge, Fac Med, Multiple Sclerosis Unit, E-08007 Barcelona, Spain; [Boiko, A.] Russian State Med Univ, Dept Neurol & Neurosurg, Moscow 117437, Russia; [Gold, R.] Ruhr Univ Bochum, St Josef Hosp, Dept Neurol, D-4630 Bochum, Germany; [Havrdova, E.] Univ Hosp, Dept Neurol, Prague, Czech Republic; [Komoly, S.] Univ Pecs, Dept Neurol, Pecs, Hungary; [Selmaj, K. W.] Med Univ Lodz, Dept Neurol, Lodz, Poland; [Sharrack, B.] Sheffield Teaching Hosp NHS Fdn Trust, Dept Neurol, Sheffield, S Yorkshire, England	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Hebrew University of Jerusalem; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Pirogov Russian National Research Medical University; Ruhr University Bochum; General University Hospital Prague; University of Pecs; Medical University Lodz; University of Sheffield	Comi, G (corresponding author), Univ Vita Salute, San Raffaele Sci Inst, Dept Neurol, Inst Expt Neurol, I-20132 Milan, Italy.	g.comi@hsr.it	Rocca, Maria Assunta/K-1619-2018; Macedo, Ana/L-9912-2018; Rovaris, Marco/AAA-6040-2020; Bertolotto, Antonio/K-8346-2015; Boyko, Alexey N/Z-2106-2018; Havrdova, Eva Kubala/P-4892-2017; Fiedler, Jiri/N-6889-2017; Filippi, Massimo/K-1755-2018; Montalban, Xavier/J-5938-2016	Rocca, Maria Assunta/0000-0003-2358-4320; Macedo, Ana/0000-0002-6978-8989; Rovaris, Marco/0000-0001-9691-1957; Bertolotto, Antonio/0000-0002-7052-1907; Havrdova, Eva Kubala/0000-0002-9543-4359; Fiedler, Jiri/0000-0001-8080-1323; Filippi, Massimo/0000-0002-5485-0479; Montalban, Xavier/0000-0002-0098-9918; Boyko, Alexei/0000-0003-3306-9541; Arnold, Douglas/0000-0003-4266-0106; Selmaj, Krzysztof/0000-0003-1213-7218				Andersen O, 1996, NEUROLOGY, V47, P895, DOI 10.1212/WNL.47.4.895; Bagnato F, 2003, BRAIN, V126, P1782, DOI 10.1093/brain/awg182; Barkhof F, 1997, NEUROLOGY, V49, P1682, DOI 10.1212/WNL.49.6.1682; BORNSTEIN MB, 1987, NEW ENGL J MED, V317, P408, DOI 10.1056/NEJM198708133170703; Brunmark C, 2002, J NEUROIMMUNOL, V130, P163, DOI 10.1016/S0165-5728(02)00225-4; Comi G, 2001, ANN NEUROL, V49, P290, DOI 10.1002/ana.64.abs; Dalton CM, 2004, J NEUROL, V251, P407, DOI 10.1007/s00415-004-0332-4; Deltenre P, 2001, GUT, V48, P264, DOI 10.1136/gut.48.2.264; DUQUETTE P, 1993, NEUROLOGY, V43, P655, DOI 10.1212/wnl.43.4.655; Ebers GC, 1998, LANCET, V352, P1498, DOI 10.1016/S0140-6736(98)03334-0; Edan G, 1997, J NEUROL NEUROSUR PS, V62, P112, DOI 10.1136/jnnp.62.2.112; Filippi M, 1998, NEUROLOGY, V50, P238, DOI 10.1212/WNL.50.1.238; Filippi M, 1998, BRAIN, V121, P2011, DOI 10.1093/brain/121.10.2011; Filippi M, 2001, NEUROLOGY, V57, P731, DOI 10.1212/WNL.57.4.731; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; Janssen HLA, 2000, BLOOD, V96, P2364; Johnson KP, 1998, NEUROLOGY, V50, P701, DOI 10.1212/WNL.50.3.701; JOHNSON KP, 1995, NEUROLOGY, V45, P1268, DOI 10.1212/WNL.45.7.1268; Karussis DM, 1996, NEUROLOGY, V47, P341, DOI 10.1212/WNL.47.2.341; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; Millefiorini E, 1997, J NEUROL, V244, P153, DOI 10.1007/s004150050066; MILLER DH, 1991, J NEUROL NEUROSUR PS, V54, P683, DOI 10.1136/jnnp.54.8.683; Noseworthy JH, 2000, NEUROLOGY, V54, P1726, DOI 10.1212/WNL.54.9.1726; Polman C, 2005, NEUROLOGY, V64, P987, DOI 10.1212/01.WNL.0000154520.48391.69; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Richert ND, 2001, MULT SCLER, V7, P49, DOI 10.1191/135245801669116174; Rovaris M, 1997, J NEUROL, V244, P266, DOI 10.1007/s004150050083; Rovaris M, 1999, J NEUROL SCI, V164, P148, DOI 10.1016/S0022-510X(99)00054-4; Sormani MP, 1999, J NEUROL SCI, V163, P74, DOI 10.1016/S0022-510X(99)00015-5; Tan IL, 2000, MULT SCLER, V6, P99, DOI 10.1191/135245800678827626; van Waesberghe JHTM, 1998, AM J NEURORADIOL, V19, P675; VANWALDERVEEN MAA, 1995, NEUROLOGY, V45, P1684, DOI 10.1212/WNL.45.9.1684; Wolinsky JS, 2000, NEUROLOGY, V54, P1734, DOI 10.1212/WNL.54.9.1734; Zou LP, 2002, NEUROPHARMACOLOGY, V42, P731, DOI 10.1016/S0028-3908(02)00015-1	35	228	237	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 21	2008	371	9630					2085	2092		10.1016/S0140-6736(08)60918-6	http://dx.doi.org/10.1016/S0140-6736(08)60918-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	316ER	18572078				2022-12-28	WOS:000256932200028
J	Alexander, CMO; Grossman, JN; Ebel, DS; Ciesla, FJ				Alexander, C. M. O'D.; Grossman, J. N.; Ebel, D. S.; Ciesla, F. J.			The formation conditions of chondrules and chondrites	SCIENCE			English	Article							STONY COSMIC SPHERULES; ISOTOPIC FRACTIONATION; FEO-RICH; POTASSIUM; SYSTEM; EVAPORATION; TURBULENCE; PETROLOGY; ORIGIN	Chondrules, which are roughly millimeter- sized silicate- rich spherules, dominate the most primitive meteorites, the chondrites. They formed as molten droplets and, judging from their abundances in chondrites, are the products of one of the most energetic processes that operated in the early inner solar system. The conditions and mechanism of chondrule formation remain poorly understood. Here we show that the abundance of the volatile element sodium remained relatively constant during chondrule formation. Prevention of the evaporation of sodium requires that chondrules formed in regions with much higher solid densities than predicted by known nebular concentration mechanisms. These regions would probably have been self- gravitating. Our model explains many other chemical characteristics of chondrules and also implies that chondrule and planetesimal formation were linked.	[Alexander, C. M. O'D.; Ciesla, F. J.] Carnegie Inst Washington, Dept Terr Magnetism, Washington, DC 20015 USA; [Grossman, J. N.] US Geol Survey, Reston, VA 20192 USA; [Ebel, D. S.] Amer Museum Nat Hist, New York, NY 10024 USA	Carnegie Institution for Science; United States Department of the Interior; United States Geological Survey; American Museum of Natural History (AMNH)	Alexander, CMO (corresponding author), Carnegie Inst Washington, Dept Terr Magnetism, 5241 Broad Branch Rd NW, Washington, DC 20015 USA.	alexande@dtm.ciw.edu	Alexander, Conel M. O'D./N-7533-2013	Alexander, Conel M. O'D./0000-0002-8558-1427				Alexander CMO, 2004, GEOCHIM COSMOCHIM AC, V68, P3943, DOI 10.1016/j.gca.2004.03.030; Alexander CMO, 2005, METEORIT PLANET SCI, V40, P541, DOI 10.1111/j.1945-5100.2005.tb00962.x; Alexander CMO, 2002, GEOCHIM COSMOCHIM AC, V66, P173, DOI 10.1016/S0016-7037(01)00764-5; ALEXANDER CMO, 2007, LUNAR PLANET SCI, V38; Cohen BA, 2004, GEOCHIM COSMOCHIM AC, V68, P1661, DOI 10.1016/j.gca.2003.09.009; Cuzzi JN, 2006, NATURE, V441, P483, DOI 10.1038/nature04834; Cuzzi JN, 2001, ASTROPHYS J, V546, P496, DOI 10.1086/318233; DAVIS AM, 2005, CHONDRITES PROTOPLAN, V341, P432; Desch S.J., 2005, CHONDRITES PROTOPLAN, V341, P849; Ebel DS, 2000, GEOCHIM COSMOCHIM AC, V64, P339, DOI 10.1016/S0016-7037(99)00284-7; GHIORSO MS, 1995, CONTRIB MINERAL PETR, V119, P197, DOI 10.1007/BF00307281; Grossman J.N., 1983, COMPOSITIONS CHONDRU; Hewins R, 2005, CHONDRITES PROTOPLAN, V341, P286; Johansen A, 2007, NATURE, V448, P1022, DOI 10.1038/nature06086; Jones R.H., 1996, CHONDRULES PROTOPLAN, P163; JONES RH, 1993, METEORITICS, V28, P213, DOI 10.1111/j.1945-5100.1993.tb00759.x; JONES RH, 1990, GEOCHIM COSMOCHIM AC, V54, P1785, DOI 10.1016/0016-7037(90)90408-D; JONES RH, 1994, GEOCHIM COSMOCHIM AC, V58, P5325, DOI 10.1016/0016-7037(94)90316-6; JONES RH, 2005, CHONDRITES PROTOPLAN, V341, P251; Joung MKR, 2004, ASTROPHYS J, V606, P532, DOI 10.1086/381651; LIBOUREL G, 2003, LUNAR PLANET SCI, V34, P1558; NAGAHARA H, 1981, NATURE, V292, P135, DOI 10.1038/292135a0; Taylor S, 2005, GEOCHIM COSMOCHIM AC, V69, P2647, DOI 10.1016/j.gca.2004.11.027; Wang JH, 2001, GEOCHIM COSMOCHIM AC, V65, P479, DOI 10.1016/S0016-7037(00)00529-9; Yu Y, 2003, GEOCHIM COSMOCHIM AC, V67, P773, DOI 10.1016/S0016-7037(02)01176-6	26	222	222	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 20	2008	320	5883					1617	1619		10.1126/science.1156561	http://dx.doi.org/10.1126/science.1156561			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	315NM	18566282				2022-12-28	WOS:000256886700042
J	Bohannon, J				Bohannon, John			Scientists invade Azeroth	SCIENCE			English	Editorial Material																		Bainbridge WS, 2007, SCIENCE, V317, P472, DOI 10.1126/science.1146930; 2008, WORLD WARCRAFT  0905	2	8	8	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 20	2008	320	5883					1592	1592		10.1126/science.1161351	http://dx.doi.org/10.1126/science.1161351			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	315NM	18566270				2022-12-28	WOS:000256886700029
J	Wolf, F; Kirchhoff, F				Wolf, Fred; Kirchhoff, Frank			Neuroscience - Imaging astrocyte activity	SCIENCE			English	Editorial Material							VISUAL-CORTEX; NETWORKS; NEURONS; BRAIN		[Wolf, Fred] Max Planck Inst Dynam & Self Org, Gottingen, Germany; [Wolf, Fred] Bernstein Ctr Computat Neurosci, Gottingen, Germany; [Kirchhoff, Frank] Max Planck Inst Expt Med, D-37075 Gottingen, Germany; [Kirchhoff, Frank] DFG Res Ctr Mol Physiol Brain, Gottingen, Germany	Max Planck Society; Max Planck Society; German Research Foundation (DFG)	Wolf, F (corresponding author), Max Planck Inst Dynam & Self Org, Gottingen, Germany.	kirchhoff@em.mpg.de	Kirchhoff, Frank/B-9335-2008; Wolf, Fred/D-5771-2011	Kirchhoff, Frank/0000-0002-2324-2761; Wolf, Fred/0000-0002-7068-3762				BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; D'Ascenzo M, 2007, P NATL ACAD SCI USA, V104, P1995, DOI 10.1073/pnas.0609408104; Grinvald A, 1999, MODERN TECHNIQUES NE, P893, DOI 10.1007/978-3-642-58552-4_34; Houades V, 2008, J NEUROSCI, V28, P5207, DOI 10.1523/JNEUROSCI.5100-07.2008; Houades V, 2006, NEURON GLIA BIOL, V2, P3, DOI 10.1017/S1740925X06000081; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; Kerr JND, 2008, NAT REV NEUROSCI, V9, P195, DOI 10.1038/nrn2338; Nishimura N, 2007, P NATL ACAD SCI USA, V104, P365, DOI 10.1073/pnas.0609551104; Ohki K, 2006, NATURE, V442, P925, DOI 10.1038/nature05019; Pasti L, 1997, J NEUROSCI, V17, P7817; Polimeni JR, 2005, P NATL ACAD SCI USA, V102, P4158, DOI 10.1073/pnas.0500291102; Schummers J, 2008, SCIENCE, V320, P1638, DOI 10.1126/science.1156120	12	26	28	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 20	2008	320	5883					1597	1599		10.1126/science.1160122	http://dx.doi.org/10.1126/science.1160122			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	315NM	18566273				2022-12-28	WOS:000256886700033
J	Hudson, KL; Holohan, MK; Collins, FS				Hudson, Kathy L.; Holohan, M. K.; Collins, Francis S.			Keeping pace with the times - The Genetic Information Nondiscrimination Act of 2008	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DISCRIMINATION		[Hudson, Kathy L.] Johns Hopkins Univ, Genet & Publ Policy Ctr, Baltimore, MD 21218 USA; [Holohan, M. K.; Collins, Francis S.] NHGRI, NIH, Bethesda, MD 20892 USA	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Hudson, KL (corresponding author), Johns Hopkins Univ, Genet & Publ Policy Ctr, Baltimore, MD 21218 USA.							HaH Services, 2008, US SYST OV GEN TEST; Hudson KL, 2007, NEW ENGL J MED, V356, P2021, DOI 10.1056/NEJMp078033; Hudson KL, 2006, SCIENCE, V313, P1853, DOI 10.1126/science.1134996; HUDSON KL, 1995, SCIENCE, V270, P391, DOI 10.1126/science.270.5235.391; Rothenberg K, 1997, SCIENCE, V275, P1755, DOI 10.1126/science.275.5307.1755	5	141	143	2	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 19	2008	358	25					2661	2663		10.1056/NEJMp0803964	http://dx.doi.org/10.1056/NEJMp0803964			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	314NC	18565857				2022-12-28	WOS:000256815100001
J	Schottenfeld, RS; Chawarski, MC; Mazlan, M				Schottenfeld, Richard S.; Chawarski, Marek C.; Mazlan, Mahmud			Maintenance treatment with buprenorphine and naltrexone for heroin dependence in Malaysia: a randomised, double-blind, placebo-controlled trial	LANCET			English	Article							OPIOID DEPENDENCE; CLINICAL-TRIAL; METHADONE-MAINTENANCE; HIV-INFECTION; ST-PETERSBURG; DRUG-USERS; DETOXIFICATION; ADDICTION; THERAPIES; EFFICACY	Background Expansion of access to effective treatments for heroin dependence is a worldwide health priority that will also reduce HIV transmission. We compared the efficacy of naltrexone, buprenorphine, and no additional treatment I in patients receiving detoxification and subsequent drug counselling, for maintenance of heroin abstinence, prevention of relapse, and reduction of HIV risk behaviours. Methods 126 detoxified heroin-dependent patients, from an outpatient research clinic and detoxification programme in Malaysia, were randomly assigned by a computer-generated randomisation sequence to 24 weeks of manual-guided drug counselling and maintenance with naltrexone (n=43), buprenorphine (n=44), or placebo (n=39). Medications were administered on a double-blind and double-dummy basis. Primary outcomes, assessed by urine testing three times per week, were days to first heroin use, days to heroin relapse (three consecutive opioid-positive urine tests), maximum consecutive days of heroin abstinence, and reductions in HIV risk behaviours over 6 months. The study was terminated after 22 months of enrolment because buprenorphine was shown to have greater efficacy in an interim safety analysis. Analysis was by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00383045. Findings We observed consistent, linear contrasts in days to first heroin use (p=0 . 0009), days to heroin relapse (p=0 . 009), and maximum consecutive days abstinent (p=0.0007), with all results best for buprenorphine and worst for placebo. Buprenorphine was associated with greater time to first heroin use than were naltrexone (hazard ratio 1.87 [95% CI 1.21-2.88]) or placebo (2.02 [1.29-3.16]). With buprenorphine, we also recorded significantly greater time to heroin relapse (2.7 [1.38-3.42]), and maximum consecutive days abstinent than with placebo (mean days 59 [95% CI 43-76] vs 24 [13-35]; p=0. 003); however, for these outcomes, differences between buprenorphine and naltrexone were not significant. Differences between naltrexone and placebo were not significant for any outcomes. HIV risk behaviours were significantly reduced from baseline across all three treatments (p=0.003), but the reductions did not differ significantly between the three groups. Interpretation Our findings lend support to the widespread dissemination of maintenance treatment with buprenorphine as an effective public-health approach to reduce problems associated with heroin dependence. Funding US National Institute on Drug Abuse.	[Schottenfeld, Richard S.; Chawarski, Marek C.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06519 USA; [Mazlan, Mahmud] Substance Abuse Ctr, Muar, Johar, Malaysia	Yale University	Schottenfeld, RS (corresponding author), Yale Univ, Sch Med, Dept Psychiat, 34 Park St S205, New Haven, CT 06519 USA.	Richard.schottenfeld@yale.edu			NIDA NIH HHS [R01 DA014718, R01 DA14718, R01 DA014718-04, K24 DA000445-10, K24 DA000445] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014718, K24DA000445] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Aceijas C, 2004, AIDS, V18, P2295, DOI 10.1097/00002030-200411190-00010; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Carroll KM, 2001, ARCH GEN PSYCHIAT, V58, P755, DOI 10.1001/archpsyc.58.8.755; Chawarski MC, 2006, DRUG ALCOHOL DEPEN, V82, pS39, DOI 10.1016/S0376-8716(06)80007-4; CHAWARSKI MC, 1997, PROBLEMS DRUG DEPEND; Comer SD, 2006, ARCH GEN PSYCHIAT, V63, P210, DOI 10.1001/archpsyc.63.2.210; Cornish JW, 1997, J SUBST ABUSE TREAT, V14, P529, DOI 10.1016/S0740-5472(97)00020-2; CURRAN S, 1976, National Institute on Drug Abuse Research Monograph, V9, P67; Fals-Stewart W, 2003, J CONSULT CLIN PSYCH, V71, P432, DOI 10.1037/0022-006X.71.3.432; Fields GS, 2006, MANCH SCH, V74, P355, DOI 10.1111/j.1467-9957.2006.00498.x; Fudala PJ, 2003, NEW ENGL J MED, V349, P949, DOI 10.1056/NEJMoa022164; GOWING L, 2004, COCHRANE DB SYST REV, V4; *I MED COMM PREV H, 2006, PREV HIV INF INJ DRU; International Narcotics Control Board, 2007, NARC DRUGS EST WORLD; Johansson BA, 2006, ADDICTION, V101, P491, DOI 10.1111/j.1360-0443.2006.01369.x; JOHNSON RE, 1995, DRUG ALCOHOL DEPEN, V40, P17, DOI 10.1016/0376-8716(95)01186-2; Johnson RE, 2000, NEW ENGL J MED, V343, P1290, DOI 10.1056/NEJM200011023431802; Kakko J, 2003, LANCET, V361, P662, DOI 10.1016/S0140-6736(03)12600-1; Kakko J, 2007, AM J PSYCHIAT, V164, P797, DOI 10.1176/appi.ajp.164.5.797; Krook AL, 2002, ADDICTION, V97, P533, DOI 10.1046/j.1360-0443.2002.00090.x; Krupitsky EM, 2004, J SUBST ABUSE TREAT, V26, P285, DOI 10.1016/j.jsat.2004.02.002; Krupitsky EM, 2006, J SUBST ABUSE TREAT, V31, P319, DOI 10.1016/j.jsat.2006.05.005; Lawless J. F., 2003, STAT MODELS METHODS; Ling W, 1998, ADDICTION, V93, P475, DOI 10.1046/j.1360-0443.1998.9344753.x; Lofwall MR, 2005, ADDICT DISORD TREAT, V4, P49, DOI 10.1097/01.adt.0000145126.17405.6a; MATTICK RP, 2003, COCHRANE DB SYST REV, V2; Mattick RP, 2003, COCHRANE DB SYST REV, V2; MAYET S, 2006, COCHRANE DB SYST REV, V3; Mazlan M, 2006, DRUG ALCOHOL REV, V25, P473, DOI 10.1080/09595230600883354; Minozzi S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001333.pub2; Miotto K, 1997, DRUG ALCOHOL DEPEN, V45, P131, DOI 10.1016/S0376-8716(97)01348-3; Montori VM, 2005, JAMA-J AM MED ASSOC, V294, P2203, DOI 10.1001/jama.294.17.2203; *N SSATS, 2005, 054112 NSSATS SMA; National Research Council Committee on Clinical Evaluation of, 1978, ARCH GEN PSYCHIAT, V35, P335; OCONNOR PG, 1993, CLIN RES, V41, pA545; Pocock SJ, 2005, JAMA-J AM MED ASSOC, V294, P2228, DOI 10.1001/jama.294.17.2228; SAN L, 1991, BRIT J ADDICT, V86, P983; Schottenfeld RS, 1997, ARCH GEN PSYCHIAT, V54, P713; Sullivan LE, 2005, ADDICTION, V100, P150, DOI 10.1111/j.1360-0443.2004.00963.x; Sullivan MA, 2005, AM J ADDICTION, V14, P486, DOI 10.1080/10550490500247230; *UNAIDS, 2006, UNAIDS 2006 REP GLOB	41	75	75	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN-JUL	2008	371	9631					2192	2200		10.1016/S0140-6736(08)60954-X	http://dx.doi.org/10.1016/S0140-6736(08)60954-X			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	326CP	18586174	Green Accepted			2022-12-28	WOS:000257635800026
J	Ratcliff, F; Harrison, BD; Baulcombe, DC				Ratcliff, F; Harrison, BD; Baulcombe, DC			A similarity between viral defense and gene silencing in plants	SCIENCE			English	Article							BLACK RING VIRUS; NUCLEOTIDE-SEQUENCE; EXPRESSION; RESISTANCE; RNA	Gene silencing in plants, in which an endogenous gene is suppressed by introduction of a related transgene, has been used for crop improvement. Observations that viruses are potentially both initiators and targets of gene silencing suggested that this phenomenon may be related to natural defense against viruses. Supporting this idea, it was found that nepovirus infection of nontransgenic plants induces a resistance mechanism that is similar to transgene-induced gene silencing.	UNIV DUNDEE,DEPT BIOL SCI,DUNDEE DD1 4HN,SCOTLAND	University of Dundee				Baulcombe, David/0000-0003-0780-6878				Baulcombe DC, 1996, PLANT CELL, V8, P1833, DOI 10.1105/tpc.8.10.1833; BAULCOMBE DC, 1995, PLANT J, V7, P1045, DOI 10.1046/j.1365-313X.1995.07061045.x; Baulcombe DC, 1996, CURR OPIN BIOTECH, V7, P173, DOI 10.1016/S0958-1669(96)80009-7; Covey SN, 1997, NATURE, V385, P781, DOI 10.1038/385781a0; Culver JN, 1996, VIROLOGY, V226, P228, DOI 10.1006/viro.1996.0650; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; English JJ, 1996, PLANT CELL, V8, P179, DOI 10.1105/tpc.8.2.179; GREIF C, 1988, J GEN VIROL, V69, P1517, DOI 10.1099/0022-1317-69-7-1517; HARRISON BD, 1958, J GEN MICROBIOL, V18, P450, DOI 10.1099/00221287-18-2-450; HUISMAN MJ, 1988, J GEN VIROL, V69, P1789, DOI 10.1099/0022-1317-69-8-1789; Jorgensen R, 1992, AGBIOTECH NEWS INFOR, V4, P265; JORGENSEN RA, 1995, SCIENCE, V268, P686, DOI 10.1126/science.268.5211.686; KUMAGAI MH, 1995, P NATL ACAD SCI USA, V92, P1679, DOI 10.1073/pnas.92.5.1679; LE GALL O, 1995, J GEN VIROL, V76, P1279, DOI 10.1099/0022-1317-76-5-1279; LINDBO JA, 1993, PLANT CELL, V5, P1749, DOI 10.1105/tpc.5.12.1749; LISTER RM, 1967, ANN APPL BIOL, V59, P49, DOI 10.1111/j.1744-7348.1967.tb04416.x; MATZKE MA, 1995, HOMOLOGOUS RECOMBINA, P271; MATZKE MA, 1995, PLANT PHYSIOL, V107, P6679; MUELLER E, 1995, PLANT J, V7, P1001, DOI 10.1046/j.1365-313X.1995.07061001.x; ROTT ME, 1995, J GEN VIROL, V76, P465, DOI 10.1099/0022-1317-76-2-465; RUIZ T, UNPUB; SHERWOOD JL, 1988, PLANT RESISTANCE VIR, P136; Sijen T, 1996, PLANT CELL, V8, P2277, DOI 10.1105/tpc.8.12.2277; SMITH HA, 1994, PLANT CELL, V6, P1441, DOI 10.1105/tpc.6.10.1441; Wingard SA, 1928, J AGRIC RES, V37, P0127	25	595	664	1	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 6	1997	276	5318					1558	1560		10.1126/science.276.5318.1558	http://dx.doi.org/10.1126/science.276.5318.1558			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XC701	18610513				2022-12-28	WOS:A1997XC70100041
J	Des Marais, DL; Rausher, MD				Des Marais, David L.; Rausher, Mark D.			Escape from adaptive conflict after duplication in an anthocyanin pathway gene	NATURE			English	Article							DIHYDROFLAVONOL 4-REDUCTASE; POSITIVE SELECTION; SUBSTRATE-SPECIFICITY; ZEA-MAYS; EVOLUTION; PRESERVATION; CONSEQUENCES; PROBABILITY; METABOLISM; FLAVONOIDS	Gene duplications have been recognized as an important source of evolutionary innovation and adaptation since at least Haldane(1), and their varying fates may partly explain the vast disparity in observed genome sizes(2). The expected fates of most gene duplications involve primarily non-adaptive substitutions leading to either non-functionalization of one duplicate copy or subfunctionalization(3), neither of which yields novel function. A significant evolutionary problem is thus elucidating the mechanisms of adaptive evolutionary change leading to evolutionary novelty. Currently, the most widely recognized adaptive process involving gene duplication is neo-functionalization (NEO-F), in which one copy undergoes directional selection to perform a novel function after duplication(4). An alternative, but understudied, adaptive fate that has been proposed is escape from adaptive conflict (EAC), in which a single-copy gene is selected to perform a novel function while maintaining its ancestral function(5,6). This gene is constrained from improving either novel or ancestral function because of detrimental pleiotropic effects on the other function. After duplication, one copy is free to improve novel function, whereas the other is selected to improve ancestral function. Here we first present two criteria that can be used to distinguish NEO-F from EAC. Using both tests for positive selection and assays of enzyme function, we then demonstrate that adaptive evolutionary change in a duplicated gene of the anthocyanin biosynthetic pathway in morning glories (Ipomoea) is best interpreted as EAC. Finally, we argue that this phenomenon likely occurs more often than has been previously believed and may thus represent an important mechanism in generating evolutionary novelty.	[Des Marais, David L.; Rausher, Mark D.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Des Marais, David L.; Rausher, Mark D.] Duke Univ, Univ Program Genet & Genom, Durham, NC 27708 USA	Duke University; Duke University	Des Marais, DL (corresponding author), Duke Univ, Dept Biol, Box 90338, Durham, NC 27708 USA.	dld3@duke.edu; mrausher@duke.edu						Benderoth M, 2006, P NATL ACAD SCI USA, V103, P9118, DOI 10.1073/pnas.0601738103; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Fischer TC, 2003, ARCH BIOCHEM BIOPHYS, V412, P223, DOI 10.1016/S0003-9861(03)00013-4; Force A, 1999, GENETICS, V151, P1531; Hahn MW, 2005, GENOME RES, V15, P1153, DOI 10.1101/gr.3567505; Halbwirth H, 2003, PLANT SCI, V164, P489, DOI 10.1016/S0168-9452(02)00433-8; Haldane JBS, 1933, AM NAT, V67, P5, DOI 10.1086/280465; Hittinger CT, 2007, NATURE, V449, P677, DOI 10.1038/nature06151; HUGHES AL, 1994, P ROY SOC B-BIOL SCI, V256, P119, DOI 10.1098/rspb.1994.0058; Inagaki Y, 1999, GENE, V226, P181, DOI 10.1016/S0378-1119(98)00571-X; Iwashina T, 2000, J PLANT RES, V113, P287, DOI 10.1007/PL00013940; Johnson ET, 2001, PLANT J, V25, P325, DOI 10.1046/j.1365-313x.2001.00962.x; Li W. H, 1997, MOL EVOLUTION; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2000, GENETICS, V154, P459; Lynch M, 2001, GENETICS, V159, P1789; Michelmore RW, 1998, GENOME RES, V8, P1113, DOI 10.1101/gr.8.11.1113; NICHOLSON RL, 1987, P NATL ACAD SCI USA, V84, P5520, DOI 10.1073/pnas.84.16.5520; Ohno S., 1970, EVOLUTION GENE DUPLI; Petit P, 2007, J MOL BIOL, V368, P1345, DOI 10.1016/j.jmb.2007.02.088; PIATIGORSKY J, 1991, SCIENCE, V252, P1078, DOI 10.1126/science.252.5009.1078; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SCHWARZSOMMER Z, 1987, EMBO J, V6, P287, DOI 10.1002/j.1460-2075.1987.tb04752.x; STAFFORD HA, 1982, PLANT PHYSIOL, V70, P695, DOI 10.1104/pp.70.3.695; STAFFORD HA, 1965, PLANT PHYSIOL, V40, P130, DOI 10.1104/pp.40.1.130; Stefanovic S, 2002, AM J BOT, V89, P1510, DOI 10.3732/ajb.89.9.1510; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhang JZ, 2002, NAT GENET, V30, P411, DOI 10.1038/ng852	30	262	265	1	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2008	454	7205					762	U85		10.1038/nature07092	http://dx.doi.org/10.1038/nature07092			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334NH	18594508				2022-12-28	WOS:000258228000044
J	Kravchenko, VV; Kaufmann, GF; Mathison, JC; Scott, DA; Katz, AZ; Grauer, DC; Lehmann, M; Meijler, MM; Janda, KD; Ulevitch, RJ				Kravchenko, Vladimir V.; Kaufmann, Gunnar F.; Mathison, John C.; Scott, David A.; Katz, Alexander Z.; Grauer, David C.; Lehmann, Mandy; Meijler, Michael M.; Janda, Kim D.; Ulevitch, Richard J.			Modulation of gene expression via disruption of NF-kappa B signaling by a bacterial small molecule	SCIENCE			English	Article							DEFICIENT MICE; MACROPHAGE APOPTOSIS; TEMPORAL CONTROL; ACTIVATION; RECOGNITION; INHIBITION; LETHALITY; MECHANISM; VIRULENCE; PATHWAYS	The control of innate immune responses through activation of the nuclear transcription factor NF-kappa B is essential for the elimination of invading microbial pathogens. We showed that the bacterial N-( 3- oxo- dodecanoyl) homoserine lactone ( C12) selectively impairs the regulation of NF-kappa B functions in activated mammalian cells. The consequence is specific repression of stimulus- mediated induction of NF-kappa B- responsive genes encoding inflammatory cytokines and other immune regulators. These findings uncover a strategy by which C12- producing opportunistic pathogens, such as Pseudomonas aeruginosa, attenuate the innate immune system to establish and maintain local persistent infection in humans, for example, in cystic fibrosis patients.	[Kravchenko, Vladimir V.; Kaufmann, Gunnar F.; Mathison, John C.; Scott, David A.; Katz, Alexander Z.; Grauer, David C.; Lehmann, Mandy; Meijler, Michael M.; Janda, Kim D.; Ulevitch, Richard J.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Kaufmann, Gunnar F.; Meijler, Michael M.; Janda, Kim D.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Kaufmann, Gunnar F.; Meijler, Michael M.; Janda, Kim D.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Janda, Kim D.] Scripps Res Inst, Worm Inst Res & Med, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Ulevitch, RJ (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ulevitch@scripps.edu	Grauer, David/F-2777-2011; Ulevitch, Richard J/Q-3393-2017	Meijler, Michael/0000-0001-7095-1467				Alcamo E, 2001, J IMMUNOL, V167, P1592, DOI 10.4049/jimmunol.167.3.1592; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; BEG AA, 1995, GENE DEV, V9, P2736, DOI 10.1101/gad.9.22.2736; BEUTLER B, 1985, SCIENCE, V229, P869, DOI 10.1126/science.3895437; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; Doi TS, 1999, P NATL ACAD SCI USA, V96, P2994, DOI 10.1073/pnas.96.6.2994; HAGBERG L, 1985, J IMMUNOL, V134, P4118; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Kravchenko VV, 2006, J BIOL CHEM, V281, P28822, DOI 10.1074/jbc.M606613200; Luo JL, 2005, J CLIN INVEST, V115, P2625, DOI 10.1172/JCI26322; Marino MW, 1997, P NATL ACAD SCI USA, V94, P8093, DOI 10.1073/pnas.94.15.8093; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Park JM, 2005, IMMUNITY, V23, P319, DOI 10.1016/j.immuni.2005.08.010; PEARSON JP, 1994, P NATL ACAD SCI USA, V91, P197, DOI 10.1073/pnas.91.1.197; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Shiner EK, 2005, FEMS MICROBIOL REV, V29, P935, DOI 10.1016/j.femsre.2005.03.001; Smith RS, 2003, J CLIN INVEST, V112, P1460, DOI 10.1172/JCI200320364; THOMPSON JE, 1995, CELL, V80, P573, DOI 10.1016/0092-8674(95)90511-1; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; Williams P, 2000, PHILOS T R SOC B, V355, P667, DOI 10.1098/rstb.2000.0607; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6	28	168	180	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 11	2008	321	5886					259	263		10.1126/science.1156499	http://dx.doi.org/10.1126/science.1156499			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	324IS	18566250				2022-12-28	WOS:000257512900043
J	Rzhetsky, A; Seringhaus, M; Gerstein, M				Rzhetsky, Andrey; Seringhaus, Michael; Gerstein, Mark			Seeking a new biology through text mining	CELL			English	Editorial Material							INFORMATION-RETRIEVAL; WILL	Tens of thousands of biomedical journals exist, and the deluge of new articles in the biomedical sciences is leading to information overload. Hence, there is much interest in text mining, the use of computational tools to enhance the human ability to parse and understand complex text.	[Rzhetsky, Andrey] Univ Chicago, Chicago, IL 60637 USA; [Seringhaus, Michael; Gerstein, Mark] Yale Univ, New Haven, CT 06510 USA	University of Chicago; Yale University	Rzhetsky, A (corresponding author), Univ Chicago, Chicago, IL 60637 USA.	arzhetsky@uchicago.edu	rzhetsky, andrey/B-6118-2012	rzhetsky, andrey/0000-0001-6959-7405	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061372] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM061372, R01 GM061372-06, R01 GM061372-07, GM61372, R01 GM061372-05] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ananiadou S, 2006, TRENDS BIOTECHNOL, V24, P571, DOI 10.1016/j.tibtech.2006.10.002; Berners-Lee T, 2001, NATURE, V410, P1023, DOI 10.1038/35074206; Bourne P, 2005, PLOS COMPUT BIOL, V1, P179, DOI 10.1371/journal.pcbi.0010034; Cohen AM, 2005, BRIEF BIOINFORM, V6, P57, DOI 10.1093/bib/6.1.57; Colosimo ME, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S12; Hamosh A, 2000, HUM MUTAT, V15, P57, DOI 10.1002/(SICI)1098-1004(200001)15:1<57::AID-HUMU12>3.0.CO;2-G; Hirschman L, 2002, J BIOMED INFORM, V35, P247, DOI 10.1016/S1532-0464(03)00014-5; Jensen LJ, 2006, NAT REV GENET, V7, P119, DOI 10.1038/nrg1768; Krallinger M, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-224; Natarajan J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-373; Seringhaus MR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-17; Shafi S.M., 2005, WEBOLOGY, V2; Shatkay H, 2007, BIOINFORMATICS, V23, P1410, DOI 10.1093/bioinformatics/btm115; Shiffrin RM, 2004, P NATL ACAD SCI USA, V101, P5183, DOI 10.1073/pnas.0307852100; Wilbur WJ, 1999, J AM MED INFORM ASSN, P176	15	53	57	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 11	2008	134	1					9	13		10.1016/j.cell.2008.06.029	http://dx.doi.org/10.1016/j.cell.2008.06.029			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	324IU	18614002	Bronze, Green Accepted			2022-12-28	WOS:000257513100005
J	Ix, JH; Wassel, CL; Kanaya, AM; Vittinghoff, E; Johnson, KC; Koster, A; Cauley, JA; Harris, TB; Cummings, SR; Shlipak, MG				Ix, Joachim H.; Wassel, Christina L.; Kanaya, Alka M.; Vittinghoff, Eric; Johnson, Karen C.; Koster, Annemarie; Cauley, Jane A.; Harris, Tamara B.; Cummings, Steven R.; Shlipak, Michael G.		Hlth ABC Study	Fetuin-A and incident diabetes mellitus in older persons	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ALPHA(2)-HEREMANS-SCHMID GLYCOPROTEIN/FETUIN-A; PLASMINOGEN-ACTIVATOR INHIBITOR-1; INSULIN-RESISTANCE; TYROSINE KINASE; ASSOCIATION; SERUM; CALCIFICATION; DISEASE; PREVALENCE; MORTALITY	Context Fetuin-A is a hepatic secretory protein that binds the insulin receptor and inhibits insulin action in vitro. In prior cross- sectional studies in humans, higher fetuin-A levels were associated with insulin resistance. However, the longitudinal association of fetuin- A with incident type 2 diabetes mellitus is unknown. Objective To determine whether fetuin- A levels are associated with incident diabetes in older persons. Design, Setting, and Participants Observational study among 3075 well-functioning persons aged 70 to 79 years. In this case- cohort study, we retrospectively measured fetuin- A levels in baseline serum among 406 randomly selected participants without prevalent diabetes, and all participants who developed incident diabetes mellitus during a 6- year follow- up ( to August 31, 2005). Main Outcome Measure Incident diabetes mellitus. Results Incident diabetes developed in 135 participants ( 10.1 cases/ 1000 person-years). Participants with fetuin- A levels within the highest tertile ( > 0.97 g/ L) had an increased risk of incident diabetes ( 13.3 cases/ 1000 person- years) compared with participants in the lowest tertile ( <= 0.76 g/ L) ( 6.5 cases/ 1000 person- years) in models adjusted for age, sex, race, waist circumference, body weight, physical activity, blood pressure level, fasting glucose level, high- density lipoprotein cholesterol concentration, triglyceride concentration, and C- reactive protein level ( adjusted hazard ratio, 2.41; 95% confidence interval, 1.28- 4.53; P=. 007). The association was not affected by adipocytokine levels but was moderately attenuated by adjustment for visceral adiposity ( adjusted hazard ratio of highest vs lowest tertile 1.72; 95% confidence interval, 0.98- 3.05; P=. 06). Conclusion Among well- functioning older persons, serum fetuin- A is associated with incident diabetes, independent of other markers of insulin resistance.	[Ix, Joachim H.] Univ Calif San Diego, Dept Med, Div Nephrol & Hypertens, San Diego, CA 92161 USA; [Ix, Joachim H.] Univ Calif San Diego, Dept Family & Prevent Med, Div Prevent Med, San Diego, CA 92161 USA; [Ix, Joachim H.] San Diego Vet Affairs Healthcare Syst, San Diego, CA 92161 USA; [Wassel, Christina L.] Univ Minnesota, Dept Epidemiol, Minneapolis, MN USA; [Wassel, Christina L.; Vittinghoff, Eric; Shlipak, Michael G.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Kanaya, Alka M.; Cummings, Steven R.; Shlipak, Michael G.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Johnson, Karen C.] Univ Tennessee, Ctr Hlth Sci, Dept Med, Memphis, TN 38163 USA; [Koster, Annemarie; Harris, Tamara B.] NIA, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA; [Cauley, Jane A.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Cummings, Steven R.] Calif Pacific Med Ctr, Dept Med, San Francisco, CA USA; [Cummings, Steven R.] San Francisco Coordinating Ctr, San Francisco, CA USA; [Shlipak, Michael G.] Vet Affairs Med Ctr, San Francisco, CA 94121 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Tennessee System; University of Tennessee Health Science Center; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; California Pacific Medical Center; California Pacific Medical Center; California Pacific Medical Center Research Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Ix, JH (corresponding author), Univ Calif San Diego, Dept Med, Div Nephrol & Hypertens, 3350 La Jolla Village Dr,Mail Code 111-H, San Diego, CA 92161 USA.	joeix@ucsd.edu	Koster, Annemarie/E-7438-2010; Cauley, Jane A/N-4836-2015; Newman, Anne B./C-6408-2013	Koster, Annemarie/0000-0003-1583-7391; Cauley, Jane A/0000-0003-0752-4408; Newman, Anne B./0000-0002-0106-1150	NATIONAL INSTITUTE ON AGING [N01AG062106, N01AG062103, ZIAAG007390, N01AG062101] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 AG007390-02] Funding Source: Medline; NIA NIH HHS [N01-AG-6-2103, N01-AG-6-2106, N01-AG-6-2101] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AUBERGER P, 1989, CELL, V58, P631, DOI 10.1016/0092-8674(89)90098-6; Barlow WE, 1999, J CLIN EPIDEMIOL, V52, P1165, DOI 10.1016/S0895-4356(99)00102-X; Borch-Johnsen K, 1998, BMJ-BRIT MED J, V317, P371; CAYATTE AJ, 1990, J BIOL CHEM, V265, P5883; Cintron V J, 2001, Int J Exp Diabetes Res, V1, P249; DECLERCK PJ, 1988, BLOOD, V71, P220; Festa A, 2002, DIABETES, V51, P1131, DOI 10.2337/diabetes.51.4.1131; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; GRUNBERGER G, 2002, FRONT ANIM DIAB RES, V3, P281; Hermans MMH, 2007, KIDNEY INT, V72, P202, DOI 10.1038/sj.ki.5002178; Howard BV, 2002, CIRCULATION, V105, pE128; Ix J, 2007, KIDNEY INT, V72, P1394, DOI 10.1038/sj.ki.5002549; Ix JH, 2006, CIRCULATION, V113, P1760, DOI 10.1161/CIRCULATIONAHA.105.588723; Ix JH, 2007, CIRCULATION, V115, P2533, DOI 10.1161/CIRCULATIONAHA.106.682450; Ix JH, 2006, NEPHROL DIAL TRANSPL, V21, P2144, DOI 10.1093/ndt/gfl204; Kaden JJ, 2007, INT J MOL MED, V20, P193; Ketteler M, 2003, LANCET, V361, P827, DOI 10.1016/S0140-6736(03)12710-9; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Kissebah AH, 2000, P NATL ACAD SCI USA, V97, P14478, DOI 10.1073/pnas.97.26.14478; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lim P, 2007, CLIN CHEM, V53, P1835, DOI 10.1373/clinchem.2006.084947; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Lindsay RS, 2002, LANCET, V360, P57, DOI 10.1016/S0140-6736(02)09335-2; Mathews ST, 1997, LIFE SCI, V61, P1583, DOI 10.1016/S0024-3205(97)00737-6; Mathews ST, 2002, DIABETES, V51, P2450, DOI 10.2337/diabetes.51.8.2450; Mathews ST, 2006, BIOCHEM BIOPH RES CO, V350, P437, DOI 10.1016/j.bbrc.2006.09.071; McNeely MJ, 1999, DIABETES CARE, V22, P65, DOI 10.2337/diacare.22.1.65; Moe SM, 2005, KIDNEY INT, V67, P2295, DOI 10.1111/j.1523-1755.2005.00333.x; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; Mori K, 2006, DIABETES CARE, V29, P468, DOI 10.2337/diacare.29.02.06.dc05-1484; *NAT DIAB INF CLEA, INC DIAB US; Perseghin G, 1997, DIABETES, V46, P1001, DOI 10.2337/diabetes.46.6.1001; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; PRENTICE RL, 1986, BIOMETRIKA, V73, P1; RAUTH G, 1992, EUR J BIOCHEM, V204, P523, DOI 10.1111/j.1432-1033.1992.tb16663.x; Resnick HE, 2001, J CLIN EPIDEMIOL, V54, P869, DOI 10.1016/S0895-4356(01)00359-6; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schafer C, 2003, J CLIN INVEST, V112, P357, DOI 10.1172/JCI17202; SRINIVAS PR, 1993, MOL ENDOCRINOL, V7, P1445, DOI 10.1210/me.7.11.1445; Stefan N, 2006, DIABETES CARE, V29, P853, DOI 10.2337/diacare.29.04.06.dc05-1938; Stenvinkel P, 2005, KIDNEY INT, V67, P2383, DOI 10.1111/j.1523-1755.2005.00345.x; Therneau TM, 1999, LIFETIME DATA ANAL, V5, P99, DOI 10.1023/A:1009691327335; Vionnet N, 2000, AM J HUM GENET, V67, P1470, DOI 10.1086/316887; Wahl PW, 1998, LANCET, V352, P1012, DOI 10.1016/S0140-6736(98)04055-0; Wang AYM, 2005, NEPHROL DIAL TRANSPL, V20, P1676, DOI 10.1093/ndt/gfh891; Westenfeld R, 2007, NEPHROL DIAL TRANSPL, V22, P1537, DOI 10.1093/ndt/gfm094	46	208	210	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 9	2008	300	2					182	188		10.1001/jama.300.2.182	http://dx.doi.org/10.1001/jama.300.2.182			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	323GV	18612115	Green Accepted			2022-12-28	WOS:000257435500022
J	Sewankambo, N; IJsselmuiden, C				Sewankambo, Nelson; IJsselmuiden, Carel			Responsive research in developing countries	LANCET			English	Editorial Material									[Sewankambo, Nelson] Makerere Univ, Fac Med, Kampala, Uganda; [IJsselmuiden, Carel] Council Hlth Res Dev, Geneva, Switzerland	Makerere University	Sewankambo, N (corresponding author), Makerere Univ, Fac Med, Kampala, Uganda.	sewankam@infocom.co.ug		Sewankambo, Nelson/0000-0001-9362-053X				ANGWAFO F, 2006, HLTH RES DIS CONTROL; CHEGE K, 2007, SCIDEVNET       0131; *COHRED, PRIOR SETT HLTH RES; Council for International Organizations of Medical Sciences WHO, 2002, INT ETH GUID BIOM RE; Deen JL, 2006, NAT REV DRUG DISCOV, V5, P932, DOI 10.1038/nrd2159; Jamison DT, 2006, PRIORITIES HLTH; London AJ, 2008, LANCET, V372, P82, DOI 10.1016/S0140-6736(08)60996-4; MUGABE J, 2007, SCIDEVNET       0501; Osmanov S, 2007, AIDS, V21, P539, DOI 10.1097/QAD.0b013e328011a0c9; Participants 2001 Conference Ethical, 2004, HASTINGS CENT REP, V34, P17; *WORLD MED ASS, 2000, WORLD MED ASS DECL H	11	11	11	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 5	2008	372	9632					11	13		10.1016/S0140-6736(08)60970-8	http://dx.doi.org/10.1016/S0140-6736(08)60970-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	321XN	18603144				2022-12-28	WOS:000257339900009
J	Alroy, J; Aberhan, M; Bottjer, DJ; Foote, M; Fursich, FT; Harries, PJ; Hendy, AJW; Holland, SM; Ivany, LC; Kiessling, W; Kosnik, MA; Marshall, CR; McGowan, AJ; Miller, AI; Olszewski, TD; Patzkowsky, ME; Peters, SE; Villier, L; Wagner, PJ; Bonuso, N; Borkow, PS; Brenneis, B; Clapham, ME; Fall, LM; Ferguson, CA; Hanson, VL; Krug, AZ; Layou, KM; Leckey, EH; Nurnberg, S; Powers, CM; Sessa, JA; Simpson, C; Tomasovych, A; Visaggi, CC				Alroy, John; Aberhan, Martin; Bottjer, David J.; Foote, Michael; Fuersich, Franz T.; Harries, Peter J.; Hendy, Austin J. W.; Holland, Steven M.; Ivany, Linda C.; Kiessling, Wolfgang; Kosnik, Matthew A.; Marshall, Charles R.; McGowan, Alistair J.; Miller, Arnold I.; Olszewski, Thomas D.; Patzkowsky, Mark E.; Peters, Shanan E.; Villier, Loic; Wagner, Peter J.; Bonuso, Nicole; Borkow, Philip S.; Brenneis, Benjamin; Clapham, Matthew E.; Fall, Leigh M.; Ferguson, Chad A.; Hanson, Victoria L.; Krug, Andrew Z.; Layou, Karen M.; Leckey, Erin H.; Nuernberg, Sabine; Powers, Catherine M.; Sessa, Jocelyn A.; Simpson, Carl; Tomasovych, Adam; Visaggi, Christy C.			Phanerozoic trends in the global diversity of marine invertebrates	SCIENCE			English	Article							TAXONOMIC DIVERSITY; SAMPLING-STANDARDIZATION; MASS EXTINCTIONS; ANIMAL DIVERSITY; ALPHA-DIVERSITY; FOSSIL RECORD; DIVERSIFICATION; COMMUNITIES; EVENNESS; INCREASE	It has previously been thought that there was a steep Cretaceous and Cenozoic radiation of marine invertebrates. This pattern can be replicated with a new data set of fossil occurrences representing 3.5 million specimens, but only when older analytical protocols are used. Moreover, analyses that employ sampling standardization and more robust counting methods show a modest rise in diversity with no clear trend after the mid- Cretaceous. Globally, locally, and at both high and low latitudes, diversity was less than twice as high in the Neogene as in the mid- Paleozoic. The ratio of global to local richness has changed little, and a latitudinal diversity gradient was present in the early Paleozoic.	[Alroy, John] Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA; [Aberhan, Martin; Kiessling, Wolfgang; Brenneis, Benjamin; Nuernberg, Sabine] Humboldt Univ, Museum Nat Kunde, D-10115 Berlin, Germany; [Bottjer, David J.; Bonuso, Nicole; Clapham, Matthew E.; Powers, Catherine M.] Univ So Calif, Dept Earth Sci, Los Angeles, CA 90089 USA; [Foote, Michael; Peters, Shanan E.; Hanson, Victoria L.; Krug, Andrew Z.; Simpson, Carl; Tomasovych, Adam] Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA; [Fuersich, Franz T.] Univ Erlangen Nurnberg, Geozentrum Nordbayern, D-91054 Erlangen, Germany; [Harries, Peter J.] Univ S Florida, Dept Geol, Tampa, FL 33620 USA; [Hendy, Austin J. W.; Miller, Arnold I.; Ferguson, Chad A.; Layou, Karen M.; Sessa, Jocelyn A.] Univ Cincinnati, Dept Geol, Cincinnati, OH 45221 USA; [Hendy, Austin J. W.] Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; [Holland, Steven M.; Hanson, Victoria L.; Layou, Karen M.] Univ Georgia, Dept Geol, Athens, GA 30602 USA; [Ivany, Linda C.; Visaggi, Christy C.] Syracuse Univ, Dept Earth Sci, Syracuse, NY 13244 USA; [Kosnik, Matthew A.; Wagner, Peter J.] Smithsonian Inst, Dept Paleobiol, Washington, DC 20013 USA; [Marshall, Charles R.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [McGowan, Alistair J.] Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England; [Olszewski, Thomas D.; Fall, Leigh M.] Texas A&M Univ, Dept Geol & Geophys, College Stn, TX 77843 USA; [Olszewski, Thomas D.; Fall, Leigh M.] Texas A&M Univ, Fac Ecol & Evolutionary Biol, College Stn, TX 77843 USA; [Patzkowsky, Mark E.; Krug, Andrew Z.; Sessa, Jocelyn A.] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Peters, Shanan E.] Univ Wisconsin, Dept Geol & Geophys, Madison, WI 53706 USA; [Villier, Loic] Univ Aix Marseille 1, Ctr Sedimentol Paleontol, F-13331 Marseille 3, France; [Bonuso, Nicole] Calif State Univ Fullerton, Dept Geol Sci, Fullerton, CA 92834 USA; [Borkow, Philip S.] Hamilton Local Sch Dist, Dept Sci, Columbus, OH 43207 USA; [Clapham, Matthew E.] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA; [Layou, Karen M.] Coll William & Mary, Dept Geol, Williamsburg, VA 23187 USA; [Leckey, Erin H.] Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA; [Simpson, Carl] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Tomasovych, Adam] Slovak Acad Sci, Inst Geol, Bratislava 84005 45, Slovakia; [Visaggi, Christy C.] Univ N Carolina, Dept Biol & Marine Biol, Wilmington, NC 28403 USA	National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; Humboldt University of Berlin; Leibniz Institut fur Evolutions und Biodiversitatsforschung; University of Southern California; University of Chicago; University of Erlangen Nuremberg; State University System of Florida; University of South Florida; University System of Ohio; University of Cincinnati; Yale University; University System of Georgia; University of Georgia; Syracuse University; Smithsonian Institution; Smithsonian National Museum of Natural History; Harvard University; Natural History Museum London; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Wisconsin System; University of Wisconsin Madison; UDICE-French Research Universities; Aix-Marseille Universite; California State University System; California State University Fullerton; University of California System; University of California Santa Cruz; William & Mary; University of Colorado System; University of Colorado Boulder; Duke University; Slovak Academy of Sciences; University of North Carolina; University of North Carolina Wilmington	Alroy, J (corresponding author), Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, 735 State St, Santa Barbara, CA 93101 USA.	alroy@nceas.ucsb.edu	Peters, Shanan E/A-5620-2013; Kosnik, Matthew/G-2312-2010; Clapham, Matthew E./A-4294-2015; Kiessling, Wolfgang/E-2259-2015; Hendy, Austin J/C-1279-2013; Kosnik, Matthew A./P-9632-2019; Holland, Steven/A-8557-2008; Simpson, Carl/E-7140-2010; Alroy, John/B-4585-2009; Tomasovych, Adam/C-9623-2010; Nürnberg, Sabine/D-5217-2013	Peters, Shanan E/0000-0002-3346-4317; Kosnik, Matthew/0000-0001-5380-7041; Clapham, Matthew E./0000-0003-4867-7304; Kiessling, Wolfgang/0000-0002-1088-2014; Hendy, Austin J/0000-0002-9818-1158; Kosnik, Matthew A./0000-0001-5380-7041; Holland, Steven/0000-0002-4527-9370; Alroy, John/0000-0002-9882-2111; Tomasovych, Adam/0000-0002-0471-9480; Harries, Peter/0000-0001-8320-9114; Simpson, Carl/0000-0003-0719-4437; Sessa, Jocelyn A./0000-0003-1509-5519				Alroy J, 1996, PALAEOGEOGR PALAEOCL, V127, P285, DOI 10.1016/S0031-0182(96)00100-9; Alroy J, 2000, PALEOBIOLOGY, V26, P707, DOI 10.1666/0094-8373(2000)026<0707:NMFQMP>2.0.CO;2; Alroy J, 2001, P NATL ACAD SCI USA, V98, P6261, DOI 10.1073/pnas.111144698; AUSICH WI, 1982, SCIENCE, V216, P173, DOI 10.1126/science.216.4542.173; Bambach RK, 1999, GEOBIOS-LYON, V32, P131, DOI 10.1016/S0016-6995(99)80025-4; Bambach RK, 2002, P NATL ACAD SCI USA, V99, P6854, DOI 10.1073/pnas.092150999; BAMBACH RK, 1993, PALEOBIOLOGY, V19, P372, DOI 10.1017/S0094837300000336; BAMBACH RK, 1983, BIOTIC INTERACTIONS, P719; BENTON MJ, 1995, SCIENCE, V268, P52, DOI 10.1126/science.7701342; Bush AM, 2004, J GEOL, V112, P625, DOI 10.1086/424576; Bush AM, 2004, PALEOBIOLOGY, V30, P666, DOI 10.1666/0094-8373(2004)030<0666:RBFDCT>2.0.CO;2; Crampton JS, 2003, SCIENCE, V301, P358, DOI 10.1126/science.1085075; Foote M, 2000, PALEOBIOLOGY, V26, P74, DOI 10.1666/0094-8373(2000)26[74:OAECOT]2.0.CO;2; Kowalewski M, 2006, PALEOBIOLOGY, V32, P533, DOI 10.1666/05074.1; Miller AI, 1996, PALEOBIOLOGY, V22, P304, DOI 10.1017/S0094837300016237; Miller AI, 2000, PALEOBIOLOGY, V26, P53, DOI 10.1666/0094-8373(2000)26[53:CAPGD]2.0.CO;2; Olszewski TD, 2004, OIKOS, V104, P377, DOI 10.1111/j.0030-1299.2004.12519.x; Peters SE, 2001, PALEOBIOLOGY, V27, P583, DOI 10.1666/0094-8373(2001)027<0583:BITPAR>2.0.CO;2; Peters SE, 2004, PALEOBIOLOGY, V30, P325, DOI 10.1666/0094-8373(2004)030<0325:EOCBMC>2.0.CO;2; Powell MG, 2005, GEOLOGY, V33, P381, DOI 10.1130/G21155.1; Powell MG, 2002, GEOLOGY, V30, P331, DOI 10.1130/0091-7613(2002)030<0331:IIEASA>2.0.CO;2; RAUP D M, 1979, Bulletin of Carnegie Museum of Natural History, P85; RAUP D M, 1976, Paleobiology, V2, P289; RAUP DM, 1972, SCIENCE, V177, P1065, DOI 10.1126/science.177.4054.1065; RAUP DM, 1982, SCIENCE, V215, P1501, DOI 10.1126/science.215.4539.1501; Schultz, 1982, GEOLOGICAL SOC AM SP, V190, P291, DOI DOI 10.1130/SPE190-P291; Sepkoski J.J., 1996, GLOBAL EVENT STRATIG, P35, DOI [10.1007/978-3-642-79634-0_4, DOI 10.1007/978-3-642-79634-0_4]; SEPKOSKI JJ, 1981, NATURE, V293, P435, DOI 10.1038/293435a0; SEPKOSKI JJ, 1984, PALEOBIOLOGY, V10, P246, DOI 10.1017/S0094837300008186; SIMPSON GG, 1960, EVOLUTION DARWIN, V1, P117; Stanley SM, 2007, PALEOBIOLOGY, V33, P1, DOI 10.1666/06020.1; Streel M, 2000, EARTH-SCI REV, V52, P121, DOI 10.1016/S0012-8252(00)00026-X; Valentine J. W., 1969, Palaeontology, V12, P684; Van valen L, 1976, EVOL THEORY, V1, P179; Wagner PJ, 2006, SCIENCE, V314, P1289, DOI 10.1126/science.1133795	35	502	531	8	169	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 4	2008	321	5885					97	100		10.1126/science.1156963	http://dx.doi.org/10.1126/science.1156963			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QE	18599780				2022-12-28	WOS:000257320800044
J	Burlaga, LF; Ness, NF; Acuna, MH; Lepping, RP; Connerney, JEP; Richardson, JD				Burlaga, L. F.; Ness, N. F.; Acuna, M. H.; Lepping, R. P.; Connerney, J. E. P.; Richardson, J. D.			Magnetic fields at the solar wind termination shock	NATURE			English	Article							COLLISIONLESS-SHOCK; PERPENDICULAR SHOCKS; VOYAGER-1; PLASMA; HELIOSHEATH; WAVES; IONS	A transition between the supersonic solar wind and the subsonic heliosheath was observed by Voyager 1, but the expected termination shock was not seen owing to a gap in the telemetry(1-4). Here we report observations of the magnetic field structure and dynamics of the termination shock, made by Voyager 2 on 31 August - 1 September 2007 at a distance of 83.7 AU from the Sun ( 1 AU is the Earth - Sun distance). A single crossing of the shock was expected, with a boundary that was stable on a timescale of several days. But the data reveal a complex, rippled, quasi- perpendicular supercritical magnetohydrodynamic shock of moderate strength undergoing reformation on a scale of a few hours. The observed structure suggests the importance of ionized interstellar atoms shock.	[Burlaga, L. F.; Acuna, M. H.; Lepping, R. P.; Connerney, J. E. P.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Ness, N. F.] Catholic Univ Amer, Washington, DC 20064 USA; [Richardson, J. D.] MIT, Cambridge, MA 02139 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Catholic University of America; Massachusetts Institute of Technology (MIT)	Burlaga, LF (corresponding author), NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA.	Leonard.F.Burlaga@nasa.gov	connerney, john/I-5127-2013	connerney, jack/0000-0001-7478-6462				Bale SD, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.205001; BEHANNON KW, 1977, SPACE SCI REV, V21, P235, DOI 10.1007/BF00211541; BISKAMP D, 1972, NUCL FUSION, V12, P663, DOI 10.1088/0029-5515/12/6/006; Burgess D, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2435317; Burlaga LF, 2005, SCIENCE, V309, P2027, DOI 10.1126/science.1117542; Decker RB, 2005, SCIENCE, V309, P2020, DOI 10.1126/science.1117569; GOODRICH CC, 1985, GEOPHYS MONOGR SER, V35, P153, DOI DOI 10.1029/GM035P0153; Gurnett DA, 2005, SCIENCE, V309, P2025, DOI 10.1126/science.1117425; LEMBEGE B, 1987, PHYS FLUIDS, V30, P1767, DOI 10.1063/1.866191; Lembege B, 2004, SPACE SCI REV, V110, P161, DOI 10.1023/B:SPAC.0000023372.12232.b7; LEMBEGE B, 1992, PHYS FLUIDS B-PLASMA, V4, P3533, DOI 10.1063/1.860361; LEROY MM, 1983, PHYS FLUIDS, V26, P2742, DOI 10.1063/1.864468; Lipatov AS, 1999, PHYS REV LETT, V82, P3609, DOI 10.1103/PhysRevLett.82.3609; LIVESEY WA, 1982, GEOPHYS RES LETT, V9, P1037, DOI 10.1029/GL009i009p01037; LOWE RE, 2003, ANN GEOPHYS, V21, P1; Newbury JA, 1998, J GEOPHYS RES-SPACE, V103, P29581, DOI 10.1029/1998JA900024; PHILLIPS PE, 1972, PHYS REV LETT, V29, P154, DOI 10.1103/PhysRevLett.29.154; SCHOLER M, 2003, J GEOPHYS RES, V108; Stone EC, 2005, SCIENCE, V309, P2017, DOI 10.1126/science.1117684; WHANG YC, 1995, J GEOPHYS RES-SPACE, V100, P17015, DOI 10.1029/95JA01106; WINSKE D, 1988, J GEOPHYS RES, V93, P9681, DOI 10.1029/JA093iA09p09681; WOODS LC, 1969, J PLASMA PHYS, V3, P435, DOI 10.1017/S0022377800004517; Zank GP, 1996, J GEOPHYS RES-SPACE, V101, P457, DOI 10.1029/95JA02860	23	193	193	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 3	2008	454	7200					75	77		10.1038/nature07029	http://dx.doi.org/10.1038/nature07029			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321MC	18596803				2022-12-28	WOS:000257308300038
J	Schouten, LMT; Hulscher, MEJL; van Everdingen, JJE; Huijsman, R; Grol, RPTM				Schouten, Loes M. T.; Hulscher, Marlies E. J. L.; van Everdingen, Jannes J. E.; Huijsman, Robbert; Grol, Richard P. T. M.			Evidence for the impact of quality improvement collaboratives: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CHRONIC ILLNESS CARE; NEONATAL INTENSIVE-CARE; HEART-FAILURE; BREAKTHROUGH SERIES; ASTHMA CARE; HEALTH-CARE; OUTCOMES; MANAGEMENT; MODEL; IMPLEMENTATION	Objective To evaluate the effectiveness of quality improvement collaboratives in improving the quatity of care. Data sources Relevant studies through Medline, Embase, PsychINFO, CINAHL, and Cochrane databases. Study selection Two reviewers independently extracted data on topics, participants, setting, study design, and outcomes. Data synthesis Of 1104 articles identified, 72 were included in the study. Twelve reports representing nine studies (including two randomised controlled trials) used a controlled design to measure the effects of the quality improvement collaborative intervention on care processes or outcomes of care. Systematic review of these nine studies showed moderate positive results. Seven studies (including one randomised controlled trial) reported an effect on some of the selected outcome measures. Two studies (including one randomised controlled trial) did not show any significant effect. Conclusions The evidence underlying quality improvement collaboratives is positive but-limited and the effects cannot be predicted with great certainty. Considering that quality improvement collaboratives seem to play a key part in current strategies focused on accelerating improvement, but may have only modest effects on outcomes at best, further knowledge of the basic components effectiveness, cost effectiveness, and success factors is crucial to determine the value of quality improvement collaboratives.	[Schouten, Loes M. T.; van Everdingen, Jannes J. E.] Dutch Inst Healthcare Improvement, NL-3502 LB Utrecht, Netherlands; [Hulscher, Marlies E. J. L.; Grol, Richard P. T. M.] Univ Nijmegen St Radboud Hosp, Med Ctr, Ctr Qual Care Res, Nijmegen, Netherlands; [Huijsman, Robbert] Univ Med Ctr Rotterdam, Inst Hlth Policy & Management, Erasmus MC, Rotterdam, Netherlands	Radboud University Nijmegen; Erasmus University Rotterdam; Erasmus MC	Schouten, LMT (corresponding author), Dutch Inst Healthcare Improvement, POB 20064, NL-3502 LB Utrecht, Netherlands.	l.schouten@cbo.nl	Young, Alexander/A-1523-2009; Grol, Richard/C-8523-2013; Hulscher, Marlies/B-1229-2014	Young, Alexander/0000-0002-9367-9213; Hulscher, Marlies/0000-0002-2160-4810; Huijsman, Robbert/0000-0002-9776-129X				Armstrong B, 2005, J HEALTHC MANAG, V50, P399, DOI 10.1097/00115514-200511000-00009; Asch SM, 2005, MED CARE, V43, P667, DOI 10.1097/01.mlr.0000167182.72251.a1; Ayers Lea R, 2005, Qual Manag Health Care, V14, P234; Baier Rosa R, 2003, J Am Med Dir Assoc, V4, P291, DOI 10.1016/S1525-8610(04)70387-4; Baier RR, 2004, J AM GERIATR SOC, V52, P1988, DOI 10.1111/j.1532-5415.2004.52553.x; BAIRD RW, 2001, BAYLOR U MED CENT P, V14, P294; Baker DW, 2005, J CARD FAIL, V11, P405, DOI 10.1016/j.cardfail.2005.03.010; Bartlett J, 2002, INT J QUAL HEALTH C, V14, P463, DOI 10.1093/intqhc/14.6.463; Benedetti Rob, 2004, Jt Comm J Qual Saf, V30, P187; Berry B B, 1998, Jt Comm J Qual Improv, V24, P459; Besserman E, 1998, Qual Manag Health Care, V6, P43; Black N, 1996, BRIT MED J, V312, P1215; Bonomi AE, 2002, HEALTH SERV RES, V37, P791, DOI 10.1111/1475-6773.00049; Brattebo G, 2002, BMJ-BRIT MED J, V324, P1386, DOI 10.1136/bmj.324.7350.1386; Bundy DG, 2005, PEDIATRICS, V116, P82, DOI 10.1542/peds.2004-2573; Burch K, 2003, PEDIATRICS, V111; Chin MH, 2004, DIABETES CARE, V27, P2, DOI 10.2337/diacare.27.1.2; Cleeland CS, 2003, CLIN J PAIN, V19, P298, DOI 10.1097/00002508-200309000-00003; Daniel D.M., 2004, JT COMM J QUAL SAF, V30, P57; Daniel Donna M, 2004, Jt Comm J Qual Saf, V30, P69; Daniel Donna M, 2004, Jt Comm J Qual Saf, V30, P103; Dellinger EP, 2005, AM J SURG, V190, P9, DOI 10.1016/j.amjsurg.2004.12.001; Doran K A, 1998, Qual Manag Health Care, V6, P29; Farbstein K, 2001, Jt Comm J Qual Improv, V27, P123; Flamm BL, 1998, BIRTH-ISS PERINAT C, V25, P117, DOI 10.1046/j.1523-536x.1998.00117.x; GITOMER RS, 2005, J CLIN OUTCOMES MANA, V12, P245; Glasgow RE, 2002, ANN BEHAV MED, V24, P80, DOI 10.1207/S15324796ABM2402_04; Green Paul L, 2002, Jt Comm J Qual Improv, V28, P55; Gregory K D, 1999, Jt Comm J Qual Improv, V25, P619; Griffith C, 2004, EJSO-EUR J SURG ONC, V30, P1, DOI 10.1016/j.ejso.2004.07.010; Hankinson MT, 2006, JT COMM J QUAL PATIE, V32, P142, DOI 10.1016/S1553-7250(06)32019-3; Henderson Diana, 2003, Mo Med, V100, P590; Henderson Diana, 2004, Front Health Serv Manage, V20, P25; Homer CJ, 2005, ARCH PEDIAT ADOL MED, V159, P464, DOI 10.1001/archpedi.159.5.464; Horbar JD, 2004, BMJ-BRIT MED J, V329, P1004, DOI 10.1136/bmj.329.7473.1004; Horbar JD, 2001, PEDIATRICS, V107, P14, DOI 10.1542/peds.107.1.14; Joshi M, 2005, JT COMM J QUAL PATIE, V31, P671, DOI 10.1016/S1553-7250(05)31087-7; Kaempf JW, 2003, PEDIATRICS, V111; Katzelnick DJ, 2005, JT COMM J QUAL PATIE, V31, P386, DOI 10.1016/S1553-7250(05)31052-X; Kilbride HW, 2003, PEDIATRICS, V111; Kilo C M, 1998, Qual Manag Health Care, V6, P1; Kilo C M, 1999, Pediatrics, V103, P384; KILO CM, 1999, PEDIATRICS SE, V103, pE384; Kirkwood B, 2004, BRIT MED J, V328, P966, DOI 10.1136/bmj.328.7446.966; Kosseff A L, 2001, Jt Comm J Qual Improv, V27, P5; LaBresh KA, 2004, ARCH INTERN MED, V164, P203, DOI 10.1001/archinte.164.2.203; Lain J, 1998, Qual Manag Health Care, V6, P37; Landis SE, 2006, FAM MED, V38, P190; Landon BE, 2004, ANN INTERN MED, V140, P887, DOI 10.7326/0003-4819-140-11-200406010-00010; Leape L L, 2000, Jt Comm J Qual Improv, V26, P321; Lynn, 1999, Cancer Control, V6, P131; Lynn J, 2002, ANN INTERN MED, V137, P117, DOI 10.7326/0003-4819-137-2-200207160-00010; Malenka D J, 1998, Jt Comm J Qual Improv, V24, P594; Mangione-Smith R, 2005, AMBUL PEDIATR, V5, P75, DOI 10.1367/A04-106R.1; Marsteller JA, 2007, JT COMM J QUAL PATIE, V33, P267, DOI 10.1016/S1553-7250(07)33031-6; McKee M, 1999, BMJ-BRIT MED J, V319, P312, DOI 10.1136/bmj.319.7205.312; Mills Peter D, 2003, Jt Comm J Qual Saf, V29, P124; Mills Peter D, 2004, Jt Comm J Qual Saf, V30, P152; Mittman BS, 2004, ANN INTERN MED, V140, P897, DOI 10.7326/0003-4819-140-11-200406010-00011; Neily J, 2005, JT COMM J QUAL PATIE, V31, P275, DOI 10.1016/S1553-7250(05)31035-X; Newton PJ, 2006, J CARDIOVASC NURS, V21, P161, DOI 10.1097/00005082-200605000-00002; Nolan K, 2005, JT COMM J QUAL PATIE, V31, P339, DOI 10.1016/S1553-7250(05)31045-2; Nugent WC, 2005, SEMIN CARDIOTHORAC V, V9, P115, DOI 10.1177/108925320500900202; OConnor GT, 1996, JAMA-J AM MED ASSOC, V275, P841, DOI 10.1001/jama.275.11.841; Ovretveit J, 2002, QUAL SAF HEALTH CARE, V11, P345, DOI 10.1136/qhc.11.4.345; Pearson ML, 2005, HEALTH SERV RES, V40, P978, DOI 10.1111/j.1475-6773.2005.00397.x; Pierce-Bulger M, 2001, Qual Manag Health Care, V9, P40; Plsek PE, 1997, AM J INFECT CONTROL, V25, P85, DOI 10.1016/S0196-6553(97)90033-X; Resar R, 2005, JT COMM J QUAL PATIE, V31, P243, DOI 10.1016/S1553-7250(05)31031-2; Rogers G, 2006, JT COMM J QUAL PATIE, V32, P37, DOI 10.1016/S1553-7250(06)32006-5; Rogowski JA, 2001, PEDIATRICS, V107, P23, DOI 10.1542/peds.107.1.23; Saunders RP, 2003, PEDIATRICS, V111; Schiff G D, 2001, Jt Comm J Qual Improv, V27, P387; Schonlau M, 2005, ANN FAM MED, V3, P200, DOI 10.1370/afm.269; SCHOUTEN LMT, IN PRESS STROKE; Shortell SM, 2004, MED CARE, V42, P1040, DOI 10.1097/00005650-200411000-00002; Silver M P, 2000, Jt Comm J Qual Improv, V26, P332; Siomos EE, 2005, AM J MANAG CARE, V11, P332; Solberg LI, 2005, ANN FAM MED, V3, P198, DOI 10.1370/afm.304; Toncich G, 2000, J Qual Clin Pract, V20, P79, DOI 10.1046/j.1440-1762.2000.00370.x; Wagner E H, 2001, Jt Comm J Qual Improv, V27, P63; Wang Anthea, 2004, Jt Comm J Qual Saf, V30, P396; Weeks W B, 2001, Jt Comm J Qual Improv, V27, P243; Whittington John, 2004, Qual Manag Health Care, V13, P53; Wilson Tim, 2003, Jt Comm J Qual Saf, V29, P85; Womer RB, 2002, J CLIN ONCOL, V20, P4705, DOI 10.1200/JCO.2002.04.108; Young PC, 2006, PEDIATRICS, V117, P1469, DOI 10.1542/peds.2005-2210; Zhang HL, 2005, AM HEART J, V149, P856, DOI 10.1016/j.ahj.2004.05.057; 1997, OR MANAGER, V13, P21	89	450	452	0	27	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 28	2008	336	7659					1491	+		10.1136/bmj.39570.749884.BE	http://dx.doi.org/10.1136/bmj.39570.749884.BE			20	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	324GN	18577559	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000257505900038
J	Levy, ED; Erba, EB; Robinson, CV; Teichmann, SA				Levy, Emmanuel D.; Erba, Elisabetta Boeri; Robinson, Carol V.; Teichmann, Sarah A.			Assembly reflects evolution of protein complexes	NATURE			English	Article							MACROMOLECULAR ASSEMBLIES; NETWORKS; SYMMETRY; SUBUNIT	A homomer is formed by self- interacting copies of a protein unit. This is functionally important(1,2), as in allostery(3-5), and structurally crucial because mis- assembly of homomers is implicated in disease(6,7). Homomers are widespread, with 50 - 70% of proteins with a known quaternary state assembling into such structures(8,9). Despite their prevalence, their role in the evolution of cellular machinery(10,11) and the potential for their use in the design of new molecular machines(12,13), little is known about the mechanisms that drive formation of homomers at the level of evolution and assembly in the cell(9,14). Here we present an analysis of over 5,000 unique atomic structures and show that the quaternary structure of homomers is conserved in over 70% of protein pairs sharing as little as 30% sequence identity. Where quaternary structure is not conserved among the members of a protein family, a detailed investigation revealed well- defined evolutionary pathways by which proteins transit between different quaternary structure types. Furthermore, we show by perturbing subunit interfaces within complexes and by mass spectrometry analysis(15), that the ( dis) assembly pathway mimics the evolutionary pathway. These data represent a molecular analogy to Haeckel's evolutionary paradigm of embryonic development, where an intermediate in the assembly of a complex represents a form that appeared in its own evolutionary history. Our model of self- assembly allows reliable prediction of evolution and assembly of a complex solely from its crystal structure.	[Levy, Emmanuel D.; Teichmann, Sarah A.] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Erba, Elisabetta Boeri; Robinson, Carol V.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	MRC Laboratory Molecular Biology; University of Cambridge	Levy, ED (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	homomers@mrc-lmb.cam.ac.uk	Erba, Elisabetta Boeri/J-1058-2014	Erba, Elisabetta Boeri/0000-0002-5910-4707; Teichmann, Sarah/0000-0002-6294-6366; robinson, carol/0000-0001-7829-5505	Medical Research Council [MC_U105161047, U.1051.04.025(78835)] Funding Source: Medline; MRC [MC_U105161047] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bahadur RP, 2007, J MOL BIOL, V367, P574, DOI 10.1016/j.jmb.2006.12.054; Blundell TL, 1996, P NATL ACAD SCI USA, V93, P14243, DOI 10.1073/pnas.93.25.14243; Brinda KV, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-296; Cabezon E, 2002, J BIOL CHEM, V277, P41334, DOI 10.1074/jbc.M207169200; Cheesman C, 2004, BIOCHEMISTRY-US, V43, P1609, DOI 10.1021/bi0354987; CLAVERIE P, 1968, CR ACAD SCI D NAT, V266, P1616; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; Grueninger D, 2008, SCIENCE, V319, P206, DOI 10.1126/science.1150421; HARDY LW, 1987, SCIENCE, V235, P448, DOI 10.1126/science.3099389; Hayouka Z, 2007, P NATL ACAD SCI USA, V104, P8316, DOI 10.1073/pnas.0700781104; Hernandez H, 2007, NAT PROTOC, V2, P715, DOI 10.1038/nprot.2007.73; Hernandez H, 2006, EMBO REP, V7, P605, DOI 10.1038/sj.embor.7400702; Iber D, 2006, NATURE, V441, P371, DOI 10.1038/nature04666; Ispolatov I, 2005, NUCLEIC ACIDS RES, V33, P3629, DOI 10.1093/nar/gki678; Janin J, 2008, SCIENCE, V319, P165, DOI 10.1126/science.1152930; Kress W, 2007, BIOCHEMISTRY-US, V46, P6183, DOI 10.1021/bi602616t; Levy ED, 2007, STRUCTURE, V15, P1364, DOI 10.1016/j.str.2007.09.019; Levy ED, 2006, PLOS COMPUT BIOL, V2, P1395, DOI 10.1371/journal.pcbi.0020155; Lukatsky DB, 2007, J MOL BIOL, V365, P1596, DOI 10.1016/j.jmb.2006.11.020; Luke K, 2006, ARCH BIOCHEM BIOPHYS, V456, P8, DOI 10.1016/j.abb.2006.10.003; Marianayagam NJ, 2004, TRENDS BIOCHEM SCI, V29, P618, DOI 10.1016/j.tibs.2004.09.006; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; MONOD J, 1968, NOB S, V11; Pereira-Leal JB, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r51; Powers ET, 2003, BIOPHYS J, V85, P3587, DOI 10.1016/S0006-3495(03)74777-8; Sobott F, 2002, ANAL CHEM, V74, P1402, DOI 10.1021/ac0110552	28	311	312	4	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2008	453	7199					1262	U66		10.1038/nature06942	http://dx.doi.org/10.1038/nature06942			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318FA	18563089	Green Accepted			2022-12-28	WOS:000257075800048
J	Giurfa, M; Eichmann, B; Menzel, R				Giurfa, M; Eichmann, B; Menzel, R			Symmetry perception in an insect	NATURE			English	Article							MALE SEXUAL ORNAMENTS; PATTERN-RECOGNITION; PREFERENCE; COLOR; BEES; DISCRIMINATION; ORIENTATION; HONEYBEE; FLOWERS; VISION	SYMMETRICAL visual patterns have a salient status in human perception, as evinced by their prevalent occurrence in art(1), and also in animal perception, where they may be an indicator of phenotypic and genotypic quality(2-4). Symmetry perception has been demonstrated in humans(5-8), birds(9-11), dolphins(12) and apes(13). Here we show that bees trained to discriminate bilaterally symmetrical from non-symmetrical patterns learn the task and transfer it appropriately to novel stimuli, thus demonstrating a capacity to detect and generalize symmetry or asymmetry. We conclude that bees, and possibly flower-visiting insects in general, can acquire a generalized preference towards symmetrical or, alternatively, asymmetrical patterns depending on experience, and that symmetry detection is preformed or can be learned as a perceptual category by insects, because it can be extracted as an independent visual pattern feature. Bees show a predisposition for learning and generalizing symmetry because, if trained to it, they choose it more frequently, come closer to and hover longer in front of the novel symmetrical stimuli than the bees trained for asymmetry do for the novel asymmetrical stimuli. Thus, even organisms with comparatively small nervous systems can generalize about symmetry, and favour symmetrical over asymmetrical patterns.			Giurfa, M (corresponding author), FREE UNIV BERLIN, INST NEUROBIOL, KONIGIN LUISE STR 28-30, D-14195 BERLIN, GERMANY.		Giurfa, Martin MG/A-7322-2008; Giurfa, Martin/H-5140-2016; Giurfa, Martin/AAS-4945-2020	Giurfa, Martin/0000-0001-7173-769X; Giurfa, Martin/0000-0001-7173-769X				BARLOW HB, 1979, VISION RES, V19, P783, DOI 10.1016/0042-6989(79)90154-8; BORNSTEIN MH, 1981, DEV PSYCHOL, V17, P82, DOI 10.1037/0012-1649.17.1.82; CAGLIOTI G, 1990, SYMMETRIEBRECHUNG WA; CORBALLIS MC, 1975, J EXP PSYCHOL HUMAN, V1, P221, DOI 10.1037/0096-1523.1.3.221; DELIUS JD, 1978, BEHAV BIOL, V22, P336, DOI 10.1016/S0091-6773(78)92411-2; DELIUS JD, 1982, PSYCHOL RES-PSYCH FO, V44, P199, DOI 10.1007/BF00308420; ENQUIST M, 1994, NATURE, V372, P169, DOI 10.1038/372169a0; GIURFA M, 1995, J COMP PHYSIOL A, V177, P247; GIURFA M, 1995, NATURWISSENSCHAFTEN, V82, P198, DOI 10.1007/BF01143197; HERTZ MATHILDE, 1929, ZEITSCHR VERGL PHYSIOL, V8, P693, DOI 10.1007/BF00340937; HORRIDGE GA, 1992, PHILOS T R SOC B, V337, P49, DOI 10.1098/rstb.1992.0082; LEHRER M, 1995, PHILOS T R SOC B, V347, P123, DOI 10.1098/rstb.1995.0017; MARCELJA S, 1980, J OPT SOC AM, V70, P1297, DOI 10.1364/JOSA.70.001297; MENNE M, 1978, Z TIERPSYCHOL, V47, P299; MENZEL R, 1993, BIOL REV, V68, P81, DOI 10.1111/j.1469-185X.1993.tb00732.x; MENZEL R, 1967, Z VERGL PHYSIOL, V56, P22, DOI 10.1007/BF00333562; MOLLER AP, 1995, P NATL ACAD SCI USA, V92, P2288, DOI 10.1073/pnas.92.6.2288; MOLLER AP, 1994, J EVOLUTION BIOL, V7, P97, DOI 10.1046/j.1420-9101.1994.7010097.x; MOLLER AP, 1992, NATURE, V357, P238, DOI 10.1038/357238a0; MOLLER AP, 1993, BEHAV ECOL SOCIOBIOL, V32, P371, DOI 10.1007/BF00168820; OCARROLL D, 1993, NATURE, V362, P541, DOI 10.1038/362541a0; Osorio D, 1996, P ROY SOC B-BIOL SCI, V263, P105, DOI 10.1098/rspb.1996.0017; PASHLER H, 1990, J EXP PSYCHOL HUMAN, V16, P150, DOI 10.1037/0096-1523.16.1.150; Rensch B., 1957, Zeitschrift fuer Tierpsychologie, V14, P71; SRINIVASAN MV, 1994, J INSECT PHYSIOL, V40, P183, DOI 10.1016/0022-1910(94)90041-8; SRINIVASAN MV, 1994, PHILOS T R SOC B, V343, P199, DOI 10.1098/rstb.1994.0021; SWADDLE JP, 1994, NATURE, V367, P165, DOI 10.1038/367165a0; VANHATEREN JH, 1990, J COMP PHYSIOL A, V167, P649, DOI 10.1007/BF00192658; VONFERSEN L, 1992, MARINE MAMMAL SENSORY SYSTEMS, P753; Wehner R, 1981, COMP PHYS EVOLUTION, VVII/ 6C, P287, DOI DOI 10.1007/978-3642-67868-4	30	214	218	0	37	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 1	1996	382	6590					458	461		10.1038/382458a0	http://dx.doi.org/10.1038/382458a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VA251	18610516				2022-12-28	WOS:A1996VA25100059
J	O'Keeffe, SA; McNally, S; Keogan, MT				O'Keeffe, Sylvia A.; McNally, Sorcha; Keogan, Mary T.			Rational imaging - Investigating painless haematuria	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INITIAL EVALUATION; CT UROGRAPHY		[O'Keeffe, Sylvia A.; McNally, Sorcha; Keogan, Mary T.] St James Hosp, Dublin 8, Ireland	Trinity College Dublin	O'Keeffe, SA (corresponding author), St James Hosp, Dublin 8, Ireland.	sylviaokeeffe@yahoo.co.uk	O'Keeffe, Sylvia/AAO-4268-2021	O'Keeffe, Sylvia/0000-0001-7419-9356				Albani JM, 2007, J UROLOGY, V177, P644, DOI 10.1016/j.juro.2006.09.065; Dalla Palma L, 2001, EUR RADIOL, V11, P931, DOI 10.1007/s003300000801; Jaffe JS, 2001, UROLOGY, V57, P889, DOI 10.1016/S0090-4295(00)01124-9; Khadra MH, 2000, J UROLOGY, V163, P524, DOI 10.1016/S0022-5347(05)67916-5; Maturen KE, 2007, AM J ROENTGENOL, V188, P563, DOI 10.2214/AJR.06.0220; Nawfel RD, 2004, RADIOLOGY, V232, P126, DOI 10.1148/radiol.2321030222; Rodgers M, 2006, HEALTH TECHNOL ASSES, V10, pIII; *SCOTT INT GUID NE, 1997, INV AS MICR HAEM AD; Sears CLG, 2002, J UROLOGY, V168, P2457, DOI 10.1097/01.ju.0000036541.52816.98; Sourtzis S, 1999, AM J ROENTGENOL, V172, P1491, DOI 10.2214/ajr.172.6.10350278; Thomson J M, 2001, Australas Radiol, V45, P291, DOI 10.1046/j.1440-1673.2001.00923.x; Van der Molen AJ, 2008, EUR RADIOL, V18, P4, DOI 10.1007/s00330-007-0792-x; Zagoria RJ, 2007, AM J ROENTGENOL, V189, P429, DOI 10.2214/AJR.07.2258	13	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 11	2008	337	7674							a260	10.1136/bmj.a260	http://dx.doi.org/10.1136/bmj.a260			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	358FU	18614519				2022-12-28	WOS:000259903300037
J	Parsons, T; Ji, C; Kirby, E				Parsons, Tom; Ji, Chen; Kirby, Eric			Stress changes from the 2008 Wenchuan earthquake and increased hazard in the Sichuan basin	NATURE			English	Article							SEISMIC HAZARD	On 12 May 2008, the devastating magnitude 7.9 (Wenchuan) earthquake struck the eastern edge of the Tibetan plateau, collapsing buildings and killing thousands in major cities aligned along the western Sichuan basin in China. After such a large-magnitude earthquake, rearrangement of stresses in the crust commonly leads to subsequent damaging earthquakes(1-5). The mainshock of the 12 May earthquake ruptured with as much as 9m of slip along the boundary between the Longmen Shan and Sichuan basin, and demonstrated the complex strike-slip and thrust motion(6) that characterizes the region(7,8). The Sichuan basin and surroundings are also crossed by other active strike-slip and thrust faults. Here we present calculations of the coseismic stress changes that resulted from the 12 May event using models of those faults, and show that many indicate significant stress increases. Rapid mapping of such stress changes can help to locate fault sections with relatively higher odds of producing large aftershocks.	[Parsons, Tom] US Geol Survey, Menlo Pk, CA 94025 USA; [Ji, Chen] Univ Calif Santa Barbara, Dept Geol Sci, Santa Barbara, CA 93106 USA; [Kirby, Eric] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA	United States Department of the Interior; United States Geological Survey; University of California System; University of California Santa Barbara; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Parsons, T (corresponding author), US Geol Survey, MS-999,345 Middlefield Rd, Menlo Pk, CA 94025 USA.	tparsons@usgs.gov	Parsons, Tom E/A-3424-2008	Parsons, Tom/0000-0002-0582-4338				Burchfiel B.C., 1995, INT GEOL REV, V37, P661, DOI [10.1080/00206819509465424, DOI 10.1080/00206819509465424]; DENSMORE AL, 2007, TECTONICS, V26; Harris RA, 1998, J GEOPHYS RES-SOL EA, V103, P24347, DOI 10.1029/98JB01576; Hubert-Ferrari A, 2000, NATURE, V404, P269, DOI 10.1038/35005054; Ji C., 2008, PRELIMINARY RESULT M; KIRBY E, 2003, J GEOPHYS RES, V108; McCloskey J, 2005, NATURE, V434, P291, DOI 10.1038/434291a; Parsons T, 2000, SCIENCE, V288, P661, DOI 10.1126/science.288.5466.661; Parsons T., 2002, J GEOPHYS RES, V107, pESE9; REASENBERG PA, 1992, SCIENCE, V255, P1687, DOI 10.1126/science.255.5052.1687; STEACY S, 2004, J GEOPHYS RES, V109; Stein RS, 1999, NATURE, V402, P605, DOI 10.1038/45144; Stein RS, 1997, GEOPHYS J INT, V128, P594, DOI 10.1111/j.1365-246X.1997.tb05321.x	13	364	453	6	235	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 24	2008	454	7203					509	510		10.1038/nature07177	http://dx.doi.org/10.1038/nature07177			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329IC	18600260				2022-12-28	WOS:000257860300049
J	Wood, C; Srivastava, P; Bukowski, R; Lacombe, L; Gorelov, AI; Gorelov, S; Mulders, P; Zielinski, H; Hoos, A; Teofilovici, F; Isakov, L; Flanigan, R; Figlin, R; Gupta, R; Escudier, B				Wood, Christopher; Srivastava, Pramod; Bukowski, Ronald; Lacombe, Louis; Gorelov, Andrei I.; Gorelov, Sergei; Mulders, Peter; Zielinski, Henryk; Hoos, Axel; Teofilovici, Florentina; Isakov, Leah; Flanigan, Robert; Figlin, Robert; Gupta, Renu; Escudier, Bernard		C-100-12 RCC Study Grp	An adjuvant autologous therapeutic vaccine (HSPPC-96 vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentrel, open-label, randomised phase III trial	LANCET			English	Article; Proceedings Paper	102nd Annual Meeting of the American-Urological-Association	MAY 19-24, 2007	Anaheim, CA	Amer Urol Assoc			HEAT-SHOCK-PROTEIN; RADICAL NEPHRECTOMY; STAGING SYSTEM; CANCER; IMMUNOTHERAPY; GP96; PROGNOSTICATION; SURVEILLANCE; MELANOMA; BENEFITS	Background Treatment of localised renal cell carcinoma consists of partial or radical nephrectomy. A substantial proportion of patients are at risk for recurrence because no effective adjuvant therapy exists. We investigated the use of an autologous, tumour-derived heat-shock protein (glycoprotein 96)-peptide complex (HSPPC-96; vitespen) as adjuvant treatment in patyients at high risk of recurrence after resection of locally advanced renal cell carcinoma. Methods In this open-label trial, patients were randomly assigned to receive either vitespen (n=409) or observation alone (n=409) after nephrectomy. Randomisation was done in a one ratio by a computer-generated pseudo-random number generator, with a block size of four, and was stratified by performance score, lymph node status, and nuclear grade. Vitespen was given intradermally once a week for 4 weeks, then every 2 weeks until vaccine depletion. The primary endpoint was recurrence-free survival. The final analysis of recurrence-free survival was planned to take place after 214 or more events of disease recurrence or deaths before recurrence had occurred. Analaysis was by intention to treat (ITT). This study is registered with ClinicalTrials.gov, number NCT 00033904. Findings 48 patients in the vitespen group and 42 in the observation group were excluded from the ITT population because they did not meet post-surgery inclusion criteria; the ITT population thus consisted of 361 patients in the vitespen group and 367 in the observation group. Final analysis of recurrence-free survival was triggered in November, 2005. Re-review of all patients in the ITT population by the clinical events committee identified 149 actual recurrences (73 in the vitespen group and 76 in the observation group), nine deaths before recurrence (two in the vitespen group and seven in the observation group), and 124 patients with baseline metastatic or residual disease (61 in the vitespen group and 63 in the observation group). Thus, after a median follow-up of 1.9 years (IQR 0.9-2.5) in the ITT population, recurrence events were reported in 136 (37.7%) patients in the vitespen group and 146 (39.8%) in the observation group (hazard ratio 0 . 923, 95% CI 0 . 729-1.169; p=0 . 506). After continued follow-up until March, 2007, there had been 70 deaths in the vitespen group and 72 in the observation group (p=0.896); however, overall survival data were not mature, and patients continue to be followed up for survival. In predefined exploratory analyses by AJCC stage, recurrence events in patients with stage I or II disease were reported in 19 (15.2%) patients in the vitespen group and 31 (27. 0%) in the observation group (hazard ratio 0 . 576, 95% CI 0 . 324-1.023; p=0.056). The most commonly reported adverse events in the vitespen group were injection-site erythema (n=158) and injection-site induration (n=153). One serious adverse event-autoimmune thyroiditis of grade 2 severity-was reported in the vitespen group; no treatment-related grade 3 or 4 adverse events were reported. Interpretation No difference in recurrence-free survival was seen between patients given vitespen and those who received no treatment after nephrectomy for renal cell carcinoma. A possible improvement in recurrence-free survival NJ, in patients with early stage disease who received vitespen will require further validation. Funding Antigenics Inc.	[Wood, Christopher] Univ Texas Houston, MD Anderson Canc Ctr, Unit 1373, Houston, TX 77030 USA; [Srivastava, Pramod] Univ Connecticut, Sch Med, Farmington, CT USA; [Bukowski, Ronald] Cleveland Clin Fdn, Cleveland, OH 44195 USA; [Lacombe, Louis] Hop Hotel Dieu, CHUQ Hotel Dieu Quebec, Quebec City, PQ, Canada; [Gorelov, Andrei I.] St Petersburg State Univ, St Petersburg, Russia; [Gorelov, Sergei] St Petersburg Hosp 122, St Petersburg, Russia; [Mulders, Peter] Radboud Univ Nijmegen Med Ctr, Nijmegen, Netherlands; [Zielinski, Henryk] WAM, Centralny Szpital Klin, Warsaw, Poland; [Hoos, Axel] Bristol Myers Squibb Co, New York, NY 10154 USA; [Teofilovici, Florentina; Isakov, Leah] Antigenics, New York, NY USA; [Flanigan, Robert] Loyola Univ, Med Ctr, Maywood, IL 60153 USA; [Figlin, Robert] City Hope Comprehens Canc Ctr, Duarte, CA USA; [Gupta, Renu] Transave Inc, Monmouth Jct, NJ USA; [Escudier, Bernard] Inst Gustave Roussy, Villejuif, France	University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Connecticut; Cleveland Clinic Foundation; Laval University; Saint Petersburg State University; Radboud University Nijmegen; Bristol-Myers Squibb; Loyola University Chicago; City of Hope; UNICANCER; Gustave Roussy	Wood, C (corresponding author), Univ Texas Houston, MD Anderson Canc Ctr, Unit 1373, 1515 Holcombe Blvd, Houston, TX 77030 USA.	cgwood@mdanderson.org	Mulders, Peter F.A./H-8076-2014; Moiseyenko, Vladimir/E-8892-2014; Gonzalez Larriba, Jose Luis/G-6177-2016	Moiseyenko, Vladimir/0000-0003-4807-7915; Srivastava, Pramod/0000-0003-2837-2861; Gonzalez Larriba, Jose Luis/0000-0003-2631-0309; Oliver, Tim/0000-0002-7879-8943; Lacombe, Louis/0000-0003-4811-0308				ASSIKIS VJ, 2003, P AN M AM SOC CLIN, V22, P386; Belli F, 2002, J CLIN ONCOL, V20, P4169, DOI 10.1200/JCO.2002.09.134; Butts C, 2005, J CLIN ONCOL, V23, P6674, DOI 10.1200/JCO.2005.13.011; DOEHN C, 2006, ONKOLOGIE S, V29, P58; Dong HD, 1999, NAT MED, V5, P1365; Ferlay J, 2004, IARC CANC BASE; Ficarra V, 2007, J UROLOGY, V178, P418, DOI 10.1016/j.juro.2007.03.104; FONSECA G, 1997, MED ONCOLOGY COMPREH; Frank I, 2003, J UROLOGY, V170, P2225, DOI 10.1097/01.ju.0000095541.10333.a7; GAIL M, 1985, BIOMETRICS, V41, P361, DOI 10.2307/2530862; Galligioni E, 1996, CANCER, V77, P2560, DOI 10.1002/(SICI)1097-0142(19960615)77:12<2560::AID-CNCR20>3.0.CO;2-P; GIULIANI L, 1990, J UROLOGY, V143, P468, DOI 10.1016/S0022-5347(17)39992-5; Gordon NF, 2004, METHODS, V32, P63, DOI 10.1016/S1046-2023(03)00188-9; Green FL, 2002, AJCC CANC STAGING MA, P323; Haas N., 2006, 5 INT S KIDN CANC AS; HERRLINGER A, 1991, J UROLOGY, V146, P1224, DOI 10.1016/S0022-5347(17)38052-7; Holtl L, 2002, CLIN CANCER RES, V8, P3369; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jocham D, 2004, LANCET, V363, P594, DOI 10.1016/S0140-6736(04)15590-6; Jonasch E, 2008, BRIT J CANCER, V98, P1336, DOI 10.1038/sj.bjc.6604266; Kattan MW, 2001, J UROLOGY, V166, P63, DOI 10.1016/S0022-5347(05)66077-6; Kovalchin J T, 2001, Cancer Immun, V1, P7; Kunkle DA, 2007, J UROLOGY, V177, P1692, DOI 10.1016/j.juro.2007.01.029; Lam JS, 2005, J UROLOGY, V173, P1853, DOI 10.1097/01.ju.0000165693.68449.c3; Margulis V, 2007, CANCER-AM CANCER SOC, V109, P2439, DOI 10.1002/cncr.22713; Mazzaferro V, 2003, CLIN CANCER RES, V9, P3235; Messing EM, 2003, J CLIN ONCOL, V21, P1214, DOI 10.1200/JCO.2003.02.005; Parsa AT, 2007, NAT MED, V13, P84, DOI 10.1038/nm1517; PARSA AT, 2007, AM ASS NEUR SURG ANN; PHILLIPS E, 1993, UROLOGY, V41, P9, DOI 10.1016/0090-4295(93)90234-2; Pizzocaro G, 2001, J CLIN ONCOL, V19, P425, DOI 10.1200/JCO.2001.19.2.425; Shvarts O, 2005, BJU INT, V95, P8, DOI 10.1111/j.1464-410X.2005.05190.x; Small EJ, 2006, J CLIN ONCOL, V24, P3089, DOI 10.1200/JCO.2005.04.5252; Srivastava P, 2002, ANNU REV IMMUNOL, V20, P395, DOI 10.1146/annurev.immunol.20.100301.064801; Tamura Y, 1997, SCIENCE, V278, P117, DOI 10.1126/science.278.5335.117; Testori A, 2008, J CLIN ONCOL, V26, P955, DOI 10.1200/JCO.2007.11.9941; Tsui KH, 2000, J UROLOGY, V163, P1090, DOI 10.1016/S0022-5347(05)67699-9; Uyl-de Groot CA, 2005, VACCINE, V23, P2379, DOI 10.1016/j.vaccine.2005.01.015; Zabrecky JR, 2004, METHODS, V32, P3, DOI 10.1016/S1046-2023(03)00179-8; Zisman A, 2002, J CLIN ONCOL, V20, P4559, DOI 10.1200/JCO.2002.05.111; Zisman A, 2001, J CLIN ONCOL, V19, P1649, DOI 10.1200/JCO.2001.19.6.1649	41	251	267	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 12	2008	372	9633					145	154		10.1016/S0140-6736(08)60697-2	http://dx.doi.org/10.1016/S0140-6736(08)60697-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	324XJ	18602688				2022-12-28	WOS:000257552400029
J	Knapp, S				Knapp, Sandra			Genetics - Celebrating spuds	SCIENCE			English	Editorial Material							POTATO		[Knapp, Sandra] Nat Hist Museum, Dept Bot, London SW7 5BD, England	Natural History Museum London	Knapp, S (corresponding author), Nat Hist Museum, Dept Bot, Cromwell Rd, London SW7 5BD, England.	s.knapp@nhm.ac.uk	Knapp, Sandra/A-4856-2011	Knapp, Sandra/0000-0001-7698-3945				Ames M, 2008, AM J BOT, V95, P252, DOI 10.3732/ajb.95.2.252; DIRETTO G, 2008, PLOS 1, V4, pE350; Diretto G, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-11; Frodin DG, 2004, TAXON, V53, P753, DOI 10.2307/4135449; HAWKES JG, 1992, ECON BOT, V46, P86, DOI 10.1007/BF02985257; HAWKES JG, 1990, POTATO EVOLUTION BIO; Jacobs MMJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-145; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Mueller LA, 2005, COMP FUNCT GENOM, V6, P153, DOI 10.1002/cfg.468; Peralta I. E., 2008, Systematic Botany Monographs, V84; Sliwka J, 2008, PLANT BREEDING, V127, P49, DOI 10.1111/j.1439-0523.2008.01420.x; Spooner DM, 2008, CROP SCI, V48, pS27, DOI 10.2135/cropsci2007.09.0504tpg; Spooner DM, 2007, P NATL ACAD SCI USA, V104, P19398, DOI 10.1073/pnas.0709796104; Spooner DM, 2005, P NATL ACAD SCI USA, V102, P14694, DOI 10.1073/pnas.0507400102; SPOONER DM, 2006, HDB POTATO PRODUCTIO, P1, DOI DOI 10.1300/5776; Weese TL, 2007, SYST BOT, V32, P445, DOI 10.1600/036364407781179671	16	5	5	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2008	321	5886					206	207		10.1126/science.1159278	http://dx.doi.org/10.1126/science.1159278			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	324IS	18621656				2022-12-28	WOS:000257512900024
J	Maier, AG; Rug, M; O'Neill, MT; Brown, M; Chakravorty, S; Szestak, T; Chesson, J; Wu, Y; Hughes, K; Coppel, RL; Newbold, C; Beeson, JG; Craig, A; Crabb, BS; Cowman, AF				Maier, Alexander G.; Rug, Melanie; O'Neill, Matthew T.; Brown, Monica; Chakravorty, Srabasti; Szestak, Tadge; Chesson, Joanne; Wu, Yang; Hughes, Katie; Coppel, Ross L.; Newbold, Chris; Beeson, James G.; Craig, Alister; Crabb, Brendan S.; Cowman, Alan F.			Exported proteins required for virulence and rigidity of Plasmodium falciparum-infected human erythrocytes	CELL			English	Article							RED-BLOOD-CELL; TARGETED GENE DELETION; NEGATIVE SELECTION; MALARIA VIRULENCE; CYTOADHERENCE; MEMBRANE; SURFACE; PARASITE; ANTIGEN; SIGNAL	A major part of virulence for Plasmodium falciparum malaria infection, the most lethal parasitic disease of humans, results from increased rigidity and adhesiveness of infected host red cells. These changes are caused by parasite proteins exported to the erythrocyte using novel trafficking machinery assembled in the host cell. To understand these unique modifications, we used a large-scale gene knockout strategy combined with functional screens to identify proteins exported into parasite-infected erythrocytes and involved in remodeling these cells. Eight genes were identified encoding proteins required for export of the parasite adhesin PfEMP1 and assembly of knobs that function as physical platforms to anchor the adhesin. Additionally, we show that multiple proteins play a role in generating increased rigidity of infected erythrocytes. Collectively these proteins function as a pathogen secretion system, similar to bacteria and may provide targets for anti-virulence based therapies to a disease responsible for millions of deaths annually.	[Maier, Alexander G.; Rug, Melanie; O'Neill, Matthew T.; Brown, Monica; Chesson, Joanne; Beeson, James G.; Crabb, Brendan S.; Cowman, Alan F.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; [Chakravorty, Srabasti; Szestak, Tadge; Wu, Yang; Hughes, Katie; Craig, Alister] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Coppel, Ross L.] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia; [Newbold, Chris] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England	Walter & Eliza Hall Institute; Liverpool School of Tropical Medicine; University of Liverpool; Monash University; University of Oxford	Cowman, AF (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia.	cowman@wehi.edu.au	Rug, Melanie/A-9504-2011; Crabb, Brendan/F-5287-2013; Maier, Alex G/A-6499-2009; Cowman, Alan F/C-7642-2013; Rug, Melanie/B-5417-2015; Coppel, Ross L/A-6626-2008	Maier, Alex G/0000-0001-7369-1058; Cowman, Alan F/0000-0001-5145-9004; Coppel, Ross L/0000-0002-4476-9124; Craig, Alister/0000-0003-0914-6164; Newbold, Chris/0000-0002-9274-3789; Hughes, Katie/0000-0002-3597-1056	MRC [G0400417] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044008] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; Medical Research Council [G0400417] Funding Source: Medline; NIAID NIH HHS [R01 AI44008, R01 AI044008] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome Trust)		Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; BARNWELL JW, 1989, EXP PARASITOL, V69, P407, DOI 10.1016/0014-4894(89)90190-2; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Beeson JG, 2007, AM J TROP MED HYG, V77, P22, DOI 10.4269/ajtmh.2007.77.22; Beeson JG, 2006, J INFECT DIS, V193, P721, DOI 10.1086/500145; Botha M, 2007, INT J BIOCHEM CELL B, V39, P1781, DOI 10.1016/j.biocel.2007.02.011; BOZDECH Z, 2003, TRANSCRIPTOME INTRAE; Cegelski L, 2008, NAT REV MICROBIOL, V6, P17, DOI 10.1038/nrmicro1818; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; Cooke BM, 2006, J CELL BIOL, V172, P899, DOI 10.1083/jcb.200509122; Cooke BM, 2004, SEMIN HEMATOL, V41, P173, DOI 10.1053/j.seminhematol.2004.01.004; Cooke BM, 2001, ADV PARASIT, V50, P1, DOI 10.1016/S0065-308X(01)50029-9; Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735; Crabb BS, 1997, CELL, V89, P287, DOI 10.1016/S0092-8674(00)80207-X; Duffy MF, 2006, MOL BIOCHEM PARASIT, V148, P117, DOI 10.1016/j.molbiopara.2006.03.006; Duraisingh MT, 2002, INT J PARASITOL, V32, P81, DOI 10.1016/S0020-7519(01)00345-9; Florens L, 2004, MOL BIOCHEM PARASIT, V135, P1, DOI 10.1016/j.molbiopara.2003.12.007; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hardeman MR, 1998, SCAND J CLIN LAB INV, V58, P617, DOI 10.1080/00365519850186049; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Knuepfer E, 2005, MOL MICROBIOL, V58, P1039, DOI 10.1111/j.1365-2958.2005.04895.x; Kriek N, 2003, MOL MICROBIOL, V50, P1215, DOI 10.1046/j.1365-2958.2003.03784.x; Kun JFJ, 1997, MOL BIOCHEM PARASIT, V85, P41, DOI 10.1016/S0166-6851(96)02805-8; LEECH JH, 1984, J EXP MED, V159, P1567, DOI 10.1084/jem.159.6.1567; Maier AG, 2007, BLOOD, V109, P1289, DOI 10.1182/blood-2006-08-043364; Maier AG, 2006, MOL BIOCHEM PARASIT, V150, P118, DOI 10.1016/j.molbiopara.2006.06.014; Marti M, 2005, J CELL BIOL, V171, P587, DOI 10.1083/jcb.200508051; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; MATTEI D, 1992, GENE, V110, P71, DOI 10.1016/0378-1119(92)90446-V; NASH GB, 1989, BLOOD, V74, P855, DOI 10.1182/blood.V74.2.855.bloodjournal742855; Papakrivos J, 2005, MOL MICROBIOL, V55, P1272, DOI 10.1111/j.1365-2958.2004.04468.x; Pei XH, 2005, J BIOL CHEM, V280, P31166, DOI 10.1074/jbc.M505298200; RAVENTOSSUAREZ C, 1985, P NATL ACAD SCI USA, V82, P3829, DOI 10.1073/pnas.82.11.3829; Rug M, 2006, BLOOD, V108, P370, DOI 10.1182/blood-2005-11-4624; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12; Silva MD, 2005, MOL MICROBIOL, V56, P990, DOI 10.1111/j.1365-2958.2005.04603.x; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; STAHL HD, 1987, MOL BIOL MED, V4, P199; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Walsh P, 2004, EMBO REP, V5, P567, DOI 10.1038/sj.embor.7400172; Waterkeyn JG, 2000, EMBO J, V19, P2813, DOI 10.1093/emboj/19.12.2813; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Wickham ME, 2001, EMBO J, V20, P5636, DOI 10.1093/emboj/20.20.5636; Winter G, 2005, J EXP MED, V201, P1853, DOI 10.1084/jem.20041392	45	347	351	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 11	2008	134	1					48	61		10.1016/j.cell.2008.04.051	http://dx.doi.org/10.1016/j.cell.2008.04.051			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	324IU	18614010	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000257513100013
J	London, AJ; Kimmelman, J				London, Alex John; Kimmelman, Jonathan			Justice in translation: from bench to bedside in the developing world	LANCET			English	Editorial Material							GENE-THERAPY; INTERNATIONAL RESEARCH; HEMOPHILIA		[Kimmelman, Jonathan] McGill Univ, Dept Social Studies Med, Biomed Eth Unit, Montreal, PQ H3A 1X1, Canada; [London, Alex John] Carnegie Mellon Univ, Dept Philosophy, Ctr Advancement Appl Eth & Polit Philosophy, Pittsburgh, PA 15213 USA	McGill University; Carnegie Mellon University	Kimmelman, J (corresponding author), McGill Univ, Dept Social Studies Med, Biomed Eth Unit, 3647 Peel St, Montreal, PQ H3A 1X1, Canada.	jonathan.kimmelman@mcgill.ca		London, Alex/0000-0002-6450-0309				Aiuti A, 2002, SCIENCE, V296, P2410, DOI 10.1126/science.1070104; CALABRO S, 2006, VACCINE, V25, P2567; *CIOMS, 2002, INT ETH GUID BIOM RE; *DEP HLTH HUM SERV, 2001, OEI010000190; Fischer A, 2001, IMMUNITY, V15, P1, DOI 10.1016/S1074-7613(01)00175-3; Glantz LH, 1998, HASTINGS CENT REP, V28, P38, DOI 10.2307/3528268; GRAVES PM, 2006, BATTLING MALARIA STR; High KA, 2001, CIRC RES, V88, P137; Hough C, 2005, J THROMB HAEMOST, V3, P1195, DOI 10.1111/j.1538-7836.2005.01401.x; Jha P, 2002, SCIENCE, V295, P2036, DOI 10.1126/science.295.5562.2036; Levine C, 2004, HASTINGS CENT REP, V34, P17, DOI 10.2307/3528172; Lie R., 2008, OXFORD TXB CLIN RES, P737; London AJ, 2005, HASTINGS CENT REP, V35, P24, DOI 10.1353/hcr.2005.0009; Macklin R, 2001, KENNEDY INST ETHIC J, V11, P17, DOI 10.1353/ken.2001.0005; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, 1978, BELM REP ETH PRINC G; Nuffield Council on Bioethics, 2002, ETH RES REL HEALTHC; SACHS J, 2001, INVESTING HLTH EC DE	18	26	27	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 5	2008	372	9632					82	85		10.1016/S0140-6736(08)60996-4	http://dx.doi.org/10.1016/S0140-6736(08)60996-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	321XN	18603162				2022-12-28	WOS:000257339900035
J	Laakso, JM; Lewis, JH; Shuman, H; Ostap, EM				Laakso, Joseph M.; Lewis, John H.; Shuman, Henry; Ostap, E. Michael			Myosin I can act as a molecular force sensor	SCIENCE			English	Article							LOAD-DEPENDENT KINETICS; HAIR-CELLS; ADAPTATION; MUSCLE; BINDING; DOMAIN; MYO1B; STEPS; MOTOR	The ability to sense molecular tension is crucial for a wide array of cellular processes, including the detection of auditory stimuli, control of cell shape, and internalization and transport of membranes. We show that myosin I, a motor protein that has been implicated in powering key steps in these processes, dramatically alters its motile properties in response to tension. We measured the displacement generated by single myosin I molecules, and we determined the actin-attachment kinetics with varying tensions using an optical trap. The rate of myosin I detachment from actin decreases > 75- fold under tension of 2 piconewtons or less, resulting in myosin I transitioning from a low (< 0.2) to a high (> 0.9) duty- ratio motor. This impressive tension sensitivity supports a role for myosin I as a molecular force sensor.	[Laakso, Joseph M.; Lewis, John H.; Shuman, Henry; Ostap, E. Michael] Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Laakso, Joseph M.; Lewis, John H.; Shuman, Henry; Ostap, E. Michael] Univ Penn, Sch Med, Penn Muscle Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Ostap, EM (corresponding author), Univ Penn, Sch Med, Dept Physiol, B400 Richards Bldg, Philadelphia, PA 19104 USA.	ostap@mail.med.upenn.edu		Laakso, Joseph/0000-0002-1991-0229; LEWIS, JOHN/0000-0003-0210-341X	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR051174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057247, R37GM057247] Funding Source: NIH RePORTER; NIAMS NIH HHS [P01 AR051174-050003, AR051174, P01 AR051174] Funding Source: Medline; NIGMS NIH HHS [R01 GM057247, R01 GM057247-10, GM057247] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altman D, 2004, CELL, V116, P737, DOI 10.1016/S0092-8674(04)00211-9; Batters C, 2004, PHILOS T R SOC B, V359, P1895, DOI 10.1098/rstb.2004.1559; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; Bose A, 2002, NATURE, V420, P821, DOI 10.1038/nature01246; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; Geeves MA, 2000, J BIOL CHEM, V275, P21624, DOI 10.1074/jbc.M000342200; Gillespie PG, 2004, ANNU REV PHYSIOL, V66, P521, DOI 10.1146/annurev.physiol.66.032102.112842; Hokanson DE, 2006, MOL BIOL CELL, V17, P4856, DOI 10.1091/mbc.e06-05-0449; Holt JR, 2002, CELL, V108, P371, DOI 10.1016/S0092-8674(02)00629-3; JONTES JD, 1995, NATURE, V378, P751, DOI 10.1038/378751a0; Lewis JH, 2006, BIOCHEMISTRY-US, V45, P11589, DOI 10.1021/bi0611917; Lin TM, 2005, J BIOL CHEM, V280, P41562, DOI 10.1074/jbc.M508653200; McConnell RE, 2007, J CELL BIOL, V177, P671, DOI 10.1083/jcb.200701144; RUPPERT C, 1993, J CELL BIOL, V120, P1393, DOI 10.1083/jcb.120.6.1393; Salas-Cortes L, 2005, J CELL SCI, V118, P4823, DOI 10.1242/jcs.02607; SIEMANKOWSKI RF, 1985, P NATL ACAD SCI USA, V82, P658, DOI 10.1073/pnas.82.3.658; Takagi Y, 2006, BIOPHYS J, V90, P1295, DOI 10.1529/biophysj.105.068429; Tsygankov D, 2007, P NATL ACAD SCI USA, V104, P19321, DOI 10.1073/pnas.0709911104; Veigel C, 2005, NAT CELL BIOL, V7, P861, DOI 10.1038/ncb1287; Veigel C, 2003, NAT CELL BIOL, V5, P980, DOI 10.1038/ncb1060; Veigel C, 1999, NATURE, V398, P530, DOI 10.1038/19104; Warshaw DM, 2000, J BIOL CHEM, V275, P37167, DOI 10.1074/jbc.M006438200	23	162	162	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 4	2008	321	5885					133	136		10.1126/science.1159419	http://dx.doi.org/10.1126/science.1159419			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QE	18599791	Green Accepted			2022-12-28	WOS:000257320800055
J	Zeebe, RE; Zachos, JC; Caldeira, K; Tyrrell, T				Zeebe, Richard E.; Zachos, James C.; Caldeira, Ken; Tyrrell, Toby			Oceans - Carbon emissions and acidification	SCIENCE			English	Editorial Material							MARINE PLANKTON; CORAL-REEFS; CALCIFICATION; CO2		[Zeebe, Richard E.] Univ Hawaii, Dept Oceanog, Honolulu, HI 96822 USA; [Zachos, James C.] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95060 USA; [Caldeira, Ken] Carnegie Inst Washington, Dept Global Ecol, Stanford, CA 94305 USA; [Tyrrell, Toby] Univ Southampton, Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England	University of Hawaii System; University of California System; University of California Santa Cruz; Carnegie Institution for Science; NERC National Oceanography Centre; University of Southampton	Zeebe, RE (corresponding author), Univ Hawaii, Dept Oceanog, Honolulu, HI 96822 USA.	zeebe@soest.hawaii.edu	Zachos, James C/A-7674-2008; Caldeira, Ken/E-7914-2011	Zachos, James C/0000-0001-8439-1886; Caldeira, Ken/0000-0002-4591-643X	Division Of Ocean Sciences [0751959] Funding Source: National Science Foundation	Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		Bijma J., 1999, USE PROXIES PALEOCEA, DOI DOI 10.1007/978-3-642-58646-0_20; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Gazeau F, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028554; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Iglesias-Rodriguez MD, 2008, SCIENCE, V320, P336, DOI 10.1126/science.1154122; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Langer G, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001227; Montenegro A, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030905; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Raven J, 2005, OCEAN ACIDIFICATION; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; US EPA, 1976, QUAL CRIT WAT; Wolf-Gladrow DA, 1999, TELLUS B, V51, P461, DOI 10.1034/j.1600-0889.1999.00023.x; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588; Zeebe R. E., 2001, CO2 SEAWATER EQUILIB	15	186	197	16	245	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 4	2008	321	5885					51	52		10.1126/science.1159124	http://dx.doi.org/10.1126/science.1159124			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QE	18599765				2022-12-28	WOS:000257320800029
J	Melbourne, BA; Hastings, A				Melbourne, Brett A.; Hastings, Alan			Extinction risk depends strongly on factors contributing to stochasticity	NATURE			English	Article							DEMOGRAPHIC STOCHASTICITY; SMALL POPULATIONS; MATING SYSTEM; SURVIVAL; DYNAMICS; TIME	Extinction risk in natural populations depends on stochastic factors that affect individuals, and is estimated by incorporating such factors into stochastic models(1-9). Stochasticity can be divided into four categories, which include the probabilistic nature of birth and death at the level of individuals ( demographic stochasticity(2)), variation in population- level birth and death rates among times or locations ( environmental stochasticity(1,3)), the sex of individuals(6,8) and variation in vital rates among individuals within a population ( demographic heterogeneity(7,9)). Mechanistic stochastic models that include all of these factors have not previously been developed to examine their combined effects on extinction risk. Here we derive a family of stochastic Ricker models using different combinations of all these stochastic factors, and show that extinction risk depends strongly on the combination of factors that contribute to stochasticity. Furthermore, we show that only with the full stochastic model can the relative importance of environmental and demographic variability, and therefore extinction risk, be correctly determined. Using the full model, we find that demographic sources of stochasticity are the prominent cause of variability in a laboratory population of Tribolium castaneum ( red flour beetle), whereas using only the standard simpler models would lead to the erroneous conclusion that environmental variability dominates. Our results demonstrate that current estimates of extinction risk for natural populations could be greatly underestimated because variability has been mistakenly attributed to the environment rather than the demographic factors described here that entail much higher extinction risk for the same variability level.	[Melbourne, Brett A.] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Hastings, Alan] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA	University of Colorado System; University of Colorado Boulder; University of California System; University of California Davis	Melbourne, BA (corresponding author), Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA.	brett.melbourne@colorado.edu	Hastings, Alan/O-6864-2019; Lin, Pei-Chun/F-7857-2012	Hastings, Alan/0000-0002-0717-8026; Lin, Pei-Chun/0000-0002-4400-923X; MELBOURNE, BRETT/0000-0002-8843-4131				ATHREYA KB, 1971, ANN MATH STAT, V42, P1499, DOI 10.1214/aoms/1177693150; Bartlett MS., 1960, STOCHASTIC POPULATIO; Burnham K.P., 2002, MODEL SELECTION MULT, VSecond edition; Costantino R. F., 1991, POPULATION DYNAMICS; Dennis B, 2001, ECOL MONOGR, V71, P277, DOI 10.1890/0012-9615(2001)071[0277:ECACDI]2.0.CO;2; Drake JM, 2005, PLOS BIOL, V3, P1300, DOI 10.1371/journal.pbio.0030222; Engen S, 2003, ECOLOGY, V84, P2378, DOI 10.1890/02-0123; FELLER W., 1939, ACTA BIOTHEORETICA, V5, P11, DOI 10.1007/BF01602932; Fox GA, 2006, J ANIM ECOL, V75, P921, DOI 10.1111/j.1365-2656.2006.01110.x; GABRIEL W, 1992, THEOR POPUL BIOL, V41, P44, DOI 10.1016/0040-5809(92)90049-Y; Goodman D., 1987, P11, DOI 10.1017/CBO9780511623400.003; Grimm V, 2004, OIKOS, V105, P501, DOI 10.1111/j.0030-1299.2004.12606.x; Kendall BE, 2003, CONSERV BIOL, V17, P1170, DOI 10.1046/j.1523-1739.2003.02411.x; KENDALL DG, 1949, J R STAT SOC B, V11, P230; LANDE R, 1993, AM NAT, V142, P911, DOI 10.1086/285580; Lande R., 2003, OXFORD SERIES ECOLOG; Legendre S, 1999, AM NAT, V153, P449, DOI 10.1086/303195; LEIGH EG, 1981, J THEOR BIOL, V90, P213; LEWONTIN RC, 1969, P NATL ACAD SCI USA, V62, P1056, DOI 10.1073/pnas.62.4.1056; Ludwig D, 1996, AM NAT, V147, P506, DOI 10.1086/285863; May R.M., 1973, STABILITY COMPLEXITY; MAY RM, 1973, AM NAT, V107, P621, DOI 10.1086/282863; Morris W. F., 2002, QUANTITATIVE CONSERV; PIMM SL, 1988, AM NAT, V132, P757, DOI 10.1086/284889; RICKER W. E., 1954, JOUR FISH RES BD CANADA, V11, P559; ROUGHGARDEN J, 1975, AM NAT, V109, P713, DOI 10.1086/283039; Saether BE, 2004, J ANIM ECOL, V73, P925, DOI 10.1111/j.0021-8790.2004.00869.x; SHAFFER ML, 1981, BIOSCIENCE, V31, P131, DOI 10.2307/1308256; Soule M., 1987, VIABLE POPULATIONS C; TULJAPURKAR S, 1989, THEOR POPUL BIOL, V35, P227, DOI 10.1016/0040-5809(89)90001-4	30	366	369	6	287	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2008	454	7200					100	103		10.1038/nature06922	http://dx.doi.org/10.1038/nature06922			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321MC	18596809				2022-12-28	WOS:000257308300045
J	Turchin, P				Turchin, Peter			Arise 'cliodynamics'	NATURE			English	Editorial Material									Univ Connecticut, Storrs, CT 06269 USA	University of Connecticut	Turchin, P (corresponding author), Univ Connecticut, Storrs, CT 06269 USA.							[Anonymous], 2006, WAR PEACE WAR LIFE C; [Anonymous], 2018, HIST DYNAMICS WHY ST, DOI DOI 10.23943/PRINCETON/9780691180779.001.0001; Demandt A, 1984, FALL ROMS AUFLOSUNG; Fischer D.H., 1996, GREAT WAVE PRICE REV; Goldstone JA., 2002, J INT AFF, V56, P3; Goldstone Jack A., 1991, REVOLUTION REBELLION; Korotayev A., 2006, INTRO SOCIAL MACRODY; Levy Sheldon G., 1991, POLITICAL VIOLENCE U; Mack Andrew, 2005, HUMAN SECURITY REPOR; NEFEDOV S, 1999, THESIS EKATERINBURG; OBOYLE L, 1970, J MOD HIST, V42, P471, DOI 10.1086/244035; TURCHIN P, 2008, SECULAR CYCLES	12	59	60	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2008	454	7200					34	35		10.1038/454034a	http://dx.doi.org/10.1038/454034a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321MC	18596791	Bronze			2022-12-28	WOS:000257308300025
J	Rohatgi, R; Scott, MP				Rohatgi, Rajat; Scott, Matthew P.			Cell biology - Arrestin' movement in Cilia	SCIENCE			English	Editorial Material							HEDGEHOG; BETA-ARRESTIN-2; TRANSPORT; PROTEINS		[Rohatgi, Rajat; Scott, Matthew P.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Dev Biol, Stanford, CA 94305 USA; [Rohatgi, Rajat; Scott, Matthew P.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, Stanford, CA 94305 USA; [Rohatgi, Rajat; Scott, Matthew P.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Bioengn, Stanford, CA 94305 USA; [Rohatgi, Rajat] Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Oncol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University	Rohatgi, R (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Dev Biol, Stanford, CA 94305 USA.	mscott@stanford.edu			Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [1K99CA129174] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K99CA129174] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Berbari NF, 2008, P NATL ACAD SCI USA, V105, P4242, DOI 10.1073/pnas.0711027105; Chen W, 2004, SCIENCE, V306, P2257, DOI 10.1126/science.1104135; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Kovacs JJ, 2008, SCIENCE, V320, P1777, DOI 10.1126/science.1157983; Lefkowitz RJ, 2006, MOL CELL, V24, P643, DOI 10.1016/j.molcel.2006.11.007; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; Meloni AR, 2006, MOL CELL BIOL, V26, P7550, DOI 10.1128/MCB.00546-06; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Wilbanks AM, 2004, SCIENCE, V306, P2264, DOI 10.1126/science.1104193	16	10	11	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2008	320	5884					1726	1727		10.1126/science.1160448	http://dx.doi.org/10.1126/science.1160448			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318VP	18583599				2022-12-28	WOS:000257121200023
J	Tadross, MR; Dick, IE; Yue, DT				Tadross, Michael R.; Dick, Ivy E.; Yue, David T.			Mechanism of local and global Ca2+ sensing by calmodulin in complex with a Ca2+ channel	CELL			English	Article							STOPPED-FLOW FLUORESCENCE; AUDITORY HAIR-CELLS; CA2+-DEPENDENT INACTIVATION; CALCIUM-CHANNELS; NEUROTRANSMITTER RELEASE; DECODING CALCIUM; GENE-EXPRESSION; KINASE-II; FREQUENCY; RECEPTOR	Calmodulin (CaM) in complex with Ca2+ channels constitutes a prototype for Ca2+ sensors that are intimately colocalized with Ca2+ sources. The C-lobe of CaM senses local, large Ca2+ oscillations due to Ca2+ influx from the host channel, and the N-lobe senses global, albeit diminutive Ca2+ changes arising from distant sources. Though biologically essential, the mechanism underlying global Ca2+ sensing has remained unknown. Here, we advance a theory of how global selectivity arises, and we experimentally validate this proposal with methodologies enabling millisecond control of Ca2+ oscillations seen by the CaM/channel complex. We find that global selectivity arises from rapid Ca2+ release from CaM combined with greater affinity of the channel for Ca2+-free versus Ca2+-bound CaM. The emergence of complex decoding properties from the juxtaposition of common elements, and the techniques developed herein, promise generalization to numerous molecules residing near Ca2+ sources.	[Tadross, Michael R.; Dick, Ivy E.; Yue, David T.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Calcium Signals Lab, Baltimore, MD 21205 USA; [Tadross, Michael R.; Dick, Ivy E.; Yue, David T.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Calcium Signals Lab, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Yue, DT (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Calcium Signals Lab, Ross Bldg,Room 713,720 Rutland Ave, Baltimore, MD 21205 USA.	dyue@bme.jhu.edu		Dick, Ivy/0000-0002-7253-6846	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL076795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065531] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC005211, T32DC000023] Funding Source: NIH RePORTER; NHLBI NIH HHS [R37 HL076795] Funding Source: Medline; NIDCD NIH HHS [T32 DC000023, P30 DC005211] Funding Source: Medline; NIMH NIH HHS [R01 MH065531] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Augustine GJ, 2003, NEURON, V40, P331, DOI 10.1016/S0896-6273(03)00639-1; BAYLEY P, 1984, BIOCHEM BIOPH RES CO, V120, P185, DOI 10.1016/0006-291X(84)91431-1; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Black DJ, 2005, AM J PHYSIOL-CELL PH, V288, pC669, DOI 10.1152/ajpcell.00191.2004; Bootman MD, 2001, J CELL SCI, V114, P2213; Bradley J, 2004, NAT NEUROSCI, V7, P705, DOI 10.1038/nn1266; Catterall WA, 1999, ANN NY ACAD SCI, V868, P144, DOI 10.1111/j.1749-6632.1999.tb11284.x; Chaudhuri D, 2005, J NEUROSCI, V25, P8282, DOI 10.1523/JNEUROSCI.2253-05.2005; Chaudhuri D, 2007, J GEN PHYSIOL, V129, P385, DOI 10.1085/jgp.200709749; Cullen PJ, 2006, CURR OPIN CELL BIOL, V18, P157, DOI 10.1016/j.ceb.2006.02.012; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; Dick IE, 2008, NATURE, V451, P830, DOI 10.1038/nature06529; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dunlap K, 2007, J GEN PHYSIOL, V129, P379, DOI 10.1085/jgp.200709786; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Erickson MG, 2003, NEURON, V39, P97, DOI 10.1016/S0896-6273(03)00395-7; Evans RM, 2006, TRENDS NEUROSCI, V29, P617, DOI 10.1016/j.tins.2006.08.006; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; Houdusse A, 2006, P NATL ACAD SCI USA, V103, P19326, DOI 10.1073/pnas.0609436103; IMREDY JP, 1994, NEURON, V12, P1301, DOI 10.1016/0896-6273(94)90446-4; Jurado LA, 1999, PHYSIOL REV, V79, P661, DOI 10.1152/physrev.1999.79.3.661; Li WH, 1998, NATURE, V392, P936, DOI 10.1038/31965; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; LINSE S, 1991, J BIOL CHEM, V266, P8050; MARTIN SR, 1985, EUR J BIOCHEM, V151, P543, DOI 10.1111/j.1432-1033.1985.tb09137.x; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Mori MX, 2004, SCIENCE, V304, P432, DOI 10.1126/science.1093490; Myers BR, 2007, NEURON, V54, P847, DOI 10.1016/j.neuron.2007.06.011; Naraghi M, 1997, J NEUROSCI, V17, P6961; NEHER E, 1978, J PHYSIOL-LONDON, V277, P153, DOI 10.1113/jphysiol.1978.sp012267; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; PEREZREYES E, 1992, J BIOL CHEM, V267, P1792; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; Saimi Y, 2002, ANNU REV PHYSIOL, V64, P289, DOI 10.1146/annurev.physiol.64.100301.111649; Schnee ME, 2003, J PHYSIOL-LONDON, V549, P697, DOI 10.1113/jphysiol.2002.037481; SHERMAN A, 1990, BIOPHYS J, V58, P985, DOI 10.1016/S0006-3495(90)82443-7; STERN MD, 1992, CELL CALCIUM, V13, P183, DOI 10.1016/0143-4160(92)90046-U; STILES J, 2001, COMPUTATION NEUROSCI; Takao K, 2005, J NEUROSCI, V25, P3107, DOI 10.1523/JNEUROSCI.0085-05.2005; TOMLINSON WJ, 1993, NEUROPHARMACOLOGY, V32, P1117, DOI 10.1016/0028-3908(93)90006-O; Wang MC, 2002, J MOL BIOL, V323, P85, DOI 10.1016/S0022-2836(02)00890-2; Winslow MM, 2005, SCIENCE, V307, P56, DOI 10.1126/science.1108163; Xiong LW, 2002, J BIOL CHEM, V277, P40862, DOI 10.1074/jbc.M206763200; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001; Yang PS, 2006, J NEUROSCI, V26, P10677, DOI 10.1523/JNEUROSCI.3236-06.2006; YANG PS, 2007, BIOPHYS J A S, V20, P1669; Zhang S, 1999, METH MOL B, V128, P103	51	149	153	1	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 27	2008	133	7					1228	1240		10.1016/j.cell.2008.05.025	http://dx.doi.org/10.1016/j.cell.2008.05.025			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	319DP	18585356	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000257144600019
J	Domingues, CM; Church, JA; White, NJ; Gleckler, PJ; Wijffels, SE; Barker, PM; Dunn, JR				Domingues, Catia M.; Church, John A.; White, Neil J.; Gleckler, Peter J.; Wijffels, Susan E.; Barker, Paul M.; Dunn, Jeff R.			Improved estimates of upper-ocean warming and multi-decadal sea-level rise	NATURE			English	Article							TEMPERATURE; PRESSURE; IMPACT	Changes in the climate system's energy budget are predominantly revealed in ocean temperatures(1,2) and the associated thermal expansion contribution to sea-level rise(2). Climate models, however, do not reproduce the large decadal variability in globally averaged ocean heat content inferred from the sparse observational database(3,4), even when volcanic and other variable climate forcings are included. The sum of the observed contributions has also not adequately explained the overall multi-decadal rise(2). Here we report improved estimates of near-global ocean heat content and thermal expansion for the upper 300 m and 700 m of the ocean for 1950-2003, using statistical techniques that allow for sparse data coverage(5-7) and applying recent corrections(8) to reduce systematic biases in the most common ocean temperature observations(9). Our ocean warming and thermal expansion trends for 1961-2003 are about 50 per cent larger than earlier estimates but about 40 per cent smaller for 1993-2003, which is consistent with the recognition that previously estimated rates for the 1990s had a positive bias as a result of instrumental errors(8-10). On average, the decadal variability of the climate models with volcanic forcing now agrees approximately with the observations, but the modelled multi-decadal trends are smaller than observed. We add our observational estimate of upper-ocean thermal expansion to other contributions to sea-level rise and find that the sum of contributions from 1961 to 2003 is about 1.5 +/- 0.4 mm yr(-1), in good agreement with our updated estimate of near-global mean sea-level rise (using techniques established in earlier studies(6,7)) of 1.6 +/- 0.2 mm yr(-1).	[Domingues, Catia M.; Church, John A.; White, Neil J.; Wijffels, Susan E.; Barker, Paul M.; Dunn, Jeff R.] CSIRO Marine & Atmospher Res, Ctr Australian Weather & Climate Res, Hobart, Tas 7001, Australia; [Church, John A.; White, Neil J.] Antarctic Climate & Ecosyst Cooperat Res Ctr, Hobart, Tas 7001, Australia; [Gleckler, Peter J.] Lawrence Livermore Natl Lab, Program Climate Model Diag & Intercomparison, Livermore, CA 94550 USA	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Antarctic Climate & Ecosystems Cooperative Research Centre (ACE CRC); United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Domingues, CM (corresponding author), CSIRO Marine & Atmospher Res, Ctr Australian Weather & Climate Res, GPO Box 1538, Hobart, Tas 7001, Australia.	catia.domingues@csiro.au	Domingues, Catia M./A-2901-2015; Gleckler, Peter/H-4762-2012; White, Neil/B-2077-2013; Jiao, Liqing/A-8821-2011; Church, John A/A-1541-2012; Wijffels, Susan/I-8215-2012; White, Nicholas J/I-4629-2012	Domingues, Catia M./0000-0001-5100-4595; Gleckler, Peter/0000-0003-2816-6224; Church, John A/0000-0002-7037-8194; Wijffels, Susan/0000-0002-4717-0811				AchutaRao KM, 2007, P NATL ACAD SCI USA, V104, P10768, DOI 10.1073/pnas.0611375104; Allan R, 2006, J CLIMATE, V19, P5816, DOI 10.1175/JCLI3937.1; Alory G, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028044; Ammann CM, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL016875; Antonov JI, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023112; Bindoff NL, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P385; Chao BF, 2008, SCIENCE, V320, P212, DOI 10.1126/science.1154580; Church JA, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P639; Church JA, 2005, NATURE, V438, P74, DOI 10.1038/nature04237; Church JA, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024826; Church JA, 2004, J CLIMATE, V17, P2609, DOI 10.1175/1520-0442(2004)017<2609:EOTRDO>2.0.CO;2; Conkright M., 2002, NOAA ATLAS NESDIS42; Delworth TL, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024457; Dyurgerov M., 2005, GLACIERS CHANGING EA; GILLE ST, IN PRESS J CLIM, DOI DOI 10.1175/2008JCL12131.1; Gleckler PJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026771; Gouretski V, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL027834; Gregory JM, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020258; Ingleby B, 2007, J MARINE SYST, V65, P158, DOI 10.1016/j.jmarsys.2005.11.019; Ishii M, 2006, J OCEANOGR, V62, P155, DOI 10.1007/s10872-006-0041-y; Jevrejeva S, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003229; JOHNSON GC, 2007, J CLIMATOL, V13, P2987; Johnson GC, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026769; Kaplan A, 2000, J CLIMATE, V13, P2987, DOI 10.1175/1520-0442(2000)013<2987:RSOIOH>2.0.CO;2; Kohl A, 2007, J PHYS OCEANOGR, V37, P313, DOI 10.1175/JPO3014.1; Lemke P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P337; Levitus S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021592; Ngo-Duc T, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022719; Rahmstorf S, 2007, SCIENCE, V316, P709, DOI 10.1126/science.1136843; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Wijffels SE, 2008, J CLIMATE, V21, P5657, DOI 10.1175/2008JCLI2290.1; Willis JK, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC002260; Willis JK, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030323	33	519	538	7	228	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2008	453	7198					1090	U6		10.1038/nature07080	http://dx.doi.org/10.1038/nature07080			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314WM	18563162				2022-12-28	WOS:000256839900054
J	Robinson, A				Robinson, Andrew			A century of puzzling	NATURE			English	Editorial Material																			0	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 19	2008	453	7198					990	991		10.1038/453990a	http://dx.doi.org/10.1038/453990a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314WM	18563139				2022-12-28	WOS:000256839900030
J	Apostolou, E; Thanos, D				Apostolou, Effie; Thanos, Dimitris			Virus infection induces NF-kappa B-dependent interchromosomal associations mediating monoallelic IFN-beta gene expression	CELL			English	Article							TRANSCRIPTION FACTORS; CHROMOSOME CONFORMATION; X-INACTIVATION; CELLS; ENHANCEOSOME; ACTIVATION; INDUCTION; BINDING; IL-4; COLOCALIZATION	Transcriptional activation of the IFN-beta gene by virus infection requires the cooperative assembly of an enhanceosome. We report that the stochastic and monoallelic expression of the IFN-beta gene depends on interchromosomal associations with three identified distinct genetic loci that could mediate binding of the limiting transcription factor NF-kappa B to the IFN-beta enhancer, thus triggering enhanceosome assembly and activation of transcription from this allele. The probability of a cell to express IFN-beta is dramatically increased when the cell is transfected with any of these loci. The secreted IFN-beta protein induces high- level expression of the enhanceosome factor IRF-7, which in turn promotes enhanceosome assembly and IFN-beta transcription from the remaining alleles and in other initially nonexpressing cells. Thus, the IFN-beta enhancer functions in a nonlinear fashion by working as a signal amplifier.	[Apostolou, Effie; Thanos, Dimitris] Acad Athens, Biomed Res Fdn, Inst Mol Biol Genet & Biotechnol, Athens 11527, Greece	Academy of Athens	Thanos, D (corresponding author), Acad Athens, Biomed Res Fdn, Inst Mol Biol Genet & Biotechnol, 4 Soranou Efesiou St, Athens 11527, Greece.	thanos@bioacademy.gr	Apostolou, Effie/AAG-1559-2020; Thanos, Dimitris/AAE-5720-2019					Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Agelopoulos M, 2006, EMBO J, V25, P4843, DOI 10.1038/sj.emboj.7601364; Bacher CP, 2006, NAT CELL BIOL, V8, P293, DOI 10.1038/ncb1365; Calado DP, 2006, J IMMUNOL, V177, P5358, DOI 10.4049/jimmunol.177.8.5358; de Laat W, 2007, CURR OPIN GENET DEV, V17, P456, DOI 10.1016/j.gde.2007.07.009; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; ENOCH T, 1986, MOL CELL BIOL, V6, P801, DOI 10.1128/MCB.6.3.801; Escalante CR, 2007, MOL CELL, V26, P703, DOI 10.1016/j.molcel.2007.04.022; Guo LY, 2005, IMMUNITY, V23, P89, DOI 10.1016/j.immuni.2005.05.008; Hollander GA, 1998, SCIENCE, V279, P2118, DOI 10.1126/science.279.5359.2118; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Hottiger MO, 1998, EMBO J, V17, P3124, DOI 10.1093/emboj/17.11.3124; Hu JZ, 2007, NUCLEIC ACIDS RES, V35, P5232, DOI 10.1093/nar/gkm557; Kelly BL, 2000, J IMMUNOL, V165, P2982, DOI 10.4049/jimmunol.165.6.2982; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Lipniacki T, 2006, BIOPHYS J, V90, P725, DOI 10.1529/biophysj.104.056754; Lomvardas S, 2002, CELL, V110, P261, DOI 10.1016/S0092-8674(02)00822-X; Lomvardas S, 2001, CELL, V106, P685, DOI 10.1016/S0092-8674(01)00490-1; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Maniatis T, 1998, COLD SPRING HARB SYM, V63, P609, DOI 10.1101/sqb.1998.63.609; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Munshi N, 1999, COLD SPRING HARB SYM, V64, P149, DOI 10.1101/sqb.1999.64.149; Munshi N, 2001, SCIENCE, V293, P1133, DOI 10.1126/science.293.5532.1133; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Papatsenko D, 2007, CURR BIOL, V17, pR955, DOI 10.1016/j.cub.2007.09.035; Paun A, 2007, ADV VIRUS RES, V69, P1, DOI 10.1016/S0065-3527(06)69001-5; Polak P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-133; Riviere I, 1998, IMMUNITY, V9, P217, DOI 10.1016/S1074-7613(00)80604-4; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Senger K, 2000, MOL CELL, V6, P931, DOI 10.1016/S1097-2765(05)00081-X; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Taniguchi T, 2002, CURR OPIN IMMUNOL, V14, P111, DOI 10.1016/S0952-7915(01)00305-3; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Wurtele H, 2006, CHROMOSOME RES, V14, P477, DOI 10.1007/s10577-006-1075-0; Xu N, 2006, SCIENCE, V311, P1149, DOI 10.1126/science.1122984; ZAWATZKY R, 1985, P NATL ACAD SCI USA, V82, P1136, DOI 10.1073/pnas.82.4.1136; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	40	190	195	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 11	2008	134	1					85	96		10.1016/j.cell.2008.05.052	http://dx.doi.org/10.1016/j.cell.2008.05.052			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	324IU	18614013	Bronze			2022-12-28	WOS:000257513100016
J	Choudhary, P; Rajamani, A; Kennedy, M				Choudhary, Preeti; Rajamani, Arvind; Kennedy, Michael			Next organ on the right	LANCET			English	Editorial Material									[Choudhary, Preeti; Rajamani, Arvind; Kennedy, Michael] Manly Hosp, Dept Internal Med, Sydney, NSW, Australia		Choudhary, P (corresponding author), Westmead Hosp, Sydney, NSW, Australia.	Preetz1@gmail.com		Choudhary, Preeti/0000-0002-2437-167X				Bolderman R, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.06.049; Hazanov N, 2004, MEDICINE, V83, P292, DOI 10.1097/01.md.0000141097.08000.99; Hoxie HJ, 1940, ARCH INTERN MED, V65, P587, DOI 10.1001/archinte.1940.00190090124007; Huang CC, 2007, AM J EMERG MED, V25, P164, DOI 10.1016/j.ajem.2006.06.010; PETERSON NE, 1968, J UROLOGY, V100, P140, DOI 10.1016/S0022-5347(17)62492-3	5	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 5	2008	372	9632					86	86		10.1016/S0140-6736(08)60997-6	http://dx.doi.org/10.1016/S0140-6736(08)60997-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	321XN	18603163				2022-12-28	WOS:000257339900036
J	Audero, E; Coppi, E; Mlinar, B; Rossetti, T; Caprioli, A; Al Banchaabouchi, M; Corradetti, R; Gross, C				Audero, Enrica; Coppi, Elisabetta; Mlinar, Boris; Rossetti, Tiziana; Caprioli, Antonio; Al Banchaabouchi, Mumna; Corradetti, Renato; Gross, Cornelius			Sporadic autonomic dysregulation and death associated with excessive serotonin autoinhibition	SCIENCE			English	Article							BROWN ADIPOSE-TISSUE; DORSAL RAPHE NEURONS; BRAIN-STEM ABNORMALITIES; SINGLE-UNIT RESPONSES; NORMAL ANXIETY-LIKE; MEDULLARY RAPHE; CONSCIOUS RATS; MICE; THERMOGENESIS; RECEPTOR	Sudden infant death syndrome is the leading cause of death in the postneonatal period in developed countries. Postmortem studies show alterations in serotonin neurons in the brainstem of such infants. However, the mechanism by which altered serotonin homeostasis might cause sudden death is unknown. We investigated the consequences of altering the autoinhibitory capacity of serotonin neurons with the reversible overexpression of serotonin 1A autoreceptors in transgenic mice. Overexpressing mice exhibited sporadic bradycardia and hypothermia that occurred during a limited developmental period and frequently progressed to death. Moreover, overexpressing mice failed to activate autonomic target organs in response to environmental challenges. These findings show that excessive serotonin autoinhibition is a risk factor for catastrophic autonomic dysregulation and provide a mechanism for a role of altered serotonin homeostasis in sudden infant death syndrome.	[Audero, Enrica; Rossetti, Tiziana; Al Banchaabouchi, Mumna; Gross, Cornelius] European Mol Biol Lab, Mouse Biol Unit, I-00015 Monterotondo, Italy; [Coppi, Elisabetta; Mlinar, Boris; Corradetti, Renato] Univ Florence, Dept Preclin & Clin Pharmacol, I-50139 Florence, Italy; [Caprioli, Antonio] Sigma Tau Pharmaceut Co, Lab Behav Neuropharmacol, I-00040 Pomezia, Italy	European Molecular Biology Laboratory (EMBL); University of Florence; Leadiant Biosciences	Gross, C (corresponding author), European Mol Biol Lab, Mouse Biol Unit, Via Ramarini 32, I-00015 Monterotondo, Italy.	gross@embl.it	Mlinar, Boris/A-7034-2008; Coppi, Elisabetta/K-6705-2016; Corradetti, Renato/A-1604-2008	Mlinar, Boris/0000-0001-9082-0827; Coppi, Elisabetta/0000-0003-4434-5919; Corradetti, Renato/0000-0002-2588-0484; Audero, Enrica/0000-0002-6138-244X	NIMH NIH HHS [MH64948] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH064948] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Celada P, 2001, J NEUROSCI, V21, P9917, DOI 10.1523/JNEUROSCI.21-24-09917.2001; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Erickson JT, 2007, RESP PHYSIOL NEUROBI, V159, P85, DOI 10.1016/j.resp.2007.06.002; FILIANO JJ, 1994, BIOL NEONATE, V65, P194; FORNAL CA, 1994, J PHARMACOL EXP THER, V270, P1345; Golozoubova V, 2001, FASEB J, V15, P2048, DOI 10.1096/fj.00-0536fje; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; Guzman-Marin R, 2000, BRAIN RES, V875, P23, DOI 10.1016/S0006-8993(00)02561-0; Haddjeri N, 2004, NEUROPSYCHOPHARMACOL, V29, P1800, DOI 10.1038/sj.npp.1300489; Hendricks TJ, 2003, NEURON, V37, P233, DOI 10.1016/S0896-6273(02)01167-4; Heron Melonie, 2007, Natl Vital Stat Rep, V56, P1; Jacobs BL, 2002, BRAIN RES REV, V40, P45, DOI 10.1016/S0165-0173(02)00187-X; Kattwinkel J, 2005, PEDIATRICS, V116, P1245, DOI 10.1542/peds.2005-1499; Kinney HC, 2003, J NEUROPATH EXP NEUR, V62, P1178, DOI 10.1093/jnen/62.11.1178; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Liu RJ, 2005, EUR J NEUROSCI, V21, P945, DOI 10.1111/j.1460-9568.2005.03930.x; Lucki I, 1998, BIOL PSYCHIAT, V44, P151, DOI 10.1016/S0006-3223(98)00139-5; Martin-Cora FJ, 2000, NEUROSCIENCE, V98, P301, DOI 10.1016/S0306-4522(00)00133-0; Mason P, 2001, ANNU REV NEUROSCI, V24, P737, DOI 10.1146/annurev.neuro.24.1.737; MCGINTY DJ, 1976, BRAIN RES, V101, P569, DOI 10.1016/0006-8993(76)90480-7; MENY RG, 1994, PEDIATRICS, V93, P44; Mlinar B, 2005, NEUROREPORT, V16, P1351, DOI 10.1097/01.wnr.0000175249.25535.bf; Morrison SF, 1999, AM J PHYSIOL-REG I, V276, pR962, DOI 10.1152/ajpregu.1999.276.4.R962; Nakamura K, 2004, J NEUROSCI, V24, P5370, DOI 10.1523/JNEUROSCI.1219-04.2004; Nakamura K, 2007, AM J PHYSIOL-REG I, V292, pR127, DOI 10.1152/ajpregu.00427.2006; Nebigil CG, 2000, P NATL ACAD SCI USA, V97, P9508, DOI 10.1073/pnas.97.17.9508; Ootsuka Y, 2006, NEUROSCI LETT, V395, P170, DOI 10.1016/j.neulet.2005.10.062; Paterson DS, 2006, JAMA-J AM MED ASSOC, V296, P2124, DOI 10.1001/jama.296.17.2124; Richer M, 2002, EUR J PHARMACOL, V435, P195, DOI 10.1016/S0014-2999(01)01607-7; Taylor NC, 2005, J PHYSIOL-LONDON, V566, P543, DOI 10.1113/jphysiol.2005.083873; Urbain N, 2006, J PHYSIOL-LONDON, V573, P679, DOI 10.1113/jphysiol.2006.108514; Zhao ZQ, 2006, J NEUROSCI, V26, P12781, DOI 10.1523/JNEUROSCI.4143-06.2006	33	72	83	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 4	2008	321	5885					130	133		10.1126/science.1157871	http://dx.doi.org/10.1126/science.1157871			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QE	18599790				2022-12-28	WOS:000257320800054
J	Daneshbod, Y				Daneshbod, Yahya			Renal osteodystrophy of the palate	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Dr Daneshbod Pathol Lab, Shiraz 71347, Iran	Shiraz University of Medical Science	Daneshbod, Y (corresponding author), Dr Daneshbod Pathol Lab, Shiraz 71347, Iran.	y@daneshbod.com							0	5	5	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 3	2008	359	1					74	74		10.1056/NEJMicm075566	http://dx.doi.org/10.1056/NEJMicm075566			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320PB	18596275				2022-12-28	WOS:000257246000009
J	Daum, RS				Daum, Robert S.			Removing the golden coat of Staphylococcus aureus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INFECTIONS		Univ Chicago, Dept Pediat, Infect Dis Sect, Chicago, IL 60637 USA	University of Chicago	Daum, RS (corresponding author), Univ Chicago, Dept Pediat, Infect Dis Sect, Chicago, IL 60637 USA.							Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Liu CI, 2008, SCIENCE, V319, P1391, DOI 10.1126/science.1153018; Spellberg B, 2008, CLIN INFECT DIS, V46, P155, DOI 10.1086/524891	3	20	20	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 3	2008	359	1					85	87		10.1056/NEJMcibr0803278	http://dx.doi.org/10.1056/NEJMcibr0803278			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320PB	18596277				2022-12-28	WOS:000257246000013
J	Sherman, SI; Wirth, LJ; Droz, JP; Hofmann, M; Bastholt, L; Martins, RG; Licitra, L; Eschenberg, MJ; Sun, YN; Juan, T; Stepan, DE; Schlumberger, MJ				Sherman, Steven I.; Wirth, Lori J.; Droz, Jean-Pierre; Hofmann, Michael; Bastholt, Lars; Martins, Renato G.; Licitra, Lisa; Eschenberg, Michael J.; Sun, Yu-Nien; Juan, Todd; Stepan, Daniel E.; Schlumberger, Martin J.		Motesanib Thyroid Canc Study Grp	Motesanib diphosphate in progressive differentiated thyroid cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PHASE-II TRIAL; MULTIKINASE INHIBITOR; SOLID TUMORS; FACTOR VEGF; CARCINOMA; PAPILLARY; EXPRESSION; THERAPY; HYPOTHYROIDISM	Background: The expression of vascular endothelial growth factor (VEGF) is characteristic of differentiated thyroid cancer and is associated with aggressive tumor behavior and a poor clinical outcome. Motesanib diphosphate (AMG 706) is a novel oral inhibitor of VEGF receptors, platelet-derived growth-factor receptor, and KIT. Methods: In an open-label, single-group, phase 2 study, we treated 93 patients who had progressive, locally advanced or metastatic, radioiodine-resistant differentiated thyroid cancer with 125 mg of motesanib diphosphate, administered orally once daily. The primary end point was an objective response as assessed by an independent radiographic review. Additional end points included the duration of the response, progression-free survival, safety, and changes in serum thyroglobulin concentration. Results: Of the 93 patients, 57 (61%) had papillary thyroid carcinoma. The objective response rate was 14%. Stable disease was achieved in 67% of the patients, and stable disease was maintained for 24 weeks or longer in 35%; 8% had progressive disease as the best response. The Kaplan-Meier estimate of the median duration of the response was 32 weeks (the lower limit of the 95% confidence interval [CI] was 24; the upper limit could not be estimated because of an insufficient number of events); the estimate of median progression-free survival was 40 weeks (95% CI, 32 to 50). Among the 75 patients in whom thyroglobulin analysis was performed, 81% had decreased serum thyroglobulin concentrations during treatment, as compared with baseline levels. The most common treatment-related adverse events were diarrhea (in 59% of the patients), hypertension (56%), fatigue (46%), and weight loss (40%). Conclusions: Motesanib diphosphate can induce partial responses in patients with advanced or metastatic differentiated thyroid cancer that is progressive. (ClinicalTrials.gov number, NCT00121628.).	[Sherman, Steven I.] Univ Texas MD Anderson Canc Ctr, Dept Endocrine Neoplasia & Hormonal Disorders, Unit 435, Houston, TX 77230 USA; [Wirth, Lori J.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Droz, Jean-Pierre] Ctr Leon Berard, F-69373 Lyon, France; [Hofmann, Michael] Med Sch Bern, Bern, Switzerland; [Bastholt, Lars] Odense Univ Hosp, DK-5000 Odense, Denmark; [Martins, Renato G.] Univ Washington, Seattle, WA 98195 USA; [Licitra, Lisa] Ist Nazl Tumori, I-20133 Milan, Italy; [Eschenberg, Michael J.; Sun, Yu-Nien; Juan, Todd; Stepan, Daniel E.] Amgen Inc, Thousand Oaks, CA USA; [Schlumberger, Martin J.] Univ Paris 11, Inst Gustave Roussy, Villejuif, France	University of Texas System; UTMD Anderson Cancer Center; Harvard University; Dana-Farber Cancer Institute; UNICANCER; Centre Leon Berard; University of Southern Denmark; Odense University Hospital; University of Washington; University of Washington Seattle; Fondazione IRCCS Istituto Nazionale Tumori Milan; Amgen; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy	Sherman, SI (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Endocrine Neoplasia & Hormonal Disorders, Unit 435, 1515 Holcombe Blvd,POB 301402, Houston, TX 77230 USA.	sisherma@mdanderson.org	Droz, Jeanpierre/AFO-2050-2022; Diaz-Cano, Salvador J./B-5256-2008; Licitra, Lisa/C-6271-2017; Jarzab, Barbara/AAI-7942-2020	Diaz-Cano, Salvador J./0000-0003-1245-2859; Sherman, Steven/0000-0002-3079-5153; Pirich, Christian/0000-0002-4502-0609; Bastholt, Lars/0000-0001-5478-9826; Licitra, Lisa/0000-0003-0623-4118; Jarzab, Barbara/0000-0001-9811-9584	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Ain KB, 2007, THYROID, V17, P663, DOI 10.1089/thy.2006.0289; Bunone G, 1999, AM J PATHOL, V155, P1967, DOI 10.1016/S0002-9440(10)65515-0; COHEN E, IN PRESS J CLIN ONCO; de Groot JWB, 2007, J CLIN ENDOCR METAB, V92, P3466, DOI 10.1210/jc.2007-0649; Delellis RA, 2006, J SURG ONCOL, V94, P662, DOI 10.1002/jso.20700; Desai J, 2006, ANN INTERN MED, V145, P660, DOI 10.7326/0003-4819-145-9-200611070-00008; DROZ JP, 1990, TUMORI, V76, P480, DOI 10.1177/030089169007600513; Durante C, 2006, J CLIN ENDOCR METAB, V91, P2892, DOI 10.1210/jc.2005-2838; Fagin JA, 2004, J ENDOCRINOL, V183, P249, DOI 10.1677/joe.1.05895; GOTTLIEB JA, 1974, NEW ENGL J MED, V290, P193, DOI 10.1056/NEJM197401242900404; GUPTAABRAMSON V, IN PRESS J CLIN ONCO; Haugen BR, 1999, SEMIN SURG ONCOL, V16, P34, DOI 10.1002/(SICI)1098-2388(199901/02)16:1<34::AID-SSU7>3.0.CO;2-2; Hundahl SA, 1998, CANCER-AM CANCER SOC, V83, P2638, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO;2-1; Jo YS, 2006, J CLIN ENDOCR METAB, V91, P3667, DOI 10.1210/jc.2005-2836; Kilicarslan AB, 2003, APMIS, V111, P439, DOI 10.1034/j.1600-0463.2003.t01-1-1110209.x; Klein M, 1999, J ENDOCRINOL, V161, P41, DOI 10.1677/joe.0.1610041; Kloos R, 2006, J CLIN ONCOL, V24, p288S; Lennard CM, 2001, SURGERY, V129, P552, DOI 10.1067/msy.2001.112592; Pennell NA, 2008, THYROID, V18, P317, DOI 10.1089/thy.2007.0120; Polverino A, 2006, CANCER RES, V66, P8715, DOI 10.1158/0008-5472.CAN-05-4665; Robinson SI, 2007, J CHEMOTHERAPY, V19, P352, DOI 10.1179/joc.2007.19.3.352; Rosen LS, 2007, J CLIN ONCOL, V25, P2369, DOI 10.1200/JCO.2006.07.8170; Schlumberger MJ, 1998, NEW ENGL J MED, V338, P297, DOI 10.1056/NEJM199801293380506; Sherman SI, 2003, LANCET, V361, P501, DOI 10.1016/S0140-6736(03)12488-9; Sisson JC, 1996, CANCER, V78, P2184, DOI 10.1002/(SICI)1097-0142(19961115)78:10<2184::AID-CNCR21>3.0.CO;2-U; Smith BR, 2006, THYROID, V16, P109, DOI 10.1089/thy.2006.16.109; Spencer CA, 1999, THYROID, V9, P435, DOI 10.1089/thy.1999.9.435; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Vieira JM, 2005, EUR J ENDOCRINOL, V153, P701, DOI 10.1530/eje.1.02009	29	370	389	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 3	2008	359	1					31	42		10.1056/NEJMoa075853	http://dx.doi.org/10.1056/NEJMoa075853			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320PB	18596272	Green Published, Green Submitted			2022-12-28	WOS:000257246000005
J	Gill, M				Gill, Mike			Why should doctors be interested in climate change?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material											Gill, M (corresponding author), Univ Surrey, Fac Med & Hlth Sci, Guildford GU2 7XH, Surrey, England.	mgilm1@gmail.com							0	13	14	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 28	2008	336	7659					1506	1506		10.1136/bmj.39617.634190.59	http://dx.doi.org/10.1136/bmj.39617.634190.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	324GN	18583684	Green Published			2022-12-28	WOS:000257505900042
J	Nottingham, RM; Pfeffer, SR				Nottingham, Ryan M.; Pfeffer, Suzanne R.			Team effort by TRAPP forces a nucleotide fumble	CELL			English	Editorial Material							STRUCTURAL BASIS; EXCHANGE; SPECIFICITY; ACTIVATION; COMPLEX; GTPASE; GOLGI	TRAPPI is a multisubunit protein complex on the Golgi that activates the small GTPase Ypt1p to facilitate the receipt of transport vesicles inbound from the endoplasmic reticulum. Cai et al. (2008) now present structural and biochemical analyses of yeast TRAPPI in a complex with Ypt1p revealing a unique mechanism by which TRAPPI catalyzes guanine nucleotide exchange.	[Nottingham, Ryan M.; Pfeffer, Suzanne R.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA	Stanford University	Pfeffer, SR (corresponding author), Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA.	pfeffer@stanford.edu						Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Delprato A, 2007, NAT STRUCT MOL BIOL, V14, P406, DOI 10.1038/nsmb1232; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Kim YG, 2006, CELL, V127, P817, DOI 10.1016/j.cell.2006.09.029; Morozova N, 2006, NAT CELL BIOL, V8, P1263, DOI 10.1038/ncb1489; Sacher M, 1998, EMBO J, V17, P2494, DOI 10.1093/emboj/17.9.2494; Sacher M, 2001, MOL CELL, V7, P433, DOI 10.1016/S1097-2765(01)00190-3; Wang W, 2000, J CELL BIOL, V151, P289, DOI 10.1083/jcb.151.2.289	8	0	0	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 27	2008	133	7					1141	1143		10.1016/j.cell.2008.06.012	http://dx.doi.org/10.1016/j.cell.2008.06.012			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	319DP	18585348	Bronze			2022-12-28	WOS:000257144600011
J	Moodie, R				Moodie, Rob			Climbing to the Australian Summit	LANCET			English	Editorial Material									Univ Melbourne, Nossal Inst, Melbourne, Vic 3010, Australia	University of Melbourne	Moodie, R (corresponding author), Univ Melbourne, Nossal Inst, Melbourne, Vic 3010, Australia.	r.moodie@unimelb.edu.au		Moodie, Alan/0000-0002-8425-7975				*AUSTR 2020, SUBM SEARCH; Australian Government, 2008, AUSTR 2020 SUMM FIN; Saunders P, 2007, MED J AUSTRALIA, V187, P530, DOI 10.5694/j.1326-5377.2007.tb01398.x; Suaning GJ, 1998, AUST NZ J OPHTHALMOL, V26, P195, DOI 10.1111/j.1442-9071.1998.tb01310.x; 2007, LANCET, V369, P1320	5	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 21	2008	371	9630					2066	2067		10.1016/S0140-6736(08)60897-1	http://dx.doi.org/10.1016/S0140-6736(08)60897-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	316ER	18572065				2022-12-28	WOS:000256932200008
J	Macurek, L; Lindqvist, A; Lim, D; Lampson, MA; Klompmaker, R; Freire, R; Clouin, C; Taylor, SS; Yaffe, MB; Medema, RH				Macurek, Libor; Lindqvist, Arne; Lim, Dan; Lampson, Michael A.; Klompmaker, Rob; Freire, Raimundo; Clouin, Christophe; Taylor, Stephen S.; Yaffe, Michael B.; Medema, Rene H.			Polo-like kinase-1 is activated by aurora A to promote checkpoint recovery	NATURE			English	Article							SMALL-MOLECULE INHIBITOR; PROTEIN-KINASE; MAMMALIAN-CELLS; DNA-DAMAGE; BIPOLAR SPINDLE; PHOSPHORYLATION; REVEALS; CYCLE; PLX1; POLO-LIKE-KINASE-1	Polo-like kinase-1 (PLK1) is an essential mitotic kinase regulating multiple aspects of the cell division process(1). Activation of PLK1 requires phosphorylation of a conserved threonine residue ( Thr 210) in the T- loop of the PLK1 kinase domain, but the kinase responsible for this has not yet been affirmatively identified(2-6). Here we show that in human cells PLK1 activation occurs several hours before entry into mitosis, and requires aurora A ( AURKA, also known as STK6)- dependent phosphorylation of Thr 210. We find that aurora A can directly phosphorylate PLK1 on Thr 210, and that activity of aurora A towards PLK1 is greatly enhanced by Bora ( also known as C13orf34 and FLJ22624), a known cofactor for aurora A ( ref. 7). We show that Bora/ aurora- A- dependent phosphorylation is a prerequisite for PLK1 to promote mitotic entry after a checkpoint- dependent arrest. Importantly, expression of a PLK1- T210D phospho- mimicking mutant partially overcomes the requirement for aurora A in checkpoint recovery. Taken together, these data demonstrate that the initial activation of PLK1 is a primary function of aurora A.	[Macurek, Libor; Lindqvist, Arne; Klompmaker, Rob; Medema, Rene H.] Univ Med Ctr Utrecht, Dept Med Oncol, NL-3584 CG Utrecht, Netherlands; [Lim, Dan; Clouin, Christophe; Yaffe, Michael B.] MIT, Ctr Canc Res, Cambridge, MA 02139 USA; [Lampson, Michael A.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Freire, Raimundo] Hosp Univ Canarias, Unidad Invest, La Cuesta 38320, Spain; [Taylor, Stephen S.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	Utrecht University; Utrecht University Medical Center; Massachusetts Institute of Technology (MIT); University of Pennsylvania; Universidad de la Laguna; University of Manchester	Medema, RH (corresponding author), Univ Med Ctr Utrecht, Dept Med Oncol, NL-3584 CG Utrecht, Netherlands.	r.h.medema@umcutrecht.nl	Medema, Rene H/G-5415-2011; Macurek, Libor/C-7865-2014; Taylor, Stephen/GZL-6499-2022; Macurek, Libor/B-8758-2009; Medema, Rene H/E-2981-2013; Lindqvist, Arne/B-6792-2008; Freire, Raimundo/Q-7660-2019	Macurek, Libor/0000-0002-0987-1238; Freire, Raimundo/0000-0003-4473-8894; Lindqvist, Arne/0000-0002-0141-1579; Taylor, Stephen/0000-0003-4621-9326; Medema, Rene/0000-0002-6754-0381	Dutch Cancer Society [UU2006-3579]; Dutch Organisation for Scientific Research [ZonMw 918.46.616, ZonMw 916.86.083]; Association for International Cancer Research [08-0172]; NIH [GM-60594, CA112967]; Wenner-Gren foundations; Netherlands Genomic Initiative of the Netherlands Organisation for Scientific Research (NWO).; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060594] Funding Source: NIH RePORTER	Dutch Cancer Society(KWF Kankerbestrijding); Dutch Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Association for International Cancer Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wenner-Gren foundations; Netherlands Genomic Initiative of the Netherlands Organisation for Scientific Research (NWO).(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are thankful to B. Ingelheim for the gift of BI2536, Millennium Pharmaceuticals for MLN8054, E. Nigg for antibodies and sharing unpublished work, A. Desai and I. Cheeseman for providing the pIC113 plasmid, M. Tanenbaum for U2OS cells expressing YFP-tubulin, S. Sen for GST-aurora A constructs, M. Vromans for recombinant GST-aurora A, Q. Verstralen for technical assistance, D. Littler for active recombinant PLK1, P. de Graaf for the U2OS-TR cell line, G. Kops for making the Deltavision imaging system available, L. Kleij for technical assistance with confocal microscopy, and all members of the Medema laboratory for discussions. We thank M. Alvarez, S. Lens, G. Kops and M. Tanenbaum for critically reading the manuscript. This work was supported by the Dutch Cancer Society (L.M. UU2006-3579), the Dutch Organisation for Scientific Research ( R. H. M. ZonMw 918.46.616 and A. L. 916.86.083), the Association for International Cancer Research ( L. M. 08-0172) and the NIH ( M. B. Y. GM-60594 and CA112967). A. L. was also funded by the Wenner-Gren foundations. R. H. M. was funded by the Netherlands Genomic Initiative of the Netherlands Organisation for Scientific Research (NWO).	Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; CHAN E, IN PRESS CHROMOSOMA; CHEESEMAN IM, 2005, SCI STKE, pI1; Dutertre S, 2004, J CELL SCI, V117, P2523, DOI 10.1242/jcs.01108; Eyers PA, 2003, CURR BIOL, V13, P691, DOI 10.1016/S0960-9822(03)00166-0; Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923; Girdler F, 2006, J CELL SCI, V119, P3664, DOI 10.1242/jcs.03145; Hoar K, 2007, MOL CELL BIOL, V27, P4513, DOI 10.1128/MCB.02364-06; Hutterer A, 2006, DEV CELL, V11, P147, DOI 10.1016/j.devcel.2006.06.002; Jang YJ, 2002, J BIOL CHEM, V277, P44115, DOI 10.1074/jbc.M202172200; Katayama H, 2001, J BIOL CHEM, V276, P46219, DOI 10.1074/jbc.M107540200; Kelm O, 2002, J BIOL CHEM, V277, P25247, DOI 10.1074/jbc.M202855200; Krystyniak A, 2006, ONCOGENE, V25, P338, DOI 10.1038/sj.onc.1209056; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Lindqvist A, 2007, PLOS BIOL, V5, P1127, DOI 10.1371/journal.pbio.0050123; Manfredi MG, 2007, P NATL ACAD SCI USA, V104, P4106, DOI 10.1073/pnas.0608798104; Marumoto T, 2002, GENES CELLS, V7, P1173, DOI 10.1046/j.1365-2443.2002.00592.x; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; OHKURA H, 1995, GENE DEV, V9, P1059, DOI 10.1101/gad.9.9.1059; Okano-Uchida T, 2003, EMBO J, V22, P5633, DOI 10.1093/emboj/cdg535; Qian YW, 1999, MOL CELL BIOL, V19, P8625; Qian YW, 1998, SCIENCE, V282, P1701, DOI 10.1126/science.282.5394.1701; Rosasco-Nitcher SE, 2008, SCIENCE, V319, P469, DOI 10.1126/science.1148980; Seki A, 2008, J CELL BIOL, V181, P65, DOI 10.1083/jcb.200712027; Smits VAJ, 2000, NAT CELL BIOL, V2, P672, DOI 10.1038/35023629; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; van de Weerdt BCM, 2005, MOL CELL BIOL, V25, P2031, DOI 10.1128/MCB.25.5.2031-2044.2005; van Vugt MATM, 2005, CANCER RES, V65, P7037, DOI 10.1158/0008-5472.CAN-05-1054; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015; van Vugt MATM, 2004, J BIOL CHEM, V279, P36841, DOI 10.1074/jbc.M313681200; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Zhang J, 2005, NATURE, V437, P569, DOI 10.1038/nature04140	32	501	514	2	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 4	2008	455	7209					119	U88		10.1038/nature07185	http://dx.doi.org/10.1038/nature07185			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	343XS	18615013				2022-12-28	WOS:000258890200049
J	Sultan, M; Schulz, MH; Richard, H; Magen, A; Klingenhoff, A; Scherf, M; Seifert, M; Borodina, T; Soldatov, A; Parkhomchuk, D; Schmidt, D; O'Keeffe, S; Haas, S; Vingron, M; Lehrach, H; Yaspo, ML				Sultan, Marc; Schulz, Marcel H.; Richard, Hugues; Magen, Alon; Klingenhoff, Andreas; Scherf, Matthias; Seifert, Martin; Borodina, Tatjana; Soldatov, Aleksey; Parkhomchuk, Dmitri; Schmidt, Dominic; O'Keeffe, Sean; Haas, Stefan; Vingron, Martin; Lehrach, Hans; Yaspo, Marie-Laure			A global view of gene activity and alternative splicing by deep sequencing of the human transcriptome	SCIENCE			English	Article							RNA-POLYMERASE-II; EXPRESSION; RESOLUTION; GENOME; IDENTIFICATION; TECHNOLOGIES; TRANSLATION; DISCOVERY; MAPS	The functional complexity of the human transcriptome is not yet fully elucidated. We report a high- throughput sequence of the human transcriptome from a human embryonic kidney and a B cell line. We used shotgun sequencing of transcripts to generate randomly distributed reads. Of these, 50% mapped to unique genomic locations, of which 80% corresponded to known exons. We found that 66% of the polyadenylated transcriptome mapped to known genes and 34% to nonannotated genomic regions. On the basis of known transcripts, RNA- Seq can detect 25% more genes than can microarrays. A global survey of messenger RNA splicing events identified 94,241 splice junctions ( 4096 of which were previously unidentified) and showed that exon skipping is the most prevalent form of alternative splicing.	[Sultan, Marc; Magen, Alon; Borodina, Tatjana; Soldatov, Aleksey; Parkhomchuk, Dmitri; Schmidt, Dominic; Lehrach, Hans; Yaspo, Marie-Laure] Max Planck Inst Mol Genet, Dept Vertebrate Genom, D-14195 Berlin, Germany; [Schulz, Marcel H.; Richard, Hugues; O'Keeffe, Sean; Haas, Stefan; Vingron, Martin] Max Planck Inst Mol Genet, Dept Computat Mol Biol, D-14195 Berlin, Germany; [Schulz, Marcel H.] Int Max Planck Res Sch Computat Biol & Sci Comp, D-80335 Munich, Germany; [Klingenhoff, Andreas; Scherf, Matthias; Seifert, Martin] Genomatrix Software Gmbh, D-80335 Munich, Germany	Max Planck Society; Max Planck Society; Max Planck Society	Yaspo, ML (corresponding author), Max Planck Inst Mol Genet, Dept Vertebrate Genom, Ihnestr 73, D-14195 Berlin, Germany.	yaspo@molgen.mpg.de	Soldatov, Alexey/V-2383-2019; Seifert, Martin/GSE-3648-2022	Richard, Hugues/0000-0001-7776-1340; Schulz, Marcel H./0000-0002-1252-3656; Haas, Stefan/0000-0003-3418-3688; Borodina, Tatiana/0000-0002-6978-016X				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Barnes M, 2005, NUCLEIC ACIDS RES, V33, P5914, DOI 10.1093/nar/gki890; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Brodsky AS, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r64; Byrd MP, 2005, J BIOL CHEM, V280, P18610, DOI 10.1074/jbc.M414014200; Calarco JA, 2007, ADV EXP MED BIOL, V623, P64, DOI 10.1007/978-0-387-77374-2_5; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Coldwell MJ, 2006, MOL CELL BIOL, V26, P8448, DOI 10.1128/MCB.01248-06; Hampton GM, 2003, TRENDS MOL MED, V9, P5, DOI 10.1016/S1471-4914(02)00006-0; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Jongeneel CV, 2005, GENOME RES, V15, P1007, DOI 10.1101/gr.4041005; Jongeneel CV, 2003, P NATL ACAD SCI USA, V100, P4702, DOI 10.1073/pnas.0831040100; Kim JB, 2007, SCIENCE, V316, P1481, DOI 10.1126/science.1137325; LEHRACH H., 1990, GENOME ANAL, P39; LENNON GG, 1991, TRENDS GENET, V7, P314, DOI 10.1016/0168-9525(91)90420-U; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Liu F, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-153; Margaritis T, 2008, CELL, V133, P581, DOI 10.1016/j.cell.2008.04.027; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Pan Q, 2004, MOL CELL, V16, P929, DOI 10.1016/j.molcel.2004.12.004; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Southern EM, 1992, CURR OPIN GENET DEV, V2, P412, DOI 10.1016/S0959-437X(05)80151-0; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Wang JPZ, 2005, J AM STAT ASSOC, V100, P942, DOI 10.1198/016214504000002005; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002	29	923	998	8	195	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 15	2008	321	5891					956	960		10.1126/science.1160342	http://dx.doi.org/10.1126/science.1160342			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337LD	18599741				2022-12-28	WOS:000258436700037
J	Meisinger, C; Sickmann, A; Pfanner, N				Meisinger, Chris; Sickmann, Albert; Pfanner, Nikolaus			The mitochondrial proteom: From inventory to function	CELL			English	Editorial Material							TANDEM MASS-SPECTROMETRY; HEART	Mitochondria are central to cellular energetics, metabolism, and signaling. In this issue, Pagliarini et al. (2008) report the largest compendium of mammalian mitochondrial proteins to date. Together with proteomic studies in yeast, this study represents an important step toward the systematic characterization of the mitochondrial proteome and of mitochondrial diseases.	[Meisinger, Chris; Pfanner, Nikolaus] Univ Freiburg, ZBMZ, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; [Sickmann, Albert] Univ Wurzburg, DFG Res Ctr Expt Biomed, Rudolf Virchow Ctr, D-97078 Wurzburg, Germany	University of Freiburg; German Research Foundation (DFG); University of Wurzburg	Pfanner, N (corresponding author), Univ Freiburg, ZBMZ, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany.	nikolaus.pfanner@biochemie.uni-freiburg.de	Meisinger, Chris/J-1110-2014; Sickmann, Albert/A-1010-2011; Pfanner, Nikolaus/AAV-7878-2021	Meisinger, Chris/0000-0002-8326-3548; Sickmann, Albert/0000-0002-2388-5265; 				Bolender N, 2008, EMBO REP, V9, P42, DOI 10.1038/sj.embor.7401126; Forner F, 2006, MOL CELL PROTEOMICS, V5, P608, DOI 10.1074/mcp.M500298-MCP200; Gaucher SP, 2004, J PROTEOME RES, V3, P495, DOI 10.1021/pr034102a; Heazlewood JL, 2004, PLANT CELL, V16, P241, DOI 10.1105/tpc.016055; Lazarou M, 2007, MOL CELL BIOL, V27, P4228, DOI 10.1128/MCB.00074-07; Prokisch H, 2004, PLOS BIOL, V2, P795, DOI 10.1371/journal.pbio.0020160; Reinders J, 2006, J PROTEOME RES, V5, P1543, DOI 10.1021/pr050477f; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; Smith DGS, 2007, J MOL BIOL, V374, P837, DOI 10.1016/j.jmb.2007.09.051	9	108	109	0	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 11	2008	134	1					22	24		10.1016/j.cell.2008.06.043	http://dx.doi.org/10.1016/j.cell.2008.06.043			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	324IU	18614007	Bronze			2022-12-28	WOS:000257513100010
J	Weake, VM; Workman, JL				Weake, Vikki M.; Workman, Jerry L.			Clearing the way for unpaused polymerases	CELL			English	Editorial Material							CHROMATIN-STRUCTURE; DROSOPHILA; BINDING; TRANSCRIPTION	Heat shock loci in the polytene chromosomes of the fruit fly Drosophila undergo a characteristic change in appearance that coincides with the onset of gene expression. Petesch and Lis ( 2008) now show that nucleosomes are lost across the entire Hsp70 locus in an initial wave that precedes transcription by RNA polymerase II.	[Weake, Vikki M.; Workman, Jerry L.] Stowers Inst Med Res, Kansas City, MO 64110 USA	Stowers Institute for Medical Research	Workman, JL (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.	jlw@stowers-institute.org	Weake, Vikki/A-5722-2018	Weake, Vikki/0000-0002-5933-9952	NIGMS NIH HHS [R01 GM099945] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099945] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Carey M, 2006, MOL CELL, V24, P481, DOI 10.1016/j.molcel.2006.09.012; Chang WJ, 2001, J BIOL CHEM, V276, P47664, DOI 10.1074/jbc.M104666200; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Lis JT, 2007, NATURE, V450, P198, DOI 10.1038/nature06324; Tulin A, 2003, SCIENCE, V299, P560, DOI 10.1126/science.1078764; Tulin A, 2006, GENETICS, V172, P363, DOI 10.1534/genetics.105.049239; Winegarden NA, 1996, J BIOL CHEM, V271, P26971, DOI 10.1074/jbc.271.43.26971; WU C, 1979, CELL, V16, P807, DOI 10.1016/0092-8674(79)90096-5; Zhao J, 2005, MOL CELL BIOL, V25, P8985, DOI 10.1128/MCB.25.20.8985-8999.2005	9	3	3	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 11	2008	134	1					16	18		10.1016/j.cell.2008.06.031	http://dx.doi.org/10.1016/j.cell.2008.06.031			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	324IU	18614004	Bronze			2022-12-28	WOS:000257513100007
J	Vilacosta, I; Godoy, VC				Vilacosta, Isidre; Canadas Godoy, Victoria			Bifid uvula and aortic aneurysm	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Vilacosta, Isidre; Canadas Godoy, Victoria] Hosp Clin San Carlos, E-28040 Madrid, Spain	Hospital Clinico San Carlos	Vilacosta, I (corresponding author), Hosp Clin San Carlos, E-28040 Madrid, Spain.								0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 10	2008	359	2					E2	E2		10.1056/NEJMicm070582	http://dx.doi.org/10.1056/NEJMicm070582			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	323PJ	18614778				2022-12-28	WOS:000257459000010
J	Shea, AM; Curtis, LH; Hammill, BG; DiMartino, LD; Abernethy, AP; Schulman, KA				Shea, Alisa M.; Curtis, Lesley H.; Hammill, Bradley G.; DiMartino, Lisa D.; Abernethy, Amy P.; Schulman, Kevin A.			Association between the medicare Modernization Act of 2003 and patient wait times and travel distance for chemotherapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BREAST-CANCER; RADIATION-THERAPY; LUNG-CANCER; SURGERY; CLAIMS; DIAGNOSIS; ACCURACY; ICD-9-CM; FLORIDA; IMPACT	Context The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 ( MMA) altered reimbursements for outpatient chemotherapy drugs and drug administration services. Anecdotal reports suggest that these adjustments may have negatively affected access to chemotherapy for Medicare beneficiaries. Objective To compare patient wait times and travel distances for chemotherapy before and after the enactment of the MMA. Design, Setting, and Patients Analysis of a nationally representative 5% sample of claims from the Centers for Medicare & Medicaid Services for the period 2003 through 2006. Patients were Medicare beneficiaries with incident breast cancer, colorectal cancer, leukemia, lung cancer, or lymphoma who received chemotherapy in inpatient hospital, institutional outpatient, or physician office settings. Main Outcome Measures Days from incident diagnosis to first chemotherapy visit and distance traveled for treatment, controlling for age, sex, race/ ethnicity, cancer type, geographic region, comorbid conditions, and year of diagnosis and treatment. Results There were 5082 incident cases of breast cancer, colorectal cancer, leukemia, lung cancer, or lymphoma in 2003; 5379 cases in 2004; 5116 cases in 2005; and 5288 cases in 2006. Approximately 70% of patients received treatment in physician office settings in each year. Although the distribution of treatment settings in 2004 and 2005 was not significantly different from 2003 ( P=. 24 and P=. 72, respectively), there was a small but significant change from 2003 to 2006 ( P=. 02). The proportion of patients receiving chemotherapy in inpatient settings decreased from 10.2% in 2003 to 8.8% in 2006 ( P=. 03), and the proportion in institutional outpatient settings increased from 21.1% to 22.5%( P=. 004). The proportion in physician offices remained at 68.7% ( P=. 29). The median time from diagnosis to initial chemotherapy visit was 28 days in 2003,27 days in 2004,29 days in 2005, and 28 days in 2006. In multivariate analyses, average wait times for chemotherapy were 1.96 days longer in 2005 than in 2003( 95% confidence interval [ CI], 0.11- 3.80 days; P=. 04) but not significantly different in 2006 ( 0.88 days; 95% CI, - 0.96 to 2.71 days; P=. 35). Median travel distance was 7 miles ( 11.2 km) in 2003 and 8 miles ( 12.8 km) in 2004 through 2006. After adjustment, average travel distance remained slightly longer in 2004( 1.47 miles [ 2.35 km]; 95% CI, 0.87- 2.07 miles [ 1.39- 3.31 km]; P < .001), 2005( 1.19 miles [ 1.90 km]; 95% CI, 0.58- 1.80 miles [ 0.93- 2.88 km]; P <. 001), and 2006 ( 1.30 miles [ 2.08 km]; 95% CI, 0.69- 1.90 miles [ 1.10- 3.04 km]; P <. 001) compared with 2003. Conclusion There have not been major changes in travel distance and patient wait times for chemotherapy in the Medicare population since 2003, the year before MMA-related changes in reimbursement.	[Shea, Alisa M.; Curtis, Lesley H.; Hammill, Bradley G.; DiMartino, Lisa D.; Schulman, Kevin A.] Duke Univ, Sch Med, Duke Clin Res Inst, Ctr Clin & Genet Econ, Durham, NC 27715 USA; [Curtis, Lesley H.; Abernethy, Amy P.; Schulman, Kevin A.] Duke Univ, Sch Med, Dept Med, Durham, NC 27715 USA	Duke University; Duke University	Curtis, LH (corresponding author), Duke Univ, Sch Med, Duke Clin Res Inst, Ctr Clin & Genet Econ, POB 17969, Durham, NC 27715 USA.	lesley.curtis@duke.edu	DiMartino, Lisa/AAL-2835-2021	DiMartino, Lisa/0000-0003-1616-7406				*AM SOC CLIN ONC, 2003, ASCO CRIT CUTS CANC; Arday SL, 2000, HEALTH CARE FINANC R, V21, P107; Athas WF, 2000, J NATL CANCER I, V92, P269, DOI 10.1093/jnci/92.3.269; BERENSON A, 2007, NY TIMES        0105, pC1; Birman-Deych E, 2005, MED CARE, V43, P480, DOI 10.1097/01.mlr.0000160417.39497.a9; Celaya MO, 2006, CANCER CAUSE CONTROL, V17, P851, DOI 10.1007/s10552-006-0025-7; Cold S, 2005, BRIT J CANCER, V93, P627, DOI 10.1038/sj.bjc.6602734; *CTR MED MED SERV, STAND AN FIL; Du XLL, 2006, MED CARE, V44, P124, DOI 10.1097/01.mlr.0000196978.34283.a6; Earle CC, 2002, J CLIN ONCOL, V20, P1786, DOI 10.1200/JCO.2002.07.142; Edwards BK, 2002, CANCER-AM CANCER SOC, V94, P2766, DOI 10.1002/cncr.10593; Friedman JY, 2007, CANCER, V110, P2304, DOI 10.1002/cncr.23042; Harris G., 2004, NEW YORK TIMES, pC1; Hershman DL, 2006, BREAST CANCER RES TR, V99, P313, DOI 10.1007/s10549-006-9206-z; Huff C, 2004, HOSP HEALTH NETWORK, V78, P62; Lamont EB, 2005, J NATL CANCER I, V97, P1080, DOI 10.1093/jnci/dji189; *MED PAYM ADV COMM, 2007, REP C EFF MED PAYM C; Nattinger AB, 2001, J NATL CANCER I, V93, P1344, DOI 10.1093/jnci/93.17.1344; *OFF INSP GEN, 2005, A060500024 US DEP HH; Phibbs CS, 1995, MED CARE RES REV, V52, P532, DOI 10.1177/107755879505200406; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Research Data Assistance Center, MED DAT FIL DESCR; Schrag D, 2001, J NATL CANCER I, V93, P850, DOI 10.1093/jnci/93.11.850; Setoguchi S, 2007, CANCER CAUSE CONTROL, V18, P561, DOI 10.1007/s10552-007-0131-1; Siegel J, 2006, AM J HEALTH-SYST PH, V63, pS18, DOI 10.2146/ajhp060114; Smith SK, 2006, J GERONTOL B-PSYCHOL, V61, pS232, DOI 10.1093/geronb/61.5.S232; STEIN R, 2004, WASH POST       1214, pA1; Twombly R, 2004, J NATL CANCER I, V96, P1268, DOI 10.1093/jnci/96.17.1268; Twombly R, 2004, J NATL CANCER I, V96, P166, DOI 10.1093/jnci/96.3.166; *US GEN ACC OFF, 2001, GAO011118; US Government Accountability Office, 2004, GAO05142R; Voti L, 2006, CANCER-AM CANCER SOC, V106, P201, DOI 10.1002/cncr.21557; Warren JL, 2002, MED CARE, V40, P55; *WWAMI RUR HLTH RE, RUR COMM AR COD VERS; 2004, LOS ANGELES TIM 0728, pA19	35	31	31	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 9	2008	300	2					189	196		10.1001/jama.300.2.189	http://dx.doi.org/10.1001/jama.300.2.189			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	323GV	18612116	Bronze			2022-12-28	WOS:000257435500023
J	Noyes, MB; Christensen, RG; Wakabayashi, A; Stormo, GD; Brodsky, MH; Wolfe, SA				Noyes, Marcus B.; Christensen, Ryan G.; Wakabayashi, Atsuya; Stormo, Gary D.; Brodsky, Michael H.; Wolfe, Scot A.			Analysis of homeodomain specificities allows the family-wide prediction of preferred recognition sites	CELL			English	Article							DNA-BINDING SPECIFICITY; CRYSTAL-STRUCTURE; SEQUENCE RECOGNITION; ANGSTROM RESOLUTION; STRUCTURAL BASIS; IDENTIFYING DNA; MINOR-GROOVE; COMPLEX; PROTEIN; SEGMENTATION	We describe the comprehensive characterization of homeodomain DNA-binding specificities from a metazoan genome. The analysis of all 84 independent homeodomains from D. melanogaster reveals the breadth of DNA sequences that can be specified by this recognition motif. The majority of these factors can be organized into 11 different specificity groups, where the preferred recognition sequence between these groups can differ at up to four of the six core recognition positions. Analysis of the recognition motifs within these groups led to a catalog of common specificity determinants that may cooperate or compete to define the binding site preference. With these recognition principles, a homeodomain can be reengineered to create factors where its specificity is altered at the majority of recognition positions. This resource also allows prediction of homeodomain specificities from other organisms, which is demonstrated by the prediction and analysis of human homeodomain specificities.	[Noyes, Marcus B.; Wakabayashi, Atsuya; Brodsky, Michael H.; Wolfe, Scot A.] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; [Noyes, Marcus B.; Wolfe, Scot A.] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA; [Wakabayashi, Atsuya; Brodsky, Michael H.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Christensen, Ryan G.; Stormo, Gary D.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Washington University (WUSTL)	Brodsky, MH (corresponding author), Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA.	michael.brodsky@umassmed.edu; scot.wolfe@umassmed.edu	Stormo, Gary D/C-5367-2013	Stormo, Gary D/0000-0001-6896-1850	NHGRI NIH HHS [HG002673, R21 HG003721-02, R21 HG003721, R01 HG000249, HG00249, 1R21HG003721, R01 HG000249-19, R01 HG002673] Funding Source: Medline; NIGMS NIH HHS [T32GM08802, T32 GM008802] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG003721, R01HG000249, R01HG002673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008802] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADES SE, 1995, BIOCHEMISTRY-US, V34, P14601, DOI 10.1021/bi00044a040; Banerjee-Basu S, 2001, NUCLEIC ACIDS RES, V29, P3258, DOI 10.1093/nar/29.15.3258; Benos PV, 2002, J MOL BIOL, V323, P701, DOI 10.1016/S0022-2836(02)00917-8; Bergman CM, 2005, BIOINFORMATICS, V21, P1747, DOI 10.1093/bioinformatics/bti173; Berman BP, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r61; Bertolino E, 1995, J BIOL CHEM, V270, P31178, DOI 10.1074/jbc.270.52.31178; Bilioni A, 2005, P NATL ACAD SCI USA, V102, P14671, DOI 10.1073/pnas.0502480102; Chang CP, 1996, MOL CELL BIOL, V16, P1734; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Damante G, 1996, EMBO J, V15, P4992, DOI 10.1002/j.1460-2075.1996.tb00879.x; Dave V, 2000, MOL CELL BIOL, V20, P7673, DOI 10.1128/MCB.20.20.7673-7684.2000; Dove SL, 1998, GENE DEV, V12, P745, DOI 10.1101/gad.12.5.745; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; EKKER SC, 1994, EMBO J, V13, P3551, DOI 10.1002/j.1460-2075.1994.tb06662.x; EKKER SC, 1992, EMBO J, V11, P4059, DOI 10.1002/j.1460-2075.1992.tb05499.x; Fraenkel E, 1998, J MOL BIOL, V284, P351, DOI 10.1006/jmbi.1998.2147; Fraenkel E, 1998, NAT STRUCT BIOL, V5, P692, DOI 10.1038/1382; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; GEHRING WJ, 1994, ANNU REV BIOCHEM, V63, P487, DOI 10.1146/annurev.biochem.63.1.487; Gruschus JM, 1997, BIOCHEMISTRY-US, V36, P5372, DOI 10.1021/bi9620060; GUTELL RR, 1992, NUCLEIC ACIDS RES, V20, P5785, DOI 10.1093/nar/20.21.5785; HANES SD, 1989, CELL, V57, P1275, DOI 10.1016/0092-8674(89)90063-9; Hazbun TR, 1997, BIOCHEMISTRY-US, V36, P3680, DOI 10.1021/bi9625206; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Hovde S, 2001, BIOCHEMISTRY-US, V40, P12013, DOI 10.1021/bi0108148; Joshi R, 2007, CELL, V131, P530, DOI 10.1016/j.cell.2007.09.024; Kheradpour P, 2007, GENOME RES, V17, P1919, DOI 10.1101/gr.7090407; KISSINGER CR, 1990, CELL, V63, P579, DOI 10.1016/0092-8674(90)90453-L; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; Liu JJ, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni139; Mahony S, 2007, BIOINFORMATICS, V23, pI297, DOI 10.1093/bioinformatics/btm215; Mathias JR, 2001, J BIOL CHEM, V276, P32696, DOI 10.1074/jbc.M103097200; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Meng XD, 2005, NAT BIOTECHNOL, V23, P988, DOI 10.1038/nbt1120; Meng X, 2006, NAT PROTOC, V1, P30, DOI 10.1038/nprot.2006.6; Mukherjee K, 2007, J MOL EVOL, V65, P137, DOI 10.1007/s00239-006-0023-0; Noyes MB, 2008, NUCLEIC ACIDS RES, V36, P2547, DOI 10.1093/nar/gkn048; Passner JM, 1999, NATURE, V397, P714, DOI 10.1038/17833; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; PERCIVALSMITH A, 1990, EMBO J, V9, P3967, DOI 10.1002/j.1460-2075.1990.tb07617.x; Piper DE, 1999, CELL, V96, P587, DOI 10.1016/S0092-8674(00)80662-5; POMERANTZ JL, 1995, SCIENCE, V267, P93, DOI 10.1126/science.7809612; Ryoo HD, 1999, GENE DEV, V13, P1704, DOI 10.1101/gad.13.13.1704; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schroeder MD, 2004, PLOS BIOL, V2, P1396, DOI 10.1371/journal.pbio.0020271; Sinha S, 2003, BIOINFORMATICS, V19, pi292, DOI 10.1093/bioinformatics/btg1040; TREISMAN J, 1989, CELL, V59, P553; TuckerKellogg L, 1997, STRUCTURE, V5, P1047, DOI 10.1016/S0969-2126(97)00256-6; Tupler R, 2001, NATURE, V409, P832, DOI 10.1038/35057011; Wilson DS, 1999, NAT STRUCT BIOL, V6, P297, DOI 10.1038/7524; WOLBERGER C, 1991, CELL, V67, P517, DOI 10.1016/0092-8674(91)90526-5; Wolberger C, 1996, CURR OPIN STRUC BIOL, V6, P62, DOI 10.1016/S0959-440X(96)80096-0; Zhu CQC, 2002, DEVELOPMENT, V129, P2835	54	310	314	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 27	2008	133	7					1277	1289		10.1016/j.cell.2008.05.023	http://dx.doi.org/10.1016/j.cell.2008.05.023			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	319DP	18585360	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000257144600023
J	Harris, A				Harris, Alan			What spaceguard did	NATURE			English	Editorial Material									[Harris, Alan] Space Sci Inst, La Canada Flintridge, CA 91011 USA		Harris, A (corresponding author), Space Sci Inst, 4603 Orange Knoll Ave, La Canada Flintridge, CA 91011 USA.							BOSLOUGH M, 2007, AM GEOPH UN FALL M; Bottke WF, 2007, NATURE, V449, P48, DOI 10.1038/nature06070; D'Abramo G, 2001, ICARUS, V153, P214, DOI 10.1006/icar.2001.6650; HARRIS AWB, 2007, AM ASTRO SOC, V39, P511; Morrison D., 1992, SPAC SURV REP NASA I; Pinter N., 2008, GSA TODAY, V18, P37, DOI [10.1130/GSAT01801GW.1, DOI 10.1130/GSAT01801GW.1]; Pravec P., 2007, P INT ASTR UN S, V236, P167; Toon OB, 1997, REV GEOPHYS, V35, P41, DOI 10.1029/96RG03038	8	38	38	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 26	2008	453	7199					1178	1179		10.1038/4531178a	http://dx.doi.org/10.1038/4531178a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318FA	18580926				2022-12-28	WOS:000257075800019
J	Galie, N; Rubin, LJ; Hoeper, MM; Jansa, P; Al-Hiti, H; Meyer, GMB; Chiossi, E; Kusic-Pajic, A; Simonneau, G				Galie, N.; Rubin, L. J.; Hoeper, M. M.; Jansa, P.; Al-Hiti, H.; Meyer, G. M. B.; Chiossi, E.; Kusic-Pajic, A.; Simonneau, G.			Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial	LANCET			English	Article							CONTINUOUS INTRAVENOUS EPOPROSTENOL; BRAIN NATRIURETIC PEPTIDE; PLACEBO-CONTROLLED TRIAL; PROSTACYCLIN ANALOG; INHALED ILOPROST; THERAPY; SURVIVAL; DISEASE; SITAXSENTAN; SILDENAFIL	Background Treatments for pulmonary arterial hypertension have been mainly studied in patients with advanced disease (WHO functional class [FC] III and IV). This study was designed to assess the effect of the dual endothelin receptor antagonist bosentan in patients with WHO FC II pulmonary arterial hypertension. Methods Patients with WHO FC II pulmonary arterial hypertension aged 12 years or over with 6-min walk distance of less than 80% of the normal predicted value or less than 500 m associated with a Borg dyspnoea index of 2 or greater were enrolled in this double-blind, placebo-controlled, multicentre trial. 185 patients were randomly assigned to receive bosentan (n=93) or placebo (n=92) for the 6-month double-blind treatment period via a centralised integrated voice recognition system. Primary endpoints were pulmonary vascular resistance at month 6 expressed as percentage of baseline and change from baseline to month 6 in 6-min walk distance. Analyses of the primary endpoints were done with all randomised patients who had a valid baseline assessment and an assessment or an imputed value for month 6. This trial was registered with ClinicalTrials.gov, number NCT00091715. Findings Analyses were done with 168 patients (80 in the bosentan group, 88 in the placebo group) for pulmonary vascular resistance and with 177 (86 and 91) for 6-min walking distance. At month 6, geometric mean pulmonary vascular resistance was 83.2% (95% Cl 73.8-93.7) of the baseline value in the bosentan group and 107.5% (97.6-118.4) of the baseline value in the placebo group (treatment effect -22.6%, 95% Cl -33. 5 to -10 . 0; p<0 . 0001). Mean 6-min walk distance increased from baseline in the bosentan group (11 . 2 m, 95% Cl -4.6 to 27 . 0) and decreased in the placebo group (-7.9 m, -24.3 to 8.5), with a mean treatment effect of 19. 1 m (95% Cl 3.6-41.8; p=0.0758). 12 (13%) patients in the bosentan group and eight (9%) in the placebo group reported serious adverse events, the most common of which were syncope in the bosentan group and right ventricular failure in the placebo group. Interpretation Bosentan treatment could be beneficial for patients with WHO FC 11 pulmonary arterial hypertension. Funding Actelion Pharmaceuticals Ltd.	[Galie, N.] Univ Bologna, Inst Cardiol, I-40138 Bologna, Italy; [Rubin, L. J.] Univ Calif San Diego, San Diego, CA 92103 USA; [Hoeper, M. M.] Hannover Med Sch, D-30623 Hannover, Germany; [Jansa, P.] Charles Univ Prague, Fac Med 1, Dept Med 2, Clin Dept Cardiol & Angiol, Prague, Czech Republic; [Al-Hiti, H.] Inst Clin & Expt Med, Clin Cardiol, Prague, Czech Republic; [Meyer, G. M. B.] Complexo Hosp Sta Casa Porto Alegre, Porto Alegre, RS, Brazil; [Chiossi, E.; Kusic-Pajic, A.] Actel Pharmaceut Ltd, Allschwil, Switzerland; [Simonneau, G.] Univ Paris 11, Hop Antoine Beclere, Clamart, France	University of Bologna; University of California System; University of California San Diego; Hannover Medical School; Charles University Prague; Institute for Clinical & Experimental Medicine (IKEM); Actelion Pharmaceuticals Ltd; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; UDICE-French Research Universities; Universite Paris Saclay	Galie, N (corresponding author), Univ Bologna, Inst Cardiol, Via Massarenti 9, I-40138 Bologna, Italy.	nazzareno.galie@unibo.it	Galie, Nazzareno/F-7004-2014; Simonneau, Gerald/ABE-6614-2020; Hoeper, Marius C/Z-1546-2019; Jansa, Pavel/O-2302-2017	Galie, Nazzareno/0000-0003-4271-8670; Hoeper, Marius C/0000-0001-9086-2293; Jansa, Pavel/0000-0002-3711-7064				Badesch DB, 2000, ANN INTERN MED, V132, P425, DOI 10.7326/0003-4819-132-6-200003210-00002; Barst RJ, 2004, AM J RESP CRIT CARE, V169, P441, DOI 10.1164/rccm.200307-957OC; Barst RJ, 1996, NEW ENGL J MED, V334, P296, DOI 10.1056/NEJM199602013340504; Barst RJ, 2003, J AM COLL CARDIOL, V41, P2119, DOI 10.1016/S0735-1097(03)00463-7; BARST RJ, 1994, ANN INTERN MED, V121, P409, DOI 10.7326/0003-4819-121-6-199409150-00003; Barst RJ, 2006, J AM COLL CARDIOL, V47, P2049, DOI 10.1016/j.jacc.2006.01.057; Channick RN, 2001, LANCET, V358, P1119, DOI 10.1016/S0140-6736(01)06250-X; Chi GYH, 1998, DRUG INF J, V32, p1347S, DOI 10.1177/00928615980320S131; Davie N, 2002, AM J RESP CRIT CARE, V165, P398, DOI 10.1164/ajrccm.165.3.2104059; Enright PL, 1998, AM J RESP CRIT CARE, V158, P1384, DOI 10.1164/ajrccm.158.5.9710086; Farber HW, 2004, NEW ENGL J MED, V351, P1655, DOI 10.1056/NEJMra035488; Frost AE, 2005, VASC PHARMACOL, V43, P36, DOI 10.1016/j.vph.2005.03.003; Galie N, 2004, J AM COLL CARDIOL, V43, p1S, DOI 10.1016/j.jacc.2004.03.003; Galie N, 2002, J AM COLL CARDIOL, V39, P1496, DOI 10.1016/S0735-1097(02)01786-2; Galie N, 2004, CARDIOVASC RES, V61, P227, DOI 10.1016/j.cardiores.2003.11.026; Galie N, 2005, NEW ENGL J MED, V353, P2148, DOI 10.1056/NEJMoa050010; Galie N, 2006, CIRCULATION, V114, P48, DOI 10.1161/CIRCULATIONAHA.106.630715; Humbert M, 2004, EUR RESPIR J, V24, P353, DOI 10.1183/09031936.04.00028404; Humbert M, 2007, EUR RESPIR J, V30, P338, DOI 10.1183/09031936.00138706; Langleben David, 2002, Am Heart J, V143, pE4; McKenna S, 2006, QUAL LIFE RES, V15, P103, DOI 10.1007/s11136-005-3513-4; McLaughlin VV, 2006, AM J RESP CRIT CARE, V174, P1257, DOI 10.1164/rccm.200603-358OC; McLaughlin VV, 2002, CIRCULATION, V106, P1477, DOI 10.1161/01.CIR.0000029100.82385.58; Nagaya N, 2000, CIRCULATION, V102, P865; Olschewski H, 2002, NEW ENGL J MED, V347, P322, DOI 10.1056/NEJMoa020204; Rubin LJ, 2002, NEW ENGL J MED, V346, P896, DOI 10.1056/NEJMoa012212; RUBIN LJ, 1990, ANN INTERN MED, V112, P485, DOI 10.7326/0003-4819-112-7-485; Rubin LJ, 1997, NEW ENGL J MED, V336, P111, DOI 10.1056/NEJM199701093360207; Sastry BKS, 2004, J AM COLL CARDIOL, V43, P1149, DOI 10.1016/j.jacc.2003.10.056; Simonneau G, 2002, AM J RESP CRIT CARE, V165, P800, DOI 10.1164/ajrccm.165.6.2106079; Sitbon O, 2002, J AM COLL CARDIOL, V40, P780, DOI 10.1016/S0735-1097(02)02012-0; The European Agency for the Evaluation of Medicinal Products, POINTS CONS MULT ISS; Ware J.E., 2000, SF 36 HLTH SURVEY MA; Williams MH, 2006, EUR HEART J, V27, P1485, DOI 10.1093/eurheartj/ehi891	34	686	729	0	34	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 21	2008	371	9630					2093	2100		10.1016/S0140-6736(08)60919-8	http://dx.doi.org/10.1016/S0140-6736(08)60919-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	316ER	18572079				2022-12-28	WOS:000256932200029
J	Emanuel, EJ; Fuchs, VR				Emanuel, Ezekiel J.; Fuchs, Victor R.			The perfect storm of overutilization	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Emanuel, Ezekiel J.] NIH, Dept Bioeth, Ctr Clin, Bethesda, MD 20892 USA; [Fuchs, Victor R.] Stanford Univ, Dept Econ, Stanford, CA 94305 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Stanford University	Emanuel, EJ (corresponding author), NIH, Dept Bioeth, Ctr Clin, Bldg 10,Room 1C118, Bethesda, MD 20892 USA.	eemanuel@nih.gov						Angrisano C, 2007, ACCOUNTING COST HLTH; [Anonymous], 2008, ANN INTERN MED, V148, P55, DOI 10.7326/0003-4819-148-1-200801010-00196; *ASS AM MED COLL, 2008, REP AAMC TASK FORC I; Congressional Research Service, 2007, US HLTH CAR SPEND CO; Danzon PM, 2008, HEALTH AFFAIR, V27, P221, DOI 10.1377/hlthaff.27.1.221; Denny CC, 2007, JAMA-J AM MED ASSOC, V297, P2515, DOI 10.1001/jama.297.22.2515; Emanuel EJ, 2007, JAMA-J AM MED ASSOC, V297, P2131, DOI 10.1001/jama.297.19.2131; *GEN ACC OFF, 2006, PRESCR DRUGS IMPR NE; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Jackevicius CA, 2008, NEW ENGL J MED, V358, P1819, DOI 10.1056/NEJMsa0801461; Kessler D, 1996, Q J ECON, V111, P353, DOI 10.2307/2946682; *ORG EC COOP DEV, HLTH GLANC 2007 OECD	12	251	255	2	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 18	2008	299	23					2789	2791		10.1001/jama.299.23.2789	http://dx.doi.org/10.1001/jama.299.23.2789			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	314JH	18560006				2022-12-28	WOS:000256805200027
J	Cals, JWL; Kotz, D				Cals, Jochen W. L.; Kotz, Daniel			Researcher identification: the right needle in the haystack	LANCET			English	Editorial Material							IMPACT		[Cals, Jochen W. L.; Kotz, Daniel] Maastricht Univ Med Ctr, Dept Gen Practice, Sch Publ Hlth & Primary Care, NL-6200 MD Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC)	Cals, JWL (corresponding author), Maastricht Univ Med Ctr, Dept Gen Practice, Sch Publ Hlth & Primary Care, NL-6200 MD Maastricht, Netherlands.	j.cals@hag.unimaas.nl	Cals, Jochen WL/A-1262-2007; Kotz, Daniel/A-1270-2007	Cals, Jochen WL/0000-0001-9550-5674; Kotz, Daniel/0000-0002-9454-023X				De Angelis C, 2005, LANCET, V365, P1827, DOI 10.1016/S0140-6736(05)66588-9; Dickersin K, 2002, JAMA-J AM MED ASSOC, V287, P2772, DOI 10.1001/jama.287.21.2772; Laine C, 2007, LANCET, V369, P1909, DOI 10.1016/S0140-6736(07)60894-0; Seglen PO, 1997, BRIT MED J, V314, P498; *THOMS REUT, THOMS SCI LAUNCH RES; Vucovich LA, 2008, J MED LIBR ASSOC, V96, P63, DOI 10.3163/1536-5050.96.1.63; Williams G, 2007, BRIT MED J, V334, P568, DOI 10.1136/bmj.39146.549225.BE; Wuchty S, 2007, SCIENCE, V316, P1036, DOI 10.1126/science.1136099	8	5	5	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN-JUL	2008	371	9631					2152	2153		10.1016/S0140-6736(08)60931-9	http://dx.doi.org/10.1016/S0140-6736(08)60931-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	326CP	18586158				2022-12-28	WOS:000257635800007
J	Ferenczi, E; Jenkins, H; Gunawardana, B				Ferenczi, Emily; Jenkins, Harri; Gunawardana, Biga			Mysterious episodic coma	LANCET			English	Editorial Material									[Ferenczi, Emily] Hammersmith Hosp, Postgrad Ctr, Dept Acute Med, London W12 0HS, England; [Jenkins, Harri] Charing Cross Hosp, Dept Neurol, London, England; [Gunawardana, Biga] Ealing Gen Hosp, Dept Care Elderly, London, England	Imperial College London; Imperial College London; Imperial College London	Ferenczi, E (corresponding author), Hammersmith Hosp, Postgrad Ctr, Dept Acute Med, Du Cane Rd, London W12 0HS, England.	emily.ferenczi@doctors.org.uk						Elphick DA, 2005, GERONTOLOGY, V51, P396, DOI 10.1159/000088704; Godey F, 2000, AM J GASTROENTEROL, V95, P3675; Jones EA, 2002, METAB BRAIN DIS, V17, P275, DOI 10.1023/A:1021949616422; Singh Virmeet V, 2003, Curr Gastroenterol Rep, V5, P365, DOI 10.1007/s11894-003-0048-0	4	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN-JUL	2008	371	9631					2222	2222		10.1016/S0140-6736(08)60957-5	http://dx.doi.org/10.1016/S0140-6736(08)60957-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	326CP	18586177				2022-12-28	WOS:000257635800030
J	Hao, LH; Sakurai, A; Watanabe, T; Sorensen, E; Nidom, CA; Newton, MA; Ahlquist, P; Kawaoka, Y				Hao, Linhui; Sakurai, Akira; Watanabe, Tokiko; Sorensen, Ericka; Nidom, Chairul A.; Newton, Michael A.; Ahlquist, Paul; Kawaoka, Yoshihiro			Drosophila RNAi screen identifies host genes important for influenza virus replication	NATURE			English	Article							CYTOCHROME-C-OXIDASE; MESSENGER-RNA; PROTEIN; EXPORT; APOPTOSIS; TARGETS	All viruses rely on host cell proteins and their associated mechanisms to complete the viral life cycle. Identifying the host molecules that participate in each step of virus replication could provide valuable new targets for antiviral therapy, but this goal may take several decades to achieve with conventional forward genetic screening methods and mammalian cell cultures. Here we describe a novel genome-wide RNA interference (RNAi) screen in Drosophila 1 that can be used to identify host genes important for influenza virus replication. After modifying influenza virus to allow infection of Drosophila cells and detection of influenza virus gene expression, we tested an RNAi library against 13,071 genes (90% of the Drosophila genome), identifying over 100 for which suppression in Drosophila cells significantly inhibited or stimulated reporter gene (Renilla luciferase) expression from an influenza-virus-derived vector. The relevance of these findings to influenza virus infection of mammalian cells is illustrated for a subset of the Drosophila genes identified; that is, for three implicated Drosophila genes, the corresponding human homologues ATP6V0D1, COX6A1 and NXF1 are shown to have key functions in the replication of H5N1 and H1N1 influenza A viruses, but not vesicular stomatitis virus or vaccinia virus, in human HEK 293 cells. Thus, we have demonstrated the feasibility of using genome-wide RNAi screens in Drosophila to identify previously unrecognized host proteins that are required for influenza virus replication. This could accelerate the development of new classes of antiviral drugs for chemoprophylaxis and treatment, which are urgently needed given the obstacles to rapid development of an effective vaccine against pandemic influenza and the probable emergence of strains resistant to available drugs.	[Sakurai, Akira; Watanabe, Tokiko; Kawaoka, Yoshihiro] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA; [Hao, Linhui; Sorensen, Ericka; Ahlquist, Paul] Univ Wisconsin, Inst Mol Virol, Madison, WI 53706 USA; [Hao, Linhui; Ahlquist, Paul] Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; [Newton, Michael A.] Univ Wisconsin, Dept Stat, Madison, WI 53706 USA; [Newton, Michael A.] Univ Wisconsin, Dept Biostat, Madison, WI 53706 USA; [Newton, Michael A.] Univ Wisconsin, Dept Med Informat, Madison, WI 53706 USA; [Nidom, Chairul A.] Airlangga Univ, Fac Vet Med, Surabaya 60115, Indonesia; [Nidom, Chairul A.] Airlangga Univ, Collaborating Res Ctr Emerging & Reemerging Infec, Trop Dis Ctr, Surabaya 60115, Indonesia; [Kawaoka, Yoshihiro] Univ Tokyo, Div Virol, Dept Microbiol & Immunol, Tokyo 1088639, Japan; [Kawaoka, Yoshihiro] Univ Tokyo, Int Res Ctr Infect Dis, Inst Med Sci, Tokyo 1088639, Japan; [Kawaoka, Yoshihiro] Kobe Univ, Grad Sch Med, Div Zoonosis, Dept Microbiol & Infect Dis, Kobe, Hyogo 6500017, Japan	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Airlangga University; Airlangga University; University of Tokyo; University of Tokyo; Kobe University	Kawaoka, Y (corresponding author), Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA.	ahlqust@wisc.edu; kawaokay@svm.vetmed.wisc.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044386, R01AI069274, R01AI047446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM035072, R01GM035072] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [R01 AI044386-10, R01 AI069274-03, R01 AI047446-09, R01 AI047446, R01 AI044386, R01 AI069274] Funding Source: Medline; NIGMS NIH HHS [R01 GM035072, R01 GM035072-23, GM35072, R37 GM035072] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bruce JW, 2005, J VIROL, V79, P12969, DOI 10.1128/JVI.79.20.12969-12978.2005; Carr SM, 2006, VIROLOGY, V344, P492, DOI 10.1016/j.virol.2005.08.041; Cherry S, 2005, GENE DEV, V19, P445, DOI 10.1101/gad.1267905; Cullen BR, 2003, TRENDS BIOCHEM SCI, V28, P419, DOI 10.1016/S0968-0004(03)00142-7; Dave RS, 2006, VIROLOGY, V348, P489, DOI 10.1016/j.virol.2006.01.013; Dearolf CR, 1999, CELL MOL LIFE SCI, V55, P1578, DOI 10.1007/s000180050397; Ge Q, 2003, P NATL ACAD SCI USA, V100, P2718, DOI 10.1073/pnas.0437841100; Gnaiger E, 1998, J EXP BIOL, V201, P1129; Hahn H, 1999, J MOL MED-JMM, V77, P459, DOI 10.1007/s001099900018; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; HINSHAW VS, 1994, J VIROL, V68, P3667, DOI 10.1128/JVI.68.6.3667-3673.1994; Kadenbach B, 2004, BBA-BIOENERGETICS, V1655, P400, DOI 10.1016/j.bbabio.2003.06.005; Kushner DB, 2003, P NATL ACAD SCI USA, V100, P15764, DOI 10.1073/pnas.2536857100; Kuttenkeuler David, 2004, Briefings in Functional Genomics & Proteomics, V3, P168, DOI 10.1093/bfgp/3.2.168; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Ludwig S, 2003, TRENDS MOL MED, V9, P46, DOI 10.1016/S1471-4914(02)00010-2; Momose F, 2001, J VIROL, V75, P1899, DOI 10.1128/JVI.75.4.1899-1908.2001; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; PEREZ L, 1994, J GEN VIROL, V75, P2595, DOI 10.1099/0022-1317-75-10-2595; Reed R, 2005, CURR OPIN CELL BIOL, V17, P269, DOI 10.1016/j.ceb.2005.04.011; Satterly N, 2007, P NATL ACAD SCI USA, V104, P1853, DOI 10.1073/pnas.0610977104; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Watanabe T, 2003, J VIROL, V77, P10575, DOI 10.1128/JVI.77.19.10575-10583.2003; Webster RG, 2006, NEW ENGL J MED, V355, P2174, DOI 10.1056/NEJMp068205; Wurzer WJ, 2003, EMBO J, V22, P2717, DOI 10.1093/emboj/cdg279; WYERS F, 1980, J VIROL, V33, P411, DOI 10.1128/JVI.33.1.411-422.1980; Zamarin D, 2006, J VIROL, V80, P7976, DOI 10.1128/JVI.00415-06	28	340	359	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 14	2008	454	7206					890	U46		10.1038/nature07151	http://dx.doi.org/10.1038/nature07151			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	336XH	18615016	Green Accepted, Bronze			2022-12-28	WOS:000258398600037
J	Butler, RN; Miller, RA; Perry, D; Carnes, BA; Williams, TF; Cassel, C; Brody, J; Bernard, MA; Partridge, L; Kirkwood, T; Martin, GM; Olshansky, SJ				Butler, Robert N.; Miller, Richard A.; Perry, Daniel; Carnes, Bruce A.; Williams, T. Franklin; Cassel, Christine; Brody, Jacob; Bernard, Marie A.; Partridge, Linda; Kirkwood, Thomas; Martin, George M.; Olshansky, S. Jay			New model of health promotion and disease prevention for the 21st century	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LIFE-SPAN EXTENSION; GROWTH-HORMONE; GENES; AGE; LONGEVITY; IMMUNE; LIMITS; MOUSE; MICE		[Butler, Robert N.] Int Longev Ctr, New York, NY USA; [Miller, Richard A.] Univ Michigan, Ann Arbor, MI 48109 USA; [Perry, Daniel] Alliance Aging Res, Washington, DC USA; [Carnes, Bruce A.; Bernard, Marie A.] Univ Oklahoma, Oklahoma City, OK USA; [Williams, T. Franklin] Univ Rochester, Sch Med & Dent, Rochester, NY USA; [Cassel, Christine] Amer Board Internal Med, Philadelphia, PA USA; [Brody, Jacob; Olshansky, S. Jay] Univ Illinois, Chicago, IL 60612 USA; [Partridge, Linda] UCL, Inst Healthy Ageing, London, England; [Kirkwood, Thomas] Univ Newcastle, Inst Ageing & Hlth, Newcastle Upon Tyne, Tyne & Wear, England; [Martin, George M.] Amer Federat Aging Res, Seattle, WA USA	University of Michigan System; University of Michigan; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Rochester; American Board of Internal Medicine; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of London; University College London; Newcastle University - UK	Butler, RN (corresponding author), Int Longev Ctr, New York, NY USA.	sjayo@uic.edu	Partridge, Linda/E-7342-2015	Partridge, Linda/0000-0001-9615-0094	Wellcome Trust [066750] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		*AGEACTION, 2007, CHANG EXP LIF; Bartke A, 2004, CURR TOP DEV BIOL, V63, P189, DOI 10.1016/S0070-2153(04)63006-7; Bartke A, 2001, J GERONTOL A-BIOL, V56, pB340, DOI 10.1093/gerona/56.8.B340; Butler R., 2008, LONGEVITY REVOLUTION; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898; HOLLIDAY R, 1984, LANCET, V2, P1386; House of Lords Science and Technology Committee, 2005, AG SCI ASP; Kirkwood TBL, 2008, NATURE, V451, P644, DOI 10.1038/451644a; Kuningas M, 2008, AGING CELL, V7, P270, DOI 10.1111/j.1474-9726.2008.00366.x; Martin GM, 2007, PLOS GENET, V3, P1121, DOI 10.1371/journal.pgen.0030125; Miller RA, 2005, AGING CELL, V4, P119, DOI 10.1111/j.1474-9726.2005.00152.x; Miller RA, 2002, MILBANK Q, V80, P155, DOI 10.1111/1468-0009.00006; Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675; Olshansky SJ, 2006, SCIENTIST, V20, P28; OLSHANSKY SJ, 1990, SCIENCE, V250, P634, DOI 10.1126/science.2237414; OLSHANSKY SJ, 1986, MILBANK Q, V64, P355, DOI 10.2307/3350025; Pinkston-Gosse J, 2007, NAT GENET, V39, P1403, DOI 10.1038/ng.2007.1; Selman C, 2008, FASEB J, V22, P807, DOI 10.1096/fj.07-9261com; STREHLER BL, 1975, THEOR CONCEPTS DEV A, V34, P5; Wessells RJ, 2004, NAT GENET, V36, P1275, DOI 10.1038/ng1476; 2008, HUMAN MORTALITY DATA	22	102	103	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 19	2008	337	7662							a399	10.1136/bmj.a399	http://dx.doi.org/10.1136/bmj.a399			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	330SB	18614506	Green Published			2022-12-28	WOS:000257962000038
J	Greenhalgh, T				Greenhalgh, Trisha			Anyone for Club Med?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									UCL, London, England	University of London; University College London	Greenhalgh, T (corresponding author), UCL, London, England.	p.greenhalgh@pcps.ucl.ac.uk	Greenhalgh, Trisha/B-1825-2015	Greenhalgh, Trisha/0000-0003-2369-8088				Martinez-Gonzalez MA, 2008, BMJ-BRIT MED J, V336, P1348, DOI 10.1136/bmj.39561.501007.BE	1	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 19	2008	337	7662							a677	10.1136/bmj.a677	http://dx.doi.org/10.1136/bmj.a677			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	330SB	18614468	Green Published			2022-12-28	WOS:000257962000048
J	O'Brien, CP				O'Brien, Charles P.			A 50-year-old woman addicted to heroin - Review of treatment of heroin addiction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							METHADONE-MAINTENANCE; FOLLOW-UP; THERAPEUTIC COMMUNITIES; COST-EFFECTIVENESS; DRUG-DEPENDENCE; UNITED-STATES; DETOXIFICATION; BUPRENORPHINE; ABUSE; NALTREXONE	Heroin addiction is a complicated medical and psychiatric issue, with well- established as well as newer modes of treatment. The case of Ms W, a 50- year- old woman with a long history of opiate addiction who has been treated successfully with methadone for 9 years and who now would like to consider newer alternatives, illustrates the complex issues of heroin addiction. The treatment of heroin addiction as a chronic disease is reviewed, including social, medical, and cultural issues and pharmacologic treatment with methadone and the more experimental medication options of buprenorphine and naltrexone.	[O'Brien, Charles P.] Univ Penn, Philadelphia VAMC MIRECC, Philadelphia, PA 19104 USA; [O'Brien, Charles P.] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	O'Brien, CP (corresponding author), Univ Penn, Philadelphia VAMC MIRECC, 3900 Chestnut St, Philadelphia, PA 19104 USA.	obrien@mail.trc.upenn.edu			NATIONAL INSTITUTE ON DRUG ABUSE [P60DA005186] Funding Source: NIH RePORTER; NIDA NIH HHS [P60 DA005186, P60 DA005186-25] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Amato L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003409.pub3; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Anthony JC, 1994, EXP CLIN PSYCHOPHARM, V2, P244, DOI 10.1037/1064-1297.2.3.244; BALE RN, 1984, ARCH GEN PSYCHIAT, V41, P185; BALE RN, 1980, ARCH GEN PSYCHIAT, V37, P179; Barnett PG, 2000, MT SINAI J MED, V67, P365; Caldiero RM, 2006, AM J ADDICTION, V15, P1, DOI 10.1080/10550490500418989; CAMPBELL H, 2007, DEVOLVING POLICY DIV, P55; Cicero TJ, 2005, J PAIN, V6, P662, DOI 10.1016/j.jpain.2005.05.004; Cicero TJ, 1999, DRUG ALCOHOL DEPEN, V57, P7, DOI 10.1016/S0376-8716(99)00041-1; COHEN E, 1994, J PSYCHOACTIVE DRUGS, V26, P233, DOI 10.1080/02791072.1994.10472436; Collins ED, 2005, JAMA-J AM MED ASSOC, V294, P903, DOI 10.1001/jama.294.8.903; Comer SD, 2006, ARCH GEN PSYCHIAT, V63, P210, DOI 10.1001/archpsyc.63.2.210; Compton WM, 2007, ARCH GEN PSYCHIAT, V64, P566, DOI 10.1001/archpsyc.64.5.566; Cornish JW, 1997, J SUBST ABUSE TREAT, V14, P529, DOI 10.1016/S0740-5472(97)00020-2; DESMOND DP, 2000, J MAINTEN ADDICT, V4, P45; Do Couto B. Ribeiro, 2003, Neural Plasticity, V10, P279, DOI 10.1155/NP.2003.279; DOLE VP, 1966, ARCH INTERN MED, V118, P304, DOI 10.1001/archinte.118.4.304; Doran CM, 2003, DRUG ALCOHOL DEPEN, V71, P295, DOI 10.1016/S0376-8716(03)00169-8; Garbutt JC, 2005, JAMA-J AM MED ASSOC, V293, P1617, DOI 10.1001/jama.293.13.1617; Gossop M, 2008, ADDICTION, V103, P119, DOI 10.1111/j.1360-0443.2007.02050.x; HAUSSER D, 1998, INT C AIDS, V12, P389; Hopfer CJ, 2002, J SUBST ABUSE TREAT, V23, P231, DOI 10.1016/S0740-5472(02)00250-7; Hser YI, 2001, ARCH GEN PSYCHIAT, V58, P503, DOI 10.1001/archpsyc.58.5.503; JOHNSON RE, 1992, JAMA-J AM MED ASSOC, V267, P2750, DOI 10.1001/jama.267.20.2750; JUDSON BA, 1984, DRUG ALCOHOL DEPEN, V13, P357, DOI 10.1016/0376-8716(84)90003-6; Kakko J, 2007, AM J PSYCHIAT, V164, P797, DOI 10.1176/appi.ajp.164.5.797; KALTENBACH K, 1984, NEUROBEH TOXICOL TER, V6, P271; KREEK MJ, 1992, RES P ARNMD, V70, P205; MANSKI C, 2001, INFORMING AM POLICY; Mark TL, 2001, DRUG ALCOHOL DEPEN, V61, P195, DOI 10.1016/S0376-8716(00)00162-9; Martell BA, 2007, ANN INTERN MED, V146, P116, DOI 10.7326/0003-4819-146-2-200701160-00006; McLellan AT, 2000, JAMA-J AM MED ASSOC, V284, P1689, DOI 10.1001/jama.284.13.1689; MINTZ J, 1975, INT J ADDICT, V10, P815, DOI 10.3109/10826087509027340; MUSTO DF, 1991, SCI AM, V265, P40, DOI 10.1038/scientificamerican0791-40; O'Brien CP, 2006, AM J PSYCHIAT, V163, P764, DOI 10.1176/appi.ajp.163.5.764; O'Brien CP, 2005, ADDICTION, V100, P1035, DOI 10.1111/j.1360-0443.2005.01213.x; O'Brien CP, 2006, GOODMAN GILMANS PHAR, P607; OBRIEN CP, 1977, SCIENCE, V195, P1000, DOI 10.1126/science.841320; OBRIEN CP, 1983, DRUG ALCOHOL DEPEN, V11, P95, DOI 10.1016/0376-8716(83)90103-5; OBRIEN CP, 1986, PHILADELPHIA MED, V82, P442; Peng PWH, 2005, CAN J ANAESTH, V52, P513, DOI 10.1007/BF03016532; ROTHENBERG S, 1977, PSYCHOPHARMACOLOGY, V52, P299, DOI 10.1007/BF00426715; Sayers SL, 2005, J NERV MENT DIS, V193, P379, DOI 10.1097/01.nmd.0000165089.14736.bf; Specka M, 2000, EUR ADDICT RES, V6, P8, DOI 10.1159/000019004; STIMMEL B, 1977, JAMA-J AM MED ASSOC, V237, P1216, DOI 10.1001/jama.237.12.1216; TYLER J, 1981, DRUG ALCOHOL DEPEN, V8, P279, DOI 10.1016/0376-8716(81)90037-5; van den Brink W, 1999, J DRUG ISSUES, V29, P587, DOI 10.1177/002204269902900309; Wang E C, 1999, J Obstet Gynecol Neonatal Nurs, V28, P615, DOI 10.1111/j.1552-6909.1999.tb02170.x; Zanis DA, 1998, DRUG ALCOHOL DEPEN, V52, P257, DOI 10.1016/S0376-8716(98)00097-0	50	11	11	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 16	2008	300	3					314	321		10.1001/jama.300.1.jrr80005	http://dx.doi.org/10.1001/jama.300.1.jrr80005			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	325ZB	18594026	Green Accepted			2022-12-28	WOS:000257626600023
J	Sofi, F; Capalbo, A; Pucci, N; Giuliattini, J; Condino, F; Alessandri, F; Abbate, R; Gensini, GF; Califano, S				Sofi, Francesco; Capalbo, Andrea; Pucci, Nicola; Giuliattini, Jacopo; Condino, Francesca; Alessandri, Flavio; Abbate, Rosanna; Gensini, Gian Franco; Califano, Sergio			Cardiovascular evaluation, including resting and exercise electrocardiography, before participation in competitive sports: cross sectional study	BRITISH MEDICAL JOURNAL			English	Article							SCREENING-PROGRAM; OF-CARDIOLOGY; PREPARTICIPATION; ABNORMALITIES; STATEMENT; EFFICACY; DEATH	Objective To evaluate the clinical usefulness of complete preparticipation cardiovascular screening in a large cohort of sports participants. Design Cross sectional study of data over a five year period. Setting Institute of Sports Medicine in Florence, Italy. Participants 30 065 (23 570 men) people seeking to obtain clinical eligibility for competitive sports. Main outcome measures Results of resting and exercise 12 lead electrocardiography. Results Resting 12 lead ECG patterns showed abnormalities in 1812 (6%) participants, with the most common abnormalities (>80%) concerning innocent ECG changes. Exercise ECG showed an abnormal pattern in 1459 (4.9%) participants. Exercise ECG showed cardiac anomalies in 1227 athletes with normal findings on resting ECG. At the end of screening, 196 (0.6%) participants were considered ineligible for competitive sports. Among the 159 participants who were disqualified at the end of the screening for cardiac reasons, a consistent proportion (n=126, 79.2%) had shown innocent or negative findings on resting 12 lead ECG but clear pathological alterations during the exercise test. After adjustment for possible confounders; logistic regression analysis showed that age >30 years was significantly associated with an increased risk of being disqualified for cardiac findings during exercise testing. Conclusions Among people seeking to take part in competitive sports, exercise ECG can identify those with cardiac abnormalities. Follow-up studies would show if disqualification of such people would reduce the incidence of CV events among athletes.	[Sofi, Francesco; Capalbo, Andrea; Pucci, Nicola; Abbate, Rosanna; Gensini, Gian Franco] Univ Florence, Azienda Osped Univ Careggi, Thrombosis Ctr, Dept Med & Surg Crit Area, Florence, Italy; [Capalbo, Andrea; Pucci, Nicola; Giuliattini, Jacopo; Condino, Francesca; Alessandri, Flavio; Gensini, Gian Franco; Califano, Sergio] Univ Florence, Ctr Study Mol & Clin Level Chron Degenerat & Neop, Florence, Italy; [Gensini, Gian Franco] Inst Sports Med, Florence, Italy; [Gensini, Gian Franco] IRCCS, Don Carlo Gnocchi Fdn, Florence, Italy	University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Florence; IRCCS Fondazione Don Carlo Gnocchi Onlus	Sofi, F (corresponding author), Univ Florence, Dept Med & Surg Crit Care Area, Thrombosis Ctr, Viale Morgagni 85, I-50134 Florence, Italy.	francescosofi@gmail.com	Sofi, Francesco/J-3941-2016; Sofi, Francesco/W-4610-2019; Alessandri, Stefano/L-2055-2013	Sofi, Francesco/0000-0001-7113-7424; Sofi, Francesco/0000-0001-7113-7424; 				Chaitman BR, 2007, CIRCULATION, V116, P2610, DOI 10.1161/CIRCULATIONAHA.107.711465; Corrado D, 2005, EUR HEART J, V26, P516, DOI 10.1093/eurheartj/ehi108; Corrado D, 2006, JAMA-J AM MED ASSOC, V296, P1593, DOI 10.1001/jama.296.13.1593; Delise Pietro, 2005, Ital Heart J, V6, P661; Di Luigi L, 2004, MED SPORT, V57, P243; *IOC MED COMM, 2004, SUDD CARD DEATH SPOR; Maron BJ, 2007, CIRCULATION, V115, P1643, DOI 10.1161/CIRCULATIONAHA.107.181423; Myerburg RJ, 2007, CIRCULATION, V116, P2616, DOI 10.1161/CIRCULATIONAHA.107.733519; Pelliccia A, 2008, NEW ENGL J MED, V358, P152, DOI 10.1056/NEJMoa060781; Pelliccia A, 2007, EUR HEART J, V28, P2703, DOI 10.1093/eurheartj/ehm455; Pelliccia A, 2007, EUR HEART J, V28, P2006, DOI 10.1093/eurheartj/ehm219; Pelliccia A, 2006, EUR HEART J, V27, P2196, DOI 10.1093/eurheartj/ehl137	12	55	56	2	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 12	2008	337	7661							a346	10.1136/bmj.a346	http://dx.doi.org/10.1136/bmj.a346			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	330SA	18599474	Green Published, Bronze			2022-12-28	WOS:000257961900032
J	Pagliarini, DJ; Calvo, SE; Chang, B; Sheth, SA; Vafai, SB; Ong, SE; Walford, GA; Sugiana, C; Boneh, A; Chen, WK; Hill, DE; Vidal, M; Evans, JG; Thorburn, DR; Carr, SA; Mootha, VK				Pagliarini, David J.; Calvo, Sarah E.; Chang, Betty; Sheth, Sunil A.; Vafai, Scott B.; Ong, Shao-En; Walford, Geoffrey A.; Sugiana, Canny; Boneh, Avihu; Chen, William K.; Hill, David E.; Vidal, Marc; Evans, James G.; Thorburn, David R.; Carr, Steven A.; Mootha, Vamsi K.			A mitochondrial protein compendium elucidates complex I disease biology	CELL			English	Article							SUBCELLULAR-LOCALIZATION; GENOME; MOUSE; YEAST; SEQUENCE; DYSFUNCTION; EXPRESSION; EVOLUTION; SUBUNITS; MUSCLE	Mitochondria are complex organelles whose dysfunction underlies a broad spectrum of human diseases. Identifying all of the proteins resident in this organelle and understanding how they integrate into pathways represent major challenges in cell biology. Toward this goal, we performed mass spectrometry, GFP tagging, and machine learning to create a mitochondrial compendium of 1098 genes and their protein expression across 14 mouse tissues. We link poorly characterized proteins in this inventory to known mitochondrial pathways by virtue of shared evolutionary history. Using this approach, we predict 19 proteins to be important for the function of complex I (CI) of the electron transport chain. Wevalidate a subset of these predictions using RNAi, including C8orf38, which we further show harbors an inherited mutation in a lethal, infantile CI deficiency. Our results have important implications for understanding CI function and pathogenesis and, more generally, illustrate how our compendium can serve as a foundation for systematic investigations of mitochondria.	[Pagliarini, David J.; Calvo, Sarah E.; Chang, Betty; Sheth, Sunil A.; Ong, Shao-En; Carr, Steven A.; Mootha, Vamsi K.] MIT, Broad Inst, Cambridge, MA 02142 USA; [Pagliarini, David J.; Calvo, Sarah E.; Chang, Betty; Sheth, Sunil A.; Ong, Shao-En; Carr, Steven A.; Mootha, Vamsi K.] Harvard Univ, Cambridge, MA 02142 USA; [Pagliarini, David J.; Calvo, Sarah E.; Sheth, Sunil A.; Vafai, Scott B.; Walford, Geoffrey A.; Chen, William K.; Mootha, Vamsi K.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Pagliarini, David J.; Calvo, Sarah E.; Sheth, Sunil A.; Vafai, Scott B.; Walford, Geoffrey A.; Chen, William K.; Mootha, Vamsi K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02446 USA; [Calvo, Sarah E.; Sheth, Sunil A.] Harvard Univ, MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Sugiana, Canny; Boneh, Avihu; Thorburn, David R.] Univ Melbourne, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Sugiana, Canny; Boneh, Avihu; Thorburn, David R.] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [Boneh, Avihu; Thorburn, David R.] Royal Childrens Hosp, Genet Hlth Serv Victoria, Parkville, Vic 3052, Australia; [Hill, David E.; Vidal, Marc] Dana Farber Canc Inst, CCSB, Boston, MA 02115 USA; [Hill, David E.; Vidal, Marc] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Hill, David E.; Vidal, Marc] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Evans, James G.] Whitehead MIT Bioimaging Ctr, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Murdoch Children's Research Institute; University of Melbourne; University of Melbourne; Royal Children's Hospital Melbourne; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Carr, SA (corresponding author), MIT, Broad Inst, Cambridge, MA 02142 USA.	scarr@broad.mit.edu; vamsi@hms.harvard.edu	Carr, Steven A./AAH-8366-2019; Hill, David E/B-6617-2011; Thorburn, David R/G-6266-2013	thorburn, david/0000-0002-7725-9470; Pagliarini, David J./0000-0002-0001-0087	Howard Hughes Medical Institute Funding Source: Medline; NIDDK NIH HHS [DK57521, P30 DK043351, DK43351, P30 DK057521] Funding Source: Medline; NIGMS NIH HHS [R01 GM077465, R01 GM077465-04, GM077465] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351, P30DK057521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077465] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; Devenish RJ, 2000, BBA-BIOENERGETICS, V1458, P428, DOI 10.1016/S0005-2728(00)00092-X; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Fontanesi F, 2006, AM J PHYSIOL-CELL PH, V291, pC1129, DOI 10.1152/ajpcell.00233.2006; Forner F, 2006, MOL CELL PROTEOMICS, V5, P608, DOI 10.1074/mcp.M500298-MCP200; Foster LJ, 2006, CELL, V125, P187, DOI 10.1016/j.cell.2006.03.022; Gabaldon T, 2005, J MOL BIOL, V348, P857, DOI 10.1016/j.jmb.2005.02.067; Guda C, 2004, BIOINFORMATICS, V20, P1785, DOI 10.1093/bioinformatics/bth171; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Huttemann M, 2003, MOL REPROD DEV, V66, P8, DOI 10.1002/mrd.10327; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Janssen RJRJ, 2006, J INHERIT METAB DIS, V29, P499, DOI 10.1007/s10545-006-0362-4; Johnson DT, 2007, AM J PHYSIOL-CELL PH, V292, pC689, DOI 10.1152/ajpcell.00108.2006; Kirby DM, 1999, NEUROLOGY, V52, P1255, DOI 10.1212/WNL.52.6.1255; Kislinger T, 2006, CELL, V125, P173, DOI 10.1016/j.cell.2006.01.044; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; Lamesch P, 2007, GENOMICS, V89, P307, DOI 10.1016/j.ygeno.2006.11.012; Lopez MF, 2000, ELECTROPHORESIS, V21, P3427, DOI 10.1002/1522-2683(20001001)21:16<3427::AID-ELPS3427>3.0.CO;2-L; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Ogilvie I, 2005, J CLIN INVEST, V115, P2784, DOI 10.1172/JCI26020; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Prokisch H, 2006, NUCLEIC ACIDS RES, V34, pD705, DOI 10.1093/nar/gkj127; Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311; Reinders J, 2006, J PROTEOME RES, V5, P1543, DOI 10.1021/pr050477f; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Saada A, 2008, AM J HUM GENET, V82, P32, DOI 10.1016/j.ajhg.2007.08.003; Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7; Schon EA, 2003, J CLIN INVEST, V111, P303, DOI 10.1172/JCI200317741; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Taylor SW, 2003, NAT BIOTECHNOL, V21, P281, DOI 10.1038/nbt793; Vogel RO, 2005, FEBS J, V272, P5317, DOI 10.1111/j.1742-4658.2005.04928.x; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751	43	1439	1477	2	148	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 11	2008	134	1					112	123		10.1016/j.cell.2008.06.016	http://dx.doi.org/10.1016/j.cell.2008.06.016			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	324IU	18614015	Green Submitted, Bronze, Green Accepted			2022-12-28	WOS:000257513100018
J	Damasio, A; Meyer, K				Damasio, Antonio; Meyer, Kaspar			Behind the looking-glass	NATURE			English	Editorial Material							CORTICAL CONNECTIONS; RECOGNITION; PREMOTOR; MONKEY; AREAS		[Damasio, Antonio; Meyer, Kaspar] Univ So Calif, Brain & Creat Inst, Los Angeles, CA 90089 USA	University of Southern California	Damasio, A (corresponding author), Univ So Calif, Brain & Creat Inst, Los Angeles, CA 90089 USA.		Damasio, Antonio/AAD-1342-2019					Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; DAMASIO AR, 1989, COGNITION, V33, P25, DOI 10.1016/0010-0277(89)90005-X; FOGASSI L, 1998, SOC NEUR ABSTR, V24, P257; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gazzola V, 2006, CURR BIOL, V16, P1824, DOI 10.1016/j.cub.2006.07.072; KEYERS C, 2004, TRENDS COGN SCI, V8, P501; Kohler E, 2002, SCIENCE, V297, P846, DOI 10.1126/science.1070311; Raos V, 2007, J NEUROSCI, V27, P12675, DOI 10.1523/JNEUROSCI.2988-07.2007; ROCKLAND KS, 1981, BRAIN RES, V212, P249, DOI 10.1016/0006-8993(81)90461-3; VANHOESEN GW, 1982, TRENDS NEUROSCI, V5, P345, DOI 10.1016/0166-2236(82)90201-6	10	47	54	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 10	2008	454	7201					167	168		10.1038/454167a	http://dx.doi.org/10.1038/454167a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	323RU	18615070				2022-12-28	WOS:000257466900027
J	Glied, SA; Frank, RG				Glied, Sherry A.; Frank, Richard G.			Shuffling toward parity - Bringing mental health care under the umbrella	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							NEED		[Glied, Sherry A.] Columbia Univ, Mailman Sch Publ Hlth, Dept Hlth Policy & Management, New York, NY 10027 USA; [Frank, Richard G.] Harvard Univ, Sch Med, Boston, MA USA	Columbia University; Harvard University; Harvard Medical School	Glied, SA (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Hlth Policy & Management, New York, NY 10027 USA.							Bergthold LA, 1995, HEALTH AFFAIR, V14, P180, DOI 10.1377/hlthaff.14.4.180; Frank RG, 2001, NEW ENGL J MED, V345, P1701, DOI 10.1056/NEJM200112063452311; Goldman HH, 2006, NEW ENGL J MED, V354, P1378, DOI 10.1056/NEJMsa053737; Mechanic D, 2003, HEALTH AFFAIR, V22, P8, DOI 10.1377/hlthaff.22.5.8	4	12	12	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 10	2008	359	2					113	115		10.1056/NEJMp0804447	http://dx.doi.org/10.1056/NEJMp0804447			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	323PJ	18614779				2022-12-28	WOS:000257459000001
J	Lountzis, NI; Rahman, O				Lountzis, Nektarios I.; Rahman, Omar			Digital verrucae	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lountzis, Nektarios I.; Rahman, Omar] Geisinger Med Ctr, Danville, PA 17822 USA	Geisinger Medical Center	Lountzis, NI (corresponding author), Geisinger Med Ctr, Danville, PA 17822 USA.								0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 10	2008	359	2					177	177		10.1056/NEJMicm071912	http://dx.doi.org/10.1056/NEJMicm071912			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	323PJ	18614785				2022-12-28	WOS:000257459000009
J	Fowkes, FGR; Murray, GD; Butcher, I; Heald, CL; Lee, RJ; Chambless, LE; Folsom, AR; Hirsch, AT; Dramaix, M; deBacker, G; Wautrecht, JC; Kornitzer, M; Newman, AB; Cushman, M; Sutton-Tyrrell, K; Lee, AJ; Price, JF; d'Agostino, RB; Murabito, JM; Norman, PE; Jamrozik, K; Curb, JD; Masaki, KH; Rodriquez, BL; Dekker, JM; Bouter, LM; Heine, RJ; Nijpels, G; Stehouwer, CDA; Ferrucci, L; McDermott, MM; Stoffers, HE; Hooi, JD; Knottnerus, JA; Ogren, M; Hedblad, B; Witteman, JC; Breteler, MMB; Hunink, MGM; Hofman, A; Criqui, MH; Langer, RD; Fronek, A; Hiatt, WR; Hamman, R; Resnick, HE; Guralnik, J; McDermott, MM				Fowkes, F. G. R.; Murray, G. D.; Butcher, I.; Heald, C. L.; Lee, R. J.; Chambless, L. E.; Folsom, A. R.; Hirsch, A. T.; Dramaix, M.; deBacker, G.; Wautrecht, J-C.; Kornitzer, M.; Newman, A. B.; Cushman, M.; Sutton-Tyrrell, K.; Lee, A. J.; Price, J. F.; d'Agostino, R. B.; Murabito, J. M.; Norman, P. E.; Jamrozik, K.; Curb, J. D.; Masaki, K. H.; Rodriquez, B. L.; Dekker, J. M.; Bouter, L. M.; Heine, R. J.; Nijpels, G.; Stehouwer, C. D. A.; Ferrucci, L.; McDermott, M. M.; Stoffers, H. E.; Hooi, J. D.; Knottnerus, J. A.; Ogren, M.; Hedblad, B.; Witteman, J. C.; Breteler, M. M. B.; Hunink, M. G. M.; Hofman, A.; Criqui, M. H.; Langer, R. D.; Fronek, A.; Hiatt, W. R.; Hamman, R.; Resnick, H. E.; Guralnik, J.; McDermott, M. M.		Ankle Brachial Index Collaboration	Ankle brachial index combined with Framingham risk score to predict cardiovascular events and mortality - A meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							PERIPHERAL ARTERIAL-DISEASE; CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; LOWER-EXTREMITY; PRESSURE INDEX; ARM INDEX; WRITING COMMITTEE; OCCLUSIVE DISEASE; TASK-FORCE; FOLLOW-UP	Context Prediction models to identify healthy individuals at high risk of cardiovascular disease have limited accuracy. A low ankle brachial index ( ABI) is an indicator of atherosclerosis and has the potential to improve prediction. Objective To determine if the ABI provides information on the risk of cardiovascular events and mortality independently of the Framingham risk score ( FRS) and can improve risk prediction. Data Sources Relevant studies were identified. A search of MEDLINE ( 1950 to February 2008) and EMBASE ( 1980 to February 2008) was conducted using common text words for the term ankle brachial index combined with text words and Medical Subject Headings to capture prospective cohort designs. Review of reference lists and conference proceedings, and correspondence with experts was conducted to identify additional published and unpublished studies. Study Selection Studies were included if participants were derived from a general population, ABI was measured at baseline, and individuals were followed up to detect total and cardiovascular mortality. Data Extraction Prespecified data on individuals in each selected study were extracted into a combined data set and an individual participant data meta- analysis was conducted on individuals who had no previous history of coronary heart disease. Results Sixteen population cohort studies fulfilling the inclusion criteria were included. During 480 325 person- years of follow- up of 24 955 men and 23 339 women, the risk of death by ABI had a reverse J- shaped distribution with a normal ( low risk) ABI of 1.11 to 1.40. The 10- year cardiovascular mortality in men with a low ABI ( <= 0.90) was 18.7% ( 95% confidence interval [ CI], 13.3%- 24.1%) and with normal ABI ( 1.11- 1.40) was 4.4% ( 95% CI, 3.2%- 5.7%) ( hazard ratio [ HR], 4.2; 95% CI, 3.3- 5.4). Corresponding mortalities in women were 12.6% ( 95% CI, 6.2%-19.0%) and 4.1% ( 95% CI, 2.2%- 6.1%) ( HR, 3.5; 95% CI, 2.4- 5.1). The HRs remained elevated after adjusting for FRS ( 2.9 [ 95% CI, 2.3- 3.7] for men vs 3.0 [ 95% CI, 2.0- 4.4] for women). A low ABI ( <= 0.90) was associated with approximately twice the 10- year total mortality, cardiovascular mortality, and major coronary event rate compared with the overall rate in each FRS category. Inclusion of the ABI in cardiovascular risk stratification using the FRS would result in reclassification of the risk category and modification of treatment recommendations in approximately 19% of men and 36% of women. Conclusion Measurement of the ABI may improve the accuracy of cardiovascular risk prediction beyond the FRS.	[Fowkes, F. G. R.] Univ Edinburgh, Dept Publ Hlth Sci, Wolfson Unit Prevent Peripheral Vasc Dis, Edinburgh EH8 9AG, Midlothian, Scotland	University of Edinburgh	Fowkes, FGR (corresponding author), Univ Edinburgh, Dept Publ Hlth Sci, Wolfson Unit Prevent Peripheral Vasc Dis, Teviot Pl, Edinburgh EH8 9AG, Midlothian, Scotland.	Gerry.Fowkes@ed.ac.uk	Stoffers, Henri E.J.H./N-3785-2019; Stehouwer, Coen/AAB-3435-2021; De Backer, Guy/AAI-4607-2021; Breteler, Monique M.B./J-5058-2014; Knottnerus, Andre/F-4866-2013; Knottnerus, Johannes A/A-3829-2009; Norman, Paul E/C-5485-2013; Newman, Anne B./C-6408-2013	Stoffers, Henri E.J.H./0000-0002-7908-5101; Breteler, Monique M.B./0000-0002-0626-9305; Norman, Paul E/0000-0003-3406-0506; Murabito, Joanne/0000-0002-0192-7516; Bouter, Lex/0000-0002-2659-5482; Stehouwer, Coen/0000-0001-8752-3223; Newman, Anne B./0000-0002-0106-1150; Murray, Gordon/0000-0001-9866-4734; Price, Jackie/0000-0003-3251-3970	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abbott RD, 2000, AM J CARDIOL, V86, P280, DOI 10.1016/S0002-9149(00)00914-0; Allison MA, 2007, AM J PREV MED, V32, P328, DOI 10.1016/j.amepre.2006.12.010; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Arad Y, 2005, J AM COLL CARDIOL, V46, P158, DOI 10.1016/j.jacc.2005.02.088; BAKER JD, 1981, SURGERY, V89, P134; Baldassarre D, 2007, ATHEROSCLEROSIS, V191, P403, DOI 10.1016/j.atherosclerosis.2006.04.008; Bernard S, 2005, DIABETES CARE, V28, P1158, DOI 10.2337/diacare.28.5.1158; Brindle P, 2006, HEART, V92, P1752, DOI 10.1136/hrt.2006.087932; Chambless LE, 2003, J CLIN EPIDEMIOL, V56, P880, DOI 10.1016/S0895-4356(03)00055-6; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; CRIQUI MH, 1992, NEW ENGL J MED, V326, P381, DOI 10.1056/NEJM199202063260605; Cushman M, 2005, CIRCULATION, V112, P25, DOI 10.1161/CIRCULATIONAHA.104.504159; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; EVERHART JE, 1988, DIABETOLOGIA, V31, P16; FARKOUH ME, 2002, INT J ANGIOL, V11, P1067; FOWKES FGR, 1988, J EPIDEMIOL COMMUN H, V42, P128, DOI 10.1136/jech.42.2.128; Fowler B, 2002, AUST NZ J PUBL HEAL, V26, P219, DOI 10.1111/j.1467-842X.2002.tb00677.x; Graham I, 2007, EUR HEART J, V28, P2375, DOI 10.1093/eurheartj/ehm316; Greenland P, 2004, JAMA-J AM MED ASSOC, V291, P210, DOI 10.1001/jama.291.2.210; Greenland P, 2001, CIRCULATION, V104, P1863, DOI 10.1161/hc4201.097189; Greenland P, 2007, J AM COLL CARDIOL, V49, P378, DOI 10.1016/j.jacc.2006.10.001; Grundy SM, 1999, J AM COLL CARDIOL, V34, P1348, DOI 10.1016/S0735-1097(99)00387-3; HIATT WR, 1995, CIRCULATION, V91, P1472, DOI 10.1161/01.CIR.91.5.1472; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; Hooi JD, 2004, J CLIN EPIDEMIOL, V57, P294, DOI 10.1016/j.jclinepi.2003.09.003; Jager A, 1999, ARTERIOSCL THROM VAS, V19, P617, DOI 10.1161/01.ATV.19.3.617; Jonsson B, 2005, EUR J VASC ENDOVASC, V30, P395, DOI 10.1016/j.ejvs.2005.05.012; KORNITZER M, 1995, ANGIOLOGY, V46, P211, DOI 10.1177/000331979504600304; Leng GC, 1996, BMJ-BRIT MED J, V313, P1440, DOI 10.1136/bmj.313.7070.1440; McDermott MM, 2005, AM J EPIDEMIOL, V162, P33, DOI 10.1093/aje/kwi167; McDermott MM, 2000, CIRCULATION, V101, P1007, DOI 10.1161/01.CIR.101.9.1007; McDermott MM, 2004, J AM GERIATR SOC, V52, P405, DOI 10.1111/j.1532-5415.2004.52113.x; Mohler ER, 2004, VASC MED, V9, P253, DOI 10.1191/1358863x04vm559oa; Murabito JM, 2002, AM HEART J, V143, P961, DOI 10.1067/mhj.2002.122871; NEWMAN AB, 1993, CIRCULATION, V88, P837, DOI 10.1161/01.CIR.88.3.837; Newman AB, 1999, ARTERIOSCL THROM VAS, V19, P538, DOI 10.1161/01.ATV.19.3.538; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; O'Hare AM, 2006, CIRCULATION, V113, P388, DOI 10.1161/CIRCULATIONAHA.105.570903; OGREN M, 1993, LANCET, V342, P1138, DOI 10.1016/0140-6736(93)92123-B; Price JF, 2008, EUR J CARDIOV PREV R, V15, P370, DOI 10.1097/HJR.0b013e3282f8b36a; Resnick HE, 2004, CIRCULATION, V109, P733, DOI 10.1161/01.CIR.0000112642.63927.54; Tsimikas S, 2006, J AM COLL CARDIOL, V47, pC19, DOI 10.1016/j.jacc.2005.10.066; van der Meer IM, 2004, CIRCULATION, V109, P1089, DOI 10.1161/01.CIR.0000120708.59903.1B; Wannamethee SG, 2005, ARCH INTERN MED, V165, P2644, DOI 10.1001/archinte.165.22.2644; Weatherley Beth D, 2007, BMC Cardiovasc Disord, V7, P3, DOI 10.1186/1471-2261-7-3; WHITEHEAD A, 2002, META ANAL CONTROLLED; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	48	1299	1346	4	77	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 9	2008	300	2					197	208						12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	323GV	18612117	Green Accepted, Green Published			2022-12-28	WOS:000257435500024
J	O'Donoghue, M; Boden, WE; Braunwald, E; Cannon, CP; Clayton, TC; de Winter, RJ; Fox, KAA; Lagerqvist, B; McCullough, PA; Murphy, SA; Spacek, R; Swahn, E; Wallentin, L; Windhausen, F; Sabatine, MS				O'Donoghue, Michelle; Boden, William E.; Braunwald, Eugene; Cannon, Christopher P.; Clayton, Tim C.; de Winter, Robbert J.; Fox, Keith A. A.; Lagerqvist, Bo; McCullough, Peter A.; Murphy, Sabina A.; Spacek, Rudolf; Swahn, Eva; Wallentin, Lars; Windhausen, Fons; Sabatine, Marc S.			Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction - A meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							ACUTE CORONARY SYNDROMES; ARTERY-BYPASS-SURGERY; INTERVENTIONAL STRATEGY; RANDOMIZED-TRIAL; MORTALITY; MANAGEMENT; REVASCULARIZATION; PECTORIS; OUTCOMES; THERAPY	Context Although an invasive strategy is frequently used in patients with non - ST-segment elevation acute coronary syndromes ( NSTE ACS), data from some trials suggest that this strategy may not benefit women. Objective To conduct a meta- analysis of randomized trials to compare the effects of an invasive vs conservative strategy in women and men with NSTE ACS. Data Sources Trials were identified through a computerized literature search of the MEDLINE and Cochrane databases ( 1970- April 2008) using the search terms invasive strategy, conservative strategy, selective invasive strategy, acute coronary syndromes, non- ST- elevation myocardial infarction, and unstable angina. Study Selection Randomized clinical trials comparing an invasive vs conservative treatment strategy in patients with NSTE ACS. Data Extraction The principal investigators for each trial provided the sex- specific incidences of death, myocardial infarction ( MI), and rehospitalization with ACS through 12 months of follow- up. Data Synthesis Data were combined across 8 trials ( 3075 women and 7075 men). The odds ratio ( OR) for the composite of death, MI, or ACS for invasive vs conservative strategy in women was 0.81 ( 95% confidence interval [ CI], 0.65- 1.01; 21.1% vs 25.0%) and in men was 0.73 ( 95% CI, 0.55- 0.98; 21.2% vs 26.3%) without significant heterogeneity between sexes ( P for interaction=. 26). Among biomarker- positive women, an invasive strategy was associated with a 33% lower odds of death, MI, or ACS ( OR, 0.67; 95% CI, 0.50- 0.88) and a nonsignificant 23% lower odds of death or MI ( OR, 0.77; 95% CI, 0.47- 1.25). In contrast, an invasive strategy was not associated with a significant reduction in the triple composite end point in biomarker- negative women ( OR, 0.94; 95% CI, 0.61- 1.44; P for interaction=. 36) and was associated with a nonsignificant 35% higher odds of death or MI ( OR, 1.35; 95% CI, 0.78- 2.35; P for interaction=. 08). Among men, the OR for death, MI, or ACS was 0.56 ( 95% CI, 0.46- 0.67) if biomarker- positive and 0.72 ( 95% CI, 0.51- 1.01) if biomarker- negative ( P for interaction=. 09). Conclusions In NSTE ACS, an invasive strategy has a comparable benefit in men and high- risk women for reducing the composite end point of death, MI, or rehospitalization with ACS. In contrast, our data provide evidence supporting the new guideline recommendation for a conservative strategy in low- risk women.	[O'Donoghue, Michelle; Braunwald, Eugene; Cannon, Christopher P.; Murphy, Sabina A.; Sabatine, Marc S.] Brigham & Womens Hosp, TIMI Study Grp, Boston, MA 02115 USA; [O'Donoghue, Michelle] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Boden, William E.] Buffalo Gen Hosp, Buffalo, NY 14203 USA; [Clayton, Tim C.] London Sch Hyg & Trop Med, London WC1, England; [de Winter, Robbert J.; Windhausen, Fons] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Fox, Keith A. A.] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Fox, Keith A. A.] Royal Infirm, Edinburgh, Midlothian, Scotland; [Lagerqvist, Bo; Wallentin, Lars] Univ Uppsala Hosp, Uppsala, Sweden; [McCullough, Peter A.] William Beaumont Hosp, Royal Oak, MI 48072 USA; [Spacek, Rudolf] Hosp Na Frantisku, Prague, Czech Republic; [Swahn, Eva] Linkoping Univ Hosp, S-58185 Linkoping, Sweden	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Buffalo General Medical Center; University of London; London School of Hygiene & Tropical Medicine; University of Amsterdam; Academic Medical Center Amsterdam; University of Edinburgh; Royal Infirmary of Edinburgh; Uppsala University; Uppsala University Hospital; Beaumont Health; Linkoping University	O'Donoghue, M (corresponding author), Brigham & Womens Hosp, TIMI Study Grp, 350 Longwood Ave,1st Floor, Boston, MA 02115 USA.	modonoghue@partners.org	Sabatine, Marc/AAJ-6751-2020; Fox, keith A A/I-3742-2013; Cannon, Christopher P/AAY-7644-2020	Sabatine, Marc/0000-0002-0691-3359; Cannon, Christopher P/0000-0003-4596-2791; Clayton, Tim/0000-0002-1266-3288; Fox, Keith/0000-0002-0140-2752	NHLBI NIH HHS [U01 HL083-1341] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL001341] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anderson JL, 2007, J AM COLL CARDIOL, V50, P652, DOI 10.1016/j.jacc.2007.02.028; [Anonymous], 1994, Circulation, V89, P1545; Bassand JP, 2007, EUR HEART J, V28, P1598, DOI 10.1093/eurheartj/ehm161; Boden WE, 1998, NEW ENGL J MED, V338, P1785, DOI 10.1056/NEJM199806183382501; BOLOOKI H, 1975, J THORAC CARDIOV SUR, V69, P271; BROWN CA, 1981, AM HEART J, V102, P959, DOI 10.1016/0002-8703(81)90477-4; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; CANNON RO, 1992, CIRCULATION, V85, P883, DOI 10.1161/01.CIR.85.3.883; Clayton TC, 2004, EUR HEART J, V25, P1641, DOI 10.1016/j.ehj.2004.07.032; de Winter RJ, 2005, NEW ENGL J MED, V353, P1095, DOI 10.1056/NEJMoa044259; DEBONO DP, 1991, BMJ-BRIT MED J, V302, P555; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DESANCTIS RW, 1993, CLIN MANIFESTATIONS; Fox KAA, 2005, LANCET, V366, P914, DOI 10.1016/S0140-6736(05)67222-4; Fox KAA, 2002, LANCET, V360, P743, DOI 10.1016/S0140-6736(02)09894-X; Glaser R, 2002, JAMA-J AM MED ASSOC, V288, P3124, DOI 10.1001/jama.288.24.3124; Hochman JS, 1997, J AM COLL CARDIOL, V30, P141, DOI 10.1016/S0735-1097(97)00107-1; Humphries KH, 2007, J AM COLL CARDIOL, V49, P1552, DOI 10.1016/j.jacc.2006.08.068; Jacobs AK, 1998, CIRCULATION, V98, P1279, DOI 10.1161/01.CIR.98.13.1279; KHAN SS, 1990, ANN INTERN MED, V112, P561, DOI 10.7326/0003-4819-112-8-561; Lagerqvist B, 2001, J AM COLL CARDIOL, V38, P41, DOI 10.1016/S0735-1097(01)01308-0; Lansky AJ, 2004, PROG CARDIOVASC DIS, V46, P305, DOI 10.1016/j.pcad.2003.08.004; LUCHI RJ, 1987, NEW ENGL J MED, V316, P977, DOI 10.1056/NEJM198704163161603; Madsen JK, 1997, CIRCULATION, V96, P748; McCullough PA, 1998, J AM COLL CARDIOL, V32, P596, DOI 10.1016/S0735-1097(98)00284-8; Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P2908, DOI 10.1001/jama.293.23.2908; Michalis LK, 2000, EUR HEART J, V21, P1954, DOI 10.1053/euhj.2000.2397; *NAT COOP STUD GRO, 1978, AM J CARDIOL, V42, P839; Naylor CD, 1997, BMJ-BRIT MED J, V315, P617, DOI 10.1136/bmj.315.7109.617; Neumann FJ, 2003, JAMA-J AM MED ASSOC, V290, P1593, DOI 10.1001/jama.290.12.1593; OCONNOR GT, 1993, CIRCULATION, V88, P2104, DOI 10.1161/01.CIR.88.5.2104; Pfisterer M, 2003, JAMA-J AM MED ASSOC, V289, P1117, DOI 10.1001/jama.289.9.1117; Rothwell PM, 2005, LANCET, V365, P176, DOI 10.1016/S0140-6736(05)17709-5; SCOTT SM, 1994, CIRCULATION, V90, P120; Spacek R, 2002, EUR HEART J, V23, P230, DOI 10.1053/euhj.2001.2735; SULLIVAN AK, 1994, BRIT MED J, V308, P883, DOI 10.1136/bmj.308.6933.883; SWAHN E, 2007, OASIS 5 WORSE OUTCOM; Wallentin L, 1999, LANCET, V354, P708; WEINTRAUB WS, 1993, CIRCULATION, V88, P79; YUSUF S, 1991, JAMA-J AM MED ASSOC, V266, P93, DOI 10.1001/jama.266.1.93	40	314	326	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 2	2008	300	1					71	80		10.1001/jama.300.1.71	http://dx.doi.org/10.1001/jama.300.1.71			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320NW	18594042				2022-12-28	WOS:000257242800026
J	Babbott, S				Babbott, Stewart			Touched	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												sbabbott@kumc.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 25	2008	299	24					2834	2834		10.1001/jama.299.24.2834	http://dx.doi.org/10.1001/jama.299.24.2834			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	317LN	18577718				2022-12-28	WOS:000257021800001
J	Gray, RH; Wawer, MJ				Gray, Ronald H.; Wawer, Maria J.			Reassessing the hypothesis on STI control for HIV prevention	LANCET			English	Editorial Material							SEXUALLY-TRANSMITTED INFECTIONS; DISEASES; WOMEN; ACQUISITION; UGANDA; MEN; SEX		[Gray, Ronald H.; Wawer, Maria J.] Johns Hopkins Univ, Baltimore, MD 21205 USA	Johns Hopkins University	Gray, RH (corresponding author), Johns Hopkins Univ, Baltimore, MD 21205 USA.	rgray@jhsph.edu						Celum C, 2008, LANCET, V371, P2109, DOI 10.1016/S0140-6736(08)60920-4; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Gray RH, 2001, AM J OBSTET GYNECOL, V185, P1209, DOI 10.1067/mob.2001.118158; Gregson S, 2007, PLOS MED, V4, P545, DOI 10.1371/journal.pmed.0040102; GROSSKURTH H, 1995, LANCET, V346, P530, DOI 10.1016/S0140-6736(95)91380-7; Huxley Thomas Henry, 1893, COLLECTED ESSAYS; Kamali A, 2003, LANCET, V361, P645, DOI 10.1016/S0140-6736(03)12598-6; Kaul R, 2004, JAMA-J AM MED ASSOC, V291, P2555, DOI 10.1001/jama.291.21.2555; Korenromp EL, 2005, J INFECT DIS, V191, pS168, DOI 10.1086/425274; Pickering JM, 2005, SEX TRANSM INFECT, V81, P488, DOI 10.1136/sti.2004.013276; Rottingen JA, 2001, SEX TRANSM DIS, V28, P579; Watson-Jones D, 2008, NEW ENGL J MED, V358, P1560, DOI 10.1056/NEJMoa0800260; Wawer MJ, 1999, LANCET, V353, P525, DOI 10.1016/S0140-6736(98)06439-3	13	61	61	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 21	2008	371	9630					2064	2065		10.1016/S0140-6736(08)60896-X	http://dx.doi.org/10.1016/S0140-6736(08)60896-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	316ER	18572064				2022-12-28	WOS:000256932200007
J	Richards, T				Richards, Tessa			Manners in medicine	BRITISH MEDICAL JOURNAL			English	Editorial Material												trichards@bmj.com						Spiegel D, 2008, BRIT MED J, V336, P967, DOI 10.1136/bmj.39535.344201.BE	1	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 21	2008	336	7658					1408	1408		10.1136/bmj.a340	http://dx.doi.org/10.1136/bmj.a340			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	318WJ	18566078	Green Published			2022-12-28	WOS:000257123200029
J	Steig, EJ; Wolfe, AP				Steig, Eric J.; Wolfe, Alexander P.			Atmospheric science - Sprucing up Greenland	SCIENCE			English	Editorial Material							LAST; WARMTH		[Steig, Eric J.] Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; [Wolfe, Alexander P.] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada	University of Washington; University of Washington Seattle; University of Alberta	Steig, EJ (corresponding author), Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA.	steig@ess.washington.edu; awolfe@ualberta.ca	Wolfe, Alexander P/G-6867-2011; Steig, Eric J/G-9088-2015	Steig, Eric J/0000-0002-8191-5549				Anderson P, 2006, QUATERNARY SCI REV, V25, P1383, DOI 10.1016/j.quascirev.2006.01.033; de Vernal A, 2008, SCIENCE, V320, P1622, DOI 10.1126/science.1153929; Hillaire-Marcel C, 2001, NATURE, V410, P1073, DOI 10.1038/35074059; MACDONALD GM, 1993, NATURE, V361, P243, DOI 10.1038/361243a0; Otto-Bliesner BL, 2006, SCIENCE, V311, P1751, DOI 10.1126/science.1120808; Raynaud D, 2005, NATURE, V436, P39, DOI 10.1038/43639b; Stirling CH, 1998, EARTH PLANET SC LETT, V160, P745, DOI 10.1016/S0012-821X(98)00125-3; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813; Willerslev E, 2007, SCIENCE, V317, P111, DOI 10.1126/science.1141758; 2004, NATURE, V141, P1447	10	5	5	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2008	320	5883					1595	1596		10.1126/science.1160004	http://dx.doi.org/10.1126/science.1160004			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	315NM	18566272				2022-12-28	WOS:000256886700031
J	Corcoran, WE; Phifer, N				Corcoran, William E.; Phifer, Nancy			Bladder foreign body	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Corcoran, William E.; Phifer, Nancy] Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Corcoran, WE (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	wcorcoran@partners.org							0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 19	2008	358	25					E29	E29		10.1056/NEJMicm070500	http://dx.doi.org/10.1056/NEJMicm070500			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	314NC	18565856				2022-12-28	WOS:000256815100009
J	Hall, WD; Mattick, RP				Hall, Wayne D.; Mattick, Richard P.			Oral substitution treatments for opioid dependence	LANCET			English	Editorial Material							DETOXIFICATION		[Hall, Wayne D.] Univ Queensland, Sch Populat Hlth, Herston, Qld 4006, Australia; [Mattick, Richard P.] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia	University of Queensland; University of New South Wales Sydney	Hall, WD (corresponding author), Univ Queensland, Sch Populat Hlth, Herston, Qld 4006, Australia.	w.hall@sph.ucl.edu.au	Hall, Wayne D/A-3283-2008	Hall, Wayne D/0000-0003-1984-0096				Amato L, 2005, J SUBST ABUSE TREAT, V28, P321, DOI 10.1016/j.jsat.2005.02.007; Bird SM, 2003, ADDICTION, V98, P185, DOI 10.1046/j.1360-0443.2003.00264.x; DEGENHARDT L, 2004, COMP QUANTIFICATION, P1109; Digiusto E, 2004, ADDICTION, V99, P450, DOI 10.1111/j.1360-0443.2004.00654.x; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Hall W, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P907; Mattick RP, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002207.pub3; Mattick RP, 1996, LANCET, V347, P97, DOI 10.1016/S0140-6736(96)90215-9; Mattick RP, 2003, COCHRANE DB SYST REV, V2; Minozzi S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001333.pub2; Schottenfeld RS, 2008, LANCET, V371, P2192, DOI 10.1016/S0140-6736(08)60954-X; Strang J, 2003, BMJ-BRIT MED J, V326, P959, DOI 10.1136/bmj.326.7396.959; van den Brink W, 2006, CAN J PSYCHIAT, V51, P635, DOI 10.1177/070674370605101003	13	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN-JUL	2008	371	9631					2150	2151		10.1016/S0140-6736(08)60930-7	http://dx.doi.org/10.1016/S0140-6736(08)60930-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	326CP	18586157				2022-12-28	WOS:000257635800006
J	Leitz, N; Khawaja, Z; Been, M				Leitz, Nicolas; Khawaja, Zarqa; Been, Martin			Lesson of the week - Slow ventricular tachycardia	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MISDIAGNOSIS		[Been, Martin] Univ Hosp Coventry & Warwickshire, Dept Cardiol, Coventry CV2 2DX, W Midlands, England; [Leitz, Nicolas] Praxis Leitz, Stuttgart, Germany; [Khawaja, Zarqa] Royal Berkshire Hosp, Reading RG1 5AN, Berks, England	University of Warwick; Royal Berkshire Hospital	Been, M (corresponding author), Univ Hosp Coventry & Warwickshire, Dept Cardiol, Coventry CV2 2DX, W Midlands, England.	martin.been@uhcw.nhs.uk						Blomstrom-Lundqvist Carina, 2003, Journal of the American College of Cardiology, V42, P1493, DOI 10.1016/j.jacc.2003.08.013; Durham D, 2002, Crit Care Resusc, V4, P35; Kumar P, 2002, CLIN MED; Podrid PJ, 2005, CLIN CARDIOL, V28, pI3; Raleigh VS, 1999, BMJ-BRIT MED J, V319, P981, DOI 10.1136/bmj.319.7215.981; Sadoul N, 2005, CIRCULATION, V112, P946, DOI 10.1161/CIRCULATIONAHA.105.533513; Spice C, 1999, LANCET, V354, P2165, DOI 10.1016/S0140-6736(05)77068-9; STEWART RB, 1986, ANN INTERN MED, V104, P766, DOI 10.7326/0003-4819-104-6-766	8	5	5	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 11	2008	337	7674							a1955	10.1136/bmj.39489.687894.DE	http://dx.doi.org/10.1136/bmj.39489.687894.DE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	358FU	18599467				2022-12-28	WOS:000259903300038
J	He, XJ; Zhou, J; Bartlam, M; Zhang, RG; Ma, JY; Lou, ZY; Li, XM; Li, JJ; Joachimiak, A; Zeng, ZH; Ge, RW; Rao, ZH; Liu, YF				He, Xiaojing; Zhou, Jie; Bartlam, Mark; Zhang, Rongguang; Ma, Jianyuan; Lou, Zhiyong; Li, Xuemei; Li, Jingjing; Joachimiak, Andrzej; Zeng, Zonghao; Ge, Ruowen; Rao, Zihe; Liu, Yingfang			Crystal structure of the polymerase PA(C)-PB1(N) complex from an avian influenza H5N1 virus	NATURE			English	Article							AMINO-ACID MUTATION; RNA-POLYMERASE; PA SUBUNIT; A VIRUS; PROMOTER-BINDING; MACROMOLECULAR STRUCTURES; PB1 PROTEIN; CAP-BINDING; MODEL; DOMAINS	The recent emergence of highly pathogenic avian influenza A virus strains with subtype H5N1 pose a global threat to human health(1). Elucidation of the underlying mechanisms of viral replication is critical for development of anti- influenza virus drugs(2). The influenza RNA- dependent RNA polymerase ( RdRp) heterotrimer has crucial roles in viral RNA replication and transcription. It contains three proteins: PA, PB1 and PB2. PB1 harbours polymerase and endonuclease activities and PB2 is responsible for cap binding(3,4); PA is implicated in RNA replication(5-10) and proteolytic activity(11-14), although its function is less clearly defined. Here we report the 2.9 angstrom structure of avian H5N1 influenza A virus PA ( PA(C), residues 257 - 716) in complex with the PA- binding region of PB1 ( PB1(N), residues 1 - 25). PA(C) has a fold resembling a dragon's head with PB1(N) clamped into its open 'jaws'. PB1(N) is a known inhibitor that blocks assembly of the polymerase heterotrimer and abolishes viral replication. Our structure provides details for the binding of PB1(N) to PA(C) at the atomic level, demonstrating a potential target for novel anti- influenza therapeutics. We also discuss a potential nucleotide binding site and the roles of some known residues involved in polymerase activity. Furthermore, to explore the role of PA in viral replication and transcription, we propose a model for the influenza RdRp heterotrimer by comparing PA(C) with the lambda 3 reovirus polymerase structure, and docking the PA(C) structure into an available low resolution electron microscopy map.	[He, Xiaojing; Zhou, Jie; Ma, Jianyuan; Li, Xuemei; Li, Jingjing; Zeng, Zonghao; Rao, Zihe; Liu, Yingfang] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Bartlam, Mark; Rao, Zihe] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Bartlam, Mark; Rao, Zihe] Nankai Univ, Tianjin State Lab Prot Sci, Tianjin 300071, Peoples R China; [Zhang, Rongguang; Joachimiak, Andrzej] Argonne Natl Lab, Midwest Ctr Struct Genom, Biosci Div, Argonne, IL 60439 USA; [Zhang, Rongguang; Joachimiak, Andrzej] Argonne Natl Lab, Struct Biol Ctr, Biosci Div, Argonne, IL 60439 USA; [Lou, Zhiyong; Li, Xuemei; Rao, Zihe] Tsinghua Univ, Struct Biol Lab, Beijing 100084, Peoples R China; [Ge, Ruowen] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore	Chinese Academy of Sciences; Institute of Biophysics, CAS; Nankai University; Nankai University; United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; Tsinghua University; National University of Singapore	Rao, ZH (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.	raozh@xtal.tsinghua.edu.cn; liuy@ibp.ac.cn	Ge, Ruowen/D-8352-2012; HE, XIAOJING/A-6040-2013; Rao, Zihe/HCH-6944-2022	Ge, Ruowen/0000-0002-0750-7336; He, Xiaojing/0000-0003-3917-1133; Bartlam, Mark/0000-0001-5173-5080	National Natural Science Foundation of China [30599432, 30221003]; Ministry of Science and Technology International Cooperation Project [2006DFB32420]; Ministry of Science and Technology 863 Project [2006AA02A314, 2006AA02A322]; Ministry of Science and Technology 973 Project [2006CB504300, 2007CB914300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology International Cooperation Project; Ministry of Science and Technology 863 Project(National High Technology Research and Development Program of China); Ministry of Science and Technology 973 Project(National Basic Research Program of China)	We thank H. Chen and K. Yu for providing the A/goose/Guangdong/1/96 influenza PA gene; J. Ortin and O. Llorca for supplying electron microscopy maps; C. Yang, X. Su, F. Sun, L. Wang and R.- M. Xu for advice and technical assistance; and S. Harrison, P. Kuhn, X. Chen and T. Toyoda for discussion. This work was supported by the National Natural Science Foundation of China ( grant numbers 30599432 and 30221003), the Ministry of Science and Technology International Cooperation Project ( grant number 2006DFB32420), the Ministry of Science and Technology 863 Project ( grant numbers 2006AA02A314 and 2006AA02A322) and the Ministry of Science and Technology 973 Project ( grant numbers 2006CB504300 and 2007CB914300).	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Area E, 2004, P NATL ACAD SCI USA, V101, P308, DOI 10.1073/pnas.0307127101; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5; DELALUNA S, 1989, VIRUS RES, V13, P143, DOI 10.1016/0168-1702(89)90012-9; Deng T, 2006, J VIROL, V80, P2337, DOI 10.1128/JVI.80.5.2337-2348.2006; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fodor E, 2003, J VIROL, V77, P5017, DOI 10.1128/JVI.77.8.5017-5020.2003; Fodor E, 2002, J VIROL, V76, P8989, DOI 10.1128/JVI.76.18.8989-9001.2002; Gabriel G, 2007, J VIROL, V81, P9601, DOI 10.1128/JVI.00666-07; Ghanem A, 2007, J VIROL, V81, P7801, DOI 10.1128/JVI.00724-07; Gonzalez S, 1999, EMBO J, V18, P3767, DOI 10.1093/emboj/18.13.3767; Gonzalez S, 1996, NUCLEIC ACIDS RES, V24, P4456, DOI 10.1093/nar/24.22.4456; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Hara K, 2001, GENES CELLS, V6, P87, DOI 10.1046/j.1365-2443.2001.00399.x; Hara K, 2006, J VIROL, V80, P7789, DOI 10.1128/JVI.00600-06; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Huarte M, 2003, J VIROL, V77, P6007, DOI 10.1128/JVI.77.10.6007-6013.2003; Jung TE, 2006, J GEN VIROL, V87, P679, DOI 10.1099/vir.0.81453-0; Kawaguchi A, 2005, J VIROL, V79, P732, DOI 10.1128/JVI.79.2.732-744.2005; Li ML, 2001, EMBO J, V20, P2078, DOI 10.1093/emboj/20.8.2078; Maier HJ, 2008, VIROLOGY, V370, P194, DOI 10.1016/j.virol.2007.08.029; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ohtsu Y, 2002, MICROBIOL IMMUNOL, V46, P167, DOI 10.1111/j.1348-0421.2002.tb02682.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perez DR, 2001, J VIROL, V75, P8127, DOI 10.1128/JVI.75.17.8127-8136.2001; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Regan JF, 2006, J VIROL, V80, P252, DOI 10.1128/JVI.80.1.252-261.2006; Rodriguez A, 2007, J VIROL, V81, P5315, DOI 10.1128/JVI.02129-06; SanzEzquerro JJ, 1996, J VIROL, V70, P1905, DOI 10.1128/JVI.70.3.1905-1911.1996; Sheldrick GM, 1998, NATO ADV SCI I C-MAT, V507, P401; SUGIURA A, 1975, VIROLOGY, V65, P363, DOI 10.1016/0042-6822(75)90042-2; Tao YZ, 2002, CELL, V111, P733, DOI 10.1016/S0092-8674(02)01110-8; Tarendeau F, 2007, NAT STRUCT MOL BIOL, V14, P229, DOI 10.1038/nsmb1212; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Torreira E, 2007, NUCLEIC ACIDS RES, V35, P3774, DOI 10.1093/nar/gkm336; Toyoda T, 1996, J GEN VIROL, V77, P2149, DOI 10.1099/0022-1317-77-9-2149; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Zurcher T, 1996, J GEN VIROL, V77, P1745, DOI 10.1099/0022-1317-77-8-1745	40	239	265	2	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 28	2008	454	7208					1123	U51		10.1038/nature07120	http://dx.doi.org/10.1038/nature07120			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341MW	18615018				2022-12-28	WOS:000258719600039
J	Jia, SD; Liu, ZN; Zhang, S; Liu, PX; Zhang, L; Lee, SH; Zhang, J; Signoretti, S; Loda, M; Roberts, TM; Zhao, JJ				Jia, Shidong; Liu, Zhenning; Zhang, Sen; Liu, Pixu; Zhang, Lei; Lee, Sang Hyun; Zhang, Jing; Signoretti, Sabina; Loda, Massimo; Roberts, Thomas M.; Zhao, Jean J.			Essential roles of PI(3)K-p110 beta in cell growth, metabolism and tumorigenesis	NATURE			English	Article							TUMOR-SUPPRESSOR GENE; PHOSPHOINOSITIDE 3-KINASE; PHOSPHATIDYLINOSITOL 3-KINASES; LYSOPHOSPHATIDIC ACID; EMBRYONIC LETHALITY; P110-ALPHA SUBUNIT; CATALYTIC SUBUNIT; PROSTATE-CANCER; PI 3-KINASE; BETA-GAMMA	On activation by receptors, the ubiquitously expressed class IA isoforms (p110 alpha and p110 beta) of phosphatidylinositol-3-OH kinase (PI(3)K) generate lipid second messengers, which initiate multiple signal transduction cascades(1-5). Recent studies have demonstrated specific functions for p110 alpha in growth factor and insulin signalling(6-8). To probe for distinct functions of p110 beta, we constructed conditional knockout mice. Here we show that ablation of p110 beta in the livers of the resulting mice leads to impaired insulin sensitivity and glucose homeostasis, while having little effect on phosphorylation of Akt, suggesting the involvement of a kinase-independent role of p110 beta in insulin metabolic action. Using established mouse embryonic fibroblasts, we found that removal of p110 beta also had little effect on Akt phosphorylation in response to stimulation by insulin and epidermal growth factor, but resulted in retarded cell proliferation. Reconstitution of p110 beta-null cells with a wild-type or kinase-dead allele of p110 beta demonstrated that p110 beta possesses kinase-independent functions in regulating cell proliferation and trafficking. However, the kinase activity of p110 beta was required for G-protein-coupled receptor signalling triggered by lysophosphatidic acid and had a function in oncogenic transformation. Most strikingly, in an animal model of prostate tumour formation induced by Pten loss, ablation of p110 beta (also known as Pik3cb), but not that of p110 alpha (also known as Pik3ca), impeded tumorigenesis with a concomitant diminution of Akt phosphorylation. Taken together, our findings demonstrate both kinase-dependent and kinase-independent functions for p110 beta, and strongly indicate the kinase-dependent functions of p110 beta as a promising target in cancer therapy.	[Jia, Shidong; Liu, Zhenning; Zhang, Sen; Liu, Pixu; Zhang, Lei; Lee, Sang Hyun; Zhang, Jing; Roberts, Thomas M.; Zhao, Jean J.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Signoretti, Sabina; Loda, Massimo] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Jia, Shidong; Liu, Zhenning; Zhang, Sen; Liu, Pixu; Zhang, Lei; Lee, Sang Hyun; Zhang, Jing; Signoretti, Sabina; Loda, Massimo; Roberts, Thomas M.; Zhao, Jean J.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Zhao, Jean J.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Roberts, TM (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.	thomas_roberts@dfci.harvard.edu; jean_zhao@dfci.harvard.edu			NATIONAL CANCER INSTITUTE [R01CA030002, P50CA090381, P01CA089021, R01CA134502, P01CA050661, R01CA131945, P50CA089393] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA089021-06A1, P01 CA089021, P50 CA090381-05, R01 CA134502-01, R01 CA131945, P01 CA050661, R01 CA030002-27, P50 CA089393-08S1, P50 CA089393, P01 CA050661-200001, R01 CA134502, P50 CA090381, R01 CA030002] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bader AG, 2006, P NATL ACAD SCI USA, V103, P1475, DOI 10.1073/pnas.0510857103; Bader AG, 2005, NAT REV CANCER, V5, P921, DOI 10.1038/nrc1753; BELLACOSA A, 1995, INT J CANCER, V64, P280, DOI 10.1002/ijc.2910640412; Bi L, 1999, J BIOL CHEM, V274, P10963, DOI 10.1074/jbc.274.16.10963; Bi L, 2002, MAMM GENOME, V13, P169, DOI 10.1007/s00335-001-2123-x; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Brachmann SM, 2005, MOL CELL BIOL, V25, P1596, DOI 10.1128/MCB.25.5.1596-1607.2005; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Daniels TR, 2006, CLIN IMMUNOL, V121, P144, DOI 10.1016/j.clim.2006.06.010; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Foukas LC, 2006, NATURE, V441, P366, DOI 10.1038/nature04694; Graner E, 2004, CANCER CELL, V5, P253, DOI 10.1016/S1535-6108(04)00055-8; Hazeki O, 1998, LIFE SCI, V62, P1555, DOI 10.1016/S0024-3205(98)00106-4; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liu ZN, 2006, CELL CYCLE, V5, P675, DOI 10.4161/cc.5.7.2605; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Ringel MD, 2001, CANCER RES, V61, P6105; Roche S, 1998, MOL CELL BIOL, V18, P7119, DOI 10.1128/MCB.18.12.7119; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sever S, 2000, J CELL BIOL, V150, P1137, DOI 10.1083/jcb.150.5.1137; SHAULIAN E, 1992, MOL CELL BIOL, V12, P5581, DOI 10.1128/MCB.12.12.5581; Shin HW, 2005, J CELL BIOL, V170, P607, DOI 10.1083/jcb.200505128; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Taniguchi CM, 2006, CELL METAB, V3, P343, DOI 10.1016/j.cmet.2006.04.005; Vanhaesebroeck B, 1999, EXP CELL RES, V253, P239, DOI 10.1006/excr.1999.4701; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Yart A, 2002, J BIOL CHEM, V277, P21167, DOI 10.1074/jbc.M110411200; Zhao JJ, 2006, P NATL ACAD SCI USA, V103, P16296, DOI 10.1073/pnas.0607899103; Zhao JJ, 2005, P NATL ACAD SCI USA, V102, P18443, DOI 10.1073/pnas.0508988102	34	546	586	1	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2008	454	7205					776	U102		10.1038/nature07091	http://dx.doi.org/10.1038/nature07091			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334NH	18594509	Green Accepted			2022-12-28	WOS:000258228000047
J	Pai, M; Zwerling, A; Menzies, D				Pai, Madhukar; Zwerling, Alice; Menzies, Dick			Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: An update	ANNALS OF INTERNAL MEDICINE			English	Review							INTERFERON-GAMMA ASSAY; LINKED IMMUNOSPOT ASSAY; QUANTIFERON TB-2G TEST; WHOLE-BLOOD; MYCOBACTERIUM-TUBERCULOSIS; ACTIVE TUBERCULOSIS; RELEASE ASSAYS; SKIN-TEST; ANTIGENS ESAT-6; PREDICTIVE-VALUE	Background: Interferon-gamma-release assays (IGRAs) are alternatives to the tuberculin skin test (TST). A recent meta-analysis showed that IGRAs have high specificity, even among populations that have received bacille Calmette-Guerin (BCG) vaccination. Sensitivity was suboptimal for TST and IGRAs. Purpose: To incorporate newly reported evidence from 20 studies into an updated meta-analysis on the sensitivity and specificity of IGRAs. Data Sources: PubMed was searched through 31 March 2008, and citations of all original articles, guidelines, and reviews for studies published in English were reviewed. Study Selection: Studies that evaluated QuantiFERON-TB Gold, QuantiFERON-TB Gold In-Tube (both from Cellestis, Victoria, Australia), and T-SPOT. TB (Oxford Immunotec, Oxford, United Kingdom) or its precommercial ELISpot version, when data on the commercial version were lacking. For assessing sensitivity, the study sample had to have microbiologically confirmed active tuberculosis. For assessing specificity, the sample had to comprise healthy, low-risk individuals without known exposure to tuberculosis. Studies with fewer than 10 participants and those that included only immunocompromised participants were excluded. Data Extraction: One reviewer abstracted data on participant characteristics, test characteristics, and test performance from 38 studies; these data were double-checked by a second reviewer. The original investigators were contacted for additional information when necessary. Data Synthesis: A fixed-effects meta-analysis with correction for overdispersion was done to pool data within prespecified subgroups. The pooled sensitivity was 78% (95% CI, 73% to 82%) for QuantiFERON-TB Gold, 70% (CI, 63% to 78%) for QuantiFERON-TB Gold In-Tube, and 90% (CI, 86% to 93%) for T-SPOT. TB. The pooled specificity for both QuantiFERON tests was 99% among non-BCG-vaccinated participants (CI, 98% to 100%) and 96% (CI, 94% to 98%) among BCG-vaccinated participants. The pooled specificity of T-SPOT. TB (including its precommercial ELISpot version) was 93% (CI, 86% to 100%). Tuberculin skin test results were heterogeneous, but specificity in non-BCG-vaccinated participants was consistently high (97% [CI, 95% to 99%]). Limitations: Most studies were small and had limitations, including no gold standard for diagnosing latent tuberculosis and variable TST methods and cutoff values. Data on the specificity of the commercial T-SPOT. TB assay were limited. Conclusion: The IGRAs, especially QuantiFERON-TB Gold and QuantiFERON-TB Gold In-Tube, have excellent specificity that is unaffected by BCG vaccination. Tuberculin skin test specificity is high in non-BCG-vaccinated populations but low and variable in BCG-vaccinated populations. Sensitivity of IGRAs and TST is not consistent across tests and populations, but T-SPOT. TB appears to be more sensitive than both QuantiFERON tests and TST.	[Pai, Madhukar] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ H3A 1A2, Canada; Montreal Chest Inst, Montreal, PQ, Canada	McGill University; McGill University	Pai, M (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, 1020 Pine Ave W, Montreal, PQ H3A 1A2, Canada.	madhukar.pai@mcgill.ca	Trajman, Anete/C-7679-2016; Pai, Madhukar/AAX-9901-2021; PAL, MRINAL/ABG-9676-2020	Trajman, Anete/0000-0002-4000-4984; Pai, Madhukar/0000-0003-3667-4536; PAL, MRINAL/0000-0002-1032-272X	CIHR [81362] Funding Source: Medline	CIHR(Canadian Institutes of Health Research (CIHR))		Adetifa IMO, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-122; Aiken AM, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-66; Andersen P, 2007, TRENDS MOL MED, V13, P175, DOI 10.1016/j.molmed.2007.03.004; Brock I, 2004, J CLIN MICROBIOL, V42, P2379, DOI 10.1128/JCM.42.6.2379-2387.2004; Brock I, 2001, INT J TUBERC LUNG D, V5, P462; Bua A, 2007, NEW MICROBIOL, V30, P477; Canadian Tuberculosis Committee, 2007, Can Commun Dis Rep, V33, P1; Chapman ALN, 2002, AIDS, V16, P2285, DOI 10.1097/00002030-200211220-00008; Connell TG, 2006, THORAX, V61, P616, DOI 10.1136/thx.2005.048033; Detjen AK, 2007, CLIN INFECT DIS, V45, P322, DOI 10.1086/519266; Dewan PK, 2007, CLIN INFECT DIS, V44, P69, DOI 10.1086/509928; Diel R, 2008, AM J RESP CRIT CARE, V177, P1164, DOI 10.1164/rccm.200711-1613OC; *DIV TUB EL NAT CT, 2005, MMWR RECOMM REP, V54, P49; Dogra S, 2007, J INFECTION, V54, P267, DOI 10.1016/j.jinf.2006.04.007; Dominguez J, 2008, CLIN VACCINE IMMUNOL, V15, P168, DOI 10.1128/CVI.00364-07; Dosanjh DPS, 2008, ANN INTERN MED, V148, P325, DOI 10.7326/0003-4819-148-5-200803040-00003; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; Ferrara G, 2005, AM J RESP CRIT CARE, V172, P631, DOI 10.1164/rccm.200502-196OC; Ferrara G, 2006, LANCET, V367, P1328, DOI 10.1016/S0140-6736(06)68579-6; Franken WPJ, 2007, CLIN VACCINE IMMUNOL, V14, P477, DOI 10.1128/CVI.00463-06; Goletti D, 2006, CLIN MICROBIOL INFEC, V12, P544, DOI 10.1111/j.1469-0691.2006.01391.x; Hill PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001379; *HPA TUB PROGR BOA, 2007, HLTH PROT AG POS STA; Jafari C, 2006, AM J RESP CRIT CARE, V174, P1048, DOI 10.1164/rccm.200604-465OC; Janssens JP, 2007, EUR RESPIR J, V30, P722, DOI 10.1183/09031936.00028507; Johnson PDR, 1999, CLIN DIAGN LAB IMMUN, V6, P934, DOI 10.1128/CDLI.6.6.934-937.1999; Kang YA, 2005, JAMA-J AM MED ASSOC, V293, P2756, DOI 10.1001/jama.293.22.2756; Kang YA, 2007, CHEST, V132, P959, DOI 10.1378/chest.06-2805; *KNCV EUR TB WORKS, 2007, EUROSURVEILLANCE, V12; KOBASHI Y, 2008, CHEST; Kobashi Y, 2008, INTERNAL MED, V47, P237, DOI 10.2169/internalmedicine.47.0389; Kobashi Y, 2006, CLIN INFECT DIS, V43, P1540, DOI 10.1086/509327; Kunst H, 2007, ANN INTERN MED, V147, P672, DOI 10.7326/0003-4819-147-9-200711060-00020; Lalvani A, 2001, AM J RESP CRIT CARE, V163, P824, DOI 10.1164/ajrccm.163.4.2009100; Lalvani A, 2001, J INFECT DIS, V183, P469, DOI 10.1086/318081; Lee JY, 2006, EUR RESPIR J, V28, P24, DOI 10.1183/09031936.06.00016906; Liebeschuetz S, 2004, LANCET, V364, P2196, DOI 10.1016/S0140-6736(04)17592-2; Mazurek GH, 2007, CLIN INFECT DIS, V45, P837, DOI 10.1086/521107; Mazurek GH, 2007, CLIN INFECT DIS, V45, P826, DOI 10.1086/521106; Meier T, 2005, EUR J CLIN MICROBIOL, V24, P529, DOI 10.1007/s10096-005-1377-8; Menzies D, 2008, ANN INTERN MED, V148, P398, DOI 10.7326/0003-4819-148-5-200803040-00011; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Mori T, 2004, AM J RESP CRIT CARE, V170, P59, DOI 10.1164/rccm.200402-179OC; Natl TB Advisory Comm, 2007, COMMUN DIS INTELL, V31, P404; Nicol MP, 2005, CLIN INFECT DIS, V40, P1301, DOI 10.1086/429245; Nishimura T, 2008, INT J TUBERC LUNG D, V12, P269; Ozekinci T, 2007, J INT MED RES, V35, P696, DOI 10.1177/147323000703500515; Pai M, 2007, INFECTION, V35, P98, DOI 10.1007/s15010-007-6114-z; Pai M, 2007, LANCET INFECT DIS, V7, P428, DOI 10.1016/S1473-3099(07)70086-5; Pai M, 2007, PLOS MED, V4, P980, DOI 10.1371/journal.pmed.0040208; Pai M, 2007, CLIN INFECT DIS, V44, P74, DOI 10.1086/509927; Palazzo R, 2008, CLIN VACCINE IMMUNOL, V15, P327, DOI 10.1128/CVI.00342-07; Pathan AA, 2001, J IMMUNOL, V167, P5217, DOI 10.4049/jimmunol.167.9.5217; Ravn P, 2005, CLIN DIAGN LAB IMMUN, V12, P491, DOI 10.1128/CDLI.12.4.491-496.2005; Scholvinck E, 2004, J CLIN MICROBIOL, V42, P829, DOI 10.1128/JCM.42.2.829-831.2004; Soborg B, 2007, SCAND J INFECT DIS, V39, P554, DOI 10.1080/00365540601148483; Soysal A, 2008, INT J TUBERC LUNG D, V12, P50; Taggart EW, 2006, AM J CLIN PATHOL, V125, P467, DOI [10.1309/LTETF72AHG94KGUY, 10.1309/LTET-F72A-HG94-KGUY]; Tsiouris SJ, 2006, J CLIN MICROBIOL, V44, P2844, DOI 10.1128/JCM.02411-05; Wang JY, 2007, EMERG INFECT DIS, V13, P553, DOI 10.3201/eid1304.051195	60	1001	1085	3	128	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 5	2008	149	3					177	184		10.7326/0003-4819-149-3-200808050-00241	http://dx.doi.org/10.7326/0003-4819-149-3-200808050-00241			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	336CW	18593687	Green Accepted			2022-12-28	WOS:000258342900004
J	Hartman, TCO; van Rijswijk, E				Hartman, Tim C. olde; van Rijswijk, Eric			10-minute consultation - Fungal nail infection	BRITISH MEDICAL JOURNAL			English	Editorial Material							ONYCHOMYCOSIS		[Hartman, Tim C. olde; van Rijswijk, Eric] Radboud Univ Nijmegen, Med Ctr, Dept Family Med, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen	Hartman, TCO (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Family Med, POB 9101, NL-6500 HB Nijmegen, Netherlands.	t.oldehartman@hag.umcn.nl	Hartman, Tim olde/O-2548-2013; Hartman, Tim Olde/N-3075-2019	Hartman, Tim olde/0000-0003-2078-1206; Hartman, Tim Olde/0000-0003-2078-1206				Crawford F, 2002, ARCH DERMATOL, V138, P811, DOI 10.1001/archderm.138.6.811; Elewski BE, 1998, CLIN MICROBIOL REV, V11, P415, DOI 10.1128/CMR.11.3.415; Hart R, 1999, BMJ-BRIT MED J, V319, P79, DOI 10.1136/bmj.319.7202.79	3	5	5	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 2	2008	337	7664							a429	10.1136/bmj.39357.558183.94	http://dx.doi.org/10.1136/bmj.39357.558183.94			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	339EN	18617498				2022-12-28	WOS:000258561000035
J	Ralston, SH; Langston, AL; Reid, IR				Ralston, Stuart H.; Langston, Anne L.; Reid, Ian R.			Pathogenesis and management of Paget's disease of bone	LANCET			English	Review							NF-KAPPA-B; MEASLES-VIRUS; DOUBLE-BLIND; OSTEOCLAST PRECURSORS; FAMILIAL AGGREGATION; DISODIUM ETIDRONATE; NUCLEAR INCLUSIONS; CONTROLLED-TRIAL; MARROW CULTURES; ZOLEDRONIC ACID	Paget's disease of bone is a common disease characterised by focal areas of increased bone turnover, affecting one or several bones throughout the skeleton. Paget's disease is often asymptomatic but can be associated with bone pain and other complications such as osteoarthritis, pathological fracture, bone deformity, deafness, and nerve compression syndromes. Genetic factors have an important role in this disease, and mutations have been identified in four genes that cause Paget's disease and related syndromes. The most important of these is Sequestosome 1 (SQSTM1), which is a scaffold protein in the nuclear factor kappa B (NF kappa B) signalling pathway. Patients with SQSTM1 mutations have severe Paget's disease of bone and a high degree of penetrance with increasing age. Environmental factors also contribute. Most research has focused on paramyxovirus infection as a possible trigger, but evidence for this notion is conflicting. Other potential triggers include deficiency of dietary calcium and repetitive mechanical loading of the skeleton. Medical management of Paget's disease of bone is based on giving inhibitors of osteoclastic bone resorption, and bisphosphonates are the treatment of first choice. Bisphosphonate therapy is primarily indicated for patients who have bone pain arising from increased metabolic activity in affected bones. Bisphosphonate therapy is highly effective at reducing bone turnover, and it has been shown to heal radiological lesions and restore normal histology; however, the long-term effects of bisphosphonates on disease progression have not been adequately studied. No firm evidence as yet exists to show that bisphosphonates can prevent the development of complications of Paget's disease of bone, and further work is needed to address the effects of treatment on long-term clinical outcome.	[Ralston, Stuart H.; Langston, Anne L.] Univ Edinburgh, Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland; [Reid, Ian R.] Univ Auckland, Fac Med & Hlth Sci, Auckland 1, New Zealand	University of Edinburgh; University of Auckland	Ralston, SH (corresponding author), Western Gen Hosp, Mol Med Ctr, Edinburgh EH4 2XU, Midlothian, Scotland.	stuart.ralston@ed.ac.uk		Reid, Ian/0000-0001-6021-5458	Arthritis Research UK Funding Source: Medline	Arthritis Research UK(Versus Arthritis)		ADAMSON BB, 1993, LANCET, V342, P1459, DOI 10.1016/0140-6736(93)92935-M; Albagha OME, 2007, CALCIFIED TISSUE INT, V80, pS34; ALTMAN RD, 1980, ARTHRITIS RHEUM-US, V23, P1121, DOI 10.1002/art.1780231008; ALTMAN RD, 1973, NEW ENGL J MED, V289, P1379, DOI 10.1056/NEJM197312272892601; BARKER DJP, 1974, BRIT J PREV SOC MED, V28, P226; BARKER DJP, 1984, BRIT MED BULL, V40, P396, DOI 10.1093/oxfordjournals.bmb.a072011; BARRY H C, 1960, Aust N Z J Surg, V29, P304, DOI 10.1111/j.1445-2197.1960.tb03855.x; Barry TIC, 1969, PAGETS DIS BONE; BENETON MNC, 1987, BONE, V8, P211, DOI 10.1016/8756-3282(87)90167-0; Beyens G, 2004, CALCIFIED TISSUE INT, V75, P144, DOI 10.1007/s00223-004-0244-4; BIANCO P, 1992, VIRCHOWS ARCH A, V421, P427, DOI 10.1007/BF01606916; Bolland MJ, 2007, J BONE MINER RES, V22, P411, DOI 10.1359/JBMR.061204; BOYCE BF, 1984, LANCET, V1, P821; Cavey JR, 2006, CALCIFIED TISSUE INT, V78, P271, DOI 10.1007/s00223-005-1299-6; Cooper C, 1999, J BONE MINER RES, V14, P192, DOI 10.1359/jbmr.1999.14.2.192; Crockett JC, 2007, CALCIFIED TISSUE INT, V81, P148; Cundy HR, 2004, CALCIFIED TISSUE INT, V75, P358, DOI 10.1007/s00223-004-0281-z; Cundy T, 2002, HUM MOL GENET, V11, P2119, DOI 10.1093/hmg/11.18.2119; Cundy T, 2005, NEW ENGL J MED, V353, P918, DOI 10.1056/NEJMoa050893; DEMULDER A, 1993, ENDOCRINOLOGY, V133, P1978, DOI 10.1210/en.133.5.1978; DETHERIDGE FM, 1982, BRIT MED J, V285, P1005, DOI 10.1136/bmj.285.6347.1005; DOUGLAS DL, 1980, LANCET, V1, P1043; Eekhoff EWM, 2004, ARTHRITIS RHEUM-US, V50, P1650, DOI 10.1002/art.20224; Fraser WD, 1997, POSTGRAD MED J, V73, P496, DOI 10.1136/pgmj.73.862.496; Friedrichs WE, 2002, J BONE MINER RES, V17, P2293, DOI 10.1359/jbmr.2002.17.12.2293; Fuller K, 1998, J EXP MED, V188, P997, DOI 10.1084/jem.188.5.997; GALLACHER SJ, 1989, LANCET, V2, P42; GARDNER MJ, 1978, INT J EPIDEMIOL, V7, P121, DOI 10.1093/ije/7.2.121; Gennari L, 2005, J BONE MINER RES, V20, P1845, DOI 10.1359/JBMR.050518; GORDON MT, 1991, BONE, V12, P195, DOI 10.1016/8756-3282(91)90042-H; Grigor C, 2004, LANCET, V364, P263, DOI 10.1016/S0140-6736(04)16676-2; HARINCK HIJ, 1986, Q J MED, V58, P133; HARINCK HIJ, 1987, BRIT MED J, V295, P1301, DOI 10.1136/bmj.295.6609.1301; Helfrich MH, 2000, J BONE MINER RES, V15, P2315, DOI 10.1359/jbmr.2000.15.12.2315; Hocking LJ, 2004, J BONE MINER RES, V19, P1122, DOI 10.1359/JBMR.0403015; Hocking LJ, 2002, HUM MOL GENET, V11, P2735, DOI 10.1093/hmg/11.22.2735; Hocking LJ, 2001, AM J HUM GENET, V69, P1055, DOI 10.1086/323798; Hosking D, 2007, J BONE MINER RES, V22, P142, DOI 10.1359/JBMR.061001; Hughes AE, 2000, NAT GENET, V24, P45, DOI 10.1038/71667; Joshi Shashank R, 2006, J Assoc Physicians India, V54, P535; Kanis JA, 1992, PATHOPHYSIOLOGY TREA; Kaplan FS, 1999, J BONE MINER RES, V14, P34, DOI 10.1002/jbmr.5650140208; KUKITA A, 1990, J CLIN INVEST, V85, P1280, DOI 10.1172/JCI114565; Kurihara N, 2006, J BONE MINER RES, V21, P446, DOI 10.1359/JBMR.051108; Langston AL, 2007, CALCIFIED TISSUE INT, V80, P1, DOI 10.1007/s00223-006-0184-2; Laurin N, 2002, AM J HUM GENET, V70, P1582, DOI 10.1086/340731; Laurin N, 2001, AM J HUM GENET, V69, P528, DOI 10.1086/322975; Layfield R, 2004, CALCIFIED TISSUE INT, V75, P347, DOI 10.1007/s00223-004-0041-0; Lever JH, 2002, BONE, V31, P434, DOI 10.1016/S8756-3282(02)00833-5; Lievre J A, 1974, Acta Orthop Belg, V40, P454; LopezAbente G, 1997, EPIDEMIOLOGY, V8, P247, DOI 10.1097/00001648-199705000-00004; Lucas GJA, 2006, J BONE MINER RES, V21, pP31, DOI 10.1359/JBMR.06S206; Lyles KW, 2001, J BONE MINER RES, V16, P1379, DOI 10.1359/jbmr.2001.16.8.1379; Mankin HJ, 2005, CLIN ORTHOP RELAT R, P97, DOI 10.1097/01.blo.0000180053.99840.27; Martini G, 2007, BONE, V40, P457, DOI 10.1016/j.bone.2006.08.003; Matthews BG, 2007, J BONE MINER RES, V22, pS281; Mayilvahanan N, 2004, J Orthop Surg (Hong Kong), V12, P243; McClung MR, 2006, NEW ENGL J MED, V354, P821, DOI 10.1056/NEJMoa044459; Menaa C, 2000, J CLIN INVEST, V105, P1833, DOI 10.1172/JCI9133; Miller PD, 1999, AM J MED, V106, P513, DOI 10.1016/S0002-9343(99)00062-5; MILLS BG, 1988, J BONE MINER RES, V3, P101; MORALESPIGA AA, 1995, J BONE MINER RES, V10, P663; Morissette J, 2006, J BONE MINER RES, V21, pP38, DOI 10.1359/JBMR.06S207; Naot D, 2007, J BONE MINER RES, V22, P298, DOI 10.1359/JBMR.061108; Neale SD, 2000, BONE, V27, P409, DOI 10.1016/S8756-3282(00)00345-8; Ooi CG, 2000, BONE, V27, P417, DOI 10.1016/S8756-3282(00)00343-4; PRICE CHG, 1962, J BONE JOINT SURG BR, V44, P366, DOI 10.1302/0301-620X.44B2.366; RALSTON SH, 1987, J BONE MINER RES, V2, P5; RASLSTON SH, 2007, J BONE MINER RES, V22, P569; RAVGAULT A, 1989, REV RHUM MAL OSTEO, V56, P293; REBEL A, 1974, REV RHUM, V41, P767; REDDEN JF, 1981, INT ORTHOP, V5, P103, DOI 10.1007/BF00267839; Reddy SV, 2001, ENDOCRINOLOGY, V142, P2898, DOI 10.1210/en.142.7.2898; REDDY SV, 1995, J CLIN ENDOCR METAB, V80, P2108, DOI 10.1210/jc.80.7.2108; Reid IR, 1996, AM J MED, V101, P341, DOI 10.1016/S0002-9343(96)00227-6; Reid IR, 2005, NEW ENGL J MED, V353, P898, DOI 10.1056/NEJMoa044241; Reid IR, 2004, BONE, V35, P224, DOI 10.1016/j.bone.2004.03.023; Rendina D, 2006, J BONE MINER RES, V21, P1828, DOI 10.1359/JBMR.060822; Rima BK, 2002, J BONE MINER RES, V17, P2290, DOI 10.1359/jbmr.2002.17.12.2290; Rogers J, 2002, J BONE MINER RES, V17, P1127, DOI 10.1359/jbmr.2002.17.6.1127; Rogers MJ, 2004, CALCIFIED TISSUE INT, V75, P451, DOI 10.1007/s00223-004-0024-1; ROUX C, 1995, ARTHRITIS RHEUM, V38, P851, DOI 10.1002/art.1780380620; RUDDLE NH, 1993, VIROLOGY, V197, P196, DOI 10.1006/viro.1993.1580; Selby PL, 2006, J BONE MINER RES, V21, P1750, DOI 10.1359/JBMR.060805; Selby PL, 2002, BONE, V31, P366, DOI 10.1016/S8756-3282(02)00817-7; Sharma H, 2005, INT ORTHOP, V29, P319, DOI 10.1007/s00264-005-0673-3; Siris E, 1996, J CLIN ENDOCR METAB, V81, P961, DOI 10.1210/jc.81.3.961; Siris ES, 1996, J BONE MINER RES, V11, P1599; SIRIS ES, 1994, SEMIN ARTHRITIS RHEU, V23, P222, DOI 10.1016/0049-0172(94)90037-X; SIRIS ES, 1991, J BONE MINER RES, V6, P495; SOFAER JA, 1983, J EPIDEMIOL COMMUN H, V37, P226, DOI 10.1136/jech.37.3.226; SOLOMON LR, 1979, BRIT MED J, V1, P931, DOI 10.1136/bmj.1.6168.931; Sparks AB, 2001, CALCIFIED TISSUE INT, V68, P151, DOI 10.1007/s002230001211; Takata S, 2006, J BONE MINER METAB, V24, P359, DOI 10.1007/s00774-006-0696-x; Tiegs RD, 2000, BONE, V27, P423, DOI 10.1016/S8756-3282(00)00333-1; Van Staa TP, 2002, J BONE MINER RES, V17, P465, DOI 10.1359/jbmr.2002.17.3.465; WALLACE E, 1995, ARCH INTERN MED, V155, P1813, DOI 10.1001/archinte.155.16.1813; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Whyte MP, 2002, NEW ENGL J MED, V347, P175, DOI 10.1056/NEJMoa013096; Woo SB, 2006, ANN INTERN MED, V144, P753, DOI 10.7326/0003-4819-144-10-200605160-00009; WOODHOUSE NJ, 1971, LANCET, V1, P1139	101	133	140	0	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 12	2008	372	9633					155	163		10.1016/S0140-6736(08)61035-1	http://dx.doi.org/10.1016/S0140-6736(08)61035-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	324XJ	18620951				2022-12-28	WOS:000257552400030
J	Dreger, DS; Ford, SR; Walter, WR				Dreger, Douglas S.; Ford, Sean R.; Walter, William R.			Source analysis of the Crandall Canyon, Utah, mine collapse	SCIENCE			English	Article									[Dreger, Douglas S.; Ford, Sean R.] Univ Calif Berkeley, Berkeley Seismol Lab, Berkeley, CA 94720 USA; [Ford, Sean R.; Walter, William R.] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Dreger, DS (corresponding author), Univ Calif Berkeley, Berkeley Seismol Lab, Berkeley, CA 94720 USA.	dreger@seismo.berkeley.edu	Dreger, Douglas/AAK-6067-2021; Walter, William R./C-2351-2013; Ford, Sean/F-9191-2011	Walter, William R./0000-0002-0331-0616; Ford, Sean/0000-0002-0376-5792				FORD S, 2007, NATL NUCL SECURITY A, P561; HUDSON JA, 1989, J GEOPHYS RES-SOLID, V94, P765, DOI 10.1029/JB094iB01p00765; Jost M. L., 1989, Seismological Research Letters, V60, P37; PECHMANN JC, 2007, EOS T AGU S, V88; PECHMANN JC, 1995, SEISMOL RES LETT, V66, P25, DOI DOI 10.1785/GSSR1.66.3.25	5	23	23	3	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 11	2008	321	5886					217	217		10.1126/science.1157392	http://dx.doi.org/10.1126/science.1157392			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	324IS	18621662	Green Submitted			2022-12-28	WOS:000257512900030
J	Bandman, CE				Bandman, Celia Engel			A Medical Humanist Says Good-bye	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												c.bandman@communicationinmedicine.org						Back Anthony L, 2005, Ann Intern Med, V142, P682; Kavanaugh K., 1991, COLLECTED WORKS ST J; KUMIN MW, 2000, ALWAYS BEGINNING ESS; POIRIER S, B HUMANITIES HLTH CA	4	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 9	2008	300	2					149	150		10.1001/jama.300.2.149	http://dx.doi.org/10.1001/jama.300.2.149			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	323GV	18612106				2022-12-28	WOS:000257435500001
J	Rodin, G				Rodin, Gary			Treatment of depression in patients with cancer	LANCET			English	Editorial Material							MORBIDITY		Princess Margaret Hosp, Univ Hlth Network, Dept Psychosocial Oncol & Palliat Care, Toronto, ON M5G 2M9, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Rodin, G (corresponding author), Princess Margaret Hosp, Univ Hlth Network, Dept Psychosocial Oncol & Palliat Care, Toronto, ON M5G 2M9, Canada.	gary.rodin@uhn.on.ca		Rodin, Gary/0000-0002-6626-6974				Braun M, 2007, J CLIN ONCOL, V25, P4829, DOI 10.1200/JCO.2006.10.0909; Fallowfield L, 2001, BRIT J CANCER, V84, P1011, DOI 10.1054/bjoc.2001.1724; Holland Jimmie C, 2007, J Natl Compr Canc Netw, V5, P66; Jacobsen Paul B, 2007, J Natl Compr Canc Netw, V5, P99; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; National Institute for Clinical Excellence, 2004, GUID CANC SERV IMPR; Rodin G, 2007, SUPPORT CARE CANCER, V15, P123, DOI 10.1007/s00520-006-0145-3; Sharpe M, 2004, BRIT J CANCER, V90, P314, DOI 10.1038/sj.bjc.6601578; Strong V, 2008, LANCET, V372, P40, DOI 10.1016/S0140-6736(08)60991-5; Zaza C, 2002, J PAIN SYMPTOM MANAG, V24, P526, DOI 10.1016/S0885-3924(02)00497-9	10	8	8	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 5	2008	372	9632					8	10		10.1016/S0140-6736(08)60968-X	http://dx.doi.org/10.1016/S0140-6736(08)60968-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	321XN	18603142				2022-12-28	WOS:000257339900007
J	Pujol, B; Pannell, JR				Pujol, Benoit; Pannell, John R.			Reduced responses to selection after species range expansion	SCIENCE			English	Article							GENETIC-VARIATION; PLANT; POPULATION; POLLEN		[Pujol, Benoit; Pannell, John R.] Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England	University of Oxford	Pannell, JR (corresponding author), Univ Oxford, Dept Plant Sci, S Parks Rd, Oxford OX1 3RB, England.	john.pannell@plants.ox.ac.uk	Pujol, Benoit/N-1575-2019; Pujol, Benoit/A-8858-2011	Pujol, Benoit/0000-0001-9703-6760; Pujol, Benoit/0000-0001-9703-6760; Pannell, John/0000-0002-0098-7074	Natural Environment Research Council [NE/C511313/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Armbruster P, 1998, EVOLUTION, V52, P1697, DOI 10.1111/j.1558-5646.1998.tb02249.x; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; ENNOS RA, 1994, HEREDITY, V72, P250, DOI 10.1038/hdy.1994.35; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; MEAGHER TR, 1991, AM NAT, V137, P738, DOI 10.1086/285191; Naciri-Graven Y, 2003, EVOLUTION, V57, P706, DOI 10.1111/j.0014-3820.2003.tb00284.x; Obbard DJ, 2006, AM NAT, V167, P354, DOI 10.1086/499546; Petit RJ, 2002, FOREST ECOL MANAG, V156, P49, DOI 10.1016/S0378-1127(01)00634-X	8	109	109	1	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 4	2008	321	5885					96	96		10.1126/science.1157570	http://dx.doi.org/10.1126/science.1157570			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QE	18599779				2022-12-28	WOS:000257320800043
J	Glasziou, P; Meats, E; Heneghan, C; Shepperd, S				Glasziou, Paul; Meats, Emma; Heneghan, Carl; Shepperd, Sasha			What is missing from descriptions of treatment in trials and reviews?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED CONTROLLED-TRIALS; QUALITY; EXERCISE; JOURNALS		[Glasziou, Paul; Meats, Emma; Heneghan, Carl] Univ Oxford, Dept Primary Hlth Care, Ctr Evidence Based Med, Oxford OX3 7LF, England; [Shepperd, Sasha] Univ Oxford, Dept Publ Hlth, Oxford OX3 7LF, England	University of Oxford; University of Oxford	Glasziou, P (corresponding author), Univ Oxford, Dept Primary Hlth Care, Ctr Evidence Based Med, Oxford OX3 7LF, England.	paul.glasziou@dphpc.ox.ac.uk	Glasziou, Paul/A-7832-2008	Glasziou, Paul/0000-0001-7564-073X; Shepperd, Sasha/0000-0001-6384-8322	National Institute for Health Research [RSES/PDA/C2/017] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Chalmers I, 1999, LANCET, V353, P490, DOI 10.1016/S0140-6736(98)07618-1; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; DOPSON S, 2006, J HEALTH SERV RES PO, V6, P23; Glasziou Paul, 2005, ACP J Club, V142, pA8; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Mayo-Wilson E, 2007, AM J PUBLIC HEALTH, V97, P630, DOI 10.2105/AJPH.2006.094169; McKibbon KA, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-33; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Pathman DE, 1996, MED CARE, V34, P873, DOI 10.1097/00005650-199609000-00002; Perera R, 2007, BRIT MED J, V334, P127, DOI 10.1136/bmj.39045.396817.68; Plint AC, 2006, MED J AUSTRALIA, V185, P263, DOI 10.5694/j.1326-5377.2006.tb00557.x; Wallman KE, 2005, MED J AUSTRALIA, V183, P142, DOI 10.5694/j.1326-5377.2005.tb06959.x; Wallman KE, 2004, MED J AUSTRALIA, V180, P444, DOI 10.5694/j.1326-5377.2004.tb06019.x	14	422	424	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 28	2008	336	7659					1472	1474		10.1136/bmj.39590.732037.47	http://dx.doi.org/10.1136/bmj.39590.732037.47			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	324GN	18583680	Green Published, Green Submitted			2022-12-28	WOS:000257505900034
J	Loytynoja, A; Goldman, N				Loytynoja, Ari; Goldman, Nick			Phylogeny-aware gap placement prevents errors in sequence alignment and evolutionary analysis	SCIENCE			English	Article							NEUTRALIZING ANTIBODY; FUNCTIONAL ELEMENTS; GENOME; SENSITIVITY; INFECTION; ACCURACY; INSIGHTS; ENVELOPE; REGION	Genetic sequence alignment is the basis of many evolutionary and comparative studies, and errors in alignments lead to errors in the interpretation of evolutionary information in genomes. Traditional multiple sequence alignment methods disregard the phylogenetic implications of gap patterns that they create and infer systematically biased alignments with excess deletions and substitutions, too few insertions, and implausible insertion-deletion- event histories. We present a method that prevents these systematic errors by recognizing insertions and deletions as distinct evolutionary events. We show theoretically and practically that this improves the quality of sequence alignments and downstream analyses over a wide range of realistic alignment problems. These results suggest that insertions and sequence turnover are more common than is currently thought and challenge the conventional picture of sequence evolution and mechanisms of functional and structural changes.	[Loytynoja, Ari; Goldman, Nick] European Bioinformat Inst, European Mol Biol Lab, Hinxton CB10 1SD, England	European Molecular Biology Laboratory (EMBL)	Loytynoja, A (corresponding author), European Bioinformat Inst, European Mol Biol Lab, Wellcome Trust Genome Campus, Hinxton CB10 1SD, England.	ari@ebi.ac.uk		Loytynoja, Ari/0000-0001-5389-6611; Goldman, Nick/0000-0001-8486-2211	Wellcome Trust [GR078968] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Frost SDW, 2005, P NATL ACAD SCI USA, V102, P18514, DOI 10.1073/pnas.0504658102; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Jansson M, 2001, AIDS RES HUM RETROV, V17, P1405, DOI 10.1089/088922201753197079; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Pollock DD, 2002, SYST BIOL, V51, P664, DOI 10.1080/10635150290102357; Rambaut A, 2004, NAT REV GENET, V5, P52, DOI 10.1038/nrg1246; Rosenberg MS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-278; Sagar M, 2006, J VIROL, V80, P9586, DOI 10.1128/JVI.00141-06; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; SULLIVAN N, 1993, J VIROL, V67, P3674, DOI 10.1128/JVI.67.6.3674-3679.1993; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wong KM, 2008, SCIENCE, V319, P473, DOI 10.1126/science.1151532	17	560	568	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 20	2008	320	5883					1632	1635		10.1126/science.1158395	http://dx.doi.org/10.1126/science.1158395			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	315NM	18566285				2022-12-28	WOS:000256886700047
J	Roberts, JM; Osthoff, HD; Brown, SS; Ravishankara, AR				Roberts, James M.; Osthoff, Hans D.; Brown, Steven S.; Ravishankara, A. R.			N2O5 oxidizes chloride to Cl-2 in acidic atmospheric aerosol	SCIENCE			English	Article							GASEOUS N2O5; NACL; CHEMISTRY; CLNO2		[Roberts, James M.; Osthoff, Hans D.; Brown, Steven S.; Ravishankara, A. R.] NOAA, Div Chem Sci, Earth Syst Res Lab, Boulder, CO 80305 USA; [Osthoff, Hans D.] NOAA, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Osthoff, Hans D.; Ravishankara, A. R.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; University of Colorado System; University of Colorado Boulder	Roberts, JM (corresponding author), NOAA, Div Chem Sci, Earth Syst Res Lab, Boulder, CO 80305 USA.	James.M.Roberts@noaa.gov	Brown, Steven S/I-1762-2013; Ravishankara, Akkihebbal R/A-2914-2011; Roberts, James M./A-1082-2009	Roberts, James M./0000-0002-8485-8172; Osthoff, Hans/0000-0001-7155-6493	NOAA's Health of the Atmosphere Program; NOAA's Climate Goal	NOAA's Health of the Atmosphere Program(National Oceanic Atmospheric Admin (NOAA) - USA); NOAA's Climate Goal(National Oceanic Atmospheric Admin (NOAA) - USA)	This work was supported in part by the NOAA's Health of the Atmosphere Program and NOAA's Climate Goal.	Behnke W, 1997, J GEOPHYS RES-ATMOS, V102, P3795, DOI 10.1029/96JD03057; Carlslaw K. S., 1995, J PHYS CHEM, V99, P11557; Clegg SL, 1998, J PHYS CHEM A, V102, P2155, DOI 10.1021/jp973043j; Finlayson-Pitts BJ, 2003, CHEM REV, V103, P4801, DOI 10.1021/cr020653t; FINLAYSONPITTS BJ, 1989, NATURE, V337, P241, DOI 10.1038/337241a0; Finley BD, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025799; Keene WC, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007689; Osthoff HD, 2008, NAT GEOSCI, V1, P324, DOI 10.1038/ngeo177; Rossi MJ, 2003, CHEM REV, V103, P4823, DOI 10.1021/cr020507n; Schweitzer F, 1998, J PHYS CHEM A, V102, P3942, DOI 10.1021/jp980748s; Spicer CW, 1998, NATURE, V394, P353, DOI 10.1038/28584	11	95	96	6	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 22	2008	321	5892					1059	1059		10.1126/science.1158777	http://dx.doi.org/10.1126/science.1158777			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	339RL	18599742				2022-12-28	WOS:000258594900030
J	Johnsson, L; Hansson, MG; Eriksson, S; Helgesson, G				Johnsson, Linus; Hansson, Mats G.; Eriksson, Stefan; Helgesson, Gert			Patients' refusal to consent to storage and use of samples in Swedish biobanks: cross sectional study	BRITISH MEDICAL JOURNAL			English	Article							INFORMED-CONSENT; GENETIC RESEARCH; BIOLOGICAL SAMPLES; TISSUE SAMPLES; DONORS; ATTITUDES; DONATION	Objectives To estimate how many people object to storage of biological samples collected in health care in Sweden and to their use in research and how many withdraw previous consent. Design Cross sectional study of register data. Setting Biobanks used in Swedish health care, 2005-6. Population Data on refusal to consent were obtained for 1.4 million biobank samples per year from 20 of 21 counties. Main outcome measures Rates of preliminary refusal to consent, confirmed refusal, and withdrawal of consent. Results Patients refused consent to either storage or use of their samples in about 1 in 690 cases; about 1 in 1600 confirmed their decision by completing a dissent form. Rather than having the samples destroyed, about 1 in 6200 patients wanted to restrict their use. Of those who had previously consented, about 1 in 19 000 withdrew their consent. Conclusions Refusal to consent to biobank research in Sweden is rare, and the interests of individuals and research interests need not be at odds. The Swedish healthcare organisation is currently obliged to obtain either consent or refusal to each potential use of each sample taken, and tack of consent to research is used as the default position. A system of presumed consent with straightforward opt out;would correspond with people's attitudes, as expressed in their actions, towards biobank research.	[Johnsson, Linus; Hansson, Mats G.; Eriksson, Stefan] Uppsala Univ, Ctr Res Eth & Bioeth, SE-75185 Uppsala, Sweden; [Helgesson, Gert] Karolinska Inst, Unit Bioeth, LIME, SE-17177 Stockholm, Sweden	Uppsala University; Karolinska Institutet	Johnsson, L (corresponding author), Uppsala Univ, Ctr Res Eth & Bioeth, Uppsala Sci Pk, SE-75185 Uppsala, Sweden.	linus.johnsson@crb.uu.se		Helgesson, Gert/0000-0002-0075-0165; Eriksson, Stefan/0000-0001-7486-4678				[Anonymous], 2007, AUTONOMY TRUST BIOET; Asai Atsushi, 2002, BMC Med Ethics, V3, pE1; Cousins G, 2005, PUBLIC PERCEPTIONS B; FJAESTAD B, 2003, SVENSKARNA GENTEKNIK; GIBBONS SMC, 2007, KINGS LAW J, V18, P201; Hansson MG, 2007, PATHOBIOLOGY, V74, P198, DOI 10.1159/000104445; Hansson MG, 2006, LANCET ONCOL, V7, P266, DOI 10.1016/S1470-2045(06)70618-0; Hansson MG, 2005, J MED ETHICS, V31, P415, DOI 10.1136/jme.2004.009456; Hoeyer K, 2005, ARCH INTERN MED, V165, P97, DOI 10.1001/archinte.165.1.97; Hoeyer K, 2004, SCAND J PUBLIC HEALT, V32, P224, DOI 10.1080/14034940310019506; Human Genetics Commission, 2001, PUBL ATT HUM GEN INF; Kettis-Lindblad A, 2007, SCAND J PUBLIC HEALT, V35, P148, DOI 10.1080/14034940600868572; Kettis-Lindblad A, 2006, EUR J PUBLIC HEALTH, V16, P433, DOI 10.1093/eurpub/cki198; *MED RES COUNC, 2002, PUBL PERC COLL HUM B; Nilstun Tore, 2006, Med Health Care Philos, V9, P81, DOI 10.1007/s11019-005-7984-4; Pardo R, 2002, J BIOTECHNOL, V98, P9, DOI 10.1016/S0168-1656(02)00082-2; RONNBERG P, 2007, KNAPPT VARANNAN VUXE; Sade RM, 2002, ARCH INTERN MED, V162, P1439, DOI 10.1001/archinte.162.13.1439; SHORE DA, 2007, TRUST CRISIS HEALTHC; Stegmayr B, 2002, BMJ-BRIT MED J, V325, P634, DOI 10.1136/bmj.325.7365.634; *VET ALLM, 2007, VA RAPP 2007 3 ALLM; Wendler D, 2006, BMJ-BRIT MED J, V332, P544, DOI 10.1136/bmj.332.7540.544; Willis G, 2006, J EMPIR RES HUM RES, V1, P9, DOI 10.1525/jer.2006.1.1.9	23	42	42	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 26	2008	337	7663							a345	10.1136/bmj.a345	http://dx.doi.org/10.1136/bmj.a345			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	335EG	18617496	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000258273000041
J	Houlton, BZ; Wang, YP; Vitousek, PM; Field, CB				Houlton, Benjamin Z.; Wang, Ying-Ping; Vitousek, Peter M.; Field, Christopher B.			A unifying framework for dinitrogen fixation in the terrestrial biosphere	NATURE			English	Article							SYMBIOTIC NITROGEN-FIXATION; SOIL; PHOSPHORUS; FOREST; AVAILABILITY; TEMPERATURE; ACQUISITION; LIMITATION; PHOSPHATASE; ECOSYSTEMS	Dinitrogen ( N(2)) fixation is widely recognized as an important process in controlling ecosystem responses to global environmental change, both today(1) and in the past(2); however, significant discrepancies exist between theory and observations of patterns of N(2) fixation across major sectors of the land biosphere. A question remains as to why symbiotic N(2)- fixing plants are more abundant in vast areas of the tropics than in many of the mature forests that seem to be nitrogen- limited in the temperate and boreal zones(3). Here we present a unifying framework for terrestrial N(2) fixation that can explain the geographic occurrence of N(2) fixers across diverse biomes and at the global scale. By examining trade- offs inherent in plant carbon, nitrogen and phosphorus capture, we find a clear advantage to symbiotic N(2) fixers in phosphorus-limited tropical savannas and lowland tropical forests. The ability of N(2) fixers to invest nitrogen into phosphorus acquisition seems vital to sustained N(2) fixation in phosphorus- limited tropical ecosystems. In contrast, modern- day temperatures seem to constrain N(2) fixation rates and N(2)- fixing species from mature forests in the high latitudes. We propose that an analysis that couples biogeochemical cycling and biophysical mechanisms is sufficient to explain the principal geographical patterns of symbiotic N(2) fixation on land, thus providing a basis for predicting the response of nutrient- limited ecosystems to climate change and increasing atmospheric CO(2).	[Houlton, Benjamin Z.; Vitousek, Peter M.] Stanford Univ, Stanford, CA 94305 USA; [Houlton, Benjamin Z.; Field, Christopher B.] Carnegie Inst Washington, Dept Global Ecol, Stanford, CA 94305 USA; [Wang, Ying-Ping] CSIRO Marine & Atmospher Res, Aspendale, Vic 3195, Australia; [Wang, Ying-Ping] Ctr Australian Weather & Climate Res, Aspendale, Vic 3195, Australia	Stanford University; Carnegie Institution for Science; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Houlton, BZ (corresponding author), Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA.	bzhoulton@ucdavis.edu	Wang, Yingping/A-9765-2011	Wang, Yingping/0000-0002-4614-6203; Houlton, Benjamin/0000-0002-1414-0261				Allison SD, 2006, SOIL BIOL BIOCHEM, V38, P1537, DOI 10.1016/j.soilbio.2005.11.008; BLOOM AJ, 1985, ANNU REV ECOL SYST, V16, P363, DOI 10.1146/annurev.es.16.110185.002051; Bormann F.H., 1979, PATTERN PROCESS FORE, DOI DOI 10.1007/978-1-4612-6232-9; Caldwell BA, 2006, APPL SOIL ECOL, V32, P149, DOI 10.1016/j.apsoil.2004.11.008; CEUTERICK F, 1978, EUR J BIOCHEM, V87, P401, DOI 10.1111/j.1432-1033.1978.tb12389.x; CHAN YK, 1991, CAN J MICROBIOL, V37, P715, DOI 10.1139/m91-122; CHAPIN DM, 1991, CAN J BOT, V69, P2744, DOI 10.1139/b91-345; Chestnut TJ, 1999, BIOGEOCHEMISTRY, V46, P85, DOI 10.1023/A:1006104229691; Cleveland CC, 1999, GLOBAL BIOGEOCHEM CY, V13, P623, DOI 10.1029/1999GB900014; COXSON DS, 1983, CAN J BOT, V61, P2658, DOI 10.1139/b83-293; Crews TE, 1999, BIOGEOCHEMISTRY, V46, P233, DOI 10.1007/BF01007581; Deutsch C, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002189; Deutsch C, 2007, NATURE, V445, P163, DOI 10.1038/nature05392; DUFF SMG, 1994, PHYSIOL PLANTARUM, V90, P791, DOI 10.1111/j.1399-3054.1994.tb02539.x; Dyhrman ST, 2006, NATURE, V439, P68, DOI 10.1038/nature04203; Falkowski PG, 1997, NATURE, V387, P272, DOI 10.1038/387272a0; GIARDINA CP, 1995, CAN J FOREST RES, V25, P1652, DOI 10.1139/x95-179; GUTSCHICK VP, 1981, AM NAT, V118, P607, DOI 10.1086/283858; Houlton BZ, 2003, ECOSYSTEMS, V6, P431, DOI 10.1007/s10021-002-0198-1; Hungate BA, 2003, SCIENCE, V302, P1512, DOI 10.1126/science.1091390; Kamh M, 2002, J PLANT NUTR SOIL SC, V165, P566, DOI 10.1002/1522-2624(200210)165:5<566::AID-JPLN566>3.0.CO;2-O; Lambers H, 2006, ANN BOT-LONDON, V98, P693, DOI 10.1093/aob/mcl114; Liengen T, 1997, CAN J MICROBIOL, V43, P759, DOI 10.1139/m97-109; Martinelli LA, 1999, BIOGEOCHEMISTRY, V46, P45, DOI 10.1023/A:1006100128782; MCGILL WB, 1981, GEODERMA, V26, P267, DOI 10.1016/0016-7061(81)90024-0; Nuruzzaman M, 2006, PLANT SOIL, V281, P109, DOI 10.1007/s11104-005-3936-2; Olander LP, 2000, BIOGEOCHEMISTRY, V49, P175, DOI 10.1023/A:1006316117817; Pons TL, 2007, NEW PHYTOL, V173, P154, DOI 10.1111/j.1469-8137.2006.01895.x; Rastetter EB, 2001, ECOSYSTEMS, V4, P369, DOI 10.1007/s10021-001-0018-z; REDFIELD AC, 1958, AM SCI, V46, P205; ROPER MM, 1985, SOIL BIOL BIOCHEM, V17, P65, DOI 10.1016/0038-0717(85)90091-4; SCHINDLER DW, 1974, SCIENCE, V184, P897, DOI 10.1126/science.184.4139.897; SCHOMBERG HH, 1992, AGRON J, V84, P1046, DOI 10.2134/agronj1992.00021962008400060026x; SPRENT JI, 1985, P ROY SOC EDINB B, V85, P215, DOI 10.1017/S0269727000004036; ter Steege H, 2006, NATURE, V443, P444, DOI 10.1038/nature05134; Treseder KK, 2001, ECOLOGY, V82, P946, DOI 10.1890/0012-9658(2001)082[0946:EOSNAO]2.0.CO;2; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; VITOUSEK PM, 1986, ANNU REV ECOL SYST, V17, P137, DOI 10.1146/annurev.es.17.110186.001033; Vitousek PM, 1999, BIOGEOCHEMISTRY, V46, P179, DOI 10.1007/BF01007579; Wang YP, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002797; ZOU XM, 1995, SOIL SCI SOC AM J, V59, P1452, DOI 10.2136/sssaj1995.03615995005900050035x	41	515	546	15	394	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 17	2008	454	7202					327	U34		10.1038/nature07028	http://dx.doi.org/10.1038/nature07028			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	326ND	18563086				2022-12-28	WOS:000257665300037
J	Currie, MJ; Mapel, JK; Heidel, TD; Goffri, S; Baldo, MA				Currie, Michael J.; Mapel, Jonathan K.; Heidel, Timothy D.; Goffri, Shalom; Baldo, Marc A.			High-efficiency organic solar concentrators for photovoltaics	SCIENCE			English	Article							ELECTROLUMINESCENT DEVICES; EMITTING DEVICES; LIGHT; PERFORMANCE; STABILITY	The cost of photovoltaic power can be reduced with organic solar concentrators. These are planar waveguides with a thin- film organic coating on the face and inorganic solar cells attached to the edges. Light is absorbed by the coating and reemitted into waveguide modes for collection by the solar cells. We report single- and tandem- waveguide organic solar concentrators with quantum efficiencies exceeding 50% and projected power conversion efficiencies as high as 6.8%. The exploitation of near- field energy transfer, solid- state solvation, and phosphorescence enables 10-fold increases in the power obtained from photovoltaic cells, without the need for solar tracking.	[Currie, Michael J.; Mapel, Jonathan K.; Heidel, Timothy D.; Goffri, Shalom; Baldo, Marc A.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Baldo, MA (corresponding author), MIT, Dept Elect Engn & Comp Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	baldo@mit.edu						Baldo MA, 1998, NATURE, V395, P151, DOI 10.1038/25954; Barnham K, 2000, APPL PHYS LETT, V76, P1197, DOI 10.1063/1.125981; BATCHELDER JS, 1981, APPL OPTICS, V20, P3733, DOI 10.1364/AO.20.003733; BATCHELDER JS, 1979, APPL OPTICS, V18, P3090, DOI 10.1364/AO.18.003090; Baur C, 2007, J SOL ENERG-T ASME, V129, P258, DOI 10.1115/1.2735346; Borek C, 2007, ANGEW CHEM INT EDIT, V46, P1109, DOI 10.1002/anie.200604240; Bulovic V, 1998, CHEM PHYS LETT, V287, P455, DOI 10.1016/S0009-2614(98)00168-7; Demtsu SH., 2005, 31 IEEE PHOT SPEC C; FORSTER T, 1959, DISCUSS FARADAY SOC, P7; GALE RP, 1990, 21 I EL EL ENG IEEE; GOETZBERGER A, 1977, APPL PHYS, V14, P123, DOI 10.1007/BF00883080; Jarikov VV, 2007, J APPL PHYS, V102, DOI 10.1063/1.2809437; Palm J, 2004, THIN SOLID FILMS, V451, P544, DOI 10.1016/j.tsf.2003.10.160; Shi JM, 1997, APPL PHYS LETT, V70, P1665, DOI 10.1063/1.118664; SMESTAD G, 1990, SOL ENERG MATER, V21, P99, DOI 10.1016/0165-1633(90)90047-5; Thompson M, 2007, MRS BULL, V32, P694, DOI 10.1557/mrs2007.144; WEBER WH, 1976, APPL OPTICS, V15, P2299, DOI 10.1364/AO.15.002299	17	550	588	3	286	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 11	2008	321	5886					226	228		10.1126/science.1158342	http://dx.doi.org/10.1126/science.1158342			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	324IS	18621664				2022-12-28	WOS:000257512900033
J	Mackelprang, R; Rubin, EM				Mackelprang, Rachel; Rubin, Edward M.			Paleontology - New tricks with old bones	SCIENCE			English	Editorial Material							NEANDERTHAL GENOMIC DNA; MODERN HUMANS; SELECTION; AMPLIFICATION; SEQUENCES; GENE		[Mackelprang, Rachel; Rubin, Edward M.] Dept Energy Joint Genome Inst, Walnut Creek, CA 94598 USA; [Mackelprang, Rachel; Rubin, Edward M.] Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Mackelprang, R (corresponding author), Dept Energy Joint Genome Inst, 2800 Mitchell Dr, Walnut Creek, CA 94598 USA.	emrubin@lbl.gov						Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; Bashiardes S, 2005, NAT METHODS, V2, P63, DOI 10.1038/nmeth0105-63; BLOW MJ, 2008, GENOME RES; Coop G, 2008, MOL BIOL EVOL, V25, P1257, DOI 10.1093/molbev/msn091; Green RE, 2006, NATURE, V444, P330, DOI 10.1038/nature05336; Krause J, 2007, CURR BIOL, V17, P1908, DOI 10.1016/j.cub.2007.10.008; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; Krings M, 1999, P NATL ACAD SCI USA, V96, P5581, DOI 10.1073/pnas.96.10.5581; Lalueza-Fox C, 2007, SCIENCE, V318, P1453, DOI 10.1126/science.1147417; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Noonan JP, 2006, SCIENCE, V314, P1113, DOI 10.1126/science.1131412; Noonan JP, 2005, SCIENCE, V309, P597, DOI 10.1126/science.1113485; Poinar HN, 2006, SCIENCE, V311, P392, DOI 10.1126/science.1123360; Porreca GJ, 2007, NAT METHODS, V4, P931, DOI 10.1038/NMETH1110; Wall JD, 2007, PLOS GENET, V3, P1862, DOI 10.1371/journal.pgen.0030175; Williams R, 2006, NAT METHODS, V3, P545, DOI 10.1038/NMETH896	16	2	2	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2008	321	5886					211	212		10.1126/science.1161890	http://dx.doi.org/10.1126/science.1161890			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	324IS	18621660				2022-12-28	WOS:000257512900028
J	Mello, MM; Rosenthal, MB				Mello, Michelle M.; Rosenthal, Meredith B.			Wellness programs and lifestyle discrimination - The legal limits	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Mello, Michelle M.; Rosenthal, Meredith B.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Mello, MM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave, Boston, MA 02115 USA.	mmello@hsph.harvard.edu		Mello, Michelle/0000-0003-2877-4270; Rosenthal, Meredith/0000-0003-3410-0184				ALVAREZ EP, 2006, HR MAGAZINE      JAN, V51; *AM BAR ASS, 2005, MON STAT DIS DISCR L; Benabou R, 2003, REV ECON STUD, V70, P489, DOI 10.1111/1467-937X.00253; *BLUE CAR NETW MIC, 2006, HLTH BLUE LIV; *BUS ROUNDT, 2007, DO WELL WELLN 2006 0; Camerer C. F., 1998, PROSPECT THEORY WILD; Chapman LS, 2006, AM J HEALTH PROMOT, V21, P1, DOI 10.4278/0890-1171-21.2.TAHP-1; Conlin M, 2007, BUS WEEK, P58; Deci EL, 1999, PSYCHOL BULL, V125, P627, DOI 10.1037/0033-2909.125.6.627; *DEP JUST, 2008, ADA TITL III TECHN A; *DEP LAB, 2007, FAQS HIPAA NOND REQ; Department of Labor Department of Treasury Department of Health and Human Services, 2006, FED REGISTER, V71, P75014; *HARR INT, 2007, STRAT HLTH PERSP DAT; Hart O., 1987, ADV EC ECONOMETRICS, P71, DOI 10.1017/CCOL0521340446.003; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kane R. L., 2004, AHRQ PUBLICATION; KENDALL J, 2005, BENEFITS LAW J, V18, P57; Kersh R, 2005, J HEALTH POLIT POLIC, V30, P839, DOI 10.1215/03616878-30-5-839; KEYES S, 2007, ANDREWS TOBACCO IND, V22, P10; Loewenstein G, 2007, JAMA-J AM MED ASSOC, V298, P2415, DOI 10.1001/jama.298.20.2415; MATHIS J, 2004, ADAS APPL INSURANCE; *MERC HUM RES CONS, 2007, NAT SURV EMPL SPONS; Okie S, 2007, NEW ENGL J MED, V357, P1465, DOI 10.1056/NEJMp078152; Redmond P, 2007, CAN INCENTIVES HLTH; Shurtz R. D., 2005, BENEFITS LAW J, V18, P31; Simon T. M., 2006, BENEFITS LAW J, V19, P46; Steinbrook R, 2006, NEW ENGL J MED, V355, P753, DOI 10.1056/NEJMp068141; *WATS WYATT WORLDW, 2007, 12 ANN NAT BUS GROUP	28	67	67	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 10	2008	359	2					192	199		10.1056/NEJMhle0801929	http://dx.doi.org/10.1056/NEJMhle0801929			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	323PJ	18614787				2022-12-28	WOS:000257459000013
J	Niu, FL; Silver, PG; Daley, TM; Cheng, X; Majer, EL				Niu, Fenglin; Silver, Paul G.; Daley, Thomas M.; Cheng, Xin; Majer, Ernest L.			Preseismic velocity changes observed from active source monitoring at the Parkfield SAFOD drill site	NATURE			English	Article							SAN-ANDREAS FAULT; COMPRESSIONAL WAVES; SEISMIC VELOCITY; ECHO SIGNALS; TRAVEL-TIME; ROCKS; STRESS; CALIFORNIA; CRACKS	Measuring stress changes within seismically active fault zones has been a long- sought goal of seismology. One approach is to exploit the stress dependence of seismic wave velocity, and we have investigated this in an active source cross- well experiment at the San Andreas Fault Observatory at Depth ( SAFOD) drill site. Here we show that stress changes are indeed measurable using this technique. Over a two- month period, we observed an excellent anti-correlation between changes in the time required for a shear wave to travel through the rock along a fixed pathway ( a few microseconds) and variations in barometric pressure. We also observed two large excursions in the travel- time data that are coincident with two earthquakes that are among those predicted to produce the largest coseismic stress changes at SAFOD. The two excursions started approximately 10 and 2 hours before the events, respectively, suggesting that they may be related to pre- rupture stress induced changes in crack properties, as observed in early laboratory studies(1,2).	[Niu, Fenglin; Cheng, Xin] Rice Univ, Dept Earth Sci, Houston, TX 77005 USA; [Silver, Paul G.] Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; [Daley, Thomas M.; Majer, Ernest L.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Earth Sci, Berkeley, CA 94720 USA	Rice University; Carnegie Institution for Science; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Niu, FL (corresponding author), Rice Univ, Dept Earth Sci, MS-126,6100 Main St, Houston, TX 77005 USA.	niu@rice.edu	Cheng, Xin/C-2973-2011; Niu, Fenglin/A-2548-2011; Daley, Thomas M/G-3274-2015	Daley, Thomas M/0000-0001-9445-0843				Abercrombie RE, 1995, J GEOPHYS RES-SOL EA, V100, P24015, DOI 10.1029/95JB02397; Aki K., 1980, QUANTITATIVE SEISMOL; BIRCH F, 1960, J GEOPHYS RES, V65, P1083, DOI 10.1029/JZ065i004p01083; BIRCH F, 1961, J GEOPHYS RES, V66, P2199, DOI 10.1029/JZ066i007p02199; BRACE WF, 1966, J GEOPHYS RES, V71, P3939, DOI 10.1029/JZ071i016p03939; CESPEDES I, 1995, ULTRASONIC IMAGING, V17, P142, DOI 10.1006/uimg.1995.1007; DEFAZIO TL, 1973, J GEOPHYS RES, V78, P1319, DOI 10.1029/JB078i008p01319; DEJONG PGM, 1990, ULTRASONIC IMAGING, V12, P84, DOI 10.1016/0161-7346(90)90152-N; LEARY PC, 1979, J GEOPHYS RES, V84, P659, DOI 10.1029/JB084iB02p00659; NUR A, 1969, EARTH PLANET SC LETT, V7, P183, DOI 10.1016/0012-821X(69)90035-1; NUR A, 1971, J GEOPHYS RES, V76, P2022, DOI 10.1029/JB076i008p02022; OCONNELL RJ, 1974, J GEOPHYS RES, V79, P5412, DOI 10.1029/JB079i035p05412; REASENBERG P, 1974, J GEOPHYS RES, V79, P399, DOI 10.1029/JB079i002p00399; Rubin AM, 2000, J GEOPHYS RES-SOL EA, V105, P19095, DOI 10.1029/2000JB900129; SCHOLZ CH, 1968, J GEOPHYS RES, V73, P1417, DOI 10.1029/JB073i004p01417; Segall P, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017995; Silver PG, 2007, B SEISMOL SOC AM, V97, P281, DOI 10.1785/0120060120; Unsworth M, 2000, GEOPHYS RES LETT, V27, P3021, DOI 10.1029/2000GL011476; WALSH JB, 1965, J GEOPHYS RES, V70, P381, DOI 10.1029/JZ070i002p00381; Yamamura K, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002005	20	174	228	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2008	454	7201					204	U44		10.1038/nature07111	http://dx.doi.org/10.1038/nature07111			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	323RU	18615082	Green Submitted			2022-12-28	WOS:000257466900041
J	Abbud, M; Al-Mousawi, M; Alobaidli, AA; Al-Rukhaimi, MN; Bagheri, A; Bakr, MA; Barbari, A; Capron, A; Chapman, JR; Couser, W; Danovitch, G; de Castro, LD; Delmonico, FL; Fazel, I; Haberal, M; Jha, V; Kobayashi, E; Lameire, N; Levin, A; Maiga, MK; Martin, D; Masri, M; Naicker, S; Noel, L; Rizvi, SAH; Rodriguez-Iturbe, B; Sayegh, MH; Shaheen, FAM; Stephan, AG; Tibell, A; Tong, MKL; Vathsala, A				Abbud-Filho, Mario; Al-Mousawi, Mustafa; Alobaidli, Ali Abdulkareem; Al-Rukhaimi, Mona Nasir; Bagheri, Alireza; Bakr, M. A.; Barbari, Antoine; Capron, Alexander; Chapman, Jeremy R.; Couser, William; Danovitch, Gabriel; de Castro, Leonardo D.; Delmonico, Francis L.; Fazel, Iraj; Haberal, Mehmet; Jha, Vivekanand; Kobayashi, Eiji; Lameire, Norbert; Levin, Adeera; Maiga, Mahamane Kalil; Martin, Dominique; Masri, Marwan; Naicker, Saraladevi; Noel, Luc; Rizvi, S. Adibul Hasan; Rodriguez-Iturbe, Bernardo; Sayegh, Mohamed H.; Shaheen, Faissal A. M.; Stephan, A. G.; Tibell, Annika; Tong, Matthew Kwok-Lung; Vathsala, A.		Steering Comm Istanbul Summit	Organ trafficking and transplant tourism and commercialism: the Declaration of Istanbul	LANCET			English	Editorial Material									[Abbud-Filho, Mario] FAMERP, Sao Paulo, Brazil; [Abbud-Filho, Mario] Inst Urol & Nephrol, Sao Paulo, Brazil; [Al-Mousawi, Mustafa] Middle E Soc Organ Transplantat, Kuwait, Kuwait; [Alobaidli, Ali Abdulkareem] Sheikh Khalifa Med City, Kidney Transplant Serv, Abu Dhabi, U Arab Emirates; [Al-Rukhaimi, Mona Nasir] Dubai Hosp, Renal Unit, Dubai, U Arab Emirates; [Bagheri, Alireza] Univ Tehran Med Sci, Tehran, Iran; [Bakr, M. A.] Mansoura Univ, Urol & Nephrol Ctr, Mansoura, Egypt; [Barbari, Antoine] Rafik Hariri Univ Hosp, Beirut, Lebanon; [Capron, Alexander] Univ So Calif, Los Angeles, CA USA; [Chapman, Jeremy R.] Transplantat Soc, Sydney, NSW, Australia; [Chapman, Jeremy R.] Univ Sydney, Sydney, NSW 2006, Australia; [Couser, William] Int Soc Nephrol, Seattle, WA USA; [Danovitch, Gabriel] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [de Castro, Leonardo D.] Univ Philippines, Quezon City 1101, Philippines; [Delmonico, Francis L.] Transplantat Soc, Boston, MA USA; [Fazel, Iraj] Acad Med Sci, Tehran, Iran; [Haberal, Mehmet] Baskent Univ, TR-06490 Ankara, Turkey; [Haberal, Mehmet] Turkish Transplantat Soc, Ankara, Turkey; [Jha, Vivekanand] Postgrad Inst Med Educ & Res, Chandigarh 160012, India; [Kobayashi, Eiji] Jichi Med Univ, Minami Kawachi, Tochigi, Japan; [Lameire, Norbert] Ghent Univ Hosp, B-9000 Ghent, Belgium; [Levin, Adeera] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Maiga, Mahamane Kalil] Univ Bamako, Bamako, Mali; [Martin, Dominique] Univ Melbourne, Ctr Appl Philosophy & Publ Eth, Melbourne, Vic 3010, Australia; [Masri, Marwan] Asian Soc Transplantat, Beirut, Lebanon; [Naicker, Saraladevi] Univ Witwatersrand, Johannesburg, South Africa; [Noel, Luc] WHO, CH-1211 Geneva, Switzerland; [Rizvi, S. Adibul Hasan] Sindh Inst Urol & Transplantat, Karachi, Pakistan; [Rodriguez-Iturbe, Bernardo] Int Soc Nephrol, Maracaibo, Venezuela; [Sayegh, Mohamed H.] Harvard Univ, Sch Med, Boston, MA USA; [Shaheen, Faissal A. M.] Saudi Council Organ Transplantat, Jeddah, Saudi Arabia; [Stephan, A. G.] Rizk Hosp, Div Nephrol, Beirut, Lebanon; [Tibell, Annika] Karolinska Inst, Stockholm, Sweden; [Tong, Matthew Kwok-Lung] Princess Margaret Hosp, Hong Kong, Hong Kong, Peoples R China; [Vathsala, A.] Natl Univ Singapore, Singapore 117548, Singapore	Dubai Hospital; Tehran University of Medical Sciences; Egyptian Knowledge Bank (EKB); Mansoura University; University of Southern California; University of Sydney; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of the Philippines System; University of the Philippines Diliman; Baskent University; Ministry of Food, Agriculture & Livestock - Turkey; Turkish Transplantation & Burn Foundation Hospital; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Jichi Medical University; Ghent University; Ghent University Hospital; University of British Columbia; University of Bamako; University of Melbourne; University of Witwatersrand; World Health Organization; Dow University of Health Sciences; Harvard University; Harvard Medical School; Saudi Center for Organ Transplantation; Lebanese American University; Karolinska Institutet; National University of Singapore	Abbud, M (corresponding author), FAMERP, Sao Paulo, Brazil.		Rodriguez, Isabel/G-3178-2016; Abbud-Filho, Mario/E-5525-2017; Haberal, Mehmet/AAJ-8097-2021	Rodriguez, Isabel/0000-0002-7178-8275; Abbud-Filho, Mario/0000-0002-5079-9813; Haberal, Mehmet/0000-0002-3462-7632; Jha, Vivekanand/0000-0002-8015-9470				Naqvi SAA, 2007, TRANSPL INT, V20, P934, DOI 10.1111/j.1432-2277.2007.00529.x; Shimazono Y, 2007, B WORLD HEALTH ORGAN, V85, P955, DOI 10.2471/BLT.06.039370; *WORLD HLTH ASS, 1991, WHA4425 WHO; *WORLD HLTH ASS, 2004, WHA5718 WHO; *WORLD HLTH ASS, 1987, WHA4013 WHO; *WORLD HLTH ASS, 1989, WHA425 WHO	6	167	169	0	30	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 5	2008	372	9632					5	6						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	321XN	18603141				2022-12-28	WOS:000257339900005
J	Wittemyer, G; Elsen, P; Bean, WT; Burton, ACO; Brashares, JS				Wittemyer, George; Elsen, Paul; Bean, William T.; Burton, A. Coleman O.; Brashares, Justin S.			Accelerated human population growth at protected area edges	SCIENCE			English	Article							CONSERVATION; WILDLIFE; POVERTY; PARKS; SIZE	Protected areas ( PAs) have long been criticized as creations of and for an elite few, where associated costs, but few benefits, are borne by marginalized rural communities. Contrary to predictions of this argument, we found that average human population growth rates on the borders of 306 PAs in 45 countries in Africa and Latin America were nearly double average rural growth, suggesting that PAs attract, rather than repel, human settlement. Higher population growth on PA edges is evident across ecoregions, countries, and continents and is correlated positively with international donor investment in national conservation programs and an index of park- related funding. These findings provide insight on the value of PAs for local people, but also highlight a looming threat to PA effectiveness and biodiversity conservation.	[Wittemyer, George; Elsen, Paul; Bean, William T.; Burton, A. Coleman O.; Brashares, Justin S.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Wittemyer, G (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	georgew@nature.berkeley.edu; brashares@nature.berkeley.edu	Burton, Cole/J-3184-2012; Elsen, Paul/H-9567-2019; Bean, William/A-9399-2012; Burton, Cole/AAF-9234-2019; Wittemyer, George/AFQ-1840-2022	Burton, Cole/0000-0002-8799-3847; Elsen, Paul/0000-0002-9953-7961; Burton, Cole/0000-0002-8799-3847; Bean, William T./0000-0001-6595-5885				Adams WM, 2004, SCIENCE, V306, P1146, DOI 10.1126/science.1097920; Balmford A, 2003, P NATL ACAD SCI USA, V100, P1046, DOI 10.1073/pnas.0236945100; Brashares JS, 2001, P ROY SOC B-BIOL SCI, V268, P2473, DOI 10.1098/rspb.2001.1815; Cernea MM, 2006, WORLD DEV, V34, P1808, DOI 10.1016/j.worlddev.2006.02.008; Cincotta RP, 2000, NATURE, V404, P990, DOI 10.1038/35010105; de Sherbinin A, 2008, ORYX, V42, P26, DOI 10.1017/S0030605308000781; de Sherbinin Alex, 1998, Parks (Newbury), V8, P38; DeFries R, 2005, ECOL APPL, V15, P19, DOI 10.1890/03-5258; DeFries R, 2007, ECOL APPL, V17, P1031, DOI 10.1890/05-1111; *GEF, 2006, GEF BIOD STRAT ACT; *GEF, 2008, GEF PROJ DAT; Hudak AT, 2004, AGR ECOSYST ENVIRON, V101, P307, DOI 10.1016/j.agee.2003.09.010; James A, 2001, BIOSCIENCE, V51, P43, DOI 10.1641/0006-3568(2001)051[0043:CWATCB]2.0.CO;2; James A. N., 1999, GLOBAL REV PROTECTED; Karanth KK, 2006, BIOL CONSERV, V128, P147, DOI 10.1016/j.biocon.2005.09.024; Luck GW, 2007, BIOL REV, V82, P607, DOI 10.1111/j.1469-185X.2007.00028.x; Newmark WD, 2000, BIOSCIENCE, V50, P585, DOI 10.1641/0006-3568(2000)050[0585:CWIAIC]2.0.CO;2; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; PELUSO NL, 1993, GLOBAL ENVIRON CHANG, V3, P199, DOI 10.1016/0959-3780(93)90006-7; Scherl L.M., 2004, OPPORTUNITIES LIMITA; Scholte P, 2003, AMBIO, V32, P58, DOI 10.1639/0044-7447(2003)032[0058:IAPTBU]2.0.CO;2; *UNEP, 2003, WORLD DAT PROT AR; *UNEP CIESIN, 2004, AFR POP DISTR DAT; *UNEP INT CTR TROP, 2004, LAT AM POP DISTR DAT; *UNEP WCMC, 2003, PROT NAT DES PROT AR; UNPD, 2007, WORLD URB PROSP 2007	26	407	432	5	243	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2008	321	5885					123	126		10.1126/science.1158900	http://dx.doi.org/10.1126/science.1158900			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QE	18599788				2022-12-28	WOS:000257320800052
J	Greaves, SJ; Wrede, E; Goldberg, NT; Zhang, JY; Miller, DJ; Zare, RN				Greaves, Stuart J.; Wrede, Eckart; Goldberg, Noah T.; Zhang, Jianyang; Miller, Daniel J.; Zare, Richard N.			Vibrational excitation through tug-of-war inelastic collisions	NATURE			English	Article							DIFFERENTIAL CROSS-SECTIONS; HYDROGEN-EXCHANGE REACTION; ENERGY-TRANSFER; SCATTERING-AMPLITUDES; MOLECULAR-COLLISIONS; NEARSIDE-FARSIDE; RESONANCES; DYNAMICS; ATOMS; CO2	Vibrationally inelastic scattering is a fundamental collision process that converts some of the kinetic energy of the colliding partners into vibrational excitation(1,2). The conventional wisdom is that collisions with high impact parameters ( where the partners only 'graze' each other) are forward scattered and essentially elastic, whereas collisions with low impact parameters transfer a large amount of energy into vibrations and are mainly back scattered(3). Here we report experimental observations of exactly the opposite behaviour for the simplest and most studied of all neutral - neutral collisions: we find that the inelastic scattering process H + D-2 (nu = 0, j = 0, 2) --> H + D-2 (nu' = 3, j' = 0, 2, 4, 6, 8) leads dominantly to forward scattering (nu and j respectively refer to the vibrational and rotational quantum numbers of the D-2 molecule). Quasi- classical trajectory calculations show that the vibrational excitation is caused by extension, not compression, of the D - D bond through interaction with the passing H atom. However, the H - D interaction never becomes strong enough for capture of the H atom before it departs with diminished kinetic energy; that is, the inelastic scattering process is essentially a frustrated reaction in which the collision typically excites the outward- going half of the H - D - D symmetric stretch before the H - D-2 complex dissociates. We suggest that this 'tug of war' between H and D-2 is a new mechanism for vibrational excitation that should play a role in all neutral - neutral collisions where strong attraction can develop between the collision partners.	[Goldberg, Noah T.; Zhang, Jianyang; Miller, Daniel J.; Zare, Richard N.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Greaves, Stuart J.] Univ Bristol, Sch Chem, Laser Chem Spect & Dynam Grp, Bristol BS8 1TS, Avon, England; [Wrede, Eckart] Univ Durham, Dept Chem, Durham DH1 3LE, England	Stanford University; University of Bristol; Durham University	Zare, RN (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	zare@stanford.edu	Zare, Richard N./A-8410-2009; Greaves, Stuart/D-9213-2011; Wrede, Eckart/E-7366-2012	Greaves, Stuart/0000-0002-5238-7150; Wrede, Eckart/0000-0001-6773-8446; Zare, Richard/0000-0001-5266-4253; Goldberg, Noah/0000-0003-2029-7780				Allison TC, 2000, CHEM PHYS LETT, V327, P439, DOI 10.1016/S0009-2614(00)00885-X; Althorpe SC, 2002, NATURE, V416, P67, DOI 10.1038/416067a; Aoiz FJ, 2005, INT REV PHYS CHEM, V24, P119, DOI 10.1080/01442350500195659; Ayers JD, 2003, J CHEM PHYS, V119, P4662, DOI 10.1063/1.1595092; Boothroyd AI, 1996, J CHEM PHYS, V104, P7139, DOI 10.1063/1.471430; FAUBEL M, 1983, ADV ATOM MOL PHYS, V19, P345, DOI 10.1016/S0065-2199(08)60257-2; Fernandez-Alonso F, 2002, ANNU REV PHYS CHEM, V53, P67, DOI 10.1146/annurev.physchem.53.091001.094554; Fernandez-Alonso F, 2000, ANGEW CHEM INT EDIT, V39, P2748, DOI 10.1002/1521-3773(20000804)39:15<2748::AID-ANIE2748>3.3.CO;2-#; GIESE CF, 1974, PHYS REV A, V10, P2156, DOI 10.1103/PhysRevA.10.2156; Goldberg NT, 2008, J PHYS CHEM A, V112, P9266, DOI 10.1021/jp801187p; Goldberg NT, 2007, CHEM PHYS LETT, V433, P439, DOI 10.1016/j.cplett.2006.11.073; Greaves SJ, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2902972; Greaves SJ, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2902973; HEGE U, 1985, Z PHYS A-HADRON NUCL, V320, P95, DOI 10.1007/BF01411930; Koszinowski K, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2771157; Koszinowski K, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2217742; KRAJNOVICH DJ, 1987, CHEM REV, V87, P237, DOI 10.1021/cr00077a012; KREUTZ TG, 1990, J CHEM PHYS, V93, P452, DOI 10.1063/1.459544; LEVINE RD, 2005, MOL REACTION DYNAMIC, P376; MCBANE GC, 1991, J CHEM PHYS, V94, P1141, DOI 10.1063/1.460020; MILLER WH, 1971, ACCOUNTS CHEM RES, V4, P161, DOI 10.1021/ar50041a001; Monks PDD, 2007, J PHYS CHEM A, V111, P10302, DOI 10.1021/jp073334k; Monks PDD, 2006, J PHYS CHEM A, V110, P741, DOI 10.1021/jp0556254; OSBORN MK, 1984, CHEM PHYS, V91, P13, DOI 10.1016/0301-0104(84)80038-5; RAPP D, 1969, CHEM REV, V69, P61, DOI 10.1021/cr60257a003; SHAFER NE, 1993, CHEM PHYS LETT, V212, P155, DOI 10.1016/0009-2614(93)87124-L; WIGHT CA, 1985, J CHEM PHYS, V83, P660, DOI 10.1063/1.449534; Wrede E, 1999, J CHEM PHYS, V110, P9971, DOI 10.1063/1.478870	28	49	50	2	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 3	2008	454	7200					88	91		10.1038/nature07079	http://dx.doi.org/10.1038/nature07079			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321MC	18596807				2022-12-28	WOS:000257308300042
J	Mirvis, DM; Bloom, DE				Mirvis, David M.; Bloom, David E.			Population health and economic development in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Mirvis, David M.] Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA; [Bloom, David E.] Harvard Univ, Sch Publ Hlth, Dept Populat & Int Hlth, Boston, MA 02115 USA	University of Tennessee System; University of Tennessee Health Science Center; Harvard University; Harvard T.H. Chan School of Public Health	Mirvis, DM (corresponding author), Univ Tennessee, Ctr Hlth Sci, 66 N Pauline St,Ste 468, Memphis, TN 38163 USA.	dmirvis@utmem.edu						Alsan M, 2006, WORLD DEV, V34, P613, DOI 10.1016/j.worlddev.2005.09.006; Bhagava A, 2001, J HEALTH ECON, V20, P423, DOI 10.1016/S0167-6296(01)00073-X; Bhattacharya J, 2006, FORUM HLTH EC POLICY, V9; Bloom DE, 2000, SCIENCE, V287, P1207, DOI 10.1126/science.287.5456.1207; Bloom DE, 2003, SCAND J ECON, V105, P319, DOI 10.1111/1467-9442.t01-1-00001; Bloom DE, 1998, WORLD BANK ECON REV, V12, P419, DOI 10.1093/wber/12.3.419; Coffield AB, 2001, AM J PREV MED, V21, P1, DOI 10.1016/S0749-3797(01)00308-7; *COMM MACR HLTH, 2003, MACR HLTH INV HLTH E; CUTLER DM, 2001, HEALTH AFFAIR, V20, P11; GROSSMAN M, 1972, J POLIT ECON, V80, P223, DOI 10.1086/259880; Murphy K, 2003, PERSPECT BIOL MED, V46, pS108, DOI 10.1353/pbm.2003.0048; Murray CJL, 2006, PLOS MED, V3, P1513, DOI 10.1371/journal.pmed.0030260; Nordhaus W.D., 2002, HLTH NATIONS CONTRIB; Sala-i-Martin X, 2005, HEALTH AND ECONOMIC GROWTH: FINDINGS AND POLICY IMPLICATIONS, P95; Schroeder SA, 2007, NEW ENGL J MED, V357, P1221, DOI 10.1056/NEJMsa073350	15	7	7	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 2	2008	300	1					93	95		10.1001/jama.300.1.93	http://dx.doi.org/10.1001/jama.300.1.93			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320NW	18594044				2022-12-28	WOS:000257242800029
J	Koszul, R; Kim, KP; Prentiss, M; Kleckner, N; Kameoka, S				Koszul, R.; Kim, K. P.; Prentiss, M.; Kleckner, N.; Kameoka, S.			Meiotic chromosomes move by linkage to dynamic actin cables with transduction of force through the nuclear envelope	CELL			English	Article							BUDDING YEAST; SACCHAROMYCES-CEREVISIAE; BOUQUET FORMATION; FISSION YEAST; MEIOSIS; SYNAPSIS; PROPHASE; RECOMBINATION; ORGANIZATION; TRANSITION	Chromosome movement is prominent during meiosis. Here, using a combination of in vitro and in vivo approaches, we elucidate the basis for dynamic mid-prophase telomere-led chromosome motion in budding yeast. Diverse findings reveal a process in which, at the pachytene stage, individual telomere/nuclear envelope (NE) ensembles attach passively to, and then move in concert with, nucleus-hugging actin cables that are continuous with the global cytoskeletal actin network. Other chromosomes move in concert with lead chromosome(s). The same process, in modulated form, explains the zygotene "bouquet'' configuration in which, immediately preceding pachytene, chromosome ends colocalize dynamically in a restricted region of the NE. Mechanical properties of the system and biological roles of mid-prophase movement for meiosis, including recombination, are discussed.	[Koszul, R.; Kim, K. P.; Kleckner, N.; Kameoka, S.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Prentiss, M.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University; Harvard University	Kleckner, N (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	kleckner@fas.harvard.edu	Prentiss, Mara/AAU-2940-2021	Koszul, Romain/0000-0002-3086-1173; Kim, Keun/0000-0002-5973-8259	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025326, R01GM044794] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM025326-31, R01 GM025326, R01 GM025326-30, R01 GM-044794, R01 GM044794-14, R01 GM044794-17, R01 GM-025326, R01 GM025326-29, R01 GM044794-16, R01 GM044794-15, R01 GM044794-18, R01 GM044794, R01 GM025326-28, R01 GM025326-27] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agarwal S, 2000, CELL, V102, P245, DOI 10.1016/S0092-8674(00)00029-5; Almagro S, 2004, J BIOL CHEM, V279, P5118, DOI 10.1074/jbc.M307221200; Bass HW, 2003, CELL MOL LIFE SCI, V60, P2319, DOI 10.1007/s00018-003-3312-4; Belgareh N, 1997, J CELL BIOL, V136, P747, DOI 10.1083/jcb.136.4.747; Benjamin KR, 2003, GENE DEV, V17, P1524, DOI 10.1101/gad.1101503; Bishop DK, 2004, CELL, V117, P9, DOI 10.1016/S0092-8674(04)00297-1; BYERS B, 1975, P NATL ACAD SCI USA, V72, P5056, DOI 10.1073/pnas.72.12.5056; Chikashige Y, 2007, CHROMOSOMA, V116, P497, DOI 10.1007/s00412-007-0114-8; Conrad MN, 2008, CELL, V133, P1175, DOI 10.1016/j.cell.2008.04.047; Conrad MN, 2007, P NATL ACAD SCI USA, V104, P8863, DOI 10.1073/pnas.0606165104; Conrad MN, 1997, SCIENCE, V276, P1252, DOI 10.1126/science.276.5316.1252; Doi M., 1988, THEORY POLYM DYNAMIC; Fehrenbacher KL, 2004, CURR BIOL, V14, P1996, DOI 10.1016/j.cub.2004.11.004; Golubovskaya IN, 2002, GENETICS, V162, P1979; Harper L, 2004, J CELL SCI, V117, P4025, DOI 10.1242/jcs.01363; Heun P, 2001, J CELL BIOL, V152, P385, DOI 10.1083/jcb.152.2.385; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kleckner N, 2004, P NATL ACAD SCI USA, V101, P12592, DOI 10.1073/pnas.0402724101; KLECKNER N, 1993, COLD SPRING HARB SYM, V58, P553, DOI 10.1101/SQB.1993.058.01.062; KLEIN F, 1992, J CELL BIOL, V117, P935, DOI 10.1083/jcb.117.5.935; Kumaran RI, 2008, CELL, V132, P929, DOI 10.1016/j.cell.2008.03.004; MARKO JF, 1997, MOL BIOL CELL, V8, DOI UNSP 221722-221731; OTT A, 1993, PHYS REV E, V48, pR1642, DOI 10.1103/PhysRevE.48.R1642; PARVINEN M, 1976, NATURE, V260, P534, DOI 10.1038/260534a0; Poirier MG, 2003, CURR TOP DEV BIOL, V55, P75, DOI 10.1016/S0070-2153(03)01002-0; RASMUSSEN SW, 1986, CARLSBERG RES COMMUN, V51, P401, DOI 10.1007/BF02907315; Sage D, 2005, IEEE T IMAGE PROCESS, V14, P1372, DOI 10.1109/TIP.2005.852787; Scherthan H, 2007, CELL MOL LIFE SCI, V64, P117, DOI 10.1007/s00018-006-6463-2; SCHERTHAN H, 1994, J CELL BIOL, V127, P273, DOI 10.1083/jcb.127.2.273; Scherthan H, 2007, P NATL ACAD SCI USA, V104, P16934, DOI 10.1073/pnas.0704860104; Shaw SL, 1997, J CELL BIOL, V139, P985, DOI 10.1083/jcb.139.4.985; Taxis C, 2006, TRAFFIC, V7, P1628, DOI 10.1111/j.1600-0854.2006.00496.x; Trelles-Sticken E, 2000, J CELL BIOL, V151, P95, DOI 10.1083/jcb.151.1.95; Trelles-Sticken E, 2005, J CELL BIOL, V170, P213, DOI 10.1083/jcb.200501042; Yamamoto A, 1999, J CELL BIOL, V145, P1233, DOI 10.1083/jcb.145.6.1233; Yang HC, 2002, P NATL ACAD SCI USA, V99, P751, DOI 10.1073/pnas.022462899; Zickler D, 2006, CHROMOSOMA, V115, P158, DOI 10.1007/s00412-006-0048-6; Zickler D, 1998, ANNU REV GENET, V32, P619, DOI 10.1146/annurev.genet.32.1.619	39	150	151	1	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 27	2008	133	7					1188	1201		10.1016/j.cell.2008.04.050	http://dx.doi.org/10.1016/j.cell.2008.04.050			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	319DP	18585353	Green Accepted, Bronze			2022-12-28	WOS:000257144600016
J	Vyas, N; Goswami, D; Manonmani, A; Sharma, P; Ranganath, HA; VijayRaghavan, K; Shashidhara, LS; Sowdhamini, R; Mayor, S				Vyas, Neha; Goswami, Debanjan; Manonmani, A.; Sharma, Pranav; Ranganath, H. A.; VijayRaghavan, K.; Shashidhara, L. S.; Sowdhamini, R.; Mayor, Satyajit			Nanoscale organization of Hedgehog is essential for long-range signaling	CELL			English	Article							GPI-ANCHORED PROTEINS; SONIC HEDGEHOG; CHOLESTEROL MODIFICATION; LIPID MODIFICATIONS; DATA-BANK; DROSOPHILA; PALMITOYLATION; IDENTIFICATION; PROTEOGLYCANS; MICROSCOPY	Hedgehog (Hh) plays crucial roles in tissue-patterning and activates signaling in Patched (Ptc)-expressing cells. Paracrine signaling requires release and transport over many cell diameters away by a process that requires interaction with heparan sulfate proteoglycans (HSPGs). Here, we examine the organization of functional, fluorescently tagged variants in living cells by using optical imaging, FRET microscopy, and mutational studies guided by bioinformatics prediction. We find that cell-surface Hh forms suboptical oligomers, further concentrated in visible clusters colocalized with HSPGs. Mutation of a conserved Lys in a predicted Hh-protomer interaction interface results in an autocrine signaling-competent Hh isoform-incapable of forming dense nanoscale oligomers, interacting with HSPGs, or paracrine signaling. Thus, Hh exhibits a hierarchical organization from the nanoscale to visible clusters with distinct functions.	[Vyas, Neha; Goswami, Debanjan; Manonmani, A.; Sharma, Pranav; VijayRaghavan, K.; Sowdhamini, R.; Mayor, Satyajit] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore 560065, Karnataka, India; [Vyas, Neha; Ranganath, H. A.] Univ Mysore, Dept Studies Zool, Mysore 570006, Karnataka, India; [Shashidhara, L. S.] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); University of Mysore; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Mayor, S (corresponding author), Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bellary Rd, Bangalore 560065, Karnataka, India.	mayor@ncbs.res.in	Vyas, Neha/K-4015-2017	Vyas, Neha/0000-0002-8873-5751				Altman D, 2007, PLOS BIOL, V5, P1712, DOI 10.1371/journal.pbio.0050210; Ashe HL, 2006, DEVELOPMENT, V133, P385, DOI 10.1242/dev.02238; Bairoch A, 1996, NUCLEIC ACIDS RES, V24, P21, DOI 10.1093/nar/24.1.21; Bellaiche Y, 1998, NATURE, V394, P85, DOI 10.1038/27932; Berman HM, 2000, NAT STRUCT BIOL, V7, P957, DOI 10.1038/80734; Blair SS, 2003, DEVELOPMENT, V130, P5065, DOI 10.1242/dev.00774; Callejo A, 2006, DEVELOPMENT, V133, P471, DOI 10.1242/dev.02217; Chamoun Z, 2001, SCIENCE, V293, P2080, DOI 10.1126/science.1064437; Chen MH, 2004, GENE DEV, V18, P641, DOI 10.1101/gad.1185804; DasGupta R, 2005, SCIENCE, V308, P826, DOI 10.1126/science.1109374; De S, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-15; Dunbrack RL, 1997, FOLD DES, V2, pR27, DOI 10.1016/S1359-0278(97)00011-4; Eugster C, 2007, DEV CELL, V13, P57, DOI 10.1016/j.devcel.2007.04.019; Gallet A, 2006, DEVELOPMENT, V133, P407, DOI 10.1242/dev.02212; Gallet A, 2003, DEV CELL, V4, P191, DOI 10.1016/S1534-5807(03)00031-5; Gautier I, 2001, BIOPHYS J, V80, P3000, DOI 10.1016/S0006-3495(01)76265-0; Goetz JA, 2006, J BIOL CHEM, V281, P4087, DOI 10.1074/jbc.M511427200; HALL TMT, 1995, NATURE, V378, P212, DOI 10.1038/378212a0; Han C, 2004, DEVELOPMENT, V131, P601, DOI 10.1242/dev.00958; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Lu XW, 2006, GENE DEV, V20, P2539, DOI 10.1101/gad.1461306; Lum L, 2003, MOL CELL, V12, P1261, DOI 10.1016/S1097-2765(03)00426-X; Mann RK, 2004, ANNU REV BIOCHEM, V73, P891, DOI 10.1146/annurev.biochem.73.011303.073933; MAYOR S, 1995, MOL BIOL CELL, V6, P929, DOI 10.1091/mbc.6.7.929; Pallavi SK, 2005, J CELL SCI, V118, P3363, DOI 10.1242/jcs.02464; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; Phelps CB, 1998, METHODS, V14, P367, DOI 10.1006/meth.1998.0592; PORTER JA, 1995, NATURE, V374, P363, DOI 10.1038/374363a0; Porter JA, 1996, CELL, V86, P21, DOI 10.1016/S0092-8674(00)80074-4; Rao M, 2005, BBA-MOL CELL RES, V1746, P221, DOI 10.1016/j.bbamcr.2005.08.002; Rubin JB, 2002, DEVELOPMENT, V129, P2223; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Strigini M, 1997, DEVELOPMENT, V124, P4697; Tabata T, 2004, DEVELOPMENT, V131, P703, DOI 10.1242/dev.01043; Torroja C, 2005, J NEUROBIOL, V64, P334, DOI 10.1002/neu.20168; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; Zeng X, 2001, NATURE, V411, P716, DOI 10.1038/35079648; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976	39	114	114	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 27	2008	133	7					1214	1227		10.1016/j.cell.2008.05.026	http://dx.doi.org/10.1016/j.cell.2008.05.026			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	319DP	18585355	Bronze			2022-12-28	WOS:000257144600018
J	Lassen, MR; Ageno, W; Borris, LC; Lieberman, JR; Rosencher, N; Bandel, TJ; Misselwitz, F; Turpie, AGG				Lassen, Michael R.; Ageno, Walter; Borris, Lars C.; Lieberman, Jay R.; Rosencher, Nadia; Bandel, Tiemo J.; Misselwitz, Frank; Turpie, Alexander G. G.		RECORD3 Investigators	Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FACTOR-XA INHIBITOR; TOTAL HIP-REPLACEMENT; DEEP-VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM; DOUBLE-BLIND; PARALLEL-GROUP; DOSE-RESPONSE; BAY 59-7939; PREVENTION; BAY-59-7939	Background: We investigated the efficacy of rivaroxaban, an orally active direct factor Xa inhibitor, in preventing venous thrombosis after total knee arthroplasty. Methods: In this randomized, double-blind trial, 2531 patients who were to undergo total knee arthroplasty received either oral rivaroxaban, 10 mg once daily, beginning 6 to 8 hours after surgery, or subcutaneous enoxaparin, 40 mg once daily, beginning 12 hours before surgery. The primary efficacy outcome was the composite of any deep-vein thrombosis, nonfatal pulmonary embolism, or death from any cause within 13 to 17 days after surgery. Secondary efficacy outcomes included major venous thromboembolism (i.e., proximal deep-vein thrombosis, nonfatal pulmonary embolism, or death related to venous thromboembolism) and symptomatic venous thromboembolism. The primary safety outcome was major bleeding. Results: The primary efficacy outcome occurred in 79 of 824 patients (9.6%) who received rivaroxaban and in 166 of 878 (18.9%) who received enoxaparin (absolute risk reduction, 9.2%; 95% confidence interval [CI], 5.9 to 12.4; P<0.001). Major venous thromboembolism occurred in 9 of 908 patients (1.0%) given rivaroxaban and 24 of 925 (2.6%) given enoxaparin (absolute risk reduction, 1.6%; 95% CI, 0.4 to 2.8; P=0.01). Symptomatic events occurred less frequently with rivaroxaban than with enoxaparin (P=0.005). Major bleeding occurred in 0.6% of patients in the rivaroxaban group and 0.5% of patients in the enoxaparin group. The incidence of drug-related adverse events, mainly gastrointestinal, was 12.0% in the rivaroxaban group and 13.0% in the enoxaparin group. Conclusions: Rivaroxaban was superior to enoxaparin for thromboprophylaxis after total knee arthroplasty, with similar rates of bleeding. (ClinicalTrials.gov number, NCT00361894.).	[Lassen, Michael R.] Nordsjaellands Hosp, Dept Orthoped Surg, DK-2970 Horsholm, Denmark; [Ageno, Walter] Univ Insubria, Varese, Italy; [Borris, Lars C.] Aarhus Univ Hosp, DK-8000 Aarhus, Denmark; [Lieberman, Jay R.] Univ Connecticut, Ctr Hlth, Dept Orthopaed Surg, Farmington, CT USA; [Rosencher, Nadia] Paris Descartes Univ, Cochin Hosp, Paris, France; [Bandel, Tiemo J.; Misselwitz, Frank] Bayer HealthCare, Wuppertal, Germany; [Turpie, Alexander G. G.] McMaster Univ, Hamilton, ON, Canada	University of Insubria; Aarhus University; University of Connecticut; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Bayer AG; Bayer Healthcare Pharmaceuticals; McMaster University	Lassen, MR (corresponding author), Nordsjaellands Hosp, Dept Orthoped Surg, Usserd Kongevej 102, DK-2970 Horsholm, Denmark.	mirula@noh.regionh.dk	Flondell, Magnus/AAB-9565-2020; Rosencher, Nadia/AAS-3888-2020	Flondell, Magnus/0000-0003-4215-4561; ageno, walter/0000-0002-1922-8879; Gomar-Sancho, Francisco/0000-0001-7672-1291; Borris, Lars/0000-0002-0527-1518; Windhager, Reinhard/0000-0002-6321-1804				Agnelli G, 2007, CIRCULATION, V116, P180, DOI 10.1161/CIRCULATIONAHA.106.668020; Bauer KA, 2001, NEW ENGL J MED, V345, P1305, DOI 10.1056/NEJMoa011099; Colwell CW, 2005, J BONE JOINT SURG AM, V87A, P2169, DOI 10.2106/JBJS.D.02184; Comp PC, 2001, J BONE JOINT SURG AM, V83A, P336, DOI 10.2106/00004623-200103000-00004; Eriksson BI, 2007, THROMB RES, V120, P685, DOI 10.1016/j.thromres.2006.12.025; Eriksson BI, 2007, LANCET, V370, P949, DOI 10.1016/S0140-6736(07)61445-7; Eriksson BI, 2006, CIRCULATION, V114, P2374, DOI 10.1161/CIRCULATIONAHA.106.642074; Eriksson BI, 2006, J THROMB HAEMOST, V4, P121, DOI 10.1111/j.1538-7836.2005.01657.x; Francis CW, 2003, NEW ENGL J MED, V349, P1703, DOI 10.1056/NEJMoa035162; FRIEDMAN RJ, 2007, J THROMB HAEMOST S1, V5; Geerts WH, 2004, CHEST, V126, p338S, DOI 10.1378/chest.126.3_suppl.338S; Heit JA, 2001, ARCH INTERN MED, V161, P2215, DOI 10.1001/archinte.161.18.2215; Hermans C, 2006, CURR MED RES OPIN, V22, P471, DOI 10.1185/030079906X89801; Lassen MR, 2006, BLOOD, V108, p173A, DOI 10.1182/blood.V108.11.574.574; Lassen MR, 2003, BLOOD, V102, p15A; Perzborn E, 2005, J THROMB HAEMOST, V3, P514, DOI 10.1111/j.1538-7836.2005.01166.x; RABINOV K, 1972, ARCH SURG-CHICAGO, V104, P134; Turpie AGG, 2005, J THROMB HAEMOST, V3, P2479, DOI 10.1111/j.1538-7836.2005.01602.x; Turpie AGG, 2002, ARCH INTERN MED, V162, P1833, DOI 10.1001/archinte.162.16.1833; Turpie AGG, 2007, ARTERIOSCL THROM VAS, V27, P1238, DOI 10.1161/ATVBAHA.107.139402	20	992	1080	1	79	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 26	2008	358	26					2776	2786		10.1056/NEJMoa076016	http://dx.doi.org/10.1056/NEJMoa076016			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	317UO	18579812	Green Published			2022-12-28	WOS:000257045900004
J	Bowles, S				Bowles, Samuel			Policies designed for self-interested citizens may undermine "the moral sentiments": Evidence from economic experiments	SCIENCE			English	Review							INTRINSIC MOTIVATION; HUMAN ALTRUISM; HIDDEN COSTS; PREFERENCES; INCENTIVES; SOCIETIES; FAIRNESS; REWARDS; GAMES	High- performance organizations and economies work on the basis not only of material interests but also of Adam Smith's "moral sentiments." Well- designed laws and public policies can harness self- interest for the common good. However, incentives that appeal to self- interest may fail when they undermine the moral values that lead people to act altruistically or in other public- spirited ways. Behavioral experiments reviewed here suggest that economic incentives may be counterproductive when they signal that selfishness is an appropriate response; constitute a learning environment through which over time people come to adopt more self- interested motivations; compromise the individual's sense of self- determination and thereby degrade intrinsic motivations; or convey a message of distrust, disrespect, and unfair intent. Many of these unintended effects of incentives occur because people act not only to acquire economic goods and services but also to constitute themselves as dignified, autonomous, and moral individuals. Good organizational and institutional design can channel the material interests for the achievement of social goals while also enhancing the contribution of the moral sentiments to the same ends.	[Bowles, Samuel] Santa Fe Inst, Santa Fe, NM 87501 USA; [Bowles, Samuel] Univ Siena, Dipartimento Econ Polit, Siena, Italy	The Santa Fe Institute; University of Siena	Bowles, S (corresponding author), Santa Fe Inst, 1399 Hyde Park Rd, Santa Fe, NM 87501 USA.	samuel.bowles@gmail.com						Andreoni J, 1998, J ECON LIT, V36, P818; [Anonymous], 1971, FRONT QUANT EC; Benabou R, 2003, REV ECON STUD, V70, P489, DOI 10.1111/1467-937X.00253; Benabou R, 2006, AM ECON REV, V96, P1652, DOI 10.1257/aer.96.5.1652; Bewley T. F., 1999, WHY WAGES DONT FALL; Bowles S, 1998, J ECON LIT, V36, P75; Bowles S., 2004, ROUNDTABLE SER BEHAV; BOWLES S, 2008, J PUBLIC ECON, V92, P8; Brown M, 2004, ECONOMETRICA, V72, P747, DOI 10.1111/j.1468-0262.2004.00511.x; Cameron J, 2001, BEHAV ANALYST, V24, P1; Cardenas JC, 2000, WORLD DEV, V28, P1719, DOI 10.1016/S0305-750X(00)00055-3; Deci E., 1975, INTRINSIC MOTIVATION; Deci EL, 1999, PSYCHOL BULL, V125, P627, DOI 10.1037/0033-2909.125.6.627; Falk A, 2006, AM ECON REV, V96, P1611, DOI 10.1257/aer.96.5.1611; Falkinger J, 2000, AM ECON REV, V90, P247, DOI 10.1257/aer.90.1.247; Fehr E, 2000, J ECON PERSPECT, V14, P159, DOI 10.1257/jep.14.3.159; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 2003, NATURE, V422, P137, DOI 10.1038/nature01474; Fehr E, 2002, EUR ECON REV, V46, P687, DOI 10.1016/S0014-2921(01)00208-2; Frey BS, 1997, ECON J, V107, P1043, DOI 10.1111/1468-0297.00205; Frey BS, 2001, J ECON SURV, V15, P589, DOI 10.1111/1467-6419.00150; GAUTHEIR D, 1986, MORALS AGREEMENT, P93; Gintis H., 2005, MORAL SENTIMENTS MAT; Gneezy U, 2000, J LEGAL STUD, V29, P1, DOI 10.1086/468061; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; HIRSCHMAN ALBERT O., 1985, ECON PHILOS, V1, P7, DOI DOI 10.1017/S0266267100001863; HOFFMAN E, 1994, GAME ECON BEHAV, V7, P346, DOI 10.1006/game.1994.1056; HOPFENSITZ A, 2006, 050751 TINB I; HUME D, 1898, D HUME PHILOS WORKS, P117; HURWICZ L, 1989, EC I DYNAMIC SOC SEA; Laffont J.-J., 1982, ADV EC THEORY, P31; MELLSTROM C, 2008, J EUR ECON ASSOC, V6, P4; Rosenthal Elisabeth, 2008, NY TIMES        0202; Schotter A, 1996, J ECON BEHAV ORGAN, V31, P37, DOI 10.1016/S0167-2681(96)00863-3; Shinada M, 2007, EVOL HUM BEHAV, V28, P330, DOI 10.1016/j.evolhumbehav.2007.04.001; Sliwka D, 2007, AM ECON REV, V97, P999, DOI 10.1257/aer.97.3.999; Titmuss R., 1971, GIFT RELATIONSHIP HU; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683	39	411	421	9	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2008	320	5883					1605	1609		10.1126/science.1152110	http://dx.doi.org/10.1126/science.1152110			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	315NM	18566278				2022-12-28	WOS:000256886700038
J	Larrick, RP; Soll, JB				Larrick, Richard P.; Soll, Jack B.			Economics - The MPG illusion	SCIENCE			English	Editorial Material							RISK		[Larrick, Richard P.] Duke Univ, Fuqua Sch Business, Durham, NC 27708 USA	Duke University	Larrick, RP (corresponding author), Duke Univ, Fuqua Sch Business, Durham, NC 27708 USA.	larrick@duke.edu	Larrick, Richard P/B-8944-2011	Larrick, Richard P/0000-0002-0491-426X				Baron J, 2004, J PUBLIC POLICY MARK, V23, P7, DOI 10.1509/jppm.23.1.7.30397; Baron J, 1997, J RISK UNCERTAINTY, V14, P301, DOI 10.1023/A:1007796310463; Heath C, 1999, COGNITIVE PSYCHOL, V38, P79, DOI 10.1006/cogp.1998.0708; Hsee CK, 2003, J CONSUM RES, V30, P1, DOI 10.1086/374702; Kahneman D., 2011, THINKING FAST SLOW; KITMAN JL, 2006, NY TIMES        0406, P12; KLAYMAN J, 1993, COGNITION, V49, P97, DOI 10.1016/0010-0277(93)90037-V; Payne JW, 1999, J RISK UNCERTAINTY, V19, P243, DOI 10.1023/A:1007843931054; Sterman JD, 2007, CLIMATIC CHANGE, V80, P213, DOI 10.1007/s10584-006-9107-5; Sunstein C. R., 2008, NUDGE; Tenbrunsel AE, 2000, ACAD MANAGE J, V43, P854, DOI 10.2307/1556414; Weber EU, 2006, CLIMATIC CHANGE, V77, P103, DOI 10.1007/s10584-006-9060-3	12	198	200	2	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 20	2008	320	5883					1593	1594		10.1126/science.1154983	http://dx.doi.org/10.1126/science.1154983			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	315NM	18566271				2022-12-28	WOS:000256886700030
J	Teng, FZ; Dauphas, N; Helz, RT				Teng, Fang-Zhen; Dauphas, Nicolas; Helz, Rosalind T.			Iron isotope fractionation during magmatic differentiation in Kilauea Iki Lava Lake	SCIENCE			English	Article							FE ISOTOPES; EXPERIMENTAL CALIBRATION; BASALT DIFFERENTIATION; OXYGEN FUGACITY; ICP-MS; MANTLE; MELT; MINERALS	Magmatic differentiation helps produce the chemical and petrographic diversity of terrestrial rocks. The extent to which magmatic differentiation fractionates nonradiogenic isotopes is uncertain for some elements. We report analyses of iron isotopes in basalts from Kilauea Iki lava lake, Hawaii. The iron isotopic compositions ((56)Fe/(54)Fe) of late- stage melt veins are 0.2 per mil (parts per thousand) greater than values for olivine cumulates. Olivine phenocrysts are up to 1.2 parts per thousand lighter than those of whole rocks. These results demonstrate that iron isotopes fractionate during magmatic differentiation at both whole- rock and crystal scales. This characteristic of iron relative to the characteristics of magnesium and lithium, for which no fractionation has been found, may be related to its complex redox chemistry in magmatic systems and makes iron a potential tool for studying planetary differentiation.	[Teng, Fang-Zhen; Dauphas, Nicolas] Univ Chicago, Origins Lab, Dept Geophys Sci, Chicago, IL 60637 USA; [Teng, Fang-Zhen; Dauphas, Nicolas] Univ Chicago, Enrico Fermi Inst, Chicago, IL 60637 USA; [Helz, Rosalind T.] US Geol Survey, Reston, VA 20192 USA	University of Chicago; University of Chicago; United States Department of the Interior; United States Geological Survey	Teng, FZ (corresponding author), Univ Arkansas, Isotope Lab, Dept Geosci, 113 Ozark Hall, Fayetteville, AR 72701 USA.	fteng@uark.edu	Teng, Fang-Zhen/F-6420-2010; Dauphas, Nicolas/E-4568-2011; Teng, Fangzhen/C-7006-2018	Teng, Fangzhen/0000-0003-3415-6137				Anbar AD, 2000, SCIENCE, V288, P126, DOI 10.1126/science.288.5463.126; Beard BL, 2003, CHEM GEOL, V195, P87, DOI 10.1016/S0009-2541(02)00390-X; Dauphas N, 2006, MASS SPECTROM REV, V25, P515, DOI 10.1002/mas.20078; Helz R. T., 1987, MAGMATIC PROCESSES P, V1, P241; HELZ RT, 1989, GEOL SOC AM BULL, V101, P578, DOI 10.1130/0016-7606(1989)101<0578:DTOMIK>2.3.CO;2; Helz RT., 1987, B VOLCANOL, V49, P651, DOI [10.1007/BF01080357, DOI 10.1007/BF01080357]; HELZ RT, 1987, US GEOL SURV PROF PA, V1350, P691; HELZ RT, 1994, 94684 US GEOL SURV, P1; Huang F, 2007, GEOCHIM COSMOCHIM AC, V71, pA422; JAMBON A, 1980, GEOCHIM COSMOCHIM AC, V44, P1373, DOI 10.1016/0016-7037(80)90096-4; Poitrasson F, 2004, EARTH PLANET SC LETT, V223, P253, DOI 10.1016/j.epsl.2004.04.032; Poitrasson F, 2005, CHEM GEOL, V222, P132, DOI 10.1016/j.chemgeo.2005.07.005; Polyakov VB, 2007, GEOCHIM COSMOCHIM AC, V71, P3833, DOI 10.1016/j.gca.2007.05.019; Richter D.H., 1970, 537E USGS, P1; Richter FM, 2008, GEOCHIM COSMOCHIM AC, V72, P206, DOI 10.1016/j.gca.2007.10.016; Richter FM, 2007, GEOCHIM COSMOCHIM AC, V71, pA839; Schauble EA, 2004, REV MINERAL GEOCHEM, V55, P65, DOI 10.2138/gsrmg.55.1.65; Schoenberg R, 2006, EARTH PLANET SC LETT, V252, P342, DOI 10.1016/j.epsl.2006.09.045; Schuessler JA, 2007, GEOCHIM COSMOCHIM AC, V71, P417, DOI 10.1016/j.gca.2006.09.012; Shahar A, 2008, EARTH PLANET SC LETT, V268, P330, DOI 10.1016/j.epsl.2008.01.026; Teng FZ, 2007, EARTH PLANET SC LETT, V261, P84, DOI 10.1016/j.epsl.2007.06.004; Tomascak PB, 1999, GEOCHIM COSMOCHIM AC, V63, P907, DOI 10.1016/S0016-7037(98)00318-4; UREY HC, 1947, J CHEM SOC, P562, DOI 10.1039/jr9470000562; Weyer S, 2007, EARTH PLANET SC LETT, V259, P119, DOI 10.1016/j.epsl.2007.04.033; Williams HM, 2004, SCIENCE, V304, P1656, DOI 10.1126/science.1095679; Williams HM, 2005, EARTH PLANET SC LETT, V235, P435, DOI 10.1016/j.epsl.2005.04.020	26	225	236	3	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 20	2008	320	5883					1620	1622		10.1126/science.1157166	http://dx.doi.org/10.1126/science.1157166			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	315NM	18566283	Green Submitted			2022-12-28	WOS:000256886700043
J	Tammela, T; Zarkada, G; Wallgard, E; Murtomaki, A; Suchting, S; Wirzenius, M; Waltari, M; Hellstrom, M; Schomber, T; Peltonen, R; Freitas, C; Duarte, A; Isoniemi, H; Laakkonen, P; Christofori, G; Yla-Herttuala, S; Shibuya, M; Pytowski, B; Eichmann, A; Betsholtz, C; Alitalo, K				Tammela, Tuomas; Zarkada, Georgia; Wallgard, Elisabet; Murtomaki, Aino; Suchting, Steven; Wirzenius, Maria; Waltari, Marika; Hellstrom, Mats; Schomber, Tibor; Peltonen, Reetta; Freitas, Catarina; Duarte, Antonio; Isoniemi, Helena; Laakkonen, Pirjo; Christofori, Gerhard; Yla-Herttuala, Seppo; Shibuya, Masabumi; Pytowski, Bronislaw; Eichmann, Anne; Betsholtz, Christer; Alitalo, Kari			Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation	NATURE			English	Article							GROWTH-FACTOR RECEPTOR-3; INHIBITS TUMOR-GROWTH; ENDOTHELIAL-CELLS; FACTOR-C; LYMPHATIC ENDOTHELIUM; LYMPHANGIOGENESIS; EXPRESSION; MOUSE; MICE; CANCER	Angiogenesis, the growth of new blood vessels from pre- existing vasculature, is a key process in several pathological conditions, including tumour growth and age- related macular degeneration(1). Vascular endothelial growth factors ( VEGFs) stimulate angiogenesis and lymphangiogenesis by activating VEGF receptor ( VEGFR) tyrosine kinases in endothelial cells(2). VEGFR- 3 ( also known as FLT- 4) is present in all endothelia during development, and in the adult it becomes restricted to the lymphatic endothelium(3). However, VEGFR- 3 is upregulated in the microvasculature of tumours and wounds(4,5). Here we demonstrate that VEGFR- 3 is highly expressed in angiogenic sprouts, and genetic targeting of VEGFR- 3 or blocking of VEGFR- 3 signalling with monoclonal antibodies results in decreased sprouting, vascular density, vessel branching and endothelial cell proliferation in mouse angiogenesis models. Stimulation of VEGFR- 3 augmented VEGF- induced angiogenesis and sustained angiogenesis even in the presence of VEGFR- 2 ( also known as KDR or FLK- 1) inhibitors, whereas antibodies against VEGFR- 3 and VEGFR- 2 in combination resulted in additive inhibition of angiogenesis and tumour growth. Furthermore, genetic or pharmacological disruption of the Notch signalling pathway led to widespread endothelial VEGFR- 3 expression and excessive sprouting, which was inhibited by blocking VEGFR- 3 signals. Our results implicate VEGFR- 3 as a regulator of vascular network formation. Targeting VEGFR- 3 may provide additional efficacy for anti- angiogenic therapies, especially towards vessels that are resistant to VEGF or VEGFR- 2 inhibitors.	[Tammela, Tuomas; Zarkada, Georgia; Murtomaki, Aino; Wirzenius, Maria; Waltari, Marika; Laakkonen, Pirjo; Alitalo, Kari] Univ Helsinki, Lab Mol Canc Biol, FIN-00014 Helsinki, Finland; [Tammela, Tuomas; Zarkada, Georgia; Murtomaki, Aino; Wirzenius, Maria; Waltari, Marika; Laakkonen, Pirjo; Alitalo, Kari] Univ Helsinki, Ludwig Inst Canc Res, Biomedicum Helsinki, FIN-00014 Helsinki, Finland; [Tammela, Tuomas; Zarkada, Georgia; Murtomaki, Aino; Wirzenius, Maria; Waltari, Marika; Laakkonen, Pirjo; Alitalo, Kari] Univ Helsinki, Haartman Inst, FIN-00014 Helsinki, Finland; [Wallgard, Elisabet; Hellstrom, Mats; Betsholtz, Christer] Karolinska Inst, Div Matrix Biol, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; [Suchting, Steven; Freitas, Catarina; Eichmann, Anne] Coll France, INSERM, U833, F-75005 Paris, France; [Schomber, Tibor; Christofori, Gerhard] Univ Basel, Ctr Biomed, Dept Clin Biol Sci, CH-4058 Basel, Switzerland; [Peltonen, Reetta; Isoniemi, Helena] Univ Helsinki, Cent Hosp, Dept Transplantat & Hepat Surg, Helsinki 00029, Finland; [Duarte, Antonio] Univ Tecn Lisbon, Fac Vet Med, Interdisciplinary Ctr Res Anim Hlth CIISA, P-1300474 Lisbon, Portugal; [Yla-Herttuala, Seppo] Univ Kuopio, AI Virtanen Inst, FIN-70211 Kuopio, Finland; [Shibuya, Masabumi] Tokyo Med & Dent Univ, Dept Mol Oncol, Bunkyo Ku, Tokyo 1138519, Japan; [Pytowski, Bronislaw] ImClone Syst, New York, NY 10014 USA	University of Helsinki; Ludwig Institute for Cancer Research; University of Helsinki; University of Helsinki; Karolinska Institutet; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; University of Basel; University of Helsinki; Helsinki University Central Hospital; Universidade de Lisboa; University of Eastern Finland; Tokyo Medical & Dental University (TMDU); Eli Lilly	Alitalo, K (corresponding author), Univ Helsinki, Lab Mol Canc Biol, POB 63,Haartmaninkatu 8, FIN-00014 Helsinki, Finland.	kari.alitalo@helsinki.fi	Duarte, Antonio/V-1178-2018; Alitalo, Kari K/J-5013-2014; Freitas, Catarina M/A-2555-2017	Duarte, Antonio/0000-0002-9255-3635; Alitalo, Kari K/0000-0002-7331-0902; Freitas, Catarina M/0000-0002-3393-5326; /0000-0003-3675-6961; Laakkonen, Pirjo/0000-0002-9620-095X; Hellstrom, Mats/0000-0002-7088-9533; Yla-Herttuala, Seppo/0000-0001-7593-2708	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075183] Funding Source: NIH RePORTER; NHLBI NIH HHS [5 R01 HL075183-02] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alitalo K, 2005, NATURE, V438, P946, DOI 10.1038/nature04480; Baldwin ME, 2001, J BIOL CHEM, V276, P19166, DOI 10.1074/jbc.M100097200; Baluk P, 2005, J CLIN INVEST, V115, P247, DOI 10.1172/JCI200522037; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Covassin LD, 2006, P NATL ACAD SCI USA, V103, P6554, DOI 10.1073/pnas.0506886103; Dixelius J, 2003, J BIOL CHEM, V278, P40973, DOI 10.1074/jbc.M304499200; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Duarte A, 2004, GENE DEV, V18, P2474, DOI 10.1101/gad.1239004; Dumont DJ, 1998, SCIENCE, V282, P946, DOI 10.1126/science.282.5390.946; Enholm B, 2001, CIRC RES, V88, P623, DOI 10.1161/01.RES.88.6.623; Esni F, 1999, J CELL BIOL, V144, P325, DOI 10.1083/jcb.144.2.325; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Gille H, 2001, J BIOL CHEM, V276, P3222, DOI 10.1074/jbc.M002016200; Goldman J, 2007, FASEB J, V21, P1003, DOI 10.1096/fj.06-6656com; HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Jussila L, 1998, CANCER RES, V58, P1599; KAIPAINEN A, 1995, P NATL ACAD SCI USA, V92, P3566, DOI 10.1073/pnas.92.8.3566; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; Karpanen T, 2001, CANCER RES, V61, P1786; Karpanen T, 2006, AM J PATHOL, V169, P708, DOI 10.2353/ajpath.2006.051200; Kiba A, 2003, BIOCHEM BIOPH RES CO, V301, P371, DOI 10.1016/S0006-291X(02)03033-4; Kozaki K, 2000, CANCER RES, V60, P2535; Kriehuber E, 2001, J EXP MED, V194, P797, DOI 10.1084/jem.194.6.797; Laakkonen P, 2007, CANCER RES, V67, P593, DOI 10.1158/0008-5472.CAN-06-3567; Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104; Makinen T, 2001, NAT MED, V7, P199, DOI 10.1038/84651; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Paavonen K, 2000, AM J PATHOL, V156, P1499, DOI 10.1016/S0002-9440(10)65021-3; Prewett M, 1999, CANCER RES, V59, P5209; Pytowski B, 2005, JNCI-J NATL CANCER I, V97, P14, DOI 10.1093/jnci/dji003; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Roca C, 2007, GENE DEV, V21, P2511, DOI 10.1101/gad.1589207; Saaristo A, 2002, J EXP MED, V196, P719, DOI 10.1084/jem.20020587; SAKAI K, 1987, J NATL CANCER I, V79, P923; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Shawber CJ, 2007, J CLIN INVEST, V117, P3369, DOI 10.1172/JCI24311; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Stacker SA, 2002, NAT REV CANCER, V2, P573, DOI 10.1038/nrc863; Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104; Tammela T, 2005, BLOOD, V105, P4642, DOI 10.1182/blood-2004-08-3327; Valtola R, 1999, AM J PATHOL, V154, P1381, DOI 10.1016/S0002-9440(10)65392-8; Veikkola T, 2003, FASEB J, V17, P2006, DOI 10.1096/fj.03-0179com; Weijzen S, 2002, J IMMUNOL, V169, P4273, DOI 10.4049/jimmunol.169.8.4273; Wirzenius M, 2007, J EXP MED, V204, P1431, DOI 10.1084/jem.20062642; Zheng YJ, 2006, ARTERIOSCL THROM VAS, V26, P2019, DOI 10.1161/01.ATV.0000233336.53574.a1	50	614	640	1	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 31	2008	454	7204					656	U68		10.1038/nature07083	http://dx.doi.org/10.1038/nature07083			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	331QC	18594512				2022-12-28	WOS:000258026500051
J	Smith, AD; Bradley, DJ; Smith, V; Blaze, M; Behrens, RH; Chiodini, PL; Whitty, CJM				Smith, Adrian D.; Bradley, David J.; Smith, Valerie; Blaze, Marie; Behrens, Ron H.; Chiodini, Peter L.; Whitty, Christopher J. M.			Imported malaria and high risk groups: observational study using UK surveillance data 1987-2006	BRITISH MEDICAL JOURNAL			English	Article							FALCIPARUM-MALARIA; TRAVELERS; PROPHYLAXIS; CHEMOPROPHYLAXIS; PREVENTION; KNOWLEDGE; COUNTRIES; MIGRANTS; FEATURES; DISEASE	Objective To examine temporal, geographic, and sociodemographic trends in case reporting and case fatality of malaria in the United Kingdom. Setting National malaria reference laboratory surveillance data in the UK. Design Observational study using prospectively gathered surveillance data and data on destinations from the international passenger survey. Participants 39 300 cases of proved malaria in the UK between 1987 and 2006. Main outcome measures Plasmodium species; sociodemographic details (including age, sex, and country of birth and residence); mortality; destination, duration, and purpose of international travel; and use of chemoprophylaxis. Results Reported cases of imported malaria increased significantly over the 20 years of the study; an increasing proportion was attributable to Plasmodium falciparum (P falciparum/P vivax reporting ratio 1.3:1 in 1987-91 and 5.4:1 in 2002-6). P vivax reports declined from 3954 in 1987-91 to 1244 in 2002-6. Case fatality of reported P falciparum malaria did not change over this period (7.4 deaths per 1000 reported cases). Travellers visiting friends and relatives, usually in a country in Africa or Asia from which members of their family migrated, accounted for 13 215/20 488 (64.5%) of all malaria reported, and reports were geographically concentrated in areas where migrants from Africa and South Asia to the UK have settled. People travelling for this purpose were at significantly higher risk of malaria than other travellers and were less likely to report the use of any chemoprophylaxis (odds ratio of reported chemoprophylaxis use 0.23, 95% confidence interval 0.21 to 0.25). Conclusions Despite the availability of highly effective preventive measures, the preventable burden from falciparum malaria has steadily increased in the UK while vivax malaria has decreased. Provision of targeted and appropriately delivered preventive messages and services for travellers from migrant families visiting friends and relatives should be a priority.	[Smith, Adrian D.; Bradley, David J.; Smith, Valerie; Blaze, Marie; Chiodini, Peter L.; Whitty, Christopher J. M.] London Sch Hyg & Trop Med, HPA Malaria Reference Lab, London WC1E 6AU, England; [Bradley, David J.; Behrens, Ron H.; Chiodini, Peter L.; Whitty, Christopher J. M.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 6AU, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Smith, AD (corresponding author), Univ Oxford, Div Publ Hlth & Primary Care, Oxford OX3 7LF, England.	adrian.smith@dphpc.ox.ac.uk	Smith, Adrian D/A-6336-2009; Whitty, Christopher/C-7740-2012	Whitty, Christopher/0000-0002-6076-5027; Smith, Adrian/0000-0003-0036-1490; Behrens, Ron/0000-0002-8166-2633				Angell SY, 2005, INFECT DIS CLIN N AM, V19, P49, DOI 10.1016/j.idc.2004.11.001; Badrinath P, 1998, BRIT MED J, V316, P1746, DOI 10.1136/bmj.316.7146.1746a; Behrens RH, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-7; Behrens RH, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-114; Bouchaud O, 2005, AM J TROP MED HYG, V72, P21, DOI 10.4269/ajtmh.2005.72.21; Bunn A, 2004, QJM-INT J MED, V97, P645, DOI 10.1093/qjmed/hch113; Casalino E, 2002, ARCH INTERN MED, V162, P1625, DOI 10.1001/archinte.162.14.1625; Chiodini P, 2007, GUIDELINES MALARIA P; DAVIDSON RN, 1993, J INFECTION, V26, P348, DOI 10.1016/0163-4453(93)96241-H; dos Santos CC, 1999, CAN MED ASSOC J, V160, P195; Evans MR, 1996, BRIT MED J, V313, P1554, DOI 10.1136/bmj.313.7071.1554b; General Register Office for Scotland, POP INF STAT; Jelinek T, 2002, CLIN INFECT DIS, V34, P572, DOI 10.1086/338235; Leonard L, 2001, J Immigr Health, V3, P31, DOI 10.1023/A:1026610602073; Matteelli A, 1999, TROP MED INT HEALTH, V4, P653, DOI 10.1046/j.1365-3156.1999.00468.x; Moore DAJ, 2004, T ROY SOC TROP MED H, V98, P55, DOI 10.1016/S0035-9203(03)00007-5; Morgan M, 2005, ETHNIC HEALTH, V10, P355, DOI 10.1080/13557850500242035; *NO IR STAT RES AG, PUBL POP MIGR; Office for National Statistics, INT PASS SURV; PHILLIPSHOWARD PA, 1990, BMJ-BRIT MED J, V300, P499, DOI 10.1136/bmj.300.6723.499; Pistone T, 2007, T ROY SOC TROP MED H, V101, P990, DOI 10.1016/j.trstmh.2007.05.009; Reid AJC, 1998, BRIT MED J, V317, P1506, DOI 10.1136/bmj.317.7171.1506; *RES GROUP IMP INF, 2005, TROPNETEUROP SENT SU; Robinson P, 2001, J TRAVEL MED, V8, P76, DOI 10.2310/7060.2001.24309; Schlagenhauf P, 2003, J TRAVEL MED, V10, P106, DOI 10.2310/7060.2003.31764; Scolari C, 2002, J TRAVEL MED, V9, P160, DOI 10.2310/7060.2002.23177; Semaille C, 1999, J TRAVEL MED, V6, P3, DOI 10.2310/7060.1999.00002; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Van Hest NAH, 2002, EPIDEMIOL INFECT, V129, P371, DOI 10.1017/S0950268802007306; *WHO, 2007, MAL DIS BURD SEA REG; WHO UNICEF, 2005, WORLD MALARIA REPORT; *WORLD TOUR ORG, 2005, WTO WORLD TOUR BAR, V3	32	108	108	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 12	2008	337	7661							a120	10.1136/bmj.a120	http://dx.doi.org/10.1136/bmj.a120			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	330SA	18599471	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000257961900036
J	Godar, S; Ince, TA; Bell, GW; Feldser, D; Donaher, JL; Bergh, J; Liu, A; Miu, K; Watnick, RS; Reinhardt, F; McAllister, SS; Jacks, T; Weinberg, RA				Godar, Samuel; Ince, Tan A.; Bell, George W.; Feldser, David; Donaher, Joana Liu; Bergh, Jonas; Liu, Anne; Miu, Kevin; Watnick, Randolph S.; Reinhardt, Ferenc; McAllister, Sandra S.; Jacks, Tyler; Weinberg, Robert A.			Growth-inhibitory and tumor-suppressive functions of p53 depend on its repression of CD44 expression	CELL			English	Article							LEUKEMIC STEM-CELLS; BREAST-CANCER CELLS; TRANSCRIPTIONAL REPRESSION; PATIENT SURVIVAL; EPITHELIAL-CELLS; IN-VIVO; GENE; P63; CARCINOMA; APOPTOSIS	The p53 tumor suppressor is a key mediator of cellular responses to various stresses. Here, we show that under conditions of basal physiologic and cellculture stress, p53 inhibits expression of the CD44 cell-surface molecule via binding to a noncanonical p53-binding sequence in the CD44 promoter. This interaction enables an untransformed cell to respond to stress- induced, p53- dependent cytostatic and apoptotic signals that would otherwise be blocked by the actions of CD44. In the absence of p53 function, the resulting derepressed CD44 expression is essential for the growth and tumor- initiating ability of highly tumorigenic mammary epithelial cells. In both tumorigenic and nontumorigenic cells, CD44' s expression is positively regulated by p63, a paralogue of p53. Our data indicate that CD44 is a key tumor-promoting agent in transformed tumor cells lacking p53 function. They also suggest that the derepression of CD44 resulting from inactivation of p53 can potentially aid the survival of immortalized, premalignant cells.	[Godar, Samuel; Ince, Tan A.; Bell, George W.; Donaher, Joana Liu; Liu, Anne; Miu, Kevin; Reinhardt, Ferenc; McAllister, Sandra S.; Weinberg, Robert A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Ince, Tan A.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Womens & Perinatal Pathol,Dept Pathol, Boston, MA 02115 USA; [Feldser, David; Jacks, Tyler] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Bergh, Jonas] Karolinska Inst, Radiumhemmet & Canc Ctr Karolinska, S-17176 Stockholm, Sweden; [Bergh, Jonas] Univ Hosp, S-17176 Stockholm, Sweden; [Watnick, Randolph S.] Harvard Univ, Sch Med, Childrens Hosp, Boston, MA 02115 USA; [Jacks, Tyler] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Jacks, Tyler; Weinberg, Robert A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Weinberg, Robert A.] Ludwig MIT Ctr Mol Oncol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Massachusetts Institute of Technology (MIT); Karolinska Institutet; Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Weinberg, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	weinberg@wi.mit.edu	McAllister, Sandra/J-7373-2012; ravegnini, gloria/K-1330-2016	ravegnini, gloria/0000-0002-7774-402X; Ince, Tan/0000-0003-0315-6425; Bergh, Jonas/0000-0001-5526-1847	NCI NIH HHS [P01 CA080111-01, P01 CA080111-10, K08 CA092013-01, P50 CA089393-03, K08 CA092013, CA089393, P01 CA080111, CA092013, P50 CA089393] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K08CA092013, P50CA089393, P01CA080111] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahrens T, 2001, ONCOGENE, V20, P3399, DOI 10.1038/sj.onc.1204435; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Aldaz CM, 2002, ONCOGENE, V21, P6366, DOI 10.1038/sj.onc.1205816; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Barbour AP, 2003, CANCER RES, V63, P887; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Boldrup L, 2007, J PATHOL, V213, P384, DOI 10.1002/path.2237; Bourguignon LYW, 1997, J BIOL CHEM, V272, P27913, DOI 10.1074/jbc.272.44.27913; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Dou J, 2007, CELL MOL IMMUNOL, V4, P467; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Endo K, 2000, J HEPATOL, V32, P78, DOI 10.1016/S0168-8278(00)80192-0; Gao AC, 1997, CANCER RES, V57, P846; Gottifredi V, 2001, MOL CELL BIOL, V21, P1066, DOI 10.1128/MCB.21.4.1066-1076.2001; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Ho J, 2003, CELL DEATH DIFFER, V10, P404, DOI 10.1038/sj.cdd.4401191; Hurt EM, 2008, BRIT J CANCER, V98, P756, DOI 10.1038/sj.bjc.6604242; IGGO R, 1990, LANCET, V335, P675, DOI 10.1016/0140-6736(90)90801-B; Ince TA, 2007, CANCER CELL, V12, P160, DOI 10.1016/j.ccr.2007.06.013; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Johnson RA, 2001, J BIOL CHEM, V276, P27716, DOI 10.1074/jbc.C100121200; Krause DS, 2006, NAT MED, V12, P1175, DOI 10.1038/nm1489; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Meletis K, 2006, DEVELOPMENT, V133, P363, DOI 10.1242/dev.02208; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Piltti K, 2006, ONCOGENE, V25, P4880, DOI 10.1038/sj.onc.1209492; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Schmits R, 1997, BLOOD, V90, P2217, DOI 10.1182/blood.V90.6.2217.2217_2217_2233; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; SHTIVELMAN E, 1991, MOL CELL BIOL, V11, P5446, DOI 10.1128/MCB.11.11.5446; Sjogren S, 1996, J NATL CANCER I, V88, P173, DOI 10.1093/jnci/88.3-4.173; Taylor WR, 2001, J BIOL CHEM, V276, P1998, DOI 10.1074/jbc.M005101200; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Weber GF, 2002, CANCER RES, V62, P2281; Wright MH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1855; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Yarden Y, 2001, ONCOLOGY-BASEL, V61, P1, DOI 10.1159/000055396; Yu Q, 1997, J EXP MED, V186, P1985, DOI 10.1084/jem.186.12.1985; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973; Zolota V, 2002, UROL ONCOL, V7, P13, DOI 10.1016/S1078-1439(01)00129-6	47	337	343	1	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 11	2008	134	1					62	73		10.1016/j.cell.2008.06.006	http://dx.doi.org/10.1016/j.cell.2008.06.006			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	324IU	18614011	Bronze, Green Accepted			2022-12-28	WOS:000257513100014
J	Levinson, NM; Seeliger, MA; Cole, PA; Kuriyan, J				Levinson, Nicholas M.; Seeliger, Markus A.; Cole, Philip A.; Kuriyan, John			Structural basis for the recognition of c-Src by its inactivator Csk	CELL			English	Article							PROTEIN-TYROSINE KINASE; CRYSTAL-STRUCTURE; SUBSTRATE RECOGNITION; V-SRC; DOMAIN; COMPLEX; ACTIVATION; PHOSPHORYLATION; RECEPTOR; ABL	The catalytic activity of the Src family of tyrosine kinases is suppressed byphosphorylation on a tyrosine residue located near the C terminus (Tyr 527 in c- Src), which is catalyzed by C-terminal Src Kinase (Csk). Given the promiscuity of most tyrosine kinases, it is remarkable that the C-terminal tails of the Src family kinases are the only known targets of Csk. We have determined the crystal structure of a complex between the kinase domains of Csk and c-Src at 2.9 angstrom resolution, revealing that interactions between these kinases position the C-terminal tail of c-Src at the edge of the active site of Csk. Csk cannot phosphorylate substrates that lack this docking mechanism because the conventional substrate binding site used by most tyrosine kinases to recognize substrates is destabilized in Csk by a deletion in the activation loop.	[Levinson, Nicholas M.; Seeliger, Markus A.; Kuriyan, John] Univ Calif Berkeley, Calif Inst Quantitat Biosci QB3, Howard Hughes Med Inst, Dept Chem,Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Cole, Philip A.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Kuriyan, John] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; Johns Hopkins University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Kuriyan, J (corresponding author), Univ Calif Berkeley, Calif Inst Quantitat Biosci QB3, Howard Hughes Med Inst, Dept Chem,Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	kuriyan@berkeley.edu	Seeliger, Markus A/D-6409-2013	Seeliger, Markus/0000-0003-0990-1756; Levinson, Nicholas/0000-0003-4338-8087	NATIONAL CANCER INSTITUTE [R29CA074305, R01CA074305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM080097] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R29 CA074305-04, R29 CA074305, R01 CA074305, R01 CA074305-07] Funding Source: Medline; NIGMS NIH HHS [K99 GM080097] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Atwell S, 2004, J BIOL CHEM, V279, P55827, DOI 10.1074/jbc.M409792200; BERGMAN M, 1995, MOL CELL BIOL, V15, P711; Boggon TJ, 2005, BLOOD, V106, P996, DOI 10.1182/blood-2005-02-0707; Breitenlechner CB, 2005, J MOL BIOL, V353, P222, DOI 10.1016/j.jmb.2005.08.023; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen HB, 2007, MOL CELL, V27, P717, DOI 10.1016/j.molcel.2007.06.028; Chong YP, 2006, J BIOL CHEM, V281, P32988, DOI 10.1074/jbc.M602951200; Cowan-Jacob SW, 2005, STRUCTURE, V13, P861, DOI 10.1016/j.str.2005.03.012; Creighton T. E., 1993, PROTEINS STRUCTURES; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Derewenda ZS, 2004, METHODS, V34, P354, DOI 10.1016/j.ymeth.2004.03.024; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faraldo-Gomez JD, 2007, P NATL ACAD SCI USA, V104, P13643, DOI 10.1073/pnas.0704041104; Favelyukis S, 2001, NAT STRUCT BIOL, V8, P1058, DOI 10.1038/nsb721; HOWELL BW, 1994, MOL CELL BIOL, V14, P5402, DOI 10.1128/MCB.14.8.5402; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Huse M, 1999, CELL, V96, P425, DOI 10.1016/S0092-8674(00)80555-3; Kholodenko BN, 2000, TRENDS CELL BIOL, V10, P173, DOI 10.1016/S0962-8924(00)01741-4; Kinoshita T, 2006, BIOCHEM BIOPH RES CO, V346, P840, DOI 10.1016/j.bbrc.2006.05.212; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; Knowles PP, 2006, J BIOL CHEM, V281, P33577, DOI 10.1074/jbc.M605604200; Konkol L, 2000, BIOCHEMISTRY-US, V39, P255, DOI 10.1021/bi992096j; Lamers MBAC, 1999, J MOL BIOL, V285, P713, DOI 10.1006/jmbi.1998.2369; Lee S, 2003, P NATL ACAD SCI USA, V100, P14707, DOI 10.1073/pnas.2534493100; Lee SS, 2006, J BIOL CHEM, V281, P8183, DOI 10.1074/jbc.M508120200; Levinson NM, 2006, PLOS BIOL, V4, P753, DOI 10.1371/journal.pbio.0040144; Lieser SA, 2005, J BIOL CHEM, V280, P7769, DOI 10.1074/jbc.M411736200; Lieser SA, 2006, J BIOL CHEM, V281, P38004, DOI 10.1074/jbc.M607824200; Lin XF, 2005, BIOCHEMISTRY-US, V44, P1561, DOI 10.1021/bi048142j; Lin XF, 2003, J BIOL CHEM, V278, P24072, DOI 10.1074/jbc.M210596200; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Miller WT, 2003, ACCOUNTS CHEM RES, V36, P393, DOI 10.1021/ar020116v; Mol CD, 2003, J BIOL CHEM, V278, P31461, DOI 10.1074/jbc.C300186200; NEET K, 1995, MOL CELL BIOL, V15, P4908; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Ogawa A, 2002, J BIOL CHEM, V277, P14351, DOI 10.1074/jbc.C200086200; OKADA M, 1991, J BIOL CHEM, V266, P24249; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; SABE H, 1994, P NATL ACAD SCI USA, V91, P3984, DOI 10.1073/pnas.91.9.3984; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Seeliger MA, 2005, PROTEIN SCI, V14, P3135, DOI 10.1110/ps.051750905; Seeliger MA, 2007, STRUCTURE, V15, P299, DOI 10.1016/j.str.2007.01.015; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Sondhi D, 1999, BIOCHEMISTRY-US, V38, P11147, DOI 10.1021/bi990827+; Sondhi D, 1998, BIOCHEMISTRY-US, V37, P165, DOI 10.1021/bi9722960; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; Sun GQ, 1999, ARCH BIOCHEM BIOPHYS, V367, P167, DOI 10.1006/abbi.1999.1253; SUPERTIFURGA G, 1993, EMBO J, V12, P2625, DOI 10.1002/j.1460-2075.1993.tb05923.x; Takashima Y, 2003, BIOCHEMISTRY-US, V42, P3567, DOI 10.1021/bi0272499; TAKEYA T, 1983, CELL, V32, P881, DOI 10.1016/0092-8674(83)90073-9; Till JH, 1999, J BIOL CHEM, V274, P4995, DOI 10.1074/jbc.274.8.4995; Walkenhorst J, 1996, ONCOGENE, V12, P1513; Wang DX, 2001, BIOCHEMISTRY-US, V40, P2004, DOI 10.1021/bi002342n; Wong L, 2005, J MOL BIOL, V351, P131, DOI 10.1016/j.jmb.2005.05.042; Wong L, 2004, J MOL BIOL, V341, P93, DOI 10.1016/j.jmb.2004.05.060; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yamaguchi H, 1996, NATURE, V384, P484, DOI 10.1038/384484a0; Yokoyama N, 1999, FEBS LETT, V456, P403, DOI 10.1016/S0014-5793(99)00992-8; Young MA, 2006, CANCER RES, V66, P1007, DOI 10.1158/0008-5472.CAN-05-2788; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhu XT, 1999, STRUCTURE, V7, P651, DOI 10.1016/S0969-2126(99)80086-0	66	91	95	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 11	2008	134	1					124	134		10.1016/j.cell.2008.05.051	http://dx.doi.org/10.1016/j.cell.2008.05.051			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	324IU	18614016	Bronze, Green Accepted			2022-12-28	WOS:000257513100019
J	Lee, JE; Fusco, ML; Hessell, AJ; Oswald, WB; Burton, DR; Saphire, EO				Lee, Jeffrey E.; Fusco, Marnie L.; Hessell, Ann J.; Oswald, Wendelien B.; Burton, Dennis R.; Saphire, Erica Ollmann			Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor	NATURE			English	Article							GP120 ENVELOPE GLYCOPROTEIN; NEUTRALIZING HUMAN-ANTIBODY; INTERNAL FUSION PEPTIDE; HEMORRHAGIC-FEVER; MARBURG VIRUSES; VIRION GLYCOPROTEINS; CYSTEINES FLANKING; NONHUMAN-PRIMATES; VACCINE PROTECTS; FILOVIRUS ENTRY	Ebola virus ( EBOV) entry requires the surface glycoprotein ( GP) to initiate attachment and fusion of viral and host membranes. Here we report the crystal structure of EBOV GP in its trimeric, pre- fusion conformation ( GP1+GP2) bound to a neutralizing antibody, KZ52, derived from a human survivor of the 1995 Kikwit outbreak. Three GP1 viral attachment subunits assemble to form a chalice, cradled by the GP2 fusion subunits, while a novel glycan cap and projected mucin- like domain restrict access to the conserved receptor- binding site sequestered in the chalice bowl. The glycocalyx surrounding GP is likely central to immune evasion and may explain why survivors have insignificant neutralizing antibody titres. KZ52 recognizes a protein epitope at the chalice base where it clamps several regions of the pre- fusion GP2 to the amino terminus of GP1. This structure provides a template for unravelling the mechanism of EBOV GP- mediated fusion and for future immunotherapeutic development.	[Lee, Jeffrey E.; Fusco, Marnie L.; Hessell, Ann J.; Oswald, Wendelien B.; Burton, Dennis R.; Saphire, Erica Ollmann] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	Scripps Research Institute	Saphire, EO (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, 10550 N Torrey Pines Rd,Mail Drop IMM-2, La Jolla, CA 92037 USA.	erica@scripps.edu	Saphire, Erica/A-7055-2009	Hessell, Ann/0000-0001-7471-9366; Saphire, Erica Ollmann/0000-0002-1206-7451	NIAID NIH HHS [R01 AI067927-03, R01 AI067927, R21 AI053423-02] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067927, R21AI053423] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alsop Z, 2007, LANCET, V370, P2085, DOI 10.1016/S0140-6736(07)61880-7; Alvarez CP, 2002, J VIROL, V76, P6841, DOI 10.1128/JVI.76.13.6841-6844.2002; Baize S, 1999, NAT MED, V5, P423, DOI 10.1038/7422; Bohne-Lang A, 2005, NUCLEIC ACIDS RES, V33, pW214, DOI 10.1093/nar/gki385; Brindley MA, 2007, J VIROL, V81, P7702, DOI 10.1128/JVI.02433-06; BRUNGER AT, 1991, ACTA CRYSTALLOGR A, V47, P195, DOI 10.1107/S0108767390011795; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Chan SY, 2001, CELL, V106, P117, DOI 10.1016/S0092-8674(01)00418-4; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DeLano W.L, PYMOL MOL GRAPHICS S; Delos SE, 2000, J VIROL, V74, P9738, DOI 10.1128/JVI.74.20.9738-9741.2000; Delos SE, 2008, J VIROL, V82, P3131, DOI 10.1128/JVI.02266-07; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fass D, 1996, NAT STRUCT BIOL, V3, P465, DOI 10.1038/nsb0596-465; Feldmann H, 1993, Arch Virol Suppl, V7, P81; Hampton T, 2005, JAMA-J AM MED ASSOC, V294, P163, DOI 10.1001/jama.294.2.163; Jeffers SA, 2002, J VIROL, V76, P12463, DOI 10.1128/JVI.76.24.12463-12472.2002; JOHNSON KM, 1977, LANCET, V1, P569; Jones SM, 2005, NAT MED, V11, P786, DOI 10.1038/nm1258; Kaletsky RL, 2007, J VIROL, V81, P13378, DOI 10.1128/JVI.01170-07; Kobinger GP, 2006, VIROLOGY, V346, P394, DOI 10.1016/j.virol.2005.10.042; Ksiazek TG, 1999, J INFECT DIS, V179, pS177, DOI 10.1086/514321; Kuhn JH, 2006, J BIOL CHEM, V281, P15951, DOI 10.1074/jbc.M601796200; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leroy EM, 2000, LANCET, V355, P2210, DOI 10.1016/S0140-6736(00)02405-3; Lutteke T, 2005, NUCLEIC ACIDS RES, V33, pD242; Lutteke T, 2004, CARBOHYD RES, V339, P1015, DOI 10.1016/j.carres.2003.09.038; Lutteke T, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-69; Malashkevich VN, 1999, P NATL ACAD SCI USA, V96, P2662, DOI 10.1073/pnas.96.6.2662; Manicassamy B, 2005, J VIROL, V79, P4793, DOI 10.1128/JVI.79.8.4793-4805.2005; Maruyama T, 1999, J INFECT DIS, V179, pS235, DOI 10.1086/514280; Maruyama T, 1999, J VIROL, V73, P6024, DOI 10.1128/JVI.73.7.6024-6030.1999; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McRee D.E., 1999, PRACTICAL PROTEIN CR, V2nd ed., P91; Mpanju OM, 2006, VIRUS RES, V121, P205, DOI 10.1016/j.virusres.2006.06.002; Oswald WB, 2007, PLOS PATHOG, V3, P62, DOI 10.1371/journal.ppat.0030009; Parren PWHI, 2002, J VIROL, V76, P6408, DOI 10.1128/JVI.76.12.6408-6412.2002; PETERS CJ, 1996, FIELDS VIROLOGY, V1, P1161; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; RITCHIE GE, 2005, THESIS U OXFORD; Rosenthal PB, 1998, NATURE, V396, P92, DOI 10.1038/23974; Sanchez A, 2004, J VIROL, V78, P10370, DOI 10.1128/JVI.78.19.10370-10377.2004; Sanchez A, 1998, J VIROL, V72, P6442, DOI 10.1128/JVI.72.8.6442-6447.1998; Sanchez A, 1996, P NATL ACAD SCI USA, V93, P3602, DOI 10.1073/pnas.93.8.3602; Sanchez A, 2001, FIELDS VIROLOGY, P1279; Sanchez A, 2007, J INFECT DIS, V196, pS251, DOI 10.1086/520597; Schornberg K, 2006, J VIROL, V80, P4174, DOI 10.1128/JVI.80.8.4174-4178.2006; Shimojima M, 2006, J VIROL, V80, P10109, DOI 10.1128/JVI.01157-06; Sullivan NJ, 2006, PLOS MED, V3, P865, DOI 10.1371/journal.pmed.0030177; Szakonyi G, 2006, NAT STRUCT MOL BIOL, V13, P996, DOI 10.1038/nsmb1161; Takada A, 2004, J VIROL, V78, P2943, DOI 10.1128/JVI.78.6.2943-2947.2004; Takada A, 2000, VIROLOGY, V278, P20, DOI 10.1006/viro.2000.0601; Takada A, 1997, P NATL ACAD SCI USA, V94, P14764, DOI 10.1073/pnas.94.26.14764; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Volchkov VE, 1998, P NATL ACAD SCI USA, V95, P5762, DOI 10.1073/pnas.95.10.5762; Weissenhorn W, 1998, MOL CELL, V2, P605, DOI 10.1016/S1097-2765(00)80159-8; *WHO, 2007, EB HAEM FEV UG; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Wool-Lewis RJ, 1998, J VIROL, V72, P3155, DOI 10.1128/JVI.72.4.3155-3160.1998; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Yang ZY, 2000, NAT MED, V6, P886, DOI 10.1038/78654; Yin HS, 2006, NATURE, V439, P38, DOI 10.1038/nature04322	68	513	551	2	216	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2008	454	7201					177	U27		10.1038/nature07082	http://dx.doi.org/10.1038/nature07082			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	323RU	18615077	Green Accepted			2022-12-28	WOS:000257466900035
J	Hasselmo, ME				Hasselmo, Michael E.			Neuroscience - The scale of experience	SCIENCE			English	Editorial Material							VENTRAL HIPPOCAMPUS; PLACE CELLS; DORSAL; INTERFERENCE; OSCILLATIONS; FREQUENCY; NEURONS; LESIONS; SPACE		[Hasselmo, Michael E.] Boston Univ, Dept Psychol, Ctr Memory & Brain, Boston, MA 02215 USA; [Hasselmo, Michael E.] Boston Univ, Program Neurosci, Boston, MA 02215 USA	Boston University; Boston University	Hasselmo, ME (corresponding author), Boston Univ, Dept Psychol, Ctr Memory & Brain, 64 Cummington St, Boston, MA 02215 USA.	hasselmo@bu.edu		Hasselmo, Michael/0000-0002-9925-6377	NIDA NIH HHS [DA16454, R01 DA016454-05, R01 DA016454] Funding Source: Medline; NIMH NIH HHS [R01 MH061492-06A2, MH61492, P50 MH060450-069002, P50 MH060450-099002, MH60450, R01 MH060013, P50 MH071702, R01 MH061492, P50 MH071702-030004, R01 MH060013-09, P50 MH060450, MH60013, MH71702] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061492, P50MH060450, R01MH060013, P50MH071702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016454] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Giocomo LM, 2007, SCIENCE, V315, P1719, DOI 10.1126/science.1139207; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hasselmo ME, 2007, HIPPOCAMPUS, V17, P1252, DOI 10.1002/hipo.20374; JUNG MW, 1994, J NEUROSCI, V14, P7347; Kjelstrup KG, 2002, P NATL ACAD SCI USA, V99, P10825, DOI 10.1073/pnas.152112399; Kjelstrup KB, 2008, SCIENCE, V321, P140, DOI 10.1126/science.1157086; Maurer AP, 2005, HIPPOCAMPUS, V15, P841, DOI 10.1002/hipo.20114; MULLER RU, 1987, J NEUROSCI, V7, P1935; OKeefe J, 1996, NATURE, V381, P425, DOI 10.1038/381425a0; POUCET B, 1994, NEUROREPORT, V5, P2045, DOI 10.1097/00001756-199410270-00014; Richmond MA, 1999, BEHAV NEUROSCI, V113, P1189, DOI 10.1037/0735-7044.113.6.1189; SOLSTAD T, 2007, SOC NEUR ABSTR, V33; Yoon T, 2007, NEUROBIOL LEARN MEM, V87, P464, DOI 10.1016/j.nlm.2006.12.006	15	8	8	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 4	2008	321	5885					46	47		10.1126/science.1160121	http://dx.doi.org/10.1126/science.1160121			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QE	18599761	Green Accepted			2022-12-28	WOS:000257320800025
J	Sanderson, MJ				Sanderson, Michael J.			Phylogenetic signal in the eukaryotic tree of life	SCIENCE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; INTERNAL SUPPORT; EVOLUTION	Molecular sequence data have been sampled from 10% of all species known to science. Although it is not yet feasible to assemble these data into a single phylogenetic tree of life, it is possible to quantify how much phylogenetic signal is present. Analysis of 14,289 phylogenies built from 2.6 million sequences in GenBank suggests that signal is strong in vertebrates and specific groups of nonvertebrate model organisms. Across eukaryotes, however, although phylogenetic evidence is very broadly distributed, for the average species in the database it is equivalent to less than one well- supported gene tree. This analysis shows that a stronger sampling effort aimed at genomic depth, in addition to taxonomic breadth, will be required to build high- resolution phylogenetic trees at this scale.	Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA	University of Arizona	Sanderson, MJ (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA.	sanderm@email.arizona.edu						Ane C, 2007, MOL BIOL EVOL, V24, P412; Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI [10.1093/nar/gkp1024, 10.1093/nar/gkt1030, 10.1093/nar/gks1195, 10.1093/nar/gkw1070, 10.1093/nar/gkq1079, 10.1093/nar/gkn723, 10.1093/nar/gkr1202, 10.1093/nar/gkx1094]; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Blanchette M, 2004, GENOME RES, V14, P2412, DOI 10.1101/gr.2800104; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards SV, 2007, P NATL ACAD SCI USA, V104, P5936, DOI 10.1073/pnas.0607004104; Forest F, 2007, NATURE, V445, P757, DOI 10.1038/nature05587; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hughes J, 2006, MOL BIOL EVOL, V23, P268, DOI 10.1093/molbev/msj041; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Kajita T, 2001, SYST BOT, V26, P515; Moles AT, 2005, SCIENCE, V307, P576, DOI 10.1126/science.1104863; Mort ME, 2000, SYST BIOL, V49, P160, DOI 10.1080/10635150050207456; Mossel E, 2005, MATHEMATICS OF EVOLUTION AND PHYLOGENY, P384; Salamin N, 2003, MOL PHYLOGENET EVOL, V27, P528, DOI 10.1016/S1055-7903(03)00011-3; Sanderson MJ, 2008, SYST BIOL, V57, P335, DOI 10.1080/10635150802158688; Sanderson MJ, 2007, AUST SYST BOT, V20, P287, DOI 10.1071/SB07006; SANDERSON MJ, 2007, PHYLOTA BROWSER; Spatafora JW, 2006, MYCOLOGIA, V98, P1018, DOI 10.3852/mycologia.98.6.1018; Steinke D, 2006, J MOL EVOL, V62, P772, DOI 10.1007/s00239-005-0170-8; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wojciechowski MF, 2004, AM J BOT, V91, P1846, DOI 10.3732/ajb.91.11.1846	24	36	42	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2008	321	5885					121	123		10.1126/science.1154449	http://dx.doi.org/10.1126/science.1154449			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QE	18599787				2022-12-28	WOS:000257320800051
J	Gurnett, DA; Kurth, WS				Gurnett, D. A.; Kurth, W. S.			Intense plasma waves at and near the solar wind termination shock	NATURE			English	Article							EARTHS BOW SHOCK; VOYAGER MISSION; OSCILLATIONS; NEPTUNE	Plasma waves are a characteristic feature of shocks in plasmas, and are produced by non- thermal particle distributions that develop in the shock transition layer. The electric fields of these waves have a key role in dissipating energy in the shock and driving the particle distributions back towards thermal equilibrium(1). Here we report the detection of intense plasma- wave electric fields at the solar wind termination shock. The observations were obtained from the plasma- wave instrument on the Voyager 2 spacecraft(2). The first evidence of the approach to the shock was the detection of upstream electron plasma oscillations on 1 August 2007 at a heliocentric radial distance of 83.4 AU ( 1 AU is the Earth - Sun distance). These narrowband oscillations continued intermittently for about a month until, starting on 31 August 2007 and ending on 1 September 2007, a series of intense bursts of broadband electrostatic waves signalled a series of crossings of the termination shock at a heliocentric radial distance of 83.7 AU. The spectrum of these waves is quantitatively similar to those observed at bow shocks upstream of Jupiter, Saturn, Uranus and Neptune.	[Gurnett, D. A.; Kurth, W. S.] Univ Iowa, Dept Phys & Astron, Iowa City, IA 52242 USA	University of Iowa	Gurnett, DA (corresponding author), Univ Iowa, Dept Phys & Astron, Iowa City, IA 52242 USA.	donald-gurnett@uiowa.edu	Kurth, William/AAA-7334-2019	Kurth, William/0000-0002-5471-6202				BRIDGE HS, 1977, SPACE SCI REV, V21, P259, DOI 10.1007/BF00211542; FILBERT PC, 1979, J GEOPHYS RES-SPACE, V84, P1369, DOI 10.1029/JA084iA04p01369; FREDRICKS RW, 1968, PHYS REV LETT, V21, P1761, DOI 10.1103/PhysRevLett.21.1761; Gurnett DA, 2005, SCIENCE, V309, P2025, DOI 10.1126/science.1117425; GURNETT DA, 1989, SCIENCE, V246, P1494, DOI 10.1126/science.246.4936.1494; GURNETT DA, 2005, INTRO PLASMA PHYS, P277; KRIMIGIS SM, 1977, SPACE SCI REV, V21, P329, DOI 10.1007/BF00211545; Kurth WS, 2006, AIP CONF PROC, V858, P116; KURTH WS, 1993, J GEOPHYS RES-SPACE, V98, P15129, DOI 10.1029/93JA01176; Lembege B, 2004, SPACE SCI REV, V110, P161, DOI 10.1023/B:SPAC.0000023372.12232.b7; MOSES SL, 1990, GEOPHYS RES LETT, V17, P1653, DOI 10.1029/GL017i010p01653; SCARF FL, 1977, SPACE SCI REV, V21, P289, DOI 10.1007/BF00211543; SCHOLER M, 2003, J GEOPHYS RES, V108; Stix T. H., 1962, THEORY PLASMA WAVES, P10; Stone EC, 2005, SCIENCE, V309, P2017, DOI 10.1126/science.1117684; Tonks L, 1929, PHYS REV, V33, P195, DOI 10.1103/PhysRev.33.195; Washimi H, 2007, ASTROPHYS J, V670, pL139, DOI 10.1086/524358	17	52	52	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 3	2008	454	7200					78	80		10.1038/nature07023	http://dx.doi.org/10.1038/nature07023			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321MC	18596804				2022-12-28	WOS:000257308300039
J	Huang, ES; Zhang, Q; Gandra, N; Chin, MH; Meltzer, DO				Huang, Elbert S.; Zhang, Qi; Gandra, Niren; Chin, Marshall H.; Meltzer, David O.			The effect of comorbid illness and functional status on the expected benefits of intensive glucose control in older patients with type 2 diabetes: A decision analysis	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; COST-EFFECTIVENESS; CARDIOVASCULAR-DISEASE; GLYCEMIC CONTROL; UNITED-STATES; RISK-FACTORS; FOOT ULCERS; HEALTH; CARE; MODEL	Background: Physicians are uncertain about when to pursue intensive glucose control among older patients with diabetes. Objective: To assess the effect of comorbid illnesses and functional status, mediated through background mortality, on the expected benefits of intensive glucose control. Design: Decision analysis. Data Sources: Major clinical studies in diabetes and geriatrics. Target Population: Patients 60 to 80 years of age who have type 2 diabetes and varied life expectancies estimated from a mortality index that was validated at the population level. Time Horizon: Patient lifetime. Perspective: Health care system. Intervention: Intensive glucose control (hemoglobin A1c [HbA1c] level of 7.0) versus moderate glucose control (HbA1c level of 7.9). Outcome Measures: Lifetime differences in incidence of complications and average quality- adjusted days. Results of Base-Case Analysis: Healthy older patients of different age groups had expected benefits of intensive glucose control ranging from 51 to 116 quality-adjusted days. Within each age group, the expected benefits of intensive control steadily declined as the level of comorbid illness and functional impairment increased (mortality index score, 1 to 26 points). For patients 60 to 64 years of age with new-onset diabetes, the benefits declined from 106 days at baseline good health (life expectancy, 14.6 years) to 44 days with 3 additional index points (life expectancy, 9.7 years) and 8 days with 7 additional index points (life expectancy, 4.8 years). A similar decline in benefits occurred among patients with prolonged duration of diabetes. Results of Sensitivity Analysis: With alternative model assumptions (such as Framingham models), expected benefits of intensive control declined as mortality index scores increased. Limitations: Diabetes clinical trial data were lacking for frail, older patients. The mortality index was not validated for use in predicting individual- level life expectancies. Adverse effects of intensive control were not taken into account. Conclusion: Among older diabetic patients, the presence of multiple comorbid illnesses or functional impairments is a more important predictor of limited life expectancy and diminishing expected benefits of intensive glucose control than is age alone.	[Huang, Elbert S.] Univ Chicago, Chicago, IL 60637 USA; Old Dominion Univ, Norfolk, VA USA; Boston Univ, Sch Med, Boston, MA 02118 USA	University of Chicago; Old Dominion University; Boston University	Huang, ES (corresponding author), Univ Chicago, 5841 S Maryland Ave,MC 2007, Chicago, IL 60637 USA.	ehuang@medicine.bsd.uchicago.edu	Meltzer, David/C-2926-2009	Meltzer, David/0000-0003-2790-7393	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD056073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020595, K24DK071933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG021963] Funding Source: NIH RePORTER; NIA NIH HHS [K23 AG021963-04, K23 AG021963] Funding Source: Medline; NICHD NIH HHS [R03 HD056073] Funding Source: Medline; NIDDK NIH HHS [P60 DK20595, K24 DK071933, P60 DK020595] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abrahamson MJ, 2007, JAMA-J AM MED ASSOC, V297, P196, DOI 10.1001/jama.297.2.196; *AM ASS CLIN END, 2002, ENDOCR PRACT S1, V8, P40; American Diabetes Association, 2004, DIABETES CARE, V27, pS15; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; ANDERSON RN, 1999, NATL VITAL STAT REPO, V50; [Anonymous], 2005, DIABETES CARE, V28, pS4; [Anonymous], 1995, DIABETES AM; [Anonymous], 2007, DIABETES CARE, V30, pS4, DOI [10.2337/dc07-S004, DOI 10.2337/DC07-S004]; [Anonymous], MED DECIS MAK; Arias Elizabeth, 2006, Natl Vital Stat Rep, V54, P1; Brown AF, 2003, J AM GERIATR SOC, V51, P665, DOI 10.1034/j.1600-0579.2003.00211.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chin MH, 2000, MED CARE, V38, P131, DOI 10.1097/00005650-200002000-00003; Chin MH, 2000, J GERONTOL A-BIOL, V55, pM601, DOI 10.1093/gerona/55.10.M601; Clarke PM, 2004, DIABETOLOGIA, V47, P1747, DOI 10.1007/s00125-004-1527-z; Durso SC, 2006, JAMA-J AM MED ASSOC, V295, P1935, DOI 10.1001/jama.295.16.1935; Eastman RC, 1997, DIABETES CARE, V20, P735, DOI 10.2337/diacare.20.5.735; Eastman RC, 1997, DIABETES CARE, V20, P725, DOI 10.2337/diacare.20.5.725; Fleming BB, 2001, DIABETES CARE, V24, P1815, DOI 10.2337/diacare.24.10.1815; Grant RW, 2004, ARCH INTERN MED, V164, P1134, DOI 10.1001/archinte.164.10.1134; Hardy SE, 2004, JAMA-J AM MED ASSOC, V291, P1596, DOI 10.1001/jama.291.13.1596; HAYWARD RA, 2007, JAMA-J AM MED ASSOC, V297, P2196; Hayward RA, 2007, JAMA-J AM MED ASSOC, V297, P2195, DOI 10.1001/jama.297.20.2195-a; Hoerger TJ, 2002, JAMA-J AM MED ASSOC, V287, P2542; Huang ES, 2007, HEALTH SERV RES, V42, P2174, DOI 10.1111/j.1475-6773.2007.00734.x; Huang ES, 2007, DIABETES CARE, V30, P2478, DOI 10.2337/dc07-0499; Huang ES, 2006, DIABETES CARE, V29, P259, DOI 10.2337/diacare.29.02.06.dc05-1443; Huang ES, 2001, AM J MED, V111, P633, DOI 10.1016/S0002-9343(01)00978-0; HUANG ES, 2007, HEALTH SERV RES, V42, P2294; HUMPHREY LL, 1989, ANN INTERN MED, V111, P788, DOI 10.7326/0003-4819-111-10-788; Hunink MGM, 1997, JAMA-J AM MED ASSOC, V277, P535, DOI 10.1001/jama.277.7.535; Kothari V, 2002, STROKE, V33, P1776, DOI 10.1161/01.STR.0000020091.07144.C7; Lee SJ, 2006, JAMA-J AM MED ASSOC, V295, P801, DOI 10.1001/jama.295.7.801; Miller CD, 2001, ARCH INTERN MED, V161, P1653, DOI 10.1001/archinte.161.13.1653; Naglie G, 1997, MED DECIS MAKING, V17, P136, DOI 10.1177/0272989X9701700203; Nathan DM, 1996, JAMA-J AM MED ASSOC, V276, P1409; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Neumann PJ, 2000, ANNU REV PUBL HEALTH, V21, P587, DOI 10.1146/annurev.publhealth.21.1.587; Palmer AJ, 2007, DIABETES CARE, V30, P1638, DOI 10.2337/dc07-9919; Petty GW, 1998, NEUROLOGY, V50, P208, DOI 10.1212/WNL.50.1.208; Qaseern A, 2007, ANN INTERN MED, V147, P417, DOI 10.7326/0003-4819-147-6-200709180-00012; Redekop W, 2004, DIABETES METAB, V30, P549, DOI 10.1016/S1262-3636(07)70154-4; Robbins JM, 2001, AM J PUBLIC HEALTH, V91, P76, DOI 10.2105/AJPH.91.1.76; Rosen AB, 2005, ANN INTERN MED, V143, P89, DOI 10.7326/0003-4819-143-2-200507190-00007; Saaddine JB, 2006, ANN INTERN MED, V144, P465, DOI 10.7326/0003-4819-144-7-200604040-00005; Saliba D, 2001, J AM GERIATR SOC, V49, P1691, DOI 10.1046/j.1532-5415.2001.49281.x; Saydah SH, 2004, JAMA-J AM MED ASSOC, V291, P335, DOI 10.1001/jama.291.3.335; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Stafford RS, 2005, PLOS MED, V2, P1292, DOI 10.1371/journal.pmed.0020353; Stevens RJ, 2001, CLIN SCI, V101, P671, DOI 10.1042/CS20000335; Tennvall GR, 2001, DIABETOLOGIA, V44, P2077; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; United States Renal Data System, 1994, USRDS 1994 ANN DAT R; Vijan S, 1997, ANN INTERN MED, V127, P788, DOI 10.7326/0003-4819-127-9-199711010-00003; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983	56	100	103	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 1	2008	149	1					11	+		10.7326/0003-4819-149-1-200807010-00005	http://dx.doi.org/10.7326/0003-4819-149-1-200807010-00005			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	323EZ	18591633	Green Accepted			2022-12-28	WOS:000257428200002
J	Halpern, SD; Shaked, A; Hasz, RD; Caplan, AL				Halpern, Scott D.; Shaked, Abraham; Hasz, Richard D.; Caplan, Arthur L.			Informing candidates for solid-organ transplantation about donor risk factors	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CARDIAC DEATH DONORS; HEART-BEATING DONORS; LIVER-TRANSPLANTATION; LUNG TRANSPLANTATION; KIDNEY-TRANSPLANTATION; INFECTED PATIENTS; TISSUE DONORS; HIV; ALLOCATION; RECIPIENTS		[Halpern, Scott D.] Univ Penn, Sch Med, Pulm Allergy & Crit Care Div, Philadelphia, PA 19104 USA; [Halpern, Scott D.; Caplan, Arthur L.] Univ Penn, Sch Med, Ctr Bioeth, Philadelphia, PA 19104 USA; [Halpern, Scott D.; Caplan, Arthur L.] Univ Penn, Sch Med, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Halpern, Scott D.] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Shaked, Abraham] Univ Penn, Sch Med, Penn Transplant Inst, Philadelphia, PA 19104 USA; [Hasz, Richard D.] Gift Life Donor Program, Philadelphia, PA USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Halpern, SD (corresponding author), Univ Penn, Sch Med, Pulm Allergy & Crit Care Div, Philadelphia, PA 19104 USA.							American Medical Association, H 370 975 ETH ISS PR; *ASS PRESS, 2007, BANN LIF GAY MEN STI; Barnato AE, 2004, CRIT CARE CLIN, V20, P345, DOI 10.1016/j.ccc.2004.03.002; Bernat JL, 2006, AM J TRANSPLANT, V6, P281, DOI 10.1111/j.1600-6143.2005.01194.x; Botha P, 2006, J THORAC CARDIOV SUR, V131, P1154, DOI 10.1016/j.jtcvs.2005.12.037; CAMPBELL D, 2007, P 2007 ORG TISS DON; CDC-Centers for Disease Control and Prevention, 1994, MMWR RECOMM REP, V43, P1; CLARKE OW, 1995, ARCH INTERN MED, V155, P29, DOI 10.1001/archinte.1995.00430010033005; D'Alessandro AM, 2000, SURGERY, V128, P579, DOI 10.1067/msy.2000.108421; D'Alessandro Anthony M, 2004, Ann Transplant, V9, P68; DeVita MA, 2001, CRIT CARE MED, V29, P1826; Feng S, 2006, AM J TRANSPLANT, V6, P783, DOI 10.1111/j.1600-6143.2006.01242.x; Fishman JA, 2007, AM J TRANSPLANT, V7, P2652, DOI 10.1111/j.1600-6143.2007.02023.x; Gomez M, 1997, TRANSPLANT P, V29, P3478, DOI 10.1016/S0041-1345(97)01116-0; GRADY D, 2007, NY TIMES        1114; GROSSMAN KN, 2007, SUN TIMES       1116; Halpern SD, 2005, JAMA-J AM MED ASSOC, V294, P734, DOI 10.1001/jama.294.6.734; Halpern SD, 2002, NEW ENGL J MED, V347, P284, DOI 10.1056/NEJMsb020632; *I MED, 2006, ORG DON OPP ACT; Kasprzyk T, 2007, TRANSPL P, V39, P2701, DOI 10.1016/j.transproceed.2007.09.021; Kawut SM, 2005, TRANSPLANTATION, V79, P310, DOI 10.1097/01.TP.0000149504.53710.AE; Krieger NR, 2003, TRANSPLANTATION, V75, P1271, DOI 10.1097/01.TP.0000061603.95572.BF; LOVE R, 2007, P 2007 ORG TISS DON; Port FK, 2002, TRANSPLANTATION, V74, P1281, DOI 10.1097/00007890-200211150-00014; Ragni MV, 2003, J INFECT DIS, V188, P1412, DOI 10.1086/379254; Rawls John, 2001, JUSTICE FAIRNESS RES, P42, DOI DOI 10.2307/J.CTV31XF5V0; REICH DJ, 2007, P 2007 ORG TISS DON; Scanlon DP, 2004, HEALTH AFFAIR, V23, P191, DOI 10.1377/hlthaff.23.2.191; Schnitzler MA, 2005, AM J TRANSPLANT, V5, P2289, DOI 10.1111/j.1600-6143.2005.01021.x; Shemie SD, 2006, CAN MED ASSOC J, V174, pS1, DOI 10.1503/cmaj.045142; SIMONDS RJ, 1992, NEW ENGL J MED, V326, P726, DOI 10.1056/NEJM199203123261102; Snell GI, 2008, AM J TRANSPLANT, V8, P1282, DOI 10.1111/j.1600-6143.2008.02231.x; Stock PG, 2003, TRANSPLANTATION, V76, P370, DOI 10.1097/01.TP.0000075973.73064.A6; Sung RS, 2007, TRANSPLANTATION, V84, P1138, DOI 10.1097/01.tp.0000287118.76725.c1; Tojimbara T, 2007, AM J TRANSPLANT, V7, P609, DOI 10.1111/j.1600-6143.2007.01664.x; Ubel PA, 1998, NEW ENGL J MED, V339, P1322, DOI 10.1056/NEJM199810293391811; Ubel PA, 1996, SOC SCI MED, V42, P1049, DOI 10.1016/0277-9536(95)00216-2; *UN NETW ORG SHAR, 2007, ORG DISTR ALL DEC KI; *UN NETW ORG SHAR, CURR DAT; *UN NETW ORG SHAR, 2007, ACQ IMM DEF SYNDR AI; Weber M, 2002, NEW ENGL J MED, V347, P248, DOI 10.1056/NEJMoa020274; WIJNEN RMH, 1995, LANCET, V345, P1067, DOI 10.1016/S0140-6736(95)90815-3; Yao F, 2007, AM J TRANSPLANT, V7, P2723, DOI 10.1111/j.1600-6143.2007.02012.x; Zou SM, 2004, NEW ENGL J MED, V351, P751, DOI 10.1056/NEJMoa032510	44	60	61	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 26	2008	358	26					2832	2837		10.1056/NEJMsb0800674	http://dx.doi.org/10.1056/NEJMsb0800674			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	317UO	18579820				2022-12-28	WOS:000257045900014
J	Ioannidis, JPA; Patsopoulos, N; Rothstein, H				Ioannidis, John P. A.; Patsopoulos, Nikolaos; Rothstein, Hannah			Research methodology - Reasons or excuses for avoiding meta-analysis in forest plots	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MIXED TREATMENT COMPARISONS; CLINICAL-TRIALS; RANDOMIZED-TRIALS; HETEROGENEITY; INTERVENTIONS; REGRESSION; BENEFITS; OUTCOMES		[Ioannidis, John P. A.; Patsopoulos, Nikolaos] Univ Ioannina, Sch Med, Clin Trials & Evidence Based Med Unit, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [Ioannidis, John P. A.; Patsopoulos, Nikolaos] Fdn Res & Technol Hellas, Biomed Res Inst, GR-45110 Ioannina, Greece; [Rothstein, Hannah] CUNY, Dept Management, Zicklin Sch Business, New York, NY 10010 USA	University of Ioannina; Foundation for Research & Technology - Hellas (FORTH); City University of New York (CUNY) System; Baruch College (CUNY)	Ioannidis, JPA (corresponding author), Univ Ioannina, Sch Med, Clin Trials & Evidence Based Med Unit, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece.	jioannid@cc.uoi.gr	Ioannidis, John P. A./G-9836-2011; Rothstein, Hannah/G-2286-2011	Rothstein, Hannah/0000-0002-2808-4790; Patsopoulos, Nikolaos/0000-0003-3757-8941				Ades AE, 2005, MED DECIS MAKING, V25, P646, DOI 10.1177/0272989X05282643; Berkey CS, 1996, STAT MED, V15, P537, DOI 10.1002/(SICI)1097-0258(19960315)15:5<537::AID-SIM176>3.3.CO;2-J; Berkey CS, 1998, STAT MED, V17, P2537, DOI 10.1002/(SICI)1097-0258(19981130)17:22<2537::AID-SIM953>3.0.CO;2-C; BERLIN JA, 1995, AM J EPIDEMIOL, V142, P383, DOI 10.1093/oxfordjournals.aje.a117645; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Chang JT, 2004, BRIT MED J, V328, P680, DOI 10.1136/bmj.328.7441.680; Curtin F, 2002, STAT MED, V21, P2161, DOI 10.1002/sim.1207; Egger M, 1998, BRIT MED J, V316, P140; GLENNY AM, 2005, HEALTH TECHNOL ASSES, P9; Golfinopoulos V, 2007, LANCET ONCOL, V8, P898, DOI 10.1016/S1470-2045(07)70281-4; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; Ioannidis JPA, 2006, LANCET, V368, P1470, DOI 10.1016/S0140-6736(06)69615-3; Ioannidis JPA, 2001, JAMA-J AM MED ASSOC, V286, P821, DOI 10.1001/jama.286.7.821; JAESCHKE R, 1995, CAN MED ASSOC J, V152, P351; Kavvoura FK, 2007, PLOS MED, V4, P456, DOI 10.1371/journal.pmed.0040079; Lau J, 1998, LANCET, V351, P123, DOI 10.1016/S0140-6736(97)08468-7; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Lu G, 2007, STAT MED, V26, P3681, DOI 10.1002/sim.2831; Orwin R.G., 1994, HDB RES SYNTHESIS; Pettiti D, 1999, METAANALYSIS DECISIO; Riley RD, 2007, STAT MED, V26, P78, DOI 10.1002/sim.2524; Salanti G, 2008, STAT METHODS MED RES, V17, P279, DOI 10.1177/0962280207080643; Schunemann HJ, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-62; Shrier I, 2007, AM J EPIDEMIOL, V166, P1203, DOI 10.1093/aje/kwm189; Simmonds MC, 2005, CLIN TRIALS, V2, P209, DOI 10.1191/1740774505cn087oa; Smith TC, 1995, STAT MED, V14, P2685, DOI 10.1002/sim.4780142408; Sutton AJ, 2002, J CLIN EPIDEMIOL, V55, P1013, DOI 10.1016/S0895-4356(02)00460-2; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Underhill K, 2007, BMJ-BRIT MED J, V335, P248, DOI 10.1136/bmj.39245.446586.BE; van Sluijs EMF, 2007, BMJ-BRIT MED J, V335, P703, DOI 10.1136/bmj.39320.843947.BE	33	303	319	1	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 21	2008	336	7658					1413	1415		10.1136/bmj.a117	http://dx.doi.org/10.1136/bmj.a117			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	318WJ	18566080	Green Published			2022-12-28	WOS:000257123200031
J	Ratschen, E; McNeill, A; Doody, GA; Britton, J				Ratschen, Elena; McNeill, Ann; Doody, Gillian A.; Britton, John			Smoking, mental health, and human rights: a UK judgment	LANCET			English	Editorial Material							SETTINGS; BANS		[Ratschen, Elena; McNeill, Ann; Britton, John] Univ Nottingham, City Hosp, UK Ctr Tobacco Control Studies, Nottingham NG5 1PB, England; [Doody, Gillian A.] Univ Nottingham, Div Psychiat, Nottingham NG7 2RD, England	Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham; University of Nottingham	Ratschen, E (corresponding author), Univ Nottingham, City Hosp, UK Ctr Tobacco Control Studies, Clin Sci Bldg, Nottingham NG5 1PB, England.	mcxer2@nottingham.ac.uk	Doody, Gillian A/A-8930-2011	doody, gillian/0000-0002-3494-438X; McNeill, Ann/0000-0002-6223-4000				Coulthard M, 2002, TOBACCO ALCOHOL DRUG; el-Guebaly N, 2002, PSYCHIATR SERV, V53, P1617, DOI 10.1176/appi.ps.53.12.1617; *HLTH DEV AG, 2004, CAS COMPL SMOK NHS E; Lawn S, 2005, AUST NZ J PSYCHIAT, V39, P866, DOI 10.1080/j.1440-1614.2005.01697.x; MCNEILL A, 2005, GUIDANCE SMOKEFREE H; MCNEILL A, 2001, SMOKING MENTAL HLTH; MELTZER H, 1996, 6 HM STAT OFF; *SMOK ENGL, 2007, SMOK ENGL FACTSH SMO	8	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 21	2008	371	9630					2067	2068		10.1016/S0140-6736(08)60898-3	http://dx.doi.org/10.1016/S0140-6736(08)60898-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	316ER	18572066				2022-12-28	WOS:000256932200009
J	Hytch, M; Houdellier, F; Hue, F; Snoeck, E				Hytch, Martin; Houdellier, Florent; Hue, Florian; Snoeck, Etienne			Nanoscale holographic interferometry for strain measurements in electronic devices	NATURE			English	Article							SILICON; DIFFRACTION; DISPLACEMENT; SI; PERFORMANCE; RELAXATION; MICROSCOPY; RESOLUTION; SYSTEM; LAYERS	Strained silicon is now an integral feature of the latest generation of transistors and electronic devices(1-3) because of the associated enhancement in carrier mobility(4,5). Strain is also expected to have an important role in future devices based on nanowires(6) and in optoelectronic components(7). Different strategies have been used to engineer strain in devices, leading to complex strain distributions in two and three dimensions(8,9). Developing methods of strain measurement at the nanoscale has therefore been an important objective in recent years but has proved elusive in practice(1,10): none of the existing techniques combines the necessary spatial resolution, precision and field of view. For example, Raman spectroscopy or X-ray diffraction techniques can map strain at the micrometre scale, whereas transmission electron microscopy allows strain measurement at the nanometre scale but only over small sample areas. Here we present a technique capable of bridging this gap and measuring strain to high precision, with nanometre spatial resolution and for micrometre fields of view(11). Our method combines the advantages of moire techniques(12) with the flexibility of off-axis electron holography(13) and is also applicable to relatively thick samples, thus reducing the influence of thin-film relaxation effects.	[Hytch, Martin; Houdellier, Florent; Hue, Florian; Snoeck, Etienne] nMat Grp, CEMES CNRS, F-31055 Toulouse, France	Centre National de la Recherche Scientifique (CNRS)	Hytch, M (corresponding author), nMat Grp, CEMES CNRS, 29 Rue Jeanne Marvig, F-31055 Toulouse, France.	hytch@cemes.fr	Hytch, Martin/N-6911-2019					Acosta T, 2006, IEEE POTENTIALS, V25, P31, DOI 10.1109/MP.2006.1664067; Antoniadis DA, 2006, IBM J RES DEV, V50, P363, DOI 10.1147/rd.504.0363; CHRISTIANSEN S, 1994, APPL PHYS LETT, V64, P3617, DOI 10.1063/1.111217; Clement L, 2004, APPL PHYS LETT, V85, P651, DOI 10.1063/1.1774275; de Jonge N, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.186807; FORAN B, 2006, FUTURE FAB INT, V20, P127; GHANI T, 2003, IEDM, P978; Harada K, 2005, J ELECTRON MICROSC, V54, P19, DOI 10.1093/jmicro/dfh098; He RR, 2006, NAT NANOTECHNOL, V1, P42, DOI 10.1038/nnano.2006.53; HIRSH PB, 1977, ELECTRON MICROS, pCH15; Houdellier F, 2006, ULTRAMICROSCOPY, V106, P951, DOI 10.1016/j.ultramic.2006.04.011; Hue F, 2005, J ELECTRON MICROSC, V54, P181, DOI 10.1093/jmicro/dfi042; Huebner KH., 2001, FINITE ELEMENT METHO; Hue F, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.156602; Hytch M J, Patent Pending FR, Patent No. [07 06711, 0706711]; Hytch MJ, 1998, ULTRAMICROSCOPY, V74, P131, DOI 10.1016/S0304-3991(98)00035-7; Hytch MJ, 2003, NATURE, V423, P270, DOI 10.1038/nature01638; Hytch MJ, 2001, ULTRAMICROSCOPY, V87, P199, DOI 10.1016/S0304-3991(00)00099-1; Ishitani T, 2004, J ELECTRON MICROSC, V53, P443, DOI 10.1093/jmicro/dfh078; ITRS, 2005, INT TECHN ROADM SEM; Jacobsen RS, 2006, NATURE, V441, P199, DOI 10.1038/nature04706; Johnson CL, 2008, NAT MATER, V7, P120, DOI 10.1038/nmat2083; Lee ML, 2005, J APPL PHYS, V97, DOI 10.1063/1.1819976; Li J, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2135388; Loo R, 2004, APPL SURF SCI, V224, P63, DOI 10.1016/j.apsusc.2003.08.030; McCartney MR, 2007, ANNU REV MATER RES, V37, P729, DOI 10.1146/annurev.matsci.37.052506.084219; Parton E, 2006, III-VS REV, V19, P28, DOI 10.1016/S0961-1290(06)71590-3; Rau WD, 1999, PHYS REV LETT, V82, P2614, DOI 10.1103/PhysRevLett.82.2614; Snoeck E., 2006, P IMC16 INT MICR C I, V2, P730; Thompson SE, 2006, IEEE T ELECTRON DEV, V53, P1010, DOI 10.1109/TED.2006.872088; TREACY MMJ, 1985, PHILOS MAG A, V51, P389, DOI 10.1080/01418618508237563; Usuda K, 2005, MAT SCI ENG B-SOLID, V124, P143, DOI 10.1016/j.mseb.2005.08.062; Wang YY, 2004, ULTRAMICROSCOPY, V101, P63, DOI 10.1016/j.ultramic.2004.04.003; Yeo YC, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1846152; Zhang P, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2362978	35	350	357	4	195	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2008	453	7198					1086	U5		10.1038/nature07049	http://dx.doi.org/10.1038/nature07049			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314WM	18563161				2022-12-28	WOS:000256839900053
J	Zabow, G; Dodd, S; Moreland, J; Koretsky, A				Zabow, Gary; Dodd, Stephen; Moreland, John; Koretsky, Alan			Micro-engineered local field control for high-sensitivity multispectral MRI	NATURE			English	Article							IRON-OXIDE; CELLS; PARTICLES; SAFETY; AGENTS	In recent years, biotechnology and biomedical research have benefited from the introduction of a variety of specialized nanoparticles whose well-defined, optically distinguishable signatures enable simultaneous tracking of numerous biological indicators. Unfortunately, equivalent multiplexing capabilities are largely absent in the field of magnetic resonance imaging (MRI). Comparable magnetic-resonance labels have generally been limited to relatively simple chemically synthesized superparamagnetic microparticles that are, to a large extent, indistinguishable from one another. Here we show how it is instead possible to use a top-down microfabrication approach to effectively encode distinguishable spectral signatures into the geometry of magnetic microstructures. Although based on different physical principles from those of optically probed nanoparticles, these geometrically defined magnetic microstructures permit a multiplexing functionality in the magnetic resonance radio-frequency spectrum that is in many ways analogous to that permitted by quantum dots in the optical spectrum. Additionally, in situ modification of particle geometries may facilitate radio-frequency probing of various local physiological variables.	[Zabow, Gary; Dodd, Stephen; Koretsky, Alan] Natl Inst Neurol Disorders & Stroke, Lab Funct & Mol Imaging, NIH, Bethesda, MD 20892 USA; [Zabow, Gary; Moreland, John] NIST, Electromagnet Div, Boulder, CO 80305 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institute of Standards & Technology (NIST) - USA	Zabow, G (corresponding author), Natl Inst Neurol Disorders & Stroke, Lab Funct & Mol Imaging, NIH, Bethesda, MD 20892 USA.	zabow@boulder.nist.gov	Koretsky, Alan P/C-7940-2015; Moreland, John/AAJ-1973-2020	Koretsky, Alan P/0000-0002-8085-4756; Zabow, Gary/0000-0002-1421-8540	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003047] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 NS003047-01] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Alivisatos P, 2004, NAT BIOTECHNOL, V22, P47, DOI 10.1038/nbt927; ASHKIN A, 1989, P NATL ACAD SCI USA, V86, P7914, DOI 10.1073/pnas.86.20.7914; Bozorth R.M., 1951, FERROMAGNETISM; Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013; Bulte JWM, 2001, NAT BIOTECHNOL, V19, P1141, DOI 10.1038/nbt1201-1141; Callaghan P., 1991, PRINCIPLES NUCL MAGN; Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016; Chikazumi S., 1997, PHYS FERROMAGNETISM; Cunningham CH, 2005, MAGNET RESON MED, V53, P999, DOI 10.1002/mrm.20477; Dodd SJ, 1999, BIOPHYS J, V76, P103, DOI 10.1016/S0006-3495(99)77182-1; Elghanian R, 1997, SCIENCE, V277, P1078, DOI 10.1126/science.277.5329.1078; GRAD J, 1990, J MAGN RESON, V90, P1, DOI 10.1016/0022-2364(90)90361-C; Haes AJ, 2002, J AM CHEM SOC, V124, P10596, DOI 10.1021/ja020393x; Henkelman RM, 2001, NMR BIOMED, V14, P57, DOI 10.1002/nbm.683; Hinds KA, 2003, BLOOD, V102, P867, DOI 10.1182/blood-2002-12-3669; Kotzar G, 2002, BIOMATERIALS, V23, P2737, DOI 10.1016/S0142-9612(02)00007-8; Lanza GM, 2005, CURR TOP DEV BIOL, V70, P57, DOI 10.1016/S0070-2153(05)70003-X; LAUTERBUR PC, 1973, NATURE, V242, P190, DOI 10.1038/242190a0; MANSFIELD P, 1973, J PHYS C SOLID STATE, V6, pL422, DOI 10.1088/0022-3719/6/22/007; Mason W.T., 1999, FLUORESCENT LUMINESC; NELSON KL, 1995, TOP MAGN RESON IMAG, V7, P124; Nicewarner-Pena SR, 2001, SCIENCE, V294, P137, DOI 10.1126/science.294.5540.137; OLSON DL, 1995, SCIENCE, V270, P1967, DOI 10.1126/science.270.5244.1967; RUNGE VM, 1995, TOP MAGN RESON IMAG, V7, P181; SATO M, 1983, J CELL BIOL, V97, P1089, DOI 10.1083/jcb.97.4.1089; Shapiro EM, 2005, MAGNET RESON MED, V53, P329, DOI 10.1002/mrm.20342; Shellock FG, 1999, J MAGN RESON IMAGING, V10, P477, DOI 10.1002/(SICI)1522-2586(199909)10:3<477::AID-JMRI33>3.0.CO;2-E; Voskerician G, 2003, BIOMATERIALS, V24, P1959, DOI 10.1016/S0142-9612(02)00565-3; WEISSLEDER R, 1990, RADIOLOGY, V175, P489, DOI 10.1148/radiology.175.2.2326474; Woods M, 2006, CHEM SOC REV, V35, P500, DOI 10.1039/b509907m; Wu YL, 2006, P NATL ACAD SCI USA, V103, P1852, DOI 10.1073/pnas.0507198103; Zurkiya O, 2006, MAGN RESON MED, V56, P726, DOI 10.1002/mrm.21024	32	102	109	0	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2008	453	7198					1058	U2		10.1038/nature07048	http://dx.doi.org/10.1038/nature07048			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314WM	18563157	Green Accepted			2022-12-28	WOS:000256839900048
J	Sharp, D				Sharp, David			Healthy walking spoiled	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Sharp, D (corresponding author), The Lancet, London NW1 7BY, England.							FARAHMAND B, 2008, SCAND J MED SCI 0527; McGwin G, 2008, J TRAUMA, V64, P1562, DOI 10.1097/TA.0b013e3181238d39; Parkkari J, 2000, AM J MED, V109, P102, DOI 10.1016/S0002-9343(00)00455-1; Watson DS, 2008, AM J PREV MED, V35, P55, DOI 10.1016/j.amepre.2008.03.029; Wells Claudia, 2008, Health Stat Q, P6; 2008, GOLFING CAN BE GOOD	6	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN-JUL	2008	371	9631					2158	2158		10.1016/S0140-6736(08)60934-4	http://dx.doi.org/10.1016/S0140-6736(08)60934-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	326CP	18586161				2022-12-28	WOS:000257635800010
J	Mancera, E; Bourgon, R; Brozzi, A; Huber, W; Steinmetz, LM				Mancera, Eugenio; Bourgon, Richard; Brozzi, Alessandro; Huber, Wolfgang; Steinmetz, Lars M.			High-resolution mapping of meiotic crossovers and non-crossovers in yeast	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; GENE CONVERSION; CROSSING-OVER; HOT-SPOTS; RECOMBINATION HOTSPOTS; MEIOSIS; DNA; EVOLUTION; GENOME; BIOINFORMATICS	Meiotic recombination has a central role in the evolution of sexually reproducing organisms. The two recombination outcomes, crossover and non-crossover, increase genetic diversity, but have the potential to homogenize alleles by gene conversion. Whereas crossover rates vary considerably across the genome, non-crossovers and gene conversions have only been identified in a handful of loci. To examine recombination genome wide and at high spatial resolution, we generated maps of crossovers, crossover-associated gene conversion and non-crossover gene conversion using dense genetic marker data collected from all four products of fifty-six yeast (Saccharomyces cerevisiae) meioses. Our maps reveal differences in the distributions of crossovers and non-crossovers, showing more regions where either crossovers or non-crossovers are favoured than expected by chance. Furthermore, we detect evidence for interference between crossovers and non-crossovers, a phenomenon previously only known to occur between crossovers. Up to 1% of the genome of each meiotic product is subject to gene conversion in a single meiosis, with detectable bias towards GC nucleotides. To our knowledge the maps represent the first high-resolution, genome-wide characterization of the multiple outcomes of recombination in any organism. In addition, because non-crossover hotspots create holes of reduced linkage within haplotype blocks, our results stress the need to incorporate non-crossovers into genetic linkage analysis.	[Mancera, Eugenio; Steinmetz, Lars M.] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Bourgon, Richard; Brozzi, Alessandro; Huber, Wolfgang] European Bioinformat Inst, European Mol Biol Lab, Cambridge CB10 1SD, England	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL)	Steinmetz, LM (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	larsms@embl.de	Mancera, Eugenio/M-6334-2016	Mancera, Eugenio/0000-0003-0146-8732; Steinmetz, Lars/0000-0002-3962-2865; Huber, Wolfgang/0000-0002-0474-2218; Bourgon, Richard/0000-0002-5890-4374	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG000205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068717] Funding Source: NIH RePORTER; NHGRI NIH HHS [P01 HG000205-19, P01 HG000205] Funding Source: Medline; NIGMS NIH HHS [R01 GM068717-06, R01 GM068717] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Ardlie K, 2001, AM J HUM GENET, V69, P582, DOI 10.1086/323251; Argueso JL, 2004, GENETICS, V168, P1805, DOI 10.1534/genetics.104.032912; Baudat F, 1997, P NATL ACAD SCI USA, V94, P5213, DOI 10.1073/pnas.94.10.5213; Baudat F, 2007, CHROMOSOME RES, V15, P565, DOI 10.1007/s10577-007-1140-3; Birdsell JA, 2002, MOL BIOL EVOL, V19, P1181, DOI 10.1093/oxfordjournals.molbev.a004176; Bishop DK, 2004, CELL, V117, P9, DOI 10.1016/S0092-8674(04)00297-1; Blitzblau HG, 2007, CURR BIOL, V17, P2003, DOI 10.1016/j.cub.2007.10.066; Borde V, 2004, MOL CELL, V13, P389, DOI 10.1016/S1097-2765(04)00034-6; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; BORTS RH, 1989, GENETICS, V123, P69; BORTS RH, 1987, SCIENCE, V237, P1459, DOI 10.1126/science.2820060; Buhler C, 2007, PLOS BIOL, V5, P2797, DOI 10.1371/journal.pbio.0050324; Chen JM, 2007, NAT REV GENET, V8, P762, DOI 10.1038/nrg2193; Chen WL, 1999, GENETICS, V151, P1299; Cherry JM, 1997, NATURE, V387, P67, DOI 10.1038/387s067; Coop G, 2008, SCIENCE, V319, P1395, DOI 10.1126/science.1151851; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Gordo I, 2001, CURR BIOL, V11, pR684, DOI 10.1016/S0960-9822(01)00408-0; Hillers KJ, 2004, CURR BIOL, V14, pR1036, DOI 10.1016/j.cub.2004.11.038; Hollingsworth NM, 2004, GENE DEV, V18, P117, DOI 10.1101/gad.1165904; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Hurles Matthew, 2005, Human Genomics, V2, P179; Jeffreys AJ, 2004, NAT GENET, V36, P151, DOI 10.1038/ng1287; Kleckner N, 2004, P NATL ACAD SCI USA, V101, P12592, DOI 10.1073/pnas.0402724101; Kunz C, 2004, CURR BIOL, V14, pR962, DOI 10.1016/j.cub.2004.10.043; Lichten M, 1995, ANNU REV GENET, V29, P423, DOI 10.1146/annurev.ge.29.120195.002231; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Malkova A, 2004, GENETICS, V168, P49, DOI 10.1534/genetics.104.027961; Martini E, 2006, CELL, V126, P285, DOI 10.1016/j.cell.2006.05.044; MCCUSKER JH, 1994, GENETICS, V136, P1261; Merker JD, 2003, GENETICS, V165, P47; MORTIMER RK, 1986, GENETICS, V113, P35; Oh SD, 2007, CELL, V130, P259, DOI 10.1016/j.cell.2007.05.035; Page SL, 2003, SCIENCE, V301, P785, DOI 10.1126/science.1086605; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; Primig M, 2000, NAT GENET, V26, P415, DOI 10.1038/82539; ROCKMILL B, 1995, GENE DEV, V9, P2684, DOI 10.1101/gad.9.21.2684; ROSSMACDONALD P, 1994, CELL, V79, P1069, DOI 10.1016/0092-8674(94)90037-X; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Terasawa M, 2007, P NATL ACAD SCI USA, V104, P5965, DOI 10.1073/pnas.0611490104; Wall JD, 2004, NAT GENET, V36, P114, DOI 10.1038/ng0204-114; Wei W, 2007, P NATL ACAD SCI USA, V104, P12825, DOI 10.1073/pnas.0701291104; WEINER BM, 1994, CELL, V77, P977, DOI 10.1016/0092-8674(94)90438-3; Whitby MC, 2005, BIOCHEM SOC T, V33, P1451, DOI 10.1042/BST0331451	49	432	436	2	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 24	2008	454	7203					479	U1		10.1038/nature07135	http://dx.doi.org/10.1038/nature07135			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329IC	18615017	Green Accepted			2022-12-28	WOS:000257860300043
J	Clarke, SE; Jukes, MCH; Njagi, JK; Khasakhala, L; Cundill, B; Otido, J; Crudder, C; Estambale, BBA; Brooker, S				Clarke, Sian E.; Jukes, Matthew C. H.; Njagi, J. Kiambo; Khasakhala, Lincoln; Cundill, Bonnie; Otido, Julius; Crudder, Christopher; Estambale, Benson B. A.; Brooker, Simon			Effect of intermittent preventive treatment of malaria on health and education in schoolchildren: a cluster-randomised, double-blind, placebo-controlled trial	LANCET			English	Article							PLASMODIUM-FALCIPARUM; HEMOGLOBIN LEVELS; IMPACT; CHILDREN; TRANSMISSION; ANEMIA; CHEMOPROPHYLAXIS; CONSEQUENCES; EPIDEMIOLOGY; PERFORMANCE	Background Malaria is a major cause of morbidity and mortality in early childhood, yet its consequences for health and education during the school-age years remain poorly understood. We examined the effect of intermittent preventive treatment (IPT) in reducing anaemia and improving classroom attention and educational achievement in semi-immune schoolchildren in an area of high perennial transmission. Methods A stratified, cluster-randomised, double-blind, placebo-controlled trial of IPT was done in 30 primary schools in western Kenya. Schools were randomly assigned to treatment (sulfadoxine-pyrimethamine in combination with amodiaquine or dual placebo) by use of a computer-generated list. Children aged 5-18 years received three treatments at 4-month intervals (IPT n=3535, placebo n=3223). The primary endpoint was the prevalence of anaemia, defined as a haemoglobin concentration below 110 g/L. This outcome was assessed through cross-sectional surveys 12 months post-intervention. Analysis was by both intention to treat, excluding children with missing data, and per protocol. This study is registered with ClinicalTrials.gov, number NCT00142246. Findings 2604 children in the IPT group and 2302 in the placebo group were included in the intention-to-treat analysis of the primary outcome; the main reason for exclusion was loss to follow-up. Prevalence of anaemia at 12 months averaged 6.3% in the IPT group and 12.6% in the placebo group (adjusted risk ratio 0 . 52, 95% Cl 0 . 29-0.93; p=0 . 028). Significant improvements were also seen in two of the class-based tests of sustained attention, with a mean increase in code transmission test score of 6.05 (95% Cl 2.83-9.27; p=0 . 0007) and counting sounds test score of 1 . 80 (0 . 19-3.41; p=0.03), compared with controls. No effect was shown for inattentive or hyperactive-compulsive behaviours or on educational achievement. The per-protocol analysis yielded similar results. 23 serious adverse events were reported within 28 days of any treatment (19 in the IPT group and four in the placebo group); the main side-effects were problems of balance, dizziness, feeling faint, nausea, and/or vomiting shortly after treatment. Interpretation IPT of malaria improves the health and cognitive ability of semi-immune schoolchildren. Effective malaria interventions could be a valuable addition to school health programmes. Funding Gates Malaria Partnership, the Norwegian Education Trust Fund and multidonor Education Development Programme Fund of the World Bank, DBL Centre for Health Research and Development, and the Wellcome Trust.	[Clarke, Sian E.; Cundill, Bonnie; Crudder, Christopher; Brooker, Simon] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Jukes, Matthew C. H.] Harvard Univ, Cambridge, MA 02138 USA; [Njagi, J. Kiambo] Minist Hlth, Div Malaria Control, Nairobi, Kenya; [Khasakhala, Lincoln] African Mental Hlth Fdn, Nairobi, Kenya; [Otido, Julius; Estambale, Benson B. A.] Univ Nairobi, Inst Trop & Infect Dis, Nairobi, Kenya; [Brooker, Simon] KEMRI Wellcome Trust Collaborat Programme, Malaria Publ Hlth & Epidemiol Grp, Ctr Geog Med Res Coast, Nairobi, Kenya	University of London; London School of Hygiene & Tropical Medicine; Harvard University; University of Nairobi	Clarke, SE (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	sian.clarke@lshtm.ac.uk	Jukes, Matthew/AAD-1961-2021; Clarke, Sian/AAF-5805-2019	Jukes, Matthew/0000-0001-6001-041X; Magnussen, Pascal/0000-0001-7372-0250; Cundill, Bonnie/0000-0002-3648-820X	Wellcome Trust [081673, 084933] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Beasley NMR, 1999, TROP MED INT HEALTH, V4, P744, DOI 10.1046/j.1365-3156.1999.00486.x; BEIER JC, 1994, AM J TROP MED HYG, V50, P529, DOI 10.4269/ajtmh.1994.50.529; Bennett S, 2002, INT J EPIDEMIOL, V31, P839, DOI 10.1093/ije/31.4.839; Bloland PB, 1999, AM J TROP MED HYG, V60, P641, DOI 10.4269/ajtmh.1999.60.641; Brooker S, 2000, PARASITOL TODAY, V16, P183, DOI 10.1016/S0169-4758(00)01663-X; Brooker S, 2001, ANN TROP MED PARASIT, V95, P343, DOI 10.1080/00034980120063437; Brooker S, 2008, T ROY SOC TROP MED H, V102, P304, DOI 10.1016/j.trstmh.2008.01.010; Brooker S, 2007, AM J TROP MED HYG, V77, P88, DOI 10.4269/ajtmh.2007.77.88; Bundy DAP, 2000, PARASITOL TODAY, V16, P181, DOI 10.1016/S0169-4758(00)01658-6; Bundy DAP, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1091; Clarke SE, 2004, AM J TROP MED HYG, V71, P732, DOI 10.4269/ajtmh.2004.71.732; COLBOURNE M. J., 1955, TRANS ROY SOC TROP MED AND HYG, V49, P356, DOI 10.1016/0035-9203(55)90058-4; Fernando D, 2006, AM J TROP MED HYG, V74, P386, DOI 10.4269/ajtmh.2006.74.386; Fernando SD, 2003, AM J TROP MED HYG, V69, P582, DOI 10.4269/ajtmh.2003.69.582; Geerligs PDP, 2003, B WORLD HEALTH ORGAN, V81, P205; Grantham-McGregor S, 2001, J NUTR, V131, p649S, DOI 10.1093/jn/131.2.649S; Greenwood B, 2004, AM J TROP MED HYG, V70, P1; GREENWOOD BM, 1991, MALARIA : WAITING FOR THE VACCINE, P83; Gulani A, 2007, BMJ-BRIT MED J, V334, P1095, DOI 10.1136/bmj.39150.510475.AE; Hall A, 2002, PUBLIC HEALTH NUTR, V5, P413, DOI 10.1079/PHN2001327; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; Hettiarachchi M, 2008, EUR J CLIN NUTR, V62, P856, DOI 10.1038/sj.ejcn.1602791; Holding PA, 2001, AM J TROP MED HYG, V64, P68, DOI 10.4269/ajtmh.2001.64.68; Jukes MCH, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010019; JUKES MCH, 2007, SCH HLTH NUTR ED ALL; Kihara M, 2006, TROP MED INT HEALTH, V11, P386, DOI 10.1111/j.1365-3156.2006.01579.x; Kurtzhals JAL, 1999, T ROY SOC TROP MED H, V93, P623, DOI 10.1016/S0035-9203(99)90073-1; Lalloo DG, 2006, LANCET INFECT DIS, V6, P780, DOI 10.1016/S1473-3099(06)70655-7; Leenstra T, 2003, AM J TROP MED HYG, V68, P86, DOI 10.4269/ajtmh.2003.68.86; Longfils P, 2005, NUTR REV, V63, pS139, DOI 10.1301/nr.2005.dec.S139-S145; Manly T., 1999, TEST EVERYDAY ATTENT; McCarney S. B., 1995, EARLY CHILDHOOD ATTE; Menendez C, 2000, PARASITOL TODAY, V16, P469, DOI 10.1016/S0169-4758(00)01774-9; Risonar MGD, 2008, EUR J CLIN NUTR, V62, P991, DOI 10.1038/sj.ejcn.1602809; Snow RW, 2002, ADV PARASIT, V52, P235, DOI 10.1016/S0065-308X(02)52013-3; SOEMANTRI AG, 1985, AM J CLIN NUTR, V42, P1221, DOI 10.1093/ajcn/42.6.1221; STEPHENSON LS, 1989, AM J TROP MED HYG, V41, P436, DOI 10.4269/ajtmh.1989.41.436; White NJ, 2005, PLOS MED, V2, P28, DOI 10.1371/journal.pmed.0020003	38	138	138	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 12	2008	372	9633					127	138		10.1016/S0140-6736(08)61034-X	http://dx.doi.org/10.1016/S0140-6736(08)61034-X			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	324XJ	18620950	Green Published, Green Accepted			2022-12-28	WOS:000257552400027
J	Van Horn, RC; Watts, HE; Holekamp, KE				Van Horn, Russell C.; Watts, Heather E.; Holekamp, Kay E.			Do female hyaenas choose mates based on tenure?	NATURE			English	Letter							HYENA CROCUTA-CROCUTA; SPOTTED HYENA; BIASED DISPERSAL; NEPOTISM		[Van Horn, Russell C.] Zool Soc San Diego, Conservat & Res Endangered Species, San Diego, CA 92112 USA; [Van Horn, Russell C.; Watts, Heather E.; Holekamp, Kay E.] Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA	Zoological Society of San Diego; Michigan State University	Van Horn, RC (corresponding author), Zool Soc San Diego, Conservat & Res Endangered Species, POB 120551, San Diego, CA 92112 USA.	rvanhorn@sandiegozoo.org	Holekamp, Kay E/G-6054-2010	Watts, Heather/0000-0002-9888-825X; Van Horn, Russell/0000-0002-5789-8822				Boydston EE, 2005, J ZOOL, V267, P271, DOI 10.1017/S0952836905007478; East ML, 2001, BEHAV ECOL, V12, P558, DOI 10.1093/beheco/12.5.558; Engh AL, 2002, BEHAV ECOL, V13, P193, DOI 10.1093/beheco/13.2.193; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Handley LJL, 2007, MOL ECOL, V16, P1559, DOI 10.1111/j.1365-294X.2006.03152.x; Honer OP, 2007, NATURE, V448, P798, DOI 10.1038/nature06040; Holekamp KE, 1998, HORM BEHAV, V33, P205, DOI 10.1006/hbeh.1998.1450; Lehmann L, 2003, AM NAT, V162, P638, DOI 10.1086/378823; Szykman M, 2007, BEHAVIOUR, V144, P815, DOI 10.1163/156853907781476418; Van Horn RC, 2004, ETHOLOGY, V110, P413, DOI 10.1111/j.1439-0310.2004.00984.x; Van Horn RC, 2003, J MAMMAL, V84, P1019, DOI 10.1644/BBa-023; Wahaj SA, 2004, BEHAV ECOL SOCIOBIOL, V56, P237, DOI 10.1007/s00265-004-0783-8	12	4	4	4	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 10	2008	454	7201					E1	E1		10.1038/nature07122	http://dx.doi.org/10.1038/nature07122			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	323RU	18615020				2022-12-28	WOS:000257466900033
J	Gratwohl, A; Dohler, B; Stern, M; Opelz, G				Gratwohl, Alois; Doehler, Bernd; Stern, Martin; Opelz, Gerhard			H-Y as a minor histocompatibifity antigen in kidney transplantation: a retrospective cohort study	LANCET			English	Article							STEM-CELL TRANSPLANTATION; RENAL-TRANSPLANTATION; GRAFT-SURVIVAL; LYMPHOCYTES-T; DONOR GENDER; HLA; REJECTION; RISK; IMPACT; SEX	Background in haematopoietic stem-cell transplantation, male recipients of female grafts have an increased risk of graft-versus-host disease and female recipients have both an increased risk of rejection of male grafts and of specific T-cell and antibody reactivity against H-Y encoded gene products. By contrast, in kidney transplantation, the role of H-Y as a minor histocompatibility antigen has been disputed. We aimed to investigate whether an immunological H-Y effect occurs in kidney transplantation. Methods We did a retrospective cohort study between 1985 and 2004 in 195 516 recipients of allografts from deceased donors. We used multivariate statistical methods to compare graft survival and death-censored graft survival rates for female and male donor kidneys in female and male recipients at 1 and 10 years. Findings Graft loss was more common with kidneys from female donors than with those from male donors (p<0.001) after both 1 and 10 years. Female recipients had a lower rate of graft failure between the end of the first year and the end of the tenth year (p<0 . 001). Compared with all other combinations of sex, transplantation of male donor kidneys into female recipients was associated with an increased risk of graft failure during the first year (hazard ratio [HR] 1 .08, 95% CI 1.03-1.14, p=0.003; death censored HR 1.11, 1.04-1.19, p=0.003) and between 2 and 10 years (HR 1.06, 1.01-1.10, p=0.008; death censored HR 1.10, 1.05-1.16, p<0.001). Interpretation H-Y minor histocompatibility affects human kidney transplantation. Funding Swiss National Research Foundation; University of Heidelberg, Germany; European Leukemia Net.	[Gratwohl, Alois; Stern, Martin] Univ Basel Hosp, Dept Haematol, CH-4031 Basel, Switzerland; [Doehler, Bernd; Opelz, Gerhard] Heidelberg Univ, Dept Transplantat Immunol, D-6900 Heidelberg, Germany	University of Basel; Ruprecht Karls University Heidelberg	Gratwohl, A (corresponding author), Univ Basel Hosp, Dept Haematol, CH-4031 Basel, Switzerland.	hematology@uhbs.ch	Stern, Martin/C-9385-2012					Bohringer D, 2006, TRANSPLANTATION, V82, P1037, DOI 10.1097/01.tp.0000235908.54766.44; BRENNER BM, 1992, J AM SOC NEPHROL, V3, P162; BRENNER BM, 1993, AM J KIDNEY DIS, V21, P66, DOI 10.1016/0272-6386(93)70097-I; CANDINAS D, 1995, LANCET, V346, P1117, DOI 10.1016/S0140-6736(95)91797-7; COX DR, 1972, J R STAT SOC B, V34, P187; DEBUEGER M, 1992, J IMMUNOL, V149, P1788; EICHWALD EJ, 1955, TRANSPLAN B, V2, P121; Gahrton G, 2005, BONE MARROW TRANSPL, V35, P609, DOI 10.1038/sj.bmt.1704861; GOULMY E, 1978, TRANSPLANTATION, V25, P315, DOI 10.1097/00007890-197806000-00007; GOULMY E, 1977, NATURE, V266, P544, DOI 10.1038/266544a0; GOULMY E, 1982, J EXP MED, V155, P1567, DOI 10.1084/jem.155.5.1567; Gratwohl A, 2003, LANCET, V362, P590, DOI 10.1016/S0140-6736(03)14207-9; Gratwohl A, 2001, Hematol J, V2, P363, DOI 10.1038/sj.thj.6200117; Gratwohl A, 1998, LANCET, V352, P1087, DOI 10.1016/S0140-6736(98)03030-X; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KAWAUCHI M, 1993, ANN THORAC SURG, V55, P716, DOI 10.1016/0003-4975(93)90281-L; Kim YS, 2001, LANCET, V357, P1180, DOI 10.1016/S0140-6736(00)04377-4; Koulack J, 1996, CLIN IMMUNOL IMMUNOP, V80, P273, DOI 10.1006/clin.1996.0123; Kwon OJ, 2004, TRANSPLANT P, V36, P2040, DOI 10.1016/j.transproceed.2004.07.046; Miklos DB, 2005, BLOOD, V105, P2973, DOI 10.1182/blood-2004-09-3660; Nicholson ML, 2000, KIDNEY INT, V58, P390, DOI 10.1046/j.1523-1755.2000.00177.x; Oh CK, 2006, CLIN TRANSPLANT, V20, P163, DOI 10.1111/j.1399-0012.2005.00459.x; PFEFFER PF, 1982, TRANSPLANTATION, V33, P52, DOI 10.1097/00007890-198201000-00011; Poggio ED, 2006, AM J TRANSPLANT, V6, P616, DOI 10.1111/j.1600-6143.2005.01225.x; Prendergast TW, 1998, ANN THORAC SURG, V65, P88, DOI 10.1016/S0003-4975(97)01105-3; Randolph SSB, 2004, BLOOD, V103, P347, DOI 10.1182/blood-2003-07-2603; Roberts DH, 2004, J HEART LUNG TRANSPL, V23, P1252, DOI 10.1016/j.healun.2003.09.014; SCHOLZ D, 1983, Z UROL NEPHROL, V76, P209; Spierings E, 2003, LANCET, V362, P610, DOI 10.1016/S0140-6736(03)14191-8; Stern M, 2006, TRANSPLANTATION, V82, P218, DOI 10.1097/01.tp.0000226156.99206.d1; TAAL MW, 1998, TRANSPLANT REV, V12, P74; TERASAKI PI, 1994, TRANSPLANTATION, V57, P1450, DOI 10.1097/00007890-199405270-00008; *U HEID, COLL TRANSPL STUD; VOOGT PJ, 1990, LANCET, V335, P131, DOI 10.1016/0140-6736(90)90003-N; Zeier M, 2002, J AM SOC NEPHROL, V13, P2570, DOI 10.1097/01.ASN.0000030078.74889.69	35	101	105	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 5	2008	372	9632					49	53		10.1016/S0140-6736(08)60992-7	http://dx.doi.org/10.1016/S0140-6736(08)60992-7			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	321XN	18603158				2022-12-28	WOS:000257339900031
J	Strong, V; Waters, R; Hibberd, C; Murray, G; Wall, L; Walker, J; McHugh, G; Walker, A; Sharpe, M				Strong, Vanessa; Waters, Rachel; Hibberd, Carina; Murray, Gordon; Wall, Lucy; Walker, Jane; McHugh, Gillian; Walker, Andrew; Sharpe, Michael			Management of depression for people with cancer 4 (SMaRT oncology 1): a randomised trial	LANCET			English	Article							COLLABORATIVE CARE; MAJOR DEPRESSION; HOSPITAL ANXIETY; INTERVENTION; DISORDERS; ONCOLOGY; VALIDITY; DESIGN; HEALTH; SCALE	Background Major depressive disorder severely impairs the quality of life of patients with medical disorders such as cancer, but evidence to guide its management is scarce. We aimed to assess the efficacy and cost of a nurse-delivered complex intervention that was designed to treat major depressive disorder in patients who have cancer. Methods We did a randomised trial in a regional cancer Centre in Scotland, UK. 200 outpatients who had cancer with a prognosis of greater than 6 months and major depressive disorder (identified by screening) were eligible and agreed to take part. Their mean age was 56.6 (S D 11 . 9) years, and 141 (71%) were women. We randomly assigned 99 of these participants to usual care, and 101 to usual care plus the intervention, with minimisation for sex, age, diagnosis, and extent of disease. The intervention was delivered by a cancer nurse at the Centre over an average of seven sessions. The primary outcome was the difference in mean score on the self-reported Symptom Checklist-20 depression scale (range 0 to 4) at 3 months after randomisation. Analysis was by intention to treat. This trial is registered as ISRCTN84767225. Findings Primary outcome data were missing for four patients. For 196 patients for whom we had data at 3 months, the adjusted difference in mean Symptom Checklist-20 depression score, between those who received the intervention and those who did not, was 0 . 34 (95% CI 0 . 13-0.55). This treatment effect was sustained at 6 and 12 months. The intervention also improved anxiety and fatigue but not pain or physical functioning. It cost an additional 5278 pound (U S $10 5 5 6) per quality-adjusted life-year gained. Interpretation The intervention-Depression Care for People with Cancer-offers a model for the management of major depressive disorder in patients with cancer and other medical disorders who are attending specialist medical services that is feasible, acceptable, and potentially cost effective. Funding Cancer Research UK.	[Strong, Vanessa; Hibberd, Carina; Wall, Lucy; Walker, Jane; Sharpe, Michael] Univ Edinburgh, Western Gen Hosp, Canc Res Ctr, Edinburgh, Midlothian, Scotland; [Waters, Rachel] Univ Oxford, Ctr Stat Med, Oxford, England; [Murray, Gordon; McHugh, Gillian] Univ Edinburgh, Sch Med, Edinburgh, Midlothian, Scotland; [Walker, Andrew] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland	University of Edinburgh; University of Oxford; University of Edinburgh; University of Glasgow	Sharpe, M (corresponding author), Univ Edinburgh, Royal Edinburgh Hosp, Sch Mol & Clin Med, Kennedy Tower,Morningside Pk, Edinburgh EH10 5HF, Midlothian, Scotland.	Michael.Sharpe@ed.ac.uk		sharpe, michael/0000-0002-6474-9980; Murray, Gordon/0000-0001-9866-4734	Cancer Research UK Funding Source: Medline	Cancer Research UK(Cancer Research UK)		AARONSON NK, 1994, INT J MENT HEALTH, V23, P75, DOI 10.1080/00207411.1994.11449284; Bower P, 2006, BRIT J PSYCHIAT, V189, P484, DOI 10.1192/bjp.bp.106.023655; *BRIT MED ASS ROYA, 2006, BRIT NAT FORM; Cacciola JS, 1999, ASSESSMENT, V6, P235, DOI 10.1177/107319119900600304; Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694; Curtis L, 2006, UNIT COSTS HLTH SOCI; Derogatis L., 1977, SCL 90 R VERSION MAN; Dolan P, 1995, SOCIAL TARIFF EUROQO; Dwight-Johnson M, 2005, PSYCHOSOMATICS, V46, P224, DOI 10.1176/appi.psy.46.3.224; Earle CC, 2000, J CLIN ONCOL, V18, P3302, DOI 10.1200/JCO.2000.18.18.3302; First MB., 1996, STRUCTURED CLIN INTE; FrasureSmith N, 1997, LANCET, V350, P473, DOI 10.1016/S0140-6736(97)02142-9; Gilbody S, 2006, BMJ-BRIT MED J, V332, P1027, DOI 10.1136/bmj.332.7548.1027; Gilbody S, 2006, ARCH INTERN MED, V166, P2314, DOI 10.1001/archinte.166.21.2314; Greenberg Donna B, 2004, J Natl Cancer Inst Monogr, P127; KATON W, 1995, JAMA-J AM MED ASSOC, V273, P1026, DOI 10.1001/jama.273.13.1026; Katon WJ, 2004, ARCH GEN PSYCHIAT, V61, P1042, DOI 10.1001/archpsyc.61.10.1042; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2007, GEN HOSP PSYCHIAT, V29, P506, DOI 10.1016/j.genhosppsych.2007.08.005; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; MYNORSWALLIS LM, 1995, BMJ-BRIT MED J, V310, P441, DOI 10.1136/bmj.310.6977.441; Sharpe M, 2004, BRIT J CANCER, V90, P314, DOI 10.1038/sj.bjc.6601578; Sharpe M, 2004, BRIT J CANCER, V90, P310, DOI 10.1038/sj.bjc.6601546; Simon GE, 2006, PSYCHOL MED, V36, P27, DOI 10.1017/S0033291705006136; Unutzer J, 2002, JAMA-J AM MED ASSOC, V288, P2836, DOI 10.1001/jama.288.22.2836; Ustun TB, 2004, BRIT J PSYCHIAT, V184, P386, DOI 10.1192/bjp.184.5.386; Von Korff M, 2001, J Fam Pract, V50, P530; Walker J, 2007, J PSYCHOSOM RES, V63, P83, DOI 10.1016/j.jpsychores.2007.01.009; Williams A, 1995, ROLE EUROQOL INSTRUM; Williams JW, 2007, GEN HOSP PSYCHIAT, V29, P91, DOI 10.1016/j.genhosppsych.2006.12.003; Williams S, 2006, BRIT J CANCER, V94, P372, DOI 10.1038/sj.bjc.6602949; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	32	228	229	1	27	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 5	2008	372	9632					40	48		10.1016/S0140-6736(08)60991-5	http://dx.doi.org/10.1016/S0140-6736(08)60991-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	321XN	18603157				2022-12-28	WOS:000257339900030
J	Robinson, MS; Murchie, SL; Blewett, DT; Domingue, DL; Hawkins, SE; Head, JW; Holsclaw, GM; McClintock, WE; McCoy, TJ; McNutt, RL; Prockter, LM; Solomon, SC; Watters, TR				Robinson, Mark S.; Murchie, Scott L.; Blewett, David T.; Domingue, Deborah L.; Hawkins, S. Edward, III; Head, James W.; Holsclaw, Gregory M.; McClintock, William E.; McCoy, Timothy J.; McNutt, Ralph L., Jr.; Prockter, Louise M.; Solomon, Sean C.; Watters, Thomas R.			Reflectance and color variations on Mercury: Regolith processes and compositional heterogeneity	SCIENCE			English	Article							HERMEAN REGOLITH; LUNAR; MARINER-10; SPECTRA; ABUNDANCE; IRON	Multispectral images of Mercury obtained by the MESSENGER spacecraft reveal that its surface has an overall relatively low reflectance with three large- scale units identified on the basis of reflectance and slope ( 0.4 to 1.0 micrometer). A higher- reflectance, relatively red material occurs as a distinct class of smooth plains that were likely emplaced volcanically; a lower-reflectance material with a lesser spectral slope may represent a distinct crustal component enriched in opaque minerals, possibly more common at depth. A spectrally intermediate terrain probably forms most of the upper crust. Three other spectrally distinct but spatially restricted units include fresh crater ejecta less affected by space weathering than other surface materials; high- reflectance deposits seen in some crater floors; and moderately high- reflectance, relatively reddish material associated with rimless depressions.	[Robinson, Mark S.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Murchie, Scott L.; Blewett, David T.; Domingue, Deborah L.; Hawkins, S. Edward, III; McNutt, Ralph L., Jr.; Prockter, Louise M.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Head, James W.] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Holsclaw, Gregory M.; McClintock, William E.] Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80303 USA; [McCoy, Timothy J.] Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20560 USA; [Solomon, Sean C.] Carnegie Inst Washington, Dept Terr Magnetism, Washington, DC 20015 USA; [Watters, Thomas R.] Smithsonian Inst, Natl Air & Space Museum, Washington, DC 20013 USA	Arizona State University; Arizona State University-Tempe; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Brown University; University of Colorado System; University of Colorado Boulder; Smithsonian Institution; Smithsonian National Museum of Natural History; Carnegie Institution for Science; Smithsonian Institution	Robinson, MS (corresponding author), Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA.	robinson@ser.asu.edu	Blewett, David T/I-4904-2012; Murchie, Scott L/E-8030-2015; Holsclaw, Greg/AAX-2486-2021; Robinson, Mark/ABI-6841-2020; McNutt, Ralph L/E-8006-2010	Blewett, David T/0000-0002-9241-6358; Murchie, Scott L/0000-0002-1616-8751; Holsclaw, Greg/0000-0002-9059-9437; McNutt, Ralph L/0000-0002-4722-9166; McCoy, Timothy/0000-0002-4573-3553				Blewett DT, 2002, METEORIT PLANET SCI, V37, P1245, DOI 10.1111/j.1945-5100.2002.tb00893.x; CINTALA MJ, 1992, J GEOPHYS RES-PLANET, V97, P947, DOI 10.1029/91JE02207; CLOUTIS EA, 2008, LUNAR PLANET SCI, V39; CLOUTIS EA, 2008, IN PRESS ICARUS; DENEVI BW, 2008, IN PRESS ICARUS; DZURISIN D, 1977, GEOPHYS RES LETT, V4, P383, DOI 10.1029/GL004i010p00383; HAPKE B, 1975, J GEOPHYS RES, V80, P2431, DOI 10.1029/JB080i017p02431; Hapke B, 2001, J GEOPHYS RES-PLANET, V106, P10039, DOI 10.1029/2000JE001338; HAPKE B, 1980, P LUNAR PLANET SCI C, V11, P817; HAWKE BR, 1986, LUNAR PLANET SCI, V17, P999; Hawkins SE, 2007, SPACE SCI REV, V131, P247, DOI 10.1007/sl11214-007-9266-3; Head JW, 2008, SCIENCE, V321, P69, DOI 10.1126/science.1159256; Lucey PG, 2000, J GEOPHYS RES-PLANET, V105, P20297, DOI 10.1029/1999JE001117; McClintock WE, 2008, SCIENCE, V321, P62, DOI 10.1126/science.1159933; MCCORD TB, 1972, ICARUS, V17, P585, DOI 10.1016/0019-1035(72)90024-3; MINNAERT M, 1961, PLANETS SATELLITES, P213; Murchie SL, 2008, SCIENCE, V321, P73, DOI 10.1126/science.1159261; Noble SK, 2003, SOLAR SYST RES+, V37, P31, DOI 10.1023/A:1022395605024; RAVA B, 1987, ICARUS, V71, P397, DOI 10.1016/0019-1035(87)90037-6; RINER MA, 2005, LUNAR PLANET SCI, V36; Robinson MS, 1997, SCIENCE, V275, P197, DOI 10.1126/science.275.5297.197; Robinson MS, 2001, METEORIT PLANET SCI, V36, P841, DOI 10.1111/j.1945-5100.2001.tb01921.x; Sprague AL, 1998, ICARUS, V133, P174, DOI 10.1006/icar.1998.5929; Spudis P.D., 1988, MERCURY, P118; Strom RG, 2008, SCIENCE, V321, P79, DOI 10.1126/science.1159317; Veverka J., 1988, MERCURY, P37; VILAS F, 1988, MERCURY, P59; Warell J, 2004, ICARUS, V167, P271, DOI 10.1016/j.icarus.2003.10.010; Warell J, 2004, ICARUS, V168, P257, DOI 10.1016/j.icarus.2003.10.020; Warell J, 2003, ICARUS, V161, P199, DOI 10.1016/S0019-1035(02)00055-6; [No title captured]	31	142	143	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 4	2008	321	5885					66	69		10.1126/science.1160080	http://dx.doi.org/10.1126/science.1160080			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QE	18599770				2022-12-28	WOS:000257320800034
J	Obermeyer, Z; Murray, CJL; Gakidou, E				Obermeyer, Ziad; Murray, Christopher J. L.; Gakidou, Emmanuela			Fifty years of violent war deaths from Vietnam to Bosnia: analysis of data from the world health survey programme	BMJ-BRITISH MEDICAL JOURNAL			English	Article							VERBAL AUTOPSY PROCEDURES; ADULT MORTALITY; IRAQ; VALIDATION; AMERICAN; CAMBODIA; GENOCIDE	Objective To provide an accurate estimate of violent war deaths. Design Analysis of survey data on mortality, adjusted for sampling bias and censoring, from nationally representative surveys designed to measure population health. Estimated deaths compared with estimates in database of passive reports. Setting 2002-3 World health surveys, in which information was collected from one respondent per household about sibling deaths, including whether such deaths resulted from war injuries. Main outcome measure Estimated deaths from war injuries in 13 countries over 50 years. Results From 1955 to 2002, data from the surveys indicated an estimated 5.4 million violent war deaths (95% confidence interval 3.0 to 8.7 million) in 13 countries, ranging from 7000 in the Democratic Republic of Congo to 3.8 million in Vietnam. From 1995 to 2002 survey data indicate 36 000 war deaths annually (16 000 to 71000) in the 13 countries studied. Data from passive surveillance, however, indicated a figure of only a third of this. On the basis of the relation between world health survey data and passive reports, we estimate 378 000 global war deaths annually from 1985-94, the last years for which complete passive surveillance data were available. Conclusions The use of data on sibling history from peacetime population surveys can retrospectively estimate mortality from war. War causes more deaths than previously estimated, and there is no evidence to support a recent decline in war deaths.	[Obermeyer, Ziad; Murray, Christopher J. L.; Gakidou, Emmanuela] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Obermeyer, Ziad] Harvard Univ, Sch Med, Boston, MA USA	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Harvard University; Harvard Medical School	Obermeyer, Z (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA.	ziad_obermeyer@hms.harvard.edu						Ahmad OB, 2001, AGE STANDARDIZATION, V31, P10; Alkhuzai AH, 2008, NEW ENGL J MED, V358, P484, DOI 10.1056/NEJMsa0707782; Apfelroth S, 2005, LANCET, V365, P1133, DOI 10.1016/S0140-6736(05)71866-3; *ASS PRESS, 2006, IR HLTH MIN EST MAN; *ASS PRESS, 2006, TRIBUNE         1109; Baiden F, 2007, B WORLD HEALTH ORGAN, V85, P570, DOI 10.2471/BLT.07.043745; Ball Patrick, 1999, STATE VIOLENCE GUATE; Bird SM, 2006, LANCET, V367, P1816, DOI 10.1016/S0140-6736(06)68797-7; Bohannon J, 2006, SCIENCE, V314, P396, DOI 10.1126/science.314.5798.396; Boot M, 2003, FOREIGN AFF, V82, P41, DOI 10.2307/20033648; Brunborg H, 2003, EUR J POPUL, V19, P229, DOI 10.1023/A:1024949307841; Burnham G, 2006, LANCET, V368, P1421, DOI 10.1016/S0140-6736(06)69491-9; CHECCHI F, 2008, 52 HUM PRACT NETW; Coghlan B, 2006, LANCET, V367, P44, DOI 10.1016/S0140-6736(06)67923-3; *CTR RES DOC, 2007, RES RES; *CTR RES DOC S, 2007, RES RES; Depoortere E, 2004, LANCET, V364, P1315, DOI 10.1016/S0140-6736(04)17187-0; EASTERBROOK G, 2005, NEW REPUBLIC    0530, P18; Gakidou E, 2004, INT J EPIDEMIOL, V33, P710, DOI 10.1093/ije/dyh099; Gakidou E, 2006, DEMOGRAPHY, V43, P569, DOI 10.1353/dem.2006.0024; Giles J, 2007, NATURE, V446, P6, DOI 10.1038/446006a; Grein T, 2003, BRIT MED J, V327, P650, DOI 10.1136/bmj.327.7416.650; Guha-Sapir D, 2007, LANCET, V369, P102, DOI 10.1016/S0140-6736(07)60061-0; Gurr T.R., 2001, PEACE CONFLICT 2001; Hagan J, 2006, SCIENCE, V313, P1578, DOI 10.1126/science.1127397; Heuveline P, 1998, POP STUD-J DEMOG, V52, P49, DOI 10.1080/0032472031000150176; HILL K, 2003, ADULT MORTALITY DEV; Hirschman C, 1995, POPUL DEV REV, V21, P783, DOI 10.2307/2137774; Huynh, 1993, VIETNAM WAR VIETNAME, P130; *IR BOD COUNT PROJ, 2008, IR BOD COUNT DOC CIV; *IR BOD COUNT PROJ, 2004, IBC RESP LANC STUD E; Jha P, 2007, LANCET, V369, P101, DOI 10.1016/S0140-6736(07)60059-2; JOHNSON N, BIAS EPIDEMIOLOGICAL; KANE D, 2007, LANCET SURVEYS MORTA; Kiernan B, 2003, CRIT ASIAN STUD, V35, P585, DOI 10.1080/1467271032000147041; King G, 2000, AM J POLIT SCI, V44, P347, DOI 10.2307/2669316; KNICKMEYER E, 2006, WASHINGTON POST 1019; Lacina B, 2005, EUR J POPUL, V21, P145, DOI 10.1007/s10680-005-6851-6; Lacina B, 2006, INT STUD QUART, V50, P673, DOI 10.1111/j.1468-2478.2006.00419.x; Lopman BA, 2006, PLOS MED, V3, P1273, DOI 10.1371/journal.pmed.0030312; MACK A, 2008, HUMAN SECURITY REPOR; *MACR INT, 1996, SAMPL MAN DHS 3 BAS; Mueller J, 2003, J PEACE RES, V40, P507, DOI 10.1177/00223433030405001; Murray CJL, 2007, PLOS MED, V4, P1754, DOI 10.1371/journal.pmed.0040326; MURRAY CJL, 2008, POPULATION HLTH METR; MURRAY CJL, POPULATION HLTH METR; Neupert RF, 2005, EUR J POPUL, V21, P217, DOI 10.1007/s10680-005-6854-3; Roberts L, 2004, LANCET, V364, P1857, DOI 10.1016/S0140-6736(04)17441-2; Rummel R. J., 1991, CHINAS BLOODY CENTUR; Setel PW, 2006, PLOS MED, V3, P1282, DOI 10.1371/journal.pmed.0030268; Spiegel PB, 2000, LANCET, V355, P2204, DOI 10.1016/S0140-6736(00)02404-1; Tabeau E, 2005, EUR J POPUL, V21, P187, DOI 10.1007/s10680-005-6852-5; *UG MIN HLTH, 2005, HLTH MORTALITY SURVE; United Nations, 2007, UN COMM DAT; Ustun TB, 2001, WHO MULTICOUNTRY SUR; VALENCIANO M, 2004, RETROSPECTIVE MORTAL; Verwimp, 2007, BOSNIAN BOOK DEAD AS; Yang GH, 2006, INT J EPIDEMIOL, V35, P741, DOI 10.1093/ije/dyi181; Zeger SL, 2007, SIGNIFICANCE, V4, P54; [No title captured]	60	75	75	2	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 28	2008	336	7659					1482A	1486		10.1136/bmj.a137	http://dx.doi.org/10.1136/bmj.a137			22	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	324GN	18566045	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000257505900036
J	Ye, J; Kimble, HJ; Katori, H				Ye, Jun; Kimble, H. J.; Katori, Hidetoshi			Quantum state engineering and precision metrology using state-insensitive light traps	SCIENCE			English	Review							OPTICAL CAVITY; SINGLE ATOMS; LATTICE CLOCK; COMMUNICATION; DYNAMICS	Precision metrology and quantum measurement often demand that matter be prepared in well-defined quantum states for both internal and external degrees of freedom. Laser- cooled neutral atoms localized in a deeply confining optical potential satisfy this requirement. With an appropriate choice of wavelength and polarization for the optical trap, two electronic states of an atom can experience the same trapping potential, permitting coherent control of electronic transitions independent of the atomic center- of- mass motion. Here, we review a number of recent experiments that use this approach to investigate precision quantum metrology for optical atomic clocks and coherent control of optical interactions of single atoms and photons within the context of cavity quantum electrodynamics. We also provide a brief survey of promising prospects for future work.	[Ye, Jun] Natl Inst Stand & Technol, Joint Inst Lab Astrophys, Boulder, CO 80309 USA; [Ye, Jun] Univ Colorado, Boulder, CO 80309 USA; [Kimble, H. J.] CALTECH, Norman Bridge Lab Phys 12 33, Pasadena, CA 91125 USA; [Katori, Hidetoshi] Univ Tokyo, Dept Appl Phys, Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan	National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder; California Institute of Technology; University of Tokyo	Ye, J (corresponding author), Natl Inst Stand & Technol, Joint Inst Lab Astrophys, Boulder, CO 80309 USA.	ye@jila.colorado.edu	Katori, Hidetoshi/E-6633-2012; Ye, Jun/C-3312-2011	Katori, Hidetoshi/0000-0002-8500-3678; Ye, Jun/0000-0003-0076-2112				Aoki T, 2006, NATURE, V443, P671, DOI 10.1038/nature05147; Baillard X, 2008, EUR PHYS J D, V48, P11, DOI 10.1140/epjd/e2007-00330-3; Barber ZW, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.083002; Birnbaum KM, 2005, NATURE, V436, P87, DOI 10.1038/nature03804; Blatt S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.140801; Boca A, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.233603; Boiron D, 1996, PHYS REV A, V53, pR3734, DOI 10.1103/PhysRevA.53.R3734; Boozer AD, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.193601; Boozer AD, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.083602; Boyd MM, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.022510; Boyd MM, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.083002; Boyd MM, 2006, SCIENCE, V314, P1430, DOI 10.1126/science.1133732; Brennecke F, 2007, NATURE, V450, P268, DOI 10.1038/nature06120; Brusch A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.103003; CAVES CM, 1987, PHYS REV A, V36, P5543, DOI 10.1103/PhysRevA.36.5543; Cerf N. J., 2007, QUANTUM INFORMATION; Cirac JI, 1997, PHYS REV LETT, V78, P3221, DOI 10.1103/PhysRevLett.78.3221; Colombe Y, 2007, NATURE, V450, P272, DOI 10.1038/nature06331; Domokos P, 2003, J OPT SOC AM B, V20, P1098, DOI 10.1364/JOSAB.20.001098; Duan LM, 2001, NATURE, V414, P413, DOI 10.1038/35106500; Foreman SM, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2437069; Fortier KM, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.233601; GORDON JP, 1980, PHYS REV A, V21, P1606, DOI 10.1103/PhysRevA.21.1606; Gupta S, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.213601; Hachisu H, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.053001; HALL JL, 1989, J OPT SOC AM B, V6, P2194, DOI 10.1364/JOSAB.6.002194; Heavner TP, 2005, METROLOGIA, V42, P411, DOI 10.1088/0026-1394/42/5/012; Hijlkema M, 2007, NAT PHYS, V3, P253, DOI 10.1038/nphys569; Katori H, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.173005; Katori H, 1999, PHYS REV LETT, V82, P1116, DOI 10.1103/PhysRevLett.82.1116; Katori H, 1999, J PHYS SOC JPN, V68, P2479, DOI 10.1143/JPSJ.68.2479; Keller M, 2004, NATURE, V431, P1075, DOI 10.1038/nature02961; Kim JY, 2003, J KOREAN PHYS SOC, V42, P483; KIMBLE HJ, 1999, LASER SPECTROSCOPY, V14, P80; Le Targat R, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.130801; Leibfried D, 2003, REV MOD PHYS, V75, P281, DOI 10.1103/RevModPhys.75.281; Loftus TH, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.073003; Ludlow AD, 2008, SCIENCE, V319, P1805, DOI 10.1126/science.1153341; Ludlow AD, 2007, OPT LETT, V32, P641, DOI 10.1364/OL.32.000641; Ludlow AD, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.033003; Maunz P, 2004, NATURE, V428, P50, DOI 10.1038/nature02387; McKeever J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.143601; McKeever J, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.133602; Miller R, 2005, J PHYS B-AT MOL OPT, V38, pS551, DOI 10.1088/0953-4075/38/9/007; Mundt AB, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.103001; Nussmann S, 2005, NAT PHYS, V1, P122, DOI 10.1038/nphys120; Rosenband T, 2008, SCIENCE, V319, P1808, DOI 10.1126/science.1154622; Santra R, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.173002; Sauer JA, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.051804; TAIEB R, 1994, PHYS REV A, V49, P4876, DOI 10.1103/PhysRevA.49.4876; Takamoto M, 2005, NATURE, V435, P321, DOI 10.1038/nature03541; Takamoto M, 2006, J PHYS SOC JPN, V75, DOI 10.1143/JPSJ.75.104302; Treutlein P, 2006, FORTSCHR PHYS, V54, P702, DOI 10.1002/prop.200610325; Trupke M, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.063601; Vahala KJ, 2003, NATURE, V424, P839, DOI 10.1038/nature01939; van Enk SJ, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.013407; Vernooy DW, 1997, PHYS REV A, V55, P1239, DOI 10.1103/PhysRevA.55.1239; Vuletic V, 2000, PHYS REV LETT, V84, P3787, DOI 10.1103/PhysRevLett.84.3787; Ye J, 1999, PHYS REV LETT, V83, P4987, DOI 10.1103/PhysRevLett.83.4987; Ye J, 1999, IEEE T INSTRUM MEAS, V48, P608, DOI 10.1109/19.769669; Zelevinsky T, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.043201; Zelevinsky T, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.203201; Zoller P, 2005, EUR PHYS J D, V36, P203, DOI 10.1140/epjd/e2005-00251-1	63	291	296	7	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2008	320	5884					1734	1738		10.1126/science.1148259	http://dx.doi.org/10.1126/science.1148259			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318VP	18583603	Green Accepted, Green Submitted			2022-12-28	WOS:000257121200027
J	Ben-Zvi, D; Shilo, BZ; Fainsod, A; Barkai, N				Ben-Zvi, Danny; Shilo, Ben-Zion; Fainsod, Abraham; Barkai, Naama			Scaling of the BMP activation gradient in Xenopus embryos	NATURE			English	Article							DORSALIZING-MORPHOGENETIC-PROTEIN; DROSOPHILA EMBRYO; TWISTED GASTRULATION; SPEMANN ORGANIZER; NEURAL INDUCTION; AMPHIBIAN EMBRYOS; VENTRAL MESODERM; MARGINAL ZONE; CHORDIN; ANTAGONIST	In groundbreaking experiments, Hans Spemann demonstrated that the dorsal part of the amphibian embryo can generate a well- proportioned tadpole, and that a small group of dorsal cells, the 'organizer', can induce a complete and well- proportioned twinned axis when transplanted into a host embryo. Key to organizer function is the localized secretion of inhibitors of bone morphogenetic protein ( BMP), which defines a graded BMP activation profile. Although the central proteins involved in shaping this gradient are well characterized, their integrated function, and in particular how pattern scales with size, is not understood. Here we present evidence that in Xenopus, the BMP activity gradient is defined by a 'shuttling- based' mechanism, whereby the BMP ligands are translocated ventrally through their association with the BMP inhibitor Chordin. This shuttling, with feedback repression of the BMP ligand Admp, offers a quantitative explanation to Spemann's observations, and accounts naturally for the scaling of embryo pattern with its size.	[Ben-Zvi, Danny; Shilo, Ben-Zion; Barkai, Naama] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Fainsod, Abraham] Hebrew Univ Jerusalem, Dept Cellular Biochem & Human Genet, Fac Med, IL-91120 Jerusalem, Israel; [Barkai, Naama] Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Hebrew University of Jerusalem; Weizmann Institute of Science	Barkai, N (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	fainsod@cc.huji.ac.il; Naama.barkai@weizmann.ac.il	Fainsod, Abraham/AAE-5633-2019	Shilo, Ben Zion/0000-0003-4903-8889; Fainsod, Abraham/0000-0002-6368-0416; Ben-Zvi, Danny/0000-0002-8697-9744				Chang CB, 2001, NATURE, V410, P483, DOI 10.1038/35068583; Collavin L, 2003, DEVELOPMENT, V130, P805, DOI 10.1242/dev.00306; COOKE J, 1981, NATURE, V290, P775, DOI 10.1038/290775a0; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; De Robertis EM, 2006, NAT REV MOL CELL BIO, V7, P296, DOI 10.1038/nrm1855; Decotto E, 2001, DEVELOPMENT, V128, P3831; Dosch R, 2000, MECH DEVELOP, V90, P195, DOI 10.1016/S0925-4773(99)00245-2; Eldar A, 2004, CURR OPIN GENET DEV, V14, P435, DOI 10.1016/j.gde.2004.06.009; Eldar A, 2002, NATURE, V419, P304, DOI 10.1038/nature01061; Fagotto F, 1997, DEVELOPMENT, V124, P453; FAINSOD A, 1994, EMBO J, V13, P5015, DOI 10.1002/j.1460-2075.1994.tb06830.x; Ferguson EL, 1996, CURR OPIN GENET DEV, V6, P424, DOI 10.1016/S0959-437X(96)80063-3; FRANCOIS V, 1995, CELL, V80, P19, DOI 10.1016/0092-8674(95)90446-8; Goodman SA, 1998, DEV BIOL, V195, P144, DOI 10.1006/dbio.1997.8840; HARLAND RM, 1994, CURR OPIN GENET DEV, V4, P543, DOI 10.1016/0959-437X(94)90070-J; Jones CM, 1996, CURR BIOL, V6, P1468, DOI 10.1016/S0960-9822(96)00751-8; Khokha MK, 2005, DEV CELL, V8, P401, DOI 10.1016/j.devcel.2005.01.013; Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; Lander AD, 2002, DEV CELL, V2, P785, DOI 10.1016/S1534-5807(02)00179-X; Larrain J, 2001, DEVELOPMENT, V128, P4439; Lee HX, 2006, CELL, V124, P147, DOI 10.1016/j.cell.2005.12.018; LEMAIRE P, 1995, CELL, V81, P85, DOI 10.1016/0092-8674(95)90373-9; Lowe CJ, 2006, PLOS BIOL, V4, P1603, DOI 10.1371/journal.pbio.0040291; Marom K, 2005, DEV BIOL, V282, P442, DOI 10.1016/j.ydbio.2005.03.024; Marques G, 1997, CELL, V91, P417, DOI 10.1016/S0092-8674(00)80425-0; Meinhardt H, 2002, NATURE, V419, P261, DOI 10.1038/419261a; Meinhardt H, 2006, DEV DYNAM, V235, P2907, DOI 10.1002/dvdy.20952; Mizutani CM, 2005, DEV CELL, V8, P915, DOI 10.1016/j.devcel.2005.04.009; Moos M, 1995, DEVELOPMENT, V121, P4293; O'Connor MB, 2006, DEVELOPMENT, V133, P183; Oelgeschlager M, 2000, NATURE, V405, P757, DOI 10.1038/35015500; Oelgeschlager M, 2003, DEV CELL, V4, P219, DOI 10.1016/S1534-5807(02)00404-5; Ohkawara B, 2002, CURR BIOL, V12, P205, DOI 10.1016/S0960-9822(01)00684-4; Piccolo S, 1997, CELL, V91, P407, DOI 10.1016/S0092-8674(00)80424-9; Reversade B, 2005, CELL, V123, P1147, DOI 10.1016/j.cell.2005.08.047; Reversade B, 2005, DEVELOPMENT, V132, P3381, DOI 10.1242/dev.01901; Ross JJ, 2001, NATURE, V410, P479, DOI 10.1038/35068578; Salic AN, 1997, DEVELOPMENT, V124, P4739; SASAI Y, 1995, NATURE, V376, P333, DOI 10.1038/376333a0; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Shimmi O, 2005, CELL, V120, P873, DOI 10.1016/j.cell.2005.02.009; Sopory S, 2006, J BIOL CHEM, V281, P34021, DOI 10.1074/jbc.M605330200; Spemann H., 1938, EMBRYONIC DEV INDUCT; Spemann Hans., 1924, ROUXS ARCH ENTW MECH, V100, P599, DOI 10.1007/BF02108133; Umulis DM, 2006, P NATL ACAD SCI USA, V103, P11613, DOI 10.1073/pnas.0510398103; van der Zee M, 2006, P NATL ACAD SCI USA, V103, P16307, DOI 10.1073/pnas.0605154103; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Wang YC, 2005, NATURE, V434, P229, DOI 10.1038/nature03318; ZernickaGoetz M, 1996, DEVELOPMENT, V122, P3719	49	187	188	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2008	453	7199					1205	U22		10.1038/nature07059	http://dx.doi.org/10.1038/nature07059			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318FA	18580943				2022-12-28	WOS:000257075800035
J	Cook, N				Cook, Nicholas			Beyond the notes	NATURE			English	Editorial Material									Univ London, Royal Holloway & Bedford New Coll, AHRC Res Ctr Hist & Anal Recorded Mus, Egham TW20 0EX, Surrey, England	UK Research & Innovation (UKRI); Arts & Humanities Research Council (AHRC); University of London; Royal Holloway University London	Cook, N (corresponding author), Univ London, Royal Holloway & Bedford New Coll, AHRC Res Ctr Hist & Anal Recorded Mus, Egham TW20 0EX, Surrey, England.								0	11	12	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 26	2008	453	7199					1186	1187		10.1038/4531186a	http://dx.doi.org/10.1038/4531186a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318FA	18580933	Bronze			2022-12-28	WOS:000257075800026
J	Kramer, EM; Lewandowski, M; Beri, S; Bernard, J; Borkowski, M; Borkowski, MH; Burchfield, LA; Mathisen, B; Normanly, J				Kramer, Eric M.; Lewandowski, Michael; Beri, Satvik; Bernard, Jessica; Borkowski, Matthew; Borkowski, Michael H.; Burchfield, Laura Ann; Mathisen, Brenda; Normanly, Jennifer			Auxin gradients are associated with polarity changes in trees	SCIENCE			English	Article							PATTERN-FORMATION; MODEL; PHYLLOTAXIS		[Kramer, Eric M.; Beri, Satvik; Borkowski, Matthew; Borkowski, Michael H.; Burchfield, Laura Ann; Mathisen, Brenda] Bard Coll Simons Rock, Dept Phys, Great Barrington, MA 01230 USA; Univ Nottingham, Ctr Plant Integrat Biol, Loughborough LE12 5RD, Leics, England; [Lewandowski, Michael; Bernard, Jessica; Normanly, Jennifer] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA	University of Nottingham; University of Massachusetts System; University of Massachusetts Amherst	Kramer, EM (corresponding author), Bard Coll Simons Rock, Dept Phys, Great Barrington, MA 01230 USA.	ekramer@simons-rock.edu	Kramer, Eric M/B-9752-2008	Kramer, Eric/0000-0002-1424-2356				Jonsson H, 2006, P NATL ACAD SCI USA, V103, P1633, DOI 10.1073/pnas.0509839103; Kramer EM, 2004, TREES-STRUCT FUNCT, V18, P493, DOI 10.1007/s00468-004-0322-2; Kramer EM, 2002, J THEOR BIOL, V216, P147, DOI 10.1006/jtbi.2002.2551; Kramer EM, 2006, J PLANT GROWTH REGUL, V25, P290, DOI 10.1007/s00344-006-0065-y; Larson, 1994, VASCULAR CAMBIUM; Mattheck C., 1995, WOOD INTERNAL OPTIMI; Smith RS, 2006, P NATL ACAD SCI USA, V103, P1301, DOI 10.1073/pnas.0510457103; Sztein AE, 2002, PLANT GROWTH REGUL, V36, P201, DOI 10.1023/A:1016586401506	8	20	21	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 20	2008	320	5883					1610	1610		10.1126/science.1156130	http://dx.doi.org/10.1126/science.1156130			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	315NM	18566279				2022-12-28	WOS:000256886700039
J	Thorne, KS				Thorne, Kip S.			Retrospective - John Archibald Wheeler (1911-2008)	SCIENCE			English	Biographical-Item									CALTECH, Pasadena, CA 91125 USA	California Institute of Technology	Thorne, KS (corresponding author), CALTECH, Pasadena, CA 91125 USA.	kip@tapir.caltech.edu							0	2	2	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2008	320	5883					1603	1603		10.1126/science.1159820	http://dx.doi.org/10.1126/science.1159820			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	315NM	18566277				2022-12-28	WOS:000256886700037
J	Olshansky, SJ; Perls, TT				Olshansky, S. Jay; Perls, Thomas T.			New developments in the illegal provision of growth hormone for "anti-aging" and bodybuilding	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Olshansky, S. Jay] Univ Illinois, Div Epidemiol & Biostat, Chicago, IL 60612 USA; [Perls, Thomas T.] Boston Univ, Sch Med, Dept Med, Geriatr Sect, Boston, MA 02118 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Boston University	Olshansky, SJ (corresponding author), Univ Illinois, Div Epidemiol & Biostat, 1603 W Taylor St,Room 885, Chicago, IL 60612 USA.	sjayo@uic.edu		Perls, Thomas/0000-0002-2492-4334				BRAVERMAN ER, 2005, ANTIAGING CLIN PROTO, P39; *COMM OV GOV REF, 2008, COMM HOLDS HEAR MYTH; Gharib Hossein, 2003, Endocr Pract, V9, P64; *HYM PHELPS MCN PC, 2007, FDA LAW BLOG SPEC PH; *INT HORM SOC BIOI, 2007, PRACT APPL TREAT AD; KLATZ RM, ANN INTERN MED  0118; Kwan AYM, 2007, PITUITARY, V10, P151, DOI 10.1007/s11102-007-0028-8; Liu H, 2008, ANN INTERN MED, V148, P747, DOI 10.7326/0003-4819-148-10-200805200-00215; Liu H, 2007, ANN INTERN MED, V146, P104, DOI 10.7326/0003-4819-146-2-200701160-00005; Molitch ME, 2006, J CLIN ENDOCR METAB, V91, P1621, DOI 10.1210/jc.2005-2227; *OFF ALB COUNT DIS, OP WHICH DOCT; QUINN T, DAILY NEWS; Suh Y, 2008, P NATL ACAD SCI USA, V105, P3438, DOI 10.1073/pnas.0705467105; *US FDA, 2007, IMP AL 66 71 DET PHY	14	17	17	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 18	2008	299	23					2792	2794		10.1001/jama.299.23.2792	http://dx.doi.org/10.1001/jama.299.23.2792			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	314JH	18560007				2022-12-28	WOS:000256805200028
J	Chen, YS; Lin, JW; Yu, HY; Ko, WJ; Jerng, JS; Chang, WT; Chen, WJ; Huang, SC; Chi, NH; Wang, CH; Chen, LC; Tsai, PR; Wang, SS; Hwang, JJ; Lin, FY				Chen, Yih-Sharng; Lin, Jou-Wei; Yu, Hsi-Yu; Ko, Wen-Je; Jerng, Jih-Shuin; Chang, Wei-Tien; Chen, Wen-Jone; Huang, Shu-Chien; Chi, Nai-Hsin; Wang, Chih-Hsien; Chen, Li-Chin; Tsai, Pi-Ru; Wang, Sheoi-Shen; Hwang, Juey-Jen; Lin, Fang-Yue			Cardiopulmonary resuscitation with assisted extracorporeal life-support versus conventional cardiopulmonary resuscitation in adults with in-hospital cardiac arrest: an observational study and propensity analysis	LANCET			English	Article							MEMBRANE-OXYGENATION; MYOCARDIAL-INFARCTION; CIRCULATORY SUPPORT; CARDIOGENIC-SHOCK; IMPROVED SURVIVAL; EXPERIENCE; OUTCOMES; CPR; PREDICTION; REGISTRY	Background Extracorporeal life-support as an adjunct to cardiac resuscitation has shown encouraging outcomes in patients with cardiac arrest. However, there is little evidence about the benefit of the procedure compared with conventional cardiopulmonary resuscitation (CPR), especially when continued for more than 10 min. We aimed to assess whether extracorporeal CPR was better than conventional CPR for patients with in-hospital cardiac arrest of cardiac origin. Methods We did a 3-year prospective observational study on the use of extracorporeal life-support for patients aged 18-75 years with witnessed in-hospital cardiac arrest of cardiac origin undergoing CPR of more than 10 min compared with patients receiving conventional CPR. A matching process based on propensity-score was done to equalise potential prognostic factors in both groups, and to formulate a balanced 1:1 matched cohort study. The primary endpoint was survival to hospital discharge, and analysis was by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00173615. Findings Of the 975 patients with in-hospital cardiac arrest events who underwent CPR for longer than 10 min, 113 were enrolled in the conventional CPR group and 59 were ertrolled in the extracorporeal CPR group. Unmatched patients who underwent extracorporeal CPR had a higher survival rate to discharge (log-rank p<0 . 0001) and a better 1-year survival than those who received conventional CPR (log rank p=0.007). Between the propensity-score matched groups, there was still a significant difference in survival to discharge (hazard ratio [HR] 0. 51, 95% CI 0.35-0.74, p<0.0001), 30-day survival (HR 0 .47, 95% CI 0 . 28-0.77, p=0.003), and 1-year survival (HR 0.53, 95% Cl 0.33-0.83, p=0.006) favouring extracorporeal CPR over conventional CPR. Interpretation Extracorporeal CPR had a short-term and long-term survival benefit over conventional CPR in patients with in-hospital cardiac arrest of cardiac origin. Funding National Science Council, Taiwan.	[Chen, Yih-Sharng; Yu, Hsi-Yu; Ko, Wen-Je; Huang, Shu-Chien; Chi, Nai-Hsin; Wang, Chih-Hsien; Tsai, Pi-Ru; Wang, Sheoi-Shen; Lin, Fang-Yue] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Jerng, Jih-Shuin; Chen, Wen-Jone; Chen, Li-Chin; Hwang, Juey-Jen] Natl Taiwan Univ Hosp, Dept Med, Taipei 100, Taiwan; [Chang, Wei-Tien] Natl Taiwan Univ Hosp, Dept Emergency, Taipei 100, Taiwan; [Lin, Jou-Wei; Hwang, Juey-Jen] Natl Taiwan Univ Hosp, Ctr Cardiovasc, Yun Lin Branch, Dou Liou City, Yun Lin, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Lin, FY (corresponding author), Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan.	yschen1234@gmail.com	Huang, Shu-chien/F-7885-2010	Huang, Shu-chien/0000-0002-0590-3474; Chi, Nai-Hsin/0000-0002-4731-1653; WANG, CHIH-HSIEN/0000-0003-3214-6867; Yu, Hsi-Yu/0000-0001-6669-4699; CHI, NAI-HSIN/0000-0003-1829-6084; Hwang, Juey-Jen/0000-0001-6437-0455; Chen, Yih-Sharng/0000-0003-3846-8162; Wang, Shoei-Shen/0000-0003-3201-4143; JERNG, JIH-SHUIN/0000-0002-5324-8523; CHANG, WEI-TIEN/0000-0002-1880-7932; CHEN, WEN-JONE/0000-0002-2098-5922	National Science Council, Taiwan [NSC 93-2314-B-002-235, NSC 94-2314-B-002-121, NSC 95-2745-B-002-232, NSC 96-2314-B-002-166]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	The study was supported by grants from the National Science Council, Taiwan: NSC 93-2314-B-002-235, 94-2314-B-002-121, 95-2745-B-002-232, and 96-2314-B-002-166.	*2005 AM HEART ASS, 2005, CIRCULATION S, V112, P203; Abella BS, 2007, RESUSCITATION, V73, P54, DOI 10.1016/j.resuscitation.2006.10.027; Ahmed A, 2007, EUR HEART J, V28, P1334, DOI 10.1093/eurheartj/ehm091; Alsoufi B, 2007, J THORAC CARDIOV SUR, V134, P952, DOI 10.1016/j.jtcvs.2007.05.054; Chen JS, 2006, CRIT CARE MED, V34, P950, DOI 10.1097/01.CCM.0000206103.35460.1F; Chen YS, 2005, J HEART LUNG TRANSPL, V24, P81, DOI 10.1016/j.healun.2003.09.038; Chen YS, 2004, AM J TRANSPLANT, V4, P1818, DOI 10.1111/j.1600-6143.2004.00578.x; Chen YS, 2003, J AM COLL CARDIOL, V41, P197, DOI 10.1016/S0735-1097(02)02716-X; Chen YS, 2001, J HEART LUNG TRANSPL, V20, P850, DOI 10.1016/S1053-2498(01)00267-4; Cooper S, 2006, RESUSCITATION, V68, P231, DOI 10.1016/j.resuscitation.2005.06.012; Eisenberg MS, 2001, NEW ENGL J MED, V344, P1304, DOI 10.1056/NEJM200104263441707; FEINSTEIN A, 1984, STAT MED, V3, P341, DOI 10.1002/sim.4780030409; Hajbaghery MA, 2005, RESUSCITATION, V66, P317, DOI 10.1016/j.resuscitation.2005.04.004; Haviland A, 2007, PSYCHOL METHODS, V12, P247, DOI 10.1037/1082-989X.12.3.247; Huang SC, 2004, J THORAC CARDIOV SUR, V128, P776, DOI 10.1016/j.jtcvs.2004.03.042; KENNEDY JH, 1966, J AMER MED ASSOC, V197, P615, DOI 10.1001/jama.197.8.615; Ko WJ, 2002, ANN THORAC SURG, V73, P538, DOI 10.1016/S0003-4975(01)03330-6; Kramer-Johansen J, 2007, RESUSCITATION, V74, P406, DOI 10.1016/j.resuscitation.2007.01.024; Massetti M, 2005, ANN THORAC SURG, V79, P178, DOI 10.1016/j.athoracsur.2004.06.095; Morris Marilyn C, 2004, Pediatr Crit Care Med, V5, P440, DOI 10.1097/01.PCC.0000137356.58150.2E; Nagao K, 2000, J AM COLL CARDIOL, V36, P776, DOI 10.1016/S0735-1097(00)00779-8; Peberdy MA, 2003, RESUSCITATION, V58, P297, DOI 10.1016/S0300-9572(03)00215-6; Prohl J, 2007, CRIT CARE MED, V35, P1230, DOI 10.1097/01.CCM.0000261892.10559.85; Schwarz B, 2003, CRIT CARE MED, V31, P758, DOI 10.1097/01.CCM.0000053522.55711.E3; Shih CL, 2007, RESUSCITATION, V72, P394, DOI 10.1016/j.resuscitation.2006.07.020; Smedira NG, 2001, J THORAC CARDIOV SUR, V122, P92, DOI 10.1067/mtc.2001.114351; Sung K, 2006, ANN THORAC SURG, V82, P651, DOI 10.1016/j.athoracsur.2006.03.017; Takasu A, 2007, RESUSCITATION, V73, P394, DOI 10.1016/j.resuscitation.2006.10.014; Tayara W, 2006, J HEART LUNG TRANSPL, V25, P504, DOI 10.1016/j.healun.2005.10.011; Thiagarajan RR, 2007, CIRCULATION, V116, P1693, DOI 10.1161/CIRCULATIONAHA.106.680678	30	752	787	3	37	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 16	2008	372	9638					554	561		10.1016/S0140-6736(08)60958-7	http://dx.doi.org/10.1016/S0140-6736(08)60958-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	339MS	18603291	Green Submitted			2022-12-28	WOS:000258582300029
J	Schuster, MA; Corona, R; Elliott, MN; Kanouse, DE; Eastman, KL; Zhou, AJ; Klein, DJ				Schuster, Mark A.; Corona, Rosalie; Elliott, Marc N.; Kanouse, David E.; Eastman, Karen L.; Zhou, Annie J.; Klein, David J.			Evaluation of Talking Parents, Healthy Teens, a new worksite based parenting programme to promote parent-adolescent communication about sexual health: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RISK BEHAVIORS; INTERCOURSE	Objective To evaluate a worksite based parenting programme-Talking Parents, Healthy Teens-designed to help parents learn to address sexual health with their adolescent children. Design Randomised controlled trial (April 2002-December 2005). Setting 13 worksites in southern California. Participants 569 parents completed baseline surveys at work, gave permission for confidential surveys to be posted to their adolescent children, and were randomised to intervention or control groups. Parents and adolescents completed follow-up surveys at one week, three months, and nine months after the programme. Intervention Talking Parents, Healthy Teens consists of eight weekly one hour sessions at worksites for parents of adolescent children aged in 6th-10th grade (about ages 11-16 years). Main outcome measures Parent-adolescent communication about a list of sexual topics; whether parent taught adolescent how to use a condom; ability to communicate with parent/adolescent about sex; openness of parent-adolescent communication about sex. Results Differences between intervention and control groups were significant for the mean number of new sexual topics that parents and adolescents reported discussing between baseline and each follow-up (P < 0.001 for each); intervention parents were less likely than controls to discuss no new topics (8% v 29%, 95% confidence interval for difference 16% to 24%) and more likely to discuss seven or more new topics (38% v8%,19% to 41%) at nine months. Some differences increased after completion of the programme: at one week after the programme, 18% of adolescents in the intervention group and 3% in the control group (6% to 30%) said that their parents had reviewed how to use a condom since baseline P < 0.001); this grew to 29% v 5% (13% to 36%) at nine months (P<0.001). Compared with controls at nine months, parents and adolescents in the intervention group reported greater ability to communicate with each other about sex (P<0.001) and more openness in communication about sex (P<0.001). Conclusions A worksite based programme can have substantial effects on communication between parents and adolescents about sexual health. Trial registration Clinical Trials NCT00465010.	[Schuster, Mark A.] Childrens Hosp, Boston, MA 02115 USA; [Schuster, Mark A.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Schuster, Mark A.; Elliott, Marc N.; Kanouse, David E.; Zhou, Annie J.; Klein, David J.] RAND Corp, Santa Monica, CA 90407 USA; [Corona, Rosalie] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA; [Schuster, Mark A.; Corona, Rosalie; Elliott, Marc N.; Kanouse, David E.; Eastman, Karen L.; Zhou, Annie J.; Klein, David J.] Univ Calif Los Angeles, UCLA RAND Ctr Adolescent Hlth Promot, Los Angeles, CA 90095 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; RAND Corporation; Virginia Commonwealth University; University of California System; University of California Los Angeles	Schuster, MA (corresponding author), Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.	mark.schuster@childrens.harvard.edu			National Institute of Mental Health [R01 MH61202]; Centers for Disease Control and Prevention [U48/CCU915773, U48/DP000056]; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U48DP000056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061202] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Grant R01 MH61202 from the National Institute of Mental Health and cooperative agreements U48/CCU915773 and U48/DP000056 from the Centers for Disease Control and Prevention.	Chenoweth D. H., 2007, WORKSITE HLTH PROMOT; Coatsworth J Douglas, 2006, J Prim Prev, V27, P171, DOI 10.1007/s10935-005-0028-2; DiClemente RJ, 2001, J PEDIATR-US, V139, P407, DOI 10.1067/mpd.2001.117075; DiIorio C., 2003, J HIVAIDS PREVENTION, V5, P7, DOI [10.1300/J129v05n03_02, DOI 10.1300/J129V05N03_02, DOI 10.1300/J129v05n03_02]; Dittus P, 2004, J CHILD FAM STUD, V13, P5, DOI DOI 10.1023/B:JCFS.0000010487.46007.08; Eastman KL, 2005, PERSPECT SEX REPRO H, V37, P62, DOI 10.1111/j.1931-2393.2005.tb00217.x; FORD L, CAMPAIGNERS RENEW CA; Hagan JF, 2001, PEDIATRICS, V108, P498; Hutchinson MK, 2003, J ADOLESCENT HEALTH, V33, P98, DOI 10.1016/S1054-139X(03)00183-6; Irvine J.M., 2004, TALK SEX BATTLES SEX; Jaccard J, 2000, J ADOLESCENT RES, V15, P187, DOI 10.1177/0743558400152001; JACCARD J, 2002, INT ENCY MARRIAGE FA, P1437; JARQUE CM, 1980, ECON LETT, V6, P255, DOI 10.1016/0165-1765(80)90024-5; Kirby DB, 2004, J ADOLESCENT HEALTH, V35, P442, DOI [10.1016/S1054-139X(04)00071-0, 10.1016/j.jadohealth.2004.02.006]; Kirby Douglas, 2002, New Dir Child Adolesc Dev, P93; KLEIN JD, 2005, J ADOLESCENT HEALTH, V37, P594; Kotchick BA, 2001, CLIN PSYCHOL REV, V21, P493, DOI 10.1016/S0272-7358(99)00070-7; Lammers C, 2000, J ADOLESCENT HEALTH, V26, P42, DOI 10.1016/S1054-139X(99)00041-5; Lefkowitz ES, 2000, CHILD DEV, V71, P1383, DOI 10.1111/1467-8624.00234; Lezin N., 2004, PARENT CHILD CONNECT; Martino SC, 2008, PEDIATRICS, V121, pE612, DOI 10.1542/peds.2007-2156; Meschke LL, 2002, J ADOLESCENT HEALTH, V31, P264, DOI 10.1016/S1054-139X(02)00499-8; Miller BC, 2001, DEV REV, V21, P1, DOI 10.1006/drev.2000.0513; Raffaelli M, 1998, J FAM ISSUES, V19, P315, DOI 10.1177/019251398019003005; Schuster M A, 2001, J Public Health Manag Pract, V7, P41; Schuster M.A., 2006, PREV CHRONIC DIS, V3, P1, DOI DOI 10.HTTP://WWW.CDC.G0V/PED/ISSUES/2006/0CT/06_; Stammers T, 2000, BMJ-BRIT MED J, V321, P1520, DOI 10.1136/bmj.321.7275.1520; Stanton BF, 2000, J ADOLESCENT HEALTH, V26, P18, DOI 10.1016/S1054-139X(99)00022-1; Stone N, 2002, PERSPECT SEX REPRO H, V34, P191, DOI 10.2307/3097729; Torgerson DJ, 2001, BMJ-BRIT MED J, V322, P355, DOI 10.1136/bmj.322.7282.355; *US BUR CENS, ANN DEM SUPPL MARCH; Wellings K, 2005, TEENAGE PREGNANCY ST; Wight D, 2006, J ADOLESCENCE, V29, P473, DOI 10.1016/j.adolescence.2005.08.007	33	47	47	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 2	2008	337	7664							a308	10.1136/bmj.39609.657581.25	http://dx.doi.org/10.1136/bmj.39609.657581.25			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	339EN	18617492	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000258561000028
J	Horton, R				Horton, Richard			The Darzi vision: quality, engagement, and professionalism	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.							*BMA, 2008, BMA LAUNCH ITS NAT S; Darzi A., 2008, HIGH QUALITY CARE AL; Levenson R., 2008, UNDERSTANDING DOCTOR; ROSE D, 2008, TIMES LOND      0625, P14; Royal College of Physicians, 2005, DOCT SOC MED PROF CH	5	9	9	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 5	2008	372	9632					3	4		10.1016/S0140-6736(08)60963-0	http://dx.doi.org/10.1016/S0140-6736(08)60963-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	321XN	18603140				2022-12-28	WOS:000257339900004
J	Schaefer, M; Baker, DJ; Gibbons, JH; Groat, CG; Kennedy, D; Kennel, CF; Rejeski, D				Schaefer, Mark; Baker, D. James; Gibbons, John H.; Groat, Charles G.; Kennedy, Donald; Kennel, Charles F.; Rejeski, David			Science and government - An Earth Systems Science Agency	SCIENCE			English	Editorial Material									[Schaefer, Mark; Groat, Charles G.] US Geol Survey, Reston, VA 20192 USA; [Baker, D. James] NOAA, Washington, DC USA; [Gibbons, John H.] White House Off Sci & Technol Policy, Washington, DC USA; [Kennedy, Donald] US FDA, Rockville, MD 20857 USA; [Kennel, Charles F.] NASA, Mission Planet Earth, Washington, DC 20546 USA	United States Department of the Interior; United States Geological Survey; National Oceanic Atmospheric Admin (NOAA) - USA; US Food & Drug Administration (FDA); National Aeronautics & Space Administration (NASA)	Schaefer, M (corresponding author), US Geol Survey, Reston, VA 20192 USA.	markschaefer24@msn.com; djamesbaker@comcast.net; jackgibbons@hughes.net; cgroat@mail.utexas.edu; kennedyd@stanford.edu; ckennel@ucsd.edu; david.rejeski@wilsoncenter.org		Kennel, Charles/0000-0001-5997-7201				*NASA, 2004, NASA EARTH SCI APPL; *NAT RES COUNC, 2007, REV ASS NASAS APPL S	2	4	4	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 4	2008	321	5885					44	45		10.1126/science.1160192	http://dx.doi.org/10.1126/science.1160192			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QE	18599760				2022-12-28	WOS:000257320800024
J	Solomon, SC; McNutt, RL; Watters, TR; Lawrence, DJ; Feldman, WC; Head, JW; Krimigis, SM; Murchie, SL; Phillips, RJ; Slavin, JA; Zuber, MT				Solomon, Sean C.; McNutt, Ralph L., Jr.; Watters, Thomas R.; Lawrence, David J.; Feldman, William C.; Head, James W.; Krimigis, Stamatios M.; Murchie, Scott L.; Phillips, Roger J.; Slavin, James A.; Zuber, Maria T.			Return to Mercury: A global perspective on MESSENGER's first mercury flyby	SCIENCE			English	Article							MAGNETIC-FIELD; SHELL; SPECTROMETER; SPACECRAFT; CORE	In January 2008, the MErcury Surface, Space ENvironment, GEochemistry, and Ranging ( MESSENGER) spacecraft became the first probe to fly past the planet Mercury in 33 years. The encounter revealed that Mercury is a dynamic system; its liquid iron- rich outer core is coupled through a dominantly dipolar magnetic field to the surface, exosphere, and magnetosphere, all of which interact with the solar wind. MESSENGER images confirm that lobate scarps are the dominant tectonic landform and record global contraction associated with cooling of the planet. The history of contraction can be related to the history of volcanism and cratering, and the total contractional strain is at least one- third greater than inferred from Mariner 10 images. On the basis of measurements of thermal neutrons made during the flyby, the average abundance of iron in Mercury's surface material is less than 6% by weight.	[Solomon, Sean C.] Carnegie Inst Washington, Dept Terr Magnetism, Washington, DC 20015 USA; [McNutt, Ralph L., Jr.; Lawrence, David J.; Krimigis, Stamatios M.; Murchie, Scott L.] Johns Hopkins Univ, Appl Phys Lab, Dept Space, Laurel, MD 20723 USA; [Watters, Thomas R.] Smithsonian Inst, Natl Air & Space Museum, Ctr Earth & Planetary Studies, Washington, DC 20560 USA; [Feldman, William C.] Planetary Sci Inst, Tucson, AZ 85719 USA; [Head, James W.] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Krimigis, Stamatios M.] Acad Athens, Athens 11527, Greece; [Phillips, Roger J.] SW Res Inst, Boulder, CO 80302 USA; [Slavin, James A.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Zuber, Maria T.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	Carnegie Institution for Science; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Smithsonian Institution; Brown University; Academy of Athens; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Massachusetts Institute of Technology (MIT)	Solomon, SC (corresponding author), Carnegie Inst Washington, Dept Terr Magnetism, 5241 Broad Branch Rd NW, Washington, DC 20015 USA.	scs@dtm.ciw.edu	Slavin, James A/H-3170-2012; Lawrence, David J/E-7463-2015; Murchie, Scott L/E-8030-2015; McNutt, Ralph L/E-8006-2010; Krimigis, Stamatios/G-4591-2019	Slavin, James A/0000-0002-9206-724X; Lawrence, David J/0000-0002-7696-6667; Murchie, Scott L/0000-0002-1616-8751; McNutt, Ralph L/0000-0002-4722-9166; Krimigis, Stamatios/0000-0003-2781-2386				Aharonson O, 2004, EARTH PLANET SC LETT, V218, P261, DOI 10.1016/S0012-821X(03)00682-4; Anderson BJ, 2008, SCIENCE, V321, P82, DOI 10.1126/science.1159081; Andrews GB, 2007, SPACE SCI REV, V131, P523, DOI 10.1007/s11214-007-9272-5; Boynton WV, 2007, SPACE SCI REV, V131, P85, DOI 10.1007/s11214-007-9258-3; Chen B, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033311; Christensen UR, 2006, NATURE, V444, P1056, DOI 10.1038/nature05342; FELDMAN WC, 1986, NUCL INSTRUM METH A, V245, P182, DOI 10.1016/0168-9002(86)90274-3; Feldman WC, 2000, J GEOPHYS RES-PLANET, V105, P20347, DOI 10.1029/1999JE001183; Goldsten JO, 2007, SPACE SCI REV, V131, P339, DOI 10.1007/s11214-007-9262-7; Hapke B, 2001, J GEOPHYS RES-PLANET, V106, P10039, DOI 10.1029/2000JE001338; Harder H, 2001, ICARUS, V151, P118, DOI 10.1006/icar.2001.6586; HASKIN L, 1991, LUNAR SOURCEBOOK USE, P357; Hauck SA, 2004, EARTH PLANET SC LETT, V222, P713, DOI 10.1016/j.epsl.2004.03.037; Hawkins SE, 2007, SPACE SCI REV, V131, P247, DOI 10.1007/sl11214-007-9266-3; Head JW, 2008, SCIENCE, V321, P69, DOI 10.1126/science.1159256; Heimpel MH, 2005, EARTH PLANET SC LETT, V236, P542, DOI 10.1016/j.epsl.2005.04.032; Lawrence DJ, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002637; LODDERS K, 1998, PLANETARY SCI COMPAN, P140; Margot JL, 2007, SCIENCE, V316, P710, DOI 10.1126/science.1140514; McAdams JV, 2007, SPACE SCI REV, V131, P219, DOI 10.1007/s11214-007-9162-x; McClintock WE, 2008, SCIENCE, V321, P92, DOI 10.1126/science.1159467; McClintock WE, 2008, SCIENCE, V321, P62, DOI 10.1126/science.1159933; Murchie SL, 2008, SCIENCE, V321, P73, DOI 10.1126/science.1159261; MURRAY BC, 1975, J GEOPHYS RES, V80, P2342, DOI 10.1029/JB080i017p02342; NESS NF, 1975, J GEOPHYS RES-SPACE, V80, P2708, DOI 10.1029/JA080i019p02708; Robinson MS, 2008, SCIENCE, V321, P66, DOI 10.1126/science.1160080; Robinson MS, 2001, METEORIT PLANET SCI, V36, P841, DOI 10.1111/j.1945-5100.2001.tb01921.x; Slavin JA, 2008, SCIENCE, V321, P85, DOI 10.1126/science.1159040; Solomon SC, 2003, EARTH PLANET SC LETT, V216, P441, DOI 10.1016/S0012-821X(03)00546-6; Solomon SC, 2007, SPACE SCI REV, V131, P3, DOI 10.1007/s11214-007-9247-6; Spudis P.D., 1988, MERCURY, P118; Stanley S, 2005, EARTH PLANET SC LETT, V234, P27, DOI 10.1016/j.epsl.2005.02.040; STROM RG, 1975, J GEOPHYS RES, V80, P2478, DOI 10.1029/JB080i017p02478; Strom RG, 2008, SCIENCE, V321, P79, DOI 10.1126/science.1159317; Watters TR, 1998, GEOLOGY, V26, P991, DOI 10.1130/0091-7613(1998)026<0991:TOLSOM>2.3.CO;2; Zuber MT, 2008, SCIENCE, V321, P77, DOI 10.1126/science.1159086; Zurbuchen TH, 2008, SCIENCE, V321, P90, DOI 10.1126/science.1159314	37	126	129	2	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2008	321	5885					59	62		10.1126/science.1159706	http://dx.doi.org/10.1126/science.1159706			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QE	18599768				2022-12-28	WOS:000257320800032
J	Berger, MF; Badis, G; Gehrke, AR; Talukder, S; Philippakis, AA; Pena-Castillo, L; Alleyne, TM; Mnaimneh, S; Botvinnik, OB; Chan, ET; Khalid, F; Zhang, W; Newburger, D; Jaeger, SA; Morris, QD; Bulyk, ML; Hughes, TR				Berger, Michael F.; Badis, Gwenael; Gehrke, Andrew R.; Talukder, Shaheynoor; Philippakis, Anthony A.; Pena-Castillo, Lourdes; Alleyne, Trevis M.; Mnaimneh, Sanie; Botvinnik, Olga B.; Chan, Esther T.; Khalid, Faiqua; Zhang, Wen; Newburger, Daniel; Jaeger, Savina A.; Morris, Quaid D.; Bulyk, Martha L.; Hughes, Timothy R.			Variation in homeodomain DNA binding revealed by high-resolution analysis of sequence preferences	CELL			English	Article							OPEN-ACCESS DATABASE; FUNCTIONAL SPECIFICITY; TRANSCRIPTION FACTORS; ANGSTROM RESOLUTION; STRUCTURAL BASIS; AMINO-ACID; IN-VIVO; RECOGNITION; HOX; PROTEIN	Most homeodomains are unique within a genome, yet many are highly conserved across vast evolutionary distances, implying strong selection on their precise DNA-binding specificities. We determined the binding preferences of the majority (168) of mouse homeodomains to all possible 8-base sequences, revealing rich and complex patterns of sequence specificity and showing that there are at least 65 distinct homeodomain DNA-binding activities. We developed a computational system that successfully predicts binding sites for homeodomain proteins as distant from mouse as Drosophila and C. elegans, and we infer full 8-mer binding profiles for the majority of known animal homeodomains. Our results provide an unprecedented level of resolution in the analysis of this simple domain structure and suggest that variation in sequence recognition may be a factor in its functional diversity and evolutionary success.	[Berger, Michael F.; Gehrke, Andrew R.; Philippakis, Anthony A.; Botvinnik, Olga B.; Newburger, Daniel; Jaeger, Savina A.; Bulyk, Martha L.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Bulyk, Martha L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Bulyk, Martha L.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Pena-Castillo, Lourdes; Mnaimneh, Sanie; Khalid, Faiqua; Morris, Quaid D.; Hughes, Timothy R.] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Badis, Gwenael; Talukder, Shaheynoor; Alleyne, Trevis M.; Chan, Esther T.; Zhang, Wen; Morris, Quaid D.; Hughes, Timothy R.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada; [Philippakis, Anthony A.; Bulyk, Martha L.] Harvard Univ, Sch Med, Harvard Mit Div Hlth Sci & Technol, Boston, MA 02115 USA; [Botvinnik, Olga B.] MIT, Dept Math, Cambridge, MA 02139 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Toronto; University of Toronto; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Bulyk, ML (corresponding author), Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA.	mlbulyk@receptor.med.harvard.edu; t.hughes@utoronto.ca	Morris, Quaid/ABE-8343-2020; Badis-Breard, Gwenael/AAE-3783-2019	Chan, Esther/0000-0002-2406-2623; Badis-Breard, Gwenael/0000-0003-2078-3076; Morris, Quaid/0000-0002-2760-6999; Pena Castillo, Lourdes/0000-0002-0643-2547	NHGRI NIH HHS [R01 HG003985, R01 HG003985-01, R01 HG003985-02] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003985] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Banerjee-Basu S, 2003, NUCLEIC ACIDS RES, V31, P304, DOI 10.1093/nar/gkg118; Benos PV, 2002, NUCLEIC ACIDS RES, V30, P4442, DOI 10.1093/nar/gkf578; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; BLACKWELL TK, 1993, MOL CELL BIOL, V13, P5216, DOI 10.1128/MCB.13.9.5216; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Bult CJ, 2004, NUCLEIC ACIDS RES, V32, pD476, DOI 10.1093/nar/gkh125; Carr A, 1999, EMBO J, V18, P1598, DOI 10.1093/emboj/18.6.1598; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; CATRON KM, 1993, MOL CELL BIOL, V13, P2354, DOI 10.1128/MCB.13.4.2354; CHAN SK, 1993, GENE DEV, V7, P796, DOI 10.1101/gad.7.5.796; CHEN CY, 1995, J BIOL CHEM, V270, P15628, DOI 10.1074/jbc.270.26.15628; Chen XY, 2007, BIOINFORMATICS, V23, pI72, DOI 10.1093/bioinformatics/btm224; Damante G, 1996, EMBO J, V15, P4992, DOI 10.1002/j.1460-2075.1996.tb00879.x; DICKINSON LA, 1992, CELL, V70, P631, DOI 10.1016/0092-8674(92)90432-C; Dudley AM, 2002, P NATL ACAD SCI USA, V99, P7554, DOI 10.1073/pnas.112683499; EKKER SC, 1994, EMBO J, V13, P3551, DOI 10.1002/j.1460-2075.1994.tb06662.x; EKKER SC, 1992, EMBO J, V11, P4059, DOI 10.1002/j.1460-2075.1992.tb05499.x; Fraenkel E, 1998, J MOL BIOL, V284, P351, DOI 10.1006/jmbi.1998.2147; FURUKUBOTOKUNAGA K, 1993, P NATL ACAD SCI USA, V90, P6360, DOI 10.1073/pnas.90.13.6360; Galant R, 2002, DEVELOPMENT, V129, P3115; Han Z, 2005, DEVELOPMENT, V132, P3525, DOI 10.1242/dev.01899; HANES SD, 1989, CELL, V57, P1275, DOI 10.1016/0092-8674(89)90063-9; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Jackson M, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-212; Joshi R, 2007, CELL, V131, P530, DOI 10.1016/j.cell.2007.09.024; KISSINGER CR, 1990, CELL, V63, P579, DOI 10.1016/0092-8674(90)90453-L; Larroux C, 2007, CURR BIOL, V17, P706, DOI 10.1016/j.cub.2007.03.008; LAUGHON A, 1991, BIOCHEMISTRY-US, V30, P11357, DOI 10.1021/bi00112a001; Li MZ, 2005, NAT GENET, V37, P311, DOI 10.1038/ng1505; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; Liberzon A, 2004, NUCLEIC ACIDS RES, V32, P54, DOI 10.1093/nar/gkh156; LIN L, 1992, GENE DEV, V6, P1071, DOI 10.1101/gad.6.6.1071; Mann RS, 1996, TRENDS GENET, V12, P258, DOI 10.1016/0168-9525(96)10026-3; MAO CA, 1994, DEV BIOL, V165, P229, DOI 10.1006/dbio.1994.1249; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Miller JC, 2001, J MOL BIOL, V313, P309, DOI 10.1006/jmbi.2001.4975; Mukherjee S, 2004, NAT GENET, V36, P1331, DOI 10.1038/ng1473; Odom DT, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100059; OVERDIER DG, 1994, MOL CELL BIOL, V14, P2755, DOI 10.1128/MCB.14.4.2755; PHILIPPAKIS AA, 2008, J COMPUT BI IN PRESS; Rajkovic A, 2002, GENOMICS, V79, P711, DOI 10.1006/geno.2002.6759; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Svingen T, 2006, HEREDITY, V97, P88, DOI 10.1038/sj.hdy.6800847; TREISMAN J, 1989, CELL, V59, P553; TuckerKellogg L, 1997, STRUCTURE, V5, P1047, DOI 10.1016/S0969-2126(97)00256-6; Wilson DS, 1999, NAT STRUCT BIOL, V6, P297, DOI 10.1038/7524; Wolberger C, 1996, CURR OPIN STRUC BIOL, V6, P62, DOI 10.1016/S0959-440X(96)80096-0; Wolfe SA, 2001, STRUCTURE, V9, P717, DOI 10.1016/S0969-2126(01)00632-3	49	443	450	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 27	2008	133	7					1266	1276		10.1016/j.cell.2008.05.024	http://dx.doi.org/10.1016/j.cell.2008.05.024			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	319DP	18585359	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000257144600022
J	Gaillardet, J; Galy, A				Gaillardet, Jerome; Galy, Albert			Atmospheric science - Himalaya-carbon sink or source?	SCIENCE			English	Editorial Material							CO2		[Gaillardet, Jerome; Galy, Albert] Univ Paris Diderot, CNRS, Inst Phys Globe, Paris, France; [Galy, Albert] Univ Cambridge, Cambridge CB2 1TN, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; University of Cambridge	Gaillardet, J (corresponding author), Univ Paris Diderot, CNRS, Inst Phys Globe, Paris, France.	gaillardet@ipgp.jussieu.fr	GAILLARDET, Jerome/F-9096-2010; Galy, Albert/M-3101-2019; Galy, Albert/A-8518-2011	GAILLARDET, Jerome/0000-0001-7982-1159; Galy, Albert/0000-0001-9978-4287; Galy, Albert/0000-0001-9978-4287				Becker JA, 2008, EARTH PLANET SC LETT, V265, P616, DOI 10.1016/j.epsl.2007.10.046; BERNER RA, 1983, AM J SCI, V283, P641, DOI 10.2475/ajs.283.7.641; BERNER RA, 1991, AM J SCI, V291, P339, DOI 10.2475/ajs.291.4.339; Evans MJ, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001796; Gaillardet J, 1999, CHEM GEOL, V159, P3, DOI 10.1016/S0009-2541(99)00031-5; Galy V, 2007, NATURE, V450, P407, DOI 10.1038/nature06273; Garrels RM, 1971, EVOLUTION SEDIMENTAR; KERRICK DM, 1993, CHEM GEOL, V108, P201, DOI 10.1016/0009-2541(93)90325-D; RAYMO ME, 1991, GEOLOGY, V19, P344, DOI 10.1130/0091-7613(1991)019<0344:GESTCC>2.3.CO;2; RAYMO ME, 1988, GEOLOGY, V16, P649, DOI 10.1130/0091-7613(1988)016<0649:IOLCMB>2.3.CO;2; WALKER JCG, 1981, J GEOPHYS RES-OCEANS, V86, P9776, DOI 10.1029/JC086iC10p09776	11	58	67	4	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 27	2008	320	5884					1727	1728		10.1126/science.1159279	http://dx.doi.org/10.1126/science.1159279			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318VP	18583600				2022-12-28	WOS:000257121200024
J	McGill, G				McGill, Gael			Molecular movies ... Coming to a lecture near you	CELL			English	Editorial Material							DYNAMICS; VISUALIZATION	Scientific visualizations are powerful tools for communicating the intricacies of cellular and molecular structures and dynamics. There is a disconnect, however, between the research data sets we seek to represent and the kinds of animation that allow us to visualize and communicate them. Scientists are increasingly turning to 3D animation software borrowed from the entertainment industry to import, animate, and even create simulations of their data.	Harvard Univ, Sch Med, Ctr Mol & Cellular Dynam, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	McGill, G (corresponding author), Harvard Univ, Sch Med, Ctr Mol & Cellular Dynam, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	mcgill@crystal.harvard.edu						Echols N, 2003, NUCLEIC ACIDS RES, V31, P478, DOI 10.1093/nar/gkg104; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; FRANKEL F, 2008, NAT MATER, V3, P417; Goodsell DS, 2005, STRUCTURE, V13, P347, DOI 10.1016/j.str.2005.01.012; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Karplus M, 2005, P NATL ACAD SCI USA, V102, P6679, DOI 10.1073/pnas.0408930102; Maragakis P, 2008, J PHYS CHEM B, V112, P6155, DOI 10.1021/jp077018h; Marsh BJ, 2005, BBA-MOL CELL RES, V1744, P273, DOI 10.1016/j.bbamcr.2005.04.002; Moerner WE, 2007, P NATL ACAD SCI USA, V104, P12596, DOI 10.1073/pnas.0610081104; Nickell S, 2006, NAT REV MOL CELL BIO, V7, P225, DOI 10.1038/nrm1861; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RICHARDSON JS, 1976, J MOL BIOL, V102, P221, DOI 10.1016/S0022-2836(76)80050-2; Robinson CV, 2007, NATURE, V450, P973, DOI 10.1038/nature06523; SHARPE J, 2008, IN SILICO; Sotomayor M, 2007, SCIENCE, V316, P1144, DOI 10.1126/science.1137591	15	35	35	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 27	2008	133	7					1127	1132		10.1016/j.cell.2008.06.013	http://dx.doi.org/10.1016/j.cell.2008.06.013			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	319DP	18585343	Bronze			2022-12-28	WOS:000257144600006
J	Busse, PM; Clark, JR; Muse, VV; Liu, V; Robbins, GK				Busse, Paul M.; Clark, John R.; Muse, Victorine V.; Liu, Vincent; Robbins, Gregory K.			Case 19-2008: A 63-year-old HIV-positive man with cutaneous Merkel-cell carcinoma - Merkel-cell carcinoma, stage III	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LUNG-CANCER; CASE SERIES; SKIN; CHEMOTHERAPY; RADIOTHERAPY; METAANALYSIS; INFECTION; RADIATION; SURVIVAL		[Busse, Paul M.] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA; [Busse, Paul M.; Clark, John R.; Muse, Victorine V.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Clark, John R.] Massachusetts Gen Hosp, Dept Hematol Oncol, Boston, MA 02114 USA; [Muse, Victorine V.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Liu, Vincent] Univ Iowa, Carver Coll Med, Dept Dermatol, Iowa City, IA USA; [Liu, Vincent] Univ Iowa, Carver Coll Med, Dept Pathol, Iowa City, IA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Iowa; University of Iowa	Busse, PM (corresponding author), Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA.			Liu, Vincent/0000-0003-1987-9521				Allen PJ, 2005, J CLIN ONCOL, V23, P2300, DOI 10.1200/JCO.2005.02.329; Burack J, 2003, J ROY SOC MED, V96, P238, DOI 10.1258/jrsm.96.5.238; Engels EA, 2002, LANCET, V359, P497, DOI 10.1016/S0140-6736(02)07668-7; Erridge SC, 2003, SEMIN ONCOL, V30, P26, DOI 10.1053/sonc.2003.50017; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; Huncharek M, 2004, ONCOLOGIST, V9, P665, DOI 10.1634/theoncologist.9-6-665; Jabbour J, 2007, ANN SURG ONCOL, V14, P1943, DOI 10.1245/s10434-006-9327-y; Kanitakis J, 2006, J CUTAN PATHOL, V33, P686, DOI 10.1111/j.1600-0560.2006.00529.x; LAWENDA BD, IN PRESS EAR NOSE TH; Lemos B, 2007, J INVEST DERMATOL, V127, P2100, DOI 10.1038/sj.jid.5700925; Medina-Franco H, 2001, ANN SURG ONCOL, V8, P204, DOI 10.1245/aso.2001.8.3.204; Mehrany K, 2002, DERMATOL SURG, V28, P113, DOI 10.1046/j.1524-4725.2002.02901.x; Mojica P, 2007, J CLIN ONCOL, V25, P1043, DOI 10.1200/JCO.2006.07.9319; Poulsen M, 2003, J CLIN ONCOL, V21, P4371, DOI 10.1200/JCO.2003.03.154; Poulsen M, 2004, LANCET ONCOL, V5, P593, DOI 10.1016/S1470-2045(04)01593-1; Schmalbach CE, 2005, ARCH OTOLARYNGOL, V131, P610, DOI 10.1001/archotol.131.7.610; Tai PTH, 2000, J CLIN ONCOL, V18, P2493, DOI 10.1200/JCO.2000.18.12.2493; TOKER C, 1972, ARCH DERMATOL, V105, P107, DOI 10.1001/archderm.105.1.107; Van Gele M, 2004, ONCOGENE, V23, P2732, DOI 10.1038/sj.onc.1207421; Voog E, 1999, CANCER, V85, P2589, DOI 10.1002/(SICI)1097-0142(19990615)85:12<2589::AID-CNCR15>3.0.CO;2-F; WEEDON D, 2002, SKIN PATHOLOGY, P989; WU H, 2002, ENDOCR PATHOL, P297	23	17	17	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 19	2008	358	25					2717	2723		10.1056/NEJMcpc0803063	http://dx.doi.org/10.1056/NEJMcpc0803063			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	314NC	18565865				2022-12-28	WOS:000256815100010
J	Kimble, HJ				Kimble, H. J.			The quantum internet	NATURE			English	Review							ELECTROMAGNETICALLY INDUCED TRANSPARENCY; ATOMIC ENSEMBLES; SINGLE PHOTONS; ENTANGLEMENT DISTRIBUTION; STATE TRANSFER; LIGHT; COMMUNICATION; CAVITY; GENERATION; MEMORIES	Quantum networks provide opportunities and challenges across a range of intellectual and technical frontiers, including quantum computation, communication and metrology. The realization of quantum networks composed of many nodes and channels requires new scientific capabilities for generating and characterizing quantum coherence and entanglement. Fundamental to this endeavour are quantum interconnects, which convert quantum states from one physical system to those of another in a reversible manner. Such quantum connectivity in networks can be achieved by the optical interactions of single photons and atoms, allowing the distribution of entanglement across the network and the teleportation of quantum states between nodes.	CALTECH, Norman Bridge Lab Phys 12 33, Pasadena, CA 91125 USA	California Institute of Technology	Kimble, HJ (corresponding author), CALTECH, Norman Bridge Lab Phys 12 33, Pasadena, CA 91125 USA.	hjkimble@caltech.edu			Division Of Physics [0803371] Funding Source: National Science Foundation	Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))		Acin A, 2007, NAT PHYS, V3, P256, DOI 10.1038/nphys549; Aoki T, 2006, NATURE, V443, P671, DOI 10.1038/nature05147; Armani DK, 2003, NATURE, V421, P925, DOI 10.1038/nature01371; Balic V, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.183601; BENNETT CH, 1992, SCI AM, V267, P50, DOI 10.1038/scientificamerican1092-50; Bergmann K, 1998, REV MOD PHYS, V70, P1003, DOI 10.1103/RevModPhys.70.1003; Berman P., 1994, CAVITY QUANTUM ELECT; Boozer AD, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.193601; Boozer AD, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.083602; BOUWMEESTER D, 2000, PHYS QUANTUM INFORMA; BRAGINSKY VB, 1989, PHYS LETT A, V137, P393, DOI 10.1016/0375-9601(89)90912-2; Briegel HJ, 1998, PHYS REV LETT, V81, P5932, DOI 10.1103/PhysRevLett.81.5932; Cerf N. J., 2007, QUANTUM INFORMATION; Chaneliere T, 2005, NATURE, V438, P833, DOI 10.1038/nature04315; Chen SA, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.173004; Chen YA, 2008, NAT PHYS, V4, P103, DOI 10.1038/nphys832; Choi KS, 2008, NATURE, V452, P67, DOI 10.1038/nature06670; Chou CW, 2007, SCIENCE, V316, P1316, DOI 10.1126/science.1140300; Chou CW, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.213601; Cirac JI, 1997, PHYS REV LETT, V78, P3221, DOI 10.1103/PhysRevLett.78.3221; Copsey D, 2003, IEEE J SEL TOP QUANT, V9, P1552, DOI 10.1109/JSTQE.2003.820922; Dayan B, 2008, SCIENCE, V319, P1062, DOI 10.1126/science.1152261; Duan LM, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.032333; Duan LM, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.127902; Duan LM, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.253601; Duan LM, 2001, NATURE, V414, P413, DOI 10.1038/35106500; Eisaman MD, 2005, NATURE, V438, P837, DOI 10.1038/nature04327; Englund D, 2007, OPT EXPRESS, V15, P5550, DOI 10.1364/OE.15.005550; Felinto D, 2006, NAT PHYS, V2, P844, DOI 10.1038/nphys450; Fortier KM, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.233601; Giovannetti V, 2004, SCIENCE, V306, P1330, DOI 10.1126/science.1104149; Guerlin C, 2007, NATURE, V448, P889, DOI 10.1038/nature06057; Harris SE, 1997, PHYS TODAY, V50, P36, DOI 10.1063/1.881806; Hijlkema M, 2007, NAT PHYS, V3, P253, DOI 10.1038/nphys569; Illuminati F, 2006, NAT PHYS, V2, P803, DOI 10.1038/nphys479; Jiang L, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.012301; Julsgaard B, 2001, NATURE, V413, P400, DOI 10.1038/35096524; Keller M, 2004, NATURE, V431, P1075, DOI 10.1038/nature02961; Khitrova G, 2006, NAT PHYS, V2, P81, DOI 10.1038/nphys227; Kuzmich A, 2003, NATURE, V423, P731, DOI 10.1038/nature01714; Lange W, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.063817; Laurat J, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.180504; Laurat J, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/207; Laurat J, 2006, OPT EXPRESS, V14, P6912, DOI 10.1364/OE.14.006912; Liu C, 2001, NATURE, V409, P490, DOI 10.1038/35054017; Lounis B, 2005, REP PROG PHYS, V68, P1129, DOI 10.1088/0034-4885/68/5/R04; Lukin MD, 2003, REV MOD PHYS, V75, P457, DOI 10.1103/RevModPhys.75.457; Matsukevich DN, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.013601; McKeever J, 2004, SCIENCE, V303, P1992, DOI 10.1126/science.1095232; MESCHEDE D, 1985, PHYS REV LETT, V54, P551, DOI 10.1103/PhysRevLett.54.551; Miller R, 2005, J PHYS B-AT MOL OPT, V38, pS551, DOI 10.1088/0953-4075/38/9/007; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Park YS, 2006, NANO LETT, V6, P2075, DOI 10.1021/nl061342r; PARKINS AS, 1993, PHYS REV LETT, V71, P3095, DOI 10.1103/PhysRevLett.71.3095; Parkins AS, 1999, J OPT B-QUANTUM S O, V1, P496, DOI 10.1088/1464-4266/1/4/323; Phillips DF, 2001, PHYS REV LETT, V86, P783, DOI 10.1103/PhysRevLett.86.783; Preskill J, 1999, NATURE, V402, P357, DOI 10.1038/46434; Raimond JM, 2005, J PHYS B-AT MOL OPT, V38, pS535, DOI 10.1088/0953-4075/38/9/006; RAYMER MG, 1985, PHYS REV A, V32, P332, DOI 10.1103/PhysRevA.32.332; SANGOUARD N, 2008, ROBUST EFFICIENT QUA; Schoelkopf RJ, 2008, NATURE, V451, P664, DOI 10.1038/451664a; Schon C, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.110503; Sherson JF, 2006, NATURE, V443, P557, DOI 10.1038/nature05136; Simon J, 2007, NAT PHYS, V3, P765, DOI 10.1038/nphys726; Simon J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.183601; Spillane SM, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.013817; Sun B, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.042316; Thompson JK, 2006, SCIENCE, V313, P74, DOI 10.1126/science.1127676; Trupke M, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.063601; Vahala KJ, 2003, NATURE, V424, P839, DOI 10.1038/nature01939; van der Wal CH, 2003, SCIENCE, V301, P196, DOI 10.1126/science.1085946; van Enk SJ, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.052318; van Enk SJ, 1998, SCIENCE, V279, P205, DOI 10.1126/science.279.5348.205; Vidal G, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.227902; Walther H, 2004, FORTSCHR PHYS, V52, P1154, DOI 10.1002/prop.200410185; Wilk T, 2007, SCIENCE, V317, P488, DOI 10.1126/science.1143835; Wootters WK, 1998, PHYS REV LETT, V80, P2245, DOI 10.1103/PhysRevLett.80.2245; Ye J, 1999, PHYS REV LETT, V83, P4987, DOI 10.1103/PhysRevLett.83.4987; YE J, SCIENCE IN PRESS; Zoller P, 2005, EUR PHYS J D, V36, P203, DOI 10.1140/epjd/e2005-00251-1	82	3312	3353	26	546	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 19	2008	453	7198					1023	1030		10.1038/nature07127	http://dx.doi.org/10.1038/nature07127			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314WM	18563153	Green Accepted			2022-12-28	WOS:000256839900044
J	Wilson, JAP				Wilson, Joanne A. P.			Tumor necrosis factor alpha and colitis-associated colon cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INFLAMMATORY-BOWEL-DISEASE; THERAPY		Duke Univ, Med Ctr, Dept Gastroenterol, Durham, NC 27710 USA	Duke University	Wilson, JAP (corresponding author), Duke Univ, Med Ctr, Dept Gastroenterol, Durham, NC 27710 USA.							Chan EP, 2006, GASTROENTEROL CLIN N, V35, P675, DOI 10.1016/j.gtc.2006.07.003; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Popivanova BK, 2008, J CLIN INVEST, V118, P560, DOI [10.1172/JC132453, 10.1172/JCI32453]; Rutgeerts P, 2006, NEW ENGL J MED, V354, P2200; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Sands BE, 2007, J GASTROENTEROL, V42, P16, DOI 10.1007/s00535-006-1995-7	6	24	28	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 19	2008	358	25					2733	2734		10.1056/NEJMcibr0803116	http://dx.doi.org/10.1056/NEJMcibr0803116			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	314NC	18565868				2022-12-28	WOS:000256815100013
J	Schiermeier, Q				Schiermeier, Quirin			Climate anomaly is an artefact	NATURE			English	News Item																			0	3	3	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 29	2008	453	7195					569	569		10.1038/453569a	http://dx.doi.org/10.1038/453569a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	305NN	18509401	Bronze			2022-12-28	WOS:000256185200005
